##fileformat=VCFv4.2
##FILTER=<ID=PASS,Description="All filters passed">
##FILTER=<ID=LowQual,Description="Low quality">
##FILTER=<ID=StandardFilter,Description="QD < 2.0 || MQ < 40.0 || FS > 60.0 || SOR > 3.0 || MQRankSum < -12.5 || ReadPosRankSum < -8.0">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Allelic depths for the ref and alt alleles in the order listed">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Approximate read depth (reads with MQ=255 or with bad mates are filtered)">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=PL,Number=G,Type=Integer,Description="Normalized, Phred-scaled likelihoods for genotypes as defined in the VCF specification">
##GATKCommandLine=<ID=HaplotypeCaller,CommandLine="HaplotypeCaller  --standard-min-confidence-threshold-for-calling 30.0 --output /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/0_test/V600041356_20230105_backpipeline/analysis/gatk/60B0162747/60B0162747.hc.vcf --intervals /mnt/B2C_USER/dongsiyao/1_HDCA/0_testpipeline/HDCAworkflow/config/tumor171.gatk.bed --input /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/0_test/V600041356_20230105_backpipeline/analysis/bwa/60B0162747/60B0162747.final.bam --reference /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/Annodb_Convert/database/hg19_genome/hg19_genome.fa  --emit-ref-confidence NONE --gvcf-gq-bands 1 --gvcf-gq-bands 2 --gvcf-gq-bands 3 --gvcf-gq-bands 4 --gvcf-gq-bands 5 --gvcf-gq-bands 6 --gvcf-gq-bands 7 --gvcf-gq-bands 8 --gvcf-gq-bands 9 --gvcf-gq-bands 10 --gvcf-gq-bands 11 --gvcf-gq-bands 12 --gvcf-gq-bands 13 --gvcf-gq-bands 14 --gvcf-gq-bands 15 --gvcf-gq-bands 16 --gvcf-gq-bands 17 --gvcf-gq-bands 18 --gvcf-gq-bands 19 --gvcf-gq-bands 20 --gvcf-gq-bands 21 --gvcf-gq-bands 22 --gvcf-gq-bands 23 --gvcf-gq-bands 24 --gvcf-gq-bands 25 --gvcf-gq-bands 26 --gvcf-gq-bands 27 --gvcf-gq-bands 28 --gvcf-gq-bands 29 --gvcf-gq-bands 30 --gvcf-gq-bands 31 --gvcf-gq-bands 32 --gvcf-gq-bands 33 --gvcf-gq-bands 34 --gvcf-gq-bands 35 --gvcf-gq-bands 36 --gvcf-gq-bands 37 --gvcf-gq-bands 38 --gvcf-gq-bands 39 --gvcf-gq-bands 40 --gvcf-gq-bands 41 --gvcf-gq-bands 42 --gvcf-gq-bands 43 --gvcf-gq-bands 44 --gvcf-gq-bands 45 --gvcf-gq-bands 46 --gvcf-gq-bands 47 --gvcf-gq-bands 48 --gvcf-gq-bands 49 --gvcf-gq-bands 50 --gvcf-gq-bands 51 --gvcf-gq-bands 52 --gvcf-gq-bands 53 --gvcf-gq-bands 54 --gvcf-gq-bands 55 --gvcf-gq-bands 56 --gvcf-gq-bands 57 --gvcf-gq-bands 58 --gvcf-gq-bands 59 --gvcf-gq-bands 60 --gvcf-gq-bands 70 --gvcf-gq-bands 80 --gvcf-gq-bands 90 --gvcf-gq-bands 99 --indel-size-to-eliminate-in-ref-model 10 --use-alleles-trigger false --disable-optimizations false --just-determine-active-regions false --dont-genotype false --max-mnp-distance 0 --dont-trim-active-regions false --max-disc-ar-extension 25 --max-gga-ar-extension 300 --padding-around-indels 150 --padding-around-snps 20 --kmer-size 10 --kmer-size 25 --dont-increase-kmer-sizes-for-cycles false --allow-non-unique-kmers-in-ref false --num-pruning-samples 1 --recover-dangling-heads false --do-not-recover-dangling-branches false --min-dangling-branch-length 4 --consensus false --max-num-haplotypes-in-population 128 --error-correct-kmers false --min-pruning 2 --debug-graph-transformations false --kmer-length-for-read-error-correction 25 --min-observations-for-kmer-to-be-solid 20 --likelihood-calculation-engine PairHMM --base-quality-score-threshold 18 --pair-hmm-gap-continuation-penalty 10 --pair-hmm-implementation FASTEST_AVAILABLE --pcr-indel-model CONSERVATIVE --phred-scaled-global-read-mismapping-rate 45 --native-pair-hmm-threads 4 --native-pair-hmm-use-double-precision false --debug false --use-filtered-reads-for-annotations false --bam-writer-type CALLED_HAPLOTYPES --dont-use-soft-clipped-bases false --capture-assembly-failure-bam false --error-correct-reads false --do-not-run-physical-phasing false --min-base-quality-score 10 --smith-waterman JAVA --use-new-qual-calculator false --annotate-with-num-discovered-alleles false --heterozygosity 0.001 --indel-heterozygosity 1.25E-4 --heterozygosity-stdev 0.01 --max-alternate-alleles 6 --max-genotype-count 1024 --sample-ploidy 2 --num-reference-samples-if-no-call 0 --genotyping-mode DISCOVERY --genotype-filtered-alleles false --contamination-fraction-to-filter 0.0 --output-mode EMIT_VARIANTS_ONLY --all-site-pls false --min-assembly-region-size 50 --max-assembly-region-size 300 --assembly-region-padding 100 --max-reads-per-alignment-start 50 --active-probability-threshold 0.002 --max-prob-propagation-distance 50 --interval-set-rule UNION --interval-padding 0 --interval-exclusion-padding 0 --interval-merging-rule ALL --read-validation-stringency SILENT --seconds-between-progress-updates 10.0 --disable-sequence-dictionary-validation false --create-output-bam-index true --create-output-bam-md5 false --create-output-variant-index true --create-output-variant-md5 false --lenient false --add-output-sam-program-record true --add-output-vcf-command-line true --cloud-prefetch-buffer 40 --cloud-index-prefetch-buffer -1 --disable-bam-index-caching false --sites-only-vcf-output false --help false --version false --showHidden false --verbosity INFO --QUIET false --use-jdk-deflater false --use-jdk-inflater false --gcs-max-retries 20 --disable-tool-default-read-filters false --minimum-mapping-quality 20 --disable-tool-default-annotations false --enable-all-annotations false",Version=4.0.8.1,Date="January 31, 2023 2:40:02 PM CST">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Allele count in genotypes, for each ALT allele, in the same order as listed">
##INFO=<ID=AF,Number=A,Type=Float,Description="Allele Frequency, for each ALT allele, in the same order as listed">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=BaseQRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt Vs. Ref base qualities">
##INFO=<ID=DP,Number=1,Type=Integer,Description="Approximate read depth; some reads may have been filtered">
##INFO=<ID=DS,Number=0,Type=Flag,Description="Were any of the samples downsampled?">
##INFO=<ID=ExcessHet,Number=1,Type=Float,Description="Phred-scaled p-value for exact test of excess heterozygosity">
##INFO=<ID=FS,Number=1,Type=Float,Description="Phred-scaled p-value using Fisher's exact test to detect strand bias">
##INFO=<ID=InbreedingCoeff,Number=1,Type=Float,Description="Inbreeding coefficient as estimated from the genotype likelihoods per-sample when compared against the Hardy-Weinberg expectation">
##INFO=<ID=MLEAC,Number=A,Type=Integer,Description="Maximum likelihood expectation (MLE) for the allele counts (not necessarily the same as the AC), for each ALT allele, in the same order as listed">
##INFO=<ID=MLEAF,Number=A,Type=Float,Description="Maximum likelihood expectation (MLE) for the allele frequency (not necessarily the same as the AF), for each ALT allele, in the same order as listed">
##INFO=<ID=MQ,Number=1,Type=Float,Description="RMS Mapping Quality">
##INFO=<ID=MQRankSum,Number=1,Type=Float,Description="Z-score From Wilcoxon rank sum test of Alt vs. Ref read mapping qualities">
##INFO=<ID=QD,Number=1,Type=Float,Description="Variant Confidence/Quality by Depth">
##INFO=<ID=RAW_MQ,Number=1,Type=Float,Description="Raw data for RMS Mapping Quality">
##INFO=<ID=ReadPosRankSum,Number=1,Type=Float,Description="Z-score from Wilcoxon rank sum test of Alt vs. Ref read position bias">
##INFO=<ID=SOR,Number=1,Type=Float,Description="Symmetric Odds Ratio of 2x2 contingency table to detect strand bias">
##contig=<ID=chr1,length=249250621>
##contig=<ID=chr2,length=243199373>
##contig=<ID=chr3,length=198022430>
##contig=<ID=chr4,length=191154276>
##contig=<ID=chr5,length=180915260>
##contig=<ID=chr6,length=171115067>
##contig=<ID=chr7,length=159138663>
##contig=<ID=chr8,length=146364022>
##contig=<ID=chr9,length=141213431>
##contig=<ID=chr10,length=135534747>
##contig=<ID=chr11,length=135006516>
##contig=<ID=chr12,length=133851895>
##contig=<ID=chr13,length=115169878>
##contig=<ID=chr14,length=107349540>
##contig=<ID=chr15,length=102531392>
##contig=<ID=chr16,length=90354753>
##contig=<ID=chr17,length=81195210>
##contig=<ID=chr18,length=78077248>
##contig=<ID=chr19,length=59128983>
##contig=<ID=chr20,length=63025520>
##contig=<ID=chr21,length=48129895>
##contig=<ID=chr22,length=51304566>
##contig=<ID=chrX,length=155270560>
##contig=<ID=chrY,length=59373566>
##contig=<ID=chrM,length=16569>
##contig=<ID=chr11_gl000202_random,length=40103>
##contig=<ID=chr17_gl000203_random,length=37498>
##contig=<ID=chr17_gl000204_random,length=81310>
##contig=<ID=chr17_gl000205_random,length=174588>
##contig=<ID=chr17_gl000206_random,length=41001>
##contig=<ID=chr18_gl000207_random,length=4262>
##contig=<ID=chr19_gl000208_random,length=92689>
##contig=<ID=chr19_gl000209_random,length=159169>
##contig=<ID=chr1_gl000191_random,length=106433>
##contig=<ID=chr1_gl000192_random,length=547496>
##contig=<ID=chr21_gl000210_random,length=27682>
##contig=<ID=chr4_gl000193_random,length=189789>
##contig=<ID=chr4_gl000194_random,length=191469>
##contig=<ID=chr7_gl000195_random,length=182896>
##contig=<ID=chr8_gl000196_random,length=38914>
##contig=<ID=chr8_gl000197_random,length=37175>
##contig=<ID=chr9_gl000198_random,length=90085>
##contig=<ID=chr9_gl000199_random,length=169874>
##contig=<ID=chr9_gl000200_random,length=187035>
##contig=<ID=chr9_gl000201_random,length=36148>
##contig=<ID=chrUn_gl000211,length=166566>
##contig=<ID=chrUn_gl000212,length=186858>
##contig=<ID=chrUn_gl000213,length=164239>
##contig=<ID=chrUn_gl000214,length=137718>
##contig=<ID=chrUn_gl000215,length=172545>
##contig=<ID=chrUn_gl000216,length=172294>
##contig=<ID=chrUn_gl000217,length=172149>
##contig=<ID=chrUn_gl000218,length=161147>
##contig=<ID=chrUn_gl000219,length=179198>
##contig=<ID=chrUn_gl000220,length=161802>
##contig=<ID=chrUn_gl000221,length=155397>
##contig=<ID=chrUn_gl000222,length=186861>
##contig=<ID=chrUn_gl000223,length=180455>
##contig=<ID=chrUn_gl000224,length=179693>
##contig=<ID=chrUn_gl000225,length=211173>
##contig=<ID=chrUn_gl000226,length=15008>
##contig=<ID=chrUn_gl000227,length=128374>
##contig=<ID=chrUn_gl000228,length=129120>
##contig=<ID=chrUn_gl000229,length=19913>
##contig=<ID=chrUn_gl000230,length=43691>
##contig=<ID=chrUn_gl000231,length=27386>
##contig=<ID=chrUn_gl000232,length=40652>
##contig=<ID=chrUn_gl000233,length=45941>
##contig=<ID=chrUn_gl000234,length=40531>
##contig=<ID=chrUn_gl000235,length=34474>
##contig=<ID=chrUn_gl000236,length=41934>
##contig=<ID=chrUn_gl000237,length=45867>
##contig=<ID=chrUn_gl000238,length=39939>
##contig=<ID=chrUn_gl000239,length=33824>
##contig=<ID=chrUn_gl000240,length=41933>
##contig=<ID=chrUn_gl000241,length=42152>
##contig=<ID=chrUn_gl000242,length=43523>
##contig=<ID=chrUn_gl000243,length=43341>
##contig=<ID=chrUn_gl000244,length=39929>
##contig=<ID=chrUn_gl000245,length=36651>
##contig=<ID=chrUn_gl000246,length=38154>
##contig=<ID=chrUn_gl000247,length=36422>
##contig=<ID=chrUn_gl000248,length=39786>
##contig=<ID=chrUn_gl000249,length=38502>
##source=HaplotypeCaller
##INFO=<ID=OLD_VARIANT,Number=1,Type=String,Description="Original variant. Format: CHR|POS|REF|ALT|USED_ALT_IDX">
##bcftools_normVersion=1.15.1+htslib-
##bcftools_normCommand=norm -f /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/Annodb_Convert/database/hg19_genome/hg19_genome.fa -m -both --old-rec-tag OLD_VARIANT /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/0_test/V600041356_20230105_backpipeline/analysis/gatk/60B0162747/60B0162747.cmb.filter.vcf; Date=Tue Jan 31 14:44:07 2023
##bcftools_normCommand=norm --rm-dup exact; Date=Tue Jan 31 14:44:07 2023
##INFO=<ID=CytoBand,Number=1,Type=String,Description="Name of cytogenetic band">
##INFO=<ID=dupName,Number=.,Type=String,Description="Other chromosome involved">
##INFO=<ID=dupScore,Number=1,Type=Integer,Description="Score based on the raw BLAST alignment score. Set to 0 and not used in later versions.">
##INFO=<ID=repName,Number=.,Type=String,Description="Name of repeat">
##INFO=<ID=repClass,Number=.,Type=String,Description="Class of repeat">
##INFO=<ID=simRepName,Number=.,Type=String,Description="Simple Repeats tag name">
##INFO=<ID=simRepCopyNum,Number=1,Type=Float,Description="Mean number of copies of repeat">
##INFO=<ID=CGD_CONDITION,Number=1,Type=String,Description="CONDITION">
##INFO=<ID=CGD_INHERITANCE,Number=1,Type=String,Description="INHERITANCE">
##INFO=<ID=Strand,Number=1,Type=String,Description=Transcript Strand>
##INFO=<ID=NP,Number=1,Type=String,Description=NP Number>
##INFO=<ID=ENSP,Number=1,Type=String,Description=ENSP Number>
##INFO=<ID=Gene_MIM_id,Number=1,Type=String,Description="Gene MIM id">
##INFO=<ID=Phenotypes,Number=1,Type=String,Description="disease phenotype and disorder MIM id">
##INFO=<ID=Possible_Inheritance,Number=1,Type=String,Description="Possible Inheritance">
##INFO=<ID=EntrezGeneID,Number=1,Type=String,Description="EntrezGeneID">
##INFO=<ID=EnsemblGeneID,Number=1,Type=String,Description="EnsemblGeneID">
##INFO=<ID=Alias,Number=1,Type=String,Description="gene's all alias">
##INFO=<ID=EXAC_AF,Number=A,Type=String,Description="Allele Frequency, for each ALT allele, in the same order as listed">
##INFO=<ID=EXAC_Hom_EAS,Number=A,Type=Integer,Description="East Asian Homozygous Counts">
##INFO=<ID=EXAC_AC_EAS,Number=A,Type=Integer,Description="East Asian Allele Counts">
##INFO=<ID=EXAC_AN_EAS,Number=1,Type=Integer,Description="East Asian Chromosome Count">
##INFO=<ID=EXAC_AC_Adj,Number=A,Type=Integer,Description="Adjusted Allele Counts">
##INFO=<ID=EXAC_AN_Adj,Number=1,Type=Integer,Description="Adjusted Chromosome Count">
##INFO=<ID=ESP6500_MAF,Number=.,Type=String,Description="Minor Allele Frequency in percent in the order of EA,AA,All">
##INFO=<ID=RS,Number=A,Type=String,Description="dbSNP ID (i.e. rs number)">
##INFO=<ID=Ensembl_transcriptid,Number=.,Type=String,Description="Ensembl transcript id. Multiple entries separated by |.">
##INFO=<ID=SIFT_pred,Number=.,Type=String,Description="If SIFTori is smaller than 0.05 (rankscore>0.395) the corresponding nsSNV is predicted as D(amaging); otherwise it is predicted as T(olerated). Multiple predictions separated by |">
##INFO=<ID=SIFT_score,Number=.,Type=String,Description="SIFT score (SIFTori). Scores range from 0 to 1. The smaller the score the more likely the SNP has damaging effect. Multiple scores separated by |, corresponding to Ensembl_proteinid.">
##INFO=<ID=Polyphen2_HVAR_pred,Number=.,Type=String,Description="Polyphen2 prediction based on HumVar, D (porobably damaging, HVAR score in [0.909,1] or rankscore in [0.62955,0.9711]), P (possibly damaging, HVAR in [0.447,0.908] or rankscore in [0.44359,0.62885]) and B (benign, HVAR score in [0,0.446] or rankscore in [0.01281,0.44315]). Score cutoff for binary classification is 0.5 for HVAR score or 0.45998 for rankscore, i.e. the prediction is neutral if the HVAR score is smaller than 0.5 (rankscore is smaller than 0.45998), and deleterious if the HVAR score is larger than 0.5 (rankscore is larger than 0.45998). Multiple entries are separated by |.">
##INFO=<ID=Polyphen2_HVAR_score,Number=.,Type=String,Description="Polyphen2 score based on HumVar, i.e. hvar_prob. The score ranges from 0 to 1. Multiple entries separated by |.">
##INFO=<ID=MutationTaster_pred,Number=1,Type=String,Description="MutationTaster prediction, A (disease_causing_automatic), D (disease_causing), N (polymorphism) or P (polymorphism_automatic). The score cutoff between D and N is 0.5 for MTori and 0.31655 for the rankscore.">
##INFO=<ID=MutationTaster_score,Number=1,Type=String,Description="MutationTaster p-value (MTori), ranges from 0 to 1.">
##INFO=<ID=CLNGENE,Number=1,Type=String,Description="Gene(s) for the variant reported as gene symbol. Multiple gene symbols delimited by a vertical bar (|)">
##INFO=<ID=CLNSIG,Number=.,Type=String,Description="Clinical significance for this single variant">
##INFO=<ID=CLNSIGINCL,Number=.,Type=String,Description="Clinical significance for a haplotype or genotype that includes this variant. Reported as pairs of VariationID:clinical significance.">
##INFO=<ID=CLNREVSTAT,Number=.,Type=String,Description="ClinVar review status for the Variation ID">
##INFO=<ID=G1000_AF,Number=A,Type=String,Description="Estimated allele frequency in the range (0,1)">
##INFO=<ID=G1000_EAS_AF,Number=A,Type=String,Description="Allele frequency in the EAS populations calculated from AC and AN, in the range (0,1)">
##INFO=<ID=G1000_EUR_AF,Number=A,Type=String,Description="Allele frequency in the EUR populations calculated from AC and AN, in the range (0,1)">
##INFO=<ID=G1000_AFR_AF,Number=A,Type=String,Description="Allele frequency in the AFR populations calculated from AC and AN, in the range (0,1)">
##INFO=<ID=G1000_SAS_AF,Number=A,Type=String,Description="Allele frequency in the SAS populations calculated from AC and AN, in the range (0,1)">
##INFO=<ID=G1000_AMR_AF,Number=A,Type=String,Description="Allele frequency in the AMR populations calculated from AC and AN, in the range (0,1)">
##INFO=<ID=gnomad_exomes_AF,Number=A,Type=String,Description="Alternate allele frequency in samples">
##INFO=<ID=gnomad_exomes_AF_EAS,Number=A,Type=String,Description="Alternate allele frequency in samples of East Asian ancestry">
##INFO=<ID=gnomad_exomes_AC,Number=A,Type=Integer,Description="Alternate allele count for samples">
##INFO=<ID=gnomad_exomes_Hom,Number=A,Type=Integer,Description="Count of homozygous individuals in samples">
##INFO=<ID=gnomad_exomes_Het,Number=A,Type=Integer,Description="Count of heterozygous individuals">
##INFO=<ID=gnomad_exomes_Hemi,Number=A,Type=Integer,Description="Count of hemizygous individuals">
##INFO=<ID=gnomad_exomes_AF_AFR,Number=A,Type=String,Description="Alternate allele frequency in samples of African-American/African ancestry">
##INFO=<ID=gnomad_exomes_AF_NFE,Number=A,Type=String,Description="Alternate allele frequency in samples of Non-Finnish European ancestry">
##INFO=<ID=gnomad_exomes_AF_AMR,Number=A,Type=String,Description="Alternate allele frequency in samples of Latino ancestry">
##INFO=<ID=gnomad_exomes_AF_SAS,Number=A,Type=String,Description="Alternate allele frequency in samples of South Asian ancestry">
##INFO=<ID=HGMD_gene,Number=A,Type=String,Description="HGMD gene.">
##INFO=<ID=HGMD_disease,Number=A,Type=String,Description="HGMD disease.">
##INFO=<ID=HGMD_tag,Number=A,Type=String,Description="HGMD tag, 'DP','FP','DFP','DM','DM?','FTV','R'.">
##INFO=<ID=HGMD_pmid,Number=A,Type=String,Description="HGMD pmid.">
##INFO=<ID=NativeFreq_Het,Number=A,Type=String,Description="Het Frequency in Native Database">
##INFO=<ID=NativeFreq_Hom,Number=A,Type=String,Description="Hom Frequency in Native Database">
##INFO=<ID=normalHetFrequency,Number=A,Type=String,Description="Het frequency in 388 normals">
##INFO=<ID=normalHetNum,Number=A,Type=Float,Description="Het number in 388 normals">
##INFO=<ID=normalHomFrequency,Number=A,Type=String,Description="Hom frequency in 388 normals">
##INFO=<ID=normalHomNum,Number=A,Type=String,Description="Hom number in 388 normals">
##INFO=<ID=patientHetFrequency,Number=A,Type=String,Description="Het frequency in 2772 patients">
##INFO=<ID=patientHetNum,Number=A,Type=String,Description="Het number in 2772 patients">
##INFO=<ID=patientHomFrequency,Number=A,Type=String,Description="Hom frequency in 2772 patients">
##INFO=<ID=patientHomNum,Number=A,Type=String,Description="Hom number in 2772 patients">
##INFO=<ID=normalHetSampleInfo,Number=A,Type=String,Description="Het samples in normals [2181][BGI4.8M]">
##INFO=<ID=normalHomSampleInfo,Number=A,Type=String,Description="Hom samples in normals [2181][BGI4.8M]">
##INFO=<ID=patientHetSampleInfo,Number=A,Type=String,Description="Het samples in patients [2181][BGI4.8M]">
##INFO=<ID=patientHomSampleInfo,Number=A,Type=String,Description="Hom samples in patients [2181][BGI4.8M]">
##INFO=<ID=AF_2700_Het,Number=A,Type=String,Description="The Allele Het Frequency based on 2700 normal population">
##INFO=<ID=AF_2700_Hom,Number=A,Type=String,Description="The Allele Hom Frequency based on 2700 normal population">
##INFO=<ID=AF_50_Het,Number=A,Type=String,Description="The Allele Het Frequency based on >50Y normal population">
##INFO=<ID=AF_50_Hom,Number=A,Type=String,Description="The Allele Hom Frequency based on >50Y normal population">
##INFO=<ID=dbscSNV_RF_score,Number=A,Type=String,Description="dbscSNV_RF_score">
##INFO=<ID=dbscSNV_ADA_score,Number=A,Type=String,Description="dbscSNV_ADA_score">
##INFO=<ID=DANN_score,Number=A,Type=String,Description="DANN_score">
##INFO=<ID=GREP_score,Number=A,Type=String,Description="GREP_score">
##INFO=<ID=HGVSnom,Number=A,Type=String,Description="HGVS nomenclature for the description of DNA sequence variants">
##INFO=<ID=Gene,Number=A,Type=String,Description="Gene names">
##INFO=<ID=Transcript,Number=A,Type=String,Description="Transcript names">
##INFO=<ID=VarType,Number=A,Type=String,Description="Variant type.">
##INFO=<ID=MolecularConsequence,Number=A,Type=String,Description="Predicted molecular consequence of variant.">
##INFO=<ID=ExonIntron,Number=A,Type=String,Description="Exon/CDS or intron id on transcripts.">
##INFO=<ID=IVSnom,Number=A,Type=String,Description="Old style nomenclature for the description of intron variants. Not recommand to use it.">
##INFO=<ID=Oldnom,Number=A,Type=String,Description="Old style nomenclature, compared with HGVSnom use gene position instead of UTR/coding position.">
##INFO=<ID=AAlength,Number=A,Type=String,Description="Amino acid length for each transcript. 0 for noncoding transcript.">
##INFO=<ID=FLKSEQ,Number=1,Type=String,Description="Upstream and downstream bases of current position on DNA sequence.">
##bcfannoVersion=v1.4rc2-83-gf7d64bc+htslib-1.6
##bcfannoCommand=/mnt/B2C_USER/dongsiyao/1_HDCA/0_testpipeline/HDCAworkflow/bin/bcfanno --flank -c /mnt/B2C_USER/dongsiyao/1_HDCA/0_testpipeline/HDCAworkflow/config/tumor171.bcfanno.hg19.json /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/0_test/V600041356_20230105_backpipeline/analysis/gatk/60B0162747/60B0162747.final.vcf.gz -O z -o /mnt/B2C_USER/dongsiyao/1_HDCA/3_update/0_test/V600041356_20230105_backpipeline/analysis/anno/60B0162747/gatk.variation.anno.gz
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	60B0162747
chr1	10357206	.	AT	A	1217.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.568;DP=268;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.07;ReadPosRankSum=-0.519;SOR=0.674;HGVSnom=NM_001365951.3:c.2043-9delT;Gene=KIF1B;Transcript=NM_001365951.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I21;IVSnom=NM_001365951.3:IVS21-9delT;AAlength=1816;EXAC_AF=0.44472799;EXAC_Hom_EAS=0;EXAC_AC_EAS=3290;EXAC_AN_EAS=7468;EXAC_AC_Adj=48100;EXAC_AN_Adj=108156;RS=rs58344165;CLNGENE=KIF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.42504828;gnomad_exomes_AF_EAS=0.42149250;gnomad_exomes_AC=86726;gnomad_exomes_Hom=0;gnomad_exomes_Het=86726;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.43079558;gnomad_exomes_AF_NFE=0.42765930;gnomad_exomes_AF_AMR=0.43204093;gnomad_exomes_AF_SAS=0.43666266;NativeFreq_Het=0.2327;NativeFreq_Hom=.;normalHetFrequency=0.3919;normalHetNum=339;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.3847;patientHetNum=2008;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1546216][_];AF_2700_Het=0.5553;AF_2700_Hom=.;AF_50_Het=0.5246;AF_50_Hom=.;CytoBand=p36.22;CGD_CONDITION=Neuroblastoma, susceptibility to. Pheochromocytoma;CGD_INHERITANCE=AD;Strand=KIF1B:NM_183416.3:+,KIF1B:NM_015074.3:+;NP=KIF1B:NM_183416.3:NP_904325.2,KIF1B:NM_015074.3:NP_055889.2;ENSP=KIF1B:NM_183416.3:.,KIF1B:NM_015074.3:ENST00000263934.10;Gene_MIM_id=605995;Phenotypes=?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant. {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Isolated cases. Pheochromocytoma, 171300 (3), Autosomal dominant. 118210(UK),171300(MK),256700(SK);Possible_Inheritance=AD;EntrezGeneID=23095;EnsemblGeneID=ENSG00000054523;Alias=KIF1B, CMT2A, CMT2A1, NBLST1;FLKSEQ=GCATTCTTGA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:138,102:240:99:1255,0,2039
chr1	10408837	.	AT	A	738.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.144;DP=246;ExcessHet=3.0103;FS=1.55;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0.624;QD=3.31;ReadPosRankSum=0.002;SOR=0.531;HGVSnom=NM_001365951.3:c.3949+60delT;Gene=KIF1B;Transcript=NM_001365951.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I37;IVSnom=NM_001365951.3:IVS37+60delT;AAlength=1816;EXAC_AF=0.24275807;EXAC_Hom_EAS=0;EXAC_AC_EAS=774;EXAC_AN_EAS=2634;EXAC_AC_Adj=10291;EXAC_AN_Adj=42392;ESP6500_MAF=0.20685523;RS=rs35253111;gnomad_exomes_AF=0.28422902;gnomad_exomes_AF_EAS=0.43201959;gnomad_exomes_AC=35594;gnomad_exomes_Hom=0;gnomad_exomes_Het=35594;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22324352;gnomad_exomes_AF_NFE=0.26933514;gnomad_exomes_AF_AMR=0.36082960;gnomad_exomes_AF_SAS=0.25569746;NativeFreq_Het=0.0149;NativeFreq_Hom=.;normalHetFrequency=0.1457;normalHetNum=126;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1469;patientHetNum=767;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16S0002126][_];CytoBand=p36.22;CGD_CONDITION=Neuroblastoma, susceptibility to. Pheochromocytoma;CGD_INHERITANCE=AD;Strand=KIF1B:NM_015074.3:+;NP=KIF1B:NM_015074.3:NP_055889.2;ENSP=KIF1B:NM_015074.3:ENST00000263934.10;Gene_MIM_id=605995;Phenotypes=?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant. {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Isolated cases. Pheochromocytoma, 171300 (3), Autosomal dominant. 118210(UK),171300(MK),256700(SK);Possible_Inheritance=AD;EntrezGeneID=23095;EnsemblGeneID=ENSG00000054523;Alias=KIF1B, CMT2A, CMT2A1, NBLST1;FLKSEQ=ACTTACAGAG.tttttttttt	GT:AD:DP:GQ:PL	0/1:159,64:223:99:776,0,3052
chr1	10436892	.	AAC	A	743.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.948;DP=261;ExcessHet=3.0103;FS=3.539;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.71;ReadPosRankSum=-0.207;SOR=0.647;HGVSnom=NM_001365951.3:c.*279_*280delCA;Gene=KIF1B;Transcript=NM_001365951.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E49;IVSnom=.;AAlength=1816;RS=rs111663673;CLNGENE=KIF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.240016;G1000_EAS_AF=0.0526;G1000_EUR_AF=0.1869;G1000_AFR_AF=0.447;G1000_SAS_AF=0.2372;G1000_AMR_AF=0.1988;NativeFreq_Het=0.0033;NativeFreq_Hom=.;normalHetFrequency=0.2925;normalHetNum=253;normalHomFrequency=0.0084;normalHomNum=4;patientHetFrequency=0.24;patientHetNum=1253;patientHomFrequency=0.0044;patientHomNum=23;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6529721|16D0161332|15D6532279|16D0166623];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6523845|16D1536872-1|16D0162334|16D1546034|16D1545680|16D0177669|16D1533006-1][16D0162251|16D0158753|16D0169432|15D6511820|15D6532801|14D1336304-1|15D6482213-1|15D6532900|15D6518734|16D0166749|16D0172377|15D6517228|16D0168799|15D6511749-1|15D6532892|15B6325494];AF_2700_Het=0.3682;AF_2700_Hom=.;AF_50_Het=0.3645;AF_50_Hom=.;CytoBand=p36.22;CGD_CONDITION=Neuroblastoma, susceptibility to. Pheochromocytoma;CGD_INHERITANCE=AD;Strand=KIF1B:NM_015074.3:+;NP=KIF1B:NM_015074.3:NP_055889.2;ENSP=KIF1B:NM_015074.3:ENST00000263934.10;Gene_MIM_id=605995;Phenotypes=?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant. {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Isolated cases. Pheochromocytoma, 171300 (3), Autosomal dominant. 118210(UK),171300(MK),256700(SK);Possible_Inheritance=AD;EntrezGeneID=23095;EnsemblGeneID=ENSG00000054523;Alias=KIF1B, CMT2A, CMT2A1, NBLST1;FLKSEQ=AATGTTTTTA.acacacacac	GT:AD:DP:GQ:PL	0/1:113,45:158:99:781,0,2919
chr1	10437995	.	GA	G	359.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.255;DP=142;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.79;ReadPosRankSum=-1.314;SOR=0.85;HGVSnom=NM_001365951.3:c.*1363delA;Gene=KIF1B;Transcript=NM_001365951.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E49;IVSnom=.;AAlength=1816;RS=rs567435289;NativeFreq_Het=0.0177;NativeFreq_Hom=.;normalHetFrequency=0.0377;normalHetNum=18;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0315;patientHetNum=77;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0407;AF_2700_Hom=.;AF_50_Het=0.0301;AF_50_Hom=.;CytoBand=p36.22;repName=AluSg;repClass=SINE;CGD_CONDITION=Neuroblastoma, susceptibility to. Pheochromocytoma;CGD_INHERITANCE=AD;Strand=KIF1B:NM_015074.3:+;NP=KIF1B:NM_015074.3:NP_055889.2;ENSP=KIF1B:NM_015074.3:ENST00000263934.10;Gene_MIM_id=605995;Phenotypes=?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant. {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Isolated cases. Pheochromocytoma, 171300 (3), Autosomal dominant. 118210(UK),171300(MK),256700(SK);Possible_Inheritance=AD;EntrezGeneID=23095;EnsemblGeneID=ENSG00000054523;Alias=KIF1B, CMT2A, CMT2A1, NBLST1;FLKSEQ=ctctgcctca.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:98,31:129:99:397,0,1884
chr1	11205058	.	C	T	6084.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.629;DP=426;ExcessHet=3.0103;FS=0.547;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.28;ReadPosRankSum=-1.147;SOR=0.739;HGVSnom=NM_004958.4:c.4731G>A(p.Ala1577Ala/p.A1577A)|NR_046600.1:n.310+115C>T;Gene=MTOR|MTOR-AS1;Transcript=NM_004958.4|NR_046600.1;VarType=Synonymous|Intron;MolecularConsequence=synonymous_variant|noncoding_transcript_intron_variant;ExonIntron=E33|I2;IVSnom=.|NR_046600.1:IVS2+115C>T;AAlength=2549|.;EXAC_AF=0.67792184;EXAC_Hom_EAS=2906;EXAC_AC_EAS=7097;EXAC_AN_EAS=8652;EXAC_AC_Adj=82297;EXAC_AN_Adj=121396;ESP6500_MAF=0.54590189;RS=rs1057079;CLNGENE=MTOR|MTOR-AS1;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.547524;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.7356;G1000_AFR_AF=0.0635;G1000_SAS_AF=0.6217;G1000_AMR_AF=0.7017;gnomad_exomes_AF=0.68593447;gnomad_exomes_AF_EAS=0.81345150;gnomad_exomes_AC=172411;gnomad_exomes_Hom=62071;gnomad_exomes_Het=48269;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14582821;gnomad_exomes_AF_NFE=0.74065310;gnomad_exomes_AF_AMR=0.72848467;gnomad_exomes_AF_SAS=0.65401202;NativeFreq_Het=0.3310;NativeFreq_Hom=0.5516;DANN_score=0.8518;GREP_score=-5.25;CytoBand=p36.22;CGD_CONDITION=Smith-Kingsmore syndrome;CGD_INHERITANCE=AD;Strand=MTOR:NM_004958.3:-,MTOR:NM_004958.4:-;NP=MTOR:NM_004958.3:NP_004949.1,MTOR:NM_004958.4:NP_004949.1;ENSP=MTOR:NM_004958.3:.,MTOR:NM_004958.4:ENST00000361445.9;Gene_MIM_id=601231;Phenotypes=Smith-Kingsmore syndrome, 616638 (3), Autosomal dominant. 616638(MK);Possible_Inheritance=NA;EntrezGeneID=2475;EnsemblGeneID=ENSG00000198793;Alias=MTOR, FRAP1, SKS;FLKSEQ=CTCCTGCCAT.GCAGTTAATT	GT:AD:DP:GQ:PL	0/1:217,209:426:99:6113,0,6383
chr1	17359676	.	C	A	11644.8	PASS	AC=2;AF=1;AN=2;DP=308;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.36;SOR=1.053;HGVSnom=NM_003000.3:c.201-36G>T;Gene=SDHB;Transcript=NM_003000.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003000.3:IVS2-36G>T;AAlength=280;EXAC_AF=0.97188690;EXAC_Hom_EAS=4242;EXAC_AC_EAS=8497;EXAC_AN_EAS=8510;EXAC_AC_Adj=114809;EXAC_AN_Adj=118130;ESP6500_MAF=0.95232969;RS=rs1022580;CLNGENE=SDHB;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.959065;G1000_EAS_AF=0.996;G1000_EUR_AF=0.9722;G1000_AFR_AF=0.8873;G1000_SAS_AF=0.9918;G1000_AMR_AF=0.9769;gnomad_exomes_AF=0.97337023;gnomad_exomes_AF_EAS=0.99901672;gnomad_exomes_AC=241645;gnomad_exomes_Hom=117639;gnomad_exomes_Het=6367;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91485714;gnomad_exomes_AF_NFE=0.97167725;gnomad_exomes_AF_AMR=0.98228128;gnomad_exomes_AF_SAS=0.98757025;NativeFreq_Het=0.0356;NativeFreq_Hom=0.9877;normalHetFrequency=0.0116;normalHetNum=10;normalHomFrequency=0.9803;normalHomNum=848;patientHetFrequency=0.0125;patientHetNum=65;patientHomFrequency=0.9762;patientHomNum=5096;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6491;GREP_score=-7.13;CytoBand=p36.13;CGD_CONDITION=Cowden syndrome 2. Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Pheochromocytoma. Paragangliomas 4;CGD_INHERITANCE=AD;Strand=SDHB:NM_003000.2:-;NP=SDHB:NM_003000.2:NP_002991.2;ENSP=SDHB:NM_003000.2:ENST00000375499.7;Gene_MIM_id=185470;Phenotypes=Cowden syndrome 2, 612359 (3), Autosomal dominant. Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 4, 115310 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 115310(MK),171300(MK),606764(MK),606864(MK),612359(MK);Possible_Inheritance=AD;EntrezGeneID=6390;EnsemblGeneID=ENSG00000117118;Alias=SDHB, SDH2, SDHIP, PGL4, CWS2;FLKSEQ=ATTTATGTAA.GTTCAACCTC	GT:AD:DP:GQ:PL	1/1:0,308:308:99:11673,927,0
chr1	17380497	.	G	T	7199.77	PASS	AC=2;AF=1;AN=2;DP=205;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.73;SOR=0.917;HGVSnom=NM_003000.3:c.18C>A(p.Ala6Ala/p.A6A);Gene=SDHB;Transcript=NM_003000.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=280;EXAC_AF=0.97210201;EXAC_Hom_EAS=4193;EXAC_AC_EAS=8398;EXAC_AN_EAS=8410;EXAC_AC_Adj=109622;EXAC_AN_Adj=112768;ESP6500_MAF=0.95146900;RS=rs2746462;CLNGENE=SDHB;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.957069;G1000_EAS_AF=0.996;G1000_EUR_AF=0.9722;G1000_AFR_AF=0.8797;G1000_SAS_AF=0.9918;G1000_AMR_AF=0.9769;gnomad_exomes_AF=0.97365937;gnomad_exomes_AF_EAS=0.99905702;gnomad_exomes_AC=235203;gnomad_exomes_Hom=114539;gnomad_exomes_Het=6125;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91287129;gnomad_exomes_AF_NFE=0.97205262;gnomad_exomes_AF_AMR=0.98275358;gnomad_exomes_AF_SAS=0.98771198;NativeFreq_Het=0.0320;NativeFreq_Hom=1;normalHetFrequency=0.0116;normalHetNum=10;normalHomFrequency=0.9746;normalHomNum=843;patientHetFrequency=0.0111;patientHetNum=58;patientHomFrequency=0.9684;patientHomNum=5055;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0012;AF_2700_Hom=0.9977;AF_50_Het=0.0016;AF_50_Hom=0.9984;DANN_score=0.694;GREP_score=1.78;CytoBand=p36.13;CGD_CONDITION=Cowden syndrome 2. Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Pheochromocytoma. Paragangliomas 4;CGD_INHERITANCE=AD;Strand=SDHB:NM_003000.2:-;NP=SDHB:NM_003000.2:NP_002991.2;ENSP=SDHB:NM_003000.2:ENST00000375499.7;Gene_MIM_id=185470;Phenotypes=Cowden syndrome 2, 612359 (3), Autosomal dominant. Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 4, 115310 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 115310(MK),171300(MK),606764(MK),606864(MK),612359(MK);Possible_Inheritance=AD;EntrezGeneID=6390;EnsemblGeneID=ENSG00000117118;Alias=SDHB, SDH2, SDHIP, PGL4, CWS2;FLKSEQ=TCAAGGAGAG.GCGACCACCG	GT:AD:DP:GQ:PL	1/1:0,205:205:99:7228,615,0
chr1	45285664	.	G	A	4093.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.041;DP=287;ExcessHet=3.0103;FS=0.437;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=1.106;SOR=0.649;HGVSnom=.;Gene=PTCH2;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs12036829;G1000_AF=0.158746;G1000_EAS_AF=0.4692;G1000_EUR_AF=0.0119;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.2035;G1000_AMR_AF=0.1571;DANN_score=0.8346;GREP_score=0.0736;CytoBand=p34.1;repName=U5;repClass=snRNA;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-;NP=PTCH2:NM_001166292.1:NP_001159764.1;ENSP=PTCH2:NM_001166292.1:.;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=agagaaaccc.agtatATTCG	GT:AD:DP:GQ:PL	0/1:154,133:287:99:4122,0,4308
chr1	45291908	.	G	A	3702.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.693;DP=262;ExcessHet=3.0103;FS=1.003;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.24;ReadPosRankSum=0.461;SOR=0.764;HGVSnom=NM_003738.5:c.3114+14C>T;Gene=PTCH2;Transcript=NM_003738.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_003738.5:IVS19+14C>T;AAlength=1203;EXAC_AF=0.19648299;EXAC_Hom_EAS=266;EXAC_AC_EAS=2192;EXAC_AN_EAS=8180;EXAC_AC_Adj=21922;EXAC_AN_Adj=111572;ESP6500_MAF=0.16184838;RS=rs11211040;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.195687;G1000_EAS_AF=0.2887;G1000_EUR_AF=0.1412;G1000_AFR_AF=0.1558;G1000_SAS_AF=0.1748;G1000_AMR_AF=0.245;gnomad_exomes_AF=0.18715790;gnomad_exomes_AF_EAS=0.26535184;gnomad_exomes_AC=46639;gnomad_exomes_Hom=4497;gnomad_exomes_Het=37645;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15456821;gnomad_exomes_AF_NFE=0.16990421;gnomad_exomes_AF_AMR=0.22144107;gnomad_exomes_AF_SAS=0.19169507;NativeFreq_Het=0.3452;NativeFreq_Hom=0.0498;DANN_score=0.8104;GREP_score=4.73;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=CCTCCCCGGG.TGCCCGTGCT	GT:AD:DP:GQ:PL	0/1:133,127:260:99:3731,0,4217
chr1	45292173	.	G	A	4154.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.826;DP=285;ExcessHet=3.0103;FS=20.659;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.58;ReadPosRankSum=-0.296;SOR=0.481;HGVSnom=NM_003738.5:c.2963C>T(p.Thr988Met/p.T988M);Gene=PTCH2;Transcript=NM_003738.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E18;IVSnom=.;AAlength=1203;EXAC_AF=0.04403677;EXAC_Hom_EAS=101;EXAC_AC_EAS=1366;EXAC_AN_EAS=8582;EXAC_AC_Adj=5269;EXAC_AN_Adj=119650;ESP6500_MAF=0.01607198;RS=rs11573590;Ensembl_transcriptid=ENST00000447098|ENST00000372192;SIFT_pred=D|D;SIFT_score=0.031|0.037;Polyphen2_HVAR_pred=B|P;Polyphen2_HVAR_score=0.408|0.787;MutationTaster_pred=P|P;MutationTaster_score=0.0751304|0.0751304;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0628994;G1000_EAS_AF=0.1677;G1000_EUR_AF=0.0219;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.0583;G1000_AMR_AF=0.0937;gnomad_exomes_AF=0.04678384;gnomad_exomes_AF_EAS=0.16490521;gnomad_exomes_AC=11675;gnomad_exomes_Hom=522;gnomad_exomes_Het=10631;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00502357;gnomad_exomes_AF_NFE=0.02101634;gnomad_exomes_AF_AMR=0.08435236;gnomad_exomes_AF_SAS=0.05986146;NativeFreq_Het=0.1673;NativeFreq_Hom=0.0249;DANN_score=0.9933;GREP_score=0.354;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=GAGGCCAGCC.TCCAGGGGTT	GT:AD:DP:GQ:PL	0/1:151,134:285:99:4183,0,4645
chr1	45293518	.	A	G	5424.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.291;DP=318;ExcessHet=3.0103;FS=6.598;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.06;ReadPosRankSum=-0.75;SOR=0.598;HGVSnom=NM_003738.5:c.2055T>C(p.Ala685Ala/p.A685A);Gene=PTCH2;Transcript=NM_003738.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=1203;EXAC_AF=0.38455986;EXAC_Hom_EAS=1014;EXAC_AC_EAS=4157;EXAC_AN_EAS=8582;EXAC_AC_Adj=46351;EXAC_AN_Adj=120530;ESP6500_MAF=0.42441950;RS=rs7525308;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.445487;G1000_EAS_AF=0.4911;G1000_EUR_AF=0.3191;G1000_AFR_AF=0.6021;G1000_SAS_AF=0.32;G1000_AMR_AF=0.4409;gnomad_exomes_AF=0.38176565;gnomad_exomes_AF_EAS=0.48006319;gnomad_exomes_AC=95672;gnomad_exomes_Hom=18933;gnomad_exomes_Het=57806;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.58721721;gnomad_exomes_AF_NFE=0.34609681;gnomad_exomes_AF_AMR=0.41692290;gnomad_exomes_AF_SAS=0.35451396;NativeFreq_Het=0.4448;NativeFreq_Hom=0.2242;DANN_score=0.4537;GREP_score=2.62;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=GTCTTACCTT.GCATGTGACT	GT:AD:DP:GQ:PL	0/1:154,164:318:99:5453,0,4799
chr1	45293752	.	T	C	4622.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.554;DP=318;ExcessHet=3.0103;FS=1.862;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.58;ReadPosRankSum=-0.517;SOR=0.576;HGVSnom=NM_003738.5:c.1821A>G(p.Glu607Glu/p.E607E);Gene=PTCH2;Transcript=NM_003738.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=1203;EXAC_AF=0.18969354;EXAC_Hom_EAS=287;EXAC_AC_EAS=2237;EXAC_AN_EAS=8630;EXAC_AC_Adj=23014;EXAC_AN_Adj=121322;ESP6500_MAF=0.17945564;RS=rs2295997;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.21266;G1000_EAS_AF=0.2897;G1000_EUR_AF=0.1412;G1000_AFR_AF=0.2156;G1000_SAS_AF=0.1748;G1000_AMR_AF=0.2522;gnomad_exomes_AF=0.19170208;gnomad_exomes_AF_EAS=0.26707264;gnomad_exomes_AC=47993;gnomad_exomes_Hom=4813;gnomad_exomes_Het=38367;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20920502;gnomad_exomes_AF_NFE=0.17048680;gnomad_exomes_AF_AMR=0.22463852;gnomad_exomes_AF_SAS=0.19199112;NativeFreq_Het=0.3594;NativeFreq_Hom=0.0534;DANN_score=0.5737;GREP_score=2.43;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=GGCTGCTGGC.TCACAGTGGG	GT:AD:DP:GQ:PL	0/1:175,142:317:99:4651,0,5389
chr1	45294156	.	T	C	5476.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.419;DP=357;ExcessHet=3.0103;FS=0.802;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.51;ReadPosRankSum=0.245;SOR=0.749;HGVSnom=NM_003738.5:c.1590+22A>G;Gene=PTCH2;Transcript=NM_003738.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_003738.5:IVS12+22A>G;AAlength=1203;EXAC_AF=0.38331725;EXAC_Hom_EAS=1020;EXAC_AC_EAS=4161;EXAC_AN_EAS=8606;EXAC_AC_Adj=46064;EXAC_AN_Adj=120172;ESP6500_MAF=0.42149777;RS=rs2273940;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.443291;G1000_EAS_AF=0.4921;G1000_EUR_AF=0.3191;G1000_AFR_AF=0.593;G1000_SAS_AF=0.32;G1000_AMR_AF=0.4409;gnomad_exomes_AF=0.38091203;gnomad_exomes_AF_EAS=0.48065606;gnomad_exomes_AC=95308;gnomad_exomes_Hom=18786;gnomad_exomes_Het=57736;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57760861;gnomad_exomes_AF_NFE=0.34555192;gnomad_exomes_AF_AMR=0.41676334;gnomad_exomes_AF_SAS=0.35426200;NativeFreq_Het=0.4448;NativeFreq_Hom=0.2242;DANN_score=0.4024;GREP_score=0.49;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=CACCCTGAGC.GCCCCGTGTG	GT:AD:DP:GQ:PL	0/1:175,178:353:99:5505,0,5557
chr1	45296752	.	C	T	2219.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.898;DP=168;ExcessHet=3.0103;FS=2.8;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.21;ReadPosRankSum=-0.701;SOR=0.926;HGVSnom=NM_003738.5:c.618-37G>A;Gene=PTCH2;Transcript=NM_003738.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_003738.5:IVS5-37G>A;AAlength=1203;EXAC_AF=0.20307296;EXAC_Hom_EAS=228;EXAC_AC_EAS=1937;EXAC_AN_EAS=6988;EXAC_AC_Adj=19878;EXAC_AN_Adj=97886;ESP6500_MAF=0.17135825;RS=rs2295998;G1000_AF=0.204473;G1000_EAS_AF=0.2887;G1000_EUR_AF=0.1431;G1000_AFR_AF=0.1853;G1000_SAS_AF=0.1748;G1000_AMR_AF=0.2493;gnomad_exomes_AF=0.19270906;gnomad_exomes_AF_EAS=0.26760317;gnomad_exomes_AC=44209;gnomad_exomes_Hom=4279;gnomad_exomes_Het=35651;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18801170;gnomad_exomes_AF_NFE=0.17486796;gnomad_exomes_AF_AMR=0.22334559;gnomad_exomes_AF_SAS=0.19195725;NativeFreq_Het=0.3345;NativeFreq_Hom=0.0427;DANN_score=0.7125;GREP_score=-3.05;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=GGGTCAGGGA.GAAAACCCAG	GT:AD:DP:GQ:PL	0/1:93,75:168:99:2248,0,2563
chr1	45297753	.	A	G	4468.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.462;DP=289;ExcessHet=3.0103;FS=3.848;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.52;ReadPosRankSum=0.463;SOR=0.797;HGVSnom=NM_003738.5:c.456-37T>C;Gene=PTCH2;Transcript=NM_003738.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_003738.5:IVS3-37T>C;AAlength=1203;EXAC_AF=0.21158919;EXAC_Hom_EAS=286;EXAC_AC_EAS=2233;EXAC_AN_EAS=8636;EXAC_AC_Adj=25670;EXAC_AN_Adj=121320;ESP6500_MAF=0.26149469;RS=rs2295999;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.28115;G1000_EAS_AF=0.2887;G1000_EUR_AF=0.1421;G1000_AFR_AF=0.4652;G1000_SAS_AF=0.1759;G1000_AMR_AF=0.2695;gnomad_exomes_AF=0.20874675;gnomad_exomes_AF_EAS=0.26625707;gnomad_exomes_AC=52471;gnomad_exomes_Hom=6185;gnomad_exomes_Het=40101;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44103164;gnomad_exomes_AF_NFE=0.17108179;gnomad_exomes_AF_AMR=0.23623482;gnomad_exomes_AF_SAS=0.19306898;NativeFreq_Het=0.3559;NativeFreq_Hom=0.0712;DANN_score=0.4362;GREP_score=-1.66;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=CAGCAGAAGA.GGGGATTCCC	GT:AD:DP:GQ:PL	0/1:146,142:288:99:4497,0,4382
chr1	45307506	.	G	A	3085.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.57;DP=218;ExcessHet=3.0103;FS=0.519;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.29;ReadPosRankSum=-0.897;SOR=0.751;HGVSnom=NM_003738.5:c.265+13C>T;Gene=PTCH2;Transcript=NM_003738.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003738.5:IVS2+13C>T;AAlength=1203;EXAC_AF=0.36751982;EXAC_Hom_EAS=813;EXAC_AC_EAS=3725;EXAC_AN_EAS=8640;EXAC_AC_Adj=44600;EXAC_AN_Adj=121354;ESP6500_MAF=0.33907427;RS=rs3795720;CLNGENE=PTCH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.372005;G1000_EAS_AF=0.4454;G1000_EUR_AF=0.3151;G1000_AFR_AF=0.3306;G1000_SAS_AF=0.3139;G1000_AMR_AF=0.5086;gnomad_exomes_AF=0.37443509;gnomad_exomes_AF_EAS=0.43355807;gnomad_exomes_AC=94121;gnomad_exomes_Hom=18396;gnomad_exomes_Het=57329;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32996923;gnomad_exomes_AF_NFE=0.34634670;gnomad_exomes_AF_AMR=0.52418002;gnomad_exomes_AF_SAS=0.34338255;NativeFreq_Het=0.4555;NativeFreq_Hom=0.1815;DANN_score=0.7274;GREP_score=1.87;CytoBand=p34.1;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH2:NM_001166292.1:-,PTCH2:NM_003738.4:-;NP=PTCH2:NM_001166292.1:NP_001159764.1,PTCH2:NM_003738.4:NP_003729.3;ENSP=PTCH2:NM_001166292.1:.,PTCH2:NM_003738.4:ENST00000372192.3;Gene_MIM_id=603673;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, somatic, 155255 (3). 109400(MK),155255(MK),605462(MK);Possible_Inheritance=AD;EntrezGeneID=8643;EnsemblGeneID=ENSG00000117425;Alias=PTCH2;FLKSEQ=TATGGCCAGT.TCCACAACTT	GT:AD:DP:GQ:PL	0/1:113,103:216:99:3114,0,3600
chr1	45796269	.	G	C	14687.8	PASS	AC=2;AF=1;AN=2;DP=397;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.97;SOR=1.085;HGVSnom=NM_001048174.2:c.1393-40C>G;Gene=MUTYH;Transcript=NM_001048174.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_001048174.2:IVS14-40C>G;AAlength=521;EXAC_AF=0.92446359;EXAC_Hom_EAS=2309;EXAC_AC_EAS=5182;EXAC_AN_EAS=5798;EXAC_AC_Adj=77899;EXAC_AN_Adj=84264;ESP6500_MAF=0.92625346;RS=rs3219493;CLNGENE=MUTYH;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.935304;G1000_EAS_AF=0.9137;G1000_EUR_AF=0.9205;G1000_AFR_AF=0.9705;G1000_SAS_AF=0.9254;G1000_AMR_AF=0.9352;gnomad_exomes_AF=0.92450939;gnomad_exomes_AF_EAS=0.89112249;gnomad_exomes_AC=199278;gnomad_exomes_Hom=92168;gnomad_exomes_Het=14942;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95911036;gnomad_exomes_AF_NFE=0.91196446;gnomad_exomes_AF_AMR=0.95115053;gnomad_exomes_AF_SAS=0.91765895;NativeFreq_Het=0.1566;NativeFreq_Hom=0.8221;normalHetFrequency=0.2577;normalHetNum=100;normalHomFrequency=0.7036;normalHomNum=273;patientHetFrequency=0.2215;patientHetNum=614;patientHomFrequency=0.7345;patientHomNum=2036;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.465;GREP_score=-0.296;CytoBand=p34.1;CGD_CONDITION=Familial adenomatous polyposis, 2. Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas ;CGD_INHERITANCE=AR;Strand=MUTYH:NM_001048174.1:-,MUTYH:NM_001293191.1:-,MUTYH:NM_001293195.1:-,MUTYH:NM_001048172.1:-,MUTYH:NM_001048173.1:-,MUTYH:NM_001293196.1:-,MUTYH:NM_001048171.1:-,MUTYH:NM_001128425.1:-,MUTYH:NM_001293190.1:-,MUTYH:NM_001293192.1:-,MUTYH:NM_012222.2:-;NP=MUTYH:NM_001048174.1:NP_001041639.1,MUTYH:NM_001293191.1:NP_001280120.1,MUTYH:NM_001293195.1:NP_001280124.1,MUTYH:NM_001048172.1:NP_001041637.1,MUTYH:NM_001048173.1:NP_001041638.1,MUTYH:NM_001293196.1:NP_001280125.1,MUTYH:NM_001048171.1:NP_001041636.1,MUTYH:NM_001128425.1:NP_001121897.1,MUTYH:NM_001293190.1:NP_001280119.1,MUTYH:NM_001293192.1:NP_001280121.1,MUTYH:NM_012222.2:NP_036354.1;ENSP=MUTYH:NM_001048174.1:.,MUTYH:NM_001293191.1:.,MUTYH:NM_001293195.1:.,MUTYH:NM_001048172.1:.,MUTYH:NM_001048173.1:.,MUTYH:NM_001293196.1:.,MUTYH:NM_001048171.1:.,MUTYH:NM_001128425.1:ENST00000450313.5,MUTYH:NM_001293190.1:.,MUTYH:NM_001293192.1:.,MUTYH:NM_012222.2:.;Gene_MIM_id=604933;Phenotypes=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive. Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3), Somatic mutation. Gastric cancer, somatic, 613659 (3). 132600(MK),608456(MK),613659(MK);Possible_Inheritance=AR;EntrezGeneID=4595;EnsemblGeneID=ENSG00000132781;Alias=MUTYH, MYH;FLKSEQ=GGCACTTTTT.CAAAAGAGAT	GT:AD:DP:GQ:PL	1/1:0,394:394:99:14716,1183,0
chr1	45798555	.	T	C	13668.8	PASS	AC=2;AF=1;AN=2;DP=380;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.24;SOR=0.979;HGVSnom=NM_001048174.2:c.420+35A>G;Gene=MUTYH;Transcript=NM_001048174.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_001048174.2:IVS6+35A>G;AAlength=521;EXAC_AF=0.92551421;EXAC_Hom_EAS=3419;EXAC_AC_EAS=7686;EXAC_AN_EAS=8654;EXAC_AC_Adj=112313;EXAC_AN_Adj=121352;ESP6500_MAF=0.93026296;RS=rs3219487;CLNGENE=MUTYH;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.937101;G1000_EAS_AF=0.9137;G1000_EUR_AF=0.9205;G1000_AFR_AF=0.9766;G1000_SAS_AF=0.9254;G1000_AMR_AF=0.9366;gnomad_exomes_AF=0.92619158;gnomad_exomes_AF_EAS=0.89022401;gnomad_exomes_AC=232563;gnomad_exomes_Hom=107789;gnomad_exomes_Het=16985;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96766445;gnomad_exomes_AF_NFE=0.91339763;gnomad_exomes_AF_AMR=0.95303100;gnomad_exomes_AF_SAS=0.91902398;NativeFreq_Het=0.2079;NativeFreq_Hom=0.8256;normalHetFrequency=0.2577;normalHetNum=100;normalHomFrequency=0.7036;normalHomNum=273;patientHetFrequency=0.2215;patientHetNum=614;patientHomFrequency=0.7363;patientHomNum=2041;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4068;GREP_score=-4.73;CytoBand=p34.1;CGD_CONDITION=Familial adenomatous polyposis, 2. Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas ;CGD_INHERITANCE=AR;Strand=MUTYH:NM_001048174.1:-,MUTYH:NM_001293191.1:-,MUTYH:NM_001293195.1:-,MUTYH:NM_001048172.1:-,MUTYH:NM_001048173.1:-,MUTYH:NM_001293196.1:-,MUTYH:NM_001048171.1:-,MUTYH:NM_001128425.1:-,MUTYH:NM_001293190.1:-,MUTYH:NM_001293192.1:-,MUTYH:NM_012222.2:-;NP=MUTYH:NM_001048174.1:NP_001041639.1,MUTYH:NM_001293191.1:NP_001280120.1,MUTYH:NM_001293195.1:NP_001280124.1,MUTYH:NM_001048172.1:NP_001041637.1,MUTYH:NM_001048173.1:NP_001041638.1,MUTYH:NM_001293196.1:NP_001280125.1,MUTYH:NM_001048171.1:NP_001041636.1,MUTYH:NM_001128425.1:NP_001121897.1,MUTYH:NM_001293190.1:NP_001280119.1,MUTYH:NM_001293192.1:NP_001280121.1,MUTYH:NM_012222.2:NP_036354.1;ENSP=MUTYH:NM_001048174.1:.,MUTYH:NM_001293191.1:.,MUTYH:NM_001293195.1:.,MUTYH:NM_001048172.1:.,MUTYH:NM_001048173.1:.,MUTYH:NM_001293196.1:.,MUTYH:NM_001048171.1:.,MUTYH:NM_001128425.1:ENST00000450313.5,MUTYH:NM_001293190.1:.,MUTYH:NM_001293192.1:.,MUTYH:NM_012222.2:.;Gene_MIM_id=604933;Phenotypes=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive. Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3), Somatic mutation. Gastric cancer, somatic, 613659 (3). 132600(MK),608456(MK),613659(MK);Possible_Inheritance=AR;EntrezGeneID=4595;EnsemblGeneID=ENSG00000132781;Alias=MUTYH, MYH;FLKSEQ=GTCCCTCTAT.GTTCCTATTT	GT:AD:DP:GQ:PL	1/1:0,378:378:99:13697,1136,0
chr1	46743900	.	C	T	6473.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.063;DP=397;ExcessHet=3.0103;FS=9.715;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.39;ReadPosRankSum=0.149;SOR=0.64;HGVSnom=NM_003579.4:c.2190C>T(p.Ala730Ala/p.A730A)|NM_006369.5:c.*637G>A;Gene=RAD54L|LRRC41;Transcript=NM_003579.4|NM_006369.5;VarType=Synonymous|UTR3;MolecularConsequence=synonymous_variant|3_prime_UTR_exon_variant;ExonIntron=E18|E10;AAlength=747|812;EXAC_AF=0.15953001;EXAC_Hom_EAS=380;EXAC_AC_EAS=2590;EXAC_AN_EAS=8500;EXAC_AC_Adj=18628;EXAC_AN_Adj=116768;ESP6500_MAF=0.09495617;RS=rs1048771;CLNGENE=LRRC41|RAD54L;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.185703;G1000_EAS_AF=0.2768;G1000_EUR_AF=0.1382;G1000_AFR_AF=0.0257;G1000_SAS_AF=0.4059;G1000_AMR_AF=0.1167;gnomad_exomes_AF=0.15152776;gnomad_exomes_AF_EAS=0.29874317;gnomad_exomes_AC=37888;gnomad_exomes_Hom=4144;gnomad_exomes_Het=29600;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.04186248;gnomad_exomes_AF_NFE=0.11602812;gnomad_exomes_AF_AMR=0.09617280;gnomad_exomes_AF_SAS=0.36864407;HGMD_gene=RAD54L;HGMD_disease=Increased_chromosome-type_aberrations_association_with;HGMD_tag=DP;HGMD_pmid=26354780;NativeFreq_Het=0.2669;NativeFreq_Hom=0.0534;DANN_score=0.8576;GREP_score=1.53;CytoBand=p34.1;Strand=RAD54L:NM_001142548.1:+,RAD54L:NM_003579.3:+;NP=RAD54L:NM_001142548.1:NP_001136020.1,RAD54L:NM_003579.3:NP_003570.2;ENSP=RAD54L:NM_001142548.1:.,RAD54L:NM_003579.3:ENST00000371975.8;Gene_MIM_id=603615;Phenotypes=Adenocarcinoma, colonic, somatic (3). {Breast cancer, invasive ductal}, 114480 (3), Autosomal dominant. Lymphoma, non-Hodgkin, somatic, 605027 (3). 114480(SK),603615(MK),605027(MK);Possible_Inheritance=AD;EntrezGeneID=8438;EnsemblGeneID=ENSG00000085999;Alias=RAD54L, HR54, HRAD54;FLKSEQ=CCTCCACTGC.ATCACCTTCG	GT:AD:DP:GQ:PL	0/1:187,208:395:99:6502,0,6134
chr1	46744019	.	C	T	6132.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.133;DP=365;ExcessHet=3.0103;FS=0.381;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.89;ReadPosRankSum=-1.383;SOR=0.658;HGVSnom=NM_003579.4:c.*65C>T|NM_006369.5:c.*518G>A;Gene=RAD54L|LRRC41;Transcript=NM_003579.4|NM_006369.5;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E18|E10;AAlength=747|812;RS=rs1660687459;DANN_score=0.5777;GREP_score=-3.24;CytoBand=p34.1;Strand=RAD54L:NM_001142548.1:+,RAD54L:NM_003579.3:+;NP=RAD54L:NM_001142548.1:NP_001136020.1,RAD54L:NM_003579.3:NP_003570.2;ENSP=RAD54L:NM_001142548.1:.,RAD54L:NM_003579.3:ENST00000371975.8;Gene_MIM_id=603615;Phenotypes=Adenocarcinoma, colonic, somatic (3). {Breast cancer, invasive ductal}, 114480 (3), Autosomal dominant. Lymphoma, non-Hodgkin, somatic, 605027 (3). 114480(SK),603615(MK),605027(MK);Possible_Inheritance=AD;EntrezGeneID=8438;EnsemblGeneID=ENSG00000085999;Alias=RAD54L, HR54, HRAD54;FLKSEQ=CCTTGCTCCA.AGGGCCCTGT	GT:AD:DP:GQ:PL	0/1:168,195:363:99:6161,0,5475
chr1	47398743	.	G	C	3640.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.521;DP=254;ExcessHet=3.0103;FS=1.511;MLEAC=1;MLEAF=0.5;MQ=59.88;MQRankSum=1.347;QD=14.33;ReadPosRankSum=2.057;SOR=0.588;HGVSnom=NM_000778.4:c.1223-24C>G;Gene=CYP4A11;Transcript=NM_000778.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000778.4:IVS9-24C>G;AAlength=519;EXAC_AF=0.70188278;EXAC_Hom_EAS=1161;EXAC_AC_EAS=4479;EXAC_AN_EAS=8618;EXAC_AC_Adj=85071;EXAC_AN_Adj=121204;ESP6500_MAF=0.66015685;RS=rs3890011;G1000_AF=0.571486;G1000_EAS_AF=0.496;G1000_EUR_AF=0.7763;G1000_AFR_AF=0.3449;G1000_SAS_AF=0.6656;G1000_AMR_AF=0.683;gnomad_exomes_AF=0.70688019;gnomad_exomes_AF_EAS=0.52556293;gnomad_exomes_AC=177311;gnomad_exomes_Hom=64412;gnomad_exomes_Het=48487;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.40475018;gnomad_exomes_AF_NFE=0.78546877;gnomad_exomes_AF_AMR=0.69372790;gnomad_exomes_AF_SAS=0.62665003;NativeFreq_Het=0.4164;NativeFreq_Hom=0.3523;DANN_score=0.5881;GREP_score=-10.0;CytoBand=p33;dupName=chr1:47600000;dupScore=0;Strand=CYP4A11:NM_000778.3:-,CYP4A11:NM_001319155.1:-;NP=CYP4A11:NM_000778.3:NP_000769.2,CYP4A11:NM_001319155.1:NP_001306084.1;ENSP=CYP4A11:NM_000778.3:.,CYP4A11:NM_001319155.1:.;Gene_MIM_id=601310;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1579;EnsemblGeneID=ENSG00000187048;Alias=CYP4A11;FLKSEQ=TGGAAACAGA.AGAAGACCAA	GT:AD:DP:GQ:PL	0/1:134,120:254:99:3669,0,4237
chr1	114940211	.	G	GT	726.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.849;DP=321;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.66;ReadPosRankSum=0.049;SOR=0.729;HGVSnom=NM_015906.4:c.*58dupA;Gene=TRIM33;Transcript=NM_015906.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1127;RS=rs66490349;NativeFreq_Het=0.0198;NativeFreq_Hom=.;AF_2700_Het=0.4470;AF_2700_Hom=0.0223;AF_50_Het=0.4358;AF_50_Hom=0.0206;CytoBand=p13.2;repName=(T)n;repClass=Simple_repeat;Strand=TRIM33:NM_015906.3:-,TRIM33:NM_033020.2:-,TRIM33:NM_015906.4:-;NP=TRIM33:NM_015906.3:NP_056990.3,TRIM33:NM_033020.2:NP_148980.2,TRIM33:NM_015906.4:NP_056990.3;ENSP=TRIM33:NM_015906.3:.,TRIM33:NM_033020.2:.,TRIM33:NM_015906.4:ENST00000358465.7;Gene_MIM_id=605769;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51592;EnsemblGeneID=ENSG00000197323;Alias=TRIM33, TIF1G, RFG7, PTC7;FLKSEQ=GGttttttgt.tttttttttt	GT:AD:DP:GQ:PL	0/1:199,74:273:99:764,0,3452
chr1	114940230	.	T	G	4408.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.632;DP=313;ExcessHet=3.0103;FS=9.306;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.09;ReadPosRankSum=-0.224;SOR=1.255;HGVSnom=NM_015906.4:c.*40A>C;Gene=TRIM33;Transcript=NM_015906.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1127;EXAC_AF=0.07316330;EXAC_Hom_EAS=0;EXAC_AC_EAS=21;EXAC_AN_EAS=1308;EXAC_AC_Adj=1681;EXAC_AN_Adj=22976;RS=rs532092215;G1000_AF=0.0161741;G1000_EAS_AF=0.001;G1000_EUR_AF=0.004;G1000_AFR_AF=0.003;G1000_SAS_AF=0.002;G1000_AMR_AF=0.1009;gnomad_exomes_AF=0.02988408;gnomad_exomes_AF_EAS=0.00367247;gnomad_exomes_AC=2382;gnomad_exomes_Hom=111;gnomad_exomes_Het=2160;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00314001;gnomad_exomes_AF_NFE=0.00791485;gnomad_exomes_AF_AMR=0.17204900;gnomad_exomes_AF_SAS=0.00349389;NativeFreq_Het=0.0178;NativeFreq_Hom=0;AF_2700_Het=0.0081;AF_2700_Hom=0.0000;AF_50_Het=0.0095;AF_50_Hom=0.0000;DANN_score=0.1027;GREP_score=0.0;CytoBand=p13.2;repName=(T)n;repClass=Simple_repeat;Strand=TRIM33:NM_015906.3:-,TRIM33:NM_033020.2:-,TRIM33:NM_015906.4:-;NP=TRIM33:NM_015906.3:NP_056990.3,TRIM33:NM_033020.2:NP_148980.2,TRIM33:NM_015906.4:NP_056990.3;ENSP=TRIM33:NM_015906.3:.,TRIM33:NM_033020.2:.,TRIM33:NM_015906.4:ENST00000358465.7;Gene_MIM_id=605769;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51592;EnsemblGeneID=ENSG00000197323;Alias=TRIM33, TIF1G, RFG7, PTC7;FLKSEQ=ttttttttcg.tttttttttt	GT:AD:DP:GQ:PL	0/1:69,205:274:99:4437,0,1113
chr1	114940632	.	CA	C	2979.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.354;DP=176;ExcessHet=3.0103;FS=1.571;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.06;ReadPosRankSum=-0.291;SOR=0.399;HGVSnom=NM_015906.4:c.3121-21delT;Gene=TRIM33;Transcript=NM_015906.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_015906.4:IVS18-21delT;AAlength=1127;EXAC_AF=0.59810044;EXAC_Hom_EAS=892;EXAC_AC_EAS=4269;EXAC_AN_EAS=6756;EXAC_AC_Adj=59950;EXAC_AN_Adj=100234;RS=rs5777192;G1000_AF=0.696685;G1000_EAS_AF=0.7202;G1000_EUR_AF=0.7018;G1000_AFR_AF=0.6936;G1000_SAS_AF=0.6329;G1000_AMR_AF=0.7507;gnomad_exomes_AF=0.59947547;gnomad_exomes_AF_EAS=0.67439146;gnomad_exomes_AC=74745;gnomad_exomes_Hom=12744;gnomad_exomes_Het=49257;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64422558;gnomad_exomes_AF_NFE=0.59006969;gnomad_exomes_AF_AMR=0.60220104;gnomad_exomes_AF_SAS=0.56989247;NativeFreq_Het=0.4950;NativeFreq_Hom=.;AF_2700_Het=0.7563;AF_2700_Hom=0.2421;AF_50_Het=0.7338;AF_50_Hom=0.2647;CytoBand=p13.2;Strand=TRIM33:NM_015906.3:-,TRIM33:NM_033020.2:-,TRIM33:NM_015906.4:-;NP=TRIM33:NM_015906.3:NP_056990.3,TRIM33:NM_033020.2:NP_148980.2,TRIM33:NM_015906.4:NP_056990.3;ENSP=TRIM33:NM_015906.3:.,TRIM33:NM_033020.2:.,TRIM33:NM_015906.4:ENST00000358465.7;Gene_MIM_id=605769;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51592;EnsemblGeneID=ENSG00000197323;Alias=TRIM33, TIF1G, RFG7, PTC7;FLKSEQ=ATACCAGAGT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:24,141:165:99:2997,0,109
chr1	120053340	.	C	CT	860.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.235;DP=150;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.76;ReadPosRankSum=0.312;SOR=1.802;OLD_VARIANT=chr1|120053340|C|CT,CTTTT|1;HGVSnom=NM_000862.3:c.146-749dupT;Gene=HSD3B1;Transcript=NM_000862.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000862.3:IVS2-749_-748insT;AAlength=373;RS=rs962978657;CytoBand=p12;simRepName=trf;simRepCopyNum=42;Strand=HSD3B1:NM_000862.2:+,HSD3B1:NM_001328615.1:+;NP=HSD3B1:NM_000862.2:NP_000853.1,HSD3B1:NM_001328615.1:NP_001315544.1;ENSP=HSD3B1:NM_000862.2:.,HSD3B1:NM_001328615.1:.;Gene_MIM_id=109715;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=3283;EnsemblGeneID=ENSG00000203857;Alias=HSD3B1;FLKSEQ=GTGTGGtttt.tttttttttt	GT:AD:DP:GQ:PL	1/0:23,27:80:99:898,471,531
chr1	120053340	.	C	CTTTT	860.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.235;DP=150;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.76;ReadPosRankSum=0.312;SOR=1.802;OLD_VARIANT=chr1|120053340|C|CT,CTTTT|2;HGVSnom=NM_000862.3:c.146-752_146-749dupTTTT;Gene=HSD3B1;Transcript=NM_000862.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000862.3:IVS2-749_-748insTTTT;AAlength=373;RS=rs962978657;CytoBand=p12;simRepName=trf;simRepCopyNum=42;Strand=HSD3B1:NM_000862.2:+,HSD3B1:NM_001328615.1:+;NP=HSD3B1:NM_000862.2:NP_000853.1,HSD3B1:NM_001328615.1:NP_001315544.1;ENSP=HSD3B1:NM_000862.2:.,HSD3B1:NM_001328615.1:.;Gene_MIM_id=109715;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=3283;EnsemblGeneID=ENSG00000203857;Alias=HSD3B1;FLKSEQ=GTGTGGtttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:23,30:80:99:898,128,797
chr1	156785617	.	G	A	11314.8	PASS	AC=2;AF=1;AN=2;DP=315;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.2;SOR=0.973;HGVSnom=NM_003975.4:c.123+181C>T;Gene=SH2D2A;Transcript=NM_003975.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003975.4:IVS2+181C>T;AAlength=389;EXAC_AF=0.66740869;EXAC_Hom_EAS=2927;EXAC_AC_EAS=7109;EXAC_AN_EAS=8650;EXAC_AC_Adj=80950;EXAC_AN_Adj=121290;ESP6500_MAF=0.61771490;RS=rs1800601;CLNGENE=NTRK1|SH2D2A;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.636981;G1000_EAS_AF=0.8135;G1000_EUR_AF=0.6948;G1000_AFR_AF=0.444;G1000_SAS_AF=0.636;G1000_AMR_AF=0.6657;gnomad_exomes_AF=0.67402915;gnomad_exomes_AF_EAS=0.81769247;gnomad_exomes_AC=169366;gnomad_exomes_Hom=57705;gnomad_exomes_Het=53956;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49889203;gnomad_exomes_AF_NFE=0.67746647;gnomad_exomes_AF_AMR=0.69510995;gnomad_exomes_AF_SAS=0.65485916;NativeFreq_Het=0.3594;NativeFreq_Hom=0.6039;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][17D0500519];patientHomSampleInfo=[_][15D6534489|16D1546239|15B6215237];AF_2700_Het=0.2948;AF_2700_Hom=0.6737;AF_50_Het=0.2631;AF_50_Hom=0.7005;DANN_score=0.7767;GREP_score=-7.85;CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=SH2D2A:NM_001161443.1:-,SH2D2A:NM_001161441.1:-,SH2D2A:NM_001161442.1:-,SH2D2A:NM_003975.3:-,SH2D2A:NM_001161444.1:-,NTRK1:NM_001007792.1:+;NP=SH2D2A:NM_001161443.1:NP_001154915.1,SH2D2A:NM_001161441.1:NP_001154913.1,SH2D2A:NM_001161442.1:NP_001154914.1,SH2D2A:NM_003975.3:NP_003966.2,SH2D2A:NM_001161444.1:NP_001154916.1,NTRK1:NM_001007792.1:NP_001007793.1;ENSP=SH2D2A:NM_001161443.1:.,SH2D2A:NM_001161441.1:.,SH2D2A:NM_001161442.1:.,SH2D2A:NM_003975.3:.,SH2D2A:NM_001161444.1:.,NTRK1:NM_001007792.1:ENST00000392302.7;Gene_MIM_id=600347,604514,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,9047,4914;EnsemblGeneID=ENSG00000132692,ENSG00000027869,ENSG00000198400;Alias=BCAN,SH2D2A, TSAD,NTRK1, TRKA, MTC;FLKSEQ=TGGGCAACTC.GCGCATGAAG	GT:AD:DP:GQ:PL	1/1:0,313:313:99:11343,941,0
chr1	156838141	.	T	C	6955.77	PASS	AC=2;AF=1;AN=2;DP=203;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.26;SOR=0.785;HGVSnom=NM_002529.4:c.574+100T>C;Gene=NTRK1;Transcript=NM_002529.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_002529.4:IVS5+100T>C;AAlength=796;RS=rs1800879;CLNGENE=NTRK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.711661;G1000_EAS_AF=0.9554;G1000_EUR_AF=0.6034;G1000_AFR_AF=0.6097;G1000_SAS_AF=0.7628;G1000_AMR_AF=0.6369;NativeFreq_Het=0.2313;NativeFreq_Hom=0.9009;normalHetFrequency=0.185;normalHetNum=160;normalHomFrequency=0.7526;normalHomNum=651;patientHetFrequency=0.1824;patientHetNum=952;patientHomFrequency=0.7548;patientHomNum=3940;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2461;GREP_score=-6.69;CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=NTRK1:NM_001007792.1:+,NTRK1:NM_001012331.1:+,NTRK1:NM_002529.3:+;NP=NTRK1:NM_001007792.1:NP_001007793.1,NTRK1:NM_001012331.1:NP_001012331.1,NTRK1:NM_002529.3:NP_002520.2;ENSP=NTRK1:NM_001007792.1:ENST00000392302.7,NTRK1:NM_001012331.1:ENST00000368196.7,NTRK1:NM_002529.3:.;Gene_MIM_id=600347,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,4914;EnsemblGeneID=ENSG00000132692,ENSG00000198400;Alias=BCAN,NTRK1, TRKA, MTC;FLKSEQ=GCCTGGGGAA.GGGCACTGGC	GT:AD:DP:GQ:PL	1/1:0,203:203:99:6984,609,0
chr1	156845492	.	AGT	A	2942.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.979;DP=219;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=23.36;ReadPosRankSum=-1.419;SOR=1.046;OLD_VARIANT=chr1|156845492|AGT|A,AGTGTGTGT|1;HGVSnom=NM_002529.4:c.1501+69_1501+70delGT;Gene=NTRK1;Transcript=NM_002529.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_002529.4:IVS12+69_+70delGT;AAlength=796;EXAC_AF=0.17332774;EXAC_Hom_EAS=62;EXAC_AC_EAS=1131;EXAC_AN_EAS=3418;EXAC_AC_Adj=8266;EXAC_AN_Adj=47690;RS=rs56185968;CLNGENE=NTRK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0693;NativeFreq_Hom=.;normalHetFrequency=0.1711;normalHetNum=148;normalHomFrequency=0.2012;normalHomNum=174;patientHetFrequency=0.1653;patientHetNum=863;patientHomFrequency=0.2197;patientHomNum=1147;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=NTRK1:NM_001007792.1:+,NTRK1:NM_001012331.1:+,NTRK1:NM_002529.3:+;NP=NTRK1:NM_001007792.1:NP_001007793.1,NTRK1:NM_001012331.1:NP_001012331.1,NTRK1:NM_002529.3:NP_002520.2;ENSP=NTRK1:NM_001007792.1:ENST00000392302.7,NTRK1:NM_001012331.1:ENST00000368196.7,NTRK1:NM_002529.3:.;Gene_MIM_id=600347,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,4914;EnsemblGeneID=ENSG00000132692,ENSG00000198400;Alias=BCAN,NTRK1, TRKA, MTC;FLKSEQ=GGCAGGGACG.gtgtgtgtgt	GT:AD:DP:GQ:PL	1/0:10,63:126:99:2980,1654,1702
chr1	156845492	.	A	AGTGTGT	2942.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.979;DP=219;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=23.36;ReadPosRankSum=-1.419;SOR=1.046;OLD_VARIANT=chr1|156845492|AGT|A,AGTGTGTGT|2;HGVSnom=NM_002529.4:c.1501+65_1501+70dupGTGTGT;Gene=NTRK1;Transcript=NM_002529.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_002529.4:IVS12+70_+71insGTGTGT;AAlength=796;EXAC_AF=0.08102328;EXAC_Hom_EAS=96;EXAC_AC_EAS=671;EXAC_AN_EAS=3418;EXAC_AC_Adj=3864;EXAC_AN_Adj=47690;RS=rs56185968;CLNGENE=NTRK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0099;NativeFreq_Hom=.;normalHetFrequency=0.1017;normalHetNum=88;normalHomFrequency=0.1434;normalHomNum=124;patientHetFrequency=0.0897;patientHetNum=468;patientHomFrequency=0.1494;patientHomNum=780;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=NTRK1:NM_001007792.1:+,NTRK1:NM_001012331.1:+,NTRK1:NM_002529.3:+;NP=NTRK1:NM_001007792.1:NP_001007793.1,NTRK1:NM_001012331.1:NP_001012331.1,NTRK1:NM_002529.3:NP_002520.2;ENSP=NTRK1:NM_001007792.1:ENST00000392302.7,NTRK1:NM_001012331.1:ENST00000368196.7,NTRK1:NM_002529.3:.;Gene_MIM_id=600347,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,4914;EnsemblGeneID=ENSG00000132692,ENSG00000198400;Alias=BCAN,NTRK1, TRKA, MTC;FLKSEQ=GGCAGGGACG.gtgtgtgtgt	GT:AD:DP:GQ:PL	0/1:10,53:126:99:2980,1295,1855
chr1	156846120	.	C	T	3204.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.529;DP=211;ExcessHet=3.0103;FS=2.446;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.33;ReadPosRankSum=-0.54;SOR=0.904;HGVSnom=NM_002529.4:c.1633-72C>T;Gene=NTRK1;Transcript=NM_002529.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_002529.4:IVS13-72C>T;AAlength=796;RS=rs1800880;CLNGENE=NTRK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.231829;G1000_EAS_AF=0.5407;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.1051;G1000_SAS_AF=0.3384;G1000_AMR_AF=0.1167;NativeFreq_Het=0.5346;NativeFreq_Hom=0.2772;normalHetFrequency=0.3538;normalHetNum=306;normalHomFrequency=0.2162;normalHomNum=187;patientHetFrequency=0.3544;patientHetNum=1850;patientHomFrequency=0.1977;patientHomNum=1032;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7776;GREP_score=-7.34;CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=NTRK1:NM_001007792.1:+,NTRK1:NM_001012331.1:+,NTRK1:NM_002529.3:+;NP=NTRK1:NM_001007792.1:NP_001007793.1,NTRK1:NM_001012331.1:NP_001012331.1,NTRK1:NM_002529.3:NP_002520.2;ENSP=NTRK1:NM_001007792.1:ENST00000392302.7,NTRK1:NM_001012331.1:ENST00000368196.7,NTRK1:NM_002529.3:.;Gene_MIM_id=600347,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,4914;EnsemblGeneID=ENSG00000132692,ENSG00000198400;Alias=BCAN,NTRK1, TRKA, MTC;FLKSEQ=CCGGGGTGGG.GGGCTGCCCT	GT:AD:DP:GQ:PL	0/1:97,112:209:99:3233,0,2700
chr1	156846233	.	G	A	3739.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.288;DP=233;ExcessHet=3.0103;FS=2.274;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.05;ReadPosRankSum=1.19;SOR=0.56;HGVSnom=NM_002529.4:c.1674G>A(p.Gln558Gln/p.Q558Q);Gene=NTRK1;Transcript=NM_002529.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=796;EXAC_AF=0.22032966;EXAC_Hom_EAS=545;EXAC_AC_EAS=3041;EXAC_AN_EAS=8560;EXAC_AC_Adj=26440;EXAC_AN_Adj=120002;ESP6500_MAF=0.19360295;RS=rs6334;CLNGENE=NTRK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.212859;G1000_EAS_AF=0.3204;G1000_EUR_AF=0.1968;G1000_AFR_AF=0.1142;G1000_SAS_AF=0.2464;G1000_AMR_AF=0.2205;gnomad_exomes_AF=0.22030722;gnomad_exomes_AF_EAS=0.34937330;gnomad_exomes_AC=55246;gnomad_exomes_Hom=6397;gnomad_exomes_Het=42452;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13138731;gnomad_exomes_AF_NFE=0.21442824;gnomad_exomes_AF_AMR=0.21632027;gnomad_exomes_AF_SAS=0.23518071;NativeFreq_Het=0.4158;NativeFreq_Hom=0.0891;normalHetFrequency=0.4023;normalHetNum=348;normalHomFrequency=0.096;normalHomNum=83;patientHetFrequency=0.3975;patientHetNum=2075;patientHomFrequency=0.1063;patientHomNum=555;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4473;AF_2700_Hom=0.1318;AF_50_Het=0.4548;AF_50_Hom=0.1268;DANN_score=0.9342;GREP_score=3.38;CytoBand=q23.1;CGD_CONDITION=Insensitivity to pain, congenital, with anhidrosis;CGD_INHERITANCE=AR;Strand=NTRK1:NM_001007792.1:+,NTRK1:NM_001012331.1:+,NTRK1:NM_002529.3:+;NP=NTRK1:NM_001007792.1:NP_001007793.1,NTRK1:NM_001012331.1:NP_001012331.1,NTRK1:NM_002529.3:NP_002520.2;ENSP=NTRK1:NM_001007792.1:ENST00000392302.7,NTRK1:NM_001012331.1:ENST00000368196.7,NTRK1:NM_002529.3:.;Gene_MIM_id=600347,191315;Phenotypes=.,Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive. Medullary thyroid carcinoma, familial, 155240 (3), Autosomal dominant. 155240(MK),256800(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=63827,4914;EnsemblGeneID=ENSG00000132692,ENSG00000198400;Alias=BCAN,NTRK1, TRKA, MTC;FLKSEQ=AGGACTTCCA.CGTGAGGCTG	GT:AD:DP:GQ:PL	0/1:110,123:233:99:3768,0,3781
chr1	161284224	.	A	AGT	4363.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.377;DP=290;ExcessHet=3.0103;FS=0.45;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.1;ReadPosRankSum=0.083;SOR=0.751;HGVSnom=NM_003001.5:c.20+11_20+12dupTG;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_003001.5:IVS1+12_+13insTG;AAlength=169;EXAC_AF=0.10525141;EXAC_Hom_EAS=160;EXAC_AC_EAS=1720;EXAC_AN_EAS=8624;EXAC_AC_Adj=12727;EXAC_AN_Adj=120920;ESP6500_MAF=0.11222045;RS=rs35215598;CLNGENE=MPZ|SDHC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.169728;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2209;G1000_AMR_AF=0.0605;gnomad_exomes_AF=0.09978180;gnomad_exomes_AF_EAS=0.19570900;gnomad_exomes_AC=25060;gnomad_exomes_Hom=1737;gnomad_exomes_Het=21586;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22372150;gnomad_exomes_AF_NFE=0.06492180;gnomad_exomes_AF_AMR=0.05231953;gnomad_exomes_AF_SAS=0.18350212;NativeFreq_Het=0.1847;NativeFreq_Hom=.;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0301;normalHomNum=26;patientHetFrequency=0.2613;patientHetNum=1364;patientHomFrequency=0.0287;patientHomNum=150;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3344;AF_2700_Hom=0.0384;AF_50_Het=0.3360;AF_50_Hom=0.0460;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=AGGTGACTTC.GTGGGACTGG	GT:AD:DP:GQ:PL	0/1:154,117:271:99:4401,0,6001
chr1	161293308	.	C	T	2134.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.582;DP=150;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.33;ReadPosRankSum=-0.417;SOR=0.595;HGVSnom=NM_003001.5:c.21-96C>T;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_003001.5:IVS1-96C>T;AAlength=169;RS=rs4255403;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.236621;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.0507;G1000_AFR_AF=0.4864;G1000_SAS_AF=0.2239;G1000_AMR_AF=0.0821;NativeFreq_Het=0.2963;NativeFreq_Hom=0.0594;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0312;normalHomNum=27;patientHetFrequency=0.2523;patientHetNum=1317;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.447;GREP_score=0.64;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=TTATATCTTA.TTTTAATCTA	GT:AD:DP:GQ:PL	0/1:78,71:149:99:2163,0,2454
chr1	161293485	.	T	TTA	3333.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.979;DP=189;ExcessHet=3.0103;FS=8.279;MLEAC=1;MLEAF=0.5;MQ=59.03;MQRankSum=-3.999;QD=18.22;ReadPosRankSum=-1.025;SOR=0.242;HGVSnom=NM_003001.5:c.77+26_77+27insAT;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003001.5:IVS2+26_+27insAT;AAlength=169;EXAC_AF=0.06077034;EXAC_Hom_EAS=15;EXAC_AC_EAS=704;EXAC_AN_EAS=6836;EXAC_AC_Adj=6513;EXAC_AN_Adj=107174;ESP6500_MAF=0.09148290;RS=rs202172527;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.122005;G1000_EAS_AF=0.1706;G1000_EUR_AF=0.0417;G1000_AFR_AF=0.1725;G1000_SAS_AF=0.1421;G1000_AMR_AF=0.0432;gnomad_exomes_AF=0.06043706;gnomad_exomes_AF_EAS=0.12822487;gnomad_exomes_AC=13546;gnomad_exomes_Hom=823;gnomad_exomes_Het=11900;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14569787;gnomad_exomes_AF_NFE=0.04095119;gnomad_exomes_AF_AMR=0.03217225;gnomad_exomes_AF_SAS=0.10844622;NativeFreq_Het=0.1217;NativeFreq_Hom=.;normalHetFrequency=0.2254;normalHetNum=195;normalHomFrequency=0.0243;normalHomNum=21;patientHetFrequency=0.2312;patientHetNum=1207;patientHomFrequency=0.0245;patientHomNum=128;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2882;AF_2700_Hom=0.0350;AF_50_Het=0.2900;AF_50_Hom=0.0428;CytoBand=q23.3;repName=AluY;repClass=SINE;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=CTGGAGATTA.ttatttattt	GT:AD:DP:GQ:PL	0/1:98,85:183:99:3371,0,5932
chr1	161293492	.	A	T	1078.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.908;DP=183;ExcessHet=3.0103;FS=8.423;MLEAC=1;MLEAF=0.5;MQ=58.93;MQRankSum=-3.537;QD=6.13;ReadPosRankSum=-0.938;SOR=0.169;HGVSnom=NM_003001.5:c.77+32A>T;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003001.5:IVS2+32A>T;AAlength=169;EXAC_AF=0.09343630;EXAC_Hom_EAS=26;EXAC_AC_EAS=743;EXAC_AN_EAS=5994;EXAC_AC_Adj=6981;EXAC_AN_Adj=74714;RS=rs77828459;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.122005;G1000_EAS_AF=0.1706;G1000_EUR_AF=0.0417;G1000_AFR_AF=0.1725;G1000_SAS_AF=0.1421;G1000_AMR_AF=0.0432;gnomad_exomes_AF=0.13370841;gnomad_exomes_AF_EAS=0.20221198;gnomad_exomes_AC=16018;gnomad_exomes_Hom=1023;gnomad_exomes_Het=13972;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27713726;gnomad_exomes_AF_NFE=0.08810738;gnomad_exomes_AF_AMR=0.08063628;gnomad_exomes_AF_SAS=0.25488554;NativeFreq_Het=0.2932;NativeFreq_Hom=0.0586;normalHetFrequency=0.2208;normalHetNum=191;normalHomFrequency=0.0277;normalHomNum=24;patientHetFrequency=0.2308;patientHetNum=1205;patientHomFrequency=0.0264;patientHomNum=138;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2526;GREP_score=0.0;CytoBand=q23.3;repName=AluY;repClass=SINE;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=TTAtttattt.tttttttttt	GT:AD:DP:GQ:PL	0/1:113,63:176:99:1116,0,6076
chr1	161293508	.	C	T	2988.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.751;DP=161;ExcessHet=3.0103;FS=1.199;MLEAC=1;MLEAF=0.5;MQ=58.78;MQRankSum=-4.225;QD=18.56;ReadPosRankSum=-1.993;SOR=0.467;HGVSnom=NM_003001.5:c.77+48C>T;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_003001.5:IVS2+48C>T;AAlength=169;EXAC_AF=0.07324244;EXAC_Hom_EAS=63;EXAC_AC_EAS=906;EXAC_AN_EAS=6022;EXAC_AC_Adj=6876;EXAC_AN_Adj=93880;ESP6500_MAF=0.06043787;RS=rs112946310;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.128395;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.0976;G1000_SAS_AF=0.2239;G1000_AMR_AF=0.0447;gnomad_exomes_AF=0.06242867;gnomad_exomes_AF_EAS=0.14232552;gnomad_exomes_AC=12582;gnomad_exomes_Hom=722;gnomad_exomes_Het=11138;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07073416;gnomad_exomes_AF_NFE=0.04535125;gnomad_exomes_AF_AMR=0.02771310;gnomad_exomes_AF_SAS=0.13795407;NativeFreq_Het=0.2747;NativeFreq_Hom=0.0031;normalHetFrequency=0.2416;normalHetNum=209;normalHomFrequency=0.0277;normalHomNum=24;patientHetFrequency=0.2379;patientHetNum=1242;patientHomFrequency=0.0285;patientHomNum=149;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8836;GREP_score=0.0;CytoBand=q23.3;repName=AluY;repClass=SINE;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=ttttttgaga.ggagtctcgc	GT:AD:DP:GQ:PL	0/1:84,77:161:99:3017,0,5519
chr1	161310519	.	C	T	5154.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.374;DP=365;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.12;ReadPosRankSum=-0.008;SOR=0.68;HGVSnom=NM_003001.5:c.241+74C>T;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_003001.5:IVS4+74C>T;AAlength=169;RS=rs9970904;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.16873;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2188;G1000_AMR_AF=0.0576;NativeFreq_Het=0.2870;NativeFreq_Hom=0.0586;normalHetFrequency=0.2532;normalHetNum=219;normalHomFrequency=0.0324;normalHomNum=28;patientHetFrequency=0.2554;patientHetNum=1333;patientHomFrequency=0.0303;patientHomNum=158;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3403;GREP_score=0.128;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=CCCTAGTCTC.GCCTCCTTTG	GT:AD:DP:GQ:PL	0/1:194,171:365:99:5183,0,5383
chr1	161326722	.	C	CT	1925.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.552;DP=255;ExcessHet=3.0103;FS=2.958;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.48;ReadPosRankSum=-0.982;SOR=0.988;HGVSnom=NM_003001.5:c.405+104dupT;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_003001.5:IVS5+104_+105insT;AAlength=169;RS=rs199612101;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.1228;NativeFreq_Hom=.;normalHetFrequency=0.2382;normalHetNum=206;normalHomFrequency=0.0116;normalHomNum=10;patientHetFrequency=0.2548;patientHetNum=1330;patientHomFrequency=0.0117;patientHomNum=61;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q23.3;repName=AluSz;repClass=SINE;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=TAGTGCTGtt.tttttttttt	GT:AD:DP:GQ:PL	0/1:121,106:227:99:1963,0,2024
chr1	161332091	.	CT	C	509.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.392;DP=168;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.27;ReadPosRankSum=0.409;SOR=0.616;HGVSnom=NM_003001.5:c.406-14delT;Gene=SDHC;Transcript=NM_003001.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_003001.5:IVS5-14delT;AAlength=169;EXAC_AF=0.39772358;EXAC_Hom_EAS=0;EXAC_AC_EAS=1056;EXAC_AN_EAS=3162;EXAC_AC_Adj=22049;EXAC_AN_Adj=55438;RS=rs34744926;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.412141;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.4423;G1000_AFR_AF=0.3865;G1000_SAS_AF=0.4018;G1000_AMR_AF=0.4193;gnomad_exomes_AF=0.42441515;gnomad_exomes_AF_EAS=0.41696365;gnomad_exomes_AC=52793;gnomad_exomes_Hom=71;gnomad_exomes_Het=52651;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.39365672;gnomad_exomes_AF_NFE=0.42556839;gnomad_exomes_AF_AMR=0.42980867;gnomad_exomes_AF_SAS=0.43086610;NativeFreq_Het=0.0111;NativeFreq_Hom=.;normalHetFrequency=0.4081;normalHetNum=353;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.4416;patientHetNum=2305;patientHomFrequency=0.0042;patientHomNum=22;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6526673|16D0166608];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1533028-1|16D1546124|16D1546210|16D1546114|16D1545717|16D1545865|16D1545715|15D6534490|15D6524787|15D6522621|15D6482242-1|16D1536880-1|16D1533040|16D1536952][16B0019057-1|15D6518638|15D6517280|15D6522050|15D6482440|16D0161321|15D6482338-1|15D6518733];AF_2700_Het=0.7790;AF_2700_Hom=.;AF_50_Het=0.7987;AF_50_Hom=.;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=ACTGAAATTC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:105,51:156:99:547,0,1927
chr1	161332346	.	C	G	3758.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.863;DP=258;ExcessHet=3.0103;FS=0.457;MLEAC=1;MLEAF=0.5;MQ=49.15;MQRankSum=1.177;QD=14.63;ReadPosRankSum=-1.101;SOR=0.731;HGVSnom=NM_003001.5:c.*123C>G;Gene=SDHC;Transcript=NM_003001.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=169;EXAC_AF=0.10287203;EXAC_Hom_EAS=155;EXAC_AC_EAS=1655;EXAC_AN_EAS=7748;EXAC_AC_Adj=10896;EXAC_AN_Adj=105918;ESP6500_MAF=0.06941398;RS=rs3813632;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.128794;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.0976;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0533;gnomad_exomes_AF=0.09319725;gnomad_exomes_AF_EAS=0.19594219;gnomad_exomes_AC=22435;gnomad_exomes_Hom=1387;gnomad_exomes_Het=19661;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10082873;gnomad_exomes_AF_NFE=0.06506624;gnomad_exomes_AF_AMR=0.05974898;gnomad_exomes_AF_SAS=0.18177579;NativeFreq_Het=0.2673;NativeFreq_Hom=0.0594;normalHetFrequency=0.2578;normalHetNum=223;normalHomFrequency=0.0277;normalHomNum=24;patientHetFrequency=0.2588;patientHetNum=1351;patientHomFrequency=0.028;patientHomNum=146;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3370;AF_2700_Hom=0.0346;AF_50_Het=0.3391;AF_50_Hom=0.0428;DANN_score=0.5164;GREP_score=2.22;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=TTTGTATTTT.AGATCTCCTT	GT:AD:DP:GQ:PL	0/1:133,124:257:99:3787,0,3873
chr1	161332608	.	G	A	3891.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.727;DP=287;ExcessHet=3.0103;FS=0.436;MLEAC=1;MLEAF=0.5;MQ=57.65;MQRankSum=-0.302;QD=13.66;ReadPosRankSum=0.639;SOR=0.663;HGVSnom=NM_003001.5:c.*385G>A;Gene=SDHC;Transcript=NM_003001.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=169;RS=rs8266;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.170128;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0663;NativeFreq_Het=0.2870;NativeFreq_Hom=0.0594;normalHetFrequency=0.1931;normalHetNum=167;normalHomFrequency=0.0254;normalHomNum=22;patientHetFrequency=0.1684;patientHetNum=879;patientHomFrequency=0.031;patientHomNum=162;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3328;AF_2700_Hom=0.0396;AF_50_Het=0.3360;AF_50_Hom=0.0475;DANN_score=0.2168;GREP_score=0.118;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=GGCCGGGTTG.GGGGTGGGTT	GT:AD:DP:GQ:PL	0/1:150,135:285:99:3920,0,4454
chr1	161333191	.	A	G	5516.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.866;DP=328;ExcessHet=3.0103;FS=4.247;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.82;ReadPosRankSum=0.478;SOR=0.923;HGVSnom=.;Gene=SDHC;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs4600063;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.16893;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0576;NativeFreq_Het=0.2901;NativeFreq_Hom=0.0594;normalHetFrequency=0.2683;normalHetNum=128;normalHomFrequency=0.015;normalHomNum=13;patientHetFrequency=0.1301;patientHetNum=679;patientHomFrequency=0.0306;patientHomNum=75;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3328;AF_2700_Hom=0.0388;AF_50_Het=0.3360;AF_50_Hom=0.0475;DANN_score=0.8015;GREP_score=-0.659;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=ATATCACAGA.AAGCCTCAGA	GT:AD:DP:GQ:PL	0/1:158,170:328:99:5545,0,5078
chr1	161333404	.	G	GA	4297.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.663;DP=487;ExcessHet=3.0103;FS=3.189;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.38;ReadPosRankSum=-0.541;SOR=0.546;HGVSnom=.;Gene=SDHC;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs34067216;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.16893;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0576;NativeFreq_Het=0.1858;NativeFreq_Hom=.;normalHetFrequency=0.2683;normalHetNum=128;normalHomFrequency=0.015;normalHomNum=13;patientHetFrequency=0.2778;patientHetNum=680;patientHomFrequency=0.0302;patientHomNum=74;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3332;AF_2700_Hom=0.0392;AF_50_Het=0.3360;AF_50_Hom=0.0475;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=GAAGCATAGA.TTTTTTTTTA	GT:AD:DP:GQ:PL	0/1:257,201:458:99:4335,0,8083
chr1	161333558	.	A	G	6668.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.236;DP=470;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.22;ReadPosRankSum=0.494;SOR=0.623;HGVSnom=.;Gene=SDHC;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3935401;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.16893;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0576;NativeFreq_Het=0.2901;NativeFreq_Hom=0.0594;normalHetFrequency=0.1491;normalHetNum=129;normalHomFrequency=0.0162;normalHomNum=14;patientHetFrequency=0.1301;patientHetNum=679;patientHomFrequency=0.0144;patientHomNum=75;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3328;AF_2700_Hom=0.0392;AF_50_Het=0.3344;AF_50_Hom=0.0491;DANN_score=0.414;GREP_score=-2.13;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=GACTTATCTC.TCTGTCACTT	GT:AD:DP:GQ:PL	0/1:240,229:469:99:6697,0,7577
chr1	161334275	.	C	G	7211.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.264;DP=475;ExcessHet=3.0103;FS=3.224;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.25;ReadPosRankSum=0.053;SOR=0.498;HGVSnom=.;Gene=CFAP126;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs12239492;CLNGENE=SDHC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.169129;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0576;NativeFreq_Het=0.2901;NativeFreq_Hom=0.0594;normalHetFrequency=0.1514;normalHetNum=131;normalHomFrequency=0.0252;normalHomNum=12;patientHetFrequency=0.1303;patientHetNum=680;patientHomFrequency=0.0146;patientHomNum=76;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3324;AF_2700_Hom=0.0400;AF_50_Het=0.3360;AF_50_Hom=0.0475;DANN_score=0.6912;GREP_score=-2.79;CytoBand=q23.3;CGD_CONDITION=Paraganglioma and gastric stromal sarcoma. Gastrointestinal stromal tumor. Paragangliomas 3;CGD_INHERITANCE=AD;Strand=SDHC:NM_001035511.1:+,SDHC:NM_001035512.1:+,SDHC:NM_001035513.1:+,SDHC:NM_001278172.1:+,SDHC:NM_003001.3:+;NP=SDHC:NM_001035511.1:NP_001030588.1,SDHC:NM_001035512.1:NP_001030589.1,SDHC:NM_001035513.1:NP_001030590.1,SDHC:NM_001278172.1:NP_001265101.1,SDHC:NM_003001.3:NP_002992.1;ENSP=SDHC:NM_001035511.1:.,SDHC:NM_001035512.1:.,SDHC:NM_001035513.1:.,SDHC:NM_001278172.1:.,SDHC:NM_003001.3:ENST00000367975.6;Gene_MIM_id=602413;Phenotypes=Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated cases. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 3, 605373 (3), Autosomal dominant. 605373(MK),606764(MK),606864(MK);Possible_Inheritance=AD;EntrezGeneID=6391;EnsemblGeneID=ENSG00000143252;Alias=SDHC, PGL3;FLKSEQ=TGTTAGTTGT.CATGCTCAGG	GT:AD:DP:GQ:PL	0/1:243,230:473:99:7240,0,7641
chr1	161334626	.	G	C	3935.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.678;DP=236;ExcessHet=3.0103;FS=4.126;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.68;ReadPosRankSum=0.123;SOR=1.004;HGVSnom=NM_001013625.4:c.*129C>G;Gene=CFAP126;Transcript=NM_001013625.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=177;RS=rs1133806;G1000_AF=0.16893;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.0487;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.0576;NativeFreq_Het=0.2654;NativeFreq_Hom=0.0556;normalHetFrequency=0.2662;normalHetNum=127;normalHomFrequency=0.0273;normalHomNum=13;patientHetFrequency=0.2749;patientHetNum=673;patientHomFrequency=0.0315;patientHomNum=77;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3878;GREP_score=-0.688;CytoBand=q23.3;Strand=CFAP126:NM_001013625.3:-;NP=CFAP126:NM_001013625.3:NP_001013647.2;ENSP=CFAP126:NM_001013625.3:.;Gene_MIM_id=616119;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=257177;EnsemblGeneID=ENSG00000188931;Alias=CFAP126, FLTP;FLKSEQ=TTATTTCACT.AGTCGCTATA	GT:AD:DP:GQ:PL	0/1:115,121:236:99:3964,0,3831
chr1	182542826	.	G	A	4716.77	PASS	AC=2;AF=1;AN=2;DP=135;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25;SOR=1.239;HGVSnom=NM_021133.4:c.*1701C>T;Gene=RNASEL;Transcript=NM_021133.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=741;RS=rs641265;G1000_AF=0.957867;G1000_EAS_AF=1.0;G1000_EUR_AF=0.998;G1000_AFR_AF=0.848;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9885;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.6122;GREP_score=1.1;CytoBand=q25.3;CGD_CONDITION=Prostate cancer, hereditary, 1;CGD_INHERITANCE=AD;Strand=RNASEL:NM_021133.4:-,RNASEL:NM_021133.3:-;NP=RNASEL:NM_021133.4:NP_066956.1,RNASEL:NM_021133.3:NP_066956.1;ENSP=RNASEL:NM_021133.4:ENST00000367559.7,RNASEL:NM_021133.3:.;Gene_MIM_id=180435;Phenotypes=Prostate cancer 1, 601518 (3), Autosomal dominant. 601518(MK);Possible_Inheritance=AD;EntrezGeneID=6041;EnsemblGeneID=ENSG00000135828;Alias=RNASEL, RNS4, PRCA1, HPC1;FLKSEQ=TAATTGACAT.TCCAGGTGCT	GT:AD:DP:GQ:PL	1/1:0,134:134:99:4745,403,0
chr1	182543175	.	G	A	8811.77	PASS	AC=2;AF=1;AN=2;DP=226;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.56;SOR=1.184;HGVSnom=NM_021133.4:c.*1352C>T;Gene=RNASEL;Transcript=NM_021133.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=741;RS=rs642917;G1000_AF=0.957867;G1000_EAS_AF=1.0;G1000_EUR_AF=0.998;G1000_AFR_AF=0.848;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9885;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.4139;GREP_score=0.674;CytoBand=q25.3;repName=MIRc;repClass=SINE;CGD_CONDITION=Prostate cancer, hereditary, 1;CGD_INHERITANCE=AD;Strand=RNASEL:NM_021133.4:-,RNASEL:NM_021133.3:-;NP=RNASEL:NM_021133.4:NP_066956.1,RNASEL:NM_021133.3:NP_066956.1;ENSP=RNASEL:NM_021133.4:ENST00000367559.7,RNASEL:NM_021133.3:.;Gene_MIM_id=180435;Phenotypes=Prostate cancer 1, 601518 (3), Autosomal dominant. 601518(MK);Possible_Inheritance=AD;EntrezGeneID=6041;EnsemblGeneID=ENSG00000135828;Alias=RNASEL, RNS4, PRCA1, HPC1;FLKSEQ=cagcaaaata.ggataacaat	GT:AD:DP:GQ:PL	1/1:0,226:226:99:8840,680,0
chr1	182544220	.	TA	T	4828.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.389;DP=348;ExcessHet=3.0103;FS=4.139;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.08;ReadPosRankSum=-0.577;SOR=0.515;HGVSnom=NM_021133.4:c.*306delT;Gene=RNASEL;Transcript=NM_021133.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=741;RS=rs138930837;G1000_AF=0.0714856;G1000_EAS_AF=0.1935;G1000_EUR_AF=0.0408;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0685;G1000_AMR_AF=0.072;NativeFreq_Het=0.1337;NativeFreq_Hom=.;normalHetFrequency=0.0232;normalHetNum=9;normalHomFrequency=0.0258;normalHomNum=10;patientHetFrequency=0.0332;patientHetNum=92;patientHomFrequency=0.0119;patientHomNum=33;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3113;AF_2700_Hom=0.0311;AF_50_Het=0.3471;AF_50_Hom=0.0254;CytoBand=q25.3;repName=MIRb;repClass=SINE;CGD_CONDITION=Prostate cancer, hereditary, 1;CGD_INHERITANCE=AD;Strand=RNASEL:NM_021133.4:-,RNASEL:NM_021133.3:-;NP=RNASEL:NM_021133.4:NP_066956.1,RNASEL:NM_021133.3:NP_066956.1;ENSP=RNASEL:NM_021133.4:ENST00000367559.7,RNASEL:NM_021133.3:.;Gene_MIM_id=180435;Phenotypes=Prostate cancer 1, 601518 (3), Autosomal dominant. 601518(MK);Possible_Inheritance=AD;EntrezGeneID=6041;EnsemblGeneID=ENSG00000135828;Alias=RNASEL, RNS4, PRCA1, HPC1;FLKSEQ=ttgggaaaat.agtgagagaa	GT:AD:DP:GQ:PL	0/1:185,158:343:99:4866,0,5847
chr1	182551337	.	A	C	10749.8	PASS	AC=2;AF=1;AN=2;DP=277;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.62;SOR=0.783;HGVSnom=NM_021133.4:c.1623T>G(p.Asp541Glu/p.D541E);Gene=RNASEL;Transcript=NM_021133.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=741;EXAC_AF=0.53798751;EXAC_Hom_EAS=2272;EXAC_AC_EAS=6242;EXAC_AN_EAS=8650;EXAC_AC_Adj=65302;EXAC_AN_Adj=121382;ESP6500_MAF=0.47216669;RS=rs627928;Ensembl_transcriptid=ENST00000367559|ENST00000539397;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.0|.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;G1000_AF=0.479832;G1000_EAS_AF=0.7093;G1000_EUR_AF=0.5686;G1000_AFR_AF=0.2632;G1000_SAS_AF=0.4714;G1000_AMR_AF=0.4424;gnomad_exomes_AF=0.53983037;gnomad_exomes_AF_EAS=0.72344243;gnomad_exomes_AC=134299;gnomad_exomes_Hom=37156;gnomad_exomes_Het=59987;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31934531;gnomad_exomes_AF_NFE=0.56215350;gnomad_exomes_AF_AMR=0.48048456;gnomad_exomes_AF_SAS=0.49918343;HGMD_gene=RNASEL;HGMD_disease=Prostate_cancer_association_with;HGMD_tag=DP;HGMD_pmid=12915880;NativeFreq_Het=0.4554;NativeFreq_Hom=0.4752;normalHetFrequency=0.4021;normalHetNum=156;normalHomFrequency=0.4536;normalHomNum=176;patientHetFrequency=0.4214;patientHetNum=1168;patientHomFrequency=0.4318;patientHomNum=1197;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4220;AF_2700_Hom=0.5015;AF_50_Het=0.4469;AF_50_Hom=0.4960;DANN_score=0.1979;GREP_score=-5.59;CytoBand=q25.3;CGD_CONDITION=Prostate cancer, hereditary, 1;CGD_INHERITANCE=AD;Strand=RNASEL:NM_021133.4:-,RNASEL:NM_021133.3:-;NP=RNASEL:NM_021133.4:NP_066956.1,RNASEL:NM_021133.3:NP_066956.1;ENSP=RNASEL:NM_021133.4:ENST00000367559.7,RNASEL:NM_021133.3:.;Gene_MIM_id=180435;Phenotypes=Prostate cancer 1, 601518 (3), Autosomal dominant. 601518(MK);Possible_Inheritance=AD;EntrezGeneID=6041;EnsemblGeneID=ENSG00000135828;Alias=RNASEL, RNS4, PRCA1, HPC1;FLKSEQ=GAGCTTTCAG.TCCTCAAATG	GT:AD:DP:GQ:PL	1/1:0,276:276:99:10778,830,0
chr1	182558398	.	T	C	8441.77	PASS	AC=2;AF=1;AN=2;DP=229;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.17;SOR=1.392;HGVSnom=.;Gene=RNASEL;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs589974;G1000_AF=0.995407;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9834;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9986;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0103;normalHomNum=4;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.004;patientHomNum=11;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0038365|15D6104554|16B0028106|15D6534493|16B0005540|16B0019035-1|15B0040463|16D0067283|16B3094884|16B0035556-1|15B6325537][_];DANN_score=0.434;GREP_score=0.0494;CytoBand=q25.3;Gene_MIM_id=180435;Phenotypes=Prostate cancer 1, 601518 (3), Autosomal dominant. 601518(MK);Possible_Inheritance=AD;EntrezGeneID=6041;EnsemblGeneID=ENSG00000135828;Alias=RNASEL, RNS4, PRCA1, HPC1;FLKSEQ=CGTCACTGAG.CAGCAGGGCG	GT:AD:DP:GQ:PL	1/1:0,228:228:99:8470,684,0
chr1	193094375	.	T	C	8001.77	PASS	AC=2;AF=1;AN=2;DP=213;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.8;SOR=1.92;HGVSnom=NM_024529.5:c.237+28T>C;Gene=CDC73;Transcript=NM_024529.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_024529.5:IVS2+28T>C;AAlength=531;EXAC_AF=0.65665434;EXAC_Hom_EAS=914;EXAC_AC_EAS=3866;EXAC_AN_EAS=8378;EXAC_AC_Adj=78155;EXAC_AN_Adj=119020;ESP6500_MAF=0.63386129;RS=rs4466634;CLNGENE=CDC73;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.590256;G1000_EAS_AF=0.4494;G1000_EUR_AF=0.6332;G1000_AFR_AF=0.5106;G1000_SAS_AF=0.773;G1000_AMR_AF=0.6268;gnomad_exomes_AF=0.65167223;gnomad_exomes_AF_EAS=0.44945670;gnomad_exomes_AC=162428;gnomad_exomes_Hom=53807;gnomad_exomes_Het=54814;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.52244872;gnomad_exomes_AF_NFE=0.68176319;gnomad_exomes_AF_AMR=0.63749855;gnomad_exomes_AF_SAS=0.76521995;NativeFreq_Het=0.5742;NativeFreq_Hom=0.2456;normalHetFrequency=0.4897;normalHetNum=190;normalHomFrequency=0.25;normalHomNum=97;patientHetFrequency=0.4315;patientHetNum=1196;patientHomFrequency=0.2987;patientHomNum=828;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4839;AF_2700_Hom=0.1795;AF_50_Het=0.4834;AF_50_Hom=0.1727;DANN_score=0.4877;GREP_score=0.747;CytoBand=q31.2;CGD_CONDITION=Hyperparathyroidism 1. Hyperparathyroidism-jaw tumor syndrome. Carcinoma, parathyroid;CGD_INHERITANCE=AD;Strand=CDC73:NM_024529.4:+;NP=CDC73:NM_024529.4:NP_078805.3;ENSP=CDC73:NM_024529.4:ENST00000367435.4;Gene_MIM_id=607393;Phenotypes=Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant. Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant. Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant. Parathyroid carcinoma, 608266 (3). 145000(MK),145001(MK),608266(MK);Possible_Inheritance=AD;EntrezGeneID=79577;EnsemblGeneID=ENSG00000134371;Alias=HRPT2, C1orf28;FLKSEQ=TACTTATCTA.CTATTTATCA	GT:AD:DP:GQ:PL	1/1:0,213:213:99:8030,641,0
chr1	193111228	.	TGA	T	643.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.877;DP=214;ExcessHet=3.0103;FS=7.066;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.13;ReadPosRankSum=0.572;SOR=0.28;HGVSnom=NM_024529.5:c.729+50_729+51delAG;Gene=CDC73;Transcript=NM_024529.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_024529.5:IVS7+50_+51delAG;AAlength=531;EXAC_AF=0.35825102;EXAC_Hom_EAS=0;EXAC_AC_EAS=1591;EXAC_AN_EAS=4616;EXAC_AC_Adj=27202;EXAC_AN_Adj=75930;RS=rs80356646;CLNGENE=CDC73;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.36480891;gnomad_exomes_AF_EAS=0.38733997;gnomad_exomes_AC=38410;gnomad_exomes_Hom=9;gnomad_exomes_Het=38392;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32325115;gnomad_exomes_AF_NFE=0.35748477;gnomad_exomes_AF_AMR=0.40004308;gnomad_exomes_AF_SAS=0.41886463;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.4021;normalHetNum=156;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.3986;patientHetNum=1105;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q31.2;CGD_CONDITION=Hyperparathyroidism 1. Hyperparathyroidism-jaw tumor syndrome. Carcinoma, parathyroid;CGD_INHERITANCE=AD;Strand=CDC73:NM_024529.4:+;NP=CDC73:NM_024529.4:NP_078805.3;ENSP=CDC73:NM_024529.4:ENST00000367435.4;Gene_MIM_id=607393;Phenotypes=Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant. Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant. Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant. Parathyroid carcinoma, 608266 (3). 145000(MK),145001(MK),608266(MK);Possible_Inheritance=AD;EntrezGeneID=79577;EnsemblGeneID=ENSG00000134371;Alias=HRPT2, C1orf28;FLKSEQ=TTCATTGGAG.GAGAGAGAGA	GT:AD:DP:GQ:PL	0/1:122,34:156:99:681,0,3858
chr1	193202032	.	CA	C	48.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.454;DP=93;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.55;ReadPosRankSum=-1.569;SOR=0.597;HGVSnom=NM_024529.5:c.1155-79delA;Gene=CDC73;Transcript=NM_024529.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_024529.5:IVS13-79delA;AAlength=531;RS=rs201897186;CLNGENE=CDC73;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.0412;normalHetNum=16;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0635;patientHetNum=176;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545647][_];CytoBand=q31.2;repName=AluSq4;repClass=SINE;CGD_CONDITION=Hyperparathyroidism 1. Hyperparathyroidism-jaw tumor syndrome. Carcinoma, parathyroid;CGD_INHERITANCE=AD;Strand=CDC73:NM_024529.4:+;NP=CDC73:NM_024529.4:NP_078805.3;ENSP=CDC73:NM_024529.4:ENST00000367435.4;Gene_MIM_id=607393;Phenotypes=Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant. Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant. Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant. Parathyroid carcinoma, 608266 (3). 145000(MK),145001(MK),608266(MK);Possible_Inheritance=AD;EntrezGeneID=79577;EnsemblGeneID=ENSG00000134371;Alias=HRPT2, C1orf28;FLKSEQ=aactctgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:75,13:88:86:86,0,1594
chr1	193220974	.	G	GT	329.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.708;DP=672;ExcessHet=3.0103;FS=0.764;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.53;ReadPosRankSum=-0.018;SOR=0.583;HGVSnom=NM_024529.5:c.*1144dupT;Gene=CDC73;Transcript=NM_024529.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=531;RS=rs538761780;CLNGENE=CDC73;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0028130][_];AF_2700_Het=0.0534;AF_2700_Hom=.;AF_50_Het=0.0523;AF_50_Hom=.;CytoBand=q31.2;CGD_CONDITION=Hyperparathyroidism 1. Hyperparathyroidism-jaw tumor syndrome. Carcinoma, parathyroid;CGD_INHERITANCE=AD;Strand=CDC73:NM_024529.4:+;NP=CDC73:NM_024529.4:NP_078805.3;ENSP=CDC73:NM_024529.4:ENST00000367435.4;Gene_MIM_id=607393;Phenotypes=Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominant. Hyperparathyroidism-jaw tumor syndrome, 145001 (3), Autosomal dominant. Parathyroid adenoma with cystic changes, 145001 (3), Autosomal dominant. Parathyroid carcinoma, 608266 (3). 145000(MK),145001(MK),608266(MK);Possible_Inheritance=AD;EntrezGeneID=79577;EnsemblGeneID=ENSG00000134371;Alias=HRPT2, C1orf28;FLKSEQ=ATTTCACTTT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:534,89:623:99:367,0,10986
chr1	241663902	.	TGA	T	3166.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.677;DP=326;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.99;ReadPosRankSum=-0.488;SOR=0.908;OLD_VARIANT=chr1|241663902|TGA|T,TGAGAGAGA|1;HGVSnom=NM_000143.4:c.1237-14_1237-13delTC;Gene=FH;Transcript=NM_000143.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000143.4:IVS8-14_-13delTC;AAlength=510;RS=rs144131869;CLNGENE=FH;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;NativeFreq_Het=0.0155;NativeFreq_Hom=.;normalHetFrequency=0.1272;normalHetNum=110;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1243;patientHetNum=649;patientHomFrequency=0.0017;patientHomNum=9;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1533073-1|15D6722398-1|16D0169459|15B0058214|15D6529789][16D3110159-1|16D0067144|15B0002461|15D6515539];AF_2700_Het=0.1649;AF_2700_Hom=.;AF_50_Het=0.1759;AF_50_Hom=.;CytoBand=q43;repName=(GA)n;repClass=Simple_repeat;CGD_CONDITION=Hereditary leiomyomatosis and renal cell cancer;CGD_INHERITANCE=AD;Strand=FH:NM_000143.3:-;NP=FH:NM_000143.3:NP_000134.2;ENSP=FH:NM_000143.3:ENST00000366560.3;Gene_MIM_id=136850;Phenotypes=Fumarase deficiency, 606812 (3), Autosomal recessive. Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant. 150800(MK),606812(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2271;EnsemblGeneID=ENSG00000091483;Alias=FH, HLRCC, MCUL1, FMRD;FLKSEQ=TTTgagtgag.gagagagaga	GT:AD:DP:GQ:PL	1/0:21,79:176:99:3204,1760,2363
chr1	241663902	.	T	TGAGAGA	3166.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.677;DP=326;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.99;ReadPosRankSum=-0.488;SOR=0.908;OLD_VARIANT=chr1|241663902|TGA|T,TGAGAGAGA|2;HGVSnom=NM_000143.4:c.1237-18_1237-13dupTCTCTC;Gene=FH;Transcript=NM_000143.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000143.4:IVS8-13_-12insTCTCTC;AAlength=510;RS=rs144131869;CLNGENE=FH;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;normalHetFrequency=0.0798;normalHetNum=69;normalHomFrequency=0.0277;normalHomNum=24;patientHetFrequency=0.0935;patientHetNum=488;patientHomFrequency=0.033;patientHomNum=172;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=.;AF_2700_Hom=.;AF_50_Het=0.6070;AF_50_Hom=.;CytoBand=q43;repName=(GA)n;repClass=Simple_repeat;CGD_CONDITION=Hereditary leiomyomatosis and renal cell cancer;CGD_INHERITANCE=AD;Strand=FH:NM_000143.3:-;NP=FH:NM_000143.3:NP_000134.2;ENSP=FH:NM_000143.3:ENST00000366560.3;Gene_MIM_id=136850;Phenotypes=Fumarase deficiency, 606812 (3), Autosomal recessive. Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant. 150800(MK),606812(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2271;EnsemblGeneID=ENSG00000091483;Alias=FH, HLRCC, MCUL1, FMRD;FLKSEQ=TTTgagtgag.gagagagaga	GT:AD:DP:GQ:PL	0/1:21,76:176:99:3204,1240,2403
chr1	241667244	.	G	T	7692.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.008;DP=202;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26;ReadPosRankSum=-0.609;SOR=1.639;HGVSnom=NM_000143.4:c.1108+98C>A;Gene=FH;Transcript=NM_000143.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000143.4:IVS7+98C>A;AAlength=510;RS=rs4659607;CLNGENE=FH;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.735823;G1000_EAS_AF=0.5694;G1000_EUR_AF=0.7048;G1000_AFR_AF=0.8018;G1000_SAS_AF=0.8855;G1000_AMR_AF=0.6859;NativeFreq_Het=0.5643;NativeFreq_Hom=0.2500;normalHetFrequency=0.4566;normalHetNum=395;normalHomFrequency=0.3503;normalHomNum=303;patientHetFrequency=0.4554;patientHetNum=2377;patientHomFrequency=0.3485;patientHomNum=1819;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5906;GREP_score=-3.8;CytoBand=q43;CGD_CONDITION=Hereditary leiomyomatosis and renal cell cancer;CGD_INHERITANCE=AD;Strand=FH:NM_000143.3:-;NP=FH:NM_000143.3:NP_000134.2;ENSP=FH:NM_000143.3:ENST00000366560.3;Gene_MIM_id=136850;Phenotypes=Fumarase deficiency, 606812 (3), Autosomal recessive. Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant. 150800(MK),606812(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2271;EnsemblGeneID=ENSG00000091483;Alias=FH, HLRCC, MCUL1, FMRD;FLKSEQ=GCATCCAGCT.CGGGATAACT	GT:AD:DP:GQ:PL	1/1:1,201:202:99:7721,568,0
chr2	17942775	.	T	A	12551.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.201;DP=358;ExcessHet=3.0103;FS=4.219;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.02;ReadPosRankSum=1.234;SOR=1.089;HGVSnom=NM_001130009.3:c.274T>A(p.Ser92Thr/p.S92T);Gene=GEN1;Transcript=NM_001130009.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E3;IVSnom=.;AAlength=908;EXAC_AF=0.71378549;EXAC_Hom_EAS=4193;EXAC_AC_EAS=8517;EXAC_AN_EAS=8654;EXAC_AC_Adj=86635;EXAC_AN_Adj=121374;ESP6500_MAF=0.67122866;RS=rs1812152;Ensembl_transcriptid=ENST00000317402|ENST00000524465|ENST00000381254|ENST00000532257;SIFT_pred=T|T|T|T;SIFT_score=1.0|0.452|1.0|0.533;Polyphen2_HVAR_pred=B|.|B|.;Polyphen2_HVAR_score=0.002|.|0.002|.;MutationTaster_pred=P|P|P;MutationTaster_score=0.999999|0.999999|8.22921e-06;CLNGENE=GEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.813698;G1000_EAS_AF=0.9861;G1000_EUR_AF=0.6382;G1000_AFR_AF=0.7708;G1000_SAS_AF=0.8978;G1000_AMR_AF=0.781;gnomad_exomes_AF=0.71765352;gnomad_exomes_AF_EAS=0.98444976;gnomad_exomes_AC=180276;gnomad_exomes_Hom=66901;gnomad_exomes_Het=46474;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76536519;gnomad_exomes_AF_NFE=0.62427613;gnomad_exomes_AF_AMR=0.83831624;gnomad_exomes_AF_SAS=0.87344710;NativeFreq_Het=0.2206;NativeFreq_Hom=0.7295;DANN_score=0.6983;GREP_score=0.326;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=GAGGAATCAG.CTCGGTATGG	GT:AD:DP:GQ:PL	1/1:1,353:354:99:12580,1036,0
chr2	17954027	.	G	A	11511.8	PASS	AC=2;AF=1;AN=2;DP=320;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.98;SOR=1.529;HGVSnom=NM_001130009.3:c.929G>A(p.Ser310Asn/p.S310N);Gene=GEN1;Transcript=NM_001130009.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E8;IVSnom=.;AAlength=908;EXAC_AF=0.99322838;EXAC_Hom_EAS=4316;EXAC_AC_EAS=8634;EXAC_AN_EAS=8636;EXAC_AC_Adj=120127;EXAC_AN_Adj=120946;ESP6500_MAF=0.98354606;RS=rs300175;Ensembl_transcriptid=ENST00000317402|ENST00000381254|ENST00000534451;SIFT_pred=T|T|.;SIFT_score=0.706|0.706|.;Polyphen2_HVAR_pred=B|B|.;Polyphen2_HVAR_score=0.001|0.001|.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;CLNGENE=GEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.977037;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9387;G1000_SAS_AF=0.9663;G1000_AMR_AF=0.9986;gnomad_exomes_AF=0.99435357;gnomad_exomes_AF_EAS=0.99978173;gnomad_exomes_AC=248129;gnomad_exomes_Hom=123386;gnomad_exomes_Het=1357;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95148747;gnomad_exomes_AF_NFE=0.99985821;gnomad_exomes_AF_AMR=0.99732903;gnomad_exomes_AF_SAS=0.98420361;NativeFreq_Het=0.0249;NativeFreq_Hom=0.9715;DANN_score=0.6461;GREP_score=-11.3;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=AGGCAACTCA.TGAAGTAGAG	GT:AD:DP:GQ:PL	1/1:0,320:320:99:11540,961,0
chr2	17954421	.	C	G	12830.8	PASS	AC=2;AF=1;AN=2;DP=339;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.51;SOR=0.964;HGVSnom=NM_001130009.3:c.990+22C>G;Gene=GEN1;Transcript=NM_001130009.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_001130009.3:IVS9+22C>G;AAlength=908;EXAC_AF=0.71648080;EXAC_Hom_EAS=4169;EXAC_AC_EAS=8469;EXAC_AN_EAS=8604;EXAC_AC_Adj=84678;EXAC_AN_Adj=118186;ESP6500_MAF=0.66981863;RS=rs300177;CLNGENE=GEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.811502;G1000_EAS_AF=0.9861;G1000_EUR_AF=0.6382;G1000_AFR_AF=0.7625;G1000_SAS_AF=0.8978;G1000_AMR_AF=0.781;gnomad_exomes_AF=0.71672036;gnomad_exomes_AF_EAS=0.98466090;gnomad_exomes_AC=176630;gnomad_exomes_Hom=65430;gnomad_exomes_Het=45770;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75614195;gnomad_exomes_AF_NFE=0.62407935;gnomad_exomes_AF_AMR=0.83762324;gnomad_exomes_AF_SAS=0.87319106;NativeFreq_Het=0.2171;NativeFreq_Hom=0.7224;DANN_score=0.4931;GREP_score=-4.79;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=TAATTCAACT.TATTAATTTT	GT:AD:DP:GQ:PL	1/1:0,339:339:99:12859,1020,0
chr2	17962450	.	A	G	14274.8	PASS	AC=2;AF=1;AN=2;DP=370;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.11;SOR=0.959;HGVSnom=NM_001130009.3:c.1971A>G(p.Glu657Glu/p.E657E);Gene=GEN1;Transcript=NM_001130009.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=908;EXAC_AF=0.57581988;EXAC_Hom_EAS=3689;EXAC_AC_EAS=7978;EXAC_AN_EAS=8640;EXAC_AC_Adj=69741;EXAC_AN_Adj=121116;ESP6500_MAF=0.42611103;RS=rs300168;CLNGENE=GEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.573882;G1000_EAS_AF=0.9226;G1000_EUR_AF=0.5249;G1000_AFR_AF=0.1536;G1000_SAS_AF=0.7894;G1000_AMR_AF=0.6354;gnomad_exomes_AF=0.58905132;gnomad_exomes_AF_EAS=0.92323177;gnomad_exomes_AC=147641;gnomad_exomes_Hom=47303;gnomad_exomes_Het=53035;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.21650246;gnomad_exomes_AF_NFE=0.51534382;gnomad_exomes_AF_AMR=0.74659598;gnomad_exomes_AF_SAS=0.76795634;NativeFreq_Het=0.2420;NativeFreq_Hom=0.5907;DANN_score=0.7944;GREP_score=1.6;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=TTAGTCCTGA.GAGCATCTAC	GT:AD:DP:GQ:PL	1/1:0,370:370:99:14303,1113,0
chr2	17962518	.	C	T	15635.8	PASS	AC=2;AF=1;AN=2;DP=428;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.08;SOR=0.707;HGVSnom=NM_001130009.3:c.2039C>T(p.Thr680Ile/p.T680I);Gene=GEN1;Transcript=NM_001130009.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E14;IVSnom=.;AAlength=908;EXAC_AF=0.69814622;EXAC_Hom_EAS=4188;EXAC_AC_EAS=8508;EXAC_AN_EAS=8644;EXAC_AC_Adj=84586;EXAC_AN_Adj=121158;ESP6500_MAF=0.61871444;RS=rs300169;Ensembl_transcriptid=ENST00000317402|ENST00000381254;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.0|0.0;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;CLNGENE=GEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.757987;G1000_EAS_AF=0.9851;G1000_EUR_AF=0.6372;G1000_AFR_AF=0.5719;G1000_SAS_AF=0.8978;G1000_AMR_AF=0.7608;gnomad_exomes_AF=0.70486533;gnomad_exomes_AF_EAS=0.98455178;gnomad_exomes_AC=176487;gnomad_exomes_Hom=64512;gnomad_exomes_Het=47463;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59578164;gnomad_exomes_AF_NFE=0.62344248;gnomad_exomes_AF_AMR=0.82732063;gnomad_exomes_AF_SAS=0.87297386;NativeFreq_Het=0.2278;NativeFreq_Hom=0.7082;DANN_score=0.6974;GREP_score=1.16;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=CGAATATTTA.AAAATTATCA	GT:AD:DP:GQ:PL	1/1:0,427:427:99:15664,1284,0
chr2	17965931	.	G	A	13979.8	PASS	AC=2;AF=1;AN=2;DP=361;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.23;SOR=1.098;HGVSnom=NM_001130009.3:c.*2725G>A;Gene=GEN1;Transcript=NM_001130009.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=908;RS=rs300170;G1000_AF=0.571885;G1000_EAS_AF=0.9167;G1000_EUR_AF=0.5249;G1000_AFR_AF=0.1536;G1000_SAS_AF=0.7853;G1000_AMR_AF=0.6354;DANN_score=0.5727;GREP_score=0.82;CytoBand=p24.2;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=AACTCTTTAA.GACTGTATTG	GT:AD:DP:GQ:PL	1/1:0,360:360:99:14008,1082,0
chr2	17966157	.	A	G	12571.8	PASS	AC=2;AF=1;AN=2;DP=325;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.03;SOR=0.699;HGVSnom=NM_001130009.3:c.*2951A>G;Gene=GEN1;Transcript=NM_001130009.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=908;RS=rs300171;G1000_AF=0.758786;G1000_EAS_AF=0.9861;G1000_EUR_AF=0.6372;G1000_AFR_AF=0.5734;G1000_SAS_AF=0.8978;G1000_AMR_AF=0.7622;DANN_score=0.23;GREP_score=-0.39;CytoBand=p24.2;repName=MER1B;repClass=DNA;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=ATAGCTcagg.gtccccaacc	GT:AD:DP:GQ:PL	1/1:0,325:325:99:12600,977,0
chr2	17966421	.	T	G	12691.8	PASS	AC=2;AF=1;AN=2;DP=355;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.67;SOR=0.958;HGVSnom=NM_001130009.3:c.*3215T>G;Gene=GEN1;Transcript=NM_001130009.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=908;RS=rs300172;G1000_AF=0.757987;G1000_EAS_AF=0.9861;G1000_EUR_AF=0.6362;G1000_AFR_AF=0.5719;G1000_SAS_AF=0.8978;G1000_AMR_AF=0.7608;DANN_score=0.2866;GREP_score=-0.47;CytoBand=p24.2;repName=MER1B;repClass=DNA;Strand=GEN1:NM_182625.4:+,GEN1:NM_001130009.2:+;NP=GEN1:NM_182625.4:NP_872431.4,GEN1:NM_001130009.2:NP_001123481.2;ENSP=GEN1:NM_182625.4:.,GEN1:NM_001130009.2:ENST00000381254.6;Gene_MIM_id=612449;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=348654;EnsemblGeneID=ENSG00000178295;Alias=GEN1;FLKSEQ=catctccccc.catcatccgt	GT:AD:DP:GQ:PL	1/1:0,354:354:99:12720,1063,0
chr2	29415792	.	G	A	17044.8	PASS	AC=2;AF=1;AN=2;DP=457;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.61;SOR=0.742;HGVSnom=NM_004304.5:c.*298C>T;Gene=ALK;Transcript=NM_004304.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E29;IVSnom=.;AAlength=1620;RS=rs1728828;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.992812;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9728;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.268;normalHomNum=104;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.2536;patientHomNum=703;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0011873][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.2228;GREP_score=-0.0415;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=CACACAATTT.AAAGAAGCAT	GT:AD:DP:GQ:PL	1/1:0,455:455:99:17073,1368,0
chr2	29416025	.	C	CATTG	9159.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.744;DP=451;ExcessHet=3.0103;FS=0.522;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.45;ReadPosRankSum=-1.484;SOR=0.772;HGVSnom=NM_004304.5:c.*61_*64dupCAAT;Gene=ALK;Transcript=NM_004304.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E29;IVSnom=.;AAlength=1620;RS=rs397706189;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.397165;G1000_EAS_AF=0.7292;G1000_EUR_AF=0.2336;G1000_AFR_AF=0.1755;G1000_SAS_AF=0.4888;G1000_AMR_AF=0.4452;NativeFreq_Het=0.4554;NativeFreq_Hom=.;normalHetFrequency=0.3995;normalHetNum=155;normalHomFrequency=0.4149;normalHomNum=161;patientHetFrequency=0.3611;patientHetNum=1001;patientHomFrequency=0.3849;patientHomNum=1067;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3755;AF_2700_Hom=0.5553;AF_50_Het=0.3946;AF_50_Hom=0.5325;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GTGAAGGAGC.ATTGCCTCTC	GT:AD:DP:GQ:PL	0/1:208,219:427:99:9197,0,9199
chr2	29416366	.	G	C	6783.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.937;DP=407;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.67;ReadPosRankSum=-0.111;SOR=0.687;HGVSnom=NM_004304.5:c.4587C>G(p.Asp1529Glu/p.D1529E);Gene=ALK;Transcript=NM_004304.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E29;IVSnom=.;AAlength=1620;EXAC_AF=0.46001978;EXAC_Hom_EAS=2430;EXAC_AC_EAS=6448;EXAC_AN_EAS=8638;EXAC_AC_Adj=55828;EXAC_AN_Adj=121360;ESP6500_MAF=0.43349223;RS=rs1881421;Ensembl_transcriptid=ENST00000642122|ENST00000389048|ENST00000618119;SIFT_pred=.|T|.;SIFT_score=.|1.0|.;Polyphen2_HVAR_pred=.|B|.;Polyphen2_HVAR_score=.|0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.572883;G1000_EAS_AF=0.7292;G1000_EUR_AF=0.3837;G1000_AFR_AF=0.643;G1000_SAS_AF=0.5133;G1000_AMR_AF=0.5706;gnomad_exomes_AF=0.46849340;gnomad_exomes_AF_EAS=0.74573138;gnomad_exomes_AC=117649;gnomad_exomes_Hom=30306;gnomad_exomes_Het=57037;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62623092;gnomad_exomes_AF_NFE=0.35877997;gnomad_exomes_AF_AMR=0.65955478;gnomad_exomes_AF_SAS=0.45815367;NativeFreq_Het=0.4164;NativeFreq_Hom=0.5643;normalHetFrequency=0.4021;normalHetNum=156;normalHomFrequency=0.4201;normalHomNum=163;patientHetFrequency=0.3766;patientHetNum=1044;patientHomFrequency=0.4004;patientHomNum=1110;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3759;AF_2700_Hom=0.5565;AF_50_Het=0.3930;AF_50_Hom=0.5341;DANN_score=0.594;GREP_score=-3.42;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GGTTACCCCT.TCGTGTGGCT	GT:AD:DP:GQ:PL	0/1:205,202:407:99:6812,0,6725
chr2	29416481	.	T	C	6917.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.026;DP=429;ExcessHet=3.0103;FS=7.083;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.2;ReadPosRankSum=-0.445;SOR=0.381;HGVSnom=NM_004304.5:c.4472A>G(p.Lys1491Arg/p.K1491R);Gene=ALK;Transcript=NM_004304.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E29;IVSnom=.;AAlength=1620;EXAC_AF=0.33181758;EXAC_Hom_EAS=2440;EXAC_AC_EAS=6461;EXAC_AN_EAS=8642;EXAC_AC_Adj=40280;EXAC_AN_Adj=121392;ESP6500_MAF=0.22335845;RS=rs1881420;Ensembl_transcriptid=ENST00000642122|ENST00000389048|ENST00000618119;SIFT_pred=.|T|.;SIFT_score=.|0.408|.;Polyphen2_HVAR_pred=.|B|.;Polyphen2_HVAR_score=.|0.003|.;MutationTaster_pred=P|P;MutationTaster_score=0.999915|0.947332;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.415136;G1000_EAS_AF=0.7312;G1000_EUR_AF=0.2336;G1000_AFR_AF=0.2405;G1000_SAS_AF=0.4898;G1000_AMR_AF=0.4467;gnomad_exomes_AF=0.34364982;gnomad_exomes_AF_EAS=0.74668334;gnomad_exomes_AC=86397;gnomad_exomes_Hom=19009;gnomad_exomes_Het=48379;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24898487;gnomad_exomes_AF_NFE=0.22291901;gnomad_exomes_AF_AMR=0.58788667;gnomad_exomes_AF_SAS=0.42265482;NativeFreq_Het=0.3416;NativeFreq_Hom=0.5841;normalHetFrequency=0.384;normalHetNum=149;normalHomFrequency=0.4098;normalHomNum=159;patientHetFrequency=0.355;patientHetNum=984;patientHomFrequency=0.3795;patientHomNum=1052;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3770;AF_2700_Hom=0.5546;AF_50_Het=0.3946;AF_50_Hom=0.5325;DANN_score=0.9867;GREP_score=1.9;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=TCCGTGGACC.TGTGCAACTC	GT:AD:DP:GQ:PL	0/1:216,211:427:99:6946,0,6852
chr2	29416572	.	T	C	16431.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.401;DP=433;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.2;ReadPosRankSum=-0.349;SOR=0.397;HGVSnom=NM_004304.5:c.4381A>G(p.Ile1461Val/p.I1461V);Gene=ALK;Transcript=NM_004304.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E29;IVSnom=.;AAlength=1620;EXAC_AF=0.99716345;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=120930;EXAC_AN_Adj=121274;ESP6500_MAF=0.99031216;RS=rs1670283;Ensembl_transcriptid=ENST00000642122|ENST00000389048|ENST00000618119;SIFT_pred=.|T|.;SIFT_score=.|1.0|.;Polyphen2_HVAR_pred=.|B|.;Polyphen2_HVAR_score=.|0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.992212;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9713;G1000_SAS_AF=0.999;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99755395;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=249995;gnomad_exomes_Hom=124701;gnomad_exomes_Het=593;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96886537;gnomad_exomes_AF_NFE=0.99979688;gnomad_exomes_AF_AMR=0.99898610;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9768;normalHomNum=379;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.9784;patientHomNum=2712;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0172231][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9996;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5289;GREP_score=-0.134;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=CGAACAGAGA.CTCTGCAGCT	GT:AD:DP:GQ:PL	1/1:1,431:432:99:16460,1259,0
chr2	29419591	.	G	T	4466.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.087;DP=279;ExcessHet=3.0103;FS=13.278;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.01;ReadPosRankSum=-0.788;SOR=1.441;HGVSnom=NM_004304.5:c.4164+45C>A;Gene=ALK;Transcript=NM_004304.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I28;IVSnom=NM_004304.5:IVS28+45C>A;AAlength=1620;EXAC_AF=0.52791753;EXAC_Hom_EAS=305;EXAC_AC_EAS=2180;EXAC_AN_EAS=8636;EXAC_AC_Adj=64010;EXAC_AN_Adj=121250;ESP6500_MAF=0.54697832;RS=rs1670284;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.420727;G1000_EAS_AF=0.2698;G1000_EUR_AF=0.6024;G1000_AFR_AF=0.3495;G1000_SAS_AF=0.4816;G1000_AMR_AF=0.4265;gnomad_exomes_AF=0.51985958;gnomad_exomes_AF_EAS=0.25296615;gnomad_exomes_AC=130465;gnomad_exomes_Hom=36453;gnomad_exomes_Het=57559;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.35390769;gnomad_exomes_AF_NFE=0.62777043;gnomad_exomes_AF_AMR=0.33480928;gnomad_exomes_AF_SAS=0.53530566;NativeFreq_Het=0.4270;NativeFreq_Hom=0.1459;normalHetFrequency=0.3995;normalHetNum=155;normalHomFrequency=0.1495;normalHomNum=58;patientHetFrequency=0.3781;patientHetNum=1048;patientHomFrequency=0.1944;patientHomNum=539;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4727;GREP_score=4.95;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=CTTTAAGACT.TTTCATATAG	GT:AD:DP:GQ:PL	0/1:140,139:279:99:4495,0,4516
chr2	29445458	.	G	T	4127.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.312;DP=306;ExcessHet=3.0103;FS=3.099;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.58;ReadPosRankSum=-1.874;SOR=0.539;HGVSnom=NM_004304.5:c.3375C>A(p.Gly1125Gly/p.G1125G);Gene=ALK;Transcript=NM_004304.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E21;IVSnom=.;AAlength=1620;EXAC_AF=0.32714881;EXAC_Hom_EAS=2351;EXAC_AC_EAS=6317;EXAC_AN_EAS=8562;EXAC_AC_Adj=39074;EXAC_AN_Adj=119438;ESP6500_MAF=0.22143626;RS=rs3795850;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.415935;G1000_EAS_AF=0.7173;G1000_EUR_AF=0.2346;G1000_AFR_AF=0.2602;G1000_SAS_AF=0.4796;G1000_AMR_AF=0.4481;gnomad_exomes_AF=0.33694194;gnomad_exomes_AF_EAS=0.73731311;gnomad_exomes_AC=84377;gnomad_exomes_Hom=18404;gnomad_exomes_Het=47569;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.25858661;gnomad_exomes_AF_NFE=0.21334924;gnomad_exomes_AF_AMR=0.59617842;gnomad_exomes_AF_SAS=0.39073759;NativeFreq_Het=0.3663;NativeFreq_Hom=0.5544;normalHetFrequency=0.3866;normalHetNum=150;normalHomFrequency=0.3918;normalHomNum=152;patientHetFrequency=0.36;patientHetNum=998;patientHomFrequency=0.3676;patientHomNum=1019;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3916;AF_2700_Hom=0.5304;AF_50_Het=0.4041;AF_50_Hom=0.5151;DANN_score=0.568;GREP_score=-8.53;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=CCCCAAAGGC.CCATGGCCCA	GT:AD:DP:GQ:PL	0/1:158,146:304:99:4156,0,4663
chr2	29446184	.	C	G	3226.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.356;DP=244;ExcessHet=3.0103;FS=1.912;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.22;ReadPosRankSum=-0.013;SOR=0.533;HGVSnom=NM_004304.5:c.3359+24G>C;Gene=ALK;Transcript=NM_004304.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_004304.5:IVS20+24G>C;AAlength=1620;EXAC_AF=0.33116331;EXAC_Hom_EAS=2494;EXAC_AC_EAS=6516;EXAC_AN_EAS=8584;EXAC_AC_Adj=39729;EXAC_AN_Adj=119968;ESP6500_MAF=0.22343534;RS=rs2276550;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.420727;G1000_EAS_AF=0.7381;G1000_EUR_AF=0.2356;G1000_AFR_AF=0.2595;G1000_SAS_AF=0.4816;G1000_AMR_AF=0.4496;gnomad_exomes_AF=0.34243510;gnomad_exomes_AF_EAS=0.76027696;gnomad_exomes_AC=85241;gnomad_exomes_Hom=18918;gnomad_exomes_Het=47405;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.26061991;gnomad_exomes_AF_NFE=0.21672145;gnomad_exomes_AF_AMR=0.59824643;gnomad_exomes_AF_SAS=0.39826684;NativeFreq_Het=0.3762;NativeFreq_Hom=0.5544;normalHetFrequency=0.3711;normalHetNum=144;normalHomFrequency=0.4149;normalHomNum=161;patientHetFrequency=0.3525;patientHetNum=977;patientHomFrequency=0.382;patientHomNum=1059;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3689;AF_2700_Hom=0.5607;AF_50_Het=0.3835;AF_50_Hom=0.5436;DANN_score=0.4788;GREP_score=-0.985;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=CCCTCTCCTC.CAGGACGGCA	GT:AD:DP:GQ:PL	0/1:126,118:244:99:3255,0,5024
chr2	29446202	.	G	A	4033.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.745;DP=258;ExcessHet=3.0103;FS=3.791;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.63;ReadPosRankSum=0.621;SOR=0.968;HGVSnom=NM_004304.5:c.3359+6C>T;Gene=ALK;Transcript=NM_004304.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_004304.5:IVS20+6C>T;AAlength=1620;EXAC_AF=0.28955976;EXAC_Hom_EAS=5;EXAC_AC_EAS=312;EXAC_AN_EAS=8640;EXAC_AC_Adj=35057;EXAC_AN_Adj=121070;ESP6500_MAF=0.26633861;RS=rs4622670;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.176518;G1000_EAS_AF=0.0536;G1000_EUR_AF=0.3519;G1000_AFR_AF=0.0098;G1000_SAS_AF=0.316;G1000_AMR_AF=0.2219;gnomad_exomes_AF=0.28517680;gnomad_exomes_AF_EAS=0.03759521;gnomad_exomes_AC=71325;gnomad_exomes_Hom=12079;gnomad_exomes_Het=47167;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.05473464;gnomad_exomes_AF_NFE=0.35431821;gnomad_exomes_AF_AMR=0.16172725;gnomad_exomes_AF_SAS=0.36007450;NativeFreq_Het=0.1957;NativeFreq_Hom=0.0427;normalHetFrequency=0.1881;normalHetNum=73;normalHomFrequency=0.0361;normalHomNum=14;patientHetFrequency=0.2009;patientHetNum=557;patientHomFrequency=0.044;patientHomNum=122;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0742;AF_2700_Hom=0.0015;AF_50_Het=0.0856;AF_50_Hom=0.0000;dbscSNV_RF_score=0.012;dbscSNV_ADA_score=0.00005905;DANN_score=0.7804;GREP_score=-0.307;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GCAGCAGGGC.CTCACCGAAT	GT:AD:DP:GQ:PL	0/1:126,132:258:99:4062,0,4620
chr2	29455267	.	A	G	6541.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.305;DP=433;ExcessHet=3.0103;FS=4.051;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.18;ReadPosRankSum=-0.23;SOR=0.657;HGVSnom=NM_004304.5:c.2535T>C(p.Gly845Gly/p.G845G);Gene=ALK;Transcript=NM_004304.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=1620;EXAC_AF=0.61210123;EXAC_Hom_EAS=125;EXAC_AC_EAS=1507;EXAC_AN_EAS=8628;EXAC_AC_Adj=74254;EXAC_AN_Adj=121310;ESP6500_MAF=0.66138705;RS=rs2256740;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.5;G1000_EAS_AF=0.1746;G1000_EUR_AF=0.7247;G1000_AFR_AF=0.534;G1000_SAS_AF=0.5245;G1000_AMR_AF=0.5476;gnomad_exomes_AF=0.60734883;gnomad_exomes_AF_EAS=0.17669132;gnomad_exomes_AC=152696;gnomad_exomes_Hom=49732;gnomad_exomes_Het=53232;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54148203;gnomad_exomes_AF_NFE=0.71011307;gnomad_exomes_AF_AMR=0.44508704;gnomad_exomes_AF_SAS=0.59789639;NativeFreq_Het=0.3381;NativeFreq_Hom=0.2420;normalHetFrequency=0.3299;normalHetNum=128;normalHomFrequency=0.1701;normalHomNum=66;patientHetFrequency=0.3059;patientHetNum=848;patientHomFrequency=0.2128;patientHomNum=590;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3040;AF_2700_Hom=0.0407;AF_50_Het=0.3312;AF_50_Hom=0.0365;DANN_score=0.6886;GREP_score=-4.96;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=AGGCCCTGCC.CCACCTCCGG	GT:AD:DP:GQ:PL	0/1:210,221:431:99:6570,0,6063
chr2	29497995	.	G	A	6248.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.789;DP=459;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.73;ReadPosRankSum=2.336;SOR=0.658;HGVSnom=NM_004304.5:c.2011C>T(p.Pro671Ser/p.P671S);Gene=ALK;Transcript=NM_004304.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=1620;EXAC_AF=0.00172968;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=8652;EXAC_AC_Adj=210;EXAC_AN_Adj=121410;ESP6500_MAF=0.00007689;RS=rs145780832;Ensembl_transcriptid=ENST00000389048|ENST00000618119;SIFT_pred=T|.;SIFT_score=0.376|.;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.003|.;MutationTaster_pred=N|N;MutationTaster_score=1|0.999925;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.00259585;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0133;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00153091;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=385;gnomad_exomes_Hom=4;gnomad_exomes_Het=377;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00009669;gnomad_exomes_AF_AMR=0.00002891;gnomad_exomes_AF_SAS=0.01211785;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D1546292|16D1545827|16D1545715][_];patientHomSampleInfo=[_][_];DANN_score=0.5201;GREP_score=0.823;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GTCTGTCTTG.TGAATTTTCC	GT:AD:DP:GQ:PL	0/1:239,216:455:99:6277,0,7393
chr2	29543663	.	T	C	17186.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.751;DP=463;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.55;ReadPosRankSum=-0.762;SOR=0.387;HGVSnom=NM_004304.5:c.1500A>G(p.Gln500Gln/p.Q500Q);Gene=ALK;Transcript=NM_004304.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=1620;EXAC_AF=0.87163309;EXAC_Hom_EAS=3559;EXAC_AC_EAS=7855;EXAC_AN_EAS=8650;EXAC_AC_Adj=105818;EXAC_AN_Adj=121402;ESP6500_MAF=0.79094264;RS=rs2293564;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.776558;G1000_EAS_AF=0.9206;G1000_EUR_AF=0.9235;G1000_AFR_AF=0.4334;G1000_SAS_AF=0.864;G1000_AMR_AF=0.8847;gnomad_exomes_AF=0.87767827;gnomad_exomes_AF_EAS=0.90725236;gnomad_exomes_AC=220708;gnomad_exomes_Hom=98158;gnomad_exomes_Het=24392;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.50393749;gnomad_exomes_AF_NFE=0.91837219;gnomad_exomes_AF_AMR=0.88529140;gnomad_exomes_AF_SAS=0.86333943;NativeFreq_Het=0.1782;NativeFreq_Hom=0.8118;normalHetFrequency=0.1546;normalHetNum=60;normalHomFrequency=0.8144;normalHomNum=316;patientHetFrequency=0.1667;patientHetNum=462;patientHomFrequency=0.8005;patientHomNum=2219;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1695;AF_2700_Hom=0.8244;AF_50_Het=0.1712;AF_50_Hom=0.8241;DANN_score=0.3863;GREP_score=0.956;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=TGACCTGCCA.TGAGGAGTGT	GT:AD:DP:GQ:PL	1/1:1,461:462:99:17215,1379,0
chr2	29940529	.	A	T	12529.8	PASS	AC=2;AF=1;AN=2;DP=346;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.42;SOR=0.771;HGVSnom=NM_004304.5:c.702T>A(p.Pro234Pro/p.P234P);Gene=ALK;Transcript=NM_004304.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1620;EXAC_AF=0.73346679;EXAC_Hom_EAS=2515;EXAC_AC_EAS=6574;EXAC_AN_EAS=8646;EXAC_AC_Adj=89037;EXAC_AN_Adj=121392;ESP6500_MAF=0.62701830;RS=rs2246745;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.589257;G1000_EAS_AF=0.7827;G1000_EUR_AF=0.7913;G1000_AFR_AF=0.1513;G1000_SAS_AF=0.7025;G1000_AMR_AF=0.6902;gnomad_exomes_AF=0.74084769;gnomad_exomes_AF_EAS=0.74548619;gnomad_exomes_AC=186258;gnomad_exomes_Hom=71602;gnomad_exomes_Het=43054;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23474409;gnomad_exomes_AF_NFE=0.81391483;gnomad_exomes_AF_AMR=0.72876308;gnomad_exomes_AF_SAS=0.71064149;NativeFreq_Het=0.4257;NativeFreq_Hom=0.5302;normalHetFrequency=0.3299;normalHetNum=128;normalHomFrequency=0.6031;normalHomNum=234;patientHetFrequency=0.3474;patientHetNum=963;patientHomFrequency=0.5783;patientHomNum=1603;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3528;AF_2700_Hom=0.5976;AF_50_Het=0.3185;AF_50_Hom=0.6339;DANN_score=0.5041;GREP_score=1.84;CytoBand=p23.2;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GAGAAGGAGA.GGCATGTTTG	GT:AD:DP:GQ:PL	1/1:0,345:345:99:12558,1037,0
chr2	30143499	.	G	C	6340.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.745;DP=166;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.53;ReadPosRankSum=-0.24;SOR=0.319;HGVSnom=NM_004304.5:c.27C>G(p.Leu9Leu/p.L9L);Gene=ALK;Transcript=NM_004304.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=1620;EXAC_AF=0.89494905;EXAC_Hom_EAS=461;EXAC_AC_EAS=922;EXAC_AN_EAS=922;EXAC_AC_Adj=20199;EXAC_AN_Adj=22570;ESP6500_MAF=0.90928571;RS=rs4358080;CLNGENE=ALK;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.89377;G1000_EAS_AF=0.998;G1000_EUR_AF=0.8837;G1000_AFR_AF=0.8003;G1000_SAS_AF=0.8916;G1000_AMR_AF=0.938;gnomad_exomes_AF=0.90663245;gnomad_exomes_AF_EAS=0.99955213;gnomad_exomes_AC=128604;gnomad_exomes_Hom=58443;gnomad_exomes_Het=11718;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.83176405;gnomad_exomes_AF_NFE=0.90778149;gnomad_exomes_AF_AMR=0.93821601;gnomad_exomes_AF_SAS=0.87980851;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0412;normalHetNum=16;normalHomFrequency=0.8119;normalHomNum=315;patientHetFrequency=0.0653;patientHetNum=181;patientHomFrequency=0.8059;patientHomNum=2234;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0046;AF_2700_Hom=0.9935;AF_50_Het=0.0032;AF_50_Hom=0.9968;DANN_score=0.5627;GREP_score=2.11;CytoBand=p23.1;CGD_CONDITION=Neuroblastoma, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=ALK:NM_004304.4:-;NP=ALK:NM_004304.4:NP_004295.2;ENSP=ALK:NM_004304.4:ENST00000389048.7;Gene_MIM_id=105590;Phenotypes={Neuroblastoma, susceptibility to, 3}, 613014 (3). 613014(SK);Possible_Inheritance=NA;EntrezGeneID=238;EnsemblGeneID=ENSG00000171094;Alias=ALK, NBLST3;FLKSEQ=GCAGCGGCAG.AGCCACAGGA	GT:AD:DP:GQ:PL	1/1:1,165:166:99:6369,489,0
chr2	39573062	.	C	CA	377.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.11;DP=61;ExcessHet=3.0103;FS=3.01;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.04;ReadPosRankSum=0.382;SOR=0.169;HGVSnom=NM_003618.4:c.246-2470dupT;Gene=MAP4K3;Transcript=NM_003618.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_003618.4:IVS3-2470_-2469insT;AAlength=894;RS=rs66729858;CytoBand=p22.1;repName=AluY;repClass=SINE;Strand=MAP4K3:NM_001270425.1:-,MAP4K3:NM_003618.3:-;NP=MAP4K3:NM_001270425.1:NP_001257354.1,MAP4K3:NM_003618.3:NP_003609.2;ENSP=MAP4K3:NM_001270425.1:.,MAP4K3:NM_003618.3:.;Gene_MIM_id=604921;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8491;EnsemblGeneID=ENSG00000011566;Alias=MAP4K3, GLK;FLKSEQ=gactctgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:28,19:47:99:155,0,187
chr2	46583278	.	C	CG	18387.7	PASS	AC=2;AF=1;AN=2;DP=401;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.97;SOR=1.598;HGVSnom=NM_001430.5:c.218-12_218-11insG;Gene=EPAS1;Transcript=NM_001430.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001430.5:IVS2-12_-11insG;AAlength=870;EXAC_AF=0.34803774;EXAC_Hom_EAS=2017;EXAC_AC_EAS=5401;EXAC_AN_EAS=7376;EXAC_AC_Adj=37034;EXAC_AN_Adj=106408;RS=rs61586942;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.366;normalHetNum=142;normalHomFrequency=0.4897;normalHomNum=190;patientHetFrequency=0.3763;patientHetNum=1043;patientHomFrequency=0.4517;patientHomNum=1252;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=TCCCACCCCC.CCCCTTTCCA	GT:AD:DP:GQ:PL	1/1:0,401:401:99:18425,1237,0
chr2	46583279	.	C	CT	18515.7	PASS	AC=2;AF=1;AN=2;DP=405;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.75;SOR=1.604;HGVSnom=NM_001430.5:c.218-11_218-10insT;Gene=EPAS1;Transcript=NM_001430.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001430.5:IVS2-11_-10insT;AAlength=870;EXAC_AF=0.36799792;EXAC_Hom_EAS=2109;EXAC_AC_EAS=5643;EXAC_AN_EAS=7550;EXAC_AC_Adj=39640;EXAC_AN_Adj=107718;RS=rs142684263;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.30925824;gnomad_exomes_AF_EAS=0.77332892;gnomad_exomes_AC=53733;gnomad_exomes_Hom=15644;gnomad_exomes_Het=22445;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.33336475;gnomad_exomes_AF_NFE=0.26209008;gnomad_exomes_AF_AMR=0.33238021;gnomad_exomes_AF_SAS=0.23661321;normalHetFrequency=0.3608;normalHetNum=140;normalHomFrequency=0.4948;normalHomNum=192;patientHetFrequency=0.3654;patientHetNum=1013;patientHomFrequency=0.4567;patientHomNum=1266;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=CCCACCCCCC.CCCTTTCCAG	GT:AD:DP:GQ:PL	1/1:0,405:405:99:18553,1249,0
chr2	46583281	.	C	T	18523.8	PASS	AC=2;AF=1;AN=2;DP=411;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.79;SOR=1.621;HGVSnom=NM_001430.5:c.218-9C>T;Gene=EPAS1;Transcript=NM_001430.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001430.5:IVS2-9C>T;AAlength=870;EXAC_AF=0.40374837;EXAC_Hom_EAS=2328;EXAC_AC_EAS=6102;EXAC_AN_EAS=8000;EXAC_AC_Adj=45735;EXAC_AN_Adj=113276;RS=rs75984373;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0662939;G1000_EAS_AF=0.001;G1000_EUR_AF=0.0298;G1000_AFR_AF=0.1974;G1000_SAS_AF=0.0184;G1000_AMR_AF=0.0317;NativeFreq_Het=0.4591;NativeFreq_Hom=0.4520;normalHetFrequency=0.1753;normalHetNum=68;normalHomFrequency=0.6289;normalHomNum=244;patientHetFrequency=0.1587;patientHetNum=440;patientHomFrequency=0.6259;patientHomNum=1735;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00003178;DANN_score=0.6609;GREP_score=4.98;CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=CACCCCCCCC.CTTTCCAGTT	GT:AD:DP:GQ:PL	1/1:0,411:411:99:18552,1249,0
chr2	46603671	.	C	G	3783.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.764;DP=322;ExcessHet=3.0103;FS=1.39;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.75;ReadPosRankSum=-1.145;SOR=0.783;HGVSnom=NM_001430.5:c.1035-7C>G;Gene=EPAS1;Transcript=NM_001430.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_001430.5:IVS8-7C>G;AAlength=870;EXAC_AF=0.41038420;EXAC_Hom_EAS=155;EXAC_AC_EAS=1556;EXAC_AN_EAS=8644;EXAC_AC_Adj=49819;EXAC_AN_Adj=121396;ESP6500_MAF=0.42910964;RS=rs7557402;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.3125;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.504;G1000_AFR_AF=0.2337;G1000_SAS_AF=0.3742;G1000_AMR_AF=0.2435;gnomad_exomes_AF=0.40493053;gnomad_exomes_AF_EAS=0.17989562;gnomad_exomes_AC=101772;gnomad_exomes_Hom=22555;gnomad_exomes_Het=56662;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.26297982;gnomad_exomes_AF_NFE=0.49869748;gnomad_exomes_AF_AMR=0.22856069;gnomad_exomes_AF_SAS=0.40664402;NativeFreq_Het=0.4413;NativeFreq_Hom=0.0783;normalHetFrequency=0.3196;normalHetNum=124;normalHomFrequency=0.0799;normalHomNum=31;patientHetFrequency=0.3355;patientHetNum=930;patientHomFrequency=0.096;patientHomNum=266;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];dbscSNV_RF_score=0.11;dbscSNV_ADA_score=0.02170627;DANN_score=0.5612;GREP_score=2.5;CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=TCTTTCCCCC.CATTAGTGAG	GT:AD:DP:GQ:PL	0/1:179,143:322:99:3812,0,5219
chr2	46605954	.	G	C	3632.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.188;DP=251;ExcessHet=3.0103;FS=0.519;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.47;ReadPosRankSum=-0.101;SOR=0.65;HGVSnom=NM_001430.5:c.1554+48G>C;Gene=EPAS1;Transcript=NM_001430.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001430.5:IVS11+48G>C;AAlength=870;EXAC_AF=0.39073531;EXAC_Hom_EAS=159;EXAC_AC_EAS=1655;EXAC_AN_EAS=8424;EXAC_AC_Adj=46932;EXAC_AN_Adj=120112;ESP6500_MAF=0.37359680;RS=rs7598371;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.260184;G1000_EAS_AF=0.2222;G1000_EUR_AF=0.4891;G1000_AFR_AF=0.0567;G1000_SAS_AF=0.365;G1000_AMR_AF=0.2233;gnomad_exomes_AF=0.38641941;gnomad_exomes_AF_EAS=0.19358540;gnomad_exomes_AC=96686;gnomad_exomes_Hom=20908;gnomad_exomes_Het=54870;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11507053;gnomad_exomes_AF_NFE=0.49109023;gnomad_exomes_AF_AMR=0.21224004;gnomad_exomes_AF_SAS=0.39220244;NativeFreq_Het=0.4021;NativeFreq_Hom=0.0854;normalHetFrequency=0.3222;normalHetNum=125;normalHomFrequency=0.0747;normalHomNum=29;patientHetFrequency=0.3362;patientHetNum=932;patientHomFrequency=0.0884;patientHomNum=245;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3987;GREP_score=0.163;CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=GCTGTCTGGT.GACAGCAAAG	GT:AD:DP:GQ:PL	0/1:122,129:251:99:3661,0,4050
chr2	46609572	.	A	C	4419.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.414;DP=286;ExcessHet=3.0103;FS=0.947;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.51;ReadPosRankSum=-0.728;SOR=0.786;HGVSnom=NM_001430.5:c.2296A>C(p.Thr766Pro/p.T766P);Gene=EPAS1;Transcript=NM_001430.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E15;IVSnom=.;AAlength=870;EXAC_AF=0.05825667;EXAC_Hom_EAS=78;EXAC_AC_EAS=1145;EXAC_AN_EAS=8646;EXAC_AC_Adj=7067;EXAC_AN_Adj=121308;ESP6500_MAF=0.14777795;RS=rs59901247;Ensembl_transcriptid=ENST00000263734;SIFT_pred=T;SIFT_score=0.089;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.001;MutationTaster_pred=P;MutationTaster_score=1;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.163339;G1000_EAS_AF=0.126;G1000_EUR_AF=0.0099;G1000_AFR_AF=0.4826;G1000_SAS_AF=0.0102;G1000_AMR_AF=0.0476;gnomad_exomes_AF=0.05178739;gnomad_exomes_AF_EAS=0.13145591;gnomad_exomes_AC=13015;gnomad_exomes_Hom=1749;gnomad_exomes_Het=9517;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42656654;gnomad_exomes_AF_NFE=0.01665376;gnomad_exomes_AF_AMR=0.02240402;gnomad_exomes_AF_SAS=0.00708780;NativeFreq_Het=0.1495;NativeFreq_Hom=0.0463;normalHetFrequency=0.1907;normalHetNum=74;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.1569;patientHetNum=435;patientHomFrequency=0.013;patientHomNum=36;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6669;GREP_score=-0.198;CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=AGATAAGTTC.CCCAAAACCC	GT:AD:DP:GQ:PL	0/1:144,141:285:99:4448,0,4172
chr2	46612326	.	GTT	G	10863.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.047;DP=403;ExcessHet=3.0103;FS=1.61;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.82;ReadPosRankSum=-2.162;SOR=0.394;HGVSnom=NM_001430.5:c.*539_*540delTT;Gene=EPAS1;Transcript=NM_001430.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=870;RS=rs75932330;CLNGENE=EPAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.885783;G1000_EAS_AF=0.8909;G1000_EUR_AF=0.8042;G1000_AFR_AF=0.9652;G1000_SAS_AF=0.8691;G1000_AMR_AF=0.8689;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15B0002935][_];patientHetSampleInfo=_;patientHomSampleInfo=_;CytoBand=p21;CGD_CONDITION=Erthyrocytosis, familial 4;CGD_INHERITANCE=AD;Strand=EPAS1:NM_001430.4:+;NP=EPAS1:NM_001430.4:NP_001421.2;ENSP=EPAS1:NM_001430.4:ENST00000263734.4;Gene_MIM_id=603349;Phenotypes=Erythrocytosis, familial, 4, 611783 (3). 611783(MK);Possible_Inheritance=NA;EntrezGeneID=2034;EnsemblGeneID=ENSG00000116016;Alias=EPAS1, MOP2, HIF2A, ECYT4;FLKSEQ=AAATTTCAGG.TTTTTTTTTT	GT:AD:DP:GQ:PL	1/1:6,325:331:99:10901,761,0
chr2	47601106	.	T	C	12059.8	PASS	AC=2;AF=1;AN=2;DP=346;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.38;SOR=0.759;HGVSnom=NM_002354.3:c.344T>C(p.Met115Thr/p.M115T);Gene=EPCAM;Transcript=NM_002354.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E3;IVSnom=.;AAlength=314;EXAC_AF=0.51978574;EXAC_Hom_EAS=2952;EXAC_AC_EAS=7151;EXAC_AN_EAS=8650;EXAC_AC_Adj=63076;EXAC_AN_Adj=121350;ESP6500_MAF=0.56673843;RS=rs1126497;Ensembl_transcriptid=ENST00000405271|ENST00000263735|ENST00000419334;SIFT_pred=T|T|T;SIFT_score=1.0|1.0|1.0;Polyphen2_HVAR_pred=B|B|.;Polyphen2_HVAR_score=0.0|0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=EPCAM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666134;G1000_EAS_AF=0.8323;G1000_EUR_AF=0.4692;G1000_AFR_AF=0.8888;G1000_SAS_AF=0.5031;G1000_AMR_AF=0.5159;gnomad_exomes_AF=0.51313319;gnomad_exomes_AF_EAS=0.83201044;gnomad_exomes_AC=129014;gnomad_exomes_Hom=35775;gnomad_exomes_Het=57464;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.84184301;gnomad_exomes_AF_NFE=0.43590961;gnomad_exomes_AF_AMR=0.47197802;gnomad_exomes_AF_SAS=0.48065865;HGMD_gene=EPCAM;HGMD_disease=Breast_cancer_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=20683652;NativeFreq_Het=0.3488;NativeFreq_Hom=0.6930;normalHetFrequency=0.3299;normalHetNum=128;normalHomFrequency=0.5284;normalHomNum=205;patientHetFrequency=0.3366;patientHetNum=933;patientHomFrequency=0.5177;patientHomNum=1435;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2786;AF_2700_Hom=0.6868;AF_50_Het=0.2773;AF_50_Hom=0.6815;DANN_score=0.7394;GREP_score=1.71;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 8. Diarrhea 5, with tufting enteropathy, congenital;CGD_INHERITANCE=AD/AR;Strand=EPCAM:NM_002354.2:+,EPCAM:NM_002354.3:+;NP=EPCAM:NM_002354.2:NP_002345.2,EPCAM:NM_002354.3:NP_002345.2;ENSP=EPCAM:NM_002354.2:ENST00000263735.8,EPCAM:NM_002354.3:ENST00000263735.9;Gene_MIM_id=185535;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3). Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive. 613217(MK),613244(MK);Possible_Inheritance=AR;EntrezGeneID=4072;EnsemblGeneID=ENSG00000119888;Alias=EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8;FLKSEQ=GGCACCTCCA.GTGCTGGTGT	GT:AD:DP:GQ:PL	1/1:0,343:343:99:12088,1031,0
chr2	47612224	.	C	T	5257.77	StandardFilter	AC=2;AF=1;AN=2;DP=135;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.41;SOR=8.424;HGVSnom=NM_002354.3:c.859-81C>T;Gene=EPCAM;Transcript=NM_002354.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_002354.3:IVS7-81C>T;AAlength=314;RS=rs7584256;CLNGENE=EPCAM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.360823;G1000_EAS_AF=0.5615;G1000_EUR_AF=0.2883;G1000_AFR_AF=0.3525;G1000_SAS_AF=0.3067;G1000_AMR_AF=0.2666;NativeFreq_Het=0.5049;NativeFreq_Hom=0.2871;normalHetFrequency=0.4149;normalHetNum=161;normalHomFrequency=0.2629;normalHomNum=102;patientHetFrequency=0.4448;patientHetNum=1233;patientHomFrequency=0.2352;patientHomNum=652;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4435;GREP_score=-4.09;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 8. Diarrhea 5, with tufting enteropathy, congenital;CGD_INHERITANCE=AD/AR;Strand=EPCAM:NM_002354.2:+,EPCAM:NM_002354.3:+;NP=EPCAM:NM_002354.2:NP_002345.2,EPCAM:NM_002354.3:NP_002345.2;ENSP=EPCAM:NM_002354.2:ENST00000263735.8,EPCAM:NM_002354.3:ENST00000263735.9;Gene_MIM_id=185535;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3). Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive. 613217(MK),613244(MK);Possible_Inheritance=AR;EntrezGeneID=4072;EnsemblGeneID=ENSG00000119888;Alias=EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8;FLKSEQ=AAATTATGTC.ATTAAAAGCA	GT:AD:DP:GQ:PL	1/1:0,135:135:99:5286,406,0
chr2	47613870	.	T	C	11171.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=12.386;DP=659;ExcessHet=3.0103;FS=2.444;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.98;ReadPosRankSum=1.028;SOR=0.728;HGVSnom=NM_002354.3:c.*118T>C;Gene=EPCAM;Transcript=NM_002354.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=314;RS=rs1421;CLNGENE=EPCAM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.10004;G1000_EAS_AF=0.1825;G1000_EUR_AF=0.1491;G1000_AFR_AF=0.0045;G1000_SAS_AF=0.0613;G1000_AMR_AF=0.1455;NativeFreq_Het=0.3465;NativeFreq_Hom=0.0285;normalHetFrequency=0.2139;normalHetNum=83;normalHomFrequency=0.0438;normalHomNum=17;patientHetFrequency=0.2403;patientHetNum=666;patientHomFrequency=0.0317;patientHomNum=88;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3055;AF_2700_Hom=0.0334;AF_50_Het=0.3154;AF_50_Hom=0.0317;DANN_score=0.7481;GREP_score=0.0007;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 8. Diarrhea 5, with tufting enteropathy, congenital;CGD_INHERITANCE=AD/AR;Strand=EPCAM:NM_002354.2:+,EPCAM:NM_002354.3:+;NP=EPCAM:NM_002354.2:NP_002345.2,EPCAM:NM_002354.3:NP_002345.2;ENSP=EPCAM:NM_002354.2:ENST00000263735.8,EPCAM:NM_002354.3:ENST00000263735.9;Gene_MIM_id=185535;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3). Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive. 613217(MK),613244(MK);Possible_Inheritance=AR;EntrezGeneID=4072;EnsemblGeneID=ENSG00000119888;Alias=EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8;FLKSEQ=TAACATCATA.ATTTGTAATA	GT:AD:DP:GQ:PL	0/1:319,339:658:99:11200,0,9577
chr2	47614203	.	CT	C	537.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.134;DP=205;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.02;ReadPosRankSum=-0.396;SOR=0.179;HGVSnom=.;Gene=EPCAM;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs565249366;G1000_AF=0.0515176;G1000_EAS_AF=0.006;G1000_EUR_AF=0.0606;G1000_AFR_AF=0.0809;G1000_SAS_AF=0.0491;G1000_AMR_AF=0.0519;CytoBand=p21;repName=AluSx4;repClass=SINE;FLKSEQ=tttttctttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:116,62:178:99:575,0,1787
chr2	47630213	.	T	C	4175.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.791;DP=302;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.92;ReadPosRankSum=0.272;SOR=0.672;HGVSnom=.;Gene=MSH2;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs2303425;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.100839;G1000_EAS_AF=0.1865;G1000_EUR_AF=0.1481;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0624;G1000_AMR_AF=0.147;HGMD_gene=MSH2;HGMD_disease=Breast_cancer_early-onset_increased_risk;HGMD_tag=DFP;HGMD_pmid=26975740;NativeFreq_Het=0.3564;NativeFreq_Hom=0.0386;normalHetFrequency=0.1873;normalHetNum=162;normalHomFrequency=0.0335;normalHomNum=29;patientHetFrequency=0.1795;patientHetNum=937;patientHomFrequency=0.0395;patientHomNum=206;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9427;GREP_score=5.7;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=TGGAAGCTGA.TGGGTGTGGT	GT:AD:DP:GQ:PL	0/1:165,135:300:99:4204,0,4965
chr2	47630550	.	C	G	6686.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.117;DP=191;ExcessHet=3.0103;FS=4.422;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.71;ReadPosRankSum=-0.944;SOR=1.232;HGVSnom=NM_000251.3:c.211+9C>G;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000251.3:IVS1+9C>G;AAlength=934;EXAC_AF=0.50469050;EXAC_Hom_EAS=2047;EXAC_AC_EAS=5166;EXAC_AN_EAS=6418;EXAC_AC_Adj=40457;EXAC_AN_Adj=80162;ESP6500_MAF=0.47587512;RS=rs2303426;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.628395;G1000_EAS_AF=0.8145;G1000_EUR_AF=0.4324;G1000_AFR_AF=0.8101;G1000_SAS_AF=0.4806;G1000_AMR_AF=0.5043;gnomad_exomes_AF=0.47349504;gnomad_exomes_AF_EAS=0.81546430;gnomad_exomes_AC=101041;gnomad_exomes_Hom=25877;gnomad_exomes_Het=49287;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76645716;gnomad_exomes_AF_NFE=0.38567821;gnomad_exomes_AF_AMR=0.45306069;gnomad_exomes_AF_SAS=0.45692029;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6277;normalHetFrequency=0.2936;normalHetNum=254;normalHomFrequency=0.4532;normalHomNum=392;patientHetFrequency=0.3;patientHetNum=1566;patientHomFrequency=0.4713;patientHomNum=2460;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2909;AF_2700_Hom=0.6426;AF_50_Het=0.2948;AF_50_Hom=0.6387;DANN_score=0.5246;GREP_score=-4.87;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=AGGTGAGGGC.GGGACGGCGC	GT:AD:DP:GQ:PL	1/1:1,190:191:99:6715,546,0
chr2	47630639	.	T	C	3993.77	StandardFilter	AC=2;AF=1;AN=2;DP=120;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.85;SOR=3.5;HGVSnom=NM_000251.3:c.211+98T>C;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000251.3:IVS1+98T>C;AAlength=934;RS=rs3815865;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.627196;G1000_EAS_AF=0.8135;G1000_EUR_AF=0.4334;G1000_AFR_AF=0.8056;G1000_SAS_AF=0.4806;G1000_AMR_AF=0.5043;NativeFreq_Het=0.2940;NativeFreq_Hom=0.0108;normalHetFrequency=0.1457;normalHetNum=126;normalHomFrequency=0.2855;normalHomNum=247;patientHetFrequency=0.1705;patientHetNum=890;patientHomFrequency=0.2822;patientHomNum=1473;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4667;GREP_score=-6.72;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=GCCTCTCCAG.GCGGAGGCAC	GT:AD:DP:GQ:PL	1/1:0,118:118:99:4022,355,0
chr2	47635523	.	C	CT	1302.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.69;DP=665;ExcessHet=3.0103;FS=1.371;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.16;ReadPosRankSum=0.342;SOR=0.833;HGVSnom=NM_000251.3:c.212-4dupT;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000251.3:IVS1-4_-3insT;AAlength=934;EXAC_AF=0.14464717;EXAC_Hom_EAS=0;EXAC_AC_EAS=839;EXAC_AN_EAS=5362;EXAC_AC_Adj=10782;EXAC_AN_Adj=74540;ESP6500_MAF=0.03820332;RS=rs746333570;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.20362614;gnomad_exomes_AF_EAS=0.21988184;gnomad_exomes_AC=21878;gnomad_exomes_Hom=0;gnomad_exomes_Het=21878;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15993745;gnomad_exomes_AF_NFE=0.17685120;gnomad_exomes_AF_AMR=0.25452489;gnomad_exomes_AF_SAS=0.25795829;NativeFreq_Het=0.0018;NativeFreq_Hom=.;normalHetFrequency=0.0948;normalHetNum=82;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1109;patientHetNum=579;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0980;AF_2700_Hom=.;AF_50_Het=0.0919;AF_50_Hom=.;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=CTGTAATGTA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:474,130:604:99:1340,0,8501
chr2	47637306	.	T	G	7808.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.282;DP=475;ExcessHet=3.0103;FS=3.176;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.44;ReadPosRankSum=-0.902;SOR=0.587;HGVSnom=NM_000251.3:c.440T>G(p.Val147Gly/p.V147G);Gene=MSH2;Transcript=NM_000251.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E3;IVSnom=.;AAlength=934;EXAC_AF=0.00001647;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=8654;EXAC_AC_Adj=2;EXAC_AN_Adj=121412;RS=rs760851623;Ensembl_transcriptid=ENST00000233146|ENST00000454849|ENST00000543555|ENST00000645506|ENST00000406134;SIFT_pred=D|D|D|.|D;SIFT_score=0.022|0.019|0.021|.|0.03;Polyphen2_HVAR_pred=B|.|.|.|B;Polyphen2_HVAR_score=0.047|.|.|.|0.057;MutationTaster_pred=D|D|D;MutationTaster_score=1|1|1;CLNGENE=MSH2;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.00000795;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=2;gnomad_exomes_Hom=0;gnomad_exomes_Het=2;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00000879;gnomad_exomes_AF_AMR=0.00002891;gnomad_exomes_AF_SAS=0.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D1546003][_];patientHomSampleInfo=[_][_];DANN_score=0.9796;GREP_score=3.22;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=TCCATTGGTG.TGTGGGTGTT	GT:AD:DP:GQ:PL	0/1:234,241:475:99:7837,0,7137
chr2	47641559	.	TAAAA	T	7385.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.929;DP=679;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.38;ReadPosRankSum=0.348;SOR=0.797;OLD_VARIANT=chr2|47641559|TAAAA|T,TAA|1;HGVSnom=NM_000251.3:c.942+26_942+29delAAAA;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000251.3:IVS5+26_+29delAAAA;AAlength=934;EXAC_AF=0.00750172;EXAC_Hom_EAS=0;EXAC_AC_EAS=4;EXAC_AN_EAS=946;EXAC_AC_Adj=109;EXAC_AN_Adj=14530;RS=rs11309117;CLNGENE=MSH2;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.08473865;gnomad_exomes_AF_EAS=0.11060365;gnomad_exomes_AC=4442;gnomad_exomes_Hom=0;gnomad_exomes_Het=4442;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08003557;gnomad_exomes_AF_NFE=0.07380865;gnomad_exomes_AF_AMR=0.11494532;gnomad_exomes_AF_SAS=0.08413686;NativeFreq_Het=0.0018;NativeFreq_Hom=.;normalHetFrequency=0.0243;normalHetNum=21;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.019;patientHetNum=99;patientHomFrequency=0.0006;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0001962][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536879-1|16D1545722][16B0033734];AF_2700_Het=0.0596;AF_2700_Hom=0.0004;AF_50_Het=0.0571;AF_50_Hom=0.0016;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=CTTTTTCAGG.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/0:37,210:330:99:7423,1531,3358
chr2	47641559	.	TAA	T	7385.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.929;DP=679;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.38;ReadPosRankSum=0.348;SOR=0.797;OLD_VARIANT=chr2|47641559|TAAAA|T,TAA|2;HGVSnom=NM_000251.3:c.942+28_942+29delAA;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000251.3:IVS5+28_+29delAA;AAlength=934;RS=rs11309117;CLNGENE=MSH2;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.09137734;gnomad_exomes_AF_EAS=0.11616362;gnomad_exomes_AC=4790;gnomad_exomes_Hom=14;gnomad_exomes_Het=4762;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08870609;gnomad_exomes_AF_NFE=0.08407888;gnomad_exomes_AF_AMR=0.11931956;gnomad_exomes_AF_SAS=0.08180404;normalHetFrequency=0.0613;normalHetNum=53;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.0768;patientHetNum=401;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1752;AF_2700_Hom=0.0607;AF_50_Het=0.1854;AF_50_Hom=0.0681;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=CTTTTTCAGG.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:37,83:330:99:7423,3094,3126
chr2	47656801	.	G	A	4203.77	StandardFilter	AC=2;AF=1;AN=2;DP=107;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.9;SOR=7.96;HGVSnom=NM_000251.3:c.1077-80G>A;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000251.3:IVS6-80G>A;AAlength=934;RS=rs2347794;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.59365;G1000_EAS_AF=0.6875;G1000_EUR_AF=0.4205;G1000_AFR_AF=0.8389;G1000_SAS_AF=0.4744;G1000_AMR_AF=0.4092;NativeFreq_Het=0.4554;NativeFreq_Hom=0.4653;normalHetFrequency=0.4162;normalHetNum=360;normalHomFrequency=0.3919;normalHomNum=339;patientHetFrequency=0.4351;patientHetNum=2271;patientHomFrequency=0.3902;patientHomNum=2037;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6596;GREP_score=0.716;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=AGCTGATTTA.TTGAGACTTA	GT:AD:DP:GQ:PL	1/1:0,107:107:99:4232,322,0
chr2	47693706	.	G	T	5763.77	StandardFilter	AC=2;AF=1;AN=2;DP=145;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.97;SOR=9.967;HGVSnom=NM_000251.3:c.1511-91G>T;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000251.3:IVS9-91G>T;AAlength=934;RS=rs3732182;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.483027;G1000_EAS_AF=0.6548;G1000_EUR_AF=0.3012;G1000_AFR_AF=0.6717;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3228;NativeFreq_Het=0.4663;NativeFreq_Hom=0.3952;normalHetFrequency=0.4058;normalHetNum=351;normalHomFrequency=0.3295;normalHomNum=285;patientHetFrequency=0.4243;patientHetNum=2215;patientHomFrequency=0.3253;patientHomNum=1698;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2998;GREP_score=-4.01;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=ATAACAGTAT.TTTTTCACTA	GT:AD:DP:GQ:PL	1/1:0,145:145:99:5792,436,0
chr2	47693959	.	G	A	10196.8	PASS	AC=2;AF=1;AN=2;DP=281;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.56;SOR=2.162;HGVSnom=NM_000251.3:c.1661+12G>A;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000251.3:IVS10+12G>A;AAlength=934;EXAC_AF=0.35014621;EXAC_Hom_EAS=1861;EXAC_AC_EAS=5685;EXAC_AN_EAS=8644;EXAC_AC_Adj=42388;EXAC_AN_Adj=121058;ESP6500_MAF=0.37867364;RS=rs3732183;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.483427;G1000_EAS_AF=0.6548;G1000_EUR_AF=0.3012;G1000_AFR_AF=0.6725;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3242;gnomad_exomes_AF=0.34297910;gnomad_exomes_AF_EAS=0.65687554;gnomad_exomes_AC=85978;gnomad_exomes_Hom=16803;gnomad_exomes_Het=52372;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62753188;gnomad_exomes_AF_NFE=0.27355878;gnomad_exomes_AF_AMR=0.29487847;gnomad_exomes_AF_SAS=0.32898181;HGMD_gene=MSH2;HGMD_disease=Colorectal_cancer_non-polyposis_association;HGMD_tag=DP;HGMD_pmid=20931542;NativeFreq_Het=0.4653;NativeFreq_Hom=0.3964;normalHetFrequency=0.415;normalHetNum=359;normalHomFrequency=0.3283;normalHomNum=284;patientHetFrequency=0.4362;patientHetNum=2277;patientHomFrequency=0.3253;patientHomNum=1698;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4400;AF_2700_Hom=0.4281;AF_50_Het=0.4485;AF_50_Hom=0.4231;DANN_score=0.6036;GREP_score=-1.33;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=TTTGCAAGTC.TTATTATATT	GT:AD:DP:GQ:PL	1/1:0,281:281:99:10225,845,0
chr2	47702451	.	GT	G	1044.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.51;DP=435;ExcessHet=3.0103;FS=3.511;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.84;ReadPosRankSum=-0.499;SOR=0.97;HGVSnom=NM_000251.3:c.2005+61delT;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000251.3:IVS12+61delT;AAlength=934;EXAC_AF=0.08502494;EXAC_Hom_EAS=0;EXAC_AC_EAS=164;EXAC_AN_EAS=1768;EXAC_AC_Adj=2421;EXAC_AN_Adj=28474;RS=rs76761634;gnomad_exomes_AF=0.11907189;gnomad_exomes_AF_EAS=0.16380311;gnomad_exomes_AC=12614;gnomad_exomes_Hom=2;gnomad_exomes_Het=12610;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11763936;gnomad_exomes_AF_NFE=0.09655377;gnomad_exomes_AF_AMR=0.17806691;gnomad_exomes_AF_SAS=0.12621435;NativeFreq_Het=0.0036;NativeFreq_Hom=.;normalHetFrequency=0.1029;normalHetNum=89;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1247;patientHetNum=651;patientHomFrequency=0.0004;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6532744][15D6524776];CytoBand=p21;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=GTAACGtttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:234,134:368:99:1082,0,2960
chr2	47703500	.	T	C	4025.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.042;DP=298;ExcessHet=3.0103;FS=1.564;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.55;ReadPosRankSum=-0.087;SOR=0.813;HGVSnom=NM_000251.3:c.2006-6T>C;Gene=MSH2;Transcript=NM_000251.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000251.3:IVS12-6T>C;AAlength=934;EXAC_AF=0.11545543;EXAC_Hom_EAS=536;EXAC_AC_EAS=3002;EXAC_AN_EAS=8578;EXAC_AC_Adj=13796;EXAC_AN_Adj=119492;ESP6500_MAF=0.07258189;RS=rs2303428;CLNGENE=MSH2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.131989;G1000_EAS_AF=0.3631;G1000_EUR_AF=0.0875;G1000_AFR_AF=0.0106;G1000_SAS_AF=0.136;G1000_AMR_AF=0.0865;gnomad_exomes_AF=0.11507807;gnomad_exomes_AF_EAS=0.35492651;gnomad_exomes_AC=28906;gnomad_exomes_Hom=2361;gnomad_exomes_Het=24184;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.02137753;gnomad_exomes_AF_NFE=0.09949640;gnomad_exomes_AF_AMR=0.07931134;gnomad_exomes_AF_SAS=0.13445708;HGMD_gene=MSH2;HGMD_disease=High-grade_dysplasia/cancer_in_ulcerative_colitis_association;HGMD_tag=DP;HGMD_pmid=7797014;NativeFreq_Het=0.4455;NativeFreq_Hom=0.1188;normalHetFrequency=0.3792;normalHetNum=328;normalHomFrequency=0.0867;normalHomNum=75;patientHetFrequency=0.3718;patientHetNum=1941;patientHomFrequency=0.0954;patientHomNum=498;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4370;AF_2700_Hom=0.1353;AF_50_Het=0.4485;AF_50_Hom=0.1094;dbscSNV_RF_score=0.724;dbscSNV_ADA_score=0.90806117;DANN_score=0.8519;GREP_score=5.55;CytoBand=p21;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 1. Endometrial cancer. Mismatch repair cancer syndrome. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MSH2:NM_000251.2:+,MSH2:NM_001258281.1:+;NP=MSH2:NM_000251.2:NP_000242.1,MSH2:NM_001258281.1:NP_001245210.1;ENSP=MSH2:NM_000251.2:ENST00000233146.6,MSH2:NM_001258281.1:.;Gene_MIM_id=609309;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant. Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 120435(MK),158320(MK),276300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4436;EnsemblGeneID=ENSG00000095002;Alias=MSH2, COCA1, FCC1, HNPCC1;FLKSEQ=ATAATTTGTT.TGTAGGCCCC	GT:AD:DP:GQ:PL	0/1:167,130:297:99:4054,0,5442
chr2	48030838	.	A	T	15494.8	PASS	AC=2;AF=1;AN=2;DP=418;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.84;SOR=1.455;HGVSnom=NM_000179.3:c.3438+14A>T;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000179.3:IVS5+14A>T;AAlength=1360;EXAC_AF=0.40426359;EXAC_Hom_EAS=1651;EXAC_AC_EAS=5322;EXAC_AN_EAS=8628;EXAC_AC_Adj=48869;EXAC_AN_Adj=120884;ESP6500_MAF=0.31462402;RS=rs2020911;CLNGENE=MSH6;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.400958;G1000_EAS_AF=0.619;G1000_EUR_AF=0.3608;G1000_AFR_AF=0.1316;G1000_SAS_AF=0.5399;G1000_AMR_AF=0.4597;gnomad_exomes_AF=0.41175156;gnomad_exomes_AF_EAS=0.62398042;gnomad_exomes_AC=103194;gnomad_exomes_Hom=22601;gnomad_exomes_Het=57992;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16845156;gnomad_exomes_AF_NFE=0.38188296;gnomad_exomes_AF_AMR=0.50752663;gnomad_exomes_AF_SAS=0.47641140;NativeFreq_Het=0.4554;NativeFreq_Hom=0.4241;normalHetFrequency=0.452;normalHetNum=391;normalHomFrequency=0.3526;normalHomNum=305;patientHetFrequency=0.445;patientHetNum=2323;patientHomFrequency=0.3452;patientHomNum=1802;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4520;AF_2700_Hom=0.4277;AF_50_Het=0.4675;AF_50_Hom=0.4216;DANN_score=0.6284;GREP_score=-2.07;CytoBand=p16.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=ACTGATTCTT.AAGTTTTGTT	GT:AD:DP:GQ:PL	1/1:0,417:417:99:15523,1254,0
chr2	48032740	.	A	AT	3091.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.48;DP=502;ExcessHet=3.0103;FS=13.161;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.81;ReadPosRankSum=0.088;SOR=1.27;HGVSnom=NM_000179.3:c.3557-4dupT;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000179.3:IVS6-4_-3insT;AAlength=1360;EXAC_AF=0.23003269;EXAC_Hom_EAS=1;EXAC_AC_EAS=608;EXAC_AN_EAS=5948;EXAC_AC_Adj=20829;EXAC_AN_Adj=90548;ESP6500_MAF=0.16397506;RS=rs267608102;CLNGENE=MSH6;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;gnomad_exomes_AF=0.29663134;gnomad_exomes_AF_EAS=0.15644676;gnomad_exomes_AC=40365;gnomad_exomes_Hom=402;gnomad_exomes_Het=39561;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14575812;gnomad_exomes_AF_NFE=0.31883745;gnomad_exomes_AF_AMR=0.26221238;gnomad_exomes_AF_SAS=0.35220588;NativeFreq_Het=0.0248;NativeFreq_Hom=.;normalHetFrequency=0.2116;normalHetNum=183;normalHomFrequency=0.0162;normalHomNum=14;patientHetFrequency=0.2272;patientHetNum=1186;patientHomFrequency=0.0176;patientHomNum=92;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1045;AF_2700_Hom=.;AF_50_Het=0.0967;AF_50_Hom=.;CytoBand=p16.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=TTCATTTGTG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:253,201:454:99:3129,0,4325
chr2	48032874	.	ACTAT	A	16039.7	PASS	AC=2;AF=1;AN=2;DP=399;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.17;SOR=2.136;HGVSnom=NM_000179.3:c.3646+35_3646+38delATCT;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000179.3:IVS7+35_+38delATCT;AAlength=1360;EXAC_AF=0.69247758;EXAC_Hom_EAS=3276;EXAC_AC_EAS=7497;EXAC_AN_EAS=8634;EXAC_AC_Adj=83715;EXAC_AN_Adj=120892;ESP6500_MAF=0.70805315;RS=rs1805181;CLNGENE=MSH6;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.762181;G1000_EAS_AF=0.87;G1000_EUR_AF=0.661;G1000_AFR_AF=0.8283;G1000_SAS_AF=0.773;G1000_AMR_AF=0.611;gnomad_exomes_AF=0.68469973;gnomad_exomes_AF_EAS=0.87027145;gnomad_exomes_AC=171342;gnomad_exomes_Hom=59705;gnomad_exomes_Het=51932;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.80123609;gnomad_exomes_AF_NFE=0.67628771;gnomad_exomes_AF_AMR=0.52973934;gnomad_exomes_AF_SAS=0.72584248;NativeFreq_Het=0.4752;NativeFreq_Hom=.;normalHetFrequency=0.2474;normalHetNum=214;normalHomFrequency=0.7087;normalHomNum=613;patientHetFrequency=0.2745;patientHetNum=1433;patientHomFrequency=0.6766;patientHomNum=3532;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2071;AF_2700_Hom=0.7759;AF_50_Het=0.1981;AF_50_Hom=0.7781;CytoBand=p16.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=TCATTTGAAG.CTATCTTAAA	GT:AD:DP:GQ:PL	1/1:0,360:360:99:16077,1085,0
chr2	48032937	.	T	C	9710.77	StandardFilter	AC=2;AF=1;AN=2;DP=240;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.6;SOR=5.429;HGVSnom=NM_000179.3:c.3646+91T>C;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000179.3:IVS7+91T>C;AAlength=1360;RS=rs3136359;CLNGENE=MSH6;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.814297;G1000_EAS_AF=0.876;G1000_EUR_AF=0.7127;G1000_AFR_AF=0.947;G1000_SAS_AF=0.7863;G1000_AMR_AF=0.6585;HGMD_gene=MSH6;HGMD_disease=Lynch_syndrome;HGMD_tag=R;HGMD_pmid=28874130;NativeFreq_Het=0.1988;NativeFreq_Hom=0.0181;normalHetFrequency=0.222;normalHetNum=192;normalHomFrequency=0.7237;normalHomNum=626;patientHetFrequency=0.2366;patientHetNum=1235;patientHomFrequency=0.6937;patientHomNum=3621;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5007;GREP_score=-3.33;CytoBand=p16.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=TGAAGTACAT.TAAACAATAT	GT:AD:DP:GQ:PL	1/1:0,239:239:99:9739,719,0
chr2	48033551	.	C	G	11899.8	PASS	AC=2;AF=1;AN=2;DP=316;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.57;SOR=1.036;HGVSnom=NM_000179.3:c.3802-40C>G;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000179.3:IVS8-40C>G;AAlength=1360;EXAC_AF=0.74264511;EXAC_Hom_EAS=3367;EXAC_AC_EAS=7613;EXAC_AN_EAS=8638;EXAC_AC_Adj=89866;EXAC_AN_Adj=121008;ESP6500_MAF=0.78721932;RS=rs3136367;CLNGENE=MSH6;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.809105;G1000_EAS_AF=0.8869;G1000_EUR_AF=0.7038;G1000_AFR_AF=0.938;G1000_SAS_AF=0.773;G1000_AMR_AF=0.6542;gnomad_exomes_AF=0.73398479;gnomad_exomes_AF_EAS=0.88279465;gnomad_exomes_AC=184101;gnomad_exomes_Hom=68350;gnomad_exomes_Het=47401;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91862343;gnomad_exomes_AF_NFE=0.72976094;gnomad_exomes_AF_AMR=0.61610715;gnomad_exomes_AF_SAS=0.73979225;NativeFreq_Het=0.2475;NativeFreq_Hom=0.7819;normalHetFrequency=0.237;normalHetNum=205;normalHomFrequency=0.7145;normalHomNum=618;patientHetFrequency=0.2496;patientHetNum=1303;patientHomFrequency=0.6989;patientHomNum=3648;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5723;GREP_score=-0.584;CytoBand=p16.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=GGGCACTTCT.TTGCTAGCAC	GT:AD:DP:GQ:PL	1/1:0,315:315:99:11928,946,0
chr2	48033890	.	CT	C	1119.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.363;DP=394;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.12;ReadPosRankSum=-0.4;SOR=0.663;HGVSnom=NM_000179.3:c.4002-10delT;Gene=MSH6;Transcript=NM_000179.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000179.3:IVS9-10delT;AAlength=1360;EXAC_AF=0.42447660;EXAC_Hom_EAS=4;EXAC_AC_EAS=999;EXAC_AN_EAS=2382;EXAC_AC_Adj=24938;EXAC_AN_Adj=58750;RS=rs59056100;CLNGENE=MSH6;CLNSIG=Likely_benign;CLNREVSTAT=reviewed_by_expert_panel;NativeFreq_Het=0.3196;NativeFreq_Hom=.;normalHetFrequency=0.7561;normalHetNum=654;normalHomFrequency=0.0335;normalHomNum=29;patientHetFrequency=0.7789;patientHetNum=4066;patientHomFrequency=0.0316;patientHomNum=165;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.8040;AF_2700_Hom=0.0023;AF_50_Het=0.8035;AF_50_Hom=0.0016;CytoBand=p16.3;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 5. Mismatch repair cancer syndrome. Endometrial cancer;CGD_INHERITANCE=AD/AR;Strand=MSH6:NM_000179.2:+,MSH6:NM_001281492.1:+,MSH6:NM_001281493.1:+,MSH6:NM_001281494.1:+;NP=MSH6:NM_000179.2:NP_000170.1,MSH6:NM_001281492.1:NP_001268421.1,MSH6:NM_001281493.1:NP_001268422.1,MSH6:NM_001281494.1:NP_001268423.1;ENSP=MSH6:NM_000179.2:ENST00000234420.10,MSH6:NM_001281492.1:.,MSH6:NM_001281493.1:.,MSH6:NM_001281494.1:.;Gene_MIM_id=600678;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant. Endometrial cancer, familial, 608089 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),608089(MK),614350(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2956;EnsemblGeneID=ENSG00000116062;Alias=MSH6, GTBP, HNPCC5;FLKSEQ=AACaaaaaaa.tttttttttt	GT:AD:DP:GQ:PL	0/1:245,114:359:99:1157,0,3544
chr2	51288511	.	TAC	T	2084.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.864;DP=415;ExcessHet=3.0103;FS=4.983;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=10.27;ReadPosRankSum=-0.112;SOR=1.092;OLD_VARIANT=chr2|51288511|TAC|T,TACAC|1;HGVSnom=NR_135237.1:n.514+8961_514+8962delCA;Gene=LOC730100;Transcript=NR_135237.1;VarType=Intron;MolecularConsequence=noncoding_transcript_intron_variant;ExonIntron=I2;IVSnom=NR_135237.1:IVS2+8961_+8962delCA;AAlength=.;RS=rs776860832;CytoBand=p16.3;repName=L1MB5;repClass=LINE;FLKSEQ=gacacagtga.acacacacac	GT:AD:DP:GQ:PL	1/0:50,94:203:99:2122,324,2064
chr2	51288511	.	T	TAC	2084.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.864;DP=415;ExcessHet=3.0103;FS=4.983;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=10.27;ReadPosRankSum=-0.112;SOR=1.092;OLD_VARIANT=chr2|51288511|TAC|T,TACAC|2;HGVSnom=NR_135237.1:n.514+8961_514+8962dupCA;Gene=LOC730100;Transcript=NR_135237.1;VarType=Intron;MolecularConsequence=noncoding_transcript_intron_variant;ExonIntron=I2;IVSnom=NR_135237.1:IVS2+8962_+8963insCA;AAlength=.;RS=rs776860832;CytoBand=p16.3;repName=L1MB5;repClass=LINE;FLKSEQ=gacacagtga.acacacacac	GT:AD:DP:GQ:PL	0/1:50,59:203:99:2122,1141,3268
chr2	58388696	.	A	G	5044.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.141;DP=350;ExcessHet=3.0103;FS=8.15;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.5;ReadPosRankSum=0.799;SOR=0.419;HGVSnom=NM_018062.4:c.981T>C(p.Ser327Ser/p.S327S);Gene=FANCL;Transcript=NM_018062.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=375;EXAC_AF=0.64866338;EXAC_Hom_EAS=1391;EXAC_AC_EAS=4872;EXAC_AN_EAS=8638;EXAC_AC_Adj=78522;EXAC_AN_Adj=121052;ESP6500_MAF=0.70409105;RS=rs848291;CLNGENE=FANCL;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.70647;G1000_EAS_AF=0.5883;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.947;G1000_SAS_AF=0.6411;G1000_AMR_AF=0.6412;gnomad_exomes_AF=0.64344426;gnomad_exomes_AF_EAS=0.55820279;gnomad_exomes_AC=161260;gnomad_exomes_Hom=52774;gnomad_exomes_Het=55712;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.90943280;gnomad_exomes_AF_NFE=0.60880211;gnomad_exomes_AF_AMR=0.67994665;gnomad_exomes_AF_SAS=0.66543517;NativeFreq_Het=0.5129;NativeFreq_Hom=0.2702;normalHetFrequency=0.4613;normalHetNum=399;normalHomFrequency=0.3387;normalHomNum=293;patientHetFrequency=0.4646;patientHetNum=2425;patientHomFrequency=0.3201;patientHomNum=1671;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7421;GREP_score=-0.489;CytoBand=p16.1;CGD_CONDITION=Fanconi anemia, complementation group L;CGD_INHERITANCE=AR;Strand=FANCL:NM_001114636.1:-,FANCL:NM_018062.3:-;NP=FANCL:NM_001114636.1:NP_001108108.1,FANCL:NM_018062.3:NP_060532.2;ENSP=FANCL:NM_001114636.1:ENST00000402135.7,FANCL:NM_018062.3:ENST00000233741.8;Gene_MIM_id=602169,608111;Phenotypes=.,Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive. 614083(MK);Possible_Inheritance=NA,AR;EntrezGeneID=7444,55120;EnsemblGeneID=ENSG00000028116,ENSG00000115392;Alias=VRK2,PHF9, FANCL;FLKSEQ=GTCCACACTG.GAATTATCAC	GT:AD:DP:GQ:PL	0/1:185,163:348:99:5073,0,5666
chr2	58449041	.	CA	C	2789.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.622;DP=200;ExcessHet=3.0103;FS=5.402;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.31;ReadPosRankSum=0.402;SOR=0.37;HGVSnom=NM_018062.4:c.374+35delT;Gene=FANCL;Transcript=NM_018062.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_018062.4:IVS5+35delT;AAlength=375;EXAC_AF=0.07743232;EXAC_Hom_EAS=1;EXAC_AC_EAS=179;EXAC_AN_EAS=4998;EXAC_AC_Adj=7053;EXAC_AN_Adj=91086;ESP6500_MAF=0.05187020;RS=rs200325071;CLNGENE=FANCL;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0365415;G1000_EAS_AF=0.0308;G1000_EUR_AF=0.0765;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.0447;gnomad_exomes_AF=0.06410545;gnomad_exomes_AF_EAS=0.02280280;gnomad_exomes_AC=15363;gnomad_exomes_Hom=586;gnomad_exomes_Het=14191;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01299920;gnomad_exomes_AF_NFE=0.07562569;gnomad_exomes_AF_AMR=0.05174850;gnomad_exomes_AF_SAS=0.04924576;NativeFreq_Het=0.0202;NativeFreq_Hom=.;normalHetFrequency=0.0335;normalHetNum=29;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0496;patientHetNum=259;patientHomFrequency=0.0006;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6524787|15D6722511-1][15D6534549];CytoBand=p16.1;CGD_CONDITION=Fanconi anemia, complementation group L;CGD_INHERITANCE=AR;Strand=FANCL:NM_001114636.1:-,FANCL:NM_018062.3:-;NP=FANCL:NM_001114636.1:NP_001108108.1,FANCL:NM_018062.3:NP_060532.2;ENSP=FANCL:NM_001114636.1:ENST00000402135.7,FANCL:NM_018062.3:ENST00000233741.8;Gene_MIM_id=608111;Phenotypes=Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive. 614083(MK);Possible_Inheritance=AR;EntrezGeneID=55120;EnsemblGeneID=ENSG00000115392;Alias=PHF9, FANCL;FLKSEQ=ATATATAAAA.AAGGCATTTA	GT:AD:DP:GQ:PL	0/1:99,96:195:99:2827,0,2926
chr2	58453843	.	GA	G	262.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.568;DP=364;ExcessHet=3.0103;FS=1.401;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.79;ReadPosRankSum=-1.383;SOR=0.825;HGVSnom=NM_018062.4:c.273+19delT;Gene=FANCL;Transcript=NM_018062.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_018062.4:IVS4+19delT;AAlength=375;EXAC_AF=0.09238986;EXAC_Hom_EAS=0;EXAC_AC_EAS=697;EXAC_AN_EAS=6412;EXAC_AC_Adj=8355;EXAC_AN_Adj=90432;ESP6500_MAF=0.09456435;RS=rs372101290;gnomad_exomes_AF=0.03281496;gnomad_exomes_AF_EAS=0.03700935;gnomad_exomes_AC=5077;gnomad_exomes_Hom=0;gnomad_exomes_Het=5077;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08961501;gnomad_exomes_AF_NFE=0.03357483;gnomad_exomes_AF_AMR=0.02737940;gnomad_exomes_AF_SAS=0.02746317;normalHetFrequency=0.0116;normalHetNum=10;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0148;patientHetNum=77;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p16.1;CGD_CONDITION=Fanconi anemia, complementation group L;CGD_INHERITANCE=AR;Strand=FANCL:NM_001114636.1:-,FANCL:NM_018062.3:-;NP=FANCL:NM_001114636.1:NP_001108108.1,FANCL:NM_018062.3:NP_060532.2;ENSP=FANCL:NM_001114636.1:ENST00000402135.7,FANCL:NM_018062.3:ENST00000233741.8;Gene_MIM_id=608111;Phenotypes=Fanconi anemia, complementation group L, 614083 (3), Autosomal recessive. 614083(MK);Possible_Inheritance=AR;EntrezGeneID=55120;EnsemblGeneID=ENSG00000115392;Alias=PHF9, FANCL;FLKSEQ=AACAGTGTCA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:281,51:332:99:300,0,5946
chr2	95849361	.	AT	A	1404.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.397;DP=311;ExcessHet=3.0103;FS=1.588;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.95;ReadPosRankSum=-0.4;SOR=0.897;HGVSnom=NM_021088.4:c.*1530delT;Gene=ZNF2;Transcript=NM_021088.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=425;RS=rs761092352;CytoBand=q11.1;Strand=ZNF2:NM_001017396.2:+,ZNF2:NM_001282398.1:+,ZNF2:NM_001291604.1:+,ZNF2:NM_001291605.1:+,ZNF2:NM_021088.3:+;NP=ZNF2:NM_001017396.2:NP_001017396.1,ZNF2:NM_001282398.1:NP_001269327.1,ZNF2:NM_001291604.1:NP_001278533.1,ZNF2:NM_001291605.1:NP_001278534.1,ZNF2:NM_021088.3:NP_066574.2;ENSP=ZNF2:NM_001017396.2:.,ZNF2:NM_001282398.1:.,ZNF2:NM_001291604.1:.,ZNF2:NM_001291605.1:.,ZNF2:NM_021088.3:.;Gene_MIM_id=194500;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7549;EnsemblGeneID=ENSG00000275111;Alias=ZNF2;FLKSEQ=GCCCAGTCCT.tttttttttt	GT:AD:DP:GQ:PL	0/1:91,145:236:99:1442,0,793
chr2	96917588	.	T	G	5584.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.749;DP=327;ExcessHet=3.0103;FS=0.401;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.18;ReadPosRankSum=2.012;SOR=0.729;HGVSnom=NM_017849.4:c.*1958A>C;Gene=TMEM127;Transcript=NM_017849.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E4;IVSnom=.;AAlength=238;RS=rs7058;CLNGENE=TMEM127;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.616414;G1000_EAS_AF=0.8423;G1000_EUR_AF=0.5209;G1000_AFR_AF=0.5862;G1000_SAS_AF=0.5174;G1000_AMR_AF=0.6239;NativeFreq_Het=0.2178;NativeFreq_Hom=0.7524;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0029;patientHomNum=8;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0050572|16B0005712][_];patientHetSampleInfo=[16B0005643|16B0028133|16D1536911-1][_];patientHomSampleInfo=[16D1545625|16B3094006|16D1878038|16B0028460|16B0028130|16B0047363|16D1533010-1|16B0028116][_];AF_2700_Het=0.2025;AF_2700_Hom=0.7798;AF_50_Het=0.1775;AF_50_Hom=0.8019;DANN_score=0.566;GREP_score=0.183;CytoBand=q11.2;CGD_CONDITION=Pheochromocytoma;CGD_INHERITANCE=AD;Strand=TMEM127:NM_001193304.2:-,TMEM127:NM_017849.3:-;NP=TMEM127:NM_001193304.2:NP_001180233.1,TMEM127:NM_017849.3:NP_060319.1;ENSP=TMEM127:NM_001193304.2:.,TMEM127:NM_017849.3:ENST00000258439.7;Gene_MIM_id=613403;Phenotypes={Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant. 171300(SK);Possible_Inheritance=AD;EntrezGeneID=55654;EnsemblGeneID=ENSG00000135956;Alias=TMEM127;FLKSEQ=ACAGGGTCAT.TACAGGTCCT	GT:AD:DP:GQ:PL	0/1:156,169:325:99:5613,0,4939
chr2	99779131	.	T	C	12599.8	PASS	AC=2;AF=1;AN=2;DP=342;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;QD=33.11;SOR=1.1;HGVSnom=NM_145199.3:c.711T>C(p.Ala237Ala/p.A237A);Gene=LIPT1;Transcript=NM_145199.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=373;EXAC_AF=0.56106517;EXAC_Hom_EAS=1904;EXAC_AC_EAS=5742;EXAC_AN_EAS=8636;EXAC_AC_Adj=67991;EXAC_AN_Adj=121182;ESP6500_MAF=0.50492081;RS=rs2516835;CLNGENE=LIPT1|MITD1;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.496805;G1000_EAS_AF=0.6617;G1000_EUR_AF=0.6103;G1000_AFR_AF=0.2065;G1000_SAS_AF=0.589;G1000_AMR_AF=0.5159;gnomad_exomes_AF=0.56198482;gnomad_exomes_AF_EAS=0.67197695;gnomad_exomes_AC=141129;gnomad_exomes_Hom=41084;gnomad_exomes_Het=58961;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.25391637;gnomad_exomes_AF_NFE=0.61734298;gnomad_exomes_AF_AMR=0.42754210;gnomad_exomes_AF_SAS=0.59725580;NativeFreq_Het=0.4413;NativeFreq_Hom=0.4093;DANN_score=0.7869;GREP_score=1.12;CytoBand=q11.2;CGD_CONDITION=Lipoyltransferase 1 deficiency;CGD_INHERITANCE=AR;Strand=LIPT1:NM_015929.3:+,LIPT1:NM_145197.2:+,LIPT1:NM_145198.2:+,LIPT1:NM_145199.2:+,LIPT1:NM_001204830.1:+;NP=LIPT1:NM_015929.3:NP_057013.1,LIPT1:NM_145197.2:NP_660198.1,LIPT1:NM_145198.2:NP_660199.1,LIPT1:NM_145199.2:NP_660200.1,LIPT1:NM_001204830.1:NP_001191759.1;ENSP=LIPT1:NM_015929.3:.,LIPT1:NM_145197.2:.,LIPT1:NM_145198.2:.,LIPT1:NM_145199.2:.,LIPT1:NM_001204830.1:.;Gene_MIM_id=610284;Phenotypes=Lipoyltransferase 1 deficiency, 616299 (3), Autosomal recessive. 616299(MK);Possible_Inheritance=AR;EntrezGeneID=51601;EnsemblGeneID=ENSG00000144182;Alias=LIPT1, LIPT1D;FLKSEQ=AGTATGCTGC.TATCATCAAA	GT:AD:DP:GQ:PL	1/1:0,341:341:99:12628,1025,0
chr2	111406968	.	G	GA	293.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.945;DP=199;ExcessHet=3.0103;FS=3.962;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.74;ReadPosRankSum=-1.628;SOR=1.274;HGVSnom=NM_004336.5:c.2204-15dupT;Gene=BUB1;Transcript=NM_004336.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_004336.5:IVS18-15_-14insT;AAlength=1085;EXAC_AF=0.29156299;EXAC_Hom_EAS=0;EXAC_AC_EAS=1937;EXAC_AN_EAS=5966;EXAC_AC_Adj=22497;EXAC_AN_Adj=77160;RS=rs375788995;gnomad_exomes_AF=0.24081499;gnomad_exomes_AF_EAS=0.25564804;gnomad_exomes_AC=20660;gnomad_exomes_Hom=0;gnomad_exomes_Het=20660;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.21696102;gnomad_exomes_AF_NFE=0.24749195;gnomad_exomes_AF_AMR=0.22815534;gnomad_exomes_AF_SAS=0.22099926;CytoBand=q13;Strand=BUB1:NM_004336.5:-,BUB1:NM_001278616.1:-,BUB1:NM_001278617.1:-,BUB1:NM_004336.4:-;NP=BUB1:NM_004336.5:NP_004327.1,BUB1:NM_001278616.1:NP_001265545.1,BUB1:NM_001278617.1:NP_001265546.1,BUB1:NM_004336.4:NP_004327.1;ENSP=BUB1:NM_004336.5:ENST00000302759.11,BUB1:NM_001278616.1:.,BUB1:NM_001278617.1:.,BUB1:NM_004336.4:.;Gene_MIM_id=602452;Phenotypes=Colorectal cancer with chromosomal instability, somatic (3). 602452(MK);Possible_Inheritance=NA;EntrezGeneID=699;EnsemblGeneID=ENSG00000169679;Alias=BUB1;FLKSEQ=AAAGGAATGA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:130,39:169:99:331,0,2394
chr2	111419426	.	A	G	5425.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.383;DP=331;ExcessHet=3.0103;FS=3.208;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.44;ReadPosRankSum=-0.251;SOR=0.89;HGVSnom=NM_004336.5:c.958-8T>C;Gene=BUB1;Transcript=NM_004336.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_004336.5:IVS9-8T>C;AAlength=1085;EXAC_AF=0.07784712;EXAC_Hom_EAS=33;EXAC_AC_EAS=688;EXAC_AN_EAS=8604;EXAC_AC_Adj=9306;EXAC_AN_Adj=119542;ESP6500_MAF=0.13409196;RS=rs7609252;G1000_AF=0.157947;G1000_EAS_AF=0.0833;G1000_EUR_AF=0.0219;G1000_AFR_AF=0.3767;G1000_SAS_AF=0.0828;G1000_AMR_AF=0.1527;gnomad_exomes_AF=0.07615549;gnomad_exomes_AF_EAS=0.08556296;gnomad_exomes_AC=18866;gnomad_exomes_Hom=1651;gnomad_exomes_Het=15564;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34835657;gnomad_exomes_AF_NFE=0.03059102;gnomad_exomes_AF_AMR=0.14526809;gnomad_exomes_AF_SAS=0.07609341;NativeFreq_Het=0.1566;NativeFreq_Hom=0;dbscSNV_RF_score=0.032;dbscSNV_ADA_score=0.00002329;DANN_score=0.6069;GREP_score=1.09;CytoBand=q13;Strand=BUB1:NM_004336.5:-,BUB1:NM_001278616.1:-,BUB1:NM_001278617.1:-,BUB1:NM_004336.4:-;NP=BUB1:NM_004336.5:NP_004327.1,BUB1:NM_001278616.1:NP_001265545.1,BUB1:NM_001278617.1:NP_001265546.1,BUB1:NM_004336.4:NP_004327.1;ENSP=BUB1:NM_004336.5:ENST00000302759.11,BUB1:NM_001278616.1:.,BUB1:NM_001278617.1:.,BUB1:NM_004336.4:.;Gene_MIM_id=602452;Phenotypes=Colorectal cancer with chromosomal instability, somatic (3). 602452(MK);Possible_Inheritance=NA;EntrezGeneID=699;EnsemblGeneID=ENSG00000169679;Alias=BUB1;FLKSEQ=AACCTTTCAT.TTAAACAAAC	GT:AD:DP:GQ:PL	0/1:161,169:330:99:5454,0,4884
chr2	128029065	.	GA	G	5950.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.157;DP=249;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=25.65;ReadPosRankSum=0.407;SOR=0.961;HGVSnom=NM_000122.2:c.1828-37delT;Gene=ERCC3;Transcript=NM_000122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000122.2:IVS11-37delT;AAlength=782;EXAC_AF=0.37421055;EXAC_Hom_EAS=595;EXAC_AC_EAS=3348;EXAC_AN_EAS=7424;EXAC_AC_Adj=37210;EXAC_AN_Adj=99436;ESP6500_MAF=0.32491609;RS=rs11345447;CLNGENE=ERCC3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.353235;G1000_EAS_AF=0.4008;G1000_EUR_AF=0.2883;G1000_AFR_AF=0.3472;G1000_SAS_AF=0.4622;G1000_AMR_AF=0.2363;gnomad_exomes_AF=0.40589004;gnomad_exomes_AF_EAS=0.48784924;gnomad_exomes_AC=68291;gnomad_exomes_Hom=9457;gnomad_exomes_Het=49377;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42735334;gnomad_exomes_AF_NFE=0.38417950;gnomad_exomes_AF_AMR=0.27922150;gnomad_exomes_AF_SAS=0.53613399;NativeFreq_Het=0.3515;NativeFreq_Hom=.;normalHetFrequency=0.4624;normalHetNum=400;normalHomFrequency=0.1595;normalHomNum=138;patientHetFrequency=0.4525;patientHetNum=2362;patientHomFrequency=0.1487;patientHomNum=776;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q14.3;CGD_CONDITION=Xeroderma pigmentosum, complementation group B. Trichothiodystrophy 2, photosensitive;CGD_INHERITANCE=AR;Strand=ERCC3:NM_001303416.1:-,ERCC3:NM_001303418.1:-,ERCC3:NM_000122.1:-;NP=ERCC3:NM_001303416.1:NP_001290345.1,ERCC3:NM_001303418.1:NP_001290347.1,ERCC3:NM_000122.1:NP_000113.1;ENSP=ERCC3:NM_001303416.1:.,ERCC3:NM_001303418.1:.,ERCC3:NM_000122.1:ENST00000285398.6;Gene_MIM_id=133510;Phenotypes=Trichothiodystrophy 2, photosensitive, 616390 (3), Autosomal recessive. Xeroderma pigmentosum, group B, 610651 (3), Autosomal recessive. 610651(MK),616390(MK);Possible_Inheritance=AR;EntrezGeneID=2071;EnsemblGeneID=ENSG00000163161;Alias=ERCC3, XPB, TTD2;FLKSEQ=TATATATGAG.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/1:8,224:232:99:5988,505,0
chr2	141751592	.	G	A	8282.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.538;DP=541;ExcessHet=3.0103;FS=2.455;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.34;ReadPosRankSum=0.68;SOR=0.917;HGVSnom=NM_018557.3:c.2616C>T(p.Asp872Asp/p.D872D);Gene=LRP1B;Transcript=NM_018557.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=4599;EXAC_AF=0.38796938;EXAC_Hom_EAS=1514;EXAC_AC_EAS=5123;EXAC_AN_EAS=8556;EXAC_AC_Adj=46928;EXAC_AN_Adj=120958;ESP6500_MAF=0.39873904;RS=rs13007735;G1000_AF=0.509585;G1000_EAS_AF=0.6141;G1000_EUR_AF=0.3748;G1000_AFR_AF=0.6059;G1000_SAS_AF=0.499;G1000_AMR_AF=0.3847;gnomad_exomes_AF=0.38317328;gnomad_exomes_AF_EAS=0.59129628;gnomad_exomes_AC=95919;gnomad_exomes_Hom=19835;gnomad_exomes_Het=56249;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55845036;gnomad_exomes_AF_NFE=0.32386364;gnomad_exomes_AF_AMR=0.38902439;gnomad_exomes_AF_SAS=0.44840102;NativeFreq_Het=0.4342;NativeFreq_Hom=0.3238;DANN_score=0.8773;GREP_score=-5.18;CytoBand=q22.1;Strand=LRP1B:NM_018557.2:-;NP=LRP1B:NM_018557.2:NP_061027.2;ENSP=LRP1B:NM_018557.2:.;FLKSEQ=CATCGCTTCC.TCTAGGCAGT	GT:AD:DP:GQ:PL	0/1:267,273:540:99:8311,0,7551
chr2	190649316	.	G	C	3634.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.157;DP=238;ExcessHet=3.0103;FS=4.458;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=15.4;ReadPosRankSum=-0.12;SOR=0.997;HGVSnom=NM_000534.5:c.-24G>C;Gene=PMS1;Transcript=NM_000534.5;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=932;RS=rs5742933;CLNGENE=PMS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.219249;G1000_EAS_AF=0.2183;G1000_EUR_AF=0.1978;G1000_AFR_AF=0.3011;G1000_SAS_AF=0.1176;G1000_AMR_AF=0.2392;NativeFreq_Het=0.3564;NativeFreq_Hom=0.0396;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16D0166662][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=_;patientHomSampleInfo=_;AF_2700_Het=0.3294;AF_2700_Hom=0.0484;AF_50_Het=0.3170;AF_50_Hom=0.0618;DANN_score=0.7631;GREP_score=1.85;CytoBand=q32.2;Strand=PMS1:NM_001321051.1:+,PMS1:NM_001321049.1:+,PMS1:NM_000534.4:+,PMS1:NM_001128143.1:+,PMS1:NM_001128144.1:+,PMS1:NM_001289408.1:+,PMS1:NM_001289409.1:+,PMS1:NM_001321044.1:+,PMS1:NM_001321045.1:+,PMS1:NM_001321046.1:+,PMS1:NM_001321047.1:+,PMS1:NM_001321048.1:+;NP=PMS1:NM_001321051.1:NP_001307980.1,PMS1:NM_001321049.1:NP_001307978.1,PMS1:NM_000534.4:NP_000525.1,PMS1:NM_001128143.1:NP_001121615.1,PMS1:NM_001128144.1:NP_001121616.1,PMS1:NM_001289408.1:NP_001276337.1,PMS1:NM_001289409.1:NP_001276338.1,PMS1:NM_001321044.1:NP_001307973.1,PMS1:NM_001321045.1:NP_001307974.1,PMS1:NM_001321046.1:NP_001307975.1,PMS1:NM_001321047.1:NP_001307976.1,PMS1:NM_001321048.1:NP_001307977.1;ENSP=PMS1:NM_001321051.1:.,PMS1:NM_001321049.1:.,PMS1:NM_000534.4:ENST00000441310.6,PMS1:NM_001128143.1:.,PMS1:NM_001128144.1:.,PMS1:NM_001289408.1:.,PMS1:NM_001289409.1:.,PMS1:NM_001321044.1:.,PMS1:NM_001321045.1:.,PMS1:NM_001321046.1:.,PMS1:NM_001321047.1:.,PMS1:NM_001321048.1:.;Gene_MIM_id=600258;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5378;EnsemblGeneID=ENSG00000064933;Alias=PMS1, PMSL1, HNPCC3;FLKSEQ=GCGCTAGCAG.AAGGTAGTGT	GT:AD:DP:GQ:PL	0/1:127,109:236:99:3663,0,4146
chr2	190670539	.	T	TA	1630.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.365;DP=274;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.63;ReadPosRankSum=-0.151;SOR=0.549;HGVSnom=NM_000534.5:c.418+70dupA;Gene=PMS1;Transcript=NM_000534.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000534.5:IVS4+70_+71insA;AAlength=932;EXAC_AF=0.24340620;EXAC_Hom_EAS=50;EXAC_AC_EAS=1168;EXAC_AN_EAS=4320;EXAC_AC_Adj=14452;EXAC_AN_Adj=59374;RS=rs3214425;CLNGENE=PMS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.215256;G1000_EAS_AF=0.2173;G1000_EUR_AF=0.1958;G1000_AFR_AF=0.2912;G1000_SAS_AF=0.1207;G1000_AMR_AF=0.2291;gnomad_exomes_AF=0.27841412;gnomad_exomes_AF_EAS=0.30475087;gnomad_exomes_AC=37092;gnomad_exomes_Hom=734;gnomad_exomes_Het=35624;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.33640257;gnomad_exomes_AF_NFE=0.26385224;gnomad_exomes_AF_AMR=0.32444978;gnomad_exomes_AF_SAS=0.21637000;NativeFreq_Het=0.2030;NativeFreq_Hom=.;normalHetFrequency=0.3247;normalHetNum=126;normalHomFrequency=0.0515;normalHomNum=20;patientHetFrequency=0.3337;patientHetNum=925;patientHomFrequency=0.0415;patientHomNum=115;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q32.2;Strand=PMS1:NM_001321051.1:+,PMS1:NM_001321049.1:+,PMS1:NM_000534.4:+,PMS1:NM_001128143.1:+,PMS1:NM_001128144.1:+,PMS1:NM_001289408.1:+,PMS1:NM_001289409.1:+,PMS1:NM_001321044.1:+,PMS1:NM_001321045.1:+,PMS1:NM_001321046.1:+,PMS1:NM_001321047.1:+,PMS1:NM_001321048.1:+;NP=PMS1:NM_001321051.1:NP_001307980.1,PMS1:NM_001321049.1:NP_001307978.1,PMS1:NM_000534.4:NP_000525.1,PMS1:NM_001128143.1:NP_001121615.1,PMS1:NM_001128144.1:NP_001121616.1,PMS1:NM_001289408.1:NP_001276337.1,PMS1:NM_001289409.1:NP_001276338.1,PMS1:NM_001321044.1:NP_001307973.1,PMS1:NM_001321045.1:NP_001307974.1,PMS1:NM_001321046.1:NP_001307975.1,PMS1:NM_001321047.1:NP_001307976.1,PMS1:NM_001321048.1:NP_001307977.1;ENSP=PMS1:NM_001321051.1:.,PMS1:NM_001321049.1:.,PMS1:NM_000534.4:ENST00000441310.6,PMS1:NM_001128143.1:.,PMS1:NM_001128144.1:.,PMS1:NM_001289408.1:.,PMS1:NM_001289409.1:.,PMS1:NM_001321044.1:.,PMS1:NM_001321045.1:.,PMS1:NM_001321046.1:.,PMS1:NM_001321047.1:.,PMS1:NM_001321048.1:.;Gene_MIM_id=600258;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5378;EnsemblGeneID=ENSG00000064933;Alias=PMS1, PMSL1, HNPCC3;FLKSEQ=ATTGTTGGTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:150,96:246:99:1668,0,3128
chr2	190742374	.	A	G	3473.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.702;DP=259;ExcessHet=3.0103;FS=0.95;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.41;ReadPosRankSum=-0.265;SOR=0.627;HGVSnom=.;Gene=PMS1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs256552;G1000_AF=0.336262;G1000_EAS_AF=0.2192;G1000_EUR_AF=0.0994;G1000_AFR_AF=0.7874;G1000_SAS_AF=0.1881;G1000_AMR_AF=0.1988;HGMD_gene=PMS1;HGMD_disease=Colorectal_cancer_non-polyposis;HGMD_tag=R;HGMD_pmid=24710284;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0819;normalHetFrequency=0.2732;normalHetNum=106;normalHomFrequency=0.0722;normalHomNum=28;patientHetFrequency=0.267;patientHetNum=740;patientHomFrequency=0.0624;patientHomNum=173;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3597;AF_2700_Hom=0.0642;AF_50_Het=0.3788;AF_50_Hom=0.0634;DANN_score=0.5524;GREP_score=-0.033;CytoBand=q32.2;FLKSEQ=TCAAGAACCA.CCATCATCAT	GT:AD:DP:GQ:PL	0/1:143,116:259:99:3502,0,4379
chr2	215593261	.	C	CT	2834.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.478;DP=270;ExcessHet=3.0103;FS=1.346;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.52;ReadPosRankSum=-0.273;SOR=0.579;HGVSnom=NM_000465.4:c.*138dupA;Gene=BARD1;Transcript=NM_000465.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=777;RS=rs113789798;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.643171;G1000_EAS_AF=0.6518;G1000_EUR_AF=0.6421;G1000_AFR_AF=0.6271;G1000_SAS_AF=0.6636;G1000_AMR_AF=0.634;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=TGGCATTAGA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:78,168:246:99:2872,0,806
chr2	215632256	.	A	G	17373.8	PASS	AC=2;AF=1;AN=2;DP=502;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.75;SOR=0.693;HGVSnom=NM_000465.4:c.1518T>C(p.His506His/p.H506H);Gene=BARD1;Transcript=NM_000465.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=777;EXAC_AF=0.81341918;EXAC_Hom_EAS=3937;EXAC_AC_EAS=8251;EXAC_AN_EAS=8650;EXAC_AC_Adj=98671;EXAC_AN_Adj=121304;ESP6500_MAF=0.71382439;RS=rs2070093;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.770567;G1000_EAS_AF=0.9484;G1000_EUR_AF=0.8181;G1000_AFR_AF=0.5545;G1000_SAS_AF=0.8384;G1000_AMR_AF=0.7594;gnomad_exomes_AF=0.81692876;gnomad_exomes_AF_EAS=0.95351745;gnomad_exomes_AC=205304;gnomad_exomes_Hom=84649;gnomad_exomes_Het=36006;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59702227;gnomad_exomes_AF_NFE=0.80619446;gnomad_exomes_AF_AMR=0.81575901;gnomad_exomes_AF_SAS=0.84079326;NativeFreq_Het=0.2206;NativeFreq_Hom=0.8712;normalHetFrequency=0.1778;normalHetNum=69;normalHomFrequency=0.7887;normalHomNum=306;patientHetFrequency=0.1634;patientHetNum=453;patientHomFrequency=0.7958;patientHomNum=2206;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0992;AF_2700_Hom=0.8978;AF_50_Het=0.0745;AF_50_Hom=0.9223;DANN_score=0.4146;GREP_score=-1.73;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=CTATATCCAC.TGCCCATTCT	GT:AD:DP:GQ:PL	1/1:0,500:500:99:17402,1502,0
chr2	215645545	.	C	G	6895.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.356;DP=524;ExcessHet=3.0103;FS=2.454;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.16;ReadPosRankSum=0.182;SOR=0.905;HGVSnom=NM_000465.4:c.1053G>C(p.Thr351Thr/p.T351T);Gene=BARD1;Transcript=NM_000465.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=777;EXAC_AF=0.20514554;EXAC_Hom_EAS=96;EXAC_AC_EAS=1352;EXAC_AN_EAS=8634;EXAC_AC_Adj=24878;EXAC_AN_Adj=121270;ESP6500_MAF=0.20344456;RS=rs2070096;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.190296;G1000_EAS_AF=0.1815;G1000_EUR_AF=0.1839;G1000_AFR_AF=0.1611;G1000_SAS_AF=0.2444;G1000_AMR_AF=0.1916;gnomad_exomes_AF=0.20613263;gnomad_exomes_AF_EAS=0.16198869;gnomad_exomes_AC=51790;gnomad_exomes_Hom=5547;gnomad_exomes_Het=40696;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16225695;gnomad_exomes_AF_NFE=0.21352113;gnomad_exomes_AF_AMR=0.23020375;gnomad_exomes_AF_SAS=0.24258461;NativeFreq_Het=0.2918;NativeFreq_Hom=0.0427;normalHetFrequency=0.2345;normalHetNum=91;normalHomFrequency=0.0309;normalHomNum=12;patientHetFrequency=0.2767;patientHetNum=767;patientHomFrequency=0.0343;patientHomNum=95;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2487;AF_2700_Hom=0.0238;AF_50_Het=0.2266;AF_50_Hom=0.0333;DANN_score=0.2998;GREP_score=-11.3;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=CTGAGGGCAC.GTTTGCTTAA	GT:AD:DP:GQ:PL	0/1:282,242:524:99:6924,0,8430
chr2	215657182	.	TA	T	1901.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.031;DP=293;ExcessHet=3.0103;FS=1.355;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.73;ReadPosRankSum=1.321;SOR=0.875;HGVSnom=NM_000465.4:c.216-14delT;Gene=BARD1;Transcript=NM_000465.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000465.4:IVS2-14delT;AAlength=777;EXAC_AF=0.43843736;EXAC_Hom_EAS=1;EXAC_AC_EAS=381;EXAC_AN_EAS=834;EXAC_AC_Adj=13389;EXAC_AN_Adj=30538;RS=rs56130510;CLNGENE=BARD1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.444888;G1000_EAS_AF=0.381;G1000_EUR_AF=0.4394;G1000_AFR_AF=0.4387;G1000_SAS_AF=0.499;G1000_AMR_AF=0.4813;gnomad_exomes_AF=0.42287582;gnomad_exomes_AF_EAS=0.45120120;gnomad_exomes_AC=40761;gnomad_exomes_Hom=258;gnomad_exomes_Het=40245;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42624836;gnomad_exomes_AF_NFE=0.41831168;gnomad_exomes_AF_AMR=0.41565375;gnomad_exomes_AF_SAS=0.43407942;NativeFreq_Het=0.2822;NativeFreq_Hom=.;normalHetFrequency=0.6186;normalHetNum=240;normalHomFrequency=0.0412;normalHomNum=16;patientHetFrequency=0.6136;patientHetNum=1701;patientHomFrequency=0.0505;patientHomNum=140;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.7137;AF_2700_Hom=0.0146;AF_50_Het=0.7227;AF_50_Hom=0.0143;CytoBand=q35;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=ttaaaataat.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:110,136:246:99:1939,0,1660
chr2	215674090	.	T	G	6096.77	PASS	AC=2;AF=1;AN=2;DP=163;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.2;SOR=0.921;HGVSnom=NM_000465.4:c.158+46A>C;Gene=BARD1;Transcript=NM_000465.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000465.4:IVS1+46A>C;AAlength=777;EXAC_AF=0.73868438;EXAC_Hom_EAS=2674;EXAC_AC_EAS=6565;EXAC_AN_EAS=7992;EXAC_AC_Adj=77618;EXAC_AN_Adj=105076;ESP6500_MAF=0.74695969;RS=rs35933323;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.744808;G1000_EAS_AF=0.7847;G1000_EUR_AF=0.7386;G1000_AFR_AF=0.7557;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.8141;gnomad_exomes_AF=0.73946332;gnomad_exomes_AF_EAS=0.81242893;gnomad_exomes_AC=172011;gnomad_exomes_Hom=64018;gnomad_exomes_Het=43975;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76590292;gnomad_exomes_AF_NFE=0.71345944;gnomad_exomes_AF_AMR=0.81962025;gnomad_exomes_AF_SAS=0.66459353;NativeFreq_Het=0.2772;NativeFreq_Hom=0.6732;normalHetFrequency=0.2861;normalHetNum=111;normalHomFrequency=0.616;normalHomNum=239;patientHetFrequency=0.2796;patientHetNum=775;patientHomFrequency=0.6035;patientHomNum=1673;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5646;GREP_score=0.557;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=CCAGAAACTG.GCGACCCGTG	GT:AD:DP:GQ:PL	1/1:0,163:163:99:6125,490,0
chr2	215674323	.	C	G	6260.77	PASS	AC=2;AF=1;AN=2;DP=143;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.49;SOR=1.179;HGVSnom=NM_000465.4:c.-30G>C;Gene=BARD1;Transcript=NM_000465.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=777;EXAC_AF=0.70723059;EXAC_Hom_EAS=164;EXAC_AC_EAS=422;EXAC_AN_EAS=532;EXAC_AC_Adj=11170;EXAC_AN_Adj=15794;ESP6500_MAF=0.77088116;RS=rs1129804;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.744609;G1000_EAS_AF=0.7817;G1000_EUR_AF=0.7406;G1000_AFR_AF=0.7557;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.8141;gnomad_exomes_AF=0.73386104;gnomad_exomes_AF_EAS=0.80365085;gnomad_exomes_AC=102538;gnomad_exomes_Hom=37929;gnomad_exomes_Het=26680;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76435761;gnomad_exomes_AF_NFE=0.70824021;gnomad_exomes_AF_AMR=0.81466041;gnomad_exomes_AF_SAS=0.66354486;NativeFreq_Het=0.2772;NativeFreq_Hom=0.6732;normalHetFrequency=0.2577;normalHetNum=100;normalHomFrequency=0.5696;normalHomNum=221;patientHetFrequency=0.2413;patientHetNum=669;patientHomFrequency=0.5635;patientHomNum=1562;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2909;AF_2700_Hom=0.6791;AF_50_Het=0.2742;AF_50_Hom=0.6894;DANN_score=0.4031;GREP_score=-3.5;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=AGGCTCCTCG.AGAGCGGGAA	GT:AD:DP:GQ:PL	1/1:0,143:143:99:6289,433,0
chr2	215674341	.	A	G	5990.77	PASS	AC=2;AF=1;AN=2;DP=129;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.67;SOR=1.027;HGVSnom=NM_000465.4:c.-48T>C;Gene=BARD1;Transcript=NM_000465.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=777;EXAC_AF=0.68950879;EXAC_Hom_EAS=104;EXAC_AC_EAS=270;EXAC_AN_EAS=342;EXAC_AC_Adj=9096;EXAC_AN_Adj=13192;ESP6500_MAF=0.78518104;RS=rs17489363;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.745008;G1000_EAS_AF=0.7837;G1000_EUR_AF=0.7406;G1000_AFR_AF=0.7557;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.8141;gnomad_exomes_AF=0.73337495;gnomad_exomes_AF_EAS=0.80469634;gnomad_exomes_AC=99849;gnomad_exomes_Hom=36910;gnomad_exomes_Het=26029;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76463339;gnomad_exomes_AF_NFE=0.70709130;gnomad_exomes_AF_AMR=0.81471334;gnomad_exomes_AF_SAS=0.66265221;NativeFreq_Het=0.2772;NativeFreq_Hom=0.6732;normalHetFrequency=0.2268;normalHetNum=88;normalHomFrequency=0.5387;normalHomNum=209;patientHetFrequency=0.219;patientHetNum=607;patientHomFrequency=0.5393;patientHomNum=1495;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2913;AF_2700_Hom=0.6787;AF_50_Het=0.2742;AF_50_Hom=0.6894;DANN_score=0.3536;GREP_score=0.21;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=GAAGCAAGGA.GCCTCGGGAA	GT:AD:DP:GQ:PL	1/1:0,129:129:99:6019,412,0
chr2	215674371	.	C	T	3977.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.69;DP=126;ExcessHet=3.0103;FS=3.153;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.08;ReadPosRankSum=1.636;SOR=0.353;HGVSnom=NM_000465.4:c.-78G>A;Gene=BARD1;Transcript=NM_000465.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=777;RS=rs34732883;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.658347;G1000_EAS_AF=0.7827;G1000_EUR_AF=0.664;G1000_AFR_AF=0.5855;G1000_SAS_AF=0.5941;G1000_AMR_AF=0.6988;NativeFreq_Het=0.2871;NativeFreq_Hom=0.6534;normalHetFrequency=0.2139;normalHetNum=83;normalHomFrequency=0.4278;normalHomNum=166;patientHetFrequency=0.1825;patientHetNum=506;patientHomFrequency=0.4311;patientHomNum=1195;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2932;AF_2700_Hom=0.6756;AF_50_Het=0.2758;AF_50_Hom=0.6894;DANN_score=0.8578;GREP_score=0.66;CytoBand=q35;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=BARD1:NM_000465.3:-,BARD1:NM_001282543.1:-,BARD1:NM_001282545.1:-,BARD1:NM_001282548.1:-,BARD1:NM_001282549.1:-;NP=BARD1:NM_000465.3:NP_000456.2,BARD1:NM_001282543.1:NP_001269472.1,BARD1:NM_001282545.1:NP_001269474.1,BARD1:NM_001282548.1:NP_001269477.1,BARD1:NM_001282549.1:NP_001269478.1;ENSP=BARD1:NM_000465.3:ENST00000260947.8,BARD1:NM_001282543.1:.,BARD1:NM_001282545.1:.,BARD1:NM_001282548.1:.,BARD1:NM_001282549.1:.;Gene_MIM_id=601593;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=580;EnsemblGeneID=ENSG00000138376;Alias=BARD1;FLKSEQ=AAGCTGCAGG.CAGCGACTCG	GT:AD:DP:GQ:PL	1/1:1,123:124:99:4006,358,0
chr2	215674436	.	C	T	3776.77	PASS	AC=2;AF=1;AN=2;DP=114;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.42;SOR=1.129;HGVSnom=.;Gene=BARD1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs13022992;CLNGENE=BARD1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.2036;normalHomNum=79;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.2525;patientHomNum=700;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0019;AF_2700_Hom=0.9593;AF_50_Het=0.0016;AF_50_Hom=0.9604;DANN_score=0.911;GREP_score=1.07;CytoBand=q35;repName=(CGGGG)n;repClass=Simple_repeat;FLKSEQ=Aggggcgggg.gcgcggggag	GT:AD:DP:GQ:PL	1/1:0,113:113:99:3805,337,0
chr2	232995569	.	T	TA	294.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.168;DP=492;ExcessHet=3.0103;FS=2.567;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.64;ReadPosRankSum=-0.745;SOR=0.711;HGVSnom=NM_152383.5:c.702+152dupA;Gene=DIS3L2;Transcript=NM_152383.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_152383.5:IVS7+152_+153insA;AAlength=885;RS=rs879745299;CytoBand=q37.1;repName=Tigger13a;repClass=DNA;CGD_CONDITION=Perlman syndrome;CGD_INHERITANCE=AR;Strand=DIS3L2:NM_001257282.1:+,DIS3L2:NM_152383.4:+,DIS3L2:NM_001257281.1:+;NP=DIS3L2:NM_001257282.1:NP_001244211.1,DIS3L2:NM_152383.4:NP_689596.4,DIS3L2:NM_001257281.1:NP_001244210.1;ENSP=DIS3L2:NM_001257282.1:.,DIS3L2:NM_152383.4:ENST00000325385.11,DIS3L2:NM_001257281.1:.;Gene_MIM_id=614184;Phenotypes=Perlman syndrome, 267000 (3), Autosomal recessive. 267000(MK);Possible_Inheritance=AR;EntrezGeneID=129563;EnsemblGeneID=ENSG00000144535;Alias=DIS3L2, PRLMNS;FLKSEQ=aaaagtgaat.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:390,69:459:99:332,0,8282
chr2	233201328	.	A	G	4511.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.754;DP=306;ExcessHet=3.0103;FS=0.878;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.79;ReadPosRankSum=-0.686;SOR=0.767;HGVSnom=NM_152383.5:c.2646A>G(p.Ser882Ser/p.S882S);Gene=DIS3L2;Transcript=NM_152383.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E21;IVSnom=.;AAlength=885;EXAC_AF=0.14248913;EXAC_Hom_EAS=792;EXAC_AC_EAS=3573;EXAC_AN_EAS=7620;EXAC_AC_Adj=14547;EXAC_AN_Adj=102092;ESP6500_MAF=0.09947013;RS=rs3811578;CLNGENE=DIS3L2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.202077;G1000_EAS_AF=0.4484;G1000_EUR_AF=0.0865;G1000_AFR_AF=0.1732;G1000_SAS_AF=0.0665;G1000_AMR_AF=0.2579;gnomad_exomes_AF=0.14266194;gnomad_exomes_AF_EAS=0.45470888;gnomad_exomes_AC=32887;gnomad_exomes_Hom=3746;gnomad_exomes_Het=25395;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15509824;gnomad_exomes_AF_NFE=0.08728529;gnomad_exomes_AF_AMR=0.25720263;gnomad_exomes_AF_SAS=0.07445439;DANN_score=0.5233;GREP_score=2.89;CytoBand=q37.1;dupName=chr2:233305992;dupScore=0;CGD_CONDITION=Perlman syndrome;CGD_INHERITANCE=AR;Strand=DIS3L2:NM_152383.4:+,DIS3L2:NM_001257281.1:+;NP=DIS3L2:NM_152383.4:NP_689596.4,DIS3L2:NM_001257281.1:NP_001244210.1;ENSP=DIS3L2:NM_152383.4:ENST00000325385.11,DIS3L2:NM_001257281.1:.;Gene_MIM_id=614184;Phenotypes=Perlman syndrome, 267000 (3), Autosomal recessive. 267000(MK);Possible_Inheritance=AR;EntrezGeneID=129563;EnsemblGeneID=ENSG00000144535;Alias=DIS3L2, PRLMNS;FLKSEQ=CCGAGGACTC.AGCACCAGCT	GT:AD:DP:GQ:PL	0/1:147,158:305:99:4540,0,4690
chr2	233201698	.	A	G	4571.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.988;DP=253;ExcessHet=3.0103;FS=3.542;MLEAC=1;MLEAF=0.5;MQ=59.62;MQRankSum=-3.204;QD=18.07;ReadPosRankSum=-1.428;SOR=0.502;HGVSnom=NM_152383.5:c.*358A>G;Gene=DIS3L2;Transcript=NM_152383.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E21;IVSnom=.;AAlength=885;RS=rs545003737;G1000_AF=0.00079872;G1000_EAS_AF=0.002;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0;DANN_score=0.516;GREP_score=3.19;CytoBand=q37.1;dupName=chr2:233305992;dupScore=0;CGD_CONDITION=Perlman syndrome;CGD_INHERITANCE=AR;Strand=DIS3L2:NM_152383.4:+,DIS3L2:NM_001257281.1:+;NP=DIS3L2:NM_152383.4:NP_689596.4,DIS3L2:NM_001257281.1:NP_001244210.1;ENSP=DIS3L2:NM_152383.4:ENST00000325385.11,DIS3L2:NM_001257281.1:.;Gene_MIM_id=614184;Phenotypes=Perlman syndrome, 267000 (3), Autosomal recessive. 267000(MK);Possible_Inheritance=AR;EntrezGeneID=129563;EnsemblGeneID=ENSG00000144535;Alias=DIS3L2, PRLMNS;FLKSEQ=TCTGGTGTGT.GGGCGCCTCT	GT:AD:DP:GQ:PL	0/1:114,139:253:99:4600,0,3452
chr2	233208534	.	T	C	5229.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.087;DP=368;ExcessHet=3.0103;FS=4.633;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.33;ReadPosRankSum=-0.278;SOR=0.506;HGVSnom=.;Gene=DIS3L2;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs6711186;CLNGENE=DIS3L2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.439297;G1000_EAS_AF=0.4812;G1000_EUR_AF=0.1561;G1000_AFR_AF=0.8079;G1000_SAS_AF=0.1912;G1000_AMR_AF=0.4366;NativeFreq_Het=0.2847;NativeFreq_Hom=0.1139;DANN_score=0.5587;GREP_score=0.122;CytoBand=q37.1;CGD_CONDITION=Perlman syndrome;CGD_INHERITANCE=AR;Strand=DIS3L2:NM_001257281.1:+;NP=DIS3L2:NM_001257281.1:NP_001244210.1;ENSP=DIS3L2:NM_001257281.1:.;Gene_MIM_id=614184;Phenotypes=Perlman syndrome, 267000 (3), Autosomal recessive. 267000(MK);Possible_Inheritance=AR;EntrezGeneID=129563;EnsemblGeneID=ENSG00000144535;Alias=DIS3L2, PRLMNS;FLKSEQ=ACCCAATCTT.TCCCTCAGAT	GT:AD:DP:GQ:PL	0/1:195,170:365:99:5258,0,6276
chr3	10088223	.	T	G	189.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=4.059;DP=178;ExcessHet=3.0103;FS=4.358;MLEAC=1;MLEAF=0.5;MQ=59.21;MQRankSum=-11.098;QD=1.07;ReadPosRankSum=-1.767;SOR=1.56;HGVSnom=NM_001018115.3:c.1135-41T>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_001018115.3:IVS14-41T>G;AAlength=1451;EXAC_AF=0.03520405;EXAC_Hom_EAS=0;EXAC_AC_EAS=206;EXAC_AN_EAS=7082;EXAC_AC_Adj=3366;EXAC_AN_Adj=95614;RS=rs200221245;gnomad_exomes_AF=0.00226373;gnomad_exomes_AF_EAS=0.00054512;gnomad_exomes_AC=470;gnomad_exomes_Hom=0;gnomad_exomes_Het=470;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00181378;gnomad_exomes_AF_NFE=0.00357197;gnomad_exomes_AF_AMR=0.00064375;gnomad_exomes_AF_SAS=0.00043503;NativeFreq_Het=0.8541;NativeFreq_Hom=0;normalHetFrequency=0.0023;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0017;patientHetNum=9;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[15B0002936][15B0062744];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1546157|17B0000887|17B0001560-1][15D6518694|15B0022389|15B0047124|15D6534491|15B0027104|16D0169436];patientHomSampleInfo=[_][_];DANN_score=0.6736;GREP_score=0.0825;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TGTACTGATT.GTTAACTGTT	GT:AD:DP:GQ:PL	0/1:164,14:178:99:218,0,5924
chr3	10088239	.	G	A	739.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.671;DP=228;ExcessHet=3.0103;FS=5.048;MLEAC=1;MLEAF=0.5;MQ=59.15;MQRankSum=-9.705;QD=3.24;ReadPosRankSum=-2.221;SOR=1.271;HGVSnom=NM_001018115.3:c.1135-25G>A;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_001018115.3:IVS14-25G>A;AAlength=1451;EXAC_AF=0.16580251;EXAC_Hom_EAS=0;EXAC_AC_EAS=1082;EXAC_AN_EAS=7528;EXAC_AC_Adj=17076;EXAC_AN_Adj=102990;RS=rs201770712;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.00840366;gnomad_exomes_AF_EAS=0.00192493;gnomad_exomes_AC=1432;gnomad_exomes_Hom=0;gnomad_exomes_Het=1432;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00764695;gnomad_exomes_AF_NFE=0.01193748;gnomad_exomes_AF_AMR=0.00161847;gnomad_exomes_AF_SAS=0.00174985;NativeFreq_Het=0.8648;NativeFreq_Hom=0;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.001;patientHetNum=5;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][15B0060449|15B0062744];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15B0047497-1][15D6529872|15D6529863|15B0022389|15D6534491];patientHomSampleInfo=[_][_];AF_2700_Het=0.0254;AF_2700_Hom=0.0000;AF_50_Het=0.0285;AF_50_Hom=0.0000;DANN_score=0.2787;GREP_score=-10.9;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=CTGTTTTTCT.TTGTTGCATA	GT:AD:DP:GQ:PL	0/1:197,31:228:99:768,0,8242
chr3	10088242	.	G	A	733.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.892;DP=235;ExcessHet=3.0103;FS=3.32;MLEAC=1;MLEAF=0.5;MQ=59.16;MQRankSum=-9.873;QD=3.12;ReadPosRankSum=-1.712;SOR=1.102;HGVSnom=NM_001018115.3:c.1135-22G>A;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_001018115.3:IVS14-22G>A;AAlength=1451;EXAC_AF=0.16912448;EXAC_Hom_EAS=0;EXAC_AC_EAS=1083;EXAC_AN_EAS=7434;EXAC_AC_Adj=17111;EXAC_AN_Adj=101174;RS=rs199726231;gnomad_exomes_AF=0.01401350;gnomad_exomes_AF_EAS=0.00342609;gnomad_exomes_AC=2346;gnomad_exomes_Hom=0;gnomad_exomes_Het=2346;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01304594;gnomad_exomes_AF_NFE=0.01945382;gnomad_exomes_AF_AMR=0.00298986;gnomad_exomes_AF_SAS=0.00326409;NativeFreq_Het=0.4554;NativeFreq_Hom=0;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0017;patientHetNum=9;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][15B0060449|15B0062744];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15B0047497-1][15D6529872|15D6529863|15D6482041-1|15D0062169|15B0022389|15B0060418|15D6534491|15B0027104];patientHomSampleInfo=[_][_];AF_2700_Het=0.0511;AF_2700_Hom=0.0000;AF_50_Het=0.0460;AF_50_Hom=0.0000;DANN_score=0.3306;GREP_score=-1.2;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TTTTTCTGTT.TTGCATATTT	GT:AD:DP:GQ:PL	0/1:202,33:235:99:762,0,8289
chr3	10088266	.	G	T	1019.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.034;DP=325;ExcessHet=3.0103;FS=12.831;MLEAC=1;MLEAF=0.5;MQ=58.26;MQRankSum=-7.067;QD=3.14;ReadPosRankSum=1.743;SOR=1.717;HGVSnom=NM_001018115.3:c.1137G>T(p.Val379Val/p.V379V);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Synonymous+SpliceSites;MolecularConsequence=synonymous_variant+exonic_splice_region_variant;ExonIntron=E15;IVSnom=.;AAlength=1451;EXAC_AF=0.37449561;EXAC_Hom_EAS=0;EXAC_AC_EAS=2614;EXAC_AN_EAS=7618;EXAC_AC_Adj=40465;EXAC_AN_Adj=108052;RS=rs72492997;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.13780073;gnomad_exomes_AF_EAS=0.06940215;gnomad_exomes_AC=20677;gnomad_exomes_Hom=0;gnomad_exomes_Het=20677;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18215385;gnomad_exomes_AF_NFE=0.18462845;gnomad_exomes_AF_AMR=0.04451076;gnomad_exomes_AF_SAS=0.05383193;NativeFreq_Het=0.7722;NativeFreq_Hom=0;normalHetFrequency=0.0809;normalHetNum=70;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0845;patientHetNum=441;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2279;AF_2700_Hom=0.0000;AF_50_Het=0.2060;AF_50_Hom=0.0000;DANN_score=0.7686;GREP_score=1.85;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GACAATAGGT.TTTGACCTGG	GT:AD:DP:GQ:PL	0/1:274,51:325:99:1048,0,9261
chr3	10088299	.	C	T	1890.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.886;DP=367;ExcessHet=3.0103;FS=21.869;MLEAC=1;MLEAF=0.5;MQ=54.55;MQRankSum=-4.585;QD=5.15;ReadPosRankSum=-0.116;SOR=1.827;HGVSnom=NM_001018115.3:c.1170C>T(p.Ser390Ser/p.S390S);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=1451;EXAC_AF=0.43038388;EXAC_Hom_EAS=0;EXAC_AC_EAS=3529;EXAC_AN_EAS=8506;EXAC_AC_Adj=51461;EXAC_AN_Adj=119570;RS=rs112887807;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.22309649;gnomad_exomes_AF_EAS=0.13004049;gnomad_exomes_AC=34024;gnomad_exomes_Hom=0;gnomad_exomes_Het=34024;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27233584;gnomad_exomes_AF_NFE=0.28238810;gnomad_exomes_AF_AMR=0.09290799;gnomad_exomes_AF_SAS=0.11380340;NativeFreq_Het=0.7722;NativeFreq_Hom=0;normalHetFrequency=0.2058;normalHetNum=178;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.2102;patientHetNum=1097;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3590;AF_2700_Hom=0.0000;AF_50_Het=0.3518;AF_50_Hom=0.0000;DANN_score=0.6715;GREP_score=2.41;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TCATCTATAG.ACCAATACTC	GT:AD:DP:GQ:PL	0/1:300,67:367:99:1919,0,12529
chr3	10088308	.	T	C	1922.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.962;DP=406;ExcessHet=3.0103;FS=9.538;MLEAC=1;MLEAF=0.5;MQ=53.13;MQRankSum=-3.855;QD=4.74;ReadPosRankSum=-0.198;SOR=1.621;HGVSnom=NM_001018115.3:c.1179T>C(p.Thr393Thr/p.T393T);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=1451;EXAC_AF=0.43314353;EXAC_Hom_EAS=0;EXAC_AC_EAS=3539;EXAC_AN_EAS=8494;EXAC_AC_Adj=51726;EXAC_AN_Adj=119420;RS=rs72492998;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.23622321;gnomad_exomes_AF_EAS=0.13979625;gnomad_exomes_AC=35999;gnomad_exomes_Hom=0;gnomad_exomes_Het=35999;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28017857;gnomad_exomes_AF_NFE=0.29527855;gnomad_exomes_AF_AMR=0.10560679;gnomad_exomes_AF_SAS=0.12869371;NativeFreq_Het=0.8019;NativeFreq_Hom=0;normalHetFrequency=0.2821;normalHetNum=244;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.2967;patientHetNum=1549;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4101;AF_2700_Hom=0.0000;AF_50_Het=0.4073;AF_50_Hom=0.0000;DANN_score=0.6866;GREP_score=-1.51;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GCACCAATAC.CAGACAAAGA	GT:AD:DP:GQ:PL	0/1:334,72:406:99:1951,0,13484
chr3	10088343	.	A	G	1183.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.667;DP=405;ExcessHet=3.0103;FS=5.855;MLEAC=1;MLEAF=0.5;MQ=48.61;MQRankSum=-4.665;QD=2.92;ReadPosRankSum=0.221;SOR=1.209;HGVSnom=NM_001018115.3:c.1214A>G(p.Asn405Ser/p.N405S);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E15;IVSnom=.;AAlength=1451;EXAC_AF=0.42006511;EXAC_Hom_EAS=0;EXAC_AC_EAS=3356;EXAC_AN_EAS=8320;EXAC_AC_Adj=49030;EXAC_AN_Adj=116720;RS=rs73126218;Ensembl_transcriptid=ENST00000287647|ENST00000383807|ENST00000419585;SIFT_pred=T|T|T;SIFT_score=0.314|0.335|0.335;Polyphen2_HVAR_pred=.|B|B;Polyphen2_HVAR_score=.|0.023|0.023;MutationTaster_pred=N|N|N|N;MutationTaster_score=0.998609|0.998609|0.998609|0.998609;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.22772768;gnomad_exomes_AF_EAS=0.14490901;gnomad_exomes_AC=37223;gnomad_exomes_Hom=0;gnomad_exomes_Het=37223;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28140704;gnomad_exomes_AF_NFE=0.28415916;gnomad_exomes_AF_AMR=0.11059947;gnomad_exomes_AF_SAS=0.12522803;NativeFreq_Het=0.8514;NativeFreq_Hom=0;normalHetFrequency=0.2659;normalHetNum=230;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.2877;patientHetNum=1502;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1533038-1][_];AF_2700_Het=0.4035;AF_2700_Hom=0.0004;AF_50_Het=0.3883;AF_50_Hom=0.0000;DANN_score=0.878;GREP_score=0.307;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GTGCTAAGAA.TAAGATTCGA	GT:AD:DP:GQ:PL	0/1:333,72:405:99:1212,0,10736
chr3	10088404	.	C	T	1133.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.236;DP=282;ExcessHet=3.0103;FS=0.637;MLEAC=1;MLEAF=0.5;MQ=40.6;MQRankSum=-1.032;QD=4.02;ReadPosRankSum=-1.47;SOR=0.581;HGVSnom=NM_001018115.3:c.1275C>T(p.Tyr425Tyr/p.Y425Y);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=1451;EXAC_AF=0.06738012;EXAC_Hom_EAS=0;EXAC_AC_EAS=305;EXAC_AN_EAS=6174;EXAC_AC_Adj=5868;EXAC_AN_Adj=87088;RS=rs764447374;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.00422921;gnomad_exomes_AF_EAS=0.00203822;gnomad_exomes_AC=865;gnomad_exomes_Hom=0;gnomad_exomes_Het=865;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01106428;gnomad_exomes_AF_NFE=0.00646801;gnomad_exomes_AF_AMR=0.00099890;gnomad_exomes_AF_SAS=0.00089960;NativeFreq_Het=0.8155;NativeFreq_Hom=0;normalHetFrequency=0.0035;normalHetNum=3;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0034;patientHetNum=18;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16D3102589][15B0022310-T|15B0002482];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1546289|16B0024328|15D6529874|16D1545850|16D1546187|16D1546070|16D1546152|15B0051502][15B0033014|15D0056978|15B0047476|15B0022371|15D6517254|16B0033211|15B0022391|15B6105727|16B0025319|15B6305692];patientHomSampleInfo=[_][_];AF_2700_Het=0.0088;AF_2700_Hom=0.0000;AF_50_Het=0.0048;AF_50_Hom=0.0000;DANN_score=0.2649;GREP_score=1.41;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=CTGTTCATTA.TTAGTAAGTG	GT:AD:DP:GQ:PL	0/1:237,45:282:99:1162,0,9849
chr3	10088407	.	AG	A	1168.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.318;DP=273;ExcessHet=3.0103;FS=2.212;MLEAC=1;MLEAF=0.5;MQ=40.18;MQRankSum=-0.705;QD=4.28;ReadPosRankSum=-2.228;SOR=0.499;HGVSnom=NM_001018115.3:c.1278+1delG;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron+SpliceDonor;MolecularConsequence=coding_transcript_intron_variant+splice_donor_variant;ExonIntron=I15;IVSnom=NM_001018115.3:IVS15+1delG;AAlength=1451;EXAC_AF=0.03479302;EXAC_Hom_EAS=0;EXAC_AC_EAS=162;EXAC_AN_EAS=8330;EXAC_AC_Adj=4041;EXAC_AN_Adj=116144;ESP6500_MAF=0.17398622;RS=rs750338758;gnomad_exomes_AF=0.00117571;gnomad_exomes_AF_EAS=0.00044929;gnomad_exomes_AC=280;gnomad_exomes_Hom=0;gnomad_exomes_Het=280;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00299151;gnomad_exomes_AF_NFE=0.00165610;gnomad_exomes_AF_AMR=0.00020659;gnomad_exomes_AF_SAS=0.00009970;NativeFreq_Het=0.0983;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0017;patientHetNum=9;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D1546187|16D1545850|15D6529874][15B6305692|16B0025319|15B6325504|15D0056978|15B0022391|16B1587021];patientHomSampleInfo=[_][_];AF_2700_Het=0.0100;AF_2700_Hom=.;AF_50_Het=0.0063;AF_50_Hom=.;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TTCATTACTT.TAAGTGTCAG	GT:AD:DP:GQ:PL	0/1:228,45:273:99:1206,0,9832
chr3	10088409	.	TAAG	T	1195.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.6;DP=275;ExcessHet=3.0103;FS=2.171;MLEAC=1;MLEAF=0.5;MQ=40.2;MQRankSum=-0.546;QD=4.35;ReadPosRankSum=-2.416;SOR=0.52;HGVSnom=NM_001018115.3:c.1278+3_1278+5delAAG;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_001018115.3:IVS15+3_+5delAAG;AAlength=1451;EXAC_AF=0.03454388;EXAC_Hom_EAS=0;EXAC_AC_EAS=158;EXAC_AN_EAS=8272;EXAC_AC_Adj=3995;EXAC_AN_Adj=115650;RS=rs375350046;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=no_assertion_criteria_provided|no_assertion_criteria_provided;gnomad_exomes_AF=0.00096654;gnomad_exomes_AF_EAS=0.00033505;gnomad_exomes_AC=232;gnomad_exomes_Hom=0;gnomad_exomes_Het=232;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00233613;gnomad_exomes_AF_NFE=0.00129606;gnomad_exomes_AF_AMR=0.00023532;gnomad_exomes_AF_SAS=0.00009954;NativeFreq_Het=0.1012;NativeFreq_Hom=.;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0013;patientHetNum=7;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][15B0022310-T];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1545850|16B0024328][15B6305692|16B0025319|15D0056978|15B0022391|16B1587021];patientHomSampleInfo=[_][_];AF_2700_Het=0.0085;AF_2700_Hom=.;AF_50_Het=0.0048;AF_50_Hom=.;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=CATTACTTAG.TGTCAGAGAC	GT:AD:DP:GQ:PL	0/1:229,46:275:99:1233,0,9582
chr3	10088422	.	C	T	980.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.126;DP=252;ExcessHet=3.0103;FS=3.538;MLEAC=1;MLEAF=0.5;MQ=39.1;MQRankSum=-1.202;QD=3.89;ReadPosRankSum=-2.447;SOR=0.423;HGVSnom=NM_001018115.3:c.1278+15C>T;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_001018115.3:IVS15+15C>T;AAlength=1451;EXAC_AF=0.03577477;EXAC_Hom_EAS=0;EXAC_AC_EAS=136;EXAC_AN_EAS=7130;EXAC_AC_Adj=3549;EXAC_AN_Adj=99204;RS=rs144167368;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.00135129;gnomad_exomes_AF_EAS=0.00029110;gnomad_exomes_AC=303;gnomad_exomes_Hom=0;gnomad_exomes_Het=303;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00463725;gnomad_exomes_AF_NFE=0.00177752;gnomad_exomes_AF_AMR=0.00027907;gnomad_exomes_AF_SAS=0.00024795;NativeFreq_Het=0.7055;NativeFreq_Hom=0.0891;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0048;patientHetNum=25;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][15B0022310-T|15B0002482];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0172157|15D6529874|15B0047497-1|15B6325526-1|16D1546187|16B0047445][15D6517259|15D6518694|15B0002773|15B0002857|16B1587021|15B6325493|15B0045761|15B0022735|16D0169454|15B6325504|15B0012181|15B0022371|16B0033211|15D6518779|15B0022391|15B6105727|16B0000533|15B6305692|15D6517255];patientHomSampleInfo=[_][_];AF_2700_Het=0.0630;AF_2700_Hom=0.0000;AF_50_Het=0.0507;AF_50_Hom=0.0000;DANN_score=0.4833;GREP_score=-4.27;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GTGTCAGAGA.TAttgatttt	GT:AD:DP:GQ:PL	0/1:212,40:252:99:1009,0,8800
chr3	10088443	.	C	A	956.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.384;DP=221;ExcessHet=3.0103;FS=5.078;MLEAC=1;MLEAF=0.5;MQ=40.98;MQRankSum=-4.266;QD=4.33;ReadPosRankSum=-2.17;SOR=1.402;HGVSnom=NM_001018115.3:c.1278+36C>A;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_001018115.3:IVS15+36C>A;AAlength=1451;EXAC_AF=0.25448667;EXAC_Hom_EAS=0;EXAC_AC_EAS=1065;EXAC_AN_EAS=4844;EXAC_AC_Adj=17867;EXAC_AN_Adj=70208;RS=rs145517746;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.04678591;gnomad_exomes_AF_EAS=0.02926383;gnomad_exomes_AC=7303;gnomad_exomes_Hom=0;gnomad_exomes_Het=7303;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08205405;gnomad_exomes_AF_NFE=0.06742999;gnomad_exomes_AF_AMR=0.02218580;gnomad_exomes_AF_SAS=0.02220333;NativeFreq_Het=0.7751;NativeFreq_Hom=0.0107;normalHetFrequency=0.0277;normalHetNum=24;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0274;patientHetNum=143;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.182;GREP_score=-6.2;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;repName=L3;repClass=LINE;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=taatctaaaa.agaaagcttt	GT:AD:DP:GQ:PL	0/1:184,37:221:99:985,0,7422
chr3	10088444	.	A	G	956.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.571;DP=209;ExcessHet=3.0103;FS=6.67;MLEAC=1;MLEAF=0.5;MQ=41.21;MQRankSum=-4.228;QD=4.58;ReadPosRankSum=-2.672;SOR=1.526;HGVSnom=NM_001018115.3:c.1278+37A>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_001018115.3:IVS15+37A>G;AAlength=1451;EXAC_AF=0.25801513;EXAC_Hom_EAS=0;EXAC_AC_EAS=1064;EXAC_AN_EAS=4732;EXAC_AC_Adj=17866;EXAC_AN_Adj=69244;RS=rs142624538;gnomad_exomes_AF=0.05213063;gnomad_exomes_AF_EAS=0.03243865;gnomad_exomes_AC=8106;gnomad_exomes_Hom=0;gnomad_exomes_Het=8106;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08933966;gnomad_exomes_AF_NFE=0.07452901;gnomad_exomes_AF_AMR=0.02544849;gnomad_exomes_AF_SAS=0.02519730;NativeFreq_Het=0.3819;NativeFreq_Hom=0.0107;normalHetFrequency=0.0301;normalHetNum=26;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0297;patientHetNum=155;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.43;GREP_score=-3.86;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;repName=L3;repClass=LINE;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=aatctaaaac.gaaagcttta	GT:AD:DP:GQ:PL	0/1:172,37:209:99:985,0,7422
chr3	10089723	.	G	A	3176.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.734;DP=607;ExcessHet=3.0103;FS=12.259;MLEAC=1;MLEAF=0.5;MQ=59.56;MQRankSum=-7.761;QD=5.26;ReadPosRankSum=-1.564;SOR=1.574;HGVSnom=NM_001018115.3:c.1401G>A(p.Thr467Thr/p.T467T);Gene=FANCD2;Transcript=NM_001018115.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=1451;EXAC_AF=0.44947796;EXAC_Hom_EAS=0;EXAC_AC_EAS=3587;EXAC_AN_EAS=8514;EXAC_AC_Adj=53985;EXAC_AN_Adj=120106;RS=rs12330369;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.42371531;gnomad_exomes_AF_EAS=0.37998252;gnomad_exomes_AC=73929;gnomad_exomes_Hom=0;gnomad_exomes_Het=73929;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.47041953;gnomad_exomes_AF_NFE=0.44701228;gnomad_exomes_AF_AMR=0.35029887;gnomad_exomes_AF_SAS=0.37382112;NativeFreq_Het=0.8811;NativeFreq_Hom=0;normalHetFrequency=0.6416;normalHetNum=555;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.6249;patientHetNum=3262;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0002483];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.7106;AF_2700_Hom=0.0000;AF_50_Het=0.7005;AF_50_Hom=0.0000;DANN_score=0.6082;GREP_score=-0.396;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TTTTTGACAC.TACTGCCAGC	GT:AD:DP:GQ:PL	0/1:462,142:604:99:3205,0,14065
chr3	10089738	.	A	G	2823.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.412;DP=567;ExcessHet=3.0103;FS=32.729;MLEAC=1;MLEAF=0.5;MQ=59.42;MQRankSum=-9.126;QD=4.98;ReadPosRankSum=-2.229;SOR=2.81;HGVSnom=NM_001018115.3:c.1413+3A>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16+3A>G;AAlength=1451;EXAC_AF=0.44169275;EXAC_Hom_EAS=0;EXAC_AC_EAS=3459;EXAC_AN_EAS=8412;EXAC_AC_Adj=52489;EXAC_AN_Adj=118836;RS=rs62245508;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.39447446;gnomad_exomes_AF_EAS=0.33008441;gnomad_exomes_AC=60454;gnomad_exomes_Hom=0;gnomad_exomes_Het=60454;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.45005774;gnomad_exomes_AF_NFE=0.42188424;gnomad_exomes_AF_AMR=0.30690832;gnomad_exomes_AF_SAS=0.33204334;NativeFreq_Het=0.8811;NativeFreq_Hom=0;normalHetFrequency=0.5861;normalHetNum=507;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.5753;patientHetNum=3003;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5715;AF_2700_Hom=0.0000;AF_50_Het=0.5642;AF_50_Hom=0.0000;dbscSNV_RF_score=0.818;dbscSNV_ADA_score=0.83825988;DANN_score=0.9407;GREP_score=4.41;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GCCAGCAGGT.TGTTGAAACA	GT:AD:DP:GQ:PL	0/1:445,122:567:99:2852,0,14379
chr3	10089749	.	T	C	2642.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=10.783;DP=558;ExcessHet=3.0103;FS=35.894;MLEAC=1;MLEAF=0.5;MQ=59.37;MQRankSum=-10.198;QD=4.74;ReadPosRankSum=-0.452;SOR=3.22;HGVSnom=NM_001018115.3:c.1413+14T>C;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16+14T>C;AAlength=1451;EXAC_AF=0.43070364;EXAC_Hom_EAS=0;EXAC_AC_EAS=3253;EXAC_AN_EAS=8258;EXAC_AC_Adj=50413;EXAC_AN_Adj=117048;RS=rs12330599;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.35730519;gnomad_exomes_AF_EAS=0.26297320;gnomad_exomes_AC=50310;gnomad_exomes_Hom=0;gnomad_exomes_Het=50310;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.41031588;gnomad_exomes_AF_NFE=0.38839064;gnomad_exomes_AF_AMR=0.26324995;gnomad_exomes_AF_SAS=0.29176129;NativeFreq_Het=0.8811;NativeFreq_Hom=0;normalHetFrequency=0.5341;normalHetNum=462;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.5297;patientHetNum=2765;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5100;AF_2700_Hom=0.0000;AF_50_Het=0.4976;AF_50_Hom=0.0000;DANN_score=0.7694;GREP_score=-2.46;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TGTTGAAACA.TTATTTTGGC	GT:AD:DP:GQ:PL	0/1:449,108:557:99:2671,0,15032
chr3	10089772	.	C	G	2631.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.875;DP=499;ExcessHet=3.0103;FS=42.748;MLEAC=1;MLEAF=0.5;MQ=59.22;MQRankSum=-10.702;QD=5.27;ReadPosRankSum=0.059;SOR=3.836;HGVSnom=NM_001018115.3:c.1413+37C>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16+37C>G;AAlength=1451;EXAC_AF=0.40901756;EXAC_Hom_EAS=0;EXAC_AC_EAS=2975;EXAC_AN_EAS=8074;EXAC_AC_Adj=47145;EXAC_AN_Adj=115264;RS=rs79830642;gnomad_exomes_AF=0.28489390;gnomad_exomes_AF_EAS=0.17495604;gnomad_exomes_AC=31254;gnomad_exomes_Hom=0;gnomad_exomes_Het=31254;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34110169;gnomad_exomes_AF_NFE=0.31716527;gnomad_exomes_AF_AMR=0.19447180;gnomad_exomes_AF_SAS=0.20687831;NativeFreq_Het=0.0502;NativeFreq_Hom=0;normalHetFrequency=0.4601;normalHetNum=398;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.4383;patientHetNum=2288;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0002483];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4445;GREP_score=-3.44;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GGAGGGAACA.AGAAAGGGAA	GT:AD:DP:GQ:PL	0/1:406,93:499:99:2660,0,24528
chr3	10089773	.	A	G	2656.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=6.661;DP=484;ExcessHet=3.0103;FS=42.414;MLEAC=1;MLEAF=0.5;MQ=59.19;MQRankSum=-10.653;QD=5.49;ReadPosRankSum=-0.183;SOR=4.011;HGVSnom=NM_001018115.3:c.1413+38A>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16+38A>G;AAlength=1451;EXAC_AF=0.31518880;EXAC_Hom_EAS=0;EXAC_AC_EAS=2651;EXAC_AN_EAS=8078;EXAC_AC_Adj=36427;EXAC_AN_Adj=115572;RS=rs7615646;gnomad_exomes_AF=0.17901439;gnomad_exomes_AF_EAS=0.13936377;gnomad_exomes_AC=25980;gnomad_exomes_Hom=0;gnomad_exomes_Het=25980;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14903846;gnomad_exomes_AF_NFE=0.19320727;gnomad_exomes_AF_AMR=0.12955562;gnomad_exomes_AF_SAS=0.12201592;NativeFreq_Het=0.0453;NativeFreq_Hom=0;normalHetFrequency=0.3503;normalHetNum=303;normalHomFrequency=0.0058;normalHomNum=5;patientHetFrequency=0.3621;patientHetNum=1890;patientHomFrequency=0.0048;patientHomNum=25;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546178|16D1545754][16D1545669|16D1546133|15B0002483];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1546296|16B1175091|16D0153219|16D1546136|16D0172476|16D1545611|16D1546051|16D1545920|16D0177669|15D6534409|15D6482379|16D0169525|16D1532948-1|17B2000167|16B3094096|16D0158742|16D0172465|16D0153161|16D1545954|16D1545691|15D6722232][16D1545749|16D1546071|15D6532885|15D6529869];DANN_score=0.4587;GREP_score=0.509;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GAGGGAACAC.GAAAGGGAAA	GT:AD:DP:GQ:PL	0/1:393,91:484:99:2685,0,24586
chr3	10089775	.	A	G	2634.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=4.803;DP=476;ExcessHet=3.0103;FS=37.083;MLEAC=1;MLEAF=0.5;MQ=59.18;MQRankSum=-10.999;QD=5.54;ReadPosRankSum=0.69;SOR=4.169;HGVSnom=NM_001018115.3:c.1413+40A>G;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16+40A>G;AAlength=1451;EXAC_AF=0.41037908;EXAC_Hom_EAS=0;EXAC_AC_EAS=2978;EXAC_AN_EAS=8036;EXAC_AC_Adj=47091;EXAC_AN_Adj=114750;RS=rs75389047;gnomad_exomes_AF=0.28709317;gnomad_exomes_AF_EAS=0.17791948;gnomad_exomes_AC=31826;gnomad_exomes_Hom=0;gnomad_exomes_Het=31826;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34136481;gnomad_exomes_AF_NFE=0.31836220;gnomad_exomes_AF_AMR=0.20209563;gnomad_exomes_AF_SAS=0.21058508;NativeFreq_Het=0.0599;NativeFreq_Hom=0;normalHetFrequency=0.452;normalHetNum=391;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.4358;patientHetNum=2275;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0002483];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3272;GREP_score=-1.3;CytoBand=p25.3;dupName=chr3:10029270;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GGGAACACAG.AAGGGAAAAT	GT:AD:DP:GQ:PL	0/1:391,85:476:99:2663,0,24149
chr3	10091035	.	T	C	906.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=9.007;DP=489;ExcessHet=3.0103;FS=22.505;MLEAC=1;MLEAF=0.5;MQ=54.94;MQRankSum=-15.159;QD=1.86;ReadPosRankSum=-1.119;SOR=2.888;HGVSnom=NM_001018115.3:c.1414-23T>C;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001018115.3:IVS16-23T>C;AAlength=1451;EXAC_AF=0.22657053;EXAC_Hom_EAS=29;EXAC_AC_EAS=789;EXAC_AN_EAS=7414;EXAC_AC_Adj=24258;EXAC_AN_Adj=107066;RS=rs10222446;CLNGENE=FANCD2|LOC107303338;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.439696;G1000_EAS_AF=0.244;G1000_EUR_AF=0.34;G1000_AFR_AF=0.8585;G1000_SAS_AF=0.2618;G1000_AMR_AF=0.3213;gnomad_exomes_AF=0.20617652;gnomad_exomes_AF_EAS=0.09137728;gnomad_exomes_AC=39456;gnomad_exomes_Hom=8907;gnomad_exomes_Het=21642;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75869809;gnomad_exomes_AF_NFE=0.18224908;gnomad_exomes_AF_AMR=0.15754868;gnomad_exomes_AF_SAS=0.12589379;NativeFreq_Het=0.0259;NativeFreq_Hom=0.0129;normalHetFrequency=0.1607;normalHetNum=139;normalHomFrequency=0.0266;normalHomNum=23;patientHetFrequency=0.1502;patientHetNum=784;patientHomFrequency=0.0324;patientHomNum=169;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1115;AF_2700_Hom=0.0169;AF_50_Het=0.1252;AF_50_Hom=0.0190;DANN_score=0.6732;GREP_score=-0.0179;CytoBand=p25.3;dupName=chr3:11911949;dupScore=0;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TTTACACTGT.CTGTTGACTC	GT:AD:DP:GQ:PL	0/1:418,70:488:99:935,0,13736
chr3	10094206	.	AT	A	268.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.915;DP=214;ExcessHet=3.0103;FS=8.908;MLEAC=1;MLEAF=0.5;MQ=59.44;MQRankSum=-5.752;QD=1.38;ReadPosRankSum=0.35;SOR=2.095;HGVSnom=NM_001018115.3:c.1656+38delT;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_001018115.3:IVS18+38delT;AAlength=1451;EXAC_AF=0.25724981;EXAC_Hom_EAS=0;EXAC_AC_EAS=1842;EXAC_AN_EAS=5322;EXAC_AC_Adj=21716;EXAC_AN_Adj=84416;ESP6500_MAF=0.17433685;RS=rs544799101;gnomad_exomes_AF=0.22758434;gnomad_exomes_AF_EAS=0.36914401;gnomad_exomes_AC=29413;gnomad_exomes_Hom=0;gnomad_exomes_Het=29413;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08895238;gnomad_exomes_AF_NFE=0.22383089;gnomad_exomes_AF_AMR=0.22160026;gnomad_exomes_AF_SAS=0.27018008;normalHetFrequency=0.0382;normalHetNum=33;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0318;patientHetNum=166;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0538;AF_2700_Hom=.;AF_50_Het=0.0460;AF_50_Hom=.;CytoBand=p25.3;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GTTGGGAAAG.tttttttttt	GT:AD:DP:GQ:PL	0/1:156,39:195:99:306,0,3255
chr3	10103931	.	C	CT	346.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.502;DP=107;ExcessHet=3.0103;FS=5.653;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.65;ReadPosRankSum=-0.837;SOR=0.176;HGVSnom=NM_001018115.3:c.1827+50dupT;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_001018115.3:IVS20+50_+51insT;AAlength=1451;EXAC_AF=0.07837007;EXAC_Hom_EAS=0;EXAC_AC_EAS=138;EXAC_AN_EAS=2032;EXAC_AC_Adj=3008;EXAC_AN_Adj=38382;ESP6500_MAF=0.05000799;RS=rs751474920;gnomad_exomes_AF=0.19564880;gnomad_exomes_AF_EAS=0.23668555;gnomad_exomes_AC=20189;gnomad_exomes_Hom=0;gnomad_exomes_Het=20189;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19282380;gnomad_exomes_AF_NFE=0.16799612;gnomad_exomes_AF_AMR=0.23060649;gnomad_exomes_AF_SAS=0.20980743;NativeFreq_Het=0.0029;NativeFreq_Hom=.;normalHetFrequency=0.1121;normalHetNum=97;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1153;patientHetNum=602;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p25.3;dupName=chr3:11919723;dupScore=0;repName=AluSz;repClass=SINE;simRepName=trf;simRepCopyNum=2.5;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=tttttcctgt.tttttttttt	GT:AD:DP:GQ:PL	0/1:62,33:95:99:384,0,1005
chr3	10128965	.	CT	C	895.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.037;DP=214;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.87;ReadPosRankSum=-0.807;SOR=0.74;OLD_VARIANT=chr3|10128965|CT|C,CTT|1;HGVSnom=NM_001018115.3:c.3466+36delT;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I34;IVSnom=NM_001018115.3:IVS34+36delT;AAlength=1451;EXAC_AF=0.21395833;EXAC_Hom_EAS=0;EXAC_AC_EAS=388;EXAC_AN_EAS=2350;EXAC_AC_Adj=8216;EXAC_AN_Adj=38400;RS=rs371321981;CLNGENE=FANCD2|FANCD2OS;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.368011;G1000_EAS_AF=0.4296;G1000_EUR_AF=0.3797;G1000_AFR_AF=0.2958;G1000_SAS_AF=0.3753;G1000_AMR_AF=0.389;gnomad_exomes_AF=0.25318449;gnomad_exomes_AF_EAS=0.27480434;gnomad_exomes_AC=21705;gnomad_exomes_Hom=3;gnomad_exomes_Het=21699;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19178681;gnomad_exomes_AF_NFE=0.24447200;gnomad_exomes_AF_AMR=0.26576867;gnomad_exomes_AF_SAS=0.26403061;NativeFreq_Het=0.2803;NativeFreq_Hom=.;normalHetFrequency=0.3202;normalHetNum=277;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.3525;patientHetNum=1840;patientHomFrequency=0.0006;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0002797-1];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0166603|16D0177697][15B0002956];AF_2700_Het=0.6115;AF_2700_Hom=.;AF_50_Het=0.5975;AF_50_Hom=.;CytoBand=p25.3;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+,FANCD2OS:NM_173472.1:-;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1,FANCD2OS:NM_173472.1:NP_775743.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.,FANCD2OS:NM_173472.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GGCCTAGATC.tttttttttt	GT:AD:DP:GQ:PL	1/0:50,70:184:99:933,198,1372
chr3	10128965	.	C	CT	895.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.037;DP=214;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.87;ReadPosRankSum=-0.807;SOR=0.74;OLD_VARIANT=chr3|10128965|CT|C,CTT|2;HGVSnom=NM_001018115.3:c.3466+36dupT;Gene=FANCD2;Transcript=NM_001018115.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I34;IVSnom=NM_001018115.3:IVS34+36_+37insT;AAlength=1451;EXAC_AF=0.03901042;EXAC_Hom_EAS=0;EXAC_AC_EAS=28;EXAC_AN_EAS=2350;EXAC_AC_Adj=1498;EXAC_AN_Adj=38400;RS=rs371321981;CLNGENE=FANCD2|FANCD2OS;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.05143010;gnomad_exomes_AF_EAS=0.02789700;gnomad_exomes_AC=4409;gnomad_exomes_Hom=88;gnomad_exomes_Het=4233;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07841852;gnomad_exomes_AF_NFE=0.04985534;gnomad_exomes_AF_AMR=0.03952250;gnomad_exomes_AF_SAS=0.07735058;normalHetFrequency=0.0197;normalHetNum=17;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0301;patientHetNum=157;patientHomFrequency=0.001;patientHomNum=5;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6523839|15D6722243|15D6518763][16D0172365|16D0172371];CytoBand=p25.3;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_033084.4:+,FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+,FANCD2OS:NM_173472.1:-;NP=FANCD2:NM_033084.4:NP_149075.2,FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1,FANCD2OS:NM_173472.1:NP_775743.1;ENSP=FANCD2:NM_033084.4:ENST00000287647.7,FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.,FANCD2OS:NM_173472.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=GGCCTAGATC.tttttttttt	GT:AD:DP:GQ:PL	0/1:50,64:184:99:933,279,1365
chr3	10143061	.	CTT	C	1213.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.187;DP=291;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0.853;QD=5.86;ReadPosRankSum=0.672;SOR=0.703;HGVSnom=NM_001018115.3:c.*139_*140delTT;Gene=FANCD2;Transcript=NM_001018115.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E44;IVSnom=.;AAlength=1451;RS=rs950337384;CLNGENE=FANCD2|FANCD2OS;CLNSIG=Likely_benign|Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.002;patientHetNum=5;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][15B0048159|15B0047305|15B0047074-1|15B0064838|15B6219955];patientHomSampleInfo=[_][_];AF_2700_Het=0.0223;AF_2700_Hom=.;AF_50_Het=0.0190;AF_50_Hom=.;CytoBand=p25.3;CGD_CONDITION=Fanconi anemia, complementation group D2;CGD_INHERITANCE=AR;Strand=FANCD2:NM_001018115.2:+,FANCD2:NM_001319984.1:+,FANCD2OS:NM_173472.1:-;NP=FANCD2:NM_001018115.2:NP_001018125.1,FANCD2:NM_001319984.1:NP_001306913.1,FANCD2OS:NM_173472.1:NP_775743.1;ENSP=FANCD2:NM_001018115.2:ENST00000383807.5,FANCD2:NM_001319984.1:.,FANCD2OS:NM_173472.1:.;Gene_MIM_id=613984;Phenotypes=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive. 227646(MK);Possible_Inheritance=AR;EntrezGeneID=2177;EnsemblGeneID=ENSG00000144554;Alias=FANCD2, FANCD, FACD, FAD;FLKSEQ=TTTTGTTCCT.tttttttttt	GT:AD:DP:GQ:PL	0/1:122,85:207:99:1251,0,2588
chr3	10183241	.	C	CAA	966.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.161;DP=53;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.17;ReadPosRankSum=-0.254;SOR=0.843;HGVSnom=.;Gene=VHL;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs36068404;CLNGENE=VHL;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.870407;G1000_EAS_AF=0.875;G1000_EUR_AF=0.8708;G1000_AFR_AF=0.9425;G1000_SAS_AF=0.7935;G1000_AMR_AF=0.8343;NativeFreq_Het=0.4010;NativeFreq_Hom=.;CytoBand=p25.3;repName=AluJb;repClass=SINE;FLKSEQ=gaccctgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:6,34:40:52:962,0,52
chr3	10183274	.	C	T	1969.77	PASS	AC=2;AF=1;AN=2;DP=58;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.96;SOR=2.468;HGVSnom=.;Gene=VHL;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs779804;CLNGENE=VHL;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.877995;G1000_EAS_AF=0.8879;G1000_EUR_AF=0.8757;G1000_AFR_AF=0.9508;G1000_SAS_AF=0.8016;G1000_AMR_AF=0.8357;NativeFreq_Het=0.1386;NativeFreq_Hom=0.7524;normalHetFrequency=0.0103;normalHetNum=4;normalHomFrequency=0.0464;normalHomNum=18;patientHetFrequency=0.0079;patientHetNum=22;patientHomFrequency=0.0501;patientHomNum=139;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D3102622|16B3258414|16D1546197|16B3098020-1|16B0033735|16B3258459|16D0038328|17B0001573-1|16D0177796|15B0022389|16B0202336|16D1536966-1|16D1536881|17B0005570|16B0047363|16B1175184|16B1175065|15B6326228-1|17D0000653-1|17B0501008|15D6722339-1|16B3258461][_];patientHomSampleInfo=[_][_];DANN_score=0.5742;GREP_score=-2.93;CytoBand=p25.3;FLKSEQ=CTTAGAGGGG.GAAAAAAAAT	GT:AD:DP:GQ:PL	1/1:0,58:58:99:1998,174,0
chr3	10183337	.	G	A	5077.77	PASS	AC=2;AF=1;AN=2;DP=135;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.53;SOR=1.99;HGVSnom=.;Gene=VHL;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs779805;CLNGENE=VHL;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.543331;G1000_EAS_AF=0.8185;G1000_EUR_AF=0.7028;G1000_AFR_AF=0.1558;G1000_SAS_AF=0.5798;G1000_AMR_AF=0.5994;NativeFreq_Het=0.3168;NativeFreq_Hom=0.6237;normalHetFrequency=0.1263;normalHetNum=49;normalHomFrequency=0.2371;normalHomNum=92;patientHetFrequency=0.1151;patientHetNum=319;patientHomFrequency=0.2471;patientHomNum=685;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3463;AF_2700_Hom=0.5999;AF_50_Het=0.3582;AF_50_Hom=0.5895;DANN_score=0.8188;GREP_score=-4.28;CytoBand=p25.3;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=CCGTTACAAC.GCCTACGGTG	GT:AD:DP:GQ:PL	1/1:0,135:135:99:5106,406,0
chr3	10191943	.	G	A	19759.8	PASS	AC=2;AF=1;AN=2;DP=545;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.63;SOR=1.127;HGVSnom=NM_000551.4:c.*294G>A;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1642742;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.557109;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.7008;G1000_AFR_AF=0.205;G1000_SAS_AF=0.5808;G1000_AMR_AF=0.6095;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6138;normalHetFrequency=0.0979;normalHetNum=38;normalHomFrequency=0.1572;normalHomNum=61;patientHetFrequency=0.0823;patientHetNum=228;patientHomFrequency=0.1995;patientHomNum=553;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3470;AF_2700_Hom=0.5999;AF_50_Het=0.3582;AF_50_Hom=0.5895;DANN_score=0.2769;GREP_score=1.03;CytoBand=p25.3;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=AAGGAGGTTT.TATAAGTAAT	GT:AD:DP:GQ:PL	1/1:0,543:543:99:19788,1632,0
chr3	10192672	.	G	A	1464.77	PASS	AC=2;AF=1;AN=2;DP=46;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.7;QD=32.55;SOR=0.829;HGVSnom=NM_000551.4:c.*1023G>A;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1681669;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.584665;G1000_EAS_AF=0.8175;G1000_EUR_AF=0.7008;G1000_AFR_AF=0.3071;G1000_SAS_AF=0.5838;G1000_AMR_AF=0.6081;NativeFreq_Het=0.3168;NativeFreq_Hom=0.5841;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6129356|16B0005712][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1878089][_];AF_2700_Het=0.3328;AF_2700_Hom=0.6088;AF_50_Het=0.3423;AF_50_Hom=0.5990;DANN_score=0.668;GREP_score=0.908;CytoBand=p25.3;repName=AluSx;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=ctgcctcctg.gttcacgtaa	GT:AD:DP:GQ:PL	1/1:0,45:45:99:1493,133,0
chr3	10192709	.	C	T	1427.77	PASS	AC=2;AF=1;AN=2;DP=44;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.77;QD=34.82;SOR=2.247;HGVSnom=NM_000551.4:c.*1060C>T;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1681668;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.556709;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.7008;G1000_AFR_AF=0.2065;G1000_SAS_AF=0.5808;G1000_AMR_AF=0.6037;NativeFreq_Het=0.2574;NativeFreq_Hom=0.5544;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6129356|16B0005712][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[17B0506807][_];AF_2700_Het=0.3297;AF_2700_Hom=0.6007;AF_50_Het=0.3344;AF_50_Hom=0.5927;DANN_score=0.666;GREP_score=-0.0722;CytoBand=p25.3;repName=AluSx;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=ggattacagg.gcctgccacc	GT:AD:DP:GQ:PL	1/1:0,41:41:99:1456,123,0
chr3	10192762	.	T	C	2266.77	StandardFilter	AC=2;AF=1;AN=2;DP=59;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.36;SOR=4.84;HGVSnom=NM_000551.4:c.*1113T>C;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1642741;G1000_AF=0.88139;G1000_EAS_AF=0.8879;G1000_EUR_AF=0.8728;G1000_AFR_AF=0.9508;G1000_SAS_AF=0.8272;G1000_AMR_AF=0.8285;NativeFreq_Het=0.1782;NativeFreq_Hom=0.8019;DANN_score=0.5287;GREP_score=-2.06;CytoBand=p25.3;repName=AluSx;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=cagtgtttcg.catgttggcc	GT:AD:DP:GQ:PL	1/1:0,59:59:99:2295,178,0
chr3	10193509	.	A	G	10142.8	PASS	AC=2;AF=1;AN=2;DP=280;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.94;QD=28.13;SOR=1.158;HGVSnom=NM_000551.4:c.*1860A>G;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs458106;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.988019;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9712;G1000_AFR_AF=0.9932;G1000_SAS_AF=0.9949;G1000_AMR_AF=0.9755;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.004;patientHomNum=11;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033386|16B0017800][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1533035-1|15D6722459-1|16D0067236|15D6524801-1|16B0200506|15B0047108|16D0164798|15D6722241-1|16B0047251|16B3258454|16B0033119][_];AF_2700_Het=0.0012;AF_2700_Hom=0.9962;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.2785;GREP_score=-0.621;CytoBand=p25.3;repName=AluJr;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=agtactttgg.aagccaaggt	GT:AD:DP:GQ:PL	1/1:0,278:278:99:10171,835,0
chr3	10193683	.	T	G	5717.77	PASS	AC=2;AF=1;AN=2;DP=162;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.97;SOR=2.288;HGVSnom=NM_000551.4:c.*2034T>G;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1136249;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.548922;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.7008;G1000_AFR_AF=0.1793;G1000_SAS_AF=0.5808;G1000_AMR_AF=0.5994;NativeFreq_Het=0.2772;NativeFreq_Hom=0.6039;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0050572][_];patientHetSampleInfo=_;patientHomSampleInfo=_;AF_2700_Het=0.2475;AF_2700_Hom=0.5496;AF_50_Het=0.2520;AF_50_Hom=0.5626;DANN_score=0.4103;GREP_score=0.43;CytoBand=p25.3;repName=AluJr;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=aattggaggc.gcagtgagcc	GT:AD:DP:GQ:PL	1/1:0,161:161:99:5746,483,0
chr3	10193744	.	CA	C	990.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.149;DP=74;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.98;ReadPosRankSum=-0.771;SOR=0.941;HGVSnom=NM_000551.4:c.*2117delA;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs757106274;CLNGENE=LOC107303340|VHL;CLNSIG=Uncertain_significance|Uncertain_significance;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;CytoBand=p25.3;repName=AluJr;repClass=SINE;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=gaccctgcct.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/1:4,58:62:99:732,101,0
chr3	10194165	.	CTTTTTT	C	2203.73	PASS	AC=2;AF=1;AN=2;DP=85;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.86;QD=31.94;SOR=2.753;HGVSnom=NM_000551.4:c.*2540_*2545delTTTTTT;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs71052299;CLNGENE=LOC107303340|VHL;CLNSIG=Uncertain_significance|Uncertain_significance;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;CytoBand=p25.3;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=AACAAATAGT.tttttttttt	GT:AD:DP:GQ:PL	1/1:1,68:69:99:1928,189,0
chr3	10194624	.	G	C	3175.77	PASS	AC=2;AF=1;AN=2;DP=77;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.31;SOR=2.804;HGVSnom=NM_000551.4:c.*2975G>C;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs801913;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.889976;G1000_EAS_AF=0.8879;G1000_EUR_AF=0.8728;G1000_AFR_AF=0.9803;G1000_SAS_AF=0.8292;G1000_AMR_AF=0.8314;NativeFreq_Het=0.1782;NativeFreq_Hom=0.8118;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0014;patientHomNum=4;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0162253|16D0172122|15D6482454-1|16B0202605][_];DANN_score=0.5332;GREP_score=0.0;CytoBand=p25.3;repName=AluSx;repClass=SINE;simRepName=trf;simRepCopyNum=1.8;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=gtcaggagct.aagaccagcc	GT:AD:DP:GQ:PL	1/1:0,77:77:99:3204,232,0
chr3	10195293	.	T	TG	13139.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-2.943;DP=467;ExcessHet=3.0103;FS=3.99;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.2;ReadPosRankSum=-2.419;SOR=1.061;HGVSnom=NM_000551.4:c.*3644_*3645insG;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs201632485;CLNGENE=LOC107303340|VHL;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.971046;G1000_EAS_AF=0.9772;G1000_EUR_AF=0.9662;G1000_AFR_AF=0.9894;G1000_SAS_AF=0.9581;G1000_AMR_AF=0.9524;CytoBand=p25.3;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=AAGttttttt.tttttttttt	GT:AD:DP:GQ:PL	1/1:5,445:450:99:13177,1207,0
chr3	10195298	.	T	G	21441.7	PASS	AC=2;AF=1;AN=2;DP=477;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.21;SOR=1.24;HGVSnom=NM_000551.4:c.*3649T>G;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs149915954;G1000_AF=0.669728;G1000_EAS_AF=0.7034;G1000_EUR_AF=0.7028;G1000_AFR_AF=0.6225;G1000_SAS_AF=0.6759;G1000_AMR_AF=0.6542;NativeFreq_Het=0.5643;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0129;normalHomNum=5;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.0043;patientHomNum=12;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722469-1][_];patientHomSampleInfo=[15D6104554|17B0000897|16D0164799|15B0002980-1|16B0005224|16B0019035-1|16S0013041|16D0067281|15D6722295-1|16B0005663|16B0017623|16D0038363][_];DANN_score=0.1987;GREP_score=0.0;CytoBand=p25.3;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=tttttttttt.tttttttttt	GT:AD:DP:GQ:PL	1/1:0,475:475:99:21479,1456,0
chr3	10195303	.	T	G	20877.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.003;DP=468;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=35.18;ReadPosRankSum=1.592;SOR=0.485;HGVSnom=NM_000551.4:c.*3654T>G;Gene=VHL;Transcript=NM_000551.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=213;RS=rs1678595;G1000_AF=0.698882;G1000_EAS_AF=0.7044;G1000_EUR_AF=0.7028;G1000_AFR_AF=0.7186;G1000_SAS_AF=0.6861;G1000_AMR_AF=0.6657;NativeFreq_Het=0.5742;NativeFreq_Hom=0.0990;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0129;normalHomNum=5;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.0036;patientHomNum=10;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722469-1][_];patientHomSampleInfo=[15D6104554|17B0000897|16B0005224|16B0019035-1|16S0013041|16D0067281|15D6722295-1|16B0005663|16B0017623|16D0038363][_];DANN_score=0.1809;GREP_score=0.0;CytoBand=p25.3;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=Von Hippel Lindau. Erythrocytosis, familial, 2 (Chuvash polycythemia). Pheochromocytoma;CGD_INHERITANCE=AD/AR;Strand=VHL:NM_000551.3:+,VHL:NM_198156.2:+;NP=VHL:NM_000551.3:NP_000542.1,VHL:NM_198156.2:NP_937799.1;ENSP=VHL:NM_000551.3:ENST00000256474.2,VHL:NM_198156.2:.;Gene_MIM_id=608537;Phenotypes=Erythrocytosis, familial, 2, 263400 (3), Autosomal recessive. Hemangioblastoma, cerebellar, somatic (3). Pheochromocytoma, 171300 (3), Autosomal dominant. Renal cell carcinoma, somatic, 144700 (3). von Hippel-Lindau syndrome, 193300 (3), Autosomal dominant. 144700(MK),171300(MK),193300(MK),263400(MK),608537(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7428;EnsemblGeneID=ENSG00000134086;Alias=VHL;FLKSEQ=tttttttttt.tttttAAAGC	GT:AD:DP:GQ:PL	1/1:1,465:466:99:20906,1412,0
chr3	14186607	.	T	TA	480.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.105;DP=35;ExcessHet=3.0103;FS=8.664;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.57;ReadPosRankSum=1.277;SOR=3.442;HGVSnom=.;Gene=XPC;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;EXAC_AF=0;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=0;EXAC_AC_Adj=0;EXAC_AN_Adj=0;RS=rs11412123;G1000_AF=0.57528;G1000_EAS_AF=0.6329;G1000_EUR_AF=0.4225;G1000_AFR_AF=0.6301;G1000_SAS_AF=0.5849;G1000_AMR_AF=0.5951;gnomad_exomes_AF=0.41995310;gnomad_exomes_AF_EAS=0.45828989;gnomad_exomes_AC=3940;gnomad_exomes_Hom=46;gnomad_exomes_Het=3848;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.45748299;gnomad_exomes_AF_NFE=0.38212251;gnomad_exomes_AF_AMR=0.43053892;gnomad_exomes_AF_SAS=0.42655699;CytoBand=p25.1;repName=FLAM_A;repClass=SINE;FLKSEQ=taagacccct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:7,26:33:54:518,0,54
chr3	14186757	.	C	G	5883.77	StandardFilter	AC=2;AF=1;AN=2;DP=144;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.59;SOR=5.435;HGVSnom=NM_004628.5:c.*684G>C;Gene=XPC;Transcript=NM_004628.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=940;EXAC_AF=0.91772913;EXAC_Hom_EAS=65;EXAC_AC_EAS=130;EXAC_AN_EAS=130;EXAC_AC_Adj=7630;EXAC_AN_Adj=8314;RS=rs1126547;CLNGENE=TMEM43|XPC;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.91893;G1000_EAS_AF=0.998;G1000_EUR_AF=0.8767;G1000_AFR_AF=0.8744;G1000_SAS_AF=0.9274;G1000_AMR_AF=0.938;gnomad_exomes_AF=0.90430212;gnomad_exomes_AF_EAS=0.99932118;gnomad_exomes_AC=109766;gnomad_exomes_Hom=49803;gnomad_exomes_Het=10160;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87579088;gnomad_exomes_AF_NFE=0.86586333;gnomad_exomes_AF_AMR=0.94003221;gnomad_exomes_AF_SAS=0.91968481;NativeFreq_Het=0.0123;NativeFreq_Hom=1;normalHetFrequency=0.0786;normalHetNum=68;normalHomFrequency=0.904;normalHomNum=782;patientHetFrequency=0.0659;patientHetNum=344;patientHomFrequency=0.9128;patientHomNum=4765;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0015;AF_2700_Hom=0.9973;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5592;GREP_score=0.123;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=GTTTAACACT.ATCTATTTTA	GT:AD:DP:GQ:PL	1/1:0,143:143:99:5912,430,0
chr3	14187345	.	G	C	12304.8	PASS	AC=2;AF=1;AN=2;DP=320;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.25;SOR=1.024;HGVSnom=NM_004628.5:c.*96C>G;Gene=XPC;Transcript=NM_004628.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=940;EXAC_AF=0.35331589;EXAC_Hom_EAS=387;EXAC_AC_EAS=2183;EXAC_AN_EAS=4566;EXAC_AC_Adj=20799;EXAC_AN_Adj=58868;RS=rs2229090;CLNGENE=TMEM43|XPC;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.254992;G1000_EAS_AF=0.4544;G1000_EUR_AF=0.2624;G1000_AFR_AF=0.1241;G1000_SAS_AF=0.2209;G1000_AMR_AF=0.2522;gnomad_exomes_AF=0.24935171;gnomad_exomes_AF_EAS=0.38840808;gnomad_exomes_AC=48463;gnomad_exomes_Hom=6255;gnomad_exomes_Het=35953;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11314961;gnomad_exomes_AF_NFE=0.24626132;gnomad_exomes_AF_AMR=0.22806384;gnomad_exomes_AF_SAS=0.20951157;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1481;normalHetFrequency=0.3873;normalHetNum=335;normalHomFrequency=0.1121;normalHomNum=97;patientHetFrequency=0.4107;patientHetNum=2144;patientHomFrequency=0.105;patientHomNum=548;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4512;AF_2700_Hom=0.1314;AF_50_Het=0.4279;AF_50_Hom=0.1331;DANN_score=0.4432;GREP_score=1.17;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=CAGCAGAGAA.CCCCCACCAC	GT:AD:DP:GQ:PL	1/1:0,318:318:99:12333,955,0
chr3	14187449	.	G	T	11634.8	PASS	AC=2;AF=1;AN=2;DP=309;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.86;SOR=0.739;HGVSnom=NM_004628.5:c.2815C>A(p.Gln939Lys/p.Q939K);Gene=XPC;Transcript=NM_004628.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E16;IVSnom=.;AAlength=940;EXAC_AF=0.63253964;EXAC_Hom_EAS=1813;EXAC_AC_EAS=5551;EXAC_AN_EAS=8608;EXAC_AC_Adj=76030;EXAC_AN_Adj=120198;ESP6500_MAF=0.64206151;RS=rs2228001;Ensembl_transcriptid=ENST00000285021;SIFT_pred=T;SIFT_score=1.0;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.0;MutationTaster_pred=P|P;MutationTaster_score=0.999997|0.999997;CLNGENE=TMEM43|XPC;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.684704;G1000_EAS_AF=0.6667;G1000_EUR_AF=0.5954;G1000_AFR_AF=0.7511;G1000_SAS_AF=0.682;G1000_AMR_AF=0.7176;gnomad_exomes_AF=0.63345754;gnomad_exomes_AF_EAS=0.63948282;gnomad_exomes_AC=156744;gnomad_exomes_Hom=50140;gnomad_exomes_Het=56464;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.73027167;gnomad_exomes_AF_NFE=0.59174402;gnomad_exomes_AF_AMR=0.70638770;gnomad_exomes_AF_SAS=0.64723522;HGMD_gene=XPC;HGMD_disease=DNA_repair_rate_association_with;HGMD_tag=DFP;HGMD_pmid=14729591;NativeFreq_Het=0.5940;NativeFreq_Hom=0.4136;normalHetFrequency=0.5075;normalHetNum=439;normalHomFrequency=0.3202;normalHomNum=277;patientHetFrequency=0.4579;patientHetNum=2390;patientHomFrequency=0.3617;patientHomNum=1888;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4616;AF_2700_Hom=0.3970;AF_50_Het=0.4675;AF_50_Hom=0.3883;DANN_score=0.9017;GREP_score=4.24;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=GCTCACAGCT.CTCAAATGGG	GT:AD:DP:GQ:PL	1/1:0,309:309:99:11663,928,0
chr3	14187699	.	T	C	12614.8	PASS	AC=2;AF=1;AN=2;DP=330;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.49;SOR=1.37;HGVSnom=NM_004628.5:c.2605-40A>G;Gene=XPC;Transcript=NM_004628.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_004628.5:IVS15-40A>G;AAlength=940;EXAC_AF=0.64668530;EXAC_Hom_EAS=618;EXAC_AC_EAS=1895;EXAC_AN_EAS=2798;EXAC_AC_Adj=31469;EXAC_AN_Adj=48662;ESP6500_MAF=0.65488350;RS=rs2733532;CLNGENE=XPC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.694289;G1000_EAS_AF=0.6726;G1000_EUR_AF=0.6004;G1000_AFR_AF=0.7738;G1000_SAS_AF=0.6851;G1000_AMR_AF=0.7233;gnomad_exomes_AF=0.63956151;gnomad_exomes_AF_EAS=0.64781192;gnomad_exomes_AC=110034;gnomad_exomes_Hom=35282;gnomad_exomes_Het=39470;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75138669;gnomad_exomes_AF_NFE=0.59957752;gnomad_exomes_AF_AMR=0.70859586;gnomad_exomes_AF_SAS=0.64827369;NativeFreq_Het=0.4290;NativeFreq_Hom=0.4105;normalHetFrequency=0.4971;normalHetNum=430;normalHomFrequency=0.3295;normalHomNum=285;patientHetFrequency=0.4467;patientHetNum=2332;patientHomFrequency=0.3724;patientHomNum=1944;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7298;GREP_score=0.361;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=AGGCGAGGGT.AGTAATCAGA	GT:AD:DP:GQ:PL	1/1:0,329:329:99:12643,989,0
chr3	14190237	.	T	G	12481.8	PASS	AC=2;AF=1;AN=2;DP=334;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.05;SOR=0.954;HGVSnom=NM_004628.5:c.2251-6A>C;Gene=XPC;Transcript=NM_004628.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_004628.5:IVS12-6A>C;AAlength=940;EXAC_AF=0.63015723;EXAC_Hom_EAS=1804;EXAC_AC_EAS=5542;EXAC_AN_EAS=8586;EXAC_AC_Adj=75910;EXAC_AN_Adj=120462;ESP6500_MAF=0.63534428;RS=rs2279017;CLNGENE=XPC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.679712;G1000_EAS_AF=0.6657;G1000_EUR_AF=0.5964;G1000_AFR_AF=0.7352;G1000_SAS_AF=0.682;G1000_AMR_AF=0.7118;gnomad_exomes_AF=0.63257031;gnomad_exomes_AF_EAS=0.64031863;gnomad_exomes_AC=157405;gnomad_exomes_Hom=50207;gnomad_exomes_Het=56991;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.70880186;gnomad_exomes_AF_NFE=0.59289351;gnomad_exomes_AF_AMR=0.70518923;gnomad_exomes_AF_SAS=0.64752223;HGMD_gene=XPC;HGMD_disease=DNA_repair_rate_association_with;HGMD_tag=DFP;HGMD_pmid=12177305;NativeFreq_Het=0.5841;NativeFreq_Hom=0.4198;normalHetFrequency=0.5121;normalHetNum=443;normalHomFrequency=0.3179;normalHomNum=275;patientHetFrequency=0.458;patientHetNum=2391;patientHomFrequency=0.3609;patientHomNum=1884;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4631;AF_2700_Hom=0.3962;AF_50_Het=0.4675;AF_50_Hom=0.3867;dbscSNV_RF_score=0.046;dbscSNV_ADA_score=0.00004812;DANN_score=0.5252;GREP_score=3.73;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=GGCACCTGTG.CGGGTGAGCA	GT:AD:DP:GQ:PL	1/1:0,333:333:99:12510,1000,0
chr3	14197987	.	A	T	12856.8	PASS	AC=2;AF=1;AN=2;DP=351;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.88;SOR=1.225;HGVSnom=NM_004628.5:c.1881T>A(p.Ala627Ala/p.A627A);Gene=XPC;Transcript=NM_004628.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E10;IVSnom=.;AAlength=940;EXAC_AF=1.00000000;EXAC_Hom_EAS=4313;EXAC_AC_EAS=8626;EXAC_AN_EAS=8626;EXAC_AC_Adj=120782;EXAC_AN_Adj=120782;RS=rs2958057;CLNGENE=XPC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=1.00000000;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=249140;gnomad_exomes_Hom=124570;gnomad_exomes_Het=0;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=1.00000000;gnomad_exomes_AF_NFE=1.00000000;gnomad_exomes_AF_AMR=1.00000000;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.7056;GREP_score=-11.5;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=CCATGTGTTT.GCCTGAAACT	GT:AD:DP:GQ:PL	1/1:0,350:350:99:12885,1052,0
chr3	14199887	.	G	A	14967.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.191;DP=420;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.31;ReadPosRankSum=1.175;SOR=0.758;HGVSnom=NM_004628.5:c.1496C>T(p.Ala499Val/p.A499V);Gene=XPC;Transcript=NM_004628.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=940;EXAC_AF=0.23775104;EXAC_Hom_EAS=570;EXAC_AC_EAS=3074;EXAC_AN_EAS=8596;EXAC_AC_Adj=28649;EXAC_AN_Adj=120500;ESP6500_MAF=0.20058252;RS=rs2228000;Ensembl_transcriptid=ENST00000285021;SIFT_pred=T;SIFT_score=0.331;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.004;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=XPC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.233027;G1000_EAS_AF=0.4127;G1000_EUR_AF=0.2584;G1000_AFR_AF=0.093;G1000_SAS_AF=0.2025;G1000_AMR_AF=0.245;gnomad_exomes_AF=0.24351924;gnomad_exomes_AF_EAS=0.36145115;gnomad_exomes_AC=60666;gnomad_exomes_Hom=7936;gnomad_exomes_Het=44794;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08993410;gnomad_exomes_AF_NFE=0.24533848;gnomad_exomes_AF_AMR=0.22330069;gnomad_exomes_AF_SAS=0.19797386;HGMD_gene=XPC;HGMD_disease=Lung_cancer_association_with;HGMD_tag=DP;HGMD_pmid=15700316;NativeFreq_Het=0.4554;NativeFreq_Hom=0.1173;normalHetFrequency=0.3838;normalHetNum=332;normalHomFrequency=0.096;normalHomNum=83;patientHetFrequency=0.3996;patientHetNum=2086;patientHomFrequency=0.0866;patientHomNum=452;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4293;AF_2700_Hom=0.1103;AF_50_Het=0.4025;AF_50_Hom=0.1173;DANN_score=0.8616;GREP_score=-1.03;CytoBand=p25.1;CGD_CONDITION=Xeroderma pigmentosum, group C;CGD_INHERITANCE=AR;Strand=XPC:NM_004628.4:-;NP=XPC:NM_004628.4:NP_004619.3;ENSP=XPC:NM_004628.4:ENST00000285021.11;Gene_MIM_id=613208;Phenotypes=Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessive. 278720(MK);Possible_Inheritance=AR;EntrezGeneID=7508;EnsemblGeneID=ENSG00000154767;Alias=XPC, XPCC;FLKSEQ=TGAGGATGCC.CTGGCAAGCT	GT:AD:DP:GQ:PL	1/1:1,418:419:99:14996,1227,0
chr3	37034946	.	G	A	7612.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.626;DP=427;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.87;ReadPosRankSum=1.395;SOR=0.717;HGVSnom=.;Gene=MLH1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs1800734;CLNGENE=MLH1;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.320487;G1000_EAS_AF=0.5476;G1000_EUR_AF=0.2654;G1000_AFR_AF=0.1528;G1000_SAS_AF=0.3865;G1000_AMR_AF=0.2968;HGMD_gene=MLH1;HGMD_disease=Lung_cancer_risk_association_with;HGMD_tag=DFP;HGMD_pmid=15382050;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3337;normalHetFrequency=0.4127;normalHetNum=357;normalHomFrequency=0.3087;normalHomNum=267;patientHetFrequency=0.4504;patientHetNum=2351;patientHomFrequency=0.2697;patientHomNum=1408;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4719;AF_2700_Hom=0.3394;AF_50_Het=0.4834;AF_50_Hom=0.3344;DANN_score=0.7681;GREP_score=-0.343;CytoBand=p22.2;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 2. Mismatch repair cancer syndrome. Endometrial cancer. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MLH1:NM_000249.3:+,MLH1:NM_001258271.1:+,MLH1:NM_001258273.1:+;NP=MLH1:NM_000249.3:NP_000240.1,MLH1:NM_001258271.1:NP_001245200.1,MLH1:NM_001258273.1:NP_001245202.1;ENSP=MLH1:NM_000249.3:ENST00000231790.7,MLH1:NM_001258271.1:.,MLH1:NM_001258273.1:.;Gene_MIM_id=120436;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 158320(MK),276300(MK),609310(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4292;EnsemblGeneID=ENSG00000076242;Alias=MLH1, COCA2, HNPCC2;FLKSEQ=AGCTACAGCT.AAGGAAGAAC	GT:AD:DP:GQ:PL	0/1:189,237:426:99:7641,0,6054
chr3	37067097	.	A	T	163.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=2.836;DP=145;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.32;ReadPosRankSum=1.836;SOR=0.593;HGVSnom=NM_000249.4:c.1039-31A>T;Gene=MLH1;Transcript=NM_000249.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000249.4:IVS11-31A>T;AAlength=756;EXAC_AF=0.06131479;EXAC_Hom_EAS=0;EXAC_AC_EAS=3;EXAC_AN_EAS=20;EXAC_AC_Adj=97;EXAC_AN_Adj=1582;RS=rs59684491;CLNGENE=MLH1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.03121362;gnomad_exomes_AF_EAS=0.04117647;gnomad_exomes_AC=429;gnomad_exomes_Hom=15;gnomad_exomes_Het=399;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03906250;gnomad_exomes_AF_NFE=0.02737705;gnomad_exomes_AF_AMR=0.04491018;gnomad_exomes_AF_SAS=0.04009434;NativeFreq_Het=0.7722;NativeFreq_Hom=0.0048;normalHetFrequency=0.0855;normalHetNum=74;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.0718;patientHetNum=375;patientHomFrequency=0.0236;patientHomNum=123;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.0556;GREP_score=-0.261;CytoBand=p22.2;repName=(TA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=12.5;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 2. Mismatch repair cancer syndrome. Endometrial cancer. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MLH1:NM_000249.3:+,MLH1:NM_001258271.1:+,MLH1:NM_001258273.1:+,MLH1:NM_001167617.1:+,MLH1:NM_001167618.1:+,MLH1:NM_001167619.1:+,MLH1:NM_001258274.1:+;NP=MLH1:NM_000249.3:NP_000240.1,MLH1:NM_001258271.1:NP_001245200.1,MLH1:NM_001258273.1:NP_001245202.1,MLH1:NM_001167617.1:NP_001161089.1,MLH1:NM_001167618.1:NP_001161090.1,MLH1:NM_001167619.1:NP_001161091.1,MLH1:NM_001258274.1:NP_001245203.1;ENSP=MLH1:NM_000249.3:ENST00000231790.7,MLH1:NM_001258271.1:.,MLH1:NM_001258273.1:.,MLH1:NM_001167617.1:.,MLH1:NM_001167618.1:.,MLH1:NM_001167619.1:.,MLH1:NM_001258274.1:.;Gene_MIM_id=120436;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 158320(MK),276300(MK),609310(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4292;EnsemblGeneID=ENSG00000076242;Alias=MLH1, COCA2, HNPCC2;FLKSEQ=atatatatat.tatttttttt	GT:AD:DP:GQ:PL	0/1:103,21:124:99:201,0,3514
chr3	37067099	.	A	T	1304.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.997;DP=144;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.88;ReadPosRankSum=1.896;SOR=0.493;HGVSnom=NM_000249.4:c.1039-29A>T;Gene=MLH1;Transcript=NM_000249.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000249.4:IVS11-29A>T;AAlength=756;EXAC_AF=0.01853123;EXAC_Hom_EAS=1;EXAC_AC_EAS=3;EXAC_AN_EAS=42;EXAC_AC_Adj=54;EXAC_AN_Adj=2914;RS=rs6771325;CLNGENE=MLH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.03661508;gnomad_exomes_AF_EAS=0.12222222;gnomad_exomes_AC=511;gnomad_exomes_Hom=104;gnomad_exomes_Het=303;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.04477612;gnomad_exomes_AF_NFE=0.03590844;gnomad_exomes_AF_AMR=0.03017241;gnomad_exomes_AF_SAS=0.05054152;NativeFreq_Het=0.7524;NativeFreq_Hom=0.1060;normalHetFrequency=0.1214;normalHetNum=105;normalHomFrequency=0.1491;normalHomNum=129;patientHetFrequency=0.136;patientHetNum=710;patientHomFrequency=0.1372;patientHomNum=716;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2829;AF_2700_Hom=0.2406;AF_50_Het=0.3074;AF_50_Hom=0.2425;DANN_score=0.0827;GREP_score=0.13;CytoBand=p22.2;repName=(TA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=12.5;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis, type 2. Mismatch repair cancer syndrome. Endometrial cancer. Muir-Torre syndrome;CGD_INHERITANCE=AD/AR;Strand=MLH1:NM_000249.3:+,MLH1:NM_001258271.1:+,MLH1:NM_001258273.1:+,MLH1:NM_001167617.1:+,MLH1:NM_001167618.1:+,MLH1:NM_001167619.1:+,MLH1:NM_001258274.1:+;NP=MLH1:NM_000249.3:NP_000240.1,MLH1:NM_001258271.1:NP_001245200.1,MLH1:NM_001258273.1:NP_001245202.1,MLH1:NM_001167617.1:NP_001161089.1,MLH1:NM_001167618.1:NP_001161090.1,MLH1:NM_001167619.1:NP_001161091.1,MLH1:NM_001258274.1:NP_001245203.1;ENSP=MLH1:NM_000249.3:ENST00000231790.7,MLH1:NM_001258271.1:.,MLH1:NM_001258273.1:.,MLH1:NM_001167617.1:.,MLH1:NM_001167618.1:.,MLH1:NM_001167619.1:.,MLH1:NM_001258274.1:.;Gene_MIM_id=120436;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. Muir-Torre syndrome, 158320 (3), Autosomal dominant. 158320(MK),276300(MK),609310(MK);Possible_Inheritance=AD,AR;EntrezGeneID=4292;EnsemblGeneID=ENSG00000076242;Alias=MLH1, COCA2, HNPCC2;FLKSEQ=atatatatat.tttttttttt	GT:AD:DP:GQ:PL	0/1:78,54:132:99:1342,0,1937
chr3	41281388	.	T	G	3844.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.08;DP=213;ExcessHet=3.0103;FS=0.632;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.05;ReadPosRankSum=0.73;SOR=0.809;HGVSnom=NM_001904.4:c.*555T>G;Gene=CTNNB1;Transcript=NM_001904.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=781;RS=rs2953;CLNGENE=CTNNB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.365216;G1000_EAS_AF=0.2817;G1000_EUR_AF=0.4334;G1000_AFR_AF=0.3419;G1000_SAS_AF=0.4315;G1000_AMR_AF=0.3386;normalHetFrequency=0.369;normalHetNum=176;normalHomFrequency=0.0734;normalHomNum=35;patientHetFrequency=0.3881;patientHetNum=950;patientHomFrequency=0.0829;patientHomNum=203;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.916;GREP_score=5.57;CytoBand=p22.1;CGD_CONDITION=Exudative vitreoretinopathy 7. Neurodevelopmental disorder with spastic diplegia and visual defect (Mental retardation, autosomal dominant 19);CGD_INHERITANCE=AD;Strand=CTNNB1:NM_001330729.1:+,CTNNB1:NM_001098209.1:+,CTNNB1:NM_001098210.1:+,CTNNB1:NM_001904.3:+,CTNNB1:NM_001904.4:+;NP=CTNNB1:NM_001330729.1:NP_001317658.1,CTNNB1:NM_001098209.1:NP_001091679.1,CTNNB1:NM_001098210.1:NP_001091680.1,CTNNB1:NM_001904.3:NP_001895.1,CTNNB1:NM_001904.4:NP_001895.1;ENSP=CTNNB1:NM_001330729.1:.,CTNNB1:NM_001098209.1:.,CTNNB1:NM_001098210.1:.,CTNNB1:NM_001904.3:.,CTNNB1:NM_001904.4:ENST00000349496.11;Gene_MIM_id=116806;Phenotypes=Colorectal cancer, somatic, 114500 (3). Hepatocellular carcinoma, somatic, 114550 (3). Medulloblastoma, somatic, 155255 (3). Mental retardation, autosomal dominant 19, 615075 (3), Autosomal dominant. Ovarian cancer, somatic, 167000 (3). Pilomatricoma, somatic, 132600 (3). 114500(MK),114550(MK),132600(MK),167000(MK),615075(MK);Possible_Inheritance=AD;EntrezGeneID=1499;EnsemblGeneID=ENSG00000168036;Alias=CTNNB1, MRD19;FLKSEQ=ATGGAATTTA.CAAACCCTAG	GT:AD:DP:GQ:PL	0/1:109,104:213:99:3873,0,3971
chr3	41281412	.	A	AT	374.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.745;DP=178;ExcessHet=3.0103;FS=10.453;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.26;ReadPosRankSum=-0.92;SOR=0.139;HGVSnom=NM_001904.4:c.*598dupT;Gene=CTNNB1;Transcript=NM_001904.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=781;RS=rs34653633;normalHetFrequency=0.4948;normalHetNum=236;normalHomFrequency=0.1992;normalHomNum=95;patientHetFrequency=0.489;patientHetNum=1197;patientHomFrequency=0.1859;patientHomNum=455;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p22.1;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Exudative vitreoretinopathy 7. Neurodevelopmental disorder with spastic diplegia and visual defect (Mental retardation, autosomal dominant 19);CGD_INHERITANCE=AD;Strand=CTNNB1:NM_001330729.1:+,CTNNB1:NM_001098209.1:+,CTNNB1:NM_001098210.1:+,CTNNB1:NM_001904.3:+,CTNNB1:NM_001904.4:+;NP=CTNNB1:NM_001330729.1:NP_001317658.1,CTNNB1:NM_001098209.1:NP_001091679.1,CTNNB1:NM_001098210.1:NP_001091680.1,CTNNB1:NM_001904.3:NP_001895.1,CTNNB1:NM_001904.4:NP_001895.1;ENSP=CTNNB1:NM_001330729.1:.,CTNNB1:NM_001098209.1:.,CTNNB1:NM_001098210.1:.,CTNNB1:NM_001904.3:.,CTNNB1:NM_001904.4:ENST00000349496.11;Gene_MIM_id=116806;Phenotypes=Colorectal cancer, somatic, 114500 (3). Hepatocellular carcinoma, somatic, 114550 (3). Medulloblastoma, somatic, 155255 (3). Mental retardation, autosomal dominant 19, 615075 (3), Autosomal dominant. Ovarian cancer, somatic, 167000 (3). Pilomatricoma, somatic, 132600 (3). 114500(MK),114550(MK),132600(MK),167000(MK),615075(MK);Possible_Inheritance=AD;EntrezGeneID=1499;EnsemblGeneID=ENSG00000168036;Alias=CTNNB1, MRD19;FLKSEQ=TGCTTGttaa.tttttttttt	GT:AD:DP:GQ:PL	0/1:113,53:166:99:412,0,3312
chr3	41281413	.	T	A	276.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.841;DP=178;ExcessHet=3.0103;FS=2.038;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.68;ReadPosRankSum=1.339;SOR=0.936;HGVSnom=NM_001904.4:c.*580T>A;Gene=CTNNB1;Transcript=NM_001904.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=781;RS=rs4135387;G1000_AF=0.269968;G1000_EAS_AF=0.246;G1000_EUR_AF=0.4125;G1000_AFR_AF=0.087;G1000_SAS_AF=0.3691;G1000_AMR_AF=0.3069;normalHetFrequency=0.3522;normalHetNum=168;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.366;patientHetNum=896;patientHomFrequency=0.0029;patientHomNum=7;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0033502|16D1545968|16D1545734|15B0002485|16B3097980-1|16B0035672-1|16B3098005-1];DANN_score=0.2281;GREP_score=-9.2;CytoBand=p22.1;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Exudative vitreoretinopathy 7. Neurodevelopmental disorder with spastic diplegia and visual defect (Mental retardation, autosomal dominant 19);CGD_INHERITANCE=AD;Strand=CTNNB1:NM_001330729.1:+,CTNNB1:NM_001098209.1:+,CTNNB1:NM_001098210.1:+,CTNNB1:NM_001904.3:+,CTNNB1:NM_001904.4:+;NP=CTNNB1:NM_001330729.1:NP_001317658.1,CTNNB1:NM_001098209.1:NP_001091679.1,CTNNB1:NM_001098210.1:NP_001091680.1,CTNNB1:NM_001904.3:NP_001895.1,CTNNB1:NM_001904.4:NP_001895.1;ENSP=CTNNB1:NM_001330729.1:.,CTNNB1:NM_001098209.1:.,CTNNB1:NM_001098210.1:.,CTNNB1:NM_001904.3:.,CTNNB1:NM_001904.4:ENST00000349496.11;Gene_MIM_id=116806;Phenotypes=Colorectal cancer, somatic, 114500 (3). Hepatocellular carcinoma, somatic, 114550 (3). Medulloblastoma, somatic, 155255 (3). Mental retardation, autosomal dominant 19, 615075 (3), Autosomal dominant. Ovarian cancer, somatic, 167000 (3). Pilomatricoma, somatic, 132600 (3). 114500(MK),114550(MK),132600(MK),167000(MK),615075(MK);Possible_Inheritance=AD;EntrezGeneID=1499;EnsemblGeneID=ENSG00000168036;Alias=CTNNB1, MRD19;FLKSEQ=GCTTGttaaa.tttttttttt	GT:AD:DP:GQ:PL	0/1:128,37:165:99:305,0,4424
chr3	41281600	.	C	CTAAT	3107.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.476;DP=155;ExcessHet=3.0103;FS=2.765;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.58;ReadPosRankSum=-1.228;SOR=1.042;HGVSnom=NM_001904.4:c.*769_*772dupAATT;Gene=CTNNB1;Transcript=NM_001904.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=781;RS=rs16339;G1000_AF=0.358027;G1000_EAS_AF=0.2798;G1000_EUR_AF=0.4334;G1000_AFR_AF=0.3185;G1000_SAS_AF=0.4315;G1000_AMR_AF=0.3343;normalHetFrequency=0.3606;normalHetNum=172;normalHomFrequency=0.0692;normalHomNum=33;patientHetFrequency=0.3803;patientHetNum=931;patientHomFrequency=0.0813;patientHomNum=199;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p22.1;CGD_CONDITION=Exudative vitreoretinopathy 7. Neurodevelopmental disorder with spastic diplegia and visual defect (Mental retardation, autosomal dominant 19);CGD_INHERITANCE=AD;Strand=CTNNB1:NM_001330729.1:+,CTNNB1:NM_001098209.1:+,CTNNB1:NM_001098210.1:+,CTNNB1:NM_001904.3:+,CTNNB1:NM_001904.4:+;NP=CTNNB1:NM_001330729.1:NP_001317658.1,CTNNB1:NM_001098209.1:NP_001091679.1,CTNNB1:NM_001098210.1:NP_001091680.1,CTNNB1:NM_001904.3:NP_001895.1,CTNNB1:NM_001904.4:NP_001895.1;ENSP=CTNNB1:NM_001330729.1:.,CTNNB1:NM_001098209.1:.,CTNNB1:NM_001098210.1:.,CTNNB1:NM_001904.3:.,CTNNB1:NM_001904.4:ENST00000349496.11;Gene_MIM_id=116806;Phenotypes=Colorectal cancer, somatic, 114500 (3). Hepatocellular carcinoma, somatic, 114550 (3). Medulloblastoma, somatic, 155255 (3). Mental retardation, autosomal dominant 19, 615075 (3), Autosomal dominant. Ovarian cancer, somatic, 167000 (3). Pilomatricoma, somatic, 132600 (3). 114500(MK),114550(MK),132600(MK),167000(MK),615075(MK);Possible_Inheritance=AD;EntrezGeneID=1499;EnsemblGeneID=ENSG00000168036;Alias=CTNNB1, MRD19;FLKSEQ=GTGTAGAACA.TAATTCATAA	GT:AD:DP:GQ:PL	0/1:68,76:144:99:3145,0,3676
chr3	52435860	.	G	A	3775.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.095;DP=296;ExcessHet=3.0103;FS=0.426;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.89;ReadPosRankSum=-1.893;SOR=0.65;HGVSnom=NM_004656.4:c.*444C>T;Gene=BAP1;Transcript=NM_004656.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=729;RS=rs123598;CLNGENE=BAP1;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.028155;G1000_EAS_AF=0.0188;G1000_EUR_AF=0.0577;G1000_AFR_AF=0.0053;G1000_SAS_AF=0.0174;G1000_AMR_AF=0.0576;DANN_score=0.2747;GREP_score=-0.562;CytoBand=p21.1;CGD_CONDITION=Tumor predisposition syndrome;CGD_INHERITANCE=AD;Strand=BAP1:NM_004656.3:-;NP=BAP1:NM_004656.3:NP_004647.1;ENSP=BAP1:NM_004656.3:ENST00000460680.5;Gene_MIM_id=603089;Phenotypes=Tumor predisposition syndrome, 614327 (3), Autosomal dominant. 614327(MK);Possible_Inheritance=AD;EntrezGeneID=8314;EnsemblGeneID=ENSG00000163930;Alias=BAP1, TPDS;FLKSEQ=CCTGTAGTTG.GACCGTGGCA	GT:AD:DP:GQ:PL	0/1:159,134:293:99:3804,0,5158
chr3	70014965	.	G	GA	5971.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.428;DP=278;ExcessHet=3.0103;FS=12.199;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=23.6;ReadPosRankSum=-0.006;SOR=1.596;OLD_VARIANT=chr3|70014965|G|GA,GAA|1;HGVSnom=NM_001354604.2:c.*576dupA;Gene=MITF;Transcript=NM_001354604.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=526;RS=rs59665466;CLNGENE=MITF;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0128;NativeFreq_Hom=.;normalHetFrequency=0.0126;normalHetNum=6;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0057;patientHetNum=14;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15D6529873|15B6105405|15D6517224|16D1532963-1|16B0017473|15D6518710|15D6534412|15B6325489|15B0045736|15B6132255|16D1546154|15B0002982-1|15D6529233|15B0022372];patientHomSampleInfo=[_][16B0017265|15D6524781];CytoBand=p13;CGD_CONDITION=Waardenburg syndrome, type 2A. Tietz albinism-deafness syndrome. Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD). Melanoma, cutaneous malignant, susceptibility to, 8. Renal cell carcinoma with or without malignant melanoma;CGD_INHERITANCE=AD;Strand=MITF:NM_198159.2:+,MITF:NM_001184967.1:+,MITF:NM_006722.2:+,MITF:NM_198177.2:+,MITF:NM_000248.3:+,MITF:NM_198158.2:+,MITF:NM_198178.2:+;NP=MITF:NM_198159.2:NP_937802.1,MITF:NM_001184967.1:NP_001171896.1,MITF:NM_006722.2:NP_006713.1,MITF:NM_198177.2:NP_937820.1,MITF:NM_000248.3:NP_000239.1,MITF:NM_198158.2:NP_937801.1,MITF:NM_198178.2:NP_937821.2;ENSP=MITF:NM_198159.2:ENST00000352241.8,MITF:NM_001184967.1:.,MITF:NM_006722.2:.,MITF:NM_198177.2:.,MITF:NM_000248.3:.,MITF:NM_198158.2:.,MITF:NM_198178.2:.;Gene_MIM_id=156845;Phenotypes=COMMAD syndrome, 617306 (3), Autosomal recessive. {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3). Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant. Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant. Waardenburg syndrome/ocular albinism, digenic, 103470 (3), Autosomal dominant. 103470(MK),103500(MK),193510(MK),614456(SK);Possible_Inheritance=AD,AR,XL;EntrezGeneID=4286;EnsemblGeneID=ENSG00000187098;Alias=MITF, WS2A, CMM8, COMMAD;FLKSEQ=TTCTGTAAAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/0:18,117:253:99:6009,2287,2064
chr3	70014965	.	G	GAA	5971.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.428;DP=278;ExcessHet=3.0103;FS=12.199;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=23.6;ReadPosRankSum=-0.006;SOR=1.596;OLD_VARIANT=chr3|70014965|G|GA,GAA|2;HGVSnom=NM_001354604.2:c.*575_*576dupAA;Gene=MITF;Transcript=NM_001354604.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=526;RS=rs59665466;CLNGENE=MITF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.296326;G1000_EAS_AF=0.2698;G1000_EUR_AF=0.2445;G1000_AFR_AF=0.3487;G1000_SAS_AF=0.3027;G1000_AMR_AF=0.3012;NativeFreq_Het=0.1077;NativeFreq_Hom=.;normalHetFrequency=0.4403;normalHetNum=210;normalHomFrequency=0.0692;normalHomNum=33;patientHetFrequency=0.3807;patientHetNum=932;patientHomFrequency=0.0385;patientHomNum=201;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p13;CGD_CONDITION=Waardenburg syndrome, type 2A. Tietz albinism-deafness syndrome. Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD). Melanoma, cutaneous malignant, susceptibility to, 8. Renal cell carcinoma with or without malignant melanoma;CGD_INHERITANCE=AD;Strand=MITF:NM_198159.2:+,MITF:NM_001184967.1:+,MITF:NM_006722.2:+,MITF:NM_198177.2:+,MITF:NM_000248.3:+,MITF:NM_198158.2:+,MITF:NM_198178.2:+;NP=MITF:NM_198159.2:NP_937802.1,MITF:NM_001184967.1:NP_001171896.1,MITF:NM_006722.2:NP_006713.1,MITF:NM_198177.2:NP_937820.1,MITF:NM_000248.3:NP_000239.1,MITF:NM_198158.2:NP_937801.1,MITF:NM_198178.2:NP_937821.2;ENSP=MITF:NM_198159.2:ENST00000352241.8,MITF:NM_001184967.1:.,MITF:NM_006722.2:.,MITF:NM_198177.2:.,MITF:NM_000248.3:.,MITF:NM_198158.2:.,MITF:NM_198178.2:.;Gene_MIM_id=156845;Phenotypes=COMMAD syndrome, 617306 (3), Autosomal recessive. {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3). Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant. Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant. Waardenburg syndrome/ocular albinism, digenic, 103470 (3), Autosomal dominant. 103470(MK),103500(MK),193510(MK),614456(SK);Possible_Inheritance=AD,AR,XL;EntrezGeneID=4286;EnsemblGeneID=ENSG00000187098;Alias=MITF, WS2A, CMM8, COMMAD;FLKSEQ=TTCTGTAAAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:18,118:253:99:6009,2467,2658
chr3	70016467	.	C	T	10691.8	PASS	AC=2;AF=1;AN=2;DP=290;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.36;SOR=1.017;HGVSnom=NM_001354604.2:c.*2068C>T;Gene=MITF;Transcript=NM_001354604.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=526;RS=rs576;CLNGENE=MITF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.341054;G1000_EAS_AF=0.2937;G1000_EUR_AF=0.2575;G1000_AFR_AF=0.4546;G1000_SAS_AF=0.3354;G1000_AMR_AF=0.3228;NativeFreq_Het=0.4821;NativeFreq_Hom=0.0928;normalHetFrequency=0.4612;normalHetNum=220;normalHomFrequency=0.109;normalHomNum=52;patientHetFrequency=0.1943;patientHetNum=1014;patientHomFrequency=0.1078;patientHomNum=264;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7972;GREP_score=3.29;CytoBand=p13;CGD_CONDITION=Waardenburg syndrome, type 2A. Tietz albinism-deafness syndrome. Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD). Melanoma, cutaneous malignant, susceptibility to, 8. Renal cell carcinoma with or without malignant melanoma;CGD_INHERITANCE=AD;Strand=MITF:NM_198159.2:+,MITF:NM_001184967.1:+,MITF:NM_006722.2:+,MITF:NM_198177.2:+,MITF:NM_000248.3:+,MITF:NM_198158.2:+,MITF:NM_198178.2:+;NP=MITF:NM_198159.2:NP_937802.1,MITF:NM_001184967.1:NP_001171896.1,MITF:NM_006722.2:NP_006713.1,MITF:NM_198177.2:NP_937820.1,MITF:NM_000248.3:NP_000239.1,MITF:NM_198158.2:NP_937801.1,MITF:NM_198178.2:NP_937821.2;ENSP=MITF:NM_198159.2:ENST00000352241.8,MITF:NM_001184967.1:.,MITF:NM_006722.2:.,MITF:NM_198177.2:.,MITF:NM_000248.3:.,MITF:NM_198158.2:.,MITF:NM_198178.2:.;Gene_MIM_id=156845;Phenotypes=COMMAD syndrome, 617306 (3), Autosomal recessive. {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3). Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant. Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant. Waardenburg syndrome/ocular albinism, digenic, 103470 (3), Autosomal dominant. 103470(MK),103500(MK),193510(MK),614456(SK);Possible_Inheritance=AD,AR,XL;EntrezGeneID=4286;EnsemblGeneID=ENSG00000187098;Alias=MITF, WS2A, CMM8, COMMAD;FLKSEQ=AGAATAGTGA.GCAAATCTGC	GT:AD:DP:GQ:PL	1/1:0,289:289:99:10720,869,0
chr3	70016904	.	C	T	16095.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.75;DP=438;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.34;ReadPosRankSum=-1.013;SOR=0.3;HGVSnom=NM_001354604.2:c.*2505C>T;Gene=MITF;Transcript=NM_001354604.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=526;RS=rs704246;CLNGENE=MITF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.295327;G1000_EAS_AF=0.2679;G1000_EUR_AF=0.2445;G1000_AFR_AF=0.348;G1000_SAS_AF=0.2996;G1000_AMR_AF=0.3026;NativeFreq_Het=0.4667;NativeFreq_Hom=0.0711;normalHetFrequency=0.4528;normalHetNum=216;normalHomFrequency=0.0629;normalHomNum=30;patientHetFrequency=0.3848;patientHetNum=942;patientHomFrequency=0.0805;patientHomNum=197;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7078;GREP_score=2.35;CytoBand=p13;CGD_CONDITION=Waardenburg syndrome, type 2A. Tietz albinism-deafness syndrome. Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness (COMMAD). Melanoma, cutaneous malignant, susceptibility to, 8. Renal cell carcinoma with or without malignant melanoma;CGD_INHERITANCE=AD;Strand=MITF:NM_198159.2:+,MITF:NM_001184967.1:+,MITF:NM_006722.2:+,MITF:NM_198177.2:+,MITF:NM_000248.3:+,MITF:NM_198158.2:+,MITF:NM_198178.2:+;NP=MITF:NM_198159.2:NP_937802.1,MITF:NM_001184967.1:NP_001171896.1,MITF:NM_006722.2:NP_006713.1,MITF:NM_198177.2:NP_937820.1,MITF:NM_000248.3:NP_000239.1,MITF:NM_198158.2:NP_937801.1,MITF:NM_198178.2:NP_937821.2;ENSP=MITF:NM_198159.2:ENST00000352241.8,MITF:NM_001184967.1:.,MITF:NM_006722.2:.,MITF:NM_198177.2:.,MITF:NM_000248.3:.,MITF:NM_198158.2:.,MITF:NM_198178.2:.;Gene_MIM_id=156845;Phenotypes=COMMAD syndrome, 617306 (3), Autosomal recessive. {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3). Tietz albinism-deafness syndrome, 103500 (3), Autosomal dominant. Waardenburg syndrome, type 2A, 193510 (3), Autosomal dominant. Waardenburg syndrome/ocular albinism, digenic, 103470 (3), Autosomal dominant. 103470(MK),103500(MK),193510(MK),614456(SK);Possible_Inheritance=AD,AR,XL;EntrezGeneID=4286;EnsemblGeneID=ENSG00000187098;Alias=MITF, WS2A, CMM8, COMMAD;FLKSEQ=GGATTCATTT.AGGGGCTAGC	GT:AD:DP:GQ:PL	1/1:1,437:438:99:16124,1274,0
chr3	121154974	.	T	C	15189.8	PASS	AC=2;AF=1;AN=2;DP=426;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=38.16;SOR=0.898;HGVSnom=NM_199420.4:c.7538A>G(p.Gln2513Arg/p.Q2513R);Gene=POLQ;Transcript=NM_199420.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E28;IVSnom=.;AAlength=2590;EXAC_AF=0.72173655;EXAC_Hom_EAS=3491;EXAC_AC_EAS=7764;EXAC_AN_EAS=8650;EXAC_AC_Adj=87512;EXAC_AN_Adj=121252;ESP6500_MAF=0.66961402;RS=rs1381057;Ensembl_transcriptid=ENST00000621776|ENST00000264233;SIFT_pred=.|T;SIFT_score=.|1.0;Polyphen2_HVAR_pred=.|B;Polyphen2_HVAR_score=.|0.0;MutationTaster_pred=P;MutationTaster_score=1;G1000_AF=0.745208;G1000_EAS_AF=0.877;G1000_EUR_AF=0.668;G1000_AFR_AF=0.6309;G1000_SAS_AF=0.8793;G1000_AMR_AF=0.6945;gnomad_exomes_AF=0.72434241;gnomad_exomes_AF_EAS=0.89911899;gnomad_exomes_AC=181639;gnomad_exomes_Hom=66686;gnomad_exomes_Het=48267;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64582051;gnomad_exomes_AF_NFE=0.68264002;gnomad_exomes_AF_AMR=0.71400429;gnomad_exomes_AF_SAS=0.87052900;NativeFreq_Het=0.3274;NativeFreq_Hom=0.6192;DANN_score=0.1494;GREP_score=-0.307;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=CAAACCTGTT.GGTCACTTTG	GT:AD:DP:GQ:PL	1/1:0,426:426:99:15218,1281,0
chr3	121202433	.	TA	T	864.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.721;DP=374;ExcessHet=3.0103;FS=0.597;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.61;ReadPosRankSum=-1.309;SOR=0.601;HGVSnom=NM_199420.4:c.5774-5delT;Gene=POLQ;Transcript=NM_199420.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_199420.4:IVS17-5delT;AAlength=2590;EXAC_AF=0.43221969;EXAC_Hom_EAS=1;EXAC_AC_EAS=2226;EXAC_AN_EAS=5236;EXAC_AC_Adj=33714;EXAC_AN_Adj=78002;RS=rs78578025;gnomad_exomes_AF=0.41120227;gnomad_exomes_AF_EAS=0.39798489;gnomad_exomes_AC=42404;gnomad_exomes_Hom=12;gnomad_exomes_Het=42380;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.38789843;gnomad_exomes_AF_NFE=0.41487040;gnomad_exomes_AF_AMR=0.41503715;gnomad_exomes_AF_SAS=0.38868236;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=CTAATTTCTT.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:235,96:331:99:902,0,3811
chr3	121208176	.	T	C	5224.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.431;DP=383;ExcessHet=3.0103;FS=3.857;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.64;ReadPosRankSum=0.319;SOR=0.529;HGVSnom=NM_199420.4:c.3602A>G(p.His1201Arg/p.H1201R);Gene=POLQ;Transcript=NM_199420.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E16;IVSnom=.;AAlength=2590;EXAC_AF=0.23250829;EXAC_Hom_EAS=1405;EXAC_AC_EAS=4906;EXAC_AN_EAS=8646;EXAC_AC_Adj=28200;EXAC_AN_Adj=121286;ESP6500_MAF=0.13247732;RS=rs3218651;Ensembl_transcriptid=ENST00000621776|ENST00000264233;SIFT_pred=.|T;SIFT_score=.|0.275;Polyphen2_HVAR_pred=.|B;Polyphen2_HVAR_score=.|0.014;MutationTaster_pred=P;MutationTaster_score=1;G1000_AF=0.289736;G1000_EAS_AF=0.5496;G1000_EUR_AF=0.1511;G1000_AFR_AF=0.1203;G1000_SAS_AF=0.3896;G1000_AMR_AF=0.2954;gnomad_exomes_AF=0.24056852;gnomad_exomes_AF_EAS=0.57062792;gnomad_exomes_AC=60273;gnomad_exomes_Hom=9744;gnomad_exomes_Het=40785;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11413445;gnomad_exomes_AF_NFE=0.15294408;gnomad_exomes_AF_AMR=0.37318377;gnomad_exomes_AF_SAS=0.34885788;NativeFreq_Het=0.4342;NativeFreq_Hom=0.1708;DANN_score=0.7932;GREP_score=4.24;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=TGTCTGTTCA.GAGATTGCTT	GT:AD:DP:GQ:PL	0/1:201,182:383:99:5253,0,6294
chr3	121208833	.	G	C	11682.8	PASS	AC=2;AF=1;AN=2;DP=300;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.75;SOR=1.082;HGVSnom=NM_199420.4:c.2945C>G(p.Thr982Arg/p.T982R);Gene=POLQ;Transcript=NM_199420.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E16;IVSnom=.;AAlength=2590;EXAC_AF=0.67412677;EXAC_Hom_EAS=3470;EXAC_AC_EAS=7727;EXAC_AN_EAS=8620;EXAC_AC_Adj=80364;EXAC_AN_Adj=119212;ESP6500_MAF=0.60276923;RS=rs3218649;Ensembl_transcriptid=ENST00000621776|ENST00000264233;SIFT_pred=.|T;SIFT_score=.|0.567;Polyphen2_HVAR_pred=.|B;Polyphen2_HVAR_score=.|0.0;MutationTaster_pred=P;MutationTaster_score=1;G1000_AF=0.696486;G1000_EAS_AF=0.876;G1000_EUR_AF=0.6143;G1000_AFR_AF=0.5424;G1000_SAS_AF=0.8487;G1000_AMR_AF=0.634;gnomad_exomes_AF=0.66881199;gnomad_exomes_AF_EAS=0.89615198;gnomad_exomes_AC=148083;gnomad_exomes_Hom=50619;gnomad_exomes_Het=46845;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55654145;gnomad_exomes_AF_NFE=0.62730196;gnomad_exomes_AF_AMR=0.66622084;gnomad_exomes_AF_SAS=0.81809452;NativeFreq_Het=0.3310;NativeFreq_Hom=0.5943;DANN_score=0.4964;GREP_score=-3.86;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=AATGGAACAT.TCTGATGTTC	GT:AD:DP:GQ:PL	1/1:0,300:300:99:11711,902,0
chr3	121212277	.	AT	A	5380.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.349;DP=205;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.9;ReadPosRankSum=-1.058;SOR=1.341;HGVSnom=NM_199420.4:c.2522+47delA;Gene=POLQ;Transcript=NM_199420.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_199420.4:IVS15+47delA;AAlength=2590;EXAC_AF=0.70665321;EXAC_Hom_EAS=3183;EXAC_AC_EAS=7099;EXAC_AN_EAS=7878;EXAC_AC_Adj=74901;EXAC_AN_Adj=105994;ESP6500_MAF=0.61326282;RS=rs11351457;G1000_AF=0.696486;G1000_EAS_AF=0.875;G1000_EUR_AF=0.6143;G1000_AFR_AF=0.5439;G1000_SAS_AF=0.8476;G1000_AMR_AF=0.634;gnomad_exomes_AF=0.70465284;gnomad_exomes_AF_EAS=0.89818974;gnomad_exomes_AC=130940;gnomad_exomes_Hom=44232;gnomad_exomes_Het=42476;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.60887356;gnomad_exomes_AF_NFE=0.66623875;gnomad_exomes_AF_AMR=0.70196443;gnomad_exomes_AF_SAS=0.83184395;CytoBand=q13.33;repName=AT_rich;repClass=Low_complexity;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=taaaattgac.ttttttttta	GT:AD:DP:GQ:PL	1/1:3,197:200:99:5418,513,0
chr3	121238749	.	G	A	12823.8	PASS	AC=2;AF=1;AN=2;DP=378;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.11;SOR=0.981;HGVSnom=NM_199420.4:c.1437C>T(p.Gly479Gly/p.G479G);Gene=POLQ;Transcript=NM_199420.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E9;IVSnom=.;AAlength=2590;EXAC_AF=0.99948099;EXAC_Hom_EAS=4326;EXAC_AC_EAS=8652;EXAC_AN_EAS=8652;EXAC_AC_Adj=121321;EXAC_AN_Adj=121384;ESP6500_MAF=0.99846225;RS=rs702018;CLNGENE=POLQ;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.997404;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9909;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9986;gnomad_exomes_AF=0.99958638;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=251332;gnomad_exomes_Hom=125614;gnomad_exomes_Het=104;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99507632;gnomad_exomes_AF_NFE=0.99999121;gnomad_exomes_AF_AMR=0.99973975;gnomad_exomes_AF_SAS=0.99996734;NativeFreq_Het=0;NativeFreq_Hom=0.9680;DANN_score=0.6365;GREP_score=1.62;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=TGCCAGCACG.CCAACCATCT	GT:AD:DP:GQ:PL	1/1:0,376:376:99:12852,1127,0
chr3	121263720	.	C	A	15415.8	PASS	AC=2;AF=1;AN=2;DP=451;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.33;SOR=0.771;HGVSnom=NM_199420.4:c.197G>T(p.Arg66Ile/p.R66I);Gene=POLQ;Transcript=NM_199420.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=2590;EXAC_AF=0.99642504;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=120966;EXAC_AN_Adj=121400;ESP6500_MAF=0.98862064;RS=rs702017;Ensembl_transcriptid=ENST00000621776|ENST00000264233;SIFT_pred=.|T;SIFT_score=.|0.525;Polyphen2_HVAR_pred=.|B;Polyphen2_HVAR_score=.|0.0;MutationTaster_pred=P;MutationTaster_score=1;G1000_AF=0.988618;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9576;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9986;gnomad_exomes_AF=0.99725781;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=250206;gnomad_exomes_Hom=124770;gnomad_exomes_Het=666;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96189362;gnomad_exomes_AF_NFE=0.99994717;gnomad_exomes_AF_AMR=0.99872078;gnomad_exomes_AF_SAS=0.99996719;NativeFreq_Het=0.0107;NativeFreq_Hom=0.9858;DANN_score=0.7448;GREP_score=-2.11;CytoBand=q13.33;Strand=POLQ:NM_199420.3:-,POLQ:NM_199420.4:-;NP=POLQ:NM_199420.3:NP_955452.3,POLQ:NM_199420.4:NP_955452.3;ENSP=POLQ:NM_199420.3:.,POLQ:NM_199420.4:ENST00000264233.6;Gene_MIM_id=604419;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10721;EnsemblGeneID=ENSG00000051341;Alias=POLQ;FLKSEQ=TAGCTTGTCT.TTTCGTAGTC	GT:AD:DP:GQ:PL	1/1:0,449:449:99:15444,1348,0
chr3	122513964	.	A	C	1276.77	PASS	AC=2;AF=1;AN=2;DP=35;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.44;SOR=2.649;HGVSnom=NM_032839.3:c.-76A>C;Gene=SLC49A4;Transcript=NM_032839.3;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=478;RS=rs891406;G1000_AF=0.917532;G1000_EAS_AF=0.9802;G1000_EUR_AF=0.8787;G1000_AFR_AF=0.8631;G1000_SAS_AF=0.9499;G1000_AMR_AF=0.9409;NativeFreq_Het=0.0792;NativeFreq_Hom=0.9207;DANN_score=0.3442;GREP_score=1.94;CytoBand=q21.1;Strand=DIRC2:NM_032839.2:+,SLC49A4:NM_032839.3:+;NP=DIRC2:NM_032839.2:NP_116228.1,SLC49A4:NM_032839.3:NP_116228.1;ENSP=DIRC2:NM_032839.2:.,SLC49A4:NM_032839.3:ENST00000261038.6;Gene_MIM_id=602773;Phenotypes=Renal cell carcinoma, 144700 (1). 144700(ML);Possible_Inheritance=NA;EntrezGeneID=84925;EnsemblGeneID=ENSG00000138463;Alias=DIRC2, RCC4;FLKSEQ=CCTGCTGCTC.GGACTATTCT	GT:AD:DP:GQ:PL	1/1:0,35:35:99:1305,105,0
chr3	122599998	.	C	CT	342.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.887;DP=161;ExcessHet=3.0103;FS=1.377;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.25;ReadPosRankSum=0.378;SOR=0.943;HGVSnom=.;Gene=LINC02035;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs201580091;CytoBand=q21.1;repName=AluSz;repClass=SINE;Gene_MIM_id=602773;Phenotypes=Renal cell carcinoma, 144700 (1). 144700(ML);Possible_Inheritance=NA;EntrezGeneID=84925;EnsemblGeneID=ENSG00000138463;Alias=DIRC2, RCC4;FLKSEQ=GCAGAAttct.tttttttttt	GT:AD:DP:GQ:PL	0/1:112,40:152:99:380,0,1999
chr3	142168331	.	C	T	17273.8	PASS	AC=2;AF=1;AN=2;DP=468;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.71;SOR=0.801;HGVSnom=NM_001184.4:c.7875G>A(p.Gln2625Gln/p.Q2625Q);Gene=ATR;Transcript=NM_001184.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E47;IVSnom=.;AAlength=2644;EXAC_AF=0.86460547;EXAC_Hom_EAS=3749;EXAC_AC_EAS=8050;EXAC_AN_EAS=8654;EXAC_AC_Adj=104951;EXAC_AN_Adj=121386;ESP6500_MAF=0.89781639;RS=rs1802904;CLNGENE=ATR;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.916334;G1000_EAS_AF=0.9266;G1000_EUR_AF=0.8658;G1000_AFR_AF=0.9856;G1000_SAS_AF=0.9407;G1000_AMR_AF=0.8084;gnomad_exomes_AF=0.85813670;gnomad_exomes_AF_EAS=0.93329347;gnomad_exomes_AC=215739;gnomad_exomes_Hom=93115;gnomad_exomes_Het=29509;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.97329231;gnomad_exomes_AF_NFE=0.85613788;gnomad_exomes_AF_AMR=0.75649257;gnomad_exomes_AF_SAS=0.93727540;NativeFreq_Het=0.1673;NativeFreq_Hom=0.8149;normalHetFrequency=0.1418;normalHetNum=55;normalHomFrequency=0.8196;normalHomNum=318;patientHetFrequency=0.123;patientHetNum=341;patientHomFrequency=0.8405;patientHomNum=2330;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7858;GREP_score=0.456;CytoBand=q23;CGD_CONDITION=Cutaneous telangiectasia and cancer syndrome, familial. Seckel syndrome 1;CGD_INHERITANCE=AD/AR;Strand=ATR:NM_001184.4:-,ATR:NM_001184.3:-;NP=ATR:NM_001184.4:NP_001175.2,ATR:NM_001184.3:NP_001175.2;ENSP=ATR:NM_001184.4:ENST00000350721.9,ATR:NM_001184.3:ENST00000350721.8;Gene_MIM_id=601215;Phenotypes=?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant. Seckel syndrome 1, 210600 (3), Autosomal recessive. 210600(MK),614564(UK);Possible_Inheritance=AD,AR;EntrezGeneID=545;EnsemblGeneID=ENSG00000175054;Alias=ATR, FRP1, SCKL1, FCTCS;FLKSEQ=CAGTAGCTTC.TGTATAAGGT	GT:AD:DP:GQ:PL	1/1:0,466:466:99:17302,1400,0
chr3	142231062	.	TA	T	565.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.268;DP=163;ExcessHet=3.0103;FS=10.026;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.35;ReadPosRankSum=-0.477;SOR=0.072;HGVSnom=NM_001184.4:c.4852+39delT;Gene=ATR;Transcript=NM_001184.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I27;IVSnom=NM_001184.4:IVS27+39delT;AAlength=2644;EXAC_AF=0.13429489;EXAC_Hom_EAS=0;EXAC_AC_EAS=423;EXAC_AN_EAS=2760;EXAC_AC_Adj=5270;EXAC_AN_Adj=39242;RS=rs74269486;CLNGENE=ATR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.18291434;gnomad_exomes_AF_EAS=0.22243780;gnomad_exomes_AC=18568;gnomad_exomes_Hom=1;gnomad_exomes_Het=18566;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14069997;gnomad_exomes_AF_NFE=0.17407884;gnomad_exomes_AF_AMR=0.22603152;gnomad_exomes_AF_SAS=0.18134462;normalHetFrequency=0.1985;normalHetNum=77;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1753;patientHetNum=486;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0200312][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0001880-1|16B0004931][_];CytoBand=q23;CGD_CONDITION=Cutaneous telangiectasia and cancer syndrome, familial. Seckel syndrome 1;CGD_INHERITANCE=AD/AR;Strand=ATR:NM_001184.4:-,ATR:NM_001184.3:-;NP=ATR:NM_001184.4:NP_001175.2,ATR:NM_001184.3:NP_001175.2;ENSP=ATR:NM_001184.4:ENST00000350721.9,ATR:NM_001184.3:ENST00000350721.8;Gene_MIM_id=601215;Phenotypes=?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant. Seckel syndrome 1, 210600 (3), Autosomal recessive. 210600(MK),614564(UK);Possible_Inheritance=AD,AR;EntrezGeneID=545;EnsemblGeneID=ENSG00000175054;Alias=ATR, FRP1, SCKL1, FCTCS;FLKSEQ=GGTGAATAGC.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:74,56:130:99:603,0,1041
chr3	142241692	.	G	GA	475.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.49;DP=270;ExcessHet=3.0103;FS=1.85;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.95;ReadPosRankSum=-0.159;SOR=0.877;HGVSnom=NM_001184.4:c.4153-10dupT;Gene=ATR;Transcript=NM_001184.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_001184.4:IVS22-10_-9insT;AAlength=2644;EXAC_AF=0.24601116;EXAC_Hom_EAS=0;EXAC_AC_EAS=1533;EXAC_AN_EAS=5816;EXAC_AC_Adj=20106;EXAC_AN_Adj=81728;ESP6500_MAF=0.11527401;RS=rs112116713;CLNGENE=ATR;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.19267210;gnomad_exomes_AF_EAS=0.22883502;gnomad_exomes_AC=14845;gnomad_exomes_Hom=1;gnomad_exomes_Het=14843;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23462453;gnomad_exomes_AF_NFE=0.16905143;gnomad_exomes_AF_AMR=0.23504106;gnomad_exomes_AF_SAS=0.23639896;normalHetFrequency=0.0567;normalHetNum=22;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0642;patientHetNum=178;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q23;CGD_CONDITION=Cutaneous telangiectasia and cancer syndrome, familial. Seckel syndrome 1;CGD_INHERITANCE=AD/AR;Strand=ATR:NM_001184.4:-,ATR:NM_001184.3:-;NP=ATR:NM_001184.4:NP_001175.2,ATR:NM_001184.3:NP_001175.2;ENSP=ATR:NM_001184.4:ENST00000350721.9,ATR:NM_001184.3:ENST00000350721.8;Gene_MIM_id=601215;Phenotypes=?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant. Seckel syndrome 1, 210600 (3), Autosomal recessive. 210600(MK),614564(UK);Possible_Inheritance=AD,AR;EntrezGeneID=545;EnsemblGeneID=ENSG00000175054;Alias=ATR, FRP1, SCKL1, FCTCS;FLKSEQ=GTCTCAATCA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:195,49:244:99:513,0,3886
chr3	142259706	.	CA	C	729.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.237;DP=279;ExcessHet=3.0103;FS=1.774;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.92;ReadPosRankSum=0.381;SOR=0.923;HGVSnom=NM_001184.4:c.3581+39delT;Gene=ATR;Transcript=NM_001184.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_001184.4:IVS18+39delT;AAlength=2644;EXAC_AF=0.45740365;EXAC_Hom_EAS=2;EXAC_AC_EAS=329;EXAC_AN_EAS=730;EXAC_AC_Adj=10373;EXAC_AN_Adj=22678;RS=rs201551475;CLNGENE=ATR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.45869607;gnomad_exomes_AF_EAS=0.46250692;gnomad_exomes_AC=48264;gnomad_exomes_Hom=129;gnomad_exomes_Het=48006;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44790964;gnomad_exomes_AF_NFE=0.46234359;gnomad_exomes_AF_AMR=0.45989206;gnomad_exomes_AF_SAS=0.45579594;normalHetFrequency=0.1778;normalHetNum=69;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.2009;patientHetNum=557;patientHomFrequency=0.0076;patientHomNum=21;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0001838-1][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0172142|16B0200523|16D0166607|16B0005730|16B0033775|15D6532890|16B0005455|15B0060314|16B0001813-1|16B0017454|16B1276306|16B0033014|16D1546129|16D0002641|15B0051535|16D1536895-1|15B0058214|16D0168604|15D6532893|15D6722232|15B6325513-1][_];CytoBand=q23;CGD_CONDITION=Cutaneous telangiectasia and cancer syndrome, familial. Seckel syndrome 1;CGD_INHERITANCE=AD/AR;Strand=ATR:NM_001184.4:-,ATR:NM_001184.3:-;NP=ATR:NM_001184.4:NP_001175.2,ATR:NM_001184.3:NP_001175.2;ENSP=ATR:NM_001184.4:ENST00000350721.9,ATR:NM_001184.3:ENST00000350721.8;Gene_MIM_id=601215;Phenotypes=?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant. Seckel syndrome 1, 210600 (3), Autosomal recessive. 210600(MK),614564(UK);Possible_Inheritance=AD,AR;EntrezGeneID=545;EnsemblGeneID=ENSG00000175054;Alias=ATR, FRP1, SCKL1, FCTCS;FLKSEQ=CTGGAAAATG.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:181,69:250:99:767,0,3579
chr3	142272275	.	AAC	A	304.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.135;DP=120;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.46;ReadPosRankSum=-0.452;SOR=0.701;HGVSnom=NM_001184.4:c.2634-37_2634-36delGT;Gene=ATR;Transcript=NM_001184.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_001184.4:IVS12-37_-36delGT;AAlength=2644;EXAC_AF=0.10944887;EXAC_Hom_EAS=0;EXAC_AC_EAS=684;EXAC_AN_EAS=5332;EXAC_AC_Adj=9306;EXAC_AN_Adj=85026;RS=rs56873611;normalHetFrequency=0.0232;normalHetNum=9;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0299;patientHetNum=83;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1532940-1][_];CytoBand=q23;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20.5;CGD_CONDITION=Cutaneous telangiectasia and cancer syndrome, familial. Seckel syndrome 1;CGD_INHERITANCE=AD/AR;Strand=ATR:NM_001184.4:-,ATR:NM_001184.3:-;NP=ATR:NM_001184.4:NP_001175.2,ATR:NM_001184.3:NP_001175.2;ENSP=ATR:NM_001184.4:ENST00000350721.9,ATR:NM_001184.3:ENST00000350721.8;Gene_MIM_id=601215;Phenotypes=?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant. Seckel syndrome 1, 210600 (3), Autosomal recessive. 210600(MK),614564(UK);Possible_Inheritance=AD,AR;EntrezGeneID=545;EnsemblGeneID=ENSG00000175054;Alias=ATR, FRP1, SCKL1, FCTCS;FLKSEQ=TGAATacaca.acacacacac	GT:AD:DP:GQ:PL	0/1:69,19:88:99:342,0,2001
chr3	186443018	.	T	C	8371.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.096;DP=496;ExcessHet=3.0103;FS=0.528;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.02;ReadPosRankSum=-0.323;SOR=0.628;HGVSnom=NM_001102416.3:c.533T>C(p.Met178Thr/p.M178T);Gene=KNG1;Transcript=NM_001102416.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=644;EXAC_AF=0.53725674;EXAC_Hom_EAS=636;EXAC_AC_EAS=3327;EXAC_AN_EAS=8648;EXAC_AC_Adj=65209;EXAC_AN_Adj=121374;ESP6500_MAF=0.54574812;RS=rs1656922;Ensembl_transcriptid=ENST00000645909|ENST00000265023|ENST00000447445|ENST00000287611|ENST00000644859;SIFT_pred=.|T|T|T|.;SIFT_score=.|0.752|0.96|0.71|.;Polyphen2_HVAR_pred=B|B|.|B|B;Polyphen2_HVAR_score=0.0|0.0|.|0.0|0.0;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;G1000_AF=0.524161;G1000_EAS_AF=0.3562;G1000_EUR_AF=0.5368;G1000_AFR_AF=0.615;G1000_SAS_AF=0.5;G1000_AMR_AF=0.611;gnomad_exomes_AF=0.53695057;gnomad_exomes_AF_EAS=0.37653583;gnomad_exomes_AC=135013;gnomad_exomes_Hom=36947;gnomad_exomes_Het=61119;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59296173;gnomad_exomes_AF_NFE=0.52775970;gnomad_exomes_AF_AMR=0.65431314;gnomad_exomes_AF_SAS=0.51744186;HGMD_gene=KNG1;HGMD_disease=Nephropathy_reduced_risk_association_with;HGMD_tag=DP;HGMD_pmid=17065357;NativeFreq_Het=0.4982;NativeFreq_Hom=0.2064;DANN_score=0.4657;GREP_score=-0.388;CytoBand=q27.3;CGD_CONDITION=High molecular weight kininogen deficiency;CGD_INHERITANCE=AR;Strand=KNG1:NM_001102416.2:+,KNG1:NM_000893.3:+,KNG1:NM_001166451.1:+;NP=KNG1:NM_001102416.2:NP_001095886.1,KNG1:NM_000893.3:NP_000884.1,KNG1:NM_001166451.1:NP_001159923.1;ENSP=KNG1:NM_001102416.2:.,KNG1:NM_000893.3:.,KNG1:NM_001166451.1:.;Gene_MIM_id=612358;Phenotypes=[High molecular weight kininogen deficiency], 228960 (3), Autosomal recessive. [Kininogen deficiency], 228960 (3), Autosomal recessive. 228960(NK);Possible_Inheritance=AR;EntrezGeneID=3827;EnsemblGeneID=ENSG00000113889;Alias=KNG1, KNG;FLKSEQ=TCCCTCTTCA.GCTTAATGAA	GT:AD:DP:GQ:PL	0/1:203,289:492:99:8400,0,5996
chr4	41746049	.	CAA	C	283.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.501;DP=48;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.35;ReadPosRankSum=0;SOR=1.179;HGVSnom=.;Gene=PHOX2B;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;CytoBand=p13;repName=A-rich;repClass=Low_complexity;Gene_MIM_id=151450,187320;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896;EnsemblGeneID=.;Alias=LAG5,TS13;FLKSEQ=aatgaccaac.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:18,16:34:99:321,0,357
chr4	55141055	.	A	G	15790.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.679;DP=456;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.78;ReadPosRankSum=0.645;SOR=0.39;HGVSnom=NM_006206.6:c.1701A>G(p.Pro567Pro/p.P567P);Gene=PDGFRA;Transcript=NM_006206.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=1089;EXAC_AF=0.98803993;EXAC_Hom_EAS=4325;EXAC_AC_EAS=8650;EXAC_AN_EAS=8650;EXAC_AC_Adj=119952;EXAC_AN_Adj=121404;ESP6500_MAF=0.95886514;RS=rs1873778;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.957668;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.8442;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.99004698;gnomad_exomes_AF_EAS=0.99994562;gnomad_exomes_AC=248680;gnomad_exomes_Hom=123190;gnomad_exomes_Het=2300;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.88508858;gnomad_exomes_AF_NFE=0.99809685;gnomad_exomes_AF_AMR=0.99135588;gnomad_exomes_AF_SAS=0.99967335;NativeFreq_Het=0.0249;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9639;normalHomNum=374;patientHetFrequency=0.0025;patientHetNum=7;patientHomFrequency=0.9697;patientHomNum=2688;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6482464|16D1533003-1|16D1536880-1|15D6722279|16D1545976|16D1532934-1|15D6722300-1][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.3955;GREP_score=-11.6;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347827.1:+,PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347827.1:NP_001334756.1,PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347827.1:.,PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=CAATCAGCCC.GATGGACATG	GT:AD:DP:GQ:PL	1/1:1,453:454:99:15819,1326,0
chr4	55143577	.	G	A	6847.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.47;DP=480;ExcessHet=3.0103;FS=4.067;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.3;ReadPosRankSum=0.118;SOR=0.474;HGVSnom=NM_006206.6:c.1809G>A(p.Ala603Ala/p.A603A);Gene=PDGFRA;Transcript=NM_006206.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=1089;EXAC_AF=0.15829667;EXAC_Hom_EAS=109;EXAC_AC_EAS=1284;EXAC_AN_EAS=8644;EXAC_AC_Adj=19215;EXAC_AN_Adj=121386;ESP6500_MAF=0.16615408;RS=rs10028020;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.228035;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.1064;G1000_AFR_AF=0.3366;G1000_SAS_AF=0.2362;G1000_AMR_AF=0.2666;gnomad_exomes_AF=0.15946346;gnomad_exomes_AF_EAS=0.14538930;gnomad_exomes_AC=40099;gnomad_exomes_Hom=4172;gnomad_exomes_Het=31755;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31243848;gnomad_exomes_AF_NFE=0.10236664;gnomad_exomes_AF_AMR=0.30160749;gnomad_exomes_AF_SAS=0.21152339;NativeFreq_Het=0.2811;NativeFreq_Hom=0.0534;normalHetFrequency=0.2216;normalHetNum=86;normalHomFrequency=0.0206;normalHomNum=8;patientHetFrequency=0.2251;patientHetNum=624;patientHomFrequency=0.018;patientHomNum=50;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2448;AF_2700_Hom=0.0215;AF_50_Het=0.2615;AF_50_Hom=0.0269;DANN_score=0.763;GREP_score=-11.3;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347827.1:+,PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347827.1:NP_001334756.1,PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347827.1:.,PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=GGTCTGGAGC.TTTGGGAAGG	GT:AD:DP:GQ:PL	0/1:254,225:479:99:6876,0,7332
chr4	55151958	.	T	TA	3858.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.73;DP=215;ExcessHet=3.0103;FS=2.453;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.95;ReadPosRankSum=-1.292;SOR=0.958;HGVSnom=NM_006206.6:c.2440-50_2440-49insA;Gene=PDGFRA;Transcript=NM_006206.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_006206.6:IVS17-50_-49insA;AAlength=1089;EXAC_AF=0.80386654;EXAC_Hom_EAS=3107;EXAC_AC_EAS=7307;EXAC_AN_EAS=8626;EXAC_AC_Adj=97382;EXAC_AN_Adj=121142;ESP6500_MAF=0.74968051;RS=rs3830355;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.713858;G1000_EAS_AF=0.8224;G1000_EUR_AF=0.8549;G1000_AFR_AF=0.4902;G1000_SAS_AF=0.7587;G1000_AMR_AF=0.7147;gnomad_exomes_AF=0.80454185;gnomad_exomes_AF_EAS=0.84982582;gnomad_exomes_AC=201018;gnomad_exomes_Hom=82184;gnomad_exomes_Het=36650;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.52452853;gnomad_exomes_AF_NFE=0.85696118;gnomad_exomes_AF_AMR=0.67723460;gnomad_exomes_AF_SAS=0.78196668;NativeFreq_Het=0.4851;NativeFreq_Hom=.;normalHetFrequency=0.2345;normalHetNum=91;normalHomFrequency=0.7423;normalHomNum=288;patientHetFrequency=0.2428;patientHetNum=673;patientHomFrequency=0.7345;patientHomNum=2036;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=GGTGATGCTA.TCAGCTACAG	GT:AD:DP:GQ:PL	0/1:103,112:215:99:3896,0,3467
chr4	55152040	.	C	T	7206.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.463;DP=448;ExcessHet=3.0103;FS=9.471;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.16;ReadPosRankSum=-0.146;SOR=1.324;HGVSnom=NM_006206.6:c.2472C>T(p.Val824Val/p.V824V);Gene=PDGFRA;Transcript=NM_006206.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E18;IVSnom=.;AAlength=1089;EXAC_AF=0.18201440;EXAC_Hom_EAS=106;EXAC_AC_EAS=1236;EXAC_AN_EAS=8640;EXAC_AC_Adj=22094;EXAC_AN_Adj=121386;ESP6500_MAF=0.19829310;RS=rs2228230;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.240415;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.1451;G1000_AFR_AF=0.3449;G1000_SAS_AF=0.2413;G1000_AMR_AF=0.2767;gnomad_exomes_AF=0.18314516;gnomad_exomes_AF_EAS=0.14065898;gnomad_exomes_AC=46035;gnomad_exomes_Hom=5051;gnomad_exomes_Het=35933;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32935531;gnomad_exomes_AF_NFE=0.14193077;gnomad_exomes_AF_AMR=0.31419485;gnomad_exomes_AF_SAS=0.21740267;NativeFreq_Het=0.3025;NativeFreq_Hom=0.0534;normalHetFrequency=0.2113;normalHetNum=82;normalHomFrequency=0.018;normalHomNum=7;patientHetFrequency=0.2302;patientHetNum=638;patientHomFrequency=0.0188;patientHomNum=52;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2367;AF_2700_Hom=0.0238;AF_50_Het=0.2472;AF_50_Hom=0.0285;DANN_score=0.7581;GREP_score=2.42;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=CTCGCAACGT.CTCCTGGCAC	GT:AD:DP:GQ:PL	0/1:221,225:446:99:7235,0,6687
chr4	55161254	.	C	T	3554.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.265;DP=245;ExcessHet=3.0103;FS=4.478;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.57;ReadPosRankSum=0.345;SOR=1.036;HGVSnom=NM_006206.6:c.3123-38C>T;Gene=PDGFRA;Transcript=NM_006206.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_006206.6:IVS22-38C>T;AAlength=1089;EXAC_AF=0.80208608;EXAC_Hom_EAS=3179;EXAC_AC_EAS=7387;EXAC_AN_EAS=8624;EXAC_AC_Adj=97277;EXAC_AN_Adj=121280;ESP6500_MAF=0.73581424;RS=rs3733540;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.699081;G1000_EAS_AF=0.8274;G1000_EUR_AF=0.8539;G1000_AFR_AF=0.438;G1000_SAS_AF=0.7546;G1000_AMR_AF=0.7075;gnomad_exomes_AF=0.80353220;gnomad_exomes_AF_EAS=0.85851214;gnomad_exomes_AC=201190;gnomad_exomes_Hom=82432;gnomad_exomes_Het=36326;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.47704050;gnomad_exomes_AF_NFE=0.86126559;gnomad_exomes_AF_AMR=0.67347766;gnomad_exomes_AF_SAS=0.78237293;NativeFreq_Het=0.3132;NativeFreq_Hom=0.8019;normalHetFrequency=0.2191;normalHetNum=85;normalHomFrequency=0.7268;normalHomNum=282;patientHetFrequency=0.2327;patientHetNum=645;patientHomFrequency=0.7197;patientHomNum=1995;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4895;GREP_score=-6.74;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=TAGTTCTGTG.AGGAGTTGTA	GT:AD:DP:GQ:PL	0/1:121,123:244:99:3583,0,3993
chr4	55161391	.	T	C	14788.8	PASS	AC=2;AF=1;AN=2;DP=414;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.19;SOR=0.988;HGVSnom=NM_006206.6:c.3222T>C(p.Asp1074Asp/p.D1074D);Gene=PDGFRA;Transcript=NM_006206.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;EXAC_AF=0.99898690;EXAC_Hom_EAS=4325;EXAC_AC_EAS=8651;EXAC_AN_EAS=8652;EXAC_AC_Adj=121287;EXAC_AN_Adj=121410;ESP6500_MAF=0.99677072;RS=rs7685117;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.997204;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9894;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99923591;gnomad_exomes_AF_EAS=0.99989126;gnomad_exomes_AC=251088;gnomad_exomes_Hom=125449;gnomad_exomes_Het=190;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99015748;gnomad_exomes_AF_NFE=0.99994717;gnomad_exomes_AF_AMR=0.99973982;gnomad_exomes_AF_SAS=0.99951006;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9639;normalHomNum=374;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9722;patientHomNum=2695;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0004;AF_2700_Hom=0.9985;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5066;GREP_score=-3.5;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ACATGATGGA.GACATCGGCA	GT:AD:DP:GQ:PL	1/1:0,414:414:99:14817,1245,0
chr4	55161517	.	A	G	16452.8	PASS	AC=2;AF=1;AN=2;DP=470;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.06;SOR=0.814;HGVSnom=NM_006206.6:c.*78A>G;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs7680422;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.997005;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9887;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9639;normalHomNum=374;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9708;patientHomNum=2691;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9992;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5445;GREP_score=3.1;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ATTGCAATGC.GAGGTTGAGA	GT:AD:DP:GQ:PL	1/1:0,469:469:99:16481,1409,0
chr4	55161813	.	A	C	5771.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.475;DP=398;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.5;ReadPosRankSum=0.251;SOR=0.691;HGVSnom=NM_006206.6:c.*374A>C;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs3690;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.242812;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.1451;G1000_AFR_AF=0.3464;G1000_SAS_AF=0.2464;G1000_AMR_AF=0.2839;NativeFreq_Het=0.1683;NativeFreq_Hom=0.0297;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0036;patientHetNum=10;patientHomFrequency=0.0025;patientHomNum=7;normalHetSampleInfo=[16B0024689][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0067305|16B0202531|15D6722311|15D6524784|15D6722463-1|15D6722238-1|16B0000421|16B0000961|15B0066696-1|16B3097913-1][_];patientHomSampleInfo=[16B0005277|16D0172482|16D1546158|16D1878151|16D1545907|16B3108657|16B0047126][_];AF_2700_Het=0.2375;AF_2700_Hom=0.0231;AF_50_Het=0.2520;AF_50_Hom=0.0285;DANN_score=0.7258;GREP_score=2.12;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ACTCTAACCA.GGCTGTGTTT	GT:AD:DP:GQ:PL	0/1:198,200:398:99:5800,0,6246
chr4	55162534	.	GTTT	G	6675.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.163;DP=436;ExcessHet=3.0103;FS=4.617;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.42;ReadPosRankSum=0.068;SOR=0.533;OLD_VARIANT=chr4|55162534|GTTT|G,GTT|1;HGVSnom=NM_006206.6:c.*1109_*1111delTTT;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs34529347;CLNGENE=PDGFRA;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0347;NativeFreq_Hom=.;AF_2700_Het=0.1284;AF_2700_Hom=0.0065;AF_50_Het=0.1347;AF_50_Hom=0.0095;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ATTTGCAGAA.TTTTTTTTTT	GT:AD:DP:GQ:PL	1/0:73,145:327:99:6713,1243,4121
chr4	55162534	.	GT	G	6675.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.163;DP=436;ExcessHet=3.0103;FS=4.617;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.42;ReadPosRankSum=0.068;SOR=0.533;OLD_VARIANT=chr4|55162534|GTTT|G,GTT|2;HGVSnom=NM_006206.6:c.*1111delT;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs34529347;CLNGENE=PDGFRA;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0545;NativeFreq_Hom=.;AF_2700_Het=0.0869;AF_2700_Hom=0.0015;AF_50_Het=0.0935;AF_50_Hom=.;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ATTTGCAGAA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:73,109:327:99:6713,3261,3775
chr4	55162950	.	C	A	18337.8	PASS	AC=2;AF=1;AN=2;DP=503;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.34;SOR=0.742;HGVSnom=NM_006206.6:c.*1511C>A;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs1565664;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.997204;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9894;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0029;patientHomNum=8;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0028108|16B0005712][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536904-1|16B0019035-1|16D0172145|16B0202449|16B0028130|16D1878159|16B0028116|16B0012197][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9985;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.3758;GREP_score=2.26;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=ACAGGGTTGG.ATTCAACCAC	GT:AD:DP:GQ:PL	1/1:0,500:500:99:18366,1502,0
chr4	55163826	.	T	G	14476.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.454;DP=483;ExcessHet=3.0103;FS=1.915;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.67;ReadPosRankSum=-0.88;SOR=0.555;HGVSnom=NM_006206.6:c.*2387T>G;Gene=PDGFRA;Transcript=NM_006206.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1089;RS=rs10034498;CLNGENE=PDGFRA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.98762;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9546;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0043;patientHomNum=12;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0005712][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B6104430|16D0157490|17B0001074|15B6325524-1|16D1532967-1|16B3094633|16B0200506|16B0028155|16B0047170|16D1533010-1|17B0000869|15D6722495-1][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.8033;GREP_score=0.628;CytoBand=q12;CGD_CONDITION=Gastrointestinal stromal tumor;CGD_INHERITANCE=AD;Strand=PDGFRA:NM_001347828.1:+,PDGFRA:NM_006206.5:+,PDGFRA:NM_001347829.1:+,PDGFRA:NM_001347830.1:+;NP=PDGFRA:NM_001347828.1:NP_001334757.1,PDGFRA:NM_006206.5:NP_006197.1,PDGFRA:NM_001347829.1:NP_001334758.1,PDGFRA:NM_001347830.1:NP_001334759.1;ENSP=PDGFRA:NM_001347828.1:.,PDGFRA:NM_006206.5:.,PDGFRA:NM_001347829.1:.,PDGFRA:NM_001347830.1:.;Gene_MIM_id=151450,187320,173490;Phenotypes=.,Gastrointestinal stromal tumor, somatic, 606764 (3). Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3), Isolated cases, Somatic mutation. 606764(MK),607685(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,5156;EnsemblGeneID=.,ENSG00000134853;Alias=LAG5,TS13,PDGFRA;FLKSEQ=TGCATTTGTG.GTGTGTGTGT	GT:AD:DP:GQ:PL	1/1:11,419:430:99:14505,902,0
chr4	55598211	.	ATT	A	2284.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.755;DP=468;ExcessHet=3.0103;FS=2.836;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=8.28;ReadPosRankSum=-1.573;SOR=0.944;HGVSnom=NM_000222.3:c.2361+71_2361+72delTT;Gene=KIT;Transcript=NM_000222.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_000222.3:IVS16+71_+72delTT;AAlength=976;EXAC_AF=0.09857230;EXAC_Hom_EAS=0;EXAC_AC_EAS=14;EXAC_AN_EAS=224;EXAC_AC_Adj=649;EXAC_AN_Adj=6584;RS=rs71662297;normalHetFrequency=0.0092;normalHetNum=8;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.0121;patientHetNum=63;patientHomFrequency=0.0006;patientHomNum=3;normalHetSampleInfo=[16B0000458|15D6535764|16B0000570|17B0005448][15B0062849|15D6129355|16B3094275|15D6518634];normalHomSampleInfo=[_][15D6518637];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6532888|16D1546026][15D6522640];CytoBand=q12;repName=(T)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=39;CGD_CONDITION=Gastrointestinal stromal tumor. Mastocytosis, cutaneous;CGD_INHERITANCE=AD;Strand=KIT:NM_000222.2:+,KIT:NM_001093772.1:+;NP=KIT:NM_000222.2:NP_000213.1,KIT:NM_001093772.1:NP_001087241.1;ENSP=KIT:NM_000222.2:ENST00000288135.5,KIT:NM_001093772.1:.;Gene_MIM_id=151450,187320,164920;Phenotypes=.,Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases. Germ cell tumors, 273300 (3), Somatic mutation. Leukemia, acute myeloid, 601626 (3), Autosomal dominant. Mast cell disease, 154800 (3), Autosomal dominant. Piebaldism, 172800 (3), Autosomal dominant. 154800(MK),172800(MK),273300(MK),601626(MK),606764(MK);Possible_Inheritance=NA,AD;EntrezGeneID=7895,7896,3815;EnsemblGeneID=.,ENSG00000157404;Alias=LAG5,TS13,KIT, PBT;FLKSEQ=tgtttttttg.tttttttttt	GT:AD:DP:GQ:PL	0/1:140,136:276:99:2322,0,2698
chr4	84382058	.	CA	C	1076.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.3;DP=54;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=22.91;ReadPosRankSum=2.323;SOR=4.849;HGVSnom=NM_016067.4:c.293-57delA|NM_139076.3:c.*1563delT;Gene=MRPS18C|ABRAXAS1;Transcript=NM_016067.4|NM_139076.3;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I4|E9;IVSnom=NM_016067.4:IVS4-57delA|.;AAlength=142|409;ESP6500_MAF=0.34658520;RS=rs34734728;G1000_AF=0.422125;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.3817;G1000_AFR_AF=0.1362;G1000_SAS_AF=0.5184;G1000_AMR_AF=0.5245;CytoBand=q21.23;repName=AluSx;repClass=SINE;Strand=MRPS18C:NM_001297767.1:+,MRPS18C:NM_001297769.1:+,MRPS18C:NM_001297770.1:+,MRPS18C:NM_016067.3:+;NP=MRPS18C:NM_001297767.1:NP_001284696.1,MRPS18C:NM_001297769.1:NP_001284698.1,MRPS18C:NM_001297770.1:NP_001284699.1,MRPS18C:NM_016067.3:NP_057151.1;ENSP=MRPS18C:NM_001297767.1:.,MRPS18C:NM_001297769.1:.,MRPS18C:NM_001297770.1:.,MRPS18C:NM_016067.3:.;Gene_MIM_id=151450,187320,611983,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,51023,84142;EnsemblGeneID=.,ENSG00000163319,ENSG00000163322;Alias=LAG5,TS13,MRPS18C, MRPS18-1,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=gactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/1:3,44:47:73:1114,73,0
chr4	84382552	.	A	T	11111.8	PASS	AC=2;AF=1;AN=2;DP=294;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=20.29;SOR=0.96;HGVSnom=NM_016067.4:c.*202A>T|NM_139076.3:c.*1070T>A;Gene=MRPS18C|ABRAXAS1;Transcript=NM_016067.4|NM_139076.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E9;AAlength=142|409;RS=rs1126971;G1000_AF=0.41893;G1000_EAS_AF=0.6756;G1000_EUR_AF=0.3787;G1000_AFR_AF=0.1225;G1000_SAS_AF=0.5204;G1000_AMR_AF=0.5259;NativeFreq_Het=0.3025;NativeFreq_Hom=0.3310;DANN_score=0.884;GREP_score=1.72;CytoBand=q21.23;dupName=chr8:17944357;dupScore=0;Strand=MRPS18C:NM_001297767.1:+,MRPS18C:NM_001297769.1:+,MRPS18C:NM_001297770.1:+,MRPS18C:NM_016067.3:+,FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=MRPS18C:NM_001297767.1:NP_001284696.1,MRPS18C:NM_001297769.1:NP_001284698.1,MRPS18C:NM_001297770.1:NP_001284699.1,MRPS18C:NM_016067.3:NP_057151.1,FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=MRPS18C:NM_001297767.1:.,MRPS18C:NM_001297769.1:.,MRPS18C:NM_001297770.1:.,MRPS18C:NM_016067.3:.,FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611983,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,51023,84142;EnsemblGeneID=.,ENSG00000163319,ENSG00000163322;Alias=LAG5,TS13,MRPS18C, MRPS18-1,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=GTTGAATAAA.GTGGTTCTGT	GT:AD:DP:GQ:PL	1/1:0,293:293:99:11140,882,0
chr4	84382763	.	C	T	12104.8	PASS	AC=2;AF=1;AN=2;DP=330;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.96;QD=29.4;SOR=0.737;HGVSnom=NM_016067.4:c.*413C>T|NM_139076.3:c.*859G>A;Gene=MRPS18C|ABRAXAS1;Transcript=NM_016067.4|NM_139076.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E9;AAlength=142|409;RS=rs11099601;G1000_AF=0.663938;G1000_EAS_AF=0.6776;G1000_EUR_AF=0.4901;G1000_AFR_AF=0.8238;G1000_SAS_AF=0.6268;G1000_AMR_AF=0.6441;DANN_score=0.7068;GREP_score=1.29;CytoBand=q21.23;dupName=chr8:17944357;dupScore=0;Strand=MRPS18C:NM_001297767.1:+,MRPS18C:NM_001297769.1:+,MRPS18C:NM_001297770.1:+,MRPS18C:NM_016067.3:+,FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=MRPS18C:NM_001297767.1:NP_001284696.1,MRPS18C:NM_001297769.1:NP_001284698.1,MRPS18C:NM_001297770.1:NP_001284699.1,MRPS18C:NM_016067.3:NP_057151.1,FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=MRPS18C:NM_001297767.1:.,MRPS18C:NM_001297769.1:.,MRPS18C:NM_001297770.1:.,MRPS18C:NM_016067.3:.,FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611983,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,51023,84142;EnsemblGeneID=.,ENSG00000163319,ENSG00000163322;Alias=LAG5,TS13,MRPS18C, MRPS18-1,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=GACGAGTCTA.CCTCAAACCA	GT:AD:DP:GQ:PL	1/1:0,327:327:99:12133,984,0
chr4	84383275	.	A	G	3411.77	PASS	AC=2;AF=1;AN=2;DP=87;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.6;SOR=1.09;HGVSnom=NM_016067.4:c.*925A>G|NM_139076.3:c.*347T>C;Gene=MRPS18C|ABRAXAS1;Transcript=NM_016067.4|NM_139076.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E9;AAlength=142|409;RS=rs6825184;G1000_AF=0.999201;G1000_EAS_AF=1.0;G1000_EUR_AF=0.996;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;DANN_score=0.2843;GREP_score=-0.969;CytoBand=q21.23;dupName=chr8:17944357;dupScore=0;repName=AluJr;repClass=SINE;Strand=FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,84142;EnsemblGeneID=.,ENSG00000163322;Alias=LAG5,TS13,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=ctaactccta.cttcaatcaa	GT:AD:DP:GQ:PL	1/1:0,87:87:99:3440,261,0
chr4	84383372	.	TC	T	7637.73	PASS	AC=2;AF=1;AN=2;DP=191;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.93;SOR=1.765;HGVSnom=NM_016067.4:c.*1023delC|NM_139076.3:c.*249delG;Gene=MRPS18C|ABRAXAS1;Transcript=NM_016067.4|NM_139076.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E9;AAlength=142|409;RS=rs34610900;CLNGENE=ABRAXAS1|MRPS18C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.419129;G1000_EAS_AF=0.6756;G1000_EUR_AF=0.3787;G1000_AFR_AF=0.1225;G1000_SAS_AF=0.5215;G1000_AMR_AF=0.5259;CytoBand=q21.23;dupName=chr8:17944357;dupScore=0;Strand=FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,84142;EnsemblGeneID=.,ENSG00000163322;Alias=LAG5,TS13,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=AAAGAATGTG.TGTGTAAGCC	GT:AD:DP:GQ:PL	1/1:0,190:190:99:7675,572,0
chr4	84383810	.	C	T	15280.8	PASS	AC=2;AF=1;AN=2;DP=422;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.94;QD=32.36;SOR=0.712;HGVSnom=NM_139076.3:c.1042G>A(p.Ala348Thr/p.A348T);Gene=ABRAXAS1;Transcript=NM_139076.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=409;EXAC_AF=0.43083564;EXAC_Hom_EAS=1908;EXAC_AC_EAS=5749;EXAC_AN_EAS=8654;EXAC_AC_Adj=52300;EXAC_AN_Adj=121392;ESP6500_MAF=0.32723358;RS=rs12642536;Ensembl_transcriptid=ENST00000321945|ENST00000506553;SIFT_pred=D|D;SIFT_score=0.011|0.01;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.436|.;MutationTaster_pred=P|P;MutationTaster_score=0.999991|0.999991;CLNGENE=ABRAXAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.41893;G1000_EAS_AF=0.6756;G1000_EUR_AF=0.3787;G1000_AFR_AF=0.1225;G1000_SAS_AF=0.5204;G1000_AMR_AF=0.5259;gnomad_exomes_AF=0.44227219;gnomad_exomes_AF_EAS=0.66806220;gnomad_exomes_AC=111166;gnomad_exomes_Hom=26679;gnomad_exomes_Het=57808;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15276240;gnomad_exomes_AF_NFE=0.40332911;gnomad_exomes_AF_AMR=0.60414619;gnomad_exomes_AF_SAS=0.46546880;NativeFreq_Het=0.3701;NativeFreq_Hom=0.3594;DANN_score=0.9889;GREP_score=2.75;CytoBand=q21.23;dupName=chr8:17944357;dupScore=0;Strand=FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,84142;EnsemblGeneID=.,ENSG00000163322;Alias=LAG5,TS13,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=AAGTCTAAGG.TTTATGCTTA	GT:AD:DP:GQ:PL	1/1:0,420:420:99:15309,1263,0
chr4	84393475	.	C	T	9553.77	StandardFilter	AC=2;AF=1;AN=2;DP=262;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.05;SOR=3.056;HGVSnom=NM_139076.3:c.216-34G>A;Gene=ABRAXAS1;Transcript=NM_139076.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_139076.3:IVS3-34G>A;AAlength=409;EXAC_AF=0.58713647;EXAC_Hom_EAS=214;EXAC_AC_EAS=660;EXAC_AN_EAS=986;EXAC_AC_Adj=16030;EXAC_AN_Adj=27302;ESP6500_MAF=0.62087004;RS=rs6535478;CLNGENE=ABRAXAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.684704;G1000_EAS_AF=0.6776;G1000_EUR_AF=0.4911;G1000_AFR_AF=0.8979;G1000_SAS_AF=0.6268;G1000_AMR_AF=0.6513;gnomad_exomes_AF=0.55730396;gnomad_exomes_AF_EAS=0.66881827;gnomad_exomes_AC=59996;gnomad_exomes_Hom=17125;gnomad_exomes_Het=25746;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.85064935;gnomad_exomes_AF_NFE=0.49993688;gnomad_exomes_AF_AMR=0.67621656;gnomad_exomes_AF_SAS=0.59647259;DANN_score=0.7892;GREP_score=-0.345;CytoBand=q21.23;Strand=FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,84142;EnsemblGeneID=.,ENSG00000163322;Alias=LAG5,TS13,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=ATTTCAAATA.GCtaaaaata	GT:AD:DP:GQ:PL	1/1:0,262:262:99:9582,787,0
chr4	84406091	.	A	AG	1077.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.482;DP=86;ExcessHet=3.0103;FS=4.334;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.83;ReadPosRankSum=-0.44;SOR=0.348;HGVSnom=NM_139076.3:c.87+47dupC;Gene=ABRAXAS1;Transcript=NM_139076.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_139076.3:IVS1+47_+48insC;AAlength=409;EXAC_AF=0.05200939;EXAC_Hom_EAS=190;EXAC_AC_EAS=1570;EXAC_AN_EAS=5788;EXAC_AC_Adj=3766;EXAC_AN_Adj=72410;ESP6500_MAF=0.03934078;RS=rs139863124;CLNGENE=ABRAXAS1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.110823;G1000_EAS_AF=0.2798;G1000_EUR_AF=0.0099;G1000_AFR_AF=0.1014;G1000_SAS_AF=0.1084;G1000_AMR_AF=0.0331;gnomad_exomes_AF=0.04077556;gnomad_exomes_AF_EAS=0.26448541;gnomad_exomes_AC=6940;gnomad_exomes_Hom=493;gnomad_exomes_Het=5954;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10902256;gnomad_exomes_AF_NFE=0.00833949;gnomad_exomes_AF_AMR=0.04296875;gnomad_exomes_AF_SAS=0.06651276;CytoBand=q21.23;Strand=FAM175A:NM_139076.2:-,FAM175A:NM_001345962.1:-;NP=FAM175A:NM_139076.2:NP_620775.2,FAM175A:NM_001345962.1:NP_001332891.1;ENSP=FAM175A:NM_139076.2:ENST00000321945.11,FAM175A:NM_001345962.1:.;Gene_MIM_id=151450,187320,611143;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7895,7896,84142;EnsemblGeneID=.,ENSG00000163322;Alias=LAG5,TS13,FAM175A, CCDC98, ABRAXAS, ABRA1;FLKSEQ=GGCCGCGCGC.GGGCTCTTCC	GT:AD:DP:GQ:PL	0/1:44,40:84:99:1115,0,1251
chr4	169418267	.	A	T	4634.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.925;DP=323;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.39;ReadPosRankSum=0.624;SOR=0.709;HGVSnom=NM_001166108.2:c.-161A>T;Gene=PALLD;Transcript=NM_001166108.2;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1123;RS=rs2710836;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.406749;G1000_EAS_AF=0.6042;G1000_EUR_AF=0.2883;G1000_AFR_AF=0.3752;G1000_SAS_AF=0.2832;G1000_AMR_AF=0.5259;DANN_score=0.7126;GREP_score=-11.2;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=CACAACCTCC.TTCTCCCAGA	GT:AD:DP:GQ:PL	0/1:174,148:322:99:4663,0,5355
chr4	169432673	.	C	T	6647.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.812;DP=437;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.21;ReadPosRankSum=-0.503;SOR=0.703;HGVSnom=NM_001166108.2:c.18C>T(p.Ser6Ser/p.S6S);Gene=PALLD;Transcript=NM_001166108.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1123;EXAC_AF=0.19430418;EXAC_Hom_EAS=140;EXAC_AC_EAS=1537;EXAC_AN_EAS=8576;EXAC_AC_Adj=23395;EXAC_AN_Adj=120404;ESP6500_MAF=0.21590035;RS=rs61051061;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.184904;G1000_EAS_AF=0.1925;G1000_EUR_AF=0.1958;G1000_AFR_AF=0.2292;G1000_SAS_AF=0.135;G1000_AMR_AF=0.1441;gnomad_exomes_AF=0.18973898;gnomad_exomes_AF_EAS=0.17379708;gnomad_exomes_AC=47541;gnomad_exomes_Hom=4734;gnomad_exomes_Het=38073;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22662137;gnomad_exomes_AF_NFE=0.20614043;gnomad_exomes_AF_AMR=0.14969332;gnomad_exomes_AF_SAS=0.13515722;NativeFreq_Het=0.3416;NativeFreq_Hom=0.0391;DANN_score=0.571;GREP_score=2.89;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=GGACCTCCTC.CATGAGTCCT	GT:AD:DP:GQ:PL	0/1:227,210:437:99:6676,0,7368
chr4	169432841	.	G	A	6917.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.221;DP=406;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.08;ReadPosRankSum=1.169;SOR=0.703;HGVSnom=NM_001166108.2:c.186G>A(p.Lys62Lys/p.K62K);Gene=PALLD;Transcript=NM_001166108.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1123;EXAC_AF=0.28407211;EXAC_Hom_EAS=142;EXAC_AC_EAS=1536;EXAC_AN_EAS=8606;EXAC_AC_Adj=34350;EXAC_AN_Adj=120920;ESP6500_MAF=0.29440258;RS=rs1806729;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.236022;G1000_EAS_AF=0.1925;G1000_EUR_AF=0.329;G1000_AFR_AF=0.2231;G1000_SAS_AF=0.2393;G1000_AMR_AF=0.1844;gnomad_exomes_AF=0.27980741;gnomad_exomes_AF_EAS=0.17462995;gnomad_exomes_AC=70202;gnomad_exomes_Hom=10575;gnomad_exomes_Het=49052;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23043746;gnomad_exomes_AF_NFE=0.32431645;gnomad_exomes_AF_AMR=0.17950943;gnomad_exomes_AF_SAS=0.22511926;NativeFreq_Het=0.3737;NativeFreq_Hom=0.0569;DANN_score=0.6486;GREP_score=3.72;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=ACTCGGAAAA.GAGATCTCGC	GT:AD:DP:GQ:PL	0/1:187,218:405:99:6946,0,5978
chr4	169433326	.	T	C	5920.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.282;DP=287;ExcessHet=3.0103;FS=0.43;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.7;ReadPosRankSum=-0.292;SOR=0.73;HGVSnom=NM_001166108.2:c.671T>C(p.Met224Thr/p.M224T);Gene=PALLD;Transcript=NM_001166108.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=1123;EXAC_AF=0.28519796;EXAC_Hom_EAS=134;EXAC_AC_EAS=1547;EXAC_AN_EAS=8630;EXAC_AC_Adj=34562;EXAC_AN_Adj=121186;ESP6500_MAF=0.28363832;RS=rs7655494;Ensembl_transcriptid=ENST00000261509|ENST00000505667|ENST00000508898;SIFT_pred=T|T|T;SIFT_score=1.0|1.0|1.0;Polyphen2_HVAR_pred=.|.|.;Polyphen2_HVAR_score=.|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|1|1|0.999942;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.239617;G1000_EAS_AF=0.1935;G1000_EUR_AF=0.33;G1000_AFR_AF=0.2368;G1000_SAS_AF=0.2372;G1000_AMR_AF=0.1844;gnomad_exomes_AF=0.28080387;gnomad_exomes_AF_EAS=0.17613142;gnomad_exomes_AC=70338;gnomad_exomes_Hom=10544;gnomad_exomes_Het=49250;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24636700;gnomad_exomes_AF_NFE=0.32464669;gnomad_exomes_AF_AMR=0.18010535;gnomad_exomes_AF_SAS=0.22238923;NativeFreq_Het=0.3772;NativeFreq_Hom=0.0569;DANN_score=0.6069;GREP_score=3.67;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=CAGAGCCCTA.GGAAGACCAA	GT:AD:DP:GQ:PL	0/1:135,151:286:99:5949,0,14216
chr4	169433327	.	G	A	5920.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.852;DP=286;ExcessHet=3.0103;FS=0.433;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.77;ReadPosRankSum=-0.275;SOR=0.745;HGVSnom=NM_001166108.2:c.672G>A(p.Met224Ile/p.M224I);Gene=PALLD;Transcript=NM_001166108.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=1123;EXAC_AF=0.28520389;EXAC_Hom_EAS=135;EXAC_AC_EAS=1545;EXAC_AN_EAS=8632;EXAC_AC_Adj=34565;EXAC_AN_Adj=121194;ESP6500_MAF=0.28363832;RS=rs7671781;Ensembl_transcriptid=ENST00000261509|ENST00000505667|ENST00000508898;SIFT_pred=T|T|T;SIFT_score=0.208|0.234|0.376;Polyphen2_HVAR_pred=.|.|.;Polyphen2_HVAR_score=.|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|1|1|0.999973;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.239617;G1000_EAS_AF=0.1935;G1000_EUR_AF=0.33;G1000_AFR_AF=0.2368;G1000_SAS_AF=0.2372;G1000_AMR_AF=0.1844;gnomad_exomes_AF=0.28072746;gnomad_exomes_AF_EAS=0.17566097;gnomad_exomes_AC=70311;gnomad_exomes_Hom=10540;gnomad_exomes_Het=49231;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24633576;gnomad_exomes_AF_NFE=0.32467187;gnomad_exomes_AF_AMR=0.17981821;gnomad_exomes_AF_SAS=0.22237470;NativeFreq_Het=0.3772;NativeFreq_Hom=0.0569;DANN_score=0.7965;GREP_score=-10.8;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=AGAGCCCTAT.GAAGACCAAG	GT:AD:DP:GQ:PL	0/1:135,150:285:99:5949,0,14216
chr4	169433333	.	C	T	6010.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.12;DP=294;ExcessHet=3.0103;FS=0.429;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.51;ReadPosRankSum=0.596;SOR=0.75;HGVSnom=NM_001166108.2:c.678C>T(p.Asp226Asp/p.D226D);Gene=PALLD;Transcript=NM_001166108.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1123;EXAC_AF=0.28514258;EXAC_Hom_EAS=133;EXAC_AC_EAS=1541;EXAC_AN_EAS=8624;EXAC_AC_Adj=34557;EXAC_AN_Adj=121192;ESP6500_MAF=0.30201445;RS=rs7673220;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.239617;G1000_EAS_AF=0.1935;G1000_EUR_AF=0.33;G1000_AFR_AF=0.2368;G1000_SAS_AF=0.2372;G1000_AMR_AF=0.1844;gnomad_exomes_AF=0.28058238;gnomad_exomes_AF_EAS=0.17560365;gnomad_exomes_AC=70264;gnomad_exomes_Hom=10518;gnomad_exomes_Het=49228;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24621352;gnomad_exomes_AF_NFE=0.32442011;gnomad_exomes_AF_AMR=0.17988423;gnomad_exomes_AF_SAS=0.22236017;NativeFreq_Het=0.3772;NativeFreq_Hom=0.0569;DANN_score=0.2829;GREP_score=-5.91;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=CTATGGAAGA.CAAGGGGAGA	GT:AD:DP:GQ:PL	0/1:143,150:293:99:6039,0,14370
chr4	169606649	.	C	A	7095.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.637;DP=466;ExcessHet=3.0103;FS=1.99;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.26;ReadPosRankSum=0.222;SOR=0.85;HGVSnom=NM_001166108.2:c.1274C>A(p.Thr425Asn/p.T425N);Gene=PALLD;Transcript=NM_001166108.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E6;IVSnom=.;AAlength=1123;EXAC_AF=0.11377527;EXAC_Hom_EAS=35;EXAC_AC_EAS=753;EXAC_AN_EAS=8654;EXAC_AC_Adj=13813;EXAC_AN_Adj=121406;ESP6500_MAF=0.11141012;RS=rs62333891;Ensembl_transcriptid=ENST00000261509|ENST00000505667|ENST00000508898|ENST00000504519|ENST00000512127|ENST00000513245|ENST00000503457;SIFT_pred=D|D|D|D|D|D|D;SIFT_score=0.01|0.008|0.003|0.004|0.031|0.005|0.004;Polyphen2_HVAR_pred=.|.|.|.|.|.|.;Polyphen2_HVAR_score=.|.|.|.|.|.|.;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=0.017861|0.179415|0.000160054|0.0781476|0.017861;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.128994;G1000_EAS_AF=0.0804;G1000_EUR_AF=0.0785;G1000_AFR_AF=0.208;G1000_SAS_AF=0.0767;G1000_AMR_AF=0.196;gnomad_exomes_AF=0.11755159;gnomad_exomes_AF_EAS=0.08187452;gnomad_exomes_AC=29552;gnomad_exomes_Hom=2533;gnomad_exomes_Het=24486;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17710384;gnomad_exomes_AF_NFE=0.08042309;gnomad_exomes_AF_AMR=0.27231187;gnomad_exomes_AF_SAS=0.07946825;NativeFreq_Het=0.1601;NativeFreq_Hom=0;DANN_score=0.9917;GREP_score=5.77;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=CACAGTCCAA.TTCATATCTC	GT:AD:DP:GQ:PL	0/1:231,234:465:99:7124,0,6957
chr4	169799448	.	A	G	2303.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.764;DP=156;ExcessHet=3.0103;FS=1.315;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.77;ReadPosRankSum=0.646;SOR=0.834;HGVSnom=NM_001166108.2:c.1965-12625A>G;Gene=PALLD;Transcript=NM_001166108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_001166108.2:IVS10-12625A>G;AAlength=1123;EXAC_AF=0.64642791;EXAC_Hom_EAS=22;EXAC_AC_EAS=75;EXAC_AN_EAS=130;EXAC_AC_Adj=6931;EXAC_AN_Adj=10722;RS=rs62333013;Ensembl_transcriptid=ENST00000507735;SIFT_pred=T;SIFT_score=0.751;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|0.999978|0.999978|0.999978;CLNGENE=PALLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.478634;G1000_EAS_AF=0.5526;G1000_EUR_AF=0.6521;G1000_AFR_AF=0.1021;G1000_SAS_AF=0.6656;G1000_AMR_AF=0.5735;gnomad_exomes_AF=0.61253717;gnomad_exomes_AF_EAS=0.52338507;gnomad_exomes_AC=74166;gnomad_exomes_Hom=23566;gnomad_exomes_Het=27034;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13580492;gnomad_exomes_AF_NFE=0.63965671;gnomad_exomes_AF_AMR=0.62639374;gnomad_exomes_AF_SAS=0.66134335;DANN_score=0.7524;GREP_score=-5.01;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=CTTCGGCCAC.GCCAGACGCC	GT:AD:DP:GQ:PL	0/1:76,80:156:99:2332,0,2338
chr4	169835048	.	C	G	5314.77	StandardFilter	AC=2;AF=1;AN=2;DP=141;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.26;SOR=4.789;HGVSnom=NM_001166108.2:c.2623-30C>G;Gene=PALLD;Transcript=NM_001166108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_001166108.2:IVS15-30C>G;AAlength=1123;EXAC_AF=0.75667151;EXAC_Hom_EAS=3969;EXAC_AC_EAS=8263;EXAC_AN_EAS=8604;EXAC_AC_Adj=91642;EXAC_AN_Adj=121112;ESP6500_MAF=0.64954636;RS=rs1532651;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.707069;G1000_EAS_AF=0.9643;G1000_EUR_AF=0.7714;G1000_AFR_AF=0.3949;G1000_SAS_AF=0.8027;G1000_AMR_AF=0.7003;gnomad_exomes_AF=0.76195277;gnomad_exomes_AF_EAS=0.96113594;gnomad_exomes_AC=191209;gnomad_exomes_Hom=74291;gnomad_exomes_Het=42627;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.43701467;gnomad_exomes_AF_NFE=0.75647015;gnomad_exomes_AF_AMR=0.79053076;gnomad_exomes_AF_SAS=0.78976270;NativeFreq_Het=0.2100;NativeFreq_Hom=0.7189;DANN_score=0.3959;GREP_score=0.245;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=TTTTAAATAG.AAATCATTTA	GT:AD:DP:GQ:PL	1/1:0,141:141:99:5343,423,0
chr4	169846255	.	T	C	15895.8	PASS	AC=2;AF=1;AN=2;DP=414;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.55;SOR=0.953;HGVSnom=NM_001166108.2:c.3358+26T>C;Gene=PALLD;Transcript=NM_001166108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_001166108.2:IVS20+26T>C;AAlength=1123;EXAC_AF=0.75987493;EXAC_Hom_EAS=3971;EXAC_AC_EAS=8262;EXAC_AN_EAS=8598;EXAC_AC_Adj=92109;EXAC_AN_Adj=121216;ESP6500_MAF=0.66184838;RS=rs3733656;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.714457;G1000_EAS_AF=0.9643;G1000_EUR_AF=0.7704;G1000_AFR_AF=0.4236;G1000_SAS_AF=0.8016;G1000_AMR_AF=0.7017;gnomad_exomes_AF=0.76416936;gnomad_exomes_AF_EAS=0.96134133;gnomad_exomes_AC=191860;gnomad_exomes_Hom=74588;gnomad_exomes_Het=42684;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.47267020;gnomad_exomes_AF_NFE=0.75590759;gnomad_exomes_AF_AMR=0.79141566;gnomad_exomes_AF_SAS=0.78973672;NativeFreq_Het=0.2171;NativeFreq_Hom=0.7153;DANN_score=0.2324;GREP_score=-5.0;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=TCTCATTTCA.TGCGTTTACT	GT:AD:DP:GQ:PL	1/1:0,412:412:99:15924,1238,0
chr4	169846359	.	GCT	G	16146.7	PASS	AC=2;AF=1;AN=2;DP=445;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.22;SOR=0.821;HGVSnom=NM_001166108.2:c.3359-14_3359-13delCT;Gene=PALLD;Transcript=NM_001166108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_001166108.2:IVS20-14_-13delCT;AAlength=1123;EXAC_AF=0.76455734;EXAC_Hom_EAS=4023;EXAC_AC_EAS=8340;EXAC_AN_EAS=8648;EXAC_AC_Adj=92646;EXAC_AN_Adj=121176;RS=rs536545858;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.717851;G1000_EAS_AF=0.9702;G1000_EUR_AF=0.7803;G1000_AFR_AF=0.4228;G1000_SAS_AF=0.8037;G1000_AMR_AF=0.7017;gnomad_exomes_AF=0.76939246;gnomad_exomes_AF_EAS=0.96475579;gnomad_exomes_AC=192899;gnomad_exomes_Hom=75553;gnomad_exomes_Het=41793;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.46980241;gnomad_exomes_AF_NFE=0.75923474;gnomad_exomes_AF_AMR=0.79483617;gnomad_exomes_AF_SAS=0.79374673;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=AATTCATATT.CTCTCTCTCT	GT:AD:DP:GQ:PL	1/1:0,413:413:99:16184,1244,0
chr4	169847646	.	TA	T	9033.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.175;DP=357;ExcessHet=3.0103;FS=2.805;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.34;ReadPosRankSum=-1.91;SOR=1.291;HGVSnom=NM_001166108.2:c.*325delA;Gene=PALLD;Transcript=NM_001166108.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1123;RS=rs796761323;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.907548;G1000_EAS_AF=0.998;G1000_EUR_AF=0.8807;G1000_AFR_AF=0.9357;G1000_SAS_AF=0.8405;G1000_AMR_AF=0.8559;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=TATAAGAAAT.AAAAAAAAAC	GT:AD:DP:GQ:PL	1/1:11,332:343:99:9071,730,0
chr4	169849389	.	C	G	12799.8	PASS	AC=2;AF=1;AN=2;DP=342;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.43;SOR=0.803;HGVSnom=NM_001166108.2:c.*2058C>G;Gene=PALLD;Transcript=NM_001166108.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1123;RS=rs1071738;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.568091;G1000_EAS_AF=0.9028;G1000_EUR_AF=0.6521;G1000_AFR_AF=0.1135;G1000_SAS_AF=0.7055;G1000_AMR_AF=0.6326;DANN_score=0.8634;GREP_score=3.87;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=GTCTTACTTG.CAAATTTTTC	GT:AD:DP:GQ:PL	1/1:0,342:342:99:12828,1027,0
chr4	169849477	.	TA	T	7506.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.565;DP=317;ExcessHet=3.0103;FS=1.528;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.53;ReadPosRankSum=-0.107;SOR=0.396;HGVSnom=NM_001166108.2:c.*2156delA;Gene=PALLD;Transcript=NM_001166108.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1123;RS=rs398064261;CLNGENE=CBR4|PALLD;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.698882;G1000_EAS_AF=0.9633;G1000_EUR_AF=0.7624;G1000_AFR_AF=0.379;G1000_SAS_AF=0.8006;G1000_AMR_AF=0.6888;CytoBand=q32.3;Strand=PALLD:NM_001166108.2:+,PALLD:NM_001166108.1:+,PALLD:NM_016081.3:+,PALLD:NM_001166109.1:+,PALLD:NM_001166110.1:+;NP=PALLD:NM_001166108.2:NP_001159580.1,PALLD:NM_001166108.1:NP_001159580.1,PALLD:NM_016081.3:NP_057165.3,PALLD:NM_001166109.1:NP_001159581.1,PALLD:NM_001166110.1:NP_001159582.1;ENSP=PALLD:NM_001166108.2:ENST00000505667.6,PALLD:NM_001166108.1:.,PALLD:NM_016081.3:.,PALLD:NM_001166109.1:.,PALLD:NM_001166110.1:.;Gene_MIM_id=151450,187320,608092;Phenotypes=.,{Pancreatic cancer, susceptibility to, 1}, 606856 (3). 606856(SK);Possible_Inheritance=NA;EntrezGeneID=7895,7896,23022;EnsemblGeneID=.,ENSG00000129116;Alias=LAG5,TS13,PALLD, KIAA0992, PNCA1;FLKSEQ=ATTGTATTTA.AAAAAAAAAG	GT:AD:DP:GQ:PL	1/1:7,276:283:99:7544,647,0
chr5	218356	.	T	C	1704.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.229;DP=112;ExcessHet=3.0103;FS=0.702;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.36;ReadPosRankSum=-0.329;SOR=0.624;HGVSnom=.;Gene=SDHA;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs2303741;CLNGENE=SDHA;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.247604;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6241;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;normalHetFrequency=0.0405;normalHetNum=35;normalHomFrequency=0.0035;normalHomNum=3;patientHetFrequency=0.0343;patientHetNum=179;patientHomFrequency=0.0075;patientHomNum=39;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215|16B0000748][15B0047125];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536945|16D1536937-1|16D1546189|16D1545999|16B3094096|17B0005627][15D6482003-1|15D6518628|16B0001902-1|15B0002971|16B0050302|15B0047474|16D0169445|15B0053988|16B0009475-1|15D6482041-1|15D6526679|15B0012160|15B0002079|15B0054129|15D6482223-1|15B0002076|15B0033222|14B0040803|16B0019175-1|15D6526671|16D1546202|15B0047128|16B3094857|15D6518632|15B0002919-1|16B0033015|16B0005159|16B0019191-1|16B0005129|15B6219955|15B0062992|15B0022413|16D3110162];DANN_score=0.4228;GREP_score=-0.377;CytoBand=p15.33;dupName=chr5:1594142,chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;simRepName=trf;simRepCopyNum=2.3;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=CCCGCTCGAC.CCGGCGTGGT	GT:AD:DP:GQ:PL	0/1:51,60:111:99:1733,0,1438
chr5	218381	.	T	TC	1155.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.312;DP=120;ExcessHet=3.0103;FS=1.617;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.44;ReadPosRankSum=0.752;SOR=0.929;HGVSnom=.;Gene=SDHA;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs35805262;CLNGENE=SDHA;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.247005;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6218;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;normalHetFrequency=0.0347;normalHetNum=30;normalHomFrequency=0.0046;normalHomNum=4;patientHetFrequency=0.0299;patientHetNum=156;patientHomFrequency=0.0059;patientHomNum=31;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215|16B0000748][15D6518708|15B0047125];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536945|16B0005515|16D1536937-1|17B0005627|17B0005664|16D1546189][15D6482160-1|16D0169445|15D6532786|16B0005129|15D6482003-1|15B0002079|15B0047474|15B0002919-1|15B0022413|15D6482223-1|15D6518628|16B0050302|15B0012160|15B6215419|15D6482041-1|15D6526679|16B0001902-1|15D6518632|15B0048480|15B0033222|16B0019191-1|16D1546202|14B0040803|15D6526671|16D3110162];CytoBand=p15.33;dupName=chr5:1594142,chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;simRepName=trf;simRepCopyNum=2.3;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=AGGCGCGGTA.CCCCCCTCCC	GT:AD:DP:GQ:PL	0/1:53,48:101:99:1193,0,1333
chr5	224633	.	A	G	2632.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.449;DP=247;ExcessHet=3.0103;FS=3.725;MLEAC=1;MLEAF=0.5;MQ=52.78;MQRankSum=-3.698;QD=10.7;ReadPosRankSum=-1.993;SOR=0.929;HGVSnom=NM_004168.4:c.309A>G(p.Ala103Ala/p.A103A);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=664;EXAC_AF=0.15290260;EXAC_Hom_EAS=10;EXAC_AC_EAS=530;EXAC_AN_EAS=8646;EXAC_AC_Adj=18511;EXAC_AN_Adj=121064;ESP6500_MAF=0.25784615;RS=rs1139424;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.240016;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1103;G1000_AFR_AF=0.5998;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2334;gnomad_exomes_AF=0.14963705;gnomad_exomes_AF_EAS=0.06026324;gnomad_exomes_AC=37476;gnomad_exomes_Hom=3993;gnomad_exomes_Het=29490;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53757154;gnomad_exomes_AF_NFE=0.12594779;gnomad_exomes_AF_AMR=0.18486590;gnomad_exomes_AF_SAS=0.08940484;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0320;normalHetFrequency=0.1098;normalHetNum=95;normalHomFrequency=0.0069;normalHomNum=6;patientHetFrequency=0.1161;patientHetNum=606;patientHomFrequency=0.0153;patientHomNum=80;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215|16B1586155][16B0047529|15B0032981|16D0166623|15D6532279];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3217;GREP_score=-6.23;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=CTGTTGCAGC.CAGGTAAGAG	GT:AD:DP:GQ:PL	0/1:153,93:246:99:2661,0,4776
chr5	226160	.	A	C	4845.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.143;DP=370;ExcessHet=3.0103;FS=1.791;MLEAC=1;MLEAF=0.5;MQ=59.75;MQRankSum=-3.848;QD=13.17;ReadPosRankSum=1.146;SOR=0.809;HGVSnom=NM_004168.4:c.619A>C(p.Arg207Arg/p.R207R);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous+SpliceSites;MolecularConsequence=synonymous_variant+exonic_splice_region_variant;ExonIntron=E5;IVSnom=.;AAlength=664;EXAC_AF=0.15683068;EXAC_Hom_EAS=16;EXAC_AC_EAS=538;EXAC_AN_EAS=8644;EXAC_AC_Adj=18990;EXAC_AN_Adj=121086;ESP6500_MAF=0.27095187;RS=rs6555055;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.247404;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6233;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.15231466;gnomad_exomes_AF_EAS=0.06062418;gnomad_exomes_AC=38252;gnomad_exomes_Hom=4448;gnomad_exomes_Het=29356;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54521932;gnomad_exomes_AF_NFE=0.12801375;gnomad_exomes_AF_AMR=0.18975294;gnomad_exomes_AF_SAS=0.09051414;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0356;normalHetFrequency=0.141;normalHetNum=122;normalHomFrequency=0.0077;normalHomNum=3;patientHetFrequency=0.141;patientHetNum=736;patientHomFrequency=0.0088;patientHomNum=46;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215|16B0033730|16B0033214][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00006783;DANN_score=0.6889;GREP_score=-0.368;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=CTTATATGGA.GGGTAAGGCC	GT:AD:DP:GQ:PL	0/1:193,175:368:99:4874,0,6178
chr5	228278	.	CT	C	2132.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.007;DP=224;ExcessHet=3.0103;FS=24.973;MLEAC=1;MLEAF=0.5;MQ=56.73;MQRankSum=-12.461;QD=10.06;ReadPosRankSum=1.442;SOR=2.255;HGVSnom=NM_004168.4:c.622-13delT;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_004168.4:IVS5-13delT;AAlength=664;EXAC_AF=0.15141088;EXAC_Hom_EAS=10;EXAC_AC_EAS=512;EXAC_AN_EAS=8332;EXAC_AC_Adj=17557;EXAC_AN_Adj=115956;ESP6500_MAF=0.25523414;RS=rs3835068;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.234625;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1103;G1000_AFR_AF=0.5764;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2392;gnomad_exomes_AF=0.14345597;gnomad_exomes_AF_EAS=0.05895099;gnomad_exomes_AC=34531;gnomad_exomes_Hom=3142;gnomad_exomes_Het=28247;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.50988546;gnomad_exomes_AF_NFE=0.12244898;gnomad_exomes_AF_AMR=0.17882775;gnomad_exomes_AF_SAS=0.08707247;normalHetFrequency=0.0775;normalHetNum=67;normalHomFrequency=0.0058;normalHomNum=5;patientHetFrequency=0.0805;patientHetNum=420;patientHomFrequency=0.0086;patientHomNum=45;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215|16B0017800][15B0002636-1|16D0155985|15B0047125];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0033213|16B0000509|16B0228555-1|15D6722250|15D6722311|15D6482448-1|16B0200341|15B6325520-1|16B0202529|16D1545795|15D6722354|15D6533577|16B0035543-1|15D6722231-1|16D0168768|16D1545678|16D1536945|16D0153171|15D6482456|15D6722491-1|16B0005848|16D0155896|16B0012066|16D1536937-1|16D0177780-1|16B0017693|17B0005627|16D1532994-1|16D1546189|15D6532738|16B0017262][15B0068100|16D1545744|15B0002079|15B0047474|16D0169453|16B0050302|15B0012160|15B6215419|16B0005848|16B0000722|16B0019191-1|15D6482368|15B6219955|16D3110162];CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=ACTTCTTGCC.TTTTTTTTCC	GT:AD:DP:GQ:PL	0/1:117,95:212:99:2170,0,2662
chr5	228362	.	T	C	5700.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.322;DP=397;ExcessHet=3.0103;FS=4.391;MLEAC=1;MLEAF=0.5;MQ=59.37;MQRankSum=-4.455;QD=14.36;ReadPosRankSum=2.133;SOR=0.9;HGVSnom=NM_004168.4:c.684T>C(p.Asn228Asn/p.N228N);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=664;EXAC_AF=0.15651880;EXAC_Hom_EAS=17;EXAC_AC_EAS=541;EXAC_AN_EAS=8646;EXAC_AC_Adj=18997;EXAC_AN_Adj=121372;ESP6500_MAF=0.27164386;RS=rs2115272;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.247404;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6233;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.15237439;gnomad_exomes_AF_EAS=0.06078069;gnomad_exomes_AC=38267;gnomad_exomes_Hom=4454;gnomad_exomes_Het=29359;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54487258;gnomad_exomes_AF_NFE=0.12801707;gnomad_exomes_AF_AMR=0.18990343;gnomad_exomes_AF_SAS=0.09050823;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0356;normalHetFrequency=0.1225;normalHetNum=106;normalHomFrequency=0.0046;normalHomNum=4;patientHetFrequency=0.1289;patientHetNum=673;patientHomFrequency=0.0121;patientHomNum=63;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6524789|16B0033215][16D0157485|16D0177695];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2598;GREP_score=-5.3;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr3:197344663;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=TGATGGAGAA.GGGGAGTGCC	GT:AD:DP:GQ:PL	0/1:197,200:397:99:5729,0,5994
chr5	230980	.	A	G	11047.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.68;DP=286;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.92;MQRankSum=0;QD=29.47;ReadPosRankSum=-1.405;SOR=1.022;HGVSnom=NM_004168.4:c.771-11A>G;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_004168.4:IVS6-11A>G;AAlength=664;EXAC_AF=0.88103875;EXAC_Hom_EAS=1903;EXAC_AC_EAS=5728;EXAC_AN_EAS=8622;EXAC_AC_Adj=106870;EXAC_AN_Adj=121300;ESP6500_MAF=0.91257881;RS=rs2288461;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.858427;G1000_EAS_AF=0.628;G1000_EUR_AF=0.8688;G1000_AFR_AF=0.9879;G1000_SAS_AF=0.9029;G1000_AMR_AF=0.8689;gnomad_exomes_AF=0.87697020;gnomad_exomes_AF_EAS=0.65941714;gnomad_exomes_AC=220444;gnomad_exomes_Hom=97313;gnomad_exomes_Het=25818;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.97285486;gnomad_exomes_AF_NFE=0.88399345;gnomad_exomes_AF_AMR=0.89317104;gnomad_exomes_AF_SAS=0.90289391;NativeFreq_Het=0.3559;NativeFreq_Hom=0.5302;normalHetFrequency=0.3803;normalHetNum=329;normalHomFrequency=0.4983;normalHomNum=431;patientHetFrequency=0.3613;patientHetNum=1886;patientHomFrequency=0.5335;patientHomNum=2785;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00001184;DANN_score=0.311;GREP_score=0.511;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=ACTGCTCTCT.TTGTTTCCAG	GT:AD:DP:GQ:PL	1/1:1,284:285:99:11076,818,0
chr5	231111	.	T	C	13023.8	PASS	AC=2;AF=1;AN=2;DP=335;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.55;QD=32.35;SOR=0.88;HGVSnom=NM_004168.4:c.891T>C(p.Pro297Pro/p.P297P);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=664;EXAC_AF=0.70782758;EXAC_Hom_EAS=458;EXAC_AC_EAS=2816;EXAC_AN_EAS=8582;EXAC_AC_Adj=85490;EXAC_AN_Adj=120778;ESP6500_MAF=0.76868656;RS=rs1126417;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.653355;G1000_EAS_AF=0.3363;G1000_EUR_AF=0.7475;G1000_AFR_AF=0.7874;G1000_SAS_AF=0.6759;G1000_AMR_AF=0.6902;gnomad_exomes_AF=0.70030242;gnomad_exomes_AF_EAS=0.31963819;gnomad_exomes_AC=175528;gnomad_exomes_Hom=63289;gnomad_exomes_Het=48950;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.78634279;gnomad_exomes_AF_NFE=0.75732332;gnomad_exomes_AF_AMR=0.65529030;gnomad_exomes_AF_SAS=0.68060638;NativeFreq_Het=0.4199;NativeFreq_Hom=0.2740;normalHetFrequency=0.3873;normalHetNum=335;normalHomFrequency=0.1942;normalHomNum=168;patientHetFrequency=0.4201;patientHetNum=2193;patientHomFrequency=0.2056;patientHomNum=1073;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.372;GREP_score=1.15;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=AGTTCCACCC.ACAGGTAGGG	GT:AD:DP:GQ:PL	1/1:0,335:335:99:13052,1008,0
chr5	231143	.	T	C	3499.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.777;DP=315;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.51;MQRankSum=-3.243;QD=11.11;ReadPosRankSum=1.167;SOR=0.702;HGVSnom=NM_004168.4:c.895+28T>C;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_004168.4:IVS7+28T>C;AAlength=664;EXAC_AF=0.15596223;EXAC_Hom_EAS=14;EXAC_AC_EAS=532;EXAC_AN_EAS=8610;EXAC_AC_Adj=18732;EXAC_AN_Adj=120106;ESP6500_MAF=0.27095187;RS=rs2288459;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.247404;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6233;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.15176066;gnomad_exomes_AF_EAS=0.06049880;gnomad_exomes_AC=37969;gnomad_exomes_Hom=4375;gnomad_exomes_Het=29219;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54475751;gnomad_exomes_AF_NFE=0.12762715;gnomad_exomes_AF_AMR=0.18913749;gnomad_exomes_AF_SAS=0.09041893;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0356;normalHetFrequency=0.141;normalHetNum=122;normalHomFrequency=0.0023;normalHomNum=2;patientHetFrequency=0.1391;patientHetNum=726;patientHomFrequency=0.0102;patientHomNum=53;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][16D0155336];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3804;GREP_score=-2.85;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=GCCCGGCAGG.GTTTGGCTTG	GT:AD:DP:GQ:PL	0/1:189,126:315:99:3528,0,5885
chr5	233572	.	A	G	3307.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.869;DP=260;ExcessHet=3.0103;FS=20.111;MLEAC=1;MLEAF=0.5;MQ=59.37;MQRankSum=-3.951;QD=12.72;ReadPosRankSum=0.13;SOR=0.199;HGVSnom=NM_004168.4:c.896-20A>G;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_004168.4:IVS7-20A>G;AAlength=664;EXAC_AF=0.15655484;EXAC_Hom_EAS=17;EXAC_AC_EAS=542;EXAC_AN_EAS=8654;EXAC_AC_Adj=19002;EXAC_AN_Adj=121376;ESP6500_MAF=0.27087498;RS=rs7710005;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.247204;G1000_EAS_AF=0.0595;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6225;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2392;gnomad_exomes_AF=0.15230255;gnomad_exomes_AF_EAS=0.06078069;gnomad_exomes_AC=38298;gnomad_exomes_Hom=4442;gnomad_exomes_Het=29414;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54203077;gnomad_exomes_AF_NFE=0.12823263;gnomad_exomes_AF_AMR=0.19025039;gnomad_exomes_AF_SAS=0.09052006;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0356;normalHetFrequency=0.1434;normalHetNum=124;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1412;patientHetNum=737;patientHomFrequency=0.009;patientHomNum=47;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162|16D0158737];DANN_score=0.2938;GREP_score=-8.11;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=TAGGTAATAA.TATGTGTGGT	GT:AD:DP:GQ:PL	0/1:151,109:260:99:3336,0,4921
chr5	233734	.	C	G	4894.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.244;DP=369;ExcessHet=3.0103;FS=5.431;MLEAC=1;MLEAF=0.5;MQ=59.62;MQRankSum=-3.049;QD=13.45;ReadPosRankSum=-0.691;SOR=0.477;HGVSnom=NM_004168.4:c.1038C>G(p.Ser346Ser/p.S346S);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E8;IVSnom=.;AAlength=664;EXAC_AF=0.15974236;EXAC_Hom_EAS=17;EXAC_AC_EAS=541;EXAC_AN_EAS=8654;EXAC_AC_Adj=19394;EXAC_AN_Adj=121408;ESP6500_MAF=0.28240812;RS=rs1041949;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.257788;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6589;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2478;gnomad_exomes_AF=0.15510837;gnomad_exomes_AF_EAS=0.06078069;gnomad_exomes_AC=39002;gnomad_exomes_Hom=4780;gnomad_exomes_Het=29442;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57518149;gnomad_exomes_AF_NFE=0.12837398;gnomad_exomes_AF_AMR=0.19093327;gnomad_exomes_AF_SAS=0.09057356;NativeFreq_Het=0.1708;NativeFreq_Hom=0.0463;normalHetFrequency=0.1434;normalHetNum=124;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1416;patientHetNum=739;patientHomFrequency=0.0088;patientHomNum=46;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];DANN_score=0.4644;GREP_score=-3.88;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=TGTCTCGGTC.ATGACTCTGG	GT:AD:DP:GQ:PL	0/1:194,170:364:99:4923,0,6576
chr5	236753	.	C	T	1755.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.267;DP=199;ExcessHet=3.0103;FS=11.946;MLEAC=1;MLEAF=0.5;MQ=45.64;MQRankSum=-6.96;QD=8.82;ReadPosRankSum=-0.765;SOR=1.685;HGVSnom=NM_004168.4:c.1432+39C>T;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_004168.4:IVS10+39C>T;AAlength=664;EXAC_AF=0.15237043;EXAC_Hom_EAS=15;EXAC_AC_EAS=533;EXAC_AN_EAS=8560;EXAC_AC_Adj=18339;EXAC_AN_Adj=120358;ESP6500_MAF=0.26461089;RS=rs10057677;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.246805;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.621;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.14900439;gnomad_exomes_AF_EAS=0.06035141;gnomad_exomes_AC=37176;gnomad_exomes_Hom=4012;gnomad_exomes_Het=29152;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53242797;gnomad_exomes_AF_NFE=0.12568287;gnomad_exomes_AF_AMR=0.18635782;gnomad_exomes_AF_SAS=0.08935237;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0320;normalHetFrequency=0.1364;normalHetNum=118;normalHomFrequency=0.0023;normalHomNum=2;patientHetFrequency=0.1324;patientHetNum=691;patientHomFrequency=0.0103;patientHomNum=54;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][15D0025166];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4524;GREP_score=-0.248;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr5:1569972;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=TTTGAGAAGG.GCAGGACGTT	GT:AD:DP:GQ:PL	0/1:147,52:199:99:1784,0,9248
chr5	236760	.	C	A	1760.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.688;DP=203;ExcessHet=3.0103;FS=10.329;MLEAC=1;MLEAF=0.5;MQ=44.84;MQRankSum=-8.172;QD=8.67;ReadPosRankSum=-0.335;SOR=1.57;HGVSnom=NM_004168.4:c.1432+46C>A;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_004168.4:IVS10+46C>A;AAlength=664;EXAC_AF=0.16036204;EXAC_Hom_EAS=14;EXAC_AC_EAS=526;EXAC_AN_EAS=8170;EXAC_AC_Adj=18958;EXAC_AN_Adj=118220;ESP6500_MAF=0.27299293;RS=rs10057678;G1000_AF=0.2498;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1233;G1000_AFR_AF=0.6225;G1000_SAS_AF=0.0798;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.15666848;gnomad_exomes_AF_EAS=0.06073525;gnomad_exomes_AC=38678;gnomad_exomes_Hom=4226;gnomad_exomes_Het=30226;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53601448;gnomad_exomes_AF_NFE=0.13385317;gnomad_exomes_AF_AMR=0.19158247;gnomad_exomes_AF_SAS=0.09013326;NativeFreq_Het=0.1851;NativeFreq_Hom=0.0356;normalHetFrequency=0.1353;normalHetNum=117;normalHomFrequency=0.0035;normalHomNum=3;patientHetFrequency=0.1335;patientHetNum=697;patientHomFrequency=0.0111;patientHomNum=58;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][15B0032981|15B0062509-1];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5603;GREP_score=-0.0392;CytoBand=p15.33;dupName=chr3:195701216,chr3:195384569,chr5:1569972;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=AGGCGCAGGA.GTTAGAAAGT	GT:AD:DP:GQ:PL	0/1:150,53:203:99:1789,0,9237
chr5	251419	.	C	T	2684.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.522;DP=191;ExcessHet=3.0103;FS=20.337;MLEAC=1;MLEAF=0.5;MQ=37.78;MQRankSum=0.471;QD=14.06;ReadPosRankSum=0.719;SOR=0.825;HGVSnom=NM_004168.4:c.1664-34C>T;Gene=SDHA;Transcript=NM_004168.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_004168.4:IVS12-34C>T;AAlength=664;EXAC_AF=0.13560523;EXAC_Hom_EAS=10;EXAC_AC_EAS=369;EXAC_AN_EAS=6262;EXAC_AC_Adj=12061;EXAC_AN_Adj=88942;RS=rs10041187;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.248203;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6256;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2421;gnomad_exomes_AF=0.13649913;gnomad_exomes_AF_EAS=0.05637708;gnomad_exomes_AC=31139;gnomad_exomes_Hom=3020;gnomad_exomes_Het=25099;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51532340;gnomad_exomes_AF_NFE=0.11739490;gnomad_exomes_AF_AMR=0.17582211;gnomad_exomes_AF_SAS=0.08639644;normalHetFrequency=0.1283;normalHetNum=111;normalHomFrequency=0.0023;normalHomNum=2;patientHetFrequency=0.1308;patientHetNum=683;patientHomFrequency=0.0126;patientHomNum=66;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][16B3094276];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4881;GREP_score=-0.346;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=GACTGGGTCC.GCCTGCCCCT	GT:AD:DP:GQ:PL	0/1:103,88:191:99:2713,0,3219
chr5	251469	.	G	A	2148.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=5.988;DP=215;ExcessHet=3.0103;FS=2.52;MLEAC=1;MLEAF=0.5;MQ=39.7;MQRankSum=-3.012;QD=9.99;ReadPosRankSum=1.009;SOR=0.531;HGVSnom=NM_004168.4:c.1680G>A(p.Thr560Thr/p.T560T);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=664;EXAC_AF=0.15268356;EXAC_Hom_EAS=12;EXAC_AC_EAS=498;EXAC_AN_EAS=8124;EXAC_AC_Adj=17285;EXAC_AN_Adj=113208;RS=rs1139449;CLNGENE=SDHA;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.248403;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6271;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.14527011;gnomad_exomes_AF_EAS=0.05856299;gnomad_exomes_AC=35830;gnomad_exomes_Hom=3797;gnomad_exomes_Het=28236;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.52856183;gnomad_exomes_AF_NFE=0.12308354;gnomad_exomes_AF_AMR=0.18219267;gnomad_exomes_AF_SAS=0.08851910;NativeFreq_Het=0.1210;NativeFreq_Hom=0;normalHetFrequency=0.1387;normalHetNum=120;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1345;patientHetNum=702;patientHomFrequency=0.01;patientHomNum=52;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|16B0067618-1|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0011646|16B0050302|15B0047474|16D1545744|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|16D0153217|15D6104506|14B0040803|16D1546202|15D6518632|16B0005331|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];DANN_score=0.7131;GREP_score=-7.25;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=TCTGGAACAC.GACCTGGTGG	GT:AD:DP:GQ:PL	0/1:140,75:215:99:2177,0,4137
chr5	251541	.	A	G	2248.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.717;DP=232;ExcessHet=3.0103;FS=3.822;MLEAC=1;MLEAF=0.5;MQ=56.19;MQRankSum=-0.561;QD=9.73;ReadPosRankSum=0.779;SOR=0.626;HGVSnom=NM_004168.4:c.1752A>G(p.Ala584Ala/p.A584A);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=664;EXAC_AF=0.15593793;EXAC_Hom_EAS=15;EXAC_AC_EAS=535;EXAC_AN_EAS=8628;EXAC_AC_Adj=18832;EXAC_AN_Adj=120766;ESP6500_MAF=0.26956789;RS=rs13070;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.248403;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.6271;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.15117515;gnomad_exomes_AF_EAS=0.06021341;gnomad_exomes_AC=37847;gnomad_exomes_Hom=4372;gnomad_exomes_Het=29103;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54511936;gnomad_exomes_AF_NFE=0.12706577;gnomad_exomes_AF_AMR=0.18808377;gnomad_exomes_AF_SAS=0.09018056;NativeFreq_Het=0.1779;NativeFreq_Hom=0.0356;normalHetFrequency=0.1399;normalHetNum=121;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1404;patientHetNum=733;patientHomFrequency=0.0088;patientHomNum=46;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];DANN_score=0.4709;GREP_score=-6.93;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=GAGCAGAGGC.CGGAAGGAGT	GT:AD:DP:GQ:PL	0/1:146,85:231:99:2277,0,4617
chr5	254599	.	A	T	2234.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=7.051;DP=218;ExcessHet=3.0103;FS=10.18;MLEAC=1;MLEAF=0.5;MQ=34.63;MQRankSum=-1.139;QD=10.25;ReadPosRankSum=-0.056;SOR=0.834;HGVSnom=NM_004168.4:c.1886A>T(p.Tyr629Phe/p.Y629F);Gene=SDHA;Transcript=NM_004168.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E14;IVSnom=.;AAlength=664;EXAC_AF=0.15153080;EXAC_Hom_EAS=3;EXAC_AC_EAS=79;EXAC_AN_EAS=1202;EXAC_AC_Adj=4108;EXAC_AN_Adj=27110;ESP6500_MAF=0.09268950;RS=rs6960;Ensembl_transcriptid=ENST00000509564|ENST00000617470|ENST00000264932|ENST00000504309|ENST00000510361;SIFT_pred=D|.|T|T|T;SIFT_score=0.0|.|0.444|0.669|0.412;Polyphen2_HVAR_pred=.|.|B|B|.;Polyphen2_HVAR_score=.|.|0.01|0.001|.;MutationTaster_pred=P|P|P|P|P|P;MutationTaster_score=6.69358e-05|0.999177|6.69358e-05|6.69358e-05|0.999177|6.69358e-05;CLNGENE=SDHA;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.14296924;gnomad_exomes_AF_EAS=0.05779831;gnomad_exomes_AC=23869;gnomad_exomes_Hom=2556;gnomad_exomes_Het=18757;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53165451;gnomad_exomes_AF_NFE=0.12244745;gnomad_exomes_AF_AMR=0.18875990;gnomad_exomes_AF_SAS=0.08983736;NativeFreq_Het=0.0783;NativeFreq_Hom=0.0249;normalHetFrequency=0.1364;normalHetNum=118;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1368;patientHetNum=714;patientHomFrequency=0.009;patientHomNum=47;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|16B0067618-1|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];DANN_score=0.6431;GREP_score=2.85;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=ACCCTGTCCT.TGTGGACGTT	GT:AD:DP:GQ:PL	0/1:133,85:218:99:2263,0,3954
chr5	256472	.	G	A	6488.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.648;DP=419;ExcessHet=3.0103;FS=8.251;MLEAC=1;MLEAF=0.5;MQ=58.07;MQRankSum=-8.043;QD=15.52;ReadPosRankSum=0.27;SOR=0.344;HGVSnom=NM_004168.4:c.1932G>A(p.Val644Val/p.V644V);Gene=SDHA;Transcript=NM_004168.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=664;EXAC_AF=0.17160127;EXAC_Hom_EAS=17;EXAC_AC_EAS=720;EXAC_AN_EAS=8310;EXAC_AC_Adj=20355;EXAC_AN_Adj=118618;ESP6500_MAF=0.27825619;RS=rs6961;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.335264;G1000_EAS_AF=0.2312;G1000_EUR_AF=0.2286;G1000_AFR_AF=0.6437;G1000_SAS_AF=0.1513;G1000_AMR_AF=0.3127;gnomad_exomes_AF=0.15668080;gnomad_exomes_AF_EAS=0.06311392;gnomad_exomes_AC=38347;gnomad_exomes_Hom=4495;gnomad_exomes_Het=29357;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55544480;gnomad_exomes_AF_NFE=0.13193537;gnomad_exomes_AF_AMR=0.19397697;gnomad_exomes_AF_SAS=0.09190103;NativeFreq_Het=0.8505;NativeFreq_Hom=0.0356;normalHetFrequency=0.1434;normalHetNum=124;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1412;patientHetNum=737;patientHomFrequency=0.0088;patientHomNum=46;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|15D6722231-1|16B0000509|15D6533577|16D1545795|15D6532203|16D1545678|15D6722250|16D0168768|16D1536945|16D1536937-1|16D1546189|15D6722311|16B0200341|16B0033213|15B6325520-1|15D6722354|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D1532993-1|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|15D6482368|15D6482041-1|15D6526679|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239|16D3110162];DANN_score=0.6024;GREP_score=-3.3;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=ATAGACCCGT.ATCGACAAAA	GT:AD:DP:GQ:PL	0/1:210,208:418:99:6517,0,6864
chr5	256509	.	G	A	6264.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.357;DP=497;ExcessHet=3.0103;FS=5.009;MLEAC=1;MLEAF=0.5;MQ=58.57;MQRankSum=-1.146;QD=12.66;ReadPosRankSum=-0.233;SOR=1.007;HGVSnom=NM_004168.4:c.1969G>A(p.Val657Ile/p.V657I);Gene=SDHA;Transcript=NM_004168.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E15;IVSnom=.;AAlength=664;EXAC_AF=0.12978850;EXAC_Hom_EAS=7;EXAC_AC_EAS=531;EXAC_AN_EAS=8654;EXAC_AC_Adj=15734;EXAC_AN_Adj=121228;ESP6500_MAF=0.19644779;RS=rs6962;Ensembl_transcriptid=ENST00000617470|ENST00000264932|ENST00000504309|ENST00000510361;SIFT_pred=.|T|T|T;SIFT_score=.|0.328|0.118|0.337;Polyphen2_HVAR_pred=.|B|B|.;Polyphen2_HVAR_score=.|0.022|0.009|.;MutationTaster_pred=P|P|P;MutationTaster_score=1.74467e-05|0.99929|1.74467e-05;CLNGENE=SDHA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.175319;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.1064;G1000_AFR_AF=0.3744;G1000_SAS_AF=0.0767;G1000_AMR_AF=0.2046;gnomad_exomes_AF=0.13135617;gnomad_exomes_AF_EAS=0.06020231;gnomad_exomes_AC=32957;gnomad_exomes_Hom=2221;gnomad_exomes_Het=28515;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32436611;gnomad_exomes_AF_NFE=0.12274371;gnomad_exomes_AF_AMR=0.16873191;gnomad_exomes_AF_SAS=0.08790670;NativeFreq_Het=0.1566;NativeFreq_Hom=0.0249;normalHetFrequency=0.1376;normalHetNum=119;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.1356;patientHetNum=708;patientHomFrequency=0.0075;patientHomNum=39;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033215][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177780-1|16D0153171|16B0000509|15D6533577|15D6532203|16D1545678|15D6722250|16D1536945|16D1536937-1|16D1546189|16B0200341|16B0033213|15B6325520-1|16B0017262|16B0035543-1|16D1532994-1|15D6722491-1|17B0005627|16B0005848|16B0017693|16D0155896|15D6482456|16B0012066][15D6518628|16B0050302|15B0047474|16B0024468|15D6482368|15D6482041-1|15B0012160|15B0002079|14B0040803|16D1546202|15D6518632|16B0019191-1|15B6215246-1|16B0005848|15B6219955|15D6529239];DANN_score=0.7193;GREP_score=4.12;CytoBand=p15.33;dupName=chr3:195384569,chr5:1569972,chr3:195688319;dupScore=0;CGD_CONDITION=Paragangliomas 5. Gastrointestinal stromal tumors. Cardiomyopathy, dilated, 1GG. Leigh syndrome/Mitochondrial respiratory chain complex II deficiency;CGD_INHERITANCE=AD/AR;Strand=SDHA:NM_001294332.1:+,SDHA:NM_001330758.1:+,SDHA:NM_004168.3:+;NP=SDHA:NM_001294332.1:NP_001281261.1,SDHA:NM_001330758.1:NP_001317687.1,SDHA:NM_004168.3:NP_004159.2;ENSP=SDHA:NM_001294332.1:.,SDHA:NM_001330758.1:.,SDHA:NM_004168.3:ENST00000264932.10;Gene_MIM_id=600857;Phenotypes=Cardiomyopathy, dilated, 1GG, 613642 (3). Leigh syndrome, 256000 (3), Autosomal recessive, Mitochondrial. Mitochondrial respiratory chain complex II deficiency, 252011 (3), Autosomal recessive. Paragangliomas 5, 614165 (3), Autosomal dominant. 252011(MK),256000(MK),613642(MK),614165(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6389;EnsemblGeneID=ENSG00000073578;Alias=SDHA, SDH1, SDHF, CMD1GG, PGL5;FLKSEQ=CTGTGCCACC.TCCCGCCAGC	GT:AD:DP:GQ:PL	0/1:283,212:495:99:6293,0,8396
chr5	1280477	.	G	A	7135.77	PASS	AC=2;AF=1;AN=2;DP=198;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.82;SOR=1.622;HGVSnom=NM_198253.3:c.1770-24C>T;Gene=TERT;Transcript=NM_198253.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_198253.3:IVS3-24C>T;AAlength=1132;EXAC_AF=0.13238911;EXAC_Hom_EAS=186;EXAC_AC_EAS=1746;EXAC_AN_EAS=8130;EXAC_AC_Adj=14750;EXAC_AN_Adj=111414;ESP6500_MAF=0.10072274;RS=rs13167280;CLNGENE=TERT;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.111422;G1000_EAS_AF=0.2143;G1000_EUR_AF=0.1292;G1000_AFR_AF=0.0166;G1000_SAS_AF=0.0971;G1000_AMR_AF=0.1369;gnomad_exomes_AF=0.12728615;gnomad_exomes_AF_EAS=0.20904296;gnomad_exomes_AC=31040;gnomad_exomes_Hom=2160;gnomad_exomes_Het=26720;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03241625;gnomad_exomes_AF_NFE=0.13541781;gnomad_exomes_AF_AMR=0.10863851;gnomad_exomes_AF_SAS=0.09927584;NativeFreq_Het=0.3382;NativeFreq_Hom=0.0502;normalHetFrequency=0.3295;normalHetNum=285;normalHomFrequency=0.037;normalHomNum=32;patientHetFrequency=0.3031;patientHetNum=1582;patientHomFrequency=0.0444;patientHomNum=232;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3459;GREP_score=-0.58;CytoBand=p15.33;CGD_CONDITION=Aplastic anemia. Dyskeratosis congenita, autosomal dominant. Dyskeratosis congenita, autosomal recessive. Pulmonary fibrosis and/or bone marrow failure, telomere-related 1;CGD_INHERITANCE=AD/AR;Strand=TERT:NM_001193376.1:-,TERT:NM_198253.2:-;NP=TERT:NM_001193376.1:NP_001180305.1,TERT:NM_198253.2:NP_937983.2;ENSP=TERT:NM_001193376.1:.,TERT:NM_198253.2:ENST00000310581.9;Gene_MIM_id=187270;Phenotypes={Dyskeratosis congenita, autosomal dominant 2}, 613989 (3), Autosomal recessive, Autosomal dominant. {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3), Autosomal recessive, Autosomal dominant. {Leukemia, acute myeloid}, 601626 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 9}, 615134 (3). {Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3), Autosomal dominant. 601626(SK),613989(SK),614742(SK),615134(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7015;EnsemblGeneID=ENSG00000164362;Alias=TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9;FLKSEQ=CCCCTCAGGA.GCTTGCTCAG	GT:AD:DP:GQ:PL	1/1:0,197:197:99:7164,592,0
chr5	1294086	.	C	T	11666.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.422;DP=325;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.61;ReadPosRankSum=1.381;SOR=0.373;HGVSnom=NM_198253.3:c.915G>A(p.Ala305Ala/p.A305A);Gene=TERT;Transcript=NM_198253.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1132;EXAC_AF=0.40447125;EXAC_Hom_EAS=98;EXAC_AC_EAS=556;EXAC_AN_EAS=1110;EXAC_AC_Adj=11199;EXAC_AN_Adj=27688;ESP6500_MAF=0.20753243;RS=rs2736098;CLNGENE=TERT;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.265575;G1000_EAS_AF=0.371;G1000_EUR_AF=0.2346;G1000_AFR_AF=0.0658;G1000_SAS_AF=0.5031;G1000_AMR_AF=0.2032;gnomad_exomes_AF=0.28677057;gnomad_exomes_AF_EAS=0.36810793;gnomad_exomes_AC=47433;gnomad_exomes_Hom=7510;gnomad_exomes_Het=32413;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10770077;gnomad_exomes_AF_NFE=0.27591877;gnomad_exomes_AF_AMR=0.20480966;gnomad_exomes_AF_SAS=0.47879933;NativeFreq_Het=0.4531;NativeFreq_Hom=0.1456;normalHetFrequency=0.4578;normalHetNum=396;normalHomFrequency=0.1503;normalHomNum=130;patientHetFrequency=0.4362;patientHetNum=2277;patientHomFrequency=0.1431;patientHomNum=747;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7258;GREP_score=-4.77;CytoBand=p15.33;CGD_CONDITION=Aplastic anemia. Dyskeratosis congenita, autosomal dominant. Dyskeratosis congenita, autosomal recessive. Pulmonary fibrosis and/or bone marrow failure, telomere-related 1;CGD_INHERITANCE=AD/AR;Strand=TERT:NM_001193376.1:-,TERT:NM_198253.2:-;NP=TERT:NM_001193376.1:NP_001180305.1,TERT:NM_198253.2:NP_937983.2;ENSP=TERT:NM_001193376.1:.,TERT:NM_198253.2:ENST00000310581.9;Gene_MIM_id=187270;Phenotypes={Dyskeratosis congenita, autosomal dominant 2}, 613989 (3), Autosomal recessive, Autosomal dominant. {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3), Autosomal recessive, Autosomal dominant. {Leukemia, acute myeloid}, 601626 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 9}, 615134 (3). {Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3), Autosomal dominant. 601626(SK),613989(SK),614742(SK),615134(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7015;EnsemblGeneID=ENSG00000164362;Alias=TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9;FLKSEQ=ATGGGGGGCC.GCGTGGTGCT	GT:AD:DP:GQ:PL	1/1:1,324:325:99:11695,950,0
chr5	79950781	.	A	G	3631.77	PASS	AC=2;AF=1;AN=2;DP=105;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.92;SOR=2.442;HGVSnom=NM_000791.4:c.-473T>C|NM_002439.5:c.235A>G(p.Ile79Val/p.I79V);Gene=DHFR|MSH3;Transcript=NM_000791.4|NM_002439.5;VarType=UTR5|Missense+SpliceSites;MolecularConsequence=5_prime_UTR_exon_variant|missense_variant+exonic_splice_region_variant;ExonIntron=E1|E1;AAlength=187|1137;EXAC_AF=0.90287651;EXAC_Hom_EAS=45;EXAC_AC_EAS=105;EXAC_AN_EAS=120;EXAC_AC_Adj=10923;EXAC_AN_Adj=12098;RS=rs1650697;Ensembl_transcriptid=ENST00000265081;SIFT_pred=T;SIFT_score=1.0;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.0;MutationTaster_pred=P|P;MutationTaster_score=0.999914|1;CLNGENE=DHFR|MSH3;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.76857;G1000_EAS_AF=0.6607;G1000_EUR_AF=0.7555;G1000_AFR_AF=0.9349;G1000_SAS_AF=0.6779;G1000_AMR_AF=0.755;gnomad_exomes_AF=0.85697741;gnomad_exomes_AF_EAS=0.82622268;gnomad_exomes_AC=68817;gnomad_exomes_Hom=30076;gnomad_exomes_Het=8665;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96713147;gnomad_exomes_AF_NFE=0.86618575;gnomad_exomes_AF_AMR=0.91337907;gnomad_exomes_AF_SAS=0.83580139;HGMD_gene=MSH3;HGMD_disease=Colon_cancer_association_with;HGMD_tag=DP;HGMD_pmid=10944853;NativeFreq_Het=0.0320;NativeFreq_Hom=0.0925;dbscSNV_RF_score=0.082;dbscSNV_ADA_score=0.00249600;DANN_score=0.4943;GREP_score=-4.46;CytoBand=q14.1;CGD_CONDITION=Megaloblastic anemia due to dihydrofolate reductase deficiency,Endometrial carcinoma;CGD_INHERITANCE=AR,AD;Strand=DHFR:NM_000791.3:-,DHFR:NM_001290354.1:-,DHFR:NM_001290357.1:-,MSH3:NM_002439.4:+;NP=DHFR:NM_000791.3:NP_000782.1,DHFR:NM_001290354.1:NP_001277283.1,DHFR:NM_001290357.1:NP_001277286.1,MSH3:NM_002439.4:NP_002430.3;ENSP=DHFR:NM_000791.3:.,DHFR:NM_001290354.1:.,DHFR:NM_001290357.1:.,MSH3:NM_002439.4:ENST00000265081.6;Gene_MIM_id=126060,600887;Phenotypes=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive. 613839(MK),Endometrial carcinoma, somatic, 608089 (3). Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive. 608089(MK);Possible_Inheritance=AR,NA;EntrezGeneID=1719,4437;EnsemblGeneID=ENSG00000228716,ENSG00000113318;Alias=DHFR,MSH3, FAP4;FLKSEQ=GCCGCCGCAC.TAGTAGGTTC	GT:AD:DP:GQ:PL	1/1:0,104:104:99:3660,311,0
chr5	79966029	.	G	A	16402.8	PASS	AC=2;AF=1;AN=2;DP=459;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30;SOR=0.878;HGVSnom=NM_002439.5:c.693G>A(p.Pro231Pro/p.P231P);Gene=MSH3;Transcript=NM_002439.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=1137;EXAC_AF=0.12625497;EXAC_Hom_EAS=457;EXAC_AC_EAS=2816;EXAC_AN_EAS=8638;EXAC_AC_Adj=15317;EXAC_AN_Adj=121318;ESP6500_MAF=0.10156851;RS=rs1805355;CLNGENE=MSH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.182907;G1000_EAS_AF=0.3383;G1000_EUR_AF=0.0537;G1000_AFR_AF=0.1974;G1000_SAS_AF=0.0777;G1000_AMR_AF=0.2651;gnomad_exomes_AF=0.13457775;gnomad_exomes_AF_EAS=0.32559278;gnomad_exomes_AC=33835;gnomad_exomes_Hom=4092;gnomad_exomes_Het=25651;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18951514;gnomad_exomes_AF_NFE=0.05899889;gnomad_exomes_AF_AMR=0.34822203;gnomad_exomes_AF_SAS=0.08019731;HGMD_gene=MSH3;HGMD_disease=Colorectal_cancer;HGMD_tag=DM?;HGMD_pmid=21128252;NativeFreq_Het=0.2954;NativeFreq_Hom=0.0712;DANN_score=0.4348;GREP_score=-6.57;CytoBand=q14.1;CGD_CONDITION=Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MSH3:NM_002439.4:+;NP=MSH3:NM_002439.4:NP_002430.3;ENSP=MSH3:NM_002439.4:ENST00000265081.6;Gene_MIM_id=600887;Phenotypes=Endometrial carcinoma, somatic, 608089 (3). Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive. 608089(MK);Possible_Inheritance=NA;EntrezGeneID=4437;EnsemblGeneID=ENSG00000113318;Alias=MSH3, FAP4;FLKSEQ=TCTATACGCC.CTAGAATTAC	GT:AD:DP:GQ:PL	1/1:0,457:457:99:16431,1372,0
chr5	80149981	.	A	G	11369.8	PASS	AC=2;AF=1;AN=2;DP=320;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.87;SOR=0.731;HGVSnom=NM_002439.5:c.2846A>G(p.Gln949Arg/p.Q949R);Gene=MSH3;Transcript=NM_002439.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E21;IVSnom=.;AAlength=1137;EXAC_AF=0.87310269;EXAC_Hom_EAS=4312;EXAC_AC_EAS=8630;EXAC_AN_EAS=8636;EXAC_AC_Adj=105841;EXAC_AN_Adj=121224;ESP6500_MAF=0.85522067;RS=rs184967;Ensembl_transcriptid=ENST00000265081;SIFT_pred=T;SIFT_score=1.0;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.001;MutationTaster_pred=P;MutationTaster_score=0.999998;CLNGENE=MSH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.902157;G1000_EAS_AF=1.0;G1000_EUR_AF=0.8598;G1000_AFR_AF=0.8956;G1000_SAS_AF=0.8742;G1000_AMR_AF=0.8732;gnomad_exomes_AF=0.87346149;gnomad_exomes_AF_EAS=0.99940126;gnomad_exomes_AC=219003;gnomad_exomes_Hom=95934;gnomad_exomes_Het=27135;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.89331857;gnomad_exomes_AF_NFE=0.84038981;gnomad_exomes_AF_AMR=0.91293258;gnomad_exomes_AF_SAS=0.88204156;HGMD_gene=MSH3;HGMD_disease=Proximal_colon_cancer_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=17205513;NativeFreq_Het=0.1459;NativeFreq_Hom=0.8327;DANN_score=0.8635;GREP_score=0.287;CytoBand=q14.1;CGD_CONDITION=Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MSH3:NM_002439.4:+;NP=MSH3:NM_002439.4:NP_002430.3;ENSP=MSH3:NM_002439.4:ENST00000265081.6;Gene_MIM_id=600887;Phenotypes=Endometrial carcinoma, somatic, 608089 (3). Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive. 608089(MK);Possible_Inheritance=NA;EntrezGeneID=4437;EnsemblGeneID=ENSG00000113318;Alias=MSH3, FAP4;FLKSEQ=TATAAAGGAC.GAGTACATTT	GT:AD:DP:GQ:PL	1/1:0,320:320:99:11398,962,0
chr5	80168937	.	G	A	16756.8	PASS	AC=2;AF=1;AN=2;DP=479;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.78;SOR=1.092;HGVSnom=NM_002439.5:c.3133G>A(p.Ala1045Thr/p.A1045T);Gene=MSH3;Transcript=NM_002439.5;VarType=Missense+SpliceSites;MolecularConsequence=missense_variant+exonic_splice_region_variant;ExonIntron=E23;IVSnom=.;AAlength=1137;EXAC_AF=0.73046431;EXAC_Hom_EAS=2394;EXAC_AC_EAS=6429;EXAC_AN_EAS=8644;EXAC_AC_Adj=88636;EXAC_AN_Adj=121342;ESP6500_MAF=0.69467938;RS=rs26279;Ensembl_transcriptid=ENST00000265081;SIFT_pred=T;SIFT_score=0.551;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.035;MutationTaster_pred=P;MutationTaster_score=1;CLNGENE=MSH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.720248;G1000_EAS_AF=0.753;G1000_EUR_AF=0.7227;G1000_AFR_AF=0.6551;G1000_SAS_AF=0.7904;G1000_AMR_AF=0.6945;gnomad_exomes_AF=0.72941251;gnomad_exomes_AF_EAS=0.74692634;gnomad_exomes_AC=183208;gnomad_exomes_Hom=67007;gnomad_exomes_Het=49194;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.66350886;gnomad_exomes_AF_NFE=0.71369824;gnomad_exomes_AF_AMR=0.75596548;gnomad_exomes_AF_SAS=0.79341787;HGMD_gene=MSH3;HGMD_disease=Colorectal_cancer_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=17205513;NativeFreq_Het=0.4235;NativeFreq_Hom=0.4947;DANN_score=0.7297;GREP_score=-2.54;CytoBand=q14.1;CGD_CONDITION=Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MSH3:NM_002439.4:+;NP=MSH3:NM_002439.4:NP_002430.3;ENSP=MSH3:NM_002439.4:ENST00000265081.6;Gene_MIM_id=600887;Phenotypes=Endometrial carcinoma, somatic, 608089 (3). Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive. 608089(MK);Possible_Inheritance=NA;EntrezGeneID=4437;EnsemblGeneID=ENSG00000113318;Alias=MSH3, FAP4;FLKSEQ=TTTCACAGGC.CAGCAGAACA	GT:AD:DP:GQ:PL	1/1:0,477:477:99:16785,1432,0
chr5	80172447	.	CA	C	84.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.54;DP=49;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.88;ReadPosRankSum=1.296;SOR=0.892;HGVSnom=NM_002439.5:c.*779delA;Gene=MSH3;Transcript=NM_002439.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1137;RS=rs71879707;G1000_AF=0.24361;G1000_EAS_AF=0.2937;G1000_EUR_AF=0.336;G1000_AFR_AF=0.1755;G1000_SAS_AF=0.1871;G1000_AMR_AF=0.2464;CytoBand=q14.1;repName=AluSx;repClass=SINE;CGD_CONDITION=Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MSH3:NM_002439.4:+;NP=MSH3:NM_002439.4:NP_002430.3;ENSP=MSH3:NM_002439.4:ENST00000265081.6;Gene_MIM_id=600887;Phenotypes=Endometrial carcinoma, somatic, 608089 (3). Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive. 608089(MK);Possible_Inheritance=NA;EntrezGeneID=4437;EnsemblGeneID=ENSG00000113318;Alias=MSH3, FAP4;FLKSEQ=gactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:33,12:45:99:122,0,659
chr5	112111309	.	TA	T	409.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.73;DP=541;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.99;MQRankSum=0;QD=0.83;ReadPosRankSum=-1.034;SOR=0.668;HGVSnom=NM_000038.6:c.423-4delA;Gene=APC;Transcript=NM_000038.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000038.6:IVS4-4delA;AAlength=2843;EXAC_AF=0.26018392;EXAC_Hom_EAS=0;EXAC_AC_EAS=1151;EXAC_AN_EAS=5066;EXAC_AC_Adj=19353;EXAC_AN_Adj=74382;ESP6500_MAF=0.10788882;RS=rs730881230;CLNGENE=APC;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.25285951;gnomad_exomes_AF_EAS=0.24869326;gnomad_exomes_AC=25644;gnomad_exomes_Hom=14;gnomad_exomes_Het=25616;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.26822844;gnomad_exomes_AF_NFE=0.23409071;gnomad_exomes_AF_AMR=0.29716701;gnomad_exomes_AF_SAS=0.31309462;HGMD_gene=APC;HGMD_disease=Adenomatous_polyposis_coli;HGMD_tag=DM;HGMD_pmid=1316610;NativeFreq_Het=0.0054;NativeFreq_Hom=.;normalHetFrequency=0.0289;normalHetNum=25;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0253;patientHetNum=132;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0334;AF_2700_Hom=.;AF_50_Het=0.0301;AF_50_Hom=.;CytoBand=q22.2;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=TACCtttttt.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:415,78:493:99:447,0,8645
chr5	112162854	.	T	C	13494.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.361;DP=392;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.43;ReadPosRankSum=0.429;SOR=0.238;HGVSnom=NM_000038.6:c.1458T>C(p.Tyr486Tyr/p.Y486Y);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=2843;EXAC_AF=0.57798180;EXAC_Hom_EAS=1977;EXAC_AC_EAS=5842;EXAC_AN_EAS=8602;EXAC_AC_Adj=70004;EXAC_AN_Adj=121118;ESP6500_MAF=0.46216549;RS=rs2229992;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.509984;G1000_EAS_AF=0.6647;G1000_EUR_AF=0.5795;G1000_AFR_AF=0.1619;G1000_SAS_AF=0.638;G1000_AMR_AF=0.6671;gnomad_exomes_AF=0.58436571;gnomad_exomes_AF_EAS=0.67336601;gnomad_exomes_AC=146698;gnomad_exomes_Hom=44737;gnomad_exomes_Het=57224;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19597588;gnomad_exomes_AF_NFE=0.59217065;gnomad_exomes_AF_AMR=0.69757878;gnomad_exomes_AF_SAS=0.63859672;NativeFreq_Het=0.4752;NativeFreq_Hom=0.4578;normalHetFrequency=0.4266;normalHetNum=369;normalHomFrequency=0.4277;normalHomNum=370;patientHetFrequency=0.4467;patientHetNum=2332;patientHomFrequency=0.4148;patientHomNum=2165;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4335;AF_2700_Hom=0.4531;AF_50_Het=0.4612;AF_50_Hom=0.4374;DANN_score=0.7823;GREP_score=0.715;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=GTGAAATGTA.GGGCTTACTA	GT:AD:DP:GQ:PL	1/1:1,391:392:99:13523,1143,0
chr5	112164561	.	G	A	8858.77	PASS	AC=2;AF=1;AN=2;DP=240;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.53;SOR=1.85;HGVSnom=NM_000038.6:c.1635G>A(p.Ala545Ala/p.A545A);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=2843;EXAC_AF=0.64811054;EXAC_Hom_EAS=2910;EXAC_AC_EAS=7083;EXAC_AN_EAS=8606;EXAC_AC_Adj=78516;EXAC_AN_Adj=121146;ESP6500_MAF=0.58643494;RS=rs351771;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666134;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.5994;G1000_AFR_AF=0.5166;G1000_SAS_AF=0.7464;G1000_AMR_AF=0.7161;gnomad_exomes_AF=0.64924219;gnomad_exomes_AF_EAS=0.82175573;gnomad_exomes_AC=162952;gnomad_exomes_Hom=53916;gnomad_exomes_Het=55120;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53174701;gnomad_exomes_AF_NFE=0.61870142;gnomad_exomes_AF_AMR=0.73300324;gnomad_exomes_AF_SAS=0.71355256;NativeFreq_Het=0.3012;NativeFreq_Hom=0.7029;normalHetFrequency=0.3283;normalHetNum=284;normalHomFrequency=0.5838;normalHomNum=505;patientHetFrequency=0.3506;patientHetNum=1830;patientHomFrequency=0.5674;patientHomNum=2962;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3109;AF_2700_Hom=0.6541;AF_50_Het=0.3376;AF_50_Hom=0.6292;DANN_score=0.7591;GREP_score=4.47;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=AGGTTATTGC.AGTGTTTTGA	GT:AD:DP:GQ:PL	1/1:0,240:240:99:8887,721,0
chr5	112170895	.	A	G	4346.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.104;DP=273;ExcessHet=3.0103;FS=2.089;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.92;ReadPosRankSum=1.724;SOR=0.882;HGVSnom=NM_000038.6:c.1958+33A>G;Gene=APC;Transcript=NM_000038.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_000038.6:IVS15+33A>G;AAlength=2843;EXAC_AF=0.00129060;EXAC_Hom_EAS=0;EXAC_AC_EAS=67;EXAC_AN_EAS=2622;EXAC_AC_Adj=72;EXAC_AN_Adj=55788;RS=rs141414393;CLNGENE=APC;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.00279553;G1000_EAS_AF=0.0129;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00102270;gnomad_exomes_AF_EAS=0.01380898;gnomad_exomes_AC=204;gnomad_exomes_Hom=1;gnomad_exomes_Het=202;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00001185;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00026479;NativeFreq_Het=0.0373;NativeFreq_Hom=0;normalHetFrequency=0.022;normalHetNum=19;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0165;patientHetNum=86;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0047108][_];DANN_score=0.3054;GREP_score=-7.48;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=CTTTTAAAGT.CAGAATTCAT	GT:AD:DP:GQ:PL	0/1:139,134:273:99:4375,0,4131
chr5	112175770	.	G	A	12778.8	PASS	AC=2;AF=1;AN=2;DP=349;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.86;SOR=0.752;HGVSnom=NM_000038.6:c.4479G>A(p.Thr1493Thr/p.T1493T);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;EXAC_AF=0.64857006;EXAC_Hom_EAS=2924;EXAC_AC_EAS=7115;EXAC_AN_EAS=8648;EXAC_AC_Adj=78512;EXAC_AN_Adj=121054;ESP6500_MAF=0.58621750;RS=rs41115;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.665535;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.5994;G1000_AFR_AF=0.5174;G1000_SAS_AF=0.7423;G1000_AMR_AF=0.7161;gnomad_exomes_AF=0.64972559;gnomad_exomes_AF_EAS=0.82164220;gnomad_exomes_AC=162664;gnomad_exomes_Hom=53850;gnomad_exomes_Het=54964;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53281466;gnomad_exomes_AF_NFE=0.61880304;gnomad_exomes_AF_AMR=0.73388731;gnomad_exomes_AF_SAS=0.71278751;NativeFreq_Het=0.3036;NativeFreq_Hom=0.7029;normalHetFrequency=0.3295;normalHetNum=285;normalHomFrequency=0.5838;normalHomNum=505;patientHetFrequency=0.3506;patientHetNum=1830;patientHomFrequency=0.5682;patientHomNum=2966;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3117;AF_2700_Hom=0.6530;AF_50_Het=0.3376;AF_50_Hom=0.6307;DANN_score=0.7715;GREP_score=2.55;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=ATTTTGCCAC.GAAAGTACTC	GT:AD:DP:GQ:PL	1/1:0,348:348:99:12807,1049,0
chr5	112176325	.	G	A	13812.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.76;DP=385;ExcessHet=3.0103;FS=3.764;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.18;ReadPosRankSum=0.769;SOR=0.774;HGVSnom=NM_000038.6:c.5034G>A(p.Gly1678Gly/p.G1678G);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;EXAC_AF=0.65139551;EXAC_Hom_EAS=2909;EXAC_AC_EAS=7078;EXAC_AN_EAS=8594;EXAC_AC_Adj=78699;EXAC_AN_Adj=120816;ESP6500_MAF=0.59012612;RS=rs42427;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666733;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.6024;G1000_AFR_AF=0.5189;G1000_SAS_AF=0.7423;G1000_AMR_AF=0.7176;gnomad_exomes_AF=0.65241277;gnomad_exomes_AF_EAS=0.82177138;gnomad_exomes_AC=163051;gnomad_exomes_Hom=54165;gnomad_exomes_Het=54721;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53530357;gnomad_exomes_AF_NFE=0.62346567;gnomad_exomes_AF_AMR=0.73632043;gnomad_exomes_AF_SAS=0.71267412;NativeFreq_Het=0.3024;NativeFreq_Hom=0.7029;normalHetFrequency=0.3295;normalHetNum=285;normalHomFrequency=0.5827;normalHomNum=504;patientHetFrequency=0.3498;patientHetNum=1826;patientHomFrequency=0.5692;patientHomNum=2971;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3105;AF_2700_Hom=0.6537;AF_50_Het=0.3376;AF_50_Hom=0.6307;DANN_score=0.7697;GREP_score=1.31;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=TTAGAGGAGG.GCACAGTCAG	GT:AD:DP:GQ:PL	1/1:1,382:383:99:13841,1140,0
chr5	112176559	.	T	G	12356.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.875;DP=359;ExcessHet=3.0103;FS=3.684;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.81;ReadPosRankSum=1.397;SOR=0.718;HGVSnom=NM_000038.6:c.5268T>G(p.Ser1756Ser/p.S1756S);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;EXAC_AF=0.65076579;EXAC_Hom_EAS=2915;EXAC_AC_EAS=7100;EXAC_AN_EAS=8634;EXAC_AC_Adj=78606;EXAC_AN_Adj=120790;ESP6500_MAF=0.58798646;RS=rs866006;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666933;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.6004;G1000_AFR_AF=0.5197;G1000_SAS_AF=0.7454;G1000_AMR_AF=0.7161;gnomad_exomes_AF=0.65125936;gnomad_exomes_AF_EAS=0.82130809;gnomad_exomes_AC=163104;gnomad_exomes_Hom=54120;gnomad_exomes_Het=54864;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53402330;gnomad_exomes_AF_NFE=0.62086055;gnomad_exomes_AF_AMR=0.73428819;gnomad_exomes_AF_SAS=0.71354337;NativeFreq_Het=0.3000;NativeFreq_Hom=0.6930;normalHetFrequency=0.3283;normalHetNum=284;normalHomFrequency=0.5838;normalHomNum=505;patientHetFrequency=0.3498;patientHetNum=1826;patientHomFrequency=0.5692;patientHomNum=2971;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3101;AF_2700_Hom=0.6530;AF_50_Het=0.3376;AF_50_Hom=0.6307;DANN_score=0.5203;GREP_score=-2.49;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=CATCTGCGTC.TCTTCTGCAC	GT:AD:DP:GQ:PL	1/1:1,354:355:99:12385,1034,0
chr5	112176756	.	T	A	9842.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.756;DP=279;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.99;ReadPosRankSum=1.384;SOR=0.25;HGVSnom=NM_000038.6:c.5465T>A(p.Val1822Asp/p.V1822D);Gene=APC;Transcript=NM_000038.6;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;EXAC_AF=0.79810491;EXAC_Hom_EAS=3507;EXAC_AC_EAS=7790;EXAC_AN_EAS=8638;EXAC_AC_Adj=96526;EXAC_AN_Adj=120944;ESP6500_MAF=0.82625750;RS=rs459552;Ensembl_transcriptid=ENST00000257430|ENST00000508376;SIFT_pred=T|T;SIFT_score=0.672|0.672;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.0|0.0;MutationTaster_pred=P|P|P;MutationTaster_score=0.980951|0.980951|0.980951;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.865415;G1000_EAS_AF=0.9008;G1000_EUR_AF=0.7654;G1000_AFR_AF=0.9909;G1000_SAS_AF=0.7955;G1000_AMR_AF=0.8184;gnomad_exomes_AF=0.79482501;gnomad_exomes_AF_EAS=0.90293798;gnomad_exomes_AC=199083;gnomad_exomes_Hom=79771;gnomad_exomes_Het=39541;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95868330;gnomad_exomes_AF_NFE=0.77063571;gnomad_exomes_AF_AMR=0.82691417;gnomad_exomes_AF_SAS=0.78204039;HGMD_gene=APC;HGMD_disease=Adenomatous_polyposis_coli_association_with;HGMD_tag=DP;HGMD_pmid=9950360;NativeFreq_Het=0.1819;NativeFreq_Hom=0.8118;normalHetFrequency=0.1908;normalHetNum=165;normalHomFrequency=0.7642;normalHomNum=661;patientHetFrequency=0.2167;patientHetNum=1131;patientHomFrequency=0.7425;patientHomNum=3876;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1810;AF_2700_Hom=0.8082;AF_50_Het=0.2029;AF_50_Hom=0.7940;DANN_score=0.8086;GREP_score=3.59;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=AATTCCAAGG.CTTCAATGAT	GT:AD:DP:GQ:PL	1/1:1,277:278:99:9871,825,0
chr5	112177171	.	G	A	9339.77	PASS	AC=2;AF=1;AN=2;DP=250;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.54;SOR=1.055;HGVSnom=NM_000038.6:c.5880G>A(p.Pro1960Pro/p.P1960P);Gene=APC;Transcript=NM_000038.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;EXAC_AF=0.64880923;EXAC_Hom_EAS=2915;EXAC_AC_EAS=7096;EXAC_AN_EAS=8628;EXAC_AC_Adj=78515;EXAC_AN_Adj=121014;ESP6500_MAF=0.58690971;RS=rs465899;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666534;G1000_EAS_AF=0.8165;G1000_EUR_AF=0.5994;G1000_AFR_AF=0.5212;G1000_SAS_AF=0.7423;G1000_AMR_AF=0.7161;gnomad_exomes_AF=0.64970882;gnomad_exomes_AF_EAS=0.82171640;gnomad_exomes_AC=162882;gnomad_exomes_Hom=53917;gnomad_exomes_Het=55048;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53668025;gnomad_exomes_AF_NFE=0.61875232;gnomad_exomes_AF_AMR=0.73362863;gnomad_exomes_AF_SAS=0.71216578;NativeFreq_Het=0.3024;NativeFreq_Hom=0.7029;normalHetFrequency=0.3283;normalHetNum=284;normalHomFrequency=0.5838;normalHomNum=505;patientHetFrequency=0.3502;patientHetNum=1828;patientHomFrequency=0.5688;patientHomNum=2969;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3105;AF_2700_Hom=0.6533;AF_50_Het=0.3360;AF_50_Hom=0.6307;DANN_score=0.6969;GREP_score=-3.69;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=AAAATACTCC.GTTTGCTTTT	GT:AD:DP:GQ:PL	1/1:0,249:249:99:9368,749,0
chr5	112180228	.	C	CA	7973.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-3.214;DP=344;ExcessHet=3.0103;FS=7.014;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=24.38;ReadPosRankSum=-0.651;SOR=1.356;HGVSnom=NM_000038.6:c.*414dupA;Gene=APC;Transcript=NM_000038.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;RS=rs397817775;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.596845;G1000_EAS_AF=0.7034;G1000_EUR_AF=0.5616;G1000_AFR_AF=0.4803;G1000_SAS_AF=0.6421;G1000_AMR_AF=0.6513;NativeFreq_Het=0.4901;NativeFreq_Hom=.;normalHetFrequency=0.2023;normalHetNum=175;normalHomFrequency=0.3133;normalHomNum=271;patientHetFrequency=0.1615;patientHetNum=843;patientHomFrequency=0.2891;patientHomNum=1509;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3086;AF_2700_Hom=0.6564;AF_50_Het=0.3233;AF_50_Hom=0.6466;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=GGTATTTATG.AAAAAAAAAT	GT:AD:DP:GQ:PL	1/1:19,308:327:99:8011,468,0
chr5	112180921	.	T	C	12901.8	PASS	AC=2;AF=1;AN=2;DP=331;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.14;SOR=0.848;HGVSnom=NM_000038.6:c.*1098T>C;Gene=APC;Transcript=NM_000038.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;RS=rs41116;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.436901;G1000_EAS_AF=0.6657;G1000_EUR_AF=0.4841;G1000_AFR_AF=0.0605;G1000_SAS_AF=0.5419;G1000_AMR_AF=0.6052;NativeFreq_Het=0.4950;NativeFreq_Hom=0.4530;normalHetFrequency=0.2474;normalHetNum=214;normalHomFrequency=0.3983;normalHomNum=190;patientHetFrequency=0.214;patientHetNum=1117;patientHomFrequency=0.192;patientHomNum=1002;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4354;AF_2700_Hom=0.4493;AF_50_Het=0.4628;AF_50_Hom=0.4342;DANN_score=0.7795;GREP_score=3.21;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=TGATTTTTAA.ATTTTTCCAC	GT:AD:DP:GQ:PL	1/1:0,330:330:99:12930,992,0
chr5	112181379	.	C	G	15464.8	PASS	AC=2;AF=1;AN=2;DP=444;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.91;SOR=0.812;HGVSnom=NM_000038.6:c.*1556C>G;Gene=APC;Transcript=NM_000038.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;RS=rs448475;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.441893;G1000_EAS_AF=0.6657;G1000_EUR_AF=0.4841;G1000_AFR_AF=0.0787;G1000_SAS_AF=0.5419;G1000_AMR_AF=0.6066;NativeFreq_Het=0.5049;NativeFreq_Hom=0.4494;normalHetFrequency=0.2439;normalHetNum=211;normalHomFrequency=0.2208;normalHomNum=191;patientHetFrequency=0.2149;patientHetNum=1122;patientHomFrequency=0.192;patientHomNum=1002;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4358;AF_2700_Hom=0.4500;AF_50_Het=0.4612;AF_50_Hom=0.4358;DANN_score=0.4229;GREP_score=-0.142;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=TAAGTGTCCC.TTATACAGTG	GT:AD:DP:GQ:PL	1/1:0,443:443:99:15493,1330,0
chr5	112181576	.	G	A	12592.8	PASS	AC=2;AF=1;AN=2;DP=347;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.4;SOR=0.777;HGVSnom=NM_000038.6:c.*1753G>A;Gene=APC;Transcript=NM_000038.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=2843;RS=rs397768;CLNGENE=APC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.697284;G1000_EAS_AF=0.8175;G1000_EUR_AF=0.6203;G1000_AFR_AF=0.6067;G1000_SAS_AF=0.7474;G1000_AMR_AF=0.7363;NativeFreq_Het=0.3012;NativeFreq_Hom=0.7029;normalHetFrequency=0.1977;normalHetNum=171;normalHomFrequency=0.3145;normalHomNum=272;patientHetFrequency=0.1617;patientHetNum=844;patientHomFrequency=0.2831;patientHomNum=1478;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3090;AF_2700_Hom=0.6549;AF_50_Het=0.3344;AF_50_Hom=0.6339;DANN_score=0.5131;GREP_score=1.51;CytoBand=q22.2;CGD_CONDITION=Familial adenomatous polyposis. Gardner syndrome. Desmoid disease, hereditary;CGD_INHERITANCE=AD;Strand=APC:NM_001127511.2:+,APC:NM_000038.5:+,APC:NM_001127510.2:+;NP=APC:NM_001127511.2:NP_001120983.2,APC:NM_000038.5:NP_000029.2,APC:NM_001127510.2:NP_001120982.1;ENSP=APC:NM_001127511.2:.,APC:NM_000038.5:ENST00000257430.8,APC:NM_001127510.2:.;Gene_MIM_id=611731;Phenotypes=Adenoma, periampullary, somatic (3). Adenomatous polyposis coli, 175100 (3), Autosomal dominant. Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Desmoid disease, hereditary, 135290 (3), Autosomal dominant. Gardner syndrome, 175100 (3), Autosomal dominant. Gastric cancer, somatic, 613659 (3). Hepatoblastoma, somatic, 114550 (3). 114500(MK),114550(MK),135290(MK),175100(MK),611731(MK),613659(MK);Possible_Inheritance=AD;EntrezGeneID=324;EnsemblGeneID=ENSG00000134982;Alias=APC, GS, FPC, BTPS2;FLKSEQ=ATTTGGGGAG.GAAAACCTTT	GT:AD:DP:GQ:PL	1/1:0,346:346:99:12621,1038,0
chr5	112213678	.	CTGTGTGTGTGTGTG	C	21003.7	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.858;DP=743;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=27.98;ReadPosRankSum=-0.935;SOR=0.697;OLD_VARIANT=chr5|112213678|CTGTGTGTGTGTGTG|C,CTG|1;HGVSnom=NM_005669.5:c.*791_*804delCACACACACACACA;Gene=REEP5;Transcript=NM_005669.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=189;RS=rs60109818;CytoBand=q22.2;Strand=SRP19:NM_001204199.1:+,REEP5:NM_005669.4:-;NP=SRP19:NM_001204199.1:NP_001191128.1,REEP5:NM_005669.4:NP_005660.4;ENSP=SRP19:NM_001204199.1:.,REEP5:NM_005669.4:.;Gene_MIM_id=182175,125265;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6728,7905;EnsemblGeneID=ENSG00000153037,ENSG00000129625;Alias=SRP19,REEP5, D5S346, DP1, C5orf18;FLKSEQ=ACAGGTTACT.tgtgtgtgtg	GT:AD:DP:GQ:PL	1/0:8,160:567:99:21041,12187,11443
chr5	112213678	.	CTGTGTGTGTGTG	C	21003.7	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.858;DP=743;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=27.98;ReadPosRankSum=-0.935;SOR=0.697;OLD_VARIANT=chr5|112213678|CTGTGTGTGTGTGTG|C,CTG|2;HGVSnom=NM_005669.5:c.*793_*804delCACACACACACA;Gene=REEP5;Transcript=NM_005669.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=189;RS=rs60109818;CytoBand=q22.2;Strand=SRP19:NM_001204199.1:+,REEP5:NM_005669.4:-;NP=SRP19:NM_001204199.1:NP_001191128.1,REEP5:NM_005669.4:NP_005660.4;ENSP=SRP19:NM_001204199.1:.,REEP5:NM_005669.4:.;Gene_MIM_id=182175,125265;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6728,7905;EnsemblGeneID=ENSG00000153037,ENSG00000129625;Alias=SRP19,REEP5, D5S346, DP1, C5orf18;FLKSEQ=ACAGGTTACT.tgtgtgtgtg	GT:AD:DP:GQ:PL	0/1:8,399:567:99:21041,4219,2904
chr5	112213747	.	GTAAC	G	21218.7	PASS	AC=2;AF=1;AN=2;DP=633;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.64;SOR=1.171;HGVSnom=NM_005669.5:c.*732_*735delGTTA;Gene=REEP5;Transcript=NM_005669.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=189;RS=rs35202418;G1000_AF=0.625998;G1000_EAS_AF=0.8194;G1000_EUR_AF=0.6392;G1000_AFR_AF=0.3109;G1000_SAS_AF=0.7751;G1000_AMR_AF=0.7161;CytoBand=q22.2;Strand=SRP19:NM_001204199.1:+,REEP5:NM_005669.4:-;NP=SRP19:NM_001204199.1:NP_001191128.1,REEP5:NM_005669.4:NP_005660.4;ENSP=SRP19:NM_001204199.1:.,REEP5:NM_005669.4:.;Gene_MIM_id=182175,125265;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6728,7905;EnsemblGeneID=ENSG00000153037,ENSG00000129625;Alias=SRP19,REEP5, D5S346, DP1, C5orf18;FLKSEQ=ACTAGAGTGA.TAACTAACTA	GT:AD:DP:GQ:PL	1/1:0,479:479:99:21256,1447,0
chr5	131892979	.	G	A	13776.8	PASS	AC=2;AF=1;AN=2;DP=397;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.97;SOR=0.766;HGVSnom=NM_005732.4:c.-38G>A;Gene=RAD50;Transcript=NM_005732.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1312;EXAC_AF=0.97522860;EXAC_Hom_EAS=4326;EXAC_AC_EAS=8652;EXAC_AN_EAS=8652;EXAC_AC_Adj=118383;EXAC_AN_Adj=121390;ESP6500_MAF=0.91872982;RS=rs4526098;G1000_AF=0.92492;G1000_EAS_AF=0.999;G1000_EUR_AF=0.994;G1000_AFR_AF=0.7398;G1000_SAS_AF=0.9949;G1000_AMR_AF=0.9712;gnomad_exomes_AF=0.97909392;gnomad_exomes_AF_EAS=0.99989126;gnomad_exomes_AC=246201;gnomad_exomes_Hom=120992;gnomad_exomes_Het=4217;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75347778;gnomad_exomes_AF_NFE=0.99666825;gnomad_exomes_AF_AMR=0.98473547;gnomad_exomes_AF_SAS=0.99176847;NativeFreq_Het=0.0569;NativeFreq_Hom=1;DANN_score=0.9233;GREP_score=3.65;CytoBand=q31.1;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=RAD50:NM_005732.3:+;NP=RAD50:NM_005732.3:NP_005723.2;ENSP=RAD50:NM_005732.3:ENST00000378823.8;Gene_MIM_id=604040;Phenotypes=Nijmegen breakage syndrome-like disorder, 613078 (3). 613078(MK);Possible_Inheritance=NA;EntrezGeneID=10111;EnsemblGeneID=ENSG00000113522;Alias=RAD50, NBSLD;FLKSEQ=GCCTTTGTGG.CTCCAGGTCC	GT:AD:DP:GQ:PL	1/1:0,394:394:99:13805,1183,0
chr5	131915213	.	G	A	3739.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.616;DP=265;ExcessHet=3.0103;FS=5.515;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.11;ReadPosRankSum=-3.459;SOR=1.104;HGVSnom=NM_005732.4:c.551+19G>A;Gene=RAD50;Transcript=NM_005732.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_005732.4:IVS4+19G>A;AAlength=1312;EXAC_AF=0.19877365;EXAC_Hom_EAS=116;EXAC_AC_EAS=1468;EXAC_AN_EAS=8628;EXAC_AC_Adj=24021;EXAC_AN_Adj=120846;ESP6500_MAF=0.17586896;RS=rs17166050;CLNGENE=RAD50;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.167732;G1000_EAS_AF=0.1865;G1000_EUR_AF=0.1909;G1000_AFR_AF=0.1165;G1000_SAS_AF=0.2209;G1000_AMR_AF=0.1297;gnomad_exomes_AF=0.19716691;gnomad_exomes_AF_EAS=0.16835512;gnomad_exomes_AC=49412;gnomad_exomes_Hom=5184;gnomad_exomes_Het=39044;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11253277;gnomad_exomes_AF_NFE=0.20763654;gnomad_exomes_AF_AMR=0.14421351;gnomad_exomes_AF_SAS=0.22818550;HGMD_gene=RAD50;HGMD_disease=Acute_lymphoblastic_leukaemia_decreased_risk;HGMD_tag=DFP;HGMD_pmid=24093751;NativeFreq_Het=0.3465;NativeFreq_Hom=0.0594;normalHetFrequency=0.2964;normalHetNum=115;normalHomFrequency=0.0335;normalHomNum=13;patientHetFrequency=0.2846;patientHetNum=789;patientHomFrequency=0.0397;patientHomNum=110;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2867;AF_2700_Hom=0.0323;AF_50_Het=0.2552;AF_50_Hom=0.0380;DANN_score=0.4147;GREP_score=-2.79;CytoBand=q31.1;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=RAD50:NM_005732.3:+;NP=RAD50:NM_005732.3:NP_005723.2;ENSP=RAD50:NM_005732.3:ENST00000378823.8;Gene_MIM_id=604040;Phenotypes=Nijmegen breakage syndrome-like disorder, 613078 (3). 613078(MK);Possible_Inheritance=NA;EntrezGeneID=10111;EnsemblGeneID=ENSG00000113522;Alias=RAD50, NBSLD;FLKSEQ=CCCTTAAATA.ACTTTGTAGT	GT:AD:DP:GQ:PL	0/1:146,119:265:99:3768,0,4949
chr5	131972954	.	A	G	6661.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.409;DP=440;ExcessHet=3.0103;FS=1.729;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.21;ReadPosRankSum=0.678;SOR=0.799;HGVSnom=NM_005732.4:c.3475+62A>G|NR_132124.1:n.153+896T>C;Gene=RAD50|TH2LCRR;Transcript=NM_005732.4|NR_132124.1;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|noncoding_transcript_intron_variant;ExonIntron=I22|I2;IVSnom=NM_005732.4:IVS22+62A>G|NR_132124.1:IVS2+896T>C;AAlength=1312|.;RS=rs17166112;CLNGENE=RAD50|TH2-LCR|TH2LCRR;CLNSIG=Benign|Benign|Benign;CLNSIGINCL=nan|nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.0389377;G1000_EAS_AF=0.1815;G1000_EUR_AF=0.001;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0112;G1000_AMR_AF=0.0;NativeFreq_Het=0.1744;NativeFreq_Hom=0.0285;normalHetFrequency=0.1546;normalHetNum=60;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.1732;patientHetNum=480;patientHomFrequency=0.0148;patientHomNum=41;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8444;GREP_score=1.8;CytoBand=q31.1;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=RAD50:NM_005732.3:+;NP=RAD50:NM_005732.3:NP_005723.2;ENSP=RAD50:NM_005732.3:ENST00000378823.8;Gene_MIM_id=604040;Phenotypes=Nijmegen breakage syndrome-like disorder, 613078 (3). 613078(MK);Possible_Inheritance=NA;EntrezGeneID=10111;EnsemblGeneID=ENSG00000113522;Alias=RAD50, NBSLD;FLKSEQ=TCTTCCCCTT.TGACCTCTCA	GT:AD:DP:GQ:PL	0/1:230,208:438:99:6690,0,7175
chr5	131979650	.	TCA	T	3022.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.521;DP=177;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.17;ReadPosRankSum=0.115;SOR=0.683;HGVSnom=NM_005732.4:c.*1597_*1598delCA;Gene=RAD50;Transcript=NM_005732.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E25;IVSnom=.;AAlength=1312;RS=rs75929455;G1000_AF=0.0860623;G1000_EAS_AF=0.2897;G1000_EUR_AF=0.0179;G1000_AFR_AF=0.0234;G1000_SAS_AF=0.0317;G1000_AMR_AF=0.085;NativeFreq_Het=0.1980;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0011;patientHomNum=3;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D0062040|16D1536911-1|16B0017241][_];AF_2700_Het=0.3517;AF_2700_Hom=0.0646;AF_50_Het=0.3281;AF_50_Hom=0.0713;CytoBand=q31.1;repName=L1M5;repClass=LINE;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=RAD50:NM_005732.3:+;NP=RAD50:NM_005732.3:NP_005723.2;ENSP=RAD50:NM_005732.3:ENST00000378823.8;Gene_MIM_id=604040;Phenotypes=Nijmegen breakage syndrome-like disorder, 613078 (3). 613078(MK);Possible_Inheritance=NA;EntrezGeneID=10111;EnsemblGeneID=ENSG00000113522;Alias=RAD50, NBSLD;FLKSEQ=tttagcaaac.CAGTTTTGCA	GT:AD:DP:GQ:PL	0/1:96,80:176:99:3060,0,3831
chr5	147204192	.	G	A	4501.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.823;DP=300;ExcessHet=3.0103;FS=8.154;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.11;ReadPosRankSum=-0.149;SOR=0.396;HGVSnom=NM_001379610.1:c.*32C>T;Gene=SPINK1;Transcript=NM_001379610.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E4;IVSnom=.;AAlength=79;EXAC_AF=0.07727598;EXAC_Hom_EAS=24;EXAC_AC_EAS=657;EXAC_AN_EAS=8512;EXAC_AC_Adj=9298;EXAC_AN_Adj=120322;ESP6500_MAF=0.02629556;RS=rs11319;CLNGENE=SPINK1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0922524;G1000_EAS_AF=0.1012;G1000_EUR_AF=0.0408;G1000_AFR_AF=0.0106;G1000_SAS_AF=0.1871;G1000_AMR_AF=0.1758;gnomad_exomes_AF=0.08308918;gnomad_exomes_AF_EAS=0.07889277;gnomad_exomes_AC=20816;gnomad_exomes_Hom=1515;gnomad_exomes_Het=17786;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01695020;gnomad_exomes_AF_NFE=0.03807075;gnomad_exomes_AF_AMR=0.20647127;gnomad_exomes_AF_SAS=0.15595160;NativeFreq_Het=0.1815;NativeFreq_Hom=0;normalHetFrequency=0.1598;normalHetNum=62;normalHomFrequency=0.0077;normalHomNum=3;patientHetFrequency=0.1439;patientHetNum=399;patientHomFrequency=0.009;patientHomNum=25;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6524789|16D0169550|16B0050564][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0202464|15D6722341-1|16B0047609|17B0005664|16B0050566|16B0017983|15D6722291|16B3108924|16B0035706-1|16B1586209|15D6722305|16D1536929|16B3094924|16D1545956|17B0001555-1|16B3258314|16B0411369|16D0067156|16B0011863|16B0050584|17B0501030|16B0005663|16D1546066|16D1536870|16D0177666][_];DANN_score=0.5697;GREP_score=0.1;CytoBand=q32;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=SPINK1:NM_003122.4:-;NP=SPINK1:NM_003122.4:NP_003113.2;ENSP=SPINK1:NM_003122.4:ENST00000296695.9;Gene_MIM_id=167790;Phenotypes={Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3), Autosomal recessive, Autosomal dominant. Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Tropical calcific pancreatitis, 608189 (3), Autosomal recessive, Autosomal dominant. 167800(MK),608189(SK);Possible_Inheritance=AD,AR;EntrezGeneID=6690;EnsemblGeneID=ENSG00000164266;Alias=SPINK1, PSTI, PCTT, TATI, TCP;FLKSEQ=CAGGCCTCGC.GTGACCTGAT	GT:AD:DP:GQ:PL	0/1:154,144:298:99:4530,0,4362
chr5	162887650	.	G	A	6127.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.731;DP=432;ExcessHet=3.0103;FS=2.437;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.32;ReadPosRankSum=-0.585;SOR=0.867;HGVSnom=NM_001142556.2:c.-49G>A;Gene=HMMR;Transcript=NM_001142556.2;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=725;EXAC_AF=0.26725542;EXAC_Hom_EAS=150;EXAC_AC_EAS=1146;EXAC_AN_EAS=4178;EXAC_AC_Adj=14768;EXAC_AN_Adj=55258;ESP6500_MAF=0.18552976;RS=rs2303076;G1000_AF=0.240615;G1000_EAS_AF=0.2996;G1000_EUR_AF=0.2147;G1000_AFR_AF=0.0749;G1000_SAS_AF=0.4387;G1000_AMR_AF=0.2291;gnomad_exomes_AF=0.24438507;gnomad_exomes_AF_EAS=0.26560380;gnomad_exomes_AC=46832;gnomad_exomes_Hom=6542;gnomad_exomes_Het=33748;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09675248;gnomad_exomes_AF_NFE=0.21618345;gnomad_exomes_AF_AMR=0.19657607;gnomad_exomes_AF_SAS=0.43777865;NativeFreq_Het=0.3843;NativeFreq_Hom=0.0891;AF_2700_Het=0.3816;AF_2700_Hom=0.0669;AF_50_Het=0.3883;AF_50_Hom=0.0777;DANN_score=0.8289;GREP_score=3.51;CytoBand=q34;Strand=HMMR:NM_001142556.1:+,HMMR:NM_001142557.1:+,HMMR:NM_012484.2:+,HMMR:NM_012485.2:+,HMMR:NM_001142556.2:+;NP=HMMR:NM_001142556.1:NP_001136028.1,HMMR:NM_001142557.1:NP_001136029.1,HMMR:NM_012484.2:NP_036616.2,HMMR:NM_012485.2:NP_036617.2,HMMR:NM_001142556.2:NP_001136028.1;ENSP=HMMR:NM_001142556.1:.,HMMR:NM_001142557.1:.,HMMR:NM_012484.2:.,HMMR:NM_012485.2:.,HMMR:NM_001142556.2:ENST00000393915.9;Gene_MIM_id=600936;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=3161;EnsemblGeneID=ENSG00000072571;Alias=HMMR;FLKSEQ=TCCGCATTCA.TTGTCGAGGA	GT:AD:DP:GQ:PL	0/1:229,199:428:99:6156,0,7383
chr5	162890953	.	G	A	12176.8	PASS	AC=2;AF=1;AN=2;DP=339;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33;SOR=1.017;HGVSnom=NM_001142556.2:c.138A>A(p.Gln46Gln/p.Q46Q);Gene=HMMR;Transcript=NM_001142556.2;VarType=NoCall;MolecularConsequence=nocall_variant;ExonIntron=E2;IVSnom=.;AAlength=725;EXAC_AF=0.99998027;EXAC_Hom_EAS=3921;EXAC_AC_EAS=7842;EXAC_AN_EAS=7842;EXAC_AC_Adj=101380;EXAC_AN_Adj=101382;RS=rs380101|rs758820243;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99997354;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=151196;gnomad_exomes_Hom=75596;gnomad_exomes_Het=4;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99989804;gnomad_exomes_AF_NFE=0.99996003;gnomad_exomes_AF_AMR=1.00000000;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.462;GREP_score=-2.57;CytoBand=q34;Strand=HMMR:NM_001142556.1:+,HMMR:NM_001142557.1:+,HMMR:NM_012484.2:+,HMMR:NM_012485.2:+,HMMR:NM_001142556.2:+;NP=HMMR:NM_001142556.1:NP_001136028.1,HMMR:NM_001142557.1:NP_001136029.1,HMMR:NM_012484.2:NP_036616.2,HMMR:NM_012485.2:NP_036617.2,HMMR:NM_001142556.2:NP_001136028.1;ENSP=HMMR:NM_001142556.1:.,HMMR:NM_001142557.1:.,HMMR:NM_012484.2:.,HMMR:NM_012485.2:.,HMMR:NM_001142556.2:ENST00000393915.9;Gene_MIM_id=600936;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=3161;EnsemblGeneID=ENSG00000072571;Alias=HMMR;FLKSEQ=GATTTAAACA.CAAAAAGGTA	GT:AD:DP:GQ:PL	1/1:0,338:338:99:12205,1014,0
chr5	162896856	.	T	C	2602.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.394;DP=158;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.58;ReadPosRankSum=-0.688;SOR=0.685;HGVSnom=NM_001142556.2:c.462+21T>C;Gene=HMMR;Transcript=NM_001142556.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_001142556.2:IVS5+21T>C;AAlength=725;EXAC_AF=0.36098746;EXAC_Hom_EAS=1338;EXAC_AC_EAS=4764;EXAC_AN_EAS=8460;EXAC_AC_Adj=42333;EXAC_AN_Adj=117270;ESP6500_MAF=0.38728279;RS=rs299283;G1000_AF=0.422524;G1000_EAS_AF=0.5288;G1000_EUR_AF=0.3002;G1000_AFR_AF=0.5968;G1000_SAS_AF=0.2689;G1000_AMR_AF=0.33;gnomad_exomes_AF=0.35327161;gnomad_exomes_AF_EAS=0.55609386;gnomad_exomes_AC=82195;gnomad_exomes_Hom=15560;gnomad_exomes_Het=51075;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57606192;gnomad_exomes_AF_NFE=0.30368104;gnomad_exomes_AF_AMR=0.38299706;gnomad_exomes_AF_SAS=0.29761905;NativeFreq_Het=0.4851;NativeFreq_Hom=0.2871;AF_2700_Het=0.4750;AF_2700_Hom=0.3259;AF_50_Het=0.4802;AF_50_Hom=0.3090;DANN_score=0.6004;GREP_score=2.5;CytoBand=q34;Strand=HMMR:NM_001142556.1:+,HMMR:NM_001142557.1:+,HMMR:NM_012484.2:+,HMMR:NM_012485.2:+,HMMR:NM_001142556.2:+;NP=HMMR:NM_001142556.1:NP_001136028.1,HMMR:NM_001142557.1:NP_001136029.1,HMMR:NM_012484.2:NP_036616.2,HMMR:NM_012485.2:NP_036617.2,HMMR:NM_001142556.2:NP_001136028.1;ENSP=HMMR:NM_001142556.1:.,HMMR:NM_001142557.1:.,HMMR:NM_012484.2:.,HMMR:NM_012485.2:.,HMMR:NM_001142556.2:ENST00000393915.9;Gene_MIM_id=600936;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=3161;EnsemblGeneID=ENSG00000072571;Alias=HMMR;FLKSEQ=CTCATGATAA.ATTTACAATT	GT:AD:DP:GQ:PL	0/1:82,75:157:99:2631,0,2587
chr5	162902516	.	T	C	3942.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.037;DP=267;ExcessHet=3.0103;FS=2.853;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.82;ReadPosRankSum=2.025;SOR=0.525;HGVSnom=NM_001142556.2:c.1106T>C(p.Val369Ala/p.V369A);Gene=HMMR;Transcript=NM_001142556.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=725;EXAC_AF=0.28388130;EXAC_Hom_EAS=1119;EXAC_AC_EAS=4357;EXAC_AN_EAS=8632;EXAC_AC_Adj=34382;EXAC_AN_Adj=121114;ESP6500_MAF=0.26357066;RS=rs299290;Ensembl_transcriptid=ENST00000353866|ENST00000393915|ENST00000432118|ENST00000358715;SIFT_pred=T|T|T|T;SIFT_score=0.214|0.195|0.21|0.2;Polyphen2_HVAR_pred=B|B|B|B;Polyphen2_HVAR_score=0.021|0.006|0.034|0.021;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|1|1|1;G1000_AF=0.3127;G1000_EAS_AF=0.4841;G1000_EUR_AF=0.2604;G1000_AFR_AF=0.2935;G1000_SAS_AF=0.2526;G1000_AMR_AF=0.2608;gnomad_exomes_AF=0.28273526;gnomad_exomes_AF_EAS=0.50464684;gnomad_exomes_AC=70707;gnomad_exomes_Hom=10744;gnomad_exomes_Het=49219;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.30044455;gnomad_exomes_AF_NFE=0.24983664;gnomad_exomes_AF_AMR=0.29772621;gnomad_exomes_AF_SAS=0.27016978;NativeFreq_Het=0.4342;NativeFreq_Hom=0.2574;AF_2700_Het=0.4858;AF_2700_Hom=0.2606;AF_50_Het=0.4834;AF_50_Hom=0.2488;DANN_score=0.5392;GREP_score=-3.29;CytoBand=q34;Strand=HMMR:NM_001142556.1:+,HMMR:NM_001142557.1:+,HMMR:NM_012484.2:+,HMMR:NM_012485.2:+,HMMR:NM_001142556.2:+;NP=HMMR:NM_001142556.1:NP_001136028.1,HMMR:NM_001142557.1:NP_001136029.1,HMMR:NM_012484.2:NP_036616.2,HMMR:NM_012485.2:NP_036617.2,HMMR:NM_001142556.2:NP_001136028.1;ENSP=HMMR:NM_001142556.1:.,HMMR:NM_001142557.1:.,HMMR:NM_012484.2:.,HMMR:NM_012485.2:.,HMMR:NM_001142556.2:ENST00000393915.9;Gene_MIM_id=600936;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=3161;EnsemblGeneID=ENSG00000072571;Alias=HMMR;FLKSEQ=GAGGAAATGG.TAAAGAGAAG	GT:AD:DP:GQ:PL	0/1:144,122:266:99:3971,0,4284
chr5	162902707	.	G	A	2337.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.657;DP=150;ExcessHet=3.0103;FS=8.42;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.69;ReadPosRankSum=0.209;SOR=0.211;HGVSnom=NM_001142556.2:c.1268+29G>A;Gene=HMMR;Transcript=NM_001142556.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001142556.2:IVS11+29G>A;AAlength=725;EXAC_AF=0.37912668;EXAC_Hom_EAS=981;EXAC_AC_EAS=3574;EXAC_AN_EAS=6156;EXAC_AC_Adj=33740;EXAC_AN_Adj=88994;ESP6500_MAF=0.37695524;RS=rs299291;G1000_AF=0.421925;G1000_EAS_AF=0.5288;G1000_EUR_AF=0.3002;G1000_AFR_AF=0.5953;G1000_SAS_AF=0.2679;G1000_AMR_AF=0.33;gnomad_exomes_AF=0.34804578;gnomad_exomes_AF_EAS=0.55185868;gnomad_exomes_AC=65986;gnomad_exomes_Hom=12200;gnomad_exomes_Het=41586;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.56862597;gnomad_exomes_AF_NFE=0.30003150;gnomad_exomes_AF_AMR=0.36828260;gnomad_exomes_AF_SAS=0.28803313;NativeFreq_Het=0.4851;NativeFreq_Hom=0.2871;AF_2700_Het=0.4731;AF_2700_Hom=0.3263;AF_50_Het=0.4770;AF_50_Hom=0.3090;DANN_score=0.6465;GREP_score=-3.98;CytoBand=q34;Strand=HMMR:NM_001142556.1:+,HMMR:NM_001142557.1:+,HMMR:NM_012484.2:+,HMMR:NM_012485.2:+,HMMR:NM_001142556.2:+;NP=HMMR:NM_001142556.1:NP_001136028.1,HMMR:NM_001142557.1:NP_001136029.1,HMMR:NM_012484.2:NP_036616.2,HMMR:NM_012485.2:NP_036617.2,HMMR:NM_001142556.2:NP_001136028.1;ENSP=HMMR:NM_001142556.1:.,HMMR:NM_001142557.1:.,HMMR:NM_012484.2:.,HMMR:NM_012485.2:.,HMMR:NM_001142556.2:ENST00000393915.9;Gene_MIM_id=600936;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=3161;EnsemblGeneID=ENSG00000072571;Alias=HMMR;FLKSEQ=TCATGTTTAT.TATGACTTCA	GT:AD:DP:GQ:PL	0/1:72,77:149:99:2366,0,2269
chr6	3000303	.	A	C	5584.77	PASS	AC=2;AF=1;AN=2;DP=159;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.03;SOR=1.04;HGVSnom=NM_000904.6:c.-102A>C;Gene=NQO2;Transcript=NM_000904.6;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=231;RS=rs2071002;G1000_AF=0.32488;G1000_EAS_AF=0.3413;G1000_EUR_AF=0.2932;G1000_AFR_AF=0.3865;G1000_SAS_AF=0.2607;G1000_AMR_AF=0.3199;HGMD_gene=NQO2;HGMD_disease=Breast_cancer_decreased_risk_association_with;HGMD_tag=DFP;HGMD_pmid=19351655;NativeFreq_Het=0.4455;NativeFreq_Hom=0.1485;AF_2700_Het=0.4612;AF_2700_Hom=0.1164;AF_50_Het=0.4992;AF_50_Hom=0.1030;DANN_score=0.6448;GREP_score=-3.9;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=CCTACTGGGG.GTGCGCTGGT	GT:AD:DP:GQ:PL	1/1:0,158:158:99:5613,475,0
chr6	3006687	.	C	T	10195.8	PASS	AC=2;AF=1;AN=2;DP=279;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.37;SOR=1.229;HGVSnom=NM_000904.6:c.-85-15C>T;Gene=NQO2;Transcript=NM_000904.6;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_000904.6:IVS1-15C>T;AAlength=231;EXAC_AF=0.09562296;EXAC_Hom_EAS=74;EXAC_AC_EAS=1178;EXAC_AN_EAS=4738;EXAC_AC_Adj=6519;EXAC_AN_Adj=68174;RS=rs3757080;G1000_AF=0.0611022;G1000_EAS_AF=0.1558;G1000_EUR_AF=0.0517;G1000_AFR_AF=0.0053;G1000_SAS_AF=0.0501;G1000_AMR_AF=0.0591;gnomad_exomes_AF=0.06722874;gnomad_exomes_AF_EAS=0.16505031;gnomad_exomes_AC=15294;gnomad_exomes_Hom=652;gnomad_exomes_Het=13990;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01203060;gnomad_exomes_AF_NFE=0.05444241;gnomad_exomes_AF_AMR=0.11622004;gnomad_exomes_AF_SAS=0.05184805;NativeFreq_Het=0.3168;NativeFreq_Hom=0.0198;AF_2700_Het=0.2533;AF_2700_Hom=0.0292;AF_50_Het=0.2805;AF_50_Hom=0.0222;DANN_score=0.276;GREP_score=-2.11;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=CCTCTGGGTT.GTTTTGTCTT	GT:AD:DP:GQ:PL	1/1:0,279:279:99:10224,839,0
chr6	3006821	.	CT	C	145.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.257;DP=213;ExcessHet=3.0103;FS=5.33;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.78;ReadPosRankSum=-0.421;SOR=1.453;HGVSnom=NM_000904.6:c.7+40delT;Gene=NQO2;Transcript=NM_000904.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000904.6:IVS2+40delT;AAlength=231;EXAC_AF=0.14942896;EXAC_Hom_EAS=0;EXAC_AC_EAS=140;EXAC_AN_EAS=1264;EXAC_AC_Adj=3742;EXAC_AN_Adj=25042;RS=rs371505172;gnomad_exomes_AF=0.22684381;gnomad_exomes_AF_EAS=0.24870912;gnomad_exomes_AC=15145;gnomad_exomes_Hom=0;gnomad_exomes_Het=15145;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16469816;gnomad_exomes_AF_NFE=0.21462482;gnomad_exomes_AF_AMR=0.27305476;gnomad_exomes_AF_SAS=0.27672273;AF_2700_Het=0.0346;AF_2700_Hom=.;AF_50_Het=0.0317;AF_50_Hom=.;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TGGAGTAAGA.tttttttttt	GT:AD:DP:GQ:PL	0/1:159,29:188:99:183,0,3411
chr6	3010390	.	C	T	13471.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.082;DP=357;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.53;ReadPosRankSum=-1.412;SOR=0.83;HGVSnom=NM_000904.6:c.139C>T(p.Leu47Phe/p.L47F);Gene=NQO2;Transcript=NM_000904.6;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E3;IVSnom=.;AAlength=231;EXAC_AF=0.79059864;EXAC_Hom_EAS=1789;EXAC_AC_EAS=5614;EXAC_AN_EAS=8608;EXAC_AC_Adj=95800;EXAC_AN_Adj=121174;ESP6500_MAF=0.84284177;RS=rs1143684;Ensembl_transcriptid=ENST00000426637|ENST00000380472|ENST00000397717|ENST00000338130|ENST00000380441|ENST00000380455|ENST00000380454|ENST00000380430;SIFT_pred=T|T|T|T|T|T|T|T;SIFT_score=1.0|1.0|1.0|1.0|1.0|1.0|1.0|1.0;Polyphen2_HVAR_pred=.|.|.|B|.|B|.|B;Polyphen2_HVAR_score=.|.|.|0.0|.|0.0|.|0.0;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=0.999647|0.999647|0.999647|0.999647|0.999647;G1000_AF=0.797524;G1000_EAS_AF=0.6558;G1000_EUR_AF=0.7893;G1000_AFR_AF=0.9849;G1000_SAS_AF=0.7198;G1000_AMR_AF=0.768;gnomad_exomes_AF=0.78655439;gnomad_exomes_AF_EAS=0.65179157;gnomad_exomes_AC=196615;gnomad_exomes_Hom=77920;gnomad_exomes_Het=40775;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96372706;gnomad_exomes_AF_NFE=0.78827770;gnomad_exomes_AF_AMR=0.78397489;gnomad_exomes_AF_SAS=0.73715506;HGMD_gene=NQO2;HGMD_disease=Delayed_memory_recall_association_with;HGMD_tag=DP;HGMD_pmid=18538895;NativeFreq_Het=0.4851;NativeFreq_Hom=0.5623;AF_2700_Het=0.4470;AF_2700_Hom=0.4497;AF_50_Het=0.4279;AF_50_Hom=0.4865;DANN_score=0.187;GREP_score=5.63;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TGCCATGAAC.TTGAGCCGAG	GT:AD:DP:GQ:PL	1/1:1,355:356:99:13500,1032,0
chr6	3010459	.	C	T	7510.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.779;DP=204;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.93;ReadPosRankSum=-0.624;SOR=2.313;HGVSnom=NM_000904.6:c.172+36C>T;Gene=NQO2;Transcript=NM_000904.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_000904.6:IVS3+36C>T;AAlength=231;EXAC_AF=0.50535605;EXAC_Hom_EAS=732;EXAC_AC_EAS=3167;EXAC_AN_EAS=6132;EXAC_AC_Adj=46327;EXAC_AN_Adj=91672;ESP6500_MAF=0.51729971;RS=rs2475208;G1000_AF=0.536542;G1000_EAS_AF=0.5327;G1000_EUR_AF=0.4871;G1000_AFR_AF=0.6256;G1000_SAS_AF=0.5276;G1000_AMR_AF=0.4568;gnomad_exomes_AF=0.49619084;gnomad_exomes_AF_EAS=0.50782933;gnomad_exomes_AC=91835;gnomad_exomes_Hom=22478;gnomad_exomes_Het=46879;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59587021;gnomad_exomes_AF_NFE=0.47714827;gnomad_exomes_AF_AMR=0.46914958;gnomad_exomes_AF_SAS=0.52971733;NativeFreq_Het=0.5552;NativeFreq_Hom=0.2420;DANN_score=0.4137;GREP_score=-2.23;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TTATAAAAAC.ATCTTTATGT	GT:AD:DP:GQ:PL	1/1:1,202:203:99:7539,568,0
chr6	3015790	.	A	G	12496.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.181;DP=369;ExcessHet=3.0103;FS=3;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.96;ReadPosRankSum=-0.66;SOR=0.135;HGVSnom=NM_000904.6:c.330A>G(p.Pro110Pro/p.P110P);Gene=NQO2;Transcript=NM_000904.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E5;IVSnom=.;AAlength=231;EXAC_AF=0.72833633;EXAC_Hom_EAS=1803;EXAC_AC_EAS=5638;EXAC_AN_EAS=8626;EXAC_AC_Adj=88337;EXAC_AN_Adj=121286;ESP6500_MAF=0.77956328;RS=rs1049115;G1000_AF=0.757388;G1000_EAS_AF=0.6538;G1000_EUR_AF=0.7147;G1000_AFR_AF=0.9312;G1000_SAS_AF=0.6902;G1000_AMR_AF=0.7334;gnomad_exomes_AF=0.72559256;gnomad_exomes_AF_EAS=0.65231824;gnomad_exomes_AC=182205;gnomad_exomes_Hom=66639;gnomad_exomes_Het=48927;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.90515756;gnomad_exomes_AF_NFE=0.72030793;gnomad_exomes_AF_AMR=0.74133642;gnomad_exomes_AF_SAS=0.69937929;NativeFreq_Het=0.4851;NativeFreq_Hom=0.5018;AF_2700_Het=0.4470;AF_2700_Hom=0.4493;AF_50_Het=0.4295;AF_50_Hom=0.4834;DANN_score=0.5621;GREP_score=-6.88;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TCAGCGTGCC.GCCATCCTGA	GT:AD:DP:GQ:PL	1/1:2,366:368:99:12525,1023,0
chr6	3015865	.	C	T	14764.8	PASS	AC=2;AF=1;AN=2;DP=394;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.8;SOR=1.027;HGVSnom=NM_000904.6:c.405C>T(p.Ser135Ser/p.S135S);Gene=NQO2;Transcript=NM_000904.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E5;IVSnom=.;AAlength=231;EXAC_AF=0.11480619;EXAC_Hom_EAS=100;EXAC_AC_EAS=1488;EXAC_AN_EAS=8626;EXAC_AC_Adj=13909;EXAC_AN_Adj=121152;ESP6500_MAF=0.15016146;RS=rs4149367;G1000_AF=0.179313;G1000_EAS_AF=0.1567;G1000_EUR_AF=0.0696;G1000_AFR_AF=0.3608;G1000_SAS_AF=0.1237;G1000_AMR_AF=0.1037;gnomad_exomes_AF=0.11432507;gnomad_exomes_AF_EAS=0.17239504;gnomad_exomes_AC=28718;gnomad_exomes_Hom=2345;gnomad_exomes_Het=24028;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32715289;gnomad_exomes_AF_NFE=0.06736034;gnomad_exomes_AF_AMR=0.19403287;gnomad_exomes_AF_SAS=0.11474124;NativeFreq_Het=0.3168;NativeFreq_Hom=0.0214;AF_2700_Het=0.2633;AF_2700_Hom=0.0315;AF_50_Het=0.2884;AF_50_Hom=0.0269;DANN_score=0.5066;GREP_score=-5.84;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TCTACGATTC.GGTTTGCTCC	GT:AD:DP:GQ:PL	1/1:0,391:391:99:14793,1176,0
chr6	3015898	.	A	T	12457.8	PASS	AC=2;AF=1;AN=2;DP=338;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.66;SOR=1.866;HGVSnom=NM_000904.6:c.417+21A>T;Gene=NQO2;Transcript=NM_000904.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000904.6:IVS5+21A>T;AAlength=231;EXAC_AF=0.11499104;EXAC_Hom_EAS=98;EXAC_AC_EAS=1490;EXAC_AN_EAS=8554;EXAC_AC_Adj=13867;EXAC_AN_Adj=120592;ESP6500_MAF=0.15023835;RS=rs4149368;G1000_AF=0.179712;G1000_EAS_AF=0.1587;G1000_EUR_AF=0.0696;G1000_AFR_AF=0.3608;G1000_SAS_AF=0.1237;G1000_AMR_AF=0.1037;gnomad_exomes_AF=0.11450589;gnomad_exomes_AF_EAS=0.17302244;gnomad_exomes_AC=28618;gnomad_exomes_Hom=2326;gnomad_exomes_Het=23966;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32703937;gnomad_exomes_AF_NFE=0.06743931;gnomad_exomes_AF_AMR=0.19415808;gnomad_exomes_AF_SAS=0.11497379;NativeFreq_Het=0.3168;NativeFreq_Hom=0.0214;AF_2700_Het=0.2644;AF_2700_Hom=0.0311;AF_50_Het=0.2884;AF_50_Hom=0.0269;DANN_score=0.7371;GREP_score=-4.48;CytoBand=p25.2;Strand=NQO2:NM_000904.4:+,NQO2:NM_001290221.1:+,NQO2:NM_001290222.1:+,NQO2:NM_001318940.1:+;NP=NQO2:NM_000904.4:NP_000895.2,NQO2:NM_001290221.1:NP_001277150.1,NQO2:NM_001290222.1:NP_001277151.1,NQO2:NM_001318940.1:NP_001305869.1;ENSP=NQO2:NM_000904.4:ENST00000380455.9,NQO2:NM_001290221.1:.,NQO2:NM_001290222.1:.,NQO2:NM_001318940.1:.;Gene_MIM_id=160998;Phenotypes={?Breast cancer susceptibility}, 114480 (1), Autosomal dominant. 114480(SA);Possible_Inheritance=AD;EntrezGeneID=4835;EnsemblGeneID=ENSG00000124588;Alias=NQO2, NMOR2;FLKSEQ=TTGGATAAGG.TCACTATGGA	GT:AD:DP:GQ:PL	1/1:0,335:335:99:12486,1007,0
chr6	35423489	.	A	G	9998.77	PASS	AC=2;AF=1;AN=2;DP=267;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.81;SOR=2.045;HGVSnom=NM_021922.3:c.249-35A>G;Gene=FANCE;Transcript=NM_021922.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_021922.3:IVS1-35A>G;AAlength=536;EXAC_AF=0.72009427;EXAC_Hom_EAS=2032;EXAC_AC_EAS=5904;EXAC_AN_EAS=8636;EXAC_AC_Adj=87382;EXAC_AN_Adj=121348;ESP6500_MAF=0.73412271;RS=rs7757405;CLNGENE=FANCE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.776558;G1000_EAS_AF=0.7123;G1000_EUR_AF=0.6779;G1000_AFR_AF=0.888;G1000_SAS_AF=0.7648;G1000_AMR_AF=0.817;gnomad_exomes_AF=0.72051095;gnomad_exomes_AF_EAS=0.68172920;gnomad_exomes_AC=179596;gnomad_exomes_Hom=65313;gnomad_exomes_Het=48970;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.86684314;gnomad_exomes_AF_NFE=0.67342900;gnomad_exomes_AF_AMR=0.81951431;gnomad_exomes_AF_SAS=0.74666841;NativeFreq_Het=0.5148;NativeFreq_Hom=0.4515;normalHetFrequency=0.3688;normalHetNum=319;normalHomFrequency=0.4879;normalHomNum=422;patientHetFrequency=0.4193;patientHetNum=2189;patientHomFrequency=0.4648;patientHomNum=2426;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7301;GREP_score=4.87;CytoBand=p21.31;CGD_CONDITION=Fanconi anemia, complementation group E;CGD_INHERITANCE=AR;Strand=FANCE:NM_021922.3:+,FANCE:NM_021922.2:+;NP=FANCE:NM_021922.3:NP_068741.1,FANCE:NM_021922.2:NP_068741.1;ENSP=FANCE:NM_021922.3:ENST00000229769.3,FANCE:NM_021922.2:ENST00000229769.2;Gene_MIM_id=613976;Phenotypes=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive. 600901(MK);Possible_Inheritance=AR;EntrezGeneID=2178;EnsemblGeneID=ENSG00000112039;Alias=FANCE, FACE;FLKSEQ=CCTTCAGCCA.ACACTTAACT	GT:AD:DP:GQ:PL	1/1:0,264:264:99:10027,793,0
chr6	35423662	.	A	C	14129.8	PASS	AC=2;AF=1;AN=2;DP=407;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.89;SOR=0.738;HGVSnom=NM_021922.3:c.387A>C(p.Pro129Pro/p.P129P);Gene=FANCE;Transcript=NM_021922.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=536;EXAC_AF=0.72113957;EXAC_Hom_EAS=2035;EXAC_AC_EAS=5907;EXAC_AN_EAS=8638;EXAC_AC_Adj=87405;EXAC_AN_Adj=121204;ESP6500_MAF=0.73566046;RS=rs4713867;CLNGENE=FANCE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.777955;G1000_EAS_AF=0.7133;G1000_EUR_AF=0.6779;G1000_AFR_AF=0.8911;G1000_SAS_AF=0.7669;G1000_AMR_AF=0.817;gnomad_exomes_AF=0.72087543;gnomad_exomes_AF_EAS=0.68189730;gnomad_exomes_AC=181094;gnomad_exomes_Hom=65881;gnomad_exomes_Het=49332;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87199704;gnomad_exomes_AF_NFE=0.67339860;gnomad_exomes_AF_AMR=0.82086056;gnomad_exomes_AF_SAS=0.74784370;NativeFreq_Het=0.5049;NativeFreq_Hom=0.4515;normalHetFrequency=0.3688;normalHetNum=319;normalHomFrequency=0.4879;normalHomNum=422;patientHetFrequency=0.4203;patientHetNum=2194;patientHomFrequency=0.4646;patientHomNum=2425;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4220;AF_2700_Hom=0.4773;AF_50_Het=0.4422;AF_50_Hom=0.4532;DANN_score=0.3909;GREP_score=-5.16;CytoBand=p21.31;CGD_CONDITION=Fanconi anemia, complementation group E;CGD_INHERITANCE=AR;Strand=FANCE:NM_021922.3:+,FANCE:NM_021922.2:+;NP=FANCE:NM_021922.3:NP_068741.1,FANCE:NM_021922.2:NP_068741.1;ENSP=FANCE:NM_021922.3:ENST00000229769.3,FANCE:NM_021922.2:ENST00000229769.2;Gene_MIM_id=613976;Phenotypes=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive. 600901(MK);Possible_Inheritance=AR;EntrezGeneID=2178;EnsemblGeneID=ENSG00000112039;Alias=FANCE, FACE;FLKSEQ=CCCCTGACCC.GATGCCTGGC	GT:AD:DP:GQ:PL	1/1:0,405:405:99:14158,1216,0
chr6	35427556	.	G	A	4354.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.971;DP=376;ExcessHet=3.0103;FS=0.791;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.61;ReadPosRankSum=0.379;SOR=0.756;HGVSnom=NM_021922.3:c.1316+19G>A;Gene=FANCE;Transcript=NM_021922.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_021922.3:IVS7+19G>A;AAlength=536;EXAC_AF=0.09763192;EXAC_Hom_EAS=64;EXAC_AC_EAS=946;EXAC_AN_EAS=8634;EXAC_AC_Adj=11849;EXAC_AN_Adj=121364;ESP6500_MAF=0.15046901;RS=rs6457823;CLNGENE=FANCE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.189497;G1000_EAS_AF=0.119;G1000_EUR_AF=0.0368;G1000_AFR_AF=0.4357;G1000_SAS_AF=0.183;G1000_AMR_AF=0.0533;gnomad_exomes_AF=0.09050613;gnomad_exomes_AF_EAS=0.11103861;gnomad_exomes_AC=22746;gnomad_exomes_Hom=1950;gnomad_exomes_Het=18846;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36723268;gnomad_exomes_AF_NFE=0.05378672;gnomad_exomes_AF_AMR=0.05123757;gnomad_exomes_AF_SAS=0.16146208;NativeFreq_Het=0.2178;NativeFreq_Hom=0.0198;normalHetFrequency=0.1503;normalHetNum=130;normalHomFrequency=0.0127;normalHomNum=11;patientHetFrequency=0.1602;patientHetNum=836;patientHomFrequency=0.0109;patientHomNum=57;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1691;AF_2700_Hom=0.0108;AF_50_Het=0.1823;AF_50_Hom=0.0095;DANN_score=0.5111;GREP_score=-8.16;CytoBand=p21.31;CGD_CONDITION=Fanconi anemia, complementation group E;CGD_INHERITANCE=AR;Strand=FANCE:NM_021922.3:+,FANCE:NM_021922.2:+;NP=FANCE:NM_021922.3:NP_068741.1,FANCE:NM_021922.2:NP_068741.1;ENSP=FANCE:NM_021922.3:ENST00000229769.3,FANCE:NM_021922.2:ENST00000229769.2;Gene_MIM_id=613976;Phenotypes=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive. 600901(MK);Possible_Inheritance=AR;EntrezGeneID=2178;EnsemblGeneID=ENSG00000112039;Alias=FANCE, FACE;FLKSEQ=GCAGGCCTCC.TGCTGTCCCC	GT:AD:DP:GQ:PL	0/1:212,163:375:99:4383,0,6021
chr6	35430686	.	G	A	3624.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.548;DP=264;ExcessHet=3.0103;FS=4.974;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.73;ReadPosRankSum=-0.02;SOR=0.995;HGVSnom=NM_021922.3:c.1504G>A(p.Ala502Thr/p.A502T);Gene=FANCE;Transcript=NM_021922.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=536;EXAC_AF=0.09787318;EXAC_Hom_EAS=66;EXAC_AC_EAS=950;EXAC_AN_EAS=8652;EXAC_AC_Adj=11882;EXAC_AN_Adj=121402;ESP6500_MAF=0.15100723;RS=rs9462088;Ensembl_transcriptid=ENST00000229769;SIFT_pred=T;SIFT_score=0.885;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.009;MutationTaster_pred=P;MutationTaster_score=0.938622;CLNGENE=FANCE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.189497;G1000_EAS_AF=0.119;G1000_EUR_AF=0.0368;G1000_AFR_AF=0.4357;G1000_SAS_AF=0.183;G1000_AMR_AF=0.0533;gnomad_exomes_AF=0.09060109;gnomad_exomes_AF_EAS=0.11134065;gnomad_exomes_AC=22784;gnomad_exomes_Hom=1975;gnomad_exomes_Het=18834;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36918533;gnomad_exomes_AF_NFE=0.05369889;gnomad_exomes_AF_AMR=0.05131244;gnomad_exomes_AF_SAS=0.16151685;NativeFreq_Het=0.2178;NativeFreq_Hom=0.0198;normalHetFrequency=0.1526;normalHetNum=132;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.1609;patientHetNum=840;patientHomFrequency=0.0105;patientHomNum=55;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1687;AF_2700_Hom=0.0108;AF_50_Het=0.1823;AF_50_Hom=0.0095;DANN_score=0.8098;GREP_score=3.16;CytoBand=p21.31;CGD_CONDITION=Fanconi anemia, complementation group E;CGD_INHERITANCE=AR;Strand=FANCE:NM_021922.3:+,FANCE:NM_021922.2:+;NP=FANCE:NM_021922.3:NP_068741.1,FANCE:NM_021922.2:NP_068741.1;ENSP=FANCE:NM_021922.3:ENST00000229769.3,FANCE:NM_021922.2:ENST00000229769.2;Gene_MIM_id=613976;Phenotypes=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive. 600901(MK);Possible_Inheritance=AR;EntrezGeneID=2178;EnsemblGeneID=ENSG00000112039;Alias=FANCE, FACE;FLKSEQ=CAAGTATCAG.CTAACGTGAG	GT:AD:DP:GQ:PL	0/1:136,128:264:99:3653,0,4169
chr6	35434337	.	TC	T	2750.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.393;DP=283;ExcessHet=3.0103;FS=0.508;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.15;ReadPosRankSum=1.761;SOR=0.753;HGVSnom=NM_021922.3:c.*216delC;Gene=FANCE;Transcript=NM_021922.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=536;RS=rs45584740;CLNGENE=FANCE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.143371;G1000_EAS_AF=0.119;G1000_EUR_AF=0.0129;G1000_AFR_AF=0.2874;G1000_SAS_AF=0.183;G1000_AMR_AF=0.0375;NativeFreq_Het=0.1139;NativeFreq_Hom=.;normalHetFrequency=0.126;normalHetNum=109;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.1412;patientHetNum=737;patientHomFrequency=0.0111;patientHomNum=58;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1664;AF_2700_Hom=0.0104;AF_50_Het=0.1775;AF_50_Hom=0.0095;CytoBand=p21.31;repName=AluJb;repClass=SINE;CGD_CONDITION=Fanconi anemia, complementation group E;CGD_INHERITANCE=AR;Strand=FANCE:NM_021922.3:+,FANCE:NM_021922.2:+;NP=FANCE:NM_021922.3:NP_068741.1,FANCE:NM_021922.2:NP_068741.1;ENSP=FANCE:NM_021922.3:ENST00000229769.3,FANCE:NM_021922.2:ENST00000229769.2;Gene_MIM_id=613976;Phenotypes=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive. 600901(MK);Possible_Inheritance=AR;EntrezGeneID=2178;EnsemblGeneID=ENSG00000112039;Alias=FANCE, FACE;FLKSEQ=AGCTATAttt.tttttcattt	GT:AD:DP:GQ:PL	0/1:144,127:271:99:2788,0,4724
chr6	43544209	.	G	C	5756.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.239;DP=374;ExcessHet=3.0103;FS=1.579;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.52;ReadPosRankSum=-0.956;SOR=0.803;HGVSnom=NM_006502.3:c.-5+32G>C;Gene=POLH;Transcript=NM_006502.3;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_006502.3:IVS1+32G>C;AAlength=713;RS=rs9333501;G1000_AF=0.0173722;G1000_EAS_AF=0.005;G1000_EUR_AF=0.0268;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.047;G1000_AMR_AF=0.0115;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0078;patientHetNum=19;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][16D1545773];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15B0047193-1|15D6482003-1|15D6534412|16D0162398|15D6518765|16D0177832-1|15D6532198|16D1546135|15D6482053-1|15D6482348|16D0166214|15D6722513-1|14D1336304-1|16D1545644|15B6217429-1|16B0005479|16B0011650|15D6529869|15D6722424-1];patientHomSampleInfo=[_][_];DANN_score=0.5956;GREP_score=-1.59;CytoBand=p21.1;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=CGCTGTCACT.TGTTCAGACT	GT:AD:DP:GQ:PL	0/1:198,173:371:99:5785,0,6217
chr6	43581935	.	A	G	6454.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.601;DP=411;ExcessHet=3.0103;FS=2.447;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.74;ReadPosRankSum=0.022;SOR=0.535;HGVSnom=NM_006502.3:c.1783A>G(p.Met595Val/p.M595V);Gene=POLH;Transcript=NM_006502.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=713;EXAC_AF=0.02246709;EXAC_Hom_EAS=0;EXAC_AC_EAS=17;EXAC_AN_EAS=8654;EXAC_AC_Adj=2724;EXAC_AN_Adj=121244;ESP6500_MAF=0.02329694;RS=rs9333555;Ensembl_transcriptid=ENST00000372236;SIFT_pred=T;SIFT_score=0.367;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.0;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=POLH|POLR1C;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0189696;G1000_EAS_AF=0.0079;G1000_EUR_AF=0.0268;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.0521;G1000_AMR_AF=0.0115;gnomad_exomes_AF=0.02117568;gnomad_exomes_AF_EAS=0.00271828;gnomad_exomes_AC=5322;gnomad_exomes_Hom=85;gnomad_exomes_Het=5152;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00467635;gnomad_exomes_AF_NFE=0.02780270;gnomad_exomes_AF_AMR=0.01603195;gnomad_exomes_AF_SAS=0.03910487;HGMD_gene=POLH;HGMD_disease=Melanoma_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=19477635;NativeFreq_Het=0.0249;NativeFreq_Hom=0;normalHetFrequency=0.0035;normalHetNum=3;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0102;patientHetNum=53;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16B0035750-1|16D0067243][16D1545773];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4597;GREP_score=-6.76;CytoBand=p21.1;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=TCCTGCAGAG.TGGATTTGGC	GT:AD:DP:GQ:PL	0/1:207,203:410:99:6483,0,6265
chr6	43582987	.	C	T	505.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.402;DP=60;ExcessHet=3.0103;FS=1.143;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.43;ReadPosRankSum=0.495;SOR=0.887;HGVSnom=NM_006502.3:c.*693C>T;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs9333558;CLNGENE=POLH|POLR1C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.0183706;G1000_EAS_AF=0.006;G1000_EUR_AF=0.0268;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.0511;G1000_AMR_AF=0.0115;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.002;patientHetNum=5;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][15D6482003-1|16D1546135|15D6482348|15D6722513-1|15D6529869];patientHomSampleInfo=[_][_];DANN_score=0.4424;GREP_score=0.158;CytoBand=p21.1;repName=AluSx1;repClass=SINE;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=ggcaacagag.gagacttcat	GT:AD:DP:GQ:PL	0/1:40,20:60:99:534,0,1162
chr6	43583385	.	TA	T	145.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.383;DP=102;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.82;ReadPosRankSum=0.903;SOR=0.639;HGVSnom=NM_006502.3:c.*1103delA;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs754993861;normalHetFrequency=0.891;normalHetNum=425;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.8991;patientHetNum=2201;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p21.1;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=CTTGCATAGT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:61,19:80:99:183,0,1227
chr6	43584016	.	C	CA	125.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.215;DP=43;ExcessHet=3.0103;FS=2.817;MLEAC=1;MLEAF=0.5;MQ=58.24;MQRankSum=0;QD=3.31;ReadPosRankSum=-0.639;SOR=1.954;HGVSnom=NM_006502.3:c.*1738dupA;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs895274732;CytoBand=p21.1;repName=AluYc;repClass=SINE;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=gactccgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:24,14:38:99:163,0,346
chr6	43584152	.	A	G	980.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.976;DP=77;ExcessHet=3.0103;FS=1.902;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.9;ReadPosRankSum=0.553;SOR=0.554;HGVSnom=NM_006502.3:c.*1858A>G;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs9472090;CLNGENE=POLH|POLR1C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.207268;G1000_EAS_AF=0.0367;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.5651;G1000_SAS_AF=0.137;G1000_AMR_AF=0.0793;normalHetFrequency=0.0419;normalHetNum=20;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.0482;patientHetNum=118;patientHomFrequency=0.0061;patientHomNum=15;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6517286|16D0168685];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0011957|15D6522036|16D0162398|15B6324690|16D1546220|15B6104438|15D6104503|15B0060437|16B0033208|15B0062793|16D0153160|15D6532786|15B0032865|15D6722424-1|15D6518627];DANN_score=0.602;GREP_score=0.399;CytoBand=p21.1;repName=AluSg4;repClass=SINE;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=gcaaggtggc.aaaccccgtc	GT:AD:DP:GQ:PL	0/1:41,35:76:99:1009,0,1370
chr6	43584323	.	C	CA	430.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.309;DP=218;ExcessHet=3.0103;FS=3.931;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.28;ReadPosRankSum=-1.035;SOR=0.276;HGVSnom=NM_006502.3:c.*2043dupA;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs368089629;CLNGENE=POLH|POLR1C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.197085;G1000_EAS_AF=0.0367;G1000_EUR_AF=0.172;G1000_AFR_AF=0.4123;G1000_SAS_AF=0.1329;G1000_AMR_AF=0.147;normalHetFrequency=0.5639;normalHetNum=269;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.5637;patientHetNum=1380;patientHomFrequency=0.0086;patientHomNum=21;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16B0033929|16B0000599];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16D1546075|16D0162338|16D0172144|15D6518769|16D1546033|15B0060437|16D0168717|16B0017391|15D6511752-1|15D6482036-1|15D6518706|16D0155248|16D0166604|16D1546184|15D6522038|15D6722254-1|16D0161325|15D6517226|15D6524792|16D0157357|16D0155903];CytoBand=p21.1;repName=AluSg4;repClass=SINE;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=gagactgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:139,50:189:99:468,0,2448
chr6	43585382	.	G	A	867.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.533;DP=57;ExcessHet=3.0103;FS=7.728;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.22;ReadPosRankSum=1.978;SOR=0.171;HGVSnom=NM_006502.3:c.*3088G>A;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs373844625;CLNGENE=POLH|POLR1C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.00419329;G1000_EAS_AF=0.001;G1000_EUR_AF=0.002;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0184;G1000_AMR_AF=0.0;DANN_score=0.4376;GREP_score=0.0;CytoBand=p21.1;repName=MER5A1;repClass=DNA;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=aattcccaat.tgggccgggt	GT:AD:DP:GQ:PL	0/1:27,30:57:99:896,0,802
chr6	43586141	.	G	A	2114.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.337;DP=139;ExcessHet=3.0103;FS=10.536;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.21;ReadPosRankSum=-1.54;SOR=0.099;HGVSnom=NM_006502.3:c.*3847G>A;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs145612937;CLNGENE=POLH|POLR1C;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.182508;G1000_EAS_AF=0.5446;G1000_EUR_AF=0.0507;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.1922;G1000_AMR_AF=0.1801;normalHetFrequency=0.3501;normalHetNum=167;normalHomFrequency=0.2621;normalHomNum=125;patientHetFrequency=0.4003;patientHetNum=980;patientHomFrequency=0.1218;patientHomNum=636;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7003;GREP_score=-1.43;CytoBand=p21.1;repName=AluSc;repClass=SINE;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=catccgcctc.gcctcccaaa	GT:AD:DP:GQ:PL	0/1:72,67:139:99:2143,0,2050
chr6	43586698	.	T	TG	248.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.591;DP=58;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.18;ReadPosRankSum=1.217;SOR=0.603;HGVSnom=NM_006502.3:c.*4414dupG;Gene=POLH;Transcript=NM_006502.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=713;RS=rs55760315;CLNGENE=POLH|POLR1C;CLNSIG=Likely_benign|Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.0599042;G1000_EAS_AF=0.0387;G1000_EUR_AF=0.0954;G1000_AFR_AF=0.0378;G1000_SAS_AF=0.0757;G1000_AMR_AF=0.0591;normalHetFrequency=0.1405;normalHetNum=67;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.1389;patientHetNum=340;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6518726|16D1545773];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B3108767|15D6482395-1];CytoBand=p21.1;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Xeroderma pigmentosum, variant type;CGD_INHERITANCE=AR;Strand=POLH:NM_001291969.1:+,POLH:NM_001291970.1:+,POLH:NM_006502.2:+;NP=POLH:NM_001291969.1:NP_001278898.1,POLH:NM_001291970.1:NP_001278899.1,POLH:NM_006502.2:NP_006493.1;ENSP=POLH:NM_001291969.1:.,POLH:NM_001291970.1:.,POLH:NM_006502.2:ENST00000372236.8;Gene_MIM_id=603968;Phenotypes=Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessive. 278750(MK);Possible_Inheritance=AR;EntrezGeneID=5429;EnsemblGeneID=ENSG00000170734;Alias=POLH, XPV;FLKSEQ=atttataaat.GGGGGGGGGG	GT:AD:DP:GQ:PL	0/1:32,16:48:99:286,0,714
chr6	111620202	.	A	G	1495.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.008;DP=144;ExcessHet=3.0103;FS=10.732;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.39;ReadPosRankSum=0.431;SOR=1.644;HGVSnom=.;Gene=REV3L;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs181294;G1000_AF=0.73103;G1000_EAS_AF=0.7758;G1000_EUR_AF=0.837;G1000_AFR_AF=0.5998;G1000_SAS_AF=0.7352;G1000_AMR_AF=0.7565;DANN_score=0.6999;GREP_score=-4.67;CytoBand=q21;FLKSEQ=TGTAACCAAT.CAGGCTTATA	GT:AD:DP:GQ:PL	0/1:94,50:144:99:1524,0,2757
chr6	111620605	.	TAAA	T	7848.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.096;DP=360;ExcessHet=3.0103;FS=0.402;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.3;ReadPosRankSum=-0.01;SOR=0.66;HGVSnom=NM_001372078.1:c.*611_*613delTTT;Gene=REV3L;Transcript=NM_001372078.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E32;IVSnom=.;AAlength=3130;RS=rs3049440;G1000_AF=0.701478;G1000_EAS_AF=0.7748;G1000_EUR_AF=0.837;G1000_AFR_AF=0.4977;G1000_SAS_AF=0.7331;G1000_AMR_AF=0.7421;CytoBand=q21;Strand=REV3L:NM_001286431.1:-,REV3L:NM_001286432.1:-,REV3L:NM_002912.4:-;NP=REV3L:NM_001286431.1:NP_001273360.1,REV3L:NM_001286432.1:NP_001273361.1,REV3L:NM_002912.4:NP_002903.3;ENSP=REV3L:NM_001286431.1:.,REV3L:NM_001286432.1:.,REV3L:NM_002912.4:ENST00000358835.7;Gene_MIM_id=602776;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5980;EnsemblGeneID=ENSG00000009413;Alias=REV3L, POLZ, REV3;FLKSEQ=CAGCATTTTT.AAAAAATAAT	GT:AD:DP:GQ:PL	0/1:149,203:352:99:7886,0,5993
chr6	111620758	.	G	A	5466.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.788;DP=340;ExcessHet=3.0103;FS=5.573;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.13;ReadPosRankSum=1.167;SOR=0.631;HGVSnom=NM_001372078.1:c.*461C>T;Gene=REV3L;Transcript=NM_001372078.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E32;IVSnom=.;AAlength=3130;RS=rs465646;G1000_AF=0.794529;G1000_EAS_AF=0.8056;G1000_EUR_AF=0.8499;G1000_AFR_AF=0.7277;G1000_SAS_AF=0.7679;G1000_AMR_AF=0.8631;HGMD_gene=REV3L;HGMD_disease=Lung_cancer_reduced_risk;HGMD_tag=DFP;HGMD_pmid=22349819;NativeFreq_Het=0.0142;NativeFreq_Hom=0;DANN_score=0.9155;GREP_score=6.04;CytoBand=q21;Strand=REV3L:NM_001286431.1:-,REV3L:NM_001286432.1:-,REV3L:NM_002912.4:-;NP=REV3L:NM_001286431.1:NP_001273360.1,REV3L:NM_001286432.1:NP_001273361.1,REV3L:NM_002912.4:NP_002903.3;ENSP=REV3L:NM_001286431.1:.,REV3L:NM_001286432.1:.,REV3L:NM_002912.4:ENST00000358835.7;Gene_MIM_id=602776;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5980;EnsemblGeneID=ENSG00000009413;Alias=REV3L, POLZ, REV3;FLKSEQ=ACATTATTTT.CTCGTTTGAA	GT:AD:DP:GQ:PL	0/1:162,177:339:99:5495,0,5435
chr6	111631316	.	A	G	5151.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.238;DP=379;ExcessHet=3.0103;FS=6.2;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.7;ReadPosRankSum=1.154;SOR=0.981;HGVSnom=NM_001372078.1:c.8796-14T>C;Gene=REV3L;Transcript=NM_001372078.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I29;IVSnom=NM_001372078.1:IVS29-14T>C;AAlength=3130;EXAC_AF=0.00091426;EXAC_Hom_EAS=2;EXAC_AC_EAS=78;EXAC_AN_EAS=8394;EXAC_AC_Adj=100;EXAC_AN_Adj=109378;ESP6500_MAF=0.00015380;RS=rs191081586;G1000_AF=0.00539137;G1000_EAS_AF=0.0218;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0051;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00117568;gnomad_exomes_AF_EAS=0.01118274;gnomad_exomes_AC=210;gnomad_exomes_Hom=3;gnomad_exomes_Het=204;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00053684;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00185701;NativeFreq_Het=0.0356;NativeFreq_Hom=0;DANN_score=0.3437;GREP_score=1.62;CytoBand=q21;Strand=REV3L:NM_001286431.1:-,REV3L:NM_001286432.1:-,REV3L:NM_002912.4:-;NP=REV3L:NM_001286431.1:NP_001273360.1,REV3L:NM_001286432.1:NP_001273361.1,REV3L:NM_002912.4:NP_002903.3;ENSP=REV3L:NM_001286431.1:.,REV3L:NM_001286432.1:.,REV3L:NM_002912.4:ENST00000358835.7;Gene_MIM_id=602776;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5980;EnsemblGeneID=ENSG00000009413;Alias=REV3L, POLZ, REV3;FLKSEQ=TTCGAATTCA.AGAAAAAAAC	GT:AD:DP:GQ:PL	0/1:209,167:376:99:5180,0,6692
chr6	111701462	.	CT	C	201.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.153;DP=200;ExcessHet=3.0103;FS=4.583;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.15;ReadPosRankSum=-0.907;SOR=1.545;HGVSnom=NM_001372078.1:c.1217-41delA;Gene=REV3L;Transcript=NM_001372078.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_001372078.1:IVS10-41delA;AAlength=3130;EXAC_AF=0.17757880;EXAC_Hom_EAS=0;EXAC_AC_EAS=648;EXAC_AN_EAS=3958;EXAC_AC_Adj=10670;EXAC_AN_Adj=60086;ESP6500_MAF=0.13620387;RS=rs36039889;gnomad_exomes_AF=0.19756138;gnomad_exomes_AF_EAS=0.21646859;gnomad_exomes_AC=16624;gnomad_exomes_Hom=0;gnomad_exomes_Het=16624;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17082467;gnomad_exomes_AF_NFE=0.18968476;gnomad_exomes_AF_AMR=0.24350966;gnomad_exomes_AF_SAS=0.22162045;CytoBand=q21;repName=AluY;repClass=SINE;Strand=REV3L:NM_001286431.1:-,REV3L:NM_001286432.1:-,REV3L:NM_002912.4:-;NP=REV3L:NM_001286431.1:NP_001273360.1,REV3L:NM_001286432.1:NP_001273361.1,REV3L:NM_002912.4:NP_002903.3;ENSP=REV3L:NM_001286431.1:.,REV3L:NM_001286432.1:.,REV3L:NM_002912.4:ENST00000358835.7;Gene_MIM_id=602776;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5980;EnsemblGeneID=ENSG00000009413;Alias=REV3L, POLZ, REV3;FLKSEQ=AATAAGtttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:146,30:176:99:239,0,2921
chr7	6022629	.	G	A	1498.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.887;DP=104;ExcessHet=3.0103;FS=3.566;MLEAC=1;MLEAF=0.5;MQ=38.46;MQRankSum=1.034;QD=14.41;ReadPosRankSum=0.186;SOR=0.967;HGVSnom=NM_000535.7:c.2007-7C>T;Gene=PMS2;Transcript=NM_000535.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000535.7:IVS11-7C>T;AAlength=862;EXAC_AF=0.08847015;EXAC_Hom_EAS=5;EXAC_AC_EAS=125;EXAC_AN_EAS=1380;EXAC_AC_Adj=2371;EXAC_AN_Adj=26800;RS=rs55954143;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.127995;G1000_EAS_AF=0.0853;G1000_EUR_AF=0.0567;G1000_AFR_AF=0.2814;G1000_SAS_AF=0.092;G1000_AMR_AF=0.0519;gnomad_exomes_AF=0.07575085;gnomad_exomes_AF_EAS=0.08846017;gnomad_exomes_AC=11269;gnomad_exomes_Hom=514;gnomad_exomes_Het=10241;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.25180879;gnomad_exomes_AF_NFE=0.06616172;gnomad_exomes_AF_AMR=0.03348088;gnomad_exomes_AF_SAS=0.08265453;NativeFreq_Het=0.1205;NativeFreq_Hom=0.0072;normalHetFrequency=0.141;normalHetNum=122;normalHomFrequency=0.0058;normalHomNum=5;patientHetFrequency=0.1307;patientHetNum=682;patientHomFrequency=0.0057;patientHomNum=30;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0011518|16D0067241][16D0161332|17B0000865|15B0002482];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6535757|16D1536949-1|15B6215224-1|16D0067250|16B0200373|16B0001818-1|16B0001882-1|16D0166603|16D0172141|16D1545723|16B0200520|16D0172142|16D0166393][15B0002571-1|15B0002857|16B0047131|15B0011957|16D0166688|15B0062812|16B0200332-1|16B0080522|16D0067237|16D0067267|16B0024469|16B3108405|16B0019057-1|15B0033288|15D6522060|16B0000533|16D1546004];AF_2700_Het=0.1334;AF_2700_Hom=0.0042;AF_50_Het=0.1141;AF_50_Hom=0.0048;dbscSNV_RF_score=0.004;dbscSNV_ADA_score=0.00002982;DANN_score=0.5536;GREP_score=-2.46;CytoBand=p22.1;dupName=chr7:6775275;dupScore=0;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=TTTACTGCAG.TAGAAAATGT	GT:AD:DP:GQ:PL	0/1:53,51:104:99:1527,0,1536
chr7	6026775	.	T	C	16453.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.22;DP=429;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=51.47;MQRankSum=-0.114;QD=28.07;ReadPosRankSum=-1.632;SOR=0.235;HGVSnom=NM_000535.7:c.1621A>G(p.Lys541Glu/p.K541E);Gene=PMS2;Transcript=NM_000535.7;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=862;EXAC_AF=0.85139237;EXAC_Hom_EAS=3687;EXAC_AC_EAS=7991;EXAC_AN_EAS=8650;EXAC_AC_Adj=102666;EXAC_AN_Adj=120586;ESP6500_MAF=0.87038462;RS=rs2228006;Ensembl_transcriptid=ENST00000265849|ENST00000441476|ENST00000642292|ENST00000642456|ENST00000644110;SIFT_pred=T|T|.|.|.;SIFT_score=1.0|1.0|.|.|.;Polyphen2_HVAR_pred=B|B|.|.|B;Polyphen2_HVAR_score=0.0|0.0|.|.|0.0;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|1|1|0.909724;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.883187;G1000_EAS_AF=0.878;G1000_EUR_AF=0.8767;G1000_AFR_AF=0.9418;G1000_SAS_AF=0.8937;G1000_AMR_AF=0.7738;gnomad_exomes_AF=0.84078279;gnomad_exomes_AF_EAS=0.92116137;gnomad_exomes_AC=210907;gnomad_exomes_Hom=89510;gnomad_exomes_Het=31887;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.92471236;gnomad_exomes_AF_NFE=0.84975491;gnomad_exomes_AF_AMR=0.66899861;gnomad_exomes_AF_SAS=0.89531617;HGMD_gene=PMS2;HGMD_disease=Colorectal_cancer_non-polyposis;HGMD_tag=R;HGMD_pmid=24072394;NativeFreq_Het=0.1157;NativeFreq_Hom=0.9009;DANN_score=0.2203;GREP_score=4.66;CytoBand=p22.1;dupName=chr7:6775275;dupScore=0;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=TCGTCAGTTT.AGGCGCTTTC	GT:AD:DP:GQ:PL	1/1:1,428:429:99:16482,1247,0
chr7	6026988	.	G	A	6346.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.029;DP=480;ExcessHet=3.0103;FS=4.979;MLEAC=1;MLEAF=0.5;MQ=57.73;MQRankSum=0.992;QD=13.36;ReadPosRankSum=0.419;SOR=0.795;HGVSnom=NM_000535.7:c.1408C>T(p.Pro470Ser/p.P470S);Gene=PMS2;Transcript=NM_000535.7;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=862;EXAC_AF=0.38539298;EXAC_Hom_EAS=615;EXAC_AC_EAS=3258;EXAC_AN_EAS=8634;EXAC_AC_Adj=46779;EXAC_AN_Adj=121380;ESP6500_MAF=0.37382746;RS=rs1805321;Ensembl_transcriptid=ENST00000265849|ENST00000441476|ENST00000642292|ENST00000642456|ENST00000644110;SIFT_pred=T|T|.|.|.;SIFT_score=0.844|0.635|.|.|.;Polyphen2_HVAR_pred=B|B|.|.|B;Polyphen2_HVAR_score=0.001|0.005|.|.|0.005;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|1|1|1;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.358227;G1000_EAS_AF=0.3601;G1000_EUR_AF=0.4374;G1000_AFR_AF=0.2723;G1000_SAS_AF=0.3415;G1000_AMR_AF=0.428;gnomad_exomes_AF=0.38778562;gnomad_exomes_AF_EAS=0.37528542;gnomad_exomes_AC=97518;gnomad_exomes_Hom=19196;gnomad_exomes_Het=59126;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28297244;gnomad_exomes_AF_NFE=0.41583593;gnomad_exomes_AF_AMR=0.38751084;gnomad_exomes_AF_SAS=0.35380193;NativeFreq_Het=0.4851;NativeFreq_Hom=0.1881;normalHetFrequency=0.4798;normalHetNum=415;normalHomFrequency=0.1618;normalHomNum=140;patientHetFrequency=0.4613;patientHetNum=2408;patientHomFrequency=0.1667;patientHomNum=870;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4881;AF_2700_Hom=0.1783;AF_50_Het=0.4960;AF_50_Hom=0.1601;DANN_score=0.2943;GREP_score=0.572;CytoBand=p22.1;dupName=chr7:6775275;dupScore=0;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=TCTTTCTGAG.TCTCAGGACG	GT:AD:DP:GQ:PL	0/1:259,216:475:99:6375,0,8102
chr7	6036980	.	G	C	6440.77	PASS	AC=2;AF=1;AN=2;DP=189;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.26;SOR=1.209;HGVSnom=NM_000535.7:c.780C>G(p.Ser260Ser/p.S260S);Gene=PMS2;Transcript=NM_000535.7;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=862;EXAC_AF=0.81085742;EXAC_Hom_EAS=3667;EXAC_AC_EAS=7965;EXAC_AN_EAS=8640;EXAC_AC_Adj=97804;EXAC_AN_Adj=120618;ESP6500_MAF=0.82377364;RS=rs1805319;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.83127;G1000_EAS_AF=0.879;G1000_EUR_AF=0.836;G1000_AFR_AF=0.8555;G1000_SAS_AF=0.8037;G1000_AMR_AF=0.7478;gnomad_exomes_AF=0.80179993;gnomad_exomes_AF_EAS=0.92066863;gnomad_exomes_AC=200814;gnomad_exomes_Hom=81226;gnomad_exomes_Het=38362;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.84249537;gnomad_exomes_AF_NFE=0.81664048;gnomad_exomes_AF_AMR=0.65109442;gnomad_exomes_AF_SAS=0.81725089;NativeFreq_Het=0.1169;NativeFreq_Hom=0.9009;normalHetFrequency=0.1538;normalHetNum=133;normalHomFrequency=0.815;normalHomNum=705;patientHetFrequency=0.1795;patientHetNum=937;patientHomFrequency=0.7847;patientHomNum=4096;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1249;AF_2700_Hom=0.8701;AF_50_Het=0.1300;AF_50_Hom=0.8637;DANN_score=0.7105;GREP_score=-10.9;CytoBand=p22.1;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=GCAGAGCATC.GAACAGCTCA	GT:AD:DP:GQ:PL	1/1:0,188:188:99:6469,564,0
chr7	6037057	.	GA	G	1526.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.608;DP=189;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.25;ReadPosRankSum=-0.665;SOR=0.681;HGVSnom=NM_000535.7:c.706-4delT;Gene=PMS2;Transcript=NM_000535.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000535.7:IVS6-4delT;AAlength=862;EXAC_AF=0.44224527;EXAC_Hom_EAS=44;EXAC_AC_EAS=2170;EXAC_AN_EAS=4704;EXAC_AC_Adj=27796;EXAC_AN_Adj=62852;RS=rs60794673;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.453075;G1000_EAS_AF=0.4931;G1000_EUR_AF=0.4533;G1000_AFR_AF=0.4024;G1000_SAS_AF=0.4785;G1000_AMR_AF=0.4553;gnomad_exomes_AF=0.43081639;gnomad_exomes_AF_EAS=0.46360879;gnomad_exomes_AC=62259;gnomad_exomes_Hom=234;gnomad_exomes_Het=61791;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.39676443;gnomad_exomes_AF_NFE=0.42667226;gnomad_exomes_AF_AMR=0.41220682;gnomad_exomes_AF_SAS=0.44945827;NativeFreq_Het=0.4851;NativeFreq_Hom=.;normalHetFrequency=0.5908;normalHetNum=511;normalHomFrequency=0.2867;normalHomNum=248;patientHetFrequency=0.5824;patientHetNum=3040;patientHomFrequency=0.2822;patientHomNum=1473;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.7867;AF_2700_Hom=0.1595;AF_50_Het=0.7987;AF_50_Hom=0.1585;CytoBand=p22.1;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=CTTTGCAACT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:64,101:165:99:1564,0,851
chr7	6038722	.	T	C	4772.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.556;DP=320;ExcessHet=3.0103;FS=4.471;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.01;ReadPosRankSum=-0.38;SOR=0.935;HGVSnom=NM_000535.7:c.705+17A>G;Gene=PMS2;Transcript=NM_000535.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000535.7:IVS6+17A>G;AAlength=862;EXAC_AF=0.36775756;EXAC_Hom_EAS=575;EXAC_AC_EAS=3158;EXAC_AN_EAS=8640;EXAC_AC_Adj=44634;EXAC_AN_Adj=121368;ESP6500_MAF=0.34391819;RS=rs62456182;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.325679;G1000_EAS_AF=0.3591;G1000_EUR_AF=0.4364;G1000_AFR_AF=0.1778;G1000_SAS_AF=0.3425;G1000_AMR_AF=0.3746;gnomad_exomes_AF=0.36821320;gnomad_exomes_AF_EAS=0.36490160;gnomad_exomes_AC=92585;gnomad_exomes_Hom=17588;gnomad_exomes_Het=57409;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19671425;gnomad_exomes_AF_NFE=0.41216086;gnomad_exomes_AF_AMR=0.31298791;gnomad_exomes_AF_SAS=0.35484714;NativeFreq_Het=0.5148;NativeFreq_Hom=0.1687;normalHetFrequency=0.4821;normalHetNum=417;normalHomFrequency=0.1572;normalHomNum=136;patientHetFrequency=0.4648;patientHetNum=2426;patientHomFrequency=0.1565;patientHomNum=817;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4816;AF_2700_Hom=0.1668;AF_50_Het=0.4881;AF_50_Hom=0.1458;DANN_score=0.5612;GREP_score=-0.0199;CytoBand=p22.1;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=GGCGTTGAAG.AACCGGCCAT	GT:AD:DP:GQ:PL	0/1:174,144:318:99:4801,0,5204
chr7	6045627	.	C	T	5156.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.088;DP=359;ExcessHet=3.0103;FS=2.237;MLEAC=1;MLEAF=0.5;MQ=57.99;MQRankSum=-0.874;QD=14.36;ReadPosRankSum=-0.532;SOR=0.815;HGVSnom=NM_000535.7:c.59G>A(p.Arg20Gln/p.R20Q);Gene=PMS2;Transcript=NM_000535.7;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=862;EXAC_AF=0.07817683;EXAC_Hom_EAS=31;EXAC_AC_EAS=805;EXAC_AN_EAS=8452;EXAC_AC_Adj=9003;EXAC_AN_Adj=115162;ESP6500_MAF=0.07090063;RS=rs10254120;Ensembl_transcriptid=ENST00000265849|ENST00000382321;SIFT_pred=T|T;SIFT_score=0.121|0.244;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.164|0.425;MutationTaster_pred=P|P|P|P;MutationTaster_score=0.614167|0.614167|0.614167|3.3553e-10;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.0756789;G1000_EAS_AF=0.0942;G1000_EUR_AF=0.0547;G1000_AFR_AF=0.0817;G1000_SAS_AF=0.0941;G1000_AMR_AF=0.0418;gnomad_exomes_AF=0.07155071;gnomad_exomes_AF_EAS=0.09537889;gnomad_exomes_AC=17574;gnomad_exomes_Hom=742;gnomad_exomes_Het=16090;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09035824;gnomad_exomes_AF_NFE=0.07564532;gnomad_exomes_AF_AMR=0.02550044;gnomad_exomes_AF_SAS=0.08821786;HGMD_gene=PMS2;HGMD_disease=Compromised_apoptotic_function;HGMD_tag=FP;HGMD_pmid=18768816;NativeFreq_Het=0.1614;NativeFreq_Hom=0.0133;normalHetFrequency=0.1457;normalHetNum=126;normalHomFrequency=0.0116;normalHomNum=10;patientHetFrequency=0.1352;patientHetNum=706;patientHomFrequency=0.0098;patientHomNum=51;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545741|16D0172154|16B0000905|15D6535757|16B1586223|17B0001559-1|16B0035689-1|15D6529802|17B0001590-1|15B0051536|15B6215224-1|15B0060370|16B0200373|17B0000750|16B0001818-1|16B0001882-1|16D0166603|16D0172141|16D1545723|16B0200520|16D0172142|16D0166393][15B0002857|16B0047131|15B0011957|15B0062812|16B3258568|15B0022718|16B0200332-1|16D1878030|16B0033046|16B0050431|15B0022803-C|16B3094648|16B3094610|15B0002860-1|16D0067237|16B0000990|16B0033894|16D0067267|16B3108947|16D0158732|16B0024469|16B3108405|16B3094669|16B0005159|15B0027190|16B0025319|15D0042896|16D0153222|16D1546004];AF_2700_Het=0.0992;AF_2700_Hom=0.0204;AF_50_Het=0.0840;AF_50_Hom=0.0190;DANN_score=0.9966;GREP_score=0.771;CytoBand=p22.1;dupName=chr7:99925047,chr7:76640837,chr7:76667079,chr7:76150897,chr7:75138830,chr7:74951633,chr7:74923611,chr7:74979650,chr7:74709346,chr7:74304655,chr7:72505732,chr7:72474390,chr7:66759180;dupScore=0;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=GACTGACTTC.GATCAATAGG	GT:AD:DP:GQ:PL	0/1:194,165:359:99:5185,0,5682
chr7	6048556	.	G	A	2557.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.384;DP=176;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.62;ReadPosRankSum=-0.688;SOR=0.758;HGVSnom=NM_000535.7:c.23+72C>T;Gene=PMS2;Transcript=NM_000535.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000535.7:IVS1+72C>T;AAlength=862;ESP6500_MAF=0.21215445;RS=rs3735295;CLNGENE=PMS2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.227436;G1000_EAS_AF=0.1597;G1000_EUR_AF=0.1789;G1000_AFR_AF=0.3442;G1000_SAS_AF=0.2434;G1000_AMR_AF=0.1513;HGMD_gene=PMS2;HGMD_disease=Lynch_syndrome;HGMD_tag=R;HGMD_pmid=28874130;NativeFreq_Het=0.2970;NativeFreq_Hom=0.0289;normalHetFrequency=0.2821;normalHetNum=244;normalHomFrequency=0.0462;normalHomNum=40;patientHetFrequency=0.2757;patientHetNum=1439;patientHomFrequency=0.0398;patientHomNum=208;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.789;GREP_score=1.91;CytoBand=p22.1;dupName=chr7:99925047,chr7:74979650,chr7:74304655,chr7:72474390,chr7:66759180;dupScore=0;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 4. Mismatch repair cancer syndrome ;CGD_INHERITANCE=AD/AR;Strand=PMS2:NM_001322005.1:-,PMS2:NM_001322009.1:-,PMS2:NM_000535.6:-,PMS2:NM_001322003.1:-,PMS2:NM_001322004.1:-,PMS2:NM_001322006.1:-,PMS2:NM_001322007.1:-,PMS2:NM_001322008.1:-,PMS2:NM_001322010.1:-,PMS2:NM_001322011.1:-,PMS2:NM_001322012.1:-,PMS2:NM_001322013.1:-,PMS2:NM_001322014.1:-,PMS2:NM_001322015.1:-;NP=PMS2:NM_001322005.1:NP_001308934.1,PMS2:NM_001322009.1:NP_001308938.1,PMS2:NM_000535.6:NP_000526.2,PMS2:NM_001322003.1:NP_001308932.1,PMS2:NM_001322004.1:NP_001308933.1,PMS2:NM_001322006.1:NP_001308935.1,PMS2:NM_001322007.1:NP_001308936.1,PMS2:NM_001322008.1:NP_001308937.1,PMS2:NM_001322010.1:NP_001308939.1,PMS2:NM_001322011.1:NP_001308940.1,PMS2:NM_001322012.1:NP_001308941.1,PMS2:NM_001322013.1:NP_001308942.1,PMS2:NM_001322014.1:NP_001308943.1,PMS2:NM_001322015.1:NP_001308944.1;ENSP=PMS2:NM_001322005.1:.,PMS2:NM_001322009.1:.,PMS2:NM_000535.6:ENST00000265849.11,PMS2:NM_001322003.1:.,PMS2:NM_001322004.1:.,PMS2:NM_001322006.1:.,PMS2:NM_001322007.1:.,PMS2:NM_001322008.1:.,PMS2:NM_001322010.1:.,PMS2:NM_001322011.1:.,PMS2:NM_001322012.1:.,PMS2:NM_001322013.1:.,PMS2:NM_001322014.1:.,PMS2:NM_001322015.1:.;Gene_MIM_id=600259;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3). Mismatch repair cancer syndrome, 276300 (3), Autosomal recessive. 276300(MK),614337(MK);Possible_Inheritance=AR;EntrezGeneID=5395;EnsemblGeneID=ENSG00000122512;Alias=PMS2, PMSL2, HNPCC4;FLKSEQ=CATTTCCAGG.AGGTTGGAAT	GT:AD:DP:GQ:PL	0/1:90,85:175:99:2586,0,2997
chr7	55086780	.	A	C	1374.77	StandardFilter	AC=2;AF=1;AN=2;DP=36;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.21;SOR=4.294;HGVSnom=NM_005228.5:c.-191A>C;Gene=EGFR;Transcript=NM_005228.5;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1210;RS=rs712830;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.929712;G1000_EAS_AF=0.998;G1000_EUR_AF=0.8658;G1000_AFR_AF=0.9887;G1000_SAS_AF=0.9622;G1000_AMR_AF=0.7651;NativeFreq_Het=0;NativeFreq_Hom=0.0792;AF_2700_Het=0.0015;AF_2700_Hom=0.2060;AF_50_Het=0.0000;AF_50_Hom=0.2092;DANN_score=0.3848;GREP_score=-0.606;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201283.1:+,EGFR:NM_201282.1:+,EGFR:NM_201284.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201283.1:NP_958440.1,EGFR:NM_201282.1:NP_958439.1,EGFR:NM_201284.1:NP_958441.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201283.1:.,EGFR:NM_201282.1:.,EGFR:NM_201284.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=TGAGCGCCCG.CGCGGCCGAG	GT:AD:DP:GQ:PL	1/1:0,36:36:99:1403,108,0
chr7	55214348	.	C	T	5053.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.077;DP=339;ExcessHet=3.0103;FS=4.306;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.95;ReadPosRankSum=-0.065;SOR=0.927;HGVSnom=NM_005228.5:c.474C>T(p.Asn158Asn/p.N158N);Gene=EGFR;Transcript=NM_005228.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=1210;EXAC_AF=0.50898584;EXAC_Hom_EAS=605;EXAC_AC_EAS=3226;EXAC_AN_EAS=8620;EXAC_AC_Adj=61741;EXAC_AN_Adj=121302;ESP6500_MAF=0.51514686;RS=rs2072454;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.475439;G1000_EAS_AF=0.3522;G1000_EUR_AF=0.4841;G1000_AFR_AF=0.4932;G1000_SAS_AF=0.5573;G1000_AMR_AF=0.4928;gnomad_exomes_AF=0.51090666;gnomad_exomes_AF_EAS=0.36741353;gnomad_exomes_AC=128445;gnomad_exomes_Hom=33086;gnomad_exomes_Het=62273;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49729197;gnomad_exomes_AF_NFE=0.52026979;gnomad_exomes_AF_AMR=0.52304401;gnomad_exomes_AF_SAS=0.55069576;NativeFreq_Het=0.4851;NativeFreq_Hom=0.2171;normalHetFrequency=0.4794;normalHetNum=186;normalHomFrequency=0.1804;normalHomNum=70;patientHetFrequency=0.4672;patientHetNum=1295;patientHomFrequency=0.1869;patientHomNum=518;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4700;AF_2700_Hom=0.1583;AF_50_Het=0.4960;AF_50_Hom=0.1268;DANN_score=0.6927;GREP_score=1.99;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201283.1:+,EGFR:NM_201282.1:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201283.1:NP_958440.1,EGFR:NM_201282.1:NP_958439.1,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201283.1:.,EGFR:NM_201282.1:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CCCTGTGCAA.GTGGAGAGCA	GT:AD:DP:GQ:PL	0/1:167,171:338:99:5082,0,4963
chr7	55221655	.	G	A	4130.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.898;DP=240;ExcessHet=3.0103;FS=8.217;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.28;ReadPosRankSum=-1.655;SOR=0.352;HGVSnom=NM_005228.5:c.748-49G>A;Gene=EGFR;Transcript=NM_005228.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_005228.5:IVS6-49G>A;AAlength=1210;EXAC_AF=0.30217234;EXAC_Hom_EAS=1726;EXAC_AC_EAS=5445;EXAC_AN_EAS=8620;EXAC_AC_Adj=36639;EXAC_AN_Adj=121252;ESP6500_MAF=0.21743811;RS=rs4947986;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.320687;G1000_EAS_AF=0.6498;G1000_EUR_AF=0.2813;G1000_AFR_AF=0.0726;G1000_SAS_AF=0.3436;G1000_AMR_AF=0.3401;gnomad_exomes_AF=0.30626713;gnomad_exomes_AF_EAS=0.63549826;gnomad_exomes_AC=76900;gnomad_exomes_Hom=13405;gnomad_exomes_Het=50090;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09607336;gnomad_exomes_AF_NFE=0.27348198;gnomad_exomes_AF_AMR=0.35240685;gnomad_exomes_AF_SAS=0.33617591;NativeFreq_Het=0.5049;NativeFreq_Hom=0.3663;normalHetFrequency=0.4149;normalHetNum=161;normalHomFrequency=0.2861;normalHomNum=111;patientHetFrequency=0.4239;patientHetNum=1175;patientHomFrequency=0.2652;patientHomNum=735;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8703;GREP_score=-2.8;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201283.1:+,EGFR:NM_201282.1:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201283.1:NP_958440.1,EGFR:NM_201282.1:NP_958439.1,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201283.1:.,EGFR:NM_201282.1:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CGTGTGTGGC.CTGAGTGTAC	GT:AD:DP:GQ:PL	0/1:105,134:239:99:4159,0,2792
chr7	55228053	.	A	T	10147.8	PASS	AC=2;AF=1;AN=2;DP=263;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.45;SOR=2.004;HGVSnom=NM_005228.5:c.1498+22A>T;Gene=EGFR;Transcript=NM_005228.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_005228.5:IVS12+22A>T;AAlength=1210;EXAC_AF=0.76973773;EXAC_Hom_EAS=4177;EXAC_AC_EAS=8376;EXAC_AN_EAS=8398;EXAC_AC_Adj=90983;EXAC_AN_Adj=118200;ESP6500_MAF=0.66343341;RS=rs1558544;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.773363;G1000_EAS_AF=0.997;G1000_EUR_AF=0.7445;G1000_AFR_AF=0.5129;G1000_SAS_AF=0.8814;G1000_AMR_AF=0.8343;gnomad_exomes_AF=0.77690446;gnomad_exomes_AF_EAS=0.99597885;gnomad_exomes_AC=190079;gnomad_exomes_Hom=75343;gnomad_exomes_Het=39393;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53052535;gnomad_exomes_AF_NFE=0.72490420;gnomad_exomes_AF_AMR=0.86992271;gnomad_exomes_AF_SAS=0.88154875;NativeFreq_Het=0.1957;NativeFreq_Hom=1;normalHetFrequency=0.067;normalHetNum=26;normalHomFrequency=0.8763;normalHomNum=340;patientHetFrequency=0.1115;patientHetNum=309;patientHomFrequency=0.8279;patientHomNum=2295;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0104;AF_2700_Hom=0.9869;AF_50_Het=0.0111;AF_50_Hom=0.9889;DANN_score=0.6874;GREP_score=0.12;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201282.1:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201282.1:NP_958439.1,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201282.1:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CTTTCTGTTT.GTTTATGGAG	GT:AD:DP:GQ:PL	1/1:0,263:263:99:10176,791,0
chr7	55229255	.	G	A	5503.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.458;DP=391;ExcessHet=3.0103;FS=5.834;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.15;ReadPosRankSum=-0.956;SOR=0.971;HGVSnom=NM_005228.5:c.1562G>A(p.Arg521Lys/p.R521K);Gene=EGFR;Transcript=NM_005228.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E13;IVSnom=.;AAlength=1210;EXAC_AF=0.28696319;EXAC_Hom_EAS=1228;EXAC_AC_EAS=4629;EXAC_AN_EAS=8638;EXAC_AC_Adj=34827;EXAC_AN_Adj=121364;ESP6500_MAF=0.20267569;RS=rs2227983;Ensembl_transcriptid=ENST00000455089|ENST00000342916|ENST00000454757|ENST00000344576|ENST00000275493|ENST00000638463;SIFT_pred=T|T|.|T|T|.;SIFT_score=0.927|0.729|.|0.922|0.92|.;Polyphen2_HVAR_pred=B|B|.|B|B|.;Polyphen2_HVAR_score=0.0|0.0|.|0.001|0.0|.;MutationTaster_pred=P|P|P|P|P|P;MutationTaster_score=1|1|1|1|1|1;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.292133;G1000_EAS_AF=0.5238;G1000_EUR_AF=0.2763;G1000_AFR_AF=0.0643;G1000_SAS_AF=0.3507;G1000_AMR_AF=0.33;gnomad_exomes_AF=0.29210217;gnomad_exomes_AF_EAS=0.53066551;gnomad_exomes_AC=73445;gnomad_exomes_Hom=11842;gnomad_exomes_Het=49761;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08858268;gnomad_exomes_AF_NFE=0.25735915;gnomad_exomes_AF_AMR=0.29754264;gnomad_exomes_AF_SAS=0.34424409;HGMD_gene=EGFR;HGMD_disease=Altered_transmembrane_signaling;HGMD_tag=DFP;HGMD_pmid=7937865;NativeFreq_Het=0.5346;NativeFreq_Hom=0.2970;normalHetFrequency=0.4433;normalHetNum=172;normalHomFrequency=0.2216;normalHomNum=86;patientHetFrequency=0.4383;patientHetNum=1215;patientHomFrequency=0.2074;patientHomNum=575;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5058;AF_2700_Hom=0.2806;AF_50_Het=0.5277;AF_50_Hom=0.2932;DANN_score=0.5895;GREP_score=-5.79;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201282.1:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201282.1:NP_958439.1,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201282.1:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CCGGAGCCCA.GGACTGCGTC	GT:AD:DP:GQ:PL	0/1:212,177:389:99:5532,0,6724
chr7	55238268	.	G	A	5488.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.429;DP=399;ExcessHet=3.0103;FS=3.154;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.79;ReadPosRankSum=-0.408;SOR=0.846;HGVSnom=NM_005228.5:c.1881-600G>A;Gene=EGFR;Transcript=NM_005228.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_005228.5:IVS15-600G>A;AAlength=1210;EXAC_AF=0.36702321;EXAC_Hom_EAS=1247;EXAC_AC_EAS=4678;EXAC_AN_EAS=8630;EXAC_AC_Adj=44539;EXAC_AN_Adj=121352;ESP6500_MAF=0.30508996;RS=rs10228436;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.376198;G1000_EAS_AF=0.5357;G1000_EUR_AF=0.3539;G1000_AFR_AF=0.2163;G1000_SAS_AF=0.4376;G1000_AMR_AF=0.3948;gnomad_exomes_AF=0.37054741;gnomad_exomes_AF_EAS=0.53936066;gnomad_exomes_AC=92479;gnomad_exomes_Hom=17864;gnomad_exomes_Het=56751;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22855912;gnomad_exomes_AF_NFE=0.34252093;gnomad_exomes_AF_AMR=0.39055633;gnomad_exomes_AF_SAS=0.42218738;NativeFreq_Het=0.4698;NativeFreq_Hom=0.1851;normalHetFrequency=0.4897;normalHetNum=190;normalHomFrequency=0.2577;normalHomNum=100;patientHetFrequency=0.4636;patientHetNum=1285;patientHomFrequency=0.25;patientHomNum=693;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5101;GREP_score=-3.17;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=TGTTCCCCCC.CTTTTCCTTT	GT:AD:DP:GQ:PL	0/1:202,196:398:99:5517,0,5340
chr7	55238459	.	G	A	6208.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.429;DP=403;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.44;ReadPosRankSum=0.415;SOR=0.678;HGVSnom=NM_005228.5:c.1881-409G>A;Gene=EGFR;Transcript=NM_005228.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_005228.5:IVS15-409G>A;AAlength=1210;RS=rs75529744;G1000_AF=0.0205671;G1000_EAS_AF=0.0843;G1000_EUR_AF=0.002;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0231;NativeFreq_Het=0.0427;NativeFreq_Hom=0;normalHetFrequency=0.0644;normalHetNum=25;normalHomFrequency=0.0129;normalHomNum=5;patientHetFrequency=0.0649;patientHetNum=180;patientHomFrequency=0.0141;patientHomNum=39;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.407;GREP_score=-0.336;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=GAAACCTGCA.GGACTCCATG	GT:AD:DP:GQ:PL	0/1:204,198:402:99:6237,0,7891
chr7	55238464	.	T	G	5666.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.689;DP=386;ExcessHet=3.0103;FS=2.162;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.76;ReadPosRankSum=-0.112;SOR=0.582;HGVSnom=NM_005228.5:c.1881-404T>G;Gene=EGFR;Transcript=NM_005228.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_005228.5:IVS15-404T>G;AAlength=1210;RS=rs10277413;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.376797;G1000_EAS_AF=0.5347;G1000_EUR_AF=0.3569;G1000_AFR_AF=0.2171;G1000_SAS_AF=0.4376;G1000_AMR_AF=0.3948;NativeFreq_Het=0.3808;NativeFreq_Hom=0.0605;normalHetFrequency=0.2732;normalHetNum=106;normalHomFrequency=0.2216;normalHomNum=86;patientHetFrequency=0.2525;patientHetNum=700;patientHomFrequency=0.2157;patientHomNum=598;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.1939;GREP_score=-1.17;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_201284.1:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_201284.1:NP_958441.1,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_201284.1:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CTGCAGGGAC.CCATGCTGCC	GT:AD:DP:GQ:PL	0/1:186,198:384:99:5695,0,7486
chr7	55238874	.	T	A	4900.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.382;DP=344;ExcessHet=3.0103;FS=4.148;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.33;ReadPosRankSum=-0.499;SOR=0.912;HGVSnom=NM_005228.5:c.1887T>A(p.Thr629Thr/p.T629T);Gene=EGFR;Transcript=NM_005228.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=1210;EXAC_AF=0.37401108;EXAC_Hom_EAS=1248;EXAC_AC_EAS=4678;EXAC_AN_EAS=8644;EXAC_AC_Adj=45384;EXAC_AN_Adj=121344;ESP6500_MAF=0.32246655;RS=rs2227984;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.390375;G1000_EAS_AF=0.5347;G1000_EUR_AF=0.3559;G1000_AFR_AF=0.2678;G1000_SAS_AF=0.4376;G1000_AMR_AF=0.3977;gnomad_exomes_AF=0.37620537;gnomad_exomes_AF_EAS=0.53876264;gnomad_exomes_AC=94569;gnomad_exomes_Hom=18426;gnomad_exomes_Het=57717;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27861186;gnomad_exomes_AF_NFE=0.34445285;gnomad_exomes_AF_AMR=0.39385879;gnomad_exomes_AF_SAS=0.42302666;NativeFreq_Het=0.5148;NativeFreq_Hom=0.3069;normalHetFrequency=0.4897;normalHetNum=190;normalHomFrequency=0.2577;normalHomNum=100;patientHetFrequency=0.4643;patientHetNum=1287;patientHomFrequency=0.1331;patientHomNum=695;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4931;AF_2700_Hom=0.3036;AF_50_Het=0.5024;AF_50_Hom=0.3106;DANN_score=0.7339;GREP_score=-5.86;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=ACAGATGCAC.GGGCCAGGTC	GT:AD:DP:GQ:PL	0/1:176,166:342:99:4929,0,5238
chr7	55266417	.	T	C	13481.8	PASS	AC=2;AF=1;AN=2;DP=384;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.99;SOR=0.827;HGVSnom=NM_005228.5:c.2709T>C(p.Thr903Thr/p.T903T);Gene=EGFR;Transcript=NM_005228.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E23;IVSnom=.;AAlength=1210;EXAC_AF=0.89567409;EXAC_Hom_EAS=3720;EXAC_AC_EAS=8017;EXAC_AN_EAS=8652;EXAC_AC_Adj=108742;EXAC_AN_Adj=121408;ESP6500_MAF=0.88905121;RS=rs1140475;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.916733;G1000_EAS_AF=0.9196;G1000_EUR_AF=0.8907;G1000_AFR_AF=0.9281;G1000_SAS_AF=0.9397;G1000_AMR_AF=0.8963;gnomad_exomes_AF=0.89456648;gnomad_exomes_AF_EAS=0.92524736;gnomad_exomes_AC=224962;gnomad_exomes_Hom=100747;gnomad_exomes_Het=23468;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.92538140;gnomad_exomes_AF_NFE=0.87462642;gnomad_exomes_AF_AMR=0.89228723;gnomad_exomes_AF_SAS=0.93947609;NativeFreq_Het=0.1673;NativeFreq_Hom=0.9207;DANN_score=0.4885;GREP_score=-6.51;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CAGGGGTGAC.GTTTGGGAGT	GT:AD:DP:GQ:PL	1/1:0,380:380:99:13510,1142,0
chr7	55268916	.	C	T	5213.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.796;DP=379;ExcessHet=3.0103;FS=4.57;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.76;ReadPosRankSum=1.078;SOR=0.923;HGVSnom=NM_005228.5:c.2982C>T(p.Asp994Asp/p.D994D);Gene=EGFR;Transcript=NM_005228.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E25;IVSnom=.;AAlength=1210;EXAC_AF=0.13371173;EXAC_Hom_EAS=351;EXAC_AC_EAS=2401;EXAC_AN_EAS=8648;EXAC_AC_Adj=16231;EXAC_AN_Adj=121388;ESP6500_MAF=0.07042903;RS=rs2293347;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.141773;G1000_EAS_AF=0.247;G1000_EUR_AF=0.1113;G1000_AFR_AF=0.0129;G1000_SAS_AF=0.2301;G1000_AMR_AF=0.1542;gnomad_exomes_AF=0.13745566;gnomad_exomes_AF_EAS=0.27207482;gnomad_exomes_AC=34569;gnomad_exomes_Hom=2977;gnomad_exomes_Het=28615;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.02362205;gnomad_exomes_AF_NFE=0.09959743;gnomad_exomes_AF_AMR=0.15043941;gnomad_exomes_AF_SAS=0.22707081;NativeFreq_Het=0.4356;NativeFreq_Hom=0.0693;normalHetFrequency=0.3737;normalHetNum=145;normalHomFrequency=0.0361;normalHomNum=14;patientHetFrequency=0.3019;patientHetNum=837;patientHomFrequency=0.0646;patientHomNum=179;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4089;AF_2700_Hom=0.1030;AF_50_Het=0.3994;AF_50_Hom=0.1173;DANN_score=0.598;GREP_score=3.85;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346897.1:+,EGFR:NM_001346898.1:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346897.1:NP_001333826.1,EGFR:NM_001346898.1:NP_001333827.1,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346897.1:.,EGFR:NM_001346898.1:.,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=GTCCTACAGA.TCCAACTTCT	GT:AD:DP:GQ:PL	0/1:206,173:379:99:5242,0,6647
chr7	55273591	.	G	GA	5089.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.587;DP=367;ExcessHet=3.0103;FS=1.264;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.66;ReadPosRankSum=-0.246;SOR=0.566;OLD_VARIANT=chr7|55273591|G|GA,GAA|1;HGVSnom=NM_005228.5:c.*294dupA;Gene=EGFR;Transcript=NM_005228.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E28;IVSnom=.;AAlength=1210;RS=rs5884404;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.452077;G1000_EAS_AF=0.6022;G1000_EUR_AF=0.2694;G1000_AFR_AF=0.5408;G1000_SAS_AF=0.4734;G1000_AMR_AF=0.2997;NativeFreq_Het=0.4703;NativeFreq_Hom=.;normalHetFrequency=0.0593;normalHetNum=23;normalHomFrequency=0.0644;normalHomNum=25;patientHetFrequency=0.0483;patientHetNum=134;patientHomFrequency=0.0538;patientHomNum=149;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4935;AF_2700_Hom=0.4527;AF_50_Het=0.4818;AF_50_Hom=0.4754;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=AGGTATATTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/0:58,199:325:99:5127,183,637
chr7	55273591	.	G	GAA	5089.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.587;DP=367;ExcessHet=3.0103;FS=1.264;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.66;ReadPosRankSum=-0.246;SOR=0.566;OLD_VARIANT=chr7|55273591|G|GA,GAA|2;HGVSnom=NM_005228.5:c.*293_*294dupAA;Gene=EGFR;Transcript=NM_005228.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E28;IVSnom=.;AAlength=1210;RS=rs5884404;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0014;patientHetNum=4;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[16D0166662][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0162334|15B0047454-1|16B0001837-1|16B0067389][_];patientHomSampleInfo=[16B0024490|15B0067672-1][_];CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=AGGTATATTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:58,68:325:99:5127,3192,4767
chr7	55274084	.	T	C	5880.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.348;DP=443;ExcessHet=3.0103;FS=2.462;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.3;ReadPosRankSum=-0.074;SOR=0.872;HGVSnom=NM_005228.5:c.*774T>C;Gene=EGFR;Transcript=NM_005228.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E28;IVSnom=.;AAlength=1210;RS=rs884225;CLNGENE=EGFR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.186901;G1000_EAS_AF=0.4643;G1000_EUR_AF=0.1103;G1000_AFR_AF=0.0537;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.1023;HGMD_gene=EGFR;HGMD_disease=Bladder_cancer_association_with;HGMD_tag=DFP;HGMD_pmid=23028094;NativeFreq_Het=0.4554;NativeFreq_Hom=0.2772;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.0011;patientHomNum=3;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[15B0062536-1][_];patientHomSampleInfo=[17B0001547-1|15B0040463|15D6722238-1][_];AF_2700_Het=0.5004;AF_2700_Hom=0.2398;AF_50_Het=0.4881;AF_50_Hom=0.2567;DANN_score=0.7184;GREP_score=2.3;CytoBand=p11.2;CGD_CONDITION=Acute myeloid leukemia, familial. Lung cancer, familial, susceptibilty to. Inflammatory skin and bowel disease, neonatal, 2;CGD_INHERITANCE=AD/AR;Strand=EGFR:NM_005228.5:+,EGFR:NM_001346899.1:+,EGFR:NM_001346941.1:+,EGFR:NM_005228.4:+,EGFR:NM_001346900.1:+;NP=EGFR:NM_005228.5:NP_005219.2,EGFR:NM_001346899.1:NP_001333828.1,EGFR:NM_001346941.1:NP_001333870.1,EGFR:NM_005228.4:NP_005219.2,EGFR:NM_001346900.1:NP_001333829.1;ENSP=EGFR:NM_005228.5:ENST00000275493.7,EGFR:NM_001346899.1:.,EGFR:NM_001346941.1:.,EGFR:NM_005228.4:.,EGFR:NM_001346900.1:.;Gene_MIM_id=131550;Phenotypes=Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3), Autosomal recessive. Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3), Autosomal recessive. {Nonsmall cell lung cancer, susceptibility to}, 211980 (3), Autosomal recessive. 211980(SK),616069(UK);Possible_Inheritance=AR;EntrezGeneID=1956;EnsemblGeneID=ENSG00000146648;Alias=EGFR, NISBD2;FLKSEQ=CTCAGTATGC.GCCCCTGTCT	GT:AD:DP:GQ:PL	0/1:240,202:442:99:5909,0,7562
chr7	75677430	.	C	G	5061.77	PASS	AC=2;AF=1;AN=2;DP=148;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.67;SOR=1.626;HGVSnom=NM_005918.4:c.-49C>G;Gene=MDH2;Transcript=NM_005918.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=338;EXAC_AF=0.98943111;EXAC_Hom_EAS=155;EXAC_AC_EAS=310;EXAC_AN_EAS=310;EXAC_AC_Adj=15166;EXAC_AN_Adj=15328;ESP6500_MAF=0.97447552;RS=rs10231092;G1000_AF=0.972444;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9002;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9914;gnomad_exomes_AF=0.99395388;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=139736;gnomad_exomes_Hom=69477;gnomad_exomes_Het=782;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91706161;gnomad_exomes_AF_NFE=0.99953966;gnomad_exomes_AF_AMR=0.99368481;gnomad_exomes_AF_SAS=0.99951228;NativeFreq_Het=0.0107;NativeFreq_Hom=0.0107;DANN_score=0.5912;GREP_score=-7.02;CytoBand=q11.23;CGD_CONDITION=Epileptic encephalopathy, early infantile, 51;CGD_INHERITANCE=AR;Strand=MDH2:NM_001282403.1:+,MDH2:NM_001282404.1:+,MDH2:NM_005918.3:+;NP=MDH2:NM_001282403.1:NP_001269332.1,MDH2:NM_001282404.1:NP_001269333.1,MDH2:NM_005918.3:NP_005909.2;ENSP=MDH2:NM_001282403.1:.,MDH2:NM_001282404.1:.,MDH2:NM_005918.3:ENST00000315758.9;Gene_MIM_id=616695,154100;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51657,4191;EnsemblGeneID=ENSG00000127952,ENSG00000146701;Alias=STYXL1, MKSTYX, DUSP24,MDH2;FLKSEQ=AGTCACTTCC.CGTCACCAGC	GT:AD:DP:GQ:PL	1/1:0,146:146:99:5090,439,0
chr7	75677504	.	C	T	2250.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.55;DP=144;ExcessHet=3.0103;FS=4.073;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.74;ReadPosRankSum=-2.427;SOR=0.429;HGVSnom=NM_005918.4:c.26C>T(p.Ala9Val/p.A9V);Gene=MDH2;Transcript=NM_005918.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E1;IVSnom=.;AAlength=338;EXAC_AF=0.44544892;EXAC_Hom_EAS=111;EXAC_AC_EAS=341;EXAC_AN_EAS=500;EXAC_AC_Adj=7194;EXAC_AN_Adj=16150;ESP6500_MAF=0.39149043;RS=rs6720;Ensembl_transcriptid=ENST00000461263|ENST00000315758|ENST00000432020;SIFT_pred=.|T|T;SIFT_score=.|0.149|0.162;Polyphen2_HVAR_pred=.|B|.;Polyphen2_HVAR_score=.|0.0|.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|0.999283;CLNGENE=MDH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.522165;G1000_EAS_AF=0.6071;G1000_EUR_AF=0.327;G1000_AFR_AF=0.7073;G1000_SAS_AF=0.4601;G1000_AMR_AF=0.4164;gnomad_exomes_AF=0.40065875;gnomad_exomes_AF_EAS=0.59516366;gnomad_exomes_AC=56807;gnomad_exomes_Hom=12483;gnomad_exomes_Het=31841;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65573770;gnomad_exomes_AF_NFE=0.29941799;gnomad_exomes_AF_AMR=0.47906117;gnomad_exomes_AF_SAS=0.44959873;NativeFreq_Het=0.2811;NativeFreq_Hom=0.0391;DANN_score=0.9947;GREP_score=0.558;CytoBand=q11.23;CGD_CONDITION=Epileptic encephalopathy, early infantile, 51;CGD_INHERITANCE=AR;Strand=MDH2:NM_001282403.1:+,MDH2:NM_001282404.1:+,MDH2:NM_005918.3:+;NP=MDH2:NM_001282403.1:NP_001269332.1,MDH2:NM_001282404.1:NP_001269333.1,MDH2:NM_005918.3:NP_005909.2;ENSP=MDH2:NM_001282403.1:.,MDH2:NM_001282404.1:.,MDH2:NM_005918.3:ENST00000315758.9;Gene_MIM_id=616695,154100;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51657,4191;EnsemblGeneID=ENSG00000127952,ENSG00000146701;Alias=STYXL1, MKSTYX, DUSP24,MDH2;FLKSEQ=GCCCGGCCTG.CAGCGCTGCT	GT:AD:DP:GQ:PL	0/1:62,81:143:99:2279,0,1932
chr7	75677578	.	G	T	1575.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.11;DP=84;ExcessHet=3.0103;FS=3.031;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.99;ReadPosRankSum=-0.688;SOR=1.34;HGVSnom=NM_005918.4:c.66+34G>T;Gene=MDH2;Transcript=NM_005918.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_005918.4:IVS1+34G>T;AAlength=338;EXAC_AF=0.22057954;EXAC_Hom_EAS=4;EXAC_AC_EAS=57;EXAC_AN_EAS=178;EXAC_AC_Adj=2238;EXAC_AN_Adj=10146;ESP6500_MAF=0.12972210;RS=rs2286828;CLNGENE=MDH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.194489;G1000_EAS_AF=0.2599;G1000_EUR_AF=0.1779;G1000_AFR_AF=0.1589;G1000_SAS_AF=0.1718;G1000_AMR_AF=0.2233;gnomad_exomes_AF=0.20320591;gnomad_exomes_AF_EAS=0.29198362;gnomad_exomes_AC=25899;gnomad_exomes_Hom=2797;gnomad_exomes_Het=20305;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17116813;gnomad_exomes_AF_NFE=0.17392983;gnomad_exomes_AF_AMR=0.23297881;gnomad_exomes_AF_SAS=0.19547402;NativeFreq_Het=0.0641;NativeFreq_Hom=0;DANN_score=0.8175;GREP_score=-0.603;CytoBand=q11.23;CGD_CONDITION=Epileptic encephalopathy, early infantile, 51;CGD_INHERITANCE=AR;Strand=MDH2:NM_001282403.1:+,MDH2:NM_001282404.1:+,MDH2:NM_005918.3:+;NP=MDH2:NM_001282403.1:NP_001269332.1,MDH2:NM_001282404.1:NP_001269333.1,MDH2:NM_005918.3:NP_005909.2;ENSP=MDH2:NM_001282403.1:.,MDH2:NM_001282404.1:.,MDH2:NM_005918.3:ENST00000315758.9;Gene_MIM_id=616695,154100;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=51657,4191;EnsemblGeneID=ENSG00000127952,ENSG00000146701;Alias=STYXL1, MKSTYX, DUSP24,MDH2;FLKSEQ=GCAGGCGGAG.CCCCCCGGCC	GT:AD:DP:GQ:PL	0/1:32,51:83:99:1604,0,983
chr7	75692927	.	C	T	4513.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.621;DP=317;ExcessHet=3.0103;FS=4.434;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.28;ReadPosRankSum=-0.833;SOR=0.933;HGVSnom=NM_005918.4:c.633+17C>T;Gene=MDH2;Transcript=NM_005918.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_005918.4:IVS6+17C>T;AAlength=338;EXAC_AF=0.40587517;EXAC_Hom_EAS=1571;EXAC_AC_EAS=5183;EXAC_AN_EAS=8628;EXAC_AC_Adj=49201;EXAC_AN_Adj=121222;ESP6500_MAF=0.44018145;RS=rs1637037;CLNGENE=MDH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.547923;G1000_EAS_AF=0.6071;G1000_EUR_AF=0.327;G1000_AFR_AF=0.8064;G1000_SAS_AF=0.4601;G1000_AMR_AF=0.4135;gnomad_exomes_AF=0.40374559;gnomad_exomes_AF_EAS=0.59454902;gnomad_exomes_AC=101454;gnomad_exomes_Hom=22720;gnomad_exomes_Het=56014;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.73128540;gnomad_exomes_AF_NFE=0.30072681;gnomad_exomes_AF_AMR=0.48686267;gnomad_exomes_AF_SAS=0.45080361;NativeFreq_Het=0.4235;NativeFreq_Hom=0.3345;DANN_score=0.4606;GREP_score=-5.84;CytoBand=q11.23;CGD_CONDITION=Epileptic encephalopathy, early infantile, 51;CGD_INHERITANCE=AR;Strand=MDH2:NM_001282403.1:+,MDH2:NM_001282404.1:+,MDH2:NM_005918.3:+;NP=MDH2:NM_001282403.1:NP_001269332.1,MDH2:NM_001282404.1:NP_001269333.1,MDH2:NM_005918.3:NP_005909.2;ENSP=MDH2:NM_001282403.1:.,MDH2:NM_001282404.1:.,MDH2:NM_005918.3:ENST00000315758.9;Gene_MIM_id=154100;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=4191;EnsemblGeneID=ENSG00000146701;Alias=MDH2;FLKSEQ=GCATATGACC.TGTGAGGGGC	GT:AD:DP:GQ:PL	0/1:165,151:316:99:4542,0,5198
chr7	75694079	.	T	G	3027.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.172;DP=185;ExcessHet=3.0103;FS=12.093;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.37;ReadPosRankSum=1.724;SOR=1.993;HGVSnom=NM_005918.4:c.734-41T>G;Gene=MDH2;Transcript=NM_005918.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_005918.4:IVS7-41T>G;AAlength=338;EXAC_AF=0.42710238;EXAC_Hom_EAS=1159;EXAC_AC_EAS=4069;EXAC_AN_EAS=6646;EXAC_AC_Adj=37837;EXAC_AN_Adj=88590;ESP6500_MAF=0.40678357;RS=rs11972240;CLNGENE=MDH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.547923;G1000_EAS_AF=0.6071;G1000_EUR_AF=0.327;G1000_AFR_AF=0.8064;G1000_SAS_AF=0.4601;G1000_AMR_AF=0.4135;gnomad_exomes_AF=0.39843815;gnomad_exomes_AF_EAS=0.59025056;gnomad_exomes_AC=86634;gnomad_exomes_Hom=18814;gnomad_exomes_Het=49006;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.72548036;gnomad_exomes_AF_NFE=0.29237746;gnomad_exomes_AF_AMR=0.48420021;gnomad_exomes_AF_SAS=0.44609721;NativeFreq_Het=0.4164;NativeFreq_Hom=0.2883;DANN_score=0.4671;GREP_score=2.93;CytoBand=q11.23;CGD_CONDITION=Epileptic encephalopathy, early infantile, 51;CGD_INHERITANCE=AR;Strand=MDH2:NM_001282403.1:+,MDH2:NM_001282404.1:+,MDH2:NM_005918.3:+;NP=MDH2:NM_001282403.1:NP_001269332.1,MDH2:NM_001282404.1:NP_001269333.1,MDH2:NM_005918.3:NP_005909.2;ENSP=MDH2:NM_001282403.1:.,MDH2:NM_001282404.1:.,MDH2:NM_005918.3:ENST00000315758.9;Gene_MIM_id=154100;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=4191;EnsemblGeneID=ENSG00000146701;Alias=MDH2;FLKSEQ=GGGCGTCACG.TTGTGGCACC	GT:AD:DP:GQ:PL	0/1:93,92:185:99:3056,0,2547
chr7	92235951	.	A	AT	4614.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.787;DP=312;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.91;ReadPosRankSum=0.969;SOR=0.705;HGVSnom=NM_001145306.2:c.*8502dupA;Gene=CDK6;Transcript=NM_001145306.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=326;RS=rs5885811;G1000_AF=0.620807;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.5567;G1000_AFR_AF=0.6157;G1000_SAS_AF=0.6401;G1000_AMR_AF=0.6196;CytoBand=q21.2;CGD_CONDITION=Microcephaly 12, primary, autosomal recessive;CGD_INHERITANCE=AR;Strand=CDK6:NM_001259.6:-,CDK6:NM_001145306.1:-;NP=CDK6:NM_001259.6:NP_001250.1,CDK6:NM_001145306.1:NP_001138778.1;ENSP=CDK6:NM_001259.6:.,CDK6:NM_001145306.1:.;Gene_MIM_id=603368;Phenotypes=?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive. 616080(UK);Possible_Inheritance=AR;EntrezGeneID=1021;EnsemblGeneID=ENSG00000105810;Alias=CDK6, PLSTIRE, MCPH12;FLKSEQ=TCCAAATTAG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:68,222:290:99:4652,0,764
chr7	92236164	.	T	C	9014.77	PASS	AC=2;AF=1;AN=2;DP=257;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.15;SOR=0.899;HGVSnom=NM_001145306.2:c.*8290A>G;Gene=CDK6;Transcript=NM_001145306.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=326;RS=rs8179;G1000_AF=0.888778;G1000_EAS_AF=0.9821;G1000_EUR_AF=0.7793;G1000_AFR_AF=0.8903;G1000_SAS_AF=0.9213;G1000_AMR_AF=0.8631;DANN_score=0.6007;GREP_score=3.28;CytoBand=q21.2;CGD_CONDITION=Microcephaly 12, primary, autosomal recessive;CGD_INHERITANCE=AR;Strand=CDK6:NM_001259.6:-,CDK6:NM_001145306.1:-;NP=CDK6:NM_001259.6:NP_001250.1,CDK6:NM_001145306.1:NP_001138778.1;ENSP=CDK6:NM_001259.6:.,CDK6:NM_001145306.1:.;Gene_MIM_id=603368;Phenotypes=?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive. 616080(UK);Possible_Inheritance=AR;EntrezGeneID=1021;EnsemblGeneID=ENSG00000105810;Alias=CDK6, PLSTIRE, MCPH12;FLKSEQ=GCACTCTACG.GAACCAATAT	GT:AD:DP:GQ:PL	1/1:0,254:254:99:9043,762,0
chr7	92237396	.	A	T	7558.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.18;DP=538;ExcessHet=3.0103;FS=9.33;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.15;ReadPosRankSum=1.898;SOR=1.256;HGVSnom=NM_001145306.2:c.*7058T>A;Gene=CDK6;Transcript=NM_001145306.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=326;RS=rs42031;G1000_AF=0.11901;G1000_EAS_AF=0.0585;G1000_EUR_AF=0.2197;G1000_AFR_AF=0.1104;G1000_SAS_AF=0.0757;G1000_AMR_AF=0.1383;DANN_score=0.7792;GREP_score=-1.97;CytoBand=q21.2;CGD_CONDITION=Microcephaly 12, primary, autosomal recessive;CGD_INHERITANCE=AR;Strand=CDK6:NM_001259.6:-,CDK6:NM_001145306.1:-;NP=CDK6:NM_001259.6:NP_001250.1,CDK6:NM_001145306.1:NP_001138778.1;ENSP=CDK6:NM_001259.6:.,CDK6:NM_001145306.1:.;Gene_MIM_id=603368;Phenotypes=?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive. 616080(UK);Possible_Inheritance=AR;EntrezGeneID=1021;EnsemblGeneID=ENSG00000105810;Alias=CDK6, PLSTIRE, MCPH12;FLKSEQ=CAGAACTTTA.CCTAAGCACA	GT:AD:DP:GQ:PL	0/1:284,250:534:99:7587,0,8520
chr7	92241633	.	G	C	16080.8	PASS	AC=2;AF=1;AN=2;DP=417;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.04;SOR=1.1;HGVSnom=NM_001145306.2:c.*2821C>G;Gene=CDK6;Transcript=NM_001145306.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=326;RS=rs2285332;G1000_AF=0.436302;G1000_EAS_AF=0.7321;G1000_EUR_AF=0.2406;G1000_AFR_AF=0.438;G1000_SAS_AF=0.2975;G1000_AMR_AF=0.4827;DANN_score=0.6917;GREP_score=4.24;CytoBand=q21.2;CGD_CONDITION=Microcephaly 12, primary, autosomal recessive;CGD_INHERITANCE=AR;Strand=CDK6:NM_001259.6:-,CDK6:NM_001145306.1:-;NP=CDK6:NM_001259.6:NP_001250.1,CDK6:NM_001145306.1:NP_001138778.1;ENSP=CDK6:NM_001259.6:.,CDK6:NM_001145306.1:.;Gene_MIM_id=603368;Phenotypes=?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive. 616080(UK);Possible_Inheritance=AR;EntrezGeneID=1021;EnsemblGeneID=ENSG00000105810;Alias=CDK6, PLSTIRE, MCPH12;FLKSEQ=GCCCTTTTCA.TTCACCACTG	GT:AD:DP:GQ:PL	1/1:0,416:416:99:16109,1251,0
chr7	92244010	.	TAC	T	1268.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.391;DP=141;ExcessHet=3.0103;FS=3.148;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=-1.359;SOR=0.801;HGVSnom=NM_001145306.2:c.*442_*443delGT;Gene=CDK6;Transcript=NM_001145306.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=326;RS=rs10552976;G1000_AF=0.670927;G1000_EAS_AF=0.8234;G1000_EUR_AF=0.4543;G1000_AFR_AF=0.8623;G1000_SAS_AF=0.5726;G1000_AMR_AF=0.5375;CytoBand=q21.2;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=25.5;CGD_CONDITION=Microcephaly 12, primary, autosomal recessive;CGD_INHERITANCE=AR;Strand=CDK6:NM_001259.6:-,CDK6:NM_001145306.1:-;NP=CDK6:NM_001259.6:NP_001250.1,CDK6:NM_001145306.1:NP_001138778.1;ENSP=CDK6:NM_001259.6:.,CDK6:NM_001145306.1:.;Gene_MIM_id=603368;Phenotypes=?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive. 616080(UK);Possible_Inheritance=AR;EntrezGeneID=1021;EnsemblGeneID=ENSG00000105810;Alias=CDK6, PLSTIRE, MCPH12;FLKSEQ=ATCTCTcaca.acacacacac	GT:AD:DP:GQ:PL	0/1:31,58:89:99:1306,0,714
chr7	116312439	.	C	G	2355.77	PASS	AC=2;AF=1;AN=2;DP=75;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.27;SOR=2.833;HGVSnom=NR_165033.1:n.88-8344G>C|NM_000245.4:c.-207C>G;Gene=COMETT|MET;Transcript=NR_165033.1|NM_000245.4;VarType=Intron|UTR5;MolecularConsequence=noncoding_transcript_intron_variant|5_prime_UTR_exon_variant;ExonIntron=I1|E1;IVSnom=NR_165033.1:IVS1-8344G>C|.;AAlength=.|1390;RS=rs1858830;CLNGENE=COMETT|MET;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.457468;G1000_EAS_AF=0.6647;G1000_EUR_AF=0.4493;G1000_AFR_AF=0.2209;G1000_SAS_AF=0.5112;G1000_AMR_AF=0.5432;HGMD_gene=MET;HGMD_disease=Autism_association_with;HGMD_tag=DFP;HGMD_pmid=17053076;NativeFreq_Het=0.4455;NativeFreq_Hom=0.4653;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0002988][_];AF_2700_Het=0.3378;AF_2700_Hom=0.3455;AF_50_Het=0.3249;AF_50_Hom=0.3661;DANN_score=0.8504;GREP_score=-6.26;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+;NP=MET:NM_001324402.1:NP_001311331.1;ENSP=MET:NM_001324402.1:.;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=GGGCTCAGCC.GGCCGCAGGT	GT:AD:DP:GQ:PL	1/1:0,73:73:99:2384,219,0
chr7	116339672	.	C	T	6107.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.604;DP=413;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.9;ReadPosRankSum=-0.086;SOR=0.774;HGVSnom=NM_000245.4:c.534C>T(p.Ser178Ser/p.S178S);Gene=MET;Transcript=NM_000245.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1390;EXAC_AF=0.05972423;EXAC_Hom_EAS=20;EXAC_AC_EAS=539;EXAC_AN_EAS=8598;EXAC_AC_Adj=7173;EXAC_AN_Adj=120102;ESP6500_MAF=0.06966274;RS=rs35775721;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0884585;G1000_EAS_AF=0.0526;G1000_EUR_AF=0.0417;G1000_AFR_AF=0.1664;G1000_SAS_AF=0.1094;G1000_AMR_AF=0.0303;gnomad_exomes_AF=0.05658094;gnomad_exomes_AF_EAS=0.06658123;gnomad_exomes_AC=13979;gnomad_exomes_Hom=618;gnomad_exomes_Het=12743;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14056199;gnomad_exomes_AF_NFE=0.04061736;gnomad_exomes_AF_AMR=0.02535138;gnomad_exomes_AF_SAS=0.11566383;NativeFreq_Het=0.0792;NativeFreq_Hom=0;normalHetFrequency=0.134;normalHetNum=52;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.1302;patientHetNum=361;patientHomFrequency=0.0047;patientHomNum=13;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1545955|16B0017801][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6482471|15D6532196|16B0202521|16B0012156|15D6532797|16B0019214-1|15D6722354|15D6533588|16B3094182|16D0166272|16B0047183|16D1546152|15D6524810][_];AF_2700_Het=0.1299;AF_2700_Hom=0.0035;AF_50_Het=0.1157;AF_50_Hom=0.0048;DANN_score=0.6809;GREP_score=-2.58;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=GTGTGGTGAG.GCCCTGGGAG	GT:AD:DP:GQ:PL	0/1:205,205:410:99:6136,0,6060
chr7	116340262	.	A	G	7027.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=11.027;DP=443;ExcessHet=3.0103;FS=1.742;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.9;ReadPosRankSum=1.396;SOR=0.641;HGVSnom=NM_000245.4:c.1124A>G(p.Asn375Ser/p.N375S);Gene=MET;Transcript=NM_000245.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=1390;EXAC_AF=0.02825882;EXAC_Hom_EAS=20;EXAC_AC_EAS=539;EXAC_AN_EAS=8592;EXAC_AC_Adj=3293;EXAC_AN_Adj=116530;ESP6500_MAF=0.01458952;RS=rs33917957;Ensembl_transcriptid=ENST00000397752|ENST00000318493|ENST00000436117;SIFT_pred=T|T|T;SIFT_score=0.096|0.086|0.138;Polyphen2_HVAR_pred=B|B|.;Polyphen2_HVAR_score=0.026|0.015|.;MutationTaster_pred=D|D|D;MutationTaster_score=0.537467|0.537467|0.537467;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0329473;G1000_EAS_AF=0.0526;G1000_EUR_AF=0.0209;G1000_AFR_AF=0.0053;G1000_SAS_AF=0.0787;G1000_AMR_AF=0.0101;gnomad_exomes_AF=0.02703860;gnomad_exomes_AF_EAS=0.06675285;gnomad_exomes_AC=6190;gnomad_exomes_Hom=184;gnomad_exomes_Het=5822;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00645756;gnomad_exomes_AF_NFE=0.01786481;gnomad_exomes_AF_AMR=0.00613394;gnomad_exomes_AF_SAS=0.07406523;NativeFreq_Het=0.0792;NativeFreq_Hom=0;normalHetFrequency=0.1082;normalHetNum=42;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0895;patientHetNum=248;patientHomFrequency=0.0018;patientHomNum=5;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0017801][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0202521|16B0012156|16B0019214-1|16B3094182|16B0047183][_];AF_2700_Het=0.1287;AF_2700_Hom=0.0035;AF_50_Het=0.1157;AF_50_Hom=0.0048;DANN_score=0.9806;GREP_score=4.91;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=GACTTCTTCA.CAAGATCGTC	GT:AD:DP:GQ:PL	0/1:231,211:442:99:7056,0,7130
chr7	116381121	.	GT	G	907.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.446;DP=384;ExcessHet=3.0103;FS=0.634;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.73;ReadPosRankSum=-0.334;SOR=0.766;HGVSnom=NM_000245.4:c.1701+58delT;Gene=MET;Transcript=NM_000245.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000245.4:IVS5+58delT;AAlength=1390;EXAC_AF=0.38319036;EXAC_Hom_EAS=0;EXAC_AC_EAS=1585;EXAC_AN_EAS=3910;EXAC_AC_Adj=22960;EXAC_AN_Adj=59918;RS=rs112241458;CLNGENE=MET;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.4716;normalHetNum=183;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.4737;patientHetNum=1313;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0028300][_];CytoBand=q31.2;repName=T-rich;repClass=Low_complexity;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=tttgtttggt.tttttttttt	GT:AD:DP:GQ:PL	0/1:234,98:332:99:945,0,3689
chr7	116397572	.	A	G	4809.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.288;DP=317;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.22;ReadPosRankSum=0.257;SOR=0.695;HGVSnom=NM_000245.4:c.1944A>G(p.Gln648Gln/p.Q648Q);Gene=MET;Transcript=NM_000245.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=1390;EXAC_AF=0.18781423;EXAC_Hom_EAS=393;EXAC_AC_EAS=2588;EXAC_AN_EAS=8612;EXAC_AC_Adj=22638;EXAC_AN_Adj=120534;ESP6500_MAF=0.16871217;RS=rs13223756;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.187899;G1000_EAS_AF=0.2728;G1000_EUR_AF=0.2048;G1000_AFR_AF=0.1089;G1000_SAS_AF=0.2342;G1000_AMR_AF=0.1254;gnomad_exomes_AF=0.18248989;gnomad_exomes_AF_EAS=0.29383623;gnomad_exomes_AC=45494;gnomad_exomes_Hom=4535;gnomad_exomes_Het=36424;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12501615;gnomad_exomes_AF_NFE=0.18887494;gnomad_exomes_AF_AMR=0.08037009;gnomad_exomes_AF_SAS=0.23073403;NativeFreq_Het=0.4554;NativeFreq_Hom=0.0792;normalHetFrequency=0.3892;normalHetNum=151;normalHomFrequency=0.0747;normalHomNum=29;patientHetFrequency=0.3492;patientHetNum=968;patientHomFrequency=0.074;patientHomNum=205;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4039;AF_2700_Hom=0.0938;AF_50_Het=0.4152;AF_50_Hom=0.0935;DANN_score=0.255;GREP_score=-6.5;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=GGACAACACA.TACAGTACAT	GT:AD:DP:GQ:PL	0/1:167,149:316:99:4838,0,5335
chr7	116398763	.	C	T	5048.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.621;DP=318;ExcessHet=3.0103;FS=7.249;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.93;ReadPosRankSum=-0.177;SOR=1.065;HGVSnom=NM_000245.4:c.2264+89C>T;Gene=MET;Transcript=NM_000245.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000245.4:IVS9+89C>T;AAlength=1390;RS=rs17138978;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0904553;G1000_EAS_AF=0.1151;G1000_EUR_AF=0.0308;G1000_AFR_AF=0.1059;G1000_SAS_AF=0.1043;G1000_AMR_AF=0.0922;normalHetFrequency=0.1649;normalHetNum=64;normalHomFrequency=0.0103;normalHomNum=4;patientHetFrequency=0.1494;patientHetNum=414;patientHomFrequency=0.0101;patientHomNum=28;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.547;GREP_score=0.953;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=GCAGTTTTAT.TCTGGCTTTG	GT:AD:DP:GQ:PL	0/1:158,159:317:99:5077,0,5052
chr7	116409675	.	CT	C	725.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.363;DP=311;ExcessHet=3.0103;FS=1.281;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.72;ReadPosRankSum=-0.613;SOR=0.725;HGVSnom=NM_000245.4:c.2584-9delT;Gene=MET;Transcript=NM_000245.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000245.4:IVS11-9delT;AAlength=1390;EXAC_AF=0.43497210;EXAC_Hom_EAS=0;EXAC_AC_EAS=2662;EXAC_AN_EAS=6936;EXAC_AC_Adj=44114;EXAC_AN_Adj=101418;RS=rs57349036;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.45376935;gnomad_exomes_AF_EAS=0.41626998;gnomad_exomes_AC=80260;gnomad_exomes_Hom=98;gnomad_exomes_Het=80064;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.45801789;gnomad_exomes_AF_NFE=0.45881127;gnomad_exomes_AF_AMR=0.45076695;gnomad_exomes_AF_SAS=0.44716633;NativeFreq_Het=0.1634;NativeFreq_Hom=.;normalHetFrequency=0.7784;normalHetNum=302;normalHomFrequency=0.0258;normalHomNum=10;patientHetFrequency=0.7781;patientHetNum=2157;patientHomFrequency=0.0307;patientHomNum=85;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.8859;AF_2700_Hom=0.0027;AF_50_Het=0.8780;AF_50_Hom=.;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_001324401.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_001324401.1:NP_001311330.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_001324401.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=TGTTAACAAC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:188,79:267:99:763,0,3322
chr7	116421967	.	T	C	5681.77	StandardFilter	AC=2;AF=1;AN=2;BaseQRankSum=1.085;DP=158;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.43;ReadPosRankSum=-1.08;SOR=4.228;HGVSnom=NM_000245.4:c.3523-75T>C;Gene=MET;Transcript=NM_000245.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_000245.4:IVS17-75T>C;AAlength=1390;RS=rs6947629;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.648562;G1000_EAS_AF=0.5337;G1000_EUR_AF=0.5577;G1000_AFR_AF=0.9705;G1000_SAS_AF=0.5051;G1000_AMR_AF=0.536;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3168;normalHetFrequency=0.4871;normalHetNum=189;normalHomFrequency=0.2887;normalHomNum=112;patientHetFrequency=0.461;patientHetNum=1278;patientHomFrequency=0.294;patientHomNum=815;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8395;GREP_score=-0.79;CytoBand=q31.2;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=tataaataaa.atttCAGAAT	GT:AD:DP:GQ:PL	1/1:1,155:156:99:5710,435,0
chr7	116436862	.	G	A	1365.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.9;DP=78;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.87;MQRankSum=-0.887;QD=17.74;ReadPosRankSum=-0.794;SOR=0.794;HGVSnom=NM_000245.4:c.*684G>A;Gene=MET;Transcript=NM_000245.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E21;IVSnom=.;AAlength=1390;RS=rs12540703;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0902556;G1000_EAS_AF=0.1151;G1000_EUR_AF=0.0328;G1000_AFR_AF=0.0983;G1000_SAS_AF=0.1155;G1000_AMR_AF=0.0865;NativeFreq_Het=0.1980;NativeFreq_Hom=0;AF_2700_Het=0.2102;AF_2700_Hom=0.0135;AF_50_Het=0.1775;AF_50_Hom=0.0190;DANN_score=0.7392;GREP_score=0.235;CytoBand=q31.2;repName=AluJb;repClass=SINE;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=ttgtagagac.gggttttgcc	GT:AD:DP:GQ:PL	0/1:35,42:77:99:1394,0,998
chr7	116437606	.	G	A	14908.8	PASS	AC=2;AF=1;AN=2;DP=426;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.35;SOR=0.722;HGVSnom=NM_000245.4:c.*1428G>A;Gene=MET;Transcript=NM_000245.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E21;IVSnom=.;AAlength=1390;RS=rs1621;CLNGENE=MET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.70647;G1000_EAS_AF=0.8591;G1000_EUR_AF=0.6809;G1000_AFR_AF=0.5045;G1000_SAS_AF=0.8517;G1000_AMR_AF=0.7017;NativeFreq_Het=0.1980;NativeFreq_Hom=0.7524;normalHetFrequency=0.0077;normalHetNum=3;normalHomFrequency=0.0077;normalHomNum=3;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0032;patientHomNum=9;normalHetSampleInfo=[16B0028108|16D0067231|15B0063117][_];normalHomSampleInfo=[17D0500507|15B0063116|16D0166707][_];patientHetSampleInfo=[15D6722244|15D6722466-1|17B0001535-1][_];patientHomSampleInfo=[16D1546145|16B3094602|16B0200465|16B0005664|16B3260468-1|16B0005639|16D0038328|15B6105813|16B0012197][_];AF_2700_Het=0.2118;AF_2700_Hom=0.7675;AF_50_Het=0.2345;AF_50_Hom=0.7433;DANN_score=0.7623;GREP_score=3.42;CytoBand=q31.2;CGD_CONDITION=Renal cell carcinoma, papillary. Deafness, autosomal recessive 97;CGD_INHERITANCE=AD/AR;Strand=MET:NM_001324402.1:+,MET:NM_000245.3:+,MET:NM_001127500.2:+;NP=MET:NM_001324402.1:NP_001311331.1,MET:NM_000245.3:NP_000236.2,MET:NM_001127500.2:NP_001120972.1;ENSP=MET:NM_001324402.1:.,MET:NM_000245.3:.,MET:NM_001127500.2:ENST00000318493.10;Gene_MIM_id=164860;Phenotypes=?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive. Hepatocellular carcinoma, childhood type, somatic, 114550 (3). {Osteofibrous dysplasia, susceptibility to}, 607278 (3), Autosomal dominant. Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3). 114550(MK),605074(MK),616705(UK);Possible_Inheritance=AR;EntrezGeneID=4233;EnsemblGeneID=ENSG00000105976;Alias=MET, DFNB97, OSFD;FLKSEQ=TTTTGTGCTT.CTACTGTATA	GT:AD:DP:GQ:PL	1/1:0,424:424:99:14937,1273,0
chr7	116438511	.	G	T	14149.8	PASS	AC=2;AF=1;AN=2;DP=379;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.3;SOR=1.706;HGVSnom=.;Gene=MET;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs41741;G1000_AF=0.70647;G1000_EAS_AF=0.8591;G1000_EUR_AF=0.6809;G1000_AFR_AF=0.5045;G1000_SAS_AF=0.8517;G1000_AMR_AF=0.7017;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0005712][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536906-1|16B1884785][_];DANN_score=0.5318;GREP_score=1.18;CytoBand=q31.2;FLKSEQ=AGCCTAAGAT.GATTTCACCT	GT:AD:DP:GQ:PL	1/1:0,379:379:99:14178,1140,0
chr7	117188660	.	ATG	A	33.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.64;DP=243;ExcessHet=3.0103;FS=2.066;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.16;ReadPosRankSum=1.388;SOR=0.932;HGVSnom=NM_000492.4:c.1210-13_1210-12delGT|NR_149084.1:n.222-6069_222-6068delCA;Gene=CFTR|CFTR-AS1;Transcript=NM_000492.4|NR_149084.1;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|noncoding_transcript_intron_variant;ExonIntron=I9|I2;IVSnom=NM_000492.4:IVS9-13_-12delGT|NR_149084.1:IVS2-6069_-6068delCA;AAlength=1480|.;EXAC_AF=0.28546453;EXAC_Hom_EAS=0;EXAC_AC_EAS=471;EXAC_AN_EAS=6442;EXAC_AC_Adj=24329;EXAC_AN_Adj=85226;RS=rs3832534;CLNGENE=CFTR|CFTR-AS1;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.216653;G1000_EAS_AF=0.0099;G1000_EUR_AF=0.2187;G1000_AFR_AF=0.5;G1000_SAS_AF=0.0838;G1000_AMR_AF=0.1614;gnomad_exomes_AF=0.22214968;gnomad_exomes_AF_EAS=0.02366412;gnomad_exomes_AC=39472;gnomad_exomes_Hom=2273;gnomad_exomes_Het=34926;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.43827701;gnomad_exomes_AF_NFE=0.27032255;gnomad_exomes_AF_AMR=0.14417021;gnomad_exomes_AF_SAS=0.16266739;NativeFreq_Het=0.0036;NativeFreq_Hom=.;normalHetFrequency=0.1029;normalHetNum=89;normalHomFrequency=0.0127;normalHomNum=11;patientHetFrequency=0.0929;patientHetNum=485;patientHomFrequency=0.0195;patientHomNum=102;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q31.2;CGD_CONDITION=Cystic fibrosis;CGD_INHERITANCE=AR;Strand=CFTR:NM_000492.3:+,CFTR:NM_000492.4:+;NP=CFTR:NM_000492.3:NP_000483.3,CFTR:NM_000492.4:NP_000483.3;ENSP=CFTR:NM_000492.3:ENST00000003084.10,CFTR:NM_000492.4:ENST00000003084.11;Gene_MIM_id=602421;Phenotypes={Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant. Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive. Cystic fibrosis, 219700 (3), Autosomal recessive. {Hypertrypsinemia, neonatal} (3). {Pancreatitis, idiopathic}, 167800 (3), Autosomal dominant. Sweat chloride elevation without CF (3). 167800(SK),211400(SK),219700(MK),277180(MK),602421(SK);Possible_Inheritance=AD,AR;EntrezGeneID=1080;EnsemblGeneID=ENSG00000001626;Alias=CFTR, ABCC7, CF, MRP7;FLKSEQ=TTTATTTTTG.tgtgtgtgtg	GT:AD:DP:GQ:PL	0/1:182,27:209:71:71,0,5598
chr7	117188736	.	C	A	476.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.398;DP=314;ExcessHet=3.0103;FS=79.883;MLEAC=1;MLEAF=0.5;MQ=45.56;MQRankSum=-8.566;QD=1.52;ReadPosRankSum=-0.421;SOR=4.976;HGVSnom=NM_000492.4:c.1251C>A(p.Asn417Lys/p.N417K)|NR_149084.1:n.222-6143G>T;Gene=CFTR|CFTR-AS1;Transcript=NM_000492.4|NR_149084.1;VarType=Missense|Intron;MolecularConsequence=missense_variant|noncoding_transcript_intron_variant;ExonIntron=E10|I2;IVSnom=.|NR_149084.1:IVS2-6143G>T;AAlength=1480|.;EXAC_AF=0.01885163;EXAC_Hom_EAS=0;EXAC_AC_EAS=70;EXAC_AN_EAS=7562;EXAC_AC_Adj=1790;EXAC_AN_Adj=94952;RS=rs4727853;Ensembl_transcriptid=ENST00000003084|ENST00000426809;SIFT_pred=T|T;SIFT_score=0.51|0.506;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.002|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=CFTR|CFTR-AS1;CLNSIG=Conflicting_interpretations_of_pathogenicity|Conflicting_interpretations_of_pathogenicity;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_conflicting_interpretations|criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.00582596;gnomad_exomes_AF_EAS=0.00020202;gnomad_exomes_AC=1117;gnomad_exomes_Hom=0;gnomad_exomes_Het=1117;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00165990;gnomad_exomes_AF_NFE=0.00447304;gnomad_exomes_AF_AMR=0.00028363;gnomad_exomes_AF_SAS=0.00011404;NativeFreq_Het=0.0024;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0015;patientHetNum=8;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D0169414][15D6529871|15D6482432|15B6129562|16D0168782|15D6104506|15B0002467|15D6529869];patientHomSampleInfo=[_][_];DANN_score=0.2307;GREP_score=-4.06;CytoBand=q31.2;CGD_CONDITION=Cystic fibrosis;CGD_INHERITANCE=AR;Strand=CFTR:NM_000492.3:+,CFTR:NM_000492.4:+;NP=CFTR:NM_000492.3:NP_000483.3,CFTR:NM_000492.4:NP_000483.3;ENSP=CFTR:NM_000492.3:ENST00000003084.10,CFTR:NM_000492.4:ENST00000003084.11;Gene_MIM_id=602421;Phenotypes={Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant. Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive. Cystic fibrosis, 219700 (3), Autosomal recessive. {Hypertrypsinemia, neonatal} (3). {Pancreatitis, idiopathic}, 167800 (3), Autosomal dominant. Sweat chloride elevation without CF (3). 167800(SK),211400(SK),219700(MK),277180(MK),602421(SK);Possible_Inheritance=AD,AR;EntrezGeneID=1080;EnsemblGeneID=ENSG00000001626;Alias=CFTR, ABCC7, CF, MRP7;FLKSEQ=AAAACAATAA.AATAGAAAAA	GT:AD:DP:GQ:PL	0/1:277,37:314:99:505,0,9661
chr7	117188797	.	A	G	30.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.592;DP=348;ExcessHet=3.0103;FS=19.264;MLEAC=1;MLEAF=0.5;MQ=39.88;MQRankSum=-7.449;QD=0.09;ReadPosRankSum=-0.801;SOR=2.015;HGVSnom=NM_000492.4:c.1312A>G(p.Thr438Ala/p.T438A)|NR_149084.1:n.222-6204T>C;Gene=CFTR|CFTR-AS1;Transcript=NM_000492.4|NR_149084.1;VarType=Missense|Intron;MolecularConsequence=missense_variant|noncoding_transcript_intron_variant;ExonIntron=E10|I2;IVSnom=.|NR_149084.1:IVS2-6204T>C;AAlength=1480|.;EXAC_AF=0.00234815;EXAC_Hom_EAS=0;EXAC_AC_EAS=15;EXAC_AN_EAS=6750;EXAC_AC_Adj=212;EXAC_AN_Adj=90284;RS=rs201434579;Ensembl_transcriptid=ENST00000003084|ENST00000426809;SIFT_pred=T|T;SIFT_score=0.312|0.305;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.0|.;MutationTaster_pred=D|N;MutationTaster_score=0.999682|0.998581;CLNGENE=CFTR|CFTR-AS1;CLNSIG=Conflicting_interpretations_of_pathogenicity|Conflicting_interpretations_of_pathogenicity;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_conflicting_interpretations|criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.00020654;gnomad_exomes_AF_EAS=0.00005766;gnomad_exomes_AC=47;gnomad_exomes_Hom=0;gnomad_exomes_Het=47;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00028539;gnomad_exomes_AF_NFE=0.00037008;gnomad_exomes_AF_AMR=0.00006101;gnomad_exomes_AF_SAS=0.0;NativeFreq_Het=0.0108;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D0169414][_];patientHomSampleInfo=[_][_];DANN_score=0.8441;GREP_score=-6.7;CytoBand=q31.2;CGD_CONDITION=Cystic fibrosis;CGD_INHERITANCE=AR;Strand=CFTR:NM_000492.3:+,CFTR:NM_000492.4:+;NP=CFTR:NM_000492.3:NP_000483.3,CFTR:NM_000492.4:NP_000483.3;ENSP=CFTR:NM_000492.3:ENST00000003084.10,CFTR:NM_000492.4:ENST00000003084.11;Gene_MIM_id=602421;Phenotypes={Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant. Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive. Cystic fibrosis, 219700 (3), Autosomal recessive. {Hypertrypsinemia, neonatal} (3). {Pancreatitis, idiopathic}, 167800 (3), Autosomal dominant. Sweat chloride elevation without CF (3). 167800(SK),211400(SK),219700(MK),277180(MK),602421(SK);Possible_Inheritance=AD,AR;EntrezGeneID=1080;EnsemblGeneID=ENSG00000001626;Alias=CFTR, ABCC7, CF, MRP7;FLKSEQ=ACTTCTTGGT.CTCCTGTCCT	GT:AD:DP:GQ:PL	0/1:313,35:348:59:59,0,9966
chr7	124462655	.	T	C	7191.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.45;DP=485;ExcessHet=3.0103;FS=0.516;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.92;ReadPosRankSum=0.144;SOR=0.747;HGVSnom=NM_015450.3:c.*1361A>G;Gene=POT1;Transcript=NM_015450.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=634;EXAC_AF=0.19319949;EXAC_Hom_EAS=4;EXAC_AC_EAS=39;EXAC_AN_EAS=198;EXAC_AC_Adj=2733;EXAC_AN_Adj=14146;RS=rs76436625;G1000_AF=0.161142;G1000_EAS_AF=0.2014;G1000_EUR_AF=0.0924;G1000_AFR_AF=0.034;G1000_SAS_AF=0.3108;G1000_AMR_AF=0.2334;gnomad_exomes_AF=0.16882976;gnomad_exomes_AF_EAS=0.20479740;gnomad_exomes_AC=23363;gnomad_exomes_Hom=2473;gnomad_exomes_Het=18417;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.04047323;gnomad_exomes_AF_NFE=0.10777411;gnomad_exomes_AF_AMR=0.27670304;gnomad_exomes_AF_SAS=0.26744394;DANN_score=0.4008;GREP_score=-5.85;CytoBand=q31.33;repName=L2c;repClass=LINE;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=gagcacatca.caacacggaa	GT:AD:DP:GQ:PL	0/1:245,237:482:99:7220,0,7312
chr7	124469267	.	A	T	6703.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.705;DP=413;ExcessHet=3.0103;FS=0.598;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.27;ReadPosRankSum=-2.682;SOR=0.748;HGVSnom=NM_015450.3:c.1594+41T>A;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_015450.3:IVS16+41T>A;AAlength=634;EXAC_AF=0.41072463;EXAC_Hom_EAS=1099;EXAC_AC_EAS=4354;EXAC_AN_EAS=8620;EXAC_AC_Adj=49618;EXAC_AN_Adj=120806;ESP6500_MAF=0.38943565;RS=rs10263573;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.41893;G1000_EAS_AF=0.4911;G1000_EUR_AF=0.4433;G1000_AFR_AF=0.3555;G1000_SAS_AF=0.3875;G1000_AMR_AF=0.4438;gnomad_exomes_AF=0.41477969;gnomad_exomes_AF_EAS=0.50292947;gnomad_exomes_AC=101480;gnomad_exomes_Hom=21282;gnomad_exomes_Het=58916;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.35463457;gnomad_exomes_AF_NFE=0.39586845;gnomad_exomes_AF_AMR=0.44013978;gnomad_exomes_AF_SAS=0.38277728;NativeFreq_Het=0.4804;NativeFreq_Hom=0.2491;DANN_score=0.3024;GREP_score=-0.288;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=TAACCTTGTA.ACAAACAGTT	GT:AD:DP:GQ:PL	0/1:194,218:412:99:6732,0,6028
chr7	124475296	.	TAAACA	T	2087.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.117;DP=146;ExcessHet=3.0103;FS=2.997;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.94;ReadPosRankSum=-1.164;SOR=0.327;HGVSnom=NM_015450.3:c.1505+32_1505+36delTGTTT;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_015450.3:IVS15+32_+36delTGTTT;AAlength=634;EXAC_AF=0.40726272;EXAC_Hom_EAS=1043;EXAC_AC_EAS=4208;EXAC_AN_EAS=8312;EXAC_AC_Adj=47956;EXAC_AN_Adj=117752;RS=rs66826272;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.40862226;gnomad_exomes_AF_EAS=0.50314007;gnomad_exomes_AC=98764;gnomad_exomes_Hom=20076;gnomad_exomes_Het=58612;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.40044053;gnomad_exomes_AF_NFE=0.38379236;gnomad_exomes_AF_AMR=0.43930793;gnomad_exomes_AF_SAS=0.36908496;CytoBand=q31.33;repName=L1PA7;repClass=LINE;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=aaaagtataa.aaacaaaaca	GT:AD:DP:GQ:PL	0/1:74,57:131:99:2125,0,4160
chr7	124481245	.	G	A	5542.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.026;DP=390;ExcessHet=3.0103;FS=6.832;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.25;ReadPosRankSum=-1.79;SOR=1.012;HGVSnom=NM_015450.3:c.1164-13C>T;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_015450.3:IVS13-13C>T;AAlength=634;EXAC_AF=0.41137868;EXAC_Hom_EAS=1095;EXAC_AC_EAS=4345;EXAC_AN_EAS=8608;EXAC_AC_Adj=49711;EXAC_AN_Adj=120840;ESP6500_MAF=0.38886325;RS=rs3815221;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.41893;G1000_EAS_AF=0.4901;G1000_EUR_AF=0.4433;G1000_AFR_AF=0.3555;G1000_SAS_AF=0.3875;G1000_AMR_AF=0.4452;gnomad_exomes_AF=0.41450752;gnomad_exomes_AF_EAS=0.50279360;gnomad_exomes_AC=102036;gnomad_exomes_Hom=21365;gnomad_exomes_Het=59306;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.35523023;gnomad_exomes_AF_NFE=0.39556673;gnomad_exomes_AF_AMR=0.43908555;gnomad_exomes_AF_SAS=0.38139567;NativeFreq_Het=0.4840;NativeFreq_Hom=0.2456;DANN_score=0.5631;GREP_score=3.96;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=AAAATTATTG.CAATGAAATG	GT:AD:DP:GQ:PL	0/1:188,201:389:99:5571,0,5833
chr7	124486980	.	T	C	7483.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.115;DP=529;ExcessHet=3.0103;FS=5.87;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.23;ReadPosRankSum=-1.048;SOR=1.006;HGVSnom=NM_015450.3:c.1006+16A>G;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_015450.3:IVS12+16A>G;AAlength=634;EXAC_AF=0.69501808;EXAC_Hom_EAS=2779;EXAC_AC_EAS=6920;EXAC_AN_EAS=8626;EXAC_AC_Adj=84207;EXAC_AN_Adj=121158;ESP6500_MAF=0.71044133;RS=rs7794637;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.721845;G1000_EAS_AF=0.7986;G1000_EUR_AF=0.7177;G1000_AFR_AF=0.7648;G1000_SAS_AF=0.6155;G1000_AMR_AF=0.6844;gnomad_exomes_AF=0.69378511;gnomad_exomes_AF_EAS=0.79985802;gnomad_exomes_AC=173388;gnomad_exomes_Hom=60388;gnomad_exomes_Het=52612;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.73362122;gnomad_exomes_AF_NFE=0.69025563;gnomad_exomes_AF_AMR=0.68095599;gnomad_exomes_AF_SAS=0.61350461;NativeFreq_Het=0.3772;NativeFreq_Hom=0.5730;DANN_score=0.3664;GREP_score=-8.83;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=ATCTCAAAAA.GATACATAGT	GT:AD:DP:GQ:PL	0/1:266,260:526:99:7512,0,8306
chr7	124492038	.	T	C	4876.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.913;DP=315;ExcessHet=3.0103;FS=11.424;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.48;ReadPosRankSum=0.504;SOR=1.264;HGVSnom=NM_015450.3:c.870-33A>G;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_015450.3:IVS10-33A>G;AAlength=634;EXAC_AF=0.33511179;EXAC_Hom_EAS=165;EXAC_AC_EAS=1640;EXAC_AN_EAS=7658;EXAC_AC_Adj=36241;EXAC_AN_Adj=108146;ESP6500_MAF=0.31271160;RS=rs7784168;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.306909;G1000_EAS_AF=0.2024;G1000_EUR_AF=0.2833;G1000_AFR_AF=0.326;G1000_SAS_AF=0.3845;G1000_AMR_AF=0.3473;gnomad_exomes_AF=0.32278297;gnomad_exomes_AF_EAS=0.20529385;gnomad_exomes_AC=75446;gnomad_exomes_Hom=12175;gnomad_exomes_Het=51096;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34330963;gnomad_exomes_AF_NFE=0.31574367;gnomad_exomes_AF_AMR=0.37655563;gnomad_exomes_AF_SAS=0.39202277;NativeFreq_Het=0.3701;NativeFreq_Hom=0.0605;DANN_score=0.899;GREP_score=-1.31;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=TCAAATTGCA.AAAACAAAGT	GT:AD:DP:GQ:PL	0/1:167,148:315:99:4905,0,5223
chr7	124499002	.	A	C	4159.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.823;DP=252;ExcessHet=3.0103;FS=3.316;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.51;ReadPosRankSum=1.078;SOR=0.963;HGVSnom=NM_015450.3:c.702+9T>G;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_015450.3:IVS9+9T>G;AAlength=634;EXAC_AF=0.59027065;EXAC_Hom_EAS=1053;EXAC_AC_EAS=4265;EXAC_AN_EAS=8598;EXAC_AC_Adj=71274;EXAC_AN_Adj=120748;ESP6500_MAF=0.09757035;RS=rs6977407;Ensembl_transcriptid=ENST00000487564;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.582069;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.5557;G1000_AFR_AF=0.6483;G1000_SAS_AF=0.6135;G1000_AMR_AF=0.5562;gnomad_exomes_AF=0.58262848;gnomad_exomes_AF_EAS=0.49381385;gnomad_exomes_AC=138041;gnomad_exomes_Hom=40524;gnomad_exomes_Het=56993;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64885977;gnomad_exomes_AF_NFE=0.60151016;gnomad_exomes_AF_AMR=0.55490350;gnomad_exomes_AF_SAS=0.61356444;NativeFreq_Het=0.4840;NativeFreq_Hom=0.2669;DANN_score=0.6727;GREP_score=-7.16;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=TTTTCCTACT.TACATCACCT	GT:AD:DP:GQ:PL	0/1:142,110:252:99:4188,0,9280
chr7	124499003	.	T	A	4159.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.121;DP=253;ExcessHet=3.0103;FS=3.31;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.44;ReadPosRankSum=1.094;SOR=0.951;HGVSnom=NM_015450.3:c.702+8A>T;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_015450.3:IVS9+8A>T;AAlength=634;EXAC_AF=0.59007749;EXAC_Hom_EAS=1054;EXAC_AC_EAS=4266;EXAC_AN_EAS=8600;EXAC_AC_Adj=71279;EXAC_AN_Adj=120796;ESP6500_MAF=0.15069968;RS=rs6959712;Ensembl_transcriptid=ENST00000487564;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.582468;G1000_EAS_AF=0.5099;G1000_EUR_AF=0.5567;G1000_AFR_AF=0.6483;G1000_SAS_AF=0.6135;G1000_AMR_AF=0.5562;gnomad_exomes_AF=0.58220992;gnomad_exomes_AF_EAS=0.49331293;gnomad_exomes_AC=138028;gnomad_exomes_Hom=40513;gnomad_exomes_Het=57002;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64872182;gnomad_exomes_AF_NFE=0.60117315;gnomad_exomes_AF_AMR=0.55407605;gnomad_exomes_AF_SAS=0.61305147;NativeFreq_Het=0.4840;NativeFreq_Hom=0.2669;dbscSNV_RF_score=0.078;dbscSNV_ADA_score=0.00016625;DANN_score=0.6184;GREP_score=1.56;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=TTTCCTACTA.ACATCACCTT	GT:AD:DP:GQ:PL	0/1:143,110:253:99:4188,0,9280
chr7	124538285	.	G	A	2872.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.798;DP=220;ExcessHet=3.0103;FS=10.746;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.06;ReadPosRankSum=0.029;SOR=1.404;HGVSnom=NM_015450.3:c.-40+30C>T;Gene=POT1;Transcript=NM_015450.3;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I4;IVSnom=NM_015450.3:IVS4+30C>T;AAlength=634;RS=rs10229152;CLNGENE=POT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.609425;G1000_EAS_AF=0.5099;G1000_EUR_AF=0.5577;G1000_AFR_AF=0.7413;G1000_SAS_AF=0.6135;G1000_AMR_AF=0.572;DANN_score=0.4046;GREP_score=1.36;CytoBand=q31.33;CGD_CONDITION=Glioma susceptibility 9. Melanoma, cutaneous malignant, susceptibility to 10;CGD_INHERITANCE=AD;Strand=POT1:NM_015450.3:-,POT1:NM_001042594.1:-,POT1:NM_015450.2:-;NP=POT1:NM_015450.3:NP_056265.2,POT1:NM_001042594.1:NP_001036059.1,POT1:NM_015450.2:NP_056265.2;ENSP=POT1:NM_015450.3:ENST00000357628.8,POT1:NM_001042594.1:.,POT1:NM_015450.2:.;Gene_MIM_id=606478;Phenotypes={Glioma susceptibility 9}, 616568 (3), Autosomal dominant. {Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3), Autosomal dominant. 615848(SK),616568(SK);Possible_Inheritance=AD;EntrezGeneID=25913;EnsemblGeneID=ENSG00000128513;Alias=POT1, CMM10, GLM9;FLKSEQ=AATCTGCAAT.TAATTAGAGA	GT:AD:DP:GQ:PL	0/1:125,95:220:99:2901,0,4157
chr7	138189192	.	CTT	C	569.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.285;DP=123;ExcessHet=3.0103;FS=3.31;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.03;ReadPosRankSum=1.212;SOR=0.162;HGVSnom=NM_015905.3:c.483+64_483+65delTT;Gene=TRIM24;Transcript=NM_015905.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_015905.3:IVS2+64_+65delTT;AAlength=1050;EXAC_AF=0.00045788;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=654;EXAC_AC_Adj=8;EXAC_AN_Adj=17472;RS=rs750956455;gnomad_exomes_AF=0.00068661;gnomad_exomes_AF_EAS=0.00129032;gnomad_exomes_AC=52;gnomad_exomes_Hom=0;gnomad_exomes_Het=52;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00248880;gnomad_exomes_AF_NFE=0.00035171;gnomad_exomes_AF_AMR=0.00051935;gnomad_exomes_AF_SAS=0.00117555;CytoBand=q33;Strand=TRIM24:NM_015905.3:+,TRIM24:NM_003852.3:+,TRIM24:NM_015905.2:+;NP=TRIM24:NM_015905.3:NP_056989.2,TRIM24:NM_003852.3:NP_003843.3,TRIM24:NM_015905.2:NP_056989.2;ENSP=TRIM24:NM_015905.3:ENST00000343526.9,TRIM24:NM_003852.3:.,TRIM24:NM_015905.2:.;Gene_MIM_id=603406;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8805;EnsemblGeneID=ENSG00000122779;Alias=TRIM24, TIF1, TIF1A, PTC6;FLKSEQ=CCTGCCAGCT.tttttttttt	GT:AD:DP:GQ:PL	0/1:44,37:81:99:607,0,793
chr7	138200117	.	A	T	2652.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.01;DP=171;ExcessHet=3.0103;FS=0.76;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.7;ReadPosRankSum=-1.146;SOR=0.58;HGVSnom=NM_015905.3:c.631+13A>T;Gene=TRIM24;Transcript=NM_015905.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_015905.3:IVS3+13A>T;AAlength=1050;EXAC_AF=0.76597358;EXAC_Hom_EAS=1096;EXAC_AC_EAS=4330;EXAC_AN_EAS=8642;EXAC_AC_Adj=92908;EXAC_AN_Adj=121294;ESP6500_MAF=0.82461941;RS=rs3757381;G1000_AF=0.71905;G1000_EAS_AF=0.5159;G1000_EUR_AF=0.8042;G1000_AFR_AF=0.826;G1000_SAS_AF=0.6575;G1000_AMR_AF=0.7738;gnomad_exomes_AF=0.76567441;gnomad_exomes_AF_EAS=0.50638646;gnomad_exomes_AC=191267;gnomad_exomes_Hom=74268;gnomad_exomes_Het=42731;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.82286277;gnomad_exomes_AF_NFE=0.81772194;gnomad_exomes_AF_AMR=0.73104853;gnomad_exomes_AF_SAS=0.70939862;NativeFreq_Het=0.4752;NativeFreq_Hom=0.4377;AF_2700_Het=0.5058;AF_2700_Hom=0.2667;AF_50_Het=0.4960;AF_50_Hom=0.2773;DANN_score=0.465;GREP_score=0.0561;CytoBand=q34;Strand=TRIM24:NM_015905.3:+,TRIM24:NM_003852.3:+,TRIM24:NM_015905.2:+;NP=TRIM24:NM_015905.3:NP_056989.2,TRIM24:NM_003852.3:NP_003843.3,TRIM24:NM_015905.2:NP_056989.2;ENSP=TRIM24:NM_015905.3:ENST00000343526.9,TRIM24:NM_003852.3:.,TRIM24:NM_015905.2:.;Gene_MIM_id=603406;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8805;EnsemblGeneID=ENSG00000122779;Alias=TRIM24, TIF1, TIF1A, PTC6;FLKSEQ=AATAAATGAG.TCTTTGCATT	GT:AD:DP:GQ:PL	0/1:86,83:169:99:2681,0,2647
chr7	138265310	.	A	G	4814.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.83;DP=332;ExcessHet=3.0103;FS=1.833;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.59;ReadPosRankSum=0.399;SOR=0.803;HGVSnom=NM_015905.3:c.2589A>G(p.Gly863Gly/p.G863G);Gene=TRIM24;Transcript=NM_015905.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=1050;EXAC_AF=0.11978952;EXAC_Hom_EAS=1;EXAC_AC_EAS=85;EXAC_AN_EAS=8650;EXAC_AC_Adj=14501;EXAC_AN_Adj=121054;ESP6500_MAF=0.11164078;RS=rs33935215;G1000_AF=0.0842652;G1000_EAS_AF=0.005;G1000_EUR_AF=0.1491;G1000_AFR_AF=0.0545;G1000_SAS_AF=0.1534;G1000_AMR_AF=0.0648;gnomad_exomes_AF=0.11717317;gnomad_exomes_AF_EAS=0.00855866;gnomad_exomes_AC=29264;gnomad_exomes_Hom=2094;gnomad_exomes_Het=25076;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.06486053;gnomad_exomes_AF_NFE=0.13960122;gnomad_exomes_AF_AMR=0.05678345;gnomad_exomes_AF_SAS=0.17423191;NativeFreq_Het=0.0819;NativeFreq_Hom=0;AF_2700_Het=0.0142;AF_2700_Hom=0.0008;AF_50_Het=0.0158;AF_50_Hom=0.0016;DANN_score=0.7593;GREP_score=4.49;CytoBand=q34;Strand=TRIM24:NM_015905.3:+,TRIM24:NM_003852.3:+,TRIM24:NM_015905.2:+;NP=TRIM24:NM_015905.3:NP_056989.2,TRIM24:NM_003852.3:NP_003843.3,TRIM24:NM_015905.2:NP_056989.2;ENSP=TRIM24:NM_015905.3:ENST00000343526.9,TRIM24:NM_003852.3:.,TRIM24:NM_015905.2:.;Gene_MIM_id=603406;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8805;EnsemblGeneID=ENSG00000122779;Alias=TRIM24, TIF1, TIF1A, PTC6;FLKSEQ=CTAACAGTGG.GAGTGGATTT	GT:AD:DP:GQ:PL	0/1:172,158:330:99:4843,0,5238
chr7	138268563	.	A	G	1396.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.086;DP=88;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.87;ReadPosRankSum=0.831;SOR=0.531;HGVSnom=NM_015905.3:c.2794-32A>G;Gene=TRIM24;Transcript=NM_015905.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_015905.3:IVS17-32A>G;AAlength=1050;EXAC_AF=0.41397005;EXAC_Hom_EAS=1;EXAC_AC_EAS=78;EXAC_AN_EAS=6592;EXAC_AC_Adj=41628;EXAC_AN_Adj=100558;ESP6500_MAF=0.48313216;RS=rs3213902;G1000_AF=0.330272;G1000_EAS_AF=0.006;G1000_EUR_AF=0.494;G1000_AFR_AF=0.4977;G1000_SAS_AF=0.2832;G1000_AMR_AF=0.3112;gnomad_exomes_AF=0.39228722;gnomad_exomes_AF_EAS=0.00918138;gnomad_exomes_AC=74879;gnomad_exomes_Hom=16742;gnomad_exomes_Het=41395;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.50030506;gnomad_exomes_AF_NFE=0.47216962;gnomad_exomes_AF_AMR=0.23783812;gnomad_exomes_AF_SAS=0.32166682;NativeFreq_Het=0.1993;NativeFreq_Hom=0.0890;DANN_score=0.7502;GREP_score=0.936;CytoBand=q34;Strand=TRIM24:NM_015905.3:+,TRIM24:NM_003852.3:+,TRIM24:NM_015905.2:+;NP=TRIM24:NM_015905.3:NP_056989.2,TRIM24:NM_003852.3:NP_003843.3,TRIM24:NM_015905.2:NP_056989.2;ENSP=TRIM24:NM_015905.3:ENST00000343526.9,TRIM24:NM_003852.3:.,TRIM24:NM_015905.2:.;Gene_MIM_id=603406;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8805;EnsemblGeneID=ENSG00000122779;Alias=TRIM24, TIF1, TIF1A, PTC6;FLKSEQ=GAATTTAGCT.TTTGTATTAT	GT:AD:DP:GQ:PL	0/1:48,40:88:99:1425,0,1533
chr7	138270340	.	AT	A	1360.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.38;DP=132;ExcessHet=3.0103;FS=15.714;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.89;ReadPosRankSum=1.761;SOR=2.36;HGVSnom=NM_015905.3:c.*649delT;Gene=TRIM24;Transcript=NM_015905.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=1050;RS=rs35023347;CytoBand=q34;Strand=TRIM24:NM_015905.3:+;NP=TRIM24:NM_015905.3:NP_056989.2;ENSP=TRIM24:NM_015905.3:ENST00000343526.9;FLKSEQ=CAAATGTTTG.TTTTGTTTTT	GT:AD:DP:GQ:PL	0/1:71,54:125:99:1398,0,1949
chr7	142458371	.	T	C	1150.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.09;DP=200;ExcessHet=3.0103;FS=20.982;MLEAC=1;MLEAF=0.5;MQ=55.69;MQRankSum=-13.882;QD=5.75;ReadPosRankSum=-1.195;SOR=0.165;HGVSnom=NM_002769.5:c.41-35T>C;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_002769.5:IVS1-35T>C;AAlength=247;EXAC_AF=0.49584227;EXAC_Hom_EAS=0;EXAC_AC_EAS=4269;EXAC_AN_EAS=8590;EXAC_AC_Adj=59629;EXAC_AN_Adj=120258;RS=rs367779270;gnomad_exomes_AF=0.41690273;gnomad_exomes_AF_EAS=0.31977740;gnomad_exomes_AC=41797;gnomad_exomes_Hom=0;gnomad_exomes_Het=41797;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.40191740;gnomad_exomes_AF_NFE=0.43116631;gnomad_exomes_AF_AMR=0.38250473;gnomad_exomes_AF_SAS=0.40237262;NativeFreq_Het=0.9929;NativeFreq_Hom=0;normalHetFrequency=0.018;normalHetNum=7;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.017;patientHetNum=47;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4504;GREP_score=-0.62;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=TAACATGCTA.TGACTTGCCT	GT:AD:DP:GQ:PL	0/1:146,54:200:99:1179,0,4820
chr7	142458451	.	A	T	712.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.982;DP=264;ExcessHet=3.0103;FS=80.995;MLEAC=1;MLEAF=0.5;MQ=56.56;MQRankSum=-16.089;QD=2.71;ReadPosRankSum=0.897;SOR=2.95;HGVSnom=NM_002769.5:c.86A>T(p.Asn29Ile/p.N29I);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=247;EXAC_AF=0.47510918;EXAC_Hom_EAS=0;EXAC_AC_EAS=4146;EXAC_AN_EAS=8574;EXAC_AC_Adj=56786;EXAC_AN_Adj=119522;RS=rs111033566;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737;SIFT_pred=D|.|D;SIFT_score=0.045|.|0.04;Polyphen2_HVAR_pred=.|.|B;Polyphen2_HVAR_score=.|.|0.001;MutationTaster_pred=A|A;MutationTaster_score=0.000183369|0.000183369;CLNGENE=PRSS1|TRB;CLNSIG=Pathogenic|Pathogenic;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.28314713;gnomad_exomes_AF_EAS=0.22195399;gnomad_exomes_AC=44150;gnomad_exomes_Hom=0;gnomad_exomes_Het=44150;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22740806;gnomad_exomes_AF_NFE=0.31218659;gnomad_exomes_AF_AMR=0.22890275;gnomad_exomes_AF_SAS=0.31922236;HGMD_gene=PRSS1;HGMD_disease=Pancreatitis_hereditary;HGMD_tag=DM;HGMD_pmid=9322498;NativeFreq_Het=0.9181;NativeFreq_Hom=0;normalHetFrequency=0.0052;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0072;patientHetNum=20;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16B0050571|16B0202338][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D0063619|16B0028363|16D1545704|16D1546020|16D0177780-1|16B3258330|16B3094146|15D6532738|15B6326215-1|15D6722436|16S0044409|16B0202355|16B0005511|16B3108060|15D6532789|15B0060332|15B0062660|16B0067592|16B0047148|16D1545868][_];patientHomSampleInfo=[_][_];DANN_score=0.9125;GREP_score=2.58;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GGGGGCTACA.CTGTGAGGAG	GT:AD:DP:GQ:PL	0/1:217,46:263:99:741,0,6979
chr7	142458486	.	C	T	40.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.015;DP=290;ExcessHet=3.0103;FS=47.869;MLEAC=1;MLEAF=0.5;MQ=58.16;MQRankSum=-16.944;QD=0.14;ReadPosRankSum=-2.733;SOR=3.074;HGVSnom=NM_002769.5:c.121C>T(p.Leu41Leu/p.L41L);Gene=PRSS1;Transcript=NM_002769.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=247;EXAC_AF=0.00375120;EXAC_Hom_EAS=0;EXAC_AC_EAS=42;EXAC_AN_EAS=8172;EXAC_AC_Adj=437;EXAC_AN_Adj=116496;RS=rs369646357;CLNGENE=PRSS1|TRB;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.00011480;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=28;gnomad_exomes_Hom=1;gnomad_exomes_Het=26;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00044097;gnomad_exomes_AF_NFE=0.00017228;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00006729;NativeFreq_Het=0.6441;NativeFreq_Hom=0;DANN_score=0.691;GREP_score=2.58;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CCAGGTGTCC.TGAATTCTGG	GT:AD:DP:GQ:PL	0/1:263,26:289:69:69,0,10414
chr7	142460255	.	C	T	35.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.819;DP=185;ExcessHet=3.0103;FS=1.123;MLEAC=1;MLEAF=0.5;MQ=59.56;MQRankSum=-10.637;QD=0.2;ReadPosRankSum=-5.449;SOR=0.416;HGVSnom=NM_002769.5:c.455-27C>T;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_002769.5:IVS3-27C>T;AAlength=247;EXAC_AF=0.00010999;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=2652;EXAC_AC_Adj=2;EXAC_AN_Adj=18184;RS=rs754595466;gnomad_exomes_AF=0.00400342;gnomad_exomes_AF_EAS=0.00025602;gnomad_exomes_AC=459;gnomad_exomes_Hom=0;gnomad_exomes_Het=459;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00144404;gnomad_exomes_AF_NFE=0.00505221;gnomad_exomes_AF_AMR=0.00251944;gnomad_exomes_AF_SAS=0.00317586;NativeFreq_Het=0.8612;NativeFreq_Hom=0;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[15B0063045][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=_;patientHomSampleInfo=_;DANN_score=0.6111;GREP_score=-4.68;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=ATTTCTACTT.CTTTGTTCTC	GT:AD:DP:GQ:PL	0/1:163,20:183:64:64,0,6747
chr7	142460261	.	T	A	5115.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.554;DP=196;ExcessHet=3.0103;FS=0.835;MLEAC=1;MLEAF=0.5;MQ=59.46;MQRankSum=10.097;QD=26.37;ReadPosRankSum=6.958;SOR=0.831;HGVSnom=NM_002769.5:c.455-21T>A;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_002769.5:IVS3-21T>A;AAlength=247;EXAC_AF=0.58146526;EXAC_Hom_EAS=1294;EXAC_AC_EAS=5422;EXAC_AN_EAS=8256;EXAC_AC_Adj=67700;EXAC_AN_Adj=116430;RS=rs201825825;G1000_AF=0.998003;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9924;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.63083229;gnomad_exomes_AF_EAS=0.74569492;gnomad_exomes_AC=155456;gnomad_exomes_Hom=32241;gnomad_exomes_Het=90974;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.66999376;gnomad_exomes_AF_NFE=0.61569335;gnomad_exomes_AF_AMR=0.66277982;gnomad_exomes_AF_SAS=0.61829464;NativeFreq_Het=0.7224;NativeFreq_Hom=0.2740;normalHetFrequency=0.3918;normalHetNum=152;normalHomFrequency=0.5644;normalHomNum=219;patientHetFrequency=0.4123;patientHetNum=1143;patientHomFrequency=0.5386;patientHomNum=1493;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8163;GREP_score=-4.1;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=ACTTCCTTTG.TCTCTTCCTG	GT:AD:DP:GQ:PL	0/1:33,161:194:99:5144,0,775
chr7	142460335	.	A	G	5134.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=5.858;DP=462;ExcessHet=3.0103;FS=7.194;MLEAC=1;MLEAF=0.5;MQ=57.23;MQRankSum=-13.13;QD=11.16;ReadPosRankSum=3.902;SOR=0.959;HGVSnom=NM_002769.5:c.508A>G(p.Lys170Glu/p.K170E);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=247;EXAC_AF=0.49999176;EXAC_Hom_EAS=0;EXAC_AC_EAS=4326;EXAC_AN_EAS=8652;EXAC_AC_Adj=60685;EXAC_AN_Adj=121372;RS=rs201550522;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737|ENST00000492062;SIFT_pred=T|.|T|T;SIFT_score=0.387|.|0.378|0.33;Polyphen2_HVAR_pred=B|.|B|.;Polyphen2_HVAR_score=0.0|.|0.0|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=PRSS1|TRB;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.00159744;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0082;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.41879299;gnomad_exomes_AF_EAS=0.32545003;gnomad_exomes_AC=98150;gnomad_exomes_Hom=2;gnomad_exomes_Het=98146;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36813187;gnomad_exomes_AF_NFE=0.43388184;gnomad_exomes_AF_AMR=0.38082420;gnomad_exomes_AF_SAS=0.42797052;HGMD_gene=PRSS1;HGMD_disease=Pancreatitis_chronic;HGMD_tag=DM?;HGMD_pmid=23455445;NativeFreq_Het=0.9858;NativeFreq_Hom=0;normalHetFrequency=0.9149;normalHetNum=355;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.9134;patientHetNum=2532;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.119;GREP_score=-6.56;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GAGCCAGGCT.AGTGTGAAGC	GT:AD:DP:GQ:PL	0/1:278,182:460:99:5163,0,8518
chr7	142460369	.	G	A	4053.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.537;DP=399;ExcessHet=3.0103;FS=26.256;MLEAC=1;MLEAF=0.5;MQ=57.09;MQRankSum=-12.676;QD=10.24;ReadPosRankSum=0.238;SOR=1.575;HGVSnom=NM_002769.5:c.542G>A(p.Ser181Asn/p.S181N);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=247;EXAC_AF=0.49974416;EXAC_Hom_EAS=0;EXAC_AC_EAS=4301;EXAC_AN_EAS=8604;EXAC_AC_Adj=60553;EXAC_AN_Adj=121168;RS=rs201719096;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737|ENST00000492062;SIFT_pred=T|.|T|T;SIFT_score=0.668|.|0.652|0.746;Polyphen2_HVAR_pred=B|.|B|.;Polyphen2_HVAR_score=0.001|.|0.0|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=PRSS1|TRB;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=no_assertion_criteria_provided|no_assertion_criteria_provided;gnomad_exomes_AF=0.38470008;gnomad_exomes_AF_EAS=0.27042774;gnomad_exomes_AC=72676;gnomad_exomes_Hom=0;gnomad_exomes_Het=72676;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34631638;gnomad_exomes_AF_NFE=0.41237704;gnomad_exomes_AF_AMR=0.30603248;gnomad_exomes_AF_SAS=0.36902486;NativeFreq_Het=0.9039;NativeFreq_Hom=0;normalHetFrequency=0.6314;normalHetNum=245;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.6468;patientHetNum=1793;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.166;GREP_score=-2.6;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=AAGATTACCA.CAACATGTTC	GT:AD:DP:GQ:PL	0/1:268,128:396:99:4082,0,10656
chr7	142460394	.	T	C	2855.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.883;DP=376;ExcessHet=3.0103;FS=70.156;MLEAC=1;MLEAF=0.5;MQ=57.11;MQRankSum=-15.577;QD=7.62;ReadPosRankSum=-4.123;SOR=3.021;HGVSnom=NM_002769.5:c.567T>C(p.Leu189Leu/p.L189L);Gene=PRSS1;Transcript=NM_002769.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=247;EXAC_AF=0.48594078;EXAC_Hom_EAS=0;EXAC_AC_EAS=4046;EXAC_AN_EAS=8288;EXAC_AC_Adj=57929;EXAC_AN_Adj=119210;RS=rs377124851;CLNGENE=PRSS1|TRB;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.00319489;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0121;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.04989163;gnomad_exomes_AF_EAS=0.02293347;gnomad_exomes_AC=3637;gnomad_exomes_Hom=3;gnomad_exomes_Het=3631;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09301181;gnomad_exomes_AF_NFE=0.06782218;gnomad_exomes_AF_AMR=0.01696911;gnomad_exomes_AF_SAS=0.02411332;NativeFreq_Het=0.4769;NativeFreq_Hom=0;normalHetFrequency=0.0335;normalHetNum=13;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0379;patientHetNum=105;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5535;GREP_score=-6.64;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=TGGGCTTCCT.GAGGGAGGCA	GT:AD:DP:GQ:PL	0/1:288,87:375:99:2884,0,11966
chr7	142460412	.	A	C	1056.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=7.946;DP=337;ExcessHet=3.0103;FS=94.919;MLEAC=1;MLEAF=0.5;MQ=57.84;MQRankSum=-17.784;QD=3.15;ReadPosRankSum=-2.735;SOR=5.421;HGVSnom=NM_002769.5:c.585A>C(p.Ser195Ser/p.S195S);Gene=PRSS1;Transcript=NM_002769.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=247;EXAC_AF=0.48556827;EXAC_Hom_EAS=0;EXAC_AC_EAS=3995;EXAC_AN_EAS=8306;EXAC_AC_Adj=58241;EXAC_AN_Adj=119944;RS=rs758274784;CLNGENE=PRSS1|TRB;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.12497384;gnomad_exomes_AF_EAS=0.03799260;gnomad_exomes_AC=11941;gnomad_exomes_Hom=0;gnomad_exomes_Het=11941;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14685573;gnomad_exomes_AF_NFE=0.17499754;gnomad_exomes_AF_AMR=0.05965414;gnomad_exomes_AF_SAS=0.06844004;NativeFreq_Het=0.4057;NativeFreq_Hom=0;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0029;patientHetNum=8;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16D1546178][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0033627|16D1546136|16B3254582|16D0172328-1|15D6482369|16D0168732|15B6325509|16D1545954][_];patientHomSampleInfo=[_][_];DANN_score=0.4756;GREP_score=1.42;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GCAAGGATTC.TGTCAGGTGA	GT:AD:DP:GQ:PL	0/1:290,46:336:99:1085,0,12830
chr7	142460415	.	T	C	927.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=8.683;DP=335;ExcessHet=3.0103;FS=70.183;MLEAC=1;MLEAF=0.5;MQ=57.82;MQRankSum=-18.208;QD=2.78;ReadPosRankSum=-1.242;SOR=4.871;HGVSnom=NM_002769.5:c.588T>C(p.Cys196Cys/p.C196C);Gene=PRSS1;Transcript=NM_002769.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=247;EXAC_AF=0.48431366;EXAC_Hom_EAS=0;EXAC_AC_EAS=3992;EXAC_AN_EAS=8354;EXAC_AC_Adj=58230;EXAC_AN_Adj=120232;RS=rs751264273;CLNGENE=PRSS1|TRB;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.12214477;gnomad_exomes_AF_EAS=0.03530043;gnomad_exomes_AC=12021;gnomad_exomes_Hom=0;gnomad_exomes_Het=12021;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14430082;gnomad_exomes_AF_NFE=0.17061021;gnomad_exomes_AF_AMR=0.05879828;gnomad_exomes_AF_SAS=0.06928082;NativeFreq_Het=0.4804;NativeFreq_Hom=0;normalHetFrequency=0.0052;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0029;patientHetNum=8;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16D1546178|15B0062605-1][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B3094632|16D1546136|16B3254582|16D0172328-1|15D6482369|16D0168732|16B0012156|16D1545954][_];patientHomSampleInfo=[_][_];DANN_score=0.4826;GREP_score=2.43;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=AGGATTCATG.CAGGTGATTT	GT:AD:DP:GQ:PL	0/1:296,38:334:99:956,0,12881
chr7	142460428	.	CCAA	C	529.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.392;DP=346;ExcessHet=3.0103;FS=49.946;MLEAC=1;MLEAF=0.5;MQ=58.05;MQRankSum=-18.517;QD=1.54;ReadPosRankSum=-0.643;SOR=3.662;HGVSnom=NM_002769.5:c.591+12_591+14delAAC;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4+12_+14delAAC;AAlength=247;EXAC_AF=0.49048866;EXAC_Hom_EAS=0;EXAC_AC_EAS=4107;EXAC_AN_EAS=8486;EXAC_AC_Adj=59201;EXAC_AN_Adj=120698;RS=rs370303567;gnomad_exomes_AF=0.24208381;gnomad_exomes_AF_EAS=0.14059769;gnomad_exomes_AC=30168;gnomad_exomes_Hom=0;gnomad_exomes_Het=30168;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23113292;gnomad_exomes_AF_NFE=0.29388339;gnomad_exomes_AF_AMR=0.16409158;gnomad_exomes_AF_SAS=0.19987021;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0065;patientHetNum=18;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[15B0062605-1][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0411316|16B0047566|16B3254582|17B0001559-1|15D6482369|16D1545620|16D1546136|16D1546060|16B3094632|16D0168716|15D6482401|15D6482365|16B1904075-1|16D1536929|16D0172328-1|16D1545954|16B0001958|15D6482464][_];patientHomSampleInfo=[_][_];CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GGTGATTTGA.CCCTTCCCAT	GT:AD:DP:GQ:PL	0/1:310,35:345:99:567,0,13042
chr7	142460461	.	C	A	1273.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.242;DP=325;ExcessHet=3.0103;FS=21.713;MLEAC=1;MLEAF=0.5;MQ=57.16;MQRankSum=-17.951;QD=3.92;ReadPosRankSum=-2.6;SOR=2.002;HGVSnom=NM_002769.5:c.591+43C>A;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4+43C>A;AAlength=247;EXAC_AF=0.48904151;EXAC_Hom_EAS=0;EXAC_AC_EAS=4139;EXAC_AN_EAS=8488;EXAC_AC_Adj=58461;EXAC_AN_Adj=119542;RS=rs764069169;gnomad_exomes_AF=0.28993017;gnomad_exomes_AF_EAS=0.21856034;gnomad_exomes_AC=41351;gnomad_exomes_Hom=0;gnomad_exomes_Het=41351;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.25189003;gnomad_exomes_AF_NFE=0.33445038;gnomad_exomes_AF_AMR=0.21001525;gnomad_exomes_AF_SAS=0.27445177;NativeFreq_Het=0.9858;NativeFreq_Hom=0;normalHetFrequency=0.0515;normalHetNum=20;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0429;patientHetNum=119;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5827;GREP_score=0.543;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CCCACTGATA.CTAGGCCCCA	GT:AD:DP:GQ:PL	0/1:274,51:325:99:1302,0,11284
chr7	142460463	.	T	C	1273.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=6.75;DP=315;ExcessHet=3.0103;FS=21.972;MLEAC=1;MLEAF=0.5;MQ=57.13;MQRankSum=-17.669;QD=4.04;ReadPosRankSum=-2.294;SOR=2.03;HGVSnom=NM_002769.5:c.591+45T>C;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4+45T>C;AAlength=247;EXAC_AF=0.49167660;EXAC_Hom_EAS=0;EXAC_AC_EAS=4142;EXAC_AN_EAS=8446;EXAC_AC_Adj=58599;EXAC_AN_Adj=119182;RS=rs751484562;gnomad_exomes_AF=0.32223308;gnomad_exomes_AF_EAS=0.23062806;gnomad_exomes_AC=52098;gnomad_exomes_Hom=0;gnomad_exomes_Het=52098;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29105035;gnomad_exomes_AF_NFE=0.36079866;gnomad_exomes_AF_AMR=0.25197100;gnomad_exomes_AF_SAS=0.30364768;NativeFreq_Het=0.9929;NativeFreq_Hom=0;normalHetFrequency=0.0722;normalHetNum=28;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0595;patientHetNum=165;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7561;GREP_score=0.543;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CACTGATACC.AGGCCCCACC	GT:AD:DP:GQ:PL	0/1:265,50:315:99:1302,0,11284
chr7	142460669	.	C	G	1995.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.78;DP=234;ExcessHet=3.0103;FS=18.726;MLEAC=1;MLEAF=0.5;MQ=57.19;MQRankSum=-12.562;QD=8.53;ReadPosRankSum=-2.242;SOR=0.519;HGVSnom=NM_002769.5:c.592-50C>G;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4-50C>G;AAlength=247;EXAC_AF=0.00656995;EXAC_Hom_EAS=0;EXAC_AC_EAS=83;EXAC_AN_EAS=8238;EXAC_AC_Adj=769;EXAC_AN_Adj=117048;RS=rs755764701;gnomad_exomes_AF=0.00011871;gnomad_exomes_AF_EAS=0.00005602;gnomad_exomes_AC=29;gnomad_exomes_Hom=0;gnomad_exomes_Het=29;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00032544;gnomad_exomes_AF_NFE=0.00019102;gnomad_exomes_AF_AMR=0.00002933;gnomad_exomes_AF_SAS=0.0;NativeFreq_Het=0.2028;NativeFreq_Hom=0;DANN_score=0.695;GREP_score=0.554;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GTAAATGTAG.TATATTCCTC	GT:AD:DP:GQ:PL	0/1:175,59:234:99:2024,0,7669
chr7	142460671	.	A	G	1998.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=2.395;DP=253;ExcessHet=3.0103;FS=17.534;MLEAC=1;MLEAF=0.5;MQ=57.2;MQRankSum=-12.911;QD=7.9;ReadPosRankSum=-1.616;SOR=0.525;HGVSnom=NM_002769.5:c.592-48A>G;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4-48A>G;AAlength=247;EXAC_AF=0.00650178;EXAC_Hom_EAS=0;EXAC_AC_EAS=83;EXAC_AN_EAS=8292;EXAC_AC_Adj=765;EXAC_AN_Adj=117660;RS=rs377695327;gnomad_exomes_AF=0.00007752;gnomad_exomes_AF_EAS=0.00005588;gnomad_exomes_AC=19;gnomad_exomes_Hom=0;gnomad_exomes_Het=19;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00025880;gnomad_exomes_AF_NFE=0.00011782;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;NativeFreq_Het=0.0996;NativeFreq_Hom=0;DANN_score=0.8147;GREP_score=-1.49;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=AAATGTAGCT.TATTCCTCCT	GT:AD:DP:GQ:PL	0/1:190,63:253:99:2027,0,7634
chr7	142460690	.	C	CTCTT	2719.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=1.635;DP=289;ExcessHet=3.0103;FS=19.444;MLEAC=1;MLEAF=0.5;MQ=57.08;MQRankSum=-12.54;QD=9.51;ReadPosRankSum=0.155;SOR=0.713;HGVSnom=NM_002769.5:c.592-29_592-28insTCTT;Gene=PRSS1;Transcript=NM_002769.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002769.5:IVS4-29_-28insTCTT;AAlength=247;EXAC_AF=0.01758730;EXAC_Hom_EAS=0;EXAC_AC_EAS=265;EXAC_AN_EAS=8420;EXAC_AC_Adj=2081;EXAC_AN_Adj=118324;RS=rs370873919;gnomad_exomes_AF=0.00003290;gnomad_exomes_AF_EAS=0.00011337;gnomad_exomes_AC=8;gnomad_exomes_Hom=0;gnomad_exomes_Het=8;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00003641;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00003396;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CTCCATCTCT.CATACAACTT	GT:AD:DP:GQ:PL	0/1:206,80:286:99:2757,0,8334
chr7	142460744	.	G	C	1902.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.693;DP=317;ExcessHet=3.0103;FS=22.923;MLEAC=1;MLEAF=0.5;MQ=57.87;MQRankSum=-12.35;QD=6.02;ReadPosRankSum=0.088;SOR=1.75;HGVSnom=NM_002769.5:c.617G>C(p.Cys206Ser/p.C206S);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=247;EXAC_AF=0.08580972;EXAC_Hom_EAS=0;EXAC_AC_EAS=1215;EXAC_AN_EAS=7168;EXAC_AC_Adj=9171;EXAC_AN_Adj=106876;RS=rs150930992;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737;SIFT_pred=D|.|D;SIFT_score=0.036|.|0.027;Polyphen2_HVAR_pred=D|.|P;Polyphen2_HVAR_score=0.927|.|0.814;MutationTaster_pred=D|D;MutationTaster_score=0.999991|0.999991;CLNGENE=PRSS1|TRB;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.00032860;gnomad_exomes_AF_EAS=0.00048396;gnomad_exomes_AC=70;gnomad_exomes_Hom=0;gnomad_exomes_Het=70;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00137652;gnomad_exomes_AF_NFE=0.00036233;gnomad_exomes_AF_AMR=0.00006521;gnomad_exomes_AF_SAS=0.00031987;NativeFreq_Het=0.2598;NativeFreq_Hom=0;DANN_score=0.9449;GREP_score=2.29;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CCTGTGGTCT.CAATGGACAG	GT:AD:DP:GQ:PL	0/1:251,65:316:99:1931,0,10259
chr7	142460752	.	C	G	1633.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.122;DP=323;ExcessHet=3.0103;FS=15.286;MLEAC=1;MLEAF=0.5;MQ=58.19;MQRankSum=-11.9;QD=5.09;ReadPosRankSum=-0.953;SOR=1.483;HGVSnom=NM_002769.5:c.625C>G(p.Gln209Glu/p.Q209E);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=247;EXAC_AF=0.08584465;EXAC_Hom_EAS=0;EXAC_AC_EAS=1215;EXAC_AN_EAS=7044;EXAC_AC_Adj=9144;EXAC_AN_Adj=106518;RS=rs140793689;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737;SIFT_pred=T|.|T;SIFT_score=1.0|.|1.0;Polyphen2_HVAR_pred=B|.|B;Polyphen2_HVAR_score=0.004|.|0.003;MutationTaster_pred=N|N;MutationTaster_score=0.99932|0.996928;gnomad_exomes_AF=0.00017401;gnomad_exomes_AF_EAS=0.00048658;gnomad_exomes_AC=37;gnomad_exomes_Hom=0;gnomad_exomes_Het=37;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00055893;gnomad_exomes_AF_NFE=0.00014538;gnomad_exomes_AF_AMR=0.00006524;gnomad_exomes_AF_SAS=0.00028208;NativeFreq_Het=0.2598;NativeFreq_Hom=0;DANN_score=0.095;GREP_score=-6.37;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=CTGCAATGGA.AGCTCCAAGG	GT:AD:DP:GQ:PL	0/1:263,58:321:99:1662,0,10849
chr7	142460764	.	G	A	552.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.405;DP=321;ExcessHet=3.0103;FS=5.985;MLEAC=1;MLEAF=0.5;MQ=58.28;MQRankSum=-12.121;QD=1.74;ReadPosRankSum=-2.666;SOR=1.003;HGVSnom=NM_002769.5:c.637G>A(p.Val213Ile/p.V213I);Gene=PRSS1;Transcript=NM_002769.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=247;EXAC_AF=0.00323430;EXAC_Hom_EAS=0;EXAC_AC_EAS=67;EXAC_AN_EAS=8440;EXAC_AC_Adj=388;EXAC_AN_Adj=119964;RS=rs200902389;Ensembl_transcriptid=ENST00000486171|ENST00000619214|ENST00000311737;SIFT_pred=T|.|T;SIFT_score=1.0|.|1.0;Polyphen2_HVAR_pred=B|.|B;Polyphen2_HVAR_score=0.004|.|0.003;MutationTaster_pred=N|N;MutationTaster_score=0.999967|0.999967;CLNGENE=PRSS1|TRB;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.00001607;gnomad_exomes_AF_EAS=0.00011060;gnomad_exomes_AC=4;gnomad_exomes_Hom=0;gnomad_exomes_Het=4;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00000887;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00003319;NativeFreq_Het=0.2562;NativeFreq_Hom=0;DANN_score=0.1282;GREP_score=-2.69;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=GCTCCAAGGA.TTGTCTCCTG	GT:AD:DP:GQ:PL	0/1:275,43:318:99:581,0,9410
chr7	142460914	.	C	T	1228.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.682;DP=238;ExcessHet=3.0103;FS=21.247;MLEAC=1;MLEAF=0.5;MQ=57.99;MQRankSum=-2.37;QD=5.21;ReadPosRankSum=-2.36;SOR=1.47;HGVSnom=NM_002769.5:c.*43C>T;Gene=PRSS1;Transcript=NM_002769.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=247;RS=rs1209958993;DANN_score=0.5789;GREP_score=0.0968;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=TAAAGTGACC.TGTTCTCACT	GT:AD:DP:GQ:PL	0/1:191,45:236:99:1257,0,15464
chr7	142460917	.	T	C	2048.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.996;DP=237;ExcessHet=3.0103;FS=14.35;MLEAC=1;MLEAF=0.5;MQ=57.98;MQRankSum=-9.852;QD=8.72;ReadPosRankSum=-1.666;SOR=1.08;HGVSnom=NM_002769.5:c.*46T>C;Gene=PRSS1;Transcript=NM_002769.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=247;EXAC_AF=0.00028559;EXAC_Hom_EAS=0;EXAC_AC_EAS=2;EXAC_AN_EAS=8446;EXAC_AC_Adj=34;EXAC_AN_Adj=119052;RS=rs775269865;gnomad_exomes_AF=0.00000402;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=1;gnomad_exomes_Hom=0;gnomad_exomes_Het=1;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00000888;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;DANN_score=0.4593;GREP_score=-2.8;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=AGTGACCCTG.TCTCACTGTC	GT:AD:DP:GQ:PL	0/1:174,61:235:99:2077,0,14264
chr7	142460919	.	C	T	1143.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.858;DP=237;ExcessHet=3.0103;FS=22.255;MLEAC=1;MLEAF=0.5;MQ=57.87;MQRankSum=-2.552;QD=4.87;ReadPosRankSum=-3.614;SOR=1.595;HGVSnom=NM_002769.5:c.*48C>T;Gene=PRSS1;Transcript=NM_002769.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E5;IVSnom=.;AAlength=247;RS=rs1191978776;DANN_score=0.3957;GREP_score=-3.05;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;CGD_CONDITION=Pancreatitis, hereditary;CGD_INHERITANCE=AD;Strand=PRSS1:NM_002769.4:+;NP=PRSS1:NM_002769.4:NP_002760.1;ENSP=PRSS1:NM_002769.4:ENST00000311737.11;Gene_MIM_id=276000;Phenotypes=Pancreatitis, hereditary, 167800 (3), Autosomal dominant. Trypsinogen deficiency, 614044 (1), Autosomal recessive. 167800(MK),614044(MA);Possible_Inheritance=AD,AR;EntrezGeneID=5644;EnsemblGeneID=ENSG00000204983;Alias=PRSS1, TRY1;FLKSEQ=TGACCCTGTT.TCACTGTCTG	GT:AD:DP:GQ:PL	0/1:194,41:235:99:1172,0,15476
chr7	142460941	.	G	C	230.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.434;DP=203;ExcessHet=3.0103;FS=4.582;MLEAC=1;MLEAF=0.5;MQ=57.78;MQRankSum=-12.369;QD=1.14;ReadPosRankSum=3.428;SOR=1.062;HGVSnom=.;Gene=PRSS1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs796699877;DANN_score=0.6293;GREP_score=-1.9;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;FLKSEQ=GTCTGTGCCT.CTCCCTCTCA	GT:AD:DP:GQ:PL	0/1:182,20:202:99:259,0,17039
chr7	142460946	.	C	T	257.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.55;DP=201;ExcessHet=3.0103;FS=6.23;MLEAC=1;MLEAF=0.5;MQ=57.83;MQRankSum=-12.539;QD=1.29;ReadPosRankSum=2.924;SOR=1.004;HGVSnom=.;Gene=PRSS1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs375126637;DANN_score=0.5239;GREP_score=-2.86;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;FLKSEQ=TGCCTGCTCC.TCTCACTCCT	GT:AD:DP:GQ:PL	0/1:180,20:200:99:286,0,16700
chr7	142460949	.	T	A	654.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.889;DP=196;ExcessHet=3.0103;FS=1.604;MLEAC=1;MLEAF=0.5;MQ=57.77;MQRankSum=-12.74;QD=3.36;ReadPosRankSum=-0.082;SOR=0.864;HGVSnom=.;Gene=PRSS1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs779805363;DANN_score=0.3531;GREP_score=-6.34;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;FLKSEQ=CTGCTCCCTC.CACTCCTTCA	GT:AD:DP:GQ:PL	0/1:166,29:195:99:683,0,10278
chr7	142460962	.	C	T	344.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.852;DP=184;ExcessHet=3.0103;FS=8.06;MLEAC=1;MLEAF=0.5;MQ=57.83;MQRankSum=-12.718;QD=1.88;ReadPosRankSum=0.193;SOR=0.967;HGVSnom=.;Gene=PRSS1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs796172877;DANN_score=0.753;GREP_score=0.494;CytoBand=q34;dupName=chr9:33776725,chr7:142468596,chr9:33611677;dupScore=0;FLKSEQ=CTCCTTCACA.TGGAAAGCAT	GT:AD:DP:GQ:PL	0/1:163,20:183:99:373,0,15473
chr7	148504716	.	AG	A	4641.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.637;DP=386;ExcessHet=3.0103;FS=6.275;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.42;ReadPosRankSum=-0.176;SOR=0.462;HGVSnom=NM_004456.5:c.*21delC;Gene=EZH2;Transcript=NM_004456.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=751;EXAC_AF=0.68970768;EXAC_Hom_EAS=1103;EXAC_AC_EAS=3552;EXAC_AN_EAS=5460;EXAC_AC_Adj=48463;EXAC_AN_Adj=70266;ESP6500_MAF=0.76937210;RS=rs3217095;CLNGENE=EZH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.770966;G1000_EAS_AF=0.7024;G1000_EUR_AF=0.673;G1000_AFR_AF=0.9788;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.7839;gnomad_exomes_AF=0.68457978;gnomad_exomes_AF_EAS=0.64805244;gnomad_exomes_AC=140510;gnomad_exomes_Hom=48709;gnomad_exomes_Het=43092;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93361884;gnomad_exomes_AF_NFE=0.67033709;gnomad_exomes_AF_AMR=0.72125084;gnomad_exomes_AF_SAS=0.66316359;normalHetFrequency=0.3943;normalHetNum=153;normalHomFrequency=0.5232;normalHomNum=203;patientHetFrequency=0.4138;patientHetNum=1147;patientHomFrequency=0.4859;patientHomNum=1347;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q36.1;CGD_CONDITION=Weaver syndrome;CGD_INHERITANCE=AD;Strand=EZH2:NM_001203249.1:-,EZH2:NM_001203247.1:-,EZH2:NM_001203248.1:-,EZH2:NM_004456.4:-,EZH2:NM_152998.2:-;NP=EZH2:NM_001203249.1:NP_001190178.1,EZH2:NM_001203247.1:NP_001190176.1,EZH2:NM_001203248.1:NP_001190177.1,EZH2:NM_004456.4:NP_004447.2,EZH2:NM_152998.2:NP_694543.1;ENSP=EZH2:NM_001203249.1:.,EZH2:NM_001203247.1:.,EZH2:NM_001203248.1:.,EZH2:NM_004456.4:ENST00000320356.6,EZH2:NM_152998.2:.;Gene_MIM_id=601573;Phenotypes=Weaver syndrome, 277590 (3), Autosomal dominant. 277590(MK);Possible_Inheritance=AD;EntrezGeneID=2146;EnsemblGeneID=ENSG00000106462;Alias=EZH2, EZH1, WVS;FLKSEQ=GTTTCAGAGG.GGGGGAGGAG	GT:AD:DP:GQ:PL	0/1:165,181:346:99:4679,0,4215
chr7	148506396	.	A	C	4371.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.655;DP=289;ExcessHet=3.0103;FS=3.174;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.13;ReadPosRankSum=-0.49;SOR=0.539;HGVSnom=NM_004456.5:c.2110+6T>G;Gene=EZH2;Transcript=NM_004456.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_004456.5:IVS18+6T>G;AAlength=751;EXAC_AF=0.06156320;EXAC_Hom_EAS=6;EXAC_AC_EAS=321;EXAC_AN_EAS=8654;EXAC_AC_Adj=7467;EXAC_AN_Adj=121290;ESP6500_MAF=0.04267261;RS=rs41277434;CLNGENE=EZH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0505192;G1000_EAS_AF=0.0427;G1000_EUR_AF=0.0586;G1000_AFR_AF=0.0121;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.1383;gnomad_exomes_AF=0.06824403;gnomad_exomes_AF_EAS=0.03604828;gnomad_exomes_AC=17153;gnomad_exomes_Hom=952;gnomad_exomes_Het=15249;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01691891;gnomad_exomes_AF_NFE=0.05264593;gnomad_exomes_AF_AMR=0.18210252;gnomad_exomes_AF_SAS=0.04675859;NativeFreq_Het=0.1068;NativeFreq_Hom=0;normalHetFrequency=0.0928;normalHetNum=36;normalHomFrequency=0.0077;normalHomNum=3;patientHetFrequency=0.0891;patientHetNum=247;patientHomFrequency=0.0043;patientHomNum=12;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6524789|15D6533569|15D6532783][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545925|16D1545620|16D1545845|16D0161303|16D1545867|16D1546304|16D0172127|15D6722314|16D1546152|16D1532999-1|16D1546217|16B0033281][_];dbscSNV_RF_score=0.04;dbscSNV_ADA_score=0.00031680;DANN_score=0.6683;GREP_score=1.4;CytoBand=q36.1;CGD_CONDITION=Weaver syndrome;CGD_INHERITANCE=AD;Strand=EZH2:NM_001203249.1:-,EZH2:NM_001203247.1:-,EZH2:NM_001203248.1:-,EZH2:NM_004456.4:-,EZH2:NM_152998.2:-;NP=EZH2:NM_001203249.1:NP_001190178.1,EZH2:NM_001203247.1:NP_001190176.1,EZH2:NM_001203248.1:NP_001190177.1,EZH2:NM_004456.4:NP_004447.2,EZH2:NM_152998.2:NP_694543.1;ENSP=EZH2:NM_001203249.1:.,EZH2:NM_001203247.1:.,EZH2:NM_001203248.1:.,EZH2:NM_004456.4:ENST00000320356.6,EZH2:NM_152998.2:.;Gene_MIM_id=601573;Phenotypes=Weaver syndrome, 277590 (3), Autosomal dominant. 277590(MK);Possible_Inheritance=AD;EntrezGeneID=2146;EnsemblGeneID=ENSG00000106462;Alias=EZH2, EZH1, WVS;FLKSEQ=CGTCAAAGGT.CCTACCTTTT	GT:AD:DP:GQ:PL	0/1:153,136:289:99:4400,0,4746
chr7	148508833	.	A	G	3725.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.344;DP=236;ExcessHet=3.0103;FS=18.745;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.79;ReadPosRankSum=1.087;SOR=1.635;HGVSnom=NM_004456.5:c.1852-21T>C;Gene=EZH2;Transcript=NM_004456.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_004456.5:IVS15-21T>C;AAlength=751;EXAC_AF=0.66826662;EXAC_Hom_EAS=1876;EXAC_AC_EAS=5603;EXAC_AN_EAS=8318;EXAC_AC_Adj=78802;EXAC_AN_Adj=117920;ESP6500_MAF=0.68230048;RS=rs2072407;CLNGENE=EZH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.690695;G1000_EAS_AF=0.7024;G1000_EUR_AF=0.6571;G1000_AFR_AF=0.7209;G1000_SAS_AF=0.6012;G1000_AMR_AF=0.7911;gnomad_exomes_AF=0.66885030;gnomad_exomes_AF_EAS=0.66777188;gnomad_exomes_AC=162544;gnomad_exomes_Hom=54502;gnomad_exomes_Het=53540;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.70738170;gnomad_exomes_AF_NFE=0.67130425;gnomad_exomes_AF_AMR=0.72830983;gnomad_exomes_AF_SAS=0.61511005;NativeFreq_Het=0.3950;NativeFreq_Hom=0.5053;normalHetFrequency=0.4124;normalHetNum=160;normalHomFrequency=0.451;normalHomNum=175;patientHetFrequency=0.4123;patientHetNum=1143;patientHomFrequency=0.4354;patientHomNum=1207;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5855;GREP_score=-0.986;CytoBand=q36.1;CGD_CONDITION=Weaver syndrome;CGD_INHERITANCE=AD;Strand=EZH2:NM_001203249.1:-,EZH2:NM_001203247.1:-,EZH2:NM_001203248.1:-,EZH2:NM_004456.4:-,EZH2:NM_152998.2:-;NP=EZH2:NM_001203249.1:NP_001190178.1,EZH2:NM_001203247.1:NP_001190176.1,EZH2:NM_001203248.1:NP_001190177.1,EZH2:NM_004456.4:NP_004447.2,EZH2:NM_152998.2:NP_694543.1;ENSP=EZH2:NM_001203249.1:.,EZH2:NM_001203247.1:.,EZH2:NM_001203248.1:.,EZH2:NM_004456.4:ENST00000320356.6,EZH2:NM_152998.2:.;Gene_MIM_id=601573;Phenotypes=Weaver syndrome, 277590 (3), Autosomal dominant. 277590(MK);Possible_Inheritance=AD;EntrezGeneID=2146;EnsemblGeneID=ENSG00000106462;Alias=EZH2, EZH1, WVS;FLKSEQ=AAACACAATC.CATCATCAAA	GT:AD:DP:GQ:PL	0/1:118,118:236:99:3754,0,3529
chr7	148543525	.	A	G	3729.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.365;DP=223;ExcessHet=3.0103;FS=0.547;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.73;ReadPosRankSum=-0.372;SOR=0.776;HGVSnom=NM_004456.5:c.246+37T>C;Gene=EZH2;Transcript=NM_004456.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_004456.5:IVS3+37T>C;AAlength=751;EXAC_AF=0.70404928;EXAC_Hom_EAS=1918;EXAC_AC_EAS=5741;EXAC_AN_EAS=8632;EXAC_AC_Adj=85266;EXAC_AN_Adj=121108;ESP6500_MAF=0.77125942;RS=rs10274535;CLNGENE=EZH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.770367;G1000_EAS_AF=0.7014;G1000_EUR_AF=0.673;G1000_AFR_AF=0.9796;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.7882;gnomad_exomes_AF=0.70233139;gnomad_exomes_AF_EAS=0.66451685;gnomad_exomes_AC=169363;gnomad_exomes_Hom=60307;gnomad_exomes_Het=48749;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93803712;gnomad_exomes_AF_NFE=0.69225744;gnomad_exomes_AF_AMR=0.73787973;gnomad_exomes_AF_SAS=0.66956677;NativeFreq_Het=0.3381;NativeFreq_Hom=0.5587;normalHetFrequency=0.3789;normalHetNum=147;normalHomFrequency=0.4897;normalHomNum=190;patientHetFrequency=0.3961;patientHetNum=1098;patientHomFrequency=0.461;patientHomNum=1278;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6465;GREP_score=4.19;CytoBand=q36.1;CGD_CONDITION=Weaver syndrome;CGD_INHERITANCE=AD;Strand=EZH2:NM_001203249.1:-,EZH2:NM_001203247.1:-,EZH2:NM_001203248.1:-,EZH2:NM_004456.4:-,EZH2:NM_152998.2:-;NP=EZH2:NM_001203249.1:NP_001190178.1,EZH2:NM_001203247.1:NP_001190176.1,EZH2:NM_001203248.1:NP_001190177.1,EZH2:NM_004456.4:NP_004447.2,EZH2:NM_152998.2:NP_694543.1;ENSP=EZH2:NM_001203249.1:.,EZH2:NM_001203247.1:.,EZH2:NM_001203248.1:.,EZH2:NM_004456.4:ENST00000320356.6,EZH2:NM_152998.2:.;Gene_MIM_id=601573;Phenotypes=Weaver syndrome, 277590 (3), Autosomal dominant. 277590(MK);Possible_Inheritance=AD;EntrezGeneID=2146;EnsemblGeneID=ENSG00000106462;Alias=EZH2, EZH1, WVS;FLKSEQ=AAACCAAAAG.TGATGATAAT	GT:AD:DP:GQ:PL	0/1:98,125:223:99:3758,0,3013
chr7	148543693	.	TA	T	2565.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.164;DP=215;ExcessHet=3.0103;FS=5.68;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.34;ReadPosRankSum=-1.217;SOR=1.209;HGVSnom=NM_004456.5:c.118-4delT;Gene=EZH2;Transcript=NM_004456.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_004456.5:IVS2-4delT;AAlength=751;EXAC_AF=0.71343160;EXAC_Hom_EAS=1582;EXAC_AC_EAS=4981;EXAC_AN_EAS=7292;EXAC_AC_Adj=73863;EXAC_AN_Adj=103532;RS=rs3214332;CLNGENE=EZH2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.761182;G1000_EAS_AF=0.6974;G1000_EUR_AF=0.67;G1000_AFR_AF=0.9569;G1000_SAS_AF=0.6401;G1000_AMR_AF=0.7839;gnomad_exomes_AF=0.70082558;gnomad_exomes_AF_EAS=0.67319771;gnomad_exomes_AC=140067;gnomad_exomes_Hom=44499;gnomad_exomes_Het=51069;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.90542358;gnomad_exomes_AF_NFE=0.69170298;gnomad_exomes_AF_AMR=0.71831463;gnomad_exomes_AF_SAS=0.67591950;normalHetFrequency=0.3969;normalHetNum=154;normalHomFrequency=0.5129;normalHomNum=199;patientHetFrequency=0.4177;patientHetNum=1158;patientHomFrequency=0.4816;patientHomNum=1335;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q36.1;CGD_CONDITION=Weaver syndrome;CGD_INHERITANCE=AD;Strand=EZH2:NM_001203249.1:-,EZH2:NM_001203247.1:-,EZH2:NM_001203248.1:-,EZH2:NM_004456.4:-,EZH2:NM_152998.2:-;NP=EZH2:NM_001203249.1:NP_001190178.1,EZH2:NM_001203247.1:NP_001190176.1,EZH2:NM_001203248.1:NP_001190177.1,EZH2:NM_004456.4:NP_004447.2,EZH2:NM_152998.2:NP_694543.1;ENSP=EZH2:NM_001203249.1:.,EZH2:NM_001203247.1:.,EZH2:NM_001203248.1:.,EZH2:NM_004456.4:ENST00000320356.6,EZH2:NM_152998.2:.;Gene_MIM_id=601573;Phenotypes=Weaver syndrome, 277590 (3), Autosomal dominant. 277590(MK);Possible_Inheritance=AD;EntrezGeneID=2146;EnsemblGeneID=ENSG00000106462;Alias=EZH2, EZH1, WVS;FLKSEQ=AACATACTCT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:82,126:208:99:2603,0,1622
chr7	152343601	.	G	A	319.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.339;DP=26;ExcessHet=3.0103;FS=1.906;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.3;ReadPosRankSum=-1.595;SOR=0.223;HGVSnom=NM_005431.2:c.*2126C>T;Gene=XRCC2;Transcript=NM_005431.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=280;RS=rs3218556;G1000_AF=0.150359;G1000_EAS_AF=0.1548;G1000_EUR_AF=0.0457;G1000_AFR_AF=0.1982;G1000_SAS_AF=0.1135;G1000_AMR_AF=0.2565;DANN_score=0.7271;GREP_score=0.0;CytoBand=q36.1;repName=AluSx3;repClass=SINE;CGD_CONDITION=Fanconi anemia, complementation group U;CGD_INHERITANCE=AR;Strand=XRCC2:NM_005431.1:-;NP=XRCC2:NM_005431.1:NP_005422.1;ENSP=XRCC2:NM_005431.1:ENST00000359321.1;Gene_MIM_id=600375;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7516;EnsemblGeneID=ENSG00000196584;Alias=XRCC2, FANCU;FLKSEQ=agatggagtc.cccaggcggg	GT:AD:DP:GQ:PL	0/1:13,13:26:99:348,0,333
chr7	152343955	.	C	T	1949.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.349;DP=174;ExcessHet=3.0103;FS=0.571;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.4;ReadPosRankSum=-0.352;SOR=0.631;HGVSnom=NM_005431.2:c.*1772G>A;Gene=XRCC2;Transcript=NM_005431.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=280;RS=rs3218550;G1000_AF=0.0992412;G1000_EAS_AF=0.1548;G1000_EUR_AF=0.0447;G1000_AFR_AF=0.0144;G1000_SAS_AF=0.1145;G1000_AMR_AF=0.2378;DANN_score=0.8075;GREP_score=0.0;CytoBand=q36.1;repName=L1PA12;repClass=LINE;CGD_CONDITION=Fanconi anemia, complementation group U;CGD_INHERITANCE=AR;Strand=XRCC2:NM_005431.1:-;NP=XRCC2:NM_005431.1:NP_005422.1;ENSP=XRCC2:NM_005431.1:ENST00000359321.1;Gene_MIM_id=600375;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7516;EnsemblGeneID=ENSG00000196584;Alias=XRCC2, FANCU;FLKSEQ=agtgctgcaa.gaacatacgc	GT:AD:DP:GQ:PL	0/1:101,70:171:99:1978,0,2930
chr7	152345228	.	G	A	1132.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.716;DP=96;ExcessHet=3.0103;FS=1.902;MLEAC=1;MLEAF=0.5;MQ=59.67;MQRankSum=-1.29;QD=12.05;ReadPosRankSum=0.555;SOR=1.023;HGVSnom=NM_005431.2:c.*499C>T;Gene=XRCC2;Transcript=NM_005431.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=280;RS=rs3218544;G1000_AF=0.327276;G1000_EAS_AF=0.4018;G1000_EUR_AF=0.496;G1000_AFR_AF=0.1203;G1000_SAS_AF=0.3374;G1000_AMR_AF=0.3545;DANN_score=0.4777;GREP_score=-0.451;CytoBand=q36.1;repName=AluSx1;repClass=SINE;CGD_CONDITION=Fanconi anemia, complementation group U;CGD_INHERITANCE=AR;Strand=XRCC2:NM_005431.1:-;NP=XRCC2:NM_005431.1:NP_005422.1;ENSP=XRCC2:NM_005431.1:ENST00000359321.1;Gene_MIM_id=600375;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7516;EnsemblGeneID=ENSG00000196584;Alias=XRCC2, FANCU;FLKSEQ=ggctgggcac.ggcctgtaat	GT:AD:DP:GQ:PL	0/1:54,40:94:99:1161,0,1660
chr7	152345498	.	GA	G	1268.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.276;DP=114;ExcessHet=3.0103;FS=1.231;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.82;ReadPosRankSum=-1.152;SOR=1.071;HGVSnom=NM_005431.2:c.*228delT;Gene=XRCC2;Transcript=NM_005431.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=280;RS=rs10707642;CLNGENE=XRCC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;CytoBand=q36.1;repName=AluSx1;repClass=SINE;CGD_CONDITION=Fanconi anemia, complementation group U;CGD_INHERITANCE=AR;Strand=XRCC2:NM_005431.1:-;NP=XRCC2:NM_005431.1:NP_005422.1;ENSP=XRCC2:NM_005431.1:ENST00000359321.1;Gene_MIM_id=600375;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7516;EnsemblGeneID=ENSG00000196584;Alias=XRCC2, FANCU;FLKSEQ=gtttcaaaaa.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:27,72:99:99:1306,0,303
chr8	15966542	.	A	G	6761.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.551;DP=497;ExcessHet=3.0103;FS=2.454;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.66;ReadPosRankSum=0.231;SOR=0.548;HGVSnom=NM_138715.3:c.*1052T>C;Gene=MSR1;Transcript=NM_138715.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=451;RS=rs9650391;G1000_AF=0.629393;G1000_EAS_AF=0.7163;G1000_EUR_AF=0.8429;G1000_AFR_AF=0.2784;G1000_SAS_AF=0.7454;G1000_AMR_AF=0.6988;NativeFreq_Het=0.3762;NativeFreq_Hom=0.5544;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0054;patientHomNum=15;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D1536904-1|15B0066696-1|15B0040503][_];patientHomSampleInfo=[16B0017700|16B0200381|16D0164799|16B0000667|15D6722466-1|15D6522620|16D1532967-1|15B0051541|16S0013041|16D0172122|15D6522627|15B0064845|17B0000869|16B0012197|16B0033119][_];AF_2700_Het=0.3832;AF_2700_Hom=0.5446;AF_50_Het=0.3788;AF_50_Hom=0.5436;DANN_score=0.6526;GREP_score=-0.0063;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=TTCAGGGTAG.ATTACTGGGT	GT:AD:DP:GQ:PL	0/1:277,218:495:99:6790,0,8790
chr8	15966683	.	ACC	A	3926.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.664;DP=164;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=26.9;ReadPosRankSum=-0.067;SOR=0.85;OLD_VARIANT=chr8|15966683|ACC|A,AC|1;HGVSnom=NM_138715.3:c.*909_*910delGG;Gene=MSR1;Transcript=NM_138715.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=451;RS=rs3036788;G1000_AF=0.955671;G1000_EAS_AF=1.0;G1000_EUR_AF=0.993;G1000_AFR_AF=0.8442;G1000_SAS_AF=0.999;G1000_AMR_AF=0.9885;NativeFreq_Het=0.3416;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16D0164799][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.6487;AF_2700_Hom=0.2640;AF_50_Het=0.6339;AF_50_Hom=0.2789;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=CGCACCCCCC.CCCCCCCCCG	GT:AD:DP:GQ:PL	1/0:7,95:146:99:3964,985,873
chr8	15966683	.	AC	A	3926.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.664;DP=164;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=26.9;ReadPosRankSum=-0.067;SOR=0.85;OLD_VARIANT=chr8|15966683|ACC|A,AC|2;HGVSnom=NM_138715.3:c.*910delG;Gene=MSR1;Transcript=NM_138715.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=451;RS=rs3036788;NativeFreq_Het=0.0050;NativeFreq_Hom=.;AF_2700_Het=0.0023;AF_2700_Hom=.;AF_50_Het=0.0032;AF_50_Hom=.;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=CGCACCCCCC.CCCCCCCCCC	GT:AD:DP:GQ:PL	0/1:7,44:146:99:3964,2267,2034
chr8	15966855	.	C	A	3975.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.189;DP=294;ExcessHet=3.0103;FS=6.44;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.76;ReadPosRankSum=1.473;SOR=1.044;HGVSnom=NM_138715.3:c.*739G>T;Gene=MSR1;Transcript=NM_138715.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=451;RS=rs6986419;G1000_AF=0.616613;G1000_EAS_AF=0.7014;G1000_EUR_AF=0.825;G1000_AFR_AF=0.2678;G1000_SAS_AF=0.7403;G1000_AMR_AF=0.6816;NativeFreq_Het=0.3960;NativeFreq_Hom=0.5247;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0014;patientHomNum=4;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0033386][_];patientHetSampleInfo=[16D1536904-1|16B0028106|16B0028114][_];patientHomSampleInfo=[15D6532160|15D6722327-1|16D1533014-1|16B0028133][_];AF_2700_Het=0.3924;AF_2700_Hom=0.5277;AF_50_Het=0.3851;AF_50_Hom=0.5277;DANN_score=0.6019;GREP_score=0.313;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=CTAATTATTC.ATTTAAAGTG	GT:AD:DP:GQ:PL	0/1:159,130:289:99:4004,0,4959
chr8	15978063	.	C	T	9596.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=3.399;DP=274;ExcessHet=3.0103;FS=9.085;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.85;ReadPosRankSum=2.526;SOR=0.043;HGVSnom=NM_138715.3:c.1086G>A(p.Arg362Arg/p.R362R);Gene=MSR1;Transcript=NM_138715.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E9;IVSnom=.;AAlength=451;EXAC_AF=0.99920088;EXAC_Hom_EAS=4324;EXAC_AC_EAS=8648;EXAC_AN_EAS=8648;EXAC_AC_Adj=121287;EXAC_AN_Adj=121384;ESP6500_MAF=0.99746271;RS=rs4338104;G1000_AF=0.997404;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9902;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99937552;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=251253;gnomad_exomes_Hom=125548;gnomad_exomes_Het=157;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99187992;gnomad_exomes_AF_NFE=0.99999121;gnomad_exomes_AF_AMR=0.99936401;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=0.9680;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9536;normalHomNum=370;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9509;patientHomNum=2636;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.0031;AF_50_Het=0.0000;AF_50_Hom=0.0032;DANN_score=0.9132;GREP_score=-3.67;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=GTATCTCCAC.CTCCCCTCGT	GT:AD:DP:GQ:PL	1/1:4,269:273:99:9625,765,0
chr8	15978125	.	T	TAAA	1494.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.308;DP=162;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.25;ReadPosRankSum=-0.703;SOR=0.283;HGVSnom=NM_138715.3:c.1034-13_1034-11dupTTT;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8-11_-10insTTT;AAlength=451;RS=rs60866666;normalHetFrequency=0.0052;normalHetNum=2;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0043;patientHetNum=12;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[16B0000459|15B0033044][_];normalHomSampleInfo=[16B0004928][_];patientHetSampleInfo=[15B0062515-1|16B0005639|16B1903675|17B0000886|16B0035508-1|16B0033125|17B0001577-1|16B0202567|16B0228552|16B0017264|16B0017412|16B0019047-1][_];patientHomSampleInfo=[16B0005438|16B3258550][_];CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=GCTGTAAAGT.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:53,39:92:99:738,0,595
chr8	15996797	.	A	G	7069.77	PASS	AC=2;AF=1;AN=2;DP=213;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.19;SOR=2.779;HGVSnom=NM_138715.3:c.1033+4270T>C;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+4270T>C;AAlength=451;RS=rs12718375;G1000_AF=0.67512;G1000_EAS_AF=0.7044;G1000_EUR_AF=0.9026;G1000_AFR_AF=0.3949;G1000_SAS_AF=0.818;G1000_AMR_AF=0.6354;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0028377|15B0063116][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545984][_];DANN_score=0.5837;GREP_score=-3.22;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=AAGCTATTCC.GTTCAGAGAG	GT:AD:DP:GQ:PL	1/1:0,213:213:99:7098,640,0
chr8	15997262	.	AAAAAAAAAAAAAAAAAAAAAAATATATATATATATATATATATATATATATATATATAT	A	7632.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.933;DP=187;ExcessHet=3.0103;FS=4.352;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.05;ReadPosRankSum=1.361;SOR=1.189;HGVSnom=NM_138715.3:c.1033+3746_1033+3804delATATATATATATATATATATATATATATATATATATATTTTTTTTTTTTTTTTTTTTTT;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3746_+3804delATATATATATATATATATATATATATATATATATATATTTTTTTTTTTTTTTTTTTTTT;AAlength=451;RS=rs1563147792;CytoBand=p22;repName=(A)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=28;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=AACTTaaaaa.atatatatat	GT:AD:DP:GQ:PL	1/1:1,180:181:99:7670,520,0
chr8	15997588	.	G	GTGAATTAA	11205.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.33;DP=270;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.61;ReadPosRankSum=0.104;SOR=0.5;HGVSnom=NM_138715.3:c.1033+3471_1033+3478dupTTAATTCA;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3478_+3479insTTAATTCA;AAlength=451;RS=rs148643816;G1000_AF=0.433706;G1000_EAS_AF=0.5565;G1000_EUR_AF=0.2167;G1000_AFR_AF=0.5401;G1000_SAS_AF=0.3691;G1000_AMR_AF=0.4582;CytoBand=p22;repName=L2c;repClass=LINE;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=taatggacat.tgaattaatg	GT:AD:DP:GQ:PL	1/1:1,233:234:99:11243,730,0
chr8	15997671	.	T	C	3176.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.222;DP=225;ExcessHet=3.0103;FS=3.782;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.12;ReadPosRankSum=-1.832;SOR=0.492;HGVSnom=NM_138715.3:c.1033+3396A>G;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3396A>G;AAlength=451;RS=rs182500387;G1000_AF=0.00898562;G1000_EAS_AF=0.0446;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;DANN_score=0.4217;GREP_score=-0.0828;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=TAAAGAACTC.CATATTATCA	GT:AD:DP:GQ:PL	0/1:120,105:225:99:3205,0,3901
chr8	15997705	.	A	T	8267.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.539;DP=226;ExcessHet=3.0103;FS=3.288;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.95;ReadPosRankSum=-0.974;SOR=0.44;HGVSnom=NM_138715.3:c.1033+3362T>A;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3362T>A;AAlength=451;RS=rs77598698;G1000_AF=0.146765;G1000_EAS_AF=0.3472;G1000_EUR_AF=0.0437;G1000_AFR_AF=0.0166;G1000_SAS_AF=0.2055;G1000_AMR_AF=0.17;DANN_score=0.838;GREP_score=1.62;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=TTCTCCTAGA.CCCAATAAAT	GT:AD:DP:GQ:PL	1/1:1,225:226:99:8296,652,0
chr8	15997770	.	A	G	8635.77	PASS	AC=2;AF=1;AN=2;DP=228;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.43;SOR=1.058;HGVSnom=NM_138715.3:c.1033+3297T>C;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3297T>C;AAlength=451;RS=rs4449796;G1000_AF=0.434305;G1000_EAS_AF=0.5565;G1000_EUR_AF=0.2187;G1000_AFR_AF=0.5401;G1000_SAS_AF=0.3701;G1000_AMR_AF=0.4582;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0172483][_];DANN_score=0.2366;GREP_score=0.149;CytoBand=p22;repName=7SLRNA;repClass=srpRNA;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=gtgcaataga.caaggctctg	GT:AD:DP:GQ:PL	1/1:0,228:228:99:8664,684,0
chr8	15997800	.	GA	G	212.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.179;DP=237;ExcessHet=3.0103;FS=1.602;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.01;ReadPosRankSum=0.203;SOR=0.915;HGVSnom=NM_138715.3:c.1033+3266delT;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3266delT;AAlength=451;RS=rs540304542;CytoBand=p22;repName=7SLRNA;repClass=srpRNA;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=acaagaaaaa.aaaaaAAAAA	GT:AD:DP:GQ:PL	0/1:179,32:211:99:250,0,4054
chr8	15997974	.	T	G	12442.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.484;DP=323;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=35.49;ReadPosRankSum=0.199;SOR=0.555;HGVSnom=NM_138715.3:c.1033+3093A>C;Gene=MSR1;Transcript=NM_138715.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_138715.3:IVS8+3093A>C;AAlength=451;RS=rs4333601;G1000_AF=0.439097;G1000_EAS_AF=0.5595;G1000_EUR_AF=0.2207;G1000_AFR_AF=0.5537;G1000_SAS_AF=0.3712;G1000_AMR_AF=0.4582;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0200186][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0017782][_];DANN_score=0.6874;GREP_score=1.26;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=ACACCCTAGT.GTAGTCTCAT	GT:AD:DP:GQ:PL	1/1:1,322:323:99:12471,931,0
chr8	16012648	.	G	C	6994.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.675;DP=186;ExcessHet=3.0103;FS=2.843;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.71;ReadPosRankSum=1.35;SOR=0.223;HGVSnom=NM_138715.3:c.823C>G(p.Pro275Ala/p.P275A);Gene=MSR1;Transcript=NM_138715.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E6;IVSnom=.;AAlength=451;EXAC_AF=0.11380620;EXAC_Hom_EAS=493;EXAC_AC_EAS=2883;EXAC_AN_EAS=8346;EXAC_AC_Adj=13006;EXAC_AN_Adj=114282;ESP6500_MAF=0.06974777;RS=rs2229388;Ensembl_transcriptid=ENST00000350896|ENST00000262101|ENST00000445506|ENST00000355282|ENST00000522672|ENST00000381998;SIFT_pred=D|D|D|D|D|D;SIFT_score=0.0|0.042|0.037|0.0|0.025|0.0;Polyphen2_HVAR_pred=D|D|D|D|.|D;Polyphen2_HVAR_score=0.997|0.999|0.999|0.997|.|0.998;MutationTaster_pred=P|P|P|P|P|P;MutationTaster_score=0.00970856|0.00586909|0.00586909|0.00586909|0.00586909|0.00586909;G1000_AF=0.165535;G1000_EAS_AF=0.3413;G1000_EUR_AF=0.0457;G1000_AFR_AF=0.0756;G1000_SAS_AF=0.2188;G1000_AMR_AF=0.1801;gnomad_exomes_AF=0.11331562;gnomad_exomes_AF_EAS=0.33119447;gnomad_exomes_AC=28231;gnomad_exomes_Hom=2817;gnomad_exomes_Het=22597;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07415702;gnomad_exomes_AF_NFE=0.05299826;gnomad_exomes_AF_AMR=0.23597080;gnomad_exomes_AF_SAS=0.18155856;HGMD_gene=MSR1;HGMD_disease=Chronic_obstructive_pulmonary_disease_in_smokers_association_with;HGMD_tag=DFP;HGMD_pmid=20081102;NativeFreq_Het=0.5148;NativeFreq_Hom=0.0854;normalHetFrequency=0.3634;normalHetNum=141;normalHomFrequency=0.0747;normalHomNum=29;patientHetFrequency=0.3499;patientHetNum=970;patientHomFrequency=0.0685;patientHomNum=190;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4358;AF_2700_Hom=0.1203;AF_50_Het=0.4532;AF_50_Hom=0.1236;DANN_score=0.9961;GREP_score=4.87;CytoBand=p22;CGD_CONDITION=Barrett esophagus/esophageal adenocarcinoma. Prostate cancer;CGD_INHERITANCE=AD;Strand=MSR1:NM_138715.2:-,MSR1:NM_138716.2:-,MSR1:NM_002445.3:-;NP=MSR1:NM_138715.2:NP_619729.1,MSR1:NM_138716.2:NP_619730.1,MSR1:NM_002445.3:NP_002436.1;ENSP=MSR1:NM_138715.2:ENST00000262101.9,MSR1:NM_138716.2:.,MSR1:NM_002445.3:.;Gene_MIM_id=615174,153622;Phenotypes=.,Barrett esophagus/esophageal adenocarcinoma, 614266 (3). Prostate cancer, hereditary, 176807 (3), Autosomal dominant. 176807(MK),614266(MK);Possible_Inheritance=NA,AD;EntrezGeneID=157739,4481;EnsemblGeneID=ENSG00000154316,ENSG00000038945;Alias=TDH,MSR1, SCARA1, SRA;FLKSEQ=GGGGGTCCAG.AGGACCTTTA	GT:AD:DP:GQ:PL	1/1:2,183:185:99:7023,505,0
chr8	16050338	.	T	TA	5765.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.353;DP=221;ExcessHet=3.0103;FS=2.52;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=27.46;ReadPosRankSum=0.964;SOR=1.703;OLD_VARIANT=chr8|16050338|T|TA,TAA|1;HGVSnom=.;Gene=MSR1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs113208440;CytoBand=p22;Gene_MIM_id=615174;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=157739;EnsemblGeneID=ENSG00000154316;Alias=TDH;FLKSEQ=TAGGCCGCTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/0:7,31:210:99:5803,3841,3465
chr8	16050338	.	T	TAA	5765.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.353;DP=221;ExcessHet=3.0103;FS=2.52;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=27.46;ReadPosRankSum=0.964;SOR=1.703;OLD_VARIANT=chr8|16050338|T|TA,TAA|2;HGVSnom=.;Gene=MSR1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs113208440;G1000_AF=0.170327;G1000_EAS_AF=0.4216;G1000_EUR_AF=0.0417;G1000_AFR_AF=0.0461;G1000_SAS_AF=0.2106;G1000_AMR_AF=0.1715;NativeFreq_Het=0.1386;NativeFreq_Hom=.;CytoBand=p22;Gene_MIM_id=615174;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=157739;EnsemblGeneID=ENSG00000154316;Alias=TDH;FLKSEQ=TAGGCCGCTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:7,172:210:99:5803,619,291
chr8	30916085	.	T	C	13783.8	PASS	AC=2;AF=1;AN=2;DP=413;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.46;SOR=2.268;HGVSnom=NM_000553.6:c.96+26T>C;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000553.6:IVS2+26T>C;AAlength=1432;EXAC_AF=0.98779619;EXAC_Hom_EAS=4224;EXAC_AC_EAS=8448;EXAC_AN_EAS=8448;EXAC_AC_Adj=116475;EXAC_AN_Adj=117914;ESP6500_MAF=0.95946777;RS=rs2737316;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.96266;G1000_EAS_AF=1.0;G1000_EUR_AF=0.998;G1000_AFR_AF=0.8638;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.98952892;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=244758;gnomad_exomes_Hom=121211;gnomad_exomes_Het=2336;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87850000;gnomad_exomes_AF_NFE=0.99738866;gnomad_exomes_AF_AMR=0.99203535;gnomad_exomes_AF_SAS=0.99956796;NativeFreq_Het=0.0249;NativeFreq_Hom=1;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.9746;normalHomNum=843;patientHetFrequency=0.0017;patientHetNum=9;patientHomFrequency=0.9684;patientHomNum=5055;normalHetSampleInfo=[_][16D0177695];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0004948|15B0047107|15D6722354|15D6532789|16D1546060][16D0155882|16D1545628|15D6534401-1|16D1545823];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9977;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.6575;GREP_score=-3.09;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=ACTATTCTTT.GGGTGAGAAA	GT:AD:DP:GQ:PL	1/1:0,412:412:99:13812,1237,0
chr8	30924509	.	A	G	2349.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.818;DP=210;ExcessHet=3.0103;FS=14.184;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.35;ReadPosRankSum=2.14;SOR=2.3;HGVSnom=NM_000553.6:c.505-40A>G;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000553.6:IVS5-40A>G;AAlength=1432;EXAC_AF=0.00004954;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=8630;EXAC_AC_Adj=6;EXAC_AN_Adj=121124;RS=rs574086493;G1000_AF=0.00059904;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0031;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00007985;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=20;gnomad_exomes_Hom=0;gnomad_exomes_Het=20;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00062116;DANN_score=0.8529;GREP_score=-2.92;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=ACCTGAAAAC.GGAACTGATT	GT:AD:DP:GQ:PL	0/1:116,91:207:99:2378,0,3754
chr8	30924557	.	C	T	9430.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.78;DP=269;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=24.87;ReadPosRankSum=-0.162;SOR=1.151;HGVSnom=NM_000553.6:c.513C>T(p.Cys171Cys/p.C171C);Gene=WRN;Transcript=NM_000553.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=1432;EXAC_AF=0.70317628;EXAC_Hom_EAS=3193;EXAC_AC_EAS=7440;EXAC_AN_EAS=8646;EXAC_AC_Adj=85277;EXAC_AN_Adj=121274;ESP6500_MAF=0.65369829;RS=rs1800389;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.6873;G1000_EAS_AF=0.87;G1000_EUR_AF=0.7087;G1000_AFR_AF=0.4902;G1000_SAS_AF=0.6677;G1000_AMR_AF=0.7939;gnomad_exomes_AF=0.71282131;gnomad_exomes_AF_EAS=0.86499130;gnomad_exomes_AC=178921;gnomad_exomes_Hom=64567;gnomad_exomes_Het=49787;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.52764098;gnomad_exomes_AF_NFE=0.70356929;gnomad_exomes_AF_AMR=0.76826656;gnomad_exomes_AF_SAS=0.65905229;NativeFreq_Het=0.3665;NativeFreq_Hom=0.7326;normalHetFrequency=0.3202;normalHetNum=277;normalHomFrequency=0.6069;normalHomNum=525;patientHetFrequency=0.282;patientHetNum=1472;patientHomFrequency=0.6389;patientHomNum=3335;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2337;AF_2700_Hom=0.7475;AF_50_Het=0.2187;AF_50_Hom=0.7623;DANN_score=0.4329;GREP_score=2.09;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=AGCTGAAATG.ACAGAGACCT	GT:AD:DP:GQ:PL	1/1:1,266:267:99:9459,760,0
chr8	30933816	.	CT	C	242.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.471;DP=232;ExcessHet=3.0103;FS=2.22;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.16;ReadPosRankSum=-0.628;SOR=0.417;HGVSnom=NM_000553.6:c.839+25delT;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000553.6:IVS8+25delT;AAlength=1432;EXAC_AF=0.40366752;EXAC_Hom_EAS=0;EXAC_AC_EAS=2088;EXAC_AN_EAS=5408;EXAC_AC_Adj=33636;EXAC_AN_Adj=83326;RS=rs370040831;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.41002511;gnomad_exomes_AF_EAS=0.38845446;gnomad_exomes_AC=50953;gnomad_exomes_Hom=1;gnomad_exomes_Het=50951;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37818591;gnomad_exomes_AF_NFE=0.40137710;gnomad_exomes_AF_AMR=0.44327465;gnomad_exomes_AF_SAS=0.43593085;NativeFreq_Het=0.0198;NativeFreq_Hom=.;normalHetFrequency=0.4069;normalHetNum=352;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.3981;patientHetNum=2078;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3497;AF_2700_Hom=.;AF_50_Het=0.3518;AF_50_Hom=.;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=TAAATATTAC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:174,36:210:99:280,0,3602
chr8	30941317	.	T	C	12253.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.394;DP=328;ExcessHet=3.0103;FS=3.532;MLEAC=2;MLEAF=1;MQ=40.02;MQRankSum=-1.724;QD=30.56;ReadPosRankSum=0.875;SOR=0.611;HGVSnom=NM_000553.6:c.1350+22T>C;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000553.6:IVS10+22T>C;AAlength=1432;EXAC_AF=0.55762849;EXAC_Hom_EAS=1317;EXAC_AC_EAS=4679;EXAC_AN_EAS=8330;EXAC_AC_Adj=64860;EXAC_AN_Adj=116314;ESP6500_MAF=0.50927214;RS=rs2737325;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.486222;G1000_EAS_AF=0.5784;G1000_EUR_AF=0.6252;G1000_AFR_AF=0.2519;G1000_SAS_AF=0.4734;G1000_AMR_AF=0.6153;gnomad_exomes_AF=0.56514939;gnomad_exomes_AF_EAS=0.56559831;gnomad_exomes_AC=137667;gnomad_exomes_Hom=40242;gnomad_exomes_Het=57183;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27868424;gnomad_exomes_AF_NFE=0.61560118;gnomad_exomes_AF_AMR=0.50319074;gnomad_exomes_AF_SAS=0.49268732;NativeFreq_Het=0.5267;NativeFreq_Hom=0.2384;normalHetFrequency=0.4636;normalHetNum=401;normalHomFrequency=0.3052;normalHomNum=264;patientHetFrequency=0.46;patientHetNum=2401;patientHomFrequency=0.3065;patientHomNum=1600;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4831;AF_2700_Hom=0.3228;AF_50_Het=0.4945;AF_50_Hom=0.3265;DANN_score=0.6517;GREP_score=-1.37;CytoBand=p12;dupName=chr8:30941554;dupScore=0;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=ATTATAAAAA.ATTACTTCAA	GT:AD:DP:GQ:PL	1/1:1,326:327:99:12282,949,0
chr8	30954244	.	G	GT	363.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.285;DP=188;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.14;ReadPosRankSum=-0.754;SOR=0.714;HGVSnom=NM_000553.6:c.1899-27dupT;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_000553.6:IVS16-27_-26insT;AAlength=1432;EXAC_AF=0.14622192;EXAC_Hom_EAS=0;EXAC_AC_EAS=278;EXAC_AN_EAS=2070;EXAC_AC_Adj=5221;EXAC_AN_Adj=35706;RS=rs376058022;NativeFreq_Het=0.0198;NativeFreq_Hom=.;normalHetFrequency=0.3029;normalHetNum=262;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.3149;patientHetNum=1644;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0011423][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B6215224-1][_];CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=TTCCCTTCCT.tttttttttt	GT:AD:DP:GQ:PL	0/1:130,40:170:99:401,0,2449
chr8	30958353	.	CT	C	8121.73	PASS	AC=2;AF=1;AN=2;DP=268;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.88;SOR=2.54;HGVSnom=NM_000553.6:c.1982-5delT;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_000553.6:IVS17-5delT;AAlength=1432;EXAC_AF=0.99433247;EXAC_Hom_EAS=4287;EXAC_AC_EAS=8574;EXAC_AN_EAS=8574;EXAC_AC_Adj=120179;EXAC_AN_Adj=120864;ESP6500_MAF=0.97835117;RS=rs397723919;CLNGENE=WRN;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.98123;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9304;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;gnomad_exomes_AF=0.99559053;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=249718;gnomad_exomes_Hom=124334;gnomad_exomes_Het=1050;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93819393;gnomad_exomes_AF_NFE=0.99994714;gnomad_exomes_AF_AMR=0.99753823;gnomad_exomes_AF_SAS=0.99996720;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9988;normalHomNum=864;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9985;patientHomNum=5212;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=.;AF_2700_Hom=0.9985;AF_50_Het=.;AF_50_Hom=1.0000;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=ATGTGTTTTT.TTTTTTACAG	GT:AD:DP:GQ:PL	1/1:0,263:263:99:8159,790,0
chr8	30969355	.	CT	C	700.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.971;DP=271;ExcessHet=3.0103;FS=4.469;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.87;ReadPosRankSum=-0.692;SOR=1.381;HGVSnom=NM_000553.6:c.2273+53delT;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_000553.6:IVS19+53delT;AAlength=1432;EXAC_AF=0.28346841;EXAC_Hom_EAS=0;EXAC_AC_EAS=979;EXAC_AN_EAS=3878;EXAC_AC_Adj=17418;EXAC_AN_Adj=61446;ESP6500_MAF=0.21818766;RS=rs111854110;gnomad_exomes_AF=0.29402395;gnomad_exomes_AF_EAS=0.26376768;gnomad_exomes_AC=29166;gnomad_exomes_Hom=51;gnomad_exomes_Het=29064;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31958646;gnomad_exomes_AF_NFE=0.27897892;gnomad_exomes_AF_AMR=0.30772048;gnomad_exomes_AF_SAS=0.33884451;normalHetFrequency=0.0832;normalHetNum=72;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0952;patientHetNum=497;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=TAATGATTTC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:181,63:244:99:738,0,3322
chr8	30973957	.	G	T	5942.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.254;DP=360;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.51;ReadPosRankSum=-0.471;SOR=0.676;HGVSnom=NM_000553.6:c.2361G>T(p.Leu787Leu/p.L787L);Gene=WRN;Transcript=NM_000553.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E20;IVSnom=.;AAlength=1432;EXAC_AF=0.44662579;EXAC_Hom_EAS=1654;EXAC_AC_EAS=5355;EXAC_AN_EAS=8634;EXAC_AC_Adj=54190;EXAC_AN_Adj=121332;ESP6500_MAF=0.44817776;RS=rs1800392;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.471246;G1000_EAS_AF=0.624;G1000_EUR_AF=0.4493;G1000_AFR_AF=0.4175;G1000_SAS_AF=0.3344;G1000_AMR_AF=0.5764;gnomad_exomes_AF=0.45402249;gnomad_exomes_AF_EAS=0.62880766;gnomad_exomes_AC=114045;gnomad_exomes_Hom=26845;gnomad_exomes_Het=60355;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.41472868;gnomad_exomes_AF_NFE=0.45081289;gnomad_exomes_AF_AMR=0.55914507;gnomad_exomes_AF_SAS=0.32528585;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3274;normalHetFrequency=0.4324;normalHetNum=374;normalHomFrequency=0.304;normalHomNum=263;patientHetFrequency=0.4431;patientHetNum=2313;patientHomFrequency=0.3069;patientHomNum=1602;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4716;AF_2700_Hom=0.3805;AF_50_Het=0.4849;AF_50_Hom=0.3819;DANN_score=0.61;GREP_score=3.85;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=TTAGGAAACT.AATCTATCCT	GT:AD:DP:GQ:PL	0/1:172,188:360:99:5971,0,5455
chr8	30977717	.	T	C	4445.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.927;DP=282;ExcessHet=3.0103;FS=3.485;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.77;ReadPosRankSum=0.816;SOR=0.479;HGVSnom=NM_000553.6:c.2449-42T>C;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000553.6:IVS20-42T>C;AAlength=1432;EXAC_AF=0.45063502;EXAC_Hom_EAS=1654;EXAC_AC_EAS=5353;EXAC_AN_EAS=8624;EXAC_AC_Adj=54571;EXAC_AN_Adj=121098;ESP6500_MAF=0.45916641;RS=rs2725352;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.480232;G1000_EAS_AF=0.625;G1000_EUR_AF=0.4503;G1000_AFR_AF=0.4478;G1000_SAS_AF=0.3364;G1000_AMR_AF=0.5778;gnomad_exomes_AF=0.45750402;gnomad_exomes_AF_EAS=0.62879695;gnomad_exomes_AC=114333;gnomad_exomes_Hom=27077;gnomad_exomes_Het=60179;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44526718;gnomad_exomes_AF_NFE=0.45181762;gnomad_exomes_AF_AMR=0.56086679;gnomad_exomes_AF_SAS=0.33077225;NativeFreq_Het=0.4752;NativeFreq_Hom=0.3310;normalHetFrequency=0.4289;normalHetNum=371;normalHomFrequency=0.3098;normalHomNum=268;patientHetFrequency=0.4444;patientHetNum=2320;patientHomFrequency=0.3077;patientHomNum=1606;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4361;GREP_score=0.435;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=GTTTTCATTC.GCTAAATATG	GT:AD:DP:GQ:PL	0/1:142,140:282:99:4474,0,4433
chr8	30999122	.	C	T	6672.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.658;DP=404;ExcessHet=3.0103;FS=2.693;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.6;ReadPosRankSum=0.842;SOR=0.936;HGVSnom=NM_000553.6:c.3138+6C>T;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I25;IVSnom=NM_000553.6:IVS25+6C>T;AAlength=1432;EXAC_AF=0.47042723;EXAC_Hom_EAS=511;EXAC_AC_EAS=2985;EXAC_AN_EAS=8636;EXAC_AC_Adj=57060;EXAC_AN_Adj=121294;ESP6500_MAF=0.38659080;RS=rs3024239;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.375;G1000_EAS_AF=0.3343;G1000_EUR_AF=0.502;G1000_AFR_AF=0.149;G1000_SAS_AF=0.589;G1000_AMR_AF=0.379;gnomad_exomes_AF=0.47036545;gnomad_exomes_AF_EAS=0.33828329;gnomad_exomes_AC=118232;gnomad_exomes_Hom=29186;gnomad_exomes_Het=59860;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18898462;gnomad_exomes_AF_NFE=0.49701800;gnomad_exomes_AF_AMR=0.40393847;gnomad_exomes_AF_SAS=0.59075466;NativeFreq_Het=0.4950;NativeFreq_Hom=0.1584;normalHetFrequency=0.4335;normalHetNum=375;normalHomFrequency=0.1988;normalHomNum=172;patientHetFrequency=0.4374;patientHetNum=2283;patientHomFrequency=0.1751;patientHomNum=914;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4566;AF_2700_Hom=0.1176;AF_50_Het=0.4723;AF_50_Hom=0.0998;dbscSNV_RF_score=0.004;dbscSNV_ADA_score=0.00008950;DANN_score=0.2474;GREP_score=1.79;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=AAAAGGTAAA.GGTGTAGGAG	GT:AD:DP:GQ:PL	0/1:189,213:402:99:6701,0,7331
chr8	30999123	.	G	A	5954.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.251;DP=393;ExcessHet=3.0103;FS=4.129;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.23;ReadPosRankSum=-1.669;SOR=0.509;HGVSnom=NM_000553.6:c.3138+7G>A;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I25;IVSnom=NM_000553.6:IVS25+7G>A;AAlength=1432;EXAC_AF=0.44790086;EXAC_Hom_EAS=1727;EXAC_AC_EAS=5459;EXAC_AN_EAS=8632;EXAC_AC_Adj=54325;EXAC_AN_Adj=121288;ESP6500_MAF=0.46601569;RS=rs2737335;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.494808;G1000_EAS_AF=0.6419;G1000_EUR_AF=0.4384;G1000_AFR_AF=0.5008;G1000_SAS_AF=0.3262;G1000_AMR_AF=0.5893;gnomad_exomes_AF=0.45383948;gnomad_exomes_AF_EAS=0.64043294;gnomad_exomes_AC=114078;gnomad_exomes_Hom=26880;gnomad_exomes_Het=60318;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.48725840;gnomad_exomes_AF_NFE=0.44042007;gnomad_exomes_AF_AMR=0.55781133;gnomad_exomes_AF_SAS=0.32311814;NativeFreq_Het=0.4950;NativeFreq_Hom=0.3488;normalHetFrequency=0.4301;normalHetNum=372;normalHomFrequency=0.3168;normalHomNum=274;patientHetFrequency=0.4383;patientHetNum=2288;patientHomFrequency=0.3215;patientHomNum=1678;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4685;AF_2700_Hom=0.4012;AF_50_Het=0.4818;AF_50_Hom=0.3994;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00004241;DANN_score=0.3706;GREP_score=-3.18;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=AAAGGTAAAC.GTGTAGGAGT	GT:AD:DP:GQ:PL	0/1:203,188:391:99:5983,0,8254
chr8	30999280	.	G	T	3407.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.04;DP=254;ExcessHet=3.0103;FS=20.921;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.47;ReadPosRankSum=0.826;SOR=1.727;HGVSnom=NM_000553.6:c.3222G>T(p.Leu1074Phe/p.L1074F);Gene=WRN;Transcript=NM_000553.6;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E26;IVSnom=.;AAlength=1432;EXAC_AF=0.44917680;EXAC_Hom_EAS=1723;EXAC_AC_EAS=5448;EXAC_AN_EAS=8618;EXAC_AC_Adj=54292;EXAC_AN_Adj=120870;ESP6500_MAF=0.46693834;RS=rs1801195;Ensembl_transcriptid=ENST00000298139;SIFT_pred=T;SIFT_score=0.764;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.0;MutationTaster_pred=P;MutationTaster_score=1;CLNGENE=WRN;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.496006;G1000_EAS_AF=0.6419;G1000_EUR_AF=0.4404;G1000_AFR_AF=0.5038;G1000_SAS_AF=0.3262;G1000_AMR_AF=0.5893;gnomad_exomes_AF=0.45459655;gnomad_exomes_AF_EAS=0.64047515;gnomad_exomes_AC=114051;gnomad_exomes_Hom=26905;gnomad_exomes_Het=60241;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.48772514;gnomad_exomes_AF_NFE=0.44158054;gnomad_exomes_AF_AMR=0.55901269;gnomad_exomes_AF_SAS=0.32347366;HGMD_gene=WRN;HGMD_disease=Coronary_stenosis_reduced_risk_association_with;HGMD_tag=DFP;HGMD_pmid=11186893;NativeFreq_Het=0.5049;NativeFreq_Hom=0.3452;normalHetFrequency=0.4312;normalHetNum=373;normalHomFrequency=0.3168;normalHomNum=274;patientHetFrequency=0.437;patientHetNum=2281;patientHomFrequency=0.3218;patientHomNum=1680;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4685;AF_2700_Hom=0.4008;AF_50_Het=0.4834;AF_50_Hom=0.3994;DANN_score=0.2294;GREP_score=1.4;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=CAAAGAAGTT.CTTCTGCCTA	GT:AD:DP:GQ:PL	0/1:132,121:253:99:3436,0,4005
chr8	31000243	.	T	C	4854.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.778;DP=290;ExcessHet=3.0103;FS=3.933;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.74;ReadPosRankSum=-1.842;SOR=0.972;HGVSnom=NM_000553.6:c.3309+26T>C;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I27;IVSnom=NM_000553.6:IVS27+26T>C;AAlength=1432;EXAC_AF=0.38961244;EXAC_Hom_EAS=1723;EXAC_AC_EAS=5451;EXAC_AN_EAS=8612;EXAC_AC_Adj=46907;EXAC_AN_Adj=120394;ESP6500_MAF=0.38096709;RS=rs2725365;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.439097;G1000_EAS_AF=0.6419;G1000_EUR_AF=0.3748;G1000_AFR_AF=0.3843;G1000_SAS_AF=0.3016;G1000_AMR_AF=0.536;gnomad_exomes_AF=0.39543311;gnomad_exomes_AF_EAS=0.63738307;gnomad_exomes_AC=95592;gnomad_exomes_Hom=20134;gnomad_exomes_Het=55324;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36702600;gnomad_exomes_AF_NFE=0.37351123;gnomad_exomes_AF_AMR=0.50945854;gnomad_exomes_AF_SAS=0.29052173;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3203;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.3098;normalHomNum=268;patientHetFrequency=0.4238;patientHetNum=2212;patientHomFrequency=0.3134;patientHomNum=1636;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4646;AF_2700_Hom=0.4012;AF_50_Het=0.4818;AF_50_Hom=0.3994;DANN_score=0.3934;GREP_score=1.28;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=ATTGTTCTGA.TTATTTCATT	GT:AD:DP:GQ:PL	0/1:146,144:290:99:4883,0,4655
chr8	31005017	.	T	TC	11772.7	PASS	AC=2;AF=1;AN=2;DP=294;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.52;SOR=2.36;HGVSnom=NM_000553.6:c.3572+25_3572+26insC;Gene=WRN;Transcript=NM_000553.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I30;IVSnom=NM_000553.6:IVS30+25_+26insC;AAlength=1432;EXAC_AF=0.99277232;EXAC_Hom_EAS=4309;EXAC_AC_EAS=8618;EXAC_AN_EAS=8618;EXAC_AC_Adj=120050;EXAC_AN_Adj=120924;ESP6500_MAF=0.97259946;RS=rs3087415;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.976238;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9138;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.99418897;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=249444;gnomad_exomes_Hom=124050;gnomad_exomes_Het=1344;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91927919;gnomad_exomes_AF_NFE=0.99981488;gnomad_exomes_AF_AMR=0.99681252;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9977;normalHomNum=863;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=0.9981;patientHomNum=5210;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0168796|16D0159560][_];patientHomSampleInfo=[_][_];AF_2700_Het=.;AF_2700_Hom=0.9985;AF_50_Het=.;AF_50_Hom=1.0000;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=GCATGTGTTC.ATTTATTTCC	GT:AD:DP:GQ:PL	1/1:0,293:293:99:11810,882,0
chr8	31024638	.	C	T	4575.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.749;DP=375;ExcessHet=3.0103;FS=4.615;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.23;ReadPosRankSum=0.367;SOR=0.912;HGVSnom=NM_000553.6:c.4083C>T(p.Ser1361Ser/p.S1361S);Gene=WRN;Transcript=NM_000553.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E34;IVSnom=.;AAlength=1432;EXAC_AF=0.29890613;EXAC_Hom_EAS=253;EXAC_AC_EAS=2007;EXAC_AN_EAS=8624;EXAC_AC_Adj=36179;EXAC_AN_Adj=121038;ESP6500_MAF=0.28210057;RS=rs1801196;CLNGENE=WRN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.273562;G1000_EAS_AF=0.2282;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.2632;G1000_SAS_AF=0.3272;G1000_AMR_AF=0.2536;gnomad_exomes_AF=0.29695794;gnomad_exomes_AF_EAS=0.22499728;gnomad_exomes_AC=74521;gnomad_exomes_Hom=11199;gnomad_exomes_Het=52123;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.26527094;gnomad_exomes_AF_NFE=0.29835369;gnomad_exomes_AF_AMR=0.26613090;gnomad_exomes_AF_SAS=0.34234617;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0990;normalHetFrequency=0.3653;normalHetNum=316;normalHomFrequency=0.0647;normalHomNum=56;patientHetFrequency=0.3498;patientHetNum=1826;patientHomFrequency=0.0747;patientHomNum=390;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3566;AF_2700_Hom=0.0515;AF_50_Het=0.3645;AF_50_Hom=0.0412;DANN_score=0.538;GREP_score=2.88;CytoBand=p12;CGD_CONDITION=Werner syndrome;CGD_INHERITANCE=AR;Strand=WRN:NM_000553.4:+,WRN:NM_000553.6:+;NP=WRN:NM_000553.4:NP_000544.2,WRN:NM_000553.6:NP_000544.2;ENSP=WRN:NM_000553.4:ENST00000298139.5,WRN:NM_000553.6:ENST00000298139.7;Gene_MIM_id=604611;Phenotypes=Werner syndrome, 277700 (3), Autosomal recessive. 277700(MK);Possible_Inheritance=AR;EntrezGeneID=7486;EnsemblGeneID=ENSG00000165392;Alias=RECQL2, RECQ3, WRN;FLKSEQ=GTCCTGACAG.GGACTTCAAC	GT:AD:DP:GQ:PL	0/1:216,158:374:99:4604,0,6264
chr8	48685753	.	G	GA	105.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.181;DP=326;ExcessHet=3.0103;FS=8.966;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.34;ReadPosRankSum=-0.389;SOR=1.449;HGVSnom=NM_006904.7:c.*980dupT;Gene=PRKDC;Transcript=NM_006904.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E87;IVSnom=.;AAlength=4127;RS=rs934018802;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=GTGTTAGAAG.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:265,45:310:99:143,0,5889
chr8	48685815	.	C	CG	3574.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.397;DP=387;ExcessHet=3.0103;FS=13.497;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.71;ReadPosRankSum=0.095;SOR=1.053;HGVSnom=NM_006904.7:c.*918dupC;Gene=PRKDC;Transcript=NM_006904.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E87;IVSnom=.;AAlength=4127;RS=rs374844654;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=GGAGGACTGG.GGGGGGGGAC	GT:AD:DP:GQ:PL	0/1:204,164:368:99:3612,0,4975
chr8	48689366	.	C	T	6242.77	StandardFilter	AC=2;AF=1;AN=2;DP=159;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29;SOR=4.287;HGVSnom=NM_006904.7:c.12180+39G>A;Gene=PRKDC;Transcript=NM_006904.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I86;IVSnom=NM_006904.7:IVS86+39G>A;AAlength=4127;EXAC_AF=0.15787322;EXAC_Hom_EAS=108;EXAC_AC_EAS=1266;EXAC_AN_EAS=8072;EXAC_AC_Adj=18151;EXAC_AN_Adj=114972;ESP6500_MAF=0.21355391;RS=rs8178258;CLNGENE=PRKDC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.304912;G1000_EAS_AF=0.1855;G1000_EUR_AF=0.0586;G1000_AFR_AF=0.6324;G1000_SAS_AF=0.2495;G1000_AMR_AF=0.2896;gnomad_exomes_AF=0.15683352;gnomad_exomes_AF_EAS=0.15847025;gnomad_exomes_AC=38401;gnomad_exomes_Hom=5766;gnomad_exomes_Het=26869;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57198469;gnomad_exomes_AF_NFE=0.05935884;gnomad_exomes_AF_AMR=0.34328803;gnomad_exomes_AF_SAS=0.19164896;normalHetFrequency=0.2242;normalHetNum=87;normalHomFrequency=0.0103;normalHomNum=4;patientHetFrequency=0.2287;patientHetNum=634;patientHomFrequency=0.0224;patientHomNum=62;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7247;GREP_score=3.03;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=AGTAGCATGT.GGTAGTCCGT	GT:AD:DP:GQ:PL	1/1:0,159:159:99:6271,478,0
chr8	48710955	.	A	G	11381.8	PASS	AC=2;AF=1;AN=2;DP=303;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.52;SOR=1.337;HGVSnom=NM_006904.7:c.10299T>C(p.Val3433Val/p.V3433V);Gene=PRKDC;Transcript=NM_006904.7;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E74;IVSnom=.;AAlength=4127;EXAC_AF=0.13740214;EXAC_Hom_EAS=27;EXAC_AC_EAS=550;EXAC_AN_EAS=6810;EXAC_AC_Adj=12918;EXAC_AN_Adj=94016;ESP6500_MAF=0.12058873;RS=rs7830743;Ensembl_transcriptid=ENST00000314191|ENST00000338368;SIFT_pred=.|.;SIFT_score=.|.;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.001|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=PRKDC;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.184505;G1000_EAS_AF=0.0804;G1000_EUR_AF=0.0547;G1000_AFR_AF=0.3086;G1000_SAS_AF=0.2035;G1000_AMR_AF=0.2608;gnomad_exomes_AF=0.11942854;gnomad_exomes_AF_EAS=0.06886581;gnomad_exomes_AC=27068;gnomad_exomes_Hom=3007;gnomad_exomes_Het=21054;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28077133;gnomad_exomes_AF_NFE=0.05422967;gnomad_exomes_AF_AMR=0.32473709;gnomad_exomes_AF_SAS=0.16476967;HGMD_gene=PRKDC;HGMD_disease=Differentiated_thyroid_carcinoma_association_with;HGMD_tag=DP;HGMD_pmid=23183621;normalHetFrequency=0.1392;normalHetNum=54;normalHomFrequency=0.0077;normalHomNum=3;patientHetFrequency=0.1356;patientHetNum=376;patientHomFrequency=0.009;patientHomNum=25;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546029|16B0000458|16B3107987][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0168716|16D1546173|15D6482405|16B0028219|16B0009482-1|16D0177798|15D6534406|16B3094098|16D1545907|16D1545667|16D1536929|16D0172293|16D0177686|16B3108396|16B0202355|16D1545715|15D6722343-1|15D6482485|16D1546177|15B0022579|16B0028416|16S0013545|16B0024498|16D1536870|16D1533054][_];DANN_score=0.2252;GREP_score=-7.65;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=TGCAGAATCA.TAACTATCAA	GT:AD:DP:GQ:PL	1/1:0,303:303:99:11410,910,0
chr8	48732074	.	TA	T	1499.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.011;DP=216;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.02;ReadPosRankSum=0.468;SOR=0.876;HGVSnom=NM_006904.7:c.9335-4delT;Gene=PRKDC;Transcript=NM_006904.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I67;IVSnom=NM_006904.7:IVS67-4delT;AAlength=4127;EXAC_AF=0.18346021;EXAC_Hom_EAS=0;EXAC_AC_EAS=151;EXAC_AN_EAS=1640;EXAC_AC_Adj=5109;EXAC_AN_Adj=27848;RS=rs11311765;CLNGENE=PRKDC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.14009327;gnomad_exomes_AF_EAS=0.08933333;gnomad_exomes_AC=4446;gnomad_exomes_Hom=0;gnomad_exomes_Het=4446;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12738215;gnomad_exomes_AF_NFE=0.14737150;gnomad_exomes_AF_AMR=0.12144054;gnomad_exomes_AF_SAS=0.14306463;normalHetFrequency=0.1108;normalHetNum=43;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.1118;patientHetNum=310;patientHomFrequency=0.0076;patientHomNum=21;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546029|16D0162396][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[17B0005533|16B0024621|16B0001884-1|16B0009395-1|16B0009388-1|15D6534406|15B0064840|16B0033426|16D0172293|16D0172478|16B0028416|15D6722355|16B0028178|16B0033509|17D0000641|16B0005264|16D1545603|15D6722452-1|16D1546077|16D1545907|17B0501030][_];CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=GAATAATTCT.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:57,130:187:99:1537,0,429
chr8	48739440	.	C	A	11488.8	PASS	AC=2;AF=1;AN=2;DP=296;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.15;SOR=1.82;HGVSnom=NM_006904.7:c.8576-18G>T;Gene=PRKDC;Transcript=NM_006904.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I63;IVSnom=NM_006904.7:IVS63-18G>T;AAlength=4127;EXAC_AF=0.15023599;EXAC_Hom_EAS=9;EXAC_AC_EAS=236;EXAC_AN_EAS=2312;EXAC_AC_Adj=5666;EXAC_AN_Adj=37714;ESP6500_MAF=0.09500082;RS=rs4873728;CLNGENE=PRKDC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.168131;G1000_EAS_AF=0.0774;G1000_EUR_AF=0.0527;G1000_AFR_AF=0.2572;G1000_SAS_AF=0.1953;G1000_AMR_AF=0.2594;gnomad_exomes_AF=0.11935388;gnomad_exomes_AF_EAS=0.06460716;gnomad_exomes_AC=21583;gnomad_exomes_Hom=2276;gnomad_exomes_Het=17031;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24058535;gnomad_exomes_AF_NFE=0.05513603;gnomad_exomes_AF_AMR=0.31355495;gnomad_exomes_AF_SAS=0.15582791;normalHetFrequency=0.1237;normalHetNum=48;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.1259;patientHetNum=349;patientHomFrequency=0.0079;patientHomNum=22;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546029|16B0000458][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0168716|16D1546173|15D6482405|16B0009482-1|15D6534406|16B3094098|16D1545907|16D1545667|16D1536929|16D0172293|16D0177686|16B3108396|16B0202355|16D1545715|15D6722343-1|15D6482485|16D1546177|15B0022579|16B0028416|16B0024498|16D1536870|16D1533054][_];DANN_score=0.475;GREP_score=2.75;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=ACCACACATA.AACCAGCTGT	GT:AD:DP:GQ:PL	1/1:0,296:296:99:11517,890,0
chr8	48801040	.	A	G	3687.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.881;DP=212;ExcessHet=3.0103;FS=7.445;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.64;ReadPosRankSum=0.138;SOR=1.7;HGVSnom=NM_006904.7:c.4411+39T>C;Gene=PRKDC;Transcript=NM_006904.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I35;IVSnom=NM_006904.7:IVS35+39T>C;AAlength=4127;EXAC_AF=0.04552079;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=656;EXAC_AC_Adj=937;EXAC_AN_Adj=20584;ESP6500_MAF=0.03619632;RS=rs8178097;CLNGENE=PRKDC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0247604;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0527;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.0432;gnomad_exomes_AF=0.04116250;gnomad_exomes_AF_EAS=0.00045725;gnomad_exomes_AC=5198;gnomad_exomes_Hom=142;gnomad_exomes_Het=4914;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00774573;gnomad_exomes_AF_NFE=0.05318904;gnomad_exomes_AF_AMR=0.03319154;gnomad_exomes_AF_SAS=0.04106839;normalHetFrequency=0.0206;normalHetNum=8;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0332;patientHetNum=92;patientHomFrequency=0.0018;patientHomNum=5;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546029][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0168716|16D1546173|15D6534406|16D1545715|15D6722343-1][_];DANN_score=0.5534;GREP_score=-8.85;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=TTATCATACT.AAGCTAAAAT	GT:AD:DP:GQ:PL	0/1:100,109:209:99:3716,0,3077
chr8	48805816	.	A	AG	10491.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.007;DP=283;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.05;ReadPosRankSum=-0.707;SOR=0.229;HGVSnom=NM_006904.7:c.3728-1dupC(p.Tyr1243Serfs*43/p.Y1243Sfs*43);Gene=PRKDC;Transcript=NM_006904.7;VarType=Frameshift+SpliceAcceptor;MolecularConsequence=frameshift_elongation+splice_acceptor_variant;ExonIntron=I31;IVSnom=.;AAlength=4127;EXAC_AF=0.99995727;EXAC_Hom_EAS=4215;EXAC_AC_EAS=8430;EXAC_AN_EAS=8430;EXAC_AC_Adj=116999;EXAC_AN_Adj=117004;ESP6500_MAF=0.99922374;RS=rs11411516;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99996742;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=245532;gnomad_exomes_Hom=122762;gnomad_exomes_Het=8;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99993325;gnomad_exomes_AF_NFE=0.99995500;gnomad_exomes_AF_AMR=0.99994132;gnomad_exomes_AF_SAS=1.00000000;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=1.0;normalHomNum=388;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9975;patientHomNum=2765;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=TGGCCCCCGA.GTACAAGAGG	GT:AD:DP:GQ:PL	1/1:1,276:277:99:10529,852,0
chr8	48846519	.	T	C	11637.8	PASS	AC=2;AF=1;AN=2;DP=317;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.63;SOR=2.07;HGVSnom=NM_006904.7:c.1623+6A>G;Gene=PRKDC;Transcript=NM_006904.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_006904.7:IVS15+6A>G;AAlength=4127;EXAC_AF=0.95984731;EXAC_Hom_EAS=4310;EXAC_AC_EAS=8623;EXAC_AN_EAS=8626;EXAC_AC_Adj=115915;EXAC_AN_Adj=120764;ESP6500_MAF=0.96227040;RS=rs1231202;CLNGENE=PRKDC;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.983626;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9453;G1000_AFR_AF=0.9992;G1000_SAS_AF=0.9908;G1000_AMR_AF=0.9755;gnomad_exomes_AF=0.96071671;gnomad_exomes_AF_EAS=0.99966469;gnomad_exomes_AC=238227;gnomad_exomes_Hom=114530;gnomad_exomes_Het=9167;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99196267;gnomad_exomes_AF_NFE=0.94355741;gnomad_exomes_AF_AMR=0.97472256;gnomad_exomes_AF_SAS=0.99361884;normalHetFrequency=0.018;normalHetNum=7;normalHomFrequency=0.9356;normalHomNum=363;patientHetFrequency=0.0159;patientHetNum=44;patientHomFrequency=0.9325;patientHomNum=2585;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5142;GREP_score=-0.934;CytoBand=q11.21;CGD_CONDITION=Immunodeficiency 26 with or without neurologic abnormalities;CGD_INHERITANCE=AR;Strand=PRKDC:NM_001081640.1:-,PRKDC:NM_006904.6:-;NP=PRKDC:NM_001081640.1:NP_001075109.1,PRKDC:NM_006904.6:NP_008835.5;ENSP=PRKDC:NM_001081640.1:.,PRKDC:NM_006904.6:.;Gene_MIM_id=600899;Phenotypes=Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessive. 615966(MK);Possible_Inheritance=AR;EntrezGeneID=5591;EnsemblGeneID=ENSG00000253729;Alias=PRKDC, HYRC1, DNPK1, IMD26;FLKSEQ=CAATGGTAAA.GTTACCATCA	GT:AD:DP:GQ:PL	1/1:0,314:314:99:11666,944,0
chr8	90945485	.	C	T	2369.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.565;DP=149;ExcessHet=3.0103;FS=6.787;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.9;ReadPosRankSum=1.079;SOR=1.39;HGVSnom=.;Gene=NBN;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs2021881;G1000_AF=0.330272;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2962;G1000_AFR_AF=0.2799;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3141;NativeFreq_Het=0.5049;NativeFreq_Hom=0.0990;normalHetFrequency=0.4444;normalHetNum=212;normalHomFrequency=0.0763;normalHomNum=66;patientHetFrequency=0.4506;patientHetNum=1103;patientHomFrequency=0.0728;patientHomNum=380;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7423;GREP_score=0.235;CytoBand=q21.3;repName=Tigger5;repClass=DNA;FLKSEQ=gtcatgagta.atttaaggta	GT:AD:DP:GQ:PL	0/1:73,76:149:99:2398,0,2210
chr8	90945514	.	C	T	2974.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.545;DP=186;ExcessHet=3.0103;FS=2.945;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.99;ReadPosRankSum=-0.098;SOR=0.941;HGVSnom=.;Gene=NBN;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs2021882;G1000_AF=0.329872;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.2799;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3141;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1049;normalHetFrequency=0.4444;normalHetNum=212;normalHomFrequency=0.0763;normalHomNum=66;patientHetFrequency=0.451;patientHetNum=1104;patientHomFrequency=0.0728;patientHomNum=380;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6688;GREP_score=0.235;CytoBand=q21.3;repName=Tigger5;repClass=DNA;FLKSEQ=taagctatga.gtaggttaag	GT:AD:DP:GQ:PL	0/1:89,97:186:99:3003,0,2550
chr8	90945598	.	C	T	5052.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.313;DP=335;ExcessHet=3.0103;FS=4.34;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.08;ReadPosRankSum=-0.306;SOR=0.926;HGVSnom=NM_002485.5:c.*2212G>A;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs10464867;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0686901;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.0249;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0593;G1000_AMR_AF=0.1254;HGMD_gene=NBN;HGMD_disease=Gastric_cancer_decreased_risk_association_with;HGMD_tag=DP;HGMD_pmid=26402912;NativeFreq_Het=0.3366;NativeFreq_Hom=0.0198;normalHetFrequency=0.1318;normalHetNum=114;normalHomFrequency=0.0168;normalHomNum=8;patientHetFrequency=0.1034;patientHetNum=540;patientHomFrequency=0.0278;patientHomNum=68;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2736;AF_2700_Hom=0.0269;AF_50_Het=0.2758;AF_50_Hom=0.0206;DANN_score=0.2629;GREP_score=-0.721;CytoBand=q21.3;repName=Tigger5;repClass=DNA;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=gtaatcccaa.ttaaggagca	GT:AD:DP:GQ:PL	0/1:167,168:335:99:5081,0,5148
chr8	90945833	.	A	G	2777.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.23;DP=195;ExcessHet=3.0103;FS=0.574;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.24;ReadPosRankSum=0.717;SOR=0.606;HGVSnom=NM_002485.5:c.*1977T>C;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs14448;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.259385;G1000_EAS_AF=0.2431;G1000_EUR_AF=0.0586;G1000_AFR_AF=0.5136;G1000_SAS_AF=0.1789;G1000_AMR_AF=0.2032;NativeFreq_Het=0.3960;NativeFreq_Hom=0.0594;normalHetFrequency=0.3103;normalHetNum=148;normalHomFrequency=0.0273;normalHomNum=13;patientHetFrequency=0.1362;patientHetNum=711;patientHomFrequency=0.0445;patientHomNum=109;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3432;AF_2700_Hom=0.0430;AF_50_Het=0.3423;AF_50_Hom=0.0412;DANN_score=0.5223;GREP_score=-0.989;CytoBand=q21.3;repName=L1MC4a;repClass=LINE;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=accctgatcc.taattcacaa	GT:AD:DP:GQ:PL	0/1:99,96:195:99:2806,0,2961
chr8	90946056	.	A	G	3396.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.117;DP=216;ExcessHet=3.0103;FS=4.761;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.73;ReadPosRankSum=-0.676;SOR=1.012;HGVSnom=NM_002485.5:c.*1754T>C;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs9995;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.335463;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2972;G1000_AFR_AF=0.2965;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3184;NativeFreq_Het=0.5049;NativeFreq_Hom=0.0990;normalHetFrequency=0.2486;normalHetNum=215;normalHomFrequency=0.1363;normalHomNum=65;patientHetFrequency=0.2128;patientHetNum=1111;patientHomFrequency=0.154;patientHomNum=377;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4735;AF_2700_Hom=0.1476;AF_50_Het=0.4548;AF_50_Hom=0.1521;DANN_score=0.4007;GREP_score=-0.714;CytoBand=q21.3;repName=L1MC4a;repClass=LINE;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=atctcaatac.tatatccgac	GT:AD:DP:GQ:PL	0/1:98,118:216:99:3425,0,3011
chr8	90946118	.	T	C	3959.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.589;DP=275;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.4;ReadPosRankSum=0.467;SOR=0.704;HGVSnom=NM_002485.5:c.*1692A>G;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs13312986;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0694888;G1000_EAS_AF=0.1756;G1000_EUR_AF=0.0249;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0593;G1000_AMR_AF=0.1268;NativeFreq_Het=0.3366;NativeFreq_Hom=0.0198;normalHetFrequency=0.2369;normalHetNum=113;normalHomFrequency=0.0168;normalHomNum=8;patientHetFrequency=0.221;patientHetNum=541;patientHomFrequency=0.0278;patientHomNum=68;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2759;AF_2700_Hom=0.0265;AF_50_Het=0.2805;AF_50_Hom=0.0206;DANN_score=0.7025;GREP_score=-1.8;CytoBand=q21.3;repName=L1MC4a;repClass=LINE;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=caatTAtagc.atcagggata	GT:AD:DP:GQ:PL	0/1:155,120:275:99:3988,0,4784
chr8	90946601	.	T	G	7186.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.347;DP=421;ExcessHet=3.0103;FS=1.781;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.11;ReadPosRankSum=2.461;SOR=0.866;HGVSnom=NM_002485.5:c.*1209A>C;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs1063054;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.335264;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2962;G1000_AFR_AF=0.2965;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3184;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1080;normalHetFrequency=0.2497;normalHetNum=216;normalHomFrequency=0.1342;normalHomNum=64;patientHetFrequency=0.2138;patientHetNum=1116;patientHomFrequency=0.0722;patientHomNum=377;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4754;AF_2700_Hom=0.1468;AF_50_Het=0.4596;AF_50_Hom=0.1490;DANN_score=0.7142;GREP_score=0.132;CytoBand=q21.3;repName=LTR67B;repClass=LTR;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=CTCACCCAAt.tctgttccct	GT:AD:DP:GQ:PL	0/1:201,219:420:99:7215,0,6168
chr8	90947269	.	C	G	6061.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.748;DP=360;ExcessHet=3.0103;FS=6.293;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.84;ReadPosRankSum=1.384;SOR=1.005;HGVSnom=NM_002485.5:c.*541G>C;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs2735383;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.330272;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2962;G1000_AFR_AF=0.2799;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3141;HGMD_gene=NBN;HGMD_disease=Lung_cancer_increased_risk_association_with;HGMD_tag=DFP;HGMD_pmid=22114071;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1080;normalHetFrequency=0.2509;normalHetNum=217;normalHomFrequency=0.1342;normalHomNum=64;patientHetFrequency=0.2128;patientHetNum=1111;patientHomFrequency=0.0722;patientHomNum=377;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4758;AF_2700_Hom=0.1472;AF_50_Het=0.4596;AF_50_Hom=0.1490;DANN_score=0.7422;GREP_score=1.4;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TTAGGTAAGA.TACAGCATAA	GT:AD:DP:GQ:PL	0/1:170,190:360:99:6090,0,5328
chr8	90947537	.	C	T	5528.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.487;DP=368;ExcessHet=3.0103;FS=0.384;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.11;ReadPosRankSum=-2.232;SOR=0.666;HGVSnom=NM_002485.5:c.*273G>A;Gene=NBN;Transcript=NM_002485.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=754;RS=rs1063053;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.321885;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.2504;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3127;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1049;normalHetFrequency=0.3688;normalHetNum=319;normalHomFrequency=0.126;normalHomNum=109;patientHetFrequency=0.3429;patientHetNum=1790;patientHomFrequency=0.1414;patientHomNum=738;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4746;AF_2700_Hom=0.1468;AF_50_Het=0.4580;AF_50_Hom=0.1490;DANN_score=0.622;GREP_score=-0.893;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=ACCTTACGTA.ATTTAGAATT	GT:AD:DP:GQ:PL	0/1:182,184:366:99:5557,0,5865
chr8	90955624	.	T	A	5303.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.619;DP=327;ExcessHet=3.0103;FS=0.447;MLEAC=1;MLEAF=0.5;MQ=59.92;MQRankSum=0;QD=16.27;ReadPosRankSum=0.488;SOR=0.743;HGVSnom=NM_002485.5:c.2071-30A>T;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_002485.5:IVS13-30A>T;AAlength=754;EXAC_AF=0.35345527;EXAC_Hom_EAS=852;EXAC_AC_EAS=3819;EXAC_AN_EAS=8568;EXAC_AC_Adj=42708;EXAC_AN_Adj=120830;ESP6500_MAF=0.31393203;RS=rs3736639;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.379193;G1000_EAS_AF=0.4663;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.3132;G1000_SAS_AF=0.453;G1000_AMR_AF=0.3804;gnomad_exomes_AF=0.35387438;gnomad_exomes_AF_EAS=0.45614513;gnomad_exomes_AC=88533;gnomad_exomes_Hom=15857;gnomad_exomes_Het=56819;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32066626;gnomad_exomes_AF_NFE=0.32539655;gnomad_exomes_AF_AMR=0.35393552;gnomad_exomes_AF_SAS=0.42900144;NativeFreq_Het=0.5544;NativeFreq_Hom=0.1683;normalHetFrequency=0.4428;normalHetNum=383;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.454;patientHetNum=2370;patientHomFrequency=0.1743;patientHomNum=910;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4862;AF_2700_Hom=0.1772;AF_50_Het=0.4770;AF_50_Hom=0.1791;DANN_score=0.3837;GREP_score=-0.0305;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=GTACAGTAAA.CATATTAACA	GT:AD:DP:GQ:PL	0/1:148,178:326:99:5332,0,4271
chr8	90958422	.	T	C	9331.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.552;DP=621;ExcessHet=3.0103;FS=0.518;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.08;ReadPosRankSum=-0.107;SOR=0.762;HGVSnom=NM_002485.5:c.2016A>G(p.Pro672Pro/p.P672P);Gene=NBN;Transcript=NM_002485.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=754;EXAC_AF=0.34505380;EXAC_Hom_EAS=859;EXAC_AC_EAS=3838;EXAC_AN_EAS=8636;EXAC_AC_Adj=41815;EXAC_AN_Adj=121184;ESP6500_MAF=0.28418705;RS=rs1061302;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.352835;G1000_EAS_AF=0.4673;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.2156;G1000_SAS_AF=0.4519;G1000_AMR_AF=0.3761;gnomad_exomes_AF=0.34672065;gnomad_exomes_AF_EAS=0.45612223;gnomad_exomes_AC=87004;gnomad_exomes_Hom=15425;gnomad_exomes_Het=56154;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22977466;gnomad_exomes_AF_NFE=0.32495812;gnomad_exomes_AF_AMR=0.34916314;gnomad_exomes_AF_SAS=0.42845002;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1683;normalHetFrequency=0.4428;normalHetNum=383;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.4525;patientHetNum=2362;patientHomFrequency=0.1747;patientHomNum=912;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4858;AF_2700_Hom=0.1783;AF_50_Het=0.4754;AF_50_Hom=0.1807;DANN_score=0.4262;GREP_score=-7.33;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TTATGCCAGA.GGATTTCTGG	GT:AD:DP:GQ:PL	0/1:296,323:619:99:9360,0,8946
chr8	90958530	.	T	C	7524.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.832;DP=593;ExcessHet=3.0103;FS=1.131;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.78;ReadPosRankSum=1.711;SOR=0.826;HGVSnom=NM_002485.5:c.1915-7A>G;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_002485.5:IVS12-7A>G;AAlength=754;EXAC_AF=0.35293486;EXAC_Hom_EAS=861;EXAC_AC_EAS=3839;EXAC_AN_EAS=8642;EXAC_AC_Adj=42751;EXAC_AN_Adj=121130;ESP6500_MAF=0.31313442;RS=rs2308962;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.378994;G1000_EAS_AF=0.4673;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.3124;G1000_SAS_AF=0.4519;G1000_AMR_AF=0.3804;gnomad_exomes_AF=0.35349125;gnomad_exomes_AF_EAS=0.45611746;gnomad_exomes_AC=88645;gnomad_exomes_Hom=15892;gnomad_exomes_Het=56861;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31862806;gnomad_exomes_AF_NFE=0.32531989;gnomad_exomes_AF_AMR=0.35388577;gnomad_exomes_AF_SAS=0.42781483;NativeFreq_Het=0.5643;NativeFreq_Hom=0.1683;normalHetFrequency=0.4382;normalHetNum=379;normalHomFrequency=0.1896;normalHomNum=164;patientHetFrequency=0.4513;patientHetNum=2356;patientHomFrequency=0.1757;patientHomNum=917;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4881;AF_2700_Hom=0.1764;AF_50_Het=0.4786;AF_50_Hom=0.1791;dbscSNV_RF_score=0.036;dbscSNV_ADA_score=0.00003018;DANN_score=0.302;GREP_score=-10.9;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TGTTCTTAAA.GGGGTTAAGA	GT:AD:DP:GQ:PL	0/1:317,272:589:99:7553,0,9535
chr8	90967711	.	A	G	9916.77	PASS	AC=2;AF=1;AN=2;DP=279;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.68;SOR=1.601;HGVSnom=NM_002485.5:c.1197T>C(p.Asp399Asp/p.D399D);Gene=NBN;Transcript=NM_002485.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E10;IVSnom=.;AAlength=754;EXAC_AF=0.46758953;EXAC_Hom_EAS=1809;EXAC_AC_EAS=5576;EXAC_AN_EAS=8624;EXAC_AC_Adj=56612;EXAC_AN_Adj=121072;ESP6500_MAF=0.49031067;RS=rs709816;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.608626;G1000_EAS_AF=0.6647;G1000_EUR_AF=0.341;G1000_AFR_AF=0.8533;G1000_SAS_AF=0.5337;G1000_AMR_AF=0.5548;gnomad_exomes_AF=0.46522415;gnomad_exomes_AF_EAS=0.64804135;gnomad_exomes_AC=116748;gnomad_exomes_Hom=29197;gnomad_exomes_Het=58354;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.77811344;gnomad_exomes_AF_NFE=0.36250573;gnomad_exomes_AF_AMR=0.57730196;gnomad_exomes_AF_SAS=0.51147359;NativeFreq_Het=0.5154;NativeFreq_Hom=0.3762;normalHetFrequency=0.4104;normalHetNum=355;normalHomFrequency=0.3572;normalHomNum=309;patientHetFrequency=0.4435;patientHetNum=2315;patientHomFrequency=0.3395;patientHomNum=1772;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4616;AF_2700_Hom=0.3905;AF_50_Het=0.4580;AF_50_Hom=0.3899;DANN_score=0.2653;GREP_score=-1.6;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=CAGTGGGTGC.TCTTGTGAAA	GT:AD:DP:GQ:PL	1/1:0,279:279:99:9945,839,0
chr8	90967862	.	G	T	1250.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.195;DP=91;ExcessHet=3.0103;FS=1.39;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.74;ReadPosRankSum=2.579;SOR=1.128;HGVSnom=NM_002485.5:c.1125-79C>A;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_002485.5:IVS9-79C>A;AAlength=754;RS=rs1805786;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.3752;G1000_EAS_AF=0.4673;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.2973;G1000_SAS_AF=0.453;G1000_AMR_AF=0.3804;NativeFreq_Het=0.4722;NativeFreq_Hom=0.1358;normalHetFrequency=0.437;normalHetNum=378;normalHomFrequency=0.1873;normalHomNum=162;patientHetFrequency=0.4479;patientHetNum=2338;patientHomFrequency=0.1762;patientHomNum=920;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2925;GREP_score=3.49;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TCGTTAAATA.TTCTAACGTA	GT:AD:DP:GQ:PL	0/1:51,40:91:99:1279,0,1620
chr8	90970862	.	G	T	2272.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.099;DP=157;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.57;ReadPosRankSum=-0.236;SOR=0.758;HGVSnom=NM_002485.5:c.1124+91C>A;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_002485.5:IVS9+91C>A;AAlength=754;RS=rs1805818;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.375;G1000_EAS_AF=0.4663;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.2973;G1000_SAS_AF=0.453;G1000_AMR_AF=0.3804;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1683;normalHetFrequency=0.4358;normalHetNum=377;normalHomFrequency=0.1873;normalHomNum=162;patientHetFrequency=0.45;patientHetNum=2349;patientHomFrequency=0.1762;patientHomNum=920;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7762;GREP_score=3.07;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TCTCTCTCAA.AGACAACCTG	GT:AD:DP:GQ:PL	0/1:80,76:156:99:2301,0,2780
chr8	90970935	.	G	A	4891.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.198;DP=346;ExcessHet=3.0103;FS=3.599;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.14;ReadPosRankSum=0.12;SOR=0.93;HGVSnom=NM_002485.5:c.1124+18C>T;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_002485.5:IVS9+18C>T;AAlength=754;EXAC_AF=0.34458791;EXAC_Hom_EAS=858;EXAC_AC_EAS=3836;EXAC_AN_EAS=8642;EXAC_AC_Adj=41793;EXAC_AN_Adj=121284;ESP6500_MAF=0.28448408;RS=rs2234744;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.353035;G1000_EAS_AF=0.4663;G1000_EUR_AF=0.3072;G1000_AFR_AF=0.2156;G1000_SAS_AF=0.453;G1000_AMR_AF=0.3761;gnomad_exomes_AF=0.34653907;gnomad_exomes_AF_EAS=0.45589515;gnomad_exomes_AC=87052;gnomad_exomes_Hom=15426;gnomad_exomes_Het=56200;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22972807;gnomad_exomes_AF_NFE=0.32496435;gnomad_exomes_AF_AMR=0.34889378;gnomad_exomes_AF_SAS=0.42793676;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1683;normalHetFrequency=0.4428;normalHetNum=383;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.4538;patientHetNum=2369;patientHomFrequency=0.1736;patientHomNum=906;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4865;AF_2700_Hom=0.1760;AF_50_Het=0.4770;AF_50_Hom=0.1791;DANN_score=0.4661;GREP_score=-7.37;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=CAATAGTACG.TAATGAAGAA	GT:AD:DP:GQ:PL	0/1:181,165:346:99:4920,0,5638
chr8	90982510	.	T	C	1817.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.3;DP=125;ExcessHet=3.0103;FS=3.066;MLEAC=1;MLEAF=0.5;MQ=59.95;MQRankSum=-1.059;QD=14.54;ReadPosRankSum=-0.979;SOR=1.075;HGVSnom=NM_002485.5:c.896+82A>G;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_002485.5:IVS7+82A>G;AAlength=754;DANN_score=0.6265;GREP_score=3.47;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TACTTTTACA.TGTTAGGTGA	GT:AD:DP:GQ:PL	0/1:67,58:125:99:1846,0,2149
chr8	90982556	.	C	T	2535.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.383;DP=171;ExcessHet=3.0103;FS=1.374;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.83;ReadPosRankSum=1.177;SOR=0.856;HGVSnom=NM_002485.5:c.896+36G>A;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_002485.5:IVS7+36G>A;AAlength=754;EXAC_AF=0.06746025;EXAC_Hom_EAS=154;EXAC_AC_EAS=1620;EXAC_AN_EAS=8278;EXAC_AC_Adj=7917;EXAC_AN_Adj=117358;ESP6500_MAF=0.02469611;RS=rs1805826;CLNGENE=NBN;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0742812;G1000_EAS_AF=0.1865;G1000_EUR_AF=0.0278;G1000_AFR_AF=0.003;G1000_SAS_AF=0.0695;G1000_AMR_AF=0.121;gnomad_exomes_AF=0.07117720;gnomad_exomes_AF_EAS=0.18144806;gnomad_exomes_AC=17475;gnomad_exomes_Hom=1222;gnomad_exomes_Het=15031;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00954918;gnomad_exomes_AF_NFE=0.02908223;gnomad_exomes_AF_AMR=0.19594316;gnomad_exomes_AF_SAS=0.06822148;NativeFreq_Het=0.3457;NativeFreq_Hom=0.0370;normalHetFrequency=0.2405;normalHetNum=208;normalHomFrequency=0.0231;normalHomNum=20;patientHetFrequency=0.2339;patientHetNum=1221;patientHomFrequency=0.0289;patientHomNum=151;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4965;GREP_score=-3.13;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=AAATCTCCTA.TTGCAGTTTT	GT:AD:DP:GQ:PL	0/1:90,81:171:99:2564,0,3011
chr8	90982803	.	C	T	5027.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.386;DP=333;ExcessHet=3.0103;FS=4.817;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.14;ReadPosRankSum=-0.437;SOR=0.985;HGVSnom=NM_002485.5:c.703-18G>A;Gene=NBN;Transcript=NM_002485.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_002485.5:IVS6-18G>A;AAlength=754;EXAC_AF=0.06823853;EXAC_Hom_EAS=154;EXAC_AC_EAS=1634;EXAC_AN_EAS=8270;EXAC_AC_Adj=7930;EXAC_AN_Adj=116210;ESP6500_MAF=0.02446530;RS=rs769418;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0742812;G1000_EAS_AF=0.1865;G1000_EUR_AF=0.0278;G1000_AFR_AF=0.003;G1000_SAS_AF=0.0695;G1000_AMR_AF=0.121;gnomad_exomes_AF=0.07157394;gnomad_exomes_AF_EAS=0.18191268;gnomad_exomes_AC=17795;gnomad_exomes_Hom=1243;gnomad_exomes_Het=15309;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00913536;gnomad_exomes_AF_NFE=0.02922888;gnomad_exomes_AF_AMR=0.19645242;gnomad_exomes_AF_SAS=0.06856582;NativeFreq_Het=0.3519;NativeFreq_Hom=0.0340;normalHetFrequency=0.2416;normalHetNum=209;normalHomFrequency=0.022;normalHomNum=19;patientHetFrequency=0.2341;patientHetNum=1222;patientHomFrequency=0.0285;patientHomNum=149;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3140;AF_2700_Hom=0.0292;AF_50_Het=0.3043;AF_50_Hom=0.0301;DANN_score=0.5097;GREP_score=-2.22;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TGGAAGGAAA.ATTTTTTAAA	GT:AD:DP:GQ:PL	0/1:168,164:332:99:5056,0,5371
chr8	90990479	.	C	G	3831.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.106;DP=326;ExcessHet=3.0103;FS=11.738;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.75;ReadPosRankSum=-1.398;SOR=1.185;HGVSnom=NM_002485.5:c.553G>C(p.Glu185Gln/p.E185Q);Gene=NBN;Transcript=NM_002485.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=754;EXAC_AF=0.34526774;EXAC_Hom_EAS=858;EXAC_AC_EAS=3838;EXAC_AN_EAS=8648;EXAC_AC_Adj=41872;EXAC_AN_Adj=121274;ESP6500_MAF=0.28656005;RS=rs1805794;Ensembl_transcriptid=ENST00000265433|ENST00000409330|ENST00000517772;SIFT_pred=T|T|T;SIFT_score=1.0|1.0|1.0;Polyphen2_HVAR_pred=B|.|.;Polyphen2_HVAR_score=0.001|.|.;MutationTaster_pred=P|P;MutationTaster_score=0.999972|0.999972;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.357029;G1000_EAS_AF=0.4673;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.2307;G1000_SAS_AF=0.453;G1000_AMR_AF=0.3761;gnomad_exomes_AF=0.34695064;gnomad_exomes_AF_EAS=0.45622145;gnomad_exomes_AC=87154;gnomad_exomes_Hom=15452;gnomad_exomes_Het=56250;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23626171;gnomad_exomes_AF_NFE=0.32460867;gnomad_exomes_AF_AMR=0.34945023;gnomad_exomes_AF_SAS=0.42810458;HGMD_gene=NBN;HGMD_disease=Lung_cancer_association_with;HGMD_tag=DP;HGMD_pmid=12917199;NativeFreq_Het=0.5643;NativeFreq_Hom=0.1683;normalHetFrequency=0.4416;normalHetNum=382;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.4525;patientHetNum=2362;patientHomFrequency=0.1739;patientHomNum=908;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4873;AF_2700_Hom=0.1768;AF_50_Het=0.4770;AF_50_Hom=0.1791;DANN_score=0.1463;GREP_score=3.08;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=TTCTTGGACT.AACTGCTTTC	GT:AD:DP:GQ:PL	0/1:202,124:326:99:3860,0,6483
chr8	90995019	.	C	T	5473.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.894;DP=380;ExcessHet=3.0103;FS=1.669;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.4;ReadPosRankSum=0.366;SOR=0.602;HGVSnom=NM_002485.5:c.102G>A(p.Leu34Leu/p.L34L);Gene=NBN;Transcript=NM_002485.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=754;EXAC_AF=0.35271631;EXAC_Hom_EAS=862;EXAC_AC_EAS=3845;EXAC_AN_EAS=8648;EXAC_AC_Adj=42812;EXAC_AN_Adj=121378;ESP6500_MAF=0.31316316;RS=rs1063045;CLNGENE=NBN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.379193;G1000_EAS_AF=0.4673;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.3124;G1000_SAS_AF=0.4519;G1000_AMR_AF=0.3818;gnomad_exomes_AF=0.35351233;gnomad_exomes_AF_EAS=0.45634446;gnomad_exomes_AC=88873;gnomad_exomes_Hom=15941;gnomad_exomes_Het=56991;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31844469;gnomad_exomes_AF_NFE=0.32529241;gnomad_exomes_AF_AMR=0.35395467;gnomad_exomes_AF_SAS=0.42829141;NativeFreq_Het=0.5643;NativeFreq_Hom=0.1683;normalHetFrequency=0.4439;normalHetNum=384;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.4531;patientHetNum=2365;patientHomFrequency=0.1749;patientHomNum=913;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4873;AF_2700_Hom=0.1768;AF_50_Het=0.4786;AF_50_Hom=0.1791;DANN_score=0.8847;GREP_score=0.564;CytoBand=q21.3;CGD_CONDITION=Breast cancer, susceptibility to. Nijmegen breakage syndrome;CGD_INHERITANCE=AD/AR;Strand=NBN:NM_002485.4:-,NBN:NM_001024688.2:-;NP=NBN:NM_002485.4:NP_002476.2,NBN:NM_001024688.2:NP_001019859.1;ENSP=NBN:NM_002485.4:ENST00000265433.7,NBN:NM_001024688.2:.;Gene_MIM_id=602667;Phenotypes=Aplastic anemia, 609135 (3). Leukemia, acute lymphoblastic, 613065 (3). Nijmegen breakage syndrome, 251260 (3), Autosomal recessive. 251260(MK),609135(MK),613065(MK);Possible_Inheritance=AR;EntrezGeneID=4683;EnsemblGeneID=ENSG00000104320;Alias=NBN, NBS1;FLKSEQ=CATTTTCAAT.AGAATGGCAC	GT:AD:DP:GQ:PL	0/1:203,177:380:99:5502,0,6678
chr8	95419698	.	A	G	5800.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.404;DP=417;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.94;ReadPosRankSum=-1.097;SOR=0.689;HGVSnom=NM_012415.3:c.750T>C(p.Asn250Asn/p.N250N);Gene=RAD54B;Transcript=NM_012415.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E5;IVSnom=.;AAlength=910;EXAC_AF=0.41251114;EXAC_Hom_EAS=936;EXAC_AC_EAS=4035;EXAC_AN_EAS=8636;EXAC_AC_Adj=49998;EXAC_AN_Adj=121204;ESP6500_MAF=0.36114101;RS=rs2291439;CLNGENE=RAD54B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.418131;G1000_EAS_AF=0.4663;G1000_EUR_AF=0.3777;G1000_AFR_AF=0.3517;G1000_SAS_AF=0.4162;G1000_AMR_AF=0.536;gnomad_exomes_AF=0.41956021;gnomad_exomes_AF_EAS=0.47169914;gnomad_exomes_AC=105245;gnomad_exomes_Hom=23060;gnomad_exomes_Het=59125;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34373461;gnomad_exomes_AF_NFE=0.37503528;gnomad_exomes_AF_AMR=0.59501711;gnomad_exomes_AF_SAS=0.41868297;NativeFreq_Het=0.5374;NativeFreq_Hom=0.1708;DANN_score=0.8488;GREP_score=2.72;CytoBand=q22.1;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10;Gene_MIM_id=604289;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK);Possible_Inheritance=AD;EntrezGeneID=25788;EnsemblGeneID=ENSG00000197275;Alias=RAD54B;FLKSEQ=GTGGTTTGCA.TTTTGGAAAT	GT:AD:DP:GQ:PL	0/1:229,187:416:99:5829,0,6999
chr8	95440159	.	TA	T	1840.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.058;DP=183;ExcessHet=3.0103;FS=2.817;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.34;ReadPosRankSum=0.254;SOR=0.499;HGVSnom=NM_012415.3:c.305-16617delT|NM_001256141.2:c.*4199delT;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-16617delT|.;AAlength=910|299;RS=rs80311026;CytoBand=q22.1;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=AATGACTCCT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:90,88:178:99:1878,0,1674
chr8	95440423	.	T	C	2629.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.851;DP=196;ExcessHet=3.0103;FS=2.6;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.49;ReadPosRankSum=0.006;SOR=0.892;HGVSnom=NM_012415.3:c.305-16880A>G|NM_001256141.2:c.*3936A>G;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-16880A>G|.;AAlength=910|299;RS=rs3019277;G1000_AF=0.264976;G1000_EAS_AF=0.4335;G1000_EUR_AF=0.337;G1000_AFR_AF=0.0197;G1000_SAS_AF=0.2924;G1000_AMR_AF=0.3444;DANN_score=0.7943;GREP_score=-0.174;CytoBand=q22.1;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=ATATACTTAG.ATATTTATCA	GT:AD:DP:GQ:PL	0/1:110,85:195:99:2658,0,3368
chr8	95440553	.	A	G	4096.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.68;DP=299;ExcessHet=3.0103;FS=13.161;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.75;ReadPosRankSum=0.152;SOR=0.527;HGVSnom=NM_012415.3:c.305-17010T>C|NM_001256141.2:c.*3806T>C;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-17010T>C|.;AAlength=910|299;RS=rs2930958;G1000_AF=0.419529;G1000_EAS_AF=0.4603;G1000_EUR_AF=0.3887;G1000_AFR_AF=0.3517;G1000_SAS_AF=0.4182;G1000_AMR_AF=0.536;DANN_score=0.6678;GREP_score=-3.83;CytoBand=q22.1;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=ATTGTCTATG.TATGCAAGAT	GT:AD:DP:GQ:PL	0/1:157,141:298:99:4125,0,4508
chr8	95440659	.	C	T	2408.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.855;DP=168;ExcessHet=3.0103;FS=2.637;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.34;ReadPosRankSum=-0.324;SOR=0.98;HGVSnom=NM_012415.3:c.305-17116G>A|NM_001256141.2:c.*3700G>A;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-17116G>A|.;AAlength=910|299;RS=rs2515109;G1000_AF=0.16893;G1000_EAS_AF=0.3313;G1000_EUR_AF=0.0338;G1000_AFR_AF=0.2179;G1000_SAS_AF=0.1524;G1000_AMR_AF=0.0591;DANN_score=0.8418;GREP_score=-0.367;CytoBand=q22.1;repName=MER2;repClass=DNA;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=atactcaagt.ccttatataa	GT:AD:DP:GQ:PL	0/1:89,79:168:99:2437,0,2710
chr8	95442538	.	CA	C	1072.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.046;DP=169;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.45;ReadPosRankSum=-0.47;SOR=0.633;HGVSnom=NM_012415.3:c.305-18996delT|NM_001256141.2:c.*1820delT;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-18996delT|.;AAlength=910|299;RS=rs60634729;CytoBand=q22.1;repName=AluSc8;repClass=SINE;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=gactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:59,85:144:99:1110,0,739
chr8	95443490	.	G	C	1441.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.59;DP=129;ExcessHet=3.0103;FS=8.653;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.35;ReadPosRankSum=-0.667;SOR=1.429;HGVSnom=NM_012415.3:c.305-19947C>G|NM_001256141.2:c.*869C>G;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-19947C>G|.;AAlength=910|299;RS=rs2450248;G1000_AF=0.16893;G1000_EAS_AF=0.3313;G1000_EUR_AF=0.0338;G1000_AFR_AF=0.2179;G1000_SAS_AF=0.1524;G1000_AMR_AF=0.0591;DANN_score=0.6004;GREP_score=-1.08;CytoBand=q22.1;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=TCCAGAACAG.ACATTCAAAA	GT:AD:DP:GQ:PL	0/1:80,47:127:99:1470,0,2582
chr8	95443806	.	T	C	5793.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.369;DP=450;ExcessHet=3.0103;FS=2.486;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.96;ReadPosRankSum=0.437;SOR=0.525;HGVSnom=NM_012415.3:c.305-20263A>G|NM_001256141.2:c.*553A>G;Gene=RAD54B|FSBP;Transcript=NM_012415.3|NM_001256141.2;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I3|E2;IVSnom=NM_012415.3:IVS3-20263A>G|.;AAlength=910|299;RS=rs2930961;G1000_AF=0.403155;G1000_EAS_AF=0.4603;G1000_EUR_AF=0.3618;G1000_AFR_AF=0.3464;G1000_SAS_AF=0.3978;G1000_AMR_AF=0.4957;DANN_score=0.6851;GREP_score=-8.29;CytoBand=q22.1;repName=MIR3;repClass=SINE;Strand=RAD54B:NM_001205263.1:-,RAD54B:NM_012415.3:-,FSBP:NM_001256141.1:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_001205263.1:NP_001192192.1,RAD54B:NM_012415.3:NP_036547.1,FSBP:NM_001256141.1:NP_001243070.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_001205263.1:.,RAD54B:NM_012415.3:ENST00000336148.10,FSBP:NM_001256141.1:.,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289,616306;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK),.;Possible_Inheritance=AD,NA;EntrezGeneID=25788,100861412;EnsemblGeneID=ENSG00000197275,ENSG00000265817;Alias=RAD54B,FSBP;FLKSEQ=aagtaagtca.tgagttctcc	GT:AD:DP:GQ:PL	0/1:258,189:447:99:5822,0,8025
chr8	95470697	.	C	A	3303.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.634;DP=225;ExcessHet=3.0103;FS=2.975;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.68;ReadPosRankSum=-0.41;SOR=1.072;HGVSnom=NM_012415.3:c.136-33G>T;Gene=RAD54B;Transcript=NM_012415.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_012415.3:IVS2-33G>T;AAlength=910;EXAC_AF=0.42673986;EXAC_Hom_EAS=855;EXAC_AC_EAS=3798;EXAC_AN_EAS=8180;EXAC_AC_Adj=47497;EXAC_AN_Adj=111302;ESP6500_MAF=0.38808162;RS=rs2919660;CLNGENE=RAD54B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.441693;G1000_EAS_AF=0.4603;G1000_EUR_AF=0.3897;G1000_AFR_AF=0.4274;G1000_SAS_AF=0.4192;G1000_AMR_AF=0.549;gnomad_exomes_AF=0.41906176;gnomad_exomes_AF_EAS=0.46426935;gnomad_exomes_AC=74215;gnomad_exomes_Hom=15814;gnomad_exomes_Het=42587;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42461144;gnomad_exomes_AF_NFE=0.37719630;gnomad_exomes_AF_AMR=0.59738372;gnomad_exomes_AF_SAS=0.42165562;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1815;DANN_score=0.3883;GREP_score=0.248;CytoBand=q22.1;Strand=RAD54B:NM_012415.3:-,RAD54B:NM_001205262.2:-;NP=RAD54B:NM_012415.3:NP_036547.1,RAD54B:NM_001205262.2:NP_001192191.1;ENSP=RAD54B:NM_012415.3:ENST00000336148.10,RAD54B:NM_001205262.2:.;Gene_MIM_id=604289;Phenotypes=Colon cancer, somatic, 114500 (3). Lymphoma, non-Hodgkin, somatic, 605027 (3). 114500(MK),605027(MK);Possible_Inheritance=AD;EntrezGeneID=25788;EnsemblGeneID=ENSG00000197275;Alias=RAD54B;FLKSEQ=TAAATCAGAA.TCAAACCTAA	GT:AD:DP:GQ:PL	0/1:115,110:225:99:3332,0,3813
chr8	118811806	.	CT	C	285.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.324;DP=485;ExcessHet=3.0103;FS=2.523;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.65;ReadPosRankSum=-1.99;SOR=0.914;HGVSnom=NM_000127.3:c.*144delA;Gene=EXT1;Transcript=NM_000127.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=746;RS=rs71739430;CLNGENE=EXT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0743;NativeFreq_Hom=.;normalHetFrequency=0.4069;normalHetNum=352;normalHomFrequency=0.0208;normalHomNum=18;patientHetFrequency=0.4023;patientHetNum=2100;patientHomFrequency=0.0268;patientHomNum=140;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2598;AF_2700_Hom=0.0077;AF_50_Het=0.2599;AF_50_Hom=0.0079;CytoBand=q24.11;CGD_CONDITION=Exostoses, multiple, type 1;CGD_INHERITANCE=AD;Strand=EXT1:NM_000127.2:-;NP=EXT1:NM_000127.2:NP_000118.2;ENSP=EXT1:NM_000127.2:ENST00000378204.6;Gene_MIM_id=608177;Phenotypes=Chondrosarcoma, 215300 (3), Autosomal recessive. Exostoses, multiple, type 1, 133700 (3), Autosomal dominant. 133700(MK),215300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2131;EnsemblGeneID=ENSG00000182197;Alias=EXT1;FLKSEQ=TCTCATTGGC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:376,64:440:99:323,0,8336
chr8	118847885	.	T	C	4546.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.758;DP=264;ExcessHet=3.0103;FS=3.173;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.22;ReadPosRankSum=0.006;SOR=0.49;HGVSnom=NM_000127.3:c.1057-95A>G;Gene=EXT1;Transcript=NM_000127.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000127.3:IVS2-95A>G;AAlength=746;RS=rs117101751;G1000_AF=0.00738818;G1000_EAS_AF=0.0357;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0;NativeFreq_Het=0.0410;NativeFreq_Hom=0;normalHetFrequency=0.0277;normalHetNum=24;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0318;patientHetNum=166;patientHomFrequency=0.0017;patientHomNum=9;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0001885-1|16D0067265|16B3108660][15B0060295|16D0067183|15B0032871|16B0033898|15S0044949|15B0032863];DANN_score=0.4368;GREP_score=0.938;CytoBand=q24.11;CGD_CONDITION=Exostoses, multiple, type 1;CGD_INHERITANCE=AD;Strand=EXT1:NM_000127.2:-;NP=EXT1:NM_000127.2:NP_000118.2;ENSP=EXT1:NM_000127.2:ENST00000378204.6;Gene_MIM_id=608177;Phenotypes=Chondrosarcoma, 215300 (3), Autosomal recessive. Exostoses, multiple, type 1, 133700 (3), Autosomal dominant. 133700(MK),215300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=2131;EnsemblGeneID=ENSG00000182197;Alias=EXT1;FLKSEQ=ATGACTGGCA.TTTTGACACT	GT:AD:DP:GQ:PL	0/1:128,136:264:99:4575,0,4015
chr8	143310815	.	G	A	4090.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.911;DP=261;ExcessHet=3.0103;FS=0.977;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.67;ReadPosRankSum=-1.108;SOR=0.774;HGVSnom=NM_145003.5:c.*11+19C>T;Gene=TSNARE1;Transcript=NM_145003.5;VarType=Intron;MolecularConsequence=3_prime_UTR_intron_variant;ExonIntron=I13;IVSnom=NM_145003.5:IVS13+19C>T;AAlength=513;EXAC_AF=0.49658706;EXAC_Hom_EAS=1129;EXAC_AC_EAS=4404;EXAC_AN_EAS=8618;EXAC_AC_Adj=60092;EXAC_AN_Adj=121010;ESP6500_MAF=0.47293557;RS=rs11167136;G1000_AF=0.535144;G1000_EAS_AF=0.495;G1000_EUR_AF=0.4314;G1000_AFR_AF=0.5681;G1000_SAS_AF=0.6115;G1000_AMR_AF=0.5735;gnomad_exomes_AF=0.49690283;gnomad_exomes_AF_EAS=0.50631464;gnomad_exomes_AC=124660;gnomad_exomes_Hom=31793;gnomad_exomes_Het=61074;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55046833;gnomad_exomes_AF_NFE=0.43257684;gnomad_exomes_AF_AMR=0.60346626;gnomad_exomes_AF_SAS=0.62494281;NativeFreq_Het=0.4947;NativeFreq_Hom=0.2456;DANN_score=0.3031;GREP_score=1.76;CytoBand=q24.3;Strand=TSNARE1:NM_145003.4:-;NP=TSNARE1:NM_145003.4:NP_659440.2;ENSP=TSNARE1:NM_145003.4:.;FLKSEQ=gatggTGTAC.GGTAGGTGGG	GT:AD:DP:GQ:PL	0/1:122,139:261:99:4119,0,3099
chr8	145737040	.	C	T	2691.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.326;DP=209;ExcessHet=3.0103;FS=0.515;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.88;ReadPosRankSum=-0.177;SOR=0.62;HGVSnom=NM_004260.4:c.3502+24G>A;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_004260.4:IVS20+24G>A;AAlength=1208;EXAC_AF=0.46396149;EXAC_Hom_EAS=1005;EXAC_AC_EAS=4100;EXAC_AN_EAS=8426;EXAC_AC_Adj=54174;EXAC_AN_Adj=116764;ESP6500_MAF=0.34600066;RS=rs2279243;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.393171;G1000_EAS_AF=0.5248;G1000_EUR_AF=0.4543;G1000_AFR_AF=0.0545;G1000_SAS_AF=0.5798;G1000_AMR_AF=0.4957;gnomad_exomes_AF=0.47124808;gnomad_exomes_AF_EAS=0.48485868;gnomad_exomes_AC=115403;gnomad_exomes_Hom=28587;gnomad_exomes_Het=58229;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10629446;gnomad_exomes_AF_NFE=0.46376627;gnomad_exomes_AF_AMR=0.55741710;gnomad_exomes_AF_SAS=0.56488575;NativeFreq_Het=0.5544;NativeFreq_Hom=0.1852;normalHetFrequency=0.4462;normalHetNum=386;normalHomFrequency=0.2393;normalHomNum=207;patientHetFrequency=0.4596;patientHetNum=2399;patientHomFrequency=0.2274;patientHomNum=1187;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4816;AF_2700_Hom=0.2183;AF_50_Het=0.4643;AF_50_Hom=0.2092;DANN_score=0.6566;GREP_score=-8.65;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=CAGCCTGCAG.GGGTGGGGCC	GT:AD:DP:GQ:PL	0/1:115,94:209:99:2720,0,3346
chr8	145737286	.	G	A	4070.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.828;DP=269;ExcessHet=3.0103;FS=0.442;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.19;ReadPosRankSum=1.92;SOR=0.662;HGVSnom=NM_004260.4:c.3393+8C>T;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_004260.4:IVS19+8C>T;AAlength=1208;EXAC_AF=0.46696222;EXAC_Hom_EAS=1033;EXAC_AC_EAS=4182;EXAC_AN_EAS=8528;EXAC_AC_Adj=55194;EXAC_AN_Adj=118198;ESP6500_MAF=0.34996876;RS=rs756627;Ensembl_transcriptid=ENST00000531875;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=.;MutationTaster_score=.;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.400559;G1000_EAS_AF=0.5357;G1000_EUR_AF=0.4463;G1000_AFR_AF=0.0772;G1000_SAS_AF=0.5828;G1000_AMR_AF=0.4971;gnomad_exomes_AF=0.47576470;gnomad_exomes_AF_EAS=0.49307804;gnomad_exomes_AC=116530;gnomad_exomes_Hom=28974;gnomad_exomes_Het=58582;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12910829;gnomad_exomes_AF_NFE=0.46981601;gnomad_exomes_AF_AMR=0.56046931;gnomad_exomes_AF_SAS=0.56724917;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1944;normalHetFrequency=0.4636;normalHetNum=401;normalHomFrequency=0.2324;normalHomNum=201;patientHetFrequency=0.4699;patientHetNum=2453;patientHomFrequency=0.2266;patientHomNum=1183;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4919;AF_2700_Hom=0.2198;AF_50_Het=0.4754;AF_50_Hom=0.2108;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00003801;DANN_score=0.6025;GREP_score=-1.53;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=TGGCCTTACT.CACTCACTCT	GT:AD:DP:GQ:PL	0/1:130,138:268:99:4099,0,3949
chr8	145737514	.	G	A	2811.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.16;DP=208;ExcessHet=3.0103;FS=4.785;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.65;ReadPosRankSum=-1.641;SOR=1;HGVSnom=NM_004260.4:c.3236+13C>T;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_004260.4:IVS18+13C>T;AAlength=1208;EXAC_AF=0.50634197;EXAC_Hom_EAS=769;EXAC_AC_EAS=3396;EXAC_AN_EAS=7154;EXAC_AC_Adj=49341;EXAC_AN_Adj=97446;ESP6500_MAF=0.39324547;RS=rs4244610;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.433307;G1000_EAS_AF=0.503;G1000_EUR_AF=0.4592;G1000_AFR_AF=0.211;G1000_SAS_AF=0.5808;G1000_AMR_AF=0.5101;gnomad_exomes_AF=0.48975699;gnomad_exomes_AF_EAS=0.46541770;gnomad_exomes_AC=112458;gnomad_exomes_Hom=28014;gnomad_exomes_Het=56430;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24712904;gnomad_exomes_AF_NFE=0.47860874;gnomad_exomes_AF_AMR=0.57070367;gnomad_exomes_AF_SAS=0.57033057;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1698;normalHetFrequency=0.4659;normalHetNum=403;normalHomFrequency=0.215;normalHomNum=186;patientHetFrequency=0.4667;patientHetNum=2436;patientHomFrequency=0.2111;patientHomNum=1102;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4877;AF_2700_Hom=0.1914;AF_50_Het=0.4612;AF_50_Hom=0.1854;DANN_score=0.8989;GREP_score=-9.84;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=GGCCCCGCCC.CCTCCTCCCA	GT:AD:DP:GQ:PL	0/1:104,102:206:99:2840,0,3100
chr8	145737636	.	A	G	10264.8	PASS	AC=2;AF=1;AN=2;DP=264;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.83;SOR=0.821;HGVSnom=NM_004260.4:c.3127T>C(p.Leu1043Leu/p.L1043L);Gene=RECQL4;Transcript=NM_004260.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E18;IVSnom=.;AAlength=1208;EXAC_AF=0.97282554;EXAC_Hom_EAS=2629;EXAC_AC_EAS=6688;EXAC_AN_EAS=8568;EXAC_AC_Adj=115739;EXAC_AN_Adj=118972;ESP6500_MAF=0.99840587;RS=rs4925828;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.946086;G1000_EAS_AF=0.7966;G1000_EUR_AF=0.998;G1000_AFR_AF=0.9924;G1000_SAS_AF=0.9969;G1000_AMR_AF=0.928;gnomad_exomes_AF=0.96953976;gnomad_exomes_AF_EAS=0.78558689;gnomad_exomes_AC=239773;gnomad_exomes_Hom=116726;gnomad_exomes_Het=6321;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99475960;gnomad_exomes_AF_NFE=0.99948014;gnomad_exomes_AF_AMR=0.90366653;gnomad_exomes_AF_SAS=0.99849644;NativeFreq_Het=0.3564;NativeFreq_Hom=0.6204;DANN_score=0.66;GREP_score=3.27;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=TCAGCGGTCA.GTCCCCCGGG	GT:AD:DP:GQ:PL	1/1:0,264:264:99:10293,794,0
chr8	145737816	.	C	T	4656.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.261;DP=253;ExcessHet=3.0103;FS=1.525;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.41;ReadPosRankSum=0.068;SOR=0.591;HGVSnom=NM_004260.4:c.3014G>A(p.Arg1005Gln/p.R1005Q);Gene=RECQL4;Transcript=NM_004260.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E17;IVSnom=.;AAlength=1208;EXAC_AF=0.46119972;EXAC_Hom_EAS=807;EXAC_AC_EAS=3700;EXAC_AN_EAS=8386;EXAC_AC_Adj=53204;EXAC_AN_Adj=115360;ESP6500_MAF=0.34191061;RS=rs4251691;Ensembl_transcriptid=ENST00000621189|ENST00000617875|ENST00000531875;SIFT_pred=.|.|.;SIFT_score=.|.|.;Polyphen2_HVAR_pred=.|B|.;Polyphen2_HVAR_score=.|0.006|.;MutationTaster_pred=.;MutationTaster_score=.;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.384385;G1000_EAS_AF=0.4762;G1000_EUR_AF=0.4543;G1000_AFR_AF=0.0635;G1000_SAS_AF=0.5767;G1000_AMR_AF=0.4899;gnomad_exomes_AF=0.46713137;gnomad_exomes_AF_EAS=0.44083605;gnomad_exomes_AC=113725;gnomad_exomes_Hom=27801;gnomad_exomes_Het=58123;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11640000;gnomad_exomes_AF_NFE=0.46558771;gnomad_exomes_AF_AMR=0.55650825;gnomad_exomes_AF_SAS=0.56316895;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1728;normalHetFrequency=0.4486;normalHetNum=388;normalHomFrequency=0.2127;normalHomNum=184;patientHetFrequency=0.4611;patientHetNum=2407;patientHomFrequency=0.1998;patientHomNum=1043;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4789;AF_2700_Hom=0.1837;AF_50_Het=0.4564;AF_50_Hom=0.1759;DANN_score=0.8288;GREP_score=0.281;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=GCAGAGAGCC.GCCGCACAGA	GT:AD:DP:GQ:PL	0/1:109,144:253:99:4685,0,3182
chr8	145738581	.	TGG	T	1548.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.647;DP=104;ExcessHet=3.0103;FS=1.33;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.12;ReadPosRankSum=-0.053;SOR=1.085;HGVSnom=NM_004260.4:c.2463+18_2463+19delCC;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_004260.4:IVS14+18_+19delCC;AAlength=1208;EXAC_AF=0.41213311;EXAC_Hom_EAS=93;EXAC_AC_EAS=981;EXAC_AN_EAS=2674;EXAC_AC_Adj=13227;EXAC_AN_Adj=32094;RS=rs71320828;CLNGENE=RECQL4;CLNSIG=Benign/Likely_benign;CLNREVSTAT=no_assertion_criteria_provided;G1000_AF=0.539537;G1000_EAS_AF=0.6349;G1000_EUR_AF=0.4891;G1000_AFR_AF=0.4614;G1000_SAS_AF=0.6115;G1000_AMR_AF=0.5216;gnomad_exomes_AF=0.36458114;gnomad_exomes_AF_EAS=0.34563514;gnomad_exomes_AC=41571;gnomad_exomes_Hom=2629;gnomad_exomes_Het=36313;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24515937;gnomad_exomes_AF_NFE=0.37399659;gnomad_exomes_AF_AMR=0.34570891;gnomad_exomes_AF_SAS=0.42330775;NativeFreq_Het=0.1438;NativeFreq_Hom=.;normalHetFrequency=0.2277;normalHetNum=197;normalHomFrequency=0.1549;normalHomNum=134;patientHetFrequency=0.2339;patientHetNum=1221;patientHomFrequency=0.1667;patientHomNum=870;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4032;AF_2700_Hom=0.1395;AF_50_Het=0.3597;AF_50_Hom=0.1506;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=ACTGGCAGTG.GGGGGGGGGG	GT:AD:DP:GQ:PL	0/1:14,56:70:99:1586,0,244
chr8	145738767	.	CG	C	8872.73	PASS	AC=2;AF=1;AN=2;DP=249;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.1;SOR=2.404;HGVSnom=NM_004260.4:c.2296delC(p.Arg766Glyfs*77/p.R766Gfs*77);Gene=RECQL4;Transcript=NM_004260.4;VarType=Frameshift;MolecularConsequence=frameshift_truncate;ExonIntron=E14;IVSnom=.;AAlength=1208;EXAC_AF=0.99987024;EXAC_Hom_EAS=4224;EXAC_AC_EAS=8448;EXAC_AN_EAS=8448;EXAC_AC_Adj=115583;EXAC_AN_Adj=115598;RS=rs1827625671;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99987039;gnomad_exomes_AF_EAS=0.99983146;gnomad_exomes_AC=239149;gnomad_exomes_Hom=119559;gnomad_exomes_Het=31;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99993172;gnomad_exomes_AF_NFE=0.99980674;gnomad_exomes_AF_AMR=0.99994169;gnomad_exomes_AF_SAS=0.99990159;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9873;normalHomNum=854;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9889;patientHomNum=5162;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0004;AF_2700_Hom=0.9942;AF_50_Het=.;AF_50_Hom=1.0000;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=CACCACCACC.GCAACTGGCC	GT:AD:DP:GQ:PL	1/1:0,240:240:99:8910,722,0
chr8	145739924	.	G	A	3497.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.944;DP=243;ExcessHet=3.0103;FS=5.501;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.39;ReadPosRankSum=0.105;SOR=1.04;HGVSnom=NM_004260.4:c.1621-15C>T;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_004260.4:IVS9-15C>T;AAlength=1208;EXAC_AF=0.48016241;EXAC_Hom_EAS=885;EXAC_AC_EAS=3834;EXAC_AN_EAS=8078;EXAC_AC_Adj=51798;EXAC_AN_Adj=107876;ESP6500_MAF=0.35052448;RS=rs4244611;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.394569;G1000_EAS_AF=0.503;G1000_EUR_AF=0.4563;G1000_AFR_AF=0.0726;G1000_SAS_AF=0.5818;G1000_AMR_AF=0.4971;gnomad_exomes_AF=0.47658019;gnomad_exomes_AF_EAS=0.46851371;gnomad_exomes_AC=114486;gnomad_exomes_Hom=28304;gnomad_exomes_Het=57878;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12584986;gnomad_exomes_AF_NFE=0.47225397;gnomad_exomes_AF_AMR=0.55995495;gnomad_exomes_AF_SAS=0.56752777;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1790;normalHetFrequency=0.4601;normalHetNum=398;normalHomFrequency=0.2162;normalHomNum=187;patientHetFrequency=0.4638;patientHetNum=2421;patientHomFrequency=0.2146;patientHomNum=1120;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4915;AF_2700_Hom=0.1910;AF_50_Het=0.4612;AF_50_Hom=0.1870;DANN_score=0.7351;GREP_score=-0.337;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=AAATGCAGGA.CGACAGCCGT	GT:AD:DP:GQ:PL	0/1:118,125:243:99:3526,0,3658
chr8	145741130	.	C	T	3409.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.883;DP=245;ExcessHet=3.0103;FS=0.526;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.97;ReadPosRankSum=0.308;SOR=0.648;HGVSnom=NM_004260.4:c.1258+18G>A;Gene=RECQL4;Transcript=NM_004260.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_004260.4:IVS6+18G>A;AAlength=1208;EXAC_AF=0.47155473;EXAC_Hom_EAS=886;EXAC_AC_EAS=3855;EXAC_AN_EAS=8316;EXAC_AC_Adj=53612;EXAC_AN_Adj=113692;ESP6500_MAF=0.36496350;RS=rs4251689;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.400958;G1000_EAS_AF=0.501;G1000_EUR_AF=0.4543;G1000_AFR_AF=0.0983;G1000_SAS_AF=0.5838;G1000_AMR_AF=0.4971;gnomad_exomes_AF=0.47520749;gnomad_exomes_AF_EAS=0.46737661;gnomad_exomes_AC=115771;gnomad_exomes_Hom=28477;gnomad_exomes_Het=58817;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15964257;gnomad_exomes_AF_NFE=0.46885079;gnomad_exomes_AF_AMR=0.55918223;gnomad_exomes_AF_SAS=0.56589327;NativeFreq_Het=0.4950;NativeFreq_Hom=0.1821;normalHetFrequency=0.4682;normalHetNum=405;normalHomFrequency=0.2104;normalHomNum=182;patientHetFrequency=0.4713;patientHetNum=2460;patientHomFrequency=0.2077;patientHomNum=1084;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4931;AF_2700_Hom=0.1883;AF_50_Het=0.4628;AF_50_Hom=0.1838;DANN_score=0.6361;GREP_score=3.26;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=GACCCACCCT.CAGGGCAGAT	GT:AD:DP:GQ:PL	0/1:135,109:244:99:3438,0,4439
chr8	145741702	.	C	G	3843.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.243;DP=237;ExcessHet=3.0103;FS=1.58;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.22;ReadPosRankSum=-1.859;SOR=0.569;HGVSnom=NM_004260.4:c.801G>C(p.Glu267Asp/p.E267D);Gene=RECQL4;Transcript=NM_004260.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=1208;EXAC_AF=0.43770694;EXAC_Hom_EAS=790;EXAC_AC_EAS=3584;EXAC_AN_EAS=8040;EXAC_AC_Adj=48912;EXAC_AN_Adj=111746;ESP6500_MAF=0.39186540;RS=rs4244612;Ensembl_transcriptid=ENST00000617875;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.004;MutationTaster_pred=.;MutationTaster_score=.;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.447684;G1000_EAS_AF=0.4821;G1000_EUR_AF=0.3827;G1000_AFR_AF=0.4198;G1000_SAS_AF=0.5051;G1000_AMR_AF=0.464;gnomad_exomes_AF=0.43742630;gnomad_exomes_AF_EAS=0.44990893;gnomad_exomes_AC=105355;gnomad_exomes_Hom=23175;gnomad_exomes_Het=59005;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42585525;gnomad_exomes_AF_NFE=0.39995224;gnomad_exomes_AF_AMR=0.53376139;gnomad_exomes_AF_SAS=0.49804429;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1605;normalHetFrequency=0.4659;normalHetNum=403;normalHomFrequency=0.1919;normalHomNum=166;patientHetFrequency=0.4575;patientHetNum=2388;patientHomFrequency=0.183;patientHomNum=955;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4839;AF_2700_Hom=0.1756;AF_50_Het=0.4707;AF_50_Hom=0.1601;DANN_score=0.4431;GREP_score=-2.99;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=TCTCCCAGGG.TCCTCGTTCC	GT:AD:DP:GQ:PL	0/1:114,123:237:99:3872,0,3888
chr8	145741765	.	G	A	4186.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.83;DP=293;ExcessHet=3.0103;FS=4.61;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.34;ReadPosRankSum=1.354;SOR=0.962;HGVSnom=NM_004260.4:c.738C>T(p.Ser246Ser/p.S246S);Gene=RECQL4;Transcript=NM_004260.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E5;IVSnom=.;AAlength=1208;EXAC_AF=0.43942754;EXAC_Hom_EAS=827;EXAC_AC_EAS=3699;EXAC_AN_EAS=8312;EXAC_AC_Adj=50325;EXAC_AN_Adj=114524;ESP6500_MAF=0.33916424;RS=rs4244613;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.370008;G1000_EAS_AF=0.4831;G1000_EUR_AF=0.4254;G1000_AFR_AF=0.0885;G1000_SAS_AF=0.5153;G1000_AMR_AF=0.4568;gnomad_exomes_AF=0.44402801;gnomad_exomes_AF_EAS=0.45211807;gnomad_exomes_AC=107810;gnomad_exomes_Hom=24935;gnomad_exomes_Het=57940;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14511147;gnomad_exomes_AF_NFE=0.43920109;gnomad_exomes_AF_AMR=0.53233263;gnomad_exomes_AF_SAS=0.50690245;NativeFreq_Het=0.4752;NativeFreq_Hom=0.1543;normalHetFrequency=0.4624;normalHetNum=400;normalHomFrequency=0.1861;normalHomNum=161;patientHetFrequency=0.4611;patientHetNum=2407;patientHomFrequency=0.1839;patientHomNum=960;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4823;AF_2700_Hom=0.1768;AF_50_Het=0.4548;AF_50_Hom=0.1696;DANN_score=0.6765;GREP_score=-9.43;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=CCACACGGAT.CTGACTTCTT	GT:AD:DP:GQ:PL	0/1:144,148:292:99:4215,0,4643
chr8	145742514	.	A	G	7788.77	PASS	AC=2;AF=1;AN=2;DP=210;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.17;SOR=0.983;HGVSnom=NM_004260.4:c.274T>C(p.Ser92Pro/p.S92P);Gene=RECQL4;Transcript=NM_004260.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=1208;EXAC_AF=0.97332114;EXAC_Hom_EAS=2712;EXAC_AC_EAS=6764;EXAC_AN_EAS=8428;EXAC_AC_Adj=113863;EXAC_AN_Adj=116984;ESP6500_MAF=0.99516552;RS=rs2721190;Ensembl_transcriptid=ENST00000617875;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=.;MutationTaster_score=.;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.943291;G1000_EAS_AF=0.8065;G1000_EUR_AF=0.998;G1000_AFR_AF=0.9781;G1000_SAS_AF=0.9959;G1000_AMR_AF=0.9222;gnomad_exomes_AF=0.96966533;gnomad_exomes_AF_EAS=0.80296064;gnomad_exomes_AC=237760;gnomad_exomes_Hom=115679;gnomad_exomes_Het=6402;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.98188454;gnomad_exomes_AF_NFE=0.99936534;gnomad_exomes_AF_AMR=0.90214219;gnomad_exomes_AF_SAS=0.99852594;NativeFreq_Het=0.3663;NativeFreq_Hom=0.6420;DANN_score=0.4532;GREP_score=1.99;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=CCTGGCGTAG.CTGTGGACTC	GT:AD:DP:GQ:PL	1/1:0,209:209:99:7817,627,0
chr8	145742879	.	T	C	2235.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.211;DP=143;ExcessHet=3.0103;FS=3.406;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.63;ReadPosRankSum=0.386;SOR=0.42;HGVSnom=NM_004260.4:c.132A>G(p.Glu44Glu/p.E44E);Gene=RECQL4;Transcript=NM_004260.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=1208;EXAC_AF=0.55522426;EXAC_Hom_EAS=768;EXAC_AC_EAS=3339;EXAC_AN_EAS=6716;EXAC_AC_Adj=47485;EXAC_AN_Adj=85524;ESP6500_MAF=0.55069211;RS=rs2306386;CLNGENE=RECQL4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.57508;G1000_EAS_AF=0.5238;G1000_EUR_AF=0.4891;G1000_AFR_AF=0.618;G1000_SAS_AF=0.6207;G1000_AMR_AF=0.6282;gnomad_exomes_AF=0.53662356;gnomad_exomes_AF_EAS=0.48565028;gnomad_exomes_AC=112047;gnomad_exomes_Hom=30572;gnomad_exomes_Het=50903;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.61588133;gnomad_exomes_AF_NFE=0.49332388;gnomad_exomes_AF_AMR=0.64476863;gnomad_exomes_AF_SAS=0.60269658;NativeFreq_Het=0.5148;NativeFreq_Hom=0.1584;normalHetFrequency=0.2393;normalHetNum=207;normalHomFrequency=0.1723;normalHomNum=149;patientHetFrequency=0.2533;patientHetNum=1322;patientHomFrequency=0.1676;patientHomNum=875;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4008;AF_2700_Hom=0.1995;AF_50_Het=0.3693;AF_50_Hom=0.1918;DANN_score=0.488;GREP_score=0.963;CytoBand=q24.3;CGD_CONDITION=Baller-Gerold syndrome. RAPADILINO syndrome. Rothmund-Thomson syndrome;CGD_INHERITANCE=AR;Strand=RECQL4:NM_004260.3:-;NP=RECQL4:NM_004260.3:NP_004251.3;ENSP=RECQL4:NM_004260.3:ENST00000617875.5;Gene_MIM_id=603780;Phenotypes=Baller-Gerold syndrome, 218600 (3), Autosomal recessive. RAPADILINO syndrome, 266280 (3), Autosomal recessive. Rothmund-Thomson syndrome, 268400 (3), Autosomal recessive. 218600(MK),266280(MK),268400(MK);Possible_Inheritance=AR;EntrezGeneID=9401;EnsemblGeneID=ENSG00000160957;Alias=RECQL4, RTS, RECQ4;FLKSEQ=GAGTGCGGTA.TCCCGGTAGA	GT:AD:DP:GQ:PL	0/1:73,70:143:99:2264,0,2340
chr9	21968159	.	G	A	4306.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.893;DP=335;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=0;QD=12.93;ReadPosRankSum=0.669;SOR=0.68;HGVSnom=NM_000077.5:c.*69C>T;Gene=CDKN2A;Transcript=NM_000077.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=156;ESP6500_MAF=0.11016207;RS=rs3088440;CLNGENE=CDKN2A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.169928;G1000_EAS_AF=0.131;G1000_EUR_AF=0.0785;G1000_AFR_AF=0.174;G1000_SAS_AF=0.1789;G1000_AMR_AF=0.3386;NativeFreq_Het=0.2598;NativeFreq_Hom=0.0214;normalHetFrequency=0.1723;normalHetNum=149;normalHomFrequency=0.0127;normalHomNum=11;patientHetFrequency=0.1943;patientHetNum=1014;patientHomFrequency=0.0136;patientHomNum=71;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1998;AF_2700_Hom=0.0150;AF_50_Het=0.1965;AF_50_Hom=0.0174;DANN_score=0.7026;GREP_score=-3.01;CytoBand=p21.3;CGD_CONDITION=Melanoma and neural system tumor syndrome. Melanoma, familial. Melanoma-pancreatic cancer syndrome;CGD_INHERITANCE=AD;Strand=CDKN2A:NM_058197.4:-,CDKN2A:NM_000077.4:-,CDKN2A:NM_001195132.1:-,CDKN2A:NM_058195.3:-;NP=CDKN2A:NM_058197.4:NP_478104.2,CDKN2A:NM_000077.4:NP_000068.1,CDKN2A:NM_001195132.1:NP_001182061.1,CDKN2A:NM_058195.3:NP_478102.2;ENSP=CDKN2A:NM_058197.4:.,CDKN2A:NM_000077.4:ENST00000304494.9,CDKN2A:NM_001195132.1:.,CDKN2A:NM_058195.3:.;Gene_MIM_id=600160;Phenotypes=Melanoma and neural system tumor syndrome, 155755 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant. Orolaryngeal cancer, multiple (3). Pancreatic cancer/melanoma syndrome, 606719 (3), Autosomal dominant. 155601(SK),155755(MK),600160(MK),606719(MK);Possible_Inheritance=AD;EntrezGeneID=1029;EnsemblGeneID=ENSG00000147889;Alias=CDKN2A, MTS1, P16, MLM, CMM2;FLKSEQ=GGGCAGTTGT.GCCCTGTAGG	GT:AD:DP:GQ:PL	0/1:183,150:333:99:4335,0,5934
chr9	21968199	.	C	G	11399.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.762;DP=323;ExcessHet=3.0103;FS=3.939;MLEAC=2;MLEAF=1;MQ=59.93;MQRankSum=0;QD=26.01;ReadPosRankSum=0.485;SOR=0.898;HGVSnom=NM_000077.5:c.*29G>C;Gene=CDKN2A;Transcript=NM_000077.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=156;EXAC_AF=0.88024001;EXAC_Hom_EAS=4125;EXAC_AC_EAS=8447;EXAC_AN_EAS=8648;EXAC_AC_Adj=106796;EXAC_AN_Adj=121326;ESP6500_MAF=0.84914655;RS=rs11515;CLNGENE=CDKN2A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.902157;G1000_EAS_AF=0.9812;G1000_EUR_AF=0.8519;G1000_AFR_AF=0.8359;G1000_SAS_AF=0.9479;G1000_AMR_AF=0.9222;gnomad_exomes_AF=0.88156460;gnomad_exomes_AF_EAS=0.97830579;gnomad_exomes_AC=221546;gnomad_exomes_Hom=97941;gnomad_exomes_Het=25664;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.83548824;gnomad_exomes_AF_NFE=0.85536666;gnomad_exomes_AF_AMR=0.91897050;gnomad_exomes_AF_SAS=0.93075616;NativeFreq_Het=0.1281;NativeFreq_Hom=0.9801;normalHetFrequency=0.1006;normalHetNum=87;normalHomFrequency=0.8682;normalHomNum=751;patientHetFrequency=0.1027;patientHetNum=536;patientHomFrequency=0.8598;patientHomNum=4488;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0588;AF_2700_Hom=0.9389;AF_50_Het=0.0777;AF_50_Hom=0.9223;DANN_score=0.6501;GREP_score=-3.17;CytoBand=p21.3;CGD_CONDITION=Melanoma and neural system tumor syndrome. Melanoma, familial. Melanoma-pancreatic cancer syndrome;CGD_INHERITANCE=AD;Strand=CDKN2A:NM_058197.4:-,CDKN2A:NM_000077.4:-,CDKN2A:NM_001195132.1:-,CDKN2A:NM_058195.3:-;NP=CDKN2A:NM_058197.4:NP_478104.2,CDKN2A:NM_000077.4:NP_000068.1,CDKN2A:NM_001195132.1:NP_001182061.1,CDKN2A:NM_058195.3:NP_478102.2;ENSP=CDKN2A:NM_058197.4:.,CDKN2A:NM_000077.4:ENST00000304494.9,CDKN2A:NM_001195132.1:.,CDKN2A:NM_058195.3:.;Gene_MIM_id=600160;Phenotypes=Melanoma and neural system tumor syndrome, 155755 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant. Orolaryngeal cancer, multiple (3). Pancreatic cancer/melanoma syndrome, 606719 (3), Autosomal dominant. 155601(SK),155755(MK),600160(MK),606719(MK);Possible_Inheritance=AD;EntrezGeneID=1029;EnsemblGeneID=ENSG00000147889;Alias=CDKN2A, MTS1, P16, MLM, CMM2;FLKSEQ=CTAAGTTTCC.GAGGTTTCTC	GT:AD:DP:GQ:PL	1/1:1,321:322:99:11428,956,0
chr9	21975017	.	C	T	2968.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.993;DP=204;ExcessHet=3.0103;FS=4.865;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.62;ReadPosRankSum=-1.052;SOR=0.593;HGVSnom=.;Gene=CDKN2A;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3814960;CLNGENE=CDKN2A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.487819;G1000_EAS_AF=0.6657;G1000_EUR_AF=0.6243;G1000_AFR_AF=0.1793;G1000_SAS_AF=0.6135;G1000_AMR_AF=0.4424;normalHetFrequency=0.1503;normalHetNum=130;normalHomFrequency=0.1618;normalHomNum=140;patientHetFrequency=0.1192;patientHetNum=622;patientHomFrequency=0.1383;patientHomNum=722;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.0058;AF_50_Het=0.0000;AF_50_Hom=0.0048;DANN_score=0.8815;GREP_score=-0.671;CytoBand=p21.3;CGD_CONDITION=Melanoma and neural system tumor syndrome. Melanoma, familial. Melanoma-pancreatic cancer syndrome;CGD_INHERITANCE=AD;Strand=CDKN2A:NM_000077.4:-,CDKN2A:NM_001195132.1:-,CDKN2A:NM_058195.3:-;NP=CDKN2A:NM_000077.4:NP_000068.1,CDKN2A:NM_001195132.1:NP_001182061.1,CDKN2A:NM_058195.3:NP_478102.2;ENSP=CDKN2A:NM_000077.4:ENST00000304494.9,CDKN2A:NM_001195132.1:.,CDKN2A:NM_058195.3:.;Gene_MIM_id=600160;Phenotypes=Melanoma and neural system tumor syndrome, 155755 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant. Orolaryngeal cancer, multiple (3). Pancreatic cancer/melanoma syndrome, 606719 (3), Autosomal dominant. 155601(SK),155755(MK),600160(MK),606719(MK);Possible_Inheritance=AD;EntrezGeneID=1029;EnsemblGeneID=ENSG00000147889;Alias=CDKN2A, MTS1, P16, MLM, CMM2;FLKSEQ=AAGGGGACGC.GTGAGCGAGT	GT:AD:DP:GQ:PL	0/1:99,104:203:99:2997,0,2750
chr9	97862118	.	C	T	11652.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.657;DP=325;ExcessHet=3.0103;FS=3.535;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.28;ReadPosRankSum=-0.656;SOR=0.614;HGVSnom=NM_000136.3:c.*1871G>A;Gene=FANCC;Transcript=NM_000136.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=558;RS=rs4647558;CLNGENE=AOPEP|FANCC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.413538;G1000_EAS_AF=0.5764;G1000_EUR_AF=0.4404;G1000_AFR_AF=0.2179;G1000_SAS_AF=0.4407;G1000_AMR_AF=0.4726;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3786;normalHetFrequency=0.2486;normalHetNum=215;normalHomFrequency=0.1572;normalHomNum=136;patientHetFrequency=0.2188;patientHetNum=1142;patientHomFrequency=0.1466;patientHomNum=765;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4892;AF_2700_Hom=0.3397;AF_50_Het=0.4770;AF_50_Hom=0.3423;DANN_score=0.4591;GREP_score=-1.44;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=AGGAAGAAGT.TTCCAGATGC	GT:AD:DP:GQ:PL	1/1:1,324:325:99:11681,939,0
chr9	97862701	.	A	G	14705.8	PASS	AC=2;AF=1;AN=2;DP=385;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.8;SOR=0.914;HGVSnom=NM_000136.3:c.*1288T>C;Gene=FANCC;Transcript=NM_000136.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E15;IVSnom=.;AAlength=558;RS=rs4647554;CLNGENE=AOPEP|FANCC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.502796;G1000_EAS_AF=0.5823;G1000_EUR_AF=0.4463;G1000_AFR_AF=0.531;G1000_SAS_AF=0.4448;G1000_AMR_AF=0.4971;NativeFreq_Het=0.5148;NativeFreq_Hom=0.3819;normalHetFrequency=0.4507;normalHetNum=215;normalHomFrequency=0.1618;normalHomNum=140;patientHetFrequency=0.2169;patientHetNum=1132;patientHomFrequency=0.1521;patientHomNum=794;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4873;AF_2700_Hom=0.3451;AF_50_Het=0.4754;AF_50_Hom=0.3487;DANN_score=0.7813;GREP_score=0.804;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=CTAAAGGTTA.CTTCTAATCC	GT:AD:DP:GQ:PL	1/1:0,378:378:99:14734,1137,0
chr9	97872712	.	C	T	10758.8	PASS	AC=2;AF=1;AN=2;DP=301;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.65;SOR=0.776;HGVSnom=NM_000136.3:c.1329+1033G>A;Gene=FANCC;Transcript=NM_000136.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_000136.3:IVS13+1033G>A;AAlength=558;RS=rs10429619;G1000_AF=0.998003;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9901;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0177664|16B0047160][_];DANN_score=0.8015;GREP_score=1.01;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-,FANCC:NM_001243744.1:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2,FANCC:NM_001243744.1:NP_001230673.1;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8,FANCC:NM_001243744.1:.;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=TTTTCCTTAG.TTAACGTGAT	GT:AD:DP:GQ:PL	1/1:0,300:300:99:10787,900,0
chr9	97873339	.	G	A	5384.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.407;DP=349;ExcessHet=3.0103;FS=9.943;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.47;ReadPosRankSum=-0.551;SOR=0.388;HGVSnom=NM_000136.3:c.1329+406C>T;Gene=FANCC;Transcript=NM_000136.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_000136.3:IVS13+406C>T;AAlength=558;RS=rs879492;CLNGENE=AOPEP|FANCC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.416733;G1000_EAS_AF=0.5873;G1000_EUR_AF=0.4384;G1000_AFR_AF=0.2247;G1000_SAS_AF=0.4356;G1000_AMR_AF=0.4769;NativeFreq_Het=0.2136;NativeFreq_Hom=0.1990;normalHetFrequency=0.3814;normalHetNum=148;normalHomFrequency=0.3299;normalHomNum=128;patientHetFrequency=0.3936;patientHetNum=1091;patientHomFrequency=0.1443;patientHomNum=753;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7285;GREP_score=-7.37;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-,FANCC:NM_001243744.1:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2,FANCC:NM_001243744.1:NP_001230673.1;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8,FANCC:NM_001243744.1:.;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=AGCCCTGGCC.GGCTGCTGGG	GT:AD:DP:GQ:PL	0/1:170,178:348:99:5413,0,4834
chr9	97873435	.	G	A	4746.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.374;DP=320;ExcessHet=3.0103;FS=0.415;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.88;ReadPosRankSum=-0.068;SOR=0.72;HGVSnom=NM_000136.3:c.1329+310C>T;Gene=FANCC;Transcript=NM_000136.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_000136.3:IVS13+310C>T;AAlength=558;EXAC_AF=0.39790153;EXAC_Hom_EAS=32;EXAC_AC_EAS=122;EXAC_AN_EAS=218;EXAC_AC_Adj=4930;EXAC_AN_Adj=12390;RS=rs2404457;CLNGENE=AOPEP|FANCC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.411142;G1000_EAS_AF=0.5873;G1000_EUR_AF=0.4423;G1000_AFR_AF=0.1997;G1000_SAS_AF=0.4346;G1000_AMR_AF=0.4798;gnomad_exomes_AF=0.43646511;gnomad_exomes_AF_EAS=0.57239217;gnomad_exomes_AC=58729;gnomad_exomes_Hom=13421;gnomad_exomes_Het=31887;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22873991;gnomad_exomes_AF_NFE=0.41038897;gnomad_exomes_AF_AMR=0.53803415;gnomad_exomes_AF_SAS=0.42210564;NativeFreq_Het=0.3560;NativeFreq_Hom=0.3252;normalHetFrequency=0.433;normalHetNum=168;normalHomFrequency=0.148;normalHomNum=128;patientHetFrequency=0.2364;patientHetNum=1234;patientHomFrequency=0.1385;patientHomNum=723;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5222;GREP_score=3.1;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-,FANCC:NM_001243744.1:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2,FANCC:NM_001243744.1:NP_001230673.1;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8,FANCC:NM_001243744.1:.;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=ACGCCTTGGA.GACGCGACCC	GT:AD:DP:GQ:PL	0/1:166,153:319:99:4775,0,5700
chr9	97873957	.	A	G	4975.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.21;DP=274;ExcessHet=3.0103;FS=3.255;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.23;ReadPosRankSum=-0.917;SOR=0.927;HGVSnom=NM_000136.3:c.1155-38T>C;Gene=FANCC;Transcript=NM_000136.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000136.3:IVS12-38T>C;AAlength=558;EXAC_AF=0.47381678;EXAC_Hom_EAS=1665;EXAC_AC_EAS=5329;EXAC_AN_EAS=8594;EXAC_AC_Adj=57184;EXAC_AN_Adj=120688;ESP6500_MAF=0.46378594;RS=rs4647534;CLNGENE=AOPEP|FANCC;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.541334;G1000_EAS_AF=0.6339;G1000_EUR_AF=0.4473;G1000_AFR_AF=0.6044;G1000_SAS_AF=0.4806;G1000_AMR_AF=0.5086;gnomad_exomes_AF=0.47341214;gnomad_exomes_AF_EAS=0.62434612;gnomad_exomes_AC=118229;gnomad_exomes_Hom=28945;gnomad_exomes_Het=60339;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59830067;gnomad_exomes_AF_NFE=0.41696757;gnomad_exomes_AF_AMR=0.56812913;gnomad_exomes_AF_SAS=0.47141923;NativeFreq_Het=0.4288;NativeFreq_Hom=0.4644;normalHetFrequency=0.4208;normalHetNum=364;normalHomFrequency=0.348;normalHomNum=301;patientHetFrequency=0.4345;patientHetNum=2268;patientHomFrequency=0.3305;patientHomNum=1725;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3361;GREP_score=-5.97;CytoBand=q22.32;CGD_CONDITION=Fanconi anemia, complementation group C;CGD_INHERITANCE=AR;Strand=FANCC:NM_001243743.1:-,FANCC:NM_000136.2:-,FANCC:NM_000136.3:-,FANCC:NM_001243744.1:-;NP=FANCC:NM_001243743.1:NP_001230672.1,FANCC:NM_000136.2:NP_000127.2,FANCC:NM_000136.3:NP_000127.2,FANCC:NM_001243744.1:NP_001230673.1;ENSP=FANCC:NM_001243743.1:.,FANCC:NM_000136.2:ENST00000289081.8,FANCC:NM_000136.3:ENST00000289081.8,FANCC:NM_001243744.1:.;Gene_MIM_id=613899;Phenotypes=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive. 227645(MK);Possible_Inheritance=AR;EntrezGeneID=2176;EnsemblGeneID=ENSG00000158169;Alias=FANCC, FACC;FLKSEQ=TTGACAACCT.AATTCTTCTT	GT:AD:DP:GQ:PL	0/1:119,154:273:99:5004,0,3739
chr9	98205645	.	T	C	3980.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.791;DP=291;ExcessHet=3.0103;FS=2.629;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.77;ReadPosRankSum=0.628;SOR=0.538;HGVSnom=NM_000264.5:c.*3030A>G;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1447;RS=rs28485160;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.212859;G1000_EAS_AF=0.1637;G1000_EUR_AF=0.0865;G1000_AFR_AF=0.5212;G1000_SAS_AF=0.0665;G1000_AMR_AF=0.0865;NativeFreq_Het=0.2970;NativeFreq_Hom=0.0495;normalHetFrequency=0.2579;normalHetNum=123;normalHomFrequency=0.0116;normalHomNum=10;patientHetFrequency=0.2578;patientHetNum=631;patientHomFrequency=0.0151;patientHomNum=79;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3201;AF_2700_Hom=0.0373;AF_50_Het=0.3201;AF_50_Hom=0.0333;DANN_score=0.6031;GREP_score=2.06;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=ACACTAACTG.CTCTCCCAAG	GT:AD:DP:GQ:PL	0/1:157,132:289:99:4009,0,4744
chr9	98206386	.	G	GT	360.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.624;DP=206;ExcessHet=3.0103;FS=3.64;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=1.86;ReadPosRankSum=-0.547;SOR=1.102;HGVSnom=NM_000264.5:c.*2288dupA;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1447;RS=rs548096592;CLNGENE=PTCH1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0495;NativeFreq_Hom=.;normalHetFrequency=0.3166;normalHetNum=151;normalHomFrequency=0.0084;normalHomNum=4;patientHetFrequency=0.3203;patientHetNum=784;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0022760-C|16B0018108|15B0022760|16B0001905-1];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0028142|16B0009401-1|16B0047232];AF_2700_Het=0.3428;AF_2700_Hom=0.0004;AF_50_Het=0.3645;AF_50_Hom=.;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=TATCAGCAAA.tttttttttt	GT:AD:DP:GQ:PL	0/1:153,41:194:99:398,0,3180
chr9	98206791	.	G	GCA	1721.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.285;DP=315;ExcessHet=3.0103;FS=10.026;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.45;ReadPosRankSum=1.251;SOR=0.644;HGVSnom=NM_000264.5:c.*1882_*1883dupTG;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1447;RS=rs59205702;CLNGENE=PTCH1;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.132788;G1000_EAS_AF=0.1339;G1000_EUR_AF=0.0775;G1000_AFR_AF=0.2776;G1000_SAS_AF=0.0419;G1000_AMR_AF=0.0634;normalHetFrequency=0.2264;normalHetNum=108;normalHomFrequency=0.0069;normalHomNum=6;patientHetFrequency=0.1036;patientHetNum=541;patientHomFrequency=0.0086;patientHomNum=45;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D0166662][16D0166743|15B0058387|17B0001033|16B0018108|16B0200331];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B6104430][16D0177832-1|16B0202382|15B0045761|15B0063025|15B0062687|16B0028157|16D0169528|16B3094968|16B3094648|16D0067164|16B0050327|16B0011452|16D0161387|16B1903636|16B0000892|15S0050992|15B0060422|16B0011504|16B0200559|15D6129439|16B3094203|15B0064959|16B0028111|16D0067102|16B0050432|16D1545706|15B6214983-1|15B0045550|15B0027057|15B0002932-1|16B0024351|16B3094669|17B0000818|16D0038294|15B0012175|15B0027313|15B0002843-1|16D0067252|16B0012021|15B0027387|15B0022623|15B0032864|16B0005375|16B1587024];AF_2700_Het=0.2829;AF_2700_Hom=0.0184;AF_50_Het=0.2742;AF_50_Hom=0.0143;CytoBand=q22.32;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=acgcacgcac.cacacacaca	GT:AD:DP:GQ:PL	0/1:155,76:231:99:1759,0,4228
chr9	98207302	.	C	G	7897.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.456;DP=499;ExcessHet=3.0103;FS=1.742;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.89;ReadPosRankSum=-0.871;SOR=0.84;HGVSnom=NM_000264.5:c.*1373G>C;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1447;RS=rs16909865;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0519169;G1000_EAS_AF=0.1062;G1000_EUR_AF=0.0785;G1000_AFR_AF=0.0045;G1000_SAS_AF=0.0317;G1000_AMR_AF=0.0533;NativeFreq_Het=0.1782;NativeFreq_Hom=0;normalHetFrequency=0.1614;normalHetNum=77;normalHomFrequency=0.0069;normalHomNum=6;patientHetFrequency=0.143;patientHetNum=350;patientHomFrequency=0.0065;patientHomNum=34;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D0166662][16D0177725|17B0001033|16B0200331|15B0058387|16D0166743];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B3094603][16B3094968|16D0169432|15B0002843-1|17B0000818|16B0000892|16B0024351|16D0177832-1|15D6129439|16B3094203|16D0067252|15B6219952-1|16B0011452|16D0038294|16B1587024|16B3097951-1|15B6214983-1|16B0200559|15S0050992|15B0012175|16D0168782|16B0024693|16D1545706|16B0028157|16D0169528|15B0027057|16B0028111|15B0045550|16D0067102|16B0012021|16D0169441|16D0161387|15B0027387|16B0050327];AF_2700_Het=0.1922;AF_2700_Hom=0.0073;AF_50_Het=0.1823;AF_50_Hom=0.0063;DANN_score=0.4169;GREP_score=-6.85;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=TTTGGATTTA.TTAGGAAGCA	GT:AD:DP:GQ:PL	0/1:250,247:497:99:7926,0,7772
chr9	98207926	.	G	GAAGT	6052.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.091;DP=308;ExcessHet=3.0103;FS=2.636;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.16;ReadPosRankSum=-1.401;SOR=0.548;HGVSnom=NM_000264.5:c.*748_*749insACTT;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=1447;RS=rs147342582;CLNGENE=PTCH1;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0545128;G1000_EAS_AF=0.1111;G1000_EUR_AF=0.0805;G1000_AFR_AF=0.0076;G1000_SAS_AF=0.0327;G1000_AMR_AF=0.0548;NativeFreq_Het=0.0693;NativeFreq_Hom=.;normalHetFrequency=0.1824;normalHetNum=87;normalHomFrequency=0.0147;normalHomNum=7;patientHetFrequency=0.1544;patientHetNum=378;patientHomFrequency=0.0096;patientHomNum=50;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0000989][15B0051715|16D0177832-1|15B6215173|15B0022386|15B0058233|16B0024693|15B0045761|16B0005717|15D6129466|16D0169432|16B0028157|15B0060286|15B0040489|16D0169528|15B6219952-1|16B3094968|16B0018084|15B0033017|16B0050327|16B0011452|15B0062663|16D0161387|16B0000892|15S0050992|15B6215160|16B0200559|15D6129439|16B0200502|16B3094203|16B0028111|16D0067102|16D1545706|15S0051105|15B6214983-1|15B0045550|15B0027057|16B0024351|17B0000818|15B0022718|16D0038294|15B0012175|15B0002843-1|16D0067252|16B0017732|16D0169441|16B0012021|15B0027387|16B3097951-1|16B1587024];AF_2700_Het=.;AF_2700_Hom=0.0142;AF_50_Het=.;AF_50_Hom=0.0143;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=TCACCAGCAC.AAGAAAAGAT	GT:AD:DP:GQ:PL	0/1:141,145:286:99:6090,0,5466
chr9	98209594	.	G	A	8541.77	PASS	AC=2;AF=1;AN=2;DP=236;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.14;SOR=0.702;HGVSnom=NM_000264.5:c.3944C>T(p.Pro1315Leu/p.P1315L);Gene=PTCH1;Transcript=NM_000264.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E23;IVSnom=.;AAlength=1447;EXAC_AF=0.38546461;EXAC_Hom_EAS=1380;EXAC_AC_EAS=4816;EXAC_AN_EAS=8498;EXAC_AC_Adj=44727;EXAC_AN_Adj=116034;ESP6500_MAF=0.29925207;RS=rs357564;Ensembl_transcriptid=ENST00000331920|ENST00000418258|ENST00000421141|ENST00000437951|ENST00000430669|ENST00000429896|ENST00000375274;SIFT_pred=D|D|D|D|D|D|D;SIFT_score=0.025|0.028|0.028|0.028|0.028|0.028|0.024;Polyphen2_HVAR_pred=B|.|.|P|P|.|P;Polyphen2_HVAR_score=0.444|.|.|0.646|0.646|.|0.714;MutationTaster_pred=P|P|P|P|P|P|P;MutationTaster_score=4.46896e-11|4.46896e-11|2.53816e-11|4.46896e-11|4.46896e-11|2.53816e-11|2.53816e-11;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.396765;G1000_EAS_AF=0.5863;G1000_EUR_AF=0.3529;G1000_AFR_AF=0.2254;G1000_SAS_AF=0.4714;G1000_AMR_AF=0.4063;gnomad_exomes_AF=0.38921837;gnomad_exomes_AF_EAS=0.56271911;gnomad_exomes_AC=95817;gnomad_exomes_Hom=19668;gnomad_exomes_Het=56481;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23271041;gnomad_exomes_AF_NFE=0.33879366;gnomad_exomes_AF_AMR=0.48721739;gnomad_exomes_AF_SAS=0.44679181;HGMD_gene=PTCH1;HGMD_disease=Skin_cancer_association_with;HGMD_tag=DP;HGMD_pmid=15888139;NativeFreq_Het=0.5247;NativeFreq_Hom=0.2772;normalHetFrequency=0.4069;normalHetNum=352;normalHomFrequency=0.2821;normalHomNum=244;patientHetFrequency=0.4226;patientHetNum=2206;patientHomFrequency=0.2623;patientHomNum=1369;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4912;AF_2700_Hom=0.2736;AF_50_Het=0.4929;AF_50_Hom=0.2742;DANN_score=0.9991;GREP_score=4.83;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=CGGTCTGTAG.GGGGTGGCCA	GT:AD:DP:GQ:PL	1/1:0,235:235:99:8570,706,0
chr9	98211572	.	T	A	4463.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.297;DP=312;ExcessHet=3.0103;FS=0.857;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.4;ReadPosRankSum=-0.367;SOR=0.747;HGVSnom=NM_000264.5:c.3583A>T(p.Thr1195Ser/p.T1195S);Gene=PTCH1;Transcript=NM_000264.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E22;IVSnom=.;AAlength=1447;EXAC_AF=0.05455872;EXAC_Hom_EAS=12;EXAC_AC_EAS=192;EXAC_AN_EAS=1088;EXAC_AC_Adj=1271;EXAC_AN_Adj=23296;ESP6500_MAF=0.04173143;RS=rs2236405;Ensembl_transcriptid=ENST00000331920|ENST00000418258|ENST00000421141|ENST00000437951|ENST00000430669|ENST00000429896|ENST00000375274;SIFT_pred=T|T|T|T|T|T|T;SIFT_score=0.086|0.092|0.092|0.09|0.09|0.092|0.082;Polyphen2_HVAR_pred=B|.|.|B|B|.|B;Polyphen2_HVAR_score=0.079|.|.|0.117|0.117|.|0.164;MutationTaster_pred=P|P|P|P|P|P|P;MutationTaster_score=4.63921e-05|2.6349e-05|2.6349e-05|4.63921e-05|2.6349e-05|2.6349e-05|2.6349e-05;CLNGENE=PTCH1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0784744;G1000_EAS_AF=0.1419;G1000_EUR_AF=0.0129;G1000_AFR_AF=0.1437;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.0115;gnomad_exomes_AF=0.03400908;gnomad_exomes_AF_EAS=0.13240418;gnomad_exomes_AC=5516;gnomad_exomes_Hom=228;gnomad_exomes_Het=5060;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11441500;gnomad_exomes_AF_NFE=0.01245208;gnomad_exomes_AF_AMR=0.01276000;gnomad_exomes_AF_SAS=0.04812036;HGMD_gene=PTCH1;HGMD_disease=Nevoid_basal_cell_carcinoma_syndrome;HGMD_tag=DM?;HGMD_pmid=12925203;NativeFreq_Het=0.2376;NativeFreq_Hom=0.0178;normalHetFrequency=0.163;normalHetNum=141;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.1695;patientHetNum=885;patientHomFrequency=0.0134;patientHomNum=70;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2421;AF_2700_Hom=0.0161;AF_50_Het=0.2742;AF_50_Hom=0.0190;DANN_score=0.9774;GREP_score=4.62;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GGGGAGGGTG.GGGCAGGCGG	GT:AD:DP:GQ:PL	0/1:156,154:310:99:4492,0,4559
chr9	98220322	.	A	C	4452.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.371;DP=313;ExcessHet=3.0103;FS=3.065;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.23;ReadPosRankSum=-1.307;SOR=0.545;HGVSnom=NM_000264.5:c.3141T>G(p.Leu1047Leu/p.L1047L);Gene=PTCH1;Transcript=NM_000264.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E18;IVSnom=.;AAlength=1447;EXAC_AF=0.02394546;EXAC_Hom_EAS=44;EXAC_AC_EAS=858;EXAC_AN_EAS=8626;EXAC_AC_Adj=2894;EXAC_AN_Adj=120858;ESP6500_MAF=0.03582962;RS=rs2066835;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.067492;G1000_EAS_AF=0.1101;G1000_EUR_AF=0.002;G1000_AFR_AF=0.1422;G1000_SAS_AF=0.0337;G1000_AMR_AF=0.0058;gnomad_exomes_AF=0.02146775;gnomad_exomes_AF_EAS=0.10137046;gnomad_exomes_AC=5393;gnomad_exomes_Hom=248;gnomad_exomes_Het=4897;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11270643;gnomad_exomes_AF_NFE=0.00123287;gnomad_exomes_AF_AMR=0.00497282;gnomad_exomes_AF_SAS=0.04335185;NativeFreq_Het=0.1584;NativeFreq_Hom=0.0142;normalHetFrequency=0.1168;normalHetNum=101;normalHomFrequency=0.0058;normalHomNum=5;patientHetFrequency=0.1261;patientHetNum=658;patientHomFrequency=0.0071;patientHomNum=37;normalHetSampleInfo=[_][_];normalHomSampleInfo=[17B0000759][15D6129440|16B0004947|16B0018108|16B0001905-1];patientHetSampleInfo=[_][_];patientHomSampleInfo=[17B0000821|15B0051301|16D0067269|16B0202349|16B0035656-1|16B3094396|16B0011808|17B0000899|16B0202355|16B3258606|16B0024277|16B0047335|16D0016007|16B0011842|16D3102688|17B0000861|16B0028414|16B0033325|15B0051532|16B3094601|16B0025311][15B0047098|16B0004976|16B0028142|15B1884173|15B0002973|16B0033833|16B0019046-1|16B0012189|16B3094648|16B0047232|16B0011504|16B0011717|15D6104550|16B0009401-1|15B0066668|15B0051396];AF_2700_Het=0.1729;AF_2700_Hom=0.0073;AF_50_Het=0.2044;AF_50_Hom=0.0063;DANN_score=0.6741;GREP_score=-2.94;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=AGGGGTTCAG.AGGAAGACAG	GT:AD:DP:GQ:PL	0/1:180,133:313:99:4481,0,5803
chr9	98221861	.	T	C	5156.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.815;DP=322;ExcessHet=3.0103;FS=3.139;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.01;ReadPosRankSum=1.932;SOR=0.524;HGVSnom=NM_000264.5:c.2887+21A>G;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_000264.5:IVS17+21A>G;AAlength=1447;EXAC_AF=0.35629850;EXAC_Hom_EAS=524;EXAC_AC_EAS=2992;EXAC_AN_EAS=8622;EXAC_AC_Adj=43162;EXAC_AN_Adj=121140;ESP6500_MAF=0.45594341;RS=rs2236406;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.392572;G1000_EAS_AF=0.3433;G1000_EUR_AF=0.338;G1000_AFR_AF=0.6899;G1000_SAS_AF=0.2117;G1000_AMR_AF=0.232;gnomad_exomes_AF=0.34452684;gnomad_exomes_AF_EAS=0.35246437;gnomad_exomes_AC=86510;gnomad_exomes_Hom=16510;gnomad_exomes_Het=53490;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.66929425;gnomad_exomes_AF_NFE=0.36011281;gnomad_exomes_AF_AMR=0.17948866;gnomad_exomes_AF_SAS=0.25895074;NativeFreq_Het=0.5544;NativeFreq_Hom=0.1317;normalHetFrequency=0.4289;normalHetNum=371;normalHomFrequency=0.1318;normalHomNum=114;patientHetFrequency=0.4467;patientHetNum=2332;patientHomFrequency=0.1255;patientHomNum=655;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4631;AF_2700_Hom=0.1434;AF_50_Het=0.4802;AF_50_Hom=0.1616;DANN_score=0.3172;GREP_score=-0.421;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=TTCCCAGACC.CCCGATAAAA	GT:AD:DP:GQ:PL	0/1:161,161:322:99:5185,0,4969
chr9	98229389	.	C	G	5043.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.192;DP=357;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.17;ReadPosRankSum=0.268;SOR=0.689;HGVSnom=NM_000264.5:c.2560+9G>C|NR_038982.1:n.368C>G;Gene=PTCH1|LOC100507346;Transcript=NM_000264.5|NR_038982.1;VarType=Intron|Noncoding;MolecularConsequence=coding_transcript_intron_variant|noncoding_transcript_exon_variant;ExonIntron=I15|E2;IVSnom=NM_000264.5:IVS15+9G>C|.;AAlength=1447|.;EXAC_AF=0.35829625;EXAC_Hom_EAS=496;EXAC_AC_EAS=2919;EXAC_AN_EAS=8550;EXAC_AC_Adj=43313;EXAC_AN_Adj=120886;ESP6500_MAF=0.45394433;RS=rs2066829;CLNGENE=LOC100507346|PTCH1;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.390575;G1000_EAS_AF=0.3383;G1000_EUR_AF=0.3459;G1000_AFR_AF=0.6793;G1000_SAS_AF=0.2137;G1000_AMR_AF=0.2305;gnomad_exomes_AF=0.34710048;gnomad_exomes_AF_EAS=0.34860536;gnomad_exomes_AC=87041;gnomad_exomes_Hom=16607;gnomad_exomes_Het=53827;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65193302;gnomad_exomes_AF_NFE=0.36613012;gnomad_exomes_AF_AMR=0.18382523;gnomad_exomes_AF_SAS=0.26104575;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1388;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.1329;normalHomNum=115;patientHetFrequency=0.4466;patientHetNum=2331;patientHomFrequency=0.1201;patientHomNum=627;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4527;AF_2700_Hom=0.1426;AF_50_Het=0.4580;AF_50_Hom=0.1648;DANN_score=0.2029;GREP_score=-1.15;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GCCTCCCACG.CGTCTTACCC	GT:AD:DP:GQ:PL	0/1:194,162:356:99:5072,0,6261
chr9	98239147	.	A	G	2437.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.2;DP=171;ExcessHet=3.0103;FS=2.895;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=0.453;SOR=0.481;HGVSnom=NM_000264.5:c.1504-8T>C;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000264.5:IVS10-8T>C;AAlength=1447;EXAC_AF=0.04762978;EXAC_Hom_EAS=85;EXAC_AC_EAS=1187;EXAC_AN_EAS=7850;EXAC_AC_Adj=5281;EXAC_AN_Adj=110876;ESP6500_MAF=0.07381209;RS=rs2277184;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.105032;G1000_EAS_AF=0.1429;G1000_EUR_AF=0.0129;G1000_AFR_AF=0.236;G1000_SAS_AF=0.0419;G1000_AMR_AF=0.0231;gnomad_exomes_AF=0.04071215;gnomad_exomes_AF_EAS=0.13985555;gnomad_exomes_AC=10169;gnomad_exomes_Hom=598;gnomad_exomes_Het=8973;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20453982;gnomad_exomes_AF_NFE=0.01245675;gnomad_exomes_AF_AMR=0.01912822;gnomad_exomes_AF_SAS=0.04877567;NativeFreq_Het=0.2475;NativeFreq_Hom=0.0142;normalHetFrequency=0.1688;normalHetNum=146;normalHomFrequency=0.0139;normalHomNum=12;patientHetFrequency=0.1753;patientHetNum=915;patientHomFrequency=0.0134;patientHomNum=70;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2517;AF_2700_Hom=0.0169;AF_50_Het=0.2837;AF_50_Hom=0.0222;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00001998;DANN_score=0.5535;GREP_score=-3.85;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=AACCTACAGC.AAAACAGAGG	GT:AD:DP:GQ:PL	0/1:88,83:171:99:2466,0,2869
chr9	98269418	.	CG	C	3566.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.576;DP=255;ExcessHet=3.0103;FS=1.512;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.04;ReadPosRankSum=-0.244;SOR=0.591;HGVSnom=NM_000264.5:c.202-538delC;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000264.5:IVS1-538delC;AAlength=1447;RS=rs11362678;G1000_AF=0.222843;G1000_EAS_AF=0.2361;G1000_EUR_AF=0.2177;G1000_AFR_AF=0.3139;G1000_SAS_AF=0.1554;G1000_AMR_AF=0.1326;NativeFreq_Het=0.1040;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0012336][_];CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083607.1:-,PTCH1:NM_001083606.1:-,PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083607.1:NP_001077076.1,PTCH1:NM_001083606.1:NP_001077075.1,PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083607.1:.,PTCH1:NM_001083606.1:.,PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GTGGTGAGCG.GCCGCCGGAG	GT:AD:DP:GQ:PL	0/1:137,117:254:99:3604,0,4310
chr9	98270168	.	A	G	1596.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.418;DP=75;ExcessHet=3.0103;FS=2.567;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.29;ReadPosRankSum=0.798;SOR=1.276;HGVSnom=NM_000264.5:c.201+275T>C;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000264.5:IVS1+275T>C;AAlength=1447;RS=rs1355620;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.327676;G1000_EAS_AF=0.3185;G1000_EUR_AF=0.3181;G1000_AFR_AF=0.5204;G1000_SAS_AF=0.1697;G1000_AMR_AF=0.2104;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=0.0022;patientHomNum=6;normalHetSampleInfo=[16D0166694][_];normalHomSampleInfo=[15B0063045][_];patientHetSampleInfo=[16B0202521|16B3108728][_];patientHomSampleInfo=[16B0200503|16B0009428-1|16D1878049|15B0062912|16B3258571|16B3098102-1][_];DANN_score=0.7345;GREP_score=0.456;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GAAAAGGCAC.CCAGGGAGGG	GT:AD:DP:GQ:PL	0/1:35,40:75:99:1625,0,2023
chr9	98270171	.	A	G	1596.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.17;DP=76;ExcessHet=3.0103;FS=1.065;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.01;ReadPosRankSum=0.704;SOR=0.906;HGVSnom=NM_000264.5:c.201+272T>C;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000264.5:IVS1+272T>C;AAlength=1447;RS=rs1355619;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.360024;G1000_EAS_AF=0.3185;G1000_EUR_AF=0.3191;G1000_AFR_AF=0.6354;G1000_SAS_AF=0.1697;G1000_AMR_AF=0.2233;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0025;patientHomNum=7;normalHetSampleInfo=[16D0166694][_];normalHomSampleInfo=[15B0063045][_];patientHetSampleInfo=[16B0202521|16B3108728|16D1545695][_];patientHomSampleInfo=[16B0200503|16B0230488|16B0009428-1|16D1878049|15B0062912|16B3258571|16B3098102-1][_];DANN_score=0.7579;GREP_score=-3.61;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=AAGGCACACC.GGGAGGGCGT	GT:AD:DP:GQ:PL	0/1:35,41:76:99:1625,0,2023
chr9	98270187	.	T	TACAC	1210.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.115;DP=96;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.93;ReadPosRankSum=0.493;SOR=0.77;HGVSnom=NM_000264.5:c.201+252_201+255dupGTGT;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000264.5:IVS1+255_+256insGTGT;AAlength=1447;RS=rs139956254;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.316693;G1000_EAS_AF=0.3135;G1000_EUR_AF=0.3131;G1000_AFR_AF=0.4902;G1000_SAS_AF=0.1687;G1000_AMR_AF=0.2046;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.0065;patientHetNum=18;patientHomFrequency=0.0015;patientHomNum=8;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15B0063045|16B0028085][_];patientHetSampleInfo=[16B0009528-1|16D1533014-1|16D1545693|16B0000727|16D1545700|17D0500518|15B0068087|17B0001586-1|16D1536900|16B0202567|15B6219972|16B0011809|16B3108728|16B0080507|15B0063018|16D0201211|16B0035773-1|16D1545695][_];patientHomSampleInfo=[16B0033666|15B0062912|16B0230488|16B3258571|16B3258606|16B0200503|16B0009428-1][16B0005179];CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GGCGTGTGTA.acacacacac	GT:AD:DP:GQ:PL	0/1:37,39:76:99:1248,0,1538
chr9	98270320	.	AGTGAGTGT	A	3394.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.422;DP=195;ExcessHet=3.0103;FS=6.75;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.96;ReadPosRankSum=-0.41;SOR=0.735;HGVSnom=NM_000264.5:c.201+115_201+122delACACTCAC;Gene=PTCH1;Transcript=NM_000264.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000264.5:IVS1+115_+122delACACTCAC;AAlength=1447;RS=rs71366292;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.1283;normalHetNum=111;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.1364;patientHetNum=712;patientHomFrequency=0.0347;patientHomNum=181;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.32;repName=(TG)n;repClass=Simple_repeat;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083604.1:-,PTCH1:NM_001083605.1:-,PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083604.1:NP_001077073.1,PTCH1:NM_001083605.1:NP_001077074.1,PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083604.1:.,PTCH1:NM_001083605.1:.,PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GAGAGgtgtg.gtgtgtgtgt	GT:AD:DP:GQ:PL	0/1:84,95:179:99:3432,0,4836
chr9	98270646	.	T	TGCC	1043.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.064;DP=88;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.4;ReadPosRankSum=-1.363;SOR=0.732;HGVSnom=NM_000264.5:c.-6_-4dupGGC;Gene=PTCH1;Transcript=NM_000264.5;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1447;EXAC_AF=0;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=0;EXAC_AC_Adj=0;EXAC_AN_Adj=22;RS=rs71366293;CLNGENE=PTCH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.202476;G1000_EAS_AF=0.2014;G1000_EUR_AF=0.2127;G1000_AFR_AF=0.2844;G1000_SAS_AF=0.1452;G1000_AMR_AF=0.1138;gnomad_exomes_AF=0.11863271;gnomad_exomes_AC=177;gnomad_exomes_Hom=12;gnomad_exomes_Het=153;gnomad_exomes_Hemi=0;gnomad_exomes_AF_NFE=0.12875197;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_000264.3:-,PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_000264.3:NP_000255.2,PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_000264.3:ENST00000331920.10,PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GAGGCCATGT.gccgccgccg	GT:AD:DP:GQ:PL	0/1:31,29:60:99:1081,0,1203
chr9	98278729	.	C	G	62.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.309;DP=88;ExcessHet=3.0103;FS=26.479;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.73;ReadPosRankSum=-1.537;SOR=4.615;HGVSnom=.;Gene=PTCH1;Transcript=.;VarType=Upstream10K;MolecularConsequence=upstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs553130743;DANN_score=0.7541;GREP_score=-0.554;CytoBand=q22.32;CGD_CONDITION=Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=PTCH1:NM_001083602.1:-,PTCH1:NM_001083603.1:-;NP=PTCH1:NM_001083602.1:NP_001077071.1,PTCH1:NM_001083603.1:NP_001077072.1;ENSP=PTCH1:NM_001083602.1:.,PTCH1:NM_001083603.1:.;Gene_MIM_id=601309;Phenotypes=Basal cell carcinoma, somatic, 605462 (3). Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Holoprosencephaly 7, 610828 (3), Autosomal dominant. 109400(MK),605462(MK),610828(MK);Possible_Inheritance=AD;EntrezGeneID=5727;EnsemblGeneID=ENSG00000185920;Alias=PTCH1, NBCCS, BCNS, HPE7;FLKSEQ=GCGTCGGCGG.CGCCGCGCTG	GT:AD:DP:GQ:PL	0/1:64,22:86:91:91,0,1096
chr9	100459693	.	G	C	2092.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.172;DP=132;ExcessHet=3.0103;FS=2.389;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.98;ReadPosRankSum=-0.088;SOR=0.995;HGVSnom=.;Gene=PTCSC2;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;EXAC_AF=0.00034473;EXAC_Hom_EAS=0;EXAC_AC_EAS=8;EXAC_AN_EAS=2528;EXAC_AC_Adj=10;EXAC_AN_Adj=29008;RS=rs371953831;gnomad_exomes_AF=0.00022970;gnomad_exomes_AF_EAS=0.00236510;gnomad_exomes_AC=30;gnomad_exomes_Hom=0;gnomad_exomes_Het=30;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00060778;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B0035689-1|16B0067592][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0012;AF_2700_Hom=0.0000;AF_50_Het=0.0032;AF_50_Hom=0.0000;DANN_score=0.7968;GREP_score=3.67;CytoBand=q22.33;FLKSEQ=TTCTGAGTGA.AGCGCCTGCG	GT:AD:DP:GQ:PL	0/1:64,67:131:99:2121,0,2142
chr9	101611887	.	C	G	5547.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.013;DP=374;ExcessHet=3.0103;FS=4.555;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.91;ReadPosRankSum=0.325;SOR=0.907;HGVSnom=NM_024642.5:c.*513C>G;Gene=GALNT12;Transcript=NM_024642.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=581;RS=rs2273849;G1000_AF=0.0766773;G1000_EAS_AF=0.1379;G1000_EUR_AF=0.004;G1000_AFR_AF=0.0658;G1000_SAS_AF=0.0491;G1000_AMR_AF=0.1527;DANN_score=0.6907;GREP_score=-0.219;CytoBand=q22.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 1;CGD_INHERITANCE=AD;Strand=GALNT12:NM_024642.4:+;NP=GALNT12:NM_024642.4:NP_078918.3;ENSP=GALNT12:NM_024642.4:ENST00000375011.3;Gene_MIM_id=610290;Phenotypes={Colorectal cancer, susceptibility to, 1}, 608812 (3). 608812(SK);Possible_Inheritance=NA;EntrezGeneID=79695;EnsemblGeneID=ENSG00000119514;Alias=GALNT12, CRCS1;FLKSEQ=TTGATTTATT.AGGTCATTGA	GT:AD:DP:GQ:PL	0/1:201,171:372:99:5576,0,6729
chr9	125424507	.	A	C	4281.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.881;DP=324;ExcessHet=3.0103;FS=1.321;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.3;ReadPosRankSum=1.05;SOR=0.772;HGVSnom=NM_001005236.3:c.513A>C(p.Ser171Ser/p.S171S);Gene=OR1L1;Transcript=NM_001005236.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=310;EXAC_AF=0.30241736;EXAC_Hom_EAS=1170;EXAC_AC_EAS=4453;EXAC_AN_EAS=8622;EXAC_AC_Adj=36705;EXAC_AN_Adj=121372;ESP6500_MAF=0.35268338;RS=rs70156;G1000_AF=0.44988;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.2147;G1000_AFR_AF=0.7292;G1000_SAS_AF=0.3446;G1000_AMR_AF=0.3213;gnomad_exomes_AF=0.29975642;gnomad_exomes_AF_EAS=0.51174424;gnomad_exomes_AC=75315;gnomad_exomes_Hom=13891;gnomad_exomes_Het=47533;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.67655020;gnomad_exomes_AF_NFE=0.19533189;gnomad_exomes_AF_AMR=0.33447040;gnomad_exomes_AF_SAS=0.38391691;NativeFreq_Het=0.3879;NativeFreq_Hom=0.2206;DANN_score=0.5623;GREP_score=-0.975;CytoBand=q33.2;Strand=OR1L1:NM_001005236.3:+;NP=OR1L1:NM_001005236.3:NP_001005236.3;ENSP=OR1L1:NM_001005236.3:.;FLKSEQ=TCTGTGCCTC.AATGTCATCC	GT:AD:DP:GQ:PL	0/1:178,144:322:99:4310,0,5342
chr9	130587052	.	A	AGGGAGG	1545.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.421;DP=98;ExcessHet=3.0103;FS=3.416;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.44;ReadPosRankSum=-1.179;SOR=0.349;HGVSnom=NM_001114753.3:c.991+21_991+26dupCCTCCC;Gene=ENG;Transcript=NM_001114753.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_001114753.3:IVS7+26_+27insCCTCCC;AAlength=658;EXAC_AF=0.22487429;EXAC_Hom_EAS=196;EXAC_AC_EAS=1569;EXAC_AN_EAS=5160;EXAC_AC_Adj=13953;EXAC_AN_Adj=62048;ESP6500_MAF=0.20999201;RS=rs148063362;CLNGENE=ENG;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.17700976;gnomad_exomes_AF_EAS=0.26292008;gnomad_exomes_AC=27017;gnomad_exomes_Hom=2747;gnomad_exomes_Het=21523;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22933312;gnomad_exomes_AF_NFE=0.15375018;gnomad_exomes_AF_AMR=0.12912337;gnomad_exomes_AF_SAS=0.25887190;normalHetFrequency=0.4046;normalHetNum=350;normalHomFrequency=0.0786;normalHomNum=68;patientHetFrequency=0.3791;patientHetNum=1979;patientHomFrequency=0.0837;patientHomNum=437;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q34.11;repName=(GGGAA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=2.3;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis syndrome;CGD_INHERITANCE=AD;Strand=ENG:NM_001278138.1:-,ENG:NM_000118.3:-,ENG:NM_001114753.2:-;NP=ENG:NM_001278138.1:NP_001265067.1,ENG:NM_000118.3:NP_000109.1,ENG:NM_001114753.2:NP_001108225.1;ENSP=ENG:NM_001278138.1:.,ENG:NM_000118.3:ENST00000344849.4,ENG:NM_001114753.2:.;Gene_MIM_id=131195;Phenotypes=Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant. 187300(MK);Possible_Inheritance=AD;EntrezGeneID=2022;EnsemblGeneID=ENSG00000106991;Alias=ENG, END, HHT1, ORW;FLKSEQ=ggggaaggga.gggaggggca	GT:AD:DP:GQ:PL	0/1:53,41:94:99:1583,0,3762
chr9	130616958	.	T	C	7756.77	PASS	AC=2;AF=1;AN=2;DP=221;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.28;SOR=0.797;HGVSnom=.;Gene=ENG;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs7033891;G1000_AF=0.99401;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9773;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;DANN_score=0.7333;GREP_score=-2.72;CytoBand=q34.11;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis syndrome;CGD_INHERITANCE=AD;Strand=ENG:NM_000118.3:-,ENG:NM_001114753.2:-;NP=ENG:NM_000118.3:NP_000109.1,ENG:NM_001114753.2:NP_001108225.1;ENSP=ENG:NM_000118.3:ENST00000344849.4,ENG:NM_001114753.2:.;Gene_MIM_id=131195;Phenotypes=Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominant. 187300(MK);Possible_Inheritance=AD;EntrezGeneID=2022;EnsemblGeneID=ENSG00000106991;Alias=ENG, END, HHT1, ORW;FLKSEQ=AGGGAGCTCC.GGCTCATCCA	GT:AD:DP:GQ:PL	1/1:0,221:221:99:7785,662,0
chr9	135767943	.	C	T	11871.8	PASS	AC=2;AF=1;AN=2;DP=322;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.26;SOR=0.926;HGVSnom=NM_000368.5:c.*3679G>A;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs1050700;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.725839;G1000_EAS_AF=0.8254;G1000_EUR_AF=0.7485;G1000_AFR_AF=0.5946;G1000_SAS_AF=0.8323;G1000_AMR_AF=0.6484;NativeFreq_Het=0.3580;NativeFreq_Hom=0.6566;normalHetFrequency=0.3438;normalHetNum=164;normalHomFrequency=0.3249;normalHomNum=281;patientHetFrequency=0.1678;patientHetNum=876;patientHomFrequency=0.2778;patientHomNum=1450;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3286;AF_2700_Hom=0.6287;AF_50_Het=0.3312;AF_50_Hom=0.6228;DANN_score=0.7319;GREP_score=-5.03;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=TGGGCGGCAC.CCATCTCACC	GT:AD:DP:GQ:PL	1/1:0,322:322:99:11900,967,0
chr9	135770080	.	TA	T	903.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.255;DP=260;ExcessHet=3.0103;FS=6.327;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.93;ReadPosRankSum=-1.372;SOR=0.34;OLD_VARIANT=chr9|135770080|TA|T,TAA|1;HGVSnom=NM_000368.5:c.*1541delT;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs748099884;NativeFreq_Het=0.0058;NativeFreq_Hom=.;normalHetFrequency=0.4298;normalHetNum=205;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.4481;patientHetNum=1097;patientHomFrequency=0.0045;patientHomNum=11;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6522645|16B0001820-1];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16D0166212|15D6482141-1|15D6515510|15D6529226|15S0055194-1|15D6532209|16D0067175|15D6532219-1|16D0157487|15D6522648|16D0169454];AF_2700_Het=0.6430;AF_2700_Hom=0.0004;AF_50_Het=0.6466;AF_50_Hom=0.0016;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=ATTGCCATGC.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/0:66,94:230:99:941,148,1381
chr9	135770080	.	T	TA	903.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.255;DP=260;ExcessHet=3.0103;FS=6.327;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.93;ReadPosRankSum=-1.372;SOR=0.34;OLD_VARIANT=chr9|135770080|TA|T,TAA|2;HGVSnom=NM_000368.5:c.*1541dupT;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs748099884;CLNGENE=TSC1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.0126;normalHetNum=6;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0147;patientHetNum=36;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0196;AF_2700_Hom=.;AF_50_Het=0.0269;AF_50_Hom=.;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=ATTGCCATGC.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:66,70:230:99:941,366,1902
chr9	135770115	.	C	T	11102.8	PASS	AC=2;AF=1;AN=2;DP=245;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.3;SOR=0.701;HGVSnom=NM_000368.5:c.*1507G>A;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs739441;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.773363;G1000_EAS_AF=0.8214;G1000_EUR_AF=0.83;G1000_AFR_AF=0.6596;G1000_SAS_AF=0.8344;G1000_AMR_AF=0.7522;NativeFreq_Het=0.3827;NativeFreq_Hom=0.6349;normalHetFrequency=0.1873;normalHetNum=162;normalHomFrequency=0.3387;normalHomNum=293;patientHetFrequency=0.3517;patientHetNum=861;patientHomFrequency=0.2791;patientHomNum=1457;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3405;AF_2700_Hom=0.6111;AF_50_Het=0.3471;AF_50_Hom=0.6101;DANN_score=0.5406;GREP_score=1.7;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=CTTTCATTCT.TCTGCTCGAG	GT:AD:DP:GQ:PL	1/1:0,245:245:99:11131,770,0
chr9	135770134	.	G	A	11561.8	PASS	AC=2;AF=1;AN=2;DP=266;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.96;SOR=0.723;HGVSnom=NM_000368.5:c.*1488C>T;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs739442;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.450679;G1000_EAS_AF=0.5813;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.056;G1000_SAS_AF=0.6513;G1000_AMR_AF=0.4957;NativeFreq_Het=0.5093;NativeFreq_Hom=0.3169;normalHetFrequency=0.2486;normalHetNum=215;normalHomFrequency=0.1711;normalHomNum=148;patientHetFrequency=0.473;patientHetNum=1158;patientHomFrequency=0.1443;patientHomNum=753;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4858;AF_2700_Hom=0.3098;AF_50_Het=0.4770;AF_50_Hom=0.3217;DANN_score=0.6674;GREP_score=-1.68;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=AGGCCTCCGT.GGCACTAAGA	GT:AD:DP:GQ:PL	1/1:0,266:266:99:11590,810,0
chr9	135770300	.	G	A	14603.8	PASS	AC=2;AF=1;AN=2;DP=403;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.48;SOR=0.888;HGVSnom=NM_000368.5:c.*1322C>T;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs2809243;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.552117;G1000_EAS_AF=0.5972;G1000_EUR_AF=0.6272;G1000_AFR_AF=0.3457;G1000_SAS_AF=0.6748;G1000_AMR_AF=0.598;NativeFreq_Het=0.5049;NativeFreq_Hom=0.3590;normalHetFrequency=0.2647;normalHetNum=229;normalHomFrequency=0.1792;normalHomNum=155;patientHetFrequency=0.2249;patientHetNum=1174;patientHomFrequency=0.1657;patientHomNum=865;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4773;AF_2700_Hom=0.3294;AF_50_Het=0.4802;AF_50_Hom=0.3265;DANN_score=0.7861;GREP_score=0.981;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=GGCTTCTAGC.TTTCTTTCAG	GT:AD:DP:GQ:PL	1/1:0,402:402:99:14632,1209,0
chr9	135770347	.	A	C	16604.8	PASS	AC=2;AF=1;AN=2;DP=435;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.89;SOR=0.712;HGVSnom=NM_000368.5:c.*1275T>G;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs2809244;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.748203;G1000_EAS_AF=0.6815;G1000_EUR_AF=0.7525;G1000_AFR_AF=0.7776;G1000_SAS_AF=0.7802;G1000_AMR_AF=0.7378;NativeFreq_Het=0.4851;NativeFreq_Hom=0.4711;normalHetFrequency=0.2439;normalHetNum=211;normalHomFrequency=0.4444;normalHomNum=212;patientHetFrequency=0.1989;patientHetNum=1038;patientHomFrequency=0.2243;patientHomNum=1171;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4458;AF_2700_Hom=0.4339;AF_50_Het=0.4358;AF_50_Hom=0.4358;DANN_score=0.552;GREP_score=-1.36;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=GCCACTGCCA.TTTTCTGACT	GT:AD:DP:GQ:PL	1/1:0,434:434:99:16633,1304,0
chr9	135771332	.	GA	G	14794.7	PASS	AC=2;AF=1;AN=2;DP=434;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.09;SOR=0.935;HGVSnom=NM_000368.5:c.*289delT;Gene=TSC1;Transcript=NM_000368.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1164;RS=rs11323835;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.439097;G1000_EAS_AF=0.5655;G1000_EUR_AF=0.5149;G1000_AFR_AF=0.1369;G1000_SAS_AF=0.6155;G1000_AMR_AF=0.4726;NativeFreq_Het=0.4027;NativeFreq_Hom=.;normalHetFrequency=0.2948;normalHetNum=255;normalHomFrequency=0.2035;normalHomNum=176;patientHetFrequency=0.2686;patientHetNum=1402;patientHomFrequency=0.1904;patientHomNum=994;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4885;AF_2700_Hom=0.2902;AF_50_Het=0.4707;AF_50_Hom=0.2995;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=ATTTGGGGGG.AAGGAAGAAA	GT:AD:DP:GQ:PL	1/1:0,422:422:99:14832,1268,0
chr9	135773000	.	G	GA	3565.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.55;DP=316;ExcessHet=3.0103;FS=1.569;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.98;ReadPosRankSum=-0.549;SOR=0.429;OLD_VARIANT=chr9|135773000|G|GA,GAA|1;HGVSnom=NM_000368.5:c.2626-4dupT;Gene=TSC1;Transcript=NM_000368.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000368.5:IVS20-4_-3insT;AAlength=1164;EXAC_AF=0.16855810;EXAC_Hom_EAS=13;EXAC_AC_EAS=987;EXAC_AN_EAS=5654;EXAC_AC_Adj=13516;EXAC_AN_Adj=80186;RS=rs5901000;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.16991254;gnomad_exomes_AF_EAS=0.17424789;gnomad_exomes_AC=17641;gnomad_exomes_Hom=883;gnomad_exomes_Het=15875;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14627980;gnomad_exomes_AF_NFE=0.16450267;gnomad_exomes_AF_AMR=0.17955848;gnomad_exomes_AF_SAS=0.19140216;HGMD_gene=TSC1;HGMD_disease=Neurofibromatosis_1;HGMD_tag=DM;HGMD_pmid=29849115;NativeFreq_Het=0.0482;NativeFreq_Hom=.;normalHetFrequency=0.0289;normalHetNum=25;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.0379;patientHetNum=198;patientHomFrequency=0.0111;patientHomNum=58;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=TCTACTTCCT.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/0:47,55:255:99:3603,1698,1793
chr9	135773000	.	G	GAA	3565.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.55;DP=316;ExcessHet=3.0103;FS=1.569;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.98;ReadPosRankSum=-0.549;SOR=0.429;OLD_VARIANT=chr9|135773000|G|GA,GAA|2;HGVSnom=NM_000368.5:c.2626-5_2626-4dupTT;Gene=TSC1;Transcript=NM_000368.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000368.5:IVS20-4_-3insTT;AAlength=1164;EXAC_AF=0.15326865;EXAC_Hom_EAS=10;EXAC_AC_EAS=783;EXAC_AN_EAS=5654;EXAC_AC_Adj=12290;EXAC_AN_Adj=80186;RS=rs5901000;CLNGENE=TSC1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.17797426;gnomad_exomes_AF_EAS=0.19867629;gnomad_exomes_AC=18478;gnomad_exomes_Hom=910;gnomad_exomes_Het=16658;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10522514;gnomad_exomes_AF_NFE=0.17493274;gnomad_exomes_AF_AMR=0.19860128;gnomad_exomes_AF_SAS=0.20945239;NativeFreq_Het=0.0498;NativeFreq_Hom=.;normalHetFrequency=0.326;normalHetNum=282;normalHomFrequency=0.1977;normalHomNum=171;patientHetFrequency=0.3471;patientHetNum=1812;patientHomFrequency=0.1979;patientHomNum=1033;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5334;AF_2700_Hom=0.1426;AF_50_Het=0.5404;AF_50_Hom=0.1284;CytoBand=q34.13;CGD_CONDITION=Tuberous sclerosis. Lymphangioleiomyomatosis;CGD_INHERITANCE=AD;Strand=TSC1:NM_000368.4:-,TSC1:NM_001162426.1:-,TSC1:NM_001162427.1:-;NP=TSC1:NM_000368.4:NP_000359.1,TSC1:NM_001162426.1:NP_001155898.1,TSC1:NM_001162427.1:NP_001155899.1;ENSP=TSC1:NM_000368.4:ENST00000298552.8,TSC1:NM_001162426.1:.,TSC1:NM_001162427.1:.;Gene_MIM_id=605284;Phenotypes=Lymphangioleiomyomatosis, 606690 (3). Tuberous sclerosis-1, 191100 (3), Autosomal dominant. 191100(MK),606690(MK),607341(MK);Possible_Inheritance=AD;EntrezGeneID=7248;EnsemblGeneID=ENSG00000165699;Alias=TSC1, LAM;FLKSEQ=TCTACTTCCT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:47,153:255:99:3603,291,781
chr10	43572458	.	C	CCCCCG	631.84	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.618;DP=17;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=25.94;ReadPosRankSum=-1.124;SOR=4.294;HGVSnom=.;Gene=RET;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs386134265;CLNGENE=LOC106736614|RET;CLNSIG=Uncertain_significance|Uncertain_significance;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;CytoBand=q11.21;repName=(CCCCG)n;repClass=Simple_repeat;FLKSEQ=ccctggaccg.ccccgccccg	GT:AD:DP:GQ:PL	0/1:1,16:17:16:669,0,16
chr10	43572507	.	A	G	1744.77	StandardFilter	AC=2;AF=1;AN=2;BaseQRankSum=1.783;DP=39;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=25.8;ReadPosRankSum=1.335;SOR=5.943;HGVSnom=.;Gene=RET;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs10900296;CLNGENE=LOC106736614|RET;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.736821;G1000_EAS_AF=0.5179;G1000_EUR_AF=0.7505;G1000_AFR_AF=0.9123;G1000_SAS_AF=0.7004;G1000_AMR_AF=0.7522;NativeFreq_Het=0.2079;NativeFreq_Hom=0.2277;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=0.0084;normalHomNum=4;patientHetFrequency=0.0069;patientHetNum=17;patientHomFrequency=0.0102;patientHomNum=25;normalHetSampleInfo=[_][17B0005695|15B0002482];normalHomSampleInfo=[_][14B0718594-A|15B0002483|16B0019265-1|16D0155905];patientHetSampleInfo=[_][15B0002570-1|16B3259993|16B0005396|15B0058492|15B6105407|15B0002485|14D1336304-1|15B6325547|15B6217383|16D1546073|16D1545997|16D1546270|15B0002467|15B0011921|16D1546169|15D6511752-1|16B3094836];patientHomSampleInfo=[_][_];AF_2700_Het=0.2663;AF_2700_Hom=0.2463;AF_50_Het=0.2789;AF_50_Hom=0.2488;DANN_score=0.4662;GREP_score=0.416;CytoBand=q11.21;FLKSEQ=GCCGGCGCTT.CCTCGCTTCA	GT:AD:DP:GQ:PL	1/1:1,38:39:76:1773,76,0
chr10	43572511	.	C	A	1778.77	StandardFilter	AC=2;AF=1;AN=2;BaseQRankSum=-1.721;DP=43;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.23;ReadPosRankSum=1.292;SOR=6.138;HGVSnom=.;Gene=RET;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs10900297;CLNGENE=LOC106736614|RET;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.409545;G1000_EAS_AF=0.3046;G1000_EUR_AF=0.3917;G1000_AFR_AF=0.4879;G1000_SAS_AF=0.41;G1000_AMR_AF=0.438;NativeFreq_Het=0.3168;NativeFreq_Hom=0.0693;normalHetFrequency=0.0063;normalHetNum=3;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.0074;patientHetNum=18;patientHomFrequency=0.0074;patientHomNum=18;normalHetSampleInfo=[_][17B0005695|16D1878132|15B0002482];normalHomSampleInfo=[_][14B0718594-A];patientHetSampleInfo=[_][15B0002570-1|16B3259993|16D1545837|16B0005396|15B0058492|17B0005531|17D0500506|15B6105407|16D0176682-1|15B6325547|16D1545970|14B0037377-A|16D1546073|16D1545997|16D1546270|16D1546169|16D1546279|16B3094836];patientHomSampleInfo=[_][15B0033121|15B0002685-1|15B6215002|15B0045754|17B0501007|15B6104367|15B0022287|15D6217203-1|15D6522047|16B0018081|15B0002868|16D1545676|17B0001558-1|15B0011925|15B0058155|15B0048053|15B6219947|14D1336301-1];AF_2700_Het=0.2294;AF_2700_Hom=0.1145;AF_50_Het=0.2393;AF_50_Hom=0.0998;DANN_score=0.6778;GREP_score=-0.908;CytoBand=q11.21;FLKSEQ=GCGCTTACCT.GCTTCAGTCC	GT:AD:DP:GQ:PL	1/1:1,42:43:79:1807,79,0
chr10	43572832	.	G	A	3776.77	PASS	AC=2;AF=1;AN=2;DP=103;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.82;SOR=1.542;HGVSnom=NM_020975.6:c.73+53G>A;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_020975.6:IVS1+53G>A;AAlength=1114;RS=rs12267460;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.365415;G1000_EAS_AF=0.3046;G1000_EUR_AF=0.3917;G1000_AFR_AF=0.3313;G1000_SAS_AF=0.41;G1000_AMR_AF=0.4179;NativeFreq_Het=0.3506;NativeFreq_Hom=0.0928;normalHetFrequency=0.0092;normalHetNum=8;normalHomFrequency=0.0464;normalHomNum=18;patientHetFrequency=0.0178;patientHetNum=93;patientHomFrequency=0.019;patientHomNum=99;normalHetSampleInfo=[16B0050586|17B0000758|17B0005598|16D1546100|16B3258555|16D1546229|16B0035696-1][16D1546084];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9846;GREP_score=0.493;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=AGTTGGCGCC.AGCAGCGGAG	GT:AD:DP:GQ:PL	1/1:0,103:103:99:3805,310,0
chr10	43595836	.	A	AT	3128.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.444;DP=281;ExcessHet=3.0103;FS=0.675;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.5;ReadPosRankSum=-0.576;SOR=0.598;HGVSnom=NM_020975.6:c.74-57dupT;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_020975.6:IVS1-57_-56insT;AAlength=1114;RS=rs57003029;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.261182;G1000_EAS_AF=0.3204;G1000_EUR_AF=0.2932;G1000_AFR_AF=0.1483;G1000_SAS_AF=0.2955;G1000_AMR_AF=0.2954;NativeFreq_Het=0.2921;NativeFreq_Hom=.;normalHetFrequency=0.548;normalHetNum=474;normalHomFrequency=0.0717;normalHomNum=62;patientHetFrequency=0.501;patientHetNum=2615;patientHomFrequency=0.0697;patientHomNum=364;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.21;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=taaattaatg.tttttttttt	GT:AD:DP:GQ:PL	0/1:89,183:272:99:3166,0,1082
chr10	43595968	.	A	G	11010.8	PASS	AC=2;AF=1;AN=2;DP=311;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.53;SOR=0.739;HGVSnom=NM_020975.6:c.135A>G(p.Ala45Ala/p.A45A);Gene=RET;Transcript=NM_020975.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=1114;EXAC_AF=0.73652873;EXAC_Hom_EAS=1303;EXAC_AC_EAS=4729;EXAC_AN_EAS=8612;EXAC_AC_Adj=89064;EXAC_AN_Adj=120924;ESP6500_MAF=0.80916500;RS=rs1800858;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.753594;G1000_EAS_AF=0.5268;G1000_EUR_AF=0.7435;G1000_AFR_AF=0.9803;G1000_SAS_AF=0.6943;G1000_AMR_AF=0.7493;gnomad_exomes_AF=0.73115636;gnomad_exomes_AF_EAS=0.55132811;gnomad_exomes_AC=182618;gnomad_exomes_Hom=67582;gnomad_exomes_Het=47454;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95300519;gnomad_exomes_AF_NFE=0.74012718;gnomad_exomes_AF_AMR=0.75885417;gnomad_exomes_AF_SAS=0.72898418;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=10528857;NativeFreq_Het=0.4554;NativeFreq_Hom=0.3465;DANN_score=0.3128;GREP_score=-6.48;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=TGGACCAGGC.GCCGGCACGC	GT:AD:DP:GQ:PL	1/1:0,309:309:99:11039,929,0
chr10	43600324	.	GCC	G	4968.73	PASS	AC=2;AF=1;AN=2;DP=119;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.09;SOR=1.449;HGVSnom=NM_020975.6:c.626-72_626-71delCC;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_020975.6:IVS3-72_-71delCC;AAlength=1114;RS=rs144431581;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.305112;G1000_EAS_AF=0.3006;G1000_EUR_AF=0.3688;G1000_AFR_AF=0.1415;G1000_SAS_AF=0.4029;G1000_AMR_AF=0.3934;NativeFreq_Het=0.3168;NativeFreq_Hom=.;normalHetFrequency=0.1838;normalHetNum=159;normalHomFrequency=0.104;normalHomNum=90;patientHetFrequency=0.2008;patientHetNum=1048;patientHomFrequency=0.099;patientHomNum=517;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=TGACCGCAGA.CCCTTCCCGA	GT:AD:DP:GQ:PL	1/1:0,113:113:99:5006,341,0
chr10	43600689	.	A	G	8244.77	PASS	AC=2;AF=1;AN=2;DP=234;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.71;SOR=0.728;HGVSnom=NM_020975.6:c.867+48A>G;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_020975.6:IVS4+48A>G;AAlength=1114;EXAC_AF=0.42742897;EXAC_Hom_EAS=778;EXAC_AC_EAS=3624;EXAC_AN_EAS=8414;EXAC_AC_Adj=49492;EXAC_AN_Adj=115790;ESP6500_MAF=0.37297797;RS=rs2435352;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.390974;G1000_EAS_AF=0.4206;G1000_EUR_AF=0.4076;G1000_AFR_AF=0.2542;G1000_SAS_AF=0.5051;G1000_AMR_AF=0.4236;gnomad_exomes_AF=0.42778383;gnomad_exomes_AF_EAS=0.43122656;gnomad_exomes_AC=103664;gnomad_exomes_Hom=22572;gnomad_exomes_Het=58520;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.30173194;gnomad_exomes_AF_NFE=0.41003726;gnomad_exomes_AF_AMR=0.50551149;gnomad_exomes_AF_SAS=0.51277169;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=12872262;NativeFreq_Het=0.4675;NativeFreq_Hom=0.2169;normalHetFrequency=0.4243;normalHetNum=367;normalHomFrequency=0.2497;normalHomNum=216;patientHetFrequency=0.4443;patientHetNum=2319;patientHomFrequency=0.2126;patientHomNum=1110;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2893;GREP_score=-0.354;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=GTCTCCGGCC.CAGTTCGTTT	GT:AD:DP:GQ:PL	1/1:0,232:232:99:8273,697,0
chr10	43601749	.	T	C	9244.77	PASS	AC=2;AF=1;AN=2;DP=245;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.68;SOR=1.202;HGVSnom=NM_020975.6:c.868-75T>C;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_020975.6:IVS4-75T>C;AAlength=1114;RS=rs2742243;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.728435;G1000_EAS_AF=0.5198;G1000_EUR_AF=0.7445;G1000_AFR_AF=0.8949;G1000_SAS_AF=0.6912;G1000_AMR_AF=0.7435;NativeFreq_Het=0.4752;NativeFreq_Hom=0.3361;normalHetFrequency=0.3618;normalHetNum=313;normalHomFrequency=0.3942;normalHomNum=341;patientHetFrequency=0.3778;patientHetNum=1972;patientHomFrequency=0.3929;patientHomNum=2051;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6839;GREP_score=-0.715;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=CGTGCAGCAT.CTAAGGTCTC	GT:AD:DP:GQ:PL	1/1:0,243:243:99:9273,730,0
chr10	43604390	.	A	T	5641.77	PASS	AC=2;AF=1;AN=2;DP=156;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.77;SOR=2.804;HGVSnom=NM_020975.6:c.1064-89A>T;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_020975.6:IVS5-89A>T;AAlength=1114;RS=rs1864404;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.751997;G1000_EAS_AF=0.5198;G1000_EUR_AF=0.7445;G1000_AFR_AF=0.9788;G1000_SAS_AF=0.6912;G1000_AMR_AF=0.7536;NativeFreq_Het=0.4851;NativeFreq_Hom=0.3325;normalHetFrequency=0.4439;normalHetNum=384;normalHomFrequency=0.3884;normalHomNum=336;patientHetFrequency=0.4554;patientHetNum=2377;patientHomFrequency=0.3795;patientHomNum=1981;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4807;GREP_score=-0.711;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=CACCAGTGTG.GTGCAGGGCT	GT:AD:DP:GQ:PL	1/1:0,156:156:99:5670,469,0
chr10	43606687	.	A	G	4927.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.878;DP=288;ExcessHet=3.0103;FS=6.447;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.17;ReadPosRankSum=0.465;SOR=0.438;HGVSnom=NM_020975.6:c.1296A>G(p.Ala432Ala/p.A432A);Gene=RET;Transcript=NM_020975.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=1114;EXAC_AF=0.70606755;EXAC_Hom_EAS=2814;EXAC_AC_EAS=6975;EXAC_AN_EAS=8638;EXAC_AC_Adj=85670;EXAC_AN_Adj=121334;ESP6500_MAF=0.74857758;RS=rs1800860;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.77516;G1000_EAS_AF=0.8006;G1000_EUR_AF=0.7237;G1000_AFR_AF=0.8903;G1000_SAS_AF=0.7536;G1000_AMR_AF=0.6239;gnomad_exomes_AF=0.69590054;gnomad_exomes_AF_EAS=0.79892309;gnomad_exomes_AC=174813;gnomad_exomes_Hom=61725;gnomad_exomes_Het=51363;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.86412308;gnomad_exomes_AF_NFE=0.69070894;gnomad_exomes_AF_AMR=0.54415337;gnomad_exomes_AF_SAS=0.74242226;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=14627689;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6542;normalHetFrequency=0.3052;normalHetNum=264;normalHomFrequency=0.6555;normalHomNum=567;patientHetFrequency=0.3182;patientHetNum=1661;patientHomFrequency=0.6354;patientHomNum=3317;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2963;AF_2700_Hom=0.6560;AF_50_Het=0.2853;AF_50_Hom=0.6609;DANN_score=0.3745;GREP_score=1.43;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=ACTGCCAGGC.TTCAGTGGCA	GT:AD:DP:GQ:PL	0/1:117,170:287:99:4956,0,3416
chr10	43607756	.	G	A	8861.77	PASS	AC=2;AF=1;AN=2;DP=202;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.54;SOR=2.21;HGVSnom=NM_020975.6:c.1648+84G>A;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_020975.6:IVS8+84G>A;AAlength=1114;RS=rs3026750;G1000_AF=0.701677;G1000_EAS_AF=0.496;G1000_EUR_AF=0.7674;G1000_AFR_AF=0.8616;G1000_SAS_AF=0.5992;G1000_AMR_AF=0.745;NativeFreq_Het=0.4566;NativeFreq_Hom=0.2880;normalHetFrequency=0.4509;normalHetNum=390;normalHomFrequency=0.3468;normalHomNum=300;patientHetFrequency=0.4533;patientHetNum=2366;patientHomFrequency=0.3494;patientHomNum=1824;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5399;GREP_score=-2.89;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=CCAGCCTGGG.TGGCTCTCCC	GT:AD:DP:GQ:PL	1/1:0,202:202:99:8890,608,0
chr10	43607759	.	GC	G	8800.73	PASS	AC=2;AF=1;AN=2;DP=190;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.1;SOR=2.204;HGVSnom=NM_020975.6:c.1648+88delC;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_020975.6:IVS8+88delC;AAlength=1114;RS=rs34827976;G1000_AF=0.70008;G1000_EAS_AF=0.4911;G1000_EUR_AF=0.7664;G1000_AFR_AF=0.8616;G1000_SAS_AF=0.5982;G1000_AMR_AF=0.7435;NativeFreq_Het=0.3960;NativeFreq_Hom=.;normalHetFrequency=0.4624;normalHetNum=400;normalHomFrequency=0.3353;normalHomNum=290;patientHetFrequency=0.4575;patientHetNum=2388;patientHomFrequency=0.3443;patientHomNum=1797;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=GCCTGGGGTG.TCTCCCTGCT	GT:AD:DP:GQ:PL	1/1:0,190:190:99:8838,602,0
chr10	43613843	.	G	T	11383.8	PASS	AC=2;AF=1;AN=2;DP=314;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.33;SOR=0.95;HGVSnom=NM_020975.6:c.2307G>T(p.Leu769Leu/p.L769L);Gene=RET;Transcript=NM_020975.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=1114;EXAC_AF=0.74191013;EXAC_Hom_EAS=1052;EXAC_AC_EAS=4292;EXAC_AN_EAS=8586;EXAC_AC_Adj=89691;EXAC_AN_Adj=120892;ESP6500_MAF=0.80262956;RS=rs1800861;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.71246;G1000_EAS_AF=0.4742;G1000_EUR_AF=0.7644;G1000_AFR_AF=0.9206;G1000_SAS_AF=0.5982;G1000_AMR_AF=0.7478;gnomad_exomes_AF=0.73921259;gnomad_exomes_AF_EAS=0.50567190;gnomad_exomes_AC=185430;gnomad_exomes_Hom=69586;gnomad_exomes_Het=46258;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.88455375;gnomad_exomes_AF_NFE=0.76880876;gnomad_exomes_AF_AMR=0.77066798;gnomad_exomes_AF_SAS=0.64256752;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=10528857;NativeFreq_Het=0.4752;NativeFreq_Hom=0.3168;DANN_score=0.7308;GREP_score=3.66;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=CGAGTGAGCT.CGAGACCTGC	GT:AD:DP:GQ:PL	1/1:0,312:312:99:11412,937,0
chr10	43615505	.	G	A	10267.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.978;DP=284;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=25.97;ReadPosRankSum=-0.404;SOR=0.472;HGVSnom=NM_020975.6:c.2608-24G>A;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_020975.6:IVS14-24G>A;AAlength=1114;EXAC_AF=0.21267395;EXAC_Hom_EAS=217;EXAC_AC_EAS=1959;EXAC_AN_EAS=8308;EXAC_AC_Adj=24147;EXAC_AN_Adj=113540;ESP6500_MAF=0.19767799;RS=rs2472737;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.173123;G1000_EAS_AF=0.1974;G1000_EUR_AF=0.2147;G1000_AFR_AF=0.1256;G1000_SAS_AF=0.1595;G1000_AMR_AF=0.1873;gnomad_exomes_AF=0.20411650;gnomad_exomes_AF_EAS=0.23313557;gnomad_exomes_AC=50418;gnomad_exomes_Hom=5325;gnomad_exomes_Het=39768;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14982179;gnomad_exomes_AF_NFE=0.22611717;gnomad_exomes_AF_AMR=0.15309218;gnomad_exomes_AF_SAS=0.15950046;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=21222160;NativeFreq_Het=0.4455;NativeFreq_Hom=0.0594;normalHetFrequency=0.3133;normalHetNum=271;normalHomFrequency=0.0601;normalHomNum=52;patientHetFrequency=0.3464;patientHetNum=1808;patientHomFrequency=0.0498;patientHomNum=260;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3759;AF_2700_Hom=0.0634;AF_50_Het=0.3899;AF_50_Hom=0.0586;DANN_score=0.7374;GREP_score=2.65;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=ATGGCCTGAC.ACTCGTGCTA	GT:AD:DP:GQ:PL	1/1:2,281:283:99:10296,808,0
chr10	43622217	.	T	C	9825.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=2.08;DP=260;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=24.7;ReadPosRankSum=0.631;SOR=1.261;HGVSnom=NM_020975.6:c.3187+47T>C;Gene=RET;Transcript=NM_020975.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_020975.6:IVS19+47T>C;AAlength=1114;EXAC_AF=0.80309449;EXAC_Hom_EAS=838;EXAC_AC_EAS=3464;EXAC_AN_EAS=6472;EXAC_AC_Adj=83411;EXAC_AN_Adj=103862;ESP6500_MAF=0.85333026;RS=rs2075912;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.754992;G1000_EAS_AF=0.4762;G1000_EUR_AF=0.828;G1000_AFR_AF=0.9425;G1000_SAS_AF=0.6953;G1000_AMR_AF=0.781;gnomad_exomes_AF=0.79050731;gnomad_exomes_AF_EAS=0.51150171;gnomad_exomes_AC=185804;gnomad_exomes_Hom=74321;gnomad_exomes_Het=37162;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91720715;gnomad_exomes_AF_NFE=0.82657649;gnomad_exomes_AF_AMR=0.79734965;gnomad_exomes_AF_SAS=0.73993943;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=12872262;NativeFreq_Het=0.4554;NativeFreq_Hom=0.3036;DANN_score=0.6998;GREP_score=4.95;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020630.4:+,RET:NM_020975.4:+;NP=RET:NM_020630.4:NP_065681.1,RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020630.4:.,RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=GCTGTCCCCT.TGCACTATCC	GT:AD:DP:GQ:PL	1/1:2,257:259:99:9854,729,0
chr10	43623812	.	C	T	18040.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.396;DP=500;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=26.96;ReadPosRankSum=-1.49;SOR=0.354;HGVSnom=NM_020975.6:c.*95C>T;Gene=RET;Transcript=NM_020975.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1114;RS=rs17028;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.136581;G1000_EAS_AF=0.1994;G1000_EUR_AF=0.2117;G1000_AFR_AF=0.0083;G1000_SAS_AF=0.1524;G1000_AMR_AF=0.1585;NativeFreq_Het=0.4455;NativeFreq_Hom=0.0594;normalHetFrequency=0.3075;normalHetNum=266;normalHomFrequency=0.0555;normalHomNum=48;patientHetFrequency=0.3402;patientHetNum=1776;patientHomFrequency=0.0477;patientHomNum=249;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3755;AF_2700_Hom=0.0630;AF_50_Het=0.3930;AF_50_Hom=0.0586;DANN_score=0.8544;GREP_score=3.45;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020975.4:+;NP=RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=TCACATTGGC.GAGCCGTGTT	GT:AD:DP:GQ:PL	1/1:1,498:499:99:18069,1461,0
chr10	43624072	.	T	C	7019.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.287;DP=446;ExcessHet=3.0103;FS=2.443;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.81;ReadPosRankSum=0.022;SOR=0.783;HGVSnom=NM_020975.6:c.*355T>C;Gene=RET;Transcript=NM_020975.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1114;RS=rs1838384253;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][15B0022624];patientHomSampleInfo=[_][_];DANN_score=0.7627;GREP_score=1.93;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020975.4:+;NP=RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=GTGTATGAAA.TGGACCTGAA	GT:AD:DP:GQ:PL	0/1:221,223:444:99:7048,0,6751
chr10	43624317	.	A	T	3800.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.82;DP=338;ExcessHet=3.0103;FS=9.968;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.38;ReadPosRankSum=1.191;SOR=0.418;HGVSnom=NM_020975.6:c.*600A>T;Gene=RET;Transcript=NM_020975.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1114;RS=rs2742240;G1000_AF=0.752396;G1000_EAS_AF=0.4762;G1000_EUR_AF=0.8231;G1000_AFR_AF=0.9418;G1000_SAS_AF=0.6902;G1000_AMR_AF=0.7781;NativeFreq_Het=0.4752;NativeFreq_Hom=0.3465;DANN_score=0.5824;GREP_score=-8.08;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020975.4:+;NP=RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=GATTTTTTTT.AATCATGCAA	GT:AD:DP:GQ:PL	0/1:165,169:334:99:3829,0,5117
chr10	43624833	.	T	C	12625.8	PASS	AC=2;AF=1;AN=2;DP=353;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.17;SOR=1.146;HGVSnom=NM_020975.6:c.*1116T>C;Gene=RET;Transcript=NM_020975.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1114;RS=rs2435355;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.189896;G1000_EAS_AF=0.2004;G1000_EUR_AF=0.2356;G1000_AFR_AF=0.1483;G1000_SAS_AF=0.1738;G1000_AMR_AF=0.2104;NativeFreq_Het=0.4455;NativeFreq_Hom=0.0594;normalHetFrequency=0.3354;normalHetNum=160;normalHomFrequency=0.065;normalHomNum=31;patientHetFrequency=0.1649;patientHetNum=861;patientHomFrequency=0.0249;patientHomNum=130;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3762;AF_2700_Hom=0.0646;AF_50_Het=0.3914;AF_50_Hom=0.0618;DANN_score=0.8692;GREP_score=3.24;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020975.4:+;NP=RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=TTATAGAGCC.GTGTGAAAGG	GT:AD:DP:GQ:PL	1/1:0,353:353:99:12654,1061,0
chr10	43625223	.	G	A	12629.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.478;DP=367;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.6;ReadPosRankSum=0.361;SOR=0.261;HGVSnom=NM_020975.6:c.*1506G>A;Gene=RET;Transcript=NM_020975.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1114;RS=rs2742241;CLNGENE=RET;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.747204;G1000_EAS_AF=0.4792;G1000_EUR_AF=0.8231;G1000_AFR_AF=0.9221;G1000_SAS_AF=0.6881;G1000_AMR_AF=0.7767;HGMD_gene=RET;HGMD_disease=Hirschsprung_disease_association_with;HGMD_tag=DP;HGMD_pmid=12872262;NativeFreq_Het=0.4950;NativeFreq_Hom=0.3267;normalHetFrequency=0.2497;normalHetNum=216;normalHomFrequency=0.2092;normalHomNum=181;patientHetFrequency=0.2182;patientHetNum=1139;patientHomFrequency=0.163;patientHomNum=851;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4858;AF_2700_Hom=0.2902;AF_50_Het=0.5008;AF_50_Hom=0.2868;DANN_score=0.5635;GREP_score=-4.72;CytoBand=q11.21;CGD_CONDITION=Central hypoventilation syndrome, congenital. Multiple endocrine neoplasia, type IIA. Multiple endocrine neoplasia, type IIB. Medullary thyroid carcinoma, familial. Pheochromocytoma. Hirschsprung disease, susceptibility to 1;CGD_INHERITANCE=AD/AR;Strand=RET:NM_020975.4:+;NP=RET:NM_020975.4:NP_066124.1;ENSP=RET:NM_020975.4:ENST00000355710.7;Gene_MIM_id=164761;Phenotypes=Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant. {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant. Medullary thyroid carcinoma, 155240 (3), Autosomal dominant. Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant. Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 142623(SK),155240(MK),162300(MK),171300(MK),171400(MK),191830(MK),209880(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5979;EnsemblGeneID=ENSG00000165731;Alias=RET, MEN2A, HSCR1;FLKSEQ=ATAGAGCCTT.TGGTGTGTGC	GT:AD:DP:GQ:PL	1/1:1,364:365:99:12658,1055,0
chr10	51568378	.	T	G	4830.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.317;DP=322;ExcessHet=3.0103;FS=4.319;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.05;ReadPosRankSum=-1.662;SOR=0.922;HGVSnom=NM_001290117.2:c.515-164394T>G|NR_158661.1:n.781-161491T>G|NM_001145263.2:c.-15+3082T>G;Gene=TIMM23B|TIMM23B-AGAP6|NCOA4;Transcript=NM_001290117.2|NR_158661.1|NM_001145263.2;VarType=Intron|Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|noncoding_transcript_intron_variant|5_prime_UTR_intron_variant;ExonIntron=I6|I7|I1;IVSnom=NM_001290117.2:IVS6-164394T>G|NR_158661.1:IVS7-161491T>G|NM_001145263.2:IVS1+3082T>G;AAlength=188|.|614;EXAC_AF=0.51641337;EXAC_Hom_EAS=71;EXAC_AC_EAS=303;EXAC_AN_EAS=620;EXAC_AC_Adj=10194;EXAC_AN_Adj=19740;ESP6500_MAF=0.41349102;RS=rs10761581;G1000_AF=0.459665;G1000_EAS_AF=0.5119;G1000_EUR_AF=0.4433;G1000_AFR_AF=0.3222;G1000_SAS_AF=0.7055;G1000_AMR_AF=0.3228;gnomad_exomes_AF=0.44497411;gnomad_exomes_AF_EAS=0.52396755;gnomad_exomes_AC=68235;gnomad_exomes_Hom=16362;gnomad_exomes_Het=35511;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34803050;gnomad_exomes_AF_NFE=0.43132932;gnomad_exomes_AF_AMR=0.27573589;gnomad_exomes_AF_SAS=0.65752759;NativeFreq_Het=0.6138;NativeFreq_Hom=0.1683;AF_2700_Het=0.4954;AF_2700_Hom=0.2840;AF_50_Het=0.4659;AF_50_Hom=0.2995;DANN_score=0.7353;GREP_score=0.858;CytoBand=q11.23;Strand=TIMM23B:NM_001290117.1:+,TIMM23B:NM_001290118.1:+,NCOA4:NM_001145260.1:+,NCOA4:NM_001145261.1:+,NCOA4:NM_001145263.1:+;NP=TIMM23B:NM_001290117.1:NP_001277046.1,TIMM23B:NM_001290118.1:NP_001277047.1,NCOA4:NM_001145260.1:NP_001138732.1,NCOA4:NM_001145261.1:NP_001138733.1,NCOA4:NM_001145263.1:NP_001138735.1;ENSP=TIMM23B:NM_001290117.1:.,TIMM23B:NM_001290118.1:.,NCOA4:NM_001145260.1:ENST00000578454.5,NCOA4:NM_001145261.1:.,NCOA4:NM_001145263.1:.;Gene_MIM_id=601984;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=8031;EnsemblGeneID=ENSG00000266412;Alias=NCOA4, ELE1, PTC3;FLKSEQ=GTTGACCACT.TTGCTCTAGC	GT:AD:DP:GQ:PL	0/1:168,153:321:99:4859,0,5438
chr10	88683890	.	T	A	15011.8	PASS	AC=2;AF=1;AN=2;DP=426;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=44.23;QD=31.99;SOR=0.876;HGVSnom=NM_004329.3:c.*414T>A;Gene=BMPR1A;Transcript=NM_004329.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E13;IVSnom=.;AAlength=532;RS=rs7078571;G1000_AF=0.965455;G1000_EAS_AF=0.9573;G1000_EUR_AF=0.9364;G1000_AFR_AF=0.9818;G1000_SAS_AF=0.9816;G1000_AMR_AF=0.9654;NativeFreq_Het=0.0198;NativeFreq_Hom=0.8019;DANN_score=0.6191;GREP_score=3.73;CytoBand=q23.2;dupName=chr6:129477680,chr11:121231094;dupScore=0;CGD_CONDITION=Polyposis syndrome, hereditary mixed, 2. Polyposis, juvenile intestinal;CGD_INHERITANCE=AD;Strand=BMPR1A:NM_004329.2:+;NP=BMPR1A:NM_004329.2:NP_004320.2;ENSP=BMPR1A:NM_004329.2:ENST00000372037.7;Gene_MIM_id=601299;Phenotypes=Juvenile polyposis syndrome, infantile form, 174900 (3), Autosomal dominant. Polyposis syndrome, hereditary mixed, 2, 610069 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 174900(MK),610069(MK);Possible_Inheritance=AD;EntrezGeneID=657;EnsemblGeneID=ENSG00000107779;Alias=BMPR1A, ACVRLK3, ALK3;FLKSEQ=TACCTGAGAC.TTCAGTTCGT	GT:AD:DP:GQ:PL	1/1:0,426:426:99:15040,1281,0
chr10	88684222	.	A	G	856.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.362;DP=375;ExcessHet=3.0103;FS=44.141;MLEAC=1;MLEAF=0.5;MQ=41.85;MQRankSum=-4.803;QD=2.28;ReadPosRankSum=1.563;SOR=2.857;HGVSnom=NM_004329.3:c.*746A>G;Gene=BMPR1A;Transcript=NM_004329.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E13;IVSnom=.;AAlength=532;RS=rs61856965;CLNGENE=BMPR1A;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B0005295][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0796;AF_2700_Hom=0.0000;AF_50_Het=0.0713;AF_50_Hom=0.0000;DANN_score=0.8447;GREP_score=5.54;CytoBand=q23.2;dupName=chr6:129477680,chr11:121231094;dupScore=0;CGD_CONDITION=Polyposis syndrome, hereditary mixed, 2. Polyposis, juvenile intestinal;CGD_INHERITANCE=AD;Strand=BMPR1A:NM_004329.2:+;NP=BMPR1A:NM_004329.2:NP_004320.2;ENSP=BMPR1A:NM_004329.2:ENST00000372037.7;Gene_MIM_id=601299;Phenotypes=Juvenile polyposis syndrome, infantile form, 174900 (3), Autosomal dominant. Polyposis syndrome, hereditary mixed, 2, 610069 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 174900(MK),610069(MK);Possible_Inheritance=AD;EntrezGeneID=657;EnsemblGeneID=ENSG00000107779;Alias=BMPR1A, ACVRLK3, ALK3;FLKSEQ=GCCAAGGCCA.AAGAAGTTTA	GT:AD:DP:GQ:PL	0/1:320,55:375:99:885,0,10569
chr10	88684973	.	T	C	2217.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.483;DP=107;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.73;ReadPosRankSum=-0.099;SOR=0.882;HGVSnom=NM_004329.3:c.*1497T>C;Gene=BMPR1A;Transcript=NM_004329.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E13;IVSnom=.;AAlength=532;RS=rs17335915;G1000_AF=0.195487;G1000_EAS_AF=0.0952;G1000_EUR_AF=0.2753;G1000_AFR_AF=0.1528;G1000_SAS_AF=0.1605;G1000_AMR_AF=0.3559;NativeFreq_Het=0.2178;NativeFreq_Hom=0.0099;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16B0005712][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=_;patientHomSampleInfo=_;AF_2700_Het=0.1514;AF_2700_Hom=0.0096;AF_50_Het=0.1553;AF_50_Hom=0.0063;DANN_score=0.7336;GREP_score=2.43;CytoBand=q23.2;Gene_MIM_id=601299;Phenotypes=Juvenile polyposis syndrome, infantile form, 174900 (3), Autosomal dominant. Polyposis syndrome, hereditary mixed, 2, 610069 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 174900(MK),610069(MK);Possible_Inheritance=AD;EntrezGeneID=657;EnsemblGeneID=ENSG00000107779;Alias=BMPR1A, ACVRLK3, ALK3;FLKSEQ=AAATCTGATT.ACATAAACTT	GT:AD:DP:GQ:PL	0/1:43,64:107:99:2246,0,1300
chr10	89620210	.	T	C	6498.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.326;DP=398;ExcessHet=3.0103;FS=1.624;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.37;ReadPosRankSum=-1.842;SOR=0.79;HGVSnom=NM_001126049.2:c.*1498A>G;Gene=KLLN;Transcript=NM_001126049.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=178;RS=rs1903860;G1000_AF=0.164137;G1000_EAS_AF=0.3323;G1000_EUR_AF=0.1302;G1000_AFR_AF=0.0696;G1000_SAS_AF=0.1288;G1000_AMR_AF=0.1988;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0047149][_];DANN_score=0.8507;GREP_score=-0.744;CytoBand=q23.31;CGD_CONDITION=Cowden syndrome 4 ;CGD_INHERITANCE=AD;Strand=KLLN:NM_001126049.1:-;NP=KLLN:NM_001126049.1:NP_001119521.1;ENSP=KLLN:NM_001126049.1:ENST00000445946.4;Gene_MIM_id=612105;Phenotypes=Cowden syndrome 4, 615107 (3). 615107(MK);Possible_Inheritance=NA;EntrezGeneID=100144748;EnsemblGeneID=ENSG00000227268;Alias=KLLN, CWS4;FLKSEQ=TCTCATATTC.AGCACTTTAG	GT:AD:DP:GQ:PL	0/1:202,195:397:99:6527,0,6347
chr10	89623716	.	G	A	1600.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.682;DP=144;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.12;ReadPosRankSum=-1.835;SOR=0.69;HGVSnom=NM_000314.8:c.-511G>A;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=403;RS=rs12573787;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.160343;G1000_EAS_AF=0.3313;G1000_EUR_AF=0.1302;G1000_AFR_AF=0.0575;G1000_SAS_AF=0.1278;G1000_AMR_AF=0.1974;NativeFreq_Het=0.2673;NativeFreq_Hom=0.1089;normalHetFrequency=0.1992;normalHetNum=95;normalHomFrequency=0.0647;normalHomNum=56;patientHetFrequency=0.2198;patientHetNum=538;patientHomFrequency=0.0607;patientHomNum=317;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3732;AF_2700_Hom=0.1503;AF_50_Het=0.3661;AF_50_Hom=0.1648;DANN_score=0.9861;GREP_score=3.26;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=CCTGGAGCGG.GGGGAGAAgc	GT:AD:DP:GQ:PL	0/1:80,64:144:99:1629,0,2591
chr10	89623860	.	CT	C	5029.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.774;DP=146;ExcessHet=3.0103;FS=1.57;MLEAC=2;MLEAF=1;MQ=54.17;MQRankSum=2.487;QD=33.17;ReadPosRankSum=1.802;SOR=1.072;HGVSnom=NM_000314.8:c.-366delT;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=403;RS=rs71022512;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0.4901;NativeFreq_Hom=.;normalHetFrequency=0.0063;normalHetNum=3;normalHomFrequency=0.4682;normalHomNum=405;patientHetFrequency=0.0034;patientHetNum=18;patientHomFrequency=0.4025;patientHomNum=2101;normalHetSampleInfo=[_][16B0000953|17B0005476|16B0001856-1];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0009499-1][15D0025100|14B0033478|16B0012322|16B0033893|15D6482016-1|16B3108776|16D0067120|15B0058423|15B0033014|15D6104520|15B0058390|16B0005186|15B6324685|15D6532213|15D6722269|15B0047099|15B0002843-1];patientHomSampleInfo=[_][_];AF_2700_Het=0.0046;AF_2700_Hom=0.9766;AF_50_Het=0.0048;AF_50_Hom=0.9826;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=GCGGCGGCGG.GGCACATCCA	GT:AD:DP:GQ:PL	1/1:6,134:140:99:5067,151,0
chr10	89623901	.	G	C	3818.77	PASS	AC=2;AF=1;AN=2;DP=102;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.41;QD=31.42;SOR=1.935;HGVSnom=NM_000314.8:c.-326G>C;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=403;RS=rs2943772;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.8933;GREP_score=2.68;CytoBand=q23.31;repName=GC_rich;repClass=Low_complexity;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=AACCTCCCGT.cgccgccgcc	GT:AD:DP:GQ:PL	1/1:0,101:101:99:3847,303,0
chr10	89624218	.	C	G	5376.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.561;DP=348;ExcessHet=3.0103;FS=3.462;MLEAC=1;MLEAF=0.5;MQ=54.48;MQRankSum=-4.614;QD=15.45;ReadPosRankSum=-0.23;SOR=0.894;HGVSnom=NM_000314.8:c.-9C>G;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=403;EXAC_AF=0.00362426;EXAC_Hom_EAS=12;EXAC_AC_EAS=394;EXAC_AN_EAS=8648;EXAC_AC_Adj=440;EXAC_AN_Adj=121404;ESP6500_MAF=0.00015378;RS=rs11202592;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.0109824;G1000_EAS_AF=0.0506;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0041;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00382135;gnomad_exomes_AF_EAS=0.04729803;gnomad_exomes_AC=961;gnomad_exomes_Hom=20;gnomad_exomes_Het=921;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00012307;gnomad_exomes_AF_AMR=0.00002891;gnomad_exomes_AF_SAS=0.00218840;HGMD_gene=PTEN;HGMD_disease=Diabetes_type_2_association_with;HGMD_tag=DP;HGMD_pmid=14623110;NativeFreq_Het=0.1636;NativeFreq_Hom=0.0062;normalHetFrequency=0.0855;normalHetNum=74;normalHomFrequency=0.0063;normalHomNum=3;patientHetFrequency=0.078;patientHetNum=407;patientHomFrequency=0.0029;patientHomNum=15;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0002681-1|15B0047126|16B3094094];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0051301|16B0200465|16B1175098|17B0005741|16B1175151|16B0009411-1|16B0047193|15B0002770-1|16D0201215|16B0033859][17D0500512|16B1587021|16B0017978|15S0031500|15B6305692];AF_2700_Het=0.1157;AF_2700_Hom=0.0042;AF_50_Het=0.1094;AF_50_Hom=0.0032;DANN_score=0.938;GREP_score=3.78;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=CAGCCACAGG.TCCCAGACAT	GT:AD:DP:GQ:PL	0/1:174,174:348:99:5405,0,5539
chr10	89653686	.	A	G	10167.8	StandardFilter	AC=2;AF=1;AN=2;BaseQRankSum=1.786;DP=255;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.48;ReadPosRankSum=0.442;SOR=4.481;HGVSnom=NM_000314.8:c.80-96A>G;Gene=PTEN;Transcript=NM_000314.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000314.8:IVS1-96A>G;AAlength=403;RS=rs1903858;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.417931;G1000_EAS_AF=0.505;G1000_EUR_AF=0.3479;G1000_AFR_AF=0.4939;G1000_SAS_AF=0.2883;G1000_AMR_AF=0.4308;NativeFreq_Het=0.4950;NativeFreq_Hom=0.2673;normalHetFrequency=0.4382;normalHetNum=379;normalHomFrequency=0.2197;normalHomNum=190;patientHetFrequency=0.4395;patientHetNum=2294;patientHomFrequency=0.2276;patientHomNum=1188;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6886;GREP_score=-5.38;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=AGTGGGGAAA.CTTTCTTTTC	GT:AD:DP:GQ:PL	1/1:1,254:255:99:10196,757,0
chr10	89720633	.	C	CT	1289.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.98;DP=234;ExcessHet=3.0103;FS=2.391;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.2;ReadPosRankSum=-0.256;SOR=0.393;HGVSnom=NM_000314.8:c.802-3dupT;Gene=PTEN;Transcript=NM_000314.8;VarType=Intron+SpliceAcceptor;MolecularConsequence=coding_transcript_intron_variant+splice_acceptor_variant;ExonIntron=I7;IVSnom=NM_000314.8:IVS7-3_-2insT;AAlength=403;EXAC_AF=0.17616888;EXAC_Hom_EAS=3;EXAC_AC_EAS=849;EXAC_AN_EAS=2764;EXAC_AC_Adj=8312;EXAC_AN_Adj=47182;ESP6500_MAF=0.14021210;RS=rs34003473;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.19186207;gnomad_exomes_AF_EAS=0.30899133;gnomad_exomes_AC=22223;gnomad_exomes_Hom=36;gnomad_exomes_Het=22151;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16314064;gnomad_exomes_AF_NFE=0.17716520;gnomad_exomes_AF_AMR=0.23820005;gnomad_exomes_AF_SAS=0.16417412;HGMD_gene=PTEN;HGMD_disease=Bannayan-Riley-Ruvalcaba_syndrome;HGMD_tag=DM?;HGMD_pmid=10400993;NativeFreq_Het=0.1832;NativeFreq_Hom=.;normalHetFrequency=0.4012;normalHetNum=347;normalHomFrequency=0.0185;normalHomNum=16;patientHetFrequency=0.4054;patientHetNum=2116;patientHomFrequency=0.0153;patientHomNum=80;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5427;AF_2700_Hom=0.0123;AF_50_Het=0.5468;AF_50_Hom=0.0111;CytoBand=q23.31;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=tttttctttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:113,95:208:99:1327,0,1532
chr10	89720907	.	T	G	14975.8	PASS	AC=2;AF=1;AN=2;DP=399;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=47.87;QD=25.18;SOR=1.156;HGVSnom=NM_000314.8:c.1026+32T>G;Gene=PTEN;Transcript=NM_000314.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000314.8:IVS8+32T>G;AAlength=403;EXAC_AF=0.36991438;EXAC_Hom_EAS=979;EXAC_AC_EAS=4121;EXAC_AN_EAS=8534;EXAC_AC_Adj=43897;EXAC_AN_Adj=118668;ESP6500_MAF=0.37864302;RS=rs555895;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.432508;G1000_EAS_AF=0.504;G1000_EUR_AF=0.3708;G1000_AFR_AF=0.5257;G1000_SAS_AF=0.2904;G1000_AMR_AF=0.4409;gnomad_exomes_AF=0.37330574;gnomad_exomes_AF_EAS=0.48870211;gnomad_exomes_AC=92706;gnomad_exomes_Hom=17918;gnomad_exomes_Het=56870;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49809586;gnomad_exomes_AF_NFE=0.33524146;gnomad_exomes_AF_AMR=0.45742580;gnomad_exomes_AF_SAS=0.30876390;NativeFreq_Het=0.5374;NativeFreq_Hom=0.1993;normalHetFrequency=0.452;normalHetNum=391;normalHomFrequency=0.2197;normalHomNum=190;patientHetFrequency=0.4649;patientHetNum=2427;patientHomFrequency=0.2238;patientHomNum=1168;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.373;GREP_score=-5.37;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=GTGGGGGTTG.TGACTTGTAT	GT:AD:DP:GQ:PL	1/1:0,399:399:99:15004,1199,0
chr10	89725293	.	CT	C	213.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.905;DP=367;ExcessHet=3.0103;FS=2.833;MLEAC=1;MLEAF=0.5;MQ=59.51;MQRankSum=-7.583;QD=0.59;ReadPosRankSum=-0.594;SOR=0.502;HGVSnom=NM_000314.8:c.*75delT;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=403;RS=rs878853930;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0553;NativeFreq_Hom=.;normalHetFrequency=0.0277;normalHetNum=24;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0205;patientHetNum=107;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0058;AF_2700_Hom=.;AF_50_Het=0.0032;AF_50_Hom=.;CytoBand=q23.31;dupName=chr9:33674357,chr17:54445431;dupScore=0;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=GAAAATGGAC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:312,49:361:99:251,0,6929
chr10	89726659	.	GTT	G	2025.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.753;DP=260;ExcessHet=3.0103;FS=7.614;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.78;ReadPosRankSum=-0.893;SOR=0.241;OLD_VARIANT=chr10|89726659|GTT|G,GTTT|1;HGVSnom=NM_000314.8:c.*1458_*1459delTT;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=403;RS=rs5786797;CLNGENE=PTEN;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0100;NativeFreq_Hom=.;normalHetFrequency=0.0419;normalHetNum=20;normalHomFrequency=0.0063;normalHomNum=3;patientHetFrequency=0.0511;patientHetNum=125;patientHomFrequency=0.0049;patientHomNum=12;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16D0157336|15D6515568-2|16D0172236];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0028490|16D1878063|16B0047255|16B0033899|16D0067143|16B0033531|16B0047430|16B0017699|15D6482378|16D0067249|15B6105710|16B0028364];AF_2700_Het=0.0999;AF_2700_Hom=0.0265;AF_50_Het=0.1252;AF_50_Hom=0.0396;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=AAAGAATAGG.tttttttttt	GT:AD:DP:GQ:PL	1/0:18,104:172:99:2063,398,1160
chr10	89726659	.	G	GT	2025.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.753;DP=260;ExcessHet=3.0103;FS=7.614;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.78;ReadPosRankSum=-0.893;SOR=0.241;OLD_VARIANT=chr10|89726659|GTT|G,GTTT|2;HGVSnom=NM_000314.8:c.*1459dupT;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=403;RS=rs5786797;CLNGENE=PTEN;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.021;normalHetNum=10;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.009;patientHetNum=22;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16B0019221-1|15D6529230];patientHetSampleInfo=[_][16B0047410|16B0411277|16B0024652|16B0047567|16B3094819|16B3108762|16B0033946|16B0067662-1|15B0048380|16B0005488|16B3108161|16B0012071|16B3094578|16B0017731|16B0067577-1|16B0047488|16D1878050|16B0009379-1|16D0168735|16B3098164-1|16D0177665|16B0005150];patientHomSampleInfo=[_][16B3258551|16B3098161-1|16B0017846];AF_2700_Het=0.0438;AF_2700_Hom=.;AF_50_Het=0.0507;AF_50_Hom=.;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=AAAGAATAGG.tttttttttt	GT:AD:DP:GQ:PL	0/1:18,50:172:99:2063,1665,2344
chr10	89727414	.	C	T	3513.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.096;DP=252;ExcessHet=3.0103;FS=0.97;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14;ReadPosRankSum=0.045;SOR=0.786;HGVSnom=NM_000314.8:c.*2185C>T;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=403;RS=rs11202607;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0788738;G1000_EAS_AF=0.1359;G1000_EUR_AF=0.0765;G1000_AFR_AF=0.0461;G1000_SAS_AF=0.0317;G1000_AMR_AF=0.1282;NativeFreq_Het=0.1636;NativeFreq_Hom=0.0198;normalHetFrequency=0.1782;normalHetNum=85;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.0824;patientHetNum=430;patientHomFrequency=0.011;patientHomNum=27;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6129440|15B6215646];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1772;AF_2700_Hom=0.0096;AF_50_Het=0.1537;AF_50_Hom=0.0095;DANN_score=0.8402;GREP_score=2.31;CytoBand=q23.31;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=CATATTAAAA.GTAACTTTAT	GT:AD:DP:GQ:PL	0/1:137,114:251:99:3542,0,3940
chr10	89727644	.	C	G	4012.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.22;DP=232;ExcessHet=3.0103;FS=10.917;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.37;ReadPosRankSum=0.041;SOR=0.322;HGVSnom=NM_000314.8:c.*2415C>G;Gene=PTEN;Transcript=NM_000314.8;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=403;RS=rs34761252;CLNGENE=PTEN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0103834;G1000_EAS_AF=0.003;G1000_EUR_AF=0.0298;G1000_AFR_AF=0.0023;G1000_SAS_AF=0.0061;G1000_AMR_AF=0.0144;normalHetFrequency=0.0105;normalHetNum=5;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0094;patientHetNum=23;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15D6482473-1|16D0166604|16D1536871|16D0161325|15D6529864|16D1546032|15B0002796-1|15D6518710|16D1546142|15D6517223|15B6217404|16D0168799|15D6482039-1|15D6523812|16D0172357|16D1545749|16B0019057-1|15D6523836|15D6482415-1|16D1545701|15D6482196-1|15D6523849|16D1545623];patientHomSampleInfo=[_][15D6522035];AF_2700_Het=0.0012;AF_2700_Hom=0.0000;AF_50_Het=0.0016;AF_50_Hom=0.0000;DANN_score=0.9047;GREP_score=5.1;CytoBand=q23.31;repName=(TA)n;repClass=Simple_repeat;CGD_CONDITION=PTEN hamartoma tumor syndrome. Cowden syndrome 1. Bannayan-Riley-Ruvalcaba syndrome. Lhermitte-Duclos syndrome. Glioma susceptibility 2. Meningioma, familial. Endometrial cancer;CGD_INHERITANCE=AD;Strand=PTEN:NM_000314.6:+,PTEN:NM_001304717.2:+,PTEN:NM_001304718.1:+;NP=PTEN:NM_000314.6:NP_000305.3,PTEN:NM_001304717.2:NP_001291646.2,PTEN:NM_001304718.1:NP_001291647.1;ENSP=PTEN:NM_000314.6:ENST00000371953.7,PTEN:NM_001304717.2:.,PTEN:NM_001304718.1:.;Gene_MIM_id=601728;Phenotypes=Bannayan-Riley-Ruvalcaba syndrome, 153480 (3), Autosomal dominant. Cowden syndrome 1, 158350 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). {Glioma susceptibility 2}, 613028 (3). Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant. Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant. Malignant melanoma, somatic, 155600 (3). {Meningioma}, 607174 (3), Autosomal dominant. PTEN hamartoma tumor syndrome (3). {Prostate cancer, somatic}, 176807 (3). Squamous cell carcinoma, head and neck, somatic, 275355 (3). VATER association with macrocephaly and ventriculomegaly, 276950 (3), Autosomal recessive. 153480(MK),155600(MK),158350(MK),176807(SK),275355(MK),276950(MK),601728(MK),605309(MK),607174(SK),608089(MK),613028(SK);Possible_Inheritance=AD,AR;EntrezGeneID=5728;EnsemblGeneID=ENSG00000171862;Alias=PTEN, MMAC1, GLM2, CWS1;FLKSEQ=atatattata.ataCTCTCCT	GT:AD:DP:GQ:PL	0/1:104,127:231:99:4041,0,3370
chr10	95279506	.	A	T	3884.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.15;DP=304;ExcessHet=3.0103;FS=3.776;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.78;ReadPosRankSum=1.262;SOR=0.711;HGVSnom=NM_018131.5:c.1133A>T(p.His378Leu/p.H378L);Gene=CEP55;Transcript=NM_018131.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E8;IVSnom=.;AAlength=464;EXAC_AF=0.70332097;EXAC_Hom_EAS=1396;EXAC_AC_EAS=4901;EXAC_AN_EAS=8636;EXAC_AC_Adj=85348;EXAC_AN_Adj=121350;ESP6500_MAF=0.61025680;RS=rs2293277;Ensembl_transcriptid=ENST00000371485;SIFT_pred=T;SIFT_score=0.089;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.084;MutationTaster_pred=P;MutationTaster_score=0.0345161;CLNGENE=CEP55;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.559704;G1000_EAS_AF=0.5437;G1000_EUR_AF=0.7525;G1000_AFR_AF=0.2587;G1000_SAS_AF=0.6769;G1000_AMR_AF=0.7118;gnomad_exomes_AF=0.71438520;gnomad_exomes_AF_EAS=0.57309910;gnomad_exomes_AC=179525;gnomad_exomes_Hom=66113;gnomad_exomes_Het=47299;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31601625;gnomad_exomes_AF_NFE=0.76585842;gnomad_exomes_AF_AMR=0.75670908;gnomad_exomes_AF_SAS=0.69189807;NativeFreq_Het=0.4591;NativeFreq_Hom=0.3416;DANN_score=0.976;GREP_score=5.79;CytoBand=q23.33;CGD_CONDITION=Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly (MARCH);CGD_INHERITANCE=AR;Strand=CEP55:NM_001127182.1:+,CEP55:NM_018131.4:+;NP=CEP55:NM_001127182.1:NP_001120654.1,CEP55:NM_018131.4:NP_060601.3;ENSP=CEP55:NM_001127182.1:.,CEP55:NM_018131.4:.;Gene_MIM_id=610000;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=55165;EnsemblGeneID=ENSG00000138180;Alias=CEP55;FLKSEQ=CATCAATTGC.TGTAATTCTT	GT:AD:DP:GQ:PL	0/1:169,135:304:99:3913,0,4867
chr10	104264107	.	C	T	3904.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.157;DP=270;ExcessHet=3.0103;FS=7.475;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.46;ReadPosRankSum=-0.155;SOR=1.077;HGVSnom=NM_016169.4:c.182+16C>T;Gene=SUFU;Transcript=NM_016169.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_016169.4:IVS1+16C>T;AAlength=484;EXAC_AF=0.48567006;EXAC_Hom_EAS=437;EXAC_AC_EAS=2668;EXAC_AN_EAS=8380;EXAC_AC_Adj=57108;EXAC_AN_Adj=117586;ESP6500_MAF=0.47954790;RS=rs2274351;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.396166;G1000_EAS_AF=0.3065;G1000_EUR_AF=0.5706;G1000_AFR_AF=0.3026;G1000_SAS_AF=0.4591;G1000_AMR_AF=0.3631;gnomad_exomes_AF=0.47572760;gnomad_exomes_AF_EAS=0.32223804;gnomad_exomes_AC=117166;gnomad_exomes_Hom=29598;gnomad_exomes_Het=57970;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31314336;gnomad_exomes_AF_NFE=0.54812673;gnomad_exomes_AF_AMR=0.29942301;gnomad_exomes_AF_SAS=0.48853662;NativeFreq_Het=0.4057;NativeFreq_Hom=0.1815;AF_2700_Het=0.4312;AF_2700_Hom=0.1138;AF_50_Het=0.4263;AF_50_Hom=0.1173;DANN_score=0.9697;GREP_score=-2.05;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_001178133.1:+,SUFU:NM_016169.3:+;NP=SUFU:NM_001178133.1:NP_001171604.1,SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_001178133.1:.,SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=CTCTGGGCCG.GGGGAGACGG	GT:AD:DP:GQ:PL	0/1:128,142:270:99:3933,0,3449
chr10	104359350	.	T	C	4162.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.095;DP=283;ExcessHet=3.0103;FS=0.469;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.76;ReadPosRankSum=1.437;SOR=0.648;HGVSnom=NM_016169.4:c.1022+49T>C;Gene=SUFU;Transcript=NM_016169.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_016169.4:IVS8+49T>C;AAlength=484;EXAC_AF=0.16060744;EXAC_Hom_EAS=709;EXAC_AC_EAS=3407;EXAC_AN_EAS=7854;EXAC_AC_Adj=18307;EXAC_AN_Adj=113986;ESP6500_MAF=0.12867251;RS=rs3824756;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.248003;G1000_EAS_AF=0.4355;G1000_EUR_AF=0.0944;G1000_AFR_AF=0.2307;G1000_SAS_AF=0.2413;G1000_AMR_AF=0.2406;gnomad_exomes_AF=0.16188048;gnomad_exomes_AF_EAS=0.41791129;gnomad_exomes_AC=39358;gnomad_exomes_Hom=4517;gnomad_exomes_Het=30324;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22427591;gnomad_exomes_AF_NFE=0.08676774;gnomad_exomes_AF_AMR=0.26861702;gnomad_exomes_AF_SAS=0.22585003;NativeFreq_Het=0.3701;NativeFreq_Hom=0.0925;DANN_score=0.4513;GREP_score=-0.719;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_001178133.1:+,SUFU:NM_016169.3:+;NP=SUFU:NM_001178133.1:NP_001171604.1,SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_001178133.1:.,SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=GACTTTTTTC.GAAGGGCCTG	GT:AD:DP:GQ:PL	0/1:132,150:282:99:4191,0,3903
chr10	104387019	.	T	C	4655.77	PASS	AC=2;AF=1;AN=2;DP=123;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.92;SOR=2.565;HGVSnom=NM_016169.4:c.1365+19T>C;Gene=SUFU;Transcript=NM_016169.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_016169.4:IVS11+19T>C;AAlength=484;EXAC_AF=0.66275295;EXAC_Hom_EAS=2405;EXAC_AC_EAS=6451;EXAC_AN_EAS=8640;EXAC_AC_Adj=80437;EXAC_AN_Adj=121368;ESP6500_MAF=0.68114716;RS=rs12414407;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.719649;G1000_EAS_AF=0.75;G1000_EUR_AF=0.6899;G1000_AFR_AF=0.7761;G1000_SAS_AF=0.7055;G1000_AMR_AF=0.6311;gnomad_exomes_AF=0.65868111;gnomad_exomes_AF_EAS=0.74475372;gnomad_exomes_AC=165628;gnomad_exomes_Hom=55054;gnomad_exomes_Het=55520;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75446154;gnomad_exomes_AF_NFE=0.64742699;gnomad_exomes_AF_AMR=0.57767496;gnomad_exomes_AF_SAS=0.71439305;NativeFreq_Het=0.3915;NativeFreq_Hom=0.6435;AF_2700_Het=0.3812;AF_2700_Hom=0.5523;AF_50_Het=0.3930;AF_50_Hom=0.5499;DANN_score=0.5953;GREP_score=3.19;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_016169.3:+;NP=SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=GTTTGACTTT.CCTGACAACA	GT:AD:DP:GQ:PL	1/1:0,123:123:99:4684,370,0
chr10	104389932	.	T	G	9567.77	PASS	AC=2;AF=1;AN=2;DP=251;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.26;SOR=1.418;HGVSnom=NM_016169.4:c.*20T>G;Gene=SUFU;Transcript=NM_016169.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=484;EXAC_AF=0.99939866;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=121323;EXAC_AN_Adj=121396;ESP6500_MAF=0.99784715;RS=rs4917980;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.997404;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.9917;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9986;gnomad_exomes_AF=0.99946271;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=251127;gnomad_exomes_Hom=125496;gnomad_exomes_Het=135;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99335630;gnomad_exomes_AF_NFE=0.99994721;gnomad_exomes_AF_AMR=0.99939285;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.6774;GREP_score=3.14;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_016169.3:+;NP=SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=GGCCCTGCAG.GGCCAGCAGG	GT:AD:DP:GQ:PL	1/1:0,250:250:99:9596,752,0
chr10	104391034	.	C	T	4792.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.807;DP=317;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.22;ReadPosRankSum=-0.812;SOR=0.707;HGVSnom=NM_016169.4:c.*1122C>T;Gene=SUFU;Transcript=NM_016169.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=484;RS=rs11596235;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.194489;G1000_EAS_AF=0.1319;G1000_EUR_AF=0.3161;G1000_AFR_AF=0.1498;G1000_SAS_AF=0.1953;G1000_AMR_AF=0.1931;NativeFreq_Het=0.2970;NativeFreq_Hom=0.0099;AF_2700_Het=0.2437;AF_2700_Hom=0.0265;AF_50_Het=0.2425;AF_50_Hom=0.0238;DANN_score=0.71;GREP_score=1.46;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_016169.3:+;NP=SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=CCCTCCCATC.TCCCTGTATC	GT:AD:DP:GQ:PL	0/1:164,151:315:99:4821,0,5391
chr10	104392497	.	T	C	5034.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.854;DP=355;ExcessHet=3.0103;FS=5.417;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=0.355;SOR=0.848;HGVSnom=NM_016169.4:c.*2585T>C;Gene=SUFU;Transcript=NM_016169.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=484;RS=rs11191355;CLNGENE=SUFU;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.308906;G1000_EAS_AF=0.5159;G1000_EUR_AF=0.165;G1000_AFR_AF=0.2693;G1000_SAS_AF=0.3262;G1000_AMR_AF=0.268;NativeFreq_Het=0.6138;NativeFreq_Hom=0.2772;AF_2700_Het=0.4958;AF_2700_Hom=0.2571;AF_50_Het=0.4945;AF_50_Hom=0.2631;DANN_score=0.784;GREP_score=0.387;CytoBand=q24.32;CGD_CONDITION=Medulloblastoma. Basal cell nevus syndrome;CGD_INHERITANCE=AD;Strand=SUFU:NM_016169.3:+;NP=SUFU:NM_016169.3:NP_057253.2;ENSP=SUFU:NM_016169.3:ENST00000369902.7;Gene_MIM_id=607035;Phenotypes=Basal cell nevus syndrome, 109400 (3), Autosomal dominant. Medulloblastoma, desmoplastic, 155255 (3), Autosomal recessive, Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 109400(MK),155255(MK),607174(SK);Possible_Inheritance=AD;EntrezGeneID=51684;EnsemblGeneID=ENSG00000107882;Alias=SUFU, SUFUXL, SUFUH;FLKSEQ=CTTGCCTAGT.GTACCCACCC	GT:AD:DP:GQ:PL	0/1:179,174:353:99:5063,0,5570
chr10	111967522	.	G	T	1310.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.855;DP=98;ExcessHet=3.0103;FS=3.295;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.38;ReadPosRankSum=-1.153;SOR=0.347;HGVSnom=NM_130439.3:c.-45G>T;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=295;EXAC_AF=0.16968326;EXAC_Hom_EAS=1;EXAC_AC_EAS=13;EXAC_AN_EAS=34;EXAC_AC_Adj=225;EXAC_AN_Adj=1326;RS=rs145057169;G1000_AF=0.113219;G1000_EAS_AF=0.2976;G1000_EUR_AF=0.0288;G1000_AFR_AF=0.0;G1000_SAS_AF=0.2239;G1000_AMR_AF=0.0274;gnomad_exomes_AF=0.05962575;gnomad_exomes_AF_EAS=0.28260870;gnomad_exomes_AC=376;gnomad_exomes_Hom=28;gnomad_exomes_Het=320;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.02384738;gnomad_exomes_AF_AMR=0.02298851;gnomad_exomes_AF_SAS=0.14192849;NativeFreq_Het=0.3564;NativeFreq_Hom=0.1089;AF_2700_Het=0.2978;AF_2700_Hom=0.0734;AF_50_Het=0.2948;AF_50_Hom=0.0666;DANN_score=0.9687;GREP_score=2.58;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+;NP=MXI1:NM_130439.3:NP_569157.2;ENSP=MXI1:NM_130439.3:ENST00000332674.9;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=CGGCCGGGCC.CGCAGCCCCG	GT:AD:DP:GQ:PL	0/1:49,49:98:99:1339,0,1483
chr10	112004562	.	CT	C	1488.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.786;DP=181;ExcessHet=3.0103;FS=4.603;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.48;ReadPosRankSum=-1.264;SOR=0.263;HGVSnom=NM_130439.3:c.408-10delT;Gene=MXI1;Transcript=NM_130439.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_130439.3:IVS2-10delT;AAlength=295;EXAC_AF=0.36132959;EXAC_Hom_EAS=26;EXAC_AC_EAS=964;EXAC_AN_EAS=2356;EXAC_AC_Adj=14425;EXAC_AN_Adj=39922;RS=rs199913141;G1000_AF=0.44988;G1000_EAS_AF=0.5327;G1000_EUR_AF=0.3897;G1000_AFR_AF=0.4342;G1000_SAS_AF=0.4877;G1000_AMR_AF=0.3934;gnomad_exomes_AF=0.36535192;gnomad_exomes_AF_EAS=0.43084767;gnomad_exomes_AC=40405;gnomad_exomes_Hom=45;gnomad_exomes_Het=40315;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32983306;gnomad_exomes_AF_NFE=0.36420271;gnomad_exomes_AF_AMR=0.37605016;gnomad_exomes_AF_SAS=0.37293755;NativeFreq_Het=0.2574;NativeFreq_Hom=.;AF_2700_Het=0.9312;AF_2700_Hom=0.0061;AF_50_Het=0.9334;AF_50_Hom=0.0063;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=ATGGCTAATG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:62,95:157:99:1526,0,999
chr10	112044553	.	G	GTTC	2722.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.985;DP=199;ExcessHet=3.0103;FS=8.146;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.38;ReadPosRankSum=-0.013;SOR=0.252;HGVSnom=NM_130439.3:c.725-23_725-21dupCTT;Gene=MXI1;Transcript=NM_130439.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_130439.3:IVS5-21_-20insCTT;AAlength=295;EXAC_AF=0.56660195;EXAC_Hom_EAS=991;EXAC_AC_EAS=4831;EXAC_AN_EAS=7682;EXAC_AC_Adj=63039;EXAC_AN_Adj=111258;ESP6500_MAF=0.75587154;RS=rs5787843;G1000_AF=0.635982;G1000_EAS_AF=0.745;G1000_EUR_AF=0.6322;G1000_AFR_AF=0.5378;G1000_SAS_AF=0.6278;G1000_AMR_AF=0.6816;gnomad_exomes_AF=0.56715624;gnomad_exomes_AF_EAS=0.63681402;gnomad_exomes_AC=103489;gnomad_exomes_Hom=16383;gnomad_exomes_Het=70723;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.50946230;gnomad_exomes_AF_NFE=0.54880717;gnomad_exomes_AF_AMR=0.59755541;gnomad_exomes_AF_SAS=0.59372805;AF_2700_Het=0.9204;AF_2700_Hom=0.0761;AF_50_Het=0.9033;AF_50_Hom=0.0951;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=GATAATTAAT.TTCTTCTTTT	GT:AD:DP:GQ:PL	0/1:55,122:177:99:2760,0,975
chr10	112044559	.	C	CTTCT	81.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.944;DP=232;ExcessHet=3.0103;FS=14.946;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.39;ReadPosRankSum=0.756;SOR=2.696;HGVSnom=NM_130439.3:c.725-21_725-20insCTTT;Gene=MXI1;Transcript=NM_130439.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_130439.3:IVS5-21_-20insCTTT;AAlength=295;EXAC_AF=0.05218250;EXAC_Hom_EAS=0;EXAC_AC_EAS=331;EXAC_AN_EAS=6430;EXAC_AC_Adj=4440;EXAC_AN_Adj=85086;RS=rs1554860458;G1000_AF=0.0171725;G1000_EAS_AF=0.0188;G1000_EUR_AF=0.0139;G1000_AFR_AF=0.0129;G1000_SAS_AF=0.0225;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06504914;gnomad_exomes_AF_EAS=0.06950262;gnomad_exomes_AC=6169;gnomad_exomes_Hom=6;gnomad_exomes_Het=6157;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03743812;gnomad_exomes_AF_NFE=0.05289602;gnomad_exomes_AF_AMR=0.09099405;gnomad_exomes_AF_SAS=0.10233018;AF_2700_Het=0.0077;AF_2700_Hom=.;AF_50_Het=0.0016;AF_50_Hom=.;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=TAATGTTCTT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:184,28:212:99:119,0,4603
chr10	112044560	.	T	TTC	214.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.347;DP=237;ExcessHet=3.0103;FS=1.937;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.99;ReadPosRankSum=0.772;SOR=0.434;HGVSnom=NM_130439.3:c.725-21_725-20insCT;Gene=MXI1;Transcript=NM_130439.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_130439.3:IVS5-21_-20insCT;AAlength=295;EXAC_AF=0.18461324;EXAC_Hom_EAS=0;EXAC_AC_EAS=1024;EXAC_AN_EAS=4080;EXAC_AC_Adj=10592;EXAC_AN_Adj=57374;RS=rs33957950;G1000_AF=0.168131;G1000_EAS_AF=0.2202;G1000_EUR_AF=0.1312;G1000_AFR_AF=0.1104;G1000_SAS_AF=0.2515;G1000_AMR_AF=0.1383;gnomad_exomes_AF=0.21817164;gnomad_exomes_AF_EAS=0.29252525;gnomad_exomes_AC=14806;gnomad_exomes_Hom=15;gnomad_exomes_Het=14776;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13420830;gnomad_exomes_AF_NFE=0.18180459;gnomad_exomes_AF_AMR=0.28092848;gnomad_exomes_AF_SAS=0.32893210;AF_2700_Het=0.0250;AF_2700_Hom=0.0004;AF_50_Het=0.0254;AF_50_Hom=.;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=AATGTTCTTC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:184,32:216:99:252,0,4596
chr10	112044842	.	TAAAAC	T	7719.73	PASS	AC=2;AF=1;AN=2;DP=236;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.16;SOR=0.932;HGVSnom=NM_130439.3:c.*118_*122delAAAAC;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs16448;G1000_AF=0.492612;G1000_EAS_AF=0.8393;G1000_EUR_AF=0.5169;G1000_AFR_AF=0.0696;G1000_SAS_AF=0.6186;G1000_AMR_AF=0.5821;NativeFreq_Het=0.4802;NativeFreq_Hom=.;AF_2700_Het=0.2775;AF_2700_Hom=0.6929;AF_50_Het=0.3074;AF_50_Hom=0.6672;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=GTCTCCTCTT.aaaacaaaac	GT:AD:DP:GQ:PL	1/1:0,175:175:99:7757,532,0
chr10	112045171	.	C	T	3511.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.718;DP=252;ExcessHet=3.0103;FS=0.984;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.99;ReadPosRankSum=0.467;SOR=0.616;HGVSnom=NM_130439.3:c.*426C>T;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs14401;G1000_AF=0.355431;G1000_EAS_AF=0.5387;G1000_EUR_AF=0.4891;G1000_AFR_AF=0.0227;G1000_SAS_AF=0.3415;G1000_AMR_AF=0.549;NativeFreq_Het=0.4950;NativeFreq_Hom=0.2871;AF_2700_Het=0.4719;AF_2700_Hom=0.3409;AF_50_Het=0.4707;AF_50_Hom=0.3423;DANN_score=0.4253;GREP_score=0.255;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=AAAAACTATT.GAATGAAAAG	GT:AD:DP:GQ:PL	0/1:137,114:251:99:3540,0,4255
chr10	112045286	.	A	AT	5908.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.957;DP=409;ExcessHet=3.0103;FS=6.591;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.63;ReadPosRankSum=1.141;SOR=0.378;HGVSnom=NM_130439.3:c.*553dupT;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs376761325;G1000_AF=0.498003;G1000_EAS_AF=0.8244;G1000_EUR_AF=0.5189;G1000_AFR_AF=0.0946;G1000_SAS_AF=0.6145;G1000_AMR_AF=0.598;NativeFreq_Het=0.4802;NativeFreq_Hom=.;AF_2700_Het=0.4596;AF_2700_Hom=0.5096;AF_50_Het=0.4865;AF_50_Hom=0.4865;CytoBand=q25.2;repName=AT_rich;repClass=Low_complexity;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=Ctttattatt.tttttttttt	GT:AD:DP:GQ:PL	0/1:71,307:378:99:5894,0,477
chr10	112045944	.	G	GT	9500.73	PASS	AC=2;AF=1;AN=2;DP=264;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.89;SOR=1.087;HGVSnom=NM_130439.3:c.*1200dupT;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs5787844;G1000_AF=0.838059;G1000_EAS_AF=0.999;G1000_EUR_AF=0.7952;G1000_AFR_AF=0.6732;G1000_SAS_AF=0.9223;G1000_AMR_AF=0.8617;NativeFreq_Het=0.5000;NativeFreq_Hom=.;AF_2700_Het=0.0069;AF_2700_Hom=0.9912;AF_50_Het=0.0111;AF_50_Hom=0.9889;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=AGTTAACATA.TAAGTTCAGC	GT:AD:DP:GQ:PL	1/1:0,255:255:99:9538,767,0
chr10	112046150	.	T	C	13488.8	PASS	AC=2;AF=1;AN=2;DP=359;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.45;SOR=1.376;HGVSnom=NM_130439.3:c.*1405T>C;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs17658;G1000_AF=0.745208;G1000_EAS_AF=0.9137;G1000_EUR_AF=0.7058;G1000_AFR_AF=0.6067;G1000_SAS_AF=0.7924;G1000_AMR_AF=0.755;NativeFreq_Het=0.1188;NativeFreq_Hom=0.8811;AF_2700_Het=0.1437;AF_2700_Hom=0.8490;AF_50_Het=0.1458;AF_50_Hom=0.8463;DANN_score=0.7477;GREP_score=-1.18;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=CAAGGTTCCC.TGTGGCCCTC	GT:AD:DP:GQ:PL	1/1:0,357:357:99:13517,1072,0
chr10	112046200	.	G	T	3972.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.374;DP=262;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.16;ReadPosRankSum=0.445;SOR=0.727;HGVSnom=NM_130439.3:c.*1455G>T;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs1803997;G1000_AF=0.131589;G1000_EAS_AF=0.2986;G1000_EUR_AF=0.0328;G1000_AFR_AF=0.0234;G1000_SAS_AF=0.2751;G1000_AMR_AF=0.036;NativeFreq_Het=0.3861;NativeFreq_Hom=0.0990;AF_2700_Het=0.3666;AF_2700_Hom=0.0696;AF_50_Het=0.3534;AF_50_Hom=0.0618;DANN_score=0.8061;GREP_score=3.54;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=CCTTACCCCT.GCTGTTTGGA	GT:AD:DP:GQ:PL	0/1:137,125:262:99:4001,0,4369
chr10	112046250	.	T	TA	4908.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.335;DP=261;ExcessHet=3.0103;FS=7.53;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.37;ReadPosRankSum=0.441;SOR=0.49;OLD_VARIANT=chr10|112046250|T|TA,TAA|1;HGVSnom=NM_130439.3:c.*1519dupA;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs369063917;G1000_AF=0.414137;G1000_EAS_AF=0.2857;G1000_EUR_AF=0.3211;G1000_AFR_AF=0.6831;G1000_SAS_AF=0.3241;G1000_AMR_AF=0.3501;NativeFreq_Het=0.1188;NativeFreq_Hom=.;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=CTTAATTACT.AAAAAAAAAA	GT:AD:DP:GQ:PL	1/0:30,55:241:99:4946,2684,2676
chr10	112046250	.	T	TAA	4908.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.335;DP=261;ExcessHet=3.0103;FS=7.53;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.37;ReadPosRankSum=0.441;SOR=0.49;OLD_VARIANT=chr10|112046250|T|TA,TAA|2;HGVSnom=NM_130439.3:c.*1518_*1519dupAA;Gene=MXI1;Transcript=NM_130439.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=295;RS=rs369063917;G1000_AF=0.423722;G1000_EAS_AF=0.6746;G1000_EUR_AF=0.4414;G1000_AFR_AF=0.0734;G1000_SAS_AF=0.5675;G1000_AMR_AF=0.4986;NativeFreq_Het=0.3713;NativeFreq_Hom=.;AF_2700_Het=0.8428;AF_2700_Hom=0.1530;AF_50_Het=0.8542;AF_50_Hom=0.1426;CytoBand=q25.2;Strand=MXI1:NM_130439.3:+,MXI1:NM_001008541.1:+,MXI1:NM_005962.4:+;NP=MXI1:NM_130439.3:NP_569157.2,MXI1:NM_001008541.1:NP_001008541.1,MXI1:NM_005962.4:NP_005953.4;ENSP=MXI1:NM_130439.3:ENST00000332674.9,MXI1:NM_001008541.1:.,MXI1:NM_005962.4:.;Gene_MIM_id=600020;Phenotypes=Neurofibrosarcoma (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 176807(SK),600020(MK);Possible_Inheritance=AD;EntrezGeneID=4601;EnsemblGeneID=ENSG00000119950;Alias=MXI1;FLKSEQ=CTTAATTACT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:30,156:241:99:4946,582,936
chr10	120917445	.	G	A	5633.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.757;DP=351;ExcessHet=3.0103;FS=4.749;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.05;ReadPosRankSum=-0.018;SOR=0.872;HGVSnom=NM_213649.2:c.415-6C>T;Gene=SFXN4;Transcript=NM_213649.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_213649.2:IVS7-6C>T;AAlength=337;EXAC_AF=0.49632498;EXAC_Hom_EAS=2238;EXAC_AC_EAS=6206;EXAC_AN_EAS=8636;EXAC_AC_Adj=60234;EXAC_AN_Adj=121360;ESP6500_MAF=0.48239274;RS=rs2275111;CLNGENE=SFXN4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.509984;G1000_EAS_AF=0.7123;G1000_EUR_AF=0.4632;G1000_AFR_AF=0.4546;G1000_SAS_AF=0.4417;G1000_AMR_AF=0.4856;gnomad_exomes_AF=0.49900963;gnomad_exomes_AF_EAS=0.72849375;gnomad_exomes_AC=125461;gnomad_exomes_Hom=32045;gnomad_exomes_Het=61371;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44240709;gnomad_exomes_AF_NFE=0.50103758;gnomad_exomes_AF_AMR=0.46449636;gnomad_exomes_AF_SAS=0.44556267;NativeFreq_Het=0.4662;NativeFreq_Hom=0.3772;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00002648;DANN_score=0.3584;GREP_score=-1.8;CytoBand=q26.11;CGD_CONDITION=Combined oxidative phosphorylation deficiency 18;CGD_INHERITANCE=AR;Strand=SFXN4:NM_213649.1:-;NP=SFXN4:NM_213649.1:NP_998814.1;ENSP=SFXN4:NM_213649.1:ENST00000355697.6;Gene_MIM_id=615564;Phenotypes=Combined oxidative phosphorylation deficiency 18, 615578 (3), Autosomal recessive. 615578(MK);Possible_Inheritance=AR;EntrezGeneID=119559;EnsemblGeneID=ENSG00000183605;Alias=SFXN4, COXPD18;FLKSEQ=AAAACCTGCC.AGAGGGGCAA	GT:AD:DP:GQ:PL	0/1:163,188:351:99:5662,0,4357
chr11	535463	.	G	A	124.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.992;DP=9;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.86;ReadPosRankSum=-1.242;SOR=0.368;HGVSnom=NM_005343.4:c.-101C>T;Gene=HRAS;Transcript=NM_005343.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=189;RS=rs8176336;CLNGENE=HRAS|LRRC56;CLNSIG=Conflicting_interpretations_of_pathogenicity|Conflicting_interpretations_of_pathogenicity;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_conflicting_interpretations|criteria_provided,_conflicting_interpretations;AF_2700_Het=0.0354;AF_2700_Hom=0.0365;AF_50_Het=0.0269;AF_50_Hom=0.0412;DANN_score=0.9174;GREP_score=0.125;CytoBand=p15.5;repName=(CGGGGG)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=8.2;CGD_CONDITION=Costello syndrome. Congenital myopathy with excess of muscle spindles;CGD_INHERITANCE=AD;Strand=HRAS:NM_001130442.2:-,HRAS:NM_001318054.1:-,HRAS:NM_005343.3:-,HRAS:NM_176795.4:-,HRAS:NM_005343.4:-;NP=HRAS:NM_001130442.2:NP_001123914.1,HRAS:NM_001318054.1:NP_001304983.1,HRAS:NM_005343.3:NP_005334.1,HRAS:NM_176795.4:NP_789765.1,HRAS:NM_005343.4:NP_005334.1;ENSP=HRAS:NM_001130442.2:.,HRAS:NM_001318054.1:.,HRAS:NM_005343.3:.,HRAS:NM_176795.4:.,HRAS:NM_005343.4:ENST00000311189.8;Gene_MIM_id=190020;Phenotypes={Bladder cancer, somatic}, 109800 (3). Congenital myopathy with excess of muscle spindles, 218040 (3), Autosomal dominant, Isolated cases. Costello syndrome, 218040 (3), Autosomal dominant, Isolated cases. {Nevus sebaceous or woolly hair nevus, somatic}, 162900 (3). Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3). {Spitz nevus or nevus spilus, somatic}, 137550 (3). {Thyroid carcinoma, follicular, somatic}, 188470 (3). 109800(SK),137550(SK),162900(SK),163200(MK),188470(SK),218040(MK);Possible_Inheritance=AD;EntrezGeneID=3265;EnsemblGeneID=ENSG00000174775;Alias=HRAS;FLKSEQ=ggccgaggcc.gggcggggcg	GT:AD:DP:GQ:PL	0/1:3,6:9:88:153,0,88
chr11	2905204	.	G	GC	2240.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.224;DP=172;ExcessHet=3.0103;FS=12.085;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.26;ReadPosRankSum=1.342;SOR=0.268;HGVSnom=NM_001122630.2:c.*5+24dupG;Gene=CDKN1C;Transcript=NM_001122630.2;VarType=Intron;MolecularConsequence=3_prime_UTR_intron_variant;ExonIntron=I3;IVSnom=NM_001122630.2:IVS3+24_+25insG;AAlength=305;EXAC_AF=0.42830708;EXAC_Hom_EAS=348;EXAC_AC_EAS=1109;EXAC_AN_EAS=1658;EXAC_AC_Adj=9953;EXAC_AN_Adj=23238;ESP6500_MAF=0.26385741;RS=rs34289096;CLNGENE=CDKN1C;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.372604;G1000_EAS_AF=0.6319;G1000_EUR_AF=0.3231;G1000_AFR_AF=0.2156;G1000_SAS_AF=0.4121;G1000_AMR_AF=0.3112;gnomad_exomes_AF=0.35862857;gnomad_exomes_AF_EAS=0.65904745;gnomad_exomes_AC=55898;gnomad_exomes_Hom=10919;gnomad_exomes_Het=34060;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20951391;gnomad_exomes_AF_NFE=0.30979569;gnomad_exomes_AF_AMR=0.34232735;gnomad_exomes_AF_SAS=0.40667349;normalHetFrequency=0.2423;normalHetNum=94;normalHomFrequency=0.25;normalHomNum=97;patientHetFrequency=0.224;patientHetNum=621;patientHomFrequency=0.2504;patientHomNum=694;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p15.4;CGD_CONDITION=IMAGE syndrome. Beckwith-Wiedemann syndrome;CGD_INHERITANCE=AD;Strand=CDKN1C:NM_000076.2:-,CDKN1C:NM_001122630.1:-,CDKN1C:NM_001122631.1:-;NP=CDKN1C:NM_000076.2:NP_000067.1,CDKN1C:NM_001122630.1:NP_001116102.1,CDKN1C:NM_001122631.1:NP_001116103.1;ENSP=CDKN1C:NM_000076.2:ENST00000430149.3,CDKN1C:NM_001122630.1:.,CDKN1C:NM_001122631.1:.;Gene_MIM_id=616121,600856;Phenotypes=.,Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant. IMAGE syndrome, 614732 (3), Autosomal dominant. 130650(MK),614732(MK);Possible_Inheritance=NA,AD;EntrezGeneID=387751,1028;EnsemblGeneID=ENSG00000254838,ENSG00000129757;Alias=GVINP1, VLIG1,CDKN1C, KIP2, BWS, IMAGE;FLKSEQ=GGCCCTCCGC.CCCCCCCAGG	GT:AD:DP:GQ:PL	0/1:80,89:169:99:2278,0,1906
chr11	2906165	.	A	G	104.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.2;DP=10;ExcessHet=3.0103;FS=2.808;MLEAC=1;MLEAF=0.5;MQ=59.71;MQRankSum=-0.674;QD=10.48;ReadPosRankSum=-0.095;SOR=1.919;HGVSnom=NM_001122630.2:c.522T>C(p.Ala174Ala/p.A174A);Gene=CDKN1C;Transcript=NM_001122630.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E2;IVSnom=.;AAlength=305;EXAC_AF=0;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=0;EXAC_AC_Adj=0;EXAC_AN_Adj=0;RS=rs191294997;CLNGENE=CDKN1C;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.222444;G1000_EAS_AF=0.1468;G1000_EUR_AF=0.2078;G1000_AFR_AF=0.3495;G1000_SAS_AF=0.1135;G1000_AMR_AF=0.2651;gnomad_exomes_AF=0.22131148;gnomad_exomes_AC=27;gnomad_exomes_Hom=3;gnomad_exomes_Het=21;gnomad_exomes_Hemi=0;gnomad_exomes_AF_NFE=0.22321429;gnomad_exomes_AF_AMR=0.50000000;DANN_score=0.1957;GREP_score=-0.143;CytoBand=p15.4;repName=(CTGGGG)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=30.2;CGD_CONDITION=IMAGE syndrome. Beckwith-Wiedemann syndrome;CGD_INHERITANCE=AD;Strand=CDKN1C:NM_000076.2:-,CDKN1C:NM_001122630.1:-,CDKN1C:NM_001122631.1:-;NP=CDKN1C:NM_000076.2:NP_000067.1,CDKN1C:NM_001122630.1:NP_001116102.1,CDKN1C:NM_001122631.1:NP_001116103.1;ENSP=CDKN1C:NM_000076.2:ENST00000430149.3,CDKN1C:NM_001122630.1:.,CDKN1C:NM_001122631.1:.;Gene_MIM_id=616121,600856;Phenotypes=.,Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominant. IMAGE syndrome, 614732 (3), Autosomal dominant. 130650(MK),614732(MK);Possible_Inheritance=NA,AD;EntrezGeneID=387751,1028;EnsemblGeneID=ENSG00000254838,ENSG00000129757;Alias=GVINP1, VLIG1,CDKN1C, KIP2, BWS, IMAGE;FLKSEQ=ccggagccgg.gccggggccg	GT:AD:DP:GQ:PL	0/1:5,5:10:99:133,0,156
chr11	22644893	.	A	AT	20356.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.419;DP=696;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.96;MQRankSum=0;QD=30.66;ReadPosRankSum=0.933;SOR=0.232;HGVSnom=NM_022725.4:c.*1338dupA;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;RS=rs45554234;CLNGENE=FANCF;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=0.0985;normalHetNum=47;normalHomFrequency=0.4902;normalHomNum=424;patientHetFrequency=0.125;patientHetNum=306;patientHomFrequency=0.4061;patientHomNum=2120;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1637;AF_2700_Hom=0.8278;AF_50_Het=0.1300;AF_50_Hom=0.8653;CytoBand=p14.3;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=TCTAAATATC.TTTTTTTCTC	GT:AD:DP:GQ:PL	1/1:1,663:664:99:20394,1997,0
chr11	22645413	.	G	A	6157.77	PASS	AC=2;AF=1;AN=2;DP=172;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.91;QD=30.46;SOR=0.765;HGVSnom=NM_022725.4:c.*819C>T;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;RS=rs450946;CLNGENE=FANCF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.949081;G1000_EAS_AF=0.9157;G1000_EUR_AF=1.0;G1000_AFR_AF=0.8971;G1000_SAS_AF=0.9703;G1000_AMR_AF=0.9928;NativeFreq_Het=0.1188;NativeFreq_Hom=0.8712;normalHetFrequency=0.1069;normalHetNum=51;normalHomFrequency=0.8868;normalHomNum=423;patientHetFrequency=0.1074;patientHetNum=263;patientHomFrequency=0.4159;patientHomNum=2171;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1272;AF_2700_Hom=0.8601;AF_50_Het=0.1157;AF_50_Hom=0.8685;DANN_score=0.9153;GREP_score=0.158;CytoBand=p14.3;repName=AluSx3;repClass=SINE;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=ggtggcctgc.cctgtaatcc	GT:AD:DP:GQ:PL	1/1:0,172:172:99:6186,516,0
chr11	22645536	.	C	CA	85.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.648;DP=304;ExcessHet=3.0103;FS=7.089;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.32;ReadPosRankSum=-0.11;SOR=1.441;HGVSnom=NM_022725.4:c.*695dupT;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;RS=rs796646840;CLNGENE=FANCF;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.0189;normalHetNum=9;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0241;patientHetNum=59;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0135;AF_2700_Hom=.;AF_50_Het=0.0143;AF_50_Hom=.;CytoBand=p14.3;repName=AluSx3;repClass=SINE;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=gactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:232,37:269:99:123,0,4823
chr11	22645600	.	C	T	16819.8	PASS	AC=2;AF=1;AN=2;DP=442;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.16;SOR=1.726;HGVSnom=NM_022725.4:c.*632G>A;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;RS=rs444923;CLNGENE=FANCF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.971446;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.8956;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.5584;normalHomNum=483;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.4722;patientHomNum=2465;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15D6482373];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9985;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5472;GREP_score=0.372;CytoBand=p14.3;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=GGCATATATT.GTATTTACTG	GT:AD:DP:GQ:PL	1/1:0,442:442:99:16848,1329,0
chr11	22646025	.	G	A	26142.8	PASS	AC=2;AF=1;AN=2;DP=722;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.01;SOR=0.905;HGVSnom=NM_022725.4:c.*207C>T;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;RS=rs4447177;CLNGENE=FANCF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.703674;G1000_EAS_AF=0.878;G1000_EUR_AF=0.8549;G1000_AFR_AF=0.3442;G1000_SAS_AF=0.817;G1000_AMR_AF=0.7565;NativeFreq_Het=0.2669;NativeFreq_Hom=0.8217;normalHetFrequency=0.2289;normalHetNum=198;normalHomFrequency=0.6775;normalHomNum=586;patientHetFrequency=0.1987;patientHetNum=1037;patientHomFrequency=0.7065;patientHomNum=3688;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1872;AF_2700_Hom=0.8002;AF_50_Het=0.1759;AF_50_Hom=0.8067;DANN_score=0.7422;GREP_score=-1.28;CytoBand=p14.3;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=TTTAAGTGGA.TACTTCCAAT	GT:AD:DP:GQ:PL	1/1:0,715:715:99:26171,2149,0
chr11	22647366	.	G	A	7171.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.923;DP=468;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.36;ReadPosRankSum=-1.392;SOR=0.703;HGVSnom=NM_022725.4:c.-10C>T;Gene=FANCF;Transcript=NM_022725.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=374;EXAC_AF=0.15668411;EXAC_Hom_EAS=207;EXAC_AC_EAS=1855;EXAC_AN_EAS=8532;EXAC_AC_Adj=18746;EXAC_AN_Adj=119642;ESP6500_MAF=0.14662463;RS=rs3740615;CLNGENE=FANCF;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.113818;G1000_EAS_AF=0.1964;G1000_EUR_AF=0.2028;G1000_AFR_AF=0.0424;G1000_SAS_AF=0.0481;G1000_AMR_AF=0.0937;gnomad_exomes_AF=0.15784265;gnomad_exomes_AF_EAS=0.21752892;gnomad_exomes_AC=39234;gnomad_exomes_Hom=3733;gnomad_exomes_Het=31768;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.06054422;gnomad_exomes_AF_NFE=0.18238575;gnomad_exomes_AF_AMR=0.07579002;gnomad_exomes_AF_SAS=0.06676907;NativeFreq_Het=0.4455;NativeFreq_Hom=0.0249;normalHetFrequency=0.2694;normalHetNum=233;normalHomFrequency=0.0358;normalHomNum=31;patientHetFrequency=0.3132;patientHetNum=1635;patientHomFrequency=0.0471;patientHomNum=246;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3578;AF_2700_Hom=0.0503;AF_50_Het=0.3550;AF_50_Hom=0.0428;DANN_score=0.8445;GREP_score=-8.62;CytoBand=p14.3;CGD_CONDITION=Fanconia anemia, complementation group F;CGD_INHERITANCE=AR;Strand=FANCF:NM_022725.3:-;NP=FANCF:NM_022725.3:NP_073562.1;ENSP=FANCF:NM_022725.3:ENST00000327470.5;Gene_MIM_id=613897;Phenotypes=Fanconi anemia, complementation group F, 603467 (3). 603467(MK);Possible_Inheritance=NA;EntrezGeneID=2188;EnsemblGeneID=ENSG00000183161;Alias=FANCF;FLKSEQ=TGAGGTGCGC.AAGGCCCTAC	GT:AD:DP:GQ:PL	0/1:234,233:467:99:7200,0,6835
chr11	32409549	.	AACACAC	A	977.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.536;DP=128;ExcessHet=3.0103;FS=1.08;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.54;ReadPosRankSum=0.496;SOR=0.465;HGVSnom=NM_024426.6:c.*1049_*1054delGTGTGT;Gene=WT1;Transcript=NM_024426.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=522;RS=rs58549495;CLNGENE=WT1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.1832;NativeFreq_Hom=.;normalHetFrequency=0.1027;normalHetNum=49;normalHomFrequency=0.1593;normalHomNum=76;patientHetFrequency=0.0935;patientHetNum=229;patientHomFrequency=0.0638;patientHomNum=333;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.7264;AF_2700_Hom=0.1199;AF_50_Het=0.7258;AF_50_Hom=0.1204;CytoBand=p13;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=4;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=aacacaacac.acacacacac	GT:AD:DP:GQ:PL	0/1:42,36:78:99:1015,0,1095
chr11	32409625	.	A	AT	3198.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.053;DP=240;ExcessHet=3.0103;FS=5.946;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.91;ReadPosRankSum=-1.363;SOR=0.405;HGVSnom=NM_024426.6:c.*978dupA;Gene=WT1;Transcript=NM_024426.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=522;RS=rs5030326;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.279553;G1000_EAS_AF=0.6558;G1000_EUR_AF=0.1441;G1000_AFR_AF=0.0552;G1000_SAS_AF=0.3272;G1000_AMR_AF=0.2896;NativeFreq_Het=0.4356;NativeFreq_Hom=.;normalHetFrequency=0.13;normalHetNum=62;normalHomFrequency=0.1384;normalHomNum=66;patientHetFrequency=0.1176;patientHetNum=288;patientHomFrequency=0.055;patientHomNum=287;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4312;AF_2700_Hom=0.4539;AF_50_Het=0.4548;AF_50_Hom=0.4422;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=AGTAAGTCTC.TTTTTTTCAC	GT:AD:DP:GQ:PL	0/1:102,128:230:99:3236,0,2383
chr11	32410002	.	T	C	6749.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.21;DP=387;ExcessHet=3.0103;FS=7.038;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.44;ReadPosRankSum=0.253;SOR=1.008;HGVSnom=NM_024426.6:c.*602A>G;Gene=WT1;Transcript=NM_024426.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=522;RS=rs5030320;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.584864;G1000_EAS_AF=0.7202;G1000_EUR_AF=0.329;G1000_AFR_AF=0.7927;G1000_SAS_AF=0.5409;G1000_AMR_AF=0.4251;NativeFreq_Het=0.4158;NativeFreq_Hom=0.5049;normalHetFrequency=0.2081;normalHetNum=180;normalHomFrequency=0.2601;normalHomNum=225;patientHetFrequency=0.1881;patientHetNum=982;patientHomFrequency=0.2142;patientHomNum=1118;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3847;AF_2700_Hom=0.5354;AF_50_Het=0.3835;AF_50_Hom=0.5404;DANN_score=0.8035;GREP_score=0.898;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=AGTTCTGATT.TTTCTTCAGC	GT:AD:DP:GQ:PL	0/1:186,201:387:99:6778,0,6025
chr11	32410337	.	C	G	5322.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.213;DP=357;ExcessHet=3.0103;FS=2.25;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.95;ReadPosRankSum=-0.499;SOR=0.597;HGVSnom=NM_024426.6:c.*267G>C;Gene=WT1;Transcript=NM_024426.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=522;RS=rs5030317;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.587859;G1000_EAS_AF=0.7192;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.8396;G1000_SAS_AF=0.5378;G1000_AMR_AF=0.4135;NativeFreq_Het=0.4235;NativeFreq_Hom=0.5148;normalHetFrequency=0.2971;normalHetNum=257;normalHomFrequency=0.3757;normalHomNum=325;patientHetFrequency=0.2722;patientHetNum=1421;patientHomFrequency=0.3536;patientHomNum=1846;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3866;AF_2700_Hom=0.5346;AF_50_Het=0.3835;AF_50_Hom=0.5388;DANN_score=0.5685;GREP_score=3.12;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=AGAAAATCCA.ACCAAATGGC	GT:AD:DP:GQ:PL	0/1:187,169:356:99:5351,0,6119
chr11	32410774	.	A	G	3987.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.401;DP=258;ExcessHet=3.0103;FS=1.802;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.52;ReadPosRankSum=0.144;SOR=0.865;HGVSnom=NM_024426.6:c.1448-49T>C;Gene=WT1;Transcript=NM_024426.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_024426.6:IVS9-49T>C;AAlength=522;EXAC_AF=0.34657618;EXAC_Hom_EAS=2226;EXAC_AC_EAS=6199;EXAC_AN_EAS=8632;EXAC_AC_Adj=41978;EXAC_AN_Adj=121122;ESP6500_MAF=0.33402553;RS=rs1799937;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.507987;G1000_EAS_AF=0.7202;G1000_EUR_AF=0.2584;G1000_AFR_AF=0.5855;G1000_SAS_AF=0.5337;G1000_AMR_AF=0.3775;gnomad_exomes_AF=0.34934986;gnomad_exomes_AF_EAS=0.72205898;gnomad_exomes_AC=87480;gnomad_exomes_Hom=18430;gnomad_exomes_Het=50620;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53189783;gnomad_exomes_AF_NFE=0.22959942;gnomad_exomes_AF_AMR=0.42886532;gnomad_exomes_AF_SAS=0.48532872;NativeFreq_Het=0.4342;NativeFreq_Hom=0.3310;normalHetFrequency=0.3931;normalHetNum=340;normalHomFrequency=0.4393;normalHomNum=380;patientHetFrequency=0.3891;patientHetNum=2031;patientHomFrequency=0.4255;patientHomNum=2221;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4398;GREP_score=-10.2;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=AGAGACAGGC.CAAGTTCAAC	GT:AD:DP:GQ:PL	0/1:131,126:257:99:4016,0,3878
chr11	32417945	.	T	C	5380.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.076;DP=378;ExcessHet=3.0103;FS=0.777;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.23;ReadPosRankSum=-0.292;SOR=0.758;HGVSnom=NM_024426.6:c.1122A>G(p.Arg374Arg/p.R374R);Gene=WT1;Transcript=NM_024426.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=522;EXAC_AF=0.23345613;EXAC_Hom_EAS=2079;EXAC_AC_EAS=5975;EXAC_AN_EAS=8620;EXAC_AC_Adj=28265;EXAC_AN_Adj=121072;ESP6500_MAF=0.13028765;RS=rs16754;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.33147;G1000_EAS_AF=0.6984;G1000_EUR_AF=0.172;G1000_AFR_AF=0.121;G1000_SAS_AF=0.4131;G1000_AMR_AF=0.3156;gnomad_exomes_AF=0.24341377;gnomad_exomes_AF_EAS=0.69606882;gnomad_exomes_AC=61110;gnomad_exomes_Hom=10791;gnomad_exomes_Het=39528;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11544615;gnomad_exomes_AF_NFE=0.14124005;gnomad_exomes_AF_AMR=0.36864039;gnomad_exomes_AF_SAS=0.35598536;NativeFreq_Het=0.3960;NativeFreq_Hom=0.4950;normalHetFrequency=0.3815;normalHetNum=330;normalHomFrequency=0.3896;normalHomNum=337;patientHetFrequency=0.3674;patientHetNum=1918;patientHomFrequency=0.3912;patientHomNum=2042;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4051;AF_2700_Hom=0.5061;AF_50_Het=0.4025;AF_50_Hom=0.5103;DANN_score=0.5301;GREP_score=-2.75;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=CAGGCACACG.CGCACATCCT	GT:AD:DP:GQ:PL	0/1:203,175:378:99:5409,0,5832
chr11	32452240	.	GC	G	2041.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.755;DP=136;ExcessHet=3.0103;FS=4.296;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.24;ReadPosRankSum=1.789;SOR=0.399;HGVSnom=NM_024426.6:c.662-2076delG;Gene=WT1;Transcript=NM_024426.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_024426.6:IVS1-2076delG;AAlength=522;RS=rs76500597;CLNGENE=WT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.3123;G1000_EAS_AF=0.6855;G1000_EUR_AF=0.167;G1000_AFR_AF=0.0877;G1000_SAS_AF=0.3763;G1000_AMR_AF=0.3184;normalHetFrequency=0.2231;normalHetNum=193;normalHomFrequency=0.2254;normalHomNum=195;patientHetFrequency=0.2153;patientHetNum=1124;patientHomFrequency=0.2125;patientHomNum=1109;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_001198551.1:-,WT1:NM_001198552.1:-,WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_001198551.1:NP_001185480.1,WT1:NM_001198552.1:NP_001185481.1,WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_001198551.1:.,WT1:NM_001198552.1:.,WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=GCCCAAGGAT.CCGTGGCCCG	GT:AD:DP:GQ:PL	0/1:64,70:134:99:2079,0,1869
chr11	32456562	.	G	A	1431.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.542;DP=81;ExcessHet=3.0103;FS=2.052;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.68;ReadPosRankSum=-0.885;SOR=1.03;HGVSnom=NM_024426.6:c.345C>T(p.Pro115Pro/p.P115P);Gene=WT1;Transcript=NM_024426.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=522;EXAC_AF=0.32425941;EXAC_Hom_EAS=16;EXAC_AC_EAS=45;EXAC_AN_EAS=70;EXAC_AC_Adj=1620;EXAC_AN_Adj=4996;RS=rs1799925;CLNGENE=LOC107982234|WT1;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.303914;G1000_EAS_AF=0.6855;G1000_EUR_AF=0.169;G1000_AFR_AF=0.0537;G1000_SAS_AF=0.3763;G1000_AMR_AF=0.3199;gnomad_exomes_AF=0.27372376;gnomad_exomes_AF_EAS=0.69099217;gnomad_exomes_AC=22949;gnomad_exomes_Hom=4465;gnomad_exomes_Het=14019;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07763615;gnomad_exomes_AF_NFE=0.15059090;gnomad_exomes_AF_AMR=0.36990596;gnomad_exomes_AF_SAS=0.34765507;NativeFreq_Het=0.3564;NativeFreq_Hom=0.4257;normalHetFrequency=0.116;normalHetNum=45;normalHomFrequency=0.1985;normalHomNum=77;patientHetFrequency=0.1068;patientHetNum=296;patientHomFrequency=0.1631;patientHomNum=452;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2171;AF_2700_Hom=0.3928;AF_50_Het=0.2187;AF_50_Hom=0.3978;DANN_score=0.9558;GREP_score=0.614;CytoBand=p13;CGD_CONDITION=Denys-Drash syndrome. Wilms tumor, type 1. Frasier syndrome;CGD_INHERITANCE=AD;Strand=WT1:NM_000378.4:-,WT1:NM_024424.3:-,WT1:NM_024426.4:-;NP=WT1:NM_000378.4:NP_000369.3,WT1:NM_024424.3:NP_077742.2,WT1:NM_024426.4:NP_077744.3;ENSP=WT1:NM_000378.4:.,WT1:NM_024424.3:.,WT1:NM_024426.4:ENST00000332351.7;Gene_MIM_id=607102;Phenotypes=Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutation. Frasier syndrome, 136680 (3), Autosomal dominant, Somatic mutation. Meacham syndrome, 608978 (3). Mesothelioma, somatic, 156240 (3). Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant. Wilms tumor, type 1, 194070 (3), Autosomal dominant, Somatic mutation. 136680(MK),156240(MK),194070(MK),194080(MK),256370(MK),608978(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7490;EnsemblGeneID=ENSG00000184937;Alias=WT1, NPHS4;FLKSEQ=AAGCGCCCGG.GGCGCAAAGT	GT:AD:DP:GQ:PL	0/1:33,48:81:99:1460,0,1067
chr11	44117898	.	T	G	8644.77	PASS	AC=2;AF=1;AN=2;DP=236;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.45;SOR=1.599;HGVSnom=NM_207122.2:c.-31+496T>G;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_207122.2:IVS1+496T>G;AAlength=718;EXAC_AF=0.71744054;EXAC_Hom_EAS=92;EXAC_AC_EAS=197;EXAC_AN_EAS=210;EXAC_AC_Adj=8869;EXAC_AN_Adj=12362;RS=rs11037860;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.741813;G1000_EAS_AF=0.9107;G1000_EUR_AF=0.7535;G1000_AFR_AF=0.5575;G1000_SAS_AF=0.7485;G1000_AMR_AF=0.8213;gnomad_exomes_AF=0.75133741;gnomad_exomes_AF_EAS=0.92256086;gnomad_exomes_AC=101402;gnomad_exomes_Hom=38648;gnomad_exomes_Het=24106;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.60763454;gnomad_exomes_AF_NFE=0.71018491;gnomad_exomes_AF_AMR=0.84869879;gnomad_exomes_AF_SAS=0.72982003;NativeFreq_Het=0.1386;NativeFreq_Hom=0.8759;normalHetFrequency=0.163;normalHetNum=141;normalHomFrequency=0.7815;normalHomNum=676;patientHetFrequency=0.1831;patientHetNum=956;patientHomFrequency=0.7699;patientHomNum=4019;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1076;AF_2700_Hom=0.8859;AF_50_Het=0.1125;AF_50_Hom=0.8811;DANN_score=0.5164;GREP_score=-0.7;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=GGGCATGTTA.GCCGGGGACT	GT:AD:DP:GQ:PL	1/1:0,234:234:99:8673,702,0
chr11	44130665	.	A	C	3284.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.169;DP=221;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.93;ReadPosRankSum=-1.004;SOR=0.697;HGVSnom=NM_207122.2:c.537-79A>C;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_207122.2:IVS2-79A>C;AAlength=718;RS=rs77233576;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0738818;G1000_EAS_AF=0.1161;G1000_EUR_AF=0.0467;G1000_AFR_AF=0.0764;G1000_SAS_AF=0.0644;G1000_AMR_AF=0.0605;NativeFreq_Het=0.1980;NativeFreq_Hom=0.0133;normalHetFrequency=0.1838;normalHetNum=159;normalHomFrequency=0.0069;normalHomNum=6;patientHetFrequency=0.1766;patientHetNum=922;patientHomFrequency=0.0126;patientHomNum=66;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546080|16B0033388][16B0024249|15B0002797-1|16D0157419|16B0017325];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.631;GREP_score=-2.99;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=GGGATCCTTG.TAGTTGTTGT	GT:AD:DP:GQ:PL	0/1:114,106:220:99:3313,0,3241
chr11	44146257	.	A	G	3389.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.748;DP=244;ExcessHet=3.0103;FS=2.929;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.95;ReadPosRankSum=0.024;SOR=0.942;HGVSnom=NM_207122.2:c.744-82A>G;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_207122.2:IVS4-82A>G;AAlength=718;RS=rs10769018;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.759585;G1000_EAS_AF=0.8641;G1000_EUR_AF=0.8221;G1000_AFR_AF=0.587;G1000_SAS_AF=0.7587;G1000_AMR_AF=0.8473;NativeFreq_Het=0.2277;NativeFreq_Hom=0.7821;normalHetFrequency=0.2601;normalHetNum=225;normalHomFrequency=0.7156;normalHomNum=619;patientHetFrequency=0.2487;patientHetNum=1298;patientHomFrequency=0.7236;patientHomNum=3777;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3124;GREP_score=-10.6;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=ACTTACTGTC.TAAGTTTAAT	GT:AD:DP:GQ:PL	0/1:121,122:243:99:3418,0,3799
chr11	44151577	.	T	A	6170.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.186;DP=403;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.31;ReadPosRankSum=-0.778;SOR=0.657;HGVSnom=NM_207122.2:c.1080-18T>A;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_207122.2:IVS6-18T>A;AAlength=718;EXAC_AF=0.32741813;EXAC_Hom_EAS=919;EXAC_AC_EAS=3964;EXAC_AN_EAS=8594;EXAC_AC_Adj=39632;EXAC_AN_Adj=121044;ESP6500_MAF=0.23369732;RS=rs11037882;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.320887;G1000_EAS_AF=0.4454;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.087;G1000_SAS_AF=0.4141;G1000_AMR_AF=0.4928;gnomad_exomes_AF=0.34312227;gnomad_exomes_AF_EAS=0.45789760;gnomad_exomes_AC=86193;gnomad_exomes_Hom=17032;gnomad_exomes_Het=52129;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11613737;gnomad_exomes_AF_NFE=0.28590543;gnomad_exomes_AF_AMR=0.58883939;gnomad_exomes_AF_SAS=0.38850402;NativeFreq_Het=0.4952;NativeFreq_Hom=0.1782;normalHetFrequency=0.474;normalHetNum=410;normalHomFrequency=0.1549;normalHomNum=134;patientHetFrequency=0.4579;patientHetNum=2390;patientHomFrequency=0.1697;patientHomNum=886;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4812;AF_2700_Hom=0.2068;AF_50_Het=0.4739;AF_50_Hom=0.2108;DANN_score=0.8625;GREP_score=0.115;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=ATGTAAACTG.TTTGCTGTTG	GT:AD:DP:GQ:PL	0/1:190,213:403:99:6199,0,5502
chr11	44219286	.	C	T	3270.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.355;DP=245;ExcessHet=3.0103;FS=1.719;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.46;ReadPosRankSum=-0.467;SOR=0.554;HGVSnom=NM_207122.2:c.1306-93C>T;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_207122.2:IVS8-93C>T;AAlength=718;RS=rs4755233;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.505391;G1000_EAS_AF=0.5308;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.4781;G1000_SAS_AF=0.4417;G1000_AMR_AF=0.4481;NativeFreq_Het=0.4880;NativeFreq_Hom=0.3663;normalHetFrequency=0.4913;normalHetNum=425;normalHomFrequency=0.3179;normalHomNum=275;patientHetFrequency=0.4707;patientHetNum=2457;patientHomFrequency=0.3262;patientHomNum=1703;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7197;GREP_score=-0.131;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=GTAAAAGCCA.CAAGCCTGCC	GT:AD:DP:GQ:PL	0/1:128,115:243:99:3299,0,3926
chr11	44255614	.	T	C	5120.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.825;DP=352;ExcessHet=3.0103;FS=0.804;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.55;ReadPosRankSum=-1.046;SOR=0.64;HGVSnom=NM_207122.2:c.1807-51T>C;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_207122.2:IVS11-51T>C;AAlength=718;EXAC_AF=0.30650243;EXAC_Hom_EAS=830;EXAC_AC_EAS=3732;EXAC_AN_EAS=8520;EXAC_AC_Adj=36776;EXAC_AN_Adj=119986;ESP6500_MAF=0.22539219;RS=rs11037909;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.311901;G1000_EAS_AF=0.4296;G1000_EUR_AF=0.2704;G1000_AFR_AF=0.112;G1000_SAS_AF=0.3967;G1000_AMR_AF=0.4625;gnomad_exomes_AF=0.32077316;gnomad_exomes_AF_EAS=0.43299082;gnomad_exomes_AC=80056;gnomad_exomes_Hom=14574;gnomad_exomes_Het=50908;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13957816;gnomad_exomes_AF_NFE=0.26286856;gnomad_exomes_AF_AMR=0.53360465;gnomad_exomes_AF_SAS=0.36962216;HGMD_gene=EXT2;HGMD_disease=Diabetes_type_2_reduced_risk_association_with;HGMD_tag=DP;HGMD_pmid=17293876;NativeFreq_Het=0.4904;NativeFreq_Hom=0.1639;normalHetFrequency=0.4705;normalHetNum=407;normalHomFrequency=0.1295;normalHomNum=112;patientHetFrequency=0.442;patientHetNum=2307;patientHomFrequency=0.1544;patientHomNum=806;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8411;GREP_score=0.79;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=ATTTATCAGC.AAAGGGAACT	GT:AD:DP:GQ:PL	0/1:188,164:352:99:5149,0,5798
chr11	44257802	.	T	C	3506.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.978;DP=301;ExcessHet=3.0103;FS=2.568;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.69;ReadPosRankSum=-0.545;SOR=0.851;HGVSnom=NM_207122.2:c.1936-41T>C;Gene=EXT2;Transcript=NM_207122.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_207122.2:IVS12-41T>C;AAlength=718;EXAC_AF=0.30283917;EXAC_Hom_EAS=840;EXAC_AC_EAS=3777;EXAC_AN_EAS=8584;EXAC_AC_Adj=36586;EXAC_AN_Adj=120810;ESP6500_MAF=0.20870501;RS=rs3740878;CLNGENE=EXT2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.300519;G1000_EAS_AF=0.4335;G1000_EUR_AF=0.2704;G1000_AFR_AF=0.0658;G1000_SAS_AF=0.3998;G1000_AMR_AF=0.4582;gnomad_exomes_AF=0.31764546;gnomad_exomes_AF_EAS=0.43441997;gnomad_exomes_AC=79304;gnomad_exomes_Hom=14531;gnomad_exomes_Het=50242;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08910952;gnomad_exomes_AF_NFE=0.26326110;gnomad_exomes_AF_AMR=0.53188221;gnomad_exomes_AF_SAS=0.37066937;HGMD_gene=EXT2;HGMD_disease=Diabetes_type_2_reduced_risk_association_with;HGMD_tag=DP;HGMD_pmid=17293876;NativeFreq_Het=0.4940;NativeFreq_Hom=0.1614;normalHetFrequency=0.4671;normalHetNum=404;normalHomFrequency=0.1353;normalHomNum=117;patientHetFrequency=0.4443;patientHetNum=2319;patientHomFrequency=0.1542;patientHomNum=805;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.462;GREP_score=-2.69;CytoBand=p11.2;CGD_CONDITION=Exostoses, multiple, type 2;CGD_INHERITANCE=AD;Strand=EXT2:NM_001178083.1:+,EXT2:NM_207122.1:+,EXT2:NM_000401.3:+;NP=EXT2:NM_001178083.1:NP_001171554.1,EXT2:NM_207122.1:NP_997005.1,EXT2:NM_000401.3:NP_000392.3;ENSP=EXT2:NM_001178083.1:.,EXT2:NM_207122.1:ENST00000533608.6,EXT2:NM_000401.3:ENST00000395673.7;Gene_MIM_id=608210;Phenotypes=Exostoses, multiple, type 2, 133701 (3), Autosomal dominant. ?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3), Autosomal recessive. 133701(MK),616682(UK);Possible_Inheritance=AD,AR;EntrezGeneID=2132;EnsemblGeneID=ENSG00000151348;Alias=EXT2, SSMS;FLKSEQ=TTATTGTCCT.GACACTGACA	GT:AD:DP:GQ:PL	0/1:175,125:300:99:3535,0,5681
chr11	44267034	.	G	A	10731.8	PASS	AC=2;AF=1;AN=2;DP=288;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.5;SOR=1.101;HGVSnom=NM_207122.2:c.*1197G>A;Gene=EXT2;Transcript=NM_207122.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=718;RS=rs4755793;G1000_AF=0.906749;G1000_EAS_AF=0.9812;G1000_EUR_AF=0.8926;G1000_AFR_AF=0.8676;G1000_SAS_AF=0.865;G1000_AMR_AF=0.9524;NativeFreq_Het=0.0313;NativeFreq_Hom=0.9663;normalHetFrequency=0.0839;normalHetNum=40;normalHomFrequency=0.9099;normalHomNum=434;patientHetFrequency=0.0609;patientHetNum=149;patientHomFrequency=0.4383;patientHomNum=2288;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8459;GREP_score=-1.26;CytoBand=p11.2;FLKSEQ=CTACCCTGGC.AATGTTAAAT	GT:AD:DP:GQ:PL	1/1:0,288:288:99:10760,866,0
chr11	47238522	.	T	C	12285.8	PASS	AC=2;AF=1;AN=2;DP=361;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.22;SOR=0.841;HGVSnom=NM_000107.3:c.378C>C(p.Thr126Thr/p.T126T);Gene=DDB2;Transcript=NM_000107.3;VarType=NoCall;MolecularConsequence=nocall_variant;ExonIntron=E3;IVSnom=.;AAlength=427;EXAC_AF=0.99873974;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=121251;EXAC_AN_Adj=121404;ESP6500_MAF=0.99530697;RS=rs1565150477|rs326212;CLNGENE=DDB2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.994209;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9788;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9986;gnomad_exomes_AF=0.99897403;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=251212;gnomad_exomes_Hom=125478;gnomad_exomes_Het=256;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.98566507;gnomad_exomes_AF_NFE=0.99998242;gnomad_exomes_AF_AMR=0.99950847;gnomad_exomes_AF_SAS=0.99993467;NativeFreq_Het=0.0107;NativeFreq_Hom=1;DANN_score=0.5475;GREP_score=1.01;CytoBand=p11.2;CGD_CONDITION=Xeroderma pigmentosum, group E;CGD_INHERITANCE=AR;Strand=DDB2:NM_000107.2:+,DDB2:NM_001300734.1:+;NP=DDB2:NM_000107.2:NP_000098.1,DDB2:NM_001300734.1:NP_001287663.1;ENSP=DDB2:NM_000107.2:ENST00000256996.8,DDB2:NM_001300734.1:.;Gene_MIM_id=600811;Phenotypes=Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive. 278740(MK);Possible_Inheritance=AR;EntrezGeneID=1643;EnsemblGeneID=ENSG00000134574;Alias=DDB2;FLKSEQ=ACCCCAGCAC.GTGGCTGTGG	GT:AD:DP:GQ:PL	1/1:0,359:359:99:12314,1078,0
chr11	47260319	.	A	G	10667.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.443;DP=283;ExcessHet=3.0103;FS=5.542;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.17;ReadPosRankSum=0.343;SOR=1.944;HGVSnom=NM_000107.3:c.1235-32A>G;Gene=DDB2;Transcript=NM_000107.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000107.3:IVS9-32A>G;AAlength=427;EXAC_AF=0.39560603;EXAC_Hom_EAS=2475;EXAC_AC_EAS=6553;EXAC_AN_EAS=8626;EXAC_AC_Adj=47862;EXAC_AN_Adj=120984;ESP6500_MAF=0.38213571;RS=rs901746;CLNGENE=DDB2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.51877;G1000_EAS_AF=0.7768;G1000_EUR_AF=0.3022;G1000_AFR_AF=0.6203;G1000_SAS_AF=0.4581;G1000_AMR_AF=0.3501;gnomad_exomes_AF=0.39650778;gnomad_exomes_AF_EAS=0.75835602;gnomad_exomes_AC=98939;gnomad_exomes_Hom=22181;gnomad_exomes_Het=54577;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57793248;gnomad_exomes_AF_NFE=0.29551002;gnomad_exomes_AF_AMR=0.44103486;gnomad_exomes_AF_SAS=0.46179489;NativeFreq_Het=0.4653;NativeFreq_Hom=0.4938;normalHetFrequency=0.4162;normalHetNum=360;normalHomFrequency=0.3965;normalHomNum=343;patientHetFrequency=0.387;patientHetNum=2020;patientHomFrequency=0.4284;patientHomNum=2236;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5252;GREP_score=-3.31;CytoBand=p11.2;CGD_CONDITION=Xeroderma pigmentosum, group E;CGD_INHERITANCE=AR;Strand=DDB2:NM_000107.2:+,DDB2:NM_001300734.1:+;NP=DDB2:NM_000107.2:NP_000098.1,DDB2:NM_001300734.1:NP_001287663.1;ENSP=DDB2:NM_000107.2:ENST00000256996.8,DDB2:NM_001300734.1:.;Gene_MIM_id=600811;Phenotypes=Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive. 278740(MK);Possible_Inheritance=AR;EntrezGeneID=1643;EnsemblGeneID=ENSG00000134574;Alias=DDB2;FLKSEQ=GGTAACAGAA.GTGTAAGTCA	GT:AD:DP:GQ:PL	1/1:1,282:283:99:10696,809,0
chr11	61205434	.	G	A	8354.77	PASS	AC=2;AF=1;AN=2;DP=237;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.69;SOR=1.258;HGVSnom=NM_017841.4:c.261-42G>A;Gene=SDHAF2;Transcript=NM_017841.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_017841.4:IVS2-42G>A;AAlength=166;EXAC_AF=0.81950319;EXAC_Hom_EAS=3821;EXAC_AC_EAS=7947;EXAC_AN_EAS=8264;EXAC_AC_Adj=97257;EXAC_AN_Adj=118678;ESP6500_MAF=0.68658668;RS=rs879647;CLNGENE=SDHAF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.718051;G1000_EAS_AF=0.9712;G1000_EUR_AF=0.8529;G1000_AFR_AF=0.292;G1000_SAS_AF=0.8098;G1000_AMR_AF=0.8372;gnomad_exomes_AF=0.83119532;gnomad_exomes_AF_EAS=0.96264463;gnomad_exomes_AC=206178;gnomad_exomes_Hom=87871;gnomad_exomes_Het=30436;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.35659257;gnomad_exomes_AF_NFE=0.85127273;gnomad_exomes_AF_AMR=0.86312119;gnomad_exomes_AF_SAS=0.83278699;NativeFreq_Het=0.1708;NativeFreq_Hom=0.9405;normalHetFrequency=0.1005;normalHetNum=39;normalHomFrequency=0.8918;normalHomNum=346;patientHetFrequency=0.1263;patientHetNum=350;patientHomFrequency=0.864;patientHomNum=2395;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.49;GREP_score=1.9;CytoBand=q12.2;CGD_CONDITION=Paragangliomas 2;CGD_INHERITANCE=AD;Strand=SDHAF2:NM_017841.2:+;NP=SDHAF2:NM_017841.2:NP_060311.1;ENSP=SDHAF2:NM_017841.2:ENST00000301761.6;Gene_MIM_id=613019;Phenotypes=Paragangliomas 2, 601650 (3), Autosomal dominant. 601650(MK);Possible_Inheritance=AD;EntrezGeneID=54949;EnsemblGeneID=ENSG00000167985;Alias=SDHAF2, SDH5, PGL2;FLKSEQ=ATTAGACACA.CCTTCTCAAC	GT:AD:DP:GQ:PL	1/1:0,236:236:99:8383,708,0
chr11	61205676	.	C	CT	1526.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.775;DP=109;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.42;ReadPosRankSum=0.534;SOR=1.431;HGVSnom=NM_017841.4:c.370+103dupT;Gene=SDHAF2;Transcript=NM_017841.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_017841.4:IVS3+103_+104insT;AAlength=166;EXAC_AF=0.57858515;EXAC_Hom_EAS=231;EXAC_AC_EAS=892;EXAC_AN_EAS=1344;EXAC_AC_Adj=21690;EXAC_AN_Adj=37488;RS=rs5792226;CLNGENE=SDHAF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.622404;G1000_EAS_AF=0.6518;G1000_EUR_AF=0.663;G1000_AFR_AF=0.5696;G1000_SAS_AF=0.5859;G1000_AMR_AF=0.6729;gnomad_exomes_AF=0.53035711;gnomad_exomes_AF_EAS=0.53383242;gnomad_exomes_AC=54980;gnomad_exomes_Hom=3978;gnomad_exomes_Het=47024;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51363909;gnomad_exomes_AF_NFE=0.53656323;gnomad_exomes_AF_AMR=0.51656708;gnomad_exomes_AF_SAS=0.51239269;NativeFreq_Het=0.4307;NativeFreq_Hom=.;normalHetFrequency=0.4485;normalHetNum=174;normalHomFrequency=0.5412;normalHomNum=210;patientHetFrequency=0.46;patientHetNum=1275;patientHomFrequency=0.5289;patientHomNum=1466;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q12.2;repName=AluSp;repClass=SINE;CGD_CONDITION=Paragangliomas 2;CGD_INHERITANCE=AD;Strand=SDHAF2:NM_017841.2:+;NP=SDHAF2:NM_017841.2:NP_060311.1;ENSP=SDHAF2:NM_017841.2:ENST00000301761.6;Gene_MIM_id=613019;Phenotypes=Paragangliomas 2, 601650 (3), Autosomal dominant. 601650(MK);Possible_Inheritance=AD;EntrezGeneID=54949;EnsemblGeneID=ENSG00000167985;Alias=SDHAF2, SDH5, PGL2;FLKSEQ=ttttttcttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:20,79:99:99:1524,0,115
chr11	61213920	.	T	C	7454.77	PASS	AC=2;AF=1;AN=2;DP=213;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35;SOR=1.001;HGVSnom=NM_017841.4:c.*377T>C;Gene=SDHAF2;Transcript=NM_017841.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E4;IVSnom=.;AAlength=166;RS=rs17702;CLNGENE=SDHAF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.861422;G1000_EAS_AF=0.9762;G1000_EUR_AF=0.8678;G1000_AFR_AF=0.7655;G1000_SAS_AF=0.8528;G1000_AMR_AF=0.8804;NativeFreq_Het=0.0594;NativeFreq_Hom=0.9405;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.018;normalHomNum=7;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0133;patientHomNum=37;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0024246|16B3094633|16D0172118][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0661;AF_2700_Hom=0.9316;AF_50_Het=0.0618;AF_50_Hom=0.9382;DANN_score=0.1707;GREP_score=-9.73;CytoBand=q12.2;CGD_CONDITION=Paragangliomas 2;CGD_INHERITANCE=AD;Strand=SDHAF2:NM_017841.2:+;NP=SDHAF2:NM_017841.2:NP_060311.1;ENSP=SDHAF2:NM_017841.2:ENST00000301761.6;Gene_MIM_id=613019;Phenotypes=Paragangliomas 2, 601650 (3), Autosomal dominant. 601650(MK);Possible_Inheritance=AD;EntrezGeneID=54949;EnsemblGeneID=ENSG00000167985;Alias=SDHAF2, SDH5, PGL2;FLKSEQ=GCGTGCTGTA.GGAAAGCCTC	GT:AD:DP:GQ:PL	1/1:0,213:213:99:7483,640,0
chr11	64572018	.	T	C	4024.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.705;DP=290;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.93;ReadPosRankSum=-0.242;SOR=0.687;HGVSnom=NM_001370259.2:c.1621A>G(p.Thr541Ala/p.T541A);Gene=MEN1;Transcript=NM_001370259.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E10;IVSnom=.;AAlength=610;EXAC_AF=0.93777521;EXAC_Hom_EAS=2138;EXAC_AC_EAS=6044;EXAC_AN_EAS=8632;EXAC_AC_Adj=113724;EXAC_AN_Adj=121270;ESP6500_MAF=0.90843336;RS=rs2959656;Ensembl_transcriptid=ENST00000377316|ENST00000377321|ENST00000377326|ENST00000312049|ENST00000315422|ENST00000394374|ENST00000394376|ENST00000337652|ENST00000377313;SIFT_pred=T|T|T|T|T|T|T|T|T;SIFT_score=0.866|0.904|0.911|0.911|0.911|0.981|0.981|0.981|0.981;Polyphen2_HVAR_pred=.|B|B|B|B|B|B|B|B;Polyphen2_HVAR_score=.|0.0|0.0|0.0|0.0|0.0|0.0|0.0|0.0;MutationTaster_pred=P|P|P|P|P|P|P|P|P|P;MutationTaster_score=1|1|1|1|1|1|1|1|1|1;CLNGENE=MEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.834465;G1000_EAS_AF=0.6964;G1000_EUR_AF=0.9911;G1000_AFR_AF=0.6664;G1000_SAS_AF=0.9949;G1000_AMR_AF=0.902;gnomad_exomes_AF=0.93740687;gnomad_exomes_AF_EAS=0.69719230;gnomad_exomes_AC=235276;gnomad_exomes_Hom=111643;gnomad_exomes_Het=11990;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.70625539;gnomad_exomes_AF_NFE=0.99597662;gnomad_exomes_AF_AMR=0.88128581;gnomad_exomes_AF_SAS=0.99487129;HGMD_gene=MEN1;HGMD_disease=Impaired_sensitisation_to_apoptosis;HGMD_tag=DFP;HGMD_pmid=18775714;NativeFreq_Het=0.4356;NativeFreq_Hom=0.6335;DANN_score=0.5414;GREP_score=3.35;CytoBand=q13.1;CGD_CONDITION=Multiple endocrine neoplasia type I. Hyperparathyroidism, familial primary;CGD_INHERITANCE=AD;Strand=MEN1:NM_130800.2:-,MEN1:NM_130801.2:-,MEN1:NM_000244.3:-,MEN1:NM_130799.2:-,MEN1:NM_130802.2:-,MEN1:NM_130803.2:-,MEN1:NM_130804.2:-;NP=MEN1:NM_130800.2:NP_570712.1,MEN1:NM_130801.2:NP_570713.1,MEN1:NM_000244.3:NP_000235.2,MEN1:NM_130799.2:NP_570711.1,MEN1:NM_130802.2:NP_570714.1,MEN1:NM_130803.2:NP_570715.1,MEN1:NM_130804.2:NP_570716.1;ENSP=MEN1:NM_130800.2:.,MEN1:NM_130801.2:.,MEN1:NM_000244.3:.,MEN1:NM_130799.2:.,MEN1:NM_130802.2:.,MEN1:NM_130803.2:ENST00000337652.5,MEN1:NM_130804.2:.;Gene_MIM_id=169710,613733;Phenotypes=.,Adrenal adenoma, somatic (3). Angiofibroma, somatic (3). Carcinoid tumor of lung (3). Lipoma, somatic (3). Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant. Parathyroid adenoma, somatic (3). 131100(MK),613733(MK);Possible_Inheritance=NA,AD;EntrezGeneID=643834,4221;EnsemblGeneID=ENSG00000229859,ENSG00000133895;Alias=PGA3,MEN1;FLKSEQ=GGTGATGCTG.GGGTGCTGGC	GT:AD:DP:GQ:PL	0/1:146,143:289:99:4053,0,4382
chr11	64572557	.	A	G	10226.8	PASS	AC=2;AF=1;AN=2;DP=295;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.9;SOR=1.238;HGVSnom=NM_001370259.2:c.1299T>C(p.His433His/p.H433H);Gene=MEN1;Transcript=NM_001370259.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E9;IVSnom=.;AAlength=610;EXAC_AF=0.99274848;EXAC_Hom_EAS=4324;EXAC_AC_EAS=8648;EXAC_AN_EAS=8648;EXAC_AC_Adj=120337;EXAC_AN_Adj=121216;ESP6500_MAF=0.97614651;RS=rs540012;CLNGENE=MEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.976038;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9115;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9957;gnomad_exomes_AF=0.99416378;gnomad_exomes_AF_EAS=0.99994562;gnomad_exomes_AC=249724;gnomad_exomes_Hom=124180;gnomad_exomes_Het=1364;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91889560;gnomad_exomes_AF_NFE=0.99988553;gnomad_exomes_AF_AMR=0.99687554;gnomad_exomes_AF_SAS=0.99986935;NativeFreq_Het=0.0142;NativeFreq_Hom=1;DANN_score=0.541;GREP_score=-2.49;CytoBand=q13.1;CGD_CONDITION=Multiple endocrine neoplasia type I. Hyperparathyroidism, familial primary;CGD_INHERITANCE=AD;Strand=MEN1:NM_130800.2:-,MEN1:NM_130801.2:-,MEN1:NM_000244.3:-,MEN1:NM_130799.2:-,MEN1:NM_130802.2:-,MEN1:NM_130803.2:-,MEN1:NM_130804.2:-;NP=MEN1:NM_130800.2:NP_570712.1,MEN1:NM_130801.2:NP_570713.1,MEN1:NM_000244.3:NP_000235.2,MEN1:NM_130799.2:NP_570711.1,MEN1:NM_130802.2:NP_570714.1,MEN1:NM_130803.2:NP_570715.1,MEN1:NM_130804.2:NP_570716.1;ENSP=MEN1:NM_130800.2:.,MEN1:NM_130801.2:.,MEN1:NM_000244.3:.,MEN1:NM_130799.2:.,MEN1:NM_130802.2:.,MEN1:NM_130803.2:ENST00000337652.5,MEN1:NM_130804.2:.;Gene_MIM_id=169710,613733;Phenotypes=.,Adrenal adenoma, somatic (3). Angiofibroma, somatic (3). Carcinoid tumor of lung (3). Lipoma, somatic (3). Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant. Parathyroid adenoma, somatic (3). 131100(MK),613733(MK);Possible_Inheritance=NA,AD;EntrezGeneID=643834,4221;EnsemblGeneID=ENSG00000229859,ENSG00000133895;Alias=PGA3,MEN1;FLKSEQ=CCCAGCCCAC.TGCAGCACAG	GT:AD:DP:GQ:PL	1/1:0,293:293:99:10255,881,0
chr11	64572602	.	G	A	5712.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.1;DP=373;ExcessHet=3.0103;FS=3.446;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.44;ReadPosRankSum=0.325;SOR=0.54;HGVSnom=NM_001370259.2:c.1254C>T(p.Asp418Asp/p.D418D);Gene=MEN1;Transcript=NM_001370259.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E9;IVSnom=.;AAlength=610;EXAC_AF=0.39335054;EXAC_Hom_EAS=653;EXAC_AC_EAS=3295;EXAC_AN_EAS=8614;EXAC_AC_Adj=47549;EXAC_AN_Adj=120882;ESP6500_MAF=0.30401662;RS=rs2071313;CLNGENE=MEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.307907;G1000_EAS_AF=0.372;G1000_EUR_AF=0.4056;G1000_AFR_AF=0.0348;G1000_SAS_AF=0.5164;G1000_AMR_AF=0.2997;gnomad_exomes_AF=0.39159588;gnomad_exomes_AF_EAS=0.38361084;gnomad_exomes_AC=98289;gnomad_exomes_Hom=20511;gnomad_exomes_Het=57267;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08185514;gnomad_exomes_AF_NFE=0.42071816;gnomad_exomes_AF_AMR=0.34038796;gnomad_exomes_AF_SAS=0.49091919;NativeFreq_Het=0.4455;NativeFreq_Hom=0.1584;normalHetFrequency=0.4647;normalHetNum=402;normalHomFrequency=0.1653;normalHomNum=143;patientHetFrequency=0.4722;patientHetNum=2465;patientHomFrequency=0.1632;patientHomNum=852;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4769;AF_2700_Hom=0.1722;AF_50_Het=0.5008;AF_50_Hom=0.1553;DANN_score=0.8881;GREP_score=-1.58;CytoBand=q13.1;CGD_CONDITION=Multiple endocrine neoplasia type I. Hyperparathyroidism, familial primary;CGD_INHERITANCE=AD;Strand=MEN1:NM_130800.2:-,MEN1:NM_130801.2:-,MEN1:NM_000244.3:-,MEN1:NM_130799.2:-,MEN1:NM_130802.2:-,MEN1:NM_130803.2:-,MEN1:NM_130804.2:-;NP=MEN1:NM_130800.2:NP_570712.1,MEN1:NM_130801.2:NP_570713.1,MEN1:NM_000244.3:NP_000235.2,MEN1:NM_130799.2:NP_570711.1,MEN1:NM_130802.2:NP_570714.1,MEN1:NM_130803.2:NP_570715.1,MEN1:NM_130804.2:NP_570716.1;ENSP=MEN1:NM_130800.2:.,MEN1:NM_130801.2:.,MEN1:NM_000244.3:.,MEN1:NM_130799.2:.,MEN1:NM_130802.2:.,MEN1:NM_130803.2:ENST00000337652.5,MEN1:NM_130804.2:.;Gene_MIM_id=169710,613733;Phenotypes=.,Adrenal adenoma, somatic (3). Angiofibroma, somatic (3). Carcinoid tumor of lung (3). Lipoma, somatic (3). Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant. Parathyroid adenoma, somatic (3). 131100(MK),613733(MK);Possible_Inheritance=NA,AD;EntrezGeneID=643834,4221;EnsemblGeneID=ENSG00000229859,ENSG00000133895;Alias=PGA3,MEN1;FLKSEQ=TGCAGATGCC.TCGTAGAATC	GT:AD:DP:GQ:PL	0/1:180,190:370:99:5741,0,5032
chr11	64578305	.	G	A	4615.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.463;DP=321;ExcessHet=3.0103;FS=4.666;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.51;ReadPosRankSum=1.595;SOR=0.487;HGVSnom=.;Gene=MEN1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs11231874;CLNGENE=MEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.134784;G1000_EAS_AF=0.3065;G1000_EUR_AF=0.0089;G1000_AFR_AF=0.2186;G1000_SAS_AF=0.0051;G1000_AMR_AF=0.0908;NativeFreq_Het=0.4257;NativeFreq_Hom=0.1089;normalHetFrequency=0.2893;normalHetNum=138;normalHomFrequency=0.065;normalHomNum=31;patientHetFrequency=0.1397;patientHetNum=729;patientHomFrequency=0.0339;patientHomNum=177;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4185;AF_2700_Hom=0.0780;AF_50_Het=0.4326;AF_50_Hom=0.0650;DANN_score=0.7507;GREP_score=-1.89;CytoBand=q13.1;CGD_CONDITION=Multiple endocrine neoplasia type I. Hyperparathyroidism, familial primary;CGD_INHERITANCE=AD;Strand=MEN1:NM_130803.2:-,MEN1:NM_130804.2:-;NP=MEN1:NM_130803.2:NP_570715.1,MEN1:NM_130804.2:NP_570716.1;ENSP=MEN1:NM_130803.2:ENST00000337652.5,MEN1:NM_130804.2:.;Gene_MIM_id=169710,613733;Phenotypes=.,Adrenal adenoma, somatic (3). Angiofibroma, somatic (3). Carcinoid tumor of lung (3). Lipoma, somatic (3). Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant. Parathyroid adenoma, somatic (3). 131100(MK),613733(MK);Possible_Inheritance=NA,AD;EntrezGeneID=643834,4221;EnsemblGeneID=ENSG00000229859,ENSG00000133895;Alias=PGA3,MEN1;FLKSEQ=ACTCGGGGTG.GAGGTCGCCG	GT:AD:DP:GQ:PL	0/1:164,154:318:99:4644,0,5189
chr11	64578620	.	A	G	2747.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.562;DP=205;ExcessHet=3.0103;FS=7.639;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.47;ReadPosRankSum=1.844;SOR=1.379;HGVSnom=.;Gene=MEN1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs7949944;CLNGENE=MEN1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.159944;G1000_EAS_AF=0.3234;G1000_EUR_AF=0.0089;G1000_AFR_AF=0.2723;G1000_SAS_AF=0.0409;G1000_AMR_AF=0.0951;NativeFreq_Het=0.4554;NativeFreq_Hom=0.1089;normalHetFrequency=0.3061;normalHetNum=146;normalHomFrequency=0.0734;normalHomNum=35;patientHetFrequency=0.3117;patientHetNum=763;patientHomFrequency=0.0372;patientHomNum=194;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4262;AF_2700_Hom=0.0884;AF_50_Het=0.4501;AF_50_Hom=0.0729;DANN_score=0.2261;GREP_score=-0.513;CytoBand=q13.1;repName=AluJb;repClass=SINE;CGD_CONDITION=Multiple endocrine neoplasia type I. Hyperparathyroidism, familial primary;CGD_INHERITANCE=AD;Strand=MEN1:NM_130803.2:-,MEN1:NM_130804.2:-;NP=MEN1:NM_130803.2:NP_570715.1,MEN1:NM_130804.2:NP_570716.1;ENSP=MEN1:NM_130803.2:ENST00000337652.5,MEN1:NM_130804.2:.;Gene_MIM_id=169710,613733;Phenotypes=.,Adrenal adenoma, somatic (3). Angiofibroma, somatic (3). Carcinoid tumor of lung (3). Lipoma, somatic (3). Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant. Parathyroid adenoma, somatic (3). 131100(MK),613733(MK);Possible_Inheritance=NA,AD;EntrezGeneID=643834,4221;EnsemblGeneID=ENSG00000229859,ENSG00000133895;Alias=PGA3,MEN1;FLKSEQ=ccaggctgga.tgcagtggct	GT:AD:DP:GQ:PL	0/1:114,90:204:99:2776,0,3585
chr11	76183924	.	A	G	4204.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.881;DP=277;ExcessHet=3.0103;FS=0.497;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.23;ReadPosRankSum=0.456;SOR=0.655;HGVSnom=NM_001300942.2:c.1153+40A>G;Gene=EMSY;Transcript=NM_001300942.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_001300942.2:IVS9+40A>G;AAlength=1337;EXAC_AF=0.61419594;EXAC_Hom_EAS=2214;EXAC_AC_EAS=6228;EXAC_AN_EAS=8634;EXAC_AC_Adj=73889;EXAC_AN_Adj=120302;ESP6500_MAF=0.52179606;RS=rs4245443;G1000_AF=0.583666;G1000_EAS_AF=0.6944;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.3283;G1000_SAS_AF=0.6687;G1000_AMR_AF=0.7478;gnomad_exomes_AF=0.62221906;gnomad_exomes_AF_EAS=0.72177375;gnomad_exomes_AC=153097;gnomad_exomes_Hom=49101;gnomad_exomes_Het=54895;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37822810;gnomad_exomes_AF_NFE=0.59866572;gnomad_exomes_AF_AMR=0.77534710;gnomad_exomes_AF_SAS=0.67464355;NativeFreq_Het=0.4128;NativeFreq_Hom=0.4128;DANN_score=0.4441;GREP_score=-8.11;CytoBand=q13.5;Strand=EMSY:NM_001300942.1:+,EMSY:NM_001300943.1:+,EMSY:NM_001300944.1:+,EMSY:NM_020193.4:+;NP=EMSY:NM_001300942.1:NP_001287871.1,EMSY:NM_001300943.1:NP_001287872.1,EMSY:NM_001300944.1:NP_001287873.1,EMSY:NM_020193.4:NP_064578.2;ENSP=EMSY:NM_001300942.1:.,EMSY:NM_001300943.1:.,EMSY:NM_001300944.1:.,EMSY:NM_020193.4:.;Gene_MIM_id=169710,608574;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=643834,56946;EnsemblGeneID=ENSG00000229859,ENSG00000158636;Alias=PGA3,EMSY, C11orf30;FLKSEQ=CACAGTTGCT.TATGGAATTT	GT:AD:DP:GQ:PL	0/1:140,136:276:99:4233,0,4257
chr11	76227182	.	G	A	5447.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.119;DP=352;ExcessHet=3.0103;FS=0.444;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.52;ReadPosRankSum=0.68;SOR=0.645;HGVSnom=NM_001300942.2:c.1559-4G>A;Gene=EMSY;Transcript=NM_001300942.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001300942.2:IVS11-4G>A;AAlength=1337;EXAC_AF=0.64384850;EXAC_Hom_EAS=2905;EXAC_AC_EAS=7098;EXAC_AN_EAS=8646;EXAC_AC_Adj=78028;EXAC_AN_Adj=121190;ESP6500_MAF=0.54990758;RS=rs2508740;G1000_AF=0.636182;G1000_EAS_AF=0.8006;G1000_EUR_AF=0.6213;G1000_AFR_AF=0.3828;G1000_SAS_AF=0.7403;G1000_AMR_AF=0.755;gnomad_exomes_AF=0.65047460;gnomad_exomes_AF_EAS=0.82467818;gnomad_exomes_AC=159672;gnomad_exomes_Hom=53500;gnomad_exomes_Het=52672;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42167928;gnomad_exomes_AF_NFE=0.61078984;gnomad_exomes_AF_AMR=0.78074786;gnomad_exomes_AF_SAS=0.72290097;NativeFreq_Het=0.3737;NativeFreq_Hom=0.5196;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00001893;DANN_score=0.4967;GREP_score=-3.92;CytoBand=q13.5;Strand=EMSY:NM_001300942.1:+,EMSY:NM_001300943.1:+,EMSY:NM_001300944.1:+,EMSY:NM_020193.4:+;NP=EMSY:NM_001300942.1:NP_001287871.1,EMSY:NM_001300943.1:NP_001287872.1,EMSY:NM_001300944.1:NP_001287873.1,EMSY:NM_020193.4:NP_064578.2;ENSP=EMSY:NM_001300942.1:.,EMSY:NM_001300943.1:.,EMSY:NM_001300944.1:.,EMSY:NM_020193.4:.;Gene_MIM_id=169710,608574;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=643834,56946;EnsemblGeneID=ENSG00000229859,ENSG00000158636;Alias=PGA3,EMSY, C11orf30;FLKSEQ=TTCCCTTTCT.TAGGCACACA	GT:AD:DP:GQ:PL	0/1:171,180:351:99:5476,0,5575
chr11	76261404	.	G	GA	5032.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.969;DP=521;ExcessHet=3.0103;FS=3.203;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.71;ReadPosRankSum=-0.663;SOR=0.937;HGVSnom=NM_001300942.2:c.*223dupA;Gene=EMSY;Transcript=NM_001300942.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1337;RS=rs11433055;G1000_AF=0.560304;G1000_EAS_AF=0.6399;G1000_EUR_AF=0.5964;G1000_AFR_AF=0.3064;G1000_SAS_AF=0.6554;G1000_AMR_AF=0.7421;CytoBand=q13.5;Strand=EMSY:NM_001300942.1:+,EMSY:NM_001300943.1:+,EMSY:NM_001300944.1:+,EMSY:NM_020193.4:+;NP=EMSY:NM_001300942.1:NP_001287871.1,EMSY:NM_001300943.1:NP_001287872.1,EMSY:NM_001300944.1:NP_001287873.1,EMSY:NM_020193.4:NP_064578.2;ENSP=EMSY:NM_001300942.1:.,EMSY:NM_001300943.1:.,EMSY:NM_001300944.1:.,EMSY:NM_020193.4:.;Gene_MIM_id=169710,608574;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=643834,56946;EnsemblGeneID=ENSG00000229859,ENSG00000158636;Alias=PGA3,EMSY, C11orf30;FLKSEQ=AAATGAAAAA.AAAAAAAAAG	GT:AD:DP:GQ:PL	0/1:227,243:470:99:5070,0,5049
chr11	76261533	.	A	G	6548.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.862;DP=428;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.41;ReadPosRankSum=0.771;SOR=0.702;HGVSnom=NM_001300942.2:c.*343A>G;Gene=EMSY;Transcript=NM_001300942.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1337;RS=rs2513513;G1000_AF=0.583866;G1000_EAS_AF=0.6964;G1000_EUR_AF=0.6103;G1000_AFR_AF=0.329;G1000_SAS_AF=0.6677;G1000_AMR_AF=0.7493;NativeFreq_Het=0.0214;NativeFreq_Hom=0.0534;DANN_score=0.6235;GREP_score=1.84;CytoBand=q13.5;Strand=EMSY:NM_001300942.1:+,EMSY:NM_001300943.1:+,EMSY:NM_001300944.1:+,EMSY:NM_020193.4:+;NP=EMSY:NM_001300942.1:NP_001287871.1,EMSY:NM_001300943.1:NP_001287872.1,EMSY:NM_001300944.1:NP_001287873.1,EMSY:NM_020193.4:NP_064578.2;ENSP=EMSY:NM_001300942.1:.,EMSY:NM_001300943.1:.,EMSY:NM_001300944.1:.,EMSY:NM_020193.4:.;Gene_MIM_id=169710,608574;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=643834,56946;EnsemblGeneID=ENSG00000229859,ENSG00000158636;Alias=PGA3,EMSY, C11orf30;FLKSEQ=ACTGGTTTCT.CTGAGCAAAA	GT:AD:DP:GQ:PL	0/1:223,202:425:99:6577,0,6618
chr11	76262128	.	A	G	3252.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.788;DP=236;ExcessHet=3.0103;FS=0.484;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.84;ReadPosRankSum=-0.775;SOR=0.64;HGVSnom=NM_001300942.2:c.*938A>G;Gene=EMSY;Transcript=NM_001300942.2;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E22;IVSnom=.;AAlength=1337;RS=rs1044265;G1000_AF=0.425519;G1000_EAS_AF=0.4663;G1000_EUR_AF=0.4374;G1000_AFR_AF=0.2799;G1000_SAS_AF=0.5112;G1000_AMR_AF=0.5058;DANN_score=0.8387;GREP_score=4.78;CytoBand=q13.5;Strand=EMSY:NM_001300942.1:+,EMSY:NM_001300943.1:+,EMSY:NM_001300944.1:+,EMSY:NM_020193.4:+;NP=EMSY:NM_001300942.1:NP_001287871.1,EMSY:NM_001300943.1:NP_001287872.1,EMSY:NM_001300944.1:NP_001287873.1,EMSY:NM_020193.4:NP_064578.2;ENSP=EMSY:NM_001300942.1:.,EMSY:NM_001300943.1:.,EMSY:NM_001300944.1:.,EMSY:NM_020193.4:.;Gene_MIM_id=169710,608574;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=643834,56946;EnsemblGeneID=ENSG00000229859,ENSG00000158636;Alias=PGA3,EMSY, C11orf30;FLKSEQ=AGACTTTGAA.ATAACTTTTA	GT:AD:DP:GQ:PL	0/1:130,105:235:99:3281,0,4291
chr11	94150790	.	T	C	7159.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.968;DP=437;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.38;ReadPosRankSum=-0.785;SOR=0.739;HGVSnom=NM_005591.4:c.*2501A>G;Gene=MRE11;Transcript=NM_005591.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=708;RS=rs2155209;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.234225;G1000_EAS_AF=0.2788;G1000_EUR_AF=0.328;G1000_AFR_AF=0.0908;G1000_SAS_AF=0.2249;G1000_AMR_AF=0.3199;NativeFreq_Het=0.4653;NativeFreq_Hom=0.0495;normalHetFrequency=0.3711;normalHetNum=177;normalHomFrequency=0.0797;normalHomNum=38;patientHetFrequency=0.377;patientHetNum=923;patientHomFrequency=0.0678;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3905;AF_2700_Hom=0.0642;AF_50_Het=0.4041;AF_50_Hom=0.0681;DANN_score=0.6529;GREP_score=-2.84;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=AAGTTAGGGC.TGTTACCCAG	GT:AD:DP:GQ:PL	0/1:218,219:437:99:7188,0,6882
chr11	94151547	.	A	AT	825.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=2.579;DP=544;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.66;ReadPosRankSum=0.658;SOR=0.697;HGVSnom=NM_005591.4:c.*1743dupA;Gene=MRE11;Transcript=NM_005591.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=708;RS=rs200848216;CLNGENE=MRE11;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.126997;G1000_EAS_AF=0.1825;G1000_EUR_AF=0.2008;G1000_AFR_AF=0.0295;G1000_SAS_AF=0.1135;G1000_AMR_AF=0.1441;NativeFreq_Het=0.1485;NativeFreq_Hom=.;normalHetFrequency=0.2767;normalHetNum=132;normalHomFrequency=0.0168;normalHomNum=8;patientHetFrequency=0.317;patientHetNum=776;patientHomFrequency=0.0351;patientHomNum=86;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3286;AF_2700_Hom=0.0111;AF_50_Het=0.3233;AF_50_Hom=0.0127;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=GCCAAGAGCA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:402,94:496:99:863,0,7804
chr11	94152631	.	GGA	G	476.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.728;DP=154;ExcessHet=3.0103;FS=3.67;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.54;ReadPosRankSum=1.751;SOR=0.315;HGVSnom=NM_005591.4:c.*658_*659delTC;Gene=MRE11;Transcript=NM_005591.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=708;RS=rs201800515;CLNGENE=MRE11;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0099;NativeFreq_Hom=.;normalHetFrequency=0.2662;normalHetNum=127;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.2582;patientHetNum=632;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0033298|15B0047126];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16D0172138|15B0060396|16B0011468];AF_2700_Het=0.2686;AF_2700_Hom=.;AF_50_Het=0.2694;AF_50_Hom=.;CytoBand=q21;repName=(GA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=18;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=GGGGGgagag.gagagagaga	GT:AD:DP:GQ:PL	0/1:70,35:105:99:514,0,1895
chr11	94197260	.	A	G	3533.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.004;DP=240;ExcessHet=3.0103;FS=6.367;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.72;ReadPosRankSum=0.994;SOR=0.28;HGVSnom=NM_005591.4:c.1225+19T>C;Gene=MRE11;Transcript=NM_005591.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_005591.4:IVS11+19T>C;AAlength=708;EXAC_AF=0.37830811;EXAC_Hom_EAS=764;EXAC_AC_EAS=3545;EXAC_AN_EAS=8538;EXAC_AC_Adj=45400;EXAC_AN_Adj=120008;ESP6500_MAF=0.35213110;RS=rs641936;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.388778;G1000_EAS_AF=0.4028;G1000_EUR_AF=0.3748;G1000_AFR_AF=0.3601;G1000_SAS_AF=0.4121;G1000_AMR_AF=0.4107;gnomad_exomes_AF=0.38152217;gnomad_exomes_AF_EAS=0.40691199;gnomad_exomes_AC=95495;gnomad_exomes_Hom=18494;gnomad_exomes_Het=58507;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37135048;gnomad_exomes_AF_NFE=0.34497049;gnomad_exomes_AF_AMR=0.44775946;gnomad_exomes_AF_SAS=0.42229796;NativeFreq_Het=0.5445;NativeFreq_Hom=0.1683;normalHetFrequency=0.4821;normalHetNum=417;normalHomFrequency=0.2023;normalHomNum=175;patientHetFrequency=0.4722;patientHetNum=2465;patientHomFrequency=0.1977;patientHomNum=1032;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4858;AF_2700_Hom=0.1972;AF_50_Het=0.4770;AF_50_Hom=0.1965;DANN_score=0.6757;GREP_score=-9.71;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=TTTTTACCTC.TAAAAATAAC	GT:AD:DP:GQ:PL	0/1:114,126:240:99:3562,0,3590
chr11	94203868	.	A	T	3704.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.684;DP=325;ExcessHet=3.0103;FS=4.257;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.4;ReadPosRankSum=0.851;SOR=0.964;HGVSnom=NM_005591.4:c.846-60T>A;Gene=MRE11;Transcript=NM_005591.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_005591.4:IVS8-60T>A;AAlength=708;RS=rs610611;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.724441;G1000_EAS_AF=0.7173;G1000_EUR_AF=0.673;G1000_AFR_AF=0.7602;G1000_SAS_AF=0.7751;G1000_AMR_AF=0.67;NativeFreq_Het=0.4128;NativeFreq_Hom=0.4982;normalHetFrequency=0.3665;normalHetNum=317;normalHomFrequency=0.5572;normalHomNum=482;patientHetFrequency=0.3757;patientHetNum=1961;patientHomFrequency=0.5511;patientHomNum=2877;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4055;GREP_score=-3.73;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=GTGATGTGCA.ACGAAAGCTT	GT:AD:DP:GQ:PL	0/1:194,131:325:99:3733,0,6131
chr11	94212048	.	C	T	4336.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.942;DP=312;ExcessHet=3.0103;FS=1.874;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.03;ReadPosRankSum=-0.797;SOR=0.591;HGVSnom=NM_005591.4:c.403-6G>A;Gene=MRE11;Transcript=NM_005591.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_005591.4:IVS5-6G>A;AAlength=708;EXAC_AF=0.32522943;EXAC_Hom_EAS=735;EXAC_AC_EAS=3479;EXAC_AN_EAS=8574;EXAC_AC_Adj=39196;EXAC_AN_Adj=120518;ESP6500_MAF=0.26957994;RS=rs535801;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.313099;G1000_EAS_AF=0.3859;G1000_EUR_AF=0.335;G1000_AFR_AF=0.171;G1000_SAS_AF=0.3558;G1000_AMR_AF=0.3862;gnomad_exomes_AF=0.33407365;gnomad_exomes_AF_EAS=0.39760943;gnomad_exomes_AC=83483;gnomad_exomes_Hom=14391;gnomad_exomes_Het=54701;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19982710;gnomad_exomes_AF_NFE=0.30642075;gnomad_exomes_AF_AMR=0.42589477;gnomad_exomes_AF_SAS=0.34777916;NativeFreq_Het=0.5643;NativeFreq_Hom=0.1386;normalHetFrequency=0.474;normalHetNum=410;normalHomFrequency=0.1688;normalHomNum=146;patientHetFrequency=0.4648;patientHetNum=2426;patientHomFrequency=0.1697;patientHomNum=886;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4827;AF_2700_Hom=0.1887;AF_50_Het=0.4802;AF_50_Hom=0.1854;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00012650;DANN_score=0.3992;GREP_score=-4.63;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=TCTGCCTATG.AAAATAATTT	GT:AD:DP:GQ:PL	0/1:159,150:309:99:4365,0,5276
chr11	94225920	.	C	T	4097.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.646;DP=294;ExcessHet=3.0103;FS=3.645;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.94;ReadPosRankSum=0.611;SOR=0.508;HGVSnom=NM_005591.4:c.20+28G>A;Gene=MRE11;Transcript=NM_005591.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_005591.4:IVS2+28G>A;AAlength=708;EXAC_AF=0.46210884;EXAC_Hom_EAS=1108;EXAC_AC_EAS=4309;EXAC_AN_EAS=8636;EXAC_AC_Adj=56027;EXAC_AN_Adj=121242;ESP6500_MAF=0.41014002;RS=rs497763;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.457268;G1000_EAS_AF=0.5;G1000_EUR_AF=0.4483;G1000_AFR_AF=0.3396;G1000_SAS_AF=0.5654;G1000_AMR_AF=0.4798;gnomad_exomes_AF=0.46828233;gnomad_exomes_AF_EAS=0.49221811;gnomad_exomes_AC=117655;gnomad_exomes_Hom=28025;gnomad_exomes_Het=61605;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37436876;gnomad_exomes_AF_NFE=0.43381382;gnomad_exomes_AF_AMR=0.53996412;gnomad_exomes_AF_SAS=0.56696954;NativeFreq_Het=0.5018;NativeFreq_Hom=0.2772;normalHetFrequency=0.504;normalHetNum=436;normalHomFrequency=0.2578;normalHomNum=223;patientHetFrequency=0.4814;patientHetNum=2513;patientHomFrequency=0.2659;patientHomNum=1388;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4819;AF_2700_Hom=0.2709;AF_50_Het=0.4596;AF_50_Hom=0.2789;DANN_score=0.7638;GREP_score=1.76;CytoBand=q21;CGD_CONDITION=Breast cancer, susceptibility to;CGD_INHERITANCE=AD;Strand=MRE11:NM_005590.3:-,MRE11:NM_005591.3:-,MRE11:NM_001330347.1:-;NP=MRE11:NM_005590.3:NP_005581.2,MRE11:NM_005591.3:NP_005582.1,MRE11:NM_001330347.1:NP_001317276.1;ENSP=MRE11:NM_005590.3:ENST00000323977.7,MRE11:NM_005591.3:ENST00000323929.7,MRE11:NM_001330347.1:.;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=CCCCAAATAA.AAGGGATTCC	GT:AD:DP:GQ:PL	0/1:160,134:294:99:4126,0,5272
chr11	94227125	.	C	A	4513.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.137;DP=299;ExcessHet=3.0103;FS=1.551;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.15;ReadPosRankSum=0.634;SOR=0.592;HGVSnom=.;Gene=ANKRD49;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs11020802;CLNGENE=MRE11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.319888;G1000_EAS_AF=0.3869;G1000_EUR_AF=0.3549;G1000_AFR_AF=0.1626;G1000_SAS_AF=0.3742;G1000_AMR_AF=0.3948;normalHetFrequency=0.4738;normalHetNum=226;normalHomFrequency=0.1824;normalHomNum=87;patientHetFrequency=0.453;patientHetNum=1109;patientHomFrequency=0.0902;patientHomNum=471;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5334;GREP_score=-6.88;CytoBand=q21;Gene_MIM_id=600814;Phenotypes=Ataxia-telangiectasia-like disorder, 604391 (3), Autosomal recessive. 604391(MK);Possible_Inheritance=AR;EntrezGeneID=4361;EnsemblGeneID=ENSG00000020922;Alias=MRE11A, MRE11, ATLD;FLKSEQ=CCCGCCCTCA.GCAGGAGCCA	GT:AD:DP:GQ:PL	0/1:153,145:298:99:4542,0,4228
chr11	95528663	.	C	CT	6735.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.225;DP=421;ExcessHet=3.0103;FS=2.506;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.5;ReadPosRankSum=0.64;SOR=0.475;HGVSnom=NM_014679.5:c.46-3722dupT;Gene=CEP57;Transcript=NM_014679.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_014679.5:IVS1-3722_-3721insT;AAlength=500;EXAC_AF=0.63690224;EXAC_Hom_EAS=10;EXAC_AC_EAS=50;EXAC_AN_EAS=80;EXAC_AC_Adj=3010;EXAC_AN_Adj=4726;RS=rs5793747;G1000_AF=0.951677;G1000_EAS_AF=0.9494;G1000_EUR_AF=0.9483;G1000_AFR_AF=0.9508;G1000_SAS_AF=0.9489;G1000_AMR_AF=0.9654;gnomad_exomes_AF=0.65057549;gnomad_exomes_AF_EAS=0.67085427;gnomad_exomes_AC=9609;gnomad_exomes_Hom=2239;gnomad_exomes_Het=5131;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.68367347;gnomad_exomes_AF_NFE=0.66193738;gnomad_exomes_AF_AMR=0.65188470;gnomad_exomes_AF_SAS=0.63668587;normalHetFrequency=0.0696;normalHetNum=27;normalHomFrequency=0.9227;normalHomNum=358;patientHetFrequency=0.074;patientHetNum=205;patientHomFrequency=0.9145;patientHomNum=2535;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q21;repName=L1M5;repClass=LINE;CGD_CONDITION=Mosaic variegated aneuploidy syndrome 2;CGD_INHERITANCE=AR;Strand=CEP57:NM_001243776.1:+,CEP57:NM_001243777.1:+,CEP57:NM_014679.4:+,CEP57:NM_014679.5:+;NP=CEP57:NM_001243776.1:NP_001230705.1,CEP57:NM_001243777.1:NP_001230706.1,CEP57:NM_014679.4:NP_055494.2,CEP57:NM_014679.5:NP_055494.2;ENSP=CEP57:NM_001243776.1:.,CEP57:NM_001243777.1:.,CEP57:NM_014679.4:.,CEP57:NM_014679.5:ENST00000325542.10;Gene_MIM_id=607951;Phenotypes=Mosaic variegated aneuploidy syndrome 2, 614114 (3), Autosomal recessive. 614114(MK);Possible_Inheritance=AR;EntrezGeneID=9702;EnsemblGeneID=ENSG00000166037;Alias=CEP57, PIG8, TSP57, KIAA0092, MVA2;FLKSEQ=agctgttatt.tttttttttt	GT:AD:DP:GQ:PL	0/1:58,327:385:99:6773,0,186
chr11	108093833	.	G	A	4108.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.664;DP=321;ExcessHet=3.0103;FS=2.404;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.88;ReadPosRankSum=0.757;SOR=0.831;HGVSnom=NM_000051.4:c.-111G>A;Gene=ATM;Transcript=NM_000051.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=3056;RS=rs189037;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.476038;G1000_EAS_AF=0.4276;G1000_EUR_AF=0.6213;G1000_AFR_AF=0.2095;G1000_SAS_AF=0.6227;G1000_AMR_AF=0.6369;HGMD_gene=ATM;HGMD_disease=Longevity_association_with;HGMD_tag=DFP;HGMD_pmid=20816691;NativeFreq_Het=0.5278;NativeFreq_Hom=0.1988;normalHetFrequency=0.4507;normalHetNum=215;normalHomFrequency=0.2579;normalHomNum=123;patientHetFrequency=0.2149;patientHetNum=1122;patientHomFrequency=0.1128;patientHomNum=589;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4885;AF_2700_Hom=0.1799;AF_50_Het=0.4929;AF_50_Hom=0.1918;DANN_score=0.9575;GREP_score=4.04;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=AGCCGTGGCC.CGGGAGGAGG	GT:AD:DP:GQ:PL	0/1:176,143:319:99:4137,0,5414
chr11	108098459	.	TAA	T	8461.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.366;DP=488;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.89;ReadPosRankSum=0.216;SOR=0.762;HGVSnom=NM_000051.4:c.72+37_72+38delAA;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000051.4:IVS2+37_+38delAA;AAlength=3056;EXAC_AF=0.42534261;EXAC_Hom_EAS=654;EXAC_AC_EAS=3350;EXAC_AN_EAS=8642;EXAC_AC_Adj=51583;EXAC_AN_Adj=121274;ESP6500_MAF=0.33578392;RS=rs2066734;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.38119;G1000_EAS_AF=0.3839;G1000_EUR_AF=0.4513;G1000_AFR_AF=0.1225;G1000_SAS_AF=0.5491;G1000_AMR_AF=0.5317;gnomad_exomes_AF=0.43521953;gnomad_exomes_AF_EAS=0.38814573;gnomad_exomes_AC=109355;gnomad_exomes_Hom=25210;gnomad_exomes_Het=58935;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16348169;gnomad_exomes_AF_NFE=0.42302615;gnomad_exomes_AF_AMR=0.56619816;gnomad_exomes_AF_SAS=0.51735521;NativeFreq_Het=0.3208;NativeFreq_Hom=.;normalHetFrequency=0.4462;normalHetNum=386;normalHomFrequency=0.2046;normalHomNum=177;patientHetFrequency=0.4749;patientHetNum=2479;patientHomFrequency=0.1937;patientHomNum=1011;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TTCCTTGAAA.GTGTGATTAG	GT:AD:DP:GQ:PL	0/1:248,225:473:99:8499,0,10330
chr11	108100105	.	G	GT	2245.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.344;DP=307;ExcessHet=3.0103;FS=7.466;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.91;ReadPosRankSum=-0.833;SOR=1.251;HGVSnom=NM_000051.4:c.331+69dupT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000051.4:IVS4+69_+70insT;AAlength=3056;EXAC_AF=0.43955995;EXAC_Hom_EAS=10;EXAC_AC_EAS=319;EXAC_AN_EAS=808;EXAC_AC_Adj=9949;EXAC_AN_Adj=22634;RS=rs11390378;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.484824;G1000_EAS_AF=0.4335;G1000_EUR_AF=0.5368;G1000_AFR_AF=0.3646;G1000_SAS_AF=0.5859;G1000_AMR_AF=0.5706;gnomad_exomes_AF=0.46282151;gnomad_exomes_AF_EAS=0.46776882;gnomad_exomes_AC=44230;gnomad_exomes_Hom=1081;gnomad_exomes_Het=42068;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42751061;gnomad_exomes_AF_NFE=0.45303266;gnomad_exomes_AF_AMR=0.47422758;gnomad_exomes_AF_SAS=0.47809006;NativeFreq_Het=0.3418;NativeFreq_Hom=.;normalHetFrequency=0.5145;normalHetNum=445;normalHomFrequency=0.1954;normalHomNum=169;patientHetFrequency=0.5241;patientHetNum=2736;patientHomFrequency=0.1768;patientHomNum=923;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TGTCGCGTGA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:132,152:284:99:2283,0,2173
chr11	108114661	.	AT	A	392.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1;DP=232;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.89;ReadPosRankSum=-0.769;SOR=0.638;HGVSnom=NM_000051.4:c.497-4delT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000051.4:IVS5-4delT;AAlength=3056;EXAC_AF=0.34937484;EXAC_Hom_EAS=0;EXAC_AC_EAS=156;EXAC_AN_EAS=432;EXAC_AC_Adj=5365;EXAC_AN_Adj=15356;ESP6500_MAF=0.19797962;RS=rs768748099;CLNGENE=ATM;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.27893599;gnomad_exomes_AF_EAS=0.24169110;gnomad_exomes_AC=16778;gnomad_exomes_Hom=0;gnomad_exomes_Het=16778;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24256560;gnomad_exomes_AF_NFE=0.28645103;gnomad_exomes_AF_AMR=0.25900307;gnomad_exomes_AF_SAS=0.30663870;NativeFreq_Het=0.0375;NativeFreq_Hom=.;normalHetFrequency=0.0197;normalHetNum=17;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0128;patientHetNum=67;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0453;AF_2700_Hom=.;AF_50_Het=0.0412;AF_50_Hom=.;CytoBand=q22.3;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ATGACtaata.tttttttttt	GT:AD:DP:GQ:PL	0/1:165,43:208:99:430,0,2964
chr11	108119615	.	CA	C	836.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.82;DP=314;ExcessHet=3.0103;FS=8.373;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.98;ReadPosRankSum=-0.072;SOR=0.327;HGVSnom=NM_000051.4:c.1066-31delA;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000051.4:IVS8-31delA;AAlength=3056;EXAC_AF=0.36082430;EXAC_Hom_EAS=0;EXAC_AC_EAS=346;EXAC_AN_EAS=948;EXAC_AC_Adj=8317;EXAC_AN_Adj=23050;RS=rs35813860;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.35615535;gnomad_exomes_AF_EAS=0.36865181;gnomad_exomes_AC=26998;gnomad_exomes_Hom=0;gnomad_exomes_Het=26998;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.30448980;gnomad_exomes_AF_NFE=0.35765565;gnomad_exomes_AF_AMR=0.35719373;gnomad_exomes_AF_SAS=0.37524197;NativeFreq_Het=0.1427;NativeFreq_Hom=.;normalHetFrequency=0.5272;normalHetNum=456;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.499;patientHetNum=2605;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.3;repName=AluSp;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=aactctggct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:201,80:281:99:874,0,3650
chr11	108121410	.	C	CT	1076.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.213;DP=261;ExcessHet=3.0103;FS=9.534;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.54;ReadPosRankSum=0.614;SOR=0.229;HGVSnom=NM_000051.4:c.1236-3dupT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron+SpliceAcceptor;MolecularConsequence=coding_transcript_intron_variant+splice_acceptor_variant;ExonIntron=I9;IVSnom=NM_000051.4:IVS9-3_-2insT;AAlength=3056;EXAC_AF=0.37171878;EXAC_Hom_EAS=17;EXAC_AC_EAS=2085;EXAC_AN_EAS=6820;EXAC_AC_Adj=34949;EXAC_AN_Adj=94020;ESP6500_MAF=0.32516795;RS=rs34325032;CLNGENE=ATM;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.40595;G1000_EAS_AF=0.3641;G1000_EUR_AF=0.4443;G1000_AFR_AF=0.3389;G1000_SAS_AF=0.4642;G1000_AMR_AF=0.4568;gnomad_exomes_AF=0.36811828;gnomad_exomes_AF_EAS=0.31895617;gnomad_exomes_AC=60152;gnomad_exomes_Hom=333;gnomad_exomes_Het=59486;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32698473;gnomad_exomes_AF_NFE=0.37036600;gnomad_exomes_AF_AMR=0.38556022;gnomad_exomes_AF_SAS=0.37701593;NativeFreq_Het=0.2946;NativeFreq_Hom=.;normalHetFrequency=0.6578;normalHetNum=569;normalHomFrequency=0.0035;normalHomNum=3;patientHetFrequency=0.6625;patientHetNum=3458;patientHomFrequency=0.0031;patientHomNum=16;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15D6533582][15B0022310-T|16D0155916];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0172476|16D0168776|16B0017649|15B0040490|16D0177727|15B0048383|16D1545826][15B6105405|15D6523812|16B0011709|15B0022074|15B6325482|15D6532213|15B6325468|16B0000702|16D0038172];AF_2700_Het=0.6464;AF_2700_Hom=0.0004;AF_50_Het=0.6545;AF_50_Hom=.;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TCAAATTATC.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:152,85:237:99:1114,0,2109
chr11	108129657	.	A	G	3829.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.794;DP=308;ExcessHet=3.0103;FS=21.096;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.43;ReadPosRankSum=0.855;SOR=1.621;HGVSnom=NM_000051.4:c.2377-56A>G;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_000051.4:IVS15-56A>G;AAlength=3056;ESP6500_MAF=0.47918493;RS=rs672655;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.476438;G1000_EAS_AF=0.4196;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.2163;G1000_SAS_AF=0.6258;G1000_AMR_AF=0.6398;NativeFreq_Het=0.5370;NativeFreq_Hom=0.1952;normalHetFrequency=0.4474;normalHetNum=387;normalHomFrequency=0.2509;normalHomNum=217;patientHetFrequency=0.4632;patientHetNum=2418;patientHomFrequency=0.2489;patientHomNum=1299;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8944;GREP_score=3.69;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ACTGTCTGCC.AGAATAATTG	GT:AD:DP:GQ:PL	0/1:170,138:308:99:3858,0,5367
chr11	108141701	.	G	T	1114.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.902;DP=83;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.59;ReadPosRankSum=0.291;SOR=0.446;HGVSnom=NM_000051.4:c.2839-90G>T;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_000051.4:IVS18-90G>T;AAlength=3056;RS=rs651030;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.373003;G1000_EAS_AF=0.3492;G1000_EUR_AF=0.4543;G1000_AFR_AF=0.1233;G1000_SAS_AF=0.546;G1000_AMR_AF=0.5216;NativeFreq_Het=0.4784;NativeFreq_Hom=0.1313;normalHetFrequency=0.4289;normalHetNum=371;normalHomFrequency=0.1838;normalHomNum=159;patientHetFrequency=0.4594;patientHetNum=2398;patientHomFrequency=0.1718;patientHomNum=897;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6456;GREP_score=0.213;CytoBand=q22.3;repName=AluSg;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=gattacaggt.tgagccactg	GT:AD:DP:GQ:PL	0/1:47,35:82:99:1143,0,1690
chr11	108141955	.	CT	C	2080.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.157;DP=423;ExcessHet=3.0103;FS=1.63;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.83;ReadPosRankSum=0.744;SOR=0.818;HGVSnom=NM_000051.4:c.2922-8delT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_000051.4:IVS19-8delT;AAlength=3056;EXAC_AF=0.43630038;EXAC_Hom_EAS=1;EXAC_AC_EAS=3118;EXAC_AN_EAS=7004;EXAC_AC_Adj=44144;EXAC_AN_Adj=101178;RS=rs373881770;CLNGENE=ATM;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.43566721;gnomad_exomes_AF_EAS=0.45799916;gnomad_exomes_AC=81177;gnomad_exomes_Hom=0;gnomad_exomes_Het=81177;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.40514246;gnomad_exomes_AF_NFE=0.45624834;gnomad_exomes_AF_AMR=0.32642449;gnomad_exomes_AF_SAS=0.46365233;NativeFreq_Het=0.0962;NativeFreq_Hom=.;normalHetFrequency=0.8775;normalHetNum=759;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.8718;patientHetNum=4551;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.8997;AF_2700_Hom=.;AF_50_Het=0.9081;AF_50_Hom=.;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TAAAGTTGAA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:200,157:357:99:2118,0,3174
chr11	108143182	.	C	T	6306.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.278;DP=483;ExcessHet=3.0103;FS=6.305;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.11;ReadPosRankSum=-0.993;SOR=1.195;HGVSnom=NM_000051.4:c.3078-77C>T;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000051.4:IVS20-77C>T;AAlength=3056;RS=rs664677;CLNGENE=ATM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.652556;G1000_EAS_AF=0.4067;G1000_EUR_AF=0.6262;G1000_AFR_AF=0.823;G1000_SAS_AF=0.6789;G1000_AMR_AF=0.6859;NativeFreq_Het=0.4851;NativeFreq_Hom=0.1663;normalHetFrequency=0.4405;normalHetNum=381;normalHomFrequency=0.252;normalHomNum=218;patientHetFrequency=0.4489;patientHetNum=2343;patientHomFrequency=0.2448;patientHomNum=1278;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2645;GREP_score=-0.759;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=AAGTAACTTA.AATAACCTTT	GT:AD:DP:GQ:PL	0/1:267,214:481:99:6335,0,8337
chr11	108151707	.	T	TA	3017.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.636;DP=255;ExcessHet=3.0103;FS=0.555;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.32;ReadPosRankSum=-1.74;SOR=0.783;HGVSnom=NM_000051.4:c.3403-13dupA;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I23;IVSnom=NM_000051.4:IVS23-13_-12insA;AAlength=3056;EXAC_AF=0.56748409;EXAC_Hom_EAS=602;EXAC_AC_EAS=3193;EXAC_AN_EAS=8304;EXAC_AC_Adj=66508;EXAC_AN_Adj=117198;ESP6500_MAF=0.55617978;RS=rs3218681;CLNGENE=ATM;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.542133;G1000_EAS_AF=0.4058;G1000_EUR_AF=0.6252;G1000_AFR_AF=0.438;G1000_SAS_AF=0.6677;G1000_AMR_AF=0.6412;gnomad_exomes_AF=0.56027779;gnomad_exomes_AF_EAS=0.37910397;gnomad_exomes_AC=129971;gnomad_exomes_Hom=36500;gnomad_exomes_Het=56971;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.45099867;gnomad_exomes_AF_NFE=0.56162549;gnomad_exomes_AF_AMR=0.61132112;gnomad_exomes_AF_SAS=0.61422430;NativeFreq_Het=0.3186;NativeFreq_Hom=.;normalHetFrequency=0.437;normalHetNum=378;normalHomFrequency=0.2486;normalHomNum=215;patientHetFrequency=0.4544;patientHetNum=2372;patientHomFrequency=0.2395;patientHomNum=1250;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4727;AF_2700_Hom=0.1576;AF_50_Het=0.4707;AF_50_Hom=0.1727;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+;NP=ATM:NM_000051.3:NP_000042.3;ENSP=ATM:NM_000051.3:ENST00000278616.8;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ATTTTTTTTT.AATTTCTTTT	GT:AD:DP:GQ:PL	0/1:121,124:245:99:3055,0,3651
chr11	108180823	.	C	A	6352.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.808;DP=465;ExcessHet=3.0103;FS=3.937;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.72;ReadPosRankSum=-1.194;SOR=1.033;HGVSnom=NM_000051.4:c.5763-64C>A;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I38;IVSnom=NM_000051.4:IVS38-64C>A;AAlength=3056;RS=rs557638014;G1000_AF=0.00039936;G1000_EAS_AF=0.002;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.001;patientHetNum=5;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B3258328][15D6129419|16D0067244|15D6129380|16B0011515];patientHomSampleInfo=[_][_];DANN_score=0.4675;GREP_score=-7.29;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TCTATATCAA.ATGCTTTTAT	GT:AD:DP:GQ:PL	0/1:261,202:463:99:6381,0,8415
chr11	108183167	.	A	G	24867.8	PASS	AC=2;AF=1;AN=2;DP=659;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.72;SOR=0.749;HGVSnom=NM_000051.4:c.5948G>G(p.Ser1983Ser/p.S1983S);Gene=ATM;Transcript=NM_000051.4;VarType=NoCall;MolecularConsequence=nocall_variant;ExonIntron=E40;IVSnom=.;AAlength=3056;EXAC_AF=1.00000000;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=121308;EXAC_AN_Adj=121308;RS=rs659243;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=1.00000000;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=251212;gnomad_exomes_Hom=125606;gnomad_exomes_Het=0;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=1.00000000;gnomad_exomes_AF_NFE=1.00000000;gnomad_exomes_AF_AMR=1.00000000;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.7855;GREP_score=-0.136;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=GGAAGCCAGA.TACAACTATT	GT:AD:DP:GQ:PL	1/1:0,656:656:99:24896,1973,0
chr11	108188266	.	AT	A	373.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.952;DP=133;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.97;ReadPosRankSum=0.13;SOR=0.548;HGVSnom=NM_000051.4:c.6347+31delT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I43;IVSnom=NM_000051.4:IVS43+31delT;AAlength=3056;EXAC_AF=0.31779439;EXAC_Hom_EAS=0;EXAC_AC_EAS=1784;EXAC_AN_EAS=6358;EXAC_AC_Adj=29082;EXAC_AN_Adj=91512;ESP6500_MAF=0.25331523;RS=rs58978479;CLNGENE=ATM|C11orf65;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.33481862;gnomad_exomes_AF_EAS=0.31441291;gnomad_exomes_AC=34114;gnomad_exomes_Hom=534;gnomad_exomes_Het=33046;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49836334;gnomad_exomes_AF_NFE=0.28825327;gnomad_exomes_AF_AMR=0.37693290;gnomad_exomes_AF_SAS=0.37314356;NativeFreq_Het=0.0125;NativeFreq_Hom=.;normalHetFrequency=0.0289;normalHetNum=25;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0318;patientHetNum=166;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0200327-1|16B0033296];AF_2700_Het=0.0911;AF_2700_Hom=0.0008;AF_50_Het=0.0935;AF_50_Hom=.;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ATTTGACTTG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:94,32:126:99:411,0,1919
chr11	108188342	.	T	TTATATATA	182	PASS	AC=2;AF=1;AN=2;DP=36;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=58.23;QD=28.59;SOR=1.609;HGVSnom=NM_000051.4:c.6347+125_6347+132dupTATATATA;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I43;IVSnom=NM_000051.4:IVS43+132_+133insTATATATA;AAlength=3056;RS=rs376158749;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=AGGAGTTGTT.tatatatata	GT:AD:DP:GQ:PL	1/1:0,5:5:12:219,12,0
chr11	108195976	.	GT	G	1849.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.092;DP=235;ExcessHet=3.0103;FS=4.403;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.25;ReadPosRankSum=-0.085;SOR=1.923;HGVSnom=NM_000051.4:c.6573-42delT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I45;IVSnom=NM_000051.4:IVS45-42delT;AAlength=3056;RS=rs11366542;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.725639;G1000_EAS_AF=0.7778;G1000_EUR_AF=0.7535;G1000_AFR_AF=0.6089;G1000_SAS_AF=0.7975;G1000_AMR_AF=0.7305;NativeFreq_Het=0.4580;NativeFreq_Hom=.;normalHetFrequency=0.8104;normalHetNum=701;normalHomFrequency=0.0971;normalHomNum=84;patientHetFrequency=0.7975;patientHetNum=4163;patientHomFrequency=0.0964;patientHomNum=503;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=AACTTACATA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:59,141:200:99:1828,0,456
chr11	108196712	.	CATT	C	1995.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.198;DP=101;ExcessHet=3.0103;FS=1.784;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.36;ReadPosRankSum=-1.205;SOR=1.22;HGVSnom=NM_000051.4:c.6808-60_6808-58delATT;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I46;IVSnom=NM_000051.4:IVS46-60_-58delATT;AAlength=3056;RS=rs3212322;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.484824;G1000_EAS_AF=0.4157;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.2519;G1000_SAS_AF=0.6247;G1000_AMR_AF=0.6398;NativeFreq_Het=0.3274;NativeFreq_Hom=.;normalHetFrequency=0.4474;normalHetNum=387;normalHomFrequency=0.2486;normalHomNum=215;patientHetFrequency=0.463;patientHetNum=2417;patientHomFrequency=0.2471;patientHomNum=1290;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ttGCTGCTTT.ATTATTATTA	GT:AD:DP:GQ:PL	0/1:46,52:98:99:2033,0,1943
chr11	108202176	.	C	T	3962.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.271;DP=262;ExcessHet=3.0103;FS=3.705;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.13;ReadPosRankSum=-0.679;SOR=0.499;HGVSnom=NM_000051.4:c.7521C>T(p.Asp2507Asp/p.D2507D);Gene=ATM;Transcript=NM_000051.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E51;IVSnom=.;AAlength=3056;EXAC_AF=0.00006837;EXAC_Hom_EAS=0;EXAC_AC_EAS=5;EXAC_AN_EAS=8346;EXAC_AC_Adj=8;EXAC_AN_Adj=117004;RS=rs751234924;CLNGENE=ATM|C11orf65;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.00007980;gnomad_exomes_AF_EAS=0.00060044;gnomad_exomes_AC=20;gnomad_exomes_Hom=0;gnomad_exomes_Het=20;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00004409;gnomad_exomes_AF_AMR=0.00008705;gnomad_exomes_AF_SAS=0.0;NativeFreq_Het=0.0012;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0006;patientHetNum=3;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[17B0005422][15D6482169-3|15B0002753];patientHomSampleInfo=[_][_];DANN_score=0.6911;GREP_score=-0.793;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=GGTAGAGAGA.GGAATGAAGA	GT:AD:DP:GQ:PL	0/1:125,137:262:99:3991,0,3600
chr11	108224697	.	G	A	8713.77	StandardFilter	AC=2;AF=1;AN=2;DP=255;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.31;SOR=4.459;HGVSnom=NM_000051.4:c.8786+90G>A;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I60;IVSnom=NM_000051.4:IVS60+90G>A;AAlength=3056;RS=rs179108;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=0.9976;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9988;normalHomNum=864;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.9967;patientHomNum=5203;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6021;GREP_score=1.03;CytoBand=q22.3;repName=FLAM_A;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=aatcccagct.ctcaagaggc	GT:AD:DP:GQ:PL	1/1:0,254:254:99:8742,762,0
chr11	108225483	.	C	T	3957.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.295;DP=272;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.6;ReadPosRankSum=-0.487;SOR=0.733;HGVSnom=NM_000051.4:c.8787-55C>T;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I60;IVSnom=NM_000051.4:IVS60-55C>T;AAlength=3056;ESP6500_MAF=0.51817784;RS=rs664982;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.535144;G1000_EAS_AF=0.4345;G1000_EUR_AF=0.6193;G1000_AFR_AF=0.3812;G1000_SAS_AF=0.6779;G1000_AMR_AF=0.6513;NativeFreq_Het=0.5432;NativeFreq_Hom=0.2048;normalHetFrequency=0.4405;normalHetNum=381;normalHomFrequency=0.2705;normalHomNum=234;patientHetFrequency=0.4676;patientHetNum=2441;patientHomFrequency=0.2607;patientHomNum=1361;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6505;GREP_score=-4.99;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=GATAAAGATA.GTTGACAACA	GT:AD:DP:GQ:PL	0/1:140,131:271:99:3986,0,4246
chr11	108225661	.	A	G	3102.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.455;DP=265;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.71;ReadPosRankSum=-1.608;SOR=0.663;HGVSnom=NM_000051.4:c.8850+60A>G;Gene=ATM;Transcript=NM_000051.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I61;IVSnom=NM_000051.4:IVS61+60A>G;AAlength=3056;ESP6500_MAF=0.60227770;RS=rs664143;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.628195;G1000_EAS_AF=0.4474;G1000_EUR_AF=0.6272;G1000_AFR_AF=0.7005;G1000_SAS_AF=0.6789;G1000_AMR_AF=0.683;HGMD_gene=ATM;HGMD_disease=Lung_cancer_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=16497724;NativeFreq_Het=0.5340;NativeFreq_Hom=0.2108;normalHetFrequency=0.4474;normalHetNum=387;normalHomFrequency=0.2786;normalHomNum=241;patientHetFrequency=0.4634;patientHetNum=2419;patientHomFrequency=0.2728;patientHomNum=1424;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3742;GREP_score=-5.34;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=TGTGTATCTC.TCAGGAAGTC	GT:AD:DP:GQ:PL	0/1:154,111:265:99:3131,0,4851
chr11	108236756	.	CAAA	C	176.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.817;DP=29;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.31;ReadPosRankSum=-1.313;SOR=0.582;HGVSnom=NM_000051.4:c.*538_*540delAAA;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs369583811;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][15B0002815];patientHomSampleInfo=[_][_];CytoBand=q22.3;repName=AluSq2;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=aactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:18,10:28:99:214,0,437
chr11	108236783	.	G	T	530.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.524;DP=33;ExcessHet=3.0103;FS=2.21;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.08;ReadPosRankSum=-0.727;SOR=0.199;HGVSnom=NM_000051.4:c.*548G>T;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs227092;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.518371;G1000_EAS_AF=0.4345;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.3215;G1000_SAS_AF=0.6779;G1000_AMR_AF=0.647;NativeFreq_Het=0.5401;NativeFreq_Hom=0.2036;normalHetFrequency=0.4361;normalHetNum=208;normalHomFrequency=0.2683;normalHomNum=128;patientHetFrequency=0.4665;patientHetNum=1142;patientHomFrequency=0.239;patientHomNum=585;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4889;AF_2700_Hom=0.1887;AF_50_Het=0.4802;AF_50_Hom=0.2044;DANN_score=0.3581;GREP_score=0.287;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=aaacagaaaC.TATTTGGATT	GT:AD:DP:GQ:PL	0/1:16,17:33:99:559,0,408
chr11	108237839	.	C	T	1529.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.63;DP=94;ExcessHet=3.0103;FS=10.259;MLEAC=1;MLEAF=0.5;MQ=57.69;MQRankSum=0.544;QD=16.27;ReadPosRankSum=0.966;SOR=1.823;HGVSnom=NM_000051.4:c.*1604C>T;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs227091;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.518171;G1000_EAS_AF=0.4345;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.3215;G1000_SAS_AF=0.6779;G1000_AMR_AF=0.6455;NativeFreq_Het=0.5432;NativeFreq_Hom=0.1904;normalHetFrequency=0.2439;normalHetNum=211;normalHomFrequency=0.2683;normalHomNum=128;patientHetFrequency=0.4632;patientHetNum=1134;patientHomFrequency=0.114;patientHomNum=595;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4881;AF_2700_Hom=0.1887;AF_50_Het=0.4818;AF_50_Hom=0.2029;DANN_score=0.7486;GREP_score=-0.317;CytoBand=q22.3;repName=AluSc8;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ctcagcctcc.gagtagctgg	GT:AD:DP:GQ:PL	0/1:46,48:94:99:1558,0,1311
chr11	108238798	.	C	T	4201.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.887;DP=289;ExcessHet=3.0103;FS=9.03;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.64;ReadPosRankSum=1.293;SOR=0.758;HGVSnom=NM_000051.4:c.*2563C>T;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs146547907;CLNGENE=ATM|C11orf65;CLNSIG=Likely_benign|Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.00319489;G1000_EAS_AF=0.0159;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;NativeFreq_Het=0.0309;NativeFreq_Hom=0;normalHetFrequency=0.0189;normalHetNum=9;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0155;patientHetNum=38;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0064836];AF_2700_Het=0.0138;AF_2700_Hom=0.0004;AF_50_Het=0.0158;AF_50_Hom=0.0000;DANN_score=0.4275;GREP_score=-4.16;CytoBand=q22.3;repName=L3;repClass=LINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=tactctttag.cttgcatggt	GT:AD:DP:GQ:PL	0/1:137,150:287:99:4230,0,4368
chr11	108239015	.	C	CA	517.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.538;DP=290;ExcessHet=3.0103;FS=0.665;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.5;ReadPosRankSum=1.391;SOR=0.787;HGVSnom=NM_000051.4:c.*2797dupA;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs765253087;NativeFreq_Het=0.0054;NativeFreq_Hom=.;normalHetFrequency=0.021;normalHetNum=10;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0151;patientHetNum=37;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0265;AF_2700_Hom=.;AF_50_Het=0.0269;AF_50_Hom=.;CytoBand=q22.3;repName=AluSz6;repClass=SINE;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=gactctgcct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:148,59:207:99:555,0,2169
chr11	108239628	.	G	T	2672.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.703;DP=197;ExcessHet=3.0103;FS=3.427;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.78;ReadPosRankSum=-2.187;SOR=0.963;HGVSnom=NM_000051.4:c.*3393G>T;Gene=ATM;Transcript=NM_000051.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E63;IVSnom=.;AAlength=3056;RS=rs4585;CLNGENE=ATM|C11orf65;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.534545;G1000_EAS_AF=0.4325;G1000_EUR_AF=0.6183;G1000_AFR_AF=0.3812;G1000_SAS_AF=0.6779;G1000_AMR_AF=0.6513;NativeFreq_Het=0.5370;NativeFreq_Hom=0.2048;normalHetFrequency=0.2428;normalHetNum=210;normalHomFrequency=0.1514;normalHomNum=131;patientHetFrequency=0.2192;patientHetNum=1144;patientHomFrequency=0.1134;patientHomNum=592;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4908;AF_2700_Hom=0.1899;AF_50_Het=0.4834;AF_50_Hom=0.2044;DANN_score=0.6047;GREP_score=-1.85;CytoBand=q22.3;CGD_CONDITION=Breast cancer, susceptibility to. Ataxia-Telangiectasia;CGD_INHERITANCE=AD/AR;Strand=ATM:NM_000051.3:+,C11orf65:NM_001330368.1:-;NP=ATM:NM_000051.3:NP_000042.3,C11orf65:NM_001330368.1:NP_001317297.1;ENSP=ATM:NM_000051.3:ENST00000278616.8,C11orf65:NM_001330368.1:.;Gene_MIM_id=607585;Phenotypes=Ataxia-telangiectasia, 208900 (3), Autosomal recessive. {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Lymphoma, B-cell non-Hodgkin, somatic (3). Lymphoma, mantle cell, somatic (3). T-cell prolymphocytic leukemia, somatic (3). 114480(SK),208900(MK),607585(MK);Possible_Inheritance=AD,AR;EntrezGeneID=472;EnsemblGeneID=ENSG00000149311;Alias=ATM, ATA, AT1;FLKSEQ=ACTTTGGACA.CGTAAAGACT	GT:AD:DP:GQ:PL	0/1:106,88:194:99:2701,0,3612
chr11	111966307	.	T	C	5328.77	PASS	AC=2;AF=1;AN=2;DP=156;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.16;SOR=1.936;HGVSnom=NM_003002.4:c.*613T>C;Gene=SDHD;Transcript=NM_003002.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E4;IVSnom=.;AAlength=159;RS=rs693441;CLNGENE=SDHD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.936102;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.7738;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9712;NativeFreq_Het=0.0099;NativeFreq_Hom=0.9900;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=0.5468;normalHomNum=473;patientHetFrequency=0.002;patientHetNum=5;patientHomFrequency=0.4709;patientHomNum=2458;normalHetSampleInfo=[_][16D0157336|15D6523843];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D0176623-1|15D6534401-1|15D6482169-3|16D0155911|15D6482196-1];patientHomSampleInfo=[_][_];AF_2700_Het=0.0008;AF_2700_Hom=0.9981;AF_50_Het=0.0016;AF_50_Hom=0.9968;DANN_score=0.5296;GREP_score=1.65;CytoBand=q23.1;CGD_CONDITION=Cowden syndrome 3. Paraganglioma and gastric stromal sarcoma. Pheochromocytoma. Paragangliomas 1. Carcinoid tumors, intestinal;CGD_INHERITANCE=AD;Strand=SDHD:NM_001276503.1:+,SDHD:NM_001276504.1:+,SDHD:NM_001276506.1:+,SDHD:NM_003002.3:+;NP=SDHD:NM_001276503.1:NP_001263432.1,SDHD:NM_001276504.1:NP_001263433.1,SDHD:NM_001276506.1:NP_001263435.1,SDHD:NM_003002.3:NP_002993.1;ENSP=SDHD:NM_001276503.1:.,SDHD:NM_001276504.1:.,SDHD:NM_001276506.1:.,SDHD:NM_003002.3:ENST00000375549.7;Gene_MIM_id=602690;Phenotypes=Carcinoid tumors, intestinal, 114900 (3), Autosomal dominant. Cowden syndrome 3, 615106 (3). Merkel cell carcinoma, somatic (3). Mitochondrial complex II deficiency, 252011 (3), Autosomal recessive. Paraganglioma and gastric stromal sarcoma, 606864 (3). Paragangliomas 1, with or without deafness, 168000 (3), Autosomal dominant. Pheochromocytoma, 171300 (3), Autosomal dominant. 114900(MK),168000(MK),171300(MK),252011(MK),602690(MK),606864(MK),615106(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6392;EnsemblGeneID=ENSG00000204370;Alias=SDHD, PGL1, CWS3;FLKSEQ=CAAGTTTCCC.GTAGATGTAT	GT:AD:DP:GQ:PL	1/1:0,156:156:99:5357,468,0
chr11	111966592	.	G	GT	1169.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.994;DP=76;ExcessHet=3.0103;FS=5.179;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.95;ReadPosRankSum=0.795;SOR=0.092;HGVSnom=.;Gene=SDHD;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs60055273;G1000_AF=0.725839;G1000_EAS_AF=0.8681;G1000_EUR_AF=0.8141;G1000_AFR_AF=0.4327;G1000_SAS_AF=0.8436;G1000_AMR_AF=0.7839;CytoBand=q23.1;FLKSEQ=ACAAAATTGG.tttttttttt	GT:AD:DP:GQ:PL	1/1:8,61:69:45:1064,45,0
chr11	125495209	.	A	AC	6618.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.506;DP=349;ExcessHet=3.0103;FS=4.178;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.76;ReadPosRankSum=0.703;SOR=0.515;HGVSnom=NR_170378.1:n.580dupG|NM_001114122.3:c.-718dupC;Gene=LOC118567325|CHEK1;Transcript=NR_170378.1|NM_001114122.3;VarType=Noncoding|UTR5;MolecularConsequence=noncoding_transcript_exon_variant|5_prime_UTR_exon_variant;ExonIntron=E1|E1;AAlength=.|476;RS=rs3216096;G1000_AF=0.307109;G1000_EAS_AF=0.4018;G1000_EUR_AF=0.3052;G1000_AFR_AF=0.2504;G1000_SAS_AF=0.3548;G1000_AMR_AF=0.2133;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=GGTTATCCTG.CTTCAAGCTC	GT:AD:DP:GQ:PL	0/1:170,165:335:99:6656,0,6835
chr11	125495211	.	T	C	6627.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.491;DP=351;ExcessHet=3.0103;FS=3.432;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.94;ReadPosRankSum=0.235;SOR=0.53;HGVSnom=NR_170378.1:n.579A>G|NM_001114122.3:c.-717T>C;Gene=LOC118567325|CHEK1;Transcript=NR_170378.1|NM_001114122.3;VarType=Noncoding|UTR5;MolecularConsequence=noncoding_transcript_exon_variant|5_prime_UTR_exon_variant;ExonIntron=E1|E1;AAlength=.|476;RS=rs1057733;G1000_AF=0.307508;G1000_EAS_AF=0.4018;G1000_EUR_AF=0.3062;G1000_AFR_AF=0.2511;G1000_SAS_AF=0.3558;G1000_AMR_AF=0.2118;DANN_score=0.594;GREP_score=-1.17;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=TTATCCTGAC.TCAAGCTCCA	GT:AD:DP:GQ:PL	0/1:177,173:350:99:6656,0,6835
chr11	125495264	.	C	T	4759.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-10.164;DP=296;ExcessHet=3.0103;FS=4.564;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.13;ReadPosRankSum=-0.535;SOR=0.495;HGVSnom=NR_170378.1:n.526G>A|NM_001114122.3:c.-664C>T;Gene=LOC118567325|CHEK1;Transcript=NR_170378.1|NM_001114122.3;VarType=Noncoding|UTR5;MolecularConsequence=noncoding_transcript_exon_variant|5_prime_UTR_exon_variant;ExonIntron=E1|E1;AAlength=.|476;RS=rs558351;G1000_AF=0.409944;G1000_EAS_AF=0.4058;G1000_EUR_AF=0.4533;G1000_AFR_AF=0.2012;G1000_SAS_AF=0.5317;G1000_AMR_AF=0.5793;DANN_score=0.768;GREP_score=0.415;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=CCCCGCCACA.ACACTTGACT	GT:AD:DP:GQ:PL	0/1:142,153:295:99:4788,0,4802
chr11	125497466	.	G	T	2392.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.229;DP=128;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.69;ReadPosRankSum=-1.919;SOR=0.533;HGVSnom=NM_001114122.3:c.66-36G>T;Gene=CHEK1;Transcript=NM_001114122.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001114122.3:IVS2-36G>T;AAlength=476;EXAC_AF=0.34811981;EXAC_Hom_EAS=581;EXAC_AC_EAS=2744;EXAC_AN_EAS=5884;EXAC_AC_Adj=28754;EXAC_AN_Adj=82598;ESP6500_MAF=0.32015719;RS=rs491528;G1000_AF=0.353035;G1000_EAS_AF=0.4306;G1000_EUR_AF=0.3072;G1000_AFR_AF=0.3911;G1000_SAS_AF=0.3579;G1000_AMR_AF=0.2277;gnomad_exomes_AF=0.30177745;gnomad_exomes_AF_EAS=0.43254128;gnomad_exomes_AC=58846;gnomad_exomes_Hom=9154;gnomad_exomes_Het=40538;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37580598;gnomad_exomes_AF_NFE=0.29440381;gnomad_exomes_AF_AMR=0.19198493;gnomad_exomes_AF_SAS=0.32972583;NativeFreq_Het=0.4484;NativeFreq_Hom=0.1530;DANN_score=0.604;GREP_score=-1.7;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+,CHEK1:NM_001330428.1:+,CHEK1:NM_001274.5:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1,CHEK1:NM_001330428.1:NP_001317357.1,CHEK1:NM_001274.5:NP_001265.2;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.,CHEK1:NM_001330428.1:.,CHEK1:NM_001274.5:ENST00000534070.5;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=TAGAAGAAAT.GAATTCTGTA	GT:AD:DP:GQ:PL	0/1:56,72:128:99:2421,0,1804
chr11	125514573	.	G	A	3144.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.481;DP=195;ExcessHet=3.0103;FS=2.502;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.21;ReadPosRankSum=0.712;SOR=0.401;HGVSnom=NM_001114122.3:c.1233+35G>A;Gene=CHEK1;Transcript=NM_001114122.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001114122.3:IVS11+35G>A;AAlength=476;EXAC_AF=0.50586980;EXAC_Hom_EAS=639;EXAC_AC_EAS=3342;EXAC_AN_EAS=8562;EXAC_AC_Adj=60672;EXAC_AN_Adj=119936;ESP6500_MAF=0.43646154;RS=rs521102;G1000_AF=0.436102;G1000_EAS_AF=0.4058;G1000_EUR_AF=0.5;G1000_AFR_AF=0.2451;G1000_SAS_AF=0.5419;G1000_AMR_AF=0.6023;gnomad_exomes_AF=0.51177583;gnomad_exomes_AF_EAS=0.38772608;gnomad_exomes_AC=121253;gnomad_exomes_Hom=31948;gnomad_exomes_Het=57357;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27710611;gnomad_exomes_AF_NFE=0.51837109;gnomad_exomes_AF_AMR=0.63216488;gnomad_exomes_AF_SAS=0.57729242;NativeFreq_Het=0.4520;NativeFreq_Hom=0.2135;DANN_score=0.4085;GREP_score=0.862;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+,CHEK1:NM_001330428.1:+,CHEK1:NM_001274.5:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1,CHEK1:NM_001330428.1:NP_001317357.1,CHEK1:NM_001274.5:NP_001265.2;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.,CHEK1:NM_001330428.1:.,CHEK1:NM_001274.5:ENST00000534070.5;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=ACCTTTTCCT.AAGAAGAATT	GT:AD:DP:GQ:PL	0/1:99,95:194:99:3173,0,3359
chr11	125525195	.	A	G	13046.8	PASS	AC=2;AF=1;AN=2;DP=355;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.22;SOR=0.903;HGVSnom=NM_001114122.3:c.1411A>G(p.Ile471Val/p.I471V);Gene=CHEK1;Transcript=NM_001114122.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E13;IVSnom=.;AAlength=476;EXAC_AF=0.97259539;EXAC_Hom_EAS=4324;EXAC_AC_EAS=8651;EXAC_AN_EAS=8654;EXAC_AC_Adj=117863;EXAC_AN_Adj=121184;ESP6500_MAF=0.97384615;RS=rs506504;Ensembl_transcriptid=ENST00000532449|ENST00000438015|ENST00000427383|ENST00000428830|ENST00000544373|ENST00000534070|ENST00000524737|ENST00000278916;SIFT_pred=.|T|T|T|.|T|T|T;SIFT_score=.|1.0|1.0|1.0|.|1.0|1.0|1.0;Polyphen2_HVAR_pred=.|B|B|B|.|B|B|.;Polyphen2_HVAR_score=.|0.0|0.001|0.0|.|0.0|0.0|.;MutationTaster_pred=P|P|P|P|P|P|P;MutationTaster_score=0.999999|0.999999|0.999999|0.999999|0.999999|0.999999|0.999999;CLNGENE=CHEK1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.985823;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9672;G1000_AFR_AF=0.997;G1000_SAS_AF=0.9847;G1000_AMR_AF=0.9726;gnomad_exomes_AF=0.97315108;gnomad_exomes_AF_EAS=0.99961944;gnomad_exomes_AC=244403;gnomad_exomes_Hom=118967;gnomad_exomes_Het=6469;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99501170;gnomad_exomes_AF_NFE=0.96266199;gnomad_exomes_AF_AMR=0.98435599;gnomad_exomes_AF_SAS=0.97979732;NativeFreq_Het=0.0285;NativeFreq_Hom=0.9680;DANN_score=0.5256;GREP_score=1.8;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+,CHEK1:NM_001330428.1:+,CHEK1:NM_001274.5:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1,CHEK1:NM_001330428.1:NP_001317357.1,CHEK1:NM_001274.5:NP_001265.2;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.,CHEK1:NM_001330428.1:.,CHEK1:NM_001274.5:ENST00000534070.5;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=CAGCCAGAAG.TTTGGCTTCC	GT:AD:DP:GQ:PL	1/1:0,354:354:99:13075,1063,0
chr11	125525588	.	A	ATTTC	5491.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.165;DP=288;ExcessHet=3.0103;FS=0.435;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.61;ReadPosRankSum=-2.166;SOR=0.744;HGVSnom=NM_001114122.3:c.*375_*376insTCTT;Gene=CHEK1;Transcript=NM_001114122.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E13;IVSnom=.;AAlength=476;RS=rs3731480;G1000_AF=0.422724;G1000_EAS_AF=0.4335;G1000_EUR_AF=0.3827;G1000_AFR_AF=0.5272;G1000_SAS_AF=0.411;G1000_AMR_AF=0.2824;CytoBand=q24.2;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+,CHEK1:NM_001330428.1:+,CHEK1:NM_001274.5:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1,CHEK1:NM_001330428.1:NP_001317357.1,CHEK1:NM_001274.5:NP_001265.2;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.,CHEK1:NM_001330428.1:.,CHEK1:NM_001274.5:ENST00000534070.5;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=AAAAGTACAT.TTCCATGTTG	GT:AD:DP:GQ:PL	0/1:135,145:280:99:5529,0,7845
chr11	125526161	.	G	A	4436.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.752;DP=289;ExcessHet=3.0103;FS=4.707;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.46;ReadPosRankSum=-1.055;SOR=0.977;HGVSnom=NM_001114122.3:c.*946G>A;Gene=CHEK1;Transcript=NM_001114122.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E13;IVSnom=.;AAlength=476;RS=rs567889;G1000_AF=0.446086;G1000_EAS_AF=0.4058;G1000_EUR_AF=0.5;G1000_AFR_AF=0.2814;G1000_SAS_AF=0.5419;G1000_AMR_AF=0.6052;DANN_score=0.3522;GREP_score=-0.841;CytoBand=q24.2;repName=AluJo;repClass=SINE;Strand=CHEK1:NM_001114122.2:+,CHEK1:NM_001244846.1:+,CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+,CHEK1:NM_001330428.1:+,CHEK1:NM_001274.5:+;NP=CHEK1:NM_001114122.2:NP_001107594.1,CHEK1:NM_001244846.1:NP_001231775.1,CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1,CHEK1:NM_001330428.1:NP_001317357.1,CHEK1:NM_001274.5:NP_001265.2;ENSP=CHEK1:NM_001114122.2:.,CHEK1:NM_001244846.1:.,CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.,CHEK1:NM_001330428.1:.,CHEK1:NM_001274.5:ENST00000534070.5;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=gaggaggatc.cgtgaacctg	GT:AD:DP:GQ:PL	0/1:140,147:287:99:4465,0,4456
chr11	125527082	.	T	TTG	695.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.287;DP=54;ExcessHet=3.0103;FS=2.644;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.44;ReadPosRankSum=0.214;SOR=0.25;OLD_VARIANT=chr11|125527082|T|TTG,TTGTG|1;HGVSnom=.;Gene=CHEK1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3831425;G1000_AF=0.560903;G1000_EAS_AF=0.5565;G1000_EUR_AF=0.5994;G1000_AFR_AF=0.3964;G1000_SAS_AF=0.6728;G1000_AMR_AF=0.6671;CytoBand=q24.2;Strand=CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+;NP=CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1;ENSP=CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=CAACCTATGC.tgtgtgtgtg	GT:AD:DP:GQ:PL	1/0:5,12:31:99:733,249,319
chr11	125527082	.	T	TTGTG	695.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.287;DP=54;ExcessHet=3.0103;FS=2.644;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.44;ReadPosRankSum=0.214;SOR=0.25;OLD_VARIANT=chr11|125527082|T|TTG,TTGTG|2;HGVSnom=.;Gene=CHEK1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3831425;CytoBand=q24.2;Strand=CHEK1:NM_001114121.2:+,CHEK1:NM_001330427.1:+;NP=CHEK1:NM_001114121.2:NP_001107593.1,CHEK1:NM_001330427.1:NP_001317356.1;ENSP=CHEK1:NM_001114121.2:.,CHEK1:NM_001330427.1:.;Gene_MIM_id=603078;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=1111;EnsemblGeneID=ENSG00000149554;Alias=CHEK1, CHK1;FLKSEQ=CAACCTATGC.tgtgtgtgtg	GT:AD:DP:GQ:PL	0/1:5,14:31:99:733,182,380
chr12	1021515	.	T	G	3880.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.139;DP=299;ExcessHet=3.0103;FS=2.524;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.02;ReadPosRankSum=0.598;SOR=0.563;HGVSnom=NM_134424.4:c.*1042A>C;Gene=RAD52;Transcript=NM_134424.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=418;RS=rs7963551;G1000_AF=0.11881;G1000_EAS_AF=0.1806;G1000_EUR_AF=0.16;G1000_AFR_AF=0.0363;G1000_SAS_AF=0.1247;G1000_AMR_AF=0.1182;HGMD_gene=RAD52;HGMD_disease=Hepatocellular_carcinoma_increased_risk_association_with;HGMD_tag=DFP;HGMD_pmid=24729511;DANN_score=0.4931;GREP_score=0.559;CytoBand=p13.33;repName=Tigger4b;repClass=DNA;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=tgtatcttct.atacaaaaac	GT:AD:DP:GQ:PL	0/1:169,129:298:99:3909,0,5525
chr12	1021557	.	G	A	4360.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.824;DP=269;ExcessHet=3.0103;FS=0.447;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.27;ReadPosRankSum=1.275;SOR=0.689;HGVSnom=NM_134424.4:c.*1000C>T;Gene=RAD52;Transcript=NM_134424.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=418;RS=rs1051672;G1000_AF=0.313698;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.2664;G1000_AFR_AF=0.4622;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.2507;DANN_score=0.5381;GREP_score=-0.555;CytoBand=p13.33;repName=Tigger4b;repClass=DNA;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=tgtgtatgag.catatacacg	GT:AD:DP:GQ:PL	0/1:120,148:268:99:4389,0,3758
chr12	1021888	.	CAAAAA	C	5479.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.358;DP=359;ExcessHet=3.0103;FS=10.567;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=0;QD=21;ReadPosRankSum=0.785;SOR=0.076;OLD_VARIANT=chr12|1021888|CAAAAA|C,CAAA|1;HGVSnom=NM_134424.4:c.*664_*668delTTTTT;Gene=RAD52;Transcript=NM_134424.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=418;RS=rs60090525;CytoBand=p13.33;repName=FRAM;repClass=SINE;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=gaccccgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/0:24,153:261:99:5517,1214,2679
chr12	1021888	.	CAA	C	5479.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.358;DP=359;ExcessHet=3.0103;FS=10.567;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=0;QD=21;ReadPosRankSum=0.785;SOR=0.076;OLD_VARIANT=chr12|1021888|CAAAAA|C,CAAA|2;HGVSnom=NM_134424.4:c.*667_*668delTT;Gene=RAD52;Transcript=NM_134424.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=418;RS=rs60090525;G1000_AF=0.604433;G1000_EAS_AF=0.6726;G1000_EUR_AF=0.6103;G1000_AFR_AF=0.5862;G1000_SAS_AF=0.5716;G1000_AMR_AF=0.5778;CytoBand=p13.33;repName=FRAM;repClass=SINE;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=gaccccgtct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:24,84:261:99:5517,3278,3266
chr12	1022452	.	C	T	8226.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.183;DP=503;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.42;ReadPosRankSum=0.79;SOR=0.736;HGVSnom=NM_134424.4:c.*105G>A;Gene=RAD52;Transcript=NM_134424.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=418;RS=rs1051669;G1000_AF=0.254792;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.2594;G1000_AFR_AF=0.3101;G1000_SAS_AF=0.2883;G1000_AMR_AF=0.2147;DANN_score=0.6822;GREP_score=-2.55;CytoBand=p13.33;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=CAAGATAAAT.GCAATGACGT	GT:AD:DP:GQ:PL	0/1:243,258:501:99:8255,0,7230
chr12	1040373	.	T	C	9139.77	PASS	AC=2;AF=1;AN=2;DP=250;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.11;SOR=2.119;HGVSnom=NM_134424.4:c.186+13A>G;Gene=RAD52;Transcript=NM_134424.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_134424.4:IVS3+13A>G;AAlength=418;EXAC_AF=0.54899980;EXAC_Hom_EAS=1006;EXAC_AC_EAS=4167;EXAC_AN_EAS=8578;EXAC_AC_Adj=66306;EXAC_AN_Adj=120776;ESP6500_MAF=0.55120714;RS=rs7303748;G1000_AF=0.544928;G1000_EAS_AF=0.4623;G1000_EUR_AF=0.5636;G1000_AFR_AF=0.5681;G1000_SAS_AF=0.6442;G1000_AMR_AF=0.4539;gnomad_exomes_AF=0.54126308;gnomad_exomes_AF_EAS=0.47213639;gnomad_exomes_AC=134112;gnomad_exomes_Hom=37117;gnomad_exomes_Het=59878;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53919742;gnomad_exomes_AF_NFE=0.54965477;gnomad_exomes_AF_AMR=0.42247949;gnomad_exomes_AF_SAS=0.65732886;NativeFreq_Het=0.4626;NativeFreq_Hom=0.2705;DANN_score=0.1971;GREP_score=-4.65;CytoBand=p13.33;Strand=RAD52:NM_001297421.1:-,RAD52:NM_134424.3:-,RAD52:NM_001297419.1:-,RAD52:NM_001297422.1:-,RAD52:NM_001297420.1:-;NP=RAD52:NM_001297421.1:NP_001284350.1,RAD52:NM_134424.3:NP_602296.2,RAD52:NM_001297419.1:NP_001284348.1,RAD52:NM_001297422.1:NP_001284351.1,RAD52:NM_001297420.1:NP_001284349.1;ENSP=RAD52:NM_001297421.1:.,RAD52:NM_134424.3:ENST00000358495.7,RAD52:NM_001297419.1:.,RAD52:NM_001297422.1:.,RAD52:NM_001297420.1:.;Gene_MIM_id=600392;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5893;EnsemblGeneID=ENSG00000002016;Alias=RAD52;FLKSEQ=TCCAGGCACA.GAATTCTCCT	GT:AD:DP:GQ:PL	1/1:0,250:250:99:9168,751,0
chr12	12874917	.	C	A	7236.77	PASS	AC=2;AF=1;AN=2;DP=196;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.92;SOR=1.597;HGVSnom=NM_004064.5:c.*956C>A;Gene=CDKN1B;Transcript=NM_004064.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E3;IVSnom=.;AAlength=198;RS=rs7330;CLNGENE=CDKN1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.625599;G1000_EAS_AF=0.8671;G1000_EUR_AF=0.6431;G1000_AFR_AF=0.3926;G1000_SAS_AF=0.7331;G1000_AMR_AF=0.5418;NativeFreq_Het=0.2079;NativeFreq_Hom=0.7722;normalHetFrequency=0.3166;normalHetNum=151;normalHomFrequency=0.6352;normalHomNum=303;patientHetFrequency=0.1182;patientHetNum=617;patientHomFrequency=0.3322;patientHomNum=1734;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2214;AF_2700_Hom=0.7575;AF_50_Het=0.2282;AF_50_Hom=0.7591;DANN_score=0.5755;GREP_score=2.05;CytoBand=p13.1;CGD_CONDITION=Multiple endocrine neoplasia, type IV;CGD_INHERITANCE=AD;Strand=CDKN1B:NM_004064.4:+;NP=CDKN1B:NM_004064.4:NP_004055.1;ENSP=CDKN1B:NM_004064.4:ENST00000228872.9;Gene_MIM_id=600778;Phenotypes=Multiple endocrine neoplasia, type IV, 610755 (3), Autosomal dominant. 610755(MK);Possible_Inheritance=AD;EntrezGeneID=1027;EnsemblGeneID=ENSG00000111276;Alias=CDKN1B, KIP1, CDKN4, MEN4;FLKSEQ=TGTTATTTTT.AAGGAAGGTT	GT:AD:DP:GQ:PL	1/1:0,195:195:99:7265,585,0
chr12	52307145	.	C	T	9109.77	PASS	AC=2;AF=1;AN=2;DP=264;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.64;SOR=1.073;HGVSnom=NM_000020.3:c.313+11C>T;Gene=ACVRL1;Transcript=NM_000020.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_000020.3:IVS3+11C>T;AAlength=503;EXAC_AF=0.42632706;EXAC_Hom_EAS=296;EXAC_AC_EAS=2251;EXAC_AN_EAS=7966;EXAC_AC_Adj=45779;EXAC_AN_Adj=107380;ESP6500_MAF=0.47285868;RS=rs2071218;CLNGENE=ACVRL1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.43111;G1000_EAS_AF=0.2669;G1000_EUR_AF=0.4404;G1000_AFR_AF=0.5877;G1000_SAS_AF=0.4969;G1000_AMR_AF=0.2651;gnomad_exomes_AF=0.40358497;gnomad_exomes_AF_EAS=0.28241819;gnomad_exomes_AC=97109;gnomad_exomes_Hom=20761;gnomad_exomes_Het=55587;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54787093;gnomad_exomes_AF_NFE=0.43259325;gnomad_exomes_AF_AMR=0.21198753;gnomad_exomes_AF_SAS=0.46735985;NativeFreq_Het=0.4021;NativeFreq_Hom=0.1495;normalHetFrequency=0.4104;normalHetNum=355;normalHomFrequency=0.1237;normalHomNum=107;patientHetFrequency=0.4149;patientHetNum=2166;patientHomFrequency=0.1088;patientHomNum=568;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8434;GREP_score=-1.38;CytoBand=q13.13;CGD_CONDITION=Telangiectasia, hereditary hemorrhagic, type 2;CGD_INHERITANCE=AD;Strand=ACVRL1:NM_000020.2:+,ACVRL1:NM_001077401.1:+;NP=ACVRL1:NM_000020.2:NP_000011.2,ACVRL1:NM_001077401.1:NP_001070869.1;ENSP=ACVRL1:NM_000020.2:ENST00000388922.8,ACVRL1:NM_001077401.1:.;Gene_MIM_id=601284;Phenotypes=Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant. 600376(MK);Possible_Inheritance=AD;EntrezGeneID=94;EnsemblGeneID=ENSG00000139567;Alias=ACVRL1, ACVRLK1, ALK1, HHT2;FLKSEQ=GTACGTCCAG.TGCCCTAGCA	GT:AD:DP:GQ:PL	1/1:0,263:263:99:9138,788,0
chr12	52307308	.	A	G	4748.77	PASS	AC=2;AF=1;AN=2;DP=127;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.62;SOR=0.791;HGVSnom=NM_000020.3:c.314-35A>G;Gene=ACVRL1;Transcript=NM_000020.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_000020.3:IVS3-35A>G;AAlength=503;EXAC_AF=0.45774556;EXAC_Hom_EAS=226;EXAC_AC_EAS=1701;EXAC_AN_EAS=5074;EXAC_AC_Adj=35175;EXAC_AN_Adj=76844;ESP6500_MAF=0.47818042;RS=rs2071219;CLNGENE=ACVRL1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.436701;G1000_EAS_AF=0.2708;G1000_EUR_AF=0.4533;G1000_AFR_AF=0.593;G1000_SAS_AF=0.4969;G1000_AMR_AF=0.2709;gnomad_exomes_AF=0.40438572;gnomad_exomes_AF_EAS=0.28465930;gnomad_exomes_AC=82874;gnomad_exomes_Hom=17797;gnomad_exomes_Het=47280;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55111509;gnomad_exomes_AF_NFE=0.44068511;gnomad_exomes_AF_AMR=0.21518399;gnomad_exomes_AF_SAS=0.46724589;HGMD_gene=ACVRL1;HGMD_disease=Arteriovenous_malformations_association_with;HGMD_tag=DP;HGMD_pmid=16179574;NativeFreq_Het=0.3950;NativeFreq_Hom=0.1601;normalHetFrequency=0.4023;normalHetNum=348;normalHomFrequency=0.1272;normalHomNum=110;patientHetFrequency=0.4117;patientHetNum=2149;patientHomFrequency=0.1113;patientHomNum=581;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3126;GREP_score=-0.211;CytoBand=q13.13;CGD_CONDITION=Telangiectasia, hereditary hemorrhagic, type 2;CGD_INHERITANCE=AD;Strand=ACVRL1:NM_000020.2:+,ACVRL1:NM_001077401.1:+;NP=ACVRL1:NM_000020.2:NP_000011.2,ACVRL1:NM_001077401.1:NP_001070869.1;ENSP=ACVRL1:NM_000020.2:ENST00000388922.8,ACVRL1:NM_001077401.1:.;Gene_MIM_id=601284;Phenotypes=Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant. 600376(MK);Possible_Inheritance=AD;EntrezGeneID=94;EnsemblGeneID=ENSG00000139567;Alias=ACVRL1, ACVRLK1, ALK1, HHT2;FLKSEQ=GAGCTGACCT.GTGGAAGCTG	GT:AD:DP:GQ:PL	1/1:0,126:126:99:4777,379,0
chr12	52315923	.	T	C	10526.8	PASS	AC=2;AF=1;AN=2;DP=286;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.52;SOR=0.789;HGVSnom=NM_000020.3:c.*1246T>C;Gene=ACVRL1;Transcript=NM_000020.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=503;RS=rs706819;CLNGENE=ACVRL1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.699681;G1000_EAS_AF=0.7371;G1000_EUR_AF=0.7237;G1000_AFR_AF=0.7428;G1000_SAS_AF=0.7209;G1000_AMR_AF=0.4986;normalHetFrequency=0.4256;normalHetNum=203;normalHomFrequency=0.289;normalHomNum=250;patientHetFrequency=0.4163;patientHetNum=1019;patientHomFrequency=0.2402;patientHomNum=1254;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7563;GREP_score=-2.41;CytoBand=q13.13;CGD_CONDITION=Telangiectasia, hereditary hemorrhagic, type 2;CGD_INHERITANCE=AD;Strand=ACVRL1:NM_000020.2:+,ACVRL1:NM_001077401.1:+;NP=ACVRL1:NM_000020.2:NP_000011.2,ACVRL1:NM_001077401.1:NP_001070869.1;ENSP=ACVRL1:NM_000020.2:ENST00000388922.8,ACVRL1:NM_001077401.1:.;Gene_MIM_id=601284;Phenotypes=Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominant. 600376(MK);Possible_Inheritance=AD;EntrezGeneID=94;EnsemblGeneID=ENSG00000139567;Alias=ACVRL1, ACVRLK1, ALK1, HHT2;FLKSEQ=AGCTAACTTC.TCAGTCTCAT	GT:AD:DP:GQ:PL	1/1:0,283:283:99:10555,851,0
chr12	58141530	.	CT	C	104.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.953;DP=79;ExcessHet=3.0103;FS=7.594;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.45;ReadPosRankSum=-0.496;SOR=0.098;HGVSnom=NM_005981.5:c.*470delT|NM_000075.4:c.*777delA;Gene=TSPAN31|CDK4;Transcript=NM_005981.5|NM_000075.4;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E8;AAlength=210|303;RS=rs146863045;CytoBand=q14.1;repName=AluSx;repClass=SINE;CGD_CONDITION=Melanoma, cutaneous malignant, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=TSPAN31:NM_001330168.1:+,TSPAN31:NM_001330169.1:+,TSPAN31:NM_005981.4:+,CDK4:NM_000075.3:-;NP=TSPAN31:NM_001330168.1:NP_001317097.1,TSPAN31:NM_001330169.1:NP_001317098.1,TSPAN31:NM_005981.4:NP_005972.1,CDK4:NM_000075.3:NP_000066.1;ENSP=TSPAN31:NM_001330168.1:.,TSPAN31:NM_001330169.1:.,TSPAN31:NM_005981.4:.,CDK4:NM_000075.3:ENST00000257904.10;Gene_MIM_id=181035,123829;Phenotypes=.,{Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant. 609048(SK);Possible_Inheritance=NA,AD;EntrezGeneID=6302,1019;EnsemblGeneID=ENSG00000135452,ENSG00000135446;Alias=TSPAN31, SAS,CDK4, CMM3;FLKSEQ=AATCTATAtt.tttttttttt	GT:AD:DP:GQ:PL	0/1:55,17:72:99:142,0,1125
chr12	58142004	.	TA	T	679.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.091;DP=351;ExcessHet=3.0103;FS=9.18;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.12;ReadPosRankSum=0.399;SOR=1.296;HGVSnom=NM_005981.5:c.*945delA|NM_000075.4:c.*303delT;Gene=TSPAN31|CDK4;Transcript=NM_005981.5|NM_000075.4;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E6|E8;AAlength=210|303;RS=rs59185470;CLNGENE=CDK4|TSPAN31;CLNSIG=Uncertain_significance|Uncertain_significance;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;normalHetFrequency=0.1434;normalHetNum=124;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.1149;patientHetNum=600;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16B3258327];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2106;AF_2700_Hom=.;AF_50_Het=0.2330;AF_50_Hom=.;CytoBand=q14.1;CGD_CONDITION=Melanoma, cutaneous malignant, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=TSPAN31:NM_001330168.1:+,TSPAN31:NM_001330169.1:+,TSPAN31:NM_005981.4:+,CDK4:NM_000075.3:-;NP=TSPAN31:NM_001330168.1:NP_001317097.1,TSPAN31:NM_001330169.1:NP_001317098.1,TSPAN31:NM_005981.4:NP_005972.1,CDK4:NM_000075.3:NP_000066.1;ENSP=TSPAN31:NM_001330168.1:.,TSPAN31:NM_001330169.1:.,TSPAN31:NM_005981.4:.,CDK4:NM_000075.3:ENST00000257904.10;Gene_MIM_id=181035,123829;Phenotypes=.,{Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant. 609048(SK);Possible_Inheritance=NA,AD;EntrezGeneID=6302,1019;EnsemblGeneID=ENSG00000135452,ENSG00000135446;Alias=TSPAN31, SAS,CDK4, CMM3;FLKSEQ=GAAGAAACAT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:242,78:320:99:717,0,4387
chr12	58142491	.	CT	C	478.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.772;DP=172;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.05;ReadPosRankSum=-2.366;SOR=0.774;HGVSnom=NM_005981.5:c.*1433delT|NM_000075.4:c.820-92delA;Gene=TSPAN31|CDK4;Transcript=NM_005981.5|NM_000075.4;VarType=UTR3|Intron;MolecularConsequence=3_prime_UTR_exon_variant|coding_transcript_intron_variant;ExonIntron=E6|I7;IVSnom=.|NM_000075.4:IVS7-92delA;AAlength=210|303;EXAC_AF=0.32781955;EXAC_Hom_EAS=0;EXAC_AC_EAS=826;EXAC_AN_EAS=2590;EXAC_AC_Adj=14388;EXAC_AN_Adj=43890;RS=rs545773931;G1000_AF=0.0173722;G1000_EAS_AF=0.0169;G1000_EUR_AF=0.0149;G1000_AFR_AF=0.0204;G1000_SAS_AF=0.0194;G1000_AMR_AF=0.013;gnomad_exomes_AF=0.32951994;gnomad_exomes_AF_EAS=0.35050349;gnomad_exomes_AC=32289;gnomad_exomes_Hom=0;gnomad_exomes_Het=32289;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27502711;gnomad_exomes_AF_NFE=0.33361615;gnomad_exomes_AF_AMR=0.35131261;gnomad_exomes_AF_SAS=0.31329401;normalHetFrequency=0.2613;normalHetNum=226;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.3088;patientHetNum=1612;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q14.1;repName=AluSx;repClass=SINE;CGD_CONDITION=Melanoma, cutaneous malignant, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=CDK4:NM_000075.3:-;NP=CDK4:NM_000075.3:NP_000066.1;ENSP=CDK4:NM_000075.3:ENST00000257904.10;Gene_MIM_id=123829;Phenotypes={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant. 609048(SK);Possible_Inheritance=AD;EntrezGeneID=1019;EnsemblGeneID=ENSG00000135446;Alias=CDK4, CMM3;FLKSEQ=cttctttttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:108,49:157:99:516,0,1811
chr12	58144665	.	C	T	5631.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.217;DP=347;ExcessHet=3.0103;FS=7.092;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.23;ReadPosRankSum=-0.547;SOR=0.451;HGVSnom=NM_000075.4:c.522+41G>A;Gene=CDK4;Transcript=NM_000075.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000075.4:IVS4+41G>A;AAlength=303;EXAC_AF=0.35405370;EXAC_Hom_EAS=1778;EXAC_AC_EAS=5533;EXAC_AN_EAS=8636;EXAC_AC_Adj=42963;EXAC_AN_Adj=121346;ESP6500_MAF=0.23958173;RS=rs2069502;CLNGENE=CDK4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.336661;G1000_EAS_AF=0.6409;G1000_EUR_AF=0.3121;G1000_AFR_AF=0.0393;G1000_SAS_AF=0.5082;G1000_AMR_AF=0.255;gnomad_exomes_AF=0.35490365;gnomad_exomes_AF_EAS=0.63679861;gnomad_exomes_AC=89210;gnomad_exomes_Hom=17912;gnomad_exomes_Het=53386;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07618462;gnomad_exomes_AF_NFE=0.32133934;gnomad_exomes_AF_AMR=0.34488840;gnomad_exomes_AF_SAS=0.49715816;NativeFreq_Het=0.3950;NativeFreq_Hom=0.4158;normalHetFrequency=0.422;normalHetNum=365;normalHomFrequency=0.3341;normalHomNum=289;patientHetFrequency=0.4408;patientHetNum=2301;patientHomFrequency=0.3257;patientHomNum=1700;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7407;GREP_score=1.62;CytoBand=q14.1;CGD_CONDITION=Melanoma, cutaneous malignant, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=CDK4:NM_000075.3:-;NP=CDK4:NM_000075.3:NP_000066.1;ENSP=CDK4:NM_000075.3:ENST00000257904.10;Gene_MIM_id=123829;Phenotypes={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant. 609048(SK);Possible_Inheritance=AD;EntrezGeneID=1019;EnsemblGeneID=ENSG00000135446;Alias=CDK4, CMM3;FLKSEQ=CACTCTCCTA.TCCCAACCAG	GT:AD:DP:GQ:PL	0/1:169,178:347:99:5660,0,5536
chr12	58145156	.	C	T	6013.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.844;DP=398;ExcessHet=3.0103;FS=2.12;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.15;ReadPosRankSum=0.076;SOR=0.58;HGVSnom=NM_000075.4:c.219-31G>A;Gene=CDK4;Transcript=NM_000075.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000075.4:IVS2-31G>A;AAlength=303;EXAC_AF=0.33921614;EXAC_Hom_EAS=124;EXAC_AC_EAS=1350;EXAC_AN_EAS=8610;EXAC_AC_Adj=41094;EXAC_AN_Adj=121144;ESP6500_MAF=0.34783946;RS=rs2270777;CLNGENE=CDK4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.248003;G1000_EAS_AF=0.1776;G1000_EUR_AF=0.4493;G1000_AFR_AF=0.1324;G1000_SAS_AF=0.2188;G1000_AMR_AF=0.3199;gnomad_exomes_AF=0.34122445;gnomad_exomes_AF_EAS=0.15801219;gnomad_exomes_AC=85676;gnomad_exomes_Hom=16487;gnomad_exomes_Het=52702;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16142751;gnomad_exomes_AF_NFE=0.43548245;gnomad_exomes_AF_AMR=0.23408933;gnomad_exomes_AF_SAS=0.23795830;NativeFreq_Het=0.3559;NativeFreq_Hom=0.1103;normalHetFrequency=0.2913;normalHetNum=252;normalHomFrequency=0.0717;normalHomNum=62;patientHetFrequency=0.3125;patientHetNum=1631;patientHomFrequency=0.0701;patientHomNum=366;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8177;GREP_score=-2.49;CytoBand=q14.1;CGD_CONDITION=Melanoma, cutaneous malignant, susceptibility to, 3;CGD_INHERITANCE=AD;Strand=CDK4:NM_000075.3:-;NP=CDK4:NM_000075.3:NP_000066.1;ENSP=CDK4:NM_000075.3:ENST00000257904.10;Gene_MIM_id=123829;Phenotypes={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant. 609048(SK);Possible_Inheritance=AD;EntrezGeneID=1019;EnsemblGeneID=ENSG00000135446;Alias=CDK4, CMM3;FLKSEQ=CTTTTCAATC.CCTTTAACCC	GT:AD:DP:GQ:PL	0/1:194,203:397:99:6042,0,6084
chr12	120995332	.	G	A	16582.8	PASS	AC=2;AF=1;AN=2;DP=462;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.27;SOR=1.072;HGVSnom=NM_014868.5:c.831-17G>A;Gene=RNF10;Transcript=NM_014868.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_014868.5:IVS5-17G>A;AAlength=811;EXAC_AF=0.61830136;EXAC_Hom_EAS=2580;EXAC_AC_EAS=6665;EXAC_AN_EAS=8636;EXAC_AC_Adj=75042;EXAC_AN_Adj=121368;ESP6500_MAF=0.50445948;RS=rs2292681;G1000_AF=0.523363;G1000_EAS_AF=0.749;G1000_EUR_AF=0.6262;G1000_AFR_AF=0.146;G1000_SAS_AF=0.6043;G1000_AMR_AF=0.6513;gnomad_exomes_AF=0.63018015;gnomad_exomes_AF_EAS=0.76981624;gnomad_exomes_AC=158392;gnomad_exomes_Hom=52074;gnomad_exomes_Het=54244;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.19844980;gnomad_exomes_AF_NFE=0.64861084;gnomad_exomes_AF_AMR=0.73290722;gnomad_exomes_AF_SAS=0.62326843;NativeFreq_Het=0.3665;NativeFreq_Hom=0.4698;DANN_score=0.2846;GREP_score=-1.37;CytoBand=q24.31;Strand=RNF10:NM_014868.4:+,RNF10:NM_001330474.1:+;NP=RNF10:NM_014868.4:NP_055683.3,RNF10:NM_001330474.1:NP_001317403.1;ENSP=RNF10:NM_014868.4:.,RNF10:NM_001330474.1:.;Gene_MIM_id=615998;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=9921;EnsemblGeneID=ENSG00000022840;Alias=RNF10, KIAA0262;FLKSEQ=TGCTACATAT.AGTGTCCATG	GT:AD:DP:GQ:PL	1/1:0,461:461:99:16611,1386,0
chr12	121416622	.	C	G	6890.77	PASS	AC=2;AF=1;AN=2;DP=181;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.94;SOR=0.965;HGVSnom=NM_000545.8:c.51C>G(p.Leu17Leu/p.L17L);Gene=HNF1A;Transcript=NM_000545.8;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=631;EXAC_AF=0.47217348;EXAC_Hom_EAS=658;EXAC_AC_EAS=3372;EXAC_AN_EAS=8496;EXAC_AC_Adj=55436;EXAC_AN_Adj=117406;ESP6500_MAF=0.41747498;RS=rs1169289;CLNGENE=HNF1A;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;G1000_AF=0.428514;G1000_EAS_AF=0.3819;G1000_EUR_AF=0.4692;G1000_AFR_AF=0.3169;G1000_SAS_AF=0.5787;G1000_AMR_AF=0.438;gnomad_exomes_AF=0.46939426;gnomad_exomes_AF_EAS=0.38966648;gnomad_exomes_AC=116345;gnomad_exomes_Hom=28020;gnomad_exomes_Het=60305;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.33352683;gnomad_exomes_AF_NFE=0.46536058;gnomad_exomes_AF_AMR=0.44299212;gnomad_exomes_AF_SAS=0.57515528;NativeFreq_Het=0.4555;NativeFreq_Hom=0.1782;normalHetFrequency=0.4407;normalHetNum=171;normalHomFrequency=0.2448;normalHomNum=95;patientHetFrequency=0.4636;patientHetNum=1285;patientHomFrequency=0.2237;patientHomNum=620;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4739;AF_2700_Hom=0.1787;AF_50_Het=0.4675;AF_50_Hom=0.1933;DANN_score=0.5775;GREP_score=-3.67;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=CGGCCCTGCT.GAGTCAGGGC	GT:AD:DP:GQ:PL	1/1:0,180:180:99:6919,541,0
chr12	121416650	.	A	C	7284.77	PASS	AC=2;AF=1;AN=2;DP=189;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.97;SOR=1.253;HGVSnom=NM_000545.8:c.79A>C(p.Ile27Leu/p.I27L);Gene=HNF1A;Transcript=NM_000545.8;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E1;IVSnom=.;AAlength=631;EXAC_AF=0.35329072;EXAC_Hom_EAS=726;EXAC_AC_EAS=3555;EXAC_AN_EAS=8502;EXAC_AC_Adj=41559;EXAC_AN_Adj=117634;ESP6500_MAF=0.26249808;RS=rs1169288;Ensembl_transcriptid=ENST00000257555|ENST00000400024|ENST00000617366|ENST00000543427|ENST00000541395|ENST00000544413;SIFT_pred=T|.|.|.|T|T;SIFT_score=0.082|.|.|.|0.101|0.103;Polyphen2_HVAR_pred=.|.|.|.|.|B;Polyphen2_HVAR_score=.|.|.|.|.|0.013;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=0.00427281|0.00427281|0.00427281|0.00103143|9.01191e-17;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.298522;G1000_EAS_AF=0.3889;G1000_EUR_AF=0.339;G1000_AFR_AF=0.0832;G1000_SAS_AF=0.4325;G1000_AMR_AF=0.33;gnomad_exomes_AF=0.35488591;gnomad_exomes_AF_EAS=0.41465414;gnomad_exomes_AC=88280;gnomad_exomes_Hom=16580;gnomad_exomes_Het=55120;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11794775;gnomad_exomes_AF_NFE=0.33651216;gnomad_exomes_AF_AMR=0.36660285;gnomad_exomes_AF_SAS=0.42681093;HGMD_gene=HNF1A;HGMD_disease=Insulin_resistance_association_with;HGMD_tag=DP;HGMD_pmid=10852449;NativeFreq_Het=0.4377;NativeFreq_Hom=0.1980;normalHetFrequency=0.4433;normalHetNum=172;normalHomFrequency=0.2371;normalHomNum=92;patientHetFrequency=0.4592;patientHetNum=1273;patientHomFrequency=0.1937;patientHomNum=537;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4804;AF_2700_Hom=0.1875;AF_50_Het=0.4691;AF_50_Hom=0.2029;DANN_score=0.9761;GREP_score=4.45;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=AGAGGCACTG.TCCAGGCACT	GT:AD:DP:GQ:PL	1/1:0,189:189:99:7313,568,0
chr12	121426594	.	G	A	7080.77	PASS	AC=2;AF=1;AN=2;DP=189;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.84;SOR=1.597;HGVSnom=NM_000545.8:c.327-42G>A;Gene=HNF1A;Transcript=NM_000545.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000545.8:IVS1-42G>A;AAlength=631;EXAC_AF=0.34638613;EXAC_Hom_EAS=640;EXAC_AC_EAS=3297;EXAC_AN_EAS=7938;EXAC_AC_Adj=38771;EXAC_AN_Adj=111930;ESP6500_MAF=0.27256651;RS=rs1169294;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.315296;G1000_EAS_AF=0.4008;G1000_EUR_AF=0.336;G1000_AFR_AF=0.1498;G1000_SAS_AF=0.407;G1000_AMR_AF=0.3473;gnomad_exomes_AF=0.34816400;gnomad_exomes_AF_EAS=0.40647079;gnomad_exomes_AC=84443;gnomad_exomes_Hom=15053;gnomad_exomes_Het=54337;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15655727;gnomad_exomes_AF_NFE=0.32522391;gnomad_exomes_AF_AMR=0.37615472;gnomad_exomes_AF_SAS=0.41132214;NativeFreq_Het=0.4455;NativeFreq_Hom=0.2178;normalHetFrequency=0.4381;normalHetNum=170;normalHomFrequency=0.2113;normalHomNum=82;patientHetFrequency=0.4701;patientHetNum=1303;patientHomFrequency=0.1948;patientHomNum=540;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5601;GREP_score=1.66;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=TATGGGGAGA.ACAGCCCTTG	GT:AD:DP:GQ:PL	1/1:0,189:189:99:7109,568,0
chr12	121431300	.	C	T	6011.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.743;DP=171;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.32;ReadPosRankSum=0.235;SOR=0.936;HGVSnom=NM_000545.8:c.527-23C>T;Gene=HNF1A;Transcript=NM_000545.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000545.8:IVS2-23C>T;AAlength=631;EXAC_AF=0.33838495;EXAC_Hom_EAS=1018;EXAC_AC_EAS=4204;EXAC_AN_EAS=8460;EXAC_AC_Adj=39968;EXAC_AN_Adj=118114;ESP6500_MAF=0.24926957;RS=rs1169301;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.31869;G1000_EAS_AF=0.4732;G1000_EUR_AF=0.3161;G1000_AFR_AF=0.118;G1000_SAS_AF=0.411;G1000_AMR_AF=0.3501;gnomad_exomes_AF=0.33901693;gnomad_exomes_AF_EAS=0.48840263;gnomad_exomes_AC=84462;gnomad_exomes_Hom=15161;gnomad_exomes_Het=54140;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12278418;gnomad_exomes_AF_NFE=0.30779465;gnomad_exomes_AF_AMR=0.37306772;gnomad_exomes_AF_SAS=0.41743179;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2574;normalHetFrequency=0.4716;normalHetNum=183;normalHomFrequency=0.2371;normalHomNum=92;patientHetFrequency=0.4766;patientHetNum=1321;patientHomFrequency=0.2417;patientHomNum=670;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4835;AF_2700_Hom=0.2456;AF_50_Het=0.4897;AF_50_Hom=0.2425;DANN_score=0.6046;GREP_score=3.82;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=CAGTACCCCA.TCACGGCTTT	GT:AD:DP:GQ:PL	1/1:1,169:170:99:6040,500,0
chr12	121435342	.	C	T	6803.77	PASS	AC=2;AF=1;AN=2;DP=190;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.85;SOR=1.536;HGVSnom=NM_000545.8:c.1375C>T(p.Leu459Leu/p.L459L);Gene=HNF1A;Transcript=NM_000545.8;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=631;EXAC_AF=0.33678381;EXAC_Hom_EAS=1033;EXAC_AC_EAS=4238;EXAC_AN_EAS=8566;EXAC_AC_Adj=40018;EXAC_AN_Adj=118824;ESP6500_MAF=0.24638573;RS=rs2259820;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.316693;G1000_EAS_AF=0.4732;G1000_EUR_AF=0.3161;G1000_AFR_AF=0.1089;G1000_SAS_AF=0.4131;G1000_AMR_AF=0.3501;gnomad_exomes_AF=0.33817870;gnomad_exomes_AF_EAS=0.48875914;gnomad_exomes_AC=84358;gnomad_exomes_Hom=15165;gnomad_exomes_Het=54028;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11803136;gnomad_exomes_AF_NFE=0.30746846;gnomad_exomes_AF_AMR=0.37179636;gnomad_exomes_AF_SAS=0.41589274;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2574;normalHetFrequency=0.4613;normalHetNum=179;normalHomFrequency=0.2423;normalHomNum=94;patientHetFrequency=0.4762;patientHetNum=1320;patientHomFrequency=0.2403;patientHomNum=666;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4854;AF_2700_Hom=0.2448;AF_50_Het=0.4929;AF_50_Hom=0.2409;DANN_score=0.8801;GREP_score=4.59;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=CCTGACCACC.TGCAGCCCGT	GT:AD:DP:GQ:PL	1/1:0,190:190:99:6832,571,0
chr12	121435427	.	G	A	7238.77	PASS	AC=2;AF=1;AN=2;DP=211;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.47;SOR=0.732;HGVSnom=NM_000545.8:c.1460G>A(p.Ser487Asn/p.S487N);Gene=HNF1A;Transcript=NM_000545.8;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E7;IVSnom=.;AAlength=631;EXAC_AF=0.34650677;EXAC_Hom_EAS=965;EXAC_AC_EAS=4093;EXAC_AN_EAS=8188;EXAC_AC_Adj=39122;EXAC_AN_Adj=112904;ESP6500_MAF=0.24734738;RS=rs2464196;Ensembl_transcriptid=ENST00000257555|ENST00000400024|ENST00000543427|ENST00000615446|ENST00000541395|ENST00000544413;SIFT_pred=T|.|.|.|T|T;SIFT_score=0.111|.|.|.|0.128|0.133;Polyphen2_HVAR_pred=.|.|.|.|.|B;Polyphen2_HVAR_score=.|.|.|.|.|0.005;MutationTaster_pred=P|P|P|P;MutationTaster_score=0.0625679|0.999997|0.0625679|0.0625679;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.317692;G1000_EAS_AF=0.4732;G1000_EUR_AF=0.3161;G1000_AFR_AF=0.112;G1000_SAS_AF=0.4141;G1000_AMR_AF=0.3501;gnomad_exomes_AF=0.33743689;gnomad_exomes_AF_EAS=0.48620614;gnomad_exomes_AC=83546;gnomad_exomes_Hom=14870;gnomad_exomes_Het=53806;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.11941323;gnomad_exomes_AF_NFE=0.30629098;gnomad_exomes_AF_AMR=0.37111202;gnomad_exomes_AF_SAS=0.41660636;HGMD_gene=HNF1A;HGMD_disease=Cadiovascular_disease_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=20031592;NativeFreq_Het=0.4554;NativeFreq_Hom=0.2574;normalHetFrequency=0.4639;normalHetNum=180;normalHomFrequency=0.2397;normalHomNum=93;patientHetFrequency=0.4751;patientHetNum=1317;patientHomFrequency=0.2406;patientHomNum=667;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4842;AF_2700_Hom=0.2467;AF_50_Het=0.4913;AF_50_Hom=0.2425;DANN_score=0.9868;GREP_score=3.53;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GTGACCCAGA.CCCCTTCATG	GT:AD:DP:GQ:PL	1/1:0,210:210:99:7267,628,0
chr12	121435475	.	G	A	7579.77	PASS	AC=2;AF=1;AN=2;DP=216;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.46;SOR=0.961;HGVSnom=NM_000545.8:c.1501+7G>A;Gene=HNF1A;Transcript=NM_000545.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000545.8:IVS7+7G>A;AAlength=631;EXAC_AF=0.43472336;EXAC_Hom_EAS=780;EXAC_AC_EAS=3406;EXAC_AN_EAS=6438;EXAC_AC_Adj=39239;EXAC_AN_Adj=90262;ESP6500_MAF=0.29006460;RS=rs2464195;Ensembl_transcriptid=ENST00000400024;SIFT_pred=.;SIFT_score=.;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P|P|P;MutationTaster_score=0.999997|0.999997|0.999997|0.999997;CLNGENE=HNF1A;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;G1000_AF=0.359625;G1000_EAS_AF=0.4802;G1000_EUR_AF=0.3777;G1000_AFR_AF=0.1263;G1000_SAS_AF=0.5061;G1000_AMR_AF=0.3963;gnomad_exomes_AF=0.38982249;gnomad_exomes_AF_EAS=0.48529759;gnomad_exomes_AC=90608;gnomad_exomes_Hom=18320;gnomad_exomes_Het=53968;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13314545;gnomad_exomes_AF_NFE=0.36371698;gnomad_exomes_AF_AMR=0.39948107;gnomad_exomes_AF_SAS=0.52056404;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2574;normalHetFrequency=0.4768;normalHetNum=185;normalHomFrequency=0.25;normalHomNum=97;patientHetFrequency=0.4708;patientHetNum=1305;patientHomFrequency=0.2655;patientHomNum=736;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4865;AF_2700_Hom=0.2479;AF_50_Het=0.4960;AF_50_Hom=0.2425;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00001420;DANN_score=0.5703;GREP_score=-8.98;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=CACGGTGAGC.CCCTGTGCCC	GT:AD:DP:GQ:PL	1/1:0,216:216:99:7608,649,0
chr12	121437221	.	T	C	6414.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.742;DP=188;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.49;ReadPosRankSum=1.333;SOR=0.236;HGVSnom=NM_000545.8:c.1623+29T>C;Gene=HNF1A;Transcript=NM_000545.8;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000545.8:IVS8+29T>C;AAlength=631;EXAC_AF=0.81453905;EXAC_Hom_EAS=3304;EXAC_AC_EAS=7555;EXAC_AN_EAS=8630;EXAC_AC_Adj=98569;EXAC_AN_Adj=121012;ESP6500_MAF=0.74388744;RS=rs1169304;Ensembl_transcriptid=ENST00000541395;SIFT_pred=D;SIFT_score=0.046;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|0.999998|0.999998|0.999998;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.776957;G1000_EAS_AF=0.8542;G1000_EUR_AF=0.834;G1000_AFR_AF=0.5401;G1000_SAS_AF=0.8589;G1000_AMR_AF=0.9179;gnomad_exomes_AF=0.82251457;gnomad_exomes_AF_EAS=0.87372088;gnomad_exomes_AC=206387;gnomad_exomes_Hom=85692;gnomad_exomes_Het=35003;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.57325352;gnomad_exomes_AF_NFE=0.81546579;gnomad_exomes_AF_AMR=0.92077719;gnomad_exomes_AF_SAS=0.83272347;NativeFreq_Het=0.2527;NativeFreq_Hom=0.7425;normalHetFrequency=0.2345;normalHetNum=91;normalHomFrequency=0.732;normalHomNum=284;patientHetFrequency=0.2244;patientHetNum=622;patientHomFrequency=0.7446;patientHomNum=2064;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2306;AF_2700_Hom=0.7513;AF_50_Het=0.2456;AF_50_Hom=0.7464;DANN_score=0.6216;GREP_score=-10.8;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GGCCCTCCCT.GGCCTGTGAC	GT:AD:DP:GQ:PL	1/1:1,185:186:99:6443,548,0
chr12	121437382	.	A	G	5351.77	PASS	AC=2;AF=1;AN=2;DP=167;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.05;SOR=1.004;HGVSnom=NM_000545.8:c.1720A>G(p.Ser574Gly/p.S574G);Gene=HNF1A;Transcript=NM_000545.8;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=631;EXAC_AF=0.99584849;EXAC_Hom_EAS=4269;EXAC_AC_EAS=8540;EXAC_AN_EAS=8542;EXAC_AC_Adj=116100;EXAC_AN_Adj=116584;ESP6500_MAF=0.98688676;RS=rs1169305;Ensembl_transcriptid=ENST00000257555|ENST00000543427|ENST00000615446|ENST00000541395|ENST00000544413;SIFT_pred=T|.|.|T|T;SIFT_score=0.779|.|.|0.826|0.841;Polyphen2_HVAR_pred=.|.|.|.|B;Polyphen2_HVAR_score=.|.|.|.|0.0;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|1|1|1;CLNGENE=HNF1A;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.985224;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9463;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9957;gnomad_exomes_AF=0.99646119;gnomad_exomes_AF_EAS=0.99983572;gnomad_exomes_AC=242441;gnomad_exomes_Hom=120811;gnomad_exomes_Het=819;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95160455;gnomad_exomes_AF_NFE=0.99980540;gnomad_exomes_AF_AMR=0.99764370;gnomad_exomes_AF_SAS=1.00000000;HGMD_gene=HNF1A;HGMD_disease=Diabetes_type_2_association_with;HGMD_tag=DFP;HGMD_pmid=10096793;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.7163;GREP_score=2.58;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GGACCCTGCC.GCATCCAGCA	GT:AD:DP:GQ:PL	1/1:0,167:167:99:5380,500,0
chr12	121438844	.	T	C	8017.77	PASS	AC=2;AF=1;AN=2;DP=211;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=36.02;SOR=1.565;HGVSnom=NM_000545.8:c.1769-24T>C|NM_022895.3:c.*3112A>G;Gene=HNF1A|C12orf43;Transcript=NM_000545.8|NM_022895.3;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I9|E6;IVSnom=NM_000545.8:IVS9-24T>C|.;AAlength=631|262;EXAC_AF=0.38840904;EXAC_Hom_EAS=1056;EXAC_AC_EAS=4274;EXAC_AN_EAS=8578;EXAC_AC_Adj=46498;EXAC_AN_Adj=119714;ESP6500_MAF=0.29201907;RS=rs735396;CLNGENE=C12orf43|HNF1A;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.360224;G1000_EAS_AF=0.4802;G1000_EUR_AF=0.3777;G1000_AFR_AF=0.1263;G1000_SAS_AF=0.5092;G1000_AMR_AF=0.3963;gnomad_exomes_AF=0.39152342;gnomad_exomes_AF_EAS=0.49236724;gnomad_exomes_AC=96664;gnomad_exomes_Hom=19950;gnomad_exomes_Het=56764;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13654345;gnomad_exomes_AF_NFE=0.36610328;gnomad_exomes_AF_AMR=0.40160084;gnomad_exomes_AF_SAS=0.52309001;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2574;normalHetFrequency=0.4613;normalHetNum=179;normalHomFrequency=0.2603;normalHomNum=101;patientHetFrequency=0.474;patientHetNum=1314;patientHomFrequency=0.2655;patientHomNum=736;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4869;AF_2700_Hom=0.2475;AF_50_Het=0.5008;AF_50_Hom=0.2409;DANN_score=0.7533;GREP_score=3.92;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GGTGGGTGGC.AGCAGCCTTG	GT:AD:DP:GQ:PL	1/1:0,210:210:99:8046,631,0
chr12	121439192	.	G	T	10978.8	PASS	AC=2;AF=1;AN=2;DP=320;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.31;SOR=0.77;HGVSnom=NM_000545.8:c.*197G>T|NM_022895.3:c.*2764C>A;Gene=HNF1A|C12orf43;Transcript=NM_000545.8|NM_022895.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E10|E6;AAlength=631|262;RS=rs1169309;CLNGENE=C12orf43|HNF1A;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.359824;G1000_EAS_AF=0.4802;G1000_EUR_AF=0.3767;G1000_AFR_AF=0.1263;G1000_SAS_AF=0.5082;G1000_AMR_AF=0.3963;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2574;normalHetFrequency=0.3763;normalHetNum=146;normalHomFrequency=0.2732;normalHomNum=106;patientHetFrequency=0.3882;patientHetNum=1076;patientHomFrequency=0.2857;patientHomNum=792;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4873;AF_2700_Hom=0.2475;AF_50_Het=0.5008;AF_50_Hom=0.2409;DANN_score=0.4897;GREP_score=-6.71;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GCTGCTCGGG.TGCACAGGAG	GT:AD:DP:GQ:PL	1/1:0,320:320:99:11007,957,0
chr12	121439433	.	G	A	9791.77	PASS	AC=2;AF=1;AN=2;DP=273;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.8;SOR=0.753;HGVSnom=NM_000545.8:c.*438G>A|NM_022895.3:c.*2523C>T;Gene=HNF1A|C12orf43;Transcript=NM_000545.8|NM_022895.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E10|E6;AAlength=631|262;RS=rs1169310;CLNGENE=C12orf43|HNF1A;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.360024;G1000_EAS_AF=0.4802;G1000_EUR_AF=0.3777;G1000_AFR_AF=0.1263;G1000_SAS_AF=0.5082;G1000_AMR_AF=0.3963;NativeFreq_Het=0.4752;NativeFreq_Hom=0.2574;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.0029;patientHetNum=8;patientHomFrequency=0.0032;patientHomNum=9;normalHetSampleInfo=[16D0166662][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0017885|16B0028106|16B3258414|16B0005266|16B3098020-1|16B0005640|16D1533010-1|15D6722469-1][_];patientHomSampleInfo=[16D0158756|16B0005351|16B3098002-1|16B0017249|15B6105813|16B0012038|15D6722232|15B0068086|16B0033119][_];AF_2700_Het=0.4869;AF_2700_Hom=0.2475;AF_50_Het=0.4992;AF_50_Hom=0.2425;DANN_score=0.5121;GREP_score=-5.87;CytoBand=q24.31;CGD_CONDITION=Renal cell carcinoma, nonpapillary clear cell. Liver adenomatosis. Maturity onset diabetes of the young, type III;CGD_INHERITANCE=AD;Strand=HNF1A:NM_000545.6:+,HNF1A:NM_001306179.1:+;NP=HNF1A:NM_000545.6:NP_000536.5,HNF1A:NM_001306179.1:NP_001293108.1;ENSP=HNF1A:NM_000545.6:ENST00000257555.10,HNF1A:NM_001306179.1:.;Gene_MIM_id=142410;Phenotypes=Diabetes mellitus, insulin-dependent, 20, 612520 (3). {Diabetes mellitus, insulin-dependent}, 222100 (3), Autosomal recessive. {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3), Autosomal dominant. Hepatic adenoma, somatic, 142330 (3). MODY, type III, 600496 (3), Autosomal dominant. Renal cell carcinoma, 144700 (3). 125853(SK),142330(MK),144700(MK),222100(SK),600496(MK),612520(MK);Possible_Inheritance=AD,AR;EntrezGeneID=6927;EnsemblGeneID=ENSG00000135100;Alias=HNF1A, TCF1, MODY3, IDDM20;FLKSEQ=GAGAGGCCCT.GATCAGCGTG	GT:AD:DP:GQ:PL	1/1:0,272:272:99:9820,817,0
chr12	133200748	.	T	C	10172.8	PASS	AC=2;AF=1;AN=2;DP=292;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.84;SOR=1.334;HGVSnom=NM_006231.4:c.*535A>G;Gene=POLE;Transcript=NM_006231.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E49;IVSnom=.;AAlength=2286;RS=rs14302;G1000_AF=0.716254;G1000_EAS_AF=0.7798;G1000_EUR_AF=0.5656;G1000_AFR_AF=0.8404;G1000_SAS_AF=0.6166;G1000_AMR_AF=0.7464;DANN_score=0.5277;GREP_score=-2.42;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=TCTGGATTCC.GGGGAAACCA	GT:AD:DP:GQ:PL	1/1:0,292:292:99:10201,877,0
chr12	133202215	.	G	A	10873.8	PASS	AC=2;AF=1;AN=2;DP=298;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.06;SOR=1.27;HGVSnom=NM_006231.4:c.6657+16C>T;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I47;IVSnom=NM_006231.4:IVS47+16C>T;AAlength=2286;EXAC_AF=0.37031548;EXAC_Hom_EAS=2122;EXAC_AC_EAS=6046;EXAC_AN_EAS=8630;EXAC_AC_Adj=44723;EXAC_AN_Adj=120770;ESP6500_MAF=0.32031370;RS=rs5745075;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.423323;G1000_EAS_AF=0.6657;G1000_EUR_AF=0.3052;G1000_AFR_AF=0.3555;G1000_SAS_AF=0.3712;G1000_AMR_AF=0.4452;gnomad_exomes_AF=0.37632816;gnomad_exomes_AF_EAS=0.69632169;gnomad_exomes_AC=94000;gnomad_exomes_Hom=19475;gnomad_exomes_Het=55050;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36536093;gnomad_exomes_AF_NFE=0.30425532;gnomad_exomes_AF_AMR=0.48912603;gnomad_exomes_AF_SAS=0.36839524;NativeFreq_Het=0.3737;NativeFreq_Hom=0.2989;DANN_score=0.4667;GREP_score=-5.1;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=ACGGGCAGGC.GCATGCACGA	GT:AD:DP:GQ:PL	1/1:0,297:297:99:10902,893,0
chr12	133208886	.	C	T	11410.8	PASS	AC=2;AF=1;AN=2;DP=321;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.39;SOR=1.595;HGVSnom=NM_006231.4:c.6330+15G>A;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I45;IVSnom=NM_006231.4:IVS45+15G>A;AAlength=2286;EXAC_AF=0.49405202;EXAC_Hom_EAS=2137;EXAC_AC_EAS=6067;EXAC_AN_EAS=8558;EXAC_AC_Adj=58808;EXAC_AN_Adj=119032;ESP6500_MAF=0.48031678;RS=rs5745023;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.565096;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4304;G1000_AFR_AF=0.6112;G1000_SAS_AF=0.5562;G1000_AMR_AF=0.5274;gnomad_exomes_AF=0.49359659;gnomad_exomes_AF_EAS=0.70448103;gnomad_exomes_AC=122871;gnomad_exomes_Hom=31412;gnomad_exomes_Het=60047;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.58393078;gnomad_exomes_AF_NFE=0.43020624;gnomad_exomes_AF_AMR=0.57105401;gnomad_exomes_AF_SAS=0.54825308;NativeFreq_Het=0.4342;NativeFreq_Hom=0.3523;DANN_score=0.4701;GREP_score=-4.65;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=CTCACACGCA.GCTGGCACTC	GT:AD:DP:GQ:PL	1/1:0,320:320:99:11439,960,0
chr12	133208979	.	T	C	12494.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.52;DP=369;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.05;ReadPosRankSum=-1.346;SOR=0.241;HGVSnom=NM_006231.4:c.6252A>G(p.Ser2084Ser/p.S2084S);Gene=POLE;Transcript=NM_006231.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E45;IVSnom=.;AAlength=2286;EXAC_AF=0.63814304;EXAC_Hom_EAS=2872;EXAC_AC_EAS=7030;EXAC_AN_EAS=8644;EXAC_AC_Adj=77431;EXAC_AN_Adj=121338;ESP6500_MAF=0.64270337;RS=rs5745022;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.699081;G1000_EAS_AF=0.7788;G1000_EUR_AF=0.5656;G1000_AFR_AF=0.7844;G1000_SAS_AF=0.6053;G1000_AMR_AF=0.7464;gnomad_exomes_AF=0.64363166;gnomad_exomes_AF_EAS=0.81348559;gnomad_exomes_AC=161809;gnomad_exomes_Hom=53311;gnomad_exomes_Het=55187;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76658462;gnomad_exomes_AF_NFE=0.58460429;gnomad_exomes_AF_AMR=0.79352414;gnomad_exomes_AF_SAS=0.61344483;NativeFreq_Het=0.3594;NativeFreq_Hom=0.5196;DANN_score=0.4073;GREP_score=-10.5;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=GAAACATCTC.GAGAGCTCAG	GT:AD:DP:GQ:PL	1/1:1,366:367:99:12523,1067,0
chr12	133210985	.	C	T	12486.8	PASS	AC=2;AF=1;AN=2;DP=356;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.55;SOR=1.024;HGVSnom=NM_006231.4:c.5812-21G>A;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I42;IVSnom=NM_006231.4:IVS42-21G>A;AAlength=2286;EXAC_AF=0.64478951;EXAC_Hom_EAS=2869;EXAC_AC_EAS=7027;EXAC_AN_EAS=8644;EXAC_AC_Adj=77318;EXAC_AN_Adj=119912;ESP6500_MAF=0.65654313;RS=rs5745005;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.713458;G1000_EAS_AF=0.7788;G1000_EUR_AF=0.5656;G1000_AFR_AF=0.8389;G1000_SAS_AF=0.6053;G1000_AMR_AF=0.7464;gnomad_exomes_AF=0.64863555;gnomad_exomes_AF_EAS=0.81362300;gnomad_exomes_AC=159205;gnomad_exomes_Hom=52922;gnomad_exomes_Het=53361;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.80903377;gnomad_exomes_AF_NFE=0.58519640;gnomad_exomes_AF_AMR=0.79614397;gnomad_exomes_AF_SAS=0.61495678;NativeFreq_Het=0.3523;NativeFreq_Hom=0.5338;DANN_score=0.6723;GREP_score=0.355;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=TGAGACAACG.GGCTGTGTTT	GT:AD:DP:GQ:PL	1/1:0,353:353:99:12515,1060,0
chr12	133214768	.	A	G	9673.77	PASS	AC=2;AF=1;AN=2;DP=274;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.61;SOR=1.887;HGVSnom=NM_006231.4:c.5553-43T>C;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I40;IVSnom=NM_006231.4:IVS40-43T>C;AAlength=2286;EXAC_AF=0.64779218;EXAC_Hom_EAS=2806;EXAC_AC_EAS=6885;EXAC_AN_EAS=8468;EXAC_AC_Adj=77577;EXAC_AN_Adj=119756;ESP6500_MAF=0.67476549;RS=rs5744970;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.729034;G1000_EAS_AF=0.7788;G1000_EUR_AF=0.5666;G1000_AFR_AF=0.8949;G1000_SAS_AF=0.6063;G1000_AMR_AF=0.7493;gnomad_exomes_AF=0.65200674;gnomad_exomes_AF_EAS=0.81483942;gnomad_exomes_AC=160082;gnomad_exomes_Hom=53516;gnomad_exomes_Het=53050;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.86163718;gnomad_exomes_AF_NFE=0.58586260;gnomad_exomes_AF_AMR=0.79972695;gnomad_exomes_AF_SAS=0.61515899;NativeFreq_Het=0.3381;NativeFreq_Hom=0.5445;DANN_score=0.1851;GREP_score=-6.48;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=CGCCACAGTC.TGGAGAGCCA	GT:AD:DP:GQ:PL	1/1:0,274:274:99:9702,823,0
chr12	133218724	.	C	T	7392.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.758;DP=199;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=25.06;ReadPosRankSum=-1.708;SOR=1.216;HGVSnom=NM_006231.4:c.5173+39G>A;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I38;IVSnom=NM_006231.4:IVS38+39G>A;AAlength=2286;EXAC_AF=0.49625445;EXAC_Hom_EAS=2133;EXAC_AC_EAS=6040;EXAC_AN_EAS=8528;EXAC_AC_Adj=54984;EXAC_AN_Adj=110798;ESP6500_MAF=0.50292173;RS=rs5744951;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.588658;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4304;G1000_AFR_AF=0.6997;G1000_SAS_AF=0.5562;G1000_AMR_AF=0.5288;gnomad_exomes_AF=0.50062815;gnomad_exomes_AF_EAS=0.70317109;gnomad_exomes_AC=92451;gnomad_exomes_Hom=24168;gnomad_exomes_Het=44115;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65797289;gnomad_exomes_AF_NFE=0.42876629;gnomad_exomes_AF_AMR=0.57298760;gnomad_exomes_AF_SAS=0.54548371;NativeFreq_Het=0.4448;NativeFreq_Hom=0.3630;DANN_score=0.7204;GREP_score=4.09;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=GCAGAAACAC.AGCCAGGTCT	GT:AD:DP:GQ:PL	1/1:1,198:199:99:7421,557,0
chr12	133219831	.	T	C	9590.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.313;DP=274;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=35.81;ReadPosRankSum=0.781;SOR=0.487;HGVSnom=NM_006231.4:c.4530A>G(p.Ala1510Ala/p.A1510A);Gene=POLE;Transcript=NM_006231.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E35;IVSnom=.;AAlength=2286;EXAC_AF=0.50320320;EXAC_Hom_EAS=2140;EXAC_AC_EAS=6065;EXAC_AN_EAS=8566;EXAC_AC_Adj=60324;EXAC_AN_Adj=119880;ESP6500_MAF=0.52237429;RS=rs5744944;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.605232;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4304;G1000_AFR_AF=0.761;G1000_SAS_AF=0.5562;G1000_AMR_AF=0.5317;gnomad_exomes_AF=0.50423564;gnomad_exomes_AF_EAS=0.70447598;gnomad_exomes_AC=124284;gnomad_exomes_Hom=32733;gnomad_exomes_Het=58818;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.71620776;gnomad_exomes_AF_NFE=0.43113440;gnomad_exomes_AF_AMR=0.57777391;gnomad_exomes_AF_SAS=0.54850648;NativeFreq_Het=0.4413;NativeFreq_Hom=0.3701;DANN_score=0.3383;GREP_score=-11.9;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=CAAAGACGGA.GCCCTGCGCT	GT:AD:DP:GQ:PL	1/1:1,272:273:99:9619,782,0
chr12	133233705	.	T	C	10937.8	PASS	AC=2;AF=1;AN=2;DP=303;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.59;SOR=1.379;HGVSnom=NM_006231.4:c.3582+17A>G;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I29;IVSnom=NM_006231.4:IVS29+17A>G;AAlength=2286;EXAC_AF=0.97117239;EXAC_Hom_EAS=4325;EXAC_AC_EAS=8652;EXAC_AN_EAS=8654;EXAC_AC_Adj=117844;EXAC_AN_Adj=121342;ESP6500_MAF=0.97293557;RS=rs5744889;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.983826;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9622;G1000_AFR_AF=0.9992;G1000_SAS_AF=0.9785;G1000_AMR_AF=0.9697;gnomad_exomes_AF=0.97135645;gnomad_exomes_AF_EAS=0.99989126;gnomad_exomes_AC=243962;gnomad_exomes_Hom=118511;gnomad_exomes_Het=6940;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99261720;gnomad_exomes_AF_NFE=0.96479431;gnomad_exomes_AF_AMR=0.97417433;gnomad_exomes_AF_SAS=0.96585860;NativeFreq_Het=0.0285;NativeFreq_Hom=0.9644;DANN_score=0.31;GREP_score=0.857;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=AGCCCAGCCT.GGGGCCCCAC	GT:AD:DP:GQ:PL	1/1:0,303:303:99:10966,910,0
chr12	133236000	.	C	T	13463.8	PASS	AC=2;AF=1;AN=2;DP=370;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.43;SOR=0.748;HGVSnom=NM_006231.4:c.3156G>A(p.Thr1052Thr/p.T1052T);Gene=POLE;Transcript=NM_006231.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E26;IVSnom=.;AAlength=2286;EXAC_AF=0.50285168;EXAC_Hom_EAS=2164;EXAC_AC_EAS=6120;EXAC_AN_EAS=8646;EXAC_AC_Adj=61012;EXAC_AN_Adj=121332;ESP6500_MAF=0.52245118;RS=rs5744857;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.605431;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4314;G1000_AFR_AF=0.7602;G1000_SAS_AF=0.5573;G1000_AMR_AF=0.5317;gnomad_exomes_AF=0.50336118;gnomad_exomes_AF_EAS=0.70481731;gnomad_exomes_AC=126545;gnomad_exomes_Hom=33325;gnomad_exomes_Het=59895;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.71600000;gnomad_exomes_AF_NFE=0.43125495;gnomad_exomes_AF_AMR=0.57754583;gnomad_exomes_AF_SAS=0.54824275;NativeFreq_Het=0.4413;NativeFreq_Hom=0.3701;DANN_score=0.4994;GREP_score=-11.7;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=TGCTGATGGA.GTAGACTTCT	GT:AD:DP:GQ:PL	1/1:0,370:370:99:13492,1111,0
chr12	133237753	.	GA	G	432.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.696;DP=241;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.99;ReadPosRankSum=-1.61;SOR=0.703;HGVSnom=NM_006231.4:c.2865-4delT;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I24;IVSnom=NM_006231.4:IVS24-4delT;AAlength=2286;EXAC_AF=0.45306919;EXAC_Hom_EAS=0;EXAC_AC_EAS=3403;EXAC_AN_EAS=7622;EXAC_AC_Adj=46677;EXAC_AN_Adj=103024;RS=rs369732588;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.38494326;gnomad_exomes_AF_EAS=0.35828811;gnomad_exomes_AC=41182;gnomad_exomes_Hom=18;gnomad_exomes_Het=41146;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36210877;gnomad_exomes_AF_NFE=0.39890864;gnomad_exomes_AF_AMR=0.40198008;gnomad_exomes_AF_SAS=0.36612681;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=CAGCATACCT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:163,54:217:99:470,0,3056
chr12	133238076	.	T	C	10446.8	PASS	AC=2;AF=1;AN=2;DP=296;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.57;SOR=2.452;HGVSnom=NM_006231.4:c.2864+37A>G;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I24;IVSnom=NM_006231.4:IVS24+37A>G;AAlength=2286;EXAC_AF=0.49554815;EXAC_Hom_EAS=2167;EXAC_AC_EAS=6122;EXAC_AN_EAS=8644;EXAC_AC_Adj=59775;EXAC_AN_Adj=120624;ESP6500_MAF=0.49269568;RS=rs5744844;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.577276;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4304;G1000_AFR_AF=0.6558;G1000_SAS_AF=0.5573;G1000_AMR_AF=0.5288;gnomad_exomes_AF=0.49688227;gnomad_exomes_AF_EAS=0.70432456;gnomad_exomes_AC=123514;gnomad_exomes_Hom=31920;gnomad_exomes_Het=59674;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62752712;gnomad_exomes_AF_NFE=0.43084917;gnomad_exomes_AF_AMR=0.57306204;gnomad_exomes_AF_SAS=0.54821949;NativeFreq_Het=0.4377;NativeFreq_Hom=0.3594;DANN_score=0.3832;GREP_score=-2.16;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=TCTCAATCCA.GTCCTTTCTA	GT:AD:DP:GQ:PL	1/1:0,296:296:99:10475,889,0
chr12	133240782	.	A	G	10621.8	PASS	AC=2;AF=1;AN=2;DP=298;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.92;QD=34.14;SOR=1.353;HGVSnom=NM_006231.4:c.2562-48T>C;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_006231.4:IVS22-48T>C;AAlength=2286;EXAC_AF=0.50482785;EXAC_Hom_EAS=2144;EXAC_AC_EAS=6070;EXAC_AN_EAS=8556;EXAC_AC_Adj=60439;EXAC_AN_Adj=119722;ESP6500_MAF=0.52260495;RS=rs4883592;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.605831;G1000_EAS_AF=0.6756;G1000_EUR_AF=0.4304;G1000_AFR_AF=0.7602;G1000_SAS_AF=0.5583;G1000_AMR_AF=0.5317;gnomad_exomes_AF=0.33196817;gnomad_exomes_AF_EAS=0.64331673;gnomad_exomes_AC=39961;gnomad_exomes_Hom=11046;gnomad_exomes_Het=17869;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64917582;gnomad_exomes_AF_NFE=0.24161015;gnomad_exomes_AF_AMR=0.41794296;gnomad_exomes_AF_SAS=0.31624154;NativeFreq_Het=0.4448;NativeFreq_Hom=0.3665;DANN_score=0.2013;GREP_score=0.0;CytoBand=q24.33;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=TTTCCTTTTC.CCCAGTGTGT	GT:AD:DP:GQ:PL	1/1:0,297:297:99:10650,892,0
chr12	133250118	.	C	T	8097.77	PASS	AC=2;AF=1;AN=2;DP=224;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=36.6;SOR=1.35;HGVSnom=NM_006231.4:c.1359+43G>A;Gene=POLE;Transcript=NM_006231.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_006231.4:IVS13+43G>A;AAlength=2286;EXAC_AF=0.49566488;EXAC_Hom_EAS=2138;EXAC_AC_EAS=6046;EXAC_AN_EAS=8516;EXAC_AC_Adj=59341;EXAC_AN_Adj=119720;ESP6500_MAF=0.49261652;RS=rs4883555;CLNGENE=POLE;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.576478;G1000_EAS_AF=0.6736;G1000_EUR_AF=0.4294;G1000_AFR_AF=0.6551;G1000_SAS_AF=0.5552;G1000_AMR_AF=0.5288;gnomad_exomes_AF=0.49958601;gnomad_exomes_AF_EAS=0.70546370;gnomad_exomes_AC=120675;gnomad_exomes_Hom=31304;gnomad_exomes_Het=58067;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62763568;gnomad_exomes_AF_NFE=0.43194675;gnomad_exomes_AF_AMR=0.57292091;gnomad_exomes_AF_SAS=0.54814522;NativeFreq_Het=0.4413;NativeFreq_Hom=0.3488;DANN_score=0.7315;GREP_score=-3.57;CytoBand=q24.33;simRepName=trf;simRepCopyNum=2;CGD_CONDITION=Colorectal cancer, susceptibility to, 12. Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome). Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (IMAGEI);CGD_INHERITANCE=AD/AR;Strand=POLE:NM_006231.3:-;NP=POLE:NM_006231.3:NP_006222.2;ENSP=POLE:NM_006231.3:ENST00000320574.9;Gene_MIM_id=174762;Phenotypes={Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant. FILS syndrome, 615139 (3), Autosomal recessive. 615083(SK),615139(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5426;EnsemblGeneID=ENSG00000177084;Alias=POLE1, CRCS12, FILS;FLKSEQ=CATCTGGATG.GTGCACACGG	GT:AD:DP:GQ:PL	1/1:0,224:224:99:8126,673,0
chr13	32889792	.	A	G	4411.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.513;DP=329;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.45;ReadPosRankSum=0.695;SOR=0.704;HGVSnom=NM_000059.4:c.-52A>G;Gene=BRCA2;Transcript=NM_000059.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=3418;RS=rs206118;CLNGENE=BRCA2|LOC106721785;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=reviewed_by_expert_panel|reviewed_by_expert_panel;G1000_AF=0.148562;G1000_EAS_AF=0.1696;G1000_EUR_AF=0.1928;G1000_AFR_AF=0.1188;G1000_SAS_AF=0.1258;G1000_AMR_AF=0.1427;NativeFreq_Het=0.2871;NativeFreq_Hom=0.0356;normalHetFrequency=0.3208;normalHetNum=153;normalHomFrequency=0.022;normalHomNum=19;patientHetFrequency=0.1416;patientHetNum=739;patientHomFrequency=0.04;patientHomNum=98;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3128;AF_2700_Hom=0.0407;AF_50_Het=0.2837;AF_50_Hom=0.0491;DANN_score=0.681;GREP_score=-0.729;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=AAAGAACTGC.CCTCTGGAGC	GT:AD:DP:GQ:PL	0/1:171,157:328:99:4440,0,5183
chr13	32903685	.	C	T	6085.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.931;DP=459;ExcessHet=3.0103;FS=0.603;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.29;ReadPosRankSum=-0.242;SOR=0.775;HGVSnom=NM_000059.4:c.681+56C>T;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000059.4:IVS8+56C>T;AAlength=3418;RS=rs2126042;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.185903;G1000_EAS_AF=0.0794;G1000_EUR_AF=0.1938;G1000_AFR_AF=0.2746;G1000_SAS_AF=0.1452;G1000_AMR_AF=0.2176;NativeFreq_Het=0.1667;NativeFreq_Hom=0.0049;normalHetFrequency=0.1792;normalHetNum=155;normalHomFrequency=0.0092;normalHomNum=8;patientHetFrequency=0.1801;patientHetNum=940;patientHomFrequency=0.0146;patientHomNum=76;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B3254577|16B0202632|15B0048119|16D0162397|16D1545859][16D0155916|16D0172283|15D6517286];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6331;GREP_score=-0.649;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=TTTGGAATGC.TTGTTAAATT	GT:AD:DP:GQ:PL	0/1:251,207:458:99:6114,0,8241
chr13	32905219	.	A	AT	335.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.899;DP=399;ExcessHet=3.0103;FS=4.166;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1;ReadPosRankSum=-1.01;SOR=1.167;HGVSnom=NM_000059.4:c.793+64dupT;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000059.4:IVS9+64_+65insT;AAlength=3418;EXAC_AF=0.08251294;EXAC_Hom_EAS=0;EXAC_AC_EAS=69;EXAC_AN_EAS=1432;EXAC_AC_Adj=2263;EXAC_AN_Adj=27426;ESP6500_MAF=0.07705892;RS=rs751977993;gnomad_exomes_AF=0.11767215;gnomad_exomes_AF_EAS=0.12011616;gnomad_exomes_AC=6620;gnomad_exomes_Hom=0;gnomad_exomes_Het=6620;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10933403;gnomad_exomes_AF_NFE=0.10515196;gnomad_exomes_AF_AMR=0.14265205;gnomad_exomes_AF_SAS=0.14237343;NativeFreq_Het=0.0029;NativeFreq_Hom=.;normalHetFrequency=0.1283;normalHetNum=111;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1113;patientHetNum=581;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=TGTTGTTTTG.tttttttttt	GT:AD:DP:GQ:PL	0/1:283,54:337:99:373,0,5775
chr13	32905265	.	G	A	9312.77	StandardFilter	AC=2;AF=1;AN=2;DP=239;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.67;SOR=5.723;HGVSnom=NM_000059.4:c.793+98G>A;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_000059.4:IVS9+98G>A;AAlength=3418;RS=rs206073;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.974042;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.9039;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;NativeFreq_Het=0.0142;NativeFreq_Hom=0.9887;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9988;normalHomNum=864;patientHetFrequency=0.0011;patientHetNum=6;patientHomFrequency=0.9939;patientHomNum=5188;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722244|15D6722289|16D0177686|16D1536899|15D6722300-1][15D6482169-3];patientHomSampleInfo=[_][_];DANN_score=0.6635;GREP_score=-0.916;CytoBand=q13.1;repName=AluSx;repClass=SINE;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=ccgtgatctc.gtttaccgca	GT:AD:DP:GQ:PL	1/1:0,238:238:99:9341,716,0
chr13	32907535	.	CT	C	517.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.321;DP=717;ExcessHet=3.0103;FS=2.596;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.76;ReadPosRankSum=-1.368;SOR=0.88;HGVSnom=NM_000059.4:c.1909+22delT;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000059.4:IVS10+22delT;AAlength=3418;EXAC_AF=0.17590708;EXAC_Hom_EAS=0;EXAC_AC_EAS=796;EXAC_AN_EAS=4866;EXAC_AC_Adj=12101;EXAC_AN_Adj=68792;ESP6500_MAF=0.08137365;RS=rs276174816;CLNGENE=BRCA2;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.11330872;gnomad_exomes_AF_EAS=0.11056999;gnomad_exomes_AC=9023;gnomad_exomes_Hom=0;gnomad_exomes_Het=9023;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08514160;gnomad_exomes_AF_NFE=0.11610065;gnomad_exomes_AF_AMR=0.14445710;gnomad_exomes_AF_SAS=0.13123186;NativeFreq_Het=0.0087;NativeFreq_Hom=.;normalHetFrequency=0.0289;normalHetNum=25;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0238;patientHetNum=124;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0085;AF_2700_Hom=.;AF_50_Het=0.0032;AF_50_Hom=.;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=GTACCTCTGT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:584,100:684:99:555,0,13019
chr13	32910328	.	T	C	7227.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.138;DP=460;ExcessHet=3.0103;FS=0.606;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.78;ReadPosRankSum=0.431;SOR=0.765;HGVSnom=NM_000059.4:c.1910-74T>C;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000059.4:IVS10-74T>C;AAlength=3418;RS=rs2320236;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.174521;G1000_EAS_AF=0.0804;G1000_EUR_AF=0.1948;G1000_AFR_AF=0.2307;G1000_SAS_AF=0.1462;G1000_AMR_AF=0.2147;NativeFreq_Het=0.1667;NativeFreq_Hom=0.0049;normalHetFrequency=0.1792;normalHetNum=155;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.1805;patientHetNum=942;patientHomFrequency=0.0151;patientHomNum=79;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8015;GREP_score=4.02;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=ACTACCTTTT.AACTTAGTGA	GT:AD:DP:GQ:PL	0/1:227,231:458:99:7256,0,6987
chr13	32912299	.	T	C	11384.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.418;DP=766;ExcessHet=3.0103;FS=5.007;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.88;ReadPosRankSum=1.452;SOR=0.425;HGVSnom=NM_000059.4:c.3807T>C(p.Val1269Val/p.V1269V);Gene=BRCA2;Transcript=NM_000059.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E11;IVSnom=.;AAlength=3418;EXAC_AF=0.18984467;EXAC_Hom_EAS=108;EXAC_AC_EAS=1419;EXAC_AN_EAS=7918;EXAC_AC_Adj=20900;EXAC_AN_Adj=110090;ESP6500_MAF=0.19110632;RS=rs543304;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.168131;G1000_EAS_AF=0.1726;G1000_EUR_AF=0.1998;G1000_AFR_AF=0.1846;G1000_SAS_AF=0.1196;G1000_AMR_AF=0.1527;gnomad_exomes_AF=0.17460256;gnomad_exomes_AF_EAS=0.16712049;gnomad_exomes_AC=40549;gnomad_exomes_Hom=3594;gnomad_exomes_Het=33361;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18846403;gnomad_exomes_AF_NFE=0.19201464;gnomad_exomes_AF_AMR=0.17544498;gnomad_exomes_AF_SAS=0.10117358;NativeFreq_Het=0.3366;NativeFreq_Hom=0.0198;normalHetFrequency=0.2925;normalHetNum=253;normalHomFrequency=0.0324;normalHomNum=28;patientHetFrequency=0.2828;patientHetNum=1476;patientHomFrequency=0.0349;patientHomNum=182;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3071;AF_2700_Hom=0.0319;AF_50_Het=0.3043;AF_50_Hom=0.0269;DANN_score=0.468;GREP_score=1.59;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=ATGATTCTGT.GTTTCAATGT	GT:AD:DP:GQ:PL	0/1:377,388:765:99:11413,0,11818
chr13	32912868	.	A	G	11093.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.459;DP=722;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.43;ReadPosRankSum=-0.147;SOR=0.707;HGVSnom=NM_000059.4:c.4376A>G(p.Asn1459Ser/p.N1459S);Gene=BRCA2;Transcript=NM_000059.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=3418;EXAC_AF=0.00002518;EXAC_Hom_EAS=0;EXAC_AC_EAS=3;EXAC_AN_EAS=8616;EXAC_AC_Adj=3;EXAC_AN_Adj=119152;RS=rs117187202;Ensembl_transcriptid=ENST00000380152|ENST00000544455;SIFT_pred=T|T;SIFT_score=0.275|0.275;Polyphen2_HVAR_pred=.|.;Polyphen2_HVAR_score=.|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=BRCA2;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;G1000_AF=0.00019968;G1000_EAS_AF=0.001;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00004080;gnomad_exomes_AF_EAS=0.00054705;gnomad_exomes_AC=10;gnomad_exomes_Hom=0;gnomad_exomes_Het=10;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;HGMD_gene=BRCA2;HGMD_disease=Ovarian_cancer;HGMD_tag=DM?;HGMD_pmid=27907908;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.001;patientHetNum=5;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16B0228550][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B3094001|16B0033060][16D1878074|16B3094616|16B0005820];patientHomSampleInfo=[_][_];AF_2700_Het=0.0012;AF_2700_Hom=0.0000;AF_50_Het=0.0016;AF_50_Hom=0.0000;DANN_score=0.8164;GREP_score=-5.73;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=GAATTGCATA.CTTTTCCTTA	GT:AD:DP:GQ:PL	0/1:368,351:719:99:11122,0,10957
chr13	32913055	.	A	G	23935.8	PASS	AC=2;AF=1;AN=2;DP=636;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.77;SOR=0.745;HGVSnom=NM_000059.4:c.4563A>G(p.Leu1521Leu/p.L1521L);Gene=BRCA2;Transcript=NM_000059.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E11;IVSnom=.;AAlength=3418;EXAC_AF=0.99313789;EXAC_Hom_EAS=4325;EXAC_AC_EAS=8651;EXAC_AN_EAS=8652;EXAC_AC_Adj=120124;EXAC_AN_Adj=120954;ESP6500_MAF=0.97577296;RS=rs206075;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.974042;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.9039;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;gnomad_exomes_AF=0.99435912;gnomad_exomes_AF_EAS=0.99994562;gnomad_exomes_AC=249256;gnomad_exomes_Hom=123962;gnomad_exomes_Het=1332;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.92568739;gnomad_exomes_AF_NFE=0.99962901;gnomad_exomes_AF_AMR=0.99574382;gnomad_exomes_AF_SAS=0.99990192;NativeFreq_Het=0.0142;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=1.0;normalHomNum=865;patientHetFrequency=0.0011;patientHetNum=6;patientHomFrequency=0.9954;patientHomNum=5196;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722244|15D6722289|16D1536899|16D1533036-1|15D6722300-1][15D6482169-3];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9992;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.4723;GREP_score=3.75;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=AACCTACTCT.TTGGGTTTTC	GT:AD:DP:GQ:PL	1/1:0,632:632:99:23964,1899,0
chr13	32915005	.	G	C	32026.8	PASS	AC=2;AF=1;AN=2;DP=843;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.7;SOR=0.879;HGVSnom=NM_000059.4:c.6513G>C(p.Val2171Val/p.V2171V);Gene=BRCA2;Transcript=NM_000059.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E11;IVSnom=.;AAlength=3418;EXAC_AF=0.99303225;EXAC_Hom_EAS=4320;EXAC_AC_EAS=8641;EXAC_AN_EAS=8642;EXAC_AC_Adj=120143;EXAC_AN_Adj=120986;ESP6500_MAF=0.97547286;RS=rs206076;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.973642;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.9024;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;gnomad_exomes_AF=0.99419857;gnomad_exomes_AF_EAS=0.99994339;gnomad_exomes_AC=238206;gnomad_exomes_Hom=118448;gnomad_exomes_Het=1310;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.92532509;gnomad_exomes_AF_NFE=0.99961964;gnomad_exomes_AF_AMR=0.99563788;gnomad_exomes_AF_SAS=0.99989077;NativeFreq_Het=0.0142;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9988;normalHomNum=864;patientHetFrequency=0.0011;patientHetNum=6;patientHomFrequency=0.9946;patientHomNum=5192;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722244|15D6722289|16D1536899|16D1533036-1|15D6722300-1][15D6482169-3];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.5855;GREP_score=-4.63;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=GAACCAAAGT.TCACTTGTTG	GT:AD:DP:GQ:PL	1/1:0,842:842:99:32055,2531,0
chr13	32929387	.	T	C	26039.8	PASS	AC=2;AF=1;AN=2;DP=668;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.06;SOR=0.758;HGVSnom=NM_000059.4:c.7397T>C(p.Val2466Ala/p.V2466A);Gene=BRCA2;Transcript=NM_000059.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E14;IVSnom=.;AAlength=3418;EXAC_AF=0.99371826;EXAC_Hom_EAS=4324;EXAC_AC_EAS=8649;EXAC_AN_EAS=8650;EXAC_AC_Adj=120542;EXAC_AN_Adj=121304;ESP6500_MAF=0.97769574;RS=rs169547;Ensembl_transcriptid=ENST00000380152|ENST00000544455;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=.|.;Polyphen2_HVAR_score=.|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.975839;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.9107;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9971;gnomad_exomes_AF=0.99487594;gnomad_exomes_AF_EAS=0.99994560;gnomad_exomes_AC=249881;gnomad_exomes_Hom=124333;gnomad_exomes_Het=1215;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93258219;gnomad_exomes_AF_NFE=0.99970938;gnomad_exomes_AF_AMR=0.99597801;gnomad_exomes_AF_SAS=0.99990194;HGMD_gene=BRCA2;HGMD_disease=Breast_cancer;HGMD_tag=DM?;HGMD_pmid=8665505;NativeFreq_Het=0.0142;NativeFreq_Hom=1;DANN_score=0.1694;GREP_score=5.07;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=AATCAAGCAG.AGCTGTAACT	GT:AD:DP:GQ:PL	1/1:0,665:665:99:26068,1999,0
chr13	32936646	.	T	C	12136.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.58;DP=727;ExcessHet=3.0103;FS=2.447;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.86;ReadPosRankSum=0.685;SOR=0.871;HGVSnom=NM_000059.4:c.7806-14T>C;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_000059.4:IVS16-14T>C;AAlength=3418;EXAC_AF=0.52082850;EXAC_Hom_EAS=1345;EXAC_AC_EAS=4781;EXAC_AN_EAS=8624;EXAC_AC_Adj=62864;EXAC_AN_Adj=120700;ESP6500_MAF=0.52015075;RS=rs9534262;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.53155;G1000_EAS_AF=0.5337;G1000_EUR_AF=0.5179;G1000_AFR_AF=0.584;G1000_SAS_AF=0.4673;G1000_AMR_AF=0.5389;gnomad_exomes_AF=0.52287114;gnomad_exomes_AF_EAS=0.55807751;gnomad_exomes_AC=130837;gnomad_exomes_Hom=34584;gnomad_exomes_Het=61669;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.56951635;gnomad_exomes_AF_NFE=0.51745799;gnomad_exomes_AF_AMR=0.51372208;gnomad_exomes_AF_SAS=0.48924485;HGMD_gene=BRCA2;HGMD_disease=Alternative_splicing;HGMD_tag=FP;HGMD_pmid=24123850;NativeFreq_Het=0.5742;NativeFreq_Hom=0.2816;normalHetFrequency=0.4659;normalHetNum=403;normalHomFrequency=0.289;normalHomNum=250;patientHetFrequency=0.4839;patientHetNum=2526;patientHomFrequency=0.2814;patientHomNum=1469;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4965;AF_2700_Hom=0.2775;AF_50_Het=0.5277;AF_50_Hom=0.2694;DANN_score=0.8121;GREP_score=-1.21;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=AATATTCTAC.TTTATTTGTT	GT:AD:DP:GQ:PL	0/1:344,376:720:99:12165,0,10579
chr13	32953388	.	T	C	4627.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.038;DP=314;ExcessHet=3.0103;FS=3.7;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.79;ReadPosRankSum=-0.416;SOR=0.492;HGVSnom=NM_000059.4:c.8755-66T>C;Gene=BRCA2;Transcript=NM_000059.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I21;IVSnom=NM_000059.4:IVS21-66T>C;AAlength=3418;RS=rs4942486;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.511581;G1000_EAS_AF=0.5327;G1000_EUR_AF=0.5159;G1000_AFR_AF=0.5113;G1000_SAS_AF=0.4683;G1000_AMR_AF=0.536;NativeFreq_Het=0.5742;NativeFreq_Hom=0.2816;normalHetFrequency=0.4636;normalHetNum=401;normalHomFrequency=0.2913;normalHomNum=252;patientHetFrequency=0.4793;patientHetNum=2502;patientHomFrequency=0.2826;patientHomNum=1475;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4662;GREP_score=-1.52;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=TAAAGCCATC.AGTTACAATA	GT:AD:DP:GQ:PL	0/1:168,145:313:99:4656,0,5334
chr13	32973012	.	A	C	10797.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.424;DP=695;ExcessHet=3.0103;FS=2.429;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.74;ReadPosRankSum=-0.387;SOR=0.737;HGVSnom=NM_000059.4:c.*105A>C;Gene=BRCA2;Transcript=NM_000059.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=3418;RS=rs15869;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.160743;G1000_EAS_AF=0.248;G1000_EUR_AF=0.2356;G1000_AFR_AF=0.0113;G1000_SAS_AF=0.2413;G1000_AMR_AF=0.0965;NativeFreq_Het=0.4059;NativeFreq_Hom=0.0615;normalHetFrequency=0.3353;normalHetNum=290;normalHomFrequency=0.0543;normalHomNum=47;patientHetFrequency=0.3295;patientHetNum=1720;patientHomFrequency=0.0559;patientHomNum=292;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3751;AF_2700_Hom=0.0523;AF_50_Het=0.3550;AF_50_Hom=0.0460;DANN_score=0.4286;GREP_score=-0.447;CytoBand=q13.1;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=GCACAATGAG.AAAGAAATTA	GT:AD:DP:GQ:PL	0/1:353,333:686:99:10826,0,10871
chr13	32973276	.	A	G	7955.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.216;DP=527;ExcessHet=3.0103;FS=1.108;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.18;ReadPosRankSum=0.551;SOR=0.787;HGVSnom=NM_000059.4:c.*369A>G;Gene=BRCA2;Transcript=NM_000059.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=3418;RS=rs7334543;CLNGENE=BRCA2;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.222045;G1000_EAS_AF=0.0714;G1000_EUR_AF=0.2744;G1000_AFR_AF=0.3177;G1000_SAS_AF=0.1748;G1000_AMR_AF=0.2493;NativeFreq_Het=0.1505;NativeFreq_Hom=0.0049;normalHetFrequency=0.1761;normalHetNum=84;normalHomFrequency=0.0084;normalHomNum=4;patientHetFrequency=0.0795;patientHetNum=415;patientHomFrequency=0.0077;patientHomNum=40;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][14B0718594-A|15D6518729|16D0155916|16D0172283];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545784|16D0172139|16B0024722|16B0011941][16D1545783|16D0168614|15D6482473-1|16B0012067|15D6515515|16B0001945|16D0162246|15D6482414-1|16D0161380|16D0177745|16D0155338|17B0005761|16B3094610|16D1546019|16D0153180|15B6215377|16D0166212|16D1546069|15D6482430|16D0155889|15D6534318-1|15B0002868|15B6217429-1|16B0019057-1|15D6522062|16D0155239|15D6482122-1|16D0166612|15D6535761|15D6722323|16B0033899|15B0022286|15B0064766|15D6511749-1|15D0062168|15D6482481];AF_2700_Het=0.1364;AF_2700_Hom=0.0042;AF_50_Het=0.1220;AF_50_Hom=0.0032;DANN_score=0.9007;GREP_score=0.225;CytoBand=q13.1;repName=AluJr;repClass=SINE;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Pancreatic cancer, susceptibility to, 2. Glioma susceptibility 3. Fanconi anemia, complementation group D1. Wilms tumor. Medulloblastoma;CGD_INHERITANCE=AD/AR;Strand=BRCA2:NM_000059.3:+;NP=BRCA2:NM_000059.3:NP_000050.2;ENSP=BRCA2:NM_000059.3:ENST00000544455.5;Gene_MIM_id=600185;Phenotypes={Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant. {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant. Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive. {Glioblastoma 3}, 613029 (3), Autosomal recessive. {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant. {Pancreatic cancer 2}, 613347 (3). {Prostate cancer}, 176807 (3), Autosomal dominant. Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation. 114480(SK),155255(SK),176807(SK),194070(MK),605724(MK),612555(SK),613029(SK),613347(SK);Possible_Inheritance=AD,AR;EntrezGeneID=675;EnsemblGeneID=ENSG00000139618;Alias=BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;FLKSEQ=ccatctttac.aagaaaaaaa	GT:AD:DP:GQ:PL	0/1:247,277:524:99:7984,0,7956
chr13	48878271	.	T	C	2030.77	StandardFilter	AC=2;AF=1;AN=2;DP=54;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=21.33;SOR=3.912;HGVSnom=NM_000321.3:c.137+86T>C;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000321.3:IVS1+86T>C;AAlength=928;RS=rs2854351;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.991014;G1000_EAS_AF=0.999;G1000_EUR_AF=0.998;G1000_AFR_AF=0.9773;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9827;NativeFreq_Het=0;NativeFreq_Hom=0.0309;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.0393;normalHomNum=34;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0448;patientHomNum=234;normalHetSampleInfo=[_][15D6129378];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5128;GREP_score=1.88;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TCGGCGGGGA.CCGTCCTCGC	GT:AD:DP:GQ:PL	1/1:0,54:54:99:2059,162,0
chr13	48881617	.	T	C	4086.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.547;DP=245;ExcessHet=3.0103;FS=2.262;MLEAC=1;MLEAF=0.5;MQ=59.91;MQRankSum=0;QD=16.75;ReadPosRankSum=-0.484;SOR=0.448;HGVSnom=NM_000321.3:c.264+75T>C;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000321.3:IVS2+75T>C;AAlength=928;RS=rs3092865;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0605032;G1000_EAS_AF=0.0069;G1000_EUR_AF=0.003;G1000_AFR_AF=0.2073;G1000_SAS_AF=0.0041;G1000_AMR_AF=0.0216;NativeFreq_Het=0.0309;NativeFreq_Hom=0.0107;normalHetFrequency=0.0208;normalHetNum=18;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.0169;patientHetNum=88;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16D0067114];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B6217411|15B0040440|15B6215174];DANN_score=0.7261;GREP_score=2.31;CytoBand=q14.2;repName=L1ME4a;repClass=LINE;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=tatacaaaaa.tgaaagatag	GT:AD:DP:GQ:PL	0/1:123,121:244:99:4115,0,4169
chr13	48919358	.	T	G	22313.8	PASS	AC=2;AF=1;AN=2;DP=599;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.67;SOR=1.063;HGVSnom=NM_000321.3:c.500+23T>G;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000321.3:IVS4+23T>G;AAlength=928;EXAC_AF=0.96074629;EXAC_Hom_EAS=4304;EXAC_AC_EAS=8629;EXAC_AN_EAS=8652;EXAC_AC_Adj=116429;EXAC_AN_Adj=121186;ESP6500_MAF=0.92831845;RS=rs198617;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.913738;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9851;G1000_AFR_AF=0.7564;G1000_SAS_AF=0.9315;G1000_AMR_AF=0.9625;gnomad_exomes_AF=0.96252624;gnomad_exomes_AF_EAS=0.99668334;gnomad_exomes_AC=239336;gnomad_exomes_Hom=115463;gnomad_exomes_Het=8410;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.81781701;gnomad_exomes_AF_NFE=0.98470370;gnomad_exomes_AF_AMR=0.95487218;gnomad_exomes_AF_SAS=0.93203979;NativeFreq_Het=0.0534;NativeFreq_Hom=1;normalHetFrequency=0.0393;normalHetNum=34;normalHomFrequency=0.9561;normalHomNum=827;patientHetFrequency=0.0318;patientHetNum=166;patientHomFrequency=0.9584;patientHomNum=5003;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0042;AF_2700_Hom=0.9946;AF_50_Het=0.0032;AF_50_Hom=0.9952;DANN_score=0.5629;GREP_score=-7.3;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TTTTATTAGG.TTACACTCTG	GT:AD:DP:GQ:PL	1/1:0,597:597:99:22342,1794,0
chr13	48921884	.	A	G	11106.8	StandardFilter	AC=2;AF=1;AN=2;DP=283;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.46;SOR=4.206;HGVSnom=NM_000321.3:c.501-77A>G;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000321.3:IVS4-77A>G;AAlength=928;ESP6500_MAF=0.92237948;RS=rs198616;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.903355;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9851;G1000_AFR_AF=0.7179;G1000_SAS_AF=0.9315;G1000_AMR_AF=0.9611;NativeFreq_Het=0.0605;NativeFreq_Hom=1;normalHetFrequency=0.0405;normalHetNum=35;normalHomFrequency=0.9468;normalHomNum=819;patientHetFrequency=0.032;patientHetNum=167;patientHomFrequency=0.9504;patientHomNum=4961;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6686;GREP_score=-4.5;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=AAAAGAAGAT.AATAAAGCAT	GT:AD:DP:GQ:PL	1/1:0,281:281:99:11135,844,0
chr13	48923061	.	G	GT	6149.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.149;DP=622;ExcessHet=3.0103;FS=1.111;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.14;ReadPosRankSum=0.794;SOR=0.592;HGVSnom=NM_000321.3:c.540-23dupT;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_000321.3:IVS5-23_-22insT;AAlength=928;EXAC_AF=0.00157358;EXAC_Hom_EAS=1;EXAC_AC_EAS=111;EXAC_AN_EAS=8232;EXAC_AC_Adj=182;EXAC_AN_Adj=115660;ESP6500_MAF=0.00233607;RS=rs3092860;G1000_AF=0.00199681;G1000_EAS_AF=0.006;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0041;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00141716;gnomad_exomes_AF_EAS=0.01198944;gnomad_exomes_AC=334;gnomad_exomes_Hom=3;gnomad_exomes_Het=328;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00098180;gnomad_exomes_AF_NFE=0.00011118;gnomad_exomes_AF_AMR=0.00003100;gnomad_exomes_AF_SAS=0.00282545;NativeFreq_Het=0.0166;NativeFreq_Hom=.;normalHetFrequency=0.0173;normalHetNum=15;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0142;patientHetNum=74;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B6215174];CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=CATTTTTCCT.TTTTTTTTCT	GT:AD:DP:GQ:PL	0/1:267,285:552:99:6187,0,6251
chr13	48942814	.	C	T	3419.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=9.941;DP=206;ExcessHet=3.0103;FS=9.488;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=-0.961;QD=16.76;ReadPosRankSum=-0.146;SOR=3.001;HGVSnom=NM_000321.3:c.1127+74C>T;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000321.3:IVS11+74C>T;AAlength=928;RS=rs3092888;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.10603;G1000_EAS_AF=0.1091;G1000_EUR_AF=0.0119;G1000_AFR_AF=0.2542;G1000_SAS_AF=0.0542;G1000_AMR_AF=0.0288;NativeFreq_Het=0.2593;NativeFreq_Hom=0.0216;normalHetFrequency=0.163;normalHetNum=141;normalHomFrequency=0.0173;normalHomNum=15;patientHetFrequency=0.172;patientHetNum=898;patientHomFrequency=0.0109;patientHomNum=57;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5571;GREP_score=-1.49;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=GATTTGTTCA.GTTTCTTTAT	GT:AD:DP:GQ:PL	0/1:99,105:204:99:3448,0,2708
chr13	48947469	.	G	T	13165.8	StandardFilter	AC=2;AF=1;AN=2;DP=339;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.76;SOR=3.285;HGVSnom=NM_000321.3:c.1128-72G>T;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_000321.3:IVS11-72G>T;AAlength=928;RS=rs185587;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.914337;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9771;G1000_AFR_AF=0.7534;G1000_SAS_AF=0.9509;G1000_AMR_AF=0.9568;NativeFreq_Het=0.0463;NativeFreq_Hom=1;normalHetFrequency=0.037;normalHetNum=32;normalHomFrequency=0.9399;normalHomNum=813;patientHetFrequency=0.0297;patientHetNum=155;patientHomFrequency=0.9441;patientHomNum=4928;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.549;GREP_score=4.36;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=CTTGGGAGAT.GAAAACATTT	GT:AD:DP:GQ:PL	1/1:0,338:338:99:13194,1017,0
chr13	48953655	.	C	CA	2392.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.102;DP=214;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.08;ReadPosRankSum=1.217;SOR=0.902;HGVSnom=NM_000321.3:c.1333-61dupA;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_000321.3:IVS13-61_-60insA;AAlength=928;RS=rs11449461;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.72524;G1000_EAS_AF=0.752;G1000_EUR_AF=0.7485;G1000_AFR_AF=0.6982;G1000_SAS_AF=0.7014;G1000_AMR_AF=0.7378;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=0.1746;normalHetNum=151;normalHomFrequency=0.8092;normalHomNum=700;patientHetFrequency=0.1736;patientHetNum=906;patientHomFrequency=0.8056;patientHomNum=4205;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q14.2;repName=FLAM_C;repClass=SINE;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=gactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:40,143:183:99:2430,0,426
chr13	48954159	.	CT	C	264.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.778;DP=128;ExcessHet=3.0103;FS=1.019;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.21;ReadPosRankSum=-1.904;SOR=0.817;HGVSnom=NM_000321.3:c.1390-17delT;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_000321.3:IVS14-17delT;AAlength=928;EXAC_AF=0.40314484;EXAC_Hom_EAS=0;EXAC_AC_EAS=122;EXAC_AN_EAS=334;EXAC_AC_Adj=5461;EXAC_AN_Adj=13546;ESP6500_MAF=0.06133272;RS=rs753535084;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.36374478;gnomad_exomes_AF_EAS=0.33480353;gnomad_exomes_AC=15860;gnomad_exomes_Hom=0;gnomad_exomes_Het=15860;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24276062;gnomad_exomes_AF_NFE=0.36242935;gnomad_exomes_AF_AMR=0.35101404;gnomad_exomes_AF_SAS=0.42301566;NativeFreq_Het=0.0940;NativeFreq_Hom=.;normalHetFrequency=0.1838;normalHetNum=159;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.1966;patientHetNum=1026;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15D6518726];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16D0176682-1];AF_2700_Het=0.1660;AF_2700_Hom=.;AF_50_Het=0.1727;AF_50_Hom=.;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TAAACAACTT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:94,26:120:99:302,0,1957
chr13	48954282	.	CT	C	108.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.345;DP=302;ExcessHet=3.0103;FS=2.72;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.37;ReadPosRankSum=0.302;SOR=0.989;HGVSnom=NM_000321.3:c.1422-8delT;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I15;IVSnom=NM_000321.3:IVS15-8delT;AAlength=928;EXAC_AF=0.32558749;EXAC_Hom_EAS=0;EXAC_AC_EAS=353;EXAC_AN_EAS=964;EXAC_AC_Adj=7454;EXAC_AN_Adj=22894;ESP6500_MAF=0.16011144;RS=rs747048469;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.14301418;gnomad_exomes_AF_EAS=0.17036655;gnomad_exomes_AC=8066;gnomad_exomes_Hom=2;gnomad_exomes_Het=8062;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17042254;gnomad_exomes_AF_NFE=0.15200554;gnomad_exomes_AF_AMR=0.18538441;gnomad_exomes_AF_SAS=0.11185468;NativeFreq_Het=0.0198;NativeFreq_Hom=.;normalHetFrequency=0.0509;normalHetNum=44;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0385;patientHetNum=201;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0234;AF_2700_Hom=.;AF_50_Het=0.0190;AF_50_Hom=.;CytoBand=q14.2;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=attttataat.tttttttttt	GT:AD:DP:GQ:PL	0/1:255,38:293:99:146,0,5922
chr13	48955676	.	T	A	13623.8	PASS	AC=2;AF=1;AN=2;DP=367;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.88;SOR=2.283;HGVSnom=NM_000321.3:c.1695+97T>A;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_000321.3:IVS17+97T>A;AAlength=928;RS=rs2804086;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.907348;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9851;G1000_AFR_AF=0.7163;G1000_SAS_AF=0.954;G1000_AMR_AF=0.9611;NativeFreq_Het=0.0534;NativeFreq_Hom=0.9815;normalHetFrequency=0.037;normalHetNum=32;normalHomFrequency=0.9561;normalHomNum=827;patientHetFrequency=0.0303;patientHetNum=158;patientHomFrequency=0.9536;patientHomNum=4978;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7859;GREP_score=-0.118;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=CTCAAGAACA.ATAGGGAATT	GT:AD:DP:GQ:PL	1/1:0,363:363:99:13652,1090,0
chr13	49033747	.	G	A	4564.77	StandardFilter	AC=2;AF=1;AN=2;DP=121;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.58;SOR=6.736;HGVSnom=NM_000321.3:c.1961-77G>A;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_000321.3:IVS19-77G>A;AAlength=928;RS=rs198580;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.867212;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9761;G1000_AFR_AF=0.584;G1000_SAS_AF=0.9509;G1000_AMR_AF=0.9409;NativeFreq_Het=0.0783;NativeFreq_Hom=1;normalHetFrequency=0.0347;normalHetNum=30;normalHomFrequency=0.704;normalHomNum=609;patientHetFrequency=0.0322;patientHetNum=168;patientHomFrequency=0.787;patientHomNum=4108;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.386;GREP_score=1.17;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TAATTAGAGC.ATTTCATGAT	GT:AD:DP:GQ:PL	1/1:0,118:118:99:4593,359,0
chr13	49034022	.	A	ATTTCT	2160.73	PASS	AC=2;AF=1;AN=2;DP=71;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.74;SOR=4.343;HGVSnom=NM_000321.3:c.2106+55_2106+56insTCTTT;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000321.3:IVS20+55_+56insTCTTT;AAlength=928;RS=rs11405303;G1000_AF=0.0175719;G1000_EAS_AF=0.0169;G1000_EUR_AF=0.004;G1000_AFR_AF=0.0386;G1000_SAS_AF=0.0082;G1000_AMR_AF=0.0115;normalHetFrequency=0.0081;normalHetNum=7;normalHomFrequency=0.1017;normalHomNum=88;patientHetFrequency=0.0071;patientHetNum=37;patientHomFrequency=0.1383;patientHomNum=722;normalHetSampleInfo=[16D1546092|16D1546229][16B3108885|16B3097953-1|16D1878154|16D1878183|15D6526672];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0162245|16D1536875-1|16B3108623|16B0202562|17B0005674|16B3097986-1|16B0202535|16B3094835|16D1545662|17B2000167|15D6722276|15D6722274|16D0177685|16B3107996|16B3094893|16D0169547|16B0047311|17B0001074|16D1545867|16B3254783|16B0202349|16D1545870|16D1536869-1|17B0001592-1|17B0001584-1|16B3094886][16D0177832-1|15D6518702|17B0005696|16D1546220|16D1545886|16B3094272|16D1546245|16B3254516|16D1546002|16B3098169-1|16D1546008];patientHomSampleInfo=[_][_];CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TTGTTAACTG.ttctttcttt	GT:AD:DP:GQ:PL	1/1:0,66:66:99:2198,197,0
chr13	49051012	.	C	T	9990.77	PASS	AC=2;AF=1;AN=2;DP=281;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;QD=27.49;SOR=1.071;HGVSnom=NM_000321.3:c.2663+33C>T;Gene=RB1;Transcript=NM_000321.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I25;IVSnom=NM_000321.3:IVS25+33C>T;AAlength=928;EXAC_AF=0.95520739;EXAC_Hom_EAS=4305;EXAC_AC_EAS=8630;EXAC_AN_EAS=8652;EXAC_AC_Adj=115838;EXAC_AN_Adj=121270;ESP6500_MAF=0.89581732;RS=rs3020646;CLNGENE=RB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.884984;G1000_EAS_AF=0.998;G1000_EUR_AF=0.9851;G1000_AFR_AF=0.6346;G1000_SAS_AF=0.954;G1000_AMR_AF=0.9553;gnomad_exomes_AF=0.95843629;gnomad_exomes_AF_EAS=0.99695520;gnomad_exomes_AC=240487;gnomad_exomes_Hom=115844;gnomad_exomes_Het=8799;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.71666256;gnomad_exomes_AF_NFE=0.98455561;gnomad_exomes_AF_AMR=0.95009564;gnomad_exomes_AF_SAS=0.95583431;NativeFreq_Het=0.0712;NativeFreq_Hom=0.9907;normalHetFrequency=0.0312;normalHetNum=27;normalHomFrequency=0.7087;normalHomNum=613;patientHetFrequency=0.027;patientHetNum=141;patientHomFrequency=0.7929;patientHomNum=4139;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4614;GREP_score=-0.713;CytoBand=q14.2;CGD_CONDITION=Retinoblastoma;CGD_INHERITANCE=AD;Strand=RB1:NM_000321.2:+;NP=RB1:NM_000321.2:NP_000312.2;ENSP=RB1:NM_000321.2:ENST00000267163.5;Gene_MIM_id=614041;Phenotypes=Bladder cancer, somatic, 109800 (3). Osteosarcoma, somatic, 259500 (3). Retinoblastoma, 180200 (3), Autosomal dominant, Somatic mutation. Retinoblastoma, trilateral, 180200 (3), Autosomal dominant, Somatic mutation. Small cell cancer of the lung, somatic, 182280 (3). 109800(MK),180200(MK),182280(MK),259500(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5925;EnsemblGeneID=ENSG00000139687;Alias=RB1;FLKSEQ=TTCCAGTAGC.GAGATGGTCA	GT:AD:DP:GQ:PL	1/1:0,277:277:99:10019,832,0
chr13	103498198	.	A	G	10269.8	PASS	AC=2;AF=1;AN=2;DP=298;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.46;SOR=1.257;HGVSnom=NM_001204425.2:c.1450+6045A>G;Gene=BIVM-ERCC5;Transcript=NM_001204425.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_001204425.2:IVS9+6045A>G;AAlength=1640;RS=rs751402;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.688898;G1000_EAS_AF=0.6062;G1000_EUR_AF=0.8111;G1000_AFR_AF=0.6687;G1000_SAS_AF=0.6943;G1000_AMR_AF=0.6628;HGMD_gene=ERCC5;HGMD_disease=Oral_squamous_cell_carcinoma_increased_risk;HGMD_tag=DFP;HGMD_pmid=22981091;NativeFreq_Het=0.4653;NativeFreq_Hom=0.4105;normalHetFrequency=0.2382;normalHetNum=206;normalHomFrequency=0.2486;normalHomNum=215;patientHetFrequency=0.1992;patientHetNum=1040;patientHomFrequency=0.2163;patientHomNum=1129;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4539;AF_2700_Hom=0.4220;AF_50_Het=0.4754;AF_50_Hom=0.3914;DANN_score=0.3346;GREP_score=-4.26;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=CCCATTTTTC.TGGGTTTGCG	GT:AD:DP:GQ:PL	1/1:0,298:298:99:10298,895,0
chr13	103498375	.	T	C	5970.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.551;DP=433;ExcessHet=3.0103;FS=6.902;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.85;ReadPosRankSum=0.85;SOR=0.891;HGVSnom=NM_001204425.2:c.1451-6093T>C;Gene=BIVM-ERCC5;Transcript=NM_001204425.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_001204425.2:IVS9-6093T>C;AAlength=1640;RS=rs2296147;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.297923;G1000_EAS_AF=0.1845;G1000_EUR_AF=0.4771;G1000_AFR_AF=0.1513;G1000_SAS_AF=0.407;G1000_AMR_AF=0.3285;NativeFreq_Het=0.3267;NativeFreq_Hom=0.0693;normalHetFrequency=0.2416;normalHetNum=209;normalHomFrequency=0.0613;normalHomNum=53;patientHetFrequency=0.2059;patientHetNum=1075;patientHomFrequency=0.0506;patientHomNum=264;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3194;AF_2700_Hom=0.0392;AF_50_Het=0.2964;AF_50_Hom=0.0475;DANN_score=0.5457;GREP_score=-1.7;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TCTCTGGACC.GTCTTTCTTC	GT:AD:DP:GQ:PL	0/1:223,208:431:99:5999,0,6976
chr13	103504517	.	T	C	4215.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.459;DP=317;ExcessHet=3.0103;FS=1.848;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.3;ReadPosRankSum=1.178;SOR=0.79;HGVSnom=NM_001204425.2:c.1500T>C(p.His500His/p.H500H)|NM_000123.4:c.138T>C(p.His46His/p.H46H);Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Synonymous|Synonymous;MolecularConsequence=synonymous_variant|synonymous_variant;ExonIntron=E10|E2;AAlength=1640|1186;EXAC_AF=0.52909726;EXAC_Hom_EAS=317;EXAC_AC_EAS=2300;EXAC_AN_EAS=8646;EXAC_AC_Adj=64225;EXAC_AN_Adj=121386;ESP6500_MAF=0.61179456;RS=rs1047768;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.493011;G1000_EAS_AF=0.25;G1000_EUR_AF=0.5845;G1000_AFR_AF=0.6778;G1000_SAS_AF=0.4663;G1000_AMR_AF=0.3991;gnomad_exomes_AF=0.51972423;gnomad_exomes_AF_EAS=0.26392212;gnomad_exomes_AC=130641;gnomad_exomes_Hom=36398;gnomad_exomes_Het=57845;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.66154035;gnomad_exomes_AF_NFE=0.58965542;gnomad_exomes_AF_AMR=0.29484954;gnomad_exomes_AF_SAS=0.49833366;NativeFreq_Het=0.4012;NativeFreq_Hom=0.0926;normalHetFrequency=0.4243;normalHetNum=367;normalHomFrequency=0.148;normalHomNum=128;patientHetFrequency=0.4251;patientHetNum=2219;patientHomFrequency=0.133;patientHomNum=694;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4070;AF_2700_Hom=0.0703;AF_50_Het=0.3962;AF_50_Hom=0.0745;DANN_score=0.3342;GREP_score=-0.358;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=GGGATCGCCA.GGGAACTCAA	GT:AD:DP:GQ:PL	0/1:163,154:317:99:4244,0,4709
chr13	103514091	.	T	C	9991.77	StandardFilter	AC=2;AF=1;AN=2;DP=250;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.58;SOR=3.047;HGVSnom=NM_001204425.2:c.2242+27T>C|NM_000123.4:c.880+27T>C;Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|coding_transcript_intron_variant;ExonIntron=I15|I7;IVSnom=NM_001204425.2:IVS15+27T>C|NM_000123.4:IVS7+27T>C;AAlength=1640|1186;EXAC_AF=0.99946219;EXAC_Hom_EAS=4313;EXAC_AC_EAS=8626;EXAC_AN_EAS=8626;EXAC_AC_Adj=120795;EXAC_AN_Adj=120860;ESP6500_MAF=0.99769266;RS=rs7982448;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.998203;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9932;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99953995;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=249859;gnomad_exomes_Hom=124872;gnomad_exomes_Het=115;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99408135;gnomad_exomes_AF_NFE=1.00000000;gnomad_exomes_AF_AMR=0.99947714;gnomad_exomes_AF_SAS=0.99996722;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9988;normalHomNum=864;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.996;patientHomNum=5199;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.7549;GREP_score=0.487;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TTTATATATT.ACATTAAAAA	GT:AD:DP:GQ:PL	1/1:0,250:250:99:10020,752,0
chr13	103518769	.	T	C	10521.8	PASS	AC=2;AF=1;AN=2;DP=270;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.47;SOR=0.878;HGVSnom=NM_001204425.2:c.3681+38T>C|NM_000123.4:c.2319+38T>C;Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|coding_transcript_intron_variant;ExonIntron=I18|I10;IVSnom=NM_001204425.2:IVS18+38T>C|NM_000123.4:IVS10+38T>C;AAlength=1640|1186;EXAC_AF=0.99944801;EXAC_Hom_EAS=4326;EXAC_AC_EAS=8652;EXAC_AN_EAS=8652;EXAC_AC_Adj=121311;EXAC_AN_Adj=121378;ESP6500_MAF=0.99746271;RS=rs6491716;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.998203;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9932;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99952975;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=250814;gnomad_exomes_Hom=125348;gnomad_exomes_Het=118;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99397071;gnomad_exomes_AF_NFE=1.00000000;gnomad_exomes_AF_AMR=0.99947962;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=0.9938;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9977;normalHomNum=863;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.996;patientHomNum=5199;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6606;GREP_score=0.827;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TACCACCTTC.TCAGACCCCT	GT:AD:DP:GQ:PL	1/1:0,269:269:99:10550,809,0
chr13	103524762	.	C	T	5062.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.834;DP=375;ExcessHet=3.0103;FS=3.102;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.65;ReadPosRankSum=-0.02;SOR=0.87;HGVSnom=NM_001204425.2:c.4241+14C>T|NM_000123.4:c.2879+14C>T;Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|coding_transcript_intron_variant;ExonIntron=I21|I13;IVSnom=NM_001204425.2:IVS21+14C>T|NM_000123.4:IVS13+14C>T;AAlength=1640|1186;EXAC_AF=0.45129476;EXAC_Hom_EAS=173;EXAC_AC_EAS=1722;EXAC_AN_EAS=8246;EXAC_AC_Adj=53538;EXAC_AN_Adj=118632;ESP6500_MAF=0.43449177;RS=rs4150360;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.317093;G1000_EAS_AF=0.1895;G1000_EUR_AF=0.5268;G1000_AFR_AF=0.1778;G1000_SAS_AF=0.407;G1000_AMR_AF=0.3372;gnomad_exomes_AF=0.44326973;gnomad_exomes_AF_EAS=0.19908116;gnomad_exomes_AC=110813;gnomad_exomes_Hom=27148;gnomad_exomes_Het=56517;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22059369;gnomad_exomes_AF_NFE=0.54419870;gnomad_exomes_AF_AMR=0.25193280;gnomad_exomes_AF_SAS=0.44192449;NativeFreq_Het=0.3366;NativeFreq_Hom=0.0617;normalHetFrequency=0.3792;normalHetNum=328;normalHomFrequency=0.0936;normalHomNum=81;patientHetFrequency=0.3655;patientHetNum=1908;patientHomFrequency=0.09;patientHomNum=470;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3190;AF_2700_Hom=0.0423;AF_50_Het=0.2964;AF_50_Hom=0.0491;DANN_score=0.7825;GREP_score=2.79;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TCCTTTGCTT.TTAAAAGAGA	GT:AD:DP:GQ:PL	0/1:206,165:371:99:5091,0,6892
chr13	103527849	.	G	C	11595.8	PASS	AC=2;AF=1;AN=2;DP=334;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.82;SOR=0.774;HGVSnom=NM_001204425.2:c.4519G>C(p.Gly1507Arg/p.G1507R)|NM_000123.4:c.3157G>C(p.Gly1053Arg/p.G1053R);Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Missense|Missense;MolecularConsequence=missense_variant|missense_variant;ExonIntron=E23|E15;AAlength=1640|1186;EXAC_AF=0.99942314;EXAC_Hom_EAS=4326;EXAC_AC_EAS=8652;EXAC_AN_EAS=8652;EXAC_AC_Adj=121276;EXAC_AN_Adj=121346;ESP6500_MAF=0.99746271;RS=rs9514066;Ensembl_transcriptid=ENST00000639435|ENST00000639132|ENST00000602836|ENST00000355739|ENST00000375954;SIFT_pred=.|.|.|D|T;SIFT_score=.|.|.|0.039|0.148;Polyphen2_HVAR_pred=.|.|.|P|.;Polyphen2_HVAR_score=.|.|.|0.454|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.998203;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9932;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99950657;gnomad_exomes_AF_EAS=0.99994563;gnomad_exomes_AC=251178;gnomad_exomes_Hom=125527;gnomad_exomes_Het=124;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99396552;gnomad_exomes_AF_NFE=0.99996480;gnomad_exomes_AF_AMR=0.99947944;gnomad_exomes_AF_SAS=1.00000000;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.9962;GREP_score=4.28;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TAAGGCAAAA.GAAAAACCCA	GT:AD:DP:GQ:PL	1/1:0,333:333:99:11624,1000,0
chr13	103527930	.	G	C	12600.8	PASS	AC=2;AF=1;AN=2;DP=368;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.33;SOR=0.778;HGVSnom=NM_001204425.2:c.4600G>C(p.Gly1534Arg/p.G1534R)|NM_000123.4:c.3238G>C(p.Gly1080Arg/p.G1080R);Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Missense|Missense;MolecularConsequence=missense_variant|missense_variant;ExonIntron=E23|E15;AAlength=1640|1186;EXAC_AF=0.99930759;EXAC_Hom_EAS=4323;EXAC_AC_EAS=8646;EXAC_AN_EAS=8646;EXAC_AC_Adj=121232;EXAC_AN_Adj=121316;ESP6500_MAF=0.99746271;RS=rs9514067;Ensembl_transcriptid=ENST00000639435|ENST00000639132|ENST00000602836|ENST00000355739|ENST00000375954;SIFT_pred=.|.|.|T|T;SIFT_score=.|.|.|0.588|0.701;Polyphen2_HVAR_pred=.|.|.|B|.;Polyphen2_HVAR_score=.|.|.|0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.997204;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9932;G1000_SAS_AF=0.9949;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99939711;gnomad_exomes_AF_EAS=0.99994554;gnomad_exomes_AC=250311;gnomad_exomes_Hom=125080;gnomad_exomes_Het=151;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99389341;gnomad_exomes_AF_NFE=0.99993820;gnomad_exomes_AF_AMR=0.99947690;gnomad_exomes_AF_SAS=0.99921110;NativeFreq_Het=0;NativeFreq_Hom=1;DANN_score=0.6273;GREP_score=0.141;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=AGATTCTAAA.GAAAGAATAC	GT:AD:DP:GQ:PL	1/1:0,367:367:99:12629,1101,0
chr13	103528002	.	G	C	5298.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.957;DP=335;ExcessHet=3.0103;FS=5.628;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.91;ReadPosRankSum=-0.537;SOR=0.808;HGVSnom=NM_001204425.2:c.4672G>C(p.Asp1558His/p.D1558H)|NM_000123.4:c.3310G>C(p.Asp1104His/p.D1104H);Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=Missense|Missense;MolecularConsequence=missense_variant|missense_variant;ExonIntron=E23|E15;AAlength=1640|1186;EXAC_AF=0.27768150;EXAC_Hom_EAS=1106;EXAC_AC_EAS=4369;EXAC_AN_EAS=8630;EXAC_AC_Adj=33650;EXAC_AN_Adj=121182;ESP6500_MAF=0.30578195;RS=rs17655;Ensembl_transcriptid=ENST00000639435|ENST00000639132|ENST00000602836|ENST00000355739|ENST00000375954;SIFT_pred=.|.|.|D|T;SIFT_score=.|.|.|0.004|0.063;Polyphen2_HVAR_pred=.|.|.|P|.;Polyphen2_HVAR_score=.|.|.|0.819|.;MutationTaster_pred=P|P;MutationTaster_score=0.00373539|0.0115738;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.361422;G1000_EAS_AF=0.4623;G1000_EUR_AF=0.2495;G1000_AFR_AF=0.5008;G1000_SAS_AF=0.2485;G1000_AMR_AF=0.2709;gnomad_exomes_AF=0.27759103;gnomad_exomes_AF_EAS=0.49417719;gnomad_exomes_AC=69697;gnomad_exomes_Hom=10863;gnomad_exomes_Het=47971;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.46266634;gnomad_exomes_AF_NFE=0.22144003;gnomad_exomes_AF_AMR=0.33022636;gnomad_exomes_AF_SAS=0.22685669;HGMD_gene=ERCC5;HGMD_disease=Single_strand_breaks_association_with;HGMD_tag=DP;HGMD_pmid=14729591;NativeFreq_Het=0.5247;NativeFreq_Hom=0.2068;normalHetFrequency=0.4879;normalHetNum=422;normalHomFrequency=0.178;normalHomNum=154;patientHetFrequency=0.4529;patientHetNum=2364;patientHomFrequency=0.1975;patientHomNum=1031;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4958;AF_2700_Hom=0.2429;AF_50_Het=0.5151;AF_50_Hom=0.2298;DANN_score=0.9884;GREP_score=4.11;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=TTCAAGTGAA.ATGCTGAAAG	GT:AD:DP:GQ:PL	0/1:167,166:333:99:5327,0,5366
chr13	103528337	.	G	A	3705.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.489;DP=259;ExcessHet=3.0103;FS=11.047;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.36;ReadPosRankSum=-1.366;SOR=1.232;HGVSnom=NM_001204425.2:c.*84G>A|NM_000123.4:c.*84G>A;Gene=BIVM-ERCC5|ERCC5;Transcript=NM_001204425.2|NM_000123.4;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E23|E15;AAlength=1640|1186;RS=rs873601;CLNGENE=BIVM-ERCC5|ERCC5;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.549521;G1000_EAS_AF=0.5248;G1000_EUR_AF=0.6988;G1000_AFR_AF=0.264;G1000_SAS_AF=0.729;G1000_AMR_AF=0.6599;NativeFreq_Het=0.5148;NativeFreq_Hom=0.2970;normalHetFrequency=0.4913;normalHetNum=425;normalHomFrequency=0.3064;normalHomNum=265;patientHetFrequency=0.4626;patientHetNum=2415;patientHomFrequency=0.3163;patientHomNum=1651;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5004;AF_2700_Hom=0.2367;AF_50_Het=0.5293;AF_50_Hom=0.2266;DANN_score=0.9304;GREP_score=2.78;CytoBand=q33.1;CGD_CONDITION=Xeroderma pigmentosum, complementation group G. Xeroderma pigmentosum, complementation group G/Cockayne syndrome;CGD_INHERITANCE=AR;Strand=BIVM-ERCC5:NM_001204425.1:+,ERCC5:NM_000123.3:+;NP=BIVM-ERCC5:NM_001204425.1:NP_001191354.1,ERCC5:NM_000123.3:NP_000114.2;ENSP=BIVM-ERCC5:NM_001204425.1:.,ERCC5:NM_000123.3:ENST00000652225.1;Gene_MIM_id=133530;Phenotypes=Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessive. Xeroderma pigmentosum, group G, 278780 (3), Autosomal recessive. Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3), Autosomal recessive. 278780(MK),616570(MK);Possible_Inheritance=AR;EntrezGeneID=2073;EnsemblGeneID=ENSG00000134899;Alias=ERCC5, XPG, COFS3;FLKSEQ=ATTAACTGGT.GCACGGTCTT	GT:AD:DP:GQ:PL	0/1:135,123:258:99:3734,0,4319
chr14	23652346	.	TAA	T	1301.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.164;DP=153;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.42;ReadPosRankSum=-0.067;SOR=0.631;HGVSnom=NM_012244.4:c.-225_-224delTT;Gene=SLC7A8;Transcript=NM_012244.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=535;RS=rs60162914;CytoBand=q11.2;Strand=SLC7A8:NM_012244.3:-;NP=SLC7A8:NM_012244.3:NP_036376.2;ENSP=SLC7A8:NM_012244.3:.;Gene_MIM_id=604235;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=23428;EnsemblGeneID=ENSG00000092068;Alias=SLC7A8, LAT2;FLKSEQ=AAAGTGTTGC.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:66,48:114:99:823,0,862
chr14	65472874	.	C	CT	2101.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.227;DP=379;ExcessHet=3.0103;FS=5.303;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.05;ReadPosRankSum=0.541;SOR=1.133;HGVSnom=NM_001202559.1:c.392+1860dupT|NM_002028.4:c.209+1860dupT;Gene=CHURC1-FNTB|FNTB;Transcript=NM_001202559.1|NM_002028.4;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|coding_transcript_intron_variant;ExonIntron=I4|I2;IVSnom=NM_001202559.1:IVS4+1860_+1861insT|NM_002028.4:IVS2+1860_+1861insT;AAlength=498|437;EXAC_AF=0.14069416;EXAC_Hom_EAS=3;EXAC_AC_EAS=1152;EXAC_AN_EAS=6144;EXAC_AC_Adj=12396;EXAC_AN_Adj=88106;RS=rs367570902;CLNGENE=CHURC1-FNTB|FNTB|MAX;CLNSIG=Benign|Benign|Benign;CLNSIGINCL=nan|nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter;AF_2700_Het=0.7978;AF_2700_Hom=0.0019;AF_50_Het=0.8098;AF_50_Hom=.;CytoBand=q23.3;CGD_CONDITION=Pheochromocytoma;CGD_INHERITANCE=AD;Strand=CHURC1-FNTB:NM_001202558.1:+,CHURC1-FNTB:NM_001202559.1:+,FNTB:NM_002028.3:+,MAX:NM_001271069.1:-,MAX:NM_197957.3:-;NP=CHURC1-FNTB:NM_001202558.1:NP_001189487.1,CHURC1-FNTB:NM_001202559.1:NP_001189488.1,FNTB:NM_002028.3:NP_002019.1,MAX:NM_001271069.1:NP_001257998.1,MAX:NM_197957.3:NP_932061.1;ENSP=CHURC1-FNTB:NM_001202558.1:.,CHURC1-FNTB:NM_001202559.1:.,FNTB:NM_002028.3:.,MAX:NM_001271069.1:.,MAX:NM_197957.3:ENST00000341653.6;Gene_MIM_id=134636,154950;Phenotypes=.,{Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant. 171300(SK);Possible_Inheritance=NA,AD;EntrezGeneID=2342,4149;EnsemblGeneID=ENSG00000257365,ENSG00000125952;Alias=FNTB,MAX;FLKSEQ=ACCTTTGTGT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:117,181:298:99:2139,0,1082
chr14	65568215	.	G	A	7589.77	PASS	AC=2;AF=1;AN=2;DP=209;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.49;SOR=2.022;HGVSnom=NM_002382.5:c.63+49C>T;Gene=MAX;Transcript=NM_002382.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_002382.5:IVS2+49C>T;AAlength=160;EXAC_AF=0.40914341;EXAC_Hom_EAS=655;EXAC_AC_EAS=3329;EXAC_AN_EAS=8048;EXAC_AC_Adj=45338;EXAC_AN_Adj=110812;ESP6500_MAF=0.50715165;RS=rs2781373;CLNGENE=MAX;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.512181;G1000_EAS_AF=0.4097;G1000_EUR_AF=0.3628;G1000_AFR_AF=0.8457;G1000_SAS_AF=0.5072;G1000_AMR_AF=0.2493;gnomad_exomes_AF=0.39235376;gnomad_exomes_AF_EAS=0.40582072;gnomad_exomes_AC=92641;gnomad_exomes_Hom=20154;gnomad_exomes_Het=52333;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.77560845;gnomad_exomes_AF_NFE=0.37294623;gnomad_exomes_AF_AMR=0.21349963;gnomad_exomes_AF_SAS=0.49454125;NativeFreq_Het=0.5148;NativeFreq_Hom=0.2028;normalHetFrequency=0.4639;normalHetNum=180;normalHomFrequency=0.1314;normalHomNum=51;patientHetFrequency=0.4394;patientHetNum=1218;patientHomFrequency=0.1429;patientHomNum=396;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8964;GREP_score=1.89;CytoBand=q23.3;CGD_CONDITION=Pheochromocytoma;CGD_INHERITANCE=AD;Strand=MAX:NM_001271069.1:-,MAX:NM_197957.3:-,MAX:NM_001320415.1:-,MAX:NM_002382.4:-,MAX:NM_145112.2:-,MAX:NM_145113.2:-,MAX:NM_001271068.1:-,MAX:NM_145114.2:-;NP=MAX:NM_001271069.1:NP_001257998.1,MAX:NM_197957.3:NP_932061.1,MAX:NM_001320415.1:NP_001307344.1,MAX:NM_002382.4:NP_002373.3,MAX:NM_145112.2:NP_660087.1,MAX:NM_145113.2:NP_660088.1,MAX:NM_001271068.1:NP_001257997.1,MAX:NM_145114.2:NP_660089.1;ENSP=MAX:NM_001271069.1:.,MAX:NM_197957.3:ENST00000341653.6,MAX:NM_001320415.1:.,MAX:NM_002382.4:.,MAX:NM_145112.2:.,MAX:NM_145113.2:.,MAX:NM_001271068.1:.,MAX:NM_145114.2:.;Gene_MIM_id=154950;Phenotypes={Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant. 171300(SK);Possible_Inheritance=AD;EntrezGeneID=4149;EnsemblGeneID=ENSG00000125952;Alias=MAX;FLKSEQ=CCCCAAAAAG.AATAGAACTG	GT:AD:DP:GQ:PL	1/1:0,208:208:99:7618,625,0
chr14	68290372	.	T	G	2650.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.284;DP=155;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.1;ReadPosRankSum=-0.229;SOR=0.771;HGVSnom=NM_133510.4:c.84+28T>G;Gene=RAD51B;Transcript=NM_133510.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_133510.4:IVS2+28T>G;AAlength=350;EXAC_AF=0.30298927;EXAC_Hom_EAS=22;EXAC_AC_EAS=648;EXAC_AN_EAS=8246;EXAC_AC_Adj=35800;EXAC_AN_Adj=118156;ESP6500_MAF=0.35522067;RS=rs17783124;CLNGENE=RAD51B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.250399;G1000_EAS_AF=0.0744;G1000_EUR_AF=0.3757;G1000_AFR_AF=0.3192;G1000_SAS_AF=0.2209;G1000_AMR_AF=0.2349;gnomad_exomes_AF=0.29264107;gnomad_exomes_AF_EAS=0.07431602;gnomad_exomes_AC=71103;gnomad_exomes_Hom=11482;gnomad_exomes_Het=48139;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34685079;gnomad_exomes_AF_NFE=0.35354939;gnomad_exomes_AF_AMR=0.19648407;gnomad_exomes_AF_SAS=0.23308084;NativeFreq_Het=0.2456;NativeFreq_Hom=0.0783;DANN_score=0.6571;GREP_score=1.78;CytoBand=q24.1;Strand=RAD51B:NM_001321819.1:+,RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_001321819.1:NP_001308748.1,RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_001321819.1:.,RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=TTTTTATTGA.AAGTTTTATG	GT:AD:DP:GQ:PL	0/1:75,80:155:99:2679,0,2408
chr14	68301767	.	G	GA	3222.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.994;DP=298;ExcessHet=3.0103;FS=2.509;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.76;ReadPosRankSum=0.908;SOR=0.911;HGVSnom=NM_133510.4:c.199-22dupA;Gene=RAD51B;Transcript=NM_133510.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_133510.4:IVS3-22_-21insA;AAlength=350;EXAC_AF=0.32026270;EXAC_Hom_EAS=89;EXAC_AC_EAS=1236;EXAC_AN_EAS=8442;EXAC_AC_Adj=38085;EXAC_AN_Adj=118918;ESP6500_MAF=0.40429781;RS=rs34564590;CLNGENE=RAD51B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.319489;G1000_EAS_AF=0.1498;G1000_EUR_AF=0.3787;G1000_AFR_AF=0.5098;G1000_SAS_AF=0.2239;G1000_AMR_AF=0.2522;gnomad_exomes_AF=0.30578255;gnomad_exomes_AF_EAS=0.14452124;gnomad_exomes_AC=73641;gnomad_exomes_Hom=11963;gnomad_exomes_Het=49715;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49277658;gnomad_exomes_AF_NFE=0.34971488;gnomad_exomes_AF_AMR=0.20601005;gnomad_exomes_AF_SAS=0.22966741;CytoBand=q24.1;Strand=RAD51B:NM_001321819.1:+,RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_001321819.1:NP_001308748.1,RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_001321819.1:.,RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=TATAGAGGTT.AAAAAAAACT	GT:AD:DP:GQ:PL	0/1:132,142:274:99:3260,0,3124
chr14	68331675	.	A	T	4823.77	StandardFilter	AC=2;AF=1;AN=2;DP=104;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.48;SOR=4.764;HGVSnom=NM_133510.4:c.316-45A>T;Gene=RAD51B;Transcript=NM_133510.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_133510.4:IVS4-45A>T;AAlength=350;EXAC_AF=0.99977881;EXAC_Hom_EAS=226;EXAC_AC_EAS=452;EXAC_AN_EAS=452;EXAC_AC_Adj=18080;EXAC_AN_Adj=18084;RS=rs1474939;CLNGENE=RAD51B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.97475677;gnomad_exomes_AF_EAS=0.92795485;gnomad_exomes_AC=59312;gnomad_exomes_Hom=28888;gnomad_exomes_Het=1536;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.95380875;gnomad_exomes_AF_NFE=0.98035439;gnomad_exomes_AF_AMR=0.94499774;gnomad_exomes_AF_SAS=0.97859327;NativeFreq_Het=0;NativeFreq_Hom=0.9537;DANN_score=0.6138;GREP_score=-0.784;CytoBand=q24.1;Strand=RAD51B:NM_001321819.1:+,RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_001321819.1:NP_001308748.1,RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_001321819.1:.,RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=TTTATCTAAA.AACttttttt	GT:AD:DP:GQ:PL	1/1:0,104:104:99:4852,349,0
chr14	68331678	.	CTTTTT	C	1138.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.155;DP=118;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.18;ReadPosRankSum=-1.666;SOR=2.419;HGVSnom=NM_133510.4:c.316-7_316-3delTTTTT;Gene=RAD51B;Transcript=NM_133510.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_133510.4:IVS4-7_-3delTTTTT;AAlength=350;RS=rs745505141;CytoBand=q24.1;Strand=RAD51B:NM_001321819.1:+,RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_001321819.1:NP_001308748.1,RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_001321819.1:.,RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=ATCTAAAAAA.tttttttttt	GT:AD:DP:GQ:PL	0/1:22,53:75:99:1124,0,321
chr14	68353893	.	A	G	5541.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.407;DP=368;ExcessHet=3.0103;FS=9.663;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.1;ReadPosRankSum=0.652;SOR=1.105;HGVSnom=NM_133510.4:c.728A>G(p.Lys243Arg/p.K243R);Gene=RAD51B;Transcript=NM_133510.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E7;IVSnom=.;AAlength=350;EXAC_AF=0.00734724;EXAC_Hom_EAS=0;EXAC_AC_EAS=0;EXAC_AN_EAS=8638;EXAC_AC_Adj=890;EXAC_AN_Adj=121134;ESP6500_MAF=0.00876519;RS=rs34594234;Ensembl_transcriptid=ENST00000487861|ENST00000471583|ENST00000487270|ENST00000390683|ENST00000488612;SIFT_pred=T|D|D|D|D;SIFT_score=0.129|0.0|0.0|0.0|0.0;Polyphen2_HVAR_pred=D|P|D|.|D;Polyphen2_HVAR_score=1.0|0.8|1.0|.|1.0;MutationTaster_pred=D|D|D|D|D;MutationTaster_score=0.997423|0.997423|0.997423|0.997423|0.997423;CLNGENE=RAD51B;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.00299521;G1000_EAS_AF=0.0;G1000_EUR_AF=0.0089;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0031;G1000_AMR_AF=0.0043;gnomad_exomes_AF=0.00733544;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=1831;gnomad_exomes_Hom=17;gnomad_exomes_Het=1797;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00228142;gnomad_exomes_AF_NFE=0.01143130;gnomad_exomes_AF_AMR=0.00371649;gnomad_exomes_AF_SAS=0.00290542;HGMD_gene=RAD51B;HGMD_disease=Pancreatic_cancer_susceptibility_to;HGMD_tag=DM?;HGMD_pmid=28767289;NativeFreq_Het=0.0178;NativeFreq_Hom=0;DANN_score=0.9989;GREP_score=5.9;CytoBand=q24.1;Strand=RAD51B:NM_001321819.1:+,RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_001321819.1:NP_001308748.1,RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_001321819.1:.,RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=TCCTCCTTGA.GTATTTGGCT	GT:AD:DP:GQ:PL	0/1:183,184:367:99:5570,0,5432
chr14	68944343	.	CT	C	939.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.712;DP=428;ExcessHet=3.0103;FS=7.427;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.49;ReadPosRankSum=-0.754;SOR=0.329;HGVSnom=NM_133510.4:c.1037-8delT;Gene=RAD51B;Transcript=NM_133510.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_133510.4:IVS10-8delT;AAlength=350;EXAC_AF=0.34061412;EXAC_Hom_EAS=0;EXAC_AC_EAS=1614;EXAC_AN_EAS=5264;EXAC_AC_Adj=25824;EXAC_AN_Adj=75816;RS=rs528099287;G1000_AF=0.295727;G1000_EAS_AF=0.2282;G1000_EUR_AF=0.2525;G1000_AFR_AF=0.3283;G1000_SAS_AF=0.3528;G1000_AMR_AF=0.3141;gnomad_exomes_AF=0.33616903;gnomad_exomes_AF_EAS=0.30685131;gnomad_exomes_AC=38726;gnomad_exomes_Hom=1;gnomad_exomes_Het=38724;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.33510773;gnomad_exomes_AF_NFE=0.34046743;gnomad_exomes_AF_AMR=0.32459677;gnomad_exomes_AF_SAS=0.34355035;CytoBand=q24.1;Strand=RAD51B:NM_133510.3:+,RAD51B:NM_002877.5:+,RAD51B:NM_001321814.1:+,RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321817.1:+,RAD51B:NM_001321812.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_133510.3:NP_598194.1,RAD51B:NM_002877.5:NP_002868.1,RAD51B:NM_001321814.1:NP_001308743.1,RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321817.1:NP_001308746.1,RAD51B:NM_001321812.1:NP_001308741.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_133510.3:.,RAD51B:NM_002877.5:ENST00000487861.5,RAD51B:NM_001321814.1:.,RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321817.1:.,RAD51B:NM_001321812.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=CAAACTTTCT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:263,115:378:99:977,0,4873
chr14	69062114	.	C	T	6019.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-10.14;DP=389;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.47;ReadPosRankSum=0.338;SOR=0.684;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs963918;G1000_AF=0.651158;G1000_EAS_AF=0.6935;G1000_EUR_AF=0.6511;G1000_AFR_AF=0.6573;G1000_SAS_AF=0.6789;G1000_AMR_AF=0.5389;DANN_score=0.6126;GREP_score=-1.46;CytoBand=q24.1;Strand=RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=ATAATGCATC.ATGAACAAAT	GT:AD:DP:GQ:PL	0/1:196,193:389:99:6048,0,6634
chr14	69062668	.	CT	C	1353.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.224;DP=179;ExcessHet=3.0103;FS=1.653;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.79;ReadPosRankSum=1.081;SOR=0.532;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs11305606;CytoBand=q24.1;repName=L1ME4a;repClass=LINE;Strand=RAD51B:NM_133509.3:+,RAD51B:NM_001321810.1:+,RAD51B:NM_001321809.1:+,RAD51B:NM_001321821.1:+,RAD51B:NM_001321818.1:+,RAD51B:NM_001321815.1:+;NP=RAD51B:NM_133509.3:NP_598193.2,RAD51B:NM_001321810.1:NP_001308739.1,RAD51B:NM_001321809.1:NP_001308738.1,RAD51B:NM_001321821.1:NP_001308750.1,RAD51B:NM_001321818.1:NP_001308747.1,RAD51B:NM_001321815.1:NP_001308744.1;ENSP=RAD51B:NM_133509.3:.,RAD51B:NM_001321810.1:.,RAD51B:NM_001321809.1:.,RAD51B:NM_001321821.1:.,RAD51B:NM_001321818.1:.,RAD51B:NM_001321815.1:.;Gene_MIM_id=602948;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5890;EnsemblGeneID=ENSG00000182185;Alias=RAD51L1;FLKSEQ=ttggaattgt.tttttttttt	GT:AD:DP:GQ:PL	0/1:61,93:154:99:1391,0,716
chr14	75483812	.	T	C	15897.8	PASS	AC=2;AF=1;AN=2;DP=421;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.01;SOR=1.027;HGVSnom=NM_001040108.2:c.4335A>G(p.Gln1445Gln/p.Q1445Q);Gene=MLH3;Transcript=NM_001040108.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=1453;EXAC_AF=0.56343505;EXAC_Hom_EAS=2969;EXAC_AC_EAS=7168;EXAC_AN_EAS=8646;EXAC_AC_Adj=68392;EXAC_AN_Adj=121384;ESP6500_MAF=0.50192219;RS=rs13712;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.580072;G1000_EAS_AF=0.8393;G1000_EUR_AF=0.5388;G1000_AFR_AF=0.4138;G1000_SAS_AF=0.5194;G1000_AMR_AF=0.6657;gnomad_exomes_AF=0.57496362;gnomad_exomes_AF_EAS=0.83255409;gnomad_exomes_AC=144593;gnomad_exomes_Hom=43389;gnomad_exomes_Het=57815;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44285187;gnomad_exomes_AF_NFE=0.53246251;gnomad_exomes_AF_AMR=0.74920497;gnomad_exomes_AF_SAS=0.49794212;NativeFreq_Het=0.4158;NativeFreq_Hom=0.5544;normalHetFrequency=0.3428;normalHetNum=133;normalHomFrequency=0.5722;normalHomNum=222;patientHetFrequency=0.3431;patientHetNum=951;patientHomFrequency=0.5437;patientHomNum=1507;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2998;AF_2700_Hom=0.6683;AF_50_Het=0.2789;AF_50_Hom=0.6941;DANN_score=0.5862;GREP_score=-2.02;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=GAGGCATGGA.TGCTGCAGGC	GT:AD:DP:GQ:PL	1/1:0,419:419:99:15926,1260,0
chr14	75485489	.	A	G	13167.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.857;DP=352;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.25;ReadPosRankSum=-0.134;SOR=0.833;HGVSnom=NM_001040108.2:c.4242+43T>C;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_001040108.2:IVS12+43T>C;AAlength=1453;EXAC_AF=0.99684400;EXAC_Hom_EAS=4326;EXAC_AC_EAS=8652;EXAC_AN_EAS=8652;EXAC_AC_Adj=120973;EXAC_AN_Adj=121356;ESP6500_MAF=0.98885130;RS=rs175053;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.990615;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9682;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.99733089;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=250350;gnomad_exomes_Hom=124850;gnomad_exomes_Het=650;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96353333;gnomad_exomes_AF_NFE=0.99991180;gnomad_exomes_AF_AMR=0.99846759;gnomad_exomes_AF_SAS=0.99983667;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9974;normalHomNum=387;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.9917;patientHomNum=2749;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722274|16D0172293|16D0162334][_];patientHomSampleInfo=[_][_];DANN_score=0.7935;GREP_score=2.59;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=AGAAAGAGAA.ATAAACTTTG	GT:AD:DP:GQ:PL	1/1:1,349:350:99:13196,1017,0
chr14	75489446	.	T	C	10965.8	PASS	AC=2;AF=1;AN=2;DP=295;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.58;SOR=1.752;HGVSnom=NM_001040108.2:c.4090+71A>G;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001040108.2:IVS11+71A>G;AAlength=1453;RS=rs175056;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.990415;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9682;G1000_SAS_AF=0.999;G1000_AMR_AF=0.9928;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9974;normalHomNum=387;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.9917;patientHomNum=2749;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722274|16D0172293|16D0162334][_];patientHomSampleInfo=[_][_];DANN_score=0.39;GREP_score=-2.46;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=CTGCCTCTTT.GTAATCCCGG	GT:AD:DP:GQ:PL	1/1:0,294:294:99:10994,884,0
chr14	75505008	.	G	C	12404.8	PASS	AC=2;AF=1;AN=2;DP=276;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.64;SOR=2.277;HGVSnom=NM_001040108.2:c.3643+35C>G;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_001040108.2:IVS6+35C>G;AAlength=1453;EXAC_AF=0.50393214;EXAC_Hom_EAS=2966;EXAC_AC_EAS=7162;EXAC_AN_EAS=8650;EXAC_AC_Adj=61131;EXAC_AN_Adj=121308;ESP6500_MAF=0.40089190;RS=rs3742780;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.496605;G1000_EAS_AF=0.8373;G1000_EUR_AF=0.502;G1000_AFR_AF=0.1861;G1000_SAS_AF=0.4724;G1000_AMR_AF=0.6196;gnomad_exomes_AF=0.52051690;gnomad_exomes_AF_EAS=0.83166594;gnomad_exomes_AC=130707;gnomad_exomes_Hom=36761;gnomad_exomes_Het=57185;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.22715517;gnomad_exomes_AF_NFE=0.48456611;gnomad_exomes_AF_AMR=0.72330518;gnomad_exomes_AF_SAS=0.44690584;NativeFreq_Het=0.4158;NativeFreq_Hom=0.5544;normalHetFrequency=0.3454;normalHetNum=134;normalHomFrequency=0.5593;normalHomNum=217;patientHetFrequency=0.3427;patientHetNum=950;patientHomFrequency=0.5299;patientHomNum=1469;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4586;GREP_score=2.0;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=AAGAAGACCA.CTGGTTAATC	GT:AD:DP:GQ:PL	1/1:0,275:275:99:12433,846,0
chr14	75505016	.	A	G	12912.8	PASS	AC=2;AF=1;AN=2;DP=298;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.19;SOR=2.131;HGVSnom=NM_001040108.2:c.3643+27T>C;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_001040108.2:IVS6+27T>C;AAlength=1453;EXAC_AF=0.99562574;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=120861;EXAC_AN_Adj=121392;ESP6500_MAF=0.98446871;RS=rs175075;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.986222;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9516;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.99630847;gnomad_exomes_AF_EAS=0.99994563;gnomad_exomes_AC=250458;gnomad_exomes_Hom=124786;gnomad_exomes_Het=886;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.94947070;gnomad_exomes_AF_NFE=0.99991208;gnomad_exomes_AF_AMR=0.99777367;gnomad_exomes_AF_SAS=0.99983667;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9974;normalHomNum=387;patientHetFrequency=0.0018;patientHetNum=5;patientHomFrequency=0.9913;patientHomNum=2748;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1546023|15D6722274|16D0172293|16D0162334|16D1536926][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9988;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.534;GREP_score=-2.32;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=CAGCTGGTTA.TCATTCAGGC	GT:AD:DP:GQ:PL	1/1:0,296:296:99:12941,891,0
chr14	75506549	.	C	CATATAT	951.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.472;DP=52;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.19;MQRankSum=0;QD=28.84;ReadPosRankSum=-0.725;SOR=3.611;HGVSnom=NM_001040108.2:c.3570+59_3570+64dupATATAT;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_001040108.2:IVS5+64_+65insATATAT;AAlength=1453;RS=rs145063005;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[15B0002935][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0035647-1][_];patientHomSampleInfo=[16D0158740|16D0158744][_];CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=AGAGTTAGGC.atatatatat	GT:AD:DP:GQ:PL	0/1:5,28:33:39:745,0,39
chr14	75513883	.	T	C	18807.8	PASS	AC=2;AF=1;AN=2;DP=478;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.82;SOR=0.749;HGVSnom=NM_001040108.2:c.2476A>G(p.Asn826Asp/p.N826D);Gene=MLH3;Transcript=NM_001040108.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=1453;EXAC_AF=0.99679572;EXAC_Hom_EAS=4327;EXAC_AC_EAS=8654;EXAC_AN_EAS=8654;EXAC_AC_Adj=121011;EXAC_AN_Adj=121400;ESP6500_MAF=0.98877441;RS=rs175081;Ensembl_transcriptid=ENST00000355774|ENST00000380968|ENST00000556257|ENST00000556740;SIFT_pred=T|.|T|T;SIFT_score=0.848|.|0.835|0.848;Polyphen2_HVAR_pred=B|B|.|B;Polyphen2_HVAR_score=0.0|0.0|.|0.0;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|1|1|0.999988;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.990415;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.9675;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.99727528;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=250717;gnomad_exomes_Hom=125027;gnomad_exomes_Het=663;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96288774;gnomad_exomes_AF_NFE=0.99991205;gnomad_exomes_AF_AMR=0.99835222;gnomad_exomes_AF_SAS=0.99983667;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9974;normalHomNum=387;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.9924;patientHomNum=2751;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[15D6722274|16D0172293|16D0162334][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0000;AF_2700_Hom=0.9996;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.6857;GREP_score=1.33;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=TTCTCTGAGT.AAGGATGTGG	GT:AD:DP:GQ:PL	1/1:0,477:477:99:18836,1435,0
chr14	75517988	.	G	A	1723.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.871;DP=148;ExcessHet=3.0103;FS=4.593;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.65;ReadPosRankSum=0.496;SOR=1.154;HGVSnom=NM_001040108.2:c.-64+95C>T;Gene=MLH3;Transcript=NM_001040108.2;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_001040108.2:IVS1+95C>T;AAlength=1453;RS=rs1170021370;DANN_score=0.9155;GREP_score=0.718;CytoBand=q24.3;CGD_CONDITION=Colorectal cancer, hereditary nonpolyposis type 7. Endometrial carcinoma;CGD_INHERITANCE=AD;Strand=MLH3:NM_001040108.1:-,MLH3:NM_014381.2:-;NP=MLH3:NM_001040108.1:NP_001035197.1,MLH3:NM_014381.2:NP_055196.2;ENSP=MLH3:NM_001040108.1:.,MLH3:NM_014381.2:ENST00000380968.6;Gene_MIM_id=604395;Phenotypes=Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3). Colorectal cancer, somatic, 114500 (3). {Endometrial cancer, susceptibility to}, 608089 (3). 114500(MK),608089(SK),614385(MK);Possible_Inheritance=AD;EntrezGeneID=27030;EnsemblGeneID=ENSG00000119684;Alias=MLH3, HNPCC7;FLKSEQ=CGCGCATCCG.CTCCGAAAGC	GT:AD:DP:GQ:PL	0/1:84,64:148:99:1752,0,2628
chr14	75518330	.	G	A	5572.77	PASS	AC=2;AF=1;AN=2;DP=169;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.17;SOR=1.725;HGVSnom=.;Gene=MLH3;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs175083;CLNGENE=MLH3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.953075;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.8336;G1000_SAS_AF=0.999;G1000_AMR_AF=0.9798;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0011835|17B0005475][_];DANN_score=0.5534;GREP_score=-0.486;CytoBand=q24.3;FLKSEQ=CTATGTCGTA.CTTTTACTTT	GT:AD:DP:GQ:PL	1/1:0,168:168:99:5601,503,0
chr14	81574687	.	T	TTCTC	2428.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.741;DP=174;ExcessHet=3.0103;FS=6.009;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.98;ReadPosRankSum=-1.219;SOR=1.367;HGVSnom=NM_000369.5:c.615-22_615-19dupCTCT;Gene=TSHR;Transcript=NM_000369.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000369.5:IVS7-19_-18insCTCT;AAlength=764;EXAC_AF=0.56176903;EXAC_Hom_EAS=299;EXAC_AC_EAS=2657;EXAC_AN_EAS=8416;EXAC_AC_Adj=64172;EXAC_AN_Adj=114232;RS=rs3837640;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.603834;G1000_EAS_AF=0.3889;G1000_EUR_AF=0.666;G1000_AFR_AF=0.6286;G1000_SAS_AF=0.7147;G1000_AMR_AF=0.6225;gnomad_exomes_AF=0.53026883;gnomad_exomes_AF_EAS=0.29320808;gnomad_exomes_AC=102414;gnomad_exomes_Hom=23026;gnomad_exomes_Het=56362;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.53619386;gnomad_exomes_AF_NFE=0.54400452;gnomad_exomes_AF_AMR=0.53832033;gnomad_exomes_AF_SAS=0.59563193;normalHetFrequency=0.4127;normalHetNum=357;normalHomFrequency=0.1965;normalHomNum=170;patientHetFrequency=0.4239;patientHetNum=2213;patientHomFrequency=0.2006;patientHomNum=1047;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_001018036.2:+,TSHR:NM_001142626.2:+,TSHR:NM_000369.2:+;NP=TSHR:NM_001018036.2:NP_001018046.1,TSHR:NM_001142626.2:NP_001136098.1,TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_001018036.2:.,TSHR:NM_001142626.2:.,TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=ACCTAATTCA.tctctctctc	GT:AD:DP:GQ:PL	0/1:85,67:152:99:2466,0,3919
chr14	81574845	.	T	TTTTTTTCTTTTTAC	5597.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.679;DP=458;ExcessHet=3.0103;FS=1.386;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.49;ReadPosRankSum=-5.228;SOR=0.791;HGVSnom=NM_000369.5:c.692+55_692+56insCTTTTTACTTTTTT;Gene=TSHR;Transcript=NM_000369.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000369.5:IVS8+55_+56insCTTTTTACTTTTTT;AAlength=764;RS=rs71103900;NativeFreq_Het=0.0289;NativeFreq_Hom=.;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.1711;normalHomNum=148;patientHetFrequency=0.4303;patientHetNum=2246;patientHomFrequency=0.1776;patientHomNum=927;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q31.1;repName=(T)n;repClass=Simple_repeat;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_001018036.2:+,TSHR:NM_001142626.2:+,TSHR:NM_000369.2:+;NP=TSHR:NM_001018036.2:NP_001018046.1,TSHR:NM_001142626.2:NP_001136098.1,TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_001018036.2:.,TSHR:NM_001142626.2:.,TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=tttctttttt.ttttttGGAA	GT:AD:DP:GQ:PL	0/1:233,182:415:99:5635,0,12277
chr14	81574959	.	A	G	6781.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.793;DP=468;ExcessHet=3.0103;FS=3.277;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.55;ReadPosRankSum=0.999;SOR=0.483;HGVSnom=NM_000369.5:c.692+163A>G;Gene=TSHR;Transcript=NM_000369.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000369.5:IVS8+163A>G;AAlength=764;EXAC_AF=0.64680609;EXAC_Hom_EAS=502;EXAC_AC_EAS=2934;EXAC_AN_EAS=8636;EXAC_AC_Adj=78433;EXAC_AN_Adj=121262;ESP6500_MAF=0.64377979;RS=rs3783942;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.611222;G1000_EAS_AF=0.3889;G1000_EUR_AF=0.671;G1000_AFR_AF=0.6369;G1000_SAS_AF=0.7331;G1000_AMR_AF=0.6268;gnomad_exomes_AF=0.64558609;gnomad_exomes_AF_EAS=0.33567232;gnomad_exomes_AC=162219;gnomad_exomes_Hom=53511;gnomad_exomes_Het=55197;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62727945;gnomad_exomes_AF_NFE=0.65403774;gnomad_exomes_AF_AMR=0.65497600;gnomad_exomes_AF_SAS=0.74067054;NativeFreq_Het=0.3544;NativeFreq_Hom=0.0971;normalHetFrequency=0.2763;normalHetNum=239;normalHomFrequency=0.1353;normalHomNum=117;patientHetFrequency=0.292;patientHetNum=1524;patientHomFrequency=0.1443;patientHomNum=753;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4836;GREP_score=-0.93;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_001018036.2:+,TSHR:NM_001142626.2:+,TSHR:NM_000369.2:+;NP=TSHR:NM_001018036.2:NP_001018046.1,TSHR:NM_001142626.2:NP_001136098.1,TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_001018036.2:.,TSHR:NM_001142626.2:.,TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=TGTATAGGCT.CCTCTTGGAA	GT:AD:DP:GQ:PL	0/1:254,212:466:99:6810,0,7508
chr14	81575005	.	C	A	5043.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.162;DP=360;ExcessHet=3.0103;FS=0.805;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.09;ReadPosRankSum=-0.788;SOR=0.746;HGVSnom=NM_000369.5:c.692+209C>A;Gene=TSHR;Transcript=NM_000369.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000369.5:IVS8+209C>A;AAlength=764;EXAC_AF=0.64652336;EXAC_Hom_EAS=502;EXAC_AC_EAS=2933;EXAC_AN_EAS=8618;EXAC_AC_Adj=78197;EXAC_AN_Adj=120950;ESP6500_MAF=0.64247270;RS=rs3783941;Ensembl_transcriptid=ENST00000342443|ENST00000554435;SIFT_pred=T|T;SIFT_score=1.0|0.526;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.0|.;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=1|1|1|1|1;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.610224;G1000_EAS_AF=0.3889;G1000_EUR_AF=0.671;G1000_AFR_AF=0.6354;G1000_SAS_AF=0.7321;G1000_AMR_AF=0.6239;gnomad_exomes_AF=0.64519927;gnomad_exomes_AF_EAS=0.33554564;gnomad_exomes_AC=161665;gnomad_exomes_Hom=53302;gnomad_exomes_Het=55061;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62363929;gnomad_exomes_AF_NFE=0.65389649;gnomad_exomes_AF_AMR=0.65444920;gnomad_exomes_AF_SAS=0.74089453;NativeFreq_Het=0.4029;NativeFreq_Hom=0.0939;normalHetFrequency=0.2566;normalHetNum=222;normalHomFrequency=0.1306;normalHomNum=113;patientHetFrequency=0.2739;patientHetNum=1430;patientHomFrequency=0.1381;patientHomNum=721;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6536;GREP_score=-8.59;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_001018036.2:+,TSHR:NM_001142626.2:+,TSHR:NM_000369.2:+;NP=TSHR:NM_001018036.2:NP_001018046.1,TSHR:NM_001142626.2:NP_001136098.1,TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_001018036.2:.,TSHR:NM_001142626.2:.,TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=GAAGGCCCCA.GCTCCAGTAT	GT:AD:DP:GQ:PL	0/1:196,162:358:99:5072,0,5793
chr14	81610583	.	G	C	13009.8	PASS	AC=2;AF=1;AN=2;DP=342;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.02;SOR=0.765;HGVSnom=NM_000369.5:c.2181G>C(p.Glu727Asp/p.E727D);Gene=TSHR;Transcript=NM_000369.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E10;IVSnom=.;AAlength=764;EXAC_AF=0.90037749;EXAC_Hom_EAS=2937;EXAC_AC_EAS=7131;EXAC_AN_EAS=8642;EXAC_AC_Adj=109241;EXAC_AN_Adj=121328;ESP6500_MAF=0.92334307;RS=rs1991517;Ensembl_transcriptid=ENST00000541158|ENST00000298171;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=.|.;Polyphen2_HVAR_score=.|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=TSHR;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.896765;G1000_EAS_AF=0.8472;G1000_EUR_AF=0.8956;G1000_AFR_AF=0.9425;G1000_SAS_AF=0.911;G1000_AMR_AF=0.8631;gnomad_exomes_AF=0.89586055;gnomad_exomes_AF_EAS=0.82106351;gnomad_exomes_AC=224904;gnomad_exomes_Hom=100932;gnomad_exomes_Het=23040;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93786145;gnomad_exomes_AF_NFE=0.91324985;gnomad_exomes_AF_AMR=0.87028561;gnomad_exomes_AF_SAS=0.91301079;HGMD_gene=TSHR;HGMD_disease=Toxic_multinodular_goitre_association_with;HGMD_tag=DFP;HGMD_pmid=10487707;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6909;normalHetFrequency=0.259;normalHetNum=224;normalHomFrequency=0.7121;normalHomNum=616;patientHetFrequency=0.2506;patientHetNum=1308;patientHomFrequency=0.7215;patientHomNum=3766;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3078;AF_2700_Hom=0.6556;AF_50_Het=0.3296;AF_50_Hom=0.6371;DANN_score=0.4518;GREP_score=2.08;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=TTACCCACGA.ATGAGGCAGG	GT:AD:DP:GQ:PL	1/1:0,342:342:99:13038,1028,0
chr14	81610869	.	C	A	7084.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.599;DP=459;ExcessHet=3.0103;FS=0.52;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.44;ReadPosRankSum=0.006;SOR=0.627;HGVSnom=NM_000369.5:c.*172C>A;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs2268477;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.243211;G1000_EAS_AF=0.3313;G1000_EUR_AF=0.0785;G1000_AFR_AF=0.3805;G1000_SAS_AF=0.2505;G1000_AMR_AF=0.0821;NativeFreq_Het=0.5049;NativeFreq_Hom=0.1036;normalHetFrequency=0.3769;normalHetNum=326;normalHomFrequency=0.096;normalHomNum=83;patientHetFrequency=0.3592;patientHetNum=1875;patientHomFrequency=0.0929;patientHomNum=485;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4439;AF_2700_Hom=0.1103;AF_50_Het=0.4422;AF_50_Hom=0.1141;DANN_score=0.7062;GREP_score=-5.51;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=TTAGTATTAA.CTAATCATTG	GT:AD:DP:GQ:PL	0/1:222,237:459:99:7113,0,6874
chr14	81610942	.	C	T	13175.8	PASS	AC=2;AF=1;AN=2;DP=358;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.79;SOR=1.227;HGVSnom=NM_000369.5:c.*245C>T;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs7144481;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.843251;G1000_EAS_AF=0.8452;G1000_EUR_AF=0.8161;G1000_AFR_AF=0.8411;G1000_SAS_AF=0.8865;G1000_AMR_AF=0.8228;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6861;normalHetFrequency=0.2555;normalHetNum=221;normalHomFrequency=0.6127;normalHomNum=530;patientHetFrequency=0.236;patientHetNum=1232;patientHomFrequency=0.6128;patientHomNum=3199;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3105;AF_2700_Hom=0.6499;AF_50_Het=0.3296;AF_50_Hom=0.6307;DANN_score=0.3514;GREP_score=-2.79;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=AAATAATCTA.ACTATCTAGA	GT:AD:DP:GQ:PL	1/1:0,358:358:99:13204,1077,0
chr14	81611849	.	T	A	16361.8	PASS	AC=2;AF=1;AN=2;DP=355;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.69;SOR=0.775;HGVSnom=NM_000369.5:c.*1152T>A;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs2288494;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.847244;G1000_EAS_AF=0.8452;G1000_EUR_AF=0.8161;G1000_AFR_AF=0.8555;G1000_SAS_AF=0.8865;G1000_AMR_AF=0.8242;NativeFreq_Het=0.3267;NativeFreq_Hom=0.6861;normalHetFrequency=0.1711;normalHetNum=148;normalHomFrequency=0.3653;normalHomNum=316;patientHetFrequency=0.141;patientHetNum=736;patientHomFrequency=0.3163;patientHomNum=1651;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3094;AF_2700_Hom=0.6533;AF_50_Het=0.3281;AF_50_Hom=0.6371;DANN_score=0.4151;GREP_score=-2.48;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=ACCCAGCTGT.ATATCAGGCC	GT:AD:DP:GQ:PL	1/1:0,354:354:99:16390,1105,0
chr14	81611850	.	A	AT	16352.7	PASS	AC=2;AF=1;AN=2;DP=368;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.76;SOR=0.85;HGVSnom=NM_000369.5:c.*1154dupT;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs3214569;CLNGENE=TSHR;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.847644;G1000_EAS_AF=0.8452;G1000_EUR_AF=0.8161;G1000_AFR_AF=0.8555;G1000_SAS_AF=0.8865;G1000_AMR_AF=0.8271;NativeFreq_Het=0.4950;NativeFreq_Hom=.;normalHetFrequency=0.1711;normalHetNum=148;normalHomFrequency=0.3653;normalHomNum=316;patientHetFrequency=0.141;patientHetNum=736;patientHomFrequency=0.3165;patientHomNum=1652;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3094;AF_2700_Hom=0.6533;AF_50_Het=0.3281;AF_50_Hom=0.6371;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=CCCAGCTGTT.TATCAGGCCA	GT:AD:DP:GQ:PL	1/1:0,367:367:99:16390,1105,0
chr14	81611919	.	G	C	5831.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.76;DP=369;ExcessHet=3.0103;FS=1.719;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.89;ReadPosRankSum=0.572;SOR=0.806;HGVSnom=NM_000369.5:c.*1222G>C;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs2288495;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.293131;G1000_EAS_AF=0.1974;G1000_EUR_AF=0.4443;G1000_AFR_AF=0.1551;G1000_SAS_AF=0.2822;G1000_AMR_AF=0.4914;NativeFreq_Het=0.3269;NativeFreq_Hom=0.0594;normalHetFrequency=0.3564;normalHetNum=170;normalHomFrequency=0.0734;normalHomNum=35;patientHetFrequency=0.3354;patientHetNum=821;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2921;AF_2700_Hom=0.0388;AF_50_Het=0.3170;AF_50_Hom=0.0317;DANN_score=0.5937;GREP_score=1.83;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=TGGCTATTTA.AGTTGCTACT	GT:AD:DP:GQ:PL	0/1:186,181:367:99:5860,0,6295
chr14	81612114	.	T	C	8580.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.387;DP=511;ExcessHet=3.0103;FS=3.211;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.83;ReadPosRankSum=0.976;SOR=0.677;HGVSnom=NM_000369.5:c.*1417T>C;Gene=TSHR;Transcript=NM_000369.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=764;RS=rs2288496;CLNGENE=TSHR;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.29353;G1000_EAS_AF=0.1984;G1000_EUR_AF=0.4443;G1000_AFR_AF=0.1551;G1000_SAS_AF=0.2832;G1000_AMR_AF=0.4914;NativeFreq_Het=0.3269;NativeFreq_Hom=0.0594;normalHetFrequency=0.3585;normalHetNum=171;normalHomFrequency=0.0405;normalHomNum=35;patientHetFrequency=0.158;patientHetNum=825;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2909;AF_2700_Hom=0.0392;AF_50_Het=0.3154;AF_50_Hom=0.0333;DANN_score=0.5655;GREP_score=1.04;CytoBand=q31.1;CGD_CONDITION=Hyperthyroidism, familial, gestational. Hyperthyroidism, nonautoimmune. Hypothyroidism, congenital, nongoitrous, 1;CGD_INHERITANCE=AD/AR;Strand=TSHR:NM_000369.2:+;NP=TSHR:NM_000369.2:NP_000360.2;ENSP=TSHR:NM_000369.2:ENST00000298171.6;Gene_MIM_id=603372;Phenotypes=Hyperthyroidism, familial gestational, 603373 (3). Hyperthyroidism, nonautoimmune, 609152 (3), Autosomal dominant, Isolated cases. Hypothyroidism, congenital, nongoitrous, 1, 275200 (3), Autosomal recessive. Thyroid adenoma, hyperfunctioning, somatic (3). Thyroid carcinoma with thyrotoxicosis (3). 275200(MK),603372(MK),603373(MK),609152(MK);Possible_Inheritance=AD,AR;EntrezGeneID=7253;EnsemblGeneID=ENSG00000165409;Alias=TSHR, CHNG1;FLKSEQ=CTTCTTTACT.AAAATAGTCA	GT:AD:DP:GQ:PL	0/1:255,255:510:99:8609,0,7916
chr14	95554142	.	T	C	5331.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.229;DP=379;ExcessHet=3.0103;FS=0.37;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.11;ReadPosRankSum=1.566;SOR=0.718;HGVSnom=NM_177438.3:c.*2693A>G;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs1057035;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.172324;G1000_EAS_AF=0.1458;G1000_EUR_AF=0.3608;G1000_AFR_AF=0.0371;G1000_SAS_AF=0.0736;G1000_AMR_AF=0.3343;HGMD_gene=DICER1;HGMD_disease=Oral_cancer_decreased_risk;HGMD_tag=DFP;HGMD_pmid=23071822;NativeFreq_Het=0.2178;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0014;patientHetNum=4;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B3094006|16B0035647-1|16D0161309|16B0028133][_];patientHomSampleInfo=[16B1586166][_];AF_2700_Het=0.2060;AF_2700_Hom=0.0127;AF_50_Het=0.2060;AF_50_Hom=0.0206;DANN_score=0.5458;GREP_score=-3.3;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=TTTACACACG.GCTCAGGGCA	GT:AD:DP:GQ:PL	0/1:196,182:378:99:5360,0,5781
chr14	95555205	.	C	T	13957.8	PASS	AC=2;AF=1;AN=2;DP=381;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.88;QD=28.08;SOR=0.863;HGVSnom=NM_177438.3:c.*1630G>A;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs1187652;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.990016;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9632;G1000_AFR_AF=0.9992;G1000_SAS_AF=0.9939;G1000_AMR_AF=0.9914;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0103;normalHomNum=4;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0047;patientHomNum=13;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0067225|16B0005277|16D1545603|15D6722459-1|16B3094006|16D1533027-1|16B3097892-1|15B0062536-1|16B0005278|16B0028114|16B0028133|16B0012197|16D1545990][_];AF_2700_Het=0.0015;AF_2700_Hom=0.9969;AF_50_Het=0.0000;AF_50_Hom=1.0000;DANN_score=0.4569;GREP_score=-9.12;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=CAGCATTCCA.GAAGCATCAA	GT:AD:DP:GQ:PL	1/1:0,380:380:99:13986,1143,0
chr14	95555386	.	C	CA	2319.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.901;DP=299;ExcessHet=3.0103;FS=4.214;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.34;ReadPosRankSum=0.106;SOR=1.008;HGVSnom=NM_177438.3:c.*1448dupT;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs35463377;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.421126;G1000_EAS_AF=0.4861;G1000_EUR_AF=0.4751;G1000_AFR_AF=0.2398;G1000_SAS_AF=0.5174;G1000_AMR_AF=0.4582;NativeFreq_Het=0.3267;NativeFreq_Hom=.;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[16B0005712][_];normalHomSampleInfo=[16B0228619-1][_];patientHetSampleInfo=[15B0062536-1][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.6426;AF_2700_Hom=0.0926;AF_50_Het=0.6307;AF_50_Hom=0.1062;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=AGTTACAGTG.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:139,139:278:99:2357,0,2257
chr14	95555537	.	G	GT	443.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.009;DP=289;ExcessHet=3.0103;FS=4.579;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.61;ReadPosRankSum=-1.131;SOR=1.13;HGVSnom=NM_177438.3:c.*1297dupA;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs578164776;NativeFreq_Het=0.0099;NativeFreq_Hom=.;AF_2700_Het=0.1760;AF_2700_Hom=.;AF_50_Het=0.1601;AF_50_Hom=.;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=GCCTAAAGAA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:221,55:276:99:481,0,4392
chr14	95556508	.	CA	C	4269.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.473;DP=269;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.79;ReadPosRankSum=0.209;SOR=0.665;HGVSnom=NM_177438.3:c.*326delT;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs35649919;CLNGENE=DICER1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.5000;NativeFreq_Hom=.;normalHetFrequency=0.0258;normalHetNum=10;normalHomFrequency=0.0799;normalHomNum=31;patientHetFrequency=0.026;patientHetNum=72;patientHomFrequency=0.0574;patientHomNum=159;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4443;AF_2700_Hom=0.5492;AF_50_Het=0.4739;AF_50_Hom=0.5230;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=GACATAAACT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:37,203:240:99:4307,0,171
chr14	95556747	.	A	T	4953.77	PASS	AC=2;AF=1;AN=2;DP=134;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.74;SOR=1.574;HGVSnom=NM_177438.3:c.*88T>A;Gene=DICER1;Transcript=NM_177438.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E27;IVSnom=.;AAlength=1922;RS=rs13078;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.908946;G1000_EAS_AF=0.9573;G1000_EUR_AF=0.8171;G1000_AFR_AF=0.9319;G1000_SAS_AF=0.9397;G1000_AMR_AF=0.8847;HGMD_gene=DICER1;HGMD_disease=Breast_cancer;HGMD_tag=R;HGMD_pmid=25526195;NativeFreq_Het=0.1386;NativeFreq_Hom=0.8613;normalHetFrequency=0.1005;normalHetNum=39;normalHomFrequency=0.884;normalHomNum=343;patientHetFrequency=0.1259;patientHetNum=349;patientHomFrequency=0.8532;patientHomNum=2365;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0945;AF_2700_Hom=0.9012;AF_50_Het=0.1094;AF_50_Hom=0.8875;DANN_score=0.4351;GREP_score=0.035;CytoBand=q32.13;dupName=chr5:67151646;dupScore=0;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=CCACTCACTA.CAACTTTAAG	GT:AD:DP:GQ:PL	1/1:0,134:134:99:4982,402,0
chr14	95566101	.	AC	A	251.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.067;DP=150;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.15;ReadPosRankSum=0.813;SOR=0.064;HGVSnom=NM_177438.3:c.4206+15delG;Gene=DICER1;Transcript=NM_177438.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_177438.3:IVS22+15delG;AAlength=1922;EXAC_AF=0.11835763;EXAC_Hom_EAS=0;EXAC_AC_EAS=411;EXAC_AN_EAS=2476;EXAC_AC_Adj=8005;EXAC_AN_Adj=67634;RS=rs778075402;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=no_assertion_criteria_provided;gnomad_exomes_AF=0.03593028;gnomad_exomes_AF_EAS=0.02480171;gnomad_exomes_AC=7367;gnomad_exomes_Hom=1726;gnomad_exomes_Het=3915;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.02947939;gnomad_exomes_AF_NFE=0.04161306;gnomad_exomes_AF_AMR=0.03045311;gnomad_exomes_AF_SAS=0.03625722;normalHetFrequency=0.1469;normalHetNum=57;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1447;patientHetNum=401;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1307;AF_2700_Hom=0.0008;AF_50_Het=0.1363;AF_50_Hom=.;CytoBand=q32.13;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20.5;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=acacacacac.acacacaAAC	GT:AD:DP:GQ:PL	0/1:61,19:80:99:289,0,1947
chr14	95566103	.	AC	A	742.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.438;DP=146;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.18;ReadPosRankSum=0.825;SOR=0.793;HGVSnom=NM_177438.3:c.4206+13delG;Gene=DICER1;Transcript=NM_177438.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_177438.3:IVS22+13delG;AAlength=1922;EXAC_AF=0.29706976;EXAC_Hom_EAS=15;EXAC_AC_EAS=873;EXAC_AN_EAS=2492;EXAC_AC_Adj=17255;EXAC_AN_Adj=58084;RS=rs35300142;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=no_assertion_criteria_provided;gnomad_exomes_AF=0.15301992;gnomad_exomes_AF_EAS=0.09413657;gnomad_exomes_AC=32054;gnomad_exomes_Hom=11398;gnomad_exomes_Het=9258;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09572054;gnomad_exomes_AF_NFE=0.18445630;gnomad_exomes_AF_AMR=0.12838714;gnomad_exomes_AF_SAS=0.13297632;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.4871;normalHetNum=189;normalHomFrequency=0.049;normalHomNum=19;patientHetFrequency=0.5011;patientHetNum=1389;patientHomFrequency=0.061;patientHomNum=169;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4881;AF_2700_Hom=0.0388;AF_50_Het=0.4691;AF_50_Hom=0.0301;CytoBand=q32.13;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20.5;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=acacacacac.acacaAACTT	GT:AD:DP:GQ:PL	0/1:29,32:61:99:780,0,706
chr14	95566105	.	ACAC	A	1088.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.198;DP=144;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.33;ReadPosRankSum=-1.01;SOR=1.244;HGVSnom=NM_177438.3:c.4206+9_4206+11delGTG;Gene=DICER1;Transcript=NM_177438.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_177438.3:IVS22+9_+11delGTG;AAlength=1922;EXAC_AF=0.30768941;EXAC_Hom_EAS=13;EXAC_AC_EAS=802;EXAC_AN_EAS=2196;EXAC_AC_Adj=16334;EXAC_AN_Adj=53086;RS=rs367764979;CLNGENE=DICER1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.15515032;gnomad_exomes_AF_EAS=0.09645570;gnomad_exomes_AC=32212;gnomad_exomes_Hom=11437;gnomad_exomes_Het=9338;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.09743966;gnomad_exomes_AF_NFE=0.18700560;gnomad_exomes_AF_AMR=0.12948084;gnomad_exomes_AF_SAS=0.13458445;NativeFreq_Het=0.0248;NativeFreq_Hom=.;normalHetFrequency=0.5515;normalHetNum=214;normalHomFrequency=0.0541;normalHomNum=21;patientHetFrequency=0.5556;patientHetNum=1540;patientHomFrequency=0.0617;patientHomNum=171;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5576;AF_2700_Hom=0.0231;AF_50_Het=0.5547;AF_50_Hom=0.0206;CytoBand=q32.13;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20.5;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=acacacacac.aAACTTACCA	GT:AD:DP:GQ:PL	0/1:21,55:76:99:1106,0,455
chr14	95566107	.	AC	A	409.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.183;DP=144;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.39;ReadPosRankSum=-1.184;SOR=0.201;HGVSnom=NM_177438.3:c.4206+9delG;Gene=DICER1;Transcript=NM_177438.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_177438.3:IVS22+9delG;AAlength=1922;EXAC_AF=0.11220743;EXAC_Hom_EAS=2;EXAC_AC_EAS=107;EXAC_AN_EAS=584;EXAC_AC_Adj=2445;EXAC_AN_Adj=21790;RS=rs368080354;CLNGENE=DICER1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.01007185;gnomad_exomes_AF_EAS=0.00619835;gnomad_exomes_AC=2100;gnomad_exomes_Hom=482;gnomad_exomes_Het=1136;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03478474;gnomad_exomes_AF_NFE=0.00893341;gnomad_exomes_AF_AMR=0.00928943;gnomad_exomes_AF_SAS=0.00880566;NativeFreq_Het=0.0297;NativeFreq_Hom=.;normalHetFrequency=0.2784;normalHetNum=108;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.2742;patientHetNum=760;patientHomFrequency=0.0025;patientHomNum=7;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0047196|16B0019183-1|15B0062867|16D1536927|16D0002677|16D0155914|16B0001987-1][_];AF_2700_Het=0.2925;AF_2700_Hom=0.0004;AF_50_Het=0.3027;AF_50_Hom=.;CytoBand=q32.13;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=20.5;CGD_CONDITION=DICER1 syndrome;CGD_INHERITANCE=AD;Strand=DICER1:NM_001195573.1:-,DICER1:NM_001271282.2:-,DICER1:NM_177438.2:-,DICER1:NM_001291628.1:-,DICER1:NM_030621.4:-;NP=DICER1:NM_001195573.1:NP_001182502.1,DICER1:NM_001271282.2:NP_001258211.1,DICER1:NM_177438.2:NP_803187.1,DICER1:NM_001291628.1:NP_001278557.1,DICER1:NM_030621.4:NP_085124.2;ENSP=DICER1:NM_001195573.1:.,DICER1:NM_001271282.2:.,DICER1:NM_177438.2:ENST00000343455.7,DICER1:NM_001291628.1:.,DICER1:NM_030621.4:.;Gene_MIM_id=107410,606241;Phenotypes=.,Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3), Autosomal dominant. Pleuropulmonary blastoma, 601200 (3), Autosomal dominant. Rhabdomyosarcoma, embryonal, 2, 180295 (3). 138800(MK),180295(MK),601200(MK);Possible_Inheritance=NA,AD;EntrezGeneID=390502,23405;EnsemblGeneID=ENSG00000258597,ENSG00000100697;Alias=SERPINA2P, PIL, ATR, ARGS,DICER1, HERNA, KIAA0928, MNG1, RMSE2;FLKSEQ=acacacacac.aAACTTACCA	GT:AD:DP:GQ:PL	0/1:52,24:76:99:447,0,1619
chr14	104165927	.	T	C	2863.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.907;DP=206;ExcessHet=3.0103;FS=3.578;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.97;ReadPosRankSum=-0.949;SOR=0.974;HGVSnom=NM_001394837.1:c.1849-1065T>C|NM_005432.4:c.562-14A>G;Gene=KLC1|XRCC3;Transcript=NM_001394837.1|NM_005432.4;VarType=Intron|Intron;MolecularConsequence=coding_transcript_intron_variant|coding_transcript_intron_variant;ExonIntron=I15|I7;IVSnom=NM_001394837.1:IVS15-1065T>C|NM_005432.4:IVS7-14A>G;AAlength=639|346;EXAC_AF=0.30475436;EXAC_Hom_EAS=538;EXAC_AC_EAS=3081;EXAC_AN_EAS=8554;EXAC_AC_Adj=36537;EXAC_AN_Adj=119890;ESP6500_MAF=0.26433954;RS=rs1799796;CLNGENE=KLC1|XRCC3;CLNSIG=risk_factor|risk_factor;CLNSIGINCL=nan|nan;CLNREVSTAT=no_assertion_criteria_provided|no_assertion_criteria_provided;G1000_AF=0.246805;G1000_EAS_AF=0.3641;G1000_EUR_AF=0.2952;G1000_AFR_AF=0.1142;G1000_SAS_AF=0.1892;G1000_AMR_AF=0.3401;gnomad_exomes_AF=0.30769138;gnomad_exomes_AF_EAS=0.36303323;gnomad_exomes_AC=76441;gnomad_exomes_Hom=12508;gnomad_exomes_Het=51425;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15585305;gnomad_exomes_AF_NFE=0.32466181;gnomad_exomes_AF_AMR=0.34193287;gnomad_exomes_AF_SAS=0.20267268;HGMD_gene=XRCC3;HGMD_disease=Breast_cancer_protection_against_association_with;HGMD_tag=DP;HGMD_pmid=12023982;NativeFreq_Het=0.4356;NativeFreq_Hom=0.0693;AF_2700_Het=0.4374;AF_2700_Hom=0.1207;AF_50_Het=0.4406;AF_50_Hom=0.1078;DANN_score=0.3666;GREP_score=-7.92;CytoBand=q32.33;Strand=KLC1:NM_001130107.1:+,KLC1:NM_182923.3:+,XRCC3:NM_001100118.1:-,XRCC3:NM_001100119.1:-,XRCC3:NM_005432.3:-;NP=KLC1:NM_001130107.1:NP_001123579.1,KLC1:NM_182923.3:NP_891553.2,XRCC3:NM_001100118.1:NP_001093588.1,XRCC3:NM_001100119.1:NP_001093589.1,XRCC3:NM_005432.3:NP_005423.1;ENSP=KLC1:NM_001130107.1:.,KLC1:NM_182923.3:.,XRCC3:NM_001100118.1:.,XRCC3:NM_001100119.1:ENST00000555055.6,XRCC3:NM_005432.3:.;Gene_MIM_id=600025,600675;Phenotypes=.,{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 6}, 613972 (3). 114480(SK),613972(SK);Possible_Inheritance=NA,AD;EntrezGeneID=3831,7517;EnsemblGeneID=ENSG00000126214,ENSG00000126215;Alias=KLC1, KNS2, KNS2A,XRCC3, CMM6;FLKSEQ=TGGGGACAGC.GTCATTGTCT	GT:AD:DP:GQ:PL	0/1:102,103:205:99:2892,0,3255
chr14	104179314	.	T	C	13155.8	PASS	AC=2;AF=1;AN=2;DP=377;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.52;SOR=1.002;HGVSnom=NM_005432.4:c.-317-46A>G;Gene=XRCC3;Transcript=NM_005432.4;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_005432.4:IVS1-46A>G;AAlength=346;RS=rs861529;G1000_AF=0.866613;G1000_EAS_AF=0.9226;G1000_EUR_AF=0.9672;G1000_AFR_AF=0.7769;G1000_SAS_AF=0.8763;G1000_AMR_AF=0.7968;dbscSNV_RF_score=.;dbscSNV_ADA_score=0.00003789;DANN_score=0.2941;GREP_score=0.137;CytoBand=q32.33;repName=MER31A;repClass=LTR;Strand=XRCC3:NM_001100118.1:-,XRCC3:NM_001100119.1:-,XRCC3:NM_005432.3:-;NP=XRCC3:NM_001100118.1:NP_001093588.1,XRCC3:NM_001100119.1:NP_001093589.1,XRCC3:NM_005432.3:NP_005423.1;ENSP=XRCC3:NM_001100118.1:.,XRCC3:NM_001100119.1:ENST00000555055.6,XRCC3:NM_005432.3:.;Gene_MIM_id=600675;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. {Melanoma, cutaneous malignant, 6}, 613972 (3). 114480(SK),613972(SK);Possible_Inheritance=AD;EntrezGeneID=7517;EnsemblGeneID=ENSG00000126215;Alias=XRCC3, CMM6;FLKSEQ=gtctgtttag.gacgacctcc	GT:AD:DP:GQ:PL	1/1:0,375:375:99:13184,1127,0
chr14	105239192	.	T	C	2733.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.685;DP=195;ExcessHet=3.0103;FS=1.171;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.02;ReadPosRankSum=0.701;SOR=0.606;HGVSnom=NM_001382430.1:c.1172+23A>G;Gene=AKT1;Transcript=NM_001382430.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_001382430.1:IVS12+23A>G;AAlength=480;EXAC_AF=0.52247553;EXAC_Hom_EAS=1959;EXAC_AC_EAS=5385;EXAC_AN_EAS=7248;EXAC_AC_Adj=51886;EXAC_AN_Adj=99308;ESP6500_MAF=0.45301446;RS=rs2494732;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.574081;G1000_EAS_AF=0.7341;G1000_EUR_AF=0.4384;G1000_AFR_AF=0.4992;G1000_SAS_AF=0.6247;G1000_AMR_AF=0.6095;gnomad_exomes_AF=0.49864681;gnomad_exomes_AF_EAS=0.73018803;gnomad_exomes_AC=114234;gnomad_exomes_Hom=29621;gnomad_exomes_Het=54992;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49010230;gnomad_exomes_AF_NFE=0.42856325;gnomad_exomes_AF_AMR=0.62455884;gnomad_exomes_AF_SAS=0.54669433;NativeFreq_Het=0.4093;NativeFreq_Hom=0.4306;normalHetFrequency=0.4035;normalHetNum=349;normalHomFrequency=0.4451;normalHomNum=385;patientHetFrequency=0.4059;patientHetNum=2119;patientHomFrequency=0.4477;patientHomNum=2337;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5531;GREP_score=-3.3;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=GTGTAGCCTG.AGCTGGGATG	GT:AD:DP:GQ:PL	0/1:102,93:195:99:2762,0,2833
chr14	105239894	.	C	T	3571.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.528;DP=220;ExcessHet=3.0103;FS=6.798;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.24;ReadPosRankSum=-0.218;SOR=1.121;HGVSnom=NM_001382430.1:c.726G>A(p.Glu242Glu/p.E242E);Gene=AKT1;Transcript=NM_001382430.1;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E10;IVSnom=.;AAlength=480;EXAC_AF=0.31413316;EXAC_Hom_EAS=1244;EXAC_AC_EAS=4328;EXAC_AN_EAS=7370;EXAC_AC_Adj=30535;EXAC_AN_Adj=97204;ESP6500_MAF=0.20163027;RS=rs1130233;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.322484;G1000_EAS_AF=0.6002;G1000_EUR_AF=0.2425;G1000_AFR_AF=0.0787;G1000_SAS_AF=0.3773;G1000_AMR_AF=0.4222;gnomad_exomes_AF=0.29754271;gnomad_exomes_AF_EAS=0.57997467;gnomad_exomes_AC=70714;gnomad_exomes_Hom=12365;gnomad_exomes_Het=45984;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10768221;gnomad_exomes_AF_NFE=0.23664378;gnomad_exomes_AF_AMR=0.47210052;gnomad_exomes_AF_SAS=0.32484142;HGMD_gene=AKT1;HGMD_disease=Schizophrenia_familial_association_with;HGMD_tag=DFP;HGMD_pmid=18497887;NativeFreq_Het=0.4164;NativeFreq_Hom=0.2562;normalHetFrequency=0.4497;normalHetNum=389;normalHomFrequency=0.2659;normalHomNum=230;patientHetFrequency=0.4341;patientHetNum=2266;patientHomFrequency=0.2818;patientHomNum=1471;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8803;GREP_score=4.78;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=AGAACACACG.TCCCGGGACA	GT:AD:DP:GQ:PL	0/1:104,116:220:99:3600,0,3325
chr14	105242966	.	T	C	2325.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.721;DP=160;ExcessHet=3.0103;FS=7.635;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.54;ReadPosRankSum=-0.448;SOR=1.308;HGVSnom=NM_001382430.1:c.287+30A>G;Gene=AKT1;Transcript=NM_001382430.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_001382430.1:IVS5+30A>G;AAlength=480;EXAC_AF=0.46484637;EXAC_Hom_EAS=1766;EXAC_AC_EAS=5462;EXAC_AN_EAS=8416;EXAC_AC_Adj=54070;EXAC_AN_Adj=116318;ESP6500_MAF=0.47177791;RS=rs2494735;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.596446;G1000_EAS_AF=0.6548;G1000_EUR_AF=0.3728;G1000_AFR_AF=0.736;G1000_SAS_AF=0.6094;G1000_AMR_AF=0.5519;gnomad_exomes_AF=0.45935468;gnomad_exomes_AF_EAS=0.64638867;gnomad_exomes_AC=111614;gnomad_exomes_Hom=27735;gnomad_exomes_Het=56144;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.70942638;gnomad_exomes_AF_NFE=0.35580342;gnomad_exomes_AF_AMR=0.58488338;gnomad_exomes_AF_SAS=0.53579769;NativeFreq_Het=0.4306;NativeFreq_Hom=0.3772;normalHetFrequency=0.4116;normalHetNum=356;normalHomFrequency=0.3873;normalHomNum=335;patientHetFrequency=0.4291;patientHetNum=2240;patientHomFrequency=0.3835;patientHomNum=2002;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.1792;GREP_score=-3.58;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=GCTGCCCAAG.GCCTGGCCTG	GT:AD:DP:GQ:PL	0/1:82,78:160:99:2354,0,2350
chr14	105246407	.	G	A	3230.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.293;DP=229;ExcessHet=3.0103;FS=3.316;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.17;ReadPosRankSum=0.583;SOR=0.489;HGVSnom=NM_001382430.1:c.175+18C>T;Gene=AKT1;Transcript=NM_001382430.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_001382430.1:IVS4+18C>T;AAlength=480;EXAC_AF=0.15894956;EXAC_Hom_EAS=16;EXAC_AC_EAS=566;EXAC_AN_EAS=8634;EXAC_AC_Adj=19066;EXAC_AN_Adj=119950;ESP6500_MAF=0.17261264;RS=rs3730358;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.174121;G1000_EAS_AF=0.0774;G1000_EUR_AF=0.161;G1000_AFR_AF=0.2103;G1000_SAS_AF=0.1943;G1000_AMR_AF=0.2363;gnomad_exomes_AF=0.15986760;gnomad_exomes_AF_EAS=0.06303302;gnomad_exomes_AC=39847;gnomad_exomes_Hom=3567;gnomad_exomes_Het=32713;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20781231;gnomad_exomes_AF_NFE=0.14680548;gnomad_exomes_AF_AMR=0.23278880;gnomad_exomes_AF_SAS=0.18853587;NativeFreq_Het=0.2171;NativeFreq_Hom=0.0356;normalHetFrequency=0.1538;normalHetNum=133;normalHomFrequency=0.0081;normalHomNum=7;patientHetFrequency=0.1552;patientHetNum=810;patientHomFrequency=0.0121;patientHomNum=63;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1546267][16D1545958|16D1546097|15D6517286|16D1545675|15B0002874-1|16D0159561];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2879;GREP_score=1.09;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=AATCCCGAGA.GCCAAGGGGA	GT:AD:DP:GQ:PL	0/1:120,108:228:99:3259,0,3915
chr14	105258892	.	C	T	2020.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.995;DP=120;ExcessHet=3.0103;FS=1.755;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.98;ReadPosRankSum=-1.212;SOR=0.523;HGVSnom=NM_001382430.1:c.46+43G>A;Gene=AKT1;Transcript=NM_001382430.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001382430.1:IVS3+43G>A;AAlength=480;EXAC_AF=0.51073525;EXAC_Hom_EAS=155;EXAC_AC_EAS=1673;EXAC_AN_EAS=8536;EXAC_AC_Adj=61087;EXAC_AN_Adj=119606;ESP6500_MAF=0.42939548;RS=rs2494748;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.35623;G1000_EAS_AF=0.2083;G1000_EUR_AF=0.6083;G1000_AFR_AF=0.1982;G1000_SAS_AF=0.3773;G1000_AMR_AF=0.4769;gnomad_exomes_AF=0.51312545;gnomad_exomes_AF_EAS=0.19704407;gnomad_exomes_AC=127368;gnomad_exomes_Hom=35222;gnomad_exomes_Het=56924;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24906763;gnomad_exomes_AF_NFE=0.61396771;gnomad_exomes_AF_AMR=0.46088544;gnomad_exomes_AF_SAS=0.42225998;NativeFreq_Het=0.3808;NativeFreq_Hom=0.1495;normalHetFrequency=0.3329;normalHetNum=288;normalHomFrequency=0.141;normalHomNum=122;patientHetFrequency=0.3435;patientHetNum=1793;patientHomFrequency=0.1238;patientHomNum=646;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.81;GREP_score=-1.24;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=CTACTACCCC.ATCTCTCCCT	GT:AD:DP:GQ:PL	0/1:66,53:119:99:2049,0,4393
chr14	105258893	.	A	G	2020.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.462;DP=126;ExcessHet=3.0103;FS=0.815;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.17;ReadPosRankSum=-0.504;SOR=0.536;HGVSnom=NM_001382430.1:c.46+42T>C;Gene=AKT1;Transcript=NM_001382430.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001382430.1:IVS3+42T>C;AAlength=480;EXAC_AF=0.82374461;EXAC_Hom_EAS=489;EXAC_AC_EAS=2911;EXAC_AN_EAS=8510;EXAC_AC_Adj=98622;EXAC_AN_Adj=119724;ESP6500_MAF=0.90909091;RS=rs2494749;CLNGENE=AKT1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.709265;G1000_EAS_AF=0.3304;G1000_EUR_AF=0.9076;G1000_AFR_AF=0.8797;G1000_SAS_AF=0.6227;G1000_AMR_AF=0.7695;gnomad_exomes_AF=0.81627757;gnomad_exomes_AF_EAS=0.33464352;gnomad_exomes_AC=202796;gnomad_exomes_Hom=86399;gnomad_exomes_Het=29998;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.88790854;gnomad_exomes_AF_NFE=0.92464973;gnomad_exomes_AF_AMR=0.70626919;gnomad_exomes_AF_SAS=0.68971376;NativeFreq_Het=0.3203;NativeFreq_Hom=0.3915;normalHetFrequency=0.3549;normalHetNum=307;normalHomFrequency=0.2867;normalHomNum=248;patientHetFrequency=0.3715;patientHetNum=1939;patientHomFrequency=0.2701;patientHomNum=1410;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2947;GREP_score=-3.79;CytoBand=q32.33;CGD_CONDITION=Cowden syndrome 6. Proteus syndrome ;CGD_INHERITANCE=AD;Strand=AKT1:NM_005163.2:-,AKT1:NM_001014431.1:-,AKT1:NM_001014432.1:-;NP=AKT1:NM_005163.2:NP_005154.2,AKT1:NM_001014431.1:NP_001014431.1,AKT1:NM_001014432.1:NP_001014432.1;ENSP=AKT1:NM_005163.2:ENST00000555528.5,AKT1:NM_001014431.1:.,AKT1:NM_001014432.1:.;Gene_MIM_id=164730;Phenotypes=Breast cancer, somatic, 114480 (3). Colorectal cancer, somatic, 114500 (3). Cowden syndrome 6, 615109 (3). Ovarian cancer, somatic, 167000 (3). Proteus syndrome, somatic, 176920 (3). {Schizophrenia, susceptibility to}, 181500 (2), Autosomal dominant. 114480(MK),114500(MK),167000(MK),176920(MK),181500(SL),615109(MK);Possible_Inheritance=AD;EntrezGeneID=207;EnsemblGeneID=ENSG00000142208;Alias=AKT1, CWS6;FLKSEQ=TACTACCCCC.TCTCTCCCTC	GT:AD:DP:GQ:PL	0/1:71,54:125:99:2049,0,4393
chr15	33010242	.	A	T	703.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.951;DP=47;ExcessHet=3.0103;FS=1.368;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.97;ReadPosRankSum=0.78;SOR=0.448;HGVSnom=NM_013372.7:c.-122A>T;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=184;RS=rs537464935;G1000_AF=0.00199681;G1000_EAS_AF=0.0089;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00047051;gnomad_exomes_AF_EAS=0.00271739;gnomad_exomes_AC=3;gnomad_exomes_Hom=0;gnomad_exomes_Het=3;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;DANN_score=0.9297;GREP_score=1.21;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=GACCCAGTGC.CGGCCGCCGC	GT:AD:DP:GQ:PL	0/1:22,25:47:99:732,0,626
chr15	33010412	.	G	A	2371.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.753;DP=71;ExcessHet=3.0103;FS=3.327;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.41;ReadPosRankSum=0.733;SOR=0.499;HGVSnom=NM_013372.7:c.-2+50G>A|NR_109767.1:n.475C>T;Gene=GREM1|GREM1-AS1;Transcript=NM_013372.7|NR_109767.1;VarType=Intron|Noncoding;MolecularConsequence=5_prime_UTR_intron_variant|noncoding_transcript_exon_variant;ExonIntron=I1|E2;IVSnom=NM_013372.7:IVS1+50G>A|.;AAlength=184|.;EXAC_AF=0.32120098;EXAC_Hom_EAS=17;EXAC_AC_EAS=83;EXAC_AN_EAS=160;EXAC_AC_Adj=2621;EXAC_AN_Adj=8160;RS=rs2293582;CLNGENE=GREM1|GREM1-AS1;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;G1000_AF=0.268371;G1000_EAS_AF=0.5119;G1000_EUR_AF=0.2038;G1000_AFR_AF=0.1626;G1000_SAS_AF=0.3139;G1000_AMR_AF=0.1455;gnomad_exomes_AF=0.23097893;gnomad_exomes_AF_EAS=0.49064171;gnomad_exomes_AC=30164;gnomad_exomes_Hom=4086;gnomad_exomes_Het=21992;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15843949;gnomad_exomes_AF_NFE=0.19375272;gnomad_exomes_AF_AMR=0.18729373;gnomad_exomes_AF_SAS=0.29095142;HGMD_gene=GREM1;HGMD_disease=Colorectal_cancer_risk_association_with;HGMD_tag=DP;HGMD_pmid=27379672;DANN_score=0.8643;GREP_score=-0.884;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=AGGGAAGAGG.CCGCAAACCA	GT:AD:DP:GQ:PL	1/1:1,70:71:99:2400,203,0
chr15	33023670	.	C	T	13900.8	PASS	AC=2;AF=1;AN=2;DP=366;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.46;SOR=0.732;HGVSnom=NM_013372.7:c.*224C>T;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs33963919;CLNGENE=GREM1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.515974;G1000_EAS_AF=0.7937;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.1755;G1000_SAS_AF=0.6145;G1000_AMR_AF=0.4827;NativeFreq_Het=0.2100;NativeFreq_Hom=0.0712;DANN_score=0.5253;GREP_score=1.42;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=AGAGAGCACT.CCTATTTTGT	GT:AD:DP:GQ:PL	1/1:0,365:365:99:13929,1098,0
chr15	33023685	.	A	C	14923.8	PASS	AC=2;AF=1;AN=2;DP=381;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.16;SOR=0.753;HGVSnom=NM_013372.7:c.*239A>C;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs17816260;CLNGENE=GREM1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.516573;G1000_EAS_AF=0.7937;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.1755;G1000_SAS_AF=0.6166;G1000_AMR_AF=0.4841;NativeFreq_Het=0.1815;NativeFreq_Hom=0.2206;DANN_score=0.401;GREP_score=-4.65;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=TTTTGTAAAC.TATCTGCTTT	GT:AD:DP:GQ:PL	1/1:0,379:379:99:14952,1140,0
chr15	33023951	.	T	C	13313.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.36;DP=354;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.58;ReadPosRankSum=-1.376;SOR=0.298;HGVSnom=NM_013372.7:c.*505T>C;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs3743105;G1000_AF=0.517572;G1000_EAS_AF=0.7956;G1000_EUR_AF=0.6133;G1000_AFR_AF=0.1755;G1000_SAS_AF=0.6145;G1000_AMR_AF=0.4899;DANN_score=0.5885;GREP_score=3.67;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=CTTAAGTTGA.AGTGACTATG	GT:AD:DP:GQ:PL	1/1:1,353:354:99:13342,1024,0
chr15	33023985	.	A	G	11841.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.017;DP=304;ExcessHet=3.0103;FS=3.039;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.27;ReadPosRankSum=0.884;SOR=0.255;HGVSnom=NM_013372.7:c.*539A>G;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs3743104;G1000_AF=0.451677;G1000_EAS_AF=0.5754;G1000_EUR_AF=0.5944;G1000_AFR_AF=0.1762;G1000_SAS_AF=0.5286;G1000_AMR_AF=0.4813;NativeFreq_Het=0.0107;NativeFreq_Hom=0;DANN_score=0.8879;GREP_score=-0.139;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=TTGTTTGCCA.GGTTCCTAAA	GT:AD:DP:GQ:PL	1/1:1,303:304:99:11870,875,0
chr15	33025627	.	C	T	16692.8	PASS	AC=2;AF=1;AN=2;DP=462;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.68;SOR=0.812;HGVSnom=NM_013372.7:c.*2181C>T;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs3743103;G1000_AF=0.473842;G1000_EAS_AF=0.5764;G1000_EUR_AF=0.5915;G1000_AFR_AF=0.2746;G1000_SAS_AF=0.5102;G1000_AMR_AF=0.4827;DANN_score=0.6763;GREP_score=0.96;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=ATTTCGTTAA.GGAGATGACT	GT:AD:DP:GQ:PL	1/1:0,460:460:99:16721,1383,0
chr15	33025979	.	C	T	7784.77	PASS	AC=2;AF=1;AN=2;DP=200;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.48;SOR=1.145;HGVSnom=NM_013372.7:c.*2533C>T;Gene=GREM1;Transcript=NM_013372.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E2;IVSnom=.;AAlength=184;RS=rs10318;G1000_AF=0.23103;G1000_EAS_AF=0.5546;G1000_EUR_AF=0.2038;G1000_AFR_AF=0.0106;G1000_SAS_AF=0.2935;G1000_AMR_AF=0.1326;DANN_score=0.6485;GREP_score=5.05;CytoBand=q13.3;CGD_CONDITION=Polyposis syndrome, mixed hereditary 1;CGD_INHERITANCE=AD;Strand=GREM1:NM_001191322.1:+,GREM1:NM_001191323.1:+,GREM1:NM_013372.6:+;NP=GREM1:NM_001191322.1:NP_001178251.1,GREM1:NM_001191323.1:NP_001178252.1,GREM1:NM_013372.6:NP_037504.1;ENSP=GREM1:NM_001191322.1:.,GREM1:NM_001191323.1:.,GREM1:NM_013372.6:ENST00000622074.1;Gene_MIM_id=603054;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=26585;EnsemblGeneID=ENSG00000166923;Alias=GREM1, CKTSF1B1;FLKSEQ=TTGATCATAC.TATTAAAATA	GT:AD:DP:GQ:PL	1/1:0,200:200:99:7813,601,0
chr15	38614525	.	G	A	24558.8	PASS	AC=2;AF=1;AN=2;DP=664;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.55;SOR=0.797;HGVSnom=NM_152594.3:c.291G>A(p.Lys97Lys/p.K97K);Gene=SPRED1;Transcript=NM_152594.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=444;EXAC_AF=0.86374497;EXAC_Hom_EAS=2711;EXAC_AC_EAS=6834;EXAC_AN_EAS=8644;EXAC_AC_Adj=104831;EXAC_AN_Adj=121368;ESP6500_MAF=0.82584270;RS=rs7182445;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.80012;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.9006;G1000_AFR_AF=0.652;G1000_SAS_AF=0.8661;G1000_AMR_AF=0.8401;gnomad_exomes_AF=0.86538477;gnomad_exomes_AF_EAS=0.78979436;gnomad_exomes_AC=217376;gnomad_exomes_Hom=94735;gnomad_exomes_Het=27906;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65386982;gnomad_exomes_AF_NFE=0.89577571;gnomad_exomes_AF_AMR=0.82603413;gnomad_exomes_AF_SAS=0.89100470;NativeFreq_Het=0.2901;NativeFreq_Hom=0.6667;normalHetFrequency=0.3029;normalHetNum=262;normalHomFrequency=0.6543;normalHomNum=566;patientHetFrequency=0.2977;patientHetNum=1554;patientHomFrequency=0.6598;patientHomNum=3444;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6619;GREP_score=2.55;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=TTGATGACAA.AAGTTTGGTC	GT:AD:DP:GQ:PL	1/1:0,663:663:99:24587,1993,0
chr15	38631930	.	C	A	9929.77	PASS	AC=2;AF=1;AN=2;DP=279;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.7;SOR=1.526;HGVSnom=NM_152594.3:c.424-8C>A;Gene=SPRED1;Transcript=NM_152594.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_152594.3:IVS4-8C>A;AAlength=444;EXAC_AF=0.86369934;EXAC_Hom_EAS=2705;EXAC_AC_EAS=6830;EXAC_AN_EAS=8642;EXAC_AC_Adj=104727;EXAC_AN_Adj=121254;ESP6500_MAF=0.82545790;RS=rs7180446;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.799321;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.9006;G1000_AFR_AF=0.649;G1000_SAS_AF=0.8661;G1000_AMR_AF=0.8401;gnomad_exomes_AF=0.86530695;gnomad_exomes_AF_EAS=0.78903275;gnomad_exomes_AC=217263;gnomad_exomes_Hom=94677;gnomad_exomes_Het=27909;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65290426;gnomad_exomes_AF_NFE=0.89576140;gnomad_exomes_AF_AMR=0.82617131;gnomad_exomes_AF_SAS=0.89109978;NativeFreq_Het=0.2840;NativeFreq_Hom=0.6574;normalHetFrequency=0.304;normalHetNum=263;normalHomFrequency=0.6543;normalHomNum=566;patientHetFrequency=0.2983;patientHetNum=1557;patientHomFrequency=0.659;patientHomNum=3440;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];dbscSNV_RF_score=0.082;dbscSNV_ADA_score=0.00510656;DANN_score=0.6662;GREP_score=-0.199;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=GAGGGTTGTT.CCAATAGGCA	GT:AD:DP:GQ:PL	1/1:0,279:279:99:9958,839,0
chr15	38641773	.	G	GTT	4790.73	PASS	AC=2;AF=1;AN=2;DP=104;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.9;SOR=5.263;HGVSnom=NM_152594.3:c.684+49_684+50insTT;Gene=SPRED1;Transcript=NM_152594.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_152594.3:IVS6+49_+50insTT;AAlength=444;EXAC_AF=0.81795459;EXAC_Hom_EAS=325;EXAC_AC_EAS=920;EXAC_AN_EAS=1412;EXAC_AC_Adj=35015;EXAC_AN_Adj=42808;RS=rs61670754;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.80844332;gnomad_exomes_AF_EAS=0.67631125;gnomad_exomes_AC=104252;gnomad_exomes_Hom=46173;gnomad_exomes_Het=11906;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51040910;gnomad_exomes_AF_NFE=0.85695441;gnomad_exomes_AF_AMR=0.72122449;gnomad_exomes_AF_SAS=0.83934687;NativeFreq_Het=0.3573;NativeFreq_Hom=.;normalHetFrequency=0.3017;normalHetNum=261;normalHomFrequency=0.6532;normalHomNum=565;patientHetFrequency=0.2981;patientHetNum=1556;patientHomFrequency=0.66;patientHomNum=3445;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=CTAATTAATA.ATAGGTAAAG	GT:AD:DP:GQ:PL	1/1:0,102:102:99:4828,324,0
chr15	38641774	.	A	AAAT	4792.73	PASS	AC=2;AF=1;AN=2;DP=107;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.9;SOR=5.343;HGVSnom=NM_152594.3:c.684+50_684+51insAAT;Gene=SPRED1;Transcript=NM_152594.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_152594.3:IVS6+50_+51insAAT;AAlength=444;EXAC_AF=0.78340820;EXAC_Hom_EAS=222;EXAC_AC_EAS=674;EXAC_AN_EAS=1150;EXAC_AC_Adj=27905;EXAC_AN_Adj=35620;RS=rs34352434;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.82133331;gnomad_exomes_AF_EAS=0.70689186;gnomad_exomes_AC=97305;gnomad_exomes_Hom=43288;gnomad_exomes_Het=10729;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51924619;gnomad_exomes_AF_NFE=0.86401547;gnomad_exomes_AF_AMR=0.74213424;gnomad_exomes_AF_SAS=0.85906654;NativeFreq_Het=0.4281;NativeFreq_Hom=.;normalHetFrequency=0.3006;normalHetNum=260;normalHomFrequency=0.6532;normalHomNum=565;patientHetFrequency=0.2983;patientHetNum=1557;patientHomFrequency=0.6596;patientHomNum=3443;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=TAATTAATAG.TAGGTAAAGT	GT:AD:DP:GQ:PL	1/1:0,106:106:99:4830,325,0
chr15	38643574	.	T	C	12988.8	PASS	AC=2;AF=1;AN=2;DP=343;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.61;SOR=0.83;HGVSnom=NM_152594.3:c.1044T>C(p.Val348Val/p.V348V);Gene=SPRED1;Transcript=NM_152594.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=444;EXAC_AF=0.86366783;EXAC_Hom_EAS=2706;EXAC_AC_EAS=6833;EXAC_AN_EAS=8640;EXAC_AC_Adj=104813;EXAC_AN_Adj=121358;ESP6500_MAF=0.82538095;RS=rs3751526;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.799521;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.9006;G1000_AFR_AF=0.649;G1000_SAS_AF=0.8661;G1000_AMR_AF=0.8415;gnomad_exomes_AF=0.86523812;gnomad_exomes_AF_EAS=0.78896987;gnomad_exomes_AC=217398;gnomad_exomes_Hom=94733;gnomad_exomes_Het=27932;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65190107;gnomad_exomes_AF_NFE=0.89576877;gnomad_exomes_AF_AMR=0.82626432;gnomad_exomes_AF_SAS=0.89107003;NativeFreq_Het=0.2901;NativeFreq_Hom=0.6605;normalHetFrequency=0.3052;normalHetNum=264;normalHomFrequency=0.6543;normalHomNum=566;patientHetFrequency=0.2996;patientHetNum=1564;patientHomFrequency=0.6598;patientHomNum=3444;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7733;GREP_score=4.0;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=AAGAAAATGT.AGGGGAAAAT	GT:AD:DP:GQ:PL	1/1:0,340:340:99:13017,1022,0
chr15	38647386	.	A	G	1778.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.311;DP=103;ExcessHet=3.0103;FS=0.969;MLEAC=1;MLEAF=0.5;MQ=59.35;MQRankSum=2.371;QD=17.44;ReadPosRankSum=-1.411;SOR=0.929;HGVSnom=NM_152594.3:c.*3521A>G;Gene=SPRED1;Transcript=NM_152594.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=444;RS=rs11634702;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.216054;G1000_EAS_AF=0.5397;G1000_EUR_AF=0.1093;G1000_AFR_AF=0.0053;G1000_SAS_AF=0.2648;G1000_AMR_AF=0.2334;NativeFreq_Het=0.4259;NativeFreq_Hom=0.3395;normalHetFrequency=0.4256;normalHetNum=203;normalHomFrequency=0.1992;normalHomNum=95;patientHetFrequency=0.4171;patientHetNum=1021;patientHomFrequency=0.1088;patientHomNum=568;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4804;GREP_score=0.43;CytoBand=q14;repName=AluSq2;repClass=SINE;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=tgaactcctg.ccttaggtga	GT:AD:DP:GQ:PL	0/1:49,53:102:99:1807,0,1452
chr15	38647811	.	G	A	8784.77	PASS	AC=2;AF=1;AN=2;DP=233;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.48;SOR=1.051;HGVSnom=NM_152594.3:c.*3946G>A;Gene=SPRED1;Transcript=NM_152594.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=444;RS=rs8039337;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.954073;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=0.8336;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9856;NativeFreq_Het=0;NativeFreq_Hom=0.9938;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.9937;normalHomNum=474;patientHetFrequency=0.0016;patientHetNum=4;patientHomFrequency=0.4678;patientHomNum=2442;normalHetSampleInfo=[_][16D0157336];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15D6482412-1|16D0166397|15D6529787|15D6482122-1];patientHomSampleInfo=[_][_];DANN_score=0.587;GREP_score=-0.144;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=ACACTTGGAA.TATGTGTTAA	GT:AD:DP:GQ:PL	1/1:0,232:232:99:8813,698,0
chr15	38648527	.	T	A	6905.77	PASS	AC=2;AF=1;AN=2;DP=183;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.79;SOR=0.883;HGVSnom=NM_152594.3:c.*4662T>A;Gene=SPRED1;Transcript=NM_152594.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=444;RS=rs10852019;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.767372;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.8757;G1000_AFR_AF=0.5567;G1000_SAS_AF=0.864;G1000_AMR_AF=0.8242;NativeFreq_Het=0.2778;NativeFreq_Hom=0.6574;normalHetFrequency=0.3396;normalHetNum=162;normalHomFrequency=0.6143;normalHomNum=293;patientHetFrequency=0.3141;patientHetNum=769;patientHomFrequency=0.2989;patientHomNum=1560;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9055;GREP_score=6.07;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=AATAATACAT.ATAAGTTTGT	GT:AD:DP:GQ:PL	1/1:0,182:182:99:6934,547,0
chr15	38648975	.	C	T	9081.77	PASS	AC=2;AF=1;AN=2;DP=237;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.71;SOR=2.501;HGVSnom=NM_152594.3:c.*5110C>T;Gene=SPRED1;Transcript=NM_152594.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=444;RS=rs8026118;CLNGENE=SPRED1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.753794;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.8748;G1000_AFR_AF=0.5068;G1000_SAS_AF=0.864;G1000_AMR_AF=0.8228;NativeFreq_Het=0.2747;NativeFreq_Hom=0.6574;normalHetFrequency=0.3417;normalHetNum=163;normalHomFrequency=0.6122;normalHomNum=292;patientHetFrequency=0.3186;patientHetNum=780;patientHomFrequency=0.2981;patientHomNum=1556;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6082;GREP_score=-5.88;CytoBand=q14;CGD_CONDITION=Legius syndrome;CGD_INHERITANCE=AD;Strand=SPRED1:NM_152594.3:+,SPRED1:NM_152594.2:+;NP=SPRED1:NM_152594.3:NP_689807.1,SPRED1:NM_152594.2:NP_689807.1;ENSP=SPRED1:NM_152594.3:ENST00000299084.9,SPRED1:NM_152594.2:.;Gene_MIM_id=609291;Phenotypes=Legius syndrome, 611431 (3), Autosomal dominant. 611431(MK);Possible_Inheritance=AD;EntrezGeneID=161742;EnsemblGeneID=ENSG00000166068;Alias=SPRED1, NFLS;FLKSEQ=TCAGTTTCAT.GTTTTACTTA	GT:AD:DP:GQ:PL	1/1:0,237:237:99:9110,713,0
chr15	40453307	.	A	G	5724.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.029;DP=368;ExcessHet=3.0103;FS=6.046;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.56;ReadPosRankSum=0.121;SOR=0.471;HGVSnom=NM_001211.6:c.-115A>G;Gene=BUB1B;Transcript=NM_001211.6;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1050;RS=rs2277559;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.613019;G1000_EAS_AF=0.3492;G1000_EUR_AF=0.6928;G1000_AFR_AF=0.7814;G1000_SAS_AF=0.5828;G1000_AMR_AF=0.6023;NativeFreq_Het=0.4448;NativeFreq_Hom=0.2705;normalHetFrequency=0.3711;normalHetNum=144;normalHomFrequency=0.1649;normalHomNum=64;patientHetFrequency=0.3939;patientHetNum=1092;patientHomFrequency=0.1959;patientHomNum=543;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4024;AF_2700_Hom=0.0972;AF_50_Het=0.3835;AF_50_Hom=0.0903;DANN_score=0.5922;GREP_score=0.519;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=GGAGTCGTGT.CGTGCCTTGG	GT:AD:DP:GQ:PL	0/1:187,181:368:99:5753,0,5501
chr15	40453497	.	G	A	3553.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.596;DP=235;ExcessHet=3.0103;FS=2.309;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.12;ReadPosRankSum=-0.258;SOR=0.875;HGVSnom=NM_001211.6:c.35+41G>A;Gene=BUB1B;Transcript=NM_001211.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_001211.6:IVS1+41G>A;AAlength=1050;EXAC_AF=0.45629310;EXAC_Hom_EAS=156;EXAC_AC_EAS=1591;EXAC_AN_EAS=6440;EXAC_AC_Adj=42344;EXAC_AN_Adj=92800;ESP6500_MAF=0.39909175;RS=rs2277560;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.349641;G1000_EAS_AF=0.2728;G1000_EUR_AF=0.5;G1000_AFR_AF=0.1513;G1000_SAS_AF=0.4908;G1000_AMR_AF=0.4222;gnomad_exomes_AF=0.44633358;gnomad_exomes_AF_EAS=0.23801782;gnomad_exomes_AC=98837;gnomad_exomes_Hom=22794;gnomad_exomes_Het=53249;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20775463;gnomad_exomes_AF_NFE=0.50222922;gnomad_exomes_AF_AMR=0.44824063;gnomad_exomes_AF_SAS=0.47011709;NativeFreq_Het=0.4342;NativeFreq_Hom=0.1174;normalHetFrequency=0.3557;normalHetNum=138;normalHomFrequency=0.0825;normalHomNum=32;patientHetFrequency=0.3773;patientHetNum=1046;patientHomFrequency=0.101;patientHomNum=280;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8751;GREP_score=2.71;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=GGCCTGAGAG.ACACGGCCTG	GT:AD:DP:GQ:PL	0/1:118,117:235:99:3582,0,3774
chr15	40477831	.	G	A	3985.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.346;DP=289;ExcessHet=3.0103;FS=0.9;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.79;ReadPosRankSum=-1.882;SOR=0.766;HGVSnom=NM_001211.6:c.1046G>A(p.Arg349Gln/p.R349Q);Gene=BUB1B;Transcript=NM_001211.6;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E8;IVSnom=.;AAlength=1050;EXAC_AF=0.65662125;EXAC_Hom_EAS=419;EXAC_AC_EAS=2746;EXAC_AN_EAS=8644;EXAC_AC_Adj=79702;EXAC_AN_Adj=121382;ESP6500_MAF=0.73596801;RS=rs1801376;Ensembl_transcriptid=ENST00000287598|ENST00000412359;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.0|0.0;MutationTaster_pred=P|P;MutationTaster_score=0.999991|0.999991;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.628195;G1000_EAS_AF=0.3462;G1000_EUR_AF=0.6928;G1000_AFR_AF=0.8593;G1000_SAS_AF=0.5562;G1000_AMR_AF=0.6052;gnomad_exomes_AF=0.65011813;gnomad_exomes_AF_EAS=0.32298576;gnomad_exomes_AC=163454;gnomad_exomes_Hom=55071;gnomad_exomes_Het=53312;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.82613511;gnomad_exomes_AF_NFE=0.70772518;gnomad_exomes_AF_AMR=0.61088302;gnomad_exomes_AF_SAS=0.54376796;HGMD_gene=BUB1B;HGMD_disease=Leukaemia_risk_association_with;HGMD_tag=DP;HGMD_pmid=16574953;NativeFreq_Het=0.4342;NativeFreq_Hom=0.2776;DANN_score=0.3016;GREP_score=4.72;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=GAGACTGCAC.ACAGCCAGTT	GT:AD:DP:GQ:PL	0/1:159,130:289:99:4014,0,4751
chr15	40488851	.	G	A	3483.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.06;DP=226;ExcessHet=3.0103;FS=0.495;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.48;ReadPosRankSum=-0.327;SOR=0.752;HGVSnom=NM_001211.6:c.1164G>A(p.Ala388Ala/p.A388A);Gene=BUB1B;Transcript=NM_001211.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E9;IVSnom=.;AAlength=1050;EXAC_AF=0.26682716;EXAC_Hom_EAS=95;EXAC_AC_EAS=1263;EXAC_AN_EAS=8644;EXAC_AC_Adj=32364;EXAC_AN_Adj=121292;ESP6500_MAF=0.22643395;RS=rs1047130;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.190695;G1000_EAS_AF=0.1627;G1000_EUR_AF=0.327;G1000_AFR_AF=0.0182;G1000_SAS_AF=0.2178;G1000_AMR_AF=0.3242;gnomad_exomes_AF=0.27180679;gnomad_exomes_AF_EAS=0.14624334;gnomad_exomes_AC=68292;gnomad_exomes_Hom=10213;gnomad_exomes_Het=47866;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.05940655;gnomad_exomes_AF_NFE=0.31328908;gnomad_exomes_AF_AMR=0.35225366;gnomad_exomes_AF_SAS=0.23659110;NativeFreq_Het=0.2918;NativeFreq_Hom=0.0534;normalHetFrequency=0.2423;normalHetNum=94;normalHomFrequency=0.0206;normalHomNum=8;patientHetFrequency=0.2706;patientHetNum=750;patientHomFrequency=0.0321;patientHomNum=89;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2260;AF_2700_Hom=0.0200;AF_50_Het=0.2092;AF_50_Hom=0.0254;DANN_score=0.5015;GREP_score=-2.78;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=ATCAGCAAGC.TCTGAGGAGA	GT:AD:DP:GQ:PL	0/1:113,112:225:99:3512,0,3144
chr15	40491952	.	A	G	3821.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.051;DP=273;ExcessHet=3.0103;FS=5.645;MLEAC=1;MLEAF=0.5;MQ=59.99;MQRankSum=0;QD=14.1;ReadPosRankSum=0.054;SOR=1.077;HGVSnom=NM_001211.6:c.1401+24A>G;Gene=BUB1B;Transcript=NM_001211.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_001211.6:IVS10+24A>G;AAlength=1050;EXAC_AF=0.49052613;EXAC_Hom_EAS=216;EXAC_AC_EAS=1910;EXAC_AN_EAS=7558;EXAC_AC_Adj=55194;EXAC_AN_Adj=112520;ESP6500_MAF=0.41639748;RS=rs2172742;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.35004;G1000_EAS_AF=0.2698;G1000_EUR_AF=0.5567;G1000_AFR_AF=0.0946;G1000_SAS_AF=0.498;G1000_AMR_AF=0.4452;gnomad_exomes_AF=0.47854436;gnomad_exomes_AF_EAS=0.23877597;gnomad_exomes_AC=117207;gnomad_exomes_Hom=29775;gnomad_exomes_Het=57657;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.15599534;gnomad_exomes_AF_NFE=0.55778129;gnomad_exomes_AF_AMR=0.46568714;gnomad_exomes_AF_SAS=0.47952105;NativeFreq_Het=0.4128;NativeFreq_Hom=0.1388;normalHetFrequency=0.3634;normalHetNum=141;normalHomFrequency=0.0773;normalHomNum=30;patientHetFrequency=0.3874;patientHetNum=1074;patientHomFrequency=0.1003;patientHomNum=278;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3186;AF_2700_Hom=0.0538;AF_50_Het=0.3043;AF_50_Hom=0.0523;DANN_score=0.8999;GREP_score=-1.68;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=TTTCATACAC.AAACTAGAAT	GT:AD:DP:GQ:PL	0/1:143,128:271:99:3850,0,4479
chr15	40500986	.	C	T	2173.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.067;DP=192;ExcessHet=3.0103;FS=26.882;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.38;ReadPosRankSum=-0.316;SOR=2.088;HGVSnom=NM_001211.6:c.2143+15C>T;Gene=BUB1B;Transcript=NM_001211.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_001211.6:IVS16+15C>T;AAlength=1050;EXAC_AF=0.49156844;EXAC_Hom_EAS=243;EXAC_AC_EAS=2078;EXAC_AN_EAS=8598;EXAC_AC_Adj=59467;EXAC_AN_Adj=120974;ESP6500_MAF=0.46670767;RS=rs11630664;CLNGENE=BUB1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.396965;G1000_EAS_AF=0.2827;G1000_EUR_AF=0.5606;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.4969;G1000_AMR_AF=0.4683;gnomad_exomes_AF=0.49253165;gnomad_exomes_AF_EAS=0.24771092;gnomad_exomes_AC=123325;gnomad_exomes_Hom=31723;gnomad_exomes_Het=59879;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29800345;gnomad_exomes_AF_NFE=0.55619988;gnomad_exomes_AF_AMR=0.50564628;gnomad_exomes_AF_SAS=0.47708102;NativeFreq_Het=0.4484;NativeFreq_Hom=0.1459;normalHetFrequency=0.366;normalHetNum=142;normalHomFrequency=0.0825;normalHomNum=32;patientHetFrequency=0.399;patientHetNum=1106;patientHomFrequency=0.1053;patientHomNum=292;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3317;AF_2700_Hom=0.0561;AF_50_Het=0.3138;AF_50_Hom=0.0491;DANN_score=0.2988;GREP_score=2.33;CytoBand=q15.1;CGD_CONDITION=Mosaic variegated aneuploidy syndrome. Premature chromatid separation trait;CGD_INHERITANCE=AD/AR;Strand=BUB1B:NM_001211.5:+;NP=BUB1B:NM_001211.5:NP_001202.4;ENSP=BUB1B:NM_001211.5:ENST00000287598.10;Gene_MIM_id=602860;Phenotypes=Colorectal cancer, somatic, 114500 (3). Mosaic variegated aneuploidy syndrome 1, 257300 (3), Autosomal recessive. [Premature chromatid separation trait], 176430 (3), Autosomal dominant. 114500(MK),176430(NK),257300(MK);Possible_Inheritance=AD,AR;EntrezGeneID=701;EnsemblGeneID=ENSG00000156970;Alias=BUB1B, BUBR1, MVA1;FLKSEQ=GATATACATA.CACTATATCC	GT:AD:DP:GQ:PL	0/1:114,77:191:99:2202,0,3638
chr15	40993974	.	ATTT	A	1967.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.573;DP=161;ExcessHet=3.0103;FS=5.491;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.71;ReadPosRankSum=1.517;SOR=1.802;OLD_VARIANT=chr15|40993974|ATTT|A,ATT|1;HGVSnom=NM_002875.5:c.225+599_225+601delTTT;Gene=RAD51;Transcript=NM_002875.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_002875.5:IVS3+599_+601delTTT;AAlength=339;RS=rs35383252;gnomad_exomes_AF=0.01694561;gnomad_exomes_AF_EAS=0.06896552;gnomad_exomes_AC=162;gnomad_exomes_Hom=0;gnomad_exomes_Het=162;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.06790123;gnomad_exomes_AF_NFE=0.00508175;gnomad_exomes_AF_AMR=0.05862832;gnomad_exomes_AF_SAS=0.02060134;CytoBand=q15.1;CGD_CONDITION=Mirror movements 2. Fanconi anemia, complementation group R;CGD_INHERITANCE=AD;Strand=RAD51:NM_001164270.1:+,RAD51:NM_002875.4:+,RAD51:NM_133487.3:+,RAD51:NM_001164269.1:+;NP=RAD51:NM_001164270.1:NP_001157742.1,RAD51:NM_002875.4:NP_002866.2,RAD51:NM_133487.3:NP_597994.3,RAD51:NM_001164269.1:NP_001157741.1;ENSP=RAD51:NM_001164270.1:.,RAD51:NM_002875.4:.,RAD51:NM_133487.3:ENST00000645673.2,RAD51:NM_001164269.1:.;Gene_MIM_id=179617;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant. Mirror movements 2, 614508 (3), Autosomal dominant. 114480(SK),614508(MK);Possible_Inheritance=AD;EntrezGeneID=5888;EnsemblGeneID=ENSG00000051180;Alias=RAD51A, RECA, MRMV2, FANCR;FLKSEQ=TATAAAGCAG.tttttttttt	GT:AD:DP:GQ:PL	1/0:11,62:95:99:2005,310,623
chr15	40993974	.	AT	A	1967.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.573;DP=161;ExcessHet=3.0103;FS=5.491;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.71;ReadPosRankSum=1.517;SOR=1.802;OLD_VARIANT=chr15|40993974|ATTT|A,ATT|2;HGVSnom=NM_002875.5:c.225+601delT;Gene=RAD51;Transcript=NM_002875.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_002875.5:IVS3+601delT;AAlength=339;RS=rs35383252;gnomad_exomes_AF=0.00146444;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=14;gnomad_exomes_Hom=0;gnomad_exomes_Het=14;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00617284;gnomad_exomes_AF_NFE=0.00066284;gnomad_exomes_AF_AMR=0.00774336;gnomad_exomes_AF_SAS=0.0;CytoBand=q15.1;CGD_CONDITION=Mirror movements 2. Fanconi anemia, complementation group R;CGD_INHERITANCE=AD;Strand=RAD51:NM_001164270.1:+,RAD51:NM_002875.4:+,RAD51:NM_133487.3:+,RAD51:NM_001164269.1:+;NP=RAD51:NM_001164270.1:NP_001157742.1,RAD51:NM_002875.4:NP_002866.2,RAD51:NM_133487.3:NP_597994.3,RAD51:NM_001164269.1:NP_001157741.1;ENSP=RAD51:NM_001164270.1:.,RAD51:NM_002875.4:.,RAD51:NM_133487.3:ENST00000645673.2,RAD51:NM_001164269.1:.;Gene_MIM_id=179617;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant. Mirror movements 2, 614508 (3), Autosomal dominant. 114480(SK),614508(MK);Possible_Inheritance=AD;EntrezGeneID=5888;EnsemblGeneID=ENSG00000051180;Alias=RAD51A, RECA, MRMV2, FANCR;FLKSEQ=TATAAAGCAG.tttttttttt	GT:AD:DP:GQ:PL	0/1:11,22:95:99:2005,1214,1117
chr15	41023878	.	T	G	16161.8	PASS	AC=2;AF=1;AN=2;DP=431;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.45;SOR=0.741;HGVSnom=NM_002875.5:c.*502T>G;Gene=RAD51;Transcript=NM_002875.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=339;RS=rs12593359;G1000_AF=0.565096;G1000_EAS_AF=0.7778;G1000_EUR_AF=0.495;G1000_AFR_AF=0.3555;G1000_SAS_AF=0.6431;G1000_AMR_AF=0.647;NativeFreq_Het=0.3069;NativeFreq_Hom=0.6435;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0052;normalHomNum=2;patientHetFrequency=0.0036;patientHetNum=10;patientHomFrequency=0.0054;patientHomNum=15;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0005712|15B6301183-1][_];patientHetSampleInfo=[15D6722319-1|16D0157490|16B0047175|16B0019233-1|16D0168682|16B0005278|15D6524784|16B0005513|16B1586166|16B3097913-1][_];patientHomSampleInfo=[16D1533020-1|16B0047123|16B0017676|16B3254724|16B0005181|16B3094002|15B0062536-1|16D1536906-1|16B0012158|16D1545950|15D6532208|16D0166603|16B0001842-1|16D1536873-1|16B0012197][_];AF_2700_Het=0.2963;AF_2700_Hom=0.6606;AF_50_Het=0.2932;AF_50_Hom=0.6719;DANN_score=0.8164;GREP_score=0.786;CytoBand=q15.1;CGD_CONDITION=Mirror movements 2. Fanconi anemia, complementation group R;CGD_INHERITANCE=AD;Strand=RAD51:NM_001164270.1:+,RAD51:NM_002875.4:+,RAD51:NM_133487.3:+,RAD51:NM_001164269.1:+;NP=RAD51:NM_001164270.1:NP_001157742.1,RAD51:NM_002875.4:NP_002866.2,RAD51:NM_133487.3:NP_597994.3,RAD51:NM_001164269.1:NP_001157741.1;ENSP=RAD51:NM_001164270.1:.,RAD51:NM_002875.4:.,RAD51:NM_133487.3:ENST00000645673.2,RAD51:NM_001164269.1:.;Gene_MIM_id=179617;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant. Mirror movements 2, 614508 (3), Autosomal dominant. 114480(SK),614508(MK);Possible_Inheritance=AD;EntrezGeneID=5888;EnsemblGeneID=ENSG00000051180;Alias=RAD51A, RECA, MRMV2, FANCR;FLKSEQ=TTGTGTAAGG.TTTGGTTATG	GT:AD:DP:GQ:PL	1/1:0,430:430:99:16190,1292,0
chr15	41024094	.	G	A	10359.8	PASS	AC=2;AF=1;AN=2;DP=281;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.6;SOR=1.011;HGVSnom=NM_002875.5:c.*718G>A;Gene=RAD51;Transcript=NM_002875.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=339;RS=rs7180135;G1000_AF=0.733227;G1000_EAS_AF=0.9067;G1000_EUR_AF=0.5696;G1000_AFR_AF=0.7012;G1000_SAS_AF=0.771;G1000_AMR_AF=0.7262;NativeFreq_Het=0.1485;NativeFreq_Hom=0.8514;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0014;patientHomNum=4;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0017800][_];patientHetSampleInfo=[16B3094604|16B0228629|16D1536911-1][_];patientHomSampleInfo=[16B0001973-1|16B0024246|16B0019233-1|15D6482079-1][_];AF_2700_Het=0.1268;AF_2700_Hom=0.8647;AF_50_Het=0.1347;AF_50_Hom=0.8605;DANN_score=0.2369;GREP_score=0.149;CytoBand=q15.1;repName=AluJb;repClass=SINE;CGD_CONDITION=Mirror movements 2. Fanconi anemia, complementation group R;CGD_INHERITANCE=AD;Strand=RAD51:NM_001164270.1:+,RAD51:NM_002875.4:+,RAD51:NM_133487.3:+,RAD51:NM_001164269.1:+;NP=RAD51:NM_001164270.1:NP_001157742.1,RAD51:NM_002875.4:NP_002866.2,RAD51:NM_133487.3:NP_597994.3,RAD51:NM_001164269.1:NP_001157741.1;ENSP=RAD51:NM_001164270.1:.,RAD51:NM_002875.4:.,RAD51:NM_133487.3:ENST00000645673.2,RAD51:NM_001164269.1:.;Gene_MIM_id=179617;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant. Mirror movements 2, 614508 (3), Autosomal dominant. 114480(SK),614508(MK);Possible_Inheritance=AD;EntrezGeneID=5888;EnsemblGeneID=ENSG00000051180;Alias=RAD51A, RECA, MRMV2, FANCR;FLKSEQ=cttggccaag.tggtgaaatc	GT:AD:DP:GQ:PL	1/1:0,279:279:99:10388,839,0
chr15	41024303	.	T	C	10621.8	PASS	AC=2;AF=1;AN=2;DP=268;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=24.49;SOR=1.289;HGVSnom=NM_002875.5:c.*927T>C;Gene=RAD51;Transcript=NM_002875.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=339;RS=rs11855560;G1000_AF=0.565096;G1000_EAS_AF=0.7778;G1000_EUR_AF=0.495;G1000_AFR_AF=0.3555;G1000_SAS_AF=0.6431;G1000_AMR_AF=0.647;NativeFreq_Het=0.3168;NativeFreq_Hom=0.6435;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=0.0032;patientHomNum=9;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0028130|16B0000989|16D1536911-1][_];patientHomSampleInfo=[15D6534493|16B0019035-1|16B0202449|16B0200196|16B0028133|15B0003000-1|17B0000747|16B0012197|15B6325537][_];AF_2700_Het=0.2967;AF_2700_Hom=0.6603;AF_50_Het=0.2948;AF_50_Hom=0.6704;DANN_score=0.741;GREP_score=1.29;CytoBand=q15.1;CGD_CONDITION=Mirror movements 2. Fanconi anemia, complementation group R;CGD_INHERITANCE=AD;Strand=RAD51:NM_001164270.1:+,RAD51:NM_002875.4:+,RAD51:NM_133487.3:+,RAD51:NM_001164269.1:+;NP=RAD51:NM_001164270.1:NP_001157742.1,RAD51:NM_002875.4:NP_002866.2,RAD51:NM_133487.3:NP_597994.3,RAD51:NM_001164269.1:NP_001157741.1;ENSP=RAD51:NM_001164270.1:.,RAD51:NM_002875.4:.,RAD51:NM_133487.3:ENST00000645673.2,RAD51:NM_001164269.1:.;Gene_MIM_id=179617;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. ?Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant. Mirror movements 2, 614508 (3), Autosomal dominant. 114480(SK),614508(MK);Possible_Inheritance=AD;EntrezGeneID=5888;EnsemblGeneID=ENSG00000051180;Alias=RAD51A, RECA, MRMV2, FANCR;FLKSEQ=TTTCAGAGGG.AAGTAAACAG	GT:AD:DP:GQ:PL	1/1:0,268:268:99:10650,806,0
chr15	43720197	.	C	T	2994.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.727;DP=218;ExcessHet=3.0103;FS=3.851;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.74;ReadPosRankSum=1.068;SOR=0.996;HGVSnom=NM_001141980.3:c.3828+17G>A;Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I18;IVSnom=NM_001141980.3:IVS18+17G>A;AAlength=1977;EXAC_AF=0.20749417;EXAC_Hom_EAS=767;EXAC_AC_EAS=3579;EXAC_AN_EAS=8642;EXAC_AC_Adj=24747;EXAC_AN_Adj=119266;ESP6500_MAF=0.28789044;RS=rs550239;G1000_AF=0.380391;G1000_EAS_AF=0.3859;G1000_EUR_AF=0.1083;G1000_AFR_AF=0.7519;G1000_SAS_AF=0.2648;G1000_AMR_AF=0.2219;gnomad_exomes_AF=0.19572564;gnomad_exomes_AF_EAS=0.40948978;gnomad_exomes_AC=42860;gnomad_exomes_Hom=6885;gnomad_exomes_Het=29090;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65597551;gnomad_exomes_AF_NFE=0.11048043;gnomad_exomes_AF_AMR=0.21121745;gnomad_exomes_AF_SAS=0.21701459;NativeFreq_Het=0.3701;NativeFreq_Hom=0.1210;DANN_score=0.7439;GREP_score=3.51;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=GCCACACAGA.TCAGAGTATG	GT:AD:DP:GQ:PL	0/1:116,102:218:99:3023,0,3515
chr15	43724646	.	T	G	7955.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.399;DP=520;ExcessHet=3.0103;FS=3.188;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.33;ReadPosRankSum=0.616;SOR=0.505;HGVSnom=NM_001141980.3:c.3421A>C(p.Lys1141Gln/p.K1141Q);Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E17;IVSnom=.;AAlength=1977;EXAC_AF=0.37503913;EXAC_Hom_EAS=776;EXAC_AC_EAS=3604;EXAC_AN_EAS=8642;EXAC_AC_Adj=45523;EXAC_AN_Adj=121382;ESP6500_MAF=0.48361286;RS=rs2602141;Ensembl_transcriptid=ENST00000382044|ENST00000263801|ENST00000382039|ENST00000450115;SIFT_pred=T|T|T|T;SIFT_score=1.0|1.0|1.0|1.0;Polyphen2_HVAR_pred=B|B|.|.;Polyphen2_HVAR_score=0.0|0.0|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|1|1|1;G1000_AF=0.526358;G1000_EAS_AF=0.3869;G1000_EUR_AF=0.3032;G1000_AFR_AF=0.9584;G1000_SAS_AF=0.456;G1000_AMR_AF=0.3285;gnomad_exomes_AF=0.36321044;gnomad_exomes_AF_EAS=0.41421116;gnomad_exomes_AC=91322;gnomad_exomes_Hom=19467;gnomad_exomes_Het=52388;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.85888287;gnomad_exomes_AF_NFE=0.30179570;gnomad_exomes_AF_AMR=0.31820284;gnomad_exomes_AF_SAS=0.44966026;HGMD_gene=TP53BP1;HGMD_disease=Lung_cancer_susceptibility_to_association_with;HGMD_tag=DP;HGMD_pmid=16741161;NativeFreq_Het=0.4306;NativeFreq_Hom=0.1601;DANN_score=0.306;GREP_score=4.45;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=GGATTTTCCT.ATTAGTACTC	GT:AD:DP:GQ:PL	0/1:275,244:519:99:7984,0,8540
chr15	43739686	.	GA	G	465.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.061;DP=257;ExcessHet=3.0103;FS=10.828;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.18;ReadPosRankSum=0.291;SOR=0.177;HGVSnom=NM_001141980.3:c.2717-4delT;Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_001141980.3:IVS12-4delT;AAlength=1977;EXAC_AF=0.35062285;EXAC_Hom_EAS=0;EXAC_AC_EAS=2183;EXAC_AN_EAS=6100;EXAC_AC_Adj=29216;EXAC_AN_Adj=83326;RS=rs749575788;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=TGGGGTTTCT.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:158,56:214:99:503,0,2644
chr15	43748304	.	A	G	7846.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.808;DP=443;ExcessHet=3.0103;FS=2.467;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.75;ReadPosRankSum=-0.345;SOR=0.526;HGVSnom=NM_001141980.3:c.2502T>C(p.Asp834Asp/p.D834D);Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=1977;EXAC_AF=0.37389822;EXAC_Hom_EAS=775;EXAC_AC_EAS=3601;EXAC_AN_EAS=8650;EXAC_AC_Adj=45389;EXAC_AN_Adj=121394;ESP6500_MAF=0.48822896;RS=rs690367;G1000_AF=0.526158;G1000_EAS_AF=0.3879;G1000_EUR_AF=0.3032;G1000_AFR_AF=0.9735;G1000_SAS_AF=0.4325;G1000_AMR_AF=0.33;gnomad_exomes_AF=0.36218377;gnomad_exomes_AF_EAS=0.41419250;gnomad_exomes_AC=91053;gnomad_exomes_Hom=19449;gnomad_exomes_Het=52155;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87320044;gnomad_exomes_AF_NFE=0.30164453;gnomad_exomes_AF_AMR=0.31854979;gnomad_exomes_AF_SAS=0.43489907;NativeFreq_Het=0.4235;NativeFreq_Hom=0.1637;DANN_score=0.6892;GREP_score=3.39;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=GCTGTGAAGA.TCTTGCTCTA	GT:AD:DP:GQ:PL	0/1:197,245:442:99:7875,0,5698
chr15	43762196	.	C	T	6427.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-10.298;DP=434;ExcessHet=3.0103;FS=5.027;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.91;ReadPosRankSum=-0.861;SOR=0.44;HGVSnom=NM_001141980.3:c.1249G>A(p.Gly417Ser/p.G417S);Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E11;IVSnom=.;AAlength=1977;EXAC_AF=0.20639300;EXAC_Hom_EAS=768;EXAC_AC_EAS=3581;EXAC_AN_EAS=8628;EXAC_AC_Adj=24988;EXAC_AN_Adj=121070;ESP6500_MAF=0.28812125;RS=rs689647;Ensembl_transcriptid=ENST00000382044|ENST00000263801|ENST00000382039|ENST00000450115|ENST00000413546;SIFT_pred=D|D|D|D|T;SIFT_score=0.049|0.049|0.049|0.049|0.055;Polyphen2_HVAR_pred=B|B|.|.|.;Polyphen2_HVAR_score=0.0|0.0|.|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=0.999943|0.999943|0.999943|0.999943;G1000_AF=0.382388;G1000_EAS_AF=0.3869;G1000_EUR_AF=0.1093;G1000_AFR_AF=0.7511;G1000_SAS_AF=0.2751;G1000_AMR_AF=0.2205;gnomad_exomes_AF=0.19875979;gnomad_exomes_AF_EAS=0.41139034;gnomad_exomes_AC=49938;gnomad_exomes_Hom=7832;gnomad_exomes_Het=34274;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65657375;gnomad_exomes_AF_NFE=0.11212239;gnomad_exomes_AF_AMR=0.21490543;gnomad_exomes_AF_SAS=0.22498856;HGMD_gene=TP53BP1;HGMD_disease=Basal_cell_carcinoma_reduced_risk_association_with;HGMD_tag=DP;HGMD_pmid=20686496;NativeFreq_Het=0.3737;NativeFreq_Hom=0.1210;DANN_score=0.9746;GREP_score=5.31;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=ACTGGTTCAC.ACTTTGAAGT	GT:AD:DP:GQ:PL	0/1:215,216:431:99:6456,0,7143
chr15	43767774	.	G	C	5092.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.35;DP=349;ExcessHet=3.0103;FS=9.014;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.68;ReadPosRankSum=-0.515;SOR=1.108;HGVSnom=NM_001141980.3:c.1074C>G(p.Asp358Glu/p.D358E);Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=1977;EXAC_AF=0.37372464;EXAC_Hom_EAS=774;EXAC_AC_EAS=3601;EXAC_AN_EAS=8630;EXAC_AC_Adj=45347;EXAC_AN_Adj=121338;ESP6500_MAF=0.48807509;RS=rs560191;Ensembl_transcriptid=ENST00000382044|ENST00000263801|ENST00000382039|ENST00000450115|ENST00000413546;SIFT_pred=T|T|T|T|T;SIFT_score=1.0|1.0|1.0|1.0|1.0;Polyphen2_HVAR_pred=B|B|.|.|.;Polyphen2_HVAR_score=0.002|0.0|.|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=0.998866|0.998866|0.998866|0.998866;G1000_AF=0.525759;G1000_EAS_AF=0.3869;G1000_EUR_AF=0.3032;G1000_AFR_AF=0.9728;G1000_SAS_AF=0.4335;G1000_AMR_AF=0.3285;gnomad_exomes_AF=0.36188650;gnomad_exomes_AF_EAS=0.41398434;gnomad_exomes_AC=90958;gnomad_exomes_Hom=19410;gnomad_exomes_Het=52138;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87298462;gnomad_exomes_AF_NFE=0.30153578;gnomad_exomes_AF_AMR=0.31781892;gnomad_exomes_AF_SAS=0.43517611;HGMD_gene=TP53BP1;HGMD_disease=Lung_cancer_susceptibility_to_association_with;HGMD_tag=DP;HGMD_pmid=16741161;NativeFreq_Het=0.4270;NativeFreq_Hom=0.1601;DANN_score=0.5344;GREP_score=1.95;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=TGGAAAGACT.TCCTGAACAA	GT:AD:DP:GQ:PL	0/1:181,166:347:99:5121,0,5762
chr15	43784000	.	C	T	11115.8	PASS	AC=2;AF=1;AN=2;DP=287;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.43;SOR=2.817;HGVSnom=NM_001141980.3:c.287-49G>A;Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001141980.3:IVS3-49G>A;AAlength=1977;EXAC_AF=0.98430101;EXAC_Hom_EAS=4303;EXAC_AC_EAS=8614;EXAC_AN_EAS=8622;EXAC_AC_Adj=119315;EXAC_AN_Adj=121218;ESP6500_MAF=0.96053239;RS=rs555252;G1000_AF=0.951478;G1000_EAS_AF=1.0;G1000_EUR_AF=0.999;G1000_AFR_AF=0.8533;G1000_SAS_AF=0.956;G1000_AMR_AF=0.9928;gnomad_exomes_AF=0.98698260;gnomad_exomes_AF_EAS=0.99934662;gnomad_exomes_AC=247174;gnomad_exomes_Hom=122116;gnomad_exomes_Het=2942;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87707868;gnomad_exomes_AF_NFE=0.99952458;gnomad_exomes_AF_AMR=0.99415577;gnomad_exomes_AF_SAS=0.96828041;NativeFreq_Het=0.0285;NativeFreq_Hom=0.9573;DANN_score=0.5599;GREP_score=1.43;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=ACCAACAAAC.TTAATACAAA	GT:AD:DP:GQ:PL	1/1:0,286:286:99:11144,859,0
chr15	43784435	.	T	TA	3223.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.037;DP=433;ExcessHet=3.0103;FS=7.877;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.31;ReadPosRankSum=1.348;SOR=1.088;HGVSnom=NM_001141980.3:c.192+46dupT;Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001141980.3:IVS2+46_+47insT;AAlength=1977;EXAC_AF=0.21939444;EXAC_Hom_EAS=412;EXAC_AC_EAS=3036;EXAC_AN_EAS=7348;EXAC_AC_Adj=20767;EXAC_AN_Adj=94656;ESP6500_MAF=0.23648865;RS=rs34075231;G1000_AF=0.326278;G1000_EAS_AF=0.379;G1000_EUR_AF=0.1143;G1000_AFR_AF=0.5522;G1000_SAS_AF=0.272;G1000_AMR_AF=0.2032;gnomad_exomes_AF=0.25583214;gnomad_exomes_AF_EAS=0.42720493;gnomad_exomes_AC=35663;gnomad_exomes_Hom=1858;gnomad_exomes_Het=31947;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.48398058;gnomad_exomes_AF_NFE=0.17434098;gnomad_exomes_AF_AMR=0.29839605;gnomad_exomes_AF_SAS=0.32500000;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=GTTTTCGGTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:209,179:388:99:3261,0,4420
chr15	43784475	.	C	T	6663.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.728;DP=441;ExcessHet=3.0103;FS=1.757;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.21;ReadPosRankSum=-0.832;SOR=0.828;HGVSnom=NM_001141980.3:c.192+7G>A;Gene=TP53BP1;Transcript=NM_001141980.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_001141980.3:IVS2+7G>A;AAlength=1977;EXAC_AF=0.20030864;EXAC_Hom_EAS=769;EXAC_AC_EAS=3585;EXAC_AN_EAS=8648;EXAC_AC_Adj=24273;EXAC_AN_Adj=121178;ESP6500_MAF=0.27058009;RS=rs2439831;G1000_AF=0.369409;G1000_EAS_AF=0.3859;G1000_EUR_AF=0.1054;G1000_AFR_AF=0.7088;G1000_SAS_AF=0.274;G1000_AMR_AF=0.2161;gnomad_exomes_AF=0.19354592;gnomad_exomes_AF_EAS=0.41174537;gnomad_exomes_AC=48011;gnomad_exomes_Hom=7265;gnomad_exomes_Het=33481;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.61547002;gnomad_exomes_AF_NFE=0.10815685;gnomad_exomes_AF_AMR=0.21148153;gnomad_exomes_AF_SAS=0.22558469;NativeFreq_Het=0.3808;NativeFreq_Hom=0.1139;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00000626;DANN_score=0.7896;GREP_score=1.09;CytoBand=q15.3;Strand=TP53BP1:NM_001141979.1:-,TP53BP1:NM_001141980.1:-,TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_001141979.1:NP_001135451.1,TP53BP1:NM_001141980.1:NP_001135452.1,TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_001141979.1:.,TP53BP1:NM_001141980.1:.,TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=AACAAGGTAT.ACTCACCAAC	GT:AD:DP:GQ:PL	0/1:224,214:438:99:6692,0,6883
chr15	43802660	.	C	A	5081.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.913;DP=333;ExcessHet=3.0103;FS=5.802;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.35;ReadPosRankSum=1.24;SOR=0.459;HGVSnom=.;Gene=MAP1A;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs45566532;G1000_AF=0.0241613;G1000_EAS_AF=0.0992;G1000_EUR_AF=0.001;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0204;G1000_AMR_AF=0.0;DANN_score=0.7352;GREP_score=0.288;CytoBand=q15.3;Strand=TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_005657.2:.;Gene_MIM_id=605230;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=7158;EnsemblGeneID=ENSG00000067369;Alias=TP53BP1, 53BP1;FLKSEQ=ACAGGGAAAC.GAGGATGGAG	GT:AD:DP:GQ:PL	0/1:158,173:331:99:5110,0,4155
chr15	43802707	.	CA	C	2630.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.414;DP=245;ExcessHet=3.0103;FS=0.793;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.96;ReadPosRankSum=-0.302;SOR=0.82;HGVSnom=.;Gene=MAP1A;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs35271859;CytoBand=q15.3;Strand=TP53BP1:NM_005657.2:-;NP=TP53BP1:NM_005657.2:NP_005648.1;ENSP=TP53BP1:NM_005657.2:.;FLKSEQ=TGACAAAAAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:91,129:220:99:2668,0,1393
chr15	43802712	.	A	C	2006.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.429;DP=241;ExcessHet=3.0103;FS=7.882;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.69;ReadPosRankSum=1.179;SOR=1.307;HGVSnom=.;Gene=MAP1A;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs34451433;G1000_AF=0.290136;G1000_EAS_AF=0.3313;G1000_EUR_AF=0.1034;G1000_AFR_AF=0.497;G1000_SAS_AF=0.2311;G1000_AMR_AF=0.1902;NativeFreq_Het=0.0107;NativeFreq_Hom=0;DANN_score=0.5333;GREP_score=-0.351;CytoBand=q15.3;FLKSEQ=AAAAACAAAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:132,99:231:99:2035,0,4904
chr15	77344793	.	T	A	4478.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.503;DP=295;ExcessHet=3.0103;FS=3.265;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.29;ReadPosRankSum=-0.453;SOR=0.515;HGVSnom=NM_005724.6:c.603A>T(p.Val201Val/p.V201V);Gene=TSPAN3;Transcript=NM_005724.6;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=252;EXAC_AF=0.59992254;EXAC_Hom_EAS=766;EXAC_AC_EAS=3594;EXAC_AN_EAS=8640;EXAC_AC_Adj=72803;EXAC_AN_Adj=121354;ESP6500_MAF=0.60585516;RS=rs11737;G1000_AF=0.491214;G1000_EAS_AF=0.4028;G1000_EUR_AF=0.6859;G1000_AFR_AF=0.3858;G1000_SAS_AF=0.4826;G1000_AMR_AF=0.5504;gnomad_exomes_AF=0.59821329;gnomad_exomes_AF_EAS=0.39915190;gnomad_exomes_AC=150398;gnomad_exomes_Hom=46416;gnomad_exomes_Het=57566;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.43796160;gnomad_exomes_AF_NFE=0.67680214;gnomad_exomes_AF_AMR=0.51494997;gnomad_exomes_AF_SAS=0.54030836;NativeFreq_Het=0.4448;NativeFreq_Hom=0.2135;DANN_score=0.7961;GREP_score=4.28;CytoBand=q24.3;Strand=TSPAN3:NM_001168412.1:-,TSPAN3:NM_005724.5:-,TSPAN3:NM_198902.2:-;NP=TSPAN3:NM_001168412.1:NP_001161884.1,TSPAN3:NM_005724.5:NP_005715.1,TSPAN3:NM_198902.2:NP_944492.1;ENSP=TSPAN3:NM_001168412.1:.,TSPAN3:NM_005724.5:.,TSPAN3:NM_198902.2:.;Gene_MIM_id=613134;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=10099;EnsemblGeneID=ENSG00000140391;Alias=TSPAN3;FLKSEQ=GCTTCTTCAC.ACTAGAGCCT	GT:AD:DP:GQ:PL	0/1:149,144:293:99:4507,0,4554
chr15	89804043	.	C	T	7990.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.412;DP=519;ExcessHet=3.0103;FS=6.056;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.55;ReadPosRankSum=0.976;SOR=1.101;HGVSnom=NM_001113378.2:c.257C>T(p.Ala86Val/p.A86V);Gene=FANCI;Transcript=NM_001113378.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=1328;EXAC_AF=0.35689689;EXAC_Hom_EAS=432;EXAC_AC_EAS=2719;EXAC_AN_EAS=8646;EXAC_AC_Adj=43323;EXAC_AN_Adj=121388;ESP6500_MAF=0.28627481;RS=rs17803620;Ensembl_transcriptid=ENST00000300027|ENST00000310775|ENST00000567891|ENST00000564920|ENST00000565255|ENST00000567996|ENST00000563250;SIFT_pred=T|T|T|T|T|T|T;SIFT_score=0.339|0.334|0.12|0.122|0.205|0.208|0.219;Polyphen2_HVAR_pred=B|B|.|.|.|.|.;Polyphen2_HVAR_score=0.062|0.055|.|.|.|.|.;MutationTaster_pred=P|P|P|P;MutationTaster_score=4.579e-07|1.43001e-06|1.43001e-06|1e-37;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.259784;G1000_EAS_AF=0.3036;G1000_EUR_AF=0.3787;G1000_AFR_AF=0.0393;G1000_SAS_AF=0.3292;G1000_AMR_AF=0.3458;gnomad_exomes_AF=0.36045688;gnomad_exomes_AF_EAS=0.31937799;gnomad_exomes_AC=90634;gnomad_exomes_Hom=17425;gnomad_exomes_Het=55784;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08010336;gnomad_exomes_AF_NFE=0.38014843;gnomad_exomes_AF_AMR=0.36170213;gnomad_exomes_AF_SAS=0.38277371;NativeFreq_Het=0.4919;NativeFreq_Hom=0.0874;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.1329;normalHomNum=115;patientHetFrequency=0.4559;patientHetNum=2380;patientHomFrequency=0.1138;patientHomNum=594;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9894;GREP_score=4.45;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=AAAGAAATAG.GTCTGAGATC	GT:AD:DP:GQ:PL	0/1:250,264:514:99:8019,0,7083
chr15	89804111	.	G	A	6155.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.952;DP=410;ExcessHet=3.0103;FS=8.501;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.2;ReadPosRankSum=-0.584;SOR=1.304;HGVSnom=NM_001113378.2:c.288+37G>A;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_001113378.2:IVS4+37G>A;AAlength=1328;EXAC_AF=0.41638065;EXAC_Hom_EAS=482;EXAC_AC_EAS=2889;EXAC_AN_EAS=8632;EXAC_AC_Adj=50467;EXAC_AN_Adj=121204;ESP6500_MAF=0.47561163;RS=rs16942918;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.449281;G1000_EAS_AF=0.3214;G1000_EUR_AF=0.3936;G1000_AFR_AF=0.6989;G1000_SAS_AF=0.3323;G1000_AMR_AF=0.4049;gnomad_exomes_AF=0.41109977;gnomad_exomes_AF_EAS=0.33886411;gnomad_exomes_AC=103140;gnomad_exomes_Hom=22015;gnomad_exomes_Het=59110;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65026612;gnomad_exomes_AF_NFE=0.38642899;gnomad_exomes_AF_AMR=0.40060729;gnomad_exomes_AF_SAS=0.38945545;NativeFreq_Het=0.5000;NativeFreq_Hom=0.1068;normalHetFrequency=0.4474;normalHetNum=387;normalHomFrequency=0.1503;normalHomNum=130;patientHetFrequency=0.4651;patientHetNum=2428;patientHomFrequency=0.1358;patientHomNum=709;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3766;GREP_score=-6.22;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=TTGGGGGTAG.TTTTTGAGGG	GT:AD:DP:GQ:PL	0/1:201,204:405:99:6184,0,6328
chr15	89806710	.	C	T	4251.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.484;DP=307;ExcessHet=3.0103;FS=0.919;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.89;ReadPosRankSum=0.866;SOR=0.76;HGVSnom=NM_001113378.2:c.545+19C>T;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_001113378.2:IVS7+19C>T;AAlength=1328;EXAC_AF=0.38196748;EXAC_Hom_EAS=441;EXAC_AC_EAS=2752;EXAC_AN_EAS=8636;EXAC_AC_Adj=46283;EXAC_AN_Adj=121170;ESP6500_MAF=0.34805355;RS=rs1981623;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.338858;G1000_EAS_AF=0.3095;G1000_EUR_AF=0.3837;G1000_AFR_AF=0.3056;G1000_SAS_AF=0.3303;G1000_AMR_AF=0.3919;gnomad_exomes_AF=0.38145416;gnomad_exomes_AF_EAS=0.32365755;gnomad_exomes_AC=95568;gnomad_exomes_Hom=18617;gnomad_exomes_Het=58334;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32779010;gnomad_exomes_AF_NFE=0.38294624;gnomad_exomes_AF_AMR=0.38155374;gnomad_exomes_AF_SAS=0.38383143;NativeFreq_Het=0.4887;NativeFreq_Hom=0.0922;normalHetFrequency=0.4335;normalHetNum=375;normalHomFrequency=0.1387;normalHomNum=120;patientHetFrequency=0.4602;patientHetNum=2402;patientHomFrequency=0.1172;patientHomNum=612;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7497;GREP_score=-1.1;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=CATCTTTTCC.TTTTCTTTGT	GT:AD:DP:GQ:PL	0/1:163,143:306:99:4280,0,5242
chr15	89806721	.	G	A	3884.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.086;DP=280;ExcessHet=3.0103;FS=0.486;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.92;ReadPosRankSum=-1.184;SOR=0.745;HGVSnom=NM_001113378.2:c.545+30G>A;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_001113378.2:IVS7+30G>A;AAlength=1328;EXAC_AF=0.38081972;EXAC_Hom_EAS=429;EXAC_AC_EAS=2730;EXAC_AN_EAS=8622;EXAC_AC_Adj=46067;EXAC_AN_Adj=120968;ESP6500_MAF=0.37067241;RS=rs1981624;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.338259;G1000_EAS_AF=0.3085;G1000_EUR_AF=0.3837;G1000_AFR_AF=0.3048;G1000_SAS_AF=0.3292;G1000_AMR_AF=0.3919;gnomad_exomes_AF=0.38085077;gnomad_exomes_AF_EAS=0.32293258;gnomad_exomes_AC=95314;gnomad_exomes_Hom=18502;gnomad_exomes_Het=58310;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32649162;gnomad_exomes_AF_NFE=0.38241741;gnomad_exomes_AF_AMR=0.38061651;gnomad_exomes_AF_SAS=0.38401809;NativeFreq_Het=0.4887;NativeFreq_Hom=0.0922;normalHetFrequency=0.4324;normalHetNum=374;normalHomFrequency=0.1387;normalHomNum=120;patientHetFrequency=0.4598;patientHetNum=2400;patientHomFrequency=0.1165;patientHomNum=608;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6201;GREP_score=-2.72;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=TTTTCTTTGT.TATCCTGCTT	GT:AD:DP:GQ:PL	0/1:144,135:279:99:3913,0,4673
chr15	89816742	.	TAAA	T	3282.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.173;DP=556;ExcessHet=3.0103;FS=1.14;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0;QD=7.83;ReadPosRankSum=-1.811;SOR=0.917;HGVSnom=NM_001113378.2:c.975+64_975+66delAAA;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_001113378.2:IVS11+64_+66delAAA;AAlength=1328;EXAC_AF=0.06761730;EXAC_Hom_EAS=0;EXAC_AC_EAS=44;EXAC_AN_EAS=530;EXAC_AC_Adj=882;EXAC_AN_Adj=13044;RS=rs34985075;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.07161280;gnomad_exomes_AF_EAS=0.08283479;gnomad_exomes_AC=3443;gnomad_exomes_Hom=1;gnomad_exomes_Het=3441;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03432282;gnomad_exomes_AF_NFE=0.07409514;gnomad_exomes_AF_AMR=0.09288594;gnomad_exomes_AF_SAS=0.07280364;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0013;patientHetNum=7;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][14B0037463];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1533054|16D1546186][15D6526668|15B0040572|15D6482109-1|16B0011469|16D0067186];patientHomSampleInfo=[_][_];CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=CTGTAGTTGG.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:215,204:419:99:3320,0,4137
chr15	89820008	.	T	C	6887.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.3;DP=534;ExcessHet=3.0103;FS=1.101;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.95;ReadPosRankSum=-0.037;SOR=0.784;HGVSnom=NM_001113378.2:c.1179T>C(p.Tyr393Tyr/p.Y393Y);Gene=FANCI;Transcript=NM_001113378.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=1328;EXAC_AF=0.00509346;EXAC_Hom_EAS=7;EXAC_AC_EAS=336;EXAC_AN_EAS=8652;EXAC_AC_Adj=618;EXAC_AN_Adj=121332;ESP6500_MAF=0.00076935;RS=rs3743377;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0135783;G1000_EAS_AF=0.0556;G1000_EUR_AF=0.001;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0144;gnomad_exomes_AF=0.00571933;gnomad_exomes_AF_EAS=0.03870827;gnomad_exomes_AC=1438;gnomad_exomes_Hom=25;gnomad_exomes_Het=1388;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00024606;gnomad_exomes_AF_NFE=0.00041329;gnomad_exomes_AF_AMR=0.01541532;gnomad_exomes_AF_SAS=0.00169846;NativeFreq_Het=0.0663;NativeFreq_Hom=0;normalHetFrequency=0.0474;normalHetNum=41;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0523;patientHetNum=273;patientHomFrequency=0.001;patientHomNum=5;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0047454-1|16B3254691][15B0027354|15B0051634|15B0011921];DANN_score=0.2925;GREP_score=-0.31;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=TGGATTCATA.GGGCCAAAGA	GT:AD:DP:GQ:PL	0/1:290,242:532:99:6916,0,9240
chr15	89826496	.	C	T	5347.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.03;DP=351;ExcessHet=3.0103;FS=3.785;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.28;ReadPosRankSum=-0.528;SOR=0.899;HGVSnom=NM_001113378.2:c.1698+15C>T;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_001113378.2:IVS17+15C>T;AAlength=1328;EXAC_AF=0.41731207;EXAC_Hom_EAS=490;EXAC_AC_EAS=2914;EXAC_AN_EAS=8632;EXAC_AC_Adj=50650;EXAC_AN_Adj=121372;ESP6500_MAF=0.46799508;RS=rs9806604;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.439297;G1000_EAS_AF=0.3214;G1000_EUR_AF=0.3966;G1000_AFR_AF=0.649;G1000_SAS_AF=0.3446;G1000_AMR_AF=0.4063;gnomad_exomes_AF=0.41199357;gnomad_exomes_AF_EAS=0.33982166;gnomad_exomes_AC=103562;gnomad_exomes_Hom=22031;gnomad_exomes_Het=59500;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.62207728;gnomad_exomes_AF_NFE=0.38924640;gnomad_exomes_AF_AMR=0.40181566;gnomad_exomes_AF_SAS=0.40249559;NativeFreq_Het=0.4951;NativeFreq_Hom=0.1100;normalHetFrequency=0.4451;normalHetNum=385;normalHomFrequency=0.1549;normalHomNum=134;patientHetFrequency=0.4672;patientHetNum=2439;patientHomFrequency=0.1381;patientHomNum=721;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6217;GREP_score=-0.187;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=GGATTATTTA.GTTAACTTGC	GT:AD:DP:GQ:PL	0/1:170,180:350:99:5376,0,4789
chr15	89836228	.	G	C	8817.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.053;DP=611;ExcessHet=3.0103;FS=0.522;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.55;ReadPosRankSum=-0.503;SOR=0.614;HGVSnom=NM_001113378.2:c.2225G>C(p.Cys742Ser/p.C742S);Gene=FANCI;Transcript=NM_001113378.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E22;IVSnom=.;AAlength=1328;EXAC_AF=0.36232829;EXAC_Hom_EAS=465;EXAC_AC_EAS=2812;EXAC_AN_EAS=8630;EXAC_AC_Adj=43891;EXAC_AN_Adj=121136;ESP6500_MAF=0.28993536;RS=rs2283432;Ensembl_transcriptid=ENST00000300027|ENST00000310775;SIFT_pred=T|T;SIFT_score=0.498|0.525;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.137|0.006;MutationTaster_pred=P|P;MutationTaster_score=0.0304295|0.00323804;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.264976;G1000_EAS_AF=0.3135;G1000_EUR_AF=0.3837;G1000_AFR_AF=0.0393;G1000_SAS_AF=0.3395;G1000_AMR_AF=0.3473;gnomad_exomes_AF=0.36483731;gnomad_exomes_AF_EAS=0.32756745;gnomad_exomes_AC=91607;gnomad_exomes_Hom=17823;gnomad_exomes_Het=55961;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08011833;gnomad_exomes_AF_NFE=0.38460318;gnomad_exomes_AF_AMR=0.36464904;gnomad_exomes_AF_SAS=0.39112113;NativeFreq_Het=0.4951;NativeFreq_Hom=0.0971;normalHetFrequency=0.4312;normalHetNum=373;normalHomFrequency=0.1387;normalHomNum=120;patientHetFrequency=0.4598;patientHetNum=2400;patientHomFrequency=0.1192;patientHomNum=622;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8699;GREP_score=4.89;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=AATAATATCT.TGCTTTTCTT	GT:AD:DP:GQ:PL	0/1:328,278:606:99:8846,0,10376
chr15	89838236	.	G	A	12793.8	PASS	AC=2;AF=1;AN=2;DP=341;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.69;SOR=1.006;HGVSnom=NM_001113378.2:c.2547A>A(p.Lys849Lys/p.K849K);Gene=FANCI;Transcript=NM_001113378.2;VarType=NoCall;MolecularConsequence=nocall_variant;ExonIntron=E24;IVSnom=.;AAlength=1328;EXAC_AF=0.95934517;EXAC_Hom_EAS=315;EXAC_AC_EAS=630;EXAC_AN_EAS=630;EXAC_AC_Adj=22913;EXAC_AN_Adj=23884;ESP6500_MAF=0.96007021;RS=rs7183618;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.980831;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9414;G1000_AFR_AF=0.9985;G1000_SAS_AF=0.9775;G1000_AMR_AF=0.9813;gnomad_exomes_AF=0.95668572;gnomad_exomes_AF_EAS=1.00000000;gnomad_exomes_AC=151937;gnomad_exomes_Hom=72772;gnomad_exomes_Het=6393;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99194905;gnomad_exomes_AF_NFE=0.94717377;gnomad_exomes_AF_AMR=0.98505534;gnomad_exomes_AF_SAS=0.97808712;NativeFreq_Het=0;NativeFreq_Hom=1.0000;DANN_score=0.4015;GREP_score=2.34;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=CTCTGCAGAA.GTACAGCAGC	GT:AD:DP:GQ:PL	1/1:0,341:341:99:12822,1026,0
chr15	89838318	.	A	T	5635.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.345;DP=329;ExcessHet=3.0103;FS=5.699;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.18;ReadPosRankSum=-0.634;SOR=0.674;HGVSnom=NM_001113378.2:c.2629A>T(p.Ile877Leu/p.I877L);Gene=FANCI;Transcript=NM_001113378.2;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E24;IVSnom=.;AAlength=1328;EXAC_AF=0.09467131;EXAC_Hom_EAS=1;EXAC_AC_EAS=34;EXAC_AN_EAS=622;EXAC_AC_Adj=2068;EXAC_AN_Adj=21844;ESP6500_MAF=0.08293111;RS=rs35875311;Ensembl_transcriptid=ENST00000310775;SIFT_pred=T;SIFT_score=0.19;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.058;MutationTaster_pred=D|D;MutationTaster_score=0.999655|1;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0595048;G1000_EAS_AF=0.0595;G1000_EUR_AF=0.0924;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.092;G1000_AMR_AF=0.072;gnomad_exomes_AF=0.08829323;gnomad_exomes_AF_EAS=0.04523722;gnomad_exomes_AC=13805;gnomad_exomes_Hom=685;gnomad_exomes_Het=12435;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01234879;gnomad_exomes_AF_NFE=0.10124097;gnomad_exomes_AF_AMR=0.07125949;gnomad_exomes_AF_SAS=0.10679697;NativeFreq_Het=0.0777;NativeFreq_Hom=0.0016;normalHetFrequency=0.0983;normalHetNum=85;normalHomFrequency=0.0046;normalHomNum=4;patientHetFrequency=0.096;patientHetNum=501;patientHomFrequency=0.005;patientHomNum=26;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16D1545636|16B0017980][16B0001820-1|15D6523842];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D0168725|16D0153181|16D1545759|15B0047454-1|15D6532797|16D0172484|16D1546304|16B3254691|16D1536888-1|16B3254708|16D1546217|16D1545903][15D6517224|15B0027354|15D6532894|15D6518737|15D6482213-1|16D0177745|15D6522030|16D1532963-1|16D0155919|15B0051634|15B6326187|16B0005479|15D6523848|16D0158737];DANN_score=0.9865;GREP_score=5.98;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=CCTCTGTGAC.TAACTCGGTA	GT:AD:DP:GQ:PL	0/1:147,181:328:99:5664,0,4441
chr15	89844688	.	A	C	17142.8	PASS	AC=2;AF=1;AN=2;DP=444;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.7;SOR=1.356;HGVSnom=NM_001113378.2:c.3006+15A>C;Gene=FANCI;Transcript=NM_001113378.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I27;IVSnom=NM_001113378.2:IVS27+15A>C;AAlength=1328;EXAC_AF=0.39437606;EXAC_Hom_EAS=628;EXAC_AC_EAS=3266;EXAC_AN_EAS=8638;EXAC_AC_Adj=47867;EXAC_AN_Adj=121374;ESP6500_MAF=0.36721034;RS=rs2159081;CLNGENE=FANCI;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.36262;G1000_EAS_AF=0.3641;G1000_EUR_AF=0.3946;G1000_AFR_AF=0.3442;G1000_SAS_AF=0.3476;G1000_AMR_AF=0.3703;gnomad_exomes_AF=0.39334855;gnomad_exomes_AF_EAS=0.38240731;gnomad_exomes_AC=98913;gnomad_exomes_Hom=19817;gnomad_exomes_Het=59279;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.32701772;gnomad_exomes_AF_NFE=0.38877363;gnomad_exomes_AF_AMR=0.38161318;gnomad_exomes_AF_SAS=0.40315521;NativeFreq_Het=0.5129;NativeFreq_Hom=0.1343;normalHetFrequency=0.4497;normalHetNum=389;normalHomFrequency=0.178;normalHomNum=154;patientHetFrequency=0.4776;patientHetNum=2493;patientHomFrequency=0.1557;patientHomNum=813;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.384;GREP_score=-1.7;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=TAGTACCGCT.ACTTAATCCC	GT:AD:DP:GQ:PL	1/1:0,443:443:99:17171,1332,0
chr15	89858602	.	T	C	5332.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.8;DP=351;ExcessHet=3.0103;FS=0.807;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.32;ReadPosRankSum=0.137;SOR=0.644;HGVSnom=NM_001113378.2:c.3906T>C(p.Gly1302Gly/p.G1302G);Gene=FANCI;Transcript=NM_001113378.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E37;IVSnom=.;AAlength=1328;EXAC_AF=0.41226074;EXAC_Hom_EAS=781;EXAC_AC_EAS=3706;EXAC_AN_EAS=8636;EXAC_AC_Adj=50013;EXAC_AN_Adj=121314;ESP6500_MAF=0.40960148;RS=rs1138465;CLNGENE=FANCI|POLG;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.41234;G1000_EAS_AF=0.4256;G1000_EUR_AF=0.3996;G1000_AFR_AF=0.4667;G1000_SAS_AF=0.3517;G1000_AMR_AF=0.3934;gnomad_exomes_AF=0.40954806;gnomad_exomes_AF_EAS=0.42843159;gnomad_exomes_AC=102944;gnomad_exomes_Hom=21395;gnomad_exomes_Het=60154;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.44030769;gnomad_exomes_AF_NFE=0.39283703;gnomad_exomes_AF_AMR=0.39149798;gnomad_exomes_AF_SAS=0.40595191;NativeFreq_Het=0.5275;NativeFreq_Hom=0.1942;normalHetFrequency=0.474;normalHetNum=410;normalHomFrequency=0.2092;normalHomNum=181;patientHetFrequency=0.4887;patientHetNum=2551;patientHomFrequency=0.1933;patientHomNum=1009;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5343;GREP_score=-2.91;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I;CGD_INHERITANCE=AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.;Gene_MIM_id=611360;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK);Possible_Inheritance=NA;EntrezGeneID=55215;EnsemblGeneID=ENSG00000140525;Alias=FANCI, KIAA1794;FLKSEQ=GAGAGGATGG.GAAGATGAAA	GT:AD:DP:GQ:PL	0/1:161,187:348:99:5361,0,4603
chr15	89859932	.	A	AC	5299.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.213;DP=398;ExcessHet=3.0103;FS=3.866;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.87;ReadPosRankSum=-0.456;SOR=0.897;HGVSnom=NM_001113378.2:c.*244dupC|NM_002693.3:c.*49dupG;Gene=FANCI|POLG;Transcript=NM_001113378.2|NM_002693.3;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E38|E23;AAlength=1328|1239;EXAC_AF=0.37081019;EXAC_Hom_EAS=439;EXAC_AC_EAS=2759;EXAC_AN_EAS=8558;EXAC_AC_Adj=44871;EXAC_AN_Adj=121008;ESP6500_MAF=0.31027321;RS=rs3087377;CLNGENE=FANCI|POLG;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.289337;G1000_EAS_AF=0.3145;G1000_EUR_AF=0.3887;G1000_AFR_AF=0.1203;G1000_SAS_AF=0.3456;G1000_AMR_AF=0.3516;gnomad_exomes_AF=0.37241208;gnomad_exomes_AF_EAS=0.32561308;gnomad_exomes_AC=92782;gnomad_exomes_Hom=18075;gnomad_exomes_Het=56632;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14390394;gnomad_exomes_AF_NFE=0.38758482;gnomad_exomes_AF_AMR=0.36959169;gnomad_exomes_AF_SAS=0.39397307;NativeFreq_Het=0.3092;NativeFreq_Hom=.;normalHetFrequency=0.4231;normalHetNum=366;normalHomFrequency=0.141;normalHomNum=122;patientHetFrequency=0.4611;patientHetNum=2407;patientHomFrequency=0.1178;patientHomNum=615;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AR,AD/AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+,POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2,POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.,POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=611360,174763;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK),Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=55215,5428;EnsemblGeneID=ENSG00000140525,ENSG00000140521;Alias=FANCI, KIAA1794,POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=GGGAGCCTGC.CCACCCCGAT	GT:AD:DP:GQ:PL	0/1:202,180:382:99:5337,0,6043
chr15	89860350	.	A	C	4320.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=6.018;DP=299;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.45;ReadPosRankSum=0.068;SOR=0.716;HGVSnom=NM_001113378.2:c.*660A>C|NM_002693.3:c.3643+257T>G;Gene=FANCI|POLG;Transcript=NM_001113378.2|NM_002693.3;VarType=UTR3|Intron;MolecularConsequence=3_prime_UTR_exon_variant|coding_transcript_intron_variant;ExonIntron=E38|I22;IVSnom=.|NM_002693.3:IVS22+257T>G;AAlength=1328|1239;RS=rs1061316;CLNGENE=FANCI|POLG;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.445887;G1000_EAS_AF=0.3254;G1000_EUR_AF=0.4026;G1000_AFR_AF=0.6619;G1000_SAS_AF=0.3476;G1000_AMR_AF=0.4107;NativeFreq_Het=0.4903;NativeFreq_Hom=0.1327;normalHetFrequency=0.4116;normalHetNum=356;normalHomFrequency=0.1584;normalHomNum=137;patientHetFrequency=0.4232;patientHetNum=2209;patientHomFrequency=0.1492;patientHomNum=779;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7632;GREP_score=-1.17;CytoBand=q26.1;CGD_CONDITION=Fanconi anemia, complementation group I,Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AR,AD/AR;Strand=FANCI:NM_001113378.1:+,FANCI:NM_018193.2:+,POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=FANCI:NM_001113378.1:NP_001106849.1,FANCI:NM_018193.2:NP_060663.2,POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=FANCI:NM_001113378.1:ENST00000310775.11,FANCI:NM_018193.2:.,POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=611360,174763;Phenotypes=Fanconi anemia, complementation group I, 609053 (3). 609053(MK),Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=NA,AD,AR;EntrezGeneID=55215,5428;EnsemblGeneID=ENSG00000140525,ENSG00000140521;Alias=FANCI, KIAA1794,POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=AGAATAAATT.TCTTTAAACA	GT:AD:DP:GQ:PL	0/1:160,139:299:99:4349,0,4783
chr15	89860786	.	A	C	5346.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.935;DP=313;ExcessHet=3.0103;FS=0.874;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.14;ReadPosRankSum=-0.71;SOR=0.764;HGVSnom=NM_002693.3:c.3483-19T>G;Gene=POLG;Transcript=NM_002693.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I21;IVSnom=NM_002693.3:IVS21-19T>G;AAlength=1239;EXAC_AF=0.42094960;EXAC_Hom_EAS=548;EXAC_AC_EAS=3046;EXAC_AN_EAS=8594;EXAC_AC_Adj=50961;EXAC_AN_Adj=121062;ESP6500_MAF=0.43545161;RS=rs2307438;CLNGENE=POLG;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.419928;G1000_EAS_AF=0.3353;G1000_EUR_AF=0.3966;G1000_AFR_AF=0.5424;G1000_SAS_AF=0.3466;G1000_AMR_AF=0.4467;gnomad_exomes_AF=0.42090652;gnomad_exomes_AF_EAS=0.35885298;gnomad_exomes_AC=105528;gnomad_exomes_Hom=22736;gnomad_exomes_Het=60056;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51467143;gnomad_exomes_AF_NFE=0.39279295;gnomad_exomes_AF_AMR=0.49884320;gnomad_exomes_AF_SAS=0.39662833;NativeFreq_Het=0.4506;NativeFreq_Hom=0.1543;normalHetFrequency=0.4474;normalHetNum=387;normalHomFrequency=0.1561;normalHomNum=135;patientHetFrequency=0.4741;patientHetNum=2475;patientHomFrequency=0.1379;patientHomNum=720;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8159;GREP_score=1.23;CytoBand=q26.1;CGD_CONDITION=Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AD/AR;Strand=POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=174763;Phenotypes=Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5428;EnsemblGeneID=ENSG00000140521;Alias=POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=GACCCAATCT.CTCTCACAGT	GT:AD:DP:GQ:PL	0/1:142,170:312:99:5375,0,4123
chr15	89862341	.	A	G	4835.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.223;DP=387;ExcessHet=3.0103;FS=0.376;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.56;ReadPosRankSum=-0.907;SOR=0.73;HGVSnom=NM_002693.3:c.3105-11T>C;Gene=POLG;Transcript=NM_002693.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_002693.3:IVS19-11T>C;AAlength=1239;EXAC_AF=0.37470946;EXAC_Hom_EAS=452;EXAC_AC_EAS=2793;EXAC_AN_EAS=8628;EXAC_AC_Adj=45462;EXAC_AN_Adj=121326;RS=rs2302084;CLNGENE=FANCI|POLG;CLNSIG=Benign/Likely_benign|Benign/Likely_benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.298123;G1000_EAS_AF=0.3125;G1000_EUR_AF=0.3936;G1000_AFR_AF=0.149;G1000_SAS_AF=0.3446;G1000_AMR_AF=0.3573;gnomad_exomes_AF=0.37650142;gnomad_exomes_AF_EAS=0.32673698;gnomad_exomes_AC=94663;gnomad_exomes_Hom=18606;gnomad_exomes_Het=57451;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17021538;gnomad_exomes_AF_NFE=0.39010235;gnomad_exomes_AF_AMR=0.37287499;gnomad_exomes_AF_SAS=0.39700118;NativeFreq_Het=0.4537;NativeFreq_Hom=0.1173;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.1422;normalHomNum=123;patientHetFrequency=0.4605;patientHetNum=2404;patientHomFrequency=0.1192;patientHomNum=622;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];dbscSNV_RF_score=0.136;dbscSNV_ADA_score=0.00007278;DANN_score=0.6364;GREP_score=2.28;CytoBand=q26.1;CGD_CONDITION=Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AD/AR;Strand=POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=174763;Phenotypes=Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5428;EnsemblGeneID=ENSG00000140521;Alias=POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=CTAAGGGACC.GAAACAGAGG	GT:AD:DP:GQ:PL	0/1:209,176:385:99:4864,0,6597
chr15	89862366	.	T	C	5250.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.684;DP=372;ExcessHet=3.0103;FS=3.325;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.19;ReadPosRankSum=1.008;SOR=0.86;HGVSnom=NM_002693.3:c.3105-36A>G;Gene=POLG;Transcript=NM_002693.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_002693.3:IVS19-36A>G;AAlength=1239;EXAC_AF=0.37189865;EXAC_Hom_EAS=450;EXAC_AC_EAS=2792;EXAC_AN_EAS=8636;EXAC_AC_Adj=45118;EXAC_AN_Adj=121318;ESP6500_MAF=0.31212494;RS=rs2246900;CLNGENE=POLG;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.291134;G1000_EAS_AF=0.3155;G1000_EUR_AF=0.3926;G1000_AFR_AF=0.1225;G1000_SAS_AF=0.3446;G1000_AMR_AF=0.3545;gnomad_exomes_AF=0.37396880;gnomad_exomes_AF_EAS=0.32646515;gnomad_exomes_AC=94018;gnomad_exomes_Hom=18436;gnomad_exomes_Het=57146;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14440478;gnomad_exomes_AF_NFE=0.38907259;gnomad_exomes_AF_AMR=0.37098080;gnomad_exomes_AF_SAS=0.39686377;NativeFreq_Het=0.4475;NativeFreq_Hom=0.1204;normalHetFrequency=0.4254;normalHetNum=368;normalHomFrequency=0.1422;normalHomNum=123;patientHetFrequency=0.4603;patientHetNum=2403;patientHomFrequency=0.1195;patientHomNum=624;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.71;GREP_score=4.05;CytoBand=q26.1;CGD_CONDITION=Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AD/AR;Strand=POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=174763;Phenotypes=Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5428;EnsemblGeneID=ENSG00000140521;Alias=POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=ACTTTGTCTT.CAGCATCTCA	GT:AD:DP:GQ:PL	0/1:206,164:370:99:5279,0,6343
chr15	89864316	.	G	GCTAC	6796.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.528;DP=372;ExcessHet=3.0103;FS=3.388;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.99;ReadPosRankSum=-0.776;SOR=0.698;HGVSnom=NM_002693.3:c.2734+39_2734+40insGTAG;Gene=POLG;Transcript=NM_002693.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_002693.3:IVS17+39_+40insGTAG;AAlength=1239;EXAC_AF=0.50070978;EXAC_Hom_EAS=769;EXAC_AC_EAS=3701;EXAC_AN_EAS=8626;EXAC_AC_Adj=60668;EXAC_AN_Adj=121164;ESP6500_MAF=0.57534356;RS=rs2307433;CLNGENE=POLG;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.558307;G1000_EAS_AF=0.4315;G1000_EUR_AF=0.4692;G1000_AFR_AF=0.8396;G1000_SAS_AF=0.4571;G1000_AMR_AF=0.4784;gnomad_exomes_AF=0.49159784;gnomad_exomes_AF_EAS=0.43097258;gnomad_exomes_AC=123336;gnomad_exomes_Hom=31209;gnomad_exomes_Het=60918;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.79422673;gnomad_exomes_AF_NFE=0.46645734;gnomad_exomes_AF_AMR=0.45019379;gnomad_exomes_AF_SAS=0.48679911;NativeFreq_Het=0.3562;NativeFreq_Hom=.;normalHetFrequency=0.4832;normalHetNum=418;normalHomFrequency=0.2312;normalHomNum=200;patientHetFrequency=0.4989;patientHetNum=2604;patientHomFrequency=0.2111;patientHomNum=1102;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q26.1;CGD_CONDITION=Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AD/AR;Strand=POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=174763;Phenotypes=Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5428;EnsemblGeneID=ENSG00000140521;Alias=POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=CTGTCAATAT.CTGAGGGGCT	GT:AD:DP:GQ:PL	0/1:191,167:358:99:6834,0,10232
chr15	89867154	.	A	G	3658.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.154;DP=259;ExcessHet=3.0103;FS=3.494;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.18;ReadPosRankSum=0.705;SOR=0.924;HGVSnom=NM_002693.3:c.2071-22T>C;Gene=POLG;Transcript=NM_002693.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I11;IVSnom=NM_002693.3:IVS11-22T>C;AAlength=1239;EXAC_AF=0.49909375;EXAC_Hom_EAS=620;EXAC_AC_EAS=3328;EXAC_AN_EAS=8510;EXAC_AC_Adj=60029;EXAC_AN_Adj=120276;ESP6500_MAF=0.57685798;RS=rs2072267;CLNGENE=POLG;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.547324;G1000_EAS_AF=0.3849;G1000_EUR_AF=0.4682;G1000_AFR_AF=0.8359;G1000_SAS_AF=0.4571;G1000_AMR_AF=0.4755;gnomad_exomes_AF=0.48789450;gnomad_exomes_AF_EAS=0.39023459;gnomad_exomes_AC=122160;gnomad_exomes_Hom=30699;gnomad_exomes_Het=60762;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.79265432;gnomad_exomes_AF_NFE=0.46671501;gnomad_exomes_AF_AMR=0.45022664;gnomad_exomes_AF_SAS=0.48542103;NativeFreq_Het=0.4753;NativeFreq_Hom=0.1883;normalHetFrequency=0.4636;normalHetNum=401;normalHomFrequency=0.2046;normalHomNum=177;patientHetFrequency=0.4883;patientHetNum=2549;patientHomFrequency=0.1799;patientHomNum=939;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4981;GREP_score=-3.76;CytoBand=q26.1;CGD_CONDITION=Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1. Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1. Mitochondrial DNA depletion syndrome 4B. Sensory ataxia, dysarthria, and ophthalmoparesis. Mitochondrial DNA depletion syndrome 4A (Alpers type). Alpers syndrome.  POLG-related ataxia neuropathy spectrum disorders;CGD_INHERITANCE=AD/AR;Strand=POLG:NM_001126131.1:-,POLG:NM_002693.2:-;NP=POLG:NM_001126131.1:NP_001119603.1,POLG:NM_002693.2:NP_002684.1;ENSP=POLG:NM_001126131.1:.,POLG:NM_002693.2:ENST00000268124.10;Gene_MIM_id=174763;Phenotypes=Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessive. Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3), Autosomal recessive. Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3), Autosomal recessive. Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3), Autosomal dominant. Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3), Autosomal recessive. 157640(MK),203700(MK),258450(MK),607459(MK),613662(MK);Possible_Inheritance=AD,AR;EntrezGeneID=5428;EnsemblGeneID=ENSG00000140521;Alias=POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;FLKSEQ=CAAGGACCAA.GTAGTGAAGC	GT:AD:DP:GQ:PL	0/1:138,120:258:99:3687,0,4440
chr15	91295110	.	C	T	7014.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.878;DP=499;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.06;ReadPosRankSum=-0.505;SOR=0.693;HGVSnom=NM_000057.4:c.893C>T(p.Thr298Met/p.T298M);Gene=BLM;Transcript=NM_000057.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=1417;EXAC_AF=0.00858886;EXAC_Hom_EAS=42;EXAC_AC_EAS=780;EXAC_AN_EAS=8654;EXAC_AC_Adj=1042;EXAC_AN_Adj=121320;ESP6500_MAF=0.00061586;RS=rs28384991;Ensembl_transcriptid=ENST00000355112|ENST00000560509;SIFT_pred=T|T;SIFT_score=0.186|0.123;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.001|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0229633;G1000_EAS_AF=0.0923;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0041;G1000_AMR_AF=0.0259;gnomad_exomes_AF=0.00981867;gnomad_exomes_AF_EAS=0.09686718;gnomad_exomes_AC=2467;gnomad_exomes_Hom=107;gnomad_exomes_Het=2253;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00092330;gnomad_exomes_AF_NFE=0.00004401;gnomad_exomes_AF_AMR=0.01683054;gnomad_exomes_AF_SAS=0.00160089;HGMD_gene=BLM;HGMD_disease=Poor_prognosis_in_neuroblastoma;HGMD_tag=DM?;HGMD_pmid=27876123;NativeFreq_Het=0.1578;NativeFreq_Hom=0.0084;normalHetFrequency=0.1017;normalHetNum=88;normalHomFrequency=0.0104;normalHomNum=9;patientHetFrequency=0.1197;patientHetNum=625;patientHomFrequency=0.0073;patientHomNum=38;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B1276308|16B1175070|16B0033062|16B3097978-1|16B0065799|16D0161309|16B0202615|16B0019213-1|16B0028299|16D0067254|15B0048471|16B0033580|17B0000728][15B0060422|15B0033099|15B6215143|16B3108464|15B0047294-1|16B0035694-1|16B0035694|16B0024573|16B0018972-1|15B6105826|16D0067200|16B0009471-1|15B0054129|15B6215396|16B0067557|15B6105424|15B0022623|16B0035694-2|15B0002756|16B0200175|15B0022624|15B0002981-1|15B0048413|15B0027219|16B3108622];AF_2700_Het=0.1530;AF_2700_Hom=0.0104;AF_50_Het=0.1537;AF_50_Hom=0.0095;DANN_score=0.892;GREP_score=0.78;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=GATTATGATA.GGATTTTGTT	GT:AD:DP:GQ:PL	0/1:267,232:499:99:7043,0,7878
chr15	91312313	.	G	A	3752.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.767;DP=198;ExcessHet=3.0103;FS=4.814;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.05;ReadPosRankSum=1.332;SOR=1.148;HGVSnom=NM_000057.4:c.2308-50G>A;Gene=BLM;Transcript=NM_000057.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000057.4:IVS10-50G>A;AAlength=1417;EXAC_AF=0.15530122;EXAC_Hom_EAS=248;EXAC_AC_EAS=2028;EXAC_AN_EAS=8614;EXAC_AC_Adj=18834;EXAC_AN_Adj=121274;ESP6500_MAF=0.16995074;RS=rs17273206;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.160942;G1000_EAS_AF=0.244;G1000_EUR_AF=0.1521;G1000_AFR_AF=0.1853;G1000_SAS_AF=0.0716;G1000_AMR_AF=0.1326;gnomad_exomes_AF=0.15305074;gnomad_exomes_AF_EAS=0.24817677;gnomad_exomes_AC=38439;gnomad_exomes_Hom=3193;gnomad_exomes_Het=32053;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17134589;gnomad_exomes_AF_NFE=0.17323279;gnomad_exomes_AF_AMR=0.11335377;gnomad_exomes_AF_SAS=0.07889579;NativeFreq_Het=0.3687;NativeFreq_Hom=0.0663;normalHetFrequency=0.3191;normalHetNum=276;normalHomFrequency=0.0439;normalHomNum=38;patientHetFrequency=0.3128;patientHetNum=1633;patientHomFrequency=0.0511;patientHomNum=267;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5719;GREP_score=-0.345;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=ACAGAATCAT.AGGTGATGTG	GT:AD:DP:GQ:PL	0/1:77,120:197:99:3781,0,2422
chr15	91312823	.	T	C	4369.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.168;DP=307;ExcessHet=3.0103;FS=6.133;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.23;ReadPosRankSum=0.356;SOR=1.006;HGVSnom=NM_000057.4:c.2555+7T>C;Gene=BLM;Transcript=NM_000057.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000057.4:IVS12+7T>C;AAlength=1417;EXAC_AF=0.29558950;EXAC_Hom_EAS=399;EXAC_AC_EAS=2597;EXAC_AN_EAS=8198;EXAC_AC_Adj=34448;EXAC_AN_Adj=116540;ESP6500_MAF=0.38192734;RS=rs3815003;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.366613;G1000_EAS_AF=0.3185;G1000_EUR_AF=0.2913;G1000_AFR_AF=0.6747;G1000_SAS_AF=0.1646;G1000_AMR_AF=0.2435;gnomad_exomes_AF=0.27984755;gnomad_exomes_AF_EAS=0.31588448;gnomad_exomes_AC=69977;gnomad_exomes_Hom=10864;gnomad_exomes_Het=48249;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.59680207;gnomad_exomes_AF_NFE=0.27658726;gnomad_exomes_AF_AMR=0.23331589;gnomad_exomes_AF_SAS=0.17889158;NativeFreq_Het=0.4398;NativeFreq_Hom=0.0964;normalHetFrequency=0.3884;normalHetNum=336;normalHomFrequency=0.0717;normalHomNum=62;patientHetFrequency=0.381;patientHetNum=1989;patientHomFrequency=0.0831;patientHomNum=434;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4220;AF_2700_Hom=0.0911;AF_50_Het=0.4200;AF_50_Hom=0.0983;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00129492;DANN_score=0.8254;GREP_score=3.4;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=AGGTGTAAGT.GTTGCACGTC	GT:AD:DP:GQ:PL	0/1:152,155:307:99:4398,0,4892
chr15	91337479	.	G	A	8614.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.468;DP=601;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.36;ReadPosRankSum=-0.846;SOR=0.659;HGVSnom=NM_000057.4:c.3102G>A(p.Thr1034Thr/p.T1034T);Gene=BLM;Transcript=NM_000057.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E16;IVSnom=.;AAlength=1417;EXAC_AF=0.16112633;EXAC_Hom_EAS=141;EXAC_AC_EAS=1500;EXAC_AN_EAS=8638;EXAC_AC_Adj=19524;EXAC_AN_Adj=121172;ESP6500_MAF=0.18455497;RS=rs2227933;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.151158;G1000_EAS_AF=0.1855;G1000_EUR_AF=0.165;G1000_AFR_AF=0.1974;G1000_SAS_AF=0.0665;G1000_AMR_AF=0.1124;gnomad_exomes_AF=0.15644113;gnomad_exomes_AF_EAS=0.18033149;gnomad_exomes_AC=38931;gnomad_exomes_Hom=3255;gnomad_exomes_Het=32421;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18780096;gnomad_exomes_AF_NFE=0.18675937;gnomad_exomes_AF_AMR=0.09135940;gnomad_exomes_AF_SAS=0.08820568;NativeFreq_Het=0.2928;NativeFreq_Hom=0.0325;normalHetFrequency=0.2555;normalHetNum=221;normalHomFrequency=0.0312;normalHomNum=27;patientHetFrequency=0.2563;patientHetNum=1338;patientHomFrequency=0.028;patientHomNum=146;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2905;AF_2700_Hom=0.0342;AF_50_Het=0.3043;AF_50_Hom=0.0396;DANN_score=0.6181;GREP_score=-8.46;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=AAAATATAAC.GAATGCAGGA	GT:AD:DP:GQ:PL	0/1:316,284:600:99:8643,0,9104
chr15	91337623	.	AT	A	2611.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.073;DP=313;ExcessHet=3.0103;FS=0.814;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.23;ReadPosRankSum=0.066;SOR=0.852;HGVSnom=NM_000057.4:c.3210+44delT;Gene=BLM;Transcript=NM_000057.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I16;IVSnom=NM_000057.4:IVS16+44delT;AAlength=1417;EXAC_AF=0.13057386;EXAC_Hom_EAS=11;EXAC_AC_EAS=100;EXAC_AN_EAS=528;EXAC_AC_Adj=2735;EXAC_AN_Adj=20946;ESP6500_MAF=0.19016036;RS=rs3214113;CLNGENE=BLM;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.151158;G1000_EAS_AF=0.1845;G1000_EUR_AF=0.165;G1000_AFR_AF=0.1974;G1000_SAS_AF=0.0665;G1000_AMR_AF=0.1138;gnomad_exomes_AF=0.15209911;gnomad_exomes_AF_EAS=0.19022770;gnomad_exomes_AC=19006;gnomad_exomes_Hom=1553;gnomad_exomes_Het=15900;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18291987;gnomad_exomes_AF_NFE=0.18066433;gnomad_exomes_AF_AMR=0.09841587;gnomad_exomes_AF_SAS=0.08531583;NativeFreq_Het=0.1643;NativeFreq_Hom=.;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0312;normalHomNum=27;patientHetFrequency=0.2529;patientHetNum=1320;patientHomFrequency=0.0276;patientHomNum=144;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q26.1;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=ttataattaa.tttttttCTC	GT:AD:DP:GQ:PL	0/1:167,116:283:99:2649,0,4200
chr15	91341599	.	T	G	3436.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.548;DP=223;ExcessHet=3.0103;FS=14.557;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.48;ReadPosRankSum=0.815;SOR=1.546;HGVSnom=NM_000057.4:c.3358+32T>G;Gene=BLM;Transcript=NM_000057.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_000057.4:IVS17+32T>G;AAlength=1417;EXAC_AF=0.15890628;EXAC_Hom_EAS=144;EXAC_AC_EAS=1499;EXAC_AN_EAS=8638;EXAC_AC_Adj=19248;EXAC_AN_Adj=121128;ESP6500_MAF=0.17644794;RS=rs17273842;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.144768;G1000_EAS_AF=0.1855;G1000_EUR_AF=0.166;G1000_AFR_AF=0.1717;G1000_SAS_AF=0.0685;G1000_AMR_AF=0.111;gnomad_exomes_AF=0.15487096;gnomad_exomes_AF_EAS=0.17934190;gnomad_exomes_AC=38443;gnomad_exomes_Hom=3174;gnomad_exomes_Het=32095;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16251557;gnomad_exomes_AF_NFE=0.18718317;gnomad_exomes_AF_AMR=0.09022180;gnomad_exomes_AF_SAS=0.08867028;NativeFreq_Het=0.2880;NativeFreq_Hom=0.0325;normalHetFrequency=0.2566;normalHetNum=222;normalHomFrequency=0.0301;normalHomNum=26;patientHetFrequency=0.2538;patientHetNum=1325;patientHomFrequency=0.0282;patientHomNum=147;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6474;GREP_score=-0.865;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=TTTGAGTTAC.TCAATTGAAA	GT:AD:DP:GQ:PL	0/1:108,114:222:99:3465,0,3310
chr15	91346923	.	C	A	9738.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.92;DP=290;ExcessHet=3.0103;FS=4.053;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.58;ReadPosRankSum=0.402;SOR=2.6;HGVSnom=NM_000057.4:c.3531C>A(p.Ala1177Ala/p.A1177A);Gene=BLM;Transcript=NM_000057.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E18;IVSnom=.;AAlength=1417;EXAC_AF=0.15527310;EXAC_Hom_EAS=144;EXAC_AC_EAS=1504;EXAC_AN_EAS=8652;EXAC_AC_Adj=18825;EXAC_AN_Adj=121238;ESP6500_MAF=0.16271552;RS=rs2227934;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.133187;G1000_EAS_AF=0.1875;G1000_EUR_AF=0.165;G1000_AFR_AF=0.1309;G1000_SAS_AF=0.0675;G1000_AMR_AF=0.1052;gnomad_exomes_AF=0.15149128;gnomad_exomes_AF_EAS=0.17975207;gnomad_exomes_AC=38074;gnomad_exomes_Hom=3104;gnomad_exomes_Het=31866;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12119719;gnomad_exomes_AF_NFE=0.18674667;gnomad_exomes_AF_AMR=0.08844619;gnomad_exomes_AF_SAS=0.08883298;NativeFreq_Het=0.2871;NativeFreq_Hom=0.0337;normalHetFrequency=0.2566;normalHetNum=222;normalHomFrequency=0.0301;normalHomNum=26;patientHetFrequency=0.2561;patientHetNum=1337;patientHomFrequency=0.0278;patientHomNum=145;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2886;AF_2700_Hom=0.0342;AF_50_Het=0.3011;AF_50_Hom=0.0396;DANN_score=0.5013;GREP_score=1.16;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=GAAATAAAGC.CAAACTGTAC	GT:AD:DP:GQ:PL	1/1:2,288:290:99:9767,821,0
chr15	91354505	.	C	T	12515.8	PASS	AC=2;AF=1;AN=2;DP=339;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.57;SOR=0.785;HGVSnom=NM_000057.4:c.3945C>T(p.Leu1315Leu/p.L1315L);Gene=BLM;Transcript=NM_000057.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E21;IVSnom=.;AAlength=1417;EXAC_AF=0.15567787;EXAC_Hom_EAS=136;EXAC_AC_EAS=1475;EXAC_AN_EAS=8638;EXAC_AC_Adj=18894;EXAC_AN_Adj=121366;ESP6500_MAF=0.16456281;RS=rs1063147;CLNGENE=BLM;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.132788;G1000_EAS_AF=0.1875;G1000_EUR_AF=0.167;G1000_AFR_AF=0.1278;G1000_SAS_AF=0.0685;G1000_AMR_AF=0.1037;gnomad_exomes_AF=0.15152925;gnomad_exomes_AF_EAS=0.17701424;gnomad_exomes_AC=38099;gnomad_exomes_Hom=3106;gnomad_exomes_Het=31887;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.12286206;gnomad_exomes_AF_NFE=0.18763630;gnomad_exomes_AF_AMR=0.08462473;gnomad_exomes_AF_SAS=0.08848893;NativeFreq_Het=0.2855;NativeFreq_Hom=0.0301;normalHetFrequency=0.2555;normalHetNum=221;normalHomFrequency=0.0301;normalHomNum=26;patientHetFrequency=0.2557;patientHetNum=1335;patientHomFrequency=0.0266;patientHomNum=139;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2844;AF_2700_Hom=0.0357;AF_50_Het=0.2916;AF_50_Hom=0.0396;DANN_score=0.5116;GREP_score=-6.6;CytoBand=q26.1;CGD_CONDITION=Bloom syndrome;CGD_INHERITANCE=AR;Strand=BLM:NM_000057.3:+,BLM:NM_001287246.1:+,BLM:NM_001287247.1:+,BLM:NM_001287248.1:+,BLM:NM_000057.4:+;NP=BLM:NM_000057.3:NP_000048.1,BLM:NM_001287246.1:NP_001274175.1,BLM:NM_001287247.1:NP_001274176.1,BLM:NM_001287248.1:NP_001274177.1,BLM:NM_000057.4:NP_000048.1;ENSP=BLM:NM_000057.3:ENST00000355112.7,BLM:NM_001287246.1:.,BLM:NM_001287247.1:.,BLM:NM_001287248.1:.,BLM:NM_000057.4:ENST00000355112.8;Gene_MIM_id=604610;Phenotypes=Bloom syndrome, 210900 (3), Autosomal recessive. 210900(MK);Possible_Inheritance=AR;EntrezGeneID=641;EnsemblGeneID=ENSG00000197299;Alias=RECQL3, RECQ2, BLM, BS;FLKSEQ=CTGAGGAGCT.GACGAGGAAA	GT:AD:DP:GQ:PL	1/1:0,339:339:99:12544,1018,0
chr16	1823444	.	C	G	1601.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.388;DP=143;ExcessHet=3.0103;FS=4.117;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.2;ReadPosRankSum=-1.818;SOR=0.577;HGVSnom=NM_001257370.2:c.216C>G(p.Val72Val/p.V72V);Gene=EME2;Transcript=NM_001257370.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=379;EXAC_AF=0.55694556;EXAC_Hom_EAS=234;EXAC_AC_EAS=1682;EXAC_AN_EAS=4696;EXAC_AC_Adj=35972;EXAC_AN_Adj=64588;ESP6500_MAF=0.41765369;RS=rs761065;G1000_AF=0.336062;G1000_EAS_AF=0.2808;G1000_EUR_AF=0.5666;G1000_AFR_AF=0.0915;G1000_SAS_AF=0.3783;G1000_AMR_AF=0.4885;gnomad_exomes_AF=0.50710966;gnomad_exomes_AF_EAS=0.30094820;gnomad_exomes_AC=91013;gnomad_exomes_Hom=24513;gnomad_exomes_Het=41987;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.13620283;gnomad_exomes_AF_NFE=0.59314869;gnomad_exomes_AF_AMR=0.56003816;gnomad_exomes_AF_SAS=0.38951353;DANN_score=0.4844;GREP_score=-5.9;CytoBand=p13.3;Strand=EME2:NM_001257370.1:+;NP=EME2:NM_001257370.1:NP_001244299.1;ENSP=EME2:NM_001257370.1:.;Gene_MIM_id=610886;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=197342;EnsemblGeneID=ENSG00000197774;Alias=EME2;FLKSEQ=CGGAGCAGGT.CTGAAGCGCC	GT:AD:DP:GQ:PL	0/1:91,52:143:99:1630,0,3018
chr16	1825768	.	A	C	5781.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.507;DP=366;ExcessHet=3.0103;FS=2.756;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.84;ReadPosRankSum=1.165;SOR=0.749;HGVSnom=NM_001257370.2:c.780-30A>C;Gene=EME2;Transcript=NM_001257370.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_001257370.2:IVS6-30A>C;AAlength=379;EXAC_AF=0.49922673;EXAC_Hom_EAS=374;EXAC_AC_EAS=2568;EXAC_AN_EAS=8620;EXAC_AC_Adj=60041;EXAC_AN_Adj=120268;ESP6500_MAF=0.45275469;RS=rs2745169;G1000_AF=0.333866;G1000_EAS_AF=0.2847;G1000_EUR_AF=0.5775;G1000_AFR_AF=0.0938;G1000_SAS_AF=0.2873;G1000_AMR_AF=0.5749;gnomad_exomes_AF=0.50781537;gnomad_exomes_AF_EAS=0.30046795;gnomad_exomes_AC=126964;gnomad_exomes_Hom=35591;gnomad_exomes_Het=55782;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14274204;gnomad_exomes_AF_NFE=0.59712773;gnomad_exomes_AF_AMR=0.66817077;gnomad_exomes_AF_SAS=0.29825536;NativeFreq_Het=0.4342;NativeFreq_Hom=0.1601;DANN_score=0.4689;GREP_score=-0.823;CytoBand=p13.3;Strand=EME2:NM_001257370.1:+;NP=EME2:NM_001257370.1:NP_001244299.1;ENSP=EME2:NM_001257370.1:.;Gene_MIM_id=610886;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=197342;EnsemblGeneID=ENSG00000197774;Alias=EME2;FLKSEQ=TGCTCACATG.GGTTCTAAAA	GT:AD:DP:GQ:PL	0/1:172,193:365:99:5810,0,5274
chr16	3639139	.	A	G	13923.8	PASS	AC=2;AF=1;AN=2;DP=361;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.53;SOR=0.953;HGVSnom=NM_032444.4:c.4500T>C(p.Asn1500Asn/p.N1500N);Gene=SLX4;Transcript=NM_032444.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=1834;EXAC_AF=0.61158582;EXAC_Hom_EAS=2279;EXAC_AC_EAS=6246;EXAC_AN_EAS=8636;EXAC_AC_Adj=74008;EXAC_AN_Adj=121010;ESP6500_MAF=0.62659689;RS=rs3810812;CLNGENE=SLX4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.739617;G1000_EAS_AF=0.7103;G1000_EUR_AF=0.5169;G1000_AFR_AF=0.9289;G1000_SAS_AF=0.8088;G1000_AMR_AF=0.647;gnomad_exomes_AF=0.60386731;gnomad_exomes_AF_EAS=0.72016752;gnomad_exomes_AC=151712;gnomad_exomes_Hom=47857;gnomad_exomes_Het=55998;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87802918;gnomad_exomes_AF_NFE=0.51331632;gnomad_exomes_AF_AMR=0.66906620;gnomad_exomes_AF_SAS=0.76143193;NativeFreq_Het=0.4078;NativeFreq_Hom=0.5162;normalHetFrequency=0.4497;normalHetNum=389;normalHomFrequency=0.4474;normalHomNum=387;patientHetFrequency=0.4161;patientHetNum=2172;patientHomFrequency=0.4743;patientHomNum=2476;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3514;GREP_score=4.62;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=TCGGCCTGCT.TTCCCCAGGG	GT:AD:DP:GQ:PL	1/1:0,360:360:99:13952,1083,0
chr16	3639793	.	C	T	5491.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.786;DP=346;ExcessHet=3.0103;FS=1.763;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.92;ReadPosRankSum=2.083;SOR=0.59;HGVSnom=NM_032444.4:c.3846G>A(p.Leu1282Leu/p.L1282L);Gene=SLX4;Transcript=NM_032444.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E12;IVSnom=.;AAlength=1834;RS=rs1040333386;CLNGENE=SLX4;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.00002394;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=6;gnomad_exomes_Hom=0;gnomad_exomes_Het=6;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00003521;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00003268;DANN_score=0.689;GREP_score=-6.21;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=CCTGCACGGC.AGCCCGCTCC	GT:AD:DP:GQ:PL	0/1:163,182:345:99:5520,0,5131
chr16	3640274	.	G	A	10074.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.111;DP=631;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.04;ReadPosRankSum=0.543;SOR=0.71;HGVSnom=NM_032444.4:c.3365C>T(p.Pro1122Leu/p.P1122L);Gene=SLX4;Transcript=NM_032444.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E12;IVSnom=.;AAlength=1834;EXAC_AF=0.13472565;EXAC_Hom_EAS=32;EXAC_AC_EAS=807;EXAC_AN_EAS=8646;EXAC_AC_Adj=16353;EXAC_AN_Adj=121380;ESP6500_MAF=0.21163614;RS=rs714181;Ensembl_transcriptid=ENST00000294008;SIFT_pred=T;SIFT_score=0.818;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.002;MutationTaster_pred=P;MutationTaster_score=1;CLNGENE=SLX4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.239617;G1000_EAS_AF=0.0843;G1000_EUR_AF=0.0865;G1000_AFR_AF=0.5484;G1000_SAS_AF=0.2055;G1000_AMR_AF=0.147;gnomad_exomes_AF=0.12530630;gnomad_exomes_AF_EAS=0.08834403;gnomad_exomes_AC=31500;gnomad_exomes_Hom=3261;gnomad_exomes_Het=24978;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.48147692;gnomad_exomes_AF_NFE=0.08217226;gnomad_exomes_AF_AMR=0.11054579;gnomad_exomes_AF_SAS=0.17951650;NativeFreq_Het=0.1570;NativeFreq_Hom=0.0097;normalHetFrequency=0.1792;normalHetNum=155;normalHomFrequency=0.0116;normalHomNum=10;patientHetFrequency=0.1799;patientHetNum=939;patientHomFrequency=0.009;patientHomNum=47;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6482483|16D1546174|15B0002954|16B1903717|16B0033047|15B0062770|16B0228629|15D6532206|16B0028460|15D6482382-1|15D6722510-1|16B0024619|16D0038328|16B0200467|16B0005273|16B0200085|16D1532994-1|15D6722310-1|16B0017940|16B1904228|16B0047193|15D6482465|16B0033206|16B0012197|15B0051502|16D0172142][16B0202637|16B0028367|15S0021119|15D6532276|15B0062847|16B0000943|15B0040441|16B0033502|15D6482355|16D0155919|16B3107988|16B0000482|15B0027356|16B0033051|16B0011712|16B0000437|16B0028359|16B0028360|16D1545891|16B0009511-1|15B0012060];DANN_score=0.2002;GREP_score=-0.664;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=GTCAATAGAC.GAGATTTTTC	GT:AD:DP:GQ:PL	0/1:304,324:628:99:10103,0,8736
chr16	3656482	.	C	T	5554.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.972;DP=411;ExcessHet=3.0103;FS=1.123;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.58;ReadPosRankSum=-0.711;SOR=0.604;HGVSnom=NM_032444.4:c.753G>A(p.Ala251Ala/p.A251A);Gene=SLX4;Transcript=NM_032444.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=1834;EXAC_AF=0.21380089;EXAC_Hom_EAS=437;EXAC_AC_EAS=2663;EXAC_AN_EAS=8650;EXAC_AC_Adj=25955;EXAC_AN_Adj=121398;ESP6500_MAF=0.21894721;RS=rs8061528;CLNGENE=SLX4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.230831;G1000_EAS_AF=0.2808;G1000_EUR_AF=0.1978;G1000_AFR_AF=0.2466;G1000_SAS_AF=0.2209;G1000_AMR_AF=0.1902;gnomad_exomes_AF=0.21246550;gnomad_exomes_AF_EAS=0.30069588;gnomad_exomes_AC=53110;gnomad_exomes_Hom=5984;gnomad_exomes_Het=41142;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.25079970;gnomad_exomes_AF_NFE=0.20156592;gnomad_exomes_AF_AMR=0.19877428;gnomad_exomes_AF_SAS=0.22715098;NativeFreq_Het=0.4401;NativeFreq_Hom=0.1117;normalHetFrequency=0.4069;normalHetNum=352;normalHomFrequency=0.0925;normalHomNum=80;patientHetFrequency=0.4056;patientHetNum=2117;patientHomFrequency=0.092;patientHomNum=480;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7044;GREP_score=-8.83;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=TACCATTCCC.GCCATCATCT	GT:AD:DP:GQ:PL	0/1:220,189:409:99:5583,0,6545
chr16	3656557	.	G	A	8249.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.134;DP=514;ExcessHet=3.0103;FS=0.524;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.18;ReadPosRankSum=1.119;SOR=0.64;HGVSnom=NM_032444.4:c.678C>T(p.His226His/p.H226H);Gene=SLX4;Transcript=NM_032444.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=1834;EXAC_AF=0.05456433;EXAC_Hom_EAS=9;EXAC_AC_EAS=461;EXAC_AN_EAS=8644;EXAC_AC_Adj=6624;EXAC_AN_Adj=121398;ESP6500_MAF=0.09512082;RS=rs28516461;CLNGENE=SLX4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.131789;G1000_EAS_AF=0.0337;G1000_EUR_AF=0.0179;G1000_AFR_AF=0.3139;G1000_SAS_AF=0.1564;G1000_AMR_AF=0.0576;gnomad_exomes_AF=0.04915562;gnomad_exomes_AF_EAS=0.05121235;gnomad_exomes_AC=12359;gnomad_exomes_Hom=887;gnomad_exomes_Het=10585;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.26002707;gnomad_exomes_AF_NFE=0.01411609;gnomad_exomes_AF_AMR=0.02697155;gnomad_exomes_AF_SAS=0.12379148;NativeFreq_Het=0.1052;NativeFreq_Hom=0.0032;normalHetFrequency=0.1156;normalHetNum=100;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0998;patientHetNum=521;patientHomFrequency=0.0048;patientHomNum=25;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0018062][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6482483|16B0033047|16D0166703|15B0062770|16B0228629|15D6722510-1|16D0038328|16B3097982-1|16B0005273|16B1904228|16B0047193|15D6482465|16D1533036-1|16B0033206|16D0172142][16B0202637|15B0062847|15D6482355|16D0155919|16B0000482|15B0027356|16B0028359|16B0028360|16B0009511-1|15B0012060];DANN_score=0.8924;GREP_score=-1.22;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=CTTCTGAAGC.TGTCTCAAAC	GT:AD:DP:GQ:PL	0/1:247,263:510:99:8278,0,6961
chr16	3659593	.	T	G	3567.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.089;DP=238;ExcessHet=3.0103;FS=4.782;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.18;ReadPosRankSum=-1.406;SOR=1.023;HGVSnom=NM_032444.4:c.-602-26A>C;Gene=SLX4;Transcript=NM_032444.4;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_032444.4:IVS1-26A>C;AAlength=1834;RS=rs78173617;CLNGENE=SLX4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0632987;G1000_EAS_AF=0.0337;G1000_EUR_AF=0.0149;G1000_AFR_AF=0.0681;G1000_SAS_AF=0.1575;G1000_AMR_AF=0.0346;NativeFreq_Het=0.1117;NativeFreq_Hom=0.0032;normalHetFrequency=0.0943;normalHetNum=45;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0964;patientHetNum=236;patientHomFrequency=0.0037;patientHomNum=9;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0202637|15B0062847|16D0155919|16B0000482|15B0027356|16B0028359|16B0028360|16B0009511-1|15B0012060];DANN_score=0.8656;GREP_score=1.1;CytoBand=p13.3;CGD_CONDITION=Fanconi anemia, complementation group P;CGD_INHERITANCE=AR;Strand=SLX4:NM_032444.3:-,SLX4:NM_032444.4:-;NP=SLX4:NM_032444.3:NP_115820.2,SLX4:NM_032444.4:NP_115820.2;ENSP=SLX4:NM_032444.3:.,SLX4:NM_032444.4:ENST00000294008.4;Gene_MIM_id=613278;Phenotypes=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive. 613951(MK);Possible_Inheritance=AR;EntrezGeneID=84464;EnsemblGeneID=ENSG00000188827;Alias=SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;FLKSEQ=AGCATGTAAG.GTAATCAGAC	GT:AD:DP:GQ:PL	0/1:121,114:235:99:3596,0,3608
chr16	14013993	.	T	A	3461.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.545;DP=256;ExcessHet=3.0103;FS=0.466;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.58;ReadPosRankSum=-0.927;SOR=0.65;HGVSnom=.;Gene=ERCC4;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;EXAC_AF=0.24387171;EXAC_Hom_EAS=246;EXAC_AC_EAS=2101;EXAC_AN_EAS=8510;EXAC_AC_Adj=28453;EXAC_AN_Adj=116672;ESP6500_MAF=0.23313646;RS=rs1799797;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.220447;G1000_EAS_AF=0.2659;G1000_EUR_AF=0.2763;G1000_AFR_AF=0.18;G1000_SAS_AF=0.2382;G1000_AMR_AF=0.1254;gnomad_exomes_AF=0.23998412;gnomad_exomes_AF_EAS=0.25315207;gnomad_exomes_AC=56834;gnomad_exomes_Hom=7233;gnomad_exomes_Het=42368;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17179453;gnomad_exomes_AF_NFE=0.27810336;gnomad_exomes_AF_AMR=0.13924124;gnomad_exomes_AF_SAS=0.22942945;NativeFreq_Het=0.4257;NativeFreq_Hom=0.0676;normalHetFrequency=0.3364;normalHetNum=291;normalHomFrequency=0.0682;normalHomNum=59;patientHetFrequency=0.3397;patientHetNum=1773;patientHomFrequency=0.0776;patientHomNum=405;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3720;AF_2700_Hom=0.0534;AF_50_Het=0.3788;AF_50_Hom=0.0396;DANN_score=0.6806;GREP_score=-3.5;CytoBand=p13.12;FLKSEQ=TTCCTTCGGC.GCGTTCGGCT	GT:AD:DP:GQ:PL	0/1:138,117:255:99:3490,0,4201
chr16	14014240	.	G	A	4058.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.548;DP=281;ExcessHet=3.0103;FS=2.048;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.55;ReadPosRankSum=0.166;SOR=0.837;HGVSnom=NM_005236.3:c.207+11G>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_005236.3:IVS1+11G>A;AAlength=916;EXAC_AF=0.33295266;EXAC_Hom_EAS=91;EXAC_AC_EAS=704;EXAC_AN_EAS=1916;EXAC_AC_Adj=11662;EXAC_AN_Adj=35026;ESP6500_MAF=0.23135861;RS=rs762521;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.220248;G1000_EAS_AF=0.2659;G1000_EUR_AF=0.2763;G1000_AFR_AF=0.1793;G1000_SAS_AF=0.2382;G1000_AMR_AF=0.1254;gnomad_exomes_AF=0.25033135;gnomad_exomes_AF_EAS=0.26308819;gnomad_exomes_AC=40797;gnomad_exomes_Hom=5338;gnomad_exomes_Het=30121;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18105002;gnomad_exomes_AF_NFE=0.29119823;gnomad_exomes_AF_AMR=0.14670770;gnomad_exomes_AF_SAS=0.25219613;NativeFreq_Het=0.4158;NativeFreq_Hom=0.0495;normalHetFrequency=0.2844;normalHetNum=246;normalHomFrequency=0.074;normalHomNum=64;patientHetFrequency=0.3033;patientHetNum=1583;patientHomFrequency=0.0866;patientHomNum=452;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3451;AF_2700_Hom=0.0669;AF_50_Het=0.3518;AF_50_Hom=0.0523;DANN_score=0.9587;GREP_score=-0.337;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=GTGCGGCCGC.CTGGCGCGGG	GT:AD:DP:GQ:PL	0/1:135,144:279:99:4087,0,3975
chr16	14016109	.	C	CT	189.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.589;DP=343;ExcessHet=3.0103;FS=1.164;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.64;ReadPosRankSum=0.297;SOR=0.439;HGVSnom=NM_005236.3:c.388+53dupT;Gene=ERCC4;Transcript=NM_005236.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_005236.3:IVS2+53_+54insT;AAlength=916;EXAC_AF=0.04085335;EXAC_Hom_EAS=0;EXAC_AC_EAS=20;EXAC_AN_EAS=1272;EXAC_AC_Adj=1126;EXAC_AN_Adj=27562;ESP6500_MAF=0.02468626;RS=rs34861763;gnomad_exomes_AF=0.06198690;gnomad_exomes_AF_EAS=0.05225523;gnomad_exomes_AC=3730;gnomad_exomes_Hom=0;gnomad_exomes_Het=3730;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.03936348;gnomad_exomes_AF_NFE=0.05398365;gnomad_exomes_AF_AMR=0.07568807;gnomad_exomes_AF_SAS=0.08615738;normalHetFrequency=0.022;normalHetNum=19;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.019;patientHetNum=99;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TAAATTTGTA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:251,44:295:99:227,0,5124
chr16	14026007	.	G	A	8758.77	StandardFilter	AC=2;AF=1;AN=2;DP=232;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.72;SOR=3.318;HGVSnom=NM_005236.3:c.974-7G>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_005236.3:IVS5-7G>A;AAlength=916;EXAC_AF=0.96614317;EXAC_Hom_EAS=2692;EXAC_AC_EAS=6813;EXAC_AN_EAS=8648;EXAC_AC_Adj=117255;EXAC_AN_Adj=121364;ESP6500_MAF=0.98460828;RS=rs254942;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.946486;G1000_EAS_AF=0.7847;G1000_EUR_AF=0.9781;G1000_AFR_AF=0.997;G1000_SAS_AF=0.9816;G1000_AMR_AF=0.9899;gnomad_exomes_AF=0.96566107;gnomad_exomes_AF_EAS=0.78695747;gnomad_exomes_AC=242632;gnomad_exomes_Hom=117506;gnomad_exomes_Het=7620;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99562053;gnomad_exomes_AF_NFE=0.98067382;gnomad_exomes_AF_AMR=0.97560130;gnomad_exomes_AF_SAS=0.97847249;NativeFreq_Het=0.3366;NativeFreq_Hom=0.7758;normalHetFrequency=0.2439;normalHetNum=211;normalHomFrequency=0.7214;normalHomNum=624;patientHetFrequency=0.2701;patientHetNum=1410;patientHomFrequency=0.6879;patientHomNum=3591;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3463;AF_2700_Hom=0.6038;AF_50_Het=0.3518;AF_50_Hom=0.6117;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00017764;DANN_score=0.8122;GREP_score=-9.29;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TTAACTTTTC.TATTAGGTTG	GT:AD:DP:GQ:PL	1/1:0,232:232:99:8787,698,0
chr16	14038545	.	T	C	3948.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.854;DP=215;ExcessHet=3.0103;FS=6.391;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.37;ReadPosRankSum=0.5;SOR=1.211;HGVSnom=NM_005236.3:c.1905-35T>C;Gene=ERCC4;Transcript=NM_005236.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_005236.3:IVS9-35T>C;AAlength=916;EXAC_AF=0.32373635;EXAC_Hom_EAS=207;EXAC_AC_EAS=1968;EXAC_AN_EAS=8376;EXAC_AC_Adj=38467;EXAC_AN_Adj=118822;ESP6500_MAF=0.38048330;RS=rs1799799;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.338059;G1000_EAS_AF=0.2609;G1000_EUR_AF=0.3529;G1000_AFR_AF=0.4985;G1000_SAS_AF=0.2505;G1000_AMR_AF=0.2464;gnomad_exomes_AF=0.31674476;gnomad_exomes_AF_EAS=0.23585009;gnomad_exomes_AC=79088;gnomad_exomes_Hom=13034;gnomad_exomes_Het=53020;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.46267361;gnomad_exomes_AF_NFE=0.34398353;gnomad_exomes_AF_AMR=0.22007677;gnomad_exomes_AF_SAS=0.27461736;NativeFreq_Het=0.4199;NativeFreq_Hom=0.1032;normalHetFrequency=0.3526;normalHetNum=305;normalHomFrequency=0.0682;normalHomNum=59;patientHetFrequency=0.3598;patientHetNum=1878;patientHomFrequency=0.0728;patientHomNum=380;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4712;GREP_score=-4.82;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TTTTGAAATT.GTTTCAGAAG	GT:AD:DP:GQ:PL	0/1:114,101:215:99:3977,0,7993
chr16	14038552	.	G	A	4022.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.798;DP=218;ExcessHet=3.0103;FS=6.842;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.45;ReadPosRankSum=-0.516;SOR=1.195;HGVSnom=NM_005236.3:c.1905-28G>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_005236.3:IVS9-28G>A;AAlength=916;EXAC_AF=0.24478819;EXAC_Hom_EAS=200;EXAC_AC_EAS=1952;EXAC_AN_EAS=8456;EXAC_AC_Adj=29308;EXAC_AN_Adj=119728;ESP6500_MAF=0.23903340;RS=rs1799800;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.212061;G1000_EAS_AF=0.25;G1000_EUR_AF=0.2773;G1000_AFR_AF=0.1626;G1000_SAS_AF=0.2372;G1000_AMR_AF=0.121;gnomad_exomes_AF=0.23996886;gnomad_exomes_AF_EAS=0.23470389;gnomad_exomes_AC=60105;gnomad_exomes_Hom=7489;gnomad_exomes_Het=45127;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16232725;gnomad_exomes_AF_NFE=0.27811169;gnomad_exomes_AF_AMR=0.13871810;gnomad_exomes_AF_SAS=0.24852594;NativeFreq_Het=0.3762;NativeFreq_Hom=0.0534;normalHetFrequency=0.3353;normalHetNum=290;normalHomFrequency=0.0543;normalHomNum=47;patientHetFrequency=0.3418;patientHetNum=1784;patientHomFrequency=0.0602;patientHomNum=314;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3424;AF_2700_Hom=0.0388;AF_50_Het=0.3471;AF_50_Hom=0.0269;DANN_score=0.2821;GREP_score=-0.312;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=ATTTGTTTCA.AAGTGTTGAC	GT:AD:DP:GQ:PL	0/1:114,104:218:99:4051,0,8046
chr16	14041958	.	T	C	5651.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.595;DP=471;ExcessHet=3.0103;FS=1.107;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12;ReadPosRankSum=-1.215;SOR=0.786;HGVSnom=NM_005236.3:c.2505T>C(p.Ser835Ser/p.S835S);Gene=ERCC4;Transcript=NM_005236.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E11;IVSnom=.;AAlength=916;EXAC_AF=0.27227657;EXAC_Hom_EAS=225;EXAC_AC_EAS=2026;EXAC_AN_EAS=8612;EXAC_AC_Adj=33007;EXAC_AN_Adj=121226;ESP6500_MAF=0.25319378;RS=rs1799801;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.241214;G1000_EAS_AF=0.2589;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.1694;G1000_SAS_AF=0.2873;G1000_AMR_AF=0.2104;gnomad_exomes_AF=0.27205601;gnomad_exomes_AF_EAS=0.24015662;gnomad_exomes_AC=68347;gnomad_exomes_Hom=9533;gnomad_exomes_Het=49281;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17265567;gnomad_exomes_AF_NFE=0.29448593;gnomad_exomes_AF_AMR=0.23290326;gnomad_exomes_AF_SAS=0.31349232;NativeFreq_Het=0.4021;NativeFreq_Hom=0.0605;normalHetFrequency=0.348;normalHetNum=301;normalHomFrequency=0.0671;normalHomNum=58;patientHetFrequency=0.3521;patientHetNum=1838;patientHomFrequency=0.0695;patientHomNum=363;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3447;AF_2700_Hom=0.0407;AF_50_Het=0.3534;AF_50_Hom=0.0254;DANN_score=0.4475;GREP_score=-12.3;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=CAGCAGATTC.GAAACCCTTC	GT:AD:DP:GQ:PL	0/1:266,205:471:99:5680,0,8408
chr16	14042688	.	G	T	6757.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.598;DP=480;ExcessHet=3.0103;FS=0.531;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.08;ReadPosRankSum=0.087;SOR=0.66;HGVSnom=NM_005236.3:c.*484G>T;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs3743538;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.349641;G1000_EAS_AF=0.255;G1000_EUR_AF=0.3569;G1000_AFR_AF=0.4697;G1000_SAS_AF=0.2904;G1000_AMR_AF=0.3314;NativeFreq_Het=0.3564;NativeFreq_Hom=0.0396;normalHetFrequency=0.1954;normalHetNum=169;normalHomFrequency=0.0462;normalHomNum=40;patientHetFrequency=0.1705;patientHetNum=890;patientHomFrequency=0.0322;patientHomNum=168;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3413;AF_2700_Hom=0.0396;AF_50_Het=0.3471;AF_50_Hom=0.0269;DANN_score=0.6266;GREP_score=-3.37;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TCCAAATCTG.TCTTTGCTGT	GT:AD:DP:GQ:PL	0/1:254,226:480:99:6786,0,8139
chr16	14042930	.	G	C	5588.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.788;DP=384;ExcessHet=3.0103;FS=1.259;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.59;ReadPosRankSum=-1.293;SOR=0.784;HGVSnom=NM_005236.3:c.*726G>C;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs2276464;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.23762;G1000_EAS_AF=0.246;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.1664;G1000_SAS_AF=0.2863;G1000_AMR_AF=0.2104;NativeFreq_Het=0.3762;NativeFreq_Hom=0.0297;normalHetFrequency=0.1861;normalHetNum=161;normalHomFrequency=0.0755;normalHomNum=36;patientHetFrequency=0.1649;patientHetNum=861;patientHomFrequency=0.0287;patientHomNum=150;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3394;AF_2700_Hom=0.0388;AF_50_Het=0.3487;AF_50_Hom=0.0238;DANN_score=0.7435;GREP_score=-0.754;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TGGTTGACTA.TCTTCTAATG	GT:AD:DP:GQ:PL	0/1:207,176:383:99:5617,0,6835
chr16	14043014	.	G	A	4621.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.983;DP=335;ExcessHet=3.0103;FS=0.396;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.8;ReadPosRankSum=-2.286;SOR=0.733;HGVSnom=NM_005236.3:c.*810G>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs2276465;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.259185;G1000_EAS_AF=0.246;G1000_EUR_AF=0.3519;G1000_AFR_AF=0.2315;G1000_SAS_AF=0.2464;G1000_AMR_AF=0.2147;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0297;normalHetFrequency=0.1896;normalHetNum=164;normalHomFrequency=0.0734;normalHomNum=35;patientHetFrequency=0.1688;patientHetNum=881;patientHomFrequency=0.0287;patientHomNum=150;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3409;AF_2700_Hom=0.0388;AF_50_Het=0.3471;AF_50_Hom=0.0254;DANN_score=0.4649;GREP_score=-9.17;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TGAATTACCT.TTTGCAAAAG	GT:AD:DP:GQ:PL	0/1:182,153:335:99:4650,0,6145
chr16	14043175	.	C	G	4077.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.576;DP=289;ExcessHet=3.0103;FS=4.763;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.16;ReadPosRankSum=-0.759;SOR=0.478;HGVSnom=NM_005236.3:c.*971C>G;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs2276466;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.23722;G1000_EAS_AF=0.246;G1000_EUR_AF=0.2942;G1000_AFR_AF=0.1649;G1000_SAS_AF=0.2863;G1000_AMR_AF=0.2104;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0297;normalHetFrequency=0.3354;normalHetNum=160;normalHomFrequency=0.0755;normalHomNum=36;patientHetFrequency=0.1648;patientHetNum=860;patientHomFrequency=0.0605;patientHomNum=148;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3397;AF_2700_Hom=0.0384;AF_50_Het=0.3487;AF_50_Hom=0.0238;DANN_score=0.5117;GREP_score=1.52;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=AGCATCATAT.CTCTAGAAAT	GT:AD:DP:GQ:PL	0/1:163,125:288:99:4106,0,5381
chr16	14044717	.	C	A	4453.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.28;DP=343;ExcessHet=3.0103;FS=3.577;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.02;ReadPosRankSum=-0.99;SOR=0.897;HGVSnom=NM_005236.3:c.*2513C>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs11075223;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.259185;G1000_EAS_AF=0.249;G1000_EUR_AF=0.3519;G1000_AFR_AF=0.2292;G1000_SAS_AF=0.2464;G1000_AMR_AF=0.2147;NativeFreq_Het=0.3564;NativeFreq_Hom=0.0396;normalHetFrequency=0.1919;normalHetNum=166;normalHomFrequency=0.0734;normalHomNum=35;patientHetFrequency=0.3619;patientHetNum=886;patientHomFrequency=0.0289;patientHomNum=151;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3417;AF_2700_Hom=0.0400;AF_50_Het=0.3502;AF_50_Hom=0.0254;DANN_score=0.738;GREP_score=-1.12;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=CATTTTCAAC.GTCCTTGTTA	GT:AD:DP:GQ:PL	0/1:200,142:342:99:4482,0,6112
chr16	14044775	.	GC	G	5384.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.509;DP=342;ExcessHet=3.0103;FS=2.428;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.72;ReadPosRankSum=-1.512;SOR=0.832;HGVSnom=NM_005236.3:c.*2577delC;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs61422086;CLNGENE=ERCC4;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.259585;G1000_EAS_AF=0.252;G1000_EUR_AF=0.3519;G1000_AFR_AF=0.2284;G1000_SAS_AF=0.2464;G1000_AMR_AF=0.2147;NativeFreq_Het=0.1980;NativeFreq_Hom=.;normalHetFrequency=0.3417;normalHetNum=163;normalHomFrequency=0.0416;normalHomNum=36;patientHetFrequency=0.1699;patientHetNum=887;patientHomFrequency=0.0613;patientHomNum=150;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3428;AF_2700_Hom=0.0392;AF_50_Het=0.3502;AF_50_Hom=0.0254;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TAATACCAGT.CCCCCTGGCT	GT:AD:DP:GQ:PL	0/1:184,138:322:99:5422,0,7479
chr16	14044781	.	C	A	5768.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.921;DP=361;ExcessHet=3.0103;FS=1.263;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.02;ReadPosRankSum=-1.825;SOR=0.773;HGVSnom=NM_005236.3:c.*2577C>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs56012340;CLNGENE=ERCC4;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.213259;G1000_EAS_AF=0.2431;G1000_EUR_AF=0.2893;G1000_AFR_AF=0.1626;G1000_SAS_AF=0.2342;G1000_AMR_AF=0.1268;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0297;normalHetFrequency=0.3208;normalHetNum=153;normalHomFrequency=0.0358;normalHomNum=31;patientHetFrequency=0.163;patientHetNum=851;patientHomFrequency=0.056;patientHomNum=137;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3397;AF_2700_Hom=0.0380;AF_50_Het=0.3502;AF_50_Hom=0.0222;DANN_score=0.5922;GREP_score=-5.02;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=CAGTGCCCCC.TGGCTCTCCA	GT:AD:DP:GQ:PL	0/1:201,159:360:99:5797,0,7773
chr16	14045236	.	G	T	3394.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.793;DP=231;ExcessHet=3.0103;FS=7.258;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.7;ReadPosRankSum=0.628;SOR=1.104;HGVSnom=NM_005236.3:c.*3032G>T;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs4781562;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.257388;G1000_EAS_AF=0.2391;G1000_EUR_AF=0.2893;G1000_AFR_AF=0.3245;G1000_SAS_AF=0.2321;G1000_AMR_AF=0.1455;NativeFreq_Het=0.3663;NativeFreq_Hom=0.0396;normalHetFrequency=0.1803;normalHetNum=156;normalHomFrequency=0.0629;normalHomNum=30;patientHetFrequency=0.1646;patientHetNum=859;patientHomFrequency=0.0276;patientHomNum=144;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3405;AF_2700_Hom=0.0411;AF_50_Het=0.3487;AF_50_Hom=0.0254;DANN_score=0.2719;GREP_score=-3.7;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=TGTATAAAAA.GTGAACATAT	GT:AD:DP:GQ:PL	0/1:122,109:231:99:3423,0,4084
chr16	14045399	.	G	A	5377.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.667;DP=332;ExcessHet=3.0103;FS=3.03;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.2;ReadPosRankSum=-0.056;SOR=0.873;HGVSnom=NM_005236.3:c.*3195G>A;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs4781563;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.213858;G1000_EAS_AF=0.2401;G1000_EUR_AF=0.2893;G1000_AFR_AF=0.1679;G1000_SAS_AF=0.2331;G1000_AMR_AF=0.1268;NativeFreq_Het=0.3762;NativeFreq_Hom=0.0297;normalHetFrequency=0.1792;normalHetNum=155;normalHomFrequency=0.0358;normalHomNum=31;patientHetFrequency=0.1623;patientHetNum=847;patientHomFrequency=0.0268;patientHomNum=140;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3397;AF_2700_Hom=0.0380;AF_50_Het=0.3502;AF_50_Hom=0.0222;DANN_score=0.6634;GREP_score=-0.252;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=CCTGAAGCTC.GTAGACAATA	GT:AD:DP:GQ:PL	0/1:160,172:332:99:5406,0,4769
chr16	14046149	.	AT	A	2025.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.584;DP=220;ExcessHet=3.0103;FS=4.928;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.98;ReadPosRankSum=-0.084;SOR=0.563;HGVSnom=NM_005236.3:c.*3953delT;Gene=ERCC4;Transcript=NM_005236.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=916;RS=rs397778750;CLNGENE=ERCC4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.213259;G1000_EAS_AF=0.244;G1000_EUR_AF=0.2893;G1000_AFR_AF=0.1626;G1000_SAS_AF=0.2331;G1000_AMR_AF=0.1268;NativeFreq_Het=0.1980;NativeFreq_Hom=.;normalHetFrequency=0.3208;normalHetNum=153;normalHomFrequency=0.0347;normalHomNum=30;patientHetFrequency=0.3472;patientHetNum=850;patientHomFrequency=0.0274;patientHomNum=143;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3417;AF_2700_Hom=0.0396;AF_50_Het=0.3518;AF_50_Hom=0.0222;CytoBand=p13.12;CGD_CONDITION=Fanconi anemia, complementation group Q. Xeroderma pigmentosum, group F;CGD_INHERITANCE=AR;Strand=ERCC4:NM_005236.3:+,ERCC4:NM_005236.2:+;NP=ERCC4:NM_005236.3:NP_005227.1,ERCC4:NM_005236.2:NP_005227.1;ENSP=ERCC4:NM_005236.3:ENST00000311895.8,ERCC4:NM_005236.2:ENST00000311895.7;Gene_MIM_id=133520;Phenotypes=Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessive. ?XFE progeroid syndrome, 610965 (3). Xeroderma pigmentosum, group F, 278760 (3), Autosomal recessive. Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3), Autosomal recessive. 278760(MK),610965(UK),615272(MK);Possible_Inheritance=AR;EntrezGeneID=2072;EnsemblGeneID=ENSG00000175595;Alias=ERCC4, XPF, FANCQ, XFEPS;FLKSEQ=AAAATGTTTC.TTTTTTTGTT	GT:AD:DP:GQ:PL	0/1:114,89:203:99:2063,0,2841
chr16	23615042	.	TA	T	393.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.143;DP=236;ExcessHet=3.0103;FS=2.197;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.89;ReadPosRankSum=-1.695;SOR=1.027;HGVSnom=NM_024675.4:c.3351-53delT;Gene=PALB2;Transcript=NM_024675.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_024675.4:IVS12-53delT;AAlength=1186;EXAC_AF=0.40729139;EXAC_Hom_EAS=11;EXAC_AC_EAS=655;EXAC_AN_EAS=1544;EXAC_AC_Adj=12222;EXAC_AN_Adj=30008;RS=rs35294437;CLNGENE=PALB2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.43015138;gnomad_exomes_AF_EAS=0.45332429;gnomad_exomes_AC=38816;gnomad_exomes_Hom=58;gnomad_exomes_Het=38700;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.42427837;gnomad_exomes_AF_NFE=0.42438401;gnomad_exomes_AF_AMR=0.42541946;gnomad_exomes_AF_SAS=0.45015178;NativeFreq_Het=0.2081;NativeFreq_Hom=.;normalHetFrequency=0.4613;normalHetNum=399;normalHomFrequency=0.022;normalHomNum=19;patientHetFrequency=0.4502;patientHetNum=2350;patientHomFrequency=0.0178;patientHomNum=93;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p12.2;CGD_CONDITION=Breast cancer. Pancreatic cancer, susceptibility to 3. Fanconi anemia, complementation group N;CGD_INHERITANCE=AD/AR;Strand=PALB2:NM_024675.3:-,PALB2:NM_024675.4:-;NP=PALB2:NM_024675.3:NP_078951.2,PALB2:NM_024675.4:NP_078951.2;ENSP=PALB2:NM_024675.3:ENST00000261584.8,PALB2:NM_024675.4:ENST00000261584.9;Gene_MIM_id=610355;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group N, 610832 (3). {Pancreatic cancer, susceptibility to, 3}, 613348 (3). 114480(SK),610832(MK),613348(SK);Possible_Inheritance=AD;EntrezGeneID=79728;EnsemblGeneID=ENSG00000083093;Alias=PALB2, FANCN, PNCA3;FLKSEQ=AAAAAACAAT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:163,45:208:99:431,0,3190
chr16	23625463	.	A	T	11255.8	PASS	AC=2;AF=1;AN=2;DP=295;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.1;SOR=2.093;HGVSnom=NM_024675.4:c.3114-51T>A;Gene=PALB2;Transcript=NM_024675.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_024675.4:IVS10-51T>A;AAlength=1186;EXAC_AF=0.99746530;EXAC_Hom_EAS=2523;EXAC_AC_EAS=5046;EXAC_AN_EAS=5046;EXAC_AC_Adj=75163;EXAC_AN_Adj=75354;RS=rs249936;CLNGENE=PALB2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.996805;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=0.9836;G1000_AMR_AF=1.0;gnomad_exomes_AF=0.99814200;gnomad_exomes_AF_EAS=0.99980348;gnomad_exomes_AC=205753;gnomad_exomes_Hom=102688;gnomad_exomes_Het=377;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=1.00000000;gnomad_exomes_AF_NFE=0.99997715;gnomad_exomes_AF_AMR=0.99996608;gnomad_exomes_AF_SAS=0.98613395;NativeFreq_Het=0;NativeFreq_Hom=1.0000;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9919;normalHomNum=858;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=0.9898;patientHomNum=5167;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1545723][_];patientHomSampleInfo=[_][_];DANN_score=0.5341;GREP_score=4.3;CytoBand=p12.2;CGD_CONDITION=Breast cancer. Pancreatic cancer, susceptibility to 3. Fanconi anemia, complementation group N;CGD_INHERITANCE=AD/AR;Strand=PALB2:NM_024675.3:-,PALB2:NM_024675.4:-;NP=PALB2:NM_024675.3:NP_078951.2,PALB2:NM_024675.4:NP_078951.2;ENSP=PALB2:NM_024675.3:ENST00000261584.8,PALB2:NM_024675.4:ENST00000261584.9;Gene_MIM_id=610355;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group N, 610832 (3). {Pancreatic cancer, susceptibility to, 3}, 613348 (3). 114480(SK),610832(MK),613348(SK);Possible_Inheritance=AD;EntrezGeneID=79728;EnsemblGeneID=ENSG00000083093;Alias=PALB2, FANCN, PNCA3;FLKSEQ=ACAAACCAGT.TTCAGAAAAT	GT:AD:DP:GQ:PL	1/1:0,295:295:99:11284,887,0
chr16	23634521	.	C	CT	441.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.118;DP=177;ExcessHet=3.0103;FS=1.633;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.07;ReadPosRankSum=-0.741;SOR=0.388;HGVSnom=NM_024675.4:c.2835-71dupA;Gene=PALB2;Transcript=NM_024675.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_024675.4:IVS8-71_-70insA;AAlength=1186;RS=rs754470879;normalHetFrequency=0.0162;normalHetNum=14;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0103;patientHetNum=54;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p12.2;CGD_CONDITION=Breast cancer. Pancreatic cancer, susceptibility to 3. Fanconi anemia, complementation group N;CGD_INHERITANCE=AD/AR;Strand=PALB2:NM_024675.3:-,PALB2:NM_024675.4:-;NP=PALB2:NM_024675.3:NP_078951.2,PALB2:NM_024675.4:NP_078951.2;ENSP=PALB2:NM_024675.3:ENST00000261584.8,PALB2:NM_024675.4:ENST00000261584.9;Gene_MIM_id=610355;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group N, 610832 (3). {Pancreatic cancer, susceptibility to, 3}, 613348 (3). 114480(SK),610832(MK),613348(SK);Possible_Inheritance=AD;EntrezGeneID=79728;EnsemblGeneID=ENSG00000083093;Alias=PALB2, FANCN, PNCA3;FLKSEQ=ACTAGGTTCA.tttttttttt	GT:AD:DP:GQ:PL	0/1:91,53:144:99:479,0,916
chr16	50827601	.	A	G	3568.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.291;DP=215;ExcessHet=3.0103;FS=0.619;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.6;ReadPosRankSum=0.198;SOR=0.786;HGVSnom=NM_001378743.1:c.2469+26A>G;Gene=CYLD;Transcript=NM_001378743.1;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I17;IVSnom=NM_001378743.1:IVS17+26A>G;AAlength=956;EXAC_AF=0.78631424;EXAC_Hom_EAS=2107;EXAC_AC_EAS=6043;EXAC_AN_EAS=8616;EXAC_AC_Adj=94927;EXAC_AN_Adj=120724;ESP6500_MAF=0.86280796;RS=rs2302759;CLNGENE=CYLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.798323;G1000_EAS_AF=0.7034;G1000_EUR_AF=0.827;G1000_AFR_AF=0.9826;G1000_SAS_AF=0.6309;G1000_AMR_AF=0.7795;gnomad_exomes_AF=0.78869929;gnomad_exomes_AF_EAS=0.70910305;gnomad_exomes_AC=196618;gnomad_exomes_Hom=78318;gnomad_exomes_Het=39982;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.96280031;gnomad_exomes_AF_NFE=0.80850180;gnomad_exomes_AF_AMR=0.75916154;gnomad_exomes_AF_SAS=0.68606327;NativeFreq_Het=0.5247;NativeFreq_Hom=0.3663;normalHetFrequency=0.4058;normalHetNum=351;normalHomFrequency=0.4925;normalHomNum=426;patientHetFrequency=0.3762;patientHetNum=1964;patientHomFrequency=0.536;patientHomNum=2798;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4224;AF_2700_Hom=0.4773;AF_50_Het=0.4263;AF_50_Hom=0.4691;DANN_score=0.4301;GREP_score=-5.78;CytoBand=q12.1;CGD_CONDITION=Spiegler-Brooke syndrome. Trichoepithelioma, multiple familial, 1. Cylindromatosis, familial;CGD_INHERITANCE=AD;Strand=CYLD:NM_001042355.1:+,CYLD:NM_015247.2:+,CYLD:NM_001042412.1:+;NP=CYLD:NM_001042355.1:NP_001035814.1,CYLD:NM_015247.2:NP_056062.1,CYLD:NM_001042412.1:NP_001035877.1;ENSP=CYLD:NM_001042355.1:.,CYLD:NM_015247.2:ENST00000311559.13,CYLD:NM_001042412.1:.;Gene_MIM_id=605018;Phenotypes=Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant. Cylindromatosis, familial, 132700 (3), Autosomal dominant. Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant. 132700(MK),601606(MK),605041(MK);Possible_Inheritance=AD;EntrezGeneID=1540;EnsemblGeneID=ENSG00000083799;Alias=CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS;FLKSEQ=CTTAATGGAT.AACTTTTGTT	GT:AD:DP:GQ:PL	0/1:106,109:215:99:3597,0,3533
chr16	50832525	.	GA	G	620.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.546;DP=281;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.42;ReadPosRankSum=-1.366;SOR=0.627;HGVSnom=NM_001378743.1:c.*2122delA;Gene=CYLD;Transcript=NM_001378743.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=956;RS=rs74757288;CLNGENE=CYLD;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.284744;G1000_EAS_AF=0.1696;G1000_EUR_AF=0.2435;G1000_AFR_AF=0.4281;G1000_SAS_AF=0.2975;G1000_AMR_AF=0.2205;NativeFreq_Het=0.2079;NativeFreq_Hom=.;normalHetFrequency=0.566;normalHetNum=270;normalHomFrequency=0.0105;normalHomNum=5;patientHetFrequency=0.5776;patientHetNum=1414;patientHomFrequency=0.011;patientHomNum=27;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.6726;AF_2700_Hom=0.0031;AF_50_Het=0.6529;AF_50_Hom=0.0032;CytoBand=q12.1;CGD_CONDITION=Spiegler-Brooke syndrome. Trichoepithelioma, multiple familial, 1. Cylindromatosis, familial;CGD_INHERITANCE=AD;Strand=CYLD:NM_001042355.1:+,CYLD:NM_015247.2:+,CYLD:NM_001042412.1:+;NP=CYLD:NM_001042355.1:NP_001035814.1,CYLD:NM_015247.2:NP_056062.1,CYLD:NM_001042412.1:NP_001035877.1;ENSP=CYLD:NM_001042355.1:.,CYLD:NM_015247.2:ENST00000311559.13,CYLD:NM_001042412.1:.;Gene_MIM_id=605018;Phenotypes=Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant. Cylindromatosis, familial, 132700 (3), Autosomal dominant. Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant. 132700(MK),601606(MK),605041(MK);Possible_Inheritance=AD;EntrezGeneID=1540;EnsemblGeneID=ENSG00000083799;Alias=CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS;FLKSEQ=TTAACAGTTG.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:184,73:257:99:658,0,2996
chr16	50832870	.	T	C	5014.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.148;DP=331;ExcessHet=3.0103;FS=6.511;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.2;ReadPosRankSum=-0.424;SOR=1.02;HGVSnom=NM_001378743.1:c.*2451T>C;Gene=CYLD;Transcript=NM_001378743.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=956;RS=rs368296872;G1000_AF=0.00139776;G1000_EAS_AF=0.006;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0012;patientHetNum=3;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][16B0028301];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][15D6532166|16S3104527|15B0002861-1];patientHomSampleInfo=[_][_];AF_2700_Het=0.0004;AF_2700_Hom=0.0000;AF_50_Het=.;AF_50_Hom=.;DANN_score=0.5519;GREP_score=-1.94;CytoBand=q12.1;CGD_CONDITION=Spiegler-Brooke syndrome. Trichoepithelioma, multiple familial, 1. Cylindromatosis, familial;CGD_INHERITANCE=AD;Strand=CYLD:NM_001042355.1:+,CYLD:NM_015247.2:+,CYLD:NM_001042412.1:+;NP=CYLD:NM_001042355.1:NP_001035814.1,CYLD:NM_015247.2:NP_056062.1,CYLD:NM_001042412.1:NP_001035877.1;ENSP=CYLD:NM_001042355.1:.,CYLD:NM_015247.2:ENST00000311559.13,CYLD:NM_001042412.1:.;Gene_MIM_id=605018;Phenotypes=Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant. Cylindromatosis, familial, 132700 (3), Autosomal dominant. Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant. 132700(MK),601606(MK),605041(MK);Possible_Inheritance=AD;EntrezGeneID=1540;EnsemblGeneID=ENSG00000083799;Alias=CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS;FLKSEQ=GCAGGAAGGT.TCCCCTGCAC	GT:AD:DP:GQ:PL	0/1:174,156:330:99:5043,0,5616
chr16	50833206	.	C	CTG	5169.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.335;DP=377;ExcessHet=3.0103;FS=1.32;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.16;ReadPosRankSum=1.924;SOR=0.78;HGVSnom=NM_001378743.1:c.*2797_*2798dupGT;Gene=CYLD;Transcript=NM_001378743.1;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=956;RS=rs773771930;normalHetFrequency=0.0273;normalHetNum=13;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0351;patientHetNum=86;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0411277|15B0040440];AF_2700_Het=0.0430;AF_2700_Hom=0.0012;AF_50_Het=0.0365;AF_50_Hom=0.0016;CytoBand=q12.1;repName=(TG)n;repClass=Simple_repeat;CGD_CONDITION=Spiegler-Brooke syndrome. Trichoepithelioma, multiple familial, 1. Cylindromatosis, familial;CGD_INHERITANCE=AD;Strand=CYLD:NM_001042355.1:+,CYLD:NM_015247.2:+,CYLD:NM_001042412.1:+;NP=CYLD:NM_001042355.1:NP_001035814.1,CYLD:NM_015247.2:NP_056062.1,CYLD:NM_001042412.1:NP_001035877.1;ENSP=CYLD:NM_001042355.1:.,CYLD:NM_015247.2:ENST00000311559.13,CYLD:NM_001042412.1:.;Gene_MIM_id=605018;Phenotypes=Brooke-Spiegler syndrome, 605041 (3), Autosomal dominant. Cylindromatosis, familial, 132700 (3), Autosomal dominant. Trichoepithelioma, multiple familial, 1, 601606 (3), Autosomal dominant. 132700(MK),601606(MK),605041(MK);Possible_Inheritance=AD;EntrezGeneID=1540;EnsemblGeneID=ENSG00000083799;Alias=CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS;FLKSEQ=Atgtgtgtgt.tgtgtgtgtg	GT:AD:DP:GQ:PL	0/1:177,164:341:99:5207,0,5683
chr16	68771347	.	C	CGCT	2925.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.884;DP=192;ExcessHet=3.0103;FS=1.899;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.31;ReadPosRankSum=-0.585;SOR=0.555;HGVSnom=NM_004360.5:c.44_46dupTGC(p.Leu15_Gln16insLeu/p.L15_Q16insL);Gene=CDH1;Transcript=NM_004360.5;VarType=InframeInsertion+SpliceSites;MolecularConsequence=conservative_inframe_insertion+exonic_splice_region_variant;ExonIntron=E1;IVSnom=.;AAlength=882;RS=rs587782476;CLNGENE=CDH1;CLNSIG=Likely_benign;CLNREVSTAT=reviewed_by_expert_panel;gnomad_exomes_AF=0.00000804;gnomad_exomes_AF_EAS=0.0;gnomad_exomes_AC=1;gnomad_exomes_Hom=0;gnomad_exomes_Het=1;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00004681;HGMD_gene=CDH1;HGMD_disease=Gastric_cancer;HGMD_tag=DM;HGMD_pmid=20373070;CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=AGCCTCTCGG.GCTGCTGCTG	GT:AD:DP:GQ:PL	0/1:89,80:169:99:2963,0,3605
chr16	68771372	.	C	T	3638.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.124;DP=198;ExcessHet=3.0103;FS=6.986;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.47;ReadPosRankSum=0.115;SOR=0.874;HGVSnom=NM_004360.5:c.48+6C>T;Gene=CDH1;Transcript=NM_004360.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_004360.5:IVS1+6C>T;AAlength=882;EXAC_AF=0.81114380;EXAC_Hom_EAS=148;EXAC_AC_EAS=451;EXAC_AN_EAS=620;EXAC_AC_Adj=13233;EXAC_AN_Adj=16314;ESP6500_MAF=0.86032553;RS=rs3743674;CLNGENE=CDH1;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.763379;G1000_EAS_AF=0.7688;G1000_EUR_AF=0.8807;G1000_AFR_AF=0.6399;G1000_SAS_AF=0.7945;G1000_AMR_AF=0.7767;gnomad_exomes_AF=0.81610229;gnomad_exomes_AF_EAS=0.76484230;gnomad_exomes_AC=108886;gnomad_exomes_Hom=44928;gnomad_exomes_Het=19030;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.64653432;gnomad_exomes_AF_NFE=0.87837464;gnomad_exomes_AF_AMR=0.74094072;gnomad_exomes_AF_SAS=0.77799141;NativeFreq_Het=0.5049;NativeFreq_Hom=0.4752;normalHetFrequency=0.1598;normalHetNum=62;normalHomFrequency=0.3428;normalHomNum=133;patientHetFrequency=0.1421;patientHetNum=394;patientHomFrequency=0.3557;patientHomNum=986;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3190;AF_2700_Hom=0.5238;AF_50_Het=0.3360;AF_50_Hom=0.5008;dbscSNV_RF_score=0.032;dbscSNV_ADA_score=0.00001643;DANN_score=0.9243;GREP_score=-1.51;CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=TGCAGGTACC.CGGATCCCCT	GT:AD:DP:GQ:PL	0/1:101,96:197:99:3667,0,3194
chr16	68771418	.	C	CGCCCCAGCCCCGT	4116.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.332;DP=206;ExcessHet=3.0103;FS=15.912;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.25;ReadPosRankSum=-4.294;SOR=0.23;HGVSnom=NM_004360.5:c.48+62_48+63insCGTGCCCCAGCCC;Gene=CDH1;Transcript=NM_004360.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_004360.5:IVS1+62_+63insCGTGCCCCAGCCC;AAlength=882;EXAC_AF=0.81004246;EXAC_Hom_EAS=51;EXAC_AC_EAS=131;EXAC_AN_EAS=178;EXAC_AC_Adj=8776;EXAC_AN_Adj=10834;ESP6500_MAF=0.80328103;RS=rs45625236;CLNGENE=CDH1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.688698;G1000_EAS_AF=0.745;G1000_EUR_AF=0.8121;G1000_AFR_AF=0.5378;G1000_SAS_AF=0.7065;G1000_AMR_AF=0.6902;gnomad_exomes_AF=0.81074121;gnomad_exomes_AF_EAS=0.76045426;gnomad_exomes_AC=95708;gnomad_exomes_Hom=39761;gnomad_exomes_Het=16186;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.63997791;gnomad_exomes_AF_NFE=0.86983621;gnomad_exomes_AF_AMR=0.73631061;gnomad_exomes_AF_SAS=0.77521229;NativeFreq_Het=0.2921;NativeFreq_Hom=.;normalHetFrequency=0.1186;normalHetNum=46;normalHomFrequency=0.2784;normalHomNum=108;patientHetFrequency=0.1129;patientHetNum=313;patientHomFrequency=0.2803;patientHomNum=777;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=GCAAGCTCCG.GCCCCAGCCC	GT:AD:DP:GQ:PL	0/1:87,98:185:99:4154,0,3334
chr16	68857441	.	T	C	15080.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.409;DP=421;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.99;ReadPosRankSum=0.759;SOR=0.253;HGVSnom=NM_004360.5:c.2076T>C(p.Ala692Ala/p.A692A);Gene=CDH1;Transcript=NM_004360.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=882;EXAC_AF=0.65480761;EXAC_Hom_EAS=1761;EXAC_AC_EAS=5524;EXAC_AN_EAS=8632;EXAC_AC_Adj=79474;EXAC_AN_Adj=121370;ESP6500_MAF=0.71614343;RS=rs1801552;CLNGENE=CDH1;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.71865;G1000_EAS_AF=0.6448;G1000_EUR_AF=0.6451;G1000_AFR_AF=0.938;G1000_SAS_AF=0.6687;G1000_AMR_AF=0.585;gnomad_exomes_AF=0.65105369;gnomad_exomes_AF_EAS=0.65034280;gnomad_exomes_AC=163615;gnomad_exomes_Hom=53968;gnomad_exomes_Het=55679;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.89055768;gnomad_exomes_AF_NFE=0.62527919;gnomad_exomes_AF_AMR=0.66578963;gnomad_exomes_AF_SAS=0.65349187;HGMD_gene=CDH1;HGMD_disease=Gastric_cancer_early-onset_diffuse_association_with;HGMD_tag=DP;HGMD_pmid=25648022;NativeFreq_Het=0.4235;NativeFreq_Hom=0.5445;normalHetFrequency=0.4562;normalHetNum=177;normalHomFrequency=0.3814;normalHomNum=148;patientHetFrequency=0.4567;patientHetNum=1266;patientHomFrequency=0.4015;patientHomNum=1113;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4523;AF_2700_Hom=0.4181;AF_50_Het=0.4437;AF_50_Hom=0.4168;DANN_score=0.4495;GREP_score=2.58;CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=AAGGGGCCGC.GGCGTCTGTA	GT:AD:DP:GQ:PL	1/1:1,419:420:99:15109,1223,0
chr16	68867611	.	CT	C	1198.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.755;DP=382;ExcessHet=3.0103;FS=3.622;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.36;ReadPosRankSum=-0.112;SOR=0.917;HGVSnom=NM_004360.5:c.*221delT;Gene=CDH1;Transcript=NM_004360.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=882;RS=rs145920869;CLNGENE=CDH1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0248;NativeFreq_Hom=.;normalHetFrequency=0.0206;normalHetNum=8;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0267;patientHetNum=74;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0009403-1|16B3094001][_];AF_2700_Het=0.1330;AF_2700_Hom=.;AF_50_Het=0.1252;AF_50_Hom=.;CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=TTTCTTAAAG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:265,92:357:99:1236,0,5583
chr16	68867863	.	CT	C	1029.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.45;DP=271;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.15;ReadPosRankSum=-0.603;SOR=0.696;HGVSnom=NM_004360.5:c.*475delT;Gene=CDH1;Transcript=NM_004360.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=882;RS=rs113202135;CLNGENE=CDH1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0198;NativeFreq_Hom=.;AF_2700_Het=0.6445;AF_2700_Hom=.;AF_50_Het=0.6529;AF_50_Hom=.;CytoBand=q22.1;CGD_CONDITION=CDH1-related cancer;CGD_INHERITANCE=AD;Strand=CDH1:NM_001317184.1:+,CDH1:NM_001317185.1:+,CDH1:NM_001317186.1:+,CDH1:NM_004360.4:+;NP=CDH1:NM_001317184.1:NP_001304113.1,CDH1:NM_001317185.1:NP_001304114.1,CDH1:NM_001317186.1:NP_001304115.1,CDH1:NM_004360.4:NP_004351.1;ENSP=CDH1:NM_001317184.1:.,CDH1:NM_001317185.1:.,CDH1:NM_001317186.1:.,CDH1:NM_004360.4:ENST00000261769.9;Gene_MIM_id=192090;Phenotypes={Breast cancer, lobular}, 114480 (3), Autosomal dominant. Endometrial carcinoma, somatic, 608089 (3). Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant. Ovarian carcinoma, somatic, 167000 (3). {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),137215(MK),167000(MK),176807(SK),608089(MK);Possible_Inheritance=AD;EntrezGeneID=999;EnsemblGeneID=ENSG00000039068;Alias=CDH1, UVO, LCAM, ECAD;FLKSEQ=GTCCCTCTGC.tttttttttt	GT:AD:DP:GQ:PL	0/1:158,90:248:99:1067,0,2843
chr16	68869449	.	A	G	11980.8	PASS	AC=2;AF=1;AN=2;DP=327;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.04;SOR=1.786;HGVSnom=.;Gene=CDH1;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs8045438;CLNGENE=CDH1;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.994808;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9861;G1000_AFR_AF=0.9992;G1000_SAS_AF=0.9949;G1000_AMR_AF=0.9914;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0011;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0012196][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0202464|15D6722466-1|16B0024694][_];AF_2700_Het=0.0008;AF_2700_Hom=0.9958;AF_50_Het=0.0000;AF_50_Hom=0.9984;DANN_score=0.5713;GREP_score=1.44;CytoBand=q22.1;FLKSEQ=AACCATTGTC.AATTTGTTTT	GT:AD:DP:GQ:PL	1/1:0,324:324:99:12009,974,0
chr16	89803928	.	C	CA	591.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.66;DP=97;ExcessHet=3.0103;FS=4.406;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.96;ReadPosRankSum=0.792;SOR=1.863;HGVSnom=NM_001113525.2:c.1475-273dupA;Gene=ZNF276;Transcript=NM_001113525.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_001113525.2:IVS9-273_-272insA;AAlength=614;RS=rs200766262;CytoBand=q24.3;repName=AluSg;repClass=SINE;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.;Gene_MIM_id=608460;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=92822;EnsemblGeneID=ENSG00000158805;Alias=ZFP276;FLKSEQ=aactccatct.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:43,42:85:99:629,0,700
chr16	89804335	.	CT	C	11939.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.62;DP=460;ExcessHet=3.0103;FS=2.244;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.56;ReadPosRankSum=-0.4;SOR=0.644;HGVSnom=NM_001113525.2:c.1574+23delT|NM_000135.4:c.*673delA;Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=Intron|UTR3;MolecularConsequence=coding_transcript_intron_variant|3_prime_UTR_exon_variant;ExonIntron=I10|E43;IVSnom=NM_001113525.2:IVS10+23delT|.;AAlength=614|1455;EXAC_AF=0.48618830;EXAC_Hom_EAS=4143;EXAC_AC_EAS=8465;EXAC_AN_EAS=8644;EXAC_AC_Adj=58786;EXAC_AN_Adj=120912;RS=rs17233826;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_single_submitter|criteria_provided,_single_submitter;gnomad_exomes_AF=0.49397287;gnomad_exomes_AF_EAS=0.97888780;gnomad_exomes_AC=123593;gnomad_exomes_Hom=34655;gnomad_exomes_Het=54283;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65173558;gnomad_exomes_AF_NFE=0.36757814;gnomad_exomes_AF_AMR=0.65726951;gnomad_exomes_AF_SAS=0.50666007;NativeFreq_Het=0.5;NativeFreq_Hom=.;normalHetFrequency=0.174;normalHetNum=83;normalHomFrequency=0.3896;normalHomNum=337;patientHetFrequency=0.1242;patientHetNum=304;patientHomFrequency=0.3707;patientHomNum=1935;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0346;AF_2700_Hom=0.9616;AF_50_Het=0.0380;AF_50_Hom=0.9588;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=TCAGGACCCC.CCCAGGGCTG	GT:AD:DP:GQ:PL	1/1:10,408:418:99:11977,982,0
chr16	89804855	.	C	T	18183.8	PASS	AC=2;AF=1;AN=2;DP=476;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.11;SOR=0.771;HGVSnom=NM_001113525.2:c.*201C>T|NM_000135.4:c.*154G>A;Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=UTR3|UTR3;MolecularConsequence=3_prime_UTR_exon_variant|3_prime_UTR_exon_variant;ExonIntron=E11|E43;AAlength=614|1455;RS=rs1230;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.697684;G1000_EAS_AF=0.9861;G1000_EUR_AF=0.3907;G1000_AFR_AF=0.8003;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.6009;NativeFreq_Het=0.0227;NativeFreq_Hom=0.9900;normalHetFrequency=0.1318;normalHetNum=114;normalHomFrequency=0.6509;normalHomNum=563;patientHetFrequency=0.1088;patientHetNum=568;patientHomFrequency=0.642;patientHomNum=3351;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0331;AF_2700_Hom=0.9643;AF_50_Het=0.0349;AF_50_Hom=0.9620;DANN_score=0.6791;GREP_score=0.0771;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=CTGAGTGACT.GGGGCCGGAC	GT:AD:DP:GQ:PL	1/1:0,476:476:99:18212,1431,0
chr16	89805261	.	A	G	10367.8	PASS	AC=2;AF=1;AN=2;DP=294;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.49;SOR=0.869;HGVSnom=NM_001113525.2:c.*607A>G|NM_000135.4:c.4260+29T>C;Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=UTR3|Intron;MolecularConsequence=3_prime_UTR_exon_variant|coding_transcript_intron_variant;ExonIntron=E11|I42;IVSnom=.|NM_000135.4:IVS42+29T>C;AAlength=614|1455;EXAC_AF=0.70444110;EXAC_Hom_EAS=4213;EXAC_AC_EAS=8537;EXAC_AN_EAS=8648;EXAC_AC_Adj=85305;EXAC_AN_Adj=121096;ESP6500_MAF=0.69906125;RS=rs1800359;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.850839;G1000_EAS_AF=0.9901;G1000_EUR_AF=0.6074;G1000_AFR_AF=0.9796;G1000_SAS_AF=0.8528;G1000_AMR_AF=0.7536;gnomad_exomes_AF=0.70212766;gnomad_exomes_AF_EAS=0.98678198;gnomad_exomes_AC=176220;gnomad_exomes_Hom=64442;gnomad_exomes_Het=47336;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93619776;gnomad_exomes_AF_NFE=0.59087062;gnomad_exomes_AF_AMR=0.78574737;gnomad_exomes_AF_SAS=0.80148356;NativeFreq_Het=0.0178;NativeFreq_Hom=0.9900;normalHetFrequency=0.141;normalHetNum=122;normalHomFrequency=0.8162;normalHomNum=706;patientHetFrequency=0.1446;patientHetNum=755;patientHomFrequency=0.8136;patientHomNum=4247;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0234;AF_2700_Hom=0.9743;AF_50_Het=0.0222;AF_50_Hom=0.9746;DANN_score=0.3487;GREP_score=-0.721;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=TGTCCCCCAC.TGGCCCAAGG	GT:AD:DP:GQ:PL	1/1:0,294:294:99:10396,883,0
chr16	89805914	.	T	C	3476.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.361;DP=273;ExcessHet=3.0103;FS=3.313;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.78;ReadPosRankSum=-0.924;SOR=0.899;HGVSnom=NM_001113525.2:c.*1260T>C|NM_000135.4:c.3982A>G(p.Thr1328Ala/p.T1328A);Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=UTR3|Missense;MolecularConsequence=3_prime_UTR_exon_variant|missense_variant;ExonIntron=E11|E40;AAlength=614|1455;EXAC_AF=0.05380030;EXAC_Hom_EAS=32;EXAC_AC_EAS=182;EXAC_AN_EAS=656;EXAC_AC_Adj=1083;EXAC_AN_Adj=20130;ESP6500_MAF=0.05131515;RS=rs9282681;Ensembl_transcriptid=ENST00000389301|ENST00000568369|ENST00000561722;SIFT_pred=T|T|T;SIFT_score=0.438|0.44|0.452;Polyphen2_HVAR_pred=B|.|.;Polyphen2_HVAR_score=0.003|.|.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|0.999994;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0722843;G1000_EAS_AF=0.2599;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06614208;gnomad_exomes_AF_EAS=0.23789400;gnomad_exomes_AC=10322;gnomad_exomes_Hom=617;gnomad_exomes_Het=9088;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01393012;gnomad_exomes_AF_NFE=0.08028333;gnomad_exomes_AF_AMR=0.02103351;gnomad_exomes_AF_SAS=0.02151433;HGMD_gene=FANCA;HGMD_disease=Fanconi_anaemia;HGMD_tag=R;HGMD_pmid=27121516;NativeFreq_Het=0.3398;NativeFreq_Hom=0.1089;normalHetFrequency=0.2405;normalHetNum=208;normalHomFrequency=0.0393;normalHomNum=34;patientHetFrequency=0.2469;patientHetNum=1289;patientHomFrequency=0.0328;patientHomNum=171;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3086;AF_2700_Hom=0.0388;AF_50_Het=0.3170;AF_50_Hom=0.0317;DANN_score=0.438;GREP_score=-1.66;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=AGCAGCCTGG.GTGCTGATCC	GT:AD:DP:GQ:PL	0/1:146,126:272:99:3505,0,4326
chr16	89805977	.	G	A	4251.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.195;DP=263;ExcessHet=3.0103;FS=3.408;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.17;ReadPosRankSum=0.39;SOR=0.903;HGVSnom=NM_001113525.2:c.*1323G>A|NM_000135.4:c.3935-16C>T;Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=UTR3|Intron;MolecularConsequence=3_prime_UTR_exon_variant|coding_transcript_intron_variant;ExonIntron=E11|I39;IVSnom=.|NM_000135.4:IVS39-16C>T;AAlength=614|1455;EXAC_AF=0.40977787;EXAC_Hom_EAS=163;EXAC_AC_EAS=450;EXAC_AN_EAS=642;EXAC_AC_Adj=8080;EXAC_AN_Adj=19718;ESP6500_MAF=0.34749659;RS=rs1061646;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.538139;G1000_EAS_AF=0.7073;G1000_EUR_AF=0.3151;G1000_AFR_AF=0.5825;G1000_SAS_AF=0.5123;G1000_AMR_AF=0.5677;gnomad_exomes_AF=0.42453949;gnomad_exomes_AF_EAS=0.72465947;gnomad_exomes_AC=65869;gnomad_exomes_Hom=16003;gnomad_exomes_Het=33863;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.54570896;gnomad_exomes_AF_NFE=0.29332661;gnomad_exomes_AF_AMR=0.61342499;gnomad_exomes_AF_SAS=0.47136080;NativeFreq_Het=0.3738;NativeFreq_Hom=0.5744;normalHetFrequency=0.3803;normalHetNum=329;normalHomFrequency=0.4347;normalHomNum=376;patientHetFrequency=0.3703;patientHetNum=1933;patientHomFrequency=0.4471;patientHomNum=2334;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3528;AF_2700_Hom=0.5957;AF_50_Het=0.3597;AF_50_Hom=0.5959;DANN_score=0.442;GREP_score=2.32;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=ACACCAAGAA.TGGCTCAGGC	GT:AD:DP:GQ:PL	0/1:122,141:263:99:4280,0,3941
chr16	89807233	.	C	G	2828.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.851;DP=200;ExcessHet=3.0103;FS=4.034;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.14;ReadPosRankSum=-0.365;SOR=0.589;HGVSnom=NM_001113525.2:c.*2579C>G|NM_000135.4:c.3807G>C(p.Leu1269Leu/p.L1269L);Gene=ZNF276|FANCA;Transcript=NM_001113525.2|NM_000135.4;VarType=UTR3|Synonymous;MolecularConsequence=3_prime_UTR_exon_variant|synonymous_variant;ExonIntron=E11|E38;AAlength=614|1455;EXAC_AF=0.09975603;EXAC_Hom_EAS=208;EXAC_AC_EAS=1907;EXAC_AN_EAS=8238;EXAC_AC_Adj=11367;EXAC_AN_Adj=113948;ESP6500_MAF=0.10795629;RS=rs11649210;CLNGENE=FANCA|ZNF276;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.137979;G1000_EAS_AF=0.2629;G1000_EUR_AF=0.0736;G1000_AFR_AF=0.1543;G1000_SAS_AF=0.1268;G1000_AMR_AF=0.0346;gnomad_exomes_AF=0.09305680;gnomad_exomes_AF_EAS=0.23211150;gnomad_exomes_AC=23291;gnomad_exomes_Hom=1440;gnomad_exomes_Het=20411;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14401334;gnomad_exomes_AF_NFE=0.08607949;gnomad_exomes_AF_AMR=0.02995886;gnomad_exomes_AF_SAS=0.10366334;NativeFreq_Het=0.3463;NativeFreq_Hom=0.1089;normalHetFrequency=0.2694;normalHetNum=233;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.2653;patientHetNum=1385;patientHomFrequency=0.0345;patientHomNum=180;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3109;AF_2700_Hom=0.0388;AF_50_Het=0.3233;AF_50_Hom=0.0301;DANN_score=0.6276;GREP_score=-7.22;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=ZNF276:NM_152287.3:+,ZNF276:NM_001113525.1:+,FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=ZNF276:NM_152287.3:NP_689500.2,ZNF276:NM_001113525.1:NP_001106997.1,FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=ZNF276:NM_152287.3:.,ZNF276:NM_001113525.1:.,FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=608460,607139;Phenotypes=.,Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=NA,AR;EntrezGeneID=92822,2175;EnsemblGeneID=ENSG00000158805,ENSG00000187741;Alias=ZFP276,FANCA, FACA, FA1, FA, FAA;FLKSEQ=GATGTGACGA.AGCAGGCCCA	GT:AD:DP:GQ:PL	0/1:107,93:200:99:2857,0,3599
chr16	89809171	.	C	T	2925.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.036;DP=190;ExcessHet=3.0103;FS=7.75;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.4;ReadPosRankSum=-1.796;SOR=1.527;HGVSnom=NM_000135.4:c.3765+37G>A;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I37;IVSnom=NM_000135.4:IVS37+37G>A;AAlength=1455;EXAC_AF=0.06495177;EXAC_Hom_EAS=230;EXAC_AC_EAS=1946;EXAC_AN_EAS=8636;EXAC_AC_Adj=7878;EXAC_AN_Adj=121290;ESP6500_MAF=0.05947984;RS=rs34420680;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.071885;G1000_EAS_AF=0.2579;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06646913;gnomad_exomes_AF_EAS=0.23104124;gnomad_exomes_AC=16690;gnomad_exomes_Hom=969;gnomad_exomes_Het=14752;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01415907;gnomad_exomes_AF_NFE=0.07661617;gnomad_exomes_AF_AMR=0.01955000;gnomad_exomes_AF_SAS=0.02094087;NativeFreq_Het=0.3430;NativeFreq_Hom=0.1089;normalHetFrequency=0.2451;normalHetNum=212;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.2471;patientHetNum=1290;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6497;GREP_score=0.0606;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=ACCAAGCTTG.GAGAAAATAA	GT:AD:DP:GQ:PL	0/1:89,101:190:99:2954,0,2849
chr16	89809319	.	T	C	5722.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.197;DP=406;ExcessHet=3.0103;FS=2.442;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.13;ReadPosRankSum=-1.091;SOR=0.889;HGVSnom=NM_000135.4:c.3654A>G(p.Pro1218Pro/p.P1218P);Gene=FANCA;Transcript=NM_000135.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E37;IVSnom=.;AAlength=1455;EXAC_AF=0.10407975;EXAC_Hom_EAS=234;EXAC_AC_EAS=1976;EXAC_AN_EAS=8618;EXAC_AC_Adj=12623;EXAC_AN_Adj=121282;ESP6500_MAF=0.13196368;RS=rs1800358;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.157548;G1000_EAS_AF=0.2629;G1000_EUR_AF=0.0765;G1000_AFR_AF=0.2216;G1000_SAS_AF=0.1299;G1000_AMR_AF=0.0389;gnomad_exomes_AF=0.10118579;gnomad_exomes_AF_EAS=0.23458941;gnomad_exomes_AC=25429;gnomad_exomes_Hom=1761;gnomad_exomes_Het=21907;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.21291395;gnomad_exomes_AF_NFE=0.08818510;gnomad_exomes_AF_AMR=0.03493349;gnomad_exomes_AF_SAS=0.10720585;NativeFreq_Het=0.3463;NativeFreq_Hom=0.1089;normalHetFrequency=0.2728;normalHetNum=236;normalHomFrequency=0.0393;normalHomNum=34;patientHetFrequency=0.2682;patientHetNum=1400;patientHomFrequency=0.0339;patientHomNum=177;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3101;AF_2700_Hom=0.0380;AF_50_Het=0.3233;AF_50_Hom=0.0301;DANN_score=0.2661;GREP_score=-9.7;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GGTTGGGTGC.GGGGAGGCAG	GT:AD:DP:GQ:PL	0/1:196,209:405:99:5751,0,5849
chr16	89813194	.	C	T	5120.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.854;DP=336;ExcessHet=3.0103;FS=3.53;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.38;ReadPosRankSum=1.559;SOR=0.746;HGVSnom=NM_000135.4:c.3408+45G>A;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I34;IVSnom=NM_000135.4:IVS34+45G>A;AAlength=1455;EXAC_AF=0.09459115;EXAC_Hom_EAS=105;EXAC_AC_EAS=974;EXAC_AN_EAS=3188;EXAC_AC_Adj=4449;EXAC_AN_Adj=47034;ESP6500_MAF=0.05889145;RS=rs1800355;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0716853;G1000_EAS_AF=0.2569;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06833744;gnomad_exomes_AF_EAS=0.23650421;gnomad_exomes_AC=13473;gnomad_exomes_Hom=764;gnomad_exomes_Het=11945;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01469332;gnomad_exomes_AF_NFE=0.08073974;gnomad_exomes_AF_AMR=0.02043655;gnomad_exomes_AF_SAS=0.02159607;NativeFreq_Het=0.3447;NativeFreq_Hom=0.1089;normalHetFrequency=0.2451;normalHetNum=212;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.246;patientHetNum=1284;patientHomFrequency=0.0318;patientHomNum=166;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4985;GREP_score=-5.23;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GATCCACCCA.GGCGTTCTGA	GT:AD:DP:GQ:PL	0/1:168,165:333:99:5149,0,4866
chr16	89815152	.	G	A	5555.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.491;DP=326;ExcessHet=3.0103;FS=0.834;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.04;ReadPosRankSum=-3.698;SOR=0.642;HGVSnom=NM_000135.4:c.3263C>T(p.Ser1088Phe/p.S1088F);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E33;IVSnom=.;AAlength=1455;EXAC_AF=0.05096203;EXAC_Hom_EAS=0;EXAC_AC_EAS=201;EXAC_AN_EAS=8548;EXAC_AC_Adj=6039;EXAC_AN_Adj=118500;ESP6500_MAF=0.05924900;RS=rs17233497;Ensembl_transcriptid=ENST00000389301|ENST00000568369;SIFT_pred=D|D;SIFT_score=0.016|0.012;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.401|.;MutationTaster_pred=N|N;MutationTaster_score=1|1;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0233626;G1000_EAS_AF=0.0218;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0123;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.05054311;gnomad_exomes_AF_EAS=0.02360748;gnomad_exomes_AC=12675;gnomad_exomes_Hom=459;gnomad_exomes_Het=11757;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01276045;gnomad_exomes_AF_NFE=0.07645586;gnomad_exomes_AF_AMR=0.01887011;gnomad_exomes_AF_SAS=0.01833094;HGMD_gene=FANCA;HGMD_disease=Fanconi_anaemia;HGMD_tag=DM?;HGMD_pmid=10094191;NativeFreq_Het=0.0583;NativeFreq_Hom=0;normalHetFrequency=0.0497;normalHetNum=43;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.0515;patientHetNum=269;patientHomFrequency=0.0011;patientHomNum=6;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16D0067115];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0068087][15D6529872|16D1546085|16D1545628|15B0022229|15B0054128];AF_2700_Het=0.0523;AF_2700_Hom=0.0012;AF_50_Het=0.0365;AF_50_Hom=0.0016;DANN_score=0.9915;GREP_score=3.68;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GCAGAGGACA.ACGAAGGCAG	GT:AD:DP:GQ:PL	0/1:155,171:326:99:5584,0,5135
chr16	89815217	.	C	T	3965.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-10.432;DP=288;ExcessHet=3.0103;FS=0.913;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.82;ReadPosRankSum=-1.143;SOR=0.767;HGVSnom=NM_000135.4:c.3240-42G>A;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I32;IVSnom=NM_000135.4:IVS32-42G>A;AAlength=1455;EXAC_AF=0.43105919;EXAC_Hom_EAS=1856;EXAC_AC_EAS=4868;EXAC_AN_EAS=6310;EXAC_AC_Adj=37897;EXAC_AN_Adj=87916;ESP6500_MAF=0.38036952;RS=rs1800345;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.544928;G1000_EAS_AF=0.7252;G1000_EUR_AF=0.3161;G1000_AFR_AF=0.5885;G1000_SAS_AF=0.5153;G1000_AMR_AF=0.5735;gnomad_exomes_AF=0.42785869;gnomad_exomes_AF_EAS=0.75276529;gnomad_exomes_AC=93476;gnomad_exomes_Hom=22633;gnomad_exomes_Het=48210;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.55545977;gnomad_exomes_AF_NFE=0.29934579;gnomad_exomes_AF_AMR=0.63089920;gnomad_exomes_AF_SAS=0.47860887;HGMD_gene=FANCA;HGMD_disease=Breast_cancer_association_with;HGMD_tag=DP;HGMD_pmid=23021409;NativeFreq_Het=0.3625;NativeFreq_Hom=0.5955;normalHetFrequency=0.3607;normalHetNum=312;normalHomFrequency=0.4566;normalHomNum=395;patientHetFrequency=0.3552;patientHetNum=1854;patientHomFrequency=0.472;patientHomNum=2464;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5305;GREP_score=-0.901;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GCACAGCGTA.ACTCTGCTCC	GT:AD:DP:GQ:PL	0/1:149,138:287:99:3994,0,5153
chr16	89816314	.	A	G	4178.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.966;DP=285;ExcessHet=3.0103;FS=8.69;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.66;ReadPosRankSum=-0.227;SOR=1.143;HGVSnom=NM_000135.4:c.3067-4T>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I31;IVSnom=NM_000135.4:IVS31-4T>C;AAlength=1455;EXAC_AF=0.06524109;EXAC_Hom_EAS=231;EXAC_AC_EAS=1950;EXAC_AN_EAS=8620;EXAC_AC_Adj=7899;EXAC_AN_Adj=121074;ESP6500_MAF=0.05878732;RS=rs17227064;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0716853;G1000_EAS_AF=0.2579;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06660699;gnomad_exomes_AF_EAS=0.23116234;gnomad_exomes_AC=16741;gnomad_exomes_Hom=975;gnomad_exomes_Het=14791;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01421014;gnomad_exomes_AF_NFE=0.07673969;gnomad_exomes_AF_AMR=0.01951431;gnomad_exomes_AF_SAS=0.02100209;NativeFreq_Het=0.3447;NativeFreq_Hom=0.1089;normalHetFrequency=0.2451;normalHetNum=212;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.2448;patientHetNum=1278;patientHomFrequency=0.0324;patientHomNum=169;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3078;AF_2700_Hom=0.0388;AF_50_Het=0.3185;AF_50_Hom=0.0301;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00004911;DANN_score=0.6838;GREP_score=1.1;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CCATCTCCTG.AAAAGAGCAG	GT:AD:DP:GQ:PL	0/1:155,130:285:99:4207,0,4788
chr16	89816333	.	C	T	3098.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.216;DP=247;ExcessHet=3.0103;FS=8.77;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.55;ReadPosRankSum=-0.944;SOR=1.198;HGVSnom=NM_000135.4:c.3067-23G>A;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I31;IVSnom=NM_000135.4:IVS31-23G>A;AAlength=1455;EXAC_AF=0.06540760;EXAC_Hom_EAS=230;EXAC_AC_EAS=1946;EXAC_AN_EAS=8592;EXAC_AC_Adj=7879;EXAC_AN_Adj=120460;ESP6500_MAF=0.05955679;RS=rs17227057;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0716853;G1000_EAS_AF=0.2579;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06659248;gnomad_exomes_AF_EAS=0.23114183;gnomad_exomes_AC=16695;gnomad_exomes_Hom=967;gnomad_exomes_Het=14761;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01416605;gnomad_exomes_AF_NFE=0.07671402;gnomad_exomes_AF_AMR=0.01952899;gnomad_exomes_AF_SAS=0.02100346;NativeFreq_Het=0.3430;NativeFreq_Hom=0.1089;normalHetFrequency=0.2451;normalHetNum=212;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.2429;patientHetNum=1268;patientHomFrequency=0.0341;patientHomNum=178;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3075;AF_2700_Hom=0.0392;AF_50_Het=0.3170;AF_50_Hom=0.0317;DANN_score=0.3469;GREP_score=-1.12;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AGTATGCTGG.ACAGGAAGGC	GT:AD:DP:GQ:PL	0/1:140,107:247:99:3127,0,4686
chr16	89825065	.	G	A	5687.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.735;DP=359;ExcessHet=3.0103;FS=4.69;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.89;ReadPosRankSum=0.488;SOR=0.934;HGVSnom=NM_000135.4:c.2901C>T(p.Ser967Ser/p.S967S);Gene=FANCA;Transcript=NM_000135.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E30;IVSnom=.;AAlength=1455;EXAC_AF=0.06552650;EXAC_Hom_EAS=242;EXAC_AC_EAS=2005;EXAC_AN_EAS=8634;EXAC_AC_Adj=7954;EXAC_AN_Adj=121386;ESP6500_MAF=0.05940289;RS=rs17226980;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0720847;G1000_EAS_AF=0.2599;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06709063;gnomad_exomes_AF_EAS=0.23760331;gnomad_exomes_AC=16869;gnomad_exomes_Hom=1007;gnomad_exomes_Het=14855;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01414862;gnomad_exomes_AF_NFE=0.07670864;gnomad_exomes_AF_AMR=0.01965772;gnomad_exomes_AF_SAS=0.02113274;NativeFreq_Het=0.3528;NativeFreq_Hom=0.1089;normalHetFrequency=0.2601;normalHetNum=225;normalHomFrequency=0.037;normalHomNum=32;patientHetFrequency=0.2523;patientHetNum=1317;patientHomFrequency=0.0339;patientHomNum=177;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3159;AF_2700_Hom=0.0400;AF_50_Het=0.3296;AF_50_Hom=0.0301;DANN_score=0.4675;GREP_score=-4.37;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CTGAAGCCGA.GACTCAGGGA	GT:AD:DP:GQ:PL	0/1:176,182:358:99:5716,0,5752
chr16	89828437	.	A	G	4370.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.839;DP=314;ExcessHet=3.0103;FS=7.805;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=-1.06;QD=14.01;ReadPosRankSum=0.324;SOR=1.089;HGVSnom=NM_000135.4:c.2779-7T>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I28;IVSnom=NM_000135.4:IVS28-7T>C;AAlength=1455;EXAC_AF=0.06557701;EXAC_Hom_EAS=242;EXAC_AC_EAS=2008;EXAC_AN_EAS=8646;EXAC_AC_Adj=7960;EXAC_AN_Adj=121384;ESP6500_MAF=0.05940289;RS=rs17233253;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0720847;G1000_EAS_AF=0.2599;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06710940;gnomad_exomes_AF_EAS=0.23744019;gnomad_exomes_AC=16876;gnomad_exomes_Hom=1009;gnomad_exomes_Het=14858;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01414862;gnomad_exomes_AF_NFE=0.07675604;gnomad_exomes_AF_AMR=0.01971554;gnomad_exomes_AF_SAS=0.02106742;NativeFreq_Het=0.3528;NativeFreq_Hom=0.1089;normalHetFrequency=0.2601;normalHetNum=225;normalHomFrequency=0.037;normalHomNum=32;patientHetFrequency=0.2527;patientHetNum=1319;patientHomFrequency=0.0337;patientHomNum=176;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3167;AF_2700_Hom=0.0400;AF_50_Het=0.3296;AF_50_Hom=0.0301;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00003180;DANN_score=0.5734;GREP_score=0.63;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=TTAACTGAGA.AGAGAGCAAG	GT:AD:DP:GQ:PL	0/1:166,146:312:99:4399,0,5409
chr16	89831520	.	A	T	4027.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.57;DP=245;ExcessHet=3.0103;FS=1.126;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.51;ReadPosRankSum=-0.012;SOR=0.594;HGVSnom=NM_000135.4:c.2602-46T>A;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I27;IVSnom=NM_000135.4:IVS27-46T>A;AAlength=1455;EXAC_AF=0.06570708;EXAC_Hom_EAS=206;EXAC_AC_EAS=1890;EXAC_AN_EAS=8144;EXAC_AC_Adj=7660;EXAC_AN_Adj=116578;ESP6500_MAF=0.05971068;RS=rs11076620;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0716853;G1000_EAS_AF=0.2589;G1000_EUR_AF=0.0636;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06719082;gnomad_exomes_AF_EAS=0.23751941;gnomad_exomes_AC=16562;gnomad_exomes_Hom=968;gnomad_exomes_Het=14626;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01410208;gnomad_exomes_AF_NFE=0.07726277;gnomad_exomes_AF_AMR=0.01970790;gnomad_exomes_AF_SAS=0.02108137;NativeFreq_Het=0.3511;NativeFreq_Hom=0.0437;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.251;patientHetNum=1310;patientHomFrequency=0.0333;patientHomNum=174;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5389;GREP_score=-2.95;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CGCAAGTTTC.CTGTGAGTGG	GT:AD:DP:GQ:PL	0/1:110,134:244:99:4056,0,3125
chr16	89836323	.	C	T	13197.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=3.051;DP=372;ExcessHet=3.0103;FS=9.317;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.87;ReadPosRankSum=-0.201;SOR=0.163;HGVSnom=NM_000135.4:c.2426G>A(p.Gly809Asp/p.G809D);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E26;IVSnom=.;AAlength=1455;EXAC_AF=0.46899071;EXAC_Hom_EAS=4197;EXAC_AC_EAS=8520;EXAC_AN_EAS=8646;EXAC_AC_Adj=56625;EXAC_AN_Adj=120738;ESP6500_MAF=0.43067098;RS=rs7195066;Ensembl_transcriptid=ENST00000389301|ENST00000568369;SIFT_pred=T|T;SIFT_score=0.528|0.523;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=FANCA;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.666733;G1000_EAS_AF=0.9881;G1000_EUR_AF=0.3221;G1000_AFR_AF=0.7398;G1000_SAS_AF=0.6513;G1000_AMR_AF=0.5821;gnomad_exomes_AF=0.47265295;gnomad_exomes_AF_EAS=0.98542211;gnomad_exomes_AC=118634;gnomad_exomes_Hom=33751;gnomad_exomes_Het=51132;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.67566399;gnomad_exomes_AF_NFE=0.30932024;gnomad_exomes_AF_AMR=0.65266844;gnomad_exomes_AF_SAS=0.58889833;HGMD_gene=FANCA;HGMD_disease=Fanconi_anaemia_A;HGMD_tag=R;HGMD_pmid=23898106;NativeFreq_Het=0.0297;NativeFreq_Hom=0.9773;normalHetFrequency=0.1526;normalHetNum=132;normalHomFrequency=0.7272;normalHomNum=629;patientHetFrequency=0.15;patientHetNum=783;patientHomFrequency=0.7351;patientHomNum=3837;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0304;AF_2700_Hom=0.9662;AF_50_Het=0.0301;AF_50_Hom=0.9667;DANN_score=0.2064;GREP_score=-0.167;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AAGGCCAGCA.CAGGTGCAGG	GT:AD:DP:GQ:PL	1/1:3,366:369:99:13226,1078,0
chr16	89838078	.	A	G	5232.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.195;DP=396;ExcessHet=3.0103;FS=0.393;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.25;ReadPosRankSum=0.934;SOR=0.66;HGVSnom=NM_000135.4:c.2151+8T>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I23;IVSnom=NM_000135.4:IVS23+8T>C;AAlength=1455;EXAC_AF=0.43148450;EXAC_Hom_EAS=2437;EXAC_AC_EAS=6489;EXAC_AN_EAS=8634;EXAC_AC_Adj=52371;EXAC_AN_Adj=121374;ESP6500_MAF=0.37426901;RS=rs1800340;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.559904;G1000_EAS_AF=0.7242;G1000_EUR_AF=0.327;G1000_AFR_AF=0.5507;G1000_SAS_AF=0.637;G1000_AMR_AF=0.5677;gnomad_exomes_AF=0.43756811;gnomad_exomes_AF_EAS=0.74295966;gnomad_exomes_AC=110023;gnomad_exomes_Hom=27519;gnomad_exomes_Het=54985;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51986959;gnomad_exomes_AF_NFE=0.30350109;gnomad_exomes_AF_AMR=0.63529140;gnomad_exomes_AF_SAS=0.57091527;NativeFreq_Het=0.3722;NativeFreq_Hom=0.5809;normalHetFrequency=0.3896;normalHetNum=337;normalHomFrequency=0.4451;normalHomNum=385;patientHetFrequency=0.3762;patientHetNum=1964;patientHomFrequency=0.4651;patientHomNum=2428;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3401;AF_2700_Hom=0.6130;AF_50_Het=0.3455;AF_50_Hom=0.6165;dbscSNV_RF_score=0.0;dbscSNV_ADA_score=0.00001916;DANN_score=0.4921;GREP_score=-5.68;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CTGAGCCCCT.CACCTACCAT	GT:AD:DP:GQ:PL	0/1:226,169:395:99:5261,0,6843
chr16	89839637	.	C	A	1880.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.634;DP=151;ExcessHet=3.0103;FS=1.403;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.54;ReadPosRankSum=-0.175;SOR=0.565;HGVSnom=NM_000135.4:c.2014+42G>T;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I22;IVSnom=NM_000135.4:IVS22+42G>T;AAlength=1455;EXAC_AF=0.05016939;EXAC_Hom_EAS=23;EXAC_AC_EAS=152;EXAC_AN_EAS=572;EXAC_AC_Adj=1007;EXAC_AN_Adj=20072;ESP6500_MAF=0.05180008;RS=rs1800339;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.072484;G1000_EAS_AF=0.2629;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06676308;gnomad_exomes_AF_EAS=0.24791111;gnomad_exomes_AC=10156;gnomad_exomes_Hom=636;gnomad_exomes_Het=8884;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01415970;gnomad_exomes_AF_NFE=0.08074481;gnomad_exomes_AF_AMR=0.02112847;gnomad_exomes_AF_SAS=0.02152143;NativeFreq_Het=0.3560;NativeFreq_Hom=0.1089;normalHetFrequency=0.2451;normalHetNum=212;normalHomFrequency=0.0405;normalHomNum=35;patientHetFrequency=0.2439;patientHetNum=1273;patientHomFrequency=0.0385;patientHomNum=201;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.765;GREP_score=0.48;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CAACCACAGG.TGCACACATG	GT:AD:DP:GQ:PL	0/1:85,65:150:99:1909,0,2936
chr16	89839766	.	G	C	3690.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.329;DP=238;ExcessHet=3.0103;FS=11.707;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.51;ReadPosRankSum=0.021;SOR=0.319;HGVSnom=NM_000135.4:c.1927C>G(p.Pro643Ala/p.P643A);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E22;IVSnom=.;AAlength=1455;EXAC_AF=0.05222211;EXAC_Hom_EAS=28;EXAC_AC_EAS=173;EXAC_AN_EAS=640;EXAC_AC_Adj=1074;EXAC_AN_Adj=20566;ESP6500_MAF=0.04765886;RS=rs17232910;Ensembl_transcriptid=ENST00000389301|ENST00000568369;SIFT_pred=T|T;SIFT_score=0.453|0.393;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.001|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0740815;G1000_EAS_AF=0.2698;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0174;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06772528;gnomad_exomes_AF_EAS=0.25654173;gnomad_exomes_AC=10573;gnomad_exomes_Hom=676;gnomad_exomes_Het=9221;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01419089;gnomad_exomes_AF_NFE=0.08085677;gnomad_exomes_AF_AMR=0.02112961;gnomad_exomes_AF_SAS=0.02167998;NativeFreq_Het=0.3706;NativeFreq_Hom=0.1089;normalHetFrequency=0.2624;normalHetNum=227;normalHomFrequency=0.0405;normalHomNum=35;patientHetFrequency=0.2579;patientHetNum=1346;patientHomFrequency=0.0366;patientHomNum=191;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3259;AF_2700_Hom=0.0446;AF_50_Het=0.3344;AF_50_Hom=0.0396;DANN_score=0.3738;GREP_score=-2.44;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GCAGAGTTGG.TTCTGCCCTC	GT:AD:DP:GQ:PL	0/1:115,123:238:99:3719,0,3338
chr16	89845178	.	T	TAC	4827.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.522;DP=274;ExcessHet=3.0103;FS=3.836;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.81;ReadPosRankSum=-0.73;SOR=1.003;HGVSnom=NM_000135.4:c.1826+30_1826+31insGT;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000135.4:IVS20+30_+31insGT;AAlength=1455;EXAC_AF=0.06558580;EXAC_Hom_EAS=234;EXAC_AC_EAS=2019;EXAC_AN_EAS=8624;EXAC_AC_Adj=7957;EXAC_AN_Adj=121322;ESP6500_MAF=0.05903499;RS=rs36204974;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0720847;G1000_EAS_AF=0.2609;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06730945;gnomad_exomes_AF_EAS=0.24093434;gnomad_exomes_AC=16922;gnomad_exomes_Hom=1018;gnomad_exomes_Het=14886;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01421364;gnomad_exomes_AF_NFE=0.07681960;gnomad_exomes_AF_AMR=0.01966000;gnomad_exomes_AF_SAS=0.02100346;NativeFreq_Het=0.2030;NativeFreq_Hom=.;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0393;normalHomNum=34;patientHetFrequency=0.254;patientHetNum=1326;patientHomFrequency=0.0349;patientHomNum=182;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AACCTGGAAG.AGTCATCCCC	GT:AD:DP:GQ:PL	0/1:144,127:271:99:4865,0,5665
chr16	89845194	.	A	G	10795.8	PASS	AC=2;AF=1;AN=2;DP=290;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.3;SOR=2.761;HGVSnom=NM_000135.4:c.1826+15T>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I20;IVSnom=NM_000135.4:IVS20+15T>C;AAlength=1455;EXAC_AF=0.51147862;EXAC_Hom_EAS=4192;EXAC_AC_EAS=8518;EXAC_AN_EAS=8652;EXAC_AC_Adj=62071;EXAC_AN_Adj=121356;ESP6500_MAF=0.48815020;RS=rs1800337;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.682508;G1000_EAS_AF=0.9871;G1000_EUR_AF=0.3887;G1000_AFR_AF=0.739;G1000_SAS_AF=0.6554;G1000_AMR_AF=0.5965;gnomad_exomes_AF=0.51646354;gnomad_exomes_AF_EAS=0.98434102;gnomad_exomes_AC=129841;gnomad_exomes_Hom=37947;gnomad_exomes_Het=53947;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.69117647;gnomad_exomes_AF_NFE=0.38064754;gnomad_exomes_AF_AMR=0.66206916;gnomad_exomes_AF_SAS=0.59169607;NativeFreq_Het=0.0297;NativeFreq_Hom=0.9773;normalHetFrequency=0.1526;normalHetNum=132;normalHomFrequency=0.7306;normalHomNum=632;patientHetFrequency=0.1531;patientHetNum=799;patientHomFrequency=0.7383;patientHomNum=3854;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0311;AF_2700_Hom=0.9662;AF_50_Het=0.0333;AF_50_Hom=0.9635;DANN_score=0.3189;GREP_score=-0.281;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=TCCCCTTCTA.CCGTTGCTGC	GT:AD:DP:GQ:PL	1/1:0,289:289:99:10824,867,0
chr16	89845287	.	A	G	6191.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.755;DP=364;ExcessHet=3.0103;FS=9.386;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.01;ReadPosRankSum=-0.087;SOR=1.017;HGVSnom=NM_000135.4:c.1777-29T>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_000135.4:IVS19-29T>C;AAlength=1455;EXAC_AF=0.06573505;EXAC_Hom_EAS=239;EXAC_AC_EAS=2029;EXAC_AN_EAS=8642;EXAC_AC_Adj=7978;EXAC_AN_Adj=121366;ESP6500_MAF=0.05955679;RS=rs2302162;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0722843;G1000_EAS_AF=0.2619;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0202;gnomad_exomes_AF=0.06744214;gnomad_exomes_AF_EAS=0.24138119;gnomad_exomes_AC=16959;gnomad_exomes_Hom=1028;gnomad_exomes_Het=14903;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01422414;gnomad_exomes_AF_NFE=0.07692511;gnomad_exomes_AF_AMR=0.01968777;gnomad_exomes_AF_SAS=0.02106742;NativeFreq_Het=0.3544;NativeFreq_Hom=0.1089;normalHetFrequency=0.2543;normalHetNum=220;normalHomFrequency=0.0382;normalHomNum=33;patientHetFrequency=0.2531;patientHetNum=1321;patientHomFrequency=0.0347;patientHomNum=181;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3171;AF_2700_Hom=0.0407;AF_50_Het=0.3312;AF_50_Hom=0.0285;DANN_score=0.3438;GREP_score=-7.95;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CCTGTGAGAG.CTGACAAGGA	GT:AD:DP:GQ:PL	0/1:173,191:364:99:6220,0,4795
chr16	89849480	.	C	T	14601.8	PASS	AC=2;AF=1;AN=2;DP=394;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.61;SOR=1.124;HGVSnom=NM_000135.4:c.1501G>A(p.Gly501Ser/p.G501S);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E16;IVSnom=.;AAlength=1455;EXAC_AF=0.49947989;EXAC_Hom_EAS=3176;EXAC_AC_EAS=7388;EXAC_AN_EAS=8640;EXAC_AC_Adj=60501;EXAC_AN_Adj=121128;ESP6500_MAF=0.48230225;RS=rs2239359;Ensembl_transcriptid=ENST00000389301|ENST00000568369;SIFT_pred=T|T;SIFT_score=1.0|1.0;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.0|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.624002;G1000_EAS_AF=0.8671;G1000_EUR_AF=0.4066;G1000_AFR_AF=0.6997;G1000_SAS_AF=0.5245;G1000_AMR_AF=0.5821;gnomad_exomes_AF=0.50202268;gnomad_exomes_AF_EAS=0.85612489;gnomad_exomes_AC=126084;gnomad_exomes_Hom=34613;gnomad_exomes_Het=56858;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.69220827;gnomad_exomes_AF_NFE=0.39084507;gnomad_exomes_AF_AMR=0.62072062;gnomad_exomes_AF_SAS=0.49274605;HGMD_gene=FANCA;HGMD_disease=Breast_cancer_association_with;HGMD_tag=DP;HGMD_pmid=23021409;NativeFreq_Het=0.2686;NativeFreq_Hom=0.7623;normalHetFrequency=0.3098;normalHetNum=268;normalHomFrequency=0.5769;normalHomNum=499;patientHetFrequency=0.323;patientHetNum=1686;patientHomFrequency=0.5603;patientHomNum=2925;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2759;AF_2700_Hom=0.6952;AF_50_Het=0.3011;AF_50_Hom=0.6719;DANN_score=0.4653;GREP_score=-4.64;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CGGTACTTGC.GGGAACCAGG	GT:AD:DP:GQ:PL	1/1:0,391:391:99:14630,1176,0
chr16	89857935	.	G	A	4675.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.934;DP=299;ExcessHet=3.0103;FS=1.916;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.74;ReadPosRankSum=-0.929;SOR=0.808;HGVSnom=NM_000135.4:c.1235C>T(p.Ala412Val/p.A412V);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E14;IVSnom=.;AAlength=1455;EXAC_AF=0.06512884;EXAC_Hom_EAS=215;EXAC_AC_EAS=1934;EXAC_AN_EAS=8582;EXAC_AC_Adj=7835;EXAC_AN_Adj=120300;ESP6500_MAF=0.05955679;RS=rs11646374;Ensembl_transcriptid=ENST00000389301|ENST00000568369;SIFT_pred=T|T;SIFT_score=0.089|0.09;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.349|.;MutationTaster_pred=P|P;MutationTaster_score=0.989124|0.989124;CLNGENE=FANCA;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0704872;G1000_EAS_AF=0.254;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06631921;gnomad_exomes_AF_EAS=0.23159559;gnomad_exomes_AC=16631;gnomad_exomes_Hom=971;gnomad_exomes_Het=14689;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01398989;gnomad_exomes_AF_NFE=0.07659120;gnomad_exomes_AF_AMR=0.01852066;gnomad_exomes_AF_SAS=0.02095456;HGMD_gene=FANCA;HGMD_disease=Fanconi_anaemia;HGMD_tag=R;HGMD_pmid=24286411;NativeFreq_Het=0.3301;NativeFreq_Hom=0.1188;normalHetFrequency=0.237;normalHetNum=205;normalHomFrequency=0.037;normalHomNum=32;patientHetFrequency=0.2423;patientHetNum=1265;patientHomFrequency=0.0328;patientHomNum=171;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3067;AF_2700_Hom=0.0384;AF_50_Het=0.3170;AF_50_Hom=0.0254;DANN_score=0.9981;GREP_score=5.13;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CATCAAACGC.CCACCCAGTC	GT:AD:DP:GQ:PL	0/1:143,154:297:99:4704,0,4225
chr16	89857964	.	T	C	5202.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.279;DP=302;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=0;QD=17.4;ReadPosRankSum=-2.248;SOR=0.668;HGVSnom=NM_000135.4:c.1226-20A>G;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_000135.4:IVS13-20A>G;AAlength=1455;EXAC_AF=0.43697598;EXAC_Hom_EAS=2484;EXAC_AC_EAS=6541;EXAC_AN_EAS=8594;EXAC_AC_Adj=52431;EXAC_AN_Adj=119986;ESP6500_MAF=0.39065866;RS=rs1800330;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.571885;G1000_EAS_AF=0.7341;G1000_EUR_AF=0.327;G1000_AFR_AF=0.5953;G1000_SAS_AF=0.6299;G1000_AMR_AF=0.5648;gnomad_exomes_AF=0.44079617;gnomad_exomes_AF_EAS=0.75316318;gnomad_exomes_AC=109976;gnomad_exomes_Hom=27758;gnomad_exomes_Het=54460;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.56006433;gnomad_exomes_AF_NFE=0.30407457;gnomad_exomes_AF_AMR=0.63785494;gnomad_exomes_AF_SAS=0.56734360;NativeFreq_Het=0.3528;NativeFreq_Hom=0.6052;normalHetFrequency=0.3688;normalHetNum=319;normalHomFrequency=0.4705;normalHomNum=407;patientHetFrequency=0.3648;patientHetNum=1904;patientHomFrequency=0.4797;patientHomNum=2504;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3267;AF_2700_Hom=0.6272;AF_50_Het=0.3296;AF_50_Hom=0.6339;DANN_score=0.5322;GREP_score=-7.1;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AACCATGACA.AGTCACAGCA	GT:AD:DP:GQ:PL	0/1:142,157:299:99:5231,0,4366
chr16	89858417	.	C	A	2976.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.665;DP=237;ExcessHet=3.0103;FS=0.482;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.56;ReadPosRankSum=0.646;SOR=0.635;HGVSnom=NM_000135.4:c.1143G>T(p.Thr381Thr/p.T381T);Gene=FANCA;Transcript=NM_000135.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E13;IVSnom=.;AAlength=1455;EXAC_AF=0.06518265;EXAC_Hom_EAS=225;EXAC_AC_EAS=1945;EXAC_AN_EAS=8648;EXAC_AC_Adj=7912;EXAC_AN_Adj=121382;ESP6500_MAF=0.06063404;RS=rs1800331;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.071885;G1000_EAS_AF=0.254;G1000_EUR_AF=0.0626;G1000_AFR_AF=0.0091;G1000_SAS_AF=0.0164;G1000_AMR_AF=0.0187;gnomad_exomes_AF=0.06670882;gnomad_exomes_AF_EAS=0.23170599;gnomad_exomes_AC=16775;gnomad_exomes_Hom=993;gnomad_exomes_Het=14789;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01796260;gnomad_exomes_AF_NFE=0.07667827;gnomad_exomes_AF_AMR=0.01876265;gnomad_exomes_AF_SAS=0.02097080;NativeFreq_Het=0.3366;NativeFreq_Hom=0.1188;normalHetFrequency=0.2382;normalHetNum=206;normalHomFrequency=0.0358;normalHomNum=31;patientHetFrequency=0.2433;patientHetNum=1270;patientHomFrequency=0.0322;patientHomNum=168;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3059;AF_2700_Hom=0.0384;AF_50_Het=0.3170;AF_50_Hom=0.0254;DANN_score=0.2845;GREP_score=-11.0;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GAACCTCCTG.GTTTCCAGAA	GT:AD:DP:GQ:PL	0/1:137,100:237:99:3005,0,4044
chr16	89858505	.	T	C	2833.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.799;DP=180;ExcessHet=3.0103;FS=2.013;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.83;ReadPosRankSum=-0.478;SOR=0.547;HGVSnom=NM_000135.4:c.1084-29A>G;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000135.4:IVS12-29A>G;AAlength=1455;EXAC_AF=0.41175113;EXAC_Hom_EAS=2477;EXAC_AC_EAS=6549;EXAC_AN_EAS=8644;EXAC_AC_Adj=49952;EXAC_AN_Adj=121316;ESP6500_MAF=0.36995999;RS=rs6500452;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.531749;G1000_EAS_AF=0.7292;G1000_EUR_AF=0.3171;G1000_AFR_AF=0.5461;G1000_SAS_AF=0.5133;G1000_AMR_AF=0.5548;gnomad_exomes_AF=0.41848916;gnomad_exomes_AF_EAS=0.74902131;gnomad_exomes_AC=105168;gnomad_exomes_Hom=25385;gnomad_exomes_Het=54398;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51514592;gnomad_exomes_AF_NFE=0.29389770;gnomad_exomes_AF_AMR=0.63108116;gnomad_exomes_AF_SAS=0.47765728;NativeFreq_Het=0.3544;NativeFreq_Hom=0.6036;normalHetFrequency=0.3676;normalHetNum=318;normalHomFrequency=0.4543;normalHomNum=393;patientHetFrequency=0.363;patientHetNum=1895;patientHomFrequency=0.468;patientHomNum=2443;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3267;AF_2700_Hom=0.6264;AF_50_Het=0.3344;AF_50_Hom=0.6292;DANN_score=0.3462;GREP_score=-7.88;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=CTCCCTTCAA.ATCCAAGCAA	GT:AD:DP:GQ:PL	0/1:88,91:179:99:2862,0,2635
chr16	89858525	.	C	G	5563.77	PASS	AC=2;AF=1;AN=2;DP=146;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.97;SOR=2.286;HGVSnom=NM_000135.4:c.1084-49G>C;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_000135.4:IVS12-49G>C;AAlength=1455;EXAC_AF=0.51748766;EXAC_Hom_EAS=4191;EXAC_AC_EAS=8516;EXAC_AN_EAS=8650;EXAC_AC_Adj=62675;EXAC_AN_Adj=121114;ESP6500_MAF=0.51184980;RS=rs1800287;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.702676;G1000_EAS_AF=0.9871;G1000_EUR_AF=0.3897;G1000_AFR_AF=0.8207;G1000_SAS_AF=0.6462;G1000_AMR_AF=0.598;gnomad_exomes_AF=0.52101222;gnomad_exomes_AF_EAS=0.98417618;gnomad_exomes_AC=130698;gnomad_exomes_Hom=38668;gnomad_exomes_Het=53362;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.76364420;gnomad_exomes_AF_NFE=0.38152164;gnomad_exomes_AF_AMR=0.66507468;gnomad_exomes_AF_SAS=0.58840826;NativeFreq_Het=0.0227;NativeFreq_Hom=0.9773;normalHetFrequency=0.1503;normalHetNum=130;normalHomFrequency=0.7329;normalHomNum=634;patientHetFrequency=0.1529;patientHetNum=798;patientHomFrequency=0.7387;patientHomNum=3856;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4112;GREP_score=0.206;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AACCAATGTG.GACAGATGAC	GT:AD:DP:GQ:PL	1/1:0,145:145:99:5592,436,0
chr16	89862434	.	T	C	3343.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.862;DP=254;ExcessHet=3.0103;FS=7.87;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.16;ReadPosRankSum=0.995;SOR=0.385;HGVSnom=NM_000135.4:c.894-8A>G;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000135.4:IVS10-8A>G;AAlength=1455;EXAC_AF=0.07173927;EXAC_Hom_EAS=273;EXAC_AC_EAS=2130;EXAC_AN_EAS=8592;EXAC_AC_Adj=8675;EXAC_AN_Adj=120924;ESP6500_MAF=0.06048015;RS=rs11648881;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0754792;G1000_EAS_AF=0.2728;G1000_EUR_AF=0.0646;G1000_AFR_AF=0.0045;G1000_SAS_AF=0.0174;G1000_AMR_AF=0.0216;gnomad_exomes_AF=0.07371971;gnomad_exomes_AF_EAS=0.25582155;gnomad_exomes_AC=18515;gnomad_exomes_Hom=1172;gnomad_exomes_Het=16171;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01441064;gnomad_exomes_AF_NFE=0.07779656;gnomad_exomes_AF_AMR=0.04283070;gnomad_exomes_AF_SAS=0.02162409;HGMD_gene=FANCA;HGMD_disease=Breast_cancer_association_with;HGMD_tag=DP;HGMD_pmid=23021409;NativeFreq_Het=0.3560;NativeFreq_Hom=0.1188;normalHetFrequency=0.2474;normalHetNum=214;normalHomFrequency=0.0451;normalHomNum=39;patientHetFrequency=0.2571;patientHetNum=1342;patientHomFrequency=0.0397;patientHomNum=207;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3240;AF_2700_Hom=0.0465;AF_50_Het=0.3312;AF_50_Hom=0.0365;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00001054;DANN_score=0.2489;GREP_score=-10.1;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AACCTGCCAA.GCAGCAGAAA	GT:AD:DP:GQ:PL	0/1:136,118:254:99:3372,0,4249
chr16	89865103	.	T	A	15749.8	PASS	AC=2;AF=1;AN=2;DP=418;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.71;SOR=0.831;HGVSnom=NM_000135.4:c.893+471A>T;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000135.4:IVS10+471A>T;AAlength=1455;RS=rs11076626;G1000_AF=0.691294;G1000_EAS_AF=0.9881;G1000_EUR_AF=0.3966;G1000_AFR_AF=0.7655;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.6009;NativeFreq_Het=0.0097;NativeFreq_Hom=0.4612;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0309;normalHomNum=12;patientHetFrequency=0.004;patientHetNum=11;patientHomFrequency=0.0174;patientHomNum=91;normalHetSampleInfo=[15B0051663][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1532975-1|16D1545925|16D0168690|16D1545768|16D1545879|16B0012350|16D0158757|15D6532784|16D1536863-1|15D6722351-1|16D1532961-1][_];patientHomSampleInfo=[_][_];DANN_score=0.4582;GREP_score=-2.87;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-,FANCA:NM_001018112.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1,FANCA:NM_001018112.1:NP_001018122.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.,FANCA:NM_001018112.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=GAGAAAAAGC.AATAGGGCCA	GT:AD:DP:GQ:PL	1/1:0,417:417:99:15778,1253,0
chr16	89865242	.	T	C	15206.8	PASS	AC=2;AF=1;AN=2;DP=409;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.22;SOR=0.862;HGVSnom=NM_000135.4:c.893+332A>G;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I10;IVSnom=NM_000135.4:IVS10+332A>G;AAlength=1455;RS=rs10852623;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.687101;G1000_EAS_AF=0.9881;G1000_EUR_AF=0.3976;G1000_AFR_AF=0.7489;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.6009;NativeFreq_Het=0.0178;NativeFreq_Hom=0.9304;normalHetFrequency=0.0347;normalHetNum=30;normalHomFrequency=0.6263;normalHomNum=243;patientHetFrequency=0.1183;patientHetNum=328;patientHomFrequency=0.3086;patientHomNum=1611;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5086;GREP_score=-3.0;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-,FANCA:NM_001018112.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1,FANCA:NM_001018112.1:NP_001018122.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.,FANCA:NM_001018112.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=AGAGCCTGAA.CACACCCAGG	GT:AD:DP:GQ:PL	1/1:0,408:408:99:15235,1225,0
chr16	89866043	.	T	C	8429.77	PASS	AC=2;AF=1;AN=2;DP=254;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.45;SOR=1.125;HGVSnom=NM_000135.4:c.796A>G(p.Thr266Ala/p.T266A);Gene=FANCA;Transcript=NM_000135.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E9;IVSnom=.;AAlength=1455;EXAC_AF=0.51659908;EXAC_Hom_EAS=4194;EXAC_AC_EAS=8520;EXAC_AN_EAS=8652;EXAC_AC_Adj=62680;EXAC_AN_Adj=121332;ESP6500_MAF=0.50600185;RS=rs7190823;Ensembl_transcriptid=ENST00000389301|ENST00000568369|ENST00000389302|ENST00000563673|ENST00000534992|ENST00000543736;SIFT_pred=T|T|T|T|T|T;SIFT_score=1.0|1.0|1.0|1.0|1.0|1.0;Polyphen2_HVAR_pred=B|.|B|.|B|B;Polyphen2_HVAR_score=0.0|.|0.0|.|0.0|0.0;MutationTaster_pred=P|P|P|P;MutationTaster_score=1|1|1|1;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.690495;G1000_EAS_AF=0.9871;G1000_EUR_AF=0.3956;G1000_AFR_AF=0.7625;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.6037;gnomad_exomes_AF=0.52081261;gnomad_exomes_AF_EAS=0.98439539;gnomad_exomes_AC=130900;gnomad_exomes_Hom=38559;gnomad_exomes_Het=53782;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.72488303;gnomad_exomes_AF_NFE=0.38468236;gnomad_exomes_AF_AMR=0.66779436;gnomad_exomes_AF_SAS=0.58994381;HGMD_gene=FANCA;HGMD_disease=Breast_cancer_association_with;HGMD_tag=DP;HGMD_pmid=23021409;NativeFreq_Het=0.0227;NativeFreq_Hom=0.9900;normalHetFrequency=0.1457;normalHetNum=126;normalHomFrequency=0.7387;normalHomNum=639;patientHetFrequency=0.1515;patientHetNum=791;patientHomFrequency=0.7402;patientHomNum=3864;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0300;AF_2700_Hom=0.9669;AF_50_Het=0.0301;AF_50_Hom=0.9667;DANN_score=0.1606;GREP_score=1.85;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-,FANCA:NM_001018112.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1,FANCA:NM_001018112.1:NP_001018122.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.,FANCA:NM_001018112.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=ACATCAACCG.GACCTGTCAA	GT:AD:DP:GQ:PL	1/1:0,252:252:99:8458,756,0
chr16	89869761	.	T	C	11239.8	PASS	AC=2;AF=1;AN=2;DP=294;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.45;SOR=1.77;HGVSnom=NM_000135.4:c.710-12A>G;Gene=FANCA;Transcript=NM_000135.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000135.4:IVS7-12A>G;AAlength=1455;EXAC_AF=0.70127772;EXAC_Hom_EAS=4237;EXAC_AC_EAS=8564;EXAC_AN_EAS=8654;EXAC_AC_Adj=85072;EXAC_AN_Adj=121310;ESP6500_MAF=0.69575254;RS=rs1800286;CLNGENE=FANCA;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.842851;G1000_EAS_AF=0.9911;G1000_EUR_AF=0.6064;G1000_AFR_AF=0.9607;G1000_SAS_AF=0.8487;G1000_AMR_AF=0.7378;gnomad_exomes_AF=0.69873265;gnomad_exomes_AF_EAS=0.98874511;gnomad_exomes_AC=175544;gnomad_exomes_Hom=63888;gnomad_exomes_Het=47768;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.92312438;gnomad_exomes_AF_NFE=0.59041298;gnomad_exomes_AF_AMR=0.78254207;gnomad_exomes_AF_SAS=0.79591637;NativeFreq_Het=0.0178;NativeFreq_Hom=0.9900;normalHetFrequency=0.1399;normalHetNum=121;normalHomFrequency=0.8185;normalHomNum=708;patientHetFrequency=0.1374;patientHetNum=717;patientHomFrequency=0.8197;patientHomNum=4279;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0215;AF_2700_Hom=0.9762;AF_50_Het=0.0206;AF_50_Hom=0.9762;dbscSNV_RF_score=0.04;dbscSNV_ADA_score=0.00016371;DANN_score=0.7939;GREP_score=-7.01;CytoBand=q24.3;CGD_CONDITION=Fanconi anemia, complementation group A;CGD_INHERITANCE=AR;Strand=FANCA:NM_000135.4:-,FANCA:NM_000135.2:-,FANCA:NM_001286167.1:-,FANCA:NM_001018112.1:-;NP=FANCA:NM_000135.4:NP_000126.2,FANCA:NM_000135.2:NP_000126.2,FANCA:NM_001286167.1:NP_001273096.1,FANCA:NM_001018112.1:NP_001018122.1;ENSP=FANCA:NM_000135.4:ENST00000389301.8,FANCA:NM_000135.2:ENST00000389301.7,FANCA:NM_001286167.1:.,FANCA:NM_001018112.1:.;Gene_MIM_id=607139;Phenotypes=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive. 227650(MK);Possible_Inheritance=AR;EntrezGeneID=2175;EnsemblGeneID=ENSG00000187741;Alias=FANCA, FACA, FA1, FA, FAA;FLKSEQ=TGAAAAACCA.AAAACCAAAG	GT:AD:DP:GQ:PL	1/1:0,293:293:99:11268,881,0
chr16	89984370	.	T	C	8515.77	PASS	AC=2;AF=1;AN=2;DP=233;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.94;SOR=0.859;HGVSnom=.;Gene=MC1R;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3212354;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.746206;G1000_EAS_AF=0.9206;G1000_EUR_AF=0.4245;G1000_AFR_AF=0.9418;G1000_SAS_AF=0.7117;G1000_AMR_AF=0.6354;normalHetFrequency=0.2893;normalHetNum=138;normalHomFrequency=0.3457;normalHomNum=299;patientHetFrequency=0.2602;patientHetNum=637;patientHomFrequency=0.3195;patientHomNum=1668;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7866;GREP_score=-0.77;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=AGGGCCCCTC.CCACCGTCCC	GT:AD:DP:GQ:PL	1/1:0,232:232:99:8544,695,0
chr16	89984604	.	T	C	5254.77	PASS	AC=2;AF=1;AN=2;DP=134;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.82;SOR=0.77;HGVSnom=.;Gene=MC1R;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3212357;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.7498;G1000_EAS_AF=0.9216;G1000_EUR_AF=0.4254;G1000_AFR_AF=0.9539;G1000_SAS_AF=0.7117;G1000_AMR_AF=0.6354;normalHetFrequency=0.2872;normalHetNum=137;normalHomFrequency=0.6247;normalHomNum=298;patientHetFrequency=0.259;patientHetNum=634;patientHomFrequency=0.318;patientHomNum=1660;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6399;GREP_score=0.804;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=AAGACCTCAC.AGGGTGCCCC	GT:AD:DP:GQ:PL	1/1:0,133:133:99:5283,400,0
chr16	89984739	.	A	G	6662.77	PASS	AC=2;AF=1;AN=2;DP=194;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.52;SOR=1.685;HGVSnom=.;Gene=MC1R;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3212358;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.746605;G1000_EAS_AF=0.9216;G1000_EUR_AF=0.4254;G1000_AFR_AF=0.9418;G1000_SAS_AF=0.7117;G1000_AMR_AF=0.6354;normalHetFrequency=0.2935;normalHetNum=140;normalHomFrequency=0.3468;normalHomNum=300;patientHetFrequency=0.2651;patientHetNum=649;patientHomFrequency=0.3195;patientHomNum=1668;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.2894;GREP_score=-0.47;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=CAGGCTCTAC.AGATGCCTGA	GT:AD:DP:GQ:PL	1/1:0,193:193:99:6691,578,0
chr16	89985177	.	C	T	2616.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.311;DP=203;ExcessHet=3.0103;FS=3.22;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.95;ReadPosRankSum=0.304;SOR=0.487;HGVSnom=.;Gene=MC1R;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3212359;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.560503;G1000_EAS_AF=0.6329;G1000_EUR_AF=0.3539;G1000_AFR_AF=0.6399;G1000_SAS_AF=0.5798;G1000_AMR_AF=0.5764;normalHetFrequency=0.478;normalHetNum=228;normalHomFrequency=0.3333;normalHomNum=159;patientHetFrequency=0.2178;patientHetNum=1137;patientHomFrequency=0.1743;patientHomNum=910;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8569;GREP_score=-1.91;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=GGTGGCAGGC.GGGCCATGGT	GT:AD:DP:GQ:PL	0/1:114,88:202:99:2645,0,3559
chr16	89985222	.	G	A	3532.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.922;DP=250;ExcessHet=3.0103;FS=0.464;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.13;ReadPosRankSum=-1.738;SOR=0.658;HGVSnom=.;Gene=MC1R;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3212361;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.455272;G1000_EAS_AF=0.627;G1000_EUR_AF=0.2634;G1000_AFR_AF=0.4289;G1000_SAS_AF=0.4908;G1000_AMR_AF=0.4841;normalHetFrequency=0.4654;normalHetNum=222;normalHomFrequency=0.1653;normalHomNum=143;patientHetFrequency=0.2119;patientHetNum=1106;patientHomFrequency=0.1646;patientHomNum=859;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9364;GREP_score=2.87;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=GCCGCCCTCA.TGGGAGGGGC	GT:AD:DP:GQ:PL	0/1:131,119:250:99:3561,0,4175
chr16	89985441	.	A	T	5086.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.558;DP=325;ExcessHet=3.0103;FS=5.758;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.7;ReadPosRankSum=1.071;SOR=0.972;HGVSnom=NM_002386.4:c.-226A>T;Gene=MC1R;Transcript=NM_002386.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=317;RS=rs3212363;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.514177;G1000_EAS_AF=0.628;G1000_EUR_AF=0.2654;G1000_AFR_AF=0.5537;G1000_SAS_AF=0.6043;G1000_AMR_AF=0.5072;normalHetFrequency=0.341;normalHetNum=295;normalHomFrequency=0.304;normalHomNum=263;patientHetFrequency=0.3238;patientHetNum=1690;patientHomFrequency=0.2954;patientHomNum=1542;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5559;GREP_score=1.28;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=CCCAGGCGGT.GATGCCAGGA	GT:AD:DP:GQ:PL	0/1:161,163:324:99:5115,0,5171
chr16	89985940	.	G	A	4893.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.1;DP=317;ExcessHet=3.0103;FS=4.314;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.49;ReadPosRankSum=0.141;SOR=0.56;HGVSnom=NM_002386.4:c.274G>A(p.Val92Met/p.V92M);Gene=MC1R;Transcript=NM_002386.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E1;IVSnom=.;AAlength=317;EXAC_AF=0.07636977;EXAC_Hom_EAS=337;EXAC_AC_EAS=2315;EXAC_AN_EAS=8536;EXAC_AC_Adj=9152;EXAC_AN_Adj=119838;ESP6500_MAF=0.06331069;RS=rs2228479;Ensembl_transcriptid=ENST00000555427|ENST00000639847|ENST00000555147|ENST00000556922;SIFT_pred=T|.|T|D;SIFT_score=0.245|.|0.312|0.002;Polyphen2_HVAR_pred=.|B|B|.;Polyphen2_HVAR_score=.|0.034|0.034|.;MutationTaster_pred=P|P;MutationTaster_score=0.945563|0.945563;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0796725;G1000_EAS_AF=0.2887;G1000_EUR_AF=0.0686;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.0184;G1000_AMR_AF=0.0231;gnomad_exomes_AF=0.07811909;gnomad_exomes_AF_EAS=0.27637154;gnomad_exomes_AC=19399;gnomad_exomes_Hom=1319;gnomad_exomes_Het=16761;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01605209;gnomad_exomes_AF_NFE=0.08283376;gnomad_exomes_AF_AMR=0.04582101;gnomad_exomes_AF_SAS=0.02412238;HGMD_gene=MC1R;HGMD_disease=Ephelides_increased_risk_association_with;HGMD_tag=DFP;HGMD_pmid=11487574;NativeFreq_Het=0.0107;NativeFreq_Hom=0;normalHetFrequency=0.2624;normalHetNum=227;normalHomFrequency=0.0509;normalHomNum=44;patientHetFrequency=0.2839;patientHetNum=1482;patientHomFrequency=0.0475;patientHomNum=248;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8268;GREP_score=0.165;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=CGGGAGCAAC.TGCTGGAGAC	GT:AD:DP:GQ:PL	0/1:156,160:316:99:4922,0,4522
chr16	89986154	.	G	A	3979.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.505;DP=236;ExcessHet=3.0103;FS=17.312;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.86;ReadPosRankSum=-0.795;SOR=0.505;HGVSnom=NM_002386.4:c.488G>A(p.Arg163Gln/p.R163Q);Gene=MC1R;Transcript=NM_002386.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E1;IVSnom=.;AAlength=317;EXAC_AF=0.13583048;EXAC_Hom_EAS=1791;EXAC_AC_EAS=5509;EXAC_AN_EAS=8552;EXAC_AC_Adj=16166;EXAC_AN_Adj=119016;ESP6500_MAF=0.03706843;RS=rs885479;Ensembl_transcriptid=ENST00000555427|ENST00000639847|ENST00000555147|ENST00000556922;SIFT_pred=D|.|T|D;SIFT_score=0.035|.|0.054|0.014;Polyphen2_HVAR_pred=.|B|B|.;Polyphen2_HVAR_score=.|0.013|0.013|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.191294;G1000_EAS_AF=0.6161;G1000_EUR_AF=0.0696;G1000_AFR_AF=0.0068;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.3156;gnomad_exomes_AF=0.15154046;gnomad_exomes_AF_EAS=0.63963612;gnomad_exomes_AC=37008;gnomad_exomes_Hom=7445;gnomad_exomes_Het=22118;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01661065;gnomad_exomes_AF_NFE=0.04822271;gnomad_exomes_AF_AMR=0.39653672;gnomad_exomes_AF_SAS=0.03752290;HGMD_gene=MC1R;HGMD_disease=Ephelides_increased_risk_association_with;HGMD_tag=DFP;HGMD_pmid=11487574;NativeFreq_Het=0.0285;NativeFreq_Hom=0;normalHetFrequency=0.3549;normalHetNum=307;normalHomFrequency=0.3006;normalHomNum=260;patientHetFrequency=0.351;patientHetNum=1832;patientHomFrequency=0.3011;patientHomNum=1572;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9858;GREP_score=4.81;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=CGGGCGCGGC.AGCCGTTGCG	GT:AD:DP:GQ:PL	0/1:112,124:236:99:4008,0,3276
chr16	89986608	.	A	G	5830.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.865;DP=409;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.29;ReadPosRankSum=-1.592;SOR=0.713;HGVSnom=NM_002386.4:c.942A>G(p.Thr314Thr/p.T314T);Gene=MC1R;Transcript=NM_002386.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=317;EXAC_AF=0.15018690;EXAC_Hom_EAS=338;EXAC_AC_EAS=2323;EXAC_AN_EAS=8536;EXAC_AC_Adj=17920;EXAC_AN_Adj=119318;ESP6500_MAF=0.20810386;RS=rs2228478;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.258986;G1000_EAS_AF=0.2927;G1000_EUR_AF=0.0924;G1000_AFR_AF=0.4871;G1000_SAS_AF=0.2117;G1000_AMR_AF=0.0836;gnomad_exomes_AF=0.14291287;gnomad_exomes_AF_EAS=0.27723269;gnomad_exomes_AC=35535;gnomad_exomes_Hom=3789;gnomad_exomes_Het=27957;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.45085692;gnomad_exomes_AF_NFE=0.10530755;gnomad_exomes_AF_AMR=0.08245360;gnomad_exomes_AF_SAS=0.18542375;NativeFreq_Het=0.0427;NativeFreq_Hom=0;normalHetFrequency=0.304;normalHetNum=263;normalHomFrequency=0.0555;normalHomNum=48;patientHetFrequency=0.3146;patientHetNum=1642;patientHomFrequency=0.05;patientHomNum=261;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4805;GREP_score=0.604;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=AGGTGCTGAC.TGCTCCTGGT	GT:AD:DP:GQ:PL	0/1:204,204:408:99:5859,0,6511
chr16	89986760	.	A	G	5900.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.938;DP=413;ExcessHet=3.0103;FS=0.517;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.39;ReadPosRankSum=-1.594;SOR=0.716;HGVSnom=NM_002386.4:c.*140A>G;Gene=MC1R;Transcript=NM_002386.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=317;RS=rs3212369;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.23143;G1000_EAS_AF=0.2917;G1000_EUR_AF=0.159;G1000_AFR_AF=0.3865;G1000_SAS_AF=0.1074;G1000_AMR_AF=0.1282;NativeFreq_Het=0.0142;NativeFreq_Hom=0;normalHetFrequency=0.3237;normalHetNum=280;normalHomFrequency=0.0647;normalHomNum=56;patientHetFrequency=0.3337;patientHetNum=1742;patientHomFrequency=0.0617;patientHomNum=322;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5748;GREP_score=1.13;CytoBand=q24.3;repName=MIR3;repClass=SINE;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=gatctctgaa.gtGTTGAAGC	GT:AD:DP:GQ:PL	0/1:213,197:410:99:5929,0,6596
chr16	89987201	.	A	G	4182.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=7.774;DP=231;ExcessHet=3.0103;FS=6.313;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.19;ReadPosRankSum=0.495;SOR=0.48;HGVSnom=NM_002386.4:c.*581A>G;Gene=MC1R;Transcript=NM_002386.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=317;EXAC_AF=0.19303385;EXAC_Hom_EAS=22;EXAC_AC_EAS=136;EXAC_AN_EAS=432;EXAC_AC_Adj=1186;EXAC_AN_Adj=6144;RS=rs3212371;CLNGENE=MC1R;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.214457;G1000_EAS_AF=0.2917;G1000_EUR_AF=0.0924;G1000_AFR_AF=0.3215;G1000_SAS_AF=0.2168;G1000_AMR_AF=0.072;gnomad_exomes_AF=0.13341545;gnomad_exomes_AF_EAS=0.27898170;gnomad_exomes_AC=14839;gnomad_exomes_Hom=1324;gnomad_exomes_Het=12191;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29884689;gnomad_exomes_AF_NFE=0.10889901;gnomad_exomes_AF_AMR=0.07188329;gnomad_exomes_AF_SAS=0.18795899;normalHetFrequency=0.3166;normalHetNum=151;normalHomFrequency=0.0587;normalHomNum=28;patientHetFrequency=0.3284;patientHetNum=804;patientHomFrequency=0.0257;patientHomNum=134;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.632;GREP_score=-5.37;CytoBand=q24.3;CGD_CONDITION=Increased analgesia from kappa-opioid receptor agonist, female specific;CGD_INHERITANCE=AD;Strand=MC1R:NM_002386.3:+;NP=MC1R:NM_002386.3:NP_002377.4;ENSP=MC1R:NM_002386.3:ENST00000555147.1;Gene_MIM_id=155555;Phenotypes={Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive. [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3). {Melanoma, cutaneous malignant, 5}, 613099 (3). [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive. [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive. {UV-induced skin damage}, 266300 (3), Autosomal recessive. 203200(SK),266300(SK),613098(NK),613099(SK);Possible_Inheritance=AR;EntrezGeneID=4157;EnsemblGeneID=ENSG00000258839;Alias=MC1R, SHEP2, CMM5;FLKSEQ=CCCTAGTGGT.TGGGGCTGAG	GT:AD:DP:GQ:PL	0/1:106,124:230:99:4211,0,3231
chr17	1733399	.	A	G	6152.77	PASS	AC=2;AF=1;AN=2;DP=165;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.67;SOR=1.193;HGVSnom=NM_002945.5:c.12A>G(p.Gln4Gln/p.Q4Q);Gene=RPA1;Transcript=NM_002945.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E1;IVSnom=.;AAlength=616;EXAC_AF=0.70230488;EXAC_Hom_EAS=37;EXAC_AC_EAS=233;EXAC_AN_EAS=528;EXAC_AC_Adj=6155;EXAC_AN_Adj=8764;ESP6500_MAF=0.74458802;RS=rs5030749;G1000_AF=0.544129;G1000_EAS_AF=0.3611;G1000_EUR_AF=0.7515;G1000_AFR_AF=0.6157;G1000_SAS_AF=0.4703;G1000_AMR_AF=0.4769;gnomad_exomes_AF=0.66175380;gnomad_exomes_AF_EAS=0.36032389;gnomad_exomes_AC=14278;gnomad_exomes_Hom=4873;gnomad_exomes_Het=4532;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.61982249;gnomad_exomes_AF_NFE=0.75738342;gnomad_exomes_AF_AMR=0.46536797;gnomad_exomes_AF_SAS=0.42731278;NativeFreq_Het=0.4128;NativeFreq_Hom=0.3025;DANN_score=0.7293;GREP_score=-9.92;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TGGTCGGCCA.CTGAGCGAGG	GT:AD:DP:GQ:PL	1/1:0,164:164:99:6181,492,0
chr17	1748028	.	A	G	7231.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.151;DP=485;ExcessHet=3.0103;FS=1.2;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.07;ReadPosRankSum=1.144;SOR=0.788;HGVSnom=NM_002945.5:c.272+48A>G;Gene=RPA1;Transcript=NM_002945.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_002945.5:IVS4+48A>G;AAlength=616;EXAC_AF=0.85833293;EXAC_Hom_EAS=1936;EXAC_AC_EAS=4956;EXAC_AN_EAS=6290;EXAC_AC_Adj=70991;EXAC_AN_Adj=82708;ESP6500_MAF=0.87803753;RS=rs4790827;G1000_AF=0.789337;G1000_EAS_AF=0.75;G1000_EUR_AF=0.9205;G1000_AFR_AF=0.7799;G1000_SAS_AF=0.7014;G1000_AMR_AF=0.7983;gnomad_exomes_AF=0.85881384;gnomad_exomes_AF_EAS=0.79143103;gnomad_exomes_AC=179444;gnomad_exomes_Hom=77511;gnomad_exomes_Het=24422;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.80519194;gnomad_exomes_AF_NFE=0.91905559;gnomad_exomes_AF_AMR=0.80340459;gnomad_exomes_AF_SAS=0.73553210;NativeFreq_Het=0.3025;NativeFreq_Hom=0.6335;DANN_score=0.2559;GREP_score=-8.11;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=GAATGGGAAC.AATTTAGGAA	GT:AD:DP:GQ:PL	0/1:244,236:480:99:7260,0,8019
chr17	1782957	.	C	T	11212.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.881;DP=692;ExcessHet=3.0103;FS=0.522;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.25;ReadPosRankSum=-0.249;SOR=0.641;HGVSnom=NM_002945.5:c.1056C>T(p.Ser352Ser/p.S352S);Gene=RPA1;Transcript=NM_002945.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E11;IVSnom=.;AAlength=616;EXAC_AF=0.22234036;EXAC_Hom_EAS=715;EXAC_AC_EAS=3557;EXAC_AN_EAS=8632;EXAC_AC_Adj=26977;EXAC_AN_Adj=121332;ESP6500_MAF=0.16284792;RS=rs2230930;G1000_AF=0.270966;G1000_EAS_AF=0.4048;G1000_EUR_AF=0.1779;G1000_AFR_AF=0.2088;G1000_SAS_AF=0.3354;G1000_AMR_AF=0.2392;gnomad_exomes_AF=0.22643116;gnomad_exomes_AF_EAS=0.41665761;gnomad_exomes_AC=56918;gnomad_exomes_Hom=7319;gnomad_exomes_Het=42280;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17733596;gnomad_exomes_AF_NFE=0.16017240;gnomad_exomes_AF_AMR=0.29028621;gnomad_exomes_AF_SAS=0.29173473;NativeFreq_Het=0.3381;NativeFreq_Hom=0.1103;DANN_score=0.5323;GREP_score=-11.1;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TGGACACATC.GGGAAGGTGG	GT:AD:DP:GQ:PL	0/1:324,366:690:99:11241,0,9175
chr17	1795180	.	T	C	8306.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.007;DP=604;ExcessHet=3.0103;FS=2.443;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.8;ReadPosRankSum=-0.056;SOR=0.66;HGVSnom=NM_002945.5:c.1605T>C(p.Ser535Ser/p.S535S);Gene=RPA1;Transcript=NM_002945.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E15;IVSnom=.;AAlength=616;EXAC_AF=0.23435826;EXAC_Hom_EAS=286;EXAC_AC_EAS=2244;EXAC_AN_EAS=8636;EXAC_AC_Adj=28430;EXAC_AN_Adj=121310;ESP6500_MAF=0.23835153;RS=rs2230931;G1000_AF=0.29393;G1000_EAS_AF=0.252;G1000_EUR_AF=0.1799;G1000_AFR_AF=0.3654;G1000_SAS_AF=0.3507;G1000_AMR_AF=0.304;gnomad_exomes_AF=0.23393468;gnomad_exomes_AF_EAS=0.25068105;gnomad_exomes_AC=58690;gnomad_exomes_Hom=7595;gnomad_exomes_Het=43500;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.35866617;gnomad_exomes_AF_NFE=0.17165493;gnomad_exomes_AF_AMR=0.32643497;gnomad_exomes_AF_SAS=0.30886109;HGMD_gene=RPA1;HGMD_disease=Altered_mRNA_folding;HGMD_tag=FP;HGMD_pmid=10393914;NativeFreq_Het=0.3879;NativeFreq_Hom=0.0498;DANN_score=0.6948;GREP_score=2.18;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TCCAGGAGTC.GCTGAAGCTA	GT:AD:DP:GQ:PL	0/1:306,296:602:99:8335,0,9363
chr17	1800600	.	C	T	24248.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.784;DP=668;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;MQRankSum=0;QD=28.28;ReadPosRankSum=1.696;SOR=0.286;HGVSnom=NM_002945.5:c.*131C>T;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs5030740;G1000_AF=0.69389;G1000_EAS_AF=0.8036;G1000_EUR_AF=0.8429;G1000_AFR_AF=0.5091;G1000_SAS_AF=0.6411;G1000_AMR_AF=0.745;NativeFreq_Het=0.3594;NativeFreq_Hom=0.5694;DANN_score=0.7033;GREP_score=-0.616;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=AGCAATTTCC.CCCTCGTGCG	GT:AD:DP:GQ:PL	1/1:1,661:662:99:24277,1980,0
chr17	1800849	.	C	G	9873.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.549;DP=695;ExcessHet=3.0103;FS=0.518;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.23;ReadPosRankSum=0.537;SOR=0.751;HGVSnom=NM_002945.5:c.*380C>G;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs3744769;G1000_AF=0.21885;G1000_EAS_AF=0.2738;G1000_EUR_AF=0.2167;G1000_AFR_AF=0.152;G1000_SAS_AF=0.2607;G1000_AMR_AF=0.2104;NativeFreq_Het=0.0320;NativeFreq_Hom=0;DANN_score=0.1629;GREP_score=-0.208;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=GTGACCACCC.CCCCCATCCC	GT:AD:DP:GQ:PL	0/1:343,351:694:99:9902,0,10588
chr17	1800886	.	G	A	11154.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.513;DP=769;ExcessHet=3.0103;FS=0.522;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.54;ReadPosRankSum=-0.46;SOR=0.626;HGVSnom=NM_002945.5:c.*417G>A;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs3744768;G1000_AF=0.197484;G1000_EAS_AF=0.2728;G1000_EUR_AF=0.2177;G1000_AFR_AF=0.0756;G1000_SAS_AF=0.2618;G1000_AMR_AF=0.2003;DANN_score=0.6388;GREP_score=-2.91;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TCTTCTCAGC.GGGCGAGCTG	GT:AD:DP:GQ:PL	0/1:397,370:767:99:11183,0,11358
chr17	1800932	.	T	C	10276.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.156;DP=741;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.89;ReadPosRankSum=-0.853;SOR=0.653;HGVSnom=NM_002945.5:c.*463T>C;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs3744767;G1000_AF=0.235024;G1000_EAS_AF=0.3075;G1000_EUR_AF=0.2366;G1000_AFR_AF=0.1573;G1000_SAS_AF=0.2771;G1000_AMR_AF=0.2161;DANN_score=0.7909;GREP_score=1.26;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TTTTAGTAAG.GTGTCTTCCT	GT:AD:DP:GQ:PL	0/1:390,350:740:99:10305,0,11687
chr17	1800949	.	C	G	11957.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=10.481;DP=780;ExcessHet=3.0103;FS=1.094;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.43;ReadPosRankSum=1.326;SOR=0.784;HGVSnom=NM_002945.5:c.*480C>G;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs3744766;G1000_AF=0.222244;G1000_EAS_AF=0.2758;G1000_EUR_AF=0.2217;G1000_AFR_AF=0.1581;G1000_SAS_AF=0.2607;G1000_AMR_AF=0.2133;DANN_score=0.8794;GREP_score=5.07;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TCCTAGAATT.GAAGGCTCTC	GT:AD:DP:GQ:PL	0/1:409,366:775:99:11986,0,12221
chr17	1801144	.	C	T	12003.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.588;DP=745;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.22;ReadPosRankSum=-0.027;SOR=0.715;HGVSnom=NM_002945.5:c.*675C>T;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs17734;G1000_AF=0.425519;G1000_EAS_AF=0.5228;G1000_EUR_AF=0.6223;G1000_AFR_AF=0.2194;G1000_SAS_AF=0.3333;G1000_AMR_AF=0.5216;DANN_score=0.8681;GREP_score=-1.53;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=ATTGACTTGC.GTCCCCTAAG	GT:AD:DP:GQ:PL	0/1:364,376:740:99:12032,0,10898
chr17	1801189	.	C	T	14207.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.073;DP=845;ExcessHet=3.0103;FS=1.103;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.95;ReadPosRankSum=-2.288;SOR=0.801;HGVSnom=NM_002945.5:c.*720C>T;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs1131636;G1000_AF=0.464657;G1000_EAS_AF=0.5238;G1000_EUR_AF=0.6262;G1000_AFR_AF=0.357;G1000_SAS_AF=0.3333;G1000_AMR_AF=0.5346;DANN_score=0.895;GREP_score=4.4;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TTCTTTACTT.TCACTTCAAT	GT:AD:DP:GQ:PL	0/1:401,437:838:99:14236,0,13014
chr17	1801263	.	T	C	11722.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=17.327;DP=816;ExcessHet=3.0103;FS=1.753;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.44;ReadPosRankSum=0.784;SOR=0.553;HGVSnom=NM_002945.5:c.*794T>C;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs9082;G1000_AF=0.227037;G1000_EAS_AF=0.2748;G1000_EUR_AF=0.2167;G1000_AFR_AF=0.146;G1000_SAS_AF=0.3098;G1000_AMR_AF=0.2104;DANN_score=0.5202;GREP_score=-0.238;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TGCATTCATG.ATTTTGTTTT	GT:AD:DP:GQ:PL	0/1:456,356:812:99:11751,0,13767
chr17	1801592	.	A	G	11851.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.371;DP=800;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.93;ReadPosRankSum=-0.325;SOR=0.712;HGVSnom=NM_002945.5:c.*1123A>G;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs9914073;G1000_AF=0.227037;G1000_EAS_AF=0.2758;G1000_EUR_AF=0.2167;G1000_AFR_AF=0.1445;G1000_SAS_AF=0.3098;G1000_AMR_AF=0.2118;DANN_score=0.7526;GREP_score=3.5;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=ATGATCTGGC.CTTGGGATTT	GT:AD:DP:GQ:PL	0/1:380,414:794:99:11880,0,10775
chr17	1802418	.	G	A	10771.8	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.506;DP=681;ExcessHet=3.0103;FS=4.013;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.96;ReadPosRankSum=0.722;SOR=0.602;HGVSnom=NM_002945.5:c.*1949G>A;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs17292622;G1000_AF=0.221446;G1000_EAS_AF=0.2748;G1000_EUR_AF=0.2097;G1000_AFR_AF=0.1725;G1000_SAS_AF=0.2526;G1000_AMR_AF=0.2104;NativeFreq_Het=0.0107;NativeFreq_Hom=0;DANN_score=0.5514;GREP_score=4.5;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=ATGTGATTGG.AACCCAGGGG	GT:AD:DP:GQ:PL	0/1:326,349:675:99:10800,0,10636
chr17	1802501	.	G	A	9328.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-11.609;DP=635;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.78;ReadPosRankSum=-1.911;SOR=0.699;HGVSnom=NM_002945.5:c.*2032G>A;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs17339395;G1000_AF=0.219449;G1000_EAS_AF=0.2748;G1000_EUR_AF=0.2127;G1000_AFR_AF=0.1589;G1000_SAS_AF=0.2566;G1000_AMR_AF=0.2118;DANN_score=0.7378;GREP_score=3.75;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=CAGATCACCA.CAGAGGAGCA	GT:AD:DP:GQ:PL	0/1:323,308:631:99:9357,0,10875
chr17	1802586	.	C	CAGTTCGTAGAATTCTCTTGGATAT	10576.7	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.477;DP=627;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.72;ReadPosRankSum=-10.047;SOR=0.734;HGVSnom=NM_002945.5:c.*2121_*2122insCGTAGAATTCTCTTGGATATAGTT;Gene=RPA1;Transcript=NM_002945.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E17;IVSnom=.;AAlength=616;RS=rs17339402;G1000_AF=0.224241;G1000_EAS_AF=0.2758;G1000_EUR_AF=0.2137;G1000_AFR_AF=0.1422;G1000_SAS_AF=0.3067;G1000_AMR_AF=0.2046;CytoBand=p13.3;Strand=RPA1:NM_002945.3:+;NP=RPA1:NM_002945.3:NP_002936.1;ENSP=RPA1:NM_002945.3:.;Gene_MIM_id=179835;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=6117;EnsemblGeneID=ENSG00000132383;Alias=RPA1;FLKSEQ=TTCTGGCCCA.AGTTTACCTC	GT:AD:DP:GQ:PL	0/1:336,261:597:99:10614,0,13189
chr17	5991344	.	C	T	11136.8	PASS	AC=2;AF=1;AN=2;DP=304;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.61;SOR=0.74;HGVSnom=NM_015253.2:c.462C>T(p.His154His/p.H154H);Gene=WSCD1;Transcript=NM_015253.2;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E3;IVSnom=.;AAlength=575;EXAC_AF=0.55456148;EXAC_Hom_EAS=2915;EXAC_AC_EAS=7102;EXAC_AN_EAS=8652;EXAC_AC_Adj=67316;EXAC_AN_Adj=121386;ESP6500_MAF=0.42787944;RS=rs2302836;G1000_AF=0.526757;G1000_EAS_AF=0.8204;G1000_EUR_AF=0.5338;G1000_AFR_AF=0.1611;G1000_SAS_AF=0.7117;G1000_AMR_AF=0.5259;gnomad_exomes_AF=0.56231107;gnomad_exomes_AF_EAS=0.81658510;gnomad_exomes_AC=141374;gnomad_exomes_Hom=41794;gnomad_exomes_Het=57786;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.20364218;gnomad_exomes_AF_NFE=0.53447912;gnomad_exomes_AF_AMR=0.55938819;gnomad_exomes_AF_SAS=0.66567583;NativeFreq_Het=0.3488;NativeFreq_Hom=0.4662;DANN_score=0.4761;GREP_score=2.78;CytoBand=p13.2;Strand=WSCD1:NM_015253.1:+;NP=WSCD1:NM_015253.1:NP_056068.1;ENSP=WSCD1:NM_015253.1:.;FLKSEQ=ACGATGGCCA.GAGAGGACTC	GT:AD:DP:GQ:PL	1/1:0,303:303:99:11165,911,0
chr17	7572154	.	GA	G	1702.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.269;DP=264;ExcessHet=3.0103;FS=0.796;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=-0.866;QD=7.31;ReadPosRankSum=-2.602;SOR=0.582;HGVSnom=NM_000546.6:c.*772delT;Gene=TP53;Transcript=NM_000546.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=393;RS=rs200757381;CLNGENE=TP53;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0396;NativeFreq_Hom=.;AF_2700_Het=0.7087;AF_2700_Hom=0.0058;AF_50_Het=0.7163;AF_50_Hom=0.0032;CytoBand=p13.1;repName=AluJb;repClass=SINE;simRepName=trf;simRepCopyNum=6;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=caaagaaaaa.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:105,128:233:99:1740,0,1207
chr17	7572442	.	C	T	6195.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.852;DP=374;ExcessHet=3.0103;FS=5.961;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.66;ReadPosRankSum=-0.042;SOR=0.558;HGVSnom=NM_000546.6:c.*485G>A;Gene=TP53;Transcript=NM_000546.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=393;RS=rs4968187;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0511182;G1000_EAS_AF=0.131;G1000_EUR_AF=0.0109;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.0123;G1000_AMR_AF=0.1427;NativeFreq_Het=0.1584;NativeFreq_Hom=0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=0.0011;patientHomNum=3;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B0033455|16B0033456][_];patientHomSampleInfo=[16B0028143|16B0028114|16B0067610][_];AF_2700_Het=0.1368;AF_2700_Hom=0.0061;AF_50_Het=0.1284;AF_50_Hom=0.0079;DANN_score=0.5796;GREP_score=-6.28;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=AGTTCTAGAC.CCATGTAATA	GT:AD:DP:GQ:PL	0/1:174,198:372:99:6224,0,5811
chr17	7577407	.	A	C	3908.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.52;DP=273;ExcessHet=3.0103;FS=1.515;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.32;ReadPosRankSum=1.342;SOR=0.801;HGVSnom=NM_000546.6:c.782+92T>G;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000546.6:IVS7+92T>G;AAlength=393;RS=rs12951053;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.178315;G1000_EAS_AF=0.3234;G1000_EUR_AF=0.0984;G1000_AFR_AF=0.1104;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.1542;NativeFreq_Het=0.4158;NativeFreq_Hom=0.1287;normalHetFrequency=0.3428;normalHetNum=133;normalHomFrequency=0.0619;normalHomNum=24;patientHetFrequency=0.3377;patientHetNum=936;patientHomFrequency=0.0696;patientHomNum=193;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7083;GREP_score=-5.2;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=AGTAGTATGG.AGAAATCGGT	GT:AD:DP:GQ:PL	0/1:155,118:273:99:3937,0,4847
chr17	7577427	.	G	A	3757.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.174;DP=303;ExcessHet=3.0103;FS=0.437;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.4;ReadPosRankSum=-3.039;SOR=0.746;HGVSnom=NM_000546.6:c.782+72C>T;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_000546.6:IVS7+72C>T;AAlength=393;RS=rs12947788;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.178315;G1000_EAS_AF=0.3234;G1000_EUR_AF=0.0984;G1000_AFR_AF=0.1104;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.1542;NativeFreq_Het=0.4158;NativeFreq_Hom=0.1287;normalHetFrequency=0.3402;normalHetNum=132;normalHomFrequency=0.0644;normalHomNum=25;patientHetFrequency=0.3369;patientHetNum=934;patientHomFrequency=0.0689;patientHomNum=191;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6903;GREP_score=1.01;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=TAAGAGGTGG.CCCAGGGGTC	GT:AD:DP:GQ:PL	0/1:167,136:303:99:3786,0,5324
chr17	7577678	.	CT	C	1028.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.212;DP=261;ExcessHet=3.0103;FS=0.673;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.42;ReadPosRankSum=-0.273;SOR=0.782;HGVSnom=NM_000546.6:c.673-71delA;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000546.6:IVS6-71delA;AAlength=393;RS=rs752774596;NativeFreq_Het=0.0990;NativeFreq_Hom=.;normalHetFrequency=0.2912;normalHetNum=113;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.3038;patientHetNum=842;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0024277|16B0200324][_];CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=CAGGGGAGGC.tttttttttt	GT:AD:DP:GQ:PL	0/1:140,93:233:99:1066,0,2455
chr17	7578115	.	T	C	8995.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.335;DP=245;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.15;ReadPosRankSum=1.57;SOR=1.179;HGVSnom=NM_000546.6:c.672+62A>G;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_000546.6:IVS6+62A>G;AAlength=393;EXAC_AF=0.86125420;EXAC_Hom_EAS=2681;EXAC_AC_EAS=5549;EXAC_AN_EAS=5740;EXAC_AC_Adj=76910;EXAC_AN_Adj=89300;RS=rs1625895;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.833666;G1000_EAS_AF=0.9762;G1000_EUR_AF=0.8569;G1000_AFR_AF=0.6846;G1000_SAS_AF=0.8108;G1000_AMR_AF=0.9092;gnomad_exomes_AF=0.86333560;gnomad_exomes_AF_EAS=0.96588206;gnomad_exomes_AC=190495;gnomad_exomes_Hom=82558;gnomad_exomes_Het=25379;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.71611694;gnomad_exomes_AF_NFE=0.86667215;gnomad_exomes_AF_AMR=0.92671114;gnomad_exomes_AF_SAS=0.79265545;NativeFreq_Het=0.1459;NativeFreq_Hom=0.9306;normalHetFrequency=0.1881;normalHetNum=73;normalHomFrequency=0.7809;normalHomNum=303;patientHetFrequency=0.1569;patientHetNum=435;patientHomFrequency=0.8066;patientHomNum=2236;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.648;GREP_score=0.067;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=ACTGCTCACC.GGAGGGCCAC	GT:AD:DP:GQ:PL	1/1:1,242:243:99:9024,690,0
chr17	7578645	.	C	T	6459.77	StandardFilter	AC=2;AF=1;AN=2;DP=170;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.89;SOR=4.06;HGVSnom=NM_000546.6:c.376-91G>A;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000546.6:IVS4-91G>A;AAlength=393;RS=rs2909430;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.842851;G1000_EAS_AF=0.9762;G1000_EUR_AF=0.8579;G1000_AFR_AF=0.7141;G1000_SAS_AF=0.8149;G1000_AMR_AF=0.9121;NativeFreq_Het=0.1352;NativeFreq_Hom=0.4448;normalHetFrequency=0.1778;normalHetNum=69;normalHomFrequency=0.7887;normalHomNum=306;patientHetFrequency=0.153;patientHetNum=424;patientHomFrequency=0.8056;patientHomNum=2233;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7628;GREP_score=-1.78;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_001126115.1:-,TP53:NM_001126116.1:-,TP53:NM_001126117.1:-,TP53:NM_001276697.1:-,TP53:NM_001276698.1:-,TP53:NM_001276699.1:-,TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_001126115.1:NP_001119587.1,TP53:NM_001126116.1:NP_001119588.1,TP53:NM_001126117.1:NP_001119589.1,TP53:NM_001276697.1:NP_001263626.1,TP53:NM_001276698.1:NP_001263627.1,TP53:NM_001276699.1:NP_001263628.1,TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_001126115.1:.,TP53:NM_001126116.1:.,TP53:NM_001126117.1:.,TP53:NM_001276697.1:.,TP53:NM_001276698.1:.,TP53:NM_001276699.1:.,TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=AACAAACATG.GTAAGCACCT	GT:AD:DP:GQ:PL	1/1:0,169:169:99:6488,508,0
chr17	7579472	.	G	C	4880.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.961;DP=381;ExcessHet=3.0103;FS=18.868;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.95;ReadPosRankSum=0.189;SOR=0.555;HGVSnom=NM_000546.6:c.215C>G(p.Pro72Arg/p.P72R);Gene=TP53;Transcript=NM_000546.6;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E4;IVSnom=.;AAlength=393;EXAC_AF=0.65995997;EXAC_Hom_EAS=1510;EXAC_AC_EAS=5079;EXAC_AN_EAS=8620;EXAC_AC_Adj=79805;EXAC_AN_Adj=120924;ESP6500_MAF=0.63003691;RS=rs1042522;Ensembl_transcriptid=ENST00000413465|ENST00000359597|ENST00000610292|ENST00000269305|ENST00000620739|ENST00000617185|ENST00000455263|ENST00000420246|ENST00000622645|ENST00000610538|ENST00000445888|ENST00000619485|ENST00000615910|ENST00000508793|ENST00000604348|ENST00000503591;SIFT_pred=T|T|.|T|.|.|T|T|.|.|T|.|.|T|.|T;SIFT_score=0.262|0.31|.|0.258|.|.|0.317|0.244|.|.|0.258|.|.|0.425|.|0.642;Polyphen2_HVAR_pred=B|.|.|B|.|B|B|B|.|.|B|.|.|B|.|.;Polyphen2_HVAR_score=0.372|.|.|0.045|.|0.128|0.147|0.128|.|.|0.045|.|.|0.0|.|.;MutationTaster_pred=P|P|P|P|P|P;MutationTaster_score=1|1|1|1|1|1;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.542931;G1000_EAS_AF=0.5863;G1000_EUR_AF=0.7147;G1000_AFR_AF=0.3313;G1000_SAS_AF=0.5082;G1000_AMR_AF=0.683;gnomad_exomes_AF=0.66816480;gnomad_exomes_AF_EAS=0.57001307;gnomad_exomes_AC=167398;gnomad_exomes_Hom=57557;gnomad_exomes_Het=52284;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37990601;gnomad_exomes_AF_NFE=0.73780348;gnomad_exomes_AF_AMR=0.71453367;gnomad_exomes_AF_SAS=0.50019599;HGMD_gene=TP53;HGMD_disease=Lung_cancer_association_with;HGMD_tag=DFP;HGMD_pmid=8625447;NativeFreq_Het=0.4093;NativeFreq_Hom=0.3663;normalHetFrequency=0.5052;normalHetNum=196;normalHomFrequency=0.3196;normalHomNum=124;patientHetFrequency=0.4708;patientHetNum=1305;patientHomFrequency=0.3467;patientHomNum=961;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4919;AF_2700_Hom=0.3194;AF_50_Het=0.5198;AF_50_Hom=0.3122;DANN_score=0.5704;GREP_score=1.87;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=AGGGGCCACG.GGGGAGCAGC	GT:AD:DP:GQ:PL	0/1:204,173:377:99:4909,0,6195
chr17	7579801	.	G	C	4910.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.844;DP=328;ExcessHet=3.0103;FS=11.465;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.16;ReadPosRankSum=-0.26;SOR=0.362;HGVSnom=NM_000546.6:c.74+38C>G;Gene=TP53;Transcript=NM_000546.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000546.6:IVS2+38C>G;AAlength=393;EXAC_AF=0.66890010;EXAC_Hom_EAS=1477;EXAC_AC_EAS=4972;EXAC_AN_EAS=8390;EXAC_AC_Adj=78767;EXAC_AN_Adj=117756;ESP6500_MAF=0.66694863;RS=rs1642785;CLNGENE=TP53;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.584864;G1000_EAS_AF=0.5823;G1000_EUR_AF=0.7117;G1000_AFR_AF=0.4924;G1000_SAS_AF=0.5051;G1000_AMR_AF=0.6931;gnomad_exomes_AF=0.67340475;gnomad_exomes_AF_EAS=0.57129497;gnomad_exomes_AC=166700;gnomad_exomes_Hom=57141;gnomad_exomes_Het=52418;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.51609960;gnomad_exomes_AF_NFE=0.73209231;gnomad_exomes_AF_AMR=0.71799721;gnomad_exomes_AF_SAS=0.49957315;HGMD_gene=TP53;HGMD_disease=Reduced_mRNA_stability;HGMD_tag=FP;HGMD_pmid=25269805;NativeFreq_Het=0.4164;NativeFreq_Hom=0.3808;normalHetFrequency=0.5052;normalHetNum=196;normalHomFrequency=0.317;normalHomNum=123;patientHetFrequency=0.4729;patientHetNum=1311;patientHomFrequency=0.3452;patientHomNum=957;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5669;GREP_score=1.81;CytoBand=p13.1;CGD_CONDITION=Li-Fraumeni syndrome. Choroid plexus papilloma. Ependymoma, intracranial. Osteogenic sarcoma. Breast cancer, familial. Hepatoblastoma. Non-Hodgkin lymphoma. Adrenocortical carcinoma. Colorectal cancer. Bone marrow failure syndrome 5;CGD_INHERITANCE=AD;Strand=TP53:NM_000546.5:-,TP53:NM_001126112.2:-,TP53:NM_001126113.2:-,TP53:NM_001126114.2:-,TP53:NM_001126118.1:-,TP53:NM_001276695.1:-,TP53:NM_001276696.1:-,TP53:NM_001276760.1:-,TP53:NM_001276761.1:-;NP=TP53:NM_000546.5:NP_000537.3,TP53:NM_001126112.2:NP_001119584.1,TP53:NM_001126113.2:NP_001119585.1,TP53:NM_001126114.2:NP_001119586.1,TP53:NM_001126118.1:NP_001119590.1,TP53:NM_001276695.1:NP_001263624.1,TP53:NM_001276696.1:NP_001263625.1,TP53:NM_001276760.1:NP_001263689.1,TP53:NM_001276761.1:NP_001263690.1;ENSP=TP53:NM_000546.5:ENST00000269305.8,TP53:NM_001126112.2:.,TP53:NM_001126113.2:.,TP53:NM_001126114.2:.,TP53:NM_001126118.1:.,TP53:NM_001276695.1:.,TP53:NM_001276696.1:.,TP53:NM_001276760.1:.,TP53:NM_001276761.1:.;Gene_MIM_id=191170;Phenotypes=Adrenal cortical carcinoma, 202300 (3), Autosomal recessive. {Basal cell carcinoma 7}, 614740 (3). Breast cancer, 114480 (3), Autosomal dominant. Choroid plexus papilloma, 260500 (3), Autosomal dominant. Colorectal cancer, 114500 (3), Autosomal dominant. {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation. Hepatocellular carcinoma, 114550 (3), Somatic mutation. Li-Fraumeni syndrome, 151623 (3), Autosomal dominant. Nasopharyngeal carcinoma, 607107 (3). Osteosarcoma, 259500 (3), Autosomal recessive. Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. 114480(MK),114500(MK),114550(MK),137800(SK),151623(MK),202300(MK),259500(MK),260350(MK),260500(MK),607107(MK),614740(SK);Possible_Inheritance=AD,AR;EntrezGeneID=7157;EnsemblGeneID=ENSG00000141510;Alias=TP53, P53, LFS1 , BCC7;FLKSEQ=GGGTTGGGGT.GGGGTGGTGG	GT:AD:DP:GQ:PL	0/1:146,178:324:99:4939,0,4612
chr17	12895186	.	TTTAC	T	3427.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.757;DP=254;ExcessHet=3.0103;FS=16.029;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.31;ReadPosRankSum=3.62;SOR=1.598;HGVSnom=NM_018127.7:c.*945_*948delGTAA;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs138282803;NativeFreq_Het=0.1188;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0040503|16S0013041][_];AF_2700_Het=0.2306;AF_2700_Hom=0.0173;AF_50_Het=0.2187;AF_50_Hom=0.0254;CytoBand=p12;repName=(CTTA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=9;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=acttacttac.ttacttactt	GT:AD:DP:GQ:PL	0/1:107,91:198:99:3465,0,4478
chr17	12895334	.	T	C	7392.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.544;DP=444;ExcessHet=3.0103;FS=1.132;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.73;ReadPosRankSum=0.173;SOR=0.807;HGVSnom=NM_018127.7:c.*801A>G;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs116931960;G1000_AF=0.0593051;G1000_EAS_AF=0.1597;G1000_EUR_AF=0.004;G1000_AFR_AF=0.0303;G1000_SAS_AF=0.091;G1000_AMR_AF=0.0043;NativeFreq_Het=0.2178;NativeFreq_Hom=0.0198;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0011;patientHetNum=3;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[15B0051578|16B0005515|16B0028133][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2344;AF_2700_Hom=0.0177;AF_50_Het=0.2219;AF_50_Hom=0.0254;DANN_score=0.5609;GREP_score=-3.0;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=CCTCTCAGTA.GGAAGCAACA	GT:AD:DP:GQ:PL	0/1:199,243:442:99:7421,0,5996
chr17	12895436	.	C	CTGAT	8042.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.028;DP=465;ExcessHet=3.0103;FS=14.704;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.11;ReadPosRankSum=-3.641;SOR=1.227;HGVSnom=NM_018127.7:c.*695_*698dupATCA;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs200938007;AF_2700_Het=0.2360;AF_2700_Hom=0.0169;AF_50_Het=0.2266;AF_50_Hom=0.0222;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=CAGGCTCTCA.tgattgattt	GT:AD:DP:GQ:PL	0/1:198,202:400:99:8080,0,14500
chr17	12895452	.	AT	A	7768.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.139;DP=430;ExcessHet=3.0103;FS=6.991;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.19;ReadPosRankSum=-1.244;SOR=1.091;HGVSnom=NM_018127.7:c.*682delA;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs66644127;G1000_AF=0.0433307;G1000_EAS_AF=0.1438;G1000_EUR_AF=0.004;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0685;G1000_AMR_AF=0.0014;NativeFreq_Het=0.1188;NativeFreq_Hom=.;AF_2700_Het=0.2337;AF_2700_Hom=0.0177;AF_50_Het=0.2219;AF_50_Hom=0.0254;CytoBand=p12;repName=(ATTG)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=8;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=gatttgattg.tgattgattg	GT:AD:DP:GQ:PL	0/1:218,209:427:99:7806,0,15026
chr17	12895669	.	C	A	6864.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-9.972;DP=323;ExcessHet=3.0103;FS=1.323;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=21.32;ReadPosRankSum=0.527;SOR=0.715;HGVSnom=NM_018127.7:c.*466G>T;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs2286341;G1000_AF=0.610623;G1000_EAS_AF=0.6825;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.4992;G1000_SAS_AF=0.6861;G1000_AMR_AF=0.6095;NativeFreq_Het=0.5841;NativeFreq_Hom=0.2970;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[15B6326226-1][_];normalHomSampleInfo=[16D0166662][_];patientHetSampleInfo=[15D0063534|16D1533010-1][_];patientHomSampleInfo=[16D0162375|16B0028133][_];AF_2700_Het=0.4408;AF_2700_Hom=0.4228;AF_50_Het=0.4437;AF_50_Hom=0.4057;DANN_score=0.6833;GREP_score=1.18;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=GCAGACCCTG.TCTGTAGCAG	GT:AD:DP:GQ:PL	0/1:149,173:322:99:6893,0,8649
chr17	12895674	.	TAGCAGCA	T	6777.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.203;DP=333;ExcessHet=3.0103;FS=2.926;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=20.41;ReadPosRankSum=0.855;SOR=0.7;HGVSnom=NM_018127.7:c.*454_*460delTGCTGCT;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs3217020;G1000_AF=0.610623;G1000_EAS_AF=0.6825;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.4992;G1000_SAS_AF=0.6861;G1000_AMR_AF=0.6095;NativeFreq_Het=0.1683;NativeFreq_Hom=.;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0014;patientHetNum=4;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[15B6326226-1][_];normalHomSampleInfo=[16D0166662][_];patientHetSampleInfo=[16D1533010-1|15D6722469-1|15D0063534|16B0033119][_];patientHomSampleInfo=[16B0028133][_];AF_2700_Het=0.4412;AF_2700_Hom=0.4228;AF_50_Het=0.4437;AF_50_Hom=0.4057;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=CCCTGCTCTG.GCAGGAGGAA	GT:AD:DP:GQ:PL	0/1:159,173:332:99:6815,0,8954
chr17	12895855	.	A	T	6452.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.975;DP=429;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.11;ReadPosRankSum=-1.077;SOR=0.705;HGVSnom=NM_018127.7:c.*280T>A;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs6949;CLNGENE=ELAC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.804513;G1000_EAS_AF=0.7173;G1000_EUR_AF=0.9274;G1000_AFR_AF=0.6573;G1000_SAS_AF=0.9335;G1000_AMR_AF=0.8516;NativeFreq_Het=0.5742;NativeFreq_Hom=0.3366;normalHetFrequency=0.0722;normalHetNum=28;normalHomFrequency=0.1108;normalHomNum=43;patientHetFrequency=0.0534;patientHetNum=148;patientHomFrequency=0.1288;patientHomNum=357;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4139;AF_2700_Hom=0.4727;AF_50_Het=0.4136;AF_50_Hom=0.4659;DANN_score=0.7199;GREP_score=0.695;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=TCTGTTTCCA.GACTTCTTTA	GT:AD:DP:GQ:PL	0/1:216,211:427:99:6481,0,6878
chr17	12896074	.	T	C	6069.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.66;DP=361;ExcessHet=3.0103;FS=1.247;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.86;ReadPosRankSum=1.95;SOR=0.771;HGVSnom=NM_018127.7:c.*61A>G;Gene=ELAC2;Transcript=NM_018127.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E24;IVSnom=.;AAlength=826;RS=rs13641;G1000_AF=0.0583067;G1000_EAS_AF=0.2173;G1000_EUR_AF=0.0219;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.0348;G1000_AMR_AF=0.0216;NativeFreq_Het=0.4554;NativeFreq_Hom=0.0495;normalHetFrequency=0.317;normalHetNum=123;normalHomFrequency=0.0438;normalHomNum=17;patientHetFrequency=0.2684;patientHetNum=744;patientHomFrequency=0.0426;patientHomNum=118;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3559;AF_2700_Hom=0.0765;AF_50_Het=0.3487;AF_50_Hom=0.0872;DANN_score=0.5092;GREP_score=-7.56;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=GGAGGGCAGA.ACGGGTGCGT	GT:AD:DP:GQ:PL	0/1:175,185:360:99:6098,0,5284
chr17	12898994	.	C	G	3142.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.258;DP=198;ExcessHet=3.0103;FS=3.994;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.87;ReadPosRankSum=-1.744;SOR=1.043;HGVSnom=NM_018127.7:c.1808+26G>C;Gene=ELAC2;Transcript=NM_018127.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_018127.7:IVS19+26G>C;AAlength=826;EXAC_AF=0.66393240;EXAC_Hom_EAS=994;EXAC_AC_EAS=3412;EXAC_AN_EAS=5318;EXAC_AC_Adj=53825;EXAC_AN_Adj=81070;ESP6500_MAF=0.62751884;RS=rs2286338;CLNGENE=ELAC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.591853;G1000_EAS_AF=0.5952;G1000_EUR_AF=0.673;G1000_AFR_AF=0.5567;G1000_SAS_AF=0.5542;G1000_AMR_AF=0.5893;gnomad_exomes_AF=0.62956430;gnomad_exomes_AF_EAS=0.59212678;gnomad_exomes_AC=135622;gnomad_exomes_Hom=42843;gnomad_exomes_Het=49936;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.58103369;gnomad_exomes_AF_NFE=0.66028935;gnomad_exomes_AF_AMR=0.56299517;gnomad_exomes_AF_SAS=0.57815051;NativeFreq_Het=0.4554;NativeFreq_Hom=0.3737;normalHetFrequency=0.4923;normalHetNum=191;normalHomFrequency=0.3402;normalHomNum=132;patientHetFrequency=0.4737;patientHetNum=1313;patientHomFrequency=0.3557;patientHomNum=986;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4573;AF_2700_Hom=0.3444;AF_50_Het=0.4945;AF_50_Hom=0.3281;DANN_score=0.5057;GREP_score=-0.669;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=AACAGCCCAG.GGGCCAGGCT	GT:AD:DP:GQ:PL	0/1:98,100:198:99:3171,0,3110
chr17	12903596	.	A	AG	4231.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.571;DP=248;ExcessHet=3.0103;FS=1.011;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.93;ReadPosRankSum=-0.539;SOR=0.598;HGVSnom=NM_018127.7:c.1305-6dupC;Gene=ELAC2;Transcript=NM_018127.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_018127.7:IVS14-6_-5insC;AAlength=826;EXAC_AF=0.01550407;EXAC_Hom_EAS=44;EXAC_AC_EAS=989;EXAC_AN_EAS=8586;EXAC_AC_Adj=1875;EXAC_AN_Adj=120936;RS=rs200410915;CLNGENE=ELAC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.00556720;gnomad_exomes_AF_EAS=0.04633979;gnomad_exomes_AC=1386;gnomad_exomes_Hom=125;gnomad_exomes_Het=1136;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00030819;gnomad_exomes_AF_AMR=0.00008679;gnomad_exomes_AF_SAS=0.01376209;NativeFreq_Het=0.0842;NativeFreq_Hom=.;normalHetFrequency=0.1521;normalHetNum=59;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.1374;patientHetNum=381;patientHomFrequency=0.0065;patientHomNum=18;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[17B0005675|16B0024619|15B0062912|16B3098053-1|16B3254599|15B0060462|15B0002679-1|16B0028040|16B0012073|16B3094001|17B0005450|16B0033058|15D0066993|16D0038237|16B0017197|16B3098047-1|16B0009506-1|16B0035743-1][_];AF_2700_Het=0.2022;AF_2700_Hom=0.0138;AF_50_Het=0.1965;AF_50_Hom=0.0143;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=GCATCCCTGC.GGAAGAGAGA	GT:AD:DP:GQ:PL	0/1:126,110:236:99:4269,0,8192
chr17	12903599	.	A	AGAG	4079.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.685;DP=249;ExcessHet=3.0103;FS=0.489;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.38;ReadPosRankSum=1.302;SOR=0.755;HGVSnom=NM_018127.7:c.1305-9_1305-8insCTC;Gene=ELAC2;Transcript=NM_018127.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_018127.7:IVS14-9_-8insCTC;AAlength=826;EXAC_AF=0.01587078;EXAC_Hom_EAS=45;EXAC_AC_EAS=1010;EXAC_AN_EAS=8472;EXAC_AC_Adj=1919;EXAC_AN_Adj=120914;ESP6500_MAF=0.00063908;RS=rs370493014;CLNGENE=ELAC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.034345;G1000_EAS_AF=0.1091;G1000_EUR_AF=0.004;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0593;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00586868;gnomad_exomes_AF_EAS=0.05097087;gnomad_exomes_AC=1449;gnomad_exomes_Hom=126;gnomad_exomes_Het=1197;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.00031708;gnomad_exomes_AF_AMR=0.00008681;gnomad_exomes_AF_SAS=0.01555130;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.1495;normalHetNum=58;normalHomFrequency=0.0155;normalHomNum=6;patientHetFrequency=0.1306;patientHetNum=362;patientHomFrequency=0.0094;patientHomNum=26;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[17B0005675|16B0000509|16B0024619|15B0062912|16B3098053-1|16B3254599|15B0060462|16B0017649|15B0002679-1|16B0000678|16B0028040|16B0012073|16B0230266|16B3094001|17B0005450|16B0033058|16D0172359|15D0066993|16D0038237|16B0017197|16B3098047-1|16B0009506-1|16B0047162|16B0035743-1|16B0051206|16B0047171][_];AF_2700_Het=0.2010;AF_2700_Hom=0.0138;AF_50_Het=0.1933;AF_50_Hom=0.0143;CytoBand=p12;CGD_CONDITION=Combined oxidative phosphorylation deficiency 17;CGD_INHERITANCE=AR;Strand=ELAC2:NM_018127.7:-,ELAC2:NM_001165962.1:-,ELAC2:NM_018127.6:-,ELAC2:NM_173717.1:-;NP=ELAC2:NM_018127.7:NP_060597.4,ELAC2:NM_001165962.1:NP_001159434.1,ELAC2:NM_018127.6:NP_060597.4,ELAC2:NM_173717.1:NP_776065.1;ENSP=ELAC2:NM_018127.7:ENST00000338034.9,ELAC2:NM_001165962.1:.,ELAC2:NM_018127.6:.,ELAC2:NM_173717.1:.;Gene_MIM_id=605367;Phenotypes=Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive. {Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3). 614731(SK),615440(MK);Possible_Inheritance=AR;EntrezGeneID=60528;EnsemblGeneID=ENSG00000006744;Alias=ELAC2, HPC2, COXPD17;FLKSEQ=TCCCTGCAGG.AGAGAGAGAA	GT:AD:DP:GQ:PL	0/1:136,113:249:99:4117,0,10416
chr17	13171091	.	A	ACG	1901.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.743;DP=418;ExcessHet=3.0103;FS=4.289;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.97;ReadPosRankSum=0.088;SOR=0.972;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs558594414;G1000_AF=0.256589;G1000_EAS_AF=0.5268;G1000_EUR_AF=0.2227;G1000_AFR_AF=0.0507;G1000_SAS_AF=0.2761;G1000_AMR_AF=0.2781;CytoBand=p12;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=22.5;FLKSEQ=ATGcacacac.cgcacacaca	GT:AD:DP:GQ:PL	0/1:177,96:273:99:1939,0,6340
chr17	13171093	.	G	GCGCACA	2900.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.745;DP=478;ExcessHet=3.0103;FS=5.262;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.82;ReadPosRankSum=0.065;SOR=0.591;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs377403582;CytoBand=p12;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=22.5;FLKSEQ=Gcacacacac.cacacacaca	GT:AD:DP:GQ:PL	0/1:168,100:268:99:2938,0,5879
chr17	13171095	.	A	G	42.77	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.504;DP=433;ExcessHet=3.0103;FS=1.416;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.14;ReadPosRankSum=1.283;SOR=0.837;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs10653707;DANN_score=0.1642;GREP_score=0.349;CytoBand=p12;repName=(CA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=22.5;FLKSEQ=acacacacgc.cacacacaca	GT:AD:DP:GQ:PL	0/1:275,35:310:71:71,0,9259
chr17	15359877	.	TAC	T	5204.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.473;DP=592;ExcessHet=3.0103;FS=9.677;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.18;ReadPosRankSum=0.711;SOR=0.762;HGVSnom=NM_001204477.2:c.-129-3480_-129-3479delGT|NM_001204478.2:c.463-16280_463-16279delGT;Gene=CDRT4|TVP23C-CDRT4;Transcript=NM_001204477.2|NM_001204478.2;VarType=Intron|Intron;MolecularConsequence=5_prime_UTR_intron_variant|coding_transcript_intron_variant;ExonIntron=I1|I5;IVSnom=NM_001204477.2:IVS1-3480_-3479delGT|NM_001204478.2:IVS5-16280_-16279delGT;AAlength=152|164;RS=rs3029212;CytoBand=p12;Strand=CDRT4:NM_001204477.1:-,TVP23C-CDRT4:NM_001204478.1:-;NP=CDRT4:NM_001204477.1:NP_001191406.1,TVP23C-CDRT4:NM_001204478.1:NP_001191407.1;ENSP=CDRT4:NM_001204477.1:.,TVP23C-CDRT4:NM_001204478.1:.;FLKSEQ=AATCTTCCTT.acacacacac	GT:AD:DP:GQ:PL	0/1:154,241:395:99:5242,0,3368
chr17	17115566	.	A	G	3440.77	PASS	AC=2;AF=1;AN=2;DP=98;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.33;SOR=1.609;HGVSnom=NM_144997.7:c.*1403T>C;Gene=FLCN;Transcript=NM_144997.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=579;RS=rs7218795;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.713059;G1000_EAS_AF=0.7619;G1000_EUR_AF=0.7664;G1000_AFR_AF=0.6536;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.7637;NativeFreq_Het=0.4257;NativeFreq_Hom=0.4851;normalHetFrequency=0.2162;normalHetNum=187;normalHomFrequency=0.2855;normalHomNum=247;patientHetFrequency=0.1851;patientHetNum=966;patientHomFrequency=0.2464;patientHomNum=1286;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4039;AF_2700_Hom=0.5150;AF_50_Het=0.4025;AF_50_Hom=0.5293;DANN_score=0.7221;GREP_score=1.53;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-;NP=FLCN:NM_144997.5:NP_659434.2;ENSP=FLCN:NM_144997.5:ENST00000285071.8;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=ATGTTGTTGC.TTATACAGAT	GT:AD:DP:GQ:PL	1/1:0,97:97:99:3469,291,0
chr17	17116412	.	A	G	12771.8	PASS	AC=2;AF=1;AN=2;DP=333;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.4;SOR=0.755;HGVSnom=NM_144997.7:c.*557T>C;Gene=FLCN;Transcript=NM_144997.7;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=579;RS=rs3803761;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.710663;G1000_EAS_AF=0.7619;G1000_EUR_AF=0.7624;G1000_AFR_AF=0.6513;G1000_SAS_AF=0.6524;G1000_AMR_AF=0.7565;HGMD_gene=FLCN;HGMD_disease=Birt-Hogg-Dubé_syndrome;HGMD_tag=R;HGMD_pmid=28222720;NativeFreq_Het=0.4257;NativeFreq_Hom=0.4851;normalHetFrequency=0.3962;normalHetNum=189;normalHomFrequency=0.2879;normalHomNum=249;patientHetFrequency=0.1851;patientHetNum=966;patientHomFrequency=0.2473;patientHomNum=1291;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4012;AF_2700_Hom=0.5169;AF_50_Het=0.3978;AF_50_Hom=0.5325;DANN_score=0.5151;GREP_score=1.26;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-;NP=FLCN:NM_144997.5:NP_659434.2;ENSP=FLCN:NM_144997.5:ENST00000285071.8;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=CAGAGGACCA.AAGATGAGGA	GT:AD:DP:GQ:PL	1/1:0,330:330:99:12800,992,0
chr17	17120426	.	C	T	5481.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-8.233;DP=369;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.94;ReadPosRankSum=0.741;SOR=0.707;HGVSnom=NM_144997.7:c.1133G>A(p.Ser378Asn/p.S378N);Gene=FLCN;Transcript=NM_144997.7;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E10;IVSnom=.;AAlength=579;EXAC_AF=0.00001667;EXAC_Hom_EAS=0;EXAC_AC_EAS=2;EXAC_AN_EAS=8598;EXAC_AC_Adj=2;EXAC_AN_Adj=119974;RS=rs769489773;Ensembl_transcriptid=ENST00000285071;SIFT_pred=D;SIFT_score=0.025;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.031;MutationTaster_pred=D;MutationTaster_score=0.995658;CLNGENE=FLCN;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.00001593;gnomad_exomes_AF_EAS=0.00021763;gnomad_exomes_AC=4;gnomad_exomes_Hom=0;gnomad_exomes_Het=4;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0004;patientHetNum=1;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[15B6128907][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0008;AF_2700_Hom=0.0000;AF_50_Het=0.0016;AF_50_Hom=0.0000;DANN_score=0.9966;GREP_score=6.06;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-;NP=FLCN:NM_144997.5:NP_659434.2;ENSP=FLCN:NM_144997.5:ENST00000285071.8;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=CACGTCTCTG.TTTTCCAGAT	GT:AD:DP:GQ:PL	0/1:179,188:367:99:5510,0,5839
chr17	17122286	.	C	T	8846.77	PASS	AC=2;AF=1;AN=2;DP=247;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.5;SOR=0.849;HGVSnom=NM_144997.7:c.1062+47G>A;Gene=FLCN;Transcript=NM_144997.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_144997.7:IVS9+47G>A;AAlength=579;EXAC_AF=0.99373899;EXAC_Hom_EAS=4017;EXAC_AC_EAS=8035;EXAC_AN_EAS=8036;EXAC_AC_Adj=113960;EXAC_AN_Adj=114678;ESP6500_MAF=0.99830821;RS=rs8065572;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=no_assertion_criteria_provided;G1000_AF=0.995807;G1000_EAS_AF=1.0;G1000_EUR_AF=0.997;G1000_AFR_AF=1.0;G1000_SAS_AF=0.998;G1000_AMR_AF=0.9769;gnomad_exomes_AF=0.99151856;gnomad_exomes_AF_EAS=0.99988911;gnomad_exomes_AC=239888;gnomad_exomes_Hom=118964;gnomad_exomes_Het=1960;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.99948947;gnomad_exomes_AF_NFE=0.99795158;gnomad_exomes_AF_AMR=0.95050985;gnomad_exomes_AF_SAS=0.99763531;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.9908;normalHomNum=857;patientHetFrequency=0.0046;patientHetNum=24;patientHomFrequency=0.9864;patientHomNum=5149;normalHetSampleInfo=[16D0166662][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1536923-1|16D1545653|16D0168615|15D6482365|16D1546319|16D1536929|16D1545873|16B0202492|16D1546140|16D1536898|16D1545695|16D0166704|16D0177737|15D6722481-1|16D1533074|16D0155896|16D1536870|16D1536924-1|16B0000728|16D1545990][16D1545698|15D6522047|15D6522639|15D6482439];patientHomSampleInfo=[_][_];DANN_score=0.4303;GREP_score=-2.93;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-;NP=FLCN:NM_144997.5:NP_659434.2;ENSP=FLCN:NM_144997.5:ENST00000285071.8;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=CAGCCCATGA.TGGCTCTCCT	GT:AD:DP:GQ:PL	1/1:0,246:246:99:8875,739,0
chr17	17122327	.	G	A	7793.77	PASS	AC=2;AF=1;AN=2;DP=236;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.59;SOR=1.404;HGVSnom=NM_144997.7:c.1062+6C>T;Gene=FLCN;Transcript=NM_144997.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I9;IVSnom=NM_144997.7:IVS9+6C>T;AAlength=579;EXAC_AF=0.50234210;EXAC_Hom_EAS=1813;EXAC_AC_EAS=5612;EXAC_AN_EAS=8572;EXAC_AC_Adj=60270;EXAC_AN_Adj=119978;ESP6500_MAF=0.44910042;RS=rs8065832;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.502995;G1000_EAS_AF=0.6974;G1000_EUR_AF=0.495;G1000_AFR_AF=0.3714;G1000_SAS_AF=0.4652;G1000_AMR_AF=0.536;gnomad_exomes_AF=0.50555489;gnomad_exomes_AF_EAS=0.65530592;gnomad_exomes_AC=126232;gnomad_exomes_Hom=32922;gnomad_exomes_Het=60388;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.36058168;gnomad_exomes_AF_NFE=0.48750710;gnomad_exomes_AF_AMR=0.56391108;gnomad_exomes_AF_SAS=0.42211187;HGMD_gene=FLCN;HGMD_disease=Colorectal_cancer_reduced_risk_association;HGMD_tag=DP;HGMD_pmid=14627671;NativeFreq_Het=0.4455;NativeFreq_Hom=0.4356;normalHetFrequency=0.4416;normalHetNum=382;normalHomFrequency=0.3434;normalHomNum=297;patientHetFrequency=0.4404;patientHetNum=2299;patientHomFrequency=0.358;patientHomNum=1869;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4500;AF_2700_Hom=0.4377;AF_50_Het=0.4453;AF_50_Hom=0.4485;dbscSNV_RF_score=0.002;dbscSNV_ADA_score=0.00001352;DANN_score=0.5256;GREP_score=-4.79;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-;NP=FLCN:NM_144997.5:NP_659434.2;ENSP=FLCN:NM_144997.5:ENST00000285071.8;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=TGCCCCTGCC.CCTACCTGCC	GT:AD:DP:GQ:PL	1/1:0,232:232:99:7822,687,0
chr17	17127471	.	G	A	11363.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.99;DP=316;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.69;ReadPosRankSum=-1.292;SOR=0.323;HGVSnom=NM_144997.7:c.397-14C>T;Gene=FLCN;Transcript=NM_144997.7;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_144997.7:IVS5-14C>T;AAlength=579;EXAC_AF=0.48407582;EXAC_Hom_EAS=644;EXAC_AC_EAS=1998;EXAC_AN_EAS=2912;EXAC_AC_Adj=20124;EXAC_AN_Adj=41572;ESP6500_MAF=0.37380659;RS=rs1736219;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.405152;G1000_EAS_AF=0.6954;G1000_EUR_AF=0.492;G1000_AFR_AF=0.0961;G1000_SAS_AF=0.3548;G1000_AMR_AF=0.5173;gnomad_exomes_AF=0.48211216;gnomad_exomes_AF_EAS=0.65816555;gnomad_exomes_AC=84710;gnomad_exomes_Hom=21671;gnomad_exomes_Het=41368;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14891612;gnomad_exomes_AF_NFE=0.48733139;gnomad_exomes_AF_AMR=0.54768610;gnomad_exomes_AF_SAS=0.35213897;NativeFreq_Het=0.4554;NativeFreq_Hom=0.4257;normalHetFrequency=0.4324;normalHetNum=374;normalHomFrequency=0.348;normalHomNum=301;patientHetFrequency=0.4402;patientHetNum=2298;patientHomFrequency=0.3552;patientHomNum=1854;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4500;AF_2700_Hom=0.4389;AF_50_Het=0.4453;AF_50_Hom=0.4485;DANN_score=0.5655;GREP_score=-4.69;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-,FLCN:NM_144606.5:-;NP=FLCN:NM_144997.5:NP_659434.2,FLCN:NM_144606.5:NP_653207.1;ENSP=FLCN:NM_144997.5:ENST00000285071.8,FLCN:NM_144606.5:.;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=GAGGGACACC.GCGACTCAGA	GT:AD:DP:GQ:PL	1/1:1,313:314:99:11392,910,0
chr17	17140297	.	G	A	4484.77	PASS	AC=2;AF=1;AN=2;DP=144;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.36;SOR=0.735;HGVSnom=NM_144997.7:c.-299C>T;Gene=FLCN;Transcript=NM_144997.7;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=579;RS=rs1708629;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.428315;G1000_EAS_AF=0.6548;G1000_EUR_AF=0.5775;G1000_AFR_AF=0.0855;G1000_SAS_AF=0.4039;G1000_AMR_AF=0.5706;NativeFreq_Het=0.4554;NativeFreq_Hom=0.3960;normalHetFrequency=0.3962;normalHetNum=189;normalHomFrequency=0.3711;normalHomNum=177;patientHetFrequency=0.1994;patientHetNum=1041;patientHomFrequency=0.1667;patientHomNum=870;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4473;AF_2700_Hom=0.4151;AF_50_Het=0.4406;AF_50_Hom=0.4216;DANN_score=0.9407;GREP_score=-3.58;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-,FLCN:NM_144606.5:-;NP=FLCN:NM_144997.5:NP_659434.2,FLCN:NM_144606.5:NP_653207.1;ENSP=FLCN:NM_144997.5:ENST00000285071.8,FLCN:NM_144606.5:.;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=TCCCAGCCCC.CCCCTGACTG	GT:AD:DP:GQ:PL	1/1:0,143:143:99:4513,423,0
chr17	17140485	.	C	G	5548.77	PASS	AC=2;AF=1;AN=2;DP=147;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.21;SOR=0.915;HGVSnom=.;Gene=FLCN;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs1736209;CLNGENE=FLCN;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.743211;G1000_EAS_AF=0.8482;G1000_EUR_AF=0.7873;G1000_AFR_AF=0.618;G1000_SAS_AF=0.7382;G1000_AMR_AF=0.7723;NativeFreq_Het=0.2178;NativeFreq_Hom=0.7722;normalHetFrequency=0.2348;normalHetNum=112;normalHomFrequency=0.3676;normalHomNum=318;patientHetFrequency=0.2312;patientHetNum=566;patientHomFrequency=0.317;patientHomNum=1655;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2152;AF_2700_Hom=0.7636;AF_50_Het=0.2171;AF_50_Hom=0.7639;DANN_score=0.6733;GREP_score=-2.18;CytoBand=p11.2;CGD_CONDITION=Birt-Hogg-Dube syndrome. Pneumothorax, primary spontaneous ;CGD_INHERITANCE=AD;Strand=FLCN:NM_144997.5:-,FLCN:NM_144606.5:-;NP=FLCN:NM_144997.5:NP_659434.2,FLCN:NM_144606.5:NP_653207.1;ENSP=FLCN:NM_144997.5:ENST00000285071.8,FLCN:NM_144606.5:.;Gene_MIM_id=607273;Phenotypes=Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominant. Colorectal cancer, somatic, 114500 (3). Pneumothorax, primary spontaneous, 173600 (3), Autosomal dominant. Renal carcinoma, chromophobe, somatic, 144700 (3). 114500(MK),135150(MK),144700(MK),173600(MK);Possible_Inheritance=AD;EntrezGeneID=201163;EnsemblGeneID=ENSG00000154803;Alias=FLCN, BHD;FLKSEQ=GCCCCGCCGA.ACCCAGGCGC	GT:AD:DP:GQ:PL	1/1:0,147:147:99:5577,441,0
chr17	29486152	.	G	A	11920.8	PASS	AC=2;AF=1;AN=2;DP=325;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.06;SOR=1.01;HGVSnom=NM_001042492.3:c.288+41G>A;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001042492.3:IVS3+41G>A;AAlength=2839;EXAC_AF=0.62299758;EXAC_Hom_EAS=1322;EXAC_AC_EAS=4721;EXAC_AN_EAS=8448;EXAC_AC_Adj=74047;EXAC_AN_Adj=118856;ESP6500_MAF=0.57414244;RS=rs2952976;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.509784;G1000_EAS_AF=0.5486;G1000_EUR_AF=0.7157;G1000_AFR_AF=0.23;G1000_SAS_AF=0.6227;G1000_AMR_AF=0.5288;gnomad_exomes_AF=0.62615929;gnomad_exomes_AF_EAS=0.56117518;gnomad_exomes_AC=155285;gnomad_exomes_Hom=50315;gnomad_exomes_Het=54655;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29058116;gnomad_exomes_AF_NFE=0.69779619;gnomad_exomes_AF_AMR=0.50723961;gnomad_exomes_AF_SAS=0.63022097;NativeFreq_Het=0.5401;NativeFreq_Hom=0.3382;normalHetFrequency=0.4543;normalHetNum=393;normalHomFrequency=0.3757;normalHomNum=325;patientHetFrequency=0.4398;patientHetNum=2296;patientHomFrequency=0.3795;patientHomNum=1981;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5175;GREP_score=0.872;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TTGTGAATTT.ATCTTGAGAA	GT:AD:DP:GQ:PL	1/1:0,323:323:99:11949,970,0
chr17	29496819	.	C	T	6639.77	StandardFilter	AC=2;AF=1;AN=2;DP=174;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.51;SOR=7.054;HGVSnom=NM_001042492.3:c.480-90C>T;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_001042492.3:IVS4-90C>T;AAlength=2839;RS=rs2905807;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.488419;G1000_EAS_AF=0.5506;G1000_EUR_AF=0.7157;G1000_AFR_AF=0.152;G1000_SAS_AF=0.6217;G1000_AMR_AF=0.5216;NativeFreq_Het=0.5401;NativeFreq_Hom=0.3382;normalHetFrequency=0.452;normalHetNum=391;normalHomFrequency=0.3792;normalHomNum=328;patientHetFrequency=0.4435;patientHetNum=2315;patientHomFrequency=0.381;patientHomNum=1989;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.5508;GREP_score=0.199;CytoBand=q11.2;repName=AluJo;repClass=SINE;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=ctgccttggc.tcctgaagtg	GT:AD:DP:GQ:PL	1/1:0,173:173:99:6668,520,0
chr17	29508775	.	G	A	19570.8	PASS	AC=2;AF=1;AN=2;DP=542;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.82;SOR=0.697;HGVSnom=NM_001042492.3:c.702G>A(p.Leu234Leu/p.L234L);Gene=NF1;Transcript=NM_001042492.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=2839;EXAC_AF=0.62280210;EXAC_Hom_EAS=1363;EXAC_AC_EAS=4815;EXAC_AN_EAS=8650;EXAC_AC_Adj=75516;EXAC_AN_Adj=121252;ESP6500_MAF=0.57439606;RS=rs1801052;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.511781;G1000_EAS_AF=0.5506;G1000_EUR_AF=0.7157;G1000_AFR_AF=0.2307;G1000_SAS_AF=0.6299;G1000_AMR_AF=0.5288;gnomad_exomes_AF=0.62719221;gnomad_exomes_AF_EAS=0.56080052;gnomad_exomes_AC=157498;gnomad_exomes_Hom=51250;gnomad_exomes_Het=54998;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29022101;gnomad_exomes_AF_NFE=0.69831305;gnomad_exomes_AF_AMR=0.50721154;gnomad_exomes_AF_SAS=0.63473739;HGMD_gene=NF1;HGMD_disease=Neurofibromatosis_1;HGMD_tag=R;HGMD_pmid=29680440;NativeFreq_Het=0.5401;NativeFreq_Hom=0.3382;normalHetFrequency=0.4555;normalHetNum=394;normalHomFrequency=0.3769;normalHomNum=326;patientHetFrequency=0.4418;patientHetNum=2306;patientHomFrequency=0.3807;patientHomNum=1987;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4885;AF_2700_Hom=0.3171;AF_50_Het=0.4643;AF_50_Hom=0.3455;DANN_score=0.6492;GREP_score=-11.8;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TTACAAAACT.TACCAGATCC	GT:AD:DP:GQ:PL	1/1:0,541:541:99:19599,1626,0
chr17	29508819	.	A	AT	4433.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.374;DP=555;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.39;ReadPosRankSum=0.29;SOR=0.707;HGVSnom=NM_001042492.3:c.730+32dupT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_001042492.3:IVS7+32_+33insT;AAlength=2839;EXAC_AF=0.31078880;EXAC_Hom_EAS=6;EXAC_AC_EAS=1497;EXAC_AN_EAS=5236;EXAC_AC_Adj=23656;EXAC_AN_Adj=76116;RS=rs71142032;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;NativeFreq_Het=0.3035;NativeFreq_Hom=.;normalHetFrequency=0.7295;normalHetNum=631;normalHomFrequency=0.0636;normalHomNum=55;patientHetFrequency=0.7186;patientHetNum=3751;patientHomFrequency=0.0588;patientHomNum=307;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.7690;AF_2700_Hom=0.0219;AF_50_Het=0.7750;AF_50_Hom=0.0174;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=GATACGATTG.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:178,294:472:99:4471,0,2028
chr17	29541437	.	T	C	13962.8	PASS	AC=2;AF=1;AN=2;DP=390;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=54.88;QD=29.58;SOR=1.775;HGVSnom=NM_001042492.3:c.1393-32T>C;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_001042492.3:IVS12-32T>C;AAlength=2839;EXAC_AF=0.61501852;EXAC_Hom_EAS=1292;EXAC_AC_EAS=4621;EXAC_AN_EAS=8298;EXAC_AC_Adj=71074;EXAC_AN_Adj=115564;ESP6500_MAF=0.56384892;RS=rs2905876;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.474042;G1000_EAS_AF=0.5516;G1000_EUR_AF=0.7167;G1000_AFR_AF=0.093;G1000_SAS_AF=0.6258;G1000_AMR_AF=0.5216;gnomad_exomes_AF=0.61969784;gnomad_exomes_AF_EAS=0.55937710;gnomad_exomes_AC=149631;gnomad_exomes_Hom=48749;gnomad_exomes_Het=52133;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.17115148;gnomad_exomes_AF_NFE=0.69725400;gnomad_exomes_AF_AMR=0.50156316;gnomad_exomes_AF_SAS=0.63331070;HGMD_gene=NF1;HGMD_disease=Neurofibromatosis_1;HGMD_tag=R;HGMD_pmid=22155606;NativeFreq_Het=0.4790;NativeFreq_Hom=0.3366;normalHetFrequency=0.3746;normalHetNum=324;normalHomFrequency=0.3919;normalHomNum=339;patientHetFrequency=0.3665;patientHetNum=1913;patientHomFrequency=0.3826;patientHomNum=1997;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7087;GREP_score=1.81;CytoBand=q11.2;dupName=chr22:16343454,chr14:20075572,chr14:19486559,chr2:131946613;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=CTGAGTCTTA.GTCTGATACC	GT:AD:DP:GQ:PL	1/1:0,390:390:99:13991,1172,0
chr17	29545987	.	A	AT	4271.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.911;DP=161;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=29.26;ReadPosRankSum=1.638;SOR=1.049;HGVSnom=NM_001042492.3:c.1528-29dupT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_001042492.3:IVS13-29_-28insT;AAlength=2839;EXAC_AF=0.65851560;EXAC_Hom_EAS=616;EXAC_AC_EAS=2258;EXAC_AN_EAS=3678;EXAC_AC_Adj=36732;EXAC_AN_Adj=55780;ESP6500_MAF=0.57959282;RS=rs398119783;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.51877;G1000_EAS_AF=0.5516;G1000_EUR_AF=0.7187;G1000_AFR_AF=0.2572;G1000_SAS_AF=0.6227;G1000_AMR_AF=0.5331;gnomad_exomes_AF=0.62568017;gnomad_exomes_AF_EAS=0.56014572;gnomad_exomes_AC=120735;gnomad_exomes_Hom=38909;gnomad_exomes_Het=42917;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.31589840;gnomad_exomes_AF_NFE=0.69433358;gnomad_exomes_AF_AMR=0.50911996;gnomad_exomes_AF_SAS=0.62803172;NativeFreq_Het=0.4093;NativeFreq_Hom=.;normalHetFrequency=0.4555;normalHetNum=394;normalHomFrequency=0.3838;normalHomNum=332;patientHetFrequency=0.446;patientHetNum=2328;patientHomFrequency=0.3851;patientHomNum=2010;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.2;dupName=chr22:16343454,chr14:20075572,chr14:19486559,chr2:131946613;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=CGATTTATTT.TTTTTTTAAT	GT:AD:DP:GQ:PL	1/1:3,143:146:99:4309,361,0
chr17	29546175	.	T	C	10764.8	PASS	AC=2;AF=1;AN=2;DP=289;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.14;SOR=1.071;HGVSnom=NM_001042492.3:c.1641+39T>C;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_001042492.3:IVS14+39T>C;AAlength=2839;EXAC_AF=0.63396467;EXAC_Hom_EAS=1079;EXAC_AC_EAS=3895;EXAC_AN_EAS=6678;EXAC_AC_Adj=56769;EXAC_AN_Adj=89546;ESP6500_MAF=0.53598339;RS=rs2905880;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.473442;G1000_EAS_AF=0.5516;G1000_EUR_AF=0.7167;G1000_AFR_AF=0.093;G1000_SAS_AF=0.6227;G1000_AMR_AF=0.5216;gnomad_exomes_AF=0.62059421;gnomad_exomes_AF_EAS=0.56418800;gnomad_exomes_AC=138781;gnomad_exomes_Hom=44945;gnomad_exomes_Het=48891;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.18026065;gnomad_exomes_AF_NFE=0.70009267;gnomad_exomes_AF_AMR=0.50596496;gnomad_exomes_AF_SAS=0.63125759;NativeFreq_Het=0.5370;NativeFreq_Hom=0.3366;normalHetFrequency=0.4532;normalHetNum=392;normalHomFrequency=0.3803;normalHomNum=329;patientHetFrequency=0.4458;patientHetNum=2327;patientHomFrequency=0.3797;patientHomNum=1982;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.694;GREP_score=-5.47;CytoBand=q11.2;dupName=chr22:16343454,chr14:20075572,chr14:19486559,chr2:131946613;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_001128147.2:+,NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_001128147.2:NP_001121619.1,NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_001128147.2:.,NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=GAAGGAAAGA.TGTAACTATG	GT:AD:DP:GQ:PL	1/1:0,289:289:99:10793,868,0
chr17	29559061	.	AT	A	988.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.575;DP=266;ExcessHet=3.0103;FS=1.836;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=-1.083;QD=4.26;ReadPosRankSum=-0.256;SOR=1.002;OLD_VARIANT=chr17|29559061|AT|A,ATT|1;HGVSnom=NM_001042492.3:c.3198-4delT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I24;IVSnom=NM_001042492.3:IVS24-4delT;AAlength=2839;RS=rs371047262;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.02937919;gnomad_exomes_AF_EAS=0.03100597;gnomad_exomes_AC=1910;gnomad_exomes_Hom=0;gnomad_exomes_Het=1910;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.05117884;gnomad_exomes_AF_NFE=0.02682891;gnomad_exomes_AF_AMR=0.06174863;gnomad_exomes_AF_SAS=0.02518780;normalHetFrequency=0.0052;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0048;patientHetNum=25;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[16B1586188|16B3108946][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B0018063|17B0001587-1|16B0200523|16B1586237|16D0166272|16B0228544|16D0168746|16B0047169|16D0172117|16D1545745|16B0005295|16D0168613|16D0172282|16B0047181|16D1532950-1|16B3258455|16B3094921|16D0172366|15D6722337-1|16B0200547|16B0011398|16B0202558|16B0099128][15D6129466|16D1546156];patientHomSampleInfo=[16D1546269][_];AF_2700_Het=0.0407;AF_2700_Hom=.;AF_50_Het=0.0475;AF_50_Hom=.;CytoBand=q11.2;dupName=chr15:22142612,chr15:21131435;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TGGTCTCTAA.tttttttttt	GT:AD:DP:GQ:PL	1/0:54,73:232:99:1026,577,1977
chr17	29559061	.	A	AT	988.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.575;DP=266;ExcessHet=3.0103;FS=1.836;MLEAC=1;MLEAF=0.5;MQ=59.94;MQRankSum=-1.083;QD=4.26;ReadPosRankSum=-0.256;SOR=1.002;OLD_VARIANT=chr17|29559061|AT|A,ATT|2;HGVSnom=NM_001042492.3:c.3198-4dupT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I24;IVSnom=NM_001042492.3:IVS24-4_-3insT;AAlength=2839;EXAC_AF=0.00517209;EXAC_Hom_EAS=1;EXAC_AC_EAS=3;EXAC_AN_EAS=320;EXAC_AC_Adj=55;EXAC_AN_Adj=10634;ESP6500_MAF=0.04292692;RS=rs371047262;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.10893374;gnomad_exomes_AF_EAS=0.24023886;gnomad_exomes_AC=7082;gnomad_exomes_Hom=769;gnomad_exomes_Het=5544;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14088557;gnomad_exomes_AF_NFE=0.09235692;gnomad_exomes_AF_AMR=0.21174863;gnomad_exomes_AF_SAS=0.09798939;NativeFreq_Het=0.0199;NativeFreq_Hom=.;normalHetFrequency=0.0532;normalHetNum=46;normalHomFrequency=0.015;normalHomNum=13;patientHetFrequency=0.049;patientHetNum=256;patientHomFrequency=0.0203;patientHomNum=106;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=.;AF_2700_Hom=0.0646;AF_50_Het=0.3994;AF_50_Hom=.;CytoBand=q11.2;dupName=chr15:22142612,chr15:21131435;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TGGTCTCTAA.tttttttttt	GT:AD:DP:GQ:PL	0/1:54,105:232:99:1026,132,1166
chr17	29563075	.	G	GT	949.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.023;DP=445;ExcessHet=3.0103;FS=3.617;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.33;ReadPosRankSum=0.076;SOR=0.507;HGVSnom=NM_001042492.3:c.3974+49dupT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I29;IVSnom=NM_001042492.3:IVS29+49_+50insT;AAlength=2839;EXAC_AF=0.09283462;EXAC_Hom_EAS=0;EXAC_AC_EAS=424;EXAC_AN_EAS=5334;EXAC_AC_Adj=7359;EXAC_AN_Adj=79270;RS=rs59745739;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=no_assertion_criteria_provided;G1000_AF=0.00998403;G1000_EAS_AF=0.0169;G1000_EUR_AF=0.0099;G1000_AFR_AF=0.0015;G1000_SAS_AF=0.0123;G1000_AMR_AF=0.013;gnomad_exomes_AF=0.15989287;gnomad_exomes_AF_EAS=0.16902335;gnomad_exomes_AC=13612;gnomad_exomes_Hom=0;gnomad_exomes_Het=13612;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.06012177;gnomad_exomes_AF_NFE=0.15528513;gnomad_exomes_AF_AMR=0.18340391;gnomad_exomes_AF_SAS=0.20048258;NativeFreq_Het=0.0033;NativeFreq_Hom=.;normalHetFrequency=0.0717;normalHetNum=62;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0625;patientHetNum=326;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q11.2;dupName=chr15:22142612,chr15:21131435;dupScore=0;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=GCTGTTTTTT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:315,93:408:99:987,0,6154
chr17	29653293	.	T	C	12753.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.758;DP=325;ExcessHet=3.0103;FS=3.274;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.04;ReadPosRankSum=0.038;SOR=0.426;HGVSnom=NM_001042492.3:c.5268+23T>C;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I37;IVSnom=NM_001042492.3:IVS37+23T>C;AAlength=2839;EXAC_AF=0.60005088;EXAC_Hom_EAS=833;EXAC_AC_EAS=3707;EXAC_AN_EAS=8342;EXAC_AC_Adj=70758;EXAC_AN_Adj=117920;ESP6500_MAF=0.67668768;RS=rs9894648;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.605831;G1000_EAS_AF=0.4494;G1000_EUR_AF=0.6392;G1000_AFR_AF=0.764;G1000_SAS_AF=0.6186;G1000_AMR_AF=0.4654;gnomad_exomes_AF=0.59118948;gnomad_exomes_AF_EAS=0.44075751;gnomad_exomes_AC=140307;gnomad_exomes_Hom=42754;gnomad_exomes_Het=54799;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.75264770;gnomad_exomes_AF_NFE=0.62528227;gnomad_exomes_AF_AMR=0.41263097;gnomad_exomes_AF_SAS=0.62467183;NativeFreq_Het=0.5000;NativeFreq_Hom=0.2673;normalHetFrequency=0.4428;normalHetNum=383;normalHomFrequency=0.3017;normalHomNum=261;patientHetFrequency=0.4594;patientHetNum=2398;patientHomFrequency=0.2722;patientHomNum=1421;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5000;AF_2700_Hom=0.1922;AF_50_Het=0.5024;AF_50_Hom=0.2155;DANN_score=0.4119;GREP_score=0.263;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=CTGTGTTTTG.AAACGATTCA	GT:AD:DP:GQ:PL	1/1:1,322:323:99:12782,962,0
chr17	29654876	.	T	A	10023.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.694;DP=293;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.33;ReadPosRankSum=-0.202;SOR=1.318;HGVSnom=NM_001042492.3:c.5609+19T>A;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I38;IVSnom=NM_001042492.3:IVS38+19T>A;AAlength=2839;EXAC_AF=0.53637877;EXAC_Hom_EAS=531;EXAC_AC_EAS=2996;EXAC_AN_EAS=8480;EXAC_AC_Adj=64462;EXAC_AN_Adj=120180;ESP6500_MAF=0.51622328;RS=rs2285894;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.431909;G1000_EAS_AF=0.371;G1000_EUR_AF=0.6163;G1000_AFR_AF=0.2481;G1000_SAS_AF=0.5665;G1000_AMR_AF=0.4135;gnomad_exomes_AF=0.53514849;gnomad_exomes_AF_EAS=0.35567067;gnomad_exomes_AC=133633;gnomad_exomes_Hom=37686;gnomad_exomes_Het=58261;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28482277;gnomad_exomes_AF_NFE=0.61072108;gnomad_exomes_AF_AMR=0.37708720;gnomad_exomes_AF_SAS=0.57214337;HGMD_gene=NF1;HGMD_disease=Neurofibromatosis_1;HGMD_tag=R;HGMD_pmid=22155606;NativeFreq_Het=0.4417;NativeFreq_Hom=0.1881;normalHetFrequency=0.4416;normalHetNum=382;normalHomFrequency=0.2139;normalHomNum=185;patientHetFrequency=0.4397;patientHetNum=2295;patientHomFrequency=0.1973;patientHomNum=1030;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4573;AF_2700_Hom=0.1145;AF_50_Het=0.4754;AF_50_Hom=0.1252;DANN_score=0.5736;GREP_score=-6.12;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TTTAAAATTC.CTTCAGTTTG	GT:AD:DP:GQ:PL	1/1:1,291:292:99:10052,852,0
chr17	29663614	.	GT	G	831.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.001;DP=475;ExcessHet=3.0103;FS=0.468;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=2.01;ReadPosRankSum=-0.147;SOR=0.75;HGVSnom=NM_001042492.3:c.6148-28delT;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I41;IVSnom=NM_001042492.3:IVS41-28delT;AAlength=2839;EXAC_AF=0.07954316;EXAC_Hom_EAS=0;EXAC_AC_EAS=83;EXAC_AN_EAS=1482;EXAC_AC_Adj=2368;EXAC_AN_Adj=29770;RS=rs398100472;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.06957212;gnomad_exomes_AF_EAS=0.03076659;gnomad_exomes_AC=5343;gnomad_exomes_Hom=13;gnomad_exomes_Het=5317;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.01128122;gnomad_exomes_AF_NFE=0.08205307;gnomad_exomes_AF_AMR=0.03949661;gnomad_exomes_AF_SAS=0.07590167;NativeFreq_Het=0.0029;NativeFreq_Hom=.;normalHetFrequency=0.0042;normalHetNum=2;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0061;patientHetNum=32;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][16B0001889-1|15B0048208];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B3094794|15B0062526-1|16B0200424-1|16D0168742|16B0200254|15B0588166|15D6524810|16D0159560|17B0005475|16B1175098|16D0166399|15D6532884|15B0067677-1][16B0033970|15B6214962|16B0005517|16B0017265|16B0009513-1|15B6104365|15B0002463|15B0032917|16B0047232|16B0001888-1|15B0002956|16B0028267|15B6105746|15B0027313|15D6482427|16B0011611|15B0064945|16B3108520|16B0005549];patientHomSampleInfo=[_][_];CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TGAGTCCCAT.tttttttttt	GT:AD:DP:GQ:PL	0/1:331,83:414:99:869,0,6918
chr17	29663624	.	T	A	5374.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.64;DP=485;ExcessHet=3.0103;FS=0.541;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=13.14;ReadPosRankSum=3.106;SOR=0.636;HGVSnom=NM_001042492.3:c.6148-29T>A;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I41;IVSnom=NM_001042492.3:IVS41-29T>A;AAlength=2839;EXAC_AF=0.43550104;EXAC_Hom_EAS=41;EXAC_AC_EAS=705;EXAC_AN_EAS=2070;EXAC_AC_Adj=17184;EXAC_AN_Adj=39458;RS=rs7406038;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.315096;G1000_EAS_AF=0.3095;G1000_EUR_AF=0.4563;G1000_AFR_AF=0.1082;G1000_SAS_AF=0.4468;G1000_AMR_AF=0.3271;gnomad_exomes_AF=0.42799742;gnomad_exomes_AF_EAS=0.31468722;gnomad_exomes_AC=63805;gnomad_exomes_Hom=5126;gnomad_exomes_Het=53553;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.16674102;gnomad_exomes_AF_NFE=0.47938526;gnomad_exomes_AF_AMR=0.35770897;gnomad_exomes_AF_SAS=0.42879992;NativeFreq_Het=0.5680;NativeFreq_Hom=0.0097;normalHetFrequency=0.4543;normalHetNum=393;normalHomFrequency=0.1642;normalHomNum=142;patientHetFrequency=0.4596;patientHetNum=2399;patientHomFrequency=0.1487;patientHomNum=776;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4677;AF_2700_Hom=0.0861;AF_50_Het=0.4818;AF_50_Hom=0.1078;DANN_score=0.0708;GREP_score=-0.093;CytoBand=q11.2;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=Gttttttttt.taaaaaaaaa	GT:AD:DP:GQ:PL	0/1:152,257:409:99:5412,0,2987
chr17	29663625	.	T	A	13963.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.914;DP=489;ExcessHet=3.0103;FS=2.921;MLEAC=2;MLEAF=1;MQ=59.96;MQRankSum=0;QD=31.17;ReadPosRankSum=1.261;SOR=0.343;HGVSnom=NM_001042492.3:c.6148-28T>A;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I41;IVSnom=NM_001042492.3:IVS41-28T>A;AAlength=2839;EXAC_AF=0.55562779;EXAC_Hom_EAS=146;EXAC_AC_EAS=726;EXAC_AN_EAS=1806;EXAC_AC_Adj=19657;EXAC_AN_Adj=35378;ESP6500_MAF=0.00458573;RS=rs7406039;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.473442;G1000_EAS_AF=0.4464;G1000_EUR_AF=0.6272;G1000_AFR_AF=0.292;G1000_SAS_AF=0.6135;G1000_AMR_AF=0.438;gnomad_exomes_AF=0.59080767;gnomad_exomes_AF_EAS=0.48606811;gnomad_exomes_AC=82615;gnomad_exomes_Hom=23397;gnomad_exomes_Het=35821;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.38641091;gnomad_exomes_AF_NFE=0.63095435;gnomad_exomes_AF_AMR=0.45160746;gnomad_exomes_AF_SAS=0.69583426;NativeFreq_Het=0.6138;NativeFreq_Hom=0.2475;normalHetFrequency=0.1087;normalHetNum=94;normalHomFrequency=0.5087;normalHomNum=440;patientHetFrequency=0.1341;patientHetNum=700;patientHomFrequency=0.5178;patientHomNum=2703;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1945;AF_2700_Hom=0.5323;AF_50_Het=0.1981;AF_50_Hom=0.5436;DANN_score=0.0798;GREP_score=0.0465;CytoBand=q11.2;repName=AT_rich;repClass=Low_complexity;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=tttttttttt.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/1:9,439:448:99:14001,1113,0
chr17	29670190	.	C	G	5889.77	StandardFilter	AC=2;AF=1;AN=2;DP=155;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.74;SOR=4.507;HGVSnom=NM_001042492.3:c.7189+37C>G;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I48;IVSnom=NM_001042492.3:IVS48+37C>G;AAlength=2839;EXAC_AF=0.90685262;EXAC_Hom_EAS=3181;EXAC_AC_EAS=7144;EXAC_AN_EAS=8044;EXAC_AC_Adj=104493;EXAC_AN_Adj=115226;ESP6500_MAF=0.88311788;RS=rs7405740;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.873802;G1000_EAS_AF=0.9028;G1000_EUR_AF=0.9026;G1000_AFR_AF=0.7663;G1000_SAS_AF=0.9571;G1000_AMR_AF=0.8775;gnomad_exomes_AF=0.90742261;gnomad_exomes_AF_EAS=0.88082728;gnomad_exomes_AC=221128;gnomad_exomes_Hom=100531;gnomad_exomes_Het=20066;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.79873352;gnomad_exomes_AF_NFE=0.91492204;gnomad_exomes_AF_AMR=0.88695780;gnomad_exomes_AF_SAS=0.94850652;NativeFreq_Het=0.2152;NativeFreq_Hom=0.7716;normalHetFrequency=0.185;normalHetNum=160;normalHomFrequency=0.7988;normalHomNum=691;patientHetFrequency=0.2071;patientHetNum=1081;patientHomFrequency=0.772;patientHomNum=4030;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6851;GREP_score=-5.99;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=TTATGAAGTA.TATTAAGAAA	GT:AD:DP:GQ:PL	1/1:0,155:155:99:5918,466,0
chr17	29679246	.	G	A	9895.77	PASS	AC=2;AF=1;AN=2;DP=261;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.52;SOR=0.831;HGVSnom=NM_001042492.3:c.7458-29G>A;Gene=NF1;Transcript=NM_001042492.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I50;IVSnom=NM_001042492.3:IVS50-29G>A;AAlength=2839;EXAC_AF=0.53336826;EXAC_Hom_EAS=518;EXAC_AC_EAS=2971;EXAC_AN_EAS=8544;EXAC_AC_Adj=64145;EXAC_AN_Adj=120264;ESP6500_MAF=0.51337844;RS=rs964288;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.430911;G1000_EAS_AF=0.369;G1000_EUR_AF=0.6203;G1000_AFR_AF=0.2345;G1000_SAS_AF=0.5767;G1000_AMR_AF=0.415;gnomad_exomes_AF=0.53484134;gnomad_exomes_AF_EAS=0.35385287;gnomad_exomes_AC=133828;gnomad_exomes_Hom=37746;gnomad_exomes_Het=58336;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27601978;gnomad_exomes_AF_NFE=0.61075305;gnomad_exomes_AF_AMR=0.37644328;gnomad_exomes_AF_SAS=0.57605136;NativeFreq_Het=0.4709;NativeFreq_Hom=0.1881;normalHetFrequency=0.437;normalHetNum=378;normalHomFrequency=0.2162;normalHomNum=187;patientHetFrequency=0.4383;patientHetNum=2288;patientHomFrequency=0.1994;patientHomNum=1041;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4550;AF_2700_Hom=0.1130;AF_50_Het=0.4707;AF_50_Hom=0.1236;DANN_score=0.5532;GREP_score=2.43;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=CATATTAATT.ATTTTTCTCT	GT:AD:DP:GQ:PL	1/1:0,261:261:99:9924,785,0
chr17	29704002	.	T	C	14636.8	PASS	AC=2;AF=1;AN=2;DP=423;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.77;SOR=1.001;HGVSnom=NM_001042492.3:c.*2829T>C;Gene=NF1;Transcript=NM_001042492.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E58;IVSnom=.;AAlength=2839;RS=rs1048317;CLNGENE=NF1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.61262;G1000_EAS_AF=0.4435;G1000_EUR_AF=0.6392;G1000_AFR_AF=0.792;G1000_SAS_AF=0.6186;G1000_AMR_AF=0.4697;NativeFreq_Het=0.5031;NativeFreq_Hom=0.2673;normalHetFrequency=0.4675;normalHetNum=223;normalHomFrequency=0.1665;normalHomNum=144;patientHetFrequency=0.2209;patientHetNum=1153;patientHomFrequency=0.1159;patientHomNum=605;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5023;AF_2700_Hom=0.1899;AF_50_Het=0.4992;AF_50_Hom=0.2155;DANN_score=0.4448;GREP_score=-5.45;CytoBand=q11.2;CGD_CONDITION=Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome. Watson syndrome;CGD_INHERITANCE=AD;Strand=NF1:NM_000267.3:+,NF1:NM_001042492.2:+;NP=NF1:NM_000267.3:NP_000258.1,NF1:NM_001042492.2:NP_001035957.1;ENSP=NF1:NM_000267.3:ENST00000356175.7,NF1:NM_001042492.2:.;Gene_MIM_id=601395,613113;Phenotypes={HIV/AIDS, susceptibility to}, 609423 (3). 609423(SK),Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation. Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant. Neurofibromatosis, type 1, 162200 (3), Autosomal dominant. Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant. Watson syndrome, 193520 (3), Autosomal dominant. 162200(MK),162210(MK),193520(MK),601321(MK),607785(MK);Possible_Inheritance=NA,AD;EntrezGeneID=6349,4763;EnsemblGeneID=ENSG00000276085,ENSG00000196712;Alias=CCL3L1, SCYA3L1, LD78,NF1, VRNF, WSS, NFNS;FLKSEQ=GTGTCCTAGT.GGGGAGACAG	GT:AD:DP:GQ:PL	1/1:0,421:421:99:14665,1265,0
chr17	36046931	.	G	T	14453.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.772;DP=378;ExcessHet=3.0103;FS=3.872;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.21;ReadPosRankSum=-0.583;SOR=0.85;HGVSnom=NM_000458.4:c.*444C>A;Gene=HNF1B;Transcript=NM_000458.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=557;RS=rs2688;CLNGENE=HNF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.5625;G1000_EAS_AF=0.5724;G1000_EUR_AF=0.6173;G1000_AFR_AF=0.5545;G1000_SAS_AF=0.5808;G1000_AMR_AF=0.4582;NativeFreq_Het=0.4752;NativeFreq_Hom=0.3465;normalHetFrequency=0.0052;normalHetNum=2;normalHomFrequency=0.0103;normalHomNum=4;patientHetFrequency=0.0054;patientHetNum=15;patientHomFrequency=0.0061;patientHomNum=17;normalHetSampleInfo=[16D0169552|16D0166662][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D1533035-1|16B0005664|15B0060314|16B3108494|15D6722466-1|16B0228604|16B3098058-1|16B0028130|16B0047126|16B0200397|16D0166607|16B0033325|16B0033225|16B0012197|16B0033119][_];patientHomSampleInfo=[16B0202464|16B0001839|15D6722498-1|16B1586212|17B2000161|16B0067389|16D1878038|16B0019035-1|16D0166666|16B0005278|15D6722463-1|16B0009499-1|15B0066696-1|16D1533010-1|16D0002661|16B3098102-1|16B3094601][_];AF_2700_Het=0.4735;AF_2700_Hom=0.3632;AF_50_Het=0.4960;AF_50_Hom=0.3328;DANN_score=0.7113;GREP_score=-0.984;CytoBand=q12;CGD_CONDITION=Renal cell carcinoma, nonpapillary chromophobe;CGD_INHERITANCE=AD;Strand=HNF1B:NM_000458.4:-,HNF1B:NM_000458.3:-,HNF1B:NM_001165923.3:-,HNF1B:NM_001304286.1:-;NP=HNF1B:NM_000458.4:NP_000449.1,HNF1B:NM_000458.3:NP_000449.1,HNF1B:NM_001165923.3:NP_001159395.1,HNF1B:NM_001304286.1:NP_001291215.1;ENSP=HNF1B:NM_000458.4:ENST00000617811.5,HNF1B:NM_000458.3:.,HNF1B:NM_001165923.3:.,HNF1B:NM_001304286.1:.;Gene_MIM_id=603782,189907;Phenotypes=.,Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant. {Renal cell carcinoma}, 144700 (3). Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant. 125853(MK),137920(MK),144700(SK);Possible_Inheritance=NA,AD;EntrezGeneID=388372,6928;EnsemblGeneID=ENSG00000276070,ENSG00000275410;Alias=CCL4L, SCYA4L, LAG1,HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;FLKSEQ=TCAAGATCAT.TGGGATGGGG	GT:AD:DP:GQ:PL	1/1:1,377:378:99:14482,1127,0
chr17	36047101	.	T	A	17201.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=2.653;DP=483;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.33;ReadPosRankSum=-0.106;SOR=0.591;HGVSnom=NM_000458.4:c.*274A>T;Gene=HNF1B;Transcript=NM_000458.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=557;RS=rs2689;CLNGENE=HNF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.361022;G1000_EAS_AF=0.4692;G1000_EUR_AF=0.4652;G1000_AFR_AF=0.1657;G1000_SAS_AF=0.4192;G1000_AMR_AF=0.3429;NativeFreq_Het=0.5247;NativeFreq_Hom=0.2079;normalHetFrequency=0.2784;normalHetNum=108;normalHomFrequency=0.2216;normalHomNum=86;patientHetFrequency=0.2771;patientHetNum=768;patientHomFrequency=0.2074;patientHomNum=575;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4965;AF_2700_Hom=0.2475;AF_50_Het=0.5103;AF_50_Hom=0.2203;DANN_score=0.5833;GREP_score=-7.6;CytoBand=q12;CGD_CONDITION=Renal cell carcinoma, nonpapillary chromophobe;CGD_INHERITANCE=AD;Strand=HNF1B:NM_000458.4:-,HNF1B:NM_000458.3:-,HNF1B:NM_001165923.3:-,HNF1B:NM_001304286.1:-;NP=HNF1B:NM_000458.4:NP_000449.1,HNF1B:NM_000458.3:NP_000449.1,HNF1B:NM_001165923.3:NP_001159395.1,HNF1B:NM_001304286.1:NP_001291215.1;ENSP=HNF1B:NM_000458.4:ENST00000617811.5,HNF1B:NM_000458.3:.,HNF1B:NM_001165923.3:.,HNF1B:NM_001304286.1:.;Gene_MIM_id=603782,189907;Phenotypes=.,Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant. {Renal cell carcinoma}, 144700 (3). Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant. 125853(MK),137920(MK),144700(SK);Possible_Inheritance=NA,AD;EntrezGeneID=388372,6928;EnsemblGeneID=ENSG00000276070,ENSG00000275410;Alias=CCL4L, SCYA4L, LAG1,HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;FLKSEQ=TCCTCTTCGG.GGTTCCTTGT	GT:AD:DP:GQ:PL	1/1:3,479:482:99:17230,1389,0
chr17	36047275	.	C	T	13974.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.741;DP=381;ExcessHet=3.0103;FS=3.691;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.72;ReadPosRankSum=1.166;SOR=0.723;HGVSnom=NM_000458.4:c.*100G>A;Gene=HNF1B;Transcript=NM_000458.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E9;IVSnom=.;AAlength=557;EXAC_AF=0.85239411;EXAC_Hom_EAS=2870;EXAC_AC_EAS=6911;EXAC_AN_EAS=8276;EXAC_AC_Adj=101186;EXAC_AN_Adj=118708;RS=rs1555818000|rs1555818014|rs1800929|rs2032003363;CLNGENE=HNF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.780351;G1000_EAS_AF=0.8363;G1000_EUR_AF=0.8738;G1000_AFR_AF=0.5877;G1000_SAS_AF=0.8211;G1000_AMR_AF=0.8732;gnomad_exomes_AF=0.85318901;gnomad_exomes_AF_EAS=0.83006392;gnomad_exomes_AC=212026;gnomad_exomes_Hom=91047;gnomad_exomes_Het=29932;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.61872972;gnomad_exomes_AF_NFE=0.88654246;gnomad_exomes_AF_AMR=0.88114802;gnomad_exomes_AF_SAS=0.81728306;NativeFreq_Het=0.2776;NativeFreq_Hom=0.7029;normalHetFrequency=0.3376;normalHetNum=131;normalHomFrequency=0.616;normalHomNum=239;patientHetFrequency=0.2478;patientHetNum=687;patientHomFrequency=0.7082;patientHomNum=1963;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2683;AF_2700_Hom=0.7064;AF_50_Het=0.2694;AF_50_Hom=0.6989;DANN_score=0.8251;GREP_score=-7.02;CytoBand=q12;CGD_CONDITION=Renal cell carcinoma, nonpapillary chromophobe;CGD_INHERITANCE=AD;Strand=HNF1B:NM_000458.4:-,HNF1B:NM_000458.3:-,HNF1B:NM_001165923.3:-,HNF1B:NM_001304286.1:-;NP=HNF1B:NM_000458.4:NP_000449.1,HNF1B:NM_000458.3:NP_000449.1,HNF1B:NM_001165923.3:NP_001159395.1,HNF1B:NM_001304286.1:NP_001291215.1;ENSP=HNF1B:NM_000458.4:ENST00000617811.5,HNF1B:NM_000458.3:.,HNF1B:NM_001165923.3:.,HNF1B:NM_001304286.1:.;Gene_MIM_id=603782,189907;Phenotypes=.,Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant. {Renal cell carcinoma}, 144700 (3). Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant. 125853(MK),137920(MK),144700(SK);Possible_Inheritance=NA,AD;EntrezGeneID=388372,6928;EnsemblGeneID=ENSG00000276070,ENSG00000275410;Alias=CCL4L, SCYA4L, LAG1,HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;FLKSEQ=TCGCAGGTGC.GGTCAGGTCA	GT:AD:DP:GQ:PL	1/1:1,378:379:99:14003,1098,0
chr17	36047417	.	A	G	10965.8	PASS	AC=2;AF=1;AN=2;DP=302;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.6;SOR=1.887;HGVSnom=NM_000458.4:c.1654-22T>C;Gene=HNF1B;Transcript=NM_000458.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_000458.4:IVS8-22T>C;AAlength=557;EXAC_AF=0.73305245;EXAC_Hom_EAS=2452;EXAC_AC_EAS=6487;EXAC_AN_EAS=8640;EXAC_AC_Adj=88909;EXAC_AN_Adj=121286;ESP6500_MAF=0.67107489;RS=rs3110641|rs775236003;CLNGENE=HNF1B;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.654952;G1000_EAS_AF=0.7659;G1000_EUR_AF=0.7445;G1000_AFR_AF=0.4145;G1000_SAS_AF=0.6851;G1000_AMR_AF=0.7795;NativeFreq_Het=0.4164;NativeFreq_Hom=0.5445;normalHetFrequency=0.4098;normalHetNum=159;normalHomFrequency=0.5232;normalHomNum=203;patientHetFrequency=0.3539;patientHetNum=981;patientHomFrequency=0.566;patientHomNum=1569;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3724;AF_2700_Hom=0.5711;AF_50_Het=0.3803;AF_50_Hom=0.5610;DANN_score=0.5527;GREP_score=3.28;CytoBand=q12;CGD_CONDITION=Renal cell carcinoma, nonpapillary chromophobe;CGD_INHERITANCE=AD;Strand=HNF1B:NM_000458.4:-,HNF1B:NM_000458.3:-,HNF1B:NM_001165923.3:-,HNF1B:NM_001304286.1:-;NP=HNF1B:NM_000458.4:NP_000449.1,HNF1B:NM_000458.3:NP_000449.1,HNF1B:NM_001165923.3:NP_001159395.1,HNF1B:NM_001304286.1:NP_001291215.1;ENSP=HNF1B:NM_000458.4:ENST00000617811.5,HNF1B:NM_000458.3:.,HNF1B:NM_001165923.3:.,HNF1B:NM_001304286.1:.;Gene_MIM_id=603782,189907;Phenotypes=.,Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant. {Renal cell carcinoma}, 144700 (3). Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant. 125853(MK),137920(MK),144700(SK);Possible_Inheritance=NA,AD;EntrezGeneID=388372,6928;EnsemblGeneID=ENSG00000276070,ENSG00000275410;Alias=CCL4L, SCYA4L, LAG1,HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;FLKSEQ=GAGGAGAGAG.GTGCTCAGCT	GT:AD:DP:GQ:PL	1/1:0,301:301:99:10994,905,0
chr17	36093863	.	G	GCAGA	2478.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.286;DP=190;ExcessHet=3.0103;FS=2.254;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.92;ReadPosRankSum=1.852;SOR=0.446;HGVSnom=NM_000458.4:c.545-53_545-50dupTCTG;Gene=HNF1B;Transcript=NM_000458.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000458.4:IVS2-50_-49insTCTG;AAlength=557;EXAC_AF=0.54302397;EXAC_Hom_EAS=1060;EXAC_AC_EAS=4616;EXAC_AN_EAS=7770;EXAC_AC_Adj=60078;EXAC_AN_Adj=110636;RS=rs3216929;gnomad_exomes_AF=0.57676107;gnomad_exomes_AF_EAS=0.64505845;gnomad_exomes_AC=129807;gnomad_exomes_Hom=33123;gnomad_exomes_Het=63561;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.46231884;gnomad_exomes_AF_NFE=0.55593862;gnomad_exomes_AF_AMR=0.61203908;gnomad_exomes_AF_SAS=0.61192110;normalHetFrequency=0.4021;normalHetNum=156;normalHomFrequency=0.4845;normalHomNum=188;patientHetFrequency=0.3972;patientHetNum=1101;patientHomFrequency=0.4989;patientHomNum=1383;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q12;CGD_CONDITION=Renal cell carcinoma, nonpapillary chromophobe;CGD_INHERITANCE=AD;Strand=HNF1B:NM_000458.4:-,HNF1B:NM_000458.3:-,HNF1B:NM_001165923.3:-,HNF1B:NM_001304286.1:-;NP=HNF1B:NM_000458.4:NP_000449.1,HNF1B:NM_000458.3:NP_000449.1,HNF1B:NM_001165923.3:NP_001159395.1,HNF1B:NM_001304286.1:NP_001291215.1;ENSP=HNF1B:NM_000458.4:ENST00000617811.5,HNF1B:NM_000458.3:.,HNF1B:NM_001165923.3:.,HNF1B:NM_001304286.1:.;Gene_MIM_id=603782,189907;Phenotypes=.,Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant. {Renal cell carcinoma}, 144700 (3). Renal cysts and diabetes syndrome, 137920 (3), Autosomal dominant. 125853(MK),137920(MK),144700(SK);Possible_Inheritance=NA,AD;EntrezGeneID=388372,6928;EnsemblGeneID=ENSG00000276070,ENSG00000275410;Alias=CCL4L, SCYA4L, LAG1,HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;FLKSEQ=CCTTCACTCA.cagacagaca	GT:AD:DP:GQ:PL	0/1:70,61:131:99:2516,0,2878
chr17	37152123	.	A	AGTGTGT	665.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.24;DP=99;ExcessHet=3.0103;FS=2.087;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.07;ReadPosRankSum=-0.891;SOR=0.202;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs10598470;CytoBand=q12;Gene_MIM_id=603782;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372;EnsemblGeneID=ENSG00000276070;Alias=CCL4L, SCYA4L, LAG1;FLKSEQ=ACCATTTGAA.gtgtgtgtgt	GT:AD:DP:GQ:PL	0/1:17,22:39:99:703,0,714
chr17	37687968	.	A	G	13432.8	PASS	AC=2;AF=1;AN=2;DP=381;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=33.88;SOR=0.84;HGVSnom=NM_016507.4:c.*399A>G;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs1054488;G1000_AF=0.782548;G1000_EAS_AF=0.7639;G1000_EUR_AF=0.837;G1000_AFR_AF=0.6589;G1000_SAS_AF=0.9192;G1000_AMR_AF=0.7738;DANN_score=0.4903;GREP_score=-2.05;CytoBand=q12;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=GGGGTGGGGG.TTGTGTGTGG	GT:AD:DP:GQ:PL	1/1:0,378:378:99:13461,1133,0
chr17	37688355	.	TTCTCTC	T	873.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.545;DP=173;ExcessHet=3.0103;FS=2.278;MLEAC=1;MLEAF=0.5;MQ=59.39;MQRankSum=2.179;QD=8.92;ReadPosRankSum=3.567;SOR=1.085;HGVSnom=NM_016507.4:c.*822_*827delCTCTCT;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs71843922;CytoBand=q12;repName=(TC)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=30.5;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=ctctctctct.tctctctctc	GT:AD:DP:GQ:PL	0/1:57,41:98:99:911,0,1840
chr17	37688367	.	C	CTA	273.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.209;DP=145;ExcessHet=3.0103;FS=10.437;MLEAC=1;MLEAF=0.5;MQ=59.27;MQRankSum=-5.451;QD=2.71;ReadPosRankSum=-0.048;SOR=1.346;HGVSnom=NM_016507.4:c.*799_*800insAT;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs199838246;CytoBand=q12;repName=(TC)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=30.5;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=ctctctctct.tctctctctc	GT:AD:DP:GQ:PL	0/1:86,15:101:99:311,0,3179
chr17	37688393	.	C	G	4719.73	PASS	AC=2;AF=1;AN=2;DP=134;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.21;QD=27.38;SOR=1.721;HGVSnom=NM_016507.4:c.*824C>G;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs8075042;DANN_score=0.3074;GREP_score=-8.68;CytoBand=q12;repName=(TC)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=30.5;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=ctctctctct.tctgtctcgc	GT:AD:DP:GQ:PL	1/1:10,109:119:99:4220,174,0
chr17	37688714	.	CA	C	3969.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.82;DP=397;ExcessHet=3.0103;FS=4.112;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.67;ReadPosRankSum=1.711;SOR=0.519;HGVSnom=NM_016507.4:c.*1155delA;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs147657554;G1000_AF=0.0910543;G1000_EAS_AF=0.0308;G1000_EUR_AF=0.0895;G1000_AFR_AF=0.1732;G1000_SAS_AF=0.0399;G1000_AMR_AF=0.0965;CytoBand=q12;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=ATTTTTATGT.AAAAAAAAAC	GT:AD:DP:GQ:PL	0/1:190,182:372:99:4007,0,4093
chr17	37689327	.	T	TA	2581.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.913;DP=335;ExcessHet=3.0103;FS=1.488;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.27;ReadPosRankSum=0.68;SOR=0.602;HGVSnom=NM_016507.4:c.*1770dupA;Gene=CDK12;Transcript=NM_016507.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=1490;RS=rs11407879;G1000_AF=0.603634;G1000_EAS_AF=0.6845;G1000_EUR_AF=0.7147;G1000_AFR_AF=0.2746;G1000_SAS_AF=0.8272;G1000_AMR_AF=0.6369;CytoBand=q12;Strand=CDK12:NM_015083.2:+,CDK12:NM_016507.3:+;NP=CDK12:NM_015083.2:NP_055898.1,CDK12:NM_016507.3:NP_057591.2;ENSP=CDK12:NM_015083.2:ENST00000430627.6,CDK12:NM_016507.3:.;Gene_MIM_id=603782,615514;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=388372,51755;EnsemblGeneID=ENSG00000276070,ENSG00000167258;Alias=CCL4L, SCYA4L, LAG1,CDK12, CRKRS, CRK7, KIAA0904;FLKSEQ=GTGCATTACT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:159,153:312:99:2619,0,3041
chr17	38783970	.	AT	A	2472.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.687;DP=117;ExcessHet=3.0103;FS=9.319;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=22.48;ReadPosRankSum=-0.42;SOR=3.446;HGVSnom=NM_003079.5:c.*1066delA;Gene=SMARCE1;Transcript=NM_003079.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=411;RS=rs3033073;G1000_AF=0.282947;G1000_EAS_AF=0.3373;G1000_EUR_AF=0.1352;G1000_AFR_AF=0.4198;G1000_SAS_AF=0.1677;G1000_AMR_AF=0.3199;CytoBand=q21.2;Strand=SMARCE1:NM_003079.5:-;NP=SMARCE1:NM_003079.5:NP_003070.3;ENSP=SMARCE1:NM_003079.5:ENST00000348513.12;FLKSEQ=CCTTTTTTTC.TTTTTTTTTT	GT:AD:DP:GQ:PL	1/1:8,102:110:99:2510,101,0
chr17	38784927	.	G	A	9395.77	PASS	AC=2;AF=1;AN=2;DP=258;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.42;SOR=0.895;HGVSnom=NM_003079.5:c.*110C>T;Gene=SMARCE1;Transcript=NM_003079.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=411;RS=rs757412;CLNGENE=SMARCE1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.265575;G1000_EAS_AF=0.3462;G1000_EUR_AF=0.1223;G1000_AFR_AF=0.3442;G1000_SAS_AF=0.1677;G1000_AMR_AF=0.3444;NativeFreq_Het=0.3879;NativeFreq_Hom=0.1032;DANN_score=0.7254;GREP_score=0.213;CytoBand=q21.2;CGD_CONDITION=Meningioma, familial, susceptibility to;CGD_INHERITANCE=AD;Strand=SMARCE1:NM_003079.5:-,SMARCE1:NM_003079.4:-;NP=SMARCE1:NM_003079.5:NP_003070.3,SMARCE1:NM_003079.4:NP_003070.3;ENSP=SMARCE1:NM_003079.5:ENST00000348513.12,SMARCE1:NM_003079.4:.;Gene_MIM_id=603111;Phenotypes=Coffin-Siris syndrome 5, 616938 (3), Autosomal dominant. {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant. 607174(SK);Possible_Inheritance=AD;EntrezGeneID=6605;EnsemblGeneID=ENSG00000073584;Alias=SMARCE1, BAF57, CSS5;FLKSEQ=CTTTGGTGGT.TGATATGGAC	GT:AD:DP:GQ:PL	1/1:0,258:258:99:9424,775,0
chr17	38804135	.	AT	A	99.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.13;DP=98;ExcessHet=3.0103;FS=9.288;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.07;ReadPosRankSum=-1.333;SOR=0.066;HGVSnom=.;Gene=KRT222;Transcript=.;VarType=Downstream1K;MolecularConsequence=downstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs111329392;CytoBand=q21.2;FLKSEQ=ACTCTTCTTA.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:75,18:93:99:137,0,1566
chr17	41196821	.	CT	C	841.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.666;DP=403;ExcessHet=3.0103;FS=0.637;MLEAC=1;MLEAF=0.5;MQ=59.98;MQRankSum=0;QD=2.69;ReadPosRankSum=-0.641;SOR=0.75;HGVSnom=NM_007294.4:c.*873delA;Gene=BRCA1;Transcript=NM_007294.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E23;IVSnom=.;AAlength=1863;EXAC_AF=0.18071520;EXAC_Hom_EAS=0;EXAC_AC_EAS=12;EXAC_AN_EAS=80;EXAC_AC_Adj=849;EXAC_AN_Adj=4698;RS=rs59541324;CLNGENE=BRCA1;CLNSIG=Benign;CLNREVSTAT=reviewed_by_expert_panel;G1000_AF=0.501997;G1000_EAS_AF=0.4583;G1000_EUR_AF=0.5358;G1000_AFR_AF=0.4924;G1000_SAS_AF=0.5521;G1000_AMR_AF=0.464;gnomad_exomes_AF=0.18675845;gnomad_exomes_AF_EAS=0.13810861;gnomad_exomes_AC=9224;gnomad_exomes_Hom=22;gnomad_exomes_Het=9180;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23402130;gnomad_exomes_AF_NFE=0.19784430;gnomad_exomes_AF_AMR=0.20118343;gnomad_exomes_AF_SAS=0.15566159;NativeFreq_Het=0.026;NativeFreq_Hom=.;normalHetFrequency=0.1272;normalHetNum=110;normalHomFrequency=0.0277;normalHomNum=24;patientHetFrequency=0.1282;patientHetNum=669;patientHomFrequency=0.023;patientHomNum=120;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1699;AF_2700_Hom=0.0123;AF_50_Het=0.1569;AF_50_Hom=0.0174;CytoBand=q21.31;repName=AluSx1;repClass=SINE;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to, 1. Pancreatic cancer, susceptibility to, 4. Fanconi anemia, complementation group S;CGD_INHERITANCE=AD/AR;Strand=BRCA1:NM_007298.3:-,BRCA1:NM_007297.3:-,BRCA1:NM_007299.3:-,BRCA1:NM_007294.3:-,BRCA1:NM_007300.3:-;NP=BRCA1:NM_007298.3:NP_009229.2,BRCA1:NM_007297.3:NP_009228.2,BRCA1:NM_007299.3:NP_009230.2,BRCA1:NM_007294.3:NP_009225.1,BRCA1:NM_007300.3:NP_009231.2;ENSP=BRCA1:NM_007298.3:.,BRCA1:NM_007297.3:.,BRCA1:NM_007299.3:.,BRCA1:NM_007294.3:ENST00000357654.8,BRCA1:NM_007300.3:.;Gene_MIM_id=113705;Phenotypes={Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial. {Pancreatic cancer, susceptibility to, 4}, 614320 (3). 604370(SK),614320(SK);Possible_Inheritance=AD;EntrezGeneID=672;EnsemblGeneID=ENSG00000012048;Alias=BRCA1, PSCP, BROVCA1, PNCA4;FLKSEQ=tttcattttc.tttttttttt	GT:AD:DP:GQ:PL	0/1:213,100:313:99:879,0,2641
chr17	47481514	.	T	C	5897.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.93;DP=417;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.21;ReadPosRankSum=-1.853;SOR=0.722;HGVSnom=NM_002634.4:c.*840A>G;Gene=PHB1;Transcript=NM_002634.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E7;IVSnom=.;AAlength=272;RS=rs1049620;G1000_AF=0.67472;G1000_EAS_AF=0.4831;G1000_EUR_AF=0.8231;G1000_AFR_AF=0.8245;G1000_SAS_AF=0.6411;G1000_AMR_AF=0.5;NativeFreq_Het=0.4257;NativeFreq_Hom=0.2772;DANN_score=0.6481;GREP_score=-5.09;CytoBand=q21.33;dupName=chr16:52969334;dupScore=0;Strand=PHB:NM_001281496.1:-,PHB:NM_001281497.1:-,PHB:NM_001281715.1:-,PHB:NM_002634.3:-;NP=PHB:NM_001281496.1:NP_001268425.1,PHB:NM_001281497.1:NP_001268426.1,PHB:NM_001281715.1:NP_001268644.1,PHB:NM_002634.3:NP_002625.1;ENSP=PHB:NM_001281496.1:.,PHB:NM_001281497.1:.,PHB:NM_001281715.1:.,PHB:NM_002634.3:ENST00000300408.7;Gene_MIM_id=176705;Phenotypes={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. 114480(SK);Possible_Inheritance=AD;EntrezGeneID=5245;EnsemblGeneID=ENSG00000167085;Alias=PHB;FLKSEQ=AGTCTCTGAA.GAGGGGGCCA	GT:AD:DP:GQ:PL	0/1:208,207:415:99:5926,0,6445
chr17	48452776	.	A	C	7307.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.816;DP=453;ExcessHet=3.0103;FS=2.498;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.13;ReadPosRankSum=0.374;SOR=0.51;HGVSnom=NM_152463.4:c.207A>C(p.Glu69Asp/p.E69D);Gene=EME1;Transcript=NM_152463.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E2;IVSnom=.;AAlength=570;EXAC_AF=0.81800956;EXAC_Hom_EAS=236;EXAC_AC_EAS=1981;EXAC_AN_EAS=8628;EXAC_AC_Adj=99290;EXAC_AN_Adj=121380;ESP6500_MAF=0.92126711;RS=rs3760413;Ensembl_transcriptid=ENST00000393271|ENST00000338165|ENST00000511519|ENST00000511648;SIFT_pred=T|T|T|T;SIFT_score=1.0|1.0|1.0|1.0;Polyphen2_HVAR_pred=B|B|.|B;Polyphen2_HVAR_score=0.001|0.0|.|0.001;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;G1000_AF=0.745407;G1000_EAS_AF=0.244;G1000_EUR_AF=0.8777;G1000_AFR_AF=0.9932;G1000_SAS_AF=0.6881;G1000_AMR_AF=0.8905;gnomad_exomes_AF=0.81645549;gnomad_exomes_AF_EAS=0.21517129;gnomad_exomes_AC=205301;gnomad_exomes_Hom=87942;gnomad_exomes_Het=29417;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.97926919;gnomad_exomes_AF_NFE=0.88381743;gnomad_exomes_AF_AMR=0.87032325;gnomad_exomes_AF_SAS=0.71664707;NativeFreq_Het=0.2883;NativeFreq_Hom=0.3808;DANN_score=0.4287;GREP_score=-6.36;CytoBand=q21.33;Strand=EME1:NM_001166131.1:+,EME1:NM_152463.2:+;NP=EME1:NM_001166131.1:NP_001159603.1,EME1:NM_152463.2:NP_689676.2;ENSP=EME1:NM_001166131.1:.,EME1:NM_152463.2:.;Gene_MIM_id=610885;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=146956;EnsemblGeneID=ENSG00000154920;Alias=EME1;FLKSEQ=CTGTCCCAGA.ATAGCTGAAA	GT:AD:DP:GQ:PL	0/1:228,225:453:99:7336,0,7284
chr17	48452978	.	A	AAGC	7711.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.104;DP=431;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.32;ReadPosRankSum=-1.243;SOR=0.633;HGVSnom=NM_152463.4:c.410_412dupAGC(p.Lys137_Pro138insGln/p.K137_P138insQ);Gene=EME1;Transcript=NM_152463.4;VarType=InframeInsertion;MolecularConsequence=conservative_inframe_insertion;ExonIntron=E2;IVSnom=.;AAlength=570;EXAC_AF=0.45243472;EXAC_Hom_EAS=55;EXAC_AC_EAS=970;EXAC_AN_EAS=8642;EXAC_AC_Adj=54893;EXAC_AN_Adj=121328;ESP6500_MAF=0.54337754;RS=rs3060668;G1000_AF=0.445887;G1000_EAS_AF=0.1111;G1000_EUR_AF=0.4473;G1000_AFR_AF=0.7269;G1000_SAS_AF=0.3119;G1000_AMR_AF=0.5836;gnomad_exomes_AF=0.45301193;gnomad_exomes_AF_EAS=0.10457907;gnomad_exomes_AC=113812;gnomad_exomes_Hom=28496;gnomad_exomes_Het=56820;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.68981653;gnomad_exomes_AF_NFE=0.47317374;gnomad_exomes_AF_AMR=0.61960989;gnomad_exomes_AF_SAS=0.30880622;CytoBand=q21.33;Strand=EME1:NM_001166131.1:+,EME1:NM_152463.2:+;NP=EME1:NM_001166131.1:NP_001159603.1,EME1:NM_152463.2:NP_689676.2;ENSP=EME1:NM_001166131.1:.,EME1:NM_152463.2:.;Gene_MIM_id=610885;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=146956;EnsemblGeneID=ENSG00000154920;Alias=EME1;FLKSEQ=TGACTGGAAA.AGCCCTTTCC	GT:AD:DP:GQ:PL	0/1:220,201:421:99:7749,0,8634
chr17	48455985	.	A	T	6887.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.259;DP=403;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.13;ReadPosRankSum=-0.802;SOR=0.683;HGVSnom=NM_152463.4:c.933A>T(p.Thr311Thr/p.T311T);Gene=EME1;Transcript=NM_152463.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=570;EXAC_AF=0.22407343;EXAC_Hom_EAS=33;EXAC_AC_EAS=692;EXAC_AN_EAS=8646;EXAC_AC_Adj=27194;EXAC_AN_Adj=121362;ESP6500_MAF=0.19990773;RS=rs2189712;Ensembl_transcriptid=ENST00000511519;SIFT_pred=D;SIFT_score=0.0;Polyphen2_HVAR_pred=.;Polyphen2_HVAR_score=.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;G1000_AF=0.142772;G1000_EAS_AF=0.0794;G1000_EUR_AF=0.2465;G1000_AFR_AF=0.0416;G1000_SAS_AF=0.1329;G1000_AMR_AF=0.2911;gnomad_exomes_AF=0.22708940;gnomad_exomes_AF_EAS=0.07307525;gnomad_exomes_AC=57093;gnomad_exomes_Hom=7542;gnomad_exomes_Het=42009;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08042087;gnomad_exomes_AF_NFE=0.27217561;gnomad_exomes_AF_AMR=0.28995143;gnomad_exomes_AF_SAS=0.12862556;NativeFreq_Het=0.2206;NativeFreq_Hom=0.0320;DANN_score=0.7072;GREP_score=-1.3;CytoBand=q21.33;Strand=EME1:NM_001166131.1:+,EME1:NM_152463.2:+;NP=EME1:NM_001166131.1:NP_001159603.1,EME1:NM_152463.2:NP_689676.2;ENSP=EME1:NM_001166131.1:.,EME1:NM_152463.2:.;Gene_MIM_id=610885;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=146956;EnsemblGeneID=ENSG00000154920;Alias=EME1;FLKSEQ=AGGAGCCAAC.GTACTGGTGT	GT:AD:DP:GQ:PL	0/1:184,218:402:99:6916,0,5532
chr17	48456193	.	T	C	6403.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.457;DP=460;ExcessHet=3.0103;FS=2.472;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.95;ReadPosRankSum=-0.955;SOR=0.516;HGVSnom=NM_152463.4:c.1049T>C(p.Ile350Thr/p.I350T);Gene=EME1;Transcript=NM_152463.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E5;IVSnom=.;AAlength=570;EXAC_AF=0.22397910;EXAC_Hom_EAS=33;EXAC_AC_EAS=692;EXAC_AN_EAS=8642;EXAC_AC_Adj=27183;EXAC_AN_Adj=121364;ESP6500_MAF=0.19998462;RS=rs12450550;Ensembl_transcriptid=ENST00000393271|ENST00000338165|ENST00000511648;SIFT_pred=T|T|T;SIFT_score=0.06|0.093|0.06;Polyphen2_HVAR_pred=B|B|B;Polyphen2_HVAR_score=0.292|0.318|0.292;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;G1000_AF=0.142572;G1000_EAS_AF=0.0804;G1000_EUR_AF=0.2445;G1000_AFR_AF=0.0416;G1000_SAS_AF=0.1329;G1000_AMR_AF=0.2911;gnomad_exomes_AF=0.22700665;gnomad_exomes_AF_EAS=0.07306730;gnomad_exomes_AC=57084;gnomad_exomes_Hom=7538;gnomad_exomes_Het=42008;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.08041098;gnomad_exomes_AF_NFE=0.27214711;gnomad_exomes_AF_AMR=0.28972476;gnomad_exomes_AF_SAS=0.12867503;HGMD_gene=EME1;HGMD_disease=Glioblastoma_multiforme_association_with;HGMD_tag=DP;HGMD_pmid=18559551;NativeFreq_Het=0.2206;NativeFreq_Hom=0.0320;DANN_score=0.9184;GREP_score=2.1;CytoBand=q21.33;Strand=EME1:NM_001166131.1:+,EME1:NM_152463.2:+;NP=EME1:NM_001166131.1:NP_001159603.1,EME1:NM_152463.2:NP_689676.2;ENSP=EME1:NM_001166131.1:.,EME1:NM_152463.2:.;Gene_MIM_id=610885;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=146956;EnsemblGeneID=ENSG00000154920;Alias=EME1;FLKSEQ=GTAACTGACA.CACAGCAAAG	GT:AD:DP:GQ:PL	0/1:253,206:459:99:6432,0,7630
chr17	56787202	.	T	C	5606.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.431;DP=337;ExcessHet=3.0103;FS=0.439;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.74;ReadPosRankSum=-0.45;SOR=0.638;HGVSnom=NM_058216.3:c.706-18T>C;Gene=RAD51C;Transcript=NM_058216.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_058216.3:IVS4-18T>C;AAlength=376;EXAC_AF=0.00117007;EXAC_Hom_EAS=0;EXAC_AC_EAS=106;EXAC_AN_EAS=8652;EXAC_AC_Adj=142;EXAC_AN_Adj=121360;ESP6500_MAF=0.00023066;RS=rs56401264;CLNGENE=RAD51C;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.00259585;G1000_EAS_AF=0.0109;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00122590;gnomad_exomes_AF_EAS=0.01163549;gnomad_exomes_AC=308;gnomad_exomes_Hom=0;gnomad_exomes_Het=308;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00030765;gnomad_exomes_AF_NFE=0.00014087;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.00039208;NativeFreq_Het=0.0297;NativeFreq_Hom=0;normalHetFrequency=0.0092;normalHetNum=8;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0096;patientHetNum=50;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[16B0024526|17B0000759|16S0025735][15B0058421|16B0011804|15B0058387|15B0002964-1|16B0011813];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16D0016221|15B0067690-1|16B0024624|15B0062895|17B0005730|15B0033297|15B0062518-1|15B0045846|15D6722257-1|16B3098114-1|16B0017937|17B0005762|16D1545680|16B0000741|16B0033255|16S0001328|16B3108928|15B0066927|15B0066843|16B0202536|16B0028133|16B1586243|16B0001842-1|17B0501008|16B0047235][16D0038172|15B0002626|16B0005221|16B3259993|16D0172144|15B0011918|15B0064863|15B0054003|16B3094501|15B0012144|16S3104527|15B0027056|15B0062707|16B0009392-1|15B6215377|15B0054101|16B0050325|15D6104524|15D6518740|16B3254516|15B0048088|16B0009401-1|15B0047483-1|16D0067272|15B0002559];patientHomSampleInfo=[16B0005730][_];AF_2700_Het=0.0165;AF_2700_Hom=0.0000;AF_50_Het=0.0190;AF_50_Hom=0.0000;DANN_score=0.5708;GREP_score=3.35;CytoBand=q22;CGD_CONDITION=Breast-ovarian cancer, familial, susceptibility to. Fanconi anemia goup O;CGD_INHERITANCE=AD/AR;Strand=RAD51C:NM_058216.2:+,RAD51C:NM_058216.3:+;NP=RAD51C:NM_058216.2:NP_478123.1,RAD51C:NM_058216.3:NP_478123.1;ENSP=RAD51C:NM_058216.2:ENST00000337432.8,RAD51C:NM_058216.3:ENST00000337432.9;Gene_MIM_id=602774;Phenotypes={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3). Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive. 613390(MK),613399(SK);Possible_Inheritance=AR;EntrezGeneID=5889;EnsemblGeneID=ENSG00000108384;Alias=RAD51C, FANCO, BROVCA3;FLKSEQ=AATCTAATAT.ATCTCTTCTG	GT:AD:DP:GQ:PL	0/1:164,171:335:99:5635,0,5338
chr17	58740530	.	G	A	4549.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.163;DP=267;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.04;ReadPosRankSum=-0.007;SOR=0.671;HGVSnom=NM_003620.4:c.1435G>A(p.Ala479Thr/p.A479T);Gene=PPM1D;Transcript=NM_003620.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E6;IVSnom=.;AAlength=605;EXAC_AF=0.00056876;EXAC_Hom_EAS=0;EXAC_AC_EAS=63;EXAC_AN_EAS=8650;EXAC_AC_Adj=69;EXAC_AN_Adj=121316;RS=rs142406693;Ensembl_transcriptid=ENST00000305921;SIFT_pred=T;SIFT_score=0.707;Polyphen2_HVAR_pred=B;Polyphen2_HVAR_score=0.0;MutationTaster_pred=N;MutationTaster_score=0.999951;CLNGENE=PPM1D;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.00259585;G1000_EAS_AF=0.0129;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00065287;gnomad_exomes_AF_EAS=0.00788301;gnomad_exomes_AC=164;gnomad_exomes_Hom=0;gnomad_exomes_Het=164;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00043072;gnomad_exomes_AF_NFE=0.00002643;gnomad_exomes_AF_AMR=0.00011569;gnomad_exomes_AF_SAS=0.00013066;NativeFreq_Het=0.0178;NativeFreq_Hom=0;AF_2700_Het=0.0077;AF_2700_Hom=0.0000;AF_50_Het=.;AF_50_Hom=.;DANN_score=0.7845;GREP_score=0.998;CytoBand=q23.2;CGD_CONDITION=Intellectual developmental disorder with gastrointestinal difficulties and high pain threhold;CGD_INHERITANCE=AD;Strand=PPM1D:NM_003620.3:+,PPM1D:NM_003620.4:+;NP=PPM1D:NM_003620.3:NP_003611.1,PPM1D:NM_003620.4:NP_003611.1;ENSP=PPM1D:NM_003620.3:.,PPM1D:NM_003620.4:ENST00000305921.8;Gene_MIM_id=605100;Phenotypes=Breast cancer, 114480 (3), Autosomal dominant. 114480(MK);Possible_Inheritance=AD;EntrezGeneID=8493;EnsemblGeneID=ENSG00000170836;Alias=PPM1D, WIP1;FLKSEQ=AGAAAATTGC.CTAAAGCCCT	GT:AD:DP:GQ:PL	0/1:120,147:267:99:4578,0,3494
chr17	58742333	.	AT	A	80.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.579;DP=40;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.24;ReadPosRankSum=-2.475;SOR=0.732;HGVSnom=NM_003620.4:c.*1437delT;Gene=PPM1D;Transcript=NM_003620.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E6;IVSnom=.;AAlength=605;RS=rs1311313661;CytoBand=q23.2;repName=AluSx;repClass=SINE;CGD_CONDITION=Intellectual developmental disorder with gastrointestinal difficulties and high pain threhold;CGD_INHERITANCE=AD;Strand=PPM1D:NM_003620.3:+,PPM1D:NM_003620.4:+;NP=PPM1D:NM_003620.3:NP_003611.1,PPM1D:NM_003620.4:NP_003611.1;ENSP=PPM1D:NM_003620.3:.,PPM1D:NM_003620.4:ENST00000305921.8;Gene_MIM_id=605100;Phenotypes=Breast cancer, 114480 (3), Autosomal dominant. 114480(MK);Possible_Inheritance=AD;EntrezGeneID=8493;EnsemblGeneID=ENSG00000170836;Alias=PPM1D, WIP1;FLKSEQ=cacccggcta.tttttttttt	GT:AD:DP:GQ:PL	0/1:25,11:36:99:118,0,412
chr17	58743652	.	AT	A	181.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.751;DP=71;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.67;ReadPosRankSum=0.991;SOR=0.484;HGVSnom=.;Gene=PPM1D;Transcript=.;VarType=Downstream10K;MolecularConsequence=downstream_10K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs776909533;CytoBand=q23.2;FLKSEQ=GTTGAGAATA.tttttttttt	GT:AD:DP:GQ:PL	0/1:49,19:68:99:219,0,907
chr17	59757143	.	A	C	21803.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.24;DP=578;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.73;ReadPosRankSum=0.57;SOR=0.463;HGVSnom=NM_032043.3:c.*3514T>G;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs10744996;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.762181;G1000_EAS_AF=0.9107;G1000_EUR_AF=0.6461;G1000_AFR_AF=0.7572;G1000_SAS_AF=0.7004;G1000_AMR_AF=0.8112;NativeFreq_Het=0.2079;NativeFreq_Hom=0.7821;normalHetFrequency=0.2474;normalHetNum=118;normalHomFrequency=0.4023;normalHomNum=348;patientHetFrequency=0.1105;patientHetNum=577;patientHomFrequency=0.3452;patientHomNum=1802;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2183;AF_2700_Hom=0.7586;AF_50_Het=0.2250;AF_50_Hom=0.7480;DANN_score=0.8423;GREP_score=-4.63;CytoBand=q23.2;repName=MIR;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=acttatttaa.tctGTAAACA	GT:AD:DP:GQ:PL	1/1:1,574:575:99:21832,1689,0
chr17	59757169	.	T	A	21842.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.197;DP=587;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.44;ReadPosRankSum=-1.338;SOR=0.396;HGVSnom=NM_032043.3:c.*3488A>T;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs11079454;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.342252;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.34;G1000_AFR_AF=0.3517;G1000_SAS_AF=0.2311;G1000_AMR_AF=0.2421;NativeFreq_Het=0.4455;NativeFreq_Hom=0.2772;normalHetFrequency=0.4885;normalHetNum=233;normalHomFrequency=0.1272;normalHomNum=110;patientHetFrequency=0.2318;patientHetNum=1210;patientHomFrequency=0.0969;patientHomNum=506;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4946;AF_2700_Hom=0.2367;AF_50_Het=0.5261;AF_50_Hom=0.2108;DANN_score=0.8441;GREP_score=0.952;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TTTAAAAGTA.GTTATCAGTA	GT:AD:DP:GQ:PL	1/1:1,583:584:99:21871,1716,0
chr17	59757542	.	TAA	T	2071.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.569;DP=171;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.03;ReadPosRankSum=-1.177;SOR=0.7;OLD_VARIANT=chr17|59757542|TAA|T,TA|1;HGVSnom=NM_032043.3:c.*3113_*3114delTT;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs35235448;normalHetFrequency=0.0105;normalHetNum=5;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.0123;patientHetNum=30;patientHomFrequency=0.0049;patientHomNum=12;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16D0067207];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0000595|16B0017439|15B0002429|16B0051119|15D6129432|16B0047605|14B0033411|16D0161370|15D6104559|15B0064959|15B0047483-1|15B0027358];AF_2700_Het=0.0177;AF_2700_Hom=0.0027;AF_50_Het=0.0174;AF_50_Hom=0.0016;CytoBand=q23.2;repName=AluSz;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=tgtcgatact.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/0:26,70:159:99:2109,655,1140
chr17	59757542	.	TA	T	2071.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.569;DP=171;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.03;ReadPosRankSum=-1.177;SOR=0.7;OLD_VARIANT=chr17|59757542|TAA|T,TA|2;HGVSnom=NM_032043.3:c.*3114delT;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs35235448;CLNGENE=BRIP1;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.392572;G1000_EAS_AF=0.4901;G1000_EUR_AF=0.3618;G1000_AFR_AF=0.503;G1000_SAS_AF=0.2526;G1000_AMR_AF=0.2824;normalHetFrequency=0.2453;normalHetNum=117;normalHomFrequency=0.1258;normalHomNum=60;patientHetFrequency=0.2365;patientHetNum=579;patientHomFrequency=0.1099;patientHomNum=269;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4735;AF_2700_Hom=0.0992;AF_50_Het=0.4786;AF_50_Hom=0.0840;CytoBand=q23.2;repName=AluSz;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=tgtcgatact.aaaaaaaaaa	GT:AD:DP:GQ:PL	0/1:26,63:159:99:2109,628,674
chr17	59757841	.	C	CTTTT	4411.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.028;DP=196;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.03;MQRankSum=-0.838;QD=27.57;ReadPosRankSum=-0.824;SOR=2.733;OLD_VARIANT=chr17|59757841|C|CTTTT,CTTTTT|1;HGVSnom=NM_032043.3:c.*2812_*2815dupAAAA;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs768910110;CLNGENE=BRIP1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.0231;normalHetNum=11;normalHomFrequency=0.086;normalHomNum=41;patientHetFrequency=0.0323;patientHetNum=79;patientHomFrequency=0.1095;patientHomNum=268;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4850;AF_2700_Hom=.;AF_50_Het=.;AF_50_Hom=.;CytoBand=q23.2;repName=AluY;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=aaggtaattt.tttttttttt	GT:AD:DP:GQ:PL	1/0:16,88:160:99:4449,467,453
chr17	59757841	.	C	CTTTTT	4411.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.028;DP=196;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.03;MQRankSum=-0.838;QD=27.57;ReadPosRankSum=-0.824;SOR=2.733;OLD_VARIANT=chr17|59757841|C|CTTTT,CTTTTT|2;HGVSnom=NM_032043.3:c.*2811_*2815dupAAAAA;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs768910110;CLNGENE=BRIP1;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=0.0105;normalHetNum=5;normalHomFrequency=0.0126;normalHomNum=6;patientHetFrequency=0.0098;patientHetNum=24;patientHomFrequency=0.0172;patientHomNum=42;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1546271|15B0022844|15B0058293|15B0002429|15B0002861-1|15B0062552|16B0000594|15B0045999|15B0002911|16B3094613|15D6482139-1|15D6104520|16D0067188|15B0022249|15D6518776|15B6325501|15D6518725|16B0000535|16D0153156|16D1546101|15S0036694|15B0047174-1|15B0064945|15D6518623];patientHomSampleInfo=[_][_];AF_2700_Het=.;AF_2700_Hom=.;AF_50_Het=0.5071;AF_50_Hom=.;CytoBand=q23.2;repName=AluY;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=aaggtaattt.tttttttttt	GT:AD:DP:GQ:PL	0/1:16,56:160:99:4449,1033,1198
chr17	59758567	.	C	G	21434.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.45;DP=486;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;MQRankSum=0;QD=21.8;ReadPosRankSum=1.561;SOR=0.426;HGVSnom=NM_032043.3:c.*2090G>C;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs60657820;CLNGENE=BRIP1;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.392173;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.34;G1000_AFR_AF=0.5303;G1000_SAS_AF=0.2311;G1000_AMR_AF=0.2622;NativeFreq_Het=0.4455;NativeFreq_Hom=0.2772;normalHetFrequency=0.2717;normalHetNum=235;normalHomFrequency=0.2264;normalHomNum=108;patientHetFrequency=0.2328;patientHetNum=1215;patientHomFrequency=0.0969;patientHomNum=506;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4942;AF_2700_Hom=0.2367;AF_50_Het=0.5277;AF_50_Hom=0.2108;DANN_score=0.3908;GREP_score=0.235;CytoBand=q23.2;repName=THE1C;repClass=LTR;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=tgagatctgg.tggggacata	GT:AD:DP:GQ:PL	1/1:1,484:485:99:21463,1350,0
chr17	59758571	.	GGACA	G	21175.7	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.829;DP=470;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;MQRankSum=0;QD=31.54;ReadPosRankSum=1.526;SOR=0.447;HGVSnom=NM_032043.3:c.*2082_*2085delTGTC;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs10601136;CLNGENE=BRIP1;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.387979;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.34;G1000_AFR_AF=0.5159;G1000_SAS_AF=0.2311;G1000_AMR_AF=0.2594;normalHetFrequency=0.2728;normalHetNum=236;normalHomFrequency=0.2285;normalHomNum=109;patientHetFrequency=0.2326;patientHetNum=1214;patientHomFrequency=0.0969;patientHomNum=506;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4946;AF_2700_Hom=0.2364;AF_50_Het=0.5277;AF_50_Hom=0.2108;CytoBand=q23.2;repName=THE1C;repClass=LTR;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=atctggctgg.tagccaaacc	GT:AD:DP:GQ:PL	1/1:1,468:469:99:21213,1326,0
chr17	59760174	.	G	A	18172.8	PASS	AC=2;AF=1;AN=2;DP=513;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.96;QD=32.64;SOR=1.667;HGVSnom=NM_032043.3:c.*483C>T;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs7213430;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.625998;G1000_EAS_AF=0.755;G1000_EUR_AF=0.5616;G1000_AFR_AF=0.68;G1000_SAS_AF=0.408;G1000_AMR_AF=0.7363;NativeFreq_Het=0.4256;NativeFreq_Hom=0.5148;normalHetFrequency=0.252;normalHetNum=218;normalHomFrequency=0.252;normalHomNum=218;patientHetFrequency=0.1916;patientHetNum=1000;patientHomFrequency=0.2324;patientHomNum=1213;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4093;AF_2700_Hom=0.5000;AF_50_Het=0.4453;AF_50_Hom=0.4754;DANN_score=0.2796;GREP_score=2.27;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TTTGAGGACA.TACTTTGTAT	GT:AD:DP:GQ:PL	1/1:0,505:505:99:18201,1517,0
chr17	59760499	.	A	G	12597.8	PASS	AC=2;AF=1;AN=2;DP=326;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.66;SOR=2.658;HGVSnom=NM_032043.3:c.*158T>C;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;RS=rs1978111;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.621805;G1000_EAS_AF=0.754;G1000_EUR_AF=0.5616;G1000_AFR_AF=0.6664;G1000_SAS_AF=0.408;G1000_AMR_AF=0.7334;NativeFreq_Het=0.4257;NativeFreq_Hom=0.5049;normalHetFrequency=0.4162;normalHetNum=360;normalHomFrequency=0.4647;normalHomNum=402;patientHetFrequency=0.3923;patientHetNum=2048;patientHomFrequency=0.4822;patientHomNum=2517;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4093;AF_2700_Hom=0.4992;AF_50_Het=0.4453;AF_50_Hom=0.4754;DANN_score=0.5571;GREP_score=1.98;CytoBand=q23.2;repName=AluSg;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=ctcaaaaaaa.aaaCCCAAAA	GT:AD:DP:GQ:PL	1/1:0,323:323:99:12626,970,0
chr17	59760996	.	A	G	21839.8	PASS	AC=2;AF=1;AN=2;DP=608;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.43;SOR=0.812;HGVSnom=NM_032043.3:c.3411T>C(p.Tyr1137Tyr/p.Y1137Y);Gene=BRIP1;Transcript=NM_032043.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E20;IVSnom=.;AAlength=1249;EXAC_AF=0.59411833;EXAC_Hom_EAS=2283;EXAC_AC_EAS=6245;EXAC_AN_EAS=8638;EXAC_AC_Adj=71880;EXAC_AN_Adj=120986;ESP6500_MAF=0.60604429;RS=rs4986763;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.620807;G1000_EAS_AF=0.754;G1000_EUR_AF=0.5616;G1000_AFR_AF=0.6641;G1000_SAS_AF=0.408;G1000_AMR_AF=0.7305;gnomad_exomes_AF=0.59930029;gnomad_exomes_AF_EAS=0.71503972;gnomad_exomes_AC=149716;gnomad_exomes_Hom=46517;gnomad_exomes_Het=56682;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.65431945;gnomad_exomes_AF_NFE=0.58668914;gnomad_exomes_AF_AMR=0.79410743;gnomad_exomes_AF_SAS=0.45533556;NativeFreq_Het=0.4257;NativeFreq_Hom=0.5049;normalHetFrequency=0.4324;normalHetNum=374;normalHomFrequency=0.4509;normalHomNum=390;patientHetFrequency=0.4057;patientHetNum=2118;patientHomFrequency=0.4759;patientHomNum=2484;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4093;AF_2700_Hom=0.5000;AF_50_Het=0.4453;AF_50_Hom=0.4754;DANN_score=0.5267;GREP_score=4.52;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=CTTCAGGATC.TAAAGTTCAG	GT:AD:DP:GQ:PL	1/1:0,602:602:99:21868,1809,0
chr17	59763114	.	A	T	5304.77	StandardFilter	AC=2;AF=1;AN=2;DP=133;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.86;SOR=6.979;HGVSnom=NM_032043.3:c.2905+83T>A;Gene=BRIP1;Transcript=NM_032043.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_032043.3:IVS19+83T>A;AAlength=1249;EXAC_AF=0.39374531;EXAC_Hom_EAS=903;EXAC_AC_EAS=3632;EXAC_AN_EAS=6388;EXAC_AC_Adj=34611;EXAC_AN_Adj=87902;RS=rs4988357;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.343051;G1000_EAS_AF=0.5089;G1000_EUR_AF=0.3419;G1000_AFR_AF=0.3517;G1000_SAS_AF=0.2331;G1000_AMR_AF=0.2421;gnomad_exomes_AF=0.32309868;gnomad_exomes_AF_EAS=0.49851403;gnomad_exomes_AC=71041;gnomad_exomes_Hom=12110;gnomad_exomes_Het=46821;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.34817271;gnomad_exomes_AF_NFE=0.34773387;gnomad_exomes_AF_AMR=0.22642343;gnomad_exomes_AF_SAS=0.25767893;NativeFreq_Het=0.4903;NativeFreq_Hom=0.2772;normalHetFrequency=0.4728;normalHetNum=409;normalHomFrequency=0.215;normalHomNum=186;patientHetFrequency=0.4724;patientHetNum=2466;patientHomFrequency=0.2044;patientHomNum=1067;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8902;GREP_score=3.21;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TTAAGGAATT.ATCTATACCC	GT:AD:DP:GQ:PL	1/1:0,133:133:99:5333,400,0
chr17	59763347	.	A	G	12981.8	PASS	AC=2;AF=1;AN=2;DP=354;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.59;SOR=0.727;HGVSnom=NM_032043.3:c.2755T>C(p.Ser919Pro/p.S919P);Gene=BRIP1;Transcript=NM_032043.3;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E19;IVSnom=.;AAlength=1249;EXAC_AF=0.59722382;EXAC_Hom_EAS=2290;EXAC_AC_EAS=6257;EXAC_AN_EAS=8648;EXAC_AC_Adj=72497;EXAC_AN_Adj=121390;ESP6500_MAF=0.61340920;RS=rs4986764;Ensembl_transcriptid=ENST00000259008|ENST00000577598;SIFT_pred=T|.;SIFT_score=0.154|.;Polyphen2_HVAR_pred=.|.;Polyphen2_HVAR_score=.|.;MutationTaster_pred=P|P;MutationTaster_score=1|1;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.627796;G1000_EAS_AF=0.755;G1000_EUR_AF=0.5616;G1000_AFR_AF=0.6861;G1000_SAS_AF=0.409;G1000_AMR_AF=0.7363;gnomad_exomes_AF=0.60185531;gnomad_exomes_AF_EAS=0.71507013;gnomad_exomes_AC=151298;gnomad_exomes_Hom=47263;gnomad_exomes_Het=56772;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.67439715;gnomad_exomes_AF_NFE=0.58753673;gnomad_exomes_AF_AMR=0.79936398;gnomad_exomes_AF_SAS=0.45550764;HGMD_gene=BRIP1;HGMD_disease=Breast_cancer_association_with;HGMD_tag=DP;HGMD_pmid=15113441;NativeFreq_Het=0.4272;NativeFreq_Hom=0.5148;normalHetFrequency=0.4324;normalHetNum=374;normalHomFrequency=0.4497;normalHomNum=389;patientHetFrequency=0.4067;patientHetNum=2123;patientHomFrequency=0.4762;patientHomNum=2486;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4105;AF_2700_Hom=0.4996;AF_50_Het=0.4469;AF_50_Hom=0.4754;DANN_score=0.9021;GREP_score=0.71;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=AAATAAGGTG.GGTACTGTAC	GT:AD:DP:GQ:PL	1/1:0,354:354:99:13010,1061,0
chr17	59763465	.	T	C	15750.8	PASS	AC=2;AF=1;AN=2;DP=427;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.33;SOR=0.766;HGVSnom=NM_032043.3:c.2637A>G(p.Glu879Glu/p.E879E);Gene=BRIP1;Transcript=NM_032043.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E19;IVSnom=.;AAlength=1249;EXAC_AF=0.71879019;EXAC_Hom_EAS=3465;EXAC_AC_EAS=7731;EXAC_AN_EAS=8654;EXAC_AC_Adj=87195;EXAC_AN_Adj=121308;ESP6500_MAF=0.73427649;RS=rs4986765;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.815096;G1000_EAS_AF=0.9127;G1000_EUR_AF=0.6531;G1000_AFR_AF=0.941;G1000_SAS_AF=0.7014;G1000_AMR_AF=0.8285;gnomad_exomes_AF=0.71791330;gnomad_exomes_AF_EAS=0.89083397;gnomad_exomes_AC=180347;gnomad_exomes_Hom=66500;gnomad_exomes_Het=47347;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91050488;gnomad_exomes_AF_NFE=0.66330716;gnomad_exomes_AF_AMR=0.86698282;gnomad_exomes_AF_SAS=0.69911129;NativeFreq_Het=0.2233;NativeFreq_Hom=0.7920;normalHetFrequency=0.2439;normalHetNum=211;normalHomFrequency=0.7202;normalHomNum=623;patientHetFrequency=0.2421;patientHetNum=1264;patientHomFrequency=0.7184;patientHomNum=3750;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2175;AF_2700_Hom=0.7610;AF_50_Het=0.2250;AF_50_Hom=0.7496;DANN_score=0.6153;GREP_score=2.78;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=CAGCCAAGGA.TCCAGTGCAC	GT:AD:DP:GQ:PL	1/1:0,427:427:99:15779,1284,0
chr17	59857599	.	C	CA	602.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.219;DP=460;ExcessHet=3.0103;FS=1.081;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.5;ReadPosRankSum=-0.956;SOR=0.769;HGVSnom=NM_032043.3:c.1935+22dupT;Gene=BRIP1;Transcript=NM_032043.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I13;IVSnom=NM_032043.3:IVS13+22_+23insT;AAlength=1249;EXAC_AF=0.16084732;EXAC_Hom_EAS=0;EXAC_AC_EAS=730;EXAC_AN_EAS=6072;EXAC_AC_Adj=13645;EXAC_AN_Adj=84832;ESP6500_MAF=0.05569762;RS=rs74268880;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=no_assertion_criteria_provided;gnomad_exomes_AF=0.16574586;gnomad_exomes_AF_EAS=0.18777056;gnomad_exomes_AC=15900;gnomad_exomes_Hom=0;gnomad_exomes_Het=15900;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.14637269;gnomad_exomes_AF_NFE=0.13500129;gnomad_exomes_AF_AMR=0.23189774;gnomad_exomes_AF_SAS=0.23632337;NativeFreq_Het=0.0607;NativeFreq_Hom=.;normalHetFrequency=0.3237;normalHetNum=280;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.2927;patientHetNum=1528;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2252;AF_2700_Hom=.;AF_50_Het=0.2330;AF_50_Hom=.;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=GAAGGCCTTC.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:332,70:402:99:640,0,7499
chr17	59857809	.	C	G	8779.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.345;DP=241;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=31.3;ReadPosRankSum=0.37;SOR=1.732;HGVSnom=NM_032043.3:c.1795-47G>C;Gene=BRIP1;Transcript=NM_032043.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_032043.3:IVS12-47G>C;AAlength=1249;EXAC_AF=0.74755180;EXAC_Hom_EAS=2892;EXAC_AC_EAS=6977;EXAC_AN_EAS=8440;EXAC_AC_Adj=88398;EXAC_AN_Adj=118250;ESP6500_MAF=0.78587910;RS=rs4988351;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.789736;G1000_EAS_AF=0.8026;G1000_EUR_AF=0.7644;G1000_AFR_AF=0.8767;G1000_SAS_AF=0.8108;G1000_AMR_AF=0.6124;gnomad_exomes_AF=0.73691546;gnomad_exomes_AF_EAS=0.82921472;gnomad_exomes_AC=182419;gnomad_exomes_Hom=68670;gnomad_exomes_Het=45079;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.85644785;gnomad_exomes_AF_NFE=0.75055120;gnomad_exomes_AF_AMR=0.49600769;gnomad_exomes_AF_SAS=0.79250229;NativeFreq_Het=0.3107;NativeFreq_Hom=0.6537;normalHetFrequency=0.2728;normalHetNum=236;normalHomFrequency=0.6775;normalHomNum=586;patientHetFrequency=0.3021;patientHetNum=1577;patientHomFrequency=0.6435;patientHomNum=3359;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8904;GREP_score=0.235;CytoBand=q23.2;repName=AluJb;repClass=SINE;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TTAGAAGAgg.tgggcaaagt	GT:AD:DP:GQ:PL	1/1:2,237:239:99:8808,643,0
chr17	59878522	.	C	CA	4239.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.341;DP=165;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27;ReadPosRankSum=-1.75;SOR=1.052;HGVSnom=NM_032043.3:c.1140+91dupT;Gene=BRIP1;Transcript=NM_032043.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I8;IVSnom=NM_032043.3:IVS8+91_+92insT;AAlength=1249;RS=rs11390869;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.4901;NativeFreq_Hom=.;normalHetFrequency=0.274;normalHetNum=237;normalHomFrequency=0.674;normalHomNum=583;patientHetFrequency=0.3057;patientHetNum=1596;patientHomFrequency=0.6381;patientHomNum=3331;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TAAATTAAAG.AAAAAAAATT	GT:AD:DP:GQ:PL	1/1:5,152:157:99:4277,329,0
chr17	59924612	.	G	C	15632.8	PASS	AC=2;AF=1;AN=2;DP=447;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.16;SOR=0.777;HGVSnom=NM_032043.3:c.508-31C>G;Gene=BRIP1;Transcript=NM_032043.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_032043.3:IVS5-31C>G;AAlength=1249;EXAC_AF=0.18994275;EXAC_Hom_EAS=1315;EXAC_AC_EAS=4790;EXAC_AN_EAS=8636;EXAC_AC_Adj=23026;EXAC_AN_Adj=121226;ESP6500_MAF=0.12924804;RS=rs4988344;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.215655;G1000_EAS_AF=0.5625;G1000_EUR_AF=0.1501;G1000_AFR_AF=0.0703;G1000_SAS_AF=0.1401;G1000_AMR_AF=0.1902;gnomad_exomes_AF=0.19682865;gnomad_exomes_AF_EAS=0.55626292;gnomad_exomes_AC=49391;gnomad_exomes_Hom=6423;gnomad_exomes_Het=36545;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.07154331;gnomad_exomes_AF_NFE=0.15943076;gnomad_exomes_AF_AMR=0.18957140;gnomad_exomes_AF_SAS=0.15537406;NativeFreq_Het=0.4951;NativeFreq_Hom=0.3026;normalHetFrequency=0.415;normalHetNum=359;normalHomFrequency=0.2139;normalHomNum=185;patientHetFrequency=0.417;patientHetNum=2177;patientHomFrequency=0.2257;patientHomNum=1178;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6203;GREP_score=-5.21;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=TGAAGTTTAA.GTGAACTAGA	GT:AD:DP:GQ:PL	1/1:0,446:446:99:15661,1340,0
chr17	59940819	.	C	T	14307.8	PASS	AC=2;AF=1;AN=2;DP=402;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.94;SOR=0.923;HGVSnom=NM_032043.3:c.-205G>A;Gene=BRIP1;Transcript=NM_032043.3;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=1249;RS=rs2048718;CLNGENE=BRIP1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.522963;G1000_EAS_AF=0.8214;G1000_EUR_AF=0.4443;G1000_AFR_AF=0.2269;G1000_SAS_AF=0.6585;G1000_AMR_AF=0.5764;NativeFreq_Het=0.3123;NativeFreq_Hom=0.6633;normalHetFrequency=0.222;normalHetNum=192;normalHomFrequency=0.5178;normalHomNum=247;patientHetFrequency=0.1655;patientHetNum=864;patientHomFrequency=0.269;patientHomNum=1404;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3267;AF_2700_Hom=0.6234;AF_50_Het=0.3090;AF_50_Hom=0.6307;DANN_score=0.6187;GREP_score=-1.16;CytoBand=q23.2;CGD_CONDITION=Breast cancer. Fanconi anemia, complementation group J;CGD_INHERITANCE=AD/AR;Strand=BRIP1:NM_032043.3:-,BRIP1:NM_032043.2:-;NP=BRIP1:NM_032043.3:NP_114432.2,BRIP1:NM_032043.2:NP_114432.2;ENSP=BRIP1:NM_032043.3:ENST00000259008.7,BRIP1:NM_032043.2:ENST00000259008.6;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=GTGTGCAGGA.TGGGGCCGCC	GT:AD:DP:GQ:PL	1/1:0,402:402:99:14336,1208,0
chr17	59941017	.	GA	G	399.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.103;DP=208;ExcessHet=3.0103;FS=0.855;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.09;ReadPosRankSum=-0.855;SOR=0.516;HGVSnom=.;Gene=BRIP1;Transcript=.;VarType=Upstream1K;MolecularConsequence=upstream_1K_of_gene;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs3840867;G1000_AF=0.162939;G1000_EAS_AF=0.2302;G1000_EUR_AF=0.1471;G1000_AFR_AF=0.1362;G1000_SAS_AF=0.1626;G1000_AMR_AF=0.1398;CytoBand=q23.2;Gene_MIM_id=605882;Phenotypes=Breast cancer, early-onset, 114480 (3), Autosomal dominant. Fanconi anemia, complementation group J, 609054 (3). 114480(MK),609054(MK);Possible_Inheritance=AD;EntrezGeneID=83990;EnsemblGeneID=ENSG00000136492;Alias=BRIP1, BACH1, FANCJ;FLKSEQ=GGAAGTCTCC.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:139,52:191:99:437,0,2092
chr17	63525082	.	A	T	6535.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.605;DP=403;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.22;ReadPosRankSum=0.044;SOR=0.688;HGVSnom=NM_004655.4:c.*1012T>A;Gene=AXIN2;Transcript=NM_004655.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=843;RS=rs7591;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.421725;G1000_EAS_AF=0.3591;G1000_EUR_AF=0.5785;G1000_AFR_AF=0.1846;G1000_SAS_AF=0.5542;G1000_AMR_AF=0.5504;NativeFreq_Het=0.4752;NativeFreq_Hom=0.1089;normalHetFrequency=0.0026;normalHetNum=1;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0029;patientHetNum=8;patientHomFrequency=0.0011;patientHomNum=3;normalHetSampleInfo=[15B0063117][_];normalHomSampleInfo=[16B0028107][_];patientHetSampleInfo=[15D6104554|15D6722296-1|16B0028130|15B6105487|16D3260843|16D1533010-1|16B0028116|15B0065047][_];patientHomSampleInfo=[16B0005270|16B0017982|16D1546012][_];AF_2700_Het=0.4331;AF_2700_Hom=0.1088;AF_50_Het=0.4532;AF_50_Hom=0.1157;DANN_score=0.655;GREP_score=0.245;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=AAACCCGAAC.TCAAAATGAA	GT:AD:DP:GQ:PL	0/1:192,211:403:99:6564,0,5899
chr17	63525462	.	G	GA	123.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.104;DP=346;ExcessHet=3.0103;FS=1.351;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=0.38;ReadPosRankSum=1.643;SOR=0.833;HGVSnom=NM_004655.4:c.*631dupT;Gene=AXIN2;Transcript=NM_004655.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E11;IVSnom=.;AAlength=843;RS=rs796431470;CLNGENE=AXIN2;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0099;NativeFreq_Hom=.;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0007;patientHetNum=2;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[16B0005639|16B3094921][_];patientHomSampleInfo=[16B0024335][_];AF_2700_Het=0.3305;AF_2700_Hom=.;AF_50_Het=0.3043;AF_50_Hom=.;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=AGCAGCATAG.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:277,47:324:99:161,0,6422
chr17	63532767	.	C	G	2505.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.406;DP=167;ExcessHet=3.0103;FS=13.586;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.09;ReadPosRankSum=0.505;SOR=1.08;HGVSnom=NM_004655.4:c.1908-96G>C;Gene=AXIN2;Transcript=NM_004655.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_004655.4:IVS7-96G>C;AAlength=843;RS=rs28684769;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.435304;G1000_EAS_AF=0.3482;G1000_EUR_AF=0.6133;G1000_AFR_AF=0.171;G1000_SAS_AF=0.6053;G1000_AMR_AF=0.5677;NativeFreq_Het=0.4448;NativeFreq_Hom=0.2028;normalHetFrequency=0.4149;normalHetNum=161;normalHomFrequency=0.1778;normalHomNum=69;patientHetFrequency=0.4369;patientHetNum=1211;patientHomFrequency=0.1901;patientHomNum=527;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7192;GREP_score=-0.766;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=CTATTCTGCT.AGAGAGAGAG	GT:AD:DP:GQ:PL	0/1:90,76:166:99:2534,0,3130
chr17	63532914	.	A	G	3262.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.308;DP=240;ExcessHet=3.0103;FS=3.627;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.71;ReadPosRankSum=-1.068;SOR=0.939;HGVSnom=NM_004655.4:c.1907+73T>C;Gene=AXIN2;Transcript=NM_004655.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_004655.4:IVS7+73T>C;AAlength=843;RS=rs28760438;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.445887;G1000_EAS_AF=0.3492;G1000_EUR_AF=0.6123;G1000_AFR_AF=0.211;G1000_SAS_AF=0.6053;G1000_AMR_AF=0.5677;NativeFreq_Het=0.4653;NativeFreq_Hom=0.2064;normalHetFrequency=0.4201;normalHetNum=163;normalHomFrequency=0.1856;normalHomNum=72;patientHetFrequency=0.438;patientHetNum=1214;patientHomFrequency=0.1923;patientHomNum=533;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9029;GREP_score=4.58;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=CTGCAAAAAC.GCCATTCCCA	GT:AD:DP:GQ:PL	0/1:124,114:238:99:3291,0,3884
chr17	63533768	.	G	A	5875.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.035;DP=299;ExcessHet=3.0103;FS=2.017;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=19.65;ReadPosRankSum=-1.161;SOR=0.571;HGVSnom=NM_004655.4:c.1386C>T(p.Pro462Pro/p.P462P);Gene=AXIN2;Transcript=NM_004655.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=843;EXAC_AF=0.62363630;EXAC_Hom_EAS=239;EXAC_AC_EAS=1306;EXAC_AN_EAS=3290;EXAC_AC_Adj=35556;EXAC_AN_Adj=57014;ESP6500_MAF=0.54006560;RS=rs1133683;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.446086;G1000_EAS_AF=0.3472;G1000_EUR_AF=0.6163;G1000_AFR_AF=0.2118;G1000_SAS_AF=0.6022;G1000_AMR_AF=0.5692;gnomad_exomes_AF=0.59987520;gnomad_exomes_AF_EAS=0.35196135;gnomad_exomes_AC=111518;gnomad_exomes_Hom=34815;gnomad_exomes_Het=41888;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.27236058;gnomad_exomes_AF_NFE=0.66381085;gnomad_exomes_AF_AMR=0.60527507;gnomad_exomes_AF_SAS=0.61540488;NativeFreq_Het=0.4455;NativeFreq_Hom=0.2064;normalHetFrequency=0.4201;normalHetNum=163;normalHomFrequency=0.1727;normalHomNum=67;patientHetFrequency=0.4383;patientHetNum=1215;patientHomFrequency=0.1905;patientHomNum=528;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4297;AF_2700_Hom=0.1084;AF_50_Het=0.4501;AF_50_Hom=0.1204;DANN_score=0.8867;GREP_score=1.63;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=AGCGGGAGCG.GGGCTATAGC	GT:AD:DP:GQ:PL	0/1:139,160:299:99:5904,0,7678
chr17	63533789	.	T	C	5749.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.908;DP=326;ExcessHet=3.0103;FS=0.872;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.64;ReadPosRankSum=1.541;SOR=0.769;HGVSnom=NM_004655.4:c.1365A>G(p.Pro455Pro/p.P455P);Gene=AXIN2;Transcript=NM_004655.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=843;EXAC_AF=0.91439862;EXAC_Hom_EAS=871;EXAC_AC_EAS=2077;EXAC_AN_EAS=2448;EXAC_AC_Adj=39107;EXAC_AN_Adj=42768;ESP6500_MAF=0.91088018;RS=rs9915936;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.909744;G1000_EAS_AF=0.8264;G1000_EUR_AF=0.9066;G1000_AFR_AF=0.9395;G1000_SAS_AF=0.9673;G1000_AMR_AF=0.8977;gnomad_exomes_AF=0.90186518;gnomad_exomes_AF_EAS=0.82442275;gnomad_exomes_AC=154632;gnomad_exomes_Hom=69841;gnomad_exomes_Het=14950;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.93341782;gnomad_exomes_AF_NFE=0.89192179;gnomad_exomes_AF_AMR=0.89090481;gnomad_exomes_AF_SAS=0.95487795;NativeFreq_Het=0.3168;NativeFreq_Hom=0.7153;normalHetFrequency=0.2552;normalHetNum=99;normalHomFrequency=0.6985;normalHomNum=271;patientHetFrequency=0.2399;patientHetNum=665;patientHomFrequency=0.715;patientHomNum=1982;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.3067;AF_2700_Hom=0.6430;AF_50_Het=0.2773;AF_50_Hom=0.6735;DANN_score=0.6503;GREP_score=-3.19;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=GGCCTACGCC.GGAGACTGGC	GT:AD:DP:GQ:PL	0/1:166,160:326:99:5778,0,8581
chr17	63534250	.	T	C	2068.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.1;DP=143;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.47;ReadPosRankSum=0.519;SOR=0.753;HGVSnom=NM_004655.4:c.1200+71A>G;Gene=AXIN2;Transcript=NM_004655.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I5;IVSnom=NM_004655.4:IVS5+71A>G;AAlength=843;EXAC_AF=0.90059512;EXAC_Hom_EAS=2850;EXAC_AC_EAS=6930;EXAC_AN_EAS=8348;EXAC_AC_Adj=105629;EXAC_AN_Adj=117288;RS=rs8078753;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.903954;G1000_EAS_AF=0.8264;G1000_EUR_AF=0.9056;G1000_AFR_AF=0.9213;G1000_SAS_AF=0.9652;G1000_AMR_AF=0.8948;gnomad_exomes_AF=0.89770921;gnomad_exomes_AF_EAS=0.82366857;gnomad_exomes_AC=219138;gnomad_exomes_Hom=98459;gnomad_exomes_Het=22220;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.91687626;gnomad_exomes_AF_NFE=0.89120540;gnomad_exomes_AF_AMR=0.88571429;gnomad_exomes_AF_SAS=0.95339346;NativeFreq_Het=0.3168;NativeFreq_Hom=0.7509;normalHetFrequency=0.2526;normalHetNum=98;normalHomFrequency=0.701;normalHomNum=272;patientHetFrequency=0.2403;patientHetNum=666;patientHomFrequency=0.7136;patientHomNum=1978;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.12;GREP_score=-2.74;CytoBand=q24.1;simRepName=trf;simRepCopyNum=2.7;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=ACGCACCCCA.GCACATGCGC	GT:AD:DP:GQ:PL	0/1:70,73:143:99:2097,0,2102
chr17	63534538	.	C	A	3828.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.428;DP=234;ExcessHet=3.0103;FS=0.585;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.43;ReadPosRankSum=-1.414;SOR=0.78;HGVSnom=NM_004655.4:c.1060-77G>T;Gene=AXIN2;Transcript=NM_004655.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_004655.4:IVS4-77G>T;AAlength=843;RS=rs4541111;CLNGENE=AXIN2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.338858;G1000_EAS_AF=0.3056;G1000_EUR_AF=0.4592;G1000_AFR_AF=0.1362;G1000_SAS_AF=0.4448;G1000_AMR_AF=0.4496;NativeFreq_Het=0.4377;NativeFreq_Hom=0.1281;normalHetFrequency=0.3995;normalHetNum=155;normalHomFrequency=0.0876;normalHomNum=34;patientHetFrequency=0.4224;patientHetNum=1171;patientHomFrequency=0.1046;patientHomNum=290;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7179;GREP_score=1.01;CytoBand=q24.1;CGD_CONDITION=Oligodontia-colorectal cancer syndrome;CGD_INHERITANCE=AD;Strand=AXIN2:NM_004655.3:-;NP=AXIN2:NM_004655.3:NP_004646.3;ENSP=AXIN2:NM_004655.3:ENST00000307078.9;Gene_MIM_id=604025;Phenotypes=Colorectal cancer, somatic, 114500 (3). Oligodontia-colorectal cancer syndrome, 608615 (3), Autosomal dominant. 114500(MK),608615(MK);Possible_Inheritance=AD;EntrezGeneID=8313;EnsemblGeneID=ENSG00000168646;Alias=AXIN2, ODCRCS;FLKSEQ=GAGCTTCCCG.ACCAGGCGCT	GT:AD:DP:GQ:PL	0/1:106,127:233:99:3857,0,3523
chr17	74467017	.	G	C	5382.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=8.266;DP=343;ExcessHet=3.0103;FS=1.4;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=15.74;ReadPosRankSum=-0.686;SOR=0.59;HGVSnom=NM_001005498.4:c.*698C>G;Gene=RHBDF2;Transcript=NM_001005498.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=827;RS=rs8150;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.384784;G1000_EAS_AF=0.5923;G1000_EUR_AF=0.3201;G1000_AFR_AF=0.2042;G1000_SAS_AF=0.4151;G1000_AMR_AF=0.4784;NativeFreq_Het=0.0107;NativeFreq_Hom=0;normalHetFrequency=0.4046;normalHetNum=193;normalHomFrequency=0.3208;normalHomNum=153;patientHetFrequency=0.433;patientHetNum=1060;patientHomFrequency=0.3252;patientHomNum=796;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6607;GREP_score=-2.49;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=GACATCGTCC.TACAAAGTTA	GT:AD:DP:GQ:PL	0/1:171,171:342:99:5411,0,4741
chr17	74467164	.	C	A	6876.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.85;DP=469;ExcessHet=3.0103;FS=2.422;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.69;ReadPosRankSum=-0.912;SOR=0.536;HGVSnom=NM_001005498.4:c.*551G>T;Gene=RHBDF2;Transcript=NM_001005498.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=827;RS=rs2289801;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.00179712;G1000_EAS_AF=0.0079;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;normalHetFrequency=0.0147;normalHetNum=7;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0237;patientHetNum=58;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B6217386|15B0012160|15B0022603];DANN_score=0.4984;GREP_score=-4.92;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=TGTGTCTCCC.CCTTGTTCTC	GT:AD:DP:GQ:PL	0/1:232,236:468:99:6905,0,7131
chr17	74467534	.	G	A	2530.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.796;DP=211;ExcessHet=3.0103;FS=1.724;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.99;ReadPosRankSum=0.583;SOR=0.832;HGVSnom=NM_001005498.4:c.*181C>T;Gene=RHBDF2;Transcript=NM_001005498.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E19;IVSnom=.;AAlength=827;RS=rs374842629;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.00199681;G1000_EAS_AF=0.0089;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.0;G1000_AMR_AF=0.0;normalHetFrequency=0.0126;normalHetNum=6;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0241;patientHetNum=59;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0012160|15B0022603];DANN_score=0.6301;GREP_score=-5.58;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=GAAAAACCCC.CCTTAACCAA	GT:AD:DP:GQ:PL	0/1:121,90:211:99:2559,0,3560
chr17	74475024	.	G	A	9637.77	PASS	AC=2;AF=1;AN=2;DP=262;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.38;SOR=1.005;HGVSnom=NM_001005498.4:c.536C>T(p.Pro179Leu/p.P179L);Gene=RHBDF2;Transcript=NM_001005498.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E6;IVSnom=.;AAlength=827;EXAC_AF=0.87865065;EXAC_Hom_EAS=3852;EXAC_AC_EAS=8150;EXAC_AN_EAS=8622;EXAC_AC_Adj=102832;EXAC_AN_Adj=117034;ESP6500_MAF=0.79524835;RS=rs3744045;Ensembl_transcriptid=ENST00000313080|ENST00000591885;SIFT_pred=T|.;SIFT_score=0.078|.;Polyphen2_HVAR_pred=B|B;Polyphen2_HVAR_score=0.125|0.141;MutationTaster_pred=P|P|P;MutationTaster_score=0.000461497|0.000461497|0.000461497;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.765176;G1000_EAS_AF=0.9226;G1000_EUR_AF=0.9245;G1000_AFR_AF=0.4221;G1000_SAS_AF=0.8323;G1000_AMR_AF=0.8646;gnomad_exomes_AF=0.88545582;gnomad_exomes_AF_EAS=0.94852620;gnomad_exomes_AC=211523;gnomad_exomes_Hom=95085;gnomad_exomes_Het=21353;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49460544;gnomad_exomes_AF_NFE=0.93676235;gnomad_exomes_AF_AMR=0.88115314;gnomad_exomes_AF_SAS=0.84133089;NativeFreq_Het=0.1459;NativeFreq_Hom=0.8043;normalHetFrequency=0.1048;normalHetNum=50;normalHomFrequency=0.8889;normalHomNum=424;patientHetFrequency=0.096;patientHetNum=235;patientHomFrequency=0.8954;patientHomNum=2192;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9951;GREP_score=4.57;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=CGGTGGGTGC.GGGCGTGGGG	GT:AD:DP:GQ:PL	1/1:0,262:262:99:9666,788,0
chr17	74475975	.	C	A	2977.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.798;DP=211;ExcessHet=3.0103;FS=3.22;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.74;ReadPosRankSum=1.23;SOR=0.497;HGVSnom=NM_001005498.4:c.151-39G>T;Gene=RHBDF2;Transcript=NM_001005498.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001005498.4:IVS3-39G>T;AAlength=827;EXAC_AF=0.50833317;EXAC_Hom_EAS=1460;EXAC_AC_EAS=4710;EXAC_AN_EAS=7274;EXAC_AC_Adj=50875;EXAC_AN_Adj=100082;ESP6500_MAF=0.40409168;RS=rs3809694;Ensembl_transcriptid=ENST00000313080|ENST00000592123;SIFT_pred=T|.;SIFT_score=0.649|.;Polyphen2_HVAR_pred=B|.;Polyphen2_HVAR_score=0.004|.;MutationTaster_pred=P|P|P;MutationTaster_score=1|1|1;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.45627;G1000_EAS_AF=0.6052;G1000_EUR_AF=0.4652;G1000_AFR_AF=0.2587;G1000_SAS_AF=0.4755;G1000_AMR_AF=0.5764;gnomad_exomes_AF=0.48941119;gnomad_exomes_AF_EAS=0.62999428;gnomad_exomes_AC=115734;gnomad_exomes_Hom=29277;gnomad_exomes_Het=57180;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28581804;gnomad_exomes_AF_NFE=0.45985643;gnomad_exomes_AF_AMR=0.64587635;gnomad_exomes_AF_SAS=0.44909694;NativeFreq_Het=0.4484;NativeFreq_Hom=0.3167;normalHetFrequency=0.4486;normalHetNum=214;normalHomFrequency=0.3291;normalHomNum=157;patientHetFrequency=0.4424;patientHetNum=1083;patientHomFrequency=0.3566;patientHomNum=873;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7446;GREP_score=-2.03;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=GTGGTGTGTG.AGCCCAGGTC	GT:AD:DP:GQ:PL	0/1:98,104:202:99:3006,0,2471
chr17	74476045	.	G	C	2398.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.505;DP=150;ExcessHet=3.0103;FS=8.789;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.1;ReadPosRankSum=0.458;SOR=1.569;HGVSnom=NM_001005498.4:c.151-109C>G;Gene=RHBDF2;Transcript=NM_001005498.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001005498.4:IVS3-109C>G;AAlength=827;EXAC_AF=0.48983685;EXAC_Hom_EAS=546;EXAC_AC_EAS=1787;EXAC_AN_EAS=2806;EXAC_AC_Adj=18315;EXAC_AN_Adj=37390;ESP6500_MAF=0.39949050;RS=rs3826287;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.45647;G1000_EAS_AF=0.6052;G1000_EUR_AF=0.4652;G1000_AFR_AF=0.2602;G1000_SAS_AF=0.4755;G1000_AMR_AF=0.5749;gnomad_exomes_AF=0.48895365;gnomad_exomes_AF_EAS=0.63112164;gnomad_exomes_AC=66440;gnomad_exomes_Hom=16716;gnomad_exomes_Het=33008;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.29040560;gnomad_exomes_AF_NFE=0.46674945;gnomad_exomes_AF_AMR=0.62240664;gnomad_exomes_AF_SAS=0.45209724;NativeFreq_Het=0.4484;NativeFreq_Hom=0.3238;normalHetFrequency=0.4486;normalHetNum=214;normalHomFrequency=0.3291;normalHomNum=157;patientHetFrequency=0.4428;patientHetNum=1084;patientHomFrequency=0.357;patientHomNum=874;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4027;GREP_score=-3.49;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=CTTCAACCCT.ATTTATGCCC	GT:AD:DP:GQ:PL	0/1:76,73:149:99:2427,0,2237
chr17	74477579	.	T	G	4577.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.272;DP=322;ExcessHet=3.0103;FS=1.4;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.26;ReadPosRankSum=0.236;SOR=0.612;HGVSnom=NM_001005498.4:c.28A>C(p.Ser10Arg/p.S10R);Gene=RHBDF2;Transcript=NM_001005498.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E3;IVSnom=.;AAlength=827;EXAC_AF=0.01049706;EXAC_Hom_EAS=30;EXAC_AC_EAS=687;EXAC_AN_EAS=7890;EXAC_AC_Adj=1069;EXAC_AN_Adj=101838;ESP6500_MAF=0.00069199;RS=rs80133178;Ensembl_transcriptid=ENST00000313080|ENST00000591885|ENST00000592123|ENST00000585989|ENST00000589526|ENST00000591697|ENST00000591879|ENST00000585701|ENST00000591192|ENST00000590322|ENST00000590288|ENST00000591255;SIFT_pred=T|.|.|.|.|.|.|.|.|.|.|.;SIFT_score=0.066|.|.|.|.|.|.|.|.|.|.|.;Polyphen2_HVAR_pred=B|B|.|.|.|.|.|.|.|.|.|.;Polyphen2_HVAR_score=0.002|0.002|.|.|.|.|.|.|.|.|.|.;MutationTaster_pred=N|N|N;MutationTaster_score=0.638537|0.638537|0.638537;CLNGENE=RHBDF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0211661;G1000_EAS_AF=0.0972;G1000_EUR_AF=0.001;G1000_AFR_AF=0.0;G1000_SAS_AF=0.001;G1000_AMR_AF=0.0086;gnomad_exomes_AF=0.01076420;gnomad_exomes_AF_EAS=0.08219410;gnomad_exomes_AC=2503;gnomad_exomes_Hom=77;gnomad_exomes_Het=2349;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00054802;gnomad_exomes_AF_NFE=0.00088980;gnomad_exomes_AF_AMR=0.02464177;gnomad_exomes_AF_SAS=0.00174468;NativeFreq_Het=0.0569;NativeFreq_Hom=0;normalHetFrequency=0.1258;normalHetNum=60;normalHomFrequency=0.0105;normalHomNum=5;patientHetFrequency=0.1368;patientHetNum=335;patientHomFrequency=0.0131;patientHomNum=32;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.9886;GREP_score=5.69;CytoBand=q25.1;CGD_CONDITION=Tylosis with esophageal cancer;CGD_INHERITANCE=AD;Strand=RHBDF2:NM_001005498.3:-,RHBDF2:NM_024599.5:-;NP=RHBDF2:NM_001005498.3:NP_001005498.2,RHBDF2:NM_024599.5:NP_078875.4;ENSP=RHBDF2:NM_001005498.3:.,RHBDF2:NM_024599.5:ENST00000313080.8;Gene_MIM_id=614404;Phenotypes=Tylosis with esophageal cancer, 148500 (3), Autosomal dominant. 148500(MK);Possible_Inheritance=AD;EntrezGeneID=79651;EnsemblGeneID=ENSG00000129667;Alias=RHBDF2, IRHOM2, TOC;FLKSEQ=GAGGACACGC.CCCGCCATTC	GT:AD:DP:GQ:PL	0/1:168,153:321:99:4606,0,4784
chr18	20555219	.	T	C	12234.8	PASS	AC=2;AF=1;AN=2;DP=315;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=38.72;SOR=2.051;HGVSnom=NM_002894.3:c.428+37T>C;Gene=RBBP8;Transcript=NM_002894.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I6;IVSnom=NM_002894.3:IVS6+37T>C;AAlength=897;EXAC_AF=0.96261810;EXAC_Hom_EAS=3547;EXAC_AC_EAS=7730;EXAC_AN_EAS=8406;EXAC_AC_Adj=112274;EXAC_AN_Adj=116634;ESP6500_MAF=0.94143302;RS=rs2336916;CLNGENE=RBBP8;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.915735;G1000_EAS_AF=0.9256;G1000_EUR_AF=0.9821;G1000_AFR_AF=0.8147;G1000_SAS_AF=0.9325;G1000_AMR_AF=0.9741;gnomad_exomes_AF=0.96503346;gnomad_exomes_AF_EAS=0.91693238;gnomad_exomes_AC=237101;gnomad_exomes_Hom=114598;gnomad_exomes_Het=7905;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.85186897;gnomad_exomes_AF_NFE=0.98440974;gnomad_exomes_AF_AMR=0.98108581;gnomad_exomes_AF_SAS=0.93657238;NativeFreq_Het=0.1210;NativeFreq_Hom=0.8683;normalHetFrequency=0.1546;normalHetNum=60;normalHomFrequency=0.8247;normalHomNum=320;patientHetFrequency=0.1356;patientHetNum=376;patientHomFrequency=0.8398;patientHomNum=2328;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7701;GREP_score=-1.16;CytoBand=q11.2;CGD_CONDITION=Seckel syndrome 2. Jawad syndrome;CGD_INHERITANCE=AR;Strand=RBBP8:NM_002894.3:+,RBBP8:NM_002894.2:+,RBBP8:NM_203291.1:+,RBBP8:NM_203292.1:+;NP=RBBP8:NM_002894.3:NP_002885.1,RBBP8:NM_002894.2:NP_002885.1,RBBP8:NM_203291.1:NP_976036.1,RBBP8:NM_203292.1:NP_976037.1;ENSP=RBBP8:NM_002894.3:ENST00000327155.10,RBBP8:NM_002894.2:.,RBBP8:NM_203291.1:ENST00000399722.6,RBBP8:NM_203292.1:.;Gene_MIM_id=604124;Phenotypes=Jawad syndrome, 251255 (3), Autosomal recessive. Pancreatic carcinoma, somatic (3). Seckel syndrome 2, 606744 (3), Autosomal recessive. 251255(MK),604124(MK),606744(MK);Possible_Inheritance=AR;EntrezGeneID=5932;EnsemblGeneID=ENSG00000101773;Alias=RBBP8, RIM, SCKL2, JWDS;FLKSEQ=TTTTATTTTA.TTAGCTATAC	GT:AD:DP:GQ:PL	1/1:0,315:315:99:12263,947,0
chr18	20577609	.	A	G	2664.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.151;DP=211;ExcessHet=3.0103;FS=1.08;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.69;ReadPosRankSum=-0.832;SOR=0.606;HGVSnom=NM_002894.3:c.2055A>G(p.Gly685Gly/p.G685G);Gene=RBBP8;Transcript=NM_002894.3;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E14;IVSnom=.;AAlength=897;EXAC_AF=0.00033605;EXAC_Hom_EAS=0;EXAC_AC_EAS=28;EXAC_AN_EAS=6108;EXAC_AC_Adj=28;EXAC_AN_Adj=83320;RS=rs773572628;CLNGENE=RBBP8;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;gnomad_exomes_AF=0.00028477;gnomad_exomes_AF_EAS=0.00379872;gnomad_exomes_AC=70;gnomad_exomes_Hom=0;gnomad_exomes_Het=70;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.0;gnomad_exomes_AF_NFE=0.0;gnomad_exomes_AF_AMR=0.0;gnomad_exomes_AF_SAS=0.0;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.004;patientHetNum=11;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=_;normalHomSampleInfo=_;patientHetSampleInfo=[15B0066782|16B0035601-1|16B3097960-1|15S0044918|17B0001556-1|16B3094918|16B0033013|15B0048350|16B0005513|17B0000886|17B0000887][_];patientHomSampleInfo=[_][_];DANN_score=0.7173;GREP_score=-2.59;CytoBand=q11.2;CGD_CONDITION=Seckel syndrome 2. Jawad syndrome;CGD_INHERITANCE=AR;Strand=RBBP8:NM_002894.3:+,RBBP8:NM_002894.2:+,RBBP8:NM_203291.1:+,RBBP8:NM_203292.1:+;NP=RBBP8:NM_002894.3:NP_002885.1,RBBP8:NM_002894.2:NP_002885.1,RBBP8:NM_203291.1:NP_976036.1,RBBP8:NM_203292.1:NP_976037.1;ENSP=RBBP8:NM_002894.3:ENST00000327155.10,RBBP8:NM_002894.2:.,RBBP8:NM_203291.1:ENST00000399722.6,RBBP8:NM_203292.1:.;Gene_MIM_id=604124;Phenotypes=Jawad syndrome, 251255 (3), Autosomal recessive. Pancreatic carcinoma, somatic (3). Seckel syndrome 2, 606744 (3), Autosomal recessive. 251255(MK),604124(MK),606744(MK);Possible_Inheritance=AR;EntrezGeneID=5932;EnsemblGeneID=ENSG00000101773;Alias=RBBP8, RIM, SCKL2, JWDS;FLKSEQ=AATTAGGAGG.GAGACAGTGG	GT:AD:DP:GQ:PL	0/1:121,89:210:99:2693,0,3808
chr18	48573268	.	CT	C	432.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.021;DP=307;ExcessHet=3.0103;FS=8.031;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.49;ReadPosRankSum=0.007;SOR=0.297;HGVSnom=NM_005359.6:c.-127-10delT;Gene=SMAD4;Transcript=NM_005359.6;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_005359.6:IVS1-10delT;AAlength=552;EXAC_AF=0.33369447;EXAC_Hom_EAS=0;EXAC_AC_EAS=30;EXAC_AN_EAS=84;EXAC_AC_Adj=616;EXAC_AN_Adj=1846;RS=rs745430558;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.1064;normalHetNum=92;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1008;patientHetNum=526;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0396;AF_2700_Hom=.;AF_50_Het=0.0301;AF_50_Hom=.;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=TGATGTGTGT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:238,53:291:99:470,0,4877
chr18	48573689	.	A	G	5841.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.845;DP=358;ExcessHet=3.0103;FS=6.153;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.46;ReadPosRankSum=1.04;SOR=0.985;HGVSnom=NM_005359.6:c.249+24A>G;Gene=SMAD4;Transcript=NM_005359.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_005359.6:IVS2+24A>G;AAlength=552;EXAC_AF=0.00647490;EXAC_Hom_EAS=8;EXAC_AC_EAS=342;EXAC_AN_EAS=8600;EXAC_AC_Adj=773;EXAC_AN_Adj=119384;ESP6500_MAF=0.00023080;RS=rs77389132;CLNGENE=SMAD4;CLNSIG=Likely_benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0119808;G1000_EAS_AF=0.0417;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0231;gnomad_exomes_AF=0.00775281;gnomad_exomes_AF_EAS=0.04126240;gnomad_exomes_AC=1920;gnomad_exomes_Hom=38;gnomad_exomes_Het=1844;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00025903;gnomad_exomes_AF_NFE=0.00021528;gnomad_exomes_AF_AMR=0.03069843;gnomad_exomes_AF_SAS=0.00091659;NativeFreq_Het=0.0783;NativeFreq_Hom=0;normalHetFrequency=0.0647;normalHetNum=56;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0533;patientHetNum=278;patientHomFrequency=0.0008;patientHomNum=4;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0047196|16B1276341|17B0000982][16B0051105];AF_2700_Het=0.0749;AF_2700_Hom=0.0008;AF_50_Het=0.0634;AF_50_Hom=0.0016;DANN_score=0.3242;GREP_score=-8.05;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=GAGTTTTTCT.TACCCTCTAT	GT:AD:DP:GQ:PL	0/1:178,177:355:99:5870,0,5163
chr18	48584855	.	AT	A	797.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.098;DP=259;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.58;ReadPosRankSum=-0.952;SOR=0.733;HGVSnom=NM_005359.6:c.904+45delT;Gene=SMAD4;Transcript=NM_005359.6;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I7;IVSnom=NM_005359.6:IVS7+45delT;AAlength=552;EXAC_AF=0.15196254;EXAC_Hom_EAS=0;EXAC_AC_EAS=509;EXAC_AN_EAS=5342;EXAC_AC_Adj=11878;EXAC_AN_Adj=78164;RS=rs386387676;CLNGENE=SMAD4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.038738;G1000_EAS_AF=0.0149;G1000_EUR_AF=0.0239;G1000_AFR_AF=0.0893;G1000_SAS_AF=0.0225;G1000_AMR_AF=0.0216;gnomad_exomes_AF=0.15802136;gnomad_exomes_AF_EAS=0.10690444;gnomad_exomes_AC=21215;gnomad_exomes_Hom=0;gnomad_exomes_Het=21215;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.23471379;gnomad_exomes_AF_NFE=0.15210509;gnomad_exomes_AF_AMR=0.15934923;gnomad_exomes_AF_SAS=0.19854947;NativeFreq_Het=0.0050;NativeFreq_Hom=.;normalHetFrequency=0.2023;normalHetNum=175;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1619;patientHetNum=845;patientHomFrequency=0.0012;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0045754|15B0002972|15D6482481];AF_2700_Het=0.1533;AF_2700_Hom=.;AF_50_Het=0.1300;AF_50_Hom=.;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=TGTAAGGGCT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:153,70:223:99:835,0,2551
chr18	48606335	.	G	GT	2357.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.442;DP=334;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=7.53;ReadPosRankSum=0.815;SOR=0.666;HGVSnom=NM_005359.6:c.*1512dupT;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs755827115;CLNGENE=SMAD4;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0495;NativeFreq_Hom=.;normalHetFrequency=0.2243;normalHetNum=107;normalHomFrequency=0.0042;normalHomNum=2;patientHetFrequency=0.2206;patientHetNum=540;patientHomFrequency=0.0041;patientHomNum=10;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B6215107|16B0018109];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0051105|16B0009569-1|15D6104520|15D6129439|16B3254614|15B0051396|16B3108464|16B0202361|15B0002966-1|16B0017843];AF_2700_Het=0.2244;AF_2700_Hom=0.0027;AF_50_Het=0.1997;AF_50_Hom=0.0032;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=TGTAGAGTTG.tttttttttt	GT:AD:DP:GQ:PL	0/1:152,161:313:99:2395,0,2560
chr18	48606703	.	A	G	3285.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.624;DP=179;ExcessHet=3.0103;FS=4.438;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.36;ReadPosRankSum=0.506;SOR=1.026;HGVSnom=NM_005359.6:c.*1866A>G;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs4940037;CLNGENE=SMAD4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0119808;G1000_EAS_AF=0.0417;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0231;NativeFreq_Het=0.0693;NativeFreq_Hom=0;normalHetFrequency=0.0587;normalHetNum=28;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0625;patientHetNum=153;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0054129|16B0051105];AF_2700_Het=0.0761;AF_2700_Hom=0.0008;AF_50_Het=0.0650;AF_50_Hom=0.0016;DANN_score=0.3079;GREP_score=-11.3;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=ATTACTTACA.ATTCTTTCAG	GT:AD:DP:GQ:PL	0/1:84,95:179:99:3314,0,2786
chr18	48607633	.	G	T	6212.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-6.039;DP=426;ExcessHet=3.0103;FS=4.991;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.65;ReadPosRankSum=1.474;SOR=0.428;HGVSnom=NM_005359.6:c.*2796G>T;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs4939651;CLNGENE=SMAD4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0119808;G1000_EAS_AF=0.0417;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0231;NativeFreq_Het=0.0693;NativeFreq_Hom=0;normalHetFrequency=0.0587;normalHetNum=28;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0621;patientHetNum=152;patientHomFrequency=0.0004;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6722295-1][16B0051105];AF_2700_Het=0.0749;AF_2700_Hom=0.0008;AF_50_Het=0.0634;AF_50_Hom=0.0016;DANN_score=0.7329;GREP_score=1.01;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=TTGAATTTCA.TGCAAGCTGA	GT:AD:DP:GQ:PL	0/1:216,208:424:99:6241,0,7008
chr18	48609102	.	G	GT	750.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.213;DP=369;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.3;ReadPosRankSum=-1.09;SOR=0.701;HGVSnom=NM_005359.6:c.*4277dupT;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs559471969;normalHetFrequency=0.1132;normalHetNum=54;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1115;patientHetNum=273;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.1141;AF_2700_Hom=0.0004;AF_50_Het=0.1109;AF_50_Hom=0.0016;CytoBand=q21.2;repName=Tigger15a;repClass=DNA;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=tgaattttta.tttttttttt	GT:AD:DP:GQ:PL	0/1:256,70:326:99:788,0,5002
chr18	48609831	.	G	GT	862.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.109;DP=523;ExcessHet=3.0103;FS=1.448;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.79;ReadPosRankSum=-1.175;SOR=0.832;HGVSnom=NM_005359.6:c.*5005dupT;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs113155703;NativeFreq_Het=0.0099;NativeFreq_Hom=.;normalHetFrequency=0.044;normalHetNum=21;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.06;patientHetNum=147;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0028268];AF_2700_Het=0.0507;AF_2700_Hom=.;AF_50_Het=0.0460;AF_50_Hom=.;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=TTTTTTTTCT.TTTTTTTTTT	GT:AD:DP:GQ:PL	0/1:385,96:481:99:900,0,8632
chr18	48610256	.	T	C	6830.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=4.785;DP=404;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.95;ReadPosRankSum=2.276;SOR=0.654;HGVSnom=NM_005359.6:c.*5419T>C;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs146551171;CLNGENE=SMAD4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.0119808;G1000_EAS_AF=0.0417;G1000_EUR_AF=0.0;G1000_AFR_AF=0.0;G1000_SAS_AF=0.002;G1000_AMR_AF=0.0231;NativeFreq_Het=0.0693;NativeFreq_Hom=0;normalHetFrequency=0.0587;normalHetNum=28;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0293;patientHetNum=153;patientHomFrequency=0.0006;patientHomNum=3;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15D6722295-1][15B0054129|16B0051105];AF_2700_Het=0.0749;AF_2700_Hom=0.0008;AF_50_Het=0.0634;AF_50_Hom=0.0016;DANN_score=0.8003;GREP_score=0.971;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=AGGCTTGATA.TTTATTACTG	GT:AD:DP:GQ:PL	0/1:192,211:403:99:6859,0,6082
chr18	48610366	.	GTGCGCA	G	2620.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.189;DP=267;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.13;ReadPosRankSum=4.586;SOR=0.675;HGVSnom=NM_005359.6:c.*5530_*5535delTGCGCA;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs1450171933;NativeFreq_Het=0.0099;NativeFreq_Hom=.;normalHetFrequency=0.0566;normalHetNum=27;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0584;patientHetNum=143;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][16B0051105|15B0054129];AF_2700_Het=0.0657;AF_2700_Hom=0.0008;AF_50_Het=0.0523;AF_50_Hom=0.0016;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=CTTAACGCGC.cgcgcgcgcg	GT:AD:DP:GQ:PL	0/1:114,102:216:99:2658,0,4159
chr18	48610376	.	GCGCGCGCACA	G	1292.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.566;DP=264;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.98;SOR=0.693;HGVSnom=NM_005359.6:c.*5541_*5550delGCGCGCACAC;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs1177765868;normalHetFrequency=0.0755;normalHetNum=36;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0715;patientHetNum=175;patientHomFrequency=0.0004;patientHomNum=1;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0067691-1];AF_2700_Het=0.0703;AF_2700_Hom=0.0004;AF_50_Het=0.0666;AF_50_Hom=.;CytoBand=q21.2;repName=(CA)n;repClass=Simple_repeat;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=GTGCGcacgc.cacacacaca	GT:AD:DP:GQ:PL	0/1:148,68:216:99:1330,0,5206
chr18	48610382	.	G	GCACA	1391.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.08;DP=262;ExcessHet=3.0103;FS=8.093;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.5;ReadPosRankSum=-1.375;SOR=1.115;HGVSnom=NM_005359.6:c.*5574_*5577dupCACA;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs56017493;normalHetFrequency=0.2579;normalHetNum=123;normalHomFrequency=0.0629;normalHomNum=30;patientHetFrequency=0.2169;patientHetNum=531;patientHomFrequency=0.065;patientHomNum=159;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5111;AF_2700_Hom=0.0135;AF_50_Het=0.5008;AF_50_Hom=0.0063;CytoBand=q21.2;repName=(CA)n;repClass=Simple_repeat;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=acgcgcgcgc.cacacacaca	GT:AD:DP:GQ:PL	0/1:152,62:214:99:1429,0,6086
chr18	48610831	.	A	C	6283.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.636;DP=440;ExcessHet=3.0103;FS=0.522;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.31;ReadPosRankSum=2.104;SOR=0.607;HGVSnom=NM_005359.6:c.*5994A>C;Gene=SMAD4;Transcript=NM_005359.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E12;IVSnom=.;AAlength=552;RS=rs3819122;CLNGENE=SMAD4;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.378195;G1000_EAS_AF=0.4583;G1000_EUR_AF=0.3996;G1000_AFR_AF=0.3888;G1000_SAS_AF=0.2311;G1000_AMR_AF=0.4179;NativeFreq_Het=0.5544;NativeFreq_Hom=0.1683;normalHetFrequency=0.2578;normalHetNum=223;normalHomFrequency=0.0775;normalHomNum=67;patientHetFrequency=0.2351;patientHetNum=1227;patientHomFrequency=0.0872;patientHomNum=455;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4950;AF_2700_Hom=0.1972;AF_50_Het=0.5024;AF_50_Hom=0.2013;DANN_score=0.575;GREP_score=1.02;CytoBand=q21.2;CGD_CONDITION=Hereditary hemorrhagic telangiectasia, type 1. Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome. Polyposis, juvenile intestinal. Myhre syndrome;CGD_INHERITANCE=AD;Strand=SMAD4:NM_005359.5:+;NP=SMAD4:NM_005359.5:NP_005350.1;ENSP=SMAD4:NM_005359.5:ENST00000342988.7;Gene_MIM_id=600993;Phenotypes=Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant. Myhre syndrome, 139210 (3), Autosomal dominant. Pancreatic cancer, somatic, 260350 (3). Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant. 139210(MK),174900(MK),175050(MK),260350(MK);Possible_Inheritance=AD;EntrezGeneID=4089;EnsemblGeneID=ENSG00000141646;Alias=SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS;FLKSEQ=AATTAATGAA.TTCATATTTT	GT:AD:DP:GQ:PL	0/1:226,213:439:99:6312,0,6591
chr18	53161388	.	G	GAC	9230.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-1.802;DP=560;ExcessHet=3.0103;FS=3.959;MLEAC=1;MLEAF=0.5;MQ=59.87;MQRankSum=-1.393;QD=22.79;ReadPosRankSum=-0.512;SOR=0.482;HGVSnom=NM_001083962.2:c.146-30022_146-30021dupGT;Gene=TCF4;Transcript=NM_001083962.2;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_001083962.2:IVS3-30021_-30020insGT;AAlength=671;RS=rs3138626;CytoBand=q21.2;Strand=TCF4:NM_001330604.1:-,TCF4:NM_001243231.1:-,TCF4:NM_001306207.1:-,TCF4:NM_001083962.1:-,TCF4:NM_001243230.1:-,TCF4:NM_003199.2:-,TCF4:NM_001243227.1:-,TCF4:NM_001243228.1:-,TCF4:NM_001243226.2:-;NP=TCF4:NM_001330604.1:NP_001317533.1,TCF4:NM_001243231.1:NP_001230160.1,TCF4:NM_001306207.1:NP_001293136.1,TCF4:NM_001083962.1:NP_001077431.1,TCF4:NM_001243230.1:NP_001230159.1,TCF4:NM_003199.2:NP_003190.1,TCF4:NM_001243227.1:NP_001230156.1,TCF4:NM_001243228.1:NP_001230157.1,TCF4:NM_001243226.2:NP_001230155.2;ENSP=TCF4:NM_001330604.1:.,TCF4:NM_001243231.1:.,TCF4:NM_001306207.1:.,TCF4:NM_001083962.1:.,TCF4:NM_001243230.1:.,TCF4:NM_003199.2:.,TCF4:NM_001243227.1:.,TCF4:NM_001243228.1:.,TCF4:NM_001243226.2:.;Gene_MIM_id=602272;Phenotypes=Corneal dystrophy, Fuchs endothelial, 3, 613267 (3), Autosomal dominant. Pitt-Hopkins syndrome, 610954 (3), Autosomal dominant. 610954(MK),613267(MK);Possible_Inheritance=AD;EntrezGeneID=6925;EnsemblGeneID=ENSG00000196628;Alias=TCF4, SEF2, ITF2, PTHS, FECD3;FLKSEQ=AAATATTATG.acacacacac	GT:AD:DP:GQ:PL	0/1:78,327:405:99:9268,0,1043
chr18	61170721	.	T	C	4941.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.721;DP=366;ExcessHet=3.0103;FS=6.054;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=13.5;ReadPosRankSum=0.077;SOR=0.981;HGVSnom=NM_002639.5:c.894T>C(p.Ser298Ser/p.S298S);Gene=SERPINB5;Transcript=NM_002639.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E7;IVSnom=.;AAlength=375;EXAC_AF=0.61630857;EXAC_Hom_EAS=1341;EXAC_AC_EAS=4821;EXAC_AN_EAS=8644;EXAC_AC_Adj=74810;EXAC_AN_Adj=121384;ESP6500_MAF=0.58688298;RS=rs1455556;G1000_AF=0.525759;G1000_EAS_AF=0.5972;G1000_EUR_AF=0.6978;G1000_AFR_AF=0.3396;G1000_SAS_AF=0.4714;G1000_AMR_AF=0.6037;gnomad_exomes_AF=0.62079146;gnomad_exomes_AF_EAS=0.56393389;gnomad_exomes_AC=156026;gnomad_exomes_Hom=49876;gnomad_exomes_Het=56274;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37789124;gnomad_exomes_AF_NFE=0.69145603;gnomad_exomes_AF_AMR=0.55369535;gnomad_exomes_AF_SAS=0.49026653;NativeFreq_Het=0.5053;NativeFreq_Hom=0.3559;DANN_score=0.5656;GREP_score=-4.78;CytoBand=q21.33;Strand=SERPINB5:NM_002639.4:+;NP=SERPINB5:NM_002639.4:NP_002630.2;ENSP=SERPINB5:NM_002639.4:.;Gene_MIM_id=154790;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=5268;EnsemblGeneID=ENSG00000206075;Alias=PI5, SERPINB5;FLKSEQ=ATATCTTCAG.GAAGACACAT	GT:AD:DP:GQ:PL	0/1:191,175:366:99:4970,0,5426
chr18	61873521	.	CTGTGTGTGTG	C	4135.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.261;DP=306;ExcessHet=3.0103;FS=5.719;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.62;ReadPosRankSum=-0.675;SOR=2.303;OLD_VARIANT=chr18|61873521|CTGTGTGTGTG|C,CTGTGTGTG|1;HGVSnom=NR_033881.1:n.201-42972_201-42963delTGTGTGTGTG;Gene=LINC01924;Transcript=NR_033881.1;VarType=Intron;MolecularConsequence=noncoding_transcript_intron_variant;ExonIntron=I2;IVSnom=NR_033881.1:IVS2-42972_-42963delTGTGTGTGTG;AAlength=.;RS=rs71164812;CytoBand=q22.1;FLKSEQ=TAATCTTATG.tgtgtgtgtg	GT:AD:DP:GQ:PL	1/0:4,100:168:99:4173,1307,2566
chr18	61873521	.	CTG	C	4135.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=2.261;DP=306;ExcessHet=3.0103;FS=5.719;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=24.62;ReadPosRankSum=-0.675;SOR=2.303;OLD_VARIANT=chr18|61873521|CTGTGTGTGTG|C,CTGTGTGTG|2;HGVSnom=NR_033881.1:n.201-42964_201-42963delTG;Gene=LINC01924;Transcript=NR_033881.1;VarType=Intron;MolecularConsequence=noncoding_transcript_intron_variant;ExonIntron=I2;IVSnom=NR_033881.1:IVS2-42964_-42963delTG;AAlength=.;RS=rs71164812;CytoBand=q22.1;FLKSEQ=TAATCTTATG.tgtgtgtgtg	GT:AD:DP:GQ:PL	0/1:4,64:168:99:4173,2884,2783
chr18	72044533	.	C	CGTGT	994.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.681;DP=344;ExcessHet=3.0103;FS=6.869;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=6.91;ReadPosRankSum=-2.453;SOR=0.269;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs57400780;CytoBand=q22.3;FLKSEQ=TCATTAAGGA.gtgtgtgtgt	GT:AD:DP:GQ:PL	0/1:102,42:144:99:1032,0,3681
chr18	72044567	.	T	TGCGC	688.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.67;DP=255;ExcessHet=3.0103;FS=5.97;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=3.51;ReadPosRankSum=2.095;SOR=1.232;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs541566711;CytoBand=q22.3;repName=(TG)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=18.5;FLKSEQ=tgtgtgtgtg.gtgCGCGCGC	GT:AD:DP:GQ:PL	0/1:146,50:196:99:726,0,5692
chr18	72044569	.	T	C	4183.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.267;DP=256;ExcessHet=3.0103;FS=6.345;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=17.22;ReadPosRankSum=-0.95;SOR=1.237;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs369486231;DANN_score=0.0861;GREP_score=0.0;CytoBand=q22.3;repName=(TG)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=18.5;FLKSEQ=tgtgtgtgtg.gCGCGCGCGC	GT:AD:DP:GQ:PL	0/1:128,115:243:99:4221,0,4369
chr18	72044662	.	A	G	3429.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.43;DP=234;ExcessHet=3.0103;FS=0.503;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=14.91;ReadPosRankSum=-1.956;SOR=0.627;HGVSnom=.;Gene=.;Transcript=.;VarType=Intergenic;MolecularConsequence=intergenic_variant;ExonIntron=.;IVSnom=.;AAlength=.;RS=rs59226478;G1000_AF=0.196486;G1000_EAS_AF=0.2123;G1000_EUR_AF=0.1223;G1000_AFR_AF=0.2489;G1000_SAS_AF=0.1769;G1000_AMR_AF=0.2089;DANN_score=0.2182;GREP_score=-1.04;CytoBand=q22.3;repName=AluSx;repClass=SINE;FLKSEQ=gatcacctga.gtcaggagtt	GT:AD:DP:GQ:PL	0/1:112,118:230:99:3458,0,3298
chr19	1207238	.	G	T	10237.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.718;DP=313;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=33.03;ReadPosRankSum=1.375;SOR=0.346;HGVSnom=NM_000455.5:c.290+36G>T;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000455.5:IVS1+36G>T;AAlength=433;EXAC_AF=0.32474147;EXAC_Hom_EAS=597;EXAC_AC_EAS=1823;EXAC_AN_EAS=2696;EXAC_AC_Adj=12624;EXAC_AN_Adj=38874;ESP6500_MAF=0.22951355;RS=rs3764640;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.353435;G1000_EAS_AF=0.7004;G1000_EUR_AF=0.2197;G1000_AFR_AF=0.2731;G1000_SAS_AF=0.318;G1000_AMR_AF=0.2464;gnomad_exomes_AF=0.29208817;gnomad_exomes_AF_EAS=0.68740231;gnomad_exomes_AC=50356;gnomad_exomes_Hom=8600;gnomad_exomes_Het=33156;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.28754540;gnomad_exomes_AF_NFE=0.22674419;gnomad_exomes_AF_AMR=0.27153906;gnomad_exomes_AF_SAS=0.32892266;NativeFreq_Het=0.4663;NativeFreq_Hom=0.4060;normalHetFrequency=0.4335;normalHetNum=375;normalHomFrequency=0.3318;normalHomNum=287;patientHetFrequency=0.4333;patientHetNum=2262;patientHomFrequency=0.341;patientHomNum=1780;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7171;GREP_score=1.91;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=GCCGGGCCGG.CCAGTCACGG	GT:AD:DP:GQ:PL	1/1:1,309:310:99:10266,922,0
chr19	1207280	.	C	T	8136.77	PASS	AC=2;AF=1;AN=2;DP=214;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.67;SOR=2.634;HGVSnom=NM_000455.5:c.290+78C>T;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I1;IVSnom=NM_000455.5:IVS1+78C>T;AAlength=433;RS=rs3764641;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.163339;G1000_EAS_AF=0.4028;G1000_EUR_AF=0.0885;G1000_AFR_AF=0.0545;G1000_SAS_AF=0.1391;G1000_AMR_AF=0.1657;NativeFreq_Het=0.4518;NativeFreq_Hom=0.1325;normalHetFrequency=0.3873;normalHetNum=335;normalHomFrequency=0.0717;normalHomNum=62;patientHetFrequency=0.3805;patientHetNum=1986;patientHomFrequency=0.0998;patientHomNum=521;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.8868;GREP_score=1.07;CytoBand=p13.3;repName=CT-rich;repClass=Low_complexity;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=tccttctctc.tccctccctc	GT:AD:DP:GQ:PL	1/1:0,214:214:99:8165,644,0
chr19	1218523	.	G	T	8740.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=2.41;DP=256;ExcessHet=3.0103;FS=2.834;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.41;ReadPosRankSum=0.793;SOR=1.807;HGVSnom=NM_000455.5:c.374+24G>T;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000455.5:IVS2+24G>T;AAlength=433;EXAC_AF=0.16184662;EXAC_Hom_EAS=739;EXAC_AC_EAS=3607;EXAC_AN_EAS=8568;EXAC_AC_Adj=19352;EXAC_AN_Adj=119570;ESP6500_MAF=0.17884487;RS=rs2075604;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.269569;G1000_EAS_AF=0.4355;G1000_EUR_AF=0.0924;G1000_AFR_AF=0.4123;G1000_SAS_AF=0.1329;G1000_AMR_AF=0.2061;gnomad_exomes_AF=0.16207982;gnomad_exomes_AF_EAS=0.41847766;gnomad_exomes_AC=40165;gnomad_exomes_Hom=4617;gnomad_exomes_Het=30931;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.37611998;gnomad_exomes_AF_NFE=0.10427774;gnomad_exomes_AF_AMR=0.21506031;gnomad_exomes_AF_SAS=0.14062500;NativeFreq_Het=0.4651;NativeFreq_Hom=0.1782;normalHetFrequency=0.4266;normalHetNum=369;normalHomFrequency=0.0809;normalHomNum=70;patientHetFrequency=0.4002;patientHetNum=2089;patientHomFrequency=0.1255;patientHomNum=655;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4931;AF_2700_Hom=0.1430;AF_50_Het=0.5087;AF_50_Hom=0.1268;DANN_score=0.7294;GREP_score=-4.56;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=TGTTGGGACC.CGGGGCCTCC	GT:AD:DP:GQ:PL	1/1:2,252:254:99:8769,738,0
chr19	1219274	.	G	A	5790.77	PASS	AC=2;AF=1;AN=2;DP=164;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.94;SOR=1.402;HGVSnom=NM_000455.5:c.375-49G>A;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_000455.5:IVS2-49G>A;AAlength=433;EXAC_AF=0.46605069;EXAC_Hom_EAS=294;EXAC_AC_EAS=738;EXAC_AN_EAS=906;EXAC_AC_Adj=10996;EXAC_AN_Adj=23594;ESP6500_MAF=0.42364415;RS=rs34928889;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.530152;G1000_EAS_AF=0.8522;G1000_EUR_AF=0.4394;G1000_AFR_AF=0.4728;G1000_SAS_AF=0.4468;G1000_AMR_AF=0.4207;gnomad_exomes_AF=0.46834558;gnomad_exomes_AF_EAS=0.85477513;gnomad_exomes_AC=73682;gnomad_exomes_Hom=18358;gnomad_exomes_Het=36966;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.47405888;gnomad_exomes_AF_NFE=0.42941997;gnomad_exomes_AF_AMR=0.41125020;gnomad_exomes_AF_SAS=0.47036779;NativeFreq_Het=0.2723;NativeFreq_Hom=0.7425;normalHetFrequency=0.3225;normalHetNum=279;normalHomFrequency=0.5711;normalHomNum=494;patientHetFrequency=0.3069;patientHetNum=1602;patientHomFrequency=0.5805;patientHomNum=3030;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.6278;GREP_score=1.98;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=GTGCTCCCTG.GCCTGTGAGT	GT:AD:DP:GQ:PL	1/1:0,163:163:99:5819,489,0
chr19	1219443	.	G	GCGGGGGC	4433.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=0.091;DP=207;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=32.84;ReadPosRankSum=-0.244;SOR=0.812;HGVSnom=NM_000455.5:c.464+40_464+46dupGGGGGCC;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_000455.5:IVS3+46_+47insGGGGGCC;AAlength=433;EXAC_AF=0.20673600;EXAC_Hom_EAS=26;EXAC_AC_EAS=112;EXAC_AN_EAS=498;EXAC_AC_Adj=3419;EXAC_AN_Adj=16538;ESP6500_MAF=0.08497508;RS=rs58579265;CLNGENE=STK11;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.251797;G1000_EAS_AF=0.4623;G1000_EUR_AF=0.1581;G1000_AFR_AF=0.2163;G1000_SAS_AF=0.2198;G1000_AMR_AF=0.1945;gnomad_exomes_AF=0.25638982;gnomad_exomes_AF_EAS=0.50160196;gnomad_exomes_AC=37958;gnomad_exomes_Hom=5662;gnomad_exomes_Het=26634;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.24639525;gnomad_exomes_AF_NFE=0.20071045;gnomad_exomes_AF_AMR=0.26448919;gnomad_exomes_AF_SAS=0.28529542;NativeFreq_Het=0.0250;NativeFreq_Hom=.;normalHetFrequency=0.3318;normalHetNum=287;normalHomFrequency=0.1272;normalHomNum=110;patientHetFrequency=0.3105;patientHetNum=1621;patientHomFrequency=0.146;patientHomNum=762;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=CCAGGGTGGG.CGGGGGCCGG	GT:AD:DP:GQ:PL	1/1:1,134:135:99:4471,385,0
chr19	1220321	.	T	C	9195.77	PASS	AC=2;AF=1;AN=2;DP=261;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34;SOR=1.196;HGVSnom=NM_000455.5:c.465-51T>C;Gene=STK11;Transcript=NM_000455.5;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_000455.5:IVS3-51T>C;AAlength=433;ESP6500_MAF=0.26840998;RS=rs2075606;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.359625;G1000_EAS_AF=0.5417;G1000_EUR_AF=0.2157;G1000_AFR_AF=0.4402;G1000_SAS_AF=0.273;G1000_AMR_AF=0.2723;NativeFreq_Het=0.4988;NativeFreq_Hom=0.2871;normalHetFrequency=0.4855;normalHetNum=420;normalHomFrequency=0.1873;normalHomNum=162;patientHetFrequency=0.4623;patientHetNum=2413;patientHomFrequency=0.2109;patientHomNum=1101;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7312;GREP_score=-1.56;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=AGGGGACCCC.GTGAGGGGCA	GT:AD:DP:GQ:PL	1/1:0,260:260:99:9224,781,0
chr19	1223125	.	C	G	11524.8	PASS	AC=2;AF=1;AN=2;DP=308;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=35.71;SOR=0.955;HGVSnom=NM_000455.5:c.1062C>G(p.Phe354Leu/p.F354L);Gene=STK11;Transcript=NM_000455.5;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E8;IVSnom=.;AAlength=433;EXAC_AF=0.00575723;EXAC_Hom_EAS=4;EXAC_AC_EAS=283;EXAC_AN_EAS=7750;EXAC_AC_Adj=583;EXAC_AN_Adj=101264;ESP6500_MAF=0.00382156;RS=rs59912467;Ensembl_transcriptid=ENST00000586243|ENST00000326873;SIFT_pred=.|T;SIFT_score=.|0.244;Polyphen2_HVAR_pred=.|B;Polyphen2_HVAR_score=.|0.04;MutationTaster_pred=A;MutationTaster_score=0.00688864;CLNGENE=STK11;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0111821;G1000_EAS_AF=0.0496;G1000_EUR_AF=0.001;G1000_AFR_AF=0.0008;G1000_SAS_AF=0.0041;G1000_AMR_AF=0.0;gnomad_exomes_AF=0.00519953;gnomad_exomes_AF_EAS=0.03459260;gnomad_exomes_AC=1274;gnomad_exomes_Hom=15;gnomad_exomes_Het=1244;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.00093048;gnomad_exomes_AF_NFE=0.00371969;gnomad_exomes_AF_AMR=0.00125350;gnomad_exomes_AF_SAS=0.00240813;HGMD_gene=STK11;HGMD_disease=Peutz-Jeghers_syndrome;HGMD_tag=DM?;HGMD_pmid=15121768;NativeFreq_Het=0.0627;NativeFreq_Hom=0.0012;normalHetFrequency=0.0428;normalHetNum=37;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.051;patientHetNum=266;patientHomFrequency=0.0015;patientHomNum=8;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][15B0022382];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0033977|16B0024328|15B0062460][15B0002971|16B0005459|15B0051366|15B0047132-1|16B3108622];AF_2700_Het=0.0665;AF_2700_Hom=0.0012;AF_50_Het=0.0713;AF_50_Hom=0.0000;DANN_score=0.5635;GREP_score=-7.52;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=AGGACCTCTT.GACATCGAGG	GT:AD:DP:GQ:PL	1/1:0,306:306:99:11553,920,0
chr19	1228191	.	T	C	8238.77	PASS	AC=2;AF=1;AN=2;DP=229;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.78;SOR=0.832;HGVSnom=NM_000455.5:c.*616T>C;Gene=STK11;Transcript=NM_000455.5;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E10;IVSnom=.;AAlength=433;RS=rs10415095;CLNGENE=STK11;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.707867;G1000_EAS_AF=0.9901;G1000_EUR_AF=0.4801;G1000_AFR_AF=0.8192;G1000_SAS_AF=0.6207;G1000_AMR_AF=0.5389;NativeFreq_Het=0.0301;NativeFreq_Hom=0.9801;normalHetFrequency=0.1593;normalHetNum=76;normalHomFrequency=0.4254;normalHomNum=368;patientHetFrequency=0.1307;patientHetNum=320;patientHomFrequency=0.3843;patientHomNum=2006;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0404;AF_2700_Hom=0.9550;AF_50_Het=0.0365;AF_50_Hom=0.9572;DANN_score=0.3458;GREP_score=-0.0494;CytoBand=p13.3;CGD_CONDITION=Peutz-Jeghers syndrome;CGD_INHERITANCE=AD;Strand=STK11:NM_000455.4:+;NP=STK11:NM_000455.4:NP_000446.1;ENSP=STK11:NM_000455.4:ENST00000326873.11;Gene_MIM_id=602216;Phenotypes=Melanoma, malignant, somatic (3). Pancreatic cancer, 260350 (3), Autosomal dominant, Somatic mutation, Multifactorial. Peutz-Jeghers syndrome, 175200 (3), Autosomal dominant. Testicular tumor, somatic, 273300 (3). 175200(MK),260350(MK),273300(MK),602216(MK);Possible_Inheritance=AD;EntrezGeneID=6794;EnsemblGeneID=ENSG00000118046;Alias=STK11, PJS, LKB1;FLKSEQ=CGGGTCACCC.GCTTTGGCGG	GT:AD:DP:GQ:PL	1/1:0,229:229:99:8267,688,0
chr19	45867259	.	C	T	2911.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.949;DP=201;ExcessHet=3.0103;FS=4.978;MLEAC=1;MLEAF=0.5;MQ=59.87;MQRankSum=-1.015;QD=14.63;ReadPosRankSum=1.272;SOR=1.053;HGVSnom=NM_000400.4:c.934G>A(p.Asp312Asn/p.D312N);Gene=ERCC2;Transcript=NM_000400.4;VarType=Missense;MolecularConsequence=missense_variant;ExonIntron=E10;IVSnom=.;AAlength=760;EXAC_AF=0.37881887;EXAC_Hom_EAS=2;EXAC_AC_EAS=40;EXAC_AN_EAS=300;EXAC_AC_Adj=5927;EXAC_AN_Adj=15646;ESP6500_MAF=0.24384901;RS=rs1799793;Ensembl_transcriptid=ENST00000391945|ENST00000391944|ENST00000391941|ENST00000485403|ENST00000586131;SIFT_pred=T|T|.|T|.;SIFT_score=0.174|0.152|.|0.172|.;Polyphen2_HVAR_pred=B|B|.|.|.;Polyphen2_HVAR_score=0.051|0.059|.|.|.;MutationTaster_pred=P|P|P|P|P;MutationTaster_score=2.17209e-08|4.88517e-09|2.17209e-08|2.17209e-08|1e-37;CLNGENE=ERCC2;CLNSIG=Benign/Likely_benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.194489;G1000_EAS_AF=0.0496;G1000_EUR_AF=0.3588;G1000_AFR_AF=0.0734;G1000_SAS_AF=0.3354;G1000_AMR_AF=0.1988;gnomad_exomes_AF=0.29003393;gnomad_exomes_AF_EAS=0.04310504;gnomad_exomes_AC=41034;gnomad_exomes_Hom=6833;gnomad_exomes_Het=27368;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.10436006;gnomad_exomes_AF_NFE=0.35390327;gnomad_exomes_AF_AMR=0.19543683;gnomad_exomes_AF_SAS=0.34990456;HGMD_gene=ERCC2;HGMD_disease=Increased_response_to_UV_association_with;HGMD_tag=DFP;HGMD_pmid=11606376;NativeFreq_Het=0.1386;NativeFreq_Hom=0.0031;normalHetFrequency=0.1549;normalHetNum=134;normalHomFrequency=0.0497;normalHomNum=43;patientHetFrequency=0.1634;patientHetNum=853;patientHomFrequency=0.0513;patientHomNum=268;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0972;AF_2700_Hom=0.0042;AF_50_Het=0.0967;AF_50_Hom=0.0063;DANN_score=0.9975;GREP_score=5.15;CytoBand=q13.32;CGD_CONDITION=Trichothiodystrophy 1, photosensitive. Xeroderma pigmentosum, group D;CGD_INHERITANCE=AR;Strand=ERCC2:NM_000400.3:-,ERCC2:NM_001130867.1:-;NP=ERCC2:NM_000400.3:NP_000391.1,ERCC2:NM_001130867.1:NP_001124339.1;ENSP=ERCC2:NM_000400.3:ENST00000391945.9,ERCC2:NM_001130867.1:.;Gene_MIM_id=126340;Phenotypes=Cerebrooculofacioskeletal syndrome 2, 610756 (3). Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive. Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive. 278730(MK),601675(MK),610756(MK);Possible_Inheritance=AR;EntrezGeneID=2068;EnsemblGeneID=ENSG00000104884;Alias=ERCC2, EM9, XPD, COFS2, TTD1;FLKSEQ=AGCACTTCGT.GGGCAGCACG	GT:AD:DP:GQ:PL	0/1:102,97:199:99:2940,0,2946
chr19	45868309	.	T	G	5454.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=9.967;DP=291;ExcessHet=3.0103;FS=7.256;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.87;ReadPosRankSum=-0.1;SOR=1.061;HGVSnom=NM_000400.4:c.468A>C(p.Arg156Arg/p.R156R);Gene=ERCC2;Transcript=NM_000400.4;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E6;IVSnom=.;AAlength=760;EXAC_AF=0.58981052;EXAC_Hom_EAS=1151;EXAC_AC_EAS=4417;EXAC_AN_EAS=8548;EXAC_AC_Adj=70723;EXAC_AN_Adj=119908;ESP6500_MAF=0.66254037;RS=rs238406;CLNGENE=ERCC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.636182;G1000_EAS_AF=0.4901;G1000_EUR_AF=0.5497;G1000_AFR_AF=0.9357;G1000_SAS_AF=0.5767;G1000_AMR_AF=0.487;gnomad_exomes_AF=0.57962520;gnomad_exomes_AF_EAS=0.50944014;gnomad_exomes_AC=144875;gnomad_exomes_Hom=42942;gnomad_exomes_Het=58991;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87744129;gnomad_exomes_AF_NFE=0.55742932;gnomad_exomes_AF_AMR=0.51735566;gnomad_exomes_AF_SAS=0.59949630;HGMD_gene=ERCC2;HGMD_disease=Lung_adenocarcinoma_increased_risk_association_with;HGMD_tag=DP;HGMD_pmid=15896456;NativeFreq_Het=0.5544;NativeFreq_Hom=0.2673;normalHetFrequency=0.4647;normalHetNum=402;normalHomFrequency=0.3561;normalHomNum=308;patientHetFrequency=0.483;patientHetNum=2521;patientHomFrequency=0.3107;patientHomNum=1622;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4946;AF_2700_Hom=0.2809;AF_50_Het=0.5246;AF_50_Hom=0.2837;DANN_score=0.6844;GREP_score=0.673;CytoBand=q13.32;CGD_CONDITION=Trichothiodystrophy 1, photosensitive. Xeroderma pigmentosum, group D;CGD_INHERITANCE=AR;Strand=ERCC2:NM_000400.3:-,ERCC2:NM_001130867.1:-;NP=ERCC2:NM_000400.3:NP_000391.1,ERCC2:NM_001130867.1:NP_001124339.1;ENSP=ERCC2:NM_000400.3:ENST00000391945.9,ERCC2:NM_001130867.1:.;Gene_MIM_id=126340;Phenotypes=Cerebrooculofacioskeletal syndrome 2, 610756 (3). Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive. Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive. 278730(MK),601675(MK),610756(MK);Possible_Inheritance=AR;EntrezGeneID=2068;EnsemblGeneID=ENSG00000104884;Alias=ERCC2, EM9, XPD, COFS2, TTD1;FLKSEQ=CCTCATAGAA.CGGCAGTGGG	GT:AD:DP:GQ:PL	0/1:132,157:289:99:5483,0,3950
chr19	45872036	.	C	T	4191.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-7.975;DP=256;ExcessHet=3.0103;FS=2.127;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.57;ReadPosRankSum=-0.87;SOR=0.549;HGVSnom=NM_000400.4:c.247-35G>A;Gene=ERCC2;Transcript=NM_000400.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I4;IVSnom=NM_000400.4:IVS4-35G>A;AAlength=760;EXAC_AF=0.59573372;EXAC_Hom_EAS=849;EXAC_AC_EAS=3284;EXAC_AN_EAS=6128;EXAC_AC_Adj=55520;EXAC_AN_Adj=93196;ESP6500_MAF=0.65687029;RS=rs1799783;CLNGENE=ERCC2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.636182;G1000_EAS_AF=0.496;G1000_EUR_AF=0.5467;G1000_AFR_AF=0.9372;G1000_SAS_AF=0.5757;G1000_AMR_AF=0.4813;gnomad_exomes_AF=0.57476309;gnomad_exomes_AF_EAS=0.51203144;gnomad_exomes_AC=129793;gnomad_exomes_Hom=37864;gnomad_exomes_Het=54065;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.87466326;gnomad_exomes_AF_NFE=0.54986740;gnomad_exomes_AF_AMR=0.51554171;gnomad_exomes_AF_SAS=0.59705396;NativeFreq_Het=0.5643;NativeFreq_Hom=0.2673;normalHetFrequency=0.474;normalHetNum=410;normalHomFrequency=0.3503;normalHomNum=303;patientHetFrequency=0.4843;patientHetNum=2528;patientHomFrequency=0.313;patientHomNum=1634;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4657;GREP_score=-0.115;CytoBand=q13.32;CGD_CONDITION=Trichothiodystrophy 1, photosensitive. Xeroderma pigmentosum, group D;CGD_INHERITANCE=AR;Strand=ERCC2:NM_000400.3:-,ERCC2:NM_001130867.1:-;NP=ERCC2:NM_000400.3:NP_000391.1,ERCC2:NM_001130867.1:NP_001124339.1;ENSP=ERCC2:NM_000400.3:ENST00000391945.9,ERCC2:NM_001130867.1:.;Gene_MIM_id=126340;Phenotypes=Cerebrooculofacioskeletal syndrome 2, 610756 (3). Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive. Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive. 278730(MK),601675(MK),610756(MK);Possible_Inheritance=AR;EntrezGeneID=2068;EnsemblGeneID=ENSG00000104884;Alias=ERCC2, EM9, XPD, COFS2, TTD1;FLKSEQ=GGAGCTTGTG.TCATTGGAGG	GT:AD:DP:GQ:PL	0/1:113,140:253:99:4220,0,3700
chr20	50238545	.	A	G	11677.8	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-0.582;DP=341;ExcessHet=3.0103;FS=3.049;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.45;ReadPosRankSum=0.93;SOR=0.261;HGVSnom=NM_006045.3:c.2115+68T>C;Gene=ATP9A;Transcript=NM_006045.3;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I19;IVSnom=NM_006045.3:IVS19+68T>C;AAlength=1047;RS=rs2235862;G1000_AF=0.47504;G1000_EAS_AF=0.2262;G1000_EUR_AF=0.4761;G1000_AFR_AF=0.6551;G1000_SAS_AF=0.3988;G1000_AMR_AF=0.5994;NativeFreq_Het=0.3381;NativeFreq_Hom=0.1530;DANN_score=0.4717;GREP_score=-3.89;CytoBand=q13.2;Strand=ATP9A:NM_006045.2:-;NP=ATP9A:NM_006045.2:NP_006036.1;ENSP=ATP9A:NM_006045.2:.;FLKSEQ=GGGCCCACTC.AGGTTAGGAG	GT:AD:DP:GQ:PL	1/1:1,338:339:99:11706,979,0
chr20	52786219	.	G	A	13371.8	PASS	AC=2;AF=1;AN=2;DP=377;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=34.72;SOR=0.835;HGVSnom=NM_000782.5:c.552C>T(p.Ala184Ala/p.A184A);Gene=CYP24A1;Transcript=NM_000782.5;VarType=Synonymous;MolecularConsequence=synonymous_variant;ExonIntron=E4;IVSnom=.;AAlength=514;EXAC_AF=0.49235477;EXAC_Hom_EAS=770;EXAC_AC_EAS=3633;EXAC_AN_EAS=8626;EXAC_AC_Adj=59699;EXAC_AN_Adj=121252;ESP6500_MAF=0.52429648;RS=rs2296241;CLNGENE=CYP24A1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.458067;G1000_EAS_AF=0.4058;G1000_EUR_AF=0.5328;G1000_AFR_AF=0.4917;G1000_SAS_AF=0.4151;G1000_AMR_AF=0.4222;gnomad_exomes_AF=0.49089845;gnomad_exomes_AF_EAS=0.41867929;gnomad_exomes_AC=123351;gnomad_exomes_Hom=30995;gnomad_exomes_Het=61361;gnomad_exomes_Hemi=0;gnomad_exomes_AF_AFR=0.49655172;gnomad_exomes_AF_NFE=0.52952874;gnomad_exomes_AF_AMR=0.38869289;gnomad_exomes_AF_SAS=0.43959096;NativeFreq_Het=0.4769;NativeFreq_Hom=0.2313;DANN_score=0.6959;GREP_score=-3.54;CytoBand=q13.2;CGD_CONDITION=Hypercalcemia, infantile 1;CGD_INHERITANCE=AR;Strand=CYP24A1:NM_000782.4:-,CYP24A1:NM_001128915.1:-;NP=CYP24A1:NM_000782.4:NP_000773.2,CYP24A1:NM_001128915.1:NP_001122387.1;ENSP=CYP24A1:NM_000782.4:.,CYP24A1:NM_001128915.1:.;Gene_MIM_id=126065;Phenotypes=Hypercalcemia, infantile, 1, 143880 (3), Autosomal recessive. 143880(MK);Possible_Inheritance=AR;EntrezGeneID=1591;EnsemblGeneID=ENSG00000019186;Alias=CYP24A1, CYP24, HCINF1;FLKSEQ=CCATAAAATC.GCCAAGACCT	GT:AD:DP:GQ:PL	1/1:0,375:375:99:13400,1127,0
chr22	24129240	.	C	T	692.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.371;DP=65;ExcessHet=3.0103;FS=0.97;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.66;ReadPosRankSum=-0.789;SOR=0.569;HGVSnom=NM_003073.5:c.-117C>T;Gene=SMARCB1;Transcript=NM_003073.5;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=385;RS=rs11090285;CLNGENE=SMARCB1;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.0958466;G1000_EAS_AF=0.1419;G1000_EUR_AF=0.1173;G1000_AFR_AF=0.0038;G1000_SAS_AF=0.1391;G1000_AMR_AF=0.1124;NativeFreq_Het=0.2772;NativeFreq_Hom=0.0198;AF_2700_Het=0.2467;AF_2700_Hom=0.0354;AF_50_Het=0.2678;AF_50_Hom=0.0349;DANN_score=0.8541;GREP_score=-4.18;CytoBand=q11.23;CGD_CONDITION=Schwannomatosis. Rhabdoid tumor predisposition syndrome 1;CGD_INHERITANCE=AD;Strand=SMARCB1:NM_001007468.2:+,SMARCB1:NM_001317946.1:+,SMARCB1:NM_003073.4:+;NP=SMARCB1:NM_001007468.2:NP_001007469.1,SMARCB1:NM_001317946.1:NP_001304875.1,SMARCB1:NM_003073.4:NP_003064.2;ENSP=SMARCB1:NM_001007468.2:.,SMARCB1:NM_001317946.1:.,SMARCB1:NM_003073.4:ENST00000644036.1;Gene_MIM_id=601607;Phenotypes=Coffin-Siris syndrome 3, 614608 (3), Autosomal dominant. {Rhabdoid predisposition syndrome 1}, 609322 (3), Autosomal dominant. Rhabdoid tumors, somatic, 609322 (3). {Schwannomatosis-1, susceptibility to}, 162091 (3), Autosomal dominant. 162091(SK),609322(SK),614608(MK);Possible_Inheritance=AD;EntrezGeneID=6598;EnsemblGeneID=ENSG00000099956;Alias=SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3;FLKSEQ=CAGTACCCGG.CCGGTCCGCA	GT:AD:DP:GQ:PL	0/1:34,31:65:99:721,0,962
chr22	29091037	.	G	C	3927.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=3.568;DP=259;ExcessHet=3.0103;FS=5.594;MLEAC=1;MLEAF=0.5;MQ=59.42;MQRankSum=0.902;QD=15.22;ReadPosRankSum=0.265;SOR=1.065;HGVSnom=NM_007194.4:c.1375+78C>G;Gene=CHEK2;Transcript=NM_007194.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I12;IVSnom=NM_007194.4:IVS12+78C>G;AAlength=543;RS=rs5762749;CLNGENE=CHEK2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.614617;G1000_EAS_AF=0.622;G1000_EUR_AF=0.6233;G1000_AFR_AF=0.4864;G1000_SAS_AF=0.773;G1000_AMR_AF=0.6124;NativeFreq_Het=0.4733;NativeFreq_Hom=0.3416;normalHetFrequency=0.4485;normalHetNum=174;normalHomFrequency=0.3969;normalHomNum=154;patientHetFrequency=0.4343;patientHetNum=1204;patientHomFrequency=0.412;patientHomNum=1142;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.7125;GREP_score=-0.671;CytoBand=q12.1;dupName=chr16:33353244,chr15:20488219;dupScore=0;CGD_CONDITION=Li-Fraumeni syndrome 2;CGD_INHERITANCE=AD/AR;Strand=CHEK2:NM_001005735.1:-,CHEK2:NM_001257387.1:-,CHEK2:NM_007194.3:-,CHEK2:NM_145862.2:-;NP=CHEK2:NM_001005735.1:NP_001005735.1,CHEK2:NM_001257387.1:NP_001244316.1,CHEK2:NM_007194.3:NP_009125.1,CHEK2:NM_145862.2:NP_665861.1;ENSP=CHEK2:NM_001005735.1:.,CHEK2:NM_001257387.1:.,CHEK2:NM_007194.3:ENST00000328354.10,CHEK2:NM_145862.2:.;Gene_MIM_id=604373;Phenotypes={Breast and colorectal cancer, susceptibility to} (3). {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Li-Fraumeni syndrome, 609265 (3). Osteosarcoma, somatic, 259500 (3). {Prostate cancer, familial, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),176807(SK),259500(MK),604373(SK),609265(MK);Possible_Inheritance=AD,AR;EntrezGeneID=11200;EnsemblGeneID=ENSG00000183765;Alias=CHEK2, RAD53, CHK2, CDS1, LFS2;FLKSEQ=AAACACCATG.AATTTGGGAA	GT:AD:DP:GQ:PL	0/1:136,122:258:99:3956,0,4286
chr22	29130300	.	C	T	3271.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-3.385;DP=226;ExcessHet=3.0103;FS=9.105;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=14.48;ReadPosRankSum=0.429;SOR=1.402;HGVSnom=NM_007194.4:c.319+91G>A;Gene=CHEK2;Transcript=NM_007194.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_007194.4:IVS2+91G>A;AAlength=543;RS=rs1033667;CLNGENE=CHEK2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.273363;G1000_EAS_AF=0.2321;G1000_EUR_AF=0.2893;G1000_AFR_AF=0.3525;G1000_SAS_AF=0.1524;G1000_AMR_AF=0.33;NativeFreq_Het=0.3762;NativeFreq_Hom=0.0925;normalHetFrequency=0.3557;normalHetNum=138;normalHomFrequency=0.0515;normalHomNum=20;patientHetFrequency=0.3315;patientHetNum=919;patientHomFrequency=0.0592;patientHomNum=164;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.3398;GREP_score=0.158;CytoBand=q12.1;repName=MER51A;repClass=LTR;CGD_CONDITION=Li-Fraumeni syndrome 2;CGD_INHERITANCE=AD/AR;Strand=CHEK2:NM_001005735.1:-,CHEK2:NM_001257387.1:-,CHEK2:NM_007194.3:-,CHEK2:NM_145862.2:-;NP=CHEK2:NM_001005735.1:NP_001005735.1,CHEK2:NM_001257387.1:NP_001244316.1,CHEK2:NM_007194.3:NP_009125.1,CHEK2:NM_145862.2:NP_665861.1;ENSP=CHEK2:NM_001005735.1:.,CHEK2:NM_001257387.1:.,CHEK2:NM_007194.3:ENST00000328354.10,CHEK2:NM_145862.2:.;Gene_MIM_id=604373;Phenotypes={Breast and colorectal cancer, susceptibility to} (3). {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Li-Fraumeni syndrome, 609265 (3). Osteosarcoma, somatic, 259500 (3). {Prostate cancer, familial, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),176807(SK),259500(MK),604373(SK),609265(MK);Possible_Inheritance=AD,AR;EntrezGeneID=11200;EnsemblGeneID=ENSG00000183765;Alias=CHEK2, RAD53, CHK2, CDS1, LFS2;FLKSEQ=aaaacctgga.aactccaatc	GT:AD:DP:GQ:PL	0/1:119,107:226:99:3300,0,3661
chr22	29130813	.	G	GA	1147.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.737;DP=155;ExcessHet=3.0103;FS=2.555;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.03;ReadPosRankSum=-1.378;SOR=0.331;HGVSnom=NM_007194.4:c.-6-99dupT;Gene=CHEK2;Transcript=NM_007194.4;VarType=Intron;MolecularConsequence=5_prime_UTR_intron_variant;ExonIntron=I1;IVSnom=NM_007194.4:IVS1-99_-98insT;AAlength=543;RS=rs201340887;CLNGENE=CHEK2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.209465;G1000_EAS_AF=0.1746;G1000_EUR_AF=0.2048;G1000_AFR_AF=0.3011;G1000_SAS_AF=0.1063;G1000_AMR_AF=0.2378;NativeFreq_Het=0.1089;NativeFreq_Hom=.;normalHetFrequency=0.4588;normalHetNum=178;normalHomFrequency=0.0387;normalHomNum=15;patientHetFrequency=0.4145;patientHetNum=1149;patientHomFrequency=0.0473;patientHomNum=131;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];CytoBand=q12.1;CGD_CONDITION=Li-Fraumeni syndrome 2;CGD_INHERITANCE=AD/AR;Strand=CHEK2:NM_001005735.1:-,CHEK2:NM_001257387.1:-,CHEK2:NM_007194.3:-,CHEK2:NM_145862.2:-;NP=CHEK2:NM_001005735.1:NP_001005735.1,CHEK2:NM_001257387.1:NP_001244316.1,CHEK2:NM_007194.3:NP_009125.1,CHEK2:NM_145862.2:NP_665861.1;ENSP=CHEK2:NM_001005735.1:.,CHEK2:NM_001257387.1:.,CHEK2:NM_007194.3:ENST00000328354.10,CHEK2:NM_145862.2:.;Gene_MIM_id=604373;Phenotypes={Breast and colorectal cancer, susceptibility to} (3). {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant. Li-Fraumeni syndrome, 609265 (3). Osteosarcoma, somatic, 259500 (3). {Prostate cancer, familial, susceptibility to}, 176807 (3), Autosomal dominant. 114480(SK),176807(SK),259500(MK),604373(SK),609265(MK);Possible_Inheritance=AD,AR;EntrezGeneID=11200;EnsemblGeneID=ENSG00000183765;Alias=CHEK2, RAD53, CHK2, CDS1, LFS2;FLKSEQ=CAAAAGAAAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:69,74:143:99:1185,0,1093
chr22	29999784	.	C	A	1354.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.951;DP=113;ExcessHet=3.0103;FS=7.982;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.1;ReadPosRankSum=0.502;SOR=1.421;HGVSnom=NM_000268.4:c.-204C>A;Gene=NF2;Transcript=NM_000268.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=595;RS=rs1800539;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.351837;G1000_EAS_AF=0.2133;G1000_EUR_AF=0.3598;G1000_AFR_AF=0.2859;G1000_SAS_AF=0.4959;G1000_AMR_AF=0.464;NativeFreq_Het=0.3960;NativeFreq_Hom=0.0495;normalHetFrequency=0.1699;normalHetNum=147;normalHomFrequency=0.0705;normalHomNum=61;patientHetFrequency=0.1602;patientHetNum=836;patientHomFrequency=0.0538;patientHomNum=281;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.2675;AF_2700_Hom=0.0511;AF_50_Het=0.2615;AF_50_Hom=0.0444;DANN_score=0.7139;GREP_score=1.3;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_181825.2:+,NF2:NM_181831.2:+,NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_181825.2:NP_861546.1,NF2:NM_181831.2:NP_861969.1,NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_181825.2:.,NF2:NM_181831.2:.,NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=GCCGTCAGGG.CCGTCCCCCA	GT:AD:DP:GQ:PL	0/1:59,53:112:99:1383,0,1932
chr22	29999878	.	G	C	6519.77	PASS	AC=2;AF=1;AN=2;DP=173;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.87;SOR=0.829;HGVSnom=NM_000268.4:c.-110G>C;Gene=NF2;Transcript=NM_000268.4;VarType=UTR5;MolecularConsequence=5_prime_UTR_exon_variant;ExonIntron=E1;IVSnom=.;AAlength=595;RS=rs1800540;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=0.870208;G1000_EAS_AF=0.9444;G1000_EUR_AF=0.8976;G1000_AFR_AF=0.82;G1000_SAS_AF=0.8323;G1000_AMR_AF=0.8718;NativeFreq_Het=0.1084;NativeFreq_Hom=0.9405;normalHetFrequency=0.096;normalHetNum=83;normalHomFrequency=0.6786;normalHomNum=587;patientHetFrequency=0.0883;patientHetNum=461;patientHomFrequency=0.6828;patientHomNum=3564;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0822;AF_2700_Hom=0.7871;AF_50_Het=0.0666;AF_50_Hom=0.7892;DANN_score=0.8858;GREP_score=0.781;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_181825.2:+,NF2:NM_181831.2:+,NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_181825.2:NP_861546.1,NF2:NM_181831.2:NP_861969.1,NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_181825.2:.,NF2:NM_181831.2:.,NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=CCCGGGCCGG.CAGCCGGCCA	GT:AD:DP:GQ:PL	1/1:0,171:171:99:6548,514,0
chr22	30077361	.	G	A	10548.8	PASS	AC=2;AF=1;AN=2;DP=288;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.99;SOR=1.773;HGVSnom=NM_000268.4:c.1575-67G>A;Gene=NF2;Transcript=NM_000268.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I14;IVSnom=NM_000268.4:IVS14-67G>A;AAlength=595;RS=rs140086;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;G1000_AF=1.0;G1000_EAS_AF=1.0;G1000_EUR_AF=1.0;G1000_AFR_AF=1.0;G1000_SAS_AF=1.0;G1000_AMR_AF=1.0;NativeFreq_Het=0;NativeFreq_Hom=1.0000;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.9896;normalHomNum=856;patientHetFrequency=_;patientHetNum=_;patientHomFrequency=0.987;patientHomNum=5152;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];DANN_score=0.4436;GREP_score=0.836;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_181825.2:+,NF2:NM_181831.2:+,NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_181825.2:NP_861546.1,NF2:NM_181831.2:NP_861969.1,NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_181825.2:.,NF2:NM_181831.2:.,NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=CTTGTGGGCC.CAGAGCACCT	GT:AD:DP:GQ:PL	1/1:0,287:287:99:10577,862,0
chr22	30091145	.	T	C	6588.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=5.675;DP=398;ExcessHet=3.0103;FS=1.175;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=16.68;ReadPosRankSum=0.653;SOR=0.757;HGVSnom=NM_000268.4:c.*354T>C;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs1008515;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.280152;G1000_EAS_AF=0.4395;G1000_EUR_AF=0.2187;G1000_AFR_AF=0.2239;G1000_SAS_AF=0.2894;G1000_AMR_AF=0.232;NativeFreq_Het=0.5148;NativeFreq_Hom=0.2407;normalHetFrequency=0.2647;normalHetNum=229;normalHomFrequency=0.1017;normalHomNum=88;patientHetFrequency=0.2228;patientHetNum=1163;patientHomFrequency=0.0943;patientHomNum=492;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5042;AF_2700_Hom=0.2145;AF_50_Het=0.4960;AF_50_Hom=0.2235;DANN_score=0.3363;GREP_score=-7.74;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=TGGGAAGTCA.TGTAGGGAGT	GT:AD:DP:GQ:PL	0/1:192,203:395:99:6617,0,5955
chr22	30091999	.	C	T	2193.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-5.551;DP=203;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.91;ReadPosRankSum=-1.136;SOR=0.725;HGVSnom=NM_000268.4:c.*1208C>T;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs2530680;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.279952;G1000_EAS_AF=0.4395;G1000_EUR_AF=0.2187;G1000_AFR_AF=0.2239;G1000_SAS_AF=0.2894;G1000_AMR_AF=0.2305;NativeFreq_Het=0.4851;NativeFreq_Hom=0.2407;normalHetFrequency=0.4654;normalHetNum=222;normalHomFrequency=0.0983;normalHomNum=85;patientHetFrequency=0.2186;patientHetNum=1141;patientHomFrequency=0.0879;patientHomNum=459;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.5035;AF_2700_Hom=0.2145;AF_50_Het=0.4976;AF_50_Hom=0.2219;DANN_score=0.6501;GREP_score=-7.58;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=CAACAGAGGG.CACAGAACCA	GT:AD:DP:GQ:PL	0/1:113,88:201:99:2222,0,3489
chr22	30092055	.	CTT	C	559.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.46;DP=136;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.28;ReadPosRankSum=0.598;SOR=0.783;HGVSnom=NM_000268.4:c.*1286_*1287delTT;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs886057354;normalHetFrequency=0.0063;normalHetNum=3;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0033;patientHetNum=8;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][15B0058386|16B0019207-1|16B0028474];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1545783|15B0002868|16B0200043-1|15B0012060|16B0230627|16B0028045|16D0002790|15B0032895];patientHomSampleInfo=[_][_];AF_2700_Het=0.0161;AF_2700_Hom=.;AF_50_Het=0.0238;AF_50_Hom=.;CytoBand=q12.2;repName=AluSx3;repClass=SINE;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=CTTGCCCttt.tttttttttt	GT:AD:DP:GQ:PL	0/1:69,37:106:99:597,0,1309
chr22	30092784	.	GT	G	511.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.265;DP=213;ExcessHet=3.0103;FS=0.827;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.61;ReadPosRankSum=-1.695;SOR=0.528;HGVSnom=NM_000268.4:c.*2007delT;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs886057365;CLNGENE=NF2;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;NativeFreq_Het=0.0029;NativeFreq_Hom=.;normalHetFrequency=0.0671;normalHetNum=32;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.0772;patientHetNum=189;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.0461;AF_2700_Hom=.;AF_50_Het=0.0571;AF_50_Hom=.;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=TGCCTCCTCC.TTTTTTTTtt	GT:AD:DP:GQ:PL	0/1:146,50:196:99:549,0,2675
chr22	30092813	.	G	GT	3305.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.464;DP=157;ExcessHet=3.0103;FS=4.827;MLEAC=1;MLEAF=0.5;MQ=59.74;MQRankSum=-0.442;QD=23.12;ReadPosRankSum=0.587;SOR=2.006;OLD_VARIANT=chr22|30092813|G|GT,GTT|1;HGVSnom=NM_000268.4:c.*2032dupT;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs11442202;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.76278;G1000_EAS_AF=0.8958;G1000_EUR_AF=0.665;G1000_AFR_AF=0.9191;G1000_SAS_AF=0.6544;G1000_AMR_AF=0.5663;NativeFreq_Het=0.4913;NativeFreq_Hom=.;normalHetFrequency=0.3103;normalHetNum=148;normalHomFrequency=0.6268;normalHomNum=299;patientHetFrequency=0.2602;patientHetNum=637;patientHomFrequency=0.694;patientHomNum=1699;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.4247;AF_2700_Hom=0.5519;AF_50_Het=0.4231;AF_50_Hom=0.5594;CytoBand=q12.2;repName=AluSx;repClass=SINE;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=ttctgtttct.tttttttttt	GT:AD:DP:GQ:PL	1/0:9,112:143:99:3343,369,188
chr22	30092813	.	G	GTT	3305.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=0.464;DP=157;ExcessHet=3.0103;FS=4.827;MLEAC=1;MLEAF=0.5;MQ=59.74;MQRankSum=-0.442;QD=23.12;ReadPosRankSum=0.587;SOR=2.006;OLD_VARIANT=chr22|30092813|G|GT,GTT|2;HGVSnom=NM_000268.4:c.*2031_*2032dupTT;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs11442202;CLNGENE=NF2;CLNSIG=Uncertain_significance;CLNREVSTAT=criteria_provided,_single_submitter;normalHetFrequency=_;normalHetNum=.;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.002;patientHetNum=5;patientHomFrequency=0.0008;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16D0153148];patientHetSampleInfo=[_][15B0058013|15B0002799-1|15B0032874|15B0054044|16D1545698];patientHomSampleInfo=[_][16D0158731|15D6529863];CytoBand=q12.2;repName=AluSx;repClass=SINE;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=ttctgtttct.tttttttttt	GT:AD:DP:GQ:PL	0/1:9,22:143:99:3343,2519,2711
chr22	30093550	.	G	A	2464.77	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-4.773;DP=229;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.81;ReadPosRankSum=1.769;SOR=0.725;HGVSnom=NM_000268.4:c.*2759G>A;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs5763430;CLNGENE=NF2;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_single_submitter;G1000_AF=0.091853;G1000_EAS_AF=0.1081;G1000_EUR_AF=0.005;G1000_AFR_AF=0.1437;G1000_SAS_AF=0.1401;G1000_AMR_AF=0.0274;NativeFreq_Het=0.1782;NativeFreq_Hom=0.0099;normalHetFrequency=0.1069;normalHetNum=51;normalHomFrequency=0.0021;normalHomNum=1;patientHetFrequency=0.1156;patientHetNum=283;patientHomFrequency=0.0045;patientHomNum=11;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][16B0200516];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][15B0051751|16D0038294|15D6129451|15B6325532|16B0051119|15B6217404|15D6104520|16B0005714|16B0033626|16B0000805|16D0067105];AF_2700_Het=0.1353;AF_2700_Hom=0.0054;AF_50_Het=0.1315;AF_50_Hom=0.0032;DANN_score=0.7849;GREP_score=-0.455;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=TGGGATGACT.CATCCttttt	GT:AD:DP:GQ:PL	0/1:136,92:228:99:2493,0,4314
chr22	30093555	.	CT	C	694.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=1.372;DP=221;ExcessHet=3.0103;FS=3.489;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.76;ReadPosRankSum=-1.338;SOR=1.242;HGVSnom=NM_000268.4:c.*2780delT;Gene=NF2;Transcript=NM_000268.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E16;IVSnom=.;AAlength=595;RS=rs113760386;NativeFreq_Het=0.0809;NativeFreq_Hom=.;normalHetFrequency=0.413;normalHetNum=197;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.4375;patientHetNum=1071;patientHomFrequency=_;patientHomNum=_;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[_][_];AF_2700_Het=0.8647;AF_2700_Hom=.;AF_50_Het=0.8637;AF_50_Hom=.;CytoBand=q12.2;CGD_CONDITION=Neurofibromatosis type II. Schwannomatosis 2;CGD_INHERITANCE=AD;Strand=NF2:NM_000268.3:+,NF2:NM_016418.5:+,NF2:NM_181828.2:+,NF2:NM_181829.2:+,NF2:NM_181830.2:+,NF2:NM_181832.2:+,NF2:NM_181833.2:+;NP=NF2:NM_000268.3:NP_000259.1,NF2:NM_016418.5:NP_057502.2,NF2:NM_181828.2:NP_861966.1,NF2:NM_181829.2:NP_861967.1,NF2:NM_181830.2:NP_861968.1,NF2:NM_181832.2:NP_861970.1,NF2:NM_181833.2:NP_861971.1;ENSP=NF2:NM_000268.3:.,NF2:NM_016418.5:.,NF2:NM_181828.2:.,NF2:NM_181829.2:.,NF2:NM_181830.2:ENST00000353887.8,NF2:NM_181832.2:.,NF2:NM_181833.2:.;Gene_MIM_id=607379;Phenotypes=Meningioma, NF2-related, somatic, 607174 (3). Neurofibromatosis, type 2, 101000 (3), Autosomal dominant. Schwannomatosis, 162091 (3), Autosomal dominant. 101000(MK),162091(MK),607174(MK);Possible_Inheritance=AD;EntrezGeneID=4771;EnsemblGeneID=ENSG00000186575;Alias=NF2;FLKSEQ=TGACTGCATC.tttttttttt	GT:AD:DP:GQ:PL	0/1:113,72:185:99:732,0,1759
chr22	38915068	.	G	GT	55.25	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.674;DP=7;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.21;ReadPosRankSum=-0.21;SOR=2.303;HGVSnom=NM_007068.4:c.*956dupA;Gene=DMC1;Transcript=NM_007068.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E14;IVSnom=.;AAlength=340;RS=rs376163280;CytoBand=q13.1;Strand=DMC1:NM_001278208.1:-,DMC1:NM_007068.3:-;NP=DMC1:NM_001278208.1:NP_001265137.1,DMC1:NM_007068.3:NP_008999.2;ENSP=DMC1:NM_001278208.1:.,DMC1:NM_007068.3:.;Gene_MIM_id=602721;Phenotypes=.;Possible_Inheritance=NA;EntrezGeneID=11144;EnsemblGeneID=ENSG00000100206;Alias=DMC1, LIM15;FLKSEQ=ttttaaaaaa.tttttttttt	GT:AD:DP:GQ:PL	0/1:1,5:6:9:92,0,9
chrX	66765158	.	TGCAGCA	T	1430.73	PASS	AC=2;AF=1;AN=2;DP=79;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;QD=30.18;SOR=0.693;HGVSnom=NM_000044.6:c.234_239delGCAGCA(p.Gln79_Gln80del/p.Q79_Q80del);Gene=AR;Transcript=NM_000044.6;VarType=InframeDeletion;MolecularConsequence=disruptive_inframe_deletion;ExonIntron=E1;IVSnom=.;AAlength=920;EXAC_AF=0.00730111;EXAC_Hom_EAS=0;EXAC_AC_EAS=7;EXAC_AN_EAS=4268;EXAC_AC_Adj=348;EXAC_AN_Adj=47664;ESP6500_MAF=0.03612784;RS=rs3032358;CLNGENE=AR|LOC109504725;CLNSIG=Benign|Benign;CLNSIGINCL=nan|nan;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts|criteria_provided,_multiple_submitters,_no_conflicts;normalHetFrequency=0.0139;normalHetNum=12;normalHomFrequency=0.0173;normalHomNum=15;patientHetFrequency=0.0088;patientHetNum=46;patientHomFrequency=0.0266;patientHomNum=139;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[16B3258582|16D1545702|15D6722352-1|16D1545780|16B0017623|16B3108629|16B0033444|16D1536872-1|16B0005261|16D3102688|16B0202535|16D1545784|16D1536928|16D1545782|17B2101070|16D1546152|16D1545625|16D1545654|17B0501008|15B0066801|17B0005450|16D1545869|16B3094205|16B3108921|15D6722494-1|16D1545766|16D0177716|16B3108593|16B0005458|15D6532738][16D1878063|15D6533593|15B0051366|15B0051753|16B3108171|16D0161370|16D0169453|15B0027193|15B0062847|15D6518632|15B6215390|16B0033987|16D0166624|15B0062643|16B0011611|15B6215658];patientHomSampleInfo=[_][_];AF_2700_Het=0.0131;AF_2700_Hom=0.0173;AF_50_Het=0.0095;AF_50_Hom=0.0174;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=TTGCTGCTGC.gcagcagcag	GT:AD:DP:GQ:PL	1/1:0,37:37:99:1419,108,0
chrX	66944119	.	CA	C	2478.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=-1.102;DP=110;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=23.83;ReadPosRankSum=0.684;SOR=0.551;HGVSnom=NM_000044.6:c.*447delA;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs11351755;G1000_AF=0.68053;G1000_EAS_AF=0.9908;G1000_EUR_AF=0.8499;G1000_AFR_AF=0.0708;G1000_SAS_AF=0.9123;G1000_AMR_AF=0.8302;CytoBand=q12;repName=(CAAAAA)n;repClass=Simple_repeat;simRepName=trf;simRepCopyNum=7.7;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=aacaagcaaa.aaaaaaaaaa	GT:AD:DP:GQ:PL	1/1:6,98:104:99:2516,142,0
chrX	66945740	.	T	C	10120.8	PASS	AC=2;AF=1;AN=2;DP=268;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.07;SOR=0.897;HGVSnom=NM_000044.6:c.*2057T>C;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs5919413;G1000_AF=0.859338;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9961;G1000_AFR_AF=0.4985;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9523;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.5503;normalHomNum=476;patientHetFrequency=0.0008;patientHetNum=2;patientHomFrequency=0.4699;patientHomNum=2453;normalHetSampleInfo=[_][16D1545742];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1532963-1|16D3110162];patientHomSampleInfo=[_][_];DANN_score=0.4635;GREP_score=2.26;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=ACTTCGTTCT.CAAGCCCAAG	GT:AD:DP:GQ:PL	1/1:0,267:267:99:10149,803,0
chrX	66946851	.	T	C	4013.77	PASS	AC=2;AF=1;AN=2;DP=102;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.68;SOR=0.952;HGVSnom=NM_000044.6:c.*3168T>C;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs1931537;G1000_AF=0.859338;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9961;G1000_AFR_AF=0.4985;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9523;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.5514;normalHomNum=477;patientHetFrequency=0.0008;patientHetNum=2;patientHomFrequency=0.4682;patientHomNum=2444;normalHetSampleInfo=[_][16D1545742];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1532963-1|16D3110162];patientHomSampleInfo=[_][_];DANN_score=0.4277;GREP_score=1.6;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=GGGAGAAGGC.CCGTCTGTGC	GT:AD:DP:GQ:PL	1/1:0,102:102:99:4042,307,0
chrX	66948019	.	G	GT	6173.73	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.766;DP=251;ExcessHet=3.0103;FS=7.531;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=25.72;ReadPosRankSum=-0.08;SOR=0.149;HGVSnom=NM_000044.6:c.*4345dupT;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs5902611;G1000_AF=0.841589;G1000_EAS_AF=0.9817;G1000_EUR_AF=0.97;G1000_AFR_AF=0.4955;G1000_SAS_AF=0.9749;G1000_AMR_AF=0.9294;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=AGCTTTGTGG.TTTTTTTTTC	GT:AD:DP:GQ:PL	1/1:9,231:240:99:6211,482,0
chrX	66948416	.	A	AAT	195.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.116;DP=68;ExcessHet=3.0103;FS=2.017;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.59;ReadPosRankSum=-2.698;SOR=1.721;HGVSnom=NM_000044.6:c.*4773_*4774dupTA;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs10666509;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=TCAAAATTGA.atatatatat	GT:AD:DP:GQ:PL	0/1:20,15:35:99:233,0,414
chrX	66949722	.	C	T	6377.77	PASS	AC=2;AF=1;AN=2;BaseQRankSum=1.763;DP=175;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=34.72;ReadPosRankSum=1.564;SOR=0.314;HGVSnom=NM_000044.6:c.*6039C>T;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs7440;G1000_AF=0.858543;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9961;G1000_AFR_AF=0.4955;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9523;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.5503;normalHomNum=476;patientHetFrequency=0.0008;patientHetNum=2;patientHomFrequency=0.4686;patientHomNum=2446;normalHetSampleInfo=[_][16D1545742];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1532963-1|16D3110162];patientHomSampleInfo=[_][_];DANN_score=0.5509;GREP_score=3.52;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=CAACCTTAGC.CTTGGTGCTA	GT:AD:DP:GQ:PL	1/1:1,173:174:99:6406,513,0
chrX	66950022	.	TAAG	T	6237.73	PASS	AC=2;AF=1;AN=2;DP=160;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=25.87;SOR=1.042;HGVSnom=NM_000044.6:c.*6344_*6346delAGA;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs4022208;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=AAAAAAGAAA.AAGAGAGAGA	GT:AD:DP:GQ:PL	1/1:0,144:144:99:6275,433,0
chrX	66950105	.	C	T	6711.77	PASS	AC=2;AF=1;AN=2;DP=181;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.28;SOR=1.11;HGVSnom=NM_000044.6:c.*6422C>T;Gene=AR;Transcript=NM_000044.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=920;RS=rs2362520;G1000_AF=0.858278;G1000_EAS_AF=1.0;G1000_EUR_AF=0.9961;G1000_AFR_AF=0.4945;G1000_SAS_AF=1.0;G1000_AMR_AF=0.9523;NativeFreq_Het=0;NativeFreq_Hom=1;normalHetFrequency=0.0021;normalHetNum=1;normalHomFrequency=0.5514;normalHomNum=477;patientHetFrequency=0.0008;patientHetNum=2;patientHomFrequency=0.469;patientHomNum=2448;normalHetSampleInfo=[_][16D1545742];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][16D1532963-1|16D3110162];patientHomSampleInfo=[_][_];DANN_score=0.7786;GREP_score=3.24;CytoBand=q12;CGD_CONDITION=Androgen insensitivity. Androgen insensitivity, partial;CGD_INHERITANCE=XL;Strand=AR:NM_000044.6:+,AR:NM_000044.3:+,AR:NM_001011645.2:+;NP=AR:NM_000044.6:NP_000035.2,AR:NM_000044.3:NP_000035.2,AR:NM_001011645.2:NP_001011645.1;ENSP=AR:NM_000044.6:ENST00000374690.9,AR:NM_000044.3:.,AR:NM_001011645.2:.;Gene_MIM_id=313700;Phenotypes=Androgen insensitivity, 300068 (3), X-linked recessive. Androgen insensitivity, partial, with or without breast cancer, 312300 (3), X-linked recessive. Hypospadias 1, X-linked, 300633 (3), X-linked recessive. {Prostate cancer, susceptibility to}, 176807 (3), Autosomal dominant. Spinal and bulbar muscular atrophy of Kennedy, 313200 (3), X-linked recessive. 176807(SK),300068(MK),300633(MK),312300(MK),313200(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=367;EnsemblGeneID=ENSG00000169083;Alias=AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;FLKSEQ=AGATGGGGCT.ATTTCTCACG	GT:AD:DP:GQ:PL	1/1:0,180:180:99:6740,541,0
chrX	76763679	.	TA	T	450.73	StandardFilter	AC=1;AF=0.5;AN=2;BaseQRankSum=0.307;DP=332;ExcessHet=3.0103;FS=5.805;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.48;ReadPosRankSum=-0.598;SOR=0.715;HGVSnom=NM_000489.6:c.*149delT;Gene=ATRX;Transcript=NM_000489.6;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E35;IVSnom=.;AAlength=2492;RS=rs1289450931;NativeFreq_Het=0.0744;NativeFreq_Hom=.;normalHetFrequency=0.0636;normalHetNum=55;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.0741;patientHetNum=387;patientHomFrequency=0.0007;patientHomNum=2;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0001838-1][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16B0005436|15D6533598][_];CytoBand=q21.1;CGD_CONDITION=Alpha-thalassemia/mental retardation syndrome. Mental retardation-hypotonic facies syndrome, X-linked;CGD_INHERITANCE=XL;Strand=ATRX:NM_000489.4:-,ATRX:NM_138270.3:-;NP=ATRX:NM_000489.4:NP_000480.3,ATRX:NM_138270.3:NP_612114.2;ENSP=ATRX:NM_000489.4:ENST00000373344.10,ATRX:NM_138270.3:.;Gene_MIM_id=300032;Phenotypes=Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3). Alpha-thalassemia/mental retardation syndrome, 301040 (3), X-linked dominant. Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3), X-linked recessive. 300448(MK),301040(MK),309580(MK);Possible_Inheritance=XD,XL,XR;EntrezGeneID=546;EnsemblGeneID=ENSG00000085224;Alias=ATRX, XH2, XNP, SHS, SFM1, MRXHF1;FLKSEQ=ATGCCCTATT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:241,63:304:99:488,0,4792
chrX	132670054	.	C	CA	1781.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.847;DP=147;ExcessHet=3.0103;FS=8.404;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=14.49;ReadPosRankSum=1.308;SOR=0.208;HGVSnom=NM_004484.4:c.*97dupT;Gene=GPC3;Transcript=NM_004484.4;VarType=UTR3;MolecularConsequence=3_prime_UTR_exon_variant;ExonIntron=E8;IVSnom=.;AAlength=580;RS=rs373139333;NativeFreq_Het=0.0060;NativeFreq_Hom=.;normalHetFrequency=0.067;normalHetNum=26;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.066;patientHetNum=183;patientHomFrequency=0.0025;patientHomNum=7;normalHetSampleInfo=[_][_];normalHomSampleInfo=[16B0202527][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1545768|16D0169547|16D0166751|15B0062525-1|16D1545723|16D0155240|16D1546024][_];AF_2700_Het=0.0208;AF_2700_Hom=0.0015;AF_50_Het=0.0158;AF_50_Hom=.;CytoBand=q26.2;CGD_CONDITION=Simpson-Golabi-Behmel syndrome, type 1;CGD_INHERITANCE=XL;Strand=GPC3:NM_001164617.1:-,GPC3:NM_001164618.1:-,GPC3:NM_001164619.1:-,GPC3:NM_004484.3:-;NP=GPC3:NM_001164617.1:NP_001158089.1,GPC3:NM_001164618.1:NP_001158090.1,GPC3:NM_001164619.1:NP_001158091.1,GPC3:NM_004484.3:NP_004475.1;ENSP=GPC3:NM_001164617.1:.,GPC3:NM_001164618.1:.,GPC3:NM_001164619.1:.,GPC3:NM_004484.3:ENST00000370818.7;Gene_MIM_id=300037;Phenotypes=Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive. Wilms tumor, somatic, 194070 (3). 194070(MK),312870(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=2719;EnsemblGeneID=ENSG00000147257;Alias=GPC3, SDYS, SGBS1;FLKSEQ=TACAGGATAA.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:29,94:123:99:1819,0,277
chrX	132838305	.	GA	G	445.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-0.745;DP=212;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.42;ReadPosRankSum=0.564;SOR=0.681;HGVSnom=NM_004484.4:c.1033-4250delT;Gene=GPC3;Transcript=NM_004484.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I3;IVSnom=NM_004484.4:IVS3-4250delT;AAlength=580;EXAC_AF=0.30760052;EXAC_Hom_EAS=0;EXAC_AC_EAS=92;EXAC_AN_EAS=236;EXAC_AC_Adj=2578;EXAC_AN_Adj=8381;RS=rs372010975;CLNGENE=GPC3;CLNSIG=Conflicting_interpretations_of_pathogenicity;CLNREVSTAT=criteria_provided,_conflicting_interpretations;gnomad_exomes_AF=0.30494402;gnomad_exomes_AF_EAS=0.29889879;gnomad_exomes_AC=8117;gnomad_exomes_Hom=0;gnomad_exomes_Het=8110;gnomad_exomes_Hemi=7;gnomad_exomes_AF_AFR=0.20041929;gnomad_exomes_AF_NFE=0.32974256;gnomad_exomes_AF_AMR=0.29164074;gnomad_exomes_AF_SAS=0.31141439;normalHetFrequency=0.1701;normalHetNum=66;normalHomFrequency=_;normalHomNum=_;patientHetFrequency=0.1753;patientHetNum=486;patientHomFrequency=0.0018;patientHomNum=5;normalHetSampleInfo=[_][_];normalHomSampleInfo=[_][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[15B0058271|15B0060372|15D6529792|16B0047202|16D1545622][_];CytoBand=q26.2;CGD_CONDITION=Simpson-Golabi-Behmel syndrome, type 1;CGD_INHERITANCE=XL;Strand=GPC3:NM_001164617.1:-,GPC3:NM_001164618.1:-,GPC3:NM_001164619.1:-,GPC3:NM_004484.3:-;NP=GPC3:NM_001164617.1:NP_001158089.1,GPC3:NM_001164618.1:NP_001158090.1,GPC3:NM_001164619.1:NP_001158091.1,GPC3:NM_004484.3:NP_004475.1;ENSP=GPC3:NM_001164617.1:.,GPC3:NM_001164618.1:.,GPC3:NM_001164619.1:.,GPC3:NM_004484.3:ENST00000370818.7;Gene_MIM_id=300037;Phenotypes=Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive. Wilms tumor, somatic, 194070 (3). 194070(MK),312870(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=2719;EnsemblGeneID=ENSG00000147257;Alias=GPC3, SDYS, SGBS1;FLKSEQ=CAGTTTCCTT.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:137,47:184:99:483,0,2800
chrX	132888207	.	TA	T	533.73	PASS	AC=1;AF=0.5;AN=2;BaseQRankSum=-2.156;DP=151;ExcessHet=3.0103;FS=3.019;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.24;ReadPosRankSum=0.669;SOR=0.312;HGVSnom=NM_004484.4:c.338-5delT;Gene=GPC3;Transcript=NM_004484.4;VarType=Intron;MolecularConsequence=coding_transcript_intron_variant;ExonIntron=I2;IVSnom=NM_004484.4:IVS2-5delT;AAlength=580;EXAC_AF=0.32925489;EXAC_Hom_EAS=0;EXAC_AC_EAS=1779;EXAC_AN_EAS=5195;EXAC_AC_Adj=23062;EXAC_AN_Adj=70043;RS=rs370737647;CLNGENE=GPC3;CLNSIG=Benign;CLNREVSTAT=criteria_provided,_multiple_submitters,_no_conflicts;gnomad_exomes_AF=0.38612558;gnomad_exomes_AF_EAS=0.37334656;gnomad_exomes_AC=27869;gnomad_exomes_Hom=4;gnomad_exomes_Het=27807;gnomad_exomes_Hemi=54;gnomad_exomes_AF_AFR=0.36324609;gnomad_exomes_AF_NFE=0.38961325;gnomad_exomes_AF_AMR=0.41833882;gnomad_exomes_AF_SAS=0.35744501;NativeFreq_Het=0.0723;NativeFreq_Hom=.;normalHetFrequency=0.6031;normalHetNum=234;normalHomFrequency=0.0026;normalHomNum=1;patientHetFrequency=0.5804;patientHetNum=1609;patientHomFrequency=0.0076;patientHomNum=21;normalHetSampleInfo=[_][_];normalHomSampleInfo=[15B0063116][_];patientHetSampleInfo=[_][_];patientHomSampleInfo=[16D1536868-1|16B0001873-1|15D6722466-1|16B0035655-1|16B3254722|15D6532790|16D0153152|16D1532962-1|16D1546020|16D1536899|16B0047166|15D6482491|16D0172116|15D6722373|15B6325510-1|16B0047176|15B0051538|16B3108414|16D0172328-1|15D6722307|16B0047066][_];AF_2700_Het=0.5984;AF_2700_Hom=0.0019;AF_50_Het=0.5832;AF_50_Hom=0.0016;CytoBand=q26.2;CGD_CONDITION=Simpson-Golabi-Behmel syndrome, type 1;CGD_INHERITANCE=XL;Strand=GPC3:NM_001164617.1:-,GPC3:NM_001164618.1:-,GPC3:NM_001164619.1:-,GPC3:NM_004484.3:-;NP=GPC3:NM_001164617.1:NP_001158089.1,GPC3:NM_001164618.1:NP_001158090.1,GPC3:NM_001164619.1:NP_001158091.1,GPC3:NM_004484.3:NP_004475.1;ENSP=GPC3:NM_001164617.1:.,GPC3:NM_001164618.1:.,GPC3:NM_001164619.1:.,GPC3:NM_004484.3:ENST00000370818.7;Gene_MIM_id=300037;Phenotypes=Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive. Wilms tumor, somatic, 194070 (3). 194070(MK),312870(MK);Possible_Inheritance=AD,XL,XR;EntrezGeneID=2719;EnsemblGeneID=ENSG00000147257;Alias=GPC3, SDYS, SGBS1;FLKSEQ=AAGGCCTCTG.AAAAAAAAAA	GT:AD:DP:GQ:PL	0/1:78,48:126:99:571,0,1084
